FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Teasdale, A
   Limbers, C
AF Teasdale, Ashley
   Limbers, Christine
TI Avoidant coping moderates the relationship between paternal involvement
   in the child's type 1 diabetes (T1D) care and parenting stress
SO JOURNAL OF CHILD HEALTH CARE
LA English
DT Article
DE Chronic illness; diabetes; father; parenting; psychology
ID YOUNG-CHILDREN; MOTHERS; FATHERS; STRATEGIES; INTERVENTIONS;
   ADOLESCENTS; INVENTORY; DISTRESS; SUPPORT
AB Fathers may experience greater parenting stress and anxiety when they are more involved in their child's type 1 diabetes (T1D) care. The present study evaluated whether seeking social support and avoidant coping strategies moderate the relationship between paternal involvement in the child's T1D care and parenting stress in an international sample. Two hundred forty-nine fathers of young children with T1D completed the Parenting Stress Index (PSI), Pediatric Inventory for Parents (PIP), Dads' Active Disease Support scale (DADS), COPE Inventory, Self-Care Inventory (SCI-R), and a demographic questionnaire online. Pearson's product moment correlations were computed, and multiple linear regression analysis was conducted with three separate models in which the PSI Child Domain, PIP Frequency, and PIP Difficulty scores represented different parenting stress outcomes. The interaction between use of denial coping and DADS Involvement was significantly correlated with general parenting stress (p < .05). There were no significant interactions between instrumental social support and DADS Involvement; however, use of instrumental social support coping was significantly correlated with difficulty of pediatric parenting stress (p < .05), DADS Involvement (p < .001), and SCI-R better adherence to the child diabetes treatment regimen (p < .001). Avoidant coping strategies are associated with more general parenting stress, especially when fathers are more involved in T1D management.
C1 [Teasdale, Ashley; Limbers, Christine] Baylor Univ, Dept Psychol & Neurosci, One Bear Pl 97334, Waco, TX 76798 USA.
RP Teasdale, A (reprint author), Baylor Univ, Dept Psychol & Neurosci, One Bear Pl 97334, Waco, TX 76798 USA.
EM ashley_teasdale@baylor.edu
FU College of Arts and Sciences at Baylor University
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by internal funding from the College of Arts and Sciences
   at Baylor University.
CR Abidin R. R., 2012, PARENTING STRESS IND
   Azar R, 2001, J Pediatr Nurs, V16, P418, DOI 10.1053/jpdn.2001.27878
   Beran D, 2013, DIABETES CARE, V36, pE144, DOI 10.2337/dc13-0744
   Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057
   Blankfeld DF, 1996, J FAM PSYCHOL, V10, P173
   Breevaart K, 2011, ANXIETY STRESS COPIN, V24, P239, DOI 10.1080/10615806.2010.527958
   CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267
   Casler K, 2013, COMPUT HUM BEHAV, V29, P2156, DOI 10.1016/j.chb.2013.05.009
   Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623
   Dardas LA, 2015, STRESS HEALTH, V31, P5, DOI 10.1002/smi.2513
   Dashiff C J, 1993, J Pediatr Nurs, V8, P361
   Davis CL, 2001, J PEDIATR PSYCHOL, V26, P123, DOI 10.1093/jpepsy/26.2.123
   FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037//0022-3514.54.3.466
   Grover Sandeep, 2016, Perspect Clin Res, V7, P32, DOI 10.4103/2229-3485.173776
   Hansen JA, 2012, FAM SYST HEALTH, V30, P47, DOI 10.1037/a0027519
   Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006
   Hessler D, 2016, J PEDIATR PSYCHOL, V41, P750, DOI 10.1093/jpepsy/jsw002
   Jaser SS, 2014, MATERN CHILD HLTH J, V18, P101, DOI 10.1007/s10995-013-1239-4
   Kalra Sanjay, 2013, J Midlife Health, V4, P176, DOI 10.4103/0976-7800.118998
   Konradsdottir E, 2011, J SPEC PEDIATR NURS, V16, P295, DOI 10.1111/j.1744-6155.2011.00297.x
   Law EF, 2014, J PEDIATR PSYCHOL, V39, P866, DOI 10.1093/jpepsy/jsu032
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Lewin A. B., 2005, FAMILIES SYSTEMS HLT, V23, P56, DOI DOI 10.1037/1091-7527.23.1.56
   Lohan A, 2015, CHILD CARE HLTH DEV, V41, P803, DOI 10.1111/cch.12278
   Lyne K, 2000, PERS INDIV DIFFER, V29, P321, DOI 10.1016/S0191-8869(99)00196-8
   Mitchell SJ, 2009, FAM SYST HEALTH, V27, P314, DOI 10.1037/a0018191
   Nieuwesteeg A, 2017, DIABETIC MED, V34, P821, DOI 10.1111/dme.13300
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   Palermo Tonya M, 2014, Clin Pract Pediatr Psychol, V2, P212
   Pottie CG, 2008, J FAM PSYCHOL, V22, P855, DOI 10.1037/a0013604
   Ryan JL, 2011, CHILD HEALTH CARE, V40, P297, DOI 10.1080/02739615.2011.617237
   Sahler OJZ, 2005, J CONSULT CLIN PSYCH, V73, P272, DOI 10.1037/0022-006X.73.2.272
   Schleider JL, 2015, J CHILD FAM STUD, V24, P3235, DOI 10.1007/s10826-015-0126-6
   Seppanen S M, 1999, Nurs Health Sci, V1, P63, DOI 10.1046/j.1442-2018.1999.00009.x
   Sparud-Lundin C, 2013, J FAM NURS, V19, P249, DOI 10.1177/1074840713484386
   Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155
   Thorsteinsson EB, 2017, PEER J PREPRINTS
   WALLANDER JL, 1989, J PEDIATR PSYCHOL, V14, P371, DOI 10.1093/jpepsy/14.3.371
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Wysocki T, 2004, J PEDIATR PSYCHOL, V29, P231, DOI 10.1093/jpepsy/jsh024
NR 40
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1367-4935
EI 1741-2889
J9 J CHILD HEALTH CARE
JI J. Child Health Care
PD DEC
PY 2018
VL 22
IS 4
BP 606
EP 618
DI 10.1177/1367493518767068
PG 13
WC Nursing; Pediatrics
SC Nursing; Pediatrics
GA HE5TT
UT WOS:000453452600008
PM 29606015
OA Bronze
DA 2019-01-08
ER

PT J
AU Vigen, CLP
   Carandang, K
   Blanchard, J
   Sequeira, PA
   Wood, JR
   Spruijt-Metz, D
   Whittemore, R
   Peters, AL
   Pyatak, EA
AF Vigen, Cheryl L. P.
   Carandang, Kristine
   Blanchard, Jeanine
   Sequeira, Paola A.
   Wood, Jamie R.
   Spruijt-Metz, Donna
   Whittemore, Robin
   Peters, Anne L.
   Pyatak, Elizabeth A.
TI Psychosocial and Behavioral Correlates of A1C and Quality of Life Among
   Young Adults With Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID SELF-MANAGEMENT; GLYCEMIC CONTROL; DEPRESSIVE SYMPTOMS; CHILDHOOD
   ADVERSITY; BLOOD-GLUCOSE; MENTAL-HEALTH; PARTICIPATION; IMPACT; CARE;
   ASSOCIATION
AB Purpose The purpose of this study was to evaluate relationships between behavioral and psychosocial constructs, A1C, and diabetes-dependent quality of life (DQoL) among low-socioeconomic status, ethnically diverse young adults with diabetes. Methods Using baseline data of 81 participants in the Resilient, Empowered, Active Living (REAL) randomized controlled trial, behavioral, cognitive, affective, and experiential variables were correlated with A1C and DQoL while adjusting for demographic characteristics, and these relationships were examined for potential effect modification. Results The data indicate that depressive symptoms and satisfaction with daily activities are associated with both A1C and DQoL, while diabetes knowledge and participation in daily activities are associated with neither A1C nor DQoL. Two constructs, diabetes distress and life satisfaction, were associated with DQoL and were unrelated to A1C, while 2 constructs, self-monitoring of blood glucose and medication adherence, were associated with A1C but unrelated to DQoL. These relationships were largely unchanged by adjusting for demographic characteristics, while numerous effect modifications were found. Conclusion The data suggest that when tailoring interventions, depressive symptoms and satisfaction with daily activities may be particularly fruitful intervention targets, as they represent modifiable risk factors that are associated with both A1C and DQoL.
C1 [Vigen, Cheryl L. P.; Carandang, Kristine; Blanchard, Jeanine; Pyatak, Elizabeth A.] Univ Southern Calif, Div Occupat Sci & Occupat Therapy, 1540 Alcazar St,CHP-133, Los Angeles, CA 90089 USA.
   [Sequeira, Paola A.] Univ Southern Calif, Dept Pediat, Los Angeles, CA 90089 USA.
   [Wood, Jamie R.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA.
   [Spruijt-Metz, Donna] Univ Southern Calif, Dornsife Ctr Econ & Social Res, Los Angeles, CA USA.
   [Whittemore, Robin] Yale Sch Nursing, New Haven, CT USA.
   [Peters, Anne L.] Univ Southern Calif, Div Endocrinol, Beverly Hills, CA USA.
RP Vigen, CLP (reprint author), Univ Southern Calif, Div Occupat Sci & Occupat Therapy, 1540 Alcazar St,CHP-133, Los Angeles, CA 90089 USA.
EM vigen@usc.edu
OI Pyatak, Elizabeth/0000-0003-3280-8912
FU National Institute of Diabetes and Digestive and Kidney Diseases at the
   National Institutes of Health (NIH/NIDDK) [1K01 DK099202-01A1]
FX This work was supported by the National Institute of Diabetes and
   Digestive and Kidney Diseases at the National Institutes of Health
   (NIH/NIDDK 1K01 DK099202-01A1). The content is solely the responsibility
   of the authors and does not represent the official view of the National
   Institutes of Health. The study is registered at ClinicalTrials.gov
   (identifier number NCT02214641).
CR American Diabetes Association, 2016, DIABETES, V39, pS13, DOI DOI 10.2337/DC16-S005
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   [Anonymous], 2000, Diabetes Care, V23, P1619
   Arora S, 2012, DIABETES TECHNOL THE, V14, P492, DOI 10.1089/dia.2011.0252
   Arora S, 2011, ETHNIC DIS, V21, P1
   Bains SS, 2011, DIABETES TECHNOL THE, V13, P335, DOI 10.1089/dia.2010.0160
   Benka J, 2016, DISABIL REHABIL, V38, P1172, DOI 10.3109/09638288.2015.1076071
   Berg C, 2013, OTJR-OCCUP PART HEAL, V33, P21, DOI 10.3928/15394492-20120607-01
   Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004
   Browne JL, 2015, DIABETIC MED, V32, P133, DOI 10.1111/dme.12566
   Dabelea D, 2017, JAMA-J AM MED ASSOC, V317, P825, DOI 10.1001/jama.2017.0686
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Elhai JD, 2013, J TRAUMA STRESS, V26, P10, DOI 10.1002/jts.21755
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Glasgow RE, 2007, DIABETES CARE, V30, P33, DOI 10.2337/dc06-1390
   Hamman RF, 2014, DIABETES CARE, V37, P3336, DOI 10.2337/dc14-0574
   Hill-Briggs F, 2011, J GEN INTERN MED, V26, P972, DOI 10.1007/s11606-011-1689-6
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Hood KK, 2009, PEDIATRICS, V124, pE1171, DOI 10.1542/peds.2009-0207
   Johnson B, 2014, DIABETIC MED, V31, P227, DOI 10.1111/dme.12305
   King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Lane JT, 2007, DIABETES RES CLIN PR, V78, P385, DOI 10.1016/j.diabres.2007.04.014
   Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Miller KM, 2013, DIABETES CARE, V36, P2009, DOI 10.2337/dc12-1770
   Nagrebetsky A, 2012, DIABETES RES CLIN PR, V96, P119, DOI 10.1016/j.diabres.2011.12.003
   Polonsky WH, 2011, DIABETES CARE, V34, P262, DOI 10.2337/dc10-1732
   Pyatak EA, 2014, DIABETIC MED, V31, P1615, DOI 10.1111/dme.12485
   Pyatak EA, 2013, DIABETIC MED, V30, P1140, DOI 10.1111/dme.12248
   Pyatak E, 2011, AM J OCCUP THER, V65, P462, DOI 10.5014/ajot.2011.001453
   Pyatak EA, 2017, CONTEMP CLIN TRIALS, V54, P8, DOI 10.1016/j.cct.2016.12.025
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   Schilling EA, 2008, SOC SCI MED, V66, P1140, DOI 10.1016/j.socscimed.2007.11.023
   Sequeira PA, 2015, DIABETES CARE, V38, P1412, DOI 10.2337/dc14-2577
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Turner HA, 2003, J YOUTH ADOLESCENCE, V32, P89, DOI 10.1023/A:1021853600645
   van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089
   Walders-Abramson N, 2014, J PEDIAT, V165
   Wood Jamie R, 2012, J Diabetes Sci Technol, V6, P380
NR 48
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD DEC
PY 2018
VL 44
IS 6
BP 489
EP 500
DI 10.1177/0145721718804170
PG 12
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA HD7KN
UT WOS:000452731000001
PM 30295170
DA 2019-01-08
ER

PT J
AU Jeong, M
   Reifsnider, E
AF Jeong, Mihyun
   Reifsnider, Elizabeth
TI Associations of Diabetes-Related Distress and Depressive Symptoms With
   Glycemic Control in Korean Americans With Type 2 Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID EMOTIONAL DISTRESS; GLUCOSE CONTROL; CUT POINTS; ADULTS; CARE;
   PREDICTORS; OUTCOMES; HEALTH; PREVALENCE; IMMIGRANTS
AB Purpose The purpose of this study was to investigate the associations of diabetes-related distress and depressive symptoms with glycemic control in Korean Americans (KAs) with type 2 diabetes mellitus (T2DM). Methods The cross-sectional, correlational descriptive study explored glycemic control in KA. A total of 119 KA adults with T2DM were recruited from Korean communities in Arizona between July and November 2016. Data were collected by a finger-stick glucose test for A1C, the Diabetes Distress Scale for diabetes-related distress, the Center for Epidemiological Studies Depression for depressive symptoms, and sociodemographics. Height and weight were measured to calculate body mass index. Descriptive statistics, bivariate correlation, and multiple linear regression analyses were performed. Results The total score for diabetes-related distress was positively associated with A1C in both unadjusted and adjusted models, while depressive symptoms were not associated with glycemic control regardless of analysis methods. In the further analysis of the 4 subscales of diabetes-related distress, only regimen-related distress was a significant predictor of poor glycemic control after adjusting for covariates. Emotional burden was not associated with glycemic control, even though there was a weak but significant correlation between emotional burden and glycemic control. Conclusions Diabetes-related distress and depressive symptoms should be recognized as different psychological aspects in T2DM, and individual-centered approaches should be used for diabetes self-management education and support. In addition, diabetes-focused psychological interventions and culturally tailored diabetes self-management programs should be included in comprehensive education and support for KAs with T2D to achieve good glycemic control.
C1 [Jeong, Mihyun] Gyeongju Univ, Dept Nursing, 188 Taejong Ro, Gyeongju 38065, Gyeongsangbuk D, South Korea.
   [Reifsnider, Elizabeth] Arizona State Univ, Coll Nursing & Hlth Innovat, Phoenix, AZ USA.
RP Jeong, M (reprint author), Gyeongju Univ, Dept Nursing, 188 Taejong Ro, Gyeongju 38065, Gyeongsangbuk D, South Korea.
EM mihyeon@naver.com
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006
   American Diabetes Association, 2017, Diabetes Care, V40, pS33
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arrendale Justin R, 2008, J Diabetes Sci Technol, V2, P822
   Asuzu CC, 2017, J DIABETES COMPLICAT, V31, P169, DOI 10.1016/j.jdiacomp.2016.09.013
   Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36
   Burns RJ, 2015, DIABETIC MED, V32, P1272, DOI 10.1111/dme.12860
   Campbell JA, 2012, ENDOCRINE, V42, P471, DOI 10.1007/s12020-012-9744-6
   Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20
   Choi E, 2007, THESIS
   Choi S, 2009, WESTERN J NURS RES, V31, P347, DOI 10.1177/0193945908328472
   Choi SE, 2013, NURS RES, V62, P115, DOI 10.1097/NNR.0b013e31827aec29
   Chung J, 2018, INT J OLDER PEOPLE N, V13, DOI 10.1111/opn.12179
   Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Hagger V, 2017, DIABETES CARE, V40, P1462, DOI 10.2337/dc17-0441
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Karter AJ, 2013, DIABETES CARE, V36, P574, DOI 10.2337/dc12-0722
   Kendzor DE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-176
   Kim MT, 2015, AM J GERIAT PSYCHIAT, V23, P671, DOI 10.1016/j.jagp.2014.11.003
   Kim Miyong To, 2017, BMJ Open Diabetes Res Care, V5, pe000337, DOI 10.1136/bmjdrc-2016-000337
   Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17
   Lin KK, 2017, DIABETES RES CLIN PR, V131, P179, DOI 10.1016/j.diabres.2017.03.013
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Meng RW, 2018, J AFFECT DISORDERS, V234, P59, DOI 10.1016/j.jad.2018.02.052
   Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273
   Noh S, 1998, CROSS CULTURAL RES J, V32, P358, DOI DOI 10.1177/106939719803200403
   Oh KM, 2014, HEALTH EDUC BEHAV, V41, P173, DOI 10.1177/1090198113496789
   Ozcan B, 2018, DIABETES CARE, V41, P1854, DOI 10.2337/dc17-2181
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   PARIKH RM, 1988, INT J PSYCHIAT MED, V18, P169, DOI 10.2190/BH75-EUYA-4FM1-J7QA
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Sidhu R, 2017, CAN J DIABETES, V41, P69, DOI 10.1016/j.jcjd.2016.07.008
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125
   Winchester RJ, 2016, J DIABETES COMPLICAT, V30, P312, DOI 10.1016/j.jdiacomp.2015.11.010
   Wong EM, 2017, CAN J DIABETES, V41, P362, DOI 10.1016/j.jcjd.2016.11.006
   Zurita-Cruz JN, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0906-y
NR 48
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD DEC
PY 2018
VL 44
IS 6
BP 531
EP 540
DI 10.1177/0145721718807443
PG 10
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA HD7KN
UT WOS:000452731000005
PM 30319059
DA 2019-01-08
ER

PT J
AU Kontopantelis, E
   Buchan, I
   Webb, RT
   Ashcroft, DM
   Mamas, MA
   Doran, T
AF Kontopantelis, Evangelos
   Buchan, Iain
   Webb, Roger T.
   Ashcroft, Darren M.
   Mamas, Mamas A.
   Doran, Tim
TI Disparities in mortality among 25-44-year-olds in England: a
   longitudinal, population-based study
SO LANCET PUBLIC HEALTH
LA English
DT Article
ID ALCOHOL-RELATED MORTALITY; TRAFFIC ACCIDENTS; LIFE EXPECTANCY;
   GREAT-BRITAIN; SOCIAL-CLASS; HEALTH; INEQUALITIES; DEPRIVATION; SUICIDE;
   TRENDS
AB Background Since the mid-1990s, excess mortality has increased markedly for adults aged 25-44 years in the north compared with the south of England. We examined the underlying causes of this excess mortality and the contribution of socioeconomic deprivation.
   Methods Mortality data from the Office of National Statistics for adults aged 25-44 years were aggregated and compared between England's five most northern versus five most southern government office regions between Jan 1,1981, and Dec 31,2016. Poisson regression models, adjusted for age and sex, were used to quantify excess mortality in the north compared with the south by underlying cause of death (accidents, alcohol related, cardiovascular disease and diabetes, drug related, suicide, cancer, and other causes). The role of socioeconomic deprivation, as measured by the 2015 Index of Multiple Deprivation, in explaining the excess and regional variability was also explored.
   Findings A mortality divide between the north and south appeared in the mid-1990s and rapidly expanded thereafter for deaths attributed to accidents, alcohol misuse, and drug misuse. In the 2014-16 period, the northern excess was incidence rate ratio (IRR) 1.47 (95% CI 1.39-1.54) for cardiovascular reasons, 2.09 (1.94-2.25) for alcohol misuse, and 1.60 (1.51-1.70) for drug misuse, across both men and women aged 25-44 years. National mortality rates for cardiovascular deaths declined over the study period but a longstanding gap between north and south persisted (from 33.3 [95% CI 31.8-34.8] in 1981 to 15.0 [14.0-15.9] in 2016 in the north vs from 23.5 [22.3-24.8] to 9.9 [9.2-10.5] in the south). Between 2014 and 2016, estimated excess numbers of death in the north versus the south for those aged 25-44 years were 1881 (95% CI 726-2627) for women and 3530 (2216-4511) for men. Socioeconomic deprivation explained up to two-thirds of the excess mortality in the north (IRR for northern effect reduced from 1.15 [95% CI 1.14-1.15; unadjusted] to 1.05 [1.04-1.05; adjusted for Index of Multiple Deprivation]). By 2016, in addition to the persistent north-south gap, mortality rates in London were lower than in all other regions, with IRRs ranging from IRR 1.13 (95% CI 1.12-1.15) for the East England to 1.22 (1.20-1.24) for the North East, even after adjusting for deprivation.
   Interpretation Sharp relative rises in deaths from cardiovascular reasons, alcohol misuse and drug misuse in the north compared with the south seem to have created new health divisions between England's regions. This gap might be due to exacerbation of existing social and health inequalities that have been experienced for many years. These divisions might suggest increasing psychological distress, despair, and risk taking among young and middle-aged adults, particularly outside of London. Copyright (C) 2018 The Author(s). Published by Elsevier Ltd.
C1 [Kontopantelis, Evangelos; Buchan, Iain] Univ Manchester, Fac Biol Med & Hlth, Div Informat Imaging & Data Sci, Manchester, Lancs, England.
   [Webb, Roger T.] Univ Manchester, Fac Biol Med & Hlth, Div Psychol & Mental Hlth, Manchester, Lancs, England.
   [Ashcroft, Darren M.] Univ Manchester, Fac Biol Med & Hlth, Div Pharm & Optometry, Manchester, Lancs, England.
   [Buchan, Iain] Univ Liverpool, Fac Hlth & Life Sci, Dept Publ Hlth & Policy, Publ Hlth & Clin Informat, Liverpool, Merseyside, England.
   [Kontopantelis, Evangelos] Univ Manchester, Natl Inst Hlth Res, Sch Primary Care Res, Manchester, Lancs, England.
   [Webb, Roger T.; Ashcroft, Darren M.] Univ Manchester, NIHR Greater Manchester Patient Safety Translat R, Manchester, Lancs, England.
   [Webb, Roger T.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.
   [Mamas, Mamas A.] Keele Univ, Ctr Prognosis Res, Inst Primary Care & Hlth Sci, Keele Cardiovasc Res Grp, Keele, Staffs, England.
   [Doran, Tim] Univ York, Dept Hlth Sci, Seebohm Rowntree Bldg, York, N Yorkshire, England.
RP Kontopantelis, E (reprint author), Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PL, Lancs, England.
EM e.kontopantelis@manchester.ac.uk
OI Kontopantelis, Evangelos/0000-0001-6450-5815; Ashcroft,
   Darren/0000-0002-2958-915X
FU Medical Research Council; Wellcome Trust
FX Medical Research Council and Wellcome Trust.
CR Asaria P, 2012, INT J EPIDEMIOL, V41, P1737, DOI 10.1093/ije/dys151
   Barbieri M, 2013, POPULATION, V68, P433, DOI 10.3917/popu.1303.0433
   Barr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5142
   Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594
   Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244
   Buchan IE, 2017, J EPIDEMIOL COMMUN H, V71, P928, DOI 10.1136/jech-2017-209195
   Cancer Research UK, 2018, DEPR GRAD CANC MORT
   Cancer Research UK, DEPR GRAD CANC MORT
   Case A, 2017, BROOKINGS PAP ECO AC, P397
   Chang MH, 2013, MMWR-MORBID MORTAL W, V62, P561
   Clarke DD, 2010, BEH RES ROAD SAF 200, P81
   Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696
   Communities and Local Government, 2015, ENGL IND DEPR 2015 T
   Connolly S, 2007, SOC SCI MED, V64, P2008, DOI 10.1016/j.socscimed.2007.02.021
   Cox E, 2011, WRONG TRACK ANAL AUT
   Davies AR, 2007, EUR HEART J, V28, P2142, DOI [10.1093/eurheartj/ehm272, 10.1093/eurheartj/ehm323]
   Doran T, 2004, BRIT MED J, V328, P1043, DOI 10.1136/bmj.328.7447.1043
   Erskine S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-99
   Gutierrez-Fisac JL, 2000, J EPIDEMIOL COMMUN H, V54, P451, DOI 10.1136/jech.54.6.451
   Hacking JM, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d508
   Harrison L, 1999, ADDICTION, V94, P1871, DOI 10.1046/j.1360-0443.1999.9412187112.x
   Health and Safety Executive, 2015, STAND IND FAT INJ RA, P11
   Holborn PG, 2003, FIRE SAFETY J, V38, P1, DOI 10.1016/S0379-7112(02)00049-8
   Jones AP, 2008, HEALTH PLACE, V14, P519, DOI 10.1016/j.healthplace.2007.10.001
   Kontopantelis E, 2018, J EPIDEMIOL COMMUN H, V72, P140, DOI 10.1136/jech-2017-209999
   Law E., 2018, DOES ITALYS N S DIVI
   Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5
   Lewis G, 1998, BMJ-BRIT MED J, V317, P1283, DOI 10.1136/bmj.317.7168.1283
   Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008
   Mackenbach JP, 2011, J EPIDEMIOL COMMUN H, V65, P568, DOI 10.1136/jech.2010.128280
   Makela P, 1999, ADDICTION, V94, P867, DOI 10.1046/j.1360-0443.1999.94686710.x
   Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014
   Mensah GA, 2017, CIRC RES, V120, P366, DOI 10.1161/CIRCRESAHA.116.309115
   National Health Service, 2000, MOD STAND SERV MOD C
   Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6
   Office for National Statistics, METH US GUID MORT ST
   Organization for Economic Co-operation Development [OECD], 2018, OECD EMPL OUTL 2018
   Parkinson J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5267-2
   Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8
   Road Safety Foundation, 2017, CUTT COST DANG ROADS
   Scantlebury R, 2015, BRIT J GEN PRACT, V65, pE649, DOI 10.3399/bjgp15X686893
   Skog OJ, 2001, ADDICTION, V96, pS49
   Social Mobility Commission, 2017, STAT NAT 2017 SOC MO
   Wardle J, 2003, PREV MED, V36, P721, DOI 10.1016/S0091-7435(03)00047-1
   Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561
   Whitehead M, 2014, DUE N REPORT INQUIRY
NR 46
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2468-2667
J9 LANCET PUBLIC HEALTH
JI Lancet Public Health
PD DEC
PY 2018
VL 3
IS 12
BP E567
EP E575
DI 10.1016/S2468-2667(18)30177-4
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HC8CP
UT WOS:000452029600010
PM 30389570
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Kane, NS
   Hoogendoorn, CJ
   Tanenbaum, ML
   Gonzalez, JS
AF Kane, N. S.
   Hoogendoorn, C. J.
   Tanenbaum, M. L.
   Gonzalez, J. S.
TI Physical symptom complaints, cognitive emotion regulation strategies,
   self-compassion and diabetes distress among adults with Type 2 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID TREATMENT ADHERENCE; GLYCEMIC CONTROL; DEPRESSION; ASSOCIATION;
   PREVALENCE; TRIAL; LIFE
AB Aims Diabetes-related distress is common among adults with Type 2 diabetes and is consistently associated with poorer self-management and treatment outcomes. However, little is known about the psychological factors that may contribute to or protect against diabetes distress. This study examined illness burden, and positive and negative ways of thinking and relating to oneself in times of stress, as independent correlates of diabetes distress, cross sectionally and longitudinally. Method A total of 120 adults treated for Type 2 diabetes reported their physical symptom complaints, cognitive emotion regulation, self-compassion and diabetes distress at baseline; 110 completed a 3-month follow-up assessment of diabetes distress. Pearson correlations and multivariable linear regression tested baseline and longitudinal relationships. Results Baseline diabetes distress was associated with greater use of negative cognitive emotion regulation strategies (r = 0.43, P < 0.01), greater tendency towards self-criticism, self-judgement and over-identification (r = 0.37, P < 0.01), and greater physical symptom burden (r = 0.50, P < 0.01). Baseline physical symptoms and negative cognitive emotion regulation were independently associated with baseline diabetes distress. Baseline physical symptoms and negative aspects of self-compassion significantly predicted diabetes distress over 3 months. Positive aspects of cognitive emotion regulation and self-compassion were not independently associated with diabetes distress cross sectionally or longitudinally. Conclusion What's new? ? Greater symptom burden along with the use of negative cognitive emotion regulation and negative aspects of self-compassion were independently associated with diabetes distress. If these relations are explained by causal influence, these modifiable factors could be fruitful targets for intervention research.
C1 [Kane, N. S.; Hoogendoorn, C. J.; Gonzalez, J. S.] Yeshiva Univ, Ferkauf Grad Sch Psychol, New York, NY 10033 USA.
   [Kane, N. S.] VA New Jersey Hlth Care Syst, War Related Injury & Illness Study Ctr, E Orange, NJ USA.
   [Tanenbaum, M. L.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.
   [Gonzalez, J. S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.
   [Gonzalez, J. S.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA.
   [Gonzalez, J. S.] New York Reg Ctr Diabet Translat Res, New York, NY 10461 USA.
RP Gonzalez, JS (reprint author), Yeshiva Univ, Ferkauf Grad Sch Psychol, New York, NY 10033 USA.; Gonzalez, JS (reprint author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.; Gonzalez, JS (reprint author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA.; Gonzalez, JS (reprint author), New York Reg Ctr Diabet Translat Res, New York, NY 10461 USA.
EM jeffrey.gonzalez@einstein.yu.edu
FU Einstein-Mount Sinai Diabetes Research Center [P30 DK020541]; New York
   Regional Center for Diabetes Translation Research [P30 DK111022];
   National Institutes of Health [R01 DK104845, R18 DK098742]; Drs David
   and Jane Willner Bloomgarden Family Fellowship Fund
FX This study was partially supported by the Einstein-Mount Sinai Diabetes
   Research Center (P30 DK020541) and the New York Regional Center for
   Diabetes Translation Research (P30 DK111022). Dr. Gonzalez is also
   supported by grants R01 DK104845 and R18 DK098742 from the National
   Institutes of Health. Support was also provided by the Drs David and
   Jane Willner Bloomgarden Family Fellowship Fund.
CR Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Bair MJ, 2010, DIABETIC MED, V27, P578, DOI 10.1111/j.1464-5491.2010.02971.x
   Coroiu A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190771
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2018, DIABETES CARE, V41, P1862, DOI 10.2337/dc18-0391
   Fisher L, 2018, PATIENT EDUC COUNS, V101, P124, DOI 10.1016/j.pec.2017.06.036
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Friis AM, 2016, DIABETES CARE, V39, P1963, DOI 10.2337/dc16-0416
   Friis Anna M, 2015, Diabetes Spectr, V28, P252, DOI 10.2337/diaspect.28.4.252
   Garnefski N, 2006, PERS INDIV DIFFER, V40, P1659, DOI 10.1016/j.paid.2005.12.009
   Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6
   Gonzalez JS, 2016, DIABETES CARE, V39, P2182, DOI 10.2337/dc16-1657
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Grierson AB, 2016, PSYCHOL MED, V46, P2467, DOI 10.1017/S0033291716001392
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348
   Huffman JC, 2015, J DIABETES RES, DOI 10.1155/2015/428349
   Iturralde E, 2017, HEALTH PSYCHOL, V36, P236, DOI 10.1037/hea0000445
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005
   Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2
   Montero-Marin J, 2016, FRONT PSYCHOL, V7, P1
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Moulton CD, 2015, LANCET DIABETES ENDO, V3, P461, DOI 10.1016/S2213-8587(15)00134-5
   Muris P, 2017, CLIN PSYCHOL PSYCHOT, V24, P373, DOI 10.1002/cpp.2005
   Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035
   Perrin NE, 2017, DIABETIC MED, V34, P1508, DOI 10.1111/dme.13448
   Wadsworth LP, 2018, COGNITIVE THER RES, V42, P236, DOI 10.1007/s10608-017-9887-0
   WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037//0033-295X.96.2.234
NR 30
TC 1
Z9 1
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD DEC
PY 2018
VL 35
IS 12
BP 1671
EP 1677
DI 10.1111/dme.13830
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA HB9SK
UT WOS:000451432800009
PM 30264898
DA 2019-01-08
ER

PT J
AU Pintaudi, B
   Fresa, R
   Dalfra, M
   Dodesini, AR
   Vitacolonna, E
   Tumminia, A
   Sciacca, L
   Lencioni, C
   Marcone, T
   Lucisano, G
   Nicolucci, A
   Bonomo, M
   Napoli, A
AF Pintaudi, Basilio
   Fresa, Raffaella
   Dalfra, Mariagrazia
   Dodesini, Alessandro Roberto
   Vitacolonna, Ester
   Tumminia, Andrea
   Sciacca, Laura
   Lencioni, Cristina
   Marcone, Teresa
   Lucisano, Giuseppe
   Nicolucci, Antonio
   Bonomo, Matteo
   Napoli, Angela
CA STRONG Study Collaborators
TI The risk stratification of adverse neonatal outcomes in women with
   gestational diabetes (STRONG) study
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Gestational diabetes; Neonatal outcomes; Risk stratification; Obesity
ID MATERNAL OBESITY; WEIGHT-GAIN; PREGNANCY; MELLITUS; HYPERGLYCEMIA;
   IMPACT; CLASSIFICATION; EPIDEMIOLOGY; ASSOCIATIONS; IMPROVEMENT
AB AimsTo assess the risk of adverse neonatal outcomes in women with gestational diabetes (GDM) by identifying subgroups of women at higher risk to recognize the characteristics most associated with an excess of risk.MethodsObservational, retrospective, multicenter study involving consecutive women with GDM. To identify distinct and homogeneous subgroups of women at a higher risk, the RECursive Partitioning and AMalgamation (RECPAM) method was used. Overall, 2736 pregnancies complicated by GDM were analyzed. The main outcome measure was the occurrence of adverse neonatal outcomes in pregnancies complicated by GDM.ResultsAmong study participants (median age 36.8 years, pre-gestational BMI 24.8kg/m(2)), six miscarriages, one neonatal death, but no maternal death was recorded. The occurrence of the cumulative adverse outcome (OR 2.48, 95% CI 1.59-3.87), large for gestational age (OR 3.99, 95% CI 2.40-6.63), fetal malformation (OR 2.66, 95% CI 1.00-7.18), and respiratory distress (OR 4.33, 95% CI 1.33-14.12) was associated with previous macrosomia. Large for gestational age was also associated with obesity (OR 1.46, 95% CI 1.00-2.15). Small for gestational age was associated with first trimester glucose levels (OR 1.96, 95% CI 1.04-3.69). Neonatal hypoglycemia was associated with overweight (OR 1.52, 95% CI 1.02-2.27) and obesity (OR 1.62, 95% CI 1.04-2.51). The RECPAM analysis identified high-risk subgroups mainly characterized by high pre-pregnancy BMI (OR 1.68, 95% CI 1.21-2.33 for obese; OR 1.38 95% CI 1.03-1.87 for overweight).ConclusionsA deep investigation on the factors associated with adverse neonatal outcomes requires a risk stratification. In particular, great attention must be paid to the prevention and treatment of obesity.
C1 [Pintaudi, Basilio; Bonomo, Matteo] Osped Niguarda Ca Granda, SSD Diabet Unit, I-20162 Milan, Italy.
   [Fresa, Raffaella] ASL Salerno, Endocrinol & Diabet Unit, Salerno, Italy.
   [Dalfra, Mariagrazia] Colli ULSS16, Diabetol, Padua, Italy.
   [Dodesini, Alessandro Roberto] Papa Giovanni XXIII Hosp, Bergamo, Italy.
   [Vitacolonna, Ester] DAnnunzio Univ, Dept Med & Aging, Chieti, Italy.
   [Tumminia, Andrea; Sciacca, Laura] Univ Catania, Endocrinol Sect, Dept Clin & Expt Med, Catania, Italy.
   [Lencioni, Cristina] Usl Nord Ovest Toscana, Diabet Unit, Lucca, Italy.
   [Marcone, Teresa] Univ Hosp, SSD Diabetol, Foggia, Italy.
   [Lucisano, Giuseppe; Nicolucci, Antonio] COREsearch, Pescara, Italy.
   [Napoli, Angela] Sapienza Univ, S Andrea Hosp, Rome, Italy.
RP Pintaudi, B (reprint author), Osped Niguarda Ca Granda, SSD Diabet Unit, I-20162 Milan, Italy.
EM basilio.pintaudi@ospedaleniguarda.it
OI Bianchi, Cristina/0000-0003-2799-2380
FU Italian Diabetes and Pregnancy AMD-SID study group
FX The authors want to thank all the participating local study
   investigators. We thank the Italian Diabetes and Pregnancy AMD-SID study
   group for its support.
CR A merican Diabetes Association, 2015, DIABETES CARE S1, V38, P13
   [Anonymous], 2001, ACOG PRACTICE B, V30
   Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5
   Beyerlein A, 2010, DIABETIC MED, V27, P1379, DOI 10.1111/j.1464-5491.2010.03109.x
   Black MH, 2010, DIABETES CARE, V33, P2524, DOI 10.2337/dc10.1445
   Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x
   Burlina S, 2017, ACTA DIABETOL, V54, P881, DOI 10.1007/s00592-017-1003-0
   Casey BM, 1997, OBSTET GYNECOL, V90, P869, DOI 10.1016/S0029-7844(97)00542-5
   Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790
   Ciampi A, 1992, P PRAG 1991 SUMM SCH, P165
   Corrado F, 2014, J MATERN-FETAL NEO M, V27, P1445, DOI 10.3109/14767058.2013.860961
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Devlieger R, 2016, EUR J OBSTET GYN R B, V201, P203, DOI 10.1016/j.ejogrb.2016.04.005
   Fadl HE, 2010, DIABETIC MED, V27, P436, DOI 10.1111/j.1464-5491.2010.02978.x
   Feig DS, 2014, DIABETES CARE, V37, P1590, DOI 10.2337/dc13-2717
   Franciosi M, 2005, DIABETIC MED, V22, P900, DOI 10.1111/j.1464-5491.2005.01546.x
   Fuchs F, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-90
   Gaillard R, 2013, OBESITY, V21, P1046, DOI 10.1002/oby.20088
   Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635
   Goueslard K, 2017, ACTA DIABETOL, V54, P645, DOI 10.1007/s00592-017-0986-x
   HJALMARSON O, 1981, ACTA PAEDIATR SCAND, V70, P773, DOI 10.1111/j.1651-2227.1981.tb06228.x
   Lai FY, 2016, J DIABETES, V8, P45, DOI 10.1111/1753-0407.12255
   Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430
   Lapolla A, 2004, DIABETES NUTR METAB, V17, P358
   MCFARLAND LV, 1986, OBSTET GYNECOL, V68, P784
   McKenzie-Sampson S, 2018, ACTA DIABETOL, V55, P315, DOI 10.1007/s00592-017-1099-2
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292
   Mokkala K, 2017, ACTA DIABETOL, V54, P1147, DOI 10.1007/s00592-017-1056-0
   Much D, 2016, HORM METAB RES, V48, P16, DOI 10.1055/s-0035-1565084
   O'Sullivan EP, 2011, DIABETOLOGIA, V54, P1670, DOI 10.1007/s00125-011-2150-4
   Parnell AS, 2017, MATERN CHILD HLTH J, V21, P1105, DOI 10.1007/s10995-016-2209-4
   Persson B, 1998, DIABETES CARE, V21, pB79
   Pintaudi B, 2014, EUR J ENDOCRINOL, V170, P87, DOI 10.1530/EJE-13-0759
   Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8
   Santangeli L, 2015, BEST PRACT RES CL OB, V29, P438, DOI 10.1016/j.bpobgyn.2014.10.009
   Shand AW, 2008, DIABETIC MED, V25, P708, DOI 10.1111/j.1464-5491.2008.02431.x
   Watson D, 2003, AUST NZ J OBSTET GYN, V43, P429, DOI 10.1046/j.0004-8666.2003.00116.x
NR 39
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD DEC
PY 2018
VL 55
IS 12
BP 1261
EP 1273
DI 10.1007/s00592-018-1208-x
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA HA7KK
UT WOS:000450459800008
PM 30221320
DA 2019-01-08
ER

PT J
AU Ehrmann, D
   Kulzer, B
   Schipfer, M
   Lippmann-Grob, B
   Haak, T
   Hermanns, N
AF Ehrmann, Dominic
   Kulzer, Bernhard
   Schipfer, Melanie
   Lippmann-Grob, Bernhard
   Haak, Thomas
   Hermanns, Norbert
TI Efficacy of an Education Program for People With Diabetes and Insulin
   Pump Treatment (INPUT): Results From a Randomized Controlled Trial
SO DIABETES CARE
LA English
DT Article
ID THERAPY; DISTRESS; MELLITUS; ADULTS; ADOLESCENTS; SYMPTOMS; DELIVERY;
   INFUSION
AB OBJECTIVE
   Continuous subcutaneous insulin infusion (CSII) is the most advanced form of insulin delivery, but it requires structured education to provide users with the necessary knowledge/skills and to support their motivation. Currently, no structured education program designed to provide this training has been evaluated. We developed a CSII-specific, structured education program (Insulin Pump Treatment [INPUT]) and evaluated its impact on glycemic control, behavior, and psychosocial status.
   RESEARCH DESIGN AND METHODS
   This was a multicenter, randomized, parallel trial with a 6-month follow-up. Eligible participants (age 16-75 years) currently were treated with insulin pump therapy. Participants were randomly assigned (1:1) to the INPUT program or to usual care using a computer-generated algorithm, with study center as the stratification factor. The primary outcome was HbA(1c) change from baseline to 6 months. Secondary outcomes were incidence of severe hypoglycemia and changes in behavioral and psychosocial measures.
   RESULTS
   Between 1 April 2016 and 26 April 2016, 268 people with diabetes and a mean duration of CSII therapy of 9.5 years were randomly assigned to the INPUT group (n = 135) or control group (n = 133). At 6 months, HbA(1c) improved in the INPUT group (8.33 +/- 0.8 vs. 8.04 +/- 0.9; P < 0.0001) but not in the control group (8.33 +/- 1.0 vs. 8.27 +/- 1.0; P = 0.11). The between-group difference in HbA(1c) reduction was significant, favoring INPUT (-0.28% vs. -0.06%, Delta -0.22%, 95% CI -0.38 to -0.06; P = 0.0029). The incidence rate ratio of severe hypoglycemia was 3.55 times higher for participants in the control group than for those in the INPUT group (95% CI 1.50-8.43; P = 0.0041).
   CONCLUSIONS
   The INPUT education program led to a significant improvement in glycemic control and incidence of severe hypoglycemia in insulin pump users.
C1 [Ehrmann, Dominic; Kulzer, Bernhard; Schipfer, Melanie; Hermanns, Norbert] Res Inst Diabet Acad Mergentheim, Bad Mergentheim, Germany.
   [Ehrmann, Dominic; Kulzer, Bernhard; Hermanns, Norbert] Univ Bamberg, Dept Clin Psychol & Psychotherapy, Bamberg, Germany.
   [Kulzer, Bernhard; Lippmann-Grob, Bernhard; Haak, Thomas; Hermanns, Norbert] Diabet Clin Mergentheim, Bad Mergentheim, Germany.
RP Hermanns, N (reprint author), Res Inst Diabet Acad Mergentheim, Bad Mergentheim, Germany.; Hermanns, N (reprint author), Univ Bamberg, Dept Clin Psychol & Psychotherapy, Bamberg, Germany.; Hermanns, N (reprint author), Diabet Clin Mergentheim, Bad Mergentheim, Germany.
EM hermanns@fidam.de
OI Hermanns, Norbert/0000-0002-2903-2677; Ehrmann,
   Dominic/0000-0002-5794-5596
FU Research Institute Diabetes Academy Mergentheim
FX The authors thank all participating study centers for their effort in
   recruiting and conducting this study: Diabeteszentrum am
   Sophie-Charlotte-Platz, Dr. Kristina Pralle (Berlin, Germany);
   Diabetes-und Stoffwechselpraxis Bochum, Stephan Bonnermann (Bochum,
   Germany); Die Zuckerpraxis, Dr. Ewald Jammers (Bramsche, Germany);
   Diabetologische Schwerpunktpraxis Dr. Golz, Dr. Stefan Golz (Esslingen,
   Germany); Praxis Dres. Sammler/Denger, Dr. Armin Sammler
   (Friedrichsthal, Germany); Zentrum fur Diabetologie Bergedorf, Dr. Jens
   Kr6ger (Hamburg, Germany); Diabetologische Schwerpunktpraxis Dr. Milek,
   Dr. Karsten Milek (Hohenmolsen, Germany); Gemeinschaftspraxis Dres.
   Puth/Konig/Brockmann, Dr. Kerstin Konig (Kamen, Germany); Hormonzentrum
   Karlsruhe, Sebastian Zink (Karlsruhe, Germany); Diabetologische
   Schwerpunktpraxis Dres. Closs/Brahimi, Dr. Beqir Brahimi (Kempen,
   Germany); Gemein-schaftspraxis Dres.
   Schlotmann/Hochlehnert/Zavaleta/Birgel, Dr. Michael Birgel (Koln,
   Germany); Praxis Dres. Reichert/Hinck, Dr. Dorothea Reichert (Landau,
   Germany); Diabetologische Schwerpunktpraxis Dr. Lang, Dr. Vera Lang
   (Lauf, Germany); Praxis Dr. GlaB, Dr. Florian GlaB (Magdeburg, Germany);
   Diabeteszentrum Neckar-Odenwald, Dr. Carsten lannello (Mosbach,
   Germany); Schwerpunktpraxis fur Diabetes und Ernahrungsmedizin Dr.
   Keuthage, Dr. Winfried Keuthage (Munster, Germany); Zentrum fur Diabetes
   und Gefasserkrankungen Munster, Dr. Ludger Rose (Munster, Germany);
   Praxis Marck-Linn-Pickel, Dr. Cornelia Marck (Pohlheim, Germany); Praxis
   Dr. Lange, Dr. Martina Lange (Rheinbach, Germany); Diabetologische
   Schwerpunktpraxis Dr. Dietlein, Dr. Michael Dietlein (Stadtbergen,
   Germany); Diabetologische Schwerpunktpraxis Dr. Schreiber, Dr. Anne
   Schreiber (Stuttgart, Germany); Praxis Dres. Etzrodt/Alexopoulos, Dr.
   Gwendolin Etzrodt-Walter (Ulm, Germany); Gemeinschaftspraxis Dr.
   Schreiber/Werkmeister, Petra Werkmeister (Volkertshausen, Germany);
   Praxis Dr. Sturmer, Dr. Annette Klupfel (Wurzburg, Germany); Diabendo
   Praxisgemeinschaft, Dr. Stephan Arndt (Rostock, Germany); and
   Diabetologische Schwerpunktpraxis Galatea-Anlage, Dr. Dorothea Herber
   (Wiesbaden, Germany). The authors also thank Chris Parkin for assistance
   with editing the final version of the manuscript (sponsored by the
   Research Institute Diabetes Academy Mergentheim).
CR American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS110
   Benkhadra K, 2017, ENDOCRINE, V55, P86, DOI 10.1007/s12020-016-1039-x
   Bergis N, 2012, DIABETOL STOFFWECHS, V7, P9
   CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517
   Deeb A, 2015, DIABETES TECHNOL THE, V17, P166, DOI 10.1089/dia.2014.0224
   Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Garmo A, 2013, DIABETIC MED, V30, P717, DOI 10.1111/dme.12155
   Gonder-Frederick Linda, 2011, J Diabetes Sci Technol, V5, P1387
   Gonder-Frederick LA, 2016, AM PSYCHOL, V71, P577, DOI 10.1037/a0040383
   Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z
   Hautzinger M, 1993, ALLGEMEINE DEPRESSIO
   Heller S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1285
   Hermanns N, 2017, DIABETOL STOFFWECHS, V12, P224
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Kalyani RR, 2018, DIABETES CARE, V41, pS3, DOI [10.2337/dc18-Sppc01, 10.2337/dc18-SPPC01]
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   KULZER B, 1995, VERHALTENSTHERAPIE, V5, pA72
   Kulzer B, 2016, DIABETES, V65, pA178
   Misso ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005103.pub2
   Muhlhauser I, 2002, DIABETOLOGIA, V45, P1723, DOI 10.1007/s00125-002-0987-2
   National Institute for Health and Care Excellence, 2008, CONT SUBC INS INF TR
   Patton Susana R, 2017, J Diabetes Sci Technol, V11, P87, DOI 10.1177/1932296816658901
   Payk M, 2018, J ADV NURS, V74, P528, DOI 10.1111/jan.13463
   PICKUP JC, 1978, BRIT MED J, V1, P204, DOI 10.1136/bmj.1.6107.204
   Pickup JC, 2012, NEW ENGL J MED, V366, P1616, DOI 10.1056/NEJMct1113948
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Reichert D, 2013, DIABETES STOFFWECH H, V22, P367
   Reimer A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181218
   Ritholz MD, 2007, DIABETES CARE, V30, P549, DOI 10.2337/dc06-1755
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Seereiner S, 2010, DIABETES TECHNOL THE, V12, P89, DOI 10.1089/dia.2009.0080
   Weisman A, 2017, LANCET DIABETES ENDO, V5, P501, DOI 10.1016/S2213-8587(17)30167-5
   Wong JC, 2015, PEDIATR DIABETES, V16, P592, DOI 10.1111/pedi.12221
   Wood JR, 2006, DIABETES CARE, V29, P2355, DOI 10.2337/dc06-1141
   Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508
   Ziegler R, 2016, PEDIATR DIABETES, V17, P311, DOI 10.1111/pedi.12290
NR 38
TC 0
Z9 0
U1 3
U2 3
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD DEC 1
PY 2018
VL 41
IS 12
BP 2453
EP 2462
DI 10.2337/dc18-0917
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA HA8RI
UT WOS:000450560000010
PM 30305343
DA 2019-01-08
ER

PT J
AU Rassart, J
   Oris, L
   Prikken, S
   Weets, I
   Moons, P
   Luyckx, K
AF Rassart, Jessica
   Oris, Leen
   Prikken, Sofie
   Weets, Ilse
   Moons, Philip
   Luyckx, Koen
TI Personality Functioning in Adolescents and Emerging Adults With Type 1
   Diabetes
SO JOURNAL OF ADOLESCENT HEALTH
LA English
DT Article
DE Personality; the Big Five; Treatment adherence; Diabetes-specific
   distress; Glycemic control; Type 1 diabetes; Adolescents; Emerging
   adults; Longitudinal; Cross-lagged analysis; Latent growth curve
   modeling
ID GLYCEMIC CONTROL; SELF-CARE; MEASUREMENT INVARIANCE; EMOTIONAL DISTRESS;
   YOUNG ADULTHOOD; LIFE-COURSE; MEAN-LEVEL; METAANALYSIS; TRAITS;
   CONSCIENTIOUSNESS
AB Purpose: Although prior research has stressed the role of personality in adjusting to type 1 diabetes, longitudinal research is lacking. The objectives of the present study were twofold: (1) to chart the development of patients' personality over a 2-year period; and (2) to examine prospective associations among personality, treatment adherence, glycemic control, and diabetes-specific distress.
   Methods: Adolescents and emerging adults with type 1 diabetes, aged 14-25 years (M-age = 18.86 years, 54% female), participated in a three-wave longitudinal study spanning 2 years (n = 560 at Time 1). Patients filled out questionnaires on Big Five personality traits, treatment adherence, and diabetes-specific distress. HbA(1c) values were obtained from treating physicians. We used latent growth curve modeling to examine the development of patients' personality. Cross-lagged path analysis was performed to examine prospective associations among the study variables.
   Results: First, we observed mean-level increases in extraversion, agreeableness, and conscientiousness over the course of the study. Second, we uncovered bidirectional associations between personality and several important indicators of adjustment. Lower conscientiousness and higher extraversion predicted a relative decrease in treatment adherence 1 year later. Poorer treatment adherence, in turn, predicted relative decreases in conscientiousness and agreeableness over time. Furthermore, lower emotional stability predicted a relative increase in distress 1 year later. Higher distress, in turn, predicted a relative decrease in agreeableness over time. Finally, lower conscientiousness predicted poorer glycemic control 1 year later.
   Conclusions: This study found young patients to move toward a more mature personality and stressed the importance of personality in adjusting to type 1 diabetes. (C) 2018 Society for Adolescent Health and Medicine. All rights reserved.
C1 [Rassart, Jessica; Oris, Leen; Prikken, Sofie; Luyckx, Koen] Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium.
   [Rassart, Jessica; Oris, Leen; Prikken, Sofie] Res Fdn Flanders, Brussels, Belgium.
   [Weets, Ilse] Free Univ Brussels, Univ Hosp Brussels, Diabet Res Ctr Clin Biol, Brussels, Belgium.
   [Moons, Philip] Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium.
   [Moons, Philip] Univ Gothenburg, Inst Hlth & Care Sci, Gothenburg, Sweden.
RP Rassart, J (reprint author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Tiensestr 102,Box 3717, B-3000 Leuven, Belgium.
EM Jessica.Rassart@kuleuven.be
FU FWO Flanders [G.0B35.14N]
FX Funding was provided through research project G.0B35.14N granted by FWO
   Flanders to K.L.
CR Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS86, DOI 10.2337/dc16-S014
   Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317
   Berg CA, 2017, DEV REV, V46, P1, DOI 10.1016/j.dr.2017.09.001
   Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909-130.6.887
   Brickman AL, 1996, PSYCHOSOMATICS, V37, P459, DOI 10.1016/S0033-3182(96)71534-7
   Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913
   Chapman BP, 2014, DEV PSYCHOL, V50, P1426, DOI 10.1037/a0034135
   Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5
   Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558
   Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080
   Denissen JJA, 2008, J PERS ASSESS, V90, P152, DOI 10.1080/00223890701845229
   Drew LM, 2010, J FAM PSYCHOL, V24, P299, DOI 10.1037/a0019352
   Gerlitz JY, 2005, DIW RES NOTES, P4
   Hilliard ME, 2013, J ADOLESCENT HEALTH, V52, P28, DOI 10.1016/j.jadohealth.2012.05.009
   Jeronimus BF, 2014, J PERS SOC PSYCHOL, V107, P751, DOI 10.1037/a0037009
   Klimstra TA, 2014, SOC PSYCH PSYCH EPID, V49, P1319, DOI 10.1007/s00127-014-0827-y
   Klimstra TA, 2009, J PERS SOC PSYCHOL, V96, P898, DOI 10.1037/a0014746
   Kline RB, PRINCIPLES PRACTICE
   KOVACS M, 1992, J AM ACAD CHILD PSY, V31, P1112, DOI 10.1097/00004583-199211000-00020
   Lane JD, 2000, DIABETES CARE, V23, P1321, DOI 10.2337/diacare.23.9.1321
   Lewin AB, 2009, J PEDIATR PSYCHOL, V34, P999, DOI 10.1093/jpepsy/jsp032
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   Luan Z, 2017, J RES PERS, V67, P44, DOI 10.1016/j.jrp.2016.03.004
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rassart J, 2014, J CLIN PSYCHOL MED S, V21, P41, DOI 10.1007/s10880-014-9387-2
   Rassart J, 2014, J PSYCHOSOM RES, V76, P139, DOI 10.1016/j.jpsychores.2013.11.015
   Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1
   Shiner RL, 2017, J RES PERS, V67, P171, DOI 10.1016/j.jrp.2016.10.002
   Skinner TC, 2002, HEALTH PSYCHOL, V21, P61, DOI 10.1037//0278-6133.21.1.61
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Tackett JL, 2006, CLIN PSYCHOL REV, V26, P584, DOI 10.1016/j.cpr.2006.04.003
   Taylor MD, 2003, DIABETIC MED, V20, P135, DOI 10.1046/j.1464-5491.2003.00887.x
   Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002
   Vollrath ME, 2007, DIABETIC MED, V24, P1028, DOI 10.1111/j.1464-5491.2007.02215.x
   Waller D, 2013, DIABETES CARE, V36, P2968, DOI 10.2337/dc12-1743
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Weissberg-Benchell J, 2007, DIABETES CARE, V30, P2441, DOI 10.2337/dc07-1249
   Wheeler K, 2012, J CHILD ADOL PS NURS, V25, P66, DOI 10.1111/j.1744-6171.2012.00329.x
NR 40
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-139X
EI 1879-1972
J9 J ADOLESCENT HEALTH
JI J. Adolesc. Health
PD DEC
PY 2018
VL 63
IS 6
BP 792
EP 798
DI 10.1016/j.jadohealth.2018.06.019
PG 7
WC Psychology, Developmental; Public, Environmental & Occupational Health;
   Pediatrics
SC Psychology; Public, Environmental & Occupational Health; Pediatrics
GA HA5FQ
UT WOS:000450295000023
PM 30266568
DA 2019-01-08
ER

PT J
AU Del Valle, KL
   McDonnell, ME
AF Del Valle, Kayla L.
   McDonnell, Marie E.
TI Chronic Care Management Services for Complex Diabetes Management: a
   Practical Overview
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Diabetes; Chronic care management; Chronic care model; Type 1 diabetes;
   Type 2 diabetes; Complex diabetes; Virtual care
ID IMPROVING PRIMARY-CARE; REGRESSION-ANALYSIS; EMOTIONAL DISTRESS;
   GLYCEMIC CONTROL; CHRONIC ILLNESS; INTERVENTIONS; COMPLICATIONS;
   OUTCOMES
AB Purpose of ReviewFormalized chronic care management has the potential to improve the quality and cost-effectiveness of complex diabetes management in adults, but has historically not been sustainably supported by health care systems. This review discusses the application of the chronic care model in the care of complex diabetes and its translation in the current reimbursement structure designed by Centers for Medicare and Medicaid Services (CMS).Recent FindingsFollowing the introduction of Wagner's Chronic Care Model (CCM) in the late 1990s, evidence gathered over the past 2 decades has supported the shift in focus of health care systems from acute to chronic disease management and proactive care. Acknowledging evidence and potential for improved cost-effectiveness, in 2015, Medicare began reimbursing for chronic care management services (CCMS) for patients with multiple chronic conditions. The CCMS billing codes allow a program to be reimbursed for up to 90min per month spent by clinical staff performing interim care within a comprehensive care plan. Recent data from local and global programs support the application of formalized CCM in diabetes management.SummaryAlthough reimbursement models for CCM have been designed for use in primary care, the challenges of the reimbursement model has opened the door for specialty areas focused on multimorbidity care such as diabetes care to explore this approach. With the broader availability of remote glucose monitoring and telemedicine, a strategy that combines goal-oriented care and telehealth solutions appears to be most effective in diabetes CCM care. Despite widespread acceptance of the chronic care model of care, there remain significant barriers to its incorporation into standard practice.
C1 [Del Valle, Kayla L.; McDonnell, Marie E.] Harvard Med Sch, Brigham & Womens Hosp, Div Endocrinol, 221 Longwood Ave,Suite 381, Boston, MA 02115 USA.
RP McDonnell, ME (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Div Endocrinol, 221 Longwood Ave,Suite 381, Boston, MA 02115 USA.
EM kdelvalle@bwh.harvard.edu; MMCDONNELL@BWH.HARVARD.EDU
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS38, DOI 10.2337/dc18-S004
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS86, DOI 10.2337/dc18-S009
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS105, DOI 10.2337/dc18-S010
   Beck J, 2017, DIABETES CARE, V40, P1409, DOI 10.2337/dci17-0025
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909
   Boehmer KR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190852
   Davy C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0854-8
   Dwyer-Lindgren L, 2016, DIABETES CARE, V39, P1556, DOI 10.2337/dc16-0678
   Fisher L, 2018, DIABETES CARE, V41, P1862, DOI 10.2337/dc18-0391
   Fremont Allen, 2018, Health Aff (Millwood), V37, P1457, DOI 10.1377/hlthaff.2018.0443
   Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799
   Huynh P, 2018, ENDOCR PRACT, V24, P489, DOI 10.4158/EP-2017-0267
   Mendola N, 2018, PREVALENCE TOTAL DIA
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Nefs G, 2015, DIABETES RES CLIN PR, V108, P94, DOI 10.1016/j.diabres.2015.01.015
   Nuckols TK, 2018, DIABETES CARE, V41, P985, DOI 10.2337/dc17-1495
   Panagioti M, 2018, JAMA INTERN MED, V178, P1317, DOI 10.1001/jamainternmed.2018.3713
   Rein R, 2017, AM DIAB ASS SCI SESS
   Sadhu AR, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0936-6
   Serrano V, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0935-7
   Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427
   Stellefson M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120180
   The Centers for Medicare & Medicaid Services (CMS), 2018, CHRON CAR MAN SERV
   Tsai AC, 2005, AM J MANAG CARE, V11, P478
   Wan EYF, 2018, DIABETES CARE, V41, P49, DOI [10.2337/dc17-0426, 10.2337/dc17-1149]
   Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007
NR 29
TC 0
Z9 0
U1 16
U2 16
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD DEC
PY 2018
VL 18
IS 12
AR 135
DI 10.1007/s11892-018-1118-x
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GX5PV
UT WOS:000447802900009
PM 30343337
DA 2019-01-08
ER

PT J
AU Sheikh, MA
AF Sheikh, Mashhood Ahmed
TI Child maltreatment, psychopathological symptoms, and onset of diabetes
   mellitus, hypothyroidism and COPD in adulthood
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Diabetes mellitus; Hypothyroidism; Low metabolism; Chronic bronchitis;
   Emphysema; COPD; Childhood maltreatment; Social epidemiology; Social
   causation; Life course
ID ACUTE MYOCARDIAL-INFARCTION; EARLY-LIFE ADVERSITY; PSYCHOLOGICAL
   DISTRESS; BIPOLAR DISORDER; INFLAMMATORY MARKERS; METABOLIC SYNDROME;
   ALLOSTATIC LOAD; RISK-FACTOR; ABUSE; DEPRESSION
AB Background: The aim of this study was to assess the associations between child maltreatment (CM), psychopathological symptoms, and onset of diabetes mellitus, hypothyroidism (i.e., low metabolism), and chronic bronchitis/emphysema/COPD in adulthood.
   Methods: The present analysis used cross-sectional data collected in 2007-2008 within the Troms phi Study, Norway (N = 12,981). CM was measured with a single item, and self-reported information on psychopathological symptoms and physical health outcomes was used. The associations between CM, psychopathological symptoms, and physical health outcomes were assessed with linear and Poisson regression models. Mediation was assessed with difference-in-coefficients method.
   Results: In the fully-adjusted models, CM was associated with higher levels of anxiety and depression, psychological distress, difficulty in sleeping, insomnia, and use of sleeping pills and antidepressants in adulthood (p < 0.05). Moreover, CM was associated with a more than two-folds increased risk of consultation with psychiatrist (p < 0.001), a 26% increased risk of forgetfulness (p < 0.001), a 15% increased risk of decline in memory (p < 0.001), and a 96% increased risk of psychiatric problems (p < 0.001) over the course of life. In the fully-adjusted models, CM was associated with a 27-82% increased risk of physical health outcomes in adulthood (p < 0.05). Indicators of psychopathological symptoms significantly (p < 0.05) mediate the associations between CM and physical health outcomes.
   Limitations: The design of this study is cross-sectional, and all measures are self-reported.
   Conclusion: The associations between retrospectively-reported CM and physical health outcomes in adulthood are partially driven by psychopathological symptoms in adulthood.
C1 [Sheikh, Mashhood Ahmed] Univ Tromso, Dept Community Med, N-9037 Tromso, Norway.
RP Sheikh, MA (reprint author), Univ Tromso, Dept Community Med, N-9037 Tromso, Norway.
EM mashhood.a.sheikh@uit.no
OI Sheikh, Mashhood Ahmed/0000-0002-3212-592X
CR Anda R. F., 2006, EUR ARCH PSYCHIAT CL, V256
   Baumeister D, 2016, MOL PSYCHIATR, V21, P642, DOI 10.1038/mp.2015.67
   Baumeister D, 2014, SOC PSYCH PSYCH EPID, V49, P841, DOI 10.1007/s00127-014-0887-z
   Blanchette CM, 2008, ANN EPIDEMIOL, V18, P316, DOI 10.1016/j.annepidem.2007.11.004
   Cerda M, 2012, DEPRESS ANXIETY, V29, P359, DOI 10.1002/da.21947
   Cigolle C. T., 2016, J GERONTOL B-PSYCHOL
   Coates D, 2010, AUST SOC WORK, V63, P391, DOI 10.1080/0312407X.2010.508533
   Coccaro EF, 2014, JAMA PSYCHIAT, V71, P158, DOI 10.1001/jamapsychiatry.2013.3297
   Coelho R, 2014, ACTA PSYCHIAT SCAND, V129, P180, DOI 10.1111/acps.12217
   Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0
   Correll CU, 2017, WORLD PSYCHIATRY, V16, P163, DOI 10.1002/wps.20420
   Correll CU, 2015, WORLD PSYCHIATRY, V14, P119, DOI 10.1002/wps.20204
   COUPLAND C, 2011, BMJ, V343
   Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019
   De Bellis MD, 2014, CHILD ADOL PSYCH CL, V23, P185, DOI 10.1016/j.chc.2014.01.002
   Dortland AKBV, 2010, ACTA PSYCHIAT SCAND, V122, P30, DOI 10.1111/j.1600-0447.2010.01565.x
   Duncan AE, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140434
   Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8
   Fosgate GT, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-7
   Gee DG, 2015, NEUROBIOL STRESS, V1, P184, DOI 10.1016/j.ynstr.2015.02.001
   Heffner KL, 2011, IMMUNOL ALLERGY CLIN, V31, P95, DOI 10.1016/j.iac.2010.09.005
   HELLHAMMER DH, 1993, PSYCHOTHER PSYCHOSOM, V60, P8, DOI 10.1159/000288675
   Hippisley-Cox J, 2001, BRIT MED J, V323, P666, DOI 10.1136/bmj.323.7314.666
   Hostinar CE, 2017, PSYCHONEUROENDOCRINO, V75, P152, DOI 10.1016/j.psyneuen.2016.10.026
   Huang KL, 2017, J PSYCHOPHARMACOL, V31, P1544, DOI 10.1177/0269881117714047
   Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049
   Joung KE, 2014, J CLIN ENDOCR METAB, V99, pE1055, DOI 10.1210/jc.2013-3669
   Kalmakis KA, 2015, J AM ASSOC NURSE PRA, V27, P457, DOI 10.1002/2327-6924.12215
   Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4
   Kaufman JS, 2009, INT J EPIDEMIOL, V38, P845, DOI 10.1093/ije/dyp163
   Lorton D, 2006, NEUROIMMUNOMODULAT, V13, P357, DOI 10.1159/000104864
   McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3
   Mock S. E., 2011, FRONT PSYCHOL, V1
   Naimi AI, 2014, INT J EPIDEMIOL, V43, P1656, DOI 10.1093/ije/dyu107
   Nusslock R, 2016, BIOL PSYCHIAT, V80, P23, DOI 10.1016/j.biopsych.2015.05.017
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Plaza A, 2012, PSYCHIAT RES, V200, P329, DOI 10.1016/j.psychres.2012.06.032
   Post RM, 2013, J AFFECT DISORDERS, V147, P288, DOI 10.1016/j.jad.2012.11.020
   Procaccini C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00143
   Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007
   Rubin RR, 2008, DIABETES CARE, V31, P420, DOI 10.2337/dc07-182T
   Scott KM, 2011, ARCH GEN PSYCHIAT, V68, P838, DOI 10.1001/archgenpsychiatry.2011.77
   Sheikh MA, 2018, J PSYCHIATR RES, V103, P173, DOI 10.1016/j.jpsychires.2018.05.027
   Sheikh MA, 2018, EUR CHILD ADOLES PSY, V27, P481, DOI 10.1007/s00787-017-1090-z
   Sheikh MA, 2018, J PSYCHOSOM RES, V108, P78, DOI 10.1016/j.jpsychores.2018.03.001
   Sheikh MA, 2018, J PSYCHIATR RES, V101, P50, DOI 10.1016/j.jpsychires.2018.02.025
   Sheikh MA, 2018, INT J PUBLIC HEALTH, V63, P181, DOI 10.1007/s00038-017-1021-2
   Sheikh MA, 2018, J AFFECT DISORDERS, V229, P206, DOI 10.1016/j.jad.2017.12.051
   Sheikh MA, 2018, J AFFECT DISORDERS, V226, P21, DOI 10.1016/j.jad.2017.09.015
   Sheikh MA, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-164
   Shields ME, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3491-1
   Slavich GM, 2010, NEUROSCI BIOBEHAV R, V35, P39, DOI 10.1016/j.neubiorev.2010.01.003
   Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383
   Springer KW, 2003, J GEN INTERN MED, V18, P864, DOI 10.1046/j.1525-1497.2003.20918.x
   Tata LJ, 2005, HEART, V91, P465, DOI 10.1136/hrt.2004.037457
   Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957
   Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X
   Vancampfort D, 2015, WORLD PSYCHIATRY, V14, P339, DOI 10.1002/wps.20252
   Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27
   Weis J. G., 1989, CRIME JUSTICE ANN RE, V11, P117
   Yang YC, 2017, BIODEMOGR SOC BIOL, V63, P87, DOI 10.1080/19485565.2017.1279536
   Yoon JM, 2013, KOREAN J FAM MED, V34, P228, DOI 10.4082/kjfm.2013.34.4.228
NR 63
TC 1
Z9 1
U1 105
U2 105
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD DEC 1
PY 2018
VL 241
BP 80
EP 85
DI 10.1016/j.jad.2018.07.085
PG 6
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA GS6OK
UT WOS:000443816800011
PM 30099267
DA 2019-01-08
ER

PT J
AU Noser, AE
   Majidi, S
   Finch, J
   Clements, MA
   Youngkin, EM
   Patton, SR
AF Noser, Amy E.
   Majidi, Shideh
   Finch, Jonathan
   Clements, Mark A.
   Youngkin, Erin M.
   Patton, Susana R.
TI Authoritarian parenting style predicts poorer glycemic control in
   children with new-onset type 1 diabetes
SO PEDIATRIC DIABETES
LA English
DT Article
DE child; hemoglobin A1c; new onset; parenting; type 1 diabetes mellitus
ID ASSOCIATION; ADOLESCENTS; YOUTH; STATEMENT; DISTRESS; PATTERNS;
   BEHAVIOR; PROGRAM; SUPPORT; MOTHERS
AB Objective: To examine cross-sectional and longitudinal associations among parenting styles (ie, authoritative, authoritarian, and permissive) and youth glycated hemoglobin (HbA1c) in a cohort of families of children with new-onset type 1 diabetes (T1D).
   Methods: One-hundred two parents completed a baseline measure of parenting style, and we collected child HbA1c values at baseline and at three- and six-month follow-ups. We examined correlations among use of different parenting strategies and child HbA1cs. We conducted multiple regressions to assess the impact of these strategies on child HbA1c at three-month and six-month follow-ups, while controlling for baseline HbA1c, family income, and T1D duration.
   Results: Correlational analyses showed negative associations between authoritative strategies and child HbA1c at baseline, three-month, and six-month assessments and positive associations between authoritarian strategies and child HbA1c at three-month and six-month assessments. Regression analyses found use of authoritarian-like strategies were the only parenting strategies associated with child HbA1c at three-month and six-month follow-ups, while controlling for baseline HbA1c, family income, and T1D duration.
   Conclusion: Parents' use of authoritarian-like strategies may negatively impact glycemic control over the course of six-month in children with new-onset T1D.
C1 [Noser, Amy E.] Univ Kansas, Clin Child Psychol Program, Lawrence, KS 66045 USA.
   [Noser, Amy E.; Finch, Jonathan; Clements, Mark A.; Patton, Susana R.] Childrens Mercy Kansas City, Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA.
   [Majidi, Shideh; Youngkin, Erin M.] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Div Endocrinol, Aurora, CO USA.
   [Finch, Jonathan; Patton, Susana R.] Univ Kansas, Med Ctr, Dept Pediat, MS 4004,3901 Rainbow Blvd, Kansas City, KS 66160 USA.
   [Clements, Mark A.] Childrens Mercy Kansas City, Div Endocrinol & Diabet, Dept Pediat, Kansas City, MO USA.
RP Patton, SR (reprint author), Univ Kansas, Med Ctr, Dept Pediat, MS 4004,3901 Rainbow Blvd, Kansas City, KS 66160 USA.
EM spatton2@kumc.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases [R01
   DK100779]
FX National Institute of Diabetes and Digestive and Kidney Diseases,
   Grant/Award Number: R01 DK100779
CR Anderson BJ, 2011, DIABETES CARE, V34, P1885, DOI 10.2337/dc11-1028
   BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.2307/1126611
   BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372
   BAUMRIND D, 1965, CHILDREN, V12, P230
   Baumrind D, 2005, NEW DIR CHILD ADOLES, V108, P61, DOI 10.1002/cd.128
   Butler DA, 2008, PEDIATR DIABETES, V9, P373, DOI 10.1111/j.1399-5448.2008.00370.x
   Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140
   Davis CL, 2001, J PEDIATR PSYCHOL, V26, P123, DOI 10.1093/jpepsy/26.2.123
   Delamater AM, 2009, PEDIATR DIABETES, V10, P175, DOI 10.1111/j.1399-5448.2009.00580.x
   Duke DC, 2008, J PEDIATR PSYCHOL, V33, P719, DOI 10.1093/jpepsy/jsn012
   Forgatch MS, 1999, J CONSULT CLIN PSYCH, V67, P711, DOI 10.1037/0022-006X.67.5.711
   Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x
   Gandhi KK, 2016, PEDIATR RES, V80, P347, DOI 10.1038/pr.2016.87
   Greene MS, 2010, DIABETES EDUCATOR, V36, P326, DOI 10.1177/0145721710361270
   Gruhn MA, 2016, HEALTH PSYCHOL, V35, P652, DOI 10.1037/hea0000349
   Harris MA, 2001, DIABETES SPECTRUM, V14, P182
   Haugstvedt A, 2011, PEDIATR DIABETES, V12, P107, DOI 10.1111/j.1399-5448.2010.00661.x
   Hessler D, 2016, J PEDIATR PSYCHOL, V41, P750, DOI 10.1093/jpepsy/jsw002
   Jaser S, 2010, J PEDIATR PSYCHOL, V35, P977
   Langer SL, 2017, APPETITE, V110, P72, DOI 10.1016/j.appet.2016.12.011
   Langer SL, 2014, J PEDIATR PSYCHOL, V39, P633, DOI 10.1093/jpepsy/jsu021
   Mlynarczyk Susan M, 2013, Pediatr Nurs, V39, P181
   Monaghan M, 2012, J CLIN PSYCHOL MED S, V19, P255, DOI 10.1007/s10880-011-9284-x
   Pierce JS, 2017, PEDIATR DIABETES, V18, P17, DOI 10.1111/pedi.12351
   Radcliff Z, 2018, J PEDIATR PSYCHOL, V43, P185, DOI 10.1093/jpepsy/jsx107
   Redondo MJ, 2014, PEDIATR DIABETES, V15, P294, DOI 10.1111/pedi.12061
   Roberts L, 2018, APPETITE, V120, P318, DOI 10.1016/j.appet.2017.09.024
   Robinson C. C., 2001, HDB FAMILY MEASUREME, V3, P319
   Rodriguez MMD, 2009, FAM PROCESS, V48, P195
   Sanders MR, 2014, CLIN PSYCHOL REV, V34, P337, DOI 10.1016/j.cpr.2014.04.003
   Shah R, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3393
   Sherifali D, 2009, DIABETES EDUCATOR, V35, P476, DOI 10.1177/0145721709333268
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Snorer M, 2011, DIABETES CARE, V34, P1735, DOI 10.2337/dc10-1602
   Sweenie R, 2014, FAM SYST HEALTH, V32, P31, DOI 10.1037/fsh0000001
   Topham GL, 2010, PUBLIC HEALTH NUTR, V13, P1237, DOI 10.1017/S1368980009992163
   Weissberg-Benchell J, 2009, J PEDIATR PSYCHOL, V34, P977, DOI 10.1093/jpepsy/jsp003
   Zhang HY, 2015, J CHILD FAM STUD, V24, P1886, DOI 10.1007/s10826-014-9990-8
NR 38
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1399-543X
EI 1399-5448
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD NOV
PY 2018
VL 19
IS 7
BP 1315
EP 1321
DI 10.1111/pedi.12726
PG 7
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA GW0NS
UT WOS:000446564900024
PM 30014608
DA 2019-01-08
ER

PT J
AU Forlenza, GP
   Messer, LH
   Berget, C
   Wadwa, RP
   Driscoll, KA
AF Forlenza, Gregory P.
   Messer, Laurel H.
   Berget, Cari
   Wadwa, R. Paul
   Driscoll, Kimberly A.
TI Biopsychosocial Factors Associated With Satisfaction and Sustained Use
   of Artificial Pancreas Technology and Its Components: a Call to the
   Technology Field
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Type 1 diabetes; Artificial pancreas; Insulin pumps; Continuous glucose
   monitoring; Behavioral health
ID INSULIN PUMP THERAPY; QUALITY-OF-LIFE; CONTINUOUS GLUCOSE MONITORS;
   RANDOMIZED CONTROLLED-TRIAL; ADVERSE EVENTS; CLINICAL-TRIAL; GLYCEMIC
   CONTROL; DELIVERY-SYSTEM; PREGNANT-WOMEN; ADULTS
AB Purpose of Review Summarize biopsychosocial factors associated with using continuous glucose monitors (CGMs), insulin pumps, and artificial pancreas (AP) systems and provide a "call to the field" about their importance to technology uptake and maintained use.
   Recent Findings Insulin pumps and CGMs are becoming standard of care for individuals with type 1 diabetes (T1D). AP systems combining a CGM, insulin pump, and automated dosing algorithm are available for commercial use. Despite improved glycemic control with AP system use, numerous barriers exist which may limit their benefit. Studies on components of AP systems (pumps, CGMs) are limited and demonstrate mixed results of their impact on fear of hypoglycemia, adherence, quality of life, depression and anxiety, and diabetes distress. Studies examining biopsychological factors associated specifically with sustained use of AP systems are also sparse.
   Summary Biological, psychological and social impacts of AP systems have been understudied and the information they provide has not been capitalized upon.
C1 [Forlenza, Gregory P.; Messer, Laurel H.; Berget, Cari; Wadwa, R. Paul; Driscoll, Kimberly A.] Univ Colorado Denver, Barbara Davis Ctr, 1775 Aurora CT MS A140, Aurora, CO 80045 USA.
RP Driscoll, KA (reprint author), Univ Colorado Denver, Barbara Davis Ctr, 1775 Aurora CT MS A140, Aurora, CO 80045 USA.
EM gregory.forlenza@ucdenver.edu; laurel.messer@ucdnver.edu;
   cari.berget@ucdenver.edu; paul.wadwa@ucdenver.edu;
   kimberly.driscoll@ucdenver.edu
FU NIH K12 grant [K12DK094712-06]
FX Dr. Forlenza's work on this project was funded in part by an NIH K12
   grant (K12DK094712-06).
CR Barnard KD, 2007, DIABETIC MED, V24, P607, DOI 10.1111/j.1464-5491.2007.02120.x
   Barnard Katharine D, 2015, J Diabetes Sci Technol, V9, P925, DOI 10.1177/1932296815588332
   Battelino T, 2012, DIABETOLOGIA, V55, P3155, DOI 10.1007/s00125-012-2708-9
   Beck RW, 2017, ANN INTERN MED, V167, P365, DOI 10.7326/M16-2855
   Beck RW, 2017, LANCET DIABETES ENDO, V5, P700, DOI 10.1016/S2213-8587(17)30217-6
   Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975
   Beck RW, 2010, DIABETES CARE, V33, P2175, DOI 10.2337/dc10-0331
   Beck RW, 2009, DIABETES CARE, V32, P1947, DOI 10.2337/dc09-0889
   Bekiari E, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1310
   Bequette B Wayne, 2013, J Diabetes Sci Technol, V7, P1632
   Berg AK, 2018, PEDIATR DIABETES, V19, P733, DOI 10.1111/pedi.12652
   Bergenstal RM, 2016, JAMA-J AM MED ASSOC, V316, P1407, DOI 10.1001/jama.2016.11708
   Bergenstal RM, 2014, DIABETES CARE, V37, P659, DOI 10.2337/dc12-2621
   Berget C, 2018, DIABETES, V67, pA254
   Binder E, 2015, EXP CLIN ENDOCR DIAB, V123, P260, DOI 10.1055/s-0034-1394381
   Cemeroglu AP, 2010, PEDIATR DIABETES, V11, P182, DOI 10.1111/j.1399-5448.2009.00549.x
   Chase HP, 2010, DIABETES TECHNOL THE, V12, P507, DOI 10.1089/dia.2010.0021
   Christiansen M, 2013, DIABETES TECHNOL THE, V15, P881, DOI 10.1089/dia.2013.0077
   Cope Judith U, 2012, J Diabetes Sci Technol, V6, P1053
   Datye Karishma A, 2018, J Diabetes Sci Technol, V12, P349, DOI 10.1177/1932296817728525
   DeSalvo DJ, 2018, PEDIAT DIABETES
   Doyle FJ, 2014, DIABETES CARE, V37, P1191, DOI 10.2337/dc13-2108
   Driscoll KA, 2017, J PEDIAT PSYCHOL
   Driscoll Kimberly A, 2016, J Diabetes Sci Technol, V10, P724, DOI 10.1177/1932296815623568
   Driscoll Kimberly A, 2013, J Diabetes Sci Technol, V7, P898
   Driscoll Kimberly A, 2013, J Diabetes Sci Technol, V7, P646
   Driscoll KA, 2011, DIABETES CARE, V34, P2170, DOI 10.2337/dc11-0388
   Englert Kimberly, 2014, J Diabetes Sci Technol, V8, P745, DOI 10.1177/1932296814529893
   Facchinetti A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122093
   Faccioli Simone, 2017, J Diabetes Sci Technol, V11, P1147, DOI 10.1177/1932296817706377
   Farrington C, 2017, LANCET DIABETES ENDO, V5, P332, DOI 10.1016/S2213-8587(16)30397-7
   Feig DS, 2017, LANCET, V390, P2347, DOI 10.1016/S0140-6736(17)32400-5
   Fisher L, 2018, DIABETES CARE, V41, P1862, DOI 10.2337/dc18-0391
   Forlenza GP, 2018, DIABETES, V67, pW204
   Forlenza GP, 2018, DIABETES TECHNOL THE, V20, P335, DOI 10.1089/dia.2017.0424
   Forlenza GP, 2016, J PEDIATR-US, V169, P13, DOI 10.1016/j.jpeds.2015.10.015
   Garg SK, 2017, DIABETES TECHNOL THE, V19, P155, DOI 10.1089/dia.2016.0421
   Garmo A, 2013, DIABETIC MED, V30, P717, DOI 10.1111/dme.12155
   Giani Elisa, 2017, J Diabetes Sci Technol, V11, P476, DOI 10.1177/1932296816676280
   Heinemann Lutz, 2012, J Diabetes Sci Technol, V6, P954
   Heller S, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21200
   Hermanides Jeroen, 2011, Evid Based Med, V16, P46, DOI 10.1136/ebm1159
   Hilliard ME, 2009, J PEDIATR PSYCHOL, V34, P137, DOI 10.1093/jpepsy/jsn062
   Hirose M, 2012, CURR DIABETES REP, V12, P711, DOI 10.1007/s11892-012-0313-4
   Hirsch IB, 2008, DIABETES TECHNOL THE, V10, P377, DOI 10.1089/dia.2008.0068
   Hirsch IB, 2009, J CLIN ENDOCR METAB, V94, P2232, DOI 10.1210/jc.2008-2625
   Hommel E, 2014, ACTA DIABETOL, V51, P845, DOI 10.1007/s00592-014-0598-7
   Iturralde E, 2017, DIABETES EDUCATOR, V43, P223, DOI 10.1177/0145721717697244
   Ives B, 2010, DIABETES EDUCATOR, V36, P53, DOI 10.1177/0145721709352010
   James Steven, 2016, J Diabetes Sci Technol, V10, P1115, DOI 10.1177/1932296816660326
   Kerr David, 2013, J Diabetes Sci Technol, V7, P1595
   Kovatchev B, 2008, DIABETES CARE, V31, P1160, DOI 10.2337/dc07-2401
   Kropff J, 2017, DIABETIC MED, V34, P262, DOI 10.1111/dme.13268
   Laffel L, 2016, DIABETES TECHNOL THE, V18, P23, DOI 10.1089/dia.2015.0380
   Lind M, 2017, JAMA-J AM MED ASSOC, V317, P379, DOI 10.1001/jama.2016.19976
   Markowitz JT, 2012, DIABETES TECHNOL THE, V14, P523, DOI 10.1089/dia.2011.0201
   Mauras N, 2012, DIABETES CARE, V35, P204, DOI 10.2337/dc11-1746
   Messer LH, 2018, DIABETIC MED, V35, P409, DOI 10.1111/dme.13568
   Messer L, 2009, DIABETES EDUCATOR, V35, P124, DOI 10.1177/0145721708325157
   Messer LH, 2018, DIABETES TECHNOL THE, V20, P54, DOI 10.1089/dia.2018.0080
   Messer LH, 2018, DIABETES CARE, V41, P789, DOI 10.2337/dc17-1682
   Messer LH, 2018, PEDIATR DIABETES, V19, P14, DOI 10.1111/pedi.12535
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Nimri R, 2006, PEDIATRICS, V117, P2126, DOI 10.1542/peds.2005-2621
   Nuboer R, 2008, PEDIATR DIABETES, V9, P291, DOI 10.1111/j.1399-5448.2008.00396.x
   O'Connell MA, 2011, PEDIATR DIABETES, V12, P556, DOI 10.1111/j.1399-5448.2010.00740.x
   Patton Susana R, 2017, J Diabetes Sci Technol, V11, P87, DOI 10.1177/1932296816658901
   Patton Susana R, 2016, J Diabetes Sci Technol, V10, P656, DOI 10.1177/1932296816638109
   Petrie JR, 2017, DIABETOLOGIA, V60, P2319, DOI 10.1007/s00125-017-4463-4
   Pickup JC, 2015, DIABETES CARE, V38, P544, DOI 10.2337/dc14-1855
   Polonsky WH, 2017, DIABETES CARE, V40, P736, DOI 10.2337/dc17-0133
   Polonsky WH, 2017, DIABETES TECHNOL THE, V19, P131, DOI 10.1089/dia.2016.0366
   Polonsky WH, 2013, DIABETES TECHNOL THE, V15, P295, DOI 10.1089/dia.2012.0298
   Rashotte J, 2014, CAN J DIABETES, V38, P256, DOI 10.1016/j.jcjd.2014.02.002
   Riddlesworth T, 2017, DIABETES THER, V8, P947, DOI 10.1007/s13300-017-0281-4
   Ritholz MD, 2010, DIABETIC MED, V27, P1060, DOI 10.1111/j.1464-5491.2010.03061.x
   Rodbard D, 2016, DIABETES TECHNOL THE, V18, P3, DOI 10.1089/dia.2015.0417
   Ross PL, 2015, ACTA DIABETOL, V52, P1017, DOI 10.1007/s00592-015-0784-2
   Rubin RR, 2012, DIABETES TECHNOL THE, V14, P143, DOI 10.1089/dia.2011.0162
   Rubin Richard R, 2009, J Diabetes Sci Technol, V3, P1402
   Ruedy Katrina J, 2017, J Diabetes Sci Technol, V11, P1138, DOI 10.1177/1932296817704445
   Ruiz Jessica L, 2012, J Diabetes Sci Technol, V6, P1123
   Secher AL, 2014, DIABETIC MED, V31, P352, DOI 10.1111/dme.12383
   Seereiner S, 2010, DIABETES TECHNOL THE, V12, P89, DOI 10.1089/dia.2009.0080
   Shah VN, 2018, DIABETES TECHNOL THE, V20, P428, DOI 10.1089/dia.2018.0143
   Sherr JL, 2016, DIABETOLOGIA, V59, P87, DOI 10.1007/s00125-015-3790-6
   Shivers Joseph P, 2013, J Diabetes Sci Technol, V7, P789
   Steil Garry M, 2013, J Diabetes Sci Technol, V7, P1621
   Tanenbaum Molly L, 2017, J Diabetes Sci Technol, V11, P484, DOI 10.1177/1932296816688010
   Tanenbaum ML, 2017, DIABETES CARE, V40, P181, DOI 10.2337/dc16-1536
   Vloemans AF, 2017, DIABETIC MED, V34, P1470, DOI 10.1111/dme.13429
   Wadwa RP, 2018, DIABETES TECHNOL THE, V20, P395, DOI 10.1089/dia.2018.0150
   Wadwa RP, 2009, DIABETES TECHNOL THE, V11, pS83, DOI 10.1089/dia.2008.0122
   Weinzimer S, 2010, DIABETES CARE, V33, P17, DOI 10.2337/dc09-1502
   Weisman A, 2017, LANCET DIABETES ENDO, V5, P501, DOI 10.1016/S2213-8587(17)30167-5
   Weissberg-Benchell J, 2003, DIABETES CARE, V26, P1079, DOI 10.2337/diacare.26.4.1079
   Weissberg-Benchell Jill, 2016, J Diabetes Sci Technol, V10, P799, DOI 10.1177/1932296815619637
   Wheeler BJ, 2014, DIABETES TECHNOL THE, V16, P558, DOI 10.1089/dia.2013.0388
   Wheeler BJ, 2014, DIABETES TECHNOL THE, V16, P204, DOI 10.1089/dia.2013.0315
   Wong Jenise C, 2017, J Diabetes Sci Technol, V11, P224, DOI 10.1177/1932296816663963
   Wong JC, 2015, PEDIATR DIABETES, V16, P592, DOI 10.1111/pedi.12221
   Wysocki T, 2016, DIABETES EDUCATOR, V42, P395, DOI 10.1177/0145721716647492
NR 102
TC 0
Z9 0
U1 4
U2 4
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD NOV
PY 2018
VL 18
IS 11
AR 114
DI 10.1007/s11892-018-1078-1
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GV5IZ
UT WOS:000446136300002
PM 30259309
DA 2019-01-08
ER

PT J
AU Hosseini, E
   Janghorbani, M
   Shahshahan, Z
AF Hosseini, Elham
   Janghorbani, Mohsen
   Shahshahan, Zahra
TI Comparison of risk factors and pregnancy outcomes of gestational
   diabetes mellitus diagnosed during early and late pregnancy
SO MIDWIFERY
LA English
DT Article
DE Early screening; Gestational diabetes; Pregnancy outcomes
ID FASTING PLASMA-GLUCOSE; 1ST PRENATAL VISIT; HYPERGLYCEMIA; IRAN
AB Objective: To compare risk factors and pregnancy outcomes of gestational diabetes mellitus (GDM) diagnosed during early and late pregnancy.
   Design: Prospective population-based cohort study.
   Setting: Community health care centers of Isfahan, Iran.
   Participants and measurements: 1000 pregnant women who were eligible and consented to participate underwent fasting plasma glucose testing at the first prenatal visit (6-14 weeks). The women free from GDM or overt diabetes were screened at 24-28 weeks of gestation using a 75-g, 2-hour oral glucose tolerance test. The diagnosis of GDM was reached through the International Association of the Diabetes and Pregnancy Study Groups. Early-onset GDM was defined as the diagnosis of GDM at the first prenatal visit. Late-onset GDM was defined as the diagnosis of GDM later at 24-28 weeks.
   Findings: Prevalence of GDM was 10% (95% CI: 8.1-11.9) at the first prenatal visit. GDM incidence was 9.3% (95% CI: 7.4-11.2) at 24-28 weeks of gestation. Family history of diabetes, and previous gestational diabetes and maternal age were the independent risk factors for GDM during early and late diagnosis. GDM was associated with increased risk of macrosomia, large for gestational age, and cesarean section in both periods while, neonates of women with early-onset GDM were more likely to have an apgar score at 1-min < 7, and neonatal respiratory distress syndrome and were more admitted to the neonatal intensive care unit.
   Key conclusion and implication for practice: Despite early screening and current practice management, early-onset GDM was associated with poorer pregnancy outcomes compared to the late-onset group. Women with early-onset GDM would benefit from more strict surveillance and management strategies to improve pregnancy outcomes. Further studies are needed to evaluate the efficacy of alternative management approaches in these high risk women.
C1 [Hosseini, Elham; Janghorbani, Mohsen] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran.
   [Shahshahan, Zahra] Isfahan Univ Med Sci, Sch Med, Dept Obstet & Gynecol, Esfahan, Iran.
RP Janghorbani, M (reprint author), Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran.
EM janghorbani@hlth.mui.ac.ir; shahshahan@med.mui.ac.ir
FU Elite Researcher Grant Committee from the National Institutes of Medical
   Research Development (NIMAD), Tehran, Iran [963232]
FX This study was supported by the Elite Researcher Grant Committee under
   award number 963232 from the National Institutes of Medical Research
   Development (NIMAD), Tehran, Iran.
CR Agarwal MM, 2016, WORLD J DIABETES, V7, P279, DOI 10.4239/wjd.v7.i14.279
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002
   Bartha JL, 2000, AM J OBSTET GYNECOL, V182, P346, DOI 10.1016/S0002-9378(00)70222-5
   Bartha JL, 2003, EUR J OBSTET GYN R B, V109, P41, DOI 10.1016/S0301-2115(02)00480-3
   Bunthalarath Sittiwate, 2004, Journal of the Medical Association of Thailand, V87, pS50
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Hawkins J. S, 2008, AM J OBSTET GYNECOL, V198
   Hollander MH, 2007, OBSTET GYNECOL SURV, V62, P125, DOI 10.1097/01.ogx.0000253303.92229.59
   Jafari-Shobeiri M, 2015, IRAN J PUBLIC HEALTH, V44, P1036
   Jain R, 2014, INT J MED SCI PUBLIC, V3, P1283
   Keshavarz M, 2005, DIABETES RES CLIN PR, V69, P279, DOI 10.1016/j.diabres.2005.01.011
   McIntyre HD, 2016, DIABETES CARE, V39, P53, DOI 10.2337/dc15-1887
   Meek CL, 2015, DIABETOLOGIA, V58, P2003, DOI 10.1007/s00125-015-3647-z
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Moosazadeh M, 2017, DIABETES METAB SYND, V11, pS99, DOI 10.1016/j.dsx.2016.12.016
   Oster RT, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-136
   Page RCL, 1996, DIABETIC MED, V13, P170, DOI 10.1002/(SICI)1096-9136(199602)13:2<170::AID-DIA8>3.0.CO;2-4
   Riskin-Mashiah S, 2009, DIABETES CARE, V32, P1639, DOI 10.2337/dc09-0688
   Sacks DA, 2003, OBSTET GYNECOL, V101, P1197, DOI 10.1016/S0029-7844(03)00049-8
   Sweeting AN, 2016, DIABETES CARE, V39, P75, DOI 10.2337/dc15-0433
   The Population  Office FamilyHealth, 2016, NAT PROT PREGN
   Vignoles P, 2011, ARCH GYNECOL OBSTET, V284, P1099, DOI 10.1007/s00404-010-1810-9
   Wong SF, 2002, DIABETES CARE, V25, P1681, DOI 10.2337/diacare.25.10.1681
   Zhu WW, 2013, DIABETES CARE, V36, P586, DOI 10.2337/dc12-1157
NR 27
TC 0
Z9 0
U1 25
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-6138
EI 1532-3099
J9 MIDWIFERY
JI Midwifery
PD NOV
PY 2018
VL 66
BP 64
EP 69
DI 10.1016/j.midw.2018.07.017
PG 6
WC Nursing
SC Nursing
GA GT3NC
UT WOS:000444409000009
PM 30130677
DA 2019-01-08
ER

PT J
AU Jeong, YM
   Quinn, L
   Kim, N
   Martyn-Nemeth, P
AF Jeong, Yoo Mi
   Quinn, Laurie
   Kim, Nahyun
   Martyn-Nemeth, Pamela
TI Health-Related Stigma in Young Adults With Type 1 Diabetes Mellitus
SO JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES
LA English
DT Article
ID LIFE-STYLE; CARE; RECOMMENDATIONS; TRANSITION; PERSPECTIVES;
   ADOLESCENCE; CHALLENGES; EPIDEMIC; PEOPLE
AB Young adults with type 1 diabetes mellitus (T1DM) often exhibit poor treatment adherence and suboptimal glucose control. Health-related stigma may adversely influence diabetes self-management behavior. The aim of the current study was to explore health-related stigma among young adults with T1DM using qualitative descriptive methods in focus groups. Data were collected from a purposive sample of 14 young adults ages 20 to 34 with T1DM. Using content analysis, transcripts from two focus groups were analyzed, and five main themes were identified: (a) Desire to be Seen as a Person, Not a Disease; (b) Wanting to be "Normal"; (c) Feeling Ashamed Managing Diabetes in Public; (d) Struggling to Overcome Anger and Distress; and (e) Feeling Distrusted by Others to Manage Their Condition. Young adults with T1DM reported experiencing a high degree of stigma in their daily lives, which negatively influenced their self-management and psychological well-being. Stigma led to delaying blood glucose monitoring and insulin dosing and feelings of anger and distress. Young adults with T1DM require strategies to help cope with stigma and the anger and distress they experience.
C1 [Jeong, Yoo Mi] Konyang Univ, Coll Nursing, Daejun Si, South Korea.
   [Kim, Nahyun] Keimyung Univ, Coll Nursing, Daegu Si, South Korea.
   [Quinn, Laurie; Martyn-Nemeth, Pamela] Univ Illinois, Coll Nursing, Biobehav Hlth Sci, Chicago, IL USA.
RP Jeong, YM (reprint author), Konyang Univ, Coll Nursing 209, Gwanjeodonglo 158, Daejun Si 35365, Chungnam Do, South Korea.
EM yjeong20@konyang.ac.kr
FU University of Illinois at Chicago College of Nursing
FX The authors have disclosed no potential conflicts of interest, financial
   or otherwise. Financial support was provided by internal funding
   supplied by the University of Illinois at Chicago College of Nursing.
   The authors thank the study participants for sharing their experience of
   health-related stigma associated with type 1 diabetes mellitus. The
   authors also acknowledge the time and expertise devoted to review by
   Kevin Grandfield, Publication Manager of the University of Illinois at
   Chicago Department of Biobehavioral Health Science.
CR Abdoli S, 2017, DIABETES EDUCATOR, V43, P206, DOI 10.1177/0145721717697245
   Abdoli Samereh, 2013, Iran J Nurs Midwifery Res, V18, P65
   Anderson BJ, 2004, PATIENT EDUC COUNS, V53, P347, DOI 10.1016/j.pec.2003.03.001
   Arnett JJ, 2001, J ADULT DEV, V8, P133, DOI 10.1023/A:1026450103225
   Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011
   Beverly E. A., 2016, J CLIN OUTCOMES MANA, V23, P509
   Browne JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005625
   Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536
   Celik Selda, 2015, Int J Community Based Nurs Midwifery, V3, P84
   Dashiff C, 2009, CHILD CARE HLTH DEV, V35, P79, DOI 10.1111/j.1365-2214.2008.00892.x
   Dashiff C, 2008, J ADV NURS, V62, P140, DOI 10.1111/j.1365-2648.2007.04549.x
   DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3
   Dudley J., 1983, LIVING STIGMA PLIGHT
   Freeborn D, 2013, J CLIN NURS, V22, P1890, DOI 10.1111/jocn.12046
   Garvey K, 2011, DIABETES SPECTRUM, V24, P22, DOI [10.2337/diaspect.24.1.22, DOI 10.2337/DIASPECT.24.1.22]
   Goffman E, 1963, STIGMA NOTES MANAGEM
   Hapunda G, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0013-6
   Horowitz AD, 2007, YOUTH SOC, V39, P209, DOI 10.1177/0044118X06296692
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Lawrence SE, 2015, PAED CHILD HEALT-CAN, V20, P35, DOI 10.1093/pch/20.1.35
   Leroux C, 2014, CAN J DIABETES, V38, P62, DOI 10.1016/j.jcjd.2013.08.268
   Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62
   Miller TA, 2013, DIABETES METAB SYNDR, V6, P421, DOI 10.2147/DMSO.S36368
   Monaghan M, 2015, CURR DIABETES REV, V11, P239, DOI 10.2174/1573399811666150421114957
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Onyeka TC, 2010, INDIAN J PALLIAT CAR, V16, P123, DOI 10.4103/0973-1075.73642
   Paterson B, 1999, QUAL HEALTH RES, V9, P786, DOI 10.1177/104973299129122289
   Pescosolido BA, 2015, ANNU REV SOCIOL, V41, P87, DOI 10.1146/annurev-soc-071312-145702
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Pitacinski S, 2014, ARCH MED SCI, V10, P124, DOI 10.5114/aoms.2014.40739
   Pyatak EA, 2013, DIABETIC MED, V30, P1140, DOI 10.1111/dme.12248
   Saarinen T, 2014, EUROPEAN DIABETES NU, V11, P38, DOI [10.1002/edn.246, DOI 10.1002/EDN.246, 10.1002/edn.246.]
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Sparud-Lundin C, 2010, J ADV NURS, V66, P128, DOI 10.1111/j.1365-2648.2009.05166.x
   Wahowiak L., 2015, DIABETES FORECAST, V68, P30
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 37
TC 0
Z9 0
U1 3
U2 3
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0279-3695
EI 1938-2413
J9 J PSYCHOSOC NURS MEN
JI J. Psychosoc. Nurs. Ment. Health Serv.
PD OCT
PY 2018
VL 56
IS 10
BP 44
EP 51
DI 10.3928/02793695-20180503-01
PG 8
WC Nursing
SC Nursing
GA GW1YX
UT WOS:000446679900008
PM 29741747
DA 2019-01-08
ER

PT J
AU Adams, RN
   Tanenbaum, ML
   Hanes, SJ
   Ambrosino, JM
   Ly, TT
   Maahs, DM
   Naranjo, D
   Walders-Abramson, N
   Weinzimer, SA
   Buckingham, BA
   Hood, KK
AF Adams, Rebecca N.
   Tanenbaum, Molly L.
   Hanes, Sarah J.
   Ambrosino, Jodie M.
   Ly, Trang T.
   Maahs, David M.
   Naranjo, Diana
   Walders-Abramson, Natalie
   Weinzimer, Stuart A.
   Buckingham, Bruce A.
   Hood, Korey K.
TI Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop
   System for Type 1 Diabetes Management
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
DE Type 1 diabetes; Artificial pancreas; Human factors
ID INSULIN DELIVERY-SYSTEM; GLYCEMIC CONTROL; ADULTS; ADOLESCENTS;
   DEPRESSION; HYPOGLYCEMIA; DISTRESS; CHILDREN; FEAR
AB Background: Hybrid closed loop (HCL) systems are designed to automate insulin delivery to improve type 1 diabetes (T1D) outcomes and reduce user burden and distress. Because the systems only automate some aspects of diabetes care, psychosocial and human factors remain an important consideration in their use. Thus, we examined whether psychosocial and human factors (i.e., distress related to diabetes management, fear of hypoglycemia, and technology attitudes) would (1) change after using the system and (2) predict glycemic outcomes during the trial. Subjects and Methods: Fourteen adults and 15 adolescents with T1D participated in a multisite clinical trial of an investigational version of the MiniMed 670G system (Medtronic, Northridge, CA) over 4 to 5 days in a semisupervised outpatient setting. Users completed surveys assessing psychosocial and human factors before beginning the HCL system and at the conclusion of the study. t-Tests and regression analyses were conducted to examine whether these factors changed following trial exposure to the HCL system and predicted glycemic outcomes during the trial. Results: Diabetes management distress decreased and diabetes technology attitudes became more positive over the trial period. Fear of hypoglycemia did not change over the trial period. There was a trend toward greater pretrial management distress predicting less time in range during the trial, controlling for time in range before the trial. Conclusions: Results suggest that this system is promising for enhancing technology attitudes and reducing management distress. Psychosocial factors, such as management distress, may negatively impact glycemic outcomes and should be a priority area for further investigation.
C1 [Adams, Rebecca N.; Tanenbaum, Molly L.; Hanes, Sarah J.; Ly, Trang T.; Maahs, David M.; Naranjo, Diana; Buckingham, Bruce A.; Hood, Korey K.] Stanford Univ, Sch Med, Dept Pediat, 780 Welch Rd,MC 5776, Palo Alto, CA 94304 USA.
   [Ambrosino, Jodie M.; Weinzimer, Stuart A.] Yale Univ, Sch Med, New Haven, CT USA.
   [Ly, Trang T.] Univ Western Australia, Sch Paediat & Child Hlth, Crawley, WA, Australia.
   [Walders-Abramson, Natalie] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA.
RP Hood, KK (reprint author), Stanford Univ, Sch Med, Dept Pediat, 780 Welch Rd,MC 5776, Palo Alto, CA 94304 USA.
EM kkhood@stanford.edu
FU JDRF; Michael D. Ryan and Rosemary McNicholas Ryan Pediatric Diabetes
   Research Fund
FX This work was supported by a grant from JDRF. Researchers at Yale were
   also supported by the Michael D. Ryan and Rosemary McNicholas Ryan
   Pediatric Diabetes Research Fund.
CR Barnard KD, 2015, DIABETIC MED, V32, P601, DOI 10.1111/dme.12706
   Barnard Katharine D, 2017, J Diabetes Sci Technol, V11, P1080, DOI 10.1177/1932296817702656
   Barnard KD, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000025
   Bergenstal RM, 2016, JAMA-J AM MED ASSOC, V316, P1407, DOI 10.1001/jama.2016.11708
   Farrington C, 2018, DIABETIC MED, V35, P436, DOI 10.1111/dme.13567
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Garg SK, 2017, DIABETES TECHNOL THE, V19, P155, DOI 10.1089/dia.2016.0421
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hilliard ME, 2018, PEDIATR DIABETES, V19, P534, DOI 10.1111/pedi.12575
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Iturralde E, 2017, DIABETES EDUCATOR, V43, P223, DOI 10.1177/0145721717697244
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Ly TT, 2017, PEDIATR DIABETES, V18, P348, DOI 10.1111/pedi.12399
   Messer LH, 2018, DIABETES CARE, V41, P789, DOI 10.2337/dc17-1682
   Naranjo Diana, 2016, J Diabetes Sci Technol, V10, P852, DOI 10.1177/1932296816650900
   Pickup JC, 2015, DIABETES CARE, V38, P544, DOI 10.2337/dc14-1855
   Quintal A, 2018, Diabetes Metab, DOI 10.1016/j.diabet.2018.04.003
   Tanenbaum Molly L, 2017, J Health Psychol, p1359105317718615, DOI 10.1177/1359105317718615
   Tanenbaum ML, 2017, DIABETES CARE, V40, P181, DOI 10.2337/dc16-1536
   Trief PM, 2014, DIABETES CARE, V37, P1563, DOI 10.2337/dc13-1867
   Vallis M, 2014, CURR DIABETES REV, V10, P364, DOI 10.2174/1573399810666141113115026
   Weissberg-Benchell J, 2017, DIABETES TECHNOL THE, V19, P723, DOI 10.1089/dia.2017.0174
   Wheeler BJ, 2014, DIABETES TECHNOL THE, V16, P558, DOI 10.1089/dia.2013.0388
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Wong JC, 2015, PEDIATR DIABETES, V16, P592, DOI 10.1111/pedi.12221
   Ziegler C, 2015, J DIABETES RES, V2015
NR 28
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD OCT
PY 2018
VL 20
IS 10
BP 648
EP 653
DI 10.1089/dia.2018.0174
EA SEP
EY 2018
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GV3NX
UT WOS:000445347300001
PM 30239219
DA 2019-01-08
ER

PT J
AU Staite, E
   Zaremba, N
   Macdonald, P
   Allan, J
   Treasure, J
   Ismail, K
   Stadler, M
AF Staite, E.
   Zaremba, N.
   Macdonald, P.
   Allan, J.
   Treasure, J.
   Ismail, K.
   Stadler, M.
TI "Diabulima' through the lens of social media: a qualitative review and
   analysis of online blogs by people with Type 1 diabetes mellitus and
   eating disorders
SO DIABETIC MEDICINE
LA English
DT Review
ID INSULIN RESTRICTION; MORTALITY; INFORMATION; OUTCOMES; COHORT; ADULTS
AB AimsTo perform a qualitative review of online blogs authored by people self-identifying as having Type 1 diabetes and an eating disorder or diabulimia', a term used by people with Type 1 diabetes to describe an eating disorder that is characterized by deliberate restriction of insulin to control weight.
   MethodsWe conducted a structured qualitative review of online blogs published between 2012 and 2017 authored by people who report having Type 1 diabetes and an eating disorder or diabulimia. The subsequent thematic analysis followed a six-phase process and was conducted by two independent researchers.
   ResultsFrom 147 000 search results, 11 blogs (304 posts) matched criteria for further analyses. Three key themes and 18 subthemes emerged: 1) different aspects of bloggers' relationship with insulin, including motives for omitting insulin, secrecy of insulin omission and perception of control; 2) bloggers' experiences of diabetes complications, and diabetes ketoacidosis in particular, as well as their worries about future complications; 3) strategies for recovery and triggers for relapse, which involved diabetes self-management and setting up a support system.
   ConclusionsQualitative analyses of blogs authored by people with Type 1 diabetes and an eating disorder or diabulimia have identified high levels of diabetes distress and provided insight into different motives for insulin omission and strategies for recovery. Considering the limited evidence for effective interventions, these findings may help the development of complex interventions to improve biomedical and psychological outcomes in this group.
C1 [Staite, E.; Zaremba, N.; Ismail, K.] Kings Coll London, Dept Psychol Med, Weston Educ Ctr, London, England.
   [Macdonald, P.; Treasure, J.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.
   [Allan, J.] Birkbeck Univ London, London, England.
   [Stadler, M.] Kings Coll London, Weston Educ Ctr, Diabet Res Grp, London, England.
RP Stadler, M (reprint author), Kings Coll London, Weston Educ Ctr, Diabet Res Grp, London, England.
EM Marietta.stadler@kcl.ac.uk
OI Zaremba, Natalie/0000-0002-1720-1621; ismail,
   khalida/0000-0001-6084-449X; Staite, Emily Rose/0000-0003-0414-9892
FU King's Health Partners; King's College London; National Institute of
   Health Research (NIHR) Mental Health Biomedical Research Centre at South
   London and Maudsley NHS Foundation Trust and King's College London;
   NIHR; Academy of Medical Sciences
FX E.S.'s salary was funded by King's Health Partners. N.Z.'s salary was
   part funded by King's College London. Parenting leave funds awarded to
   M.S., J.T. and K.I. are part funded by the National Institute of Health
   Research (NIHR) Mental Health Biomedical Research Centre at South London
   and Maudsley NHS Foundation Trust and King's College London. M.S. was
   funded through an NIHR Academic Clinical Lecturership, NIHR Clinician
   Scientist Fellowship and Academy of Medical Sciences Starter Grant for
   Clinical Lecturers (2017). The views expressed are those of the
   author(s) and not necessarily those of the NHS, the NIHR or the
   Department of Health.
CR Allan JA, 2015, J DIABETES NURS, V19, P99
   Anderson JG, 2017, J FAM NURS, V23, P34, DOI 10.1177/1074840716681289
   [Anonymous], 1996, DIABETES, V45, P1289
   [Anonymous], 2013, DIAGN STAT MAN MENT
   Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010
   Braun V., 2008, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Clery P, 2017, DIABETIC MED, V34, P1667, DOI 10.1111/dme.13509
   Davidson Jennifer, 2014, Nurs Stand, V29, P44, DOI 10.7748/ns.29.2.44.e7877
   de Groot M, 2016, AM PSYCHOL, V71, P552, DOI 10.1037/a0040408
   Dickinson JK, 2017, DIABETES CARE, V40, P1790, DOI 10.2337/dci17-0041
   Eynon R., 2009, TWENTY FIRST CENTURY, V4, P187, DOI DOI 10.1080/17450140903000308
   Feltbower RG, 2008, DIABETES CARE, V31, P922, DOI 10.2337/dc07-2029
   Garbett K, 2017, J HEALTH PSYCHOL, V22, P1755, DOI 10.1177/1359105316638549
   Goebel-Fabbri AE, 2008, DIABETES CARE, V31, P415, DOI 10.2337/dc07-2026
   Goebel-Fabbri AE, 2011, DIABETES CARE, V34, P545, DOI 10.2337/dc10-1547
   Griffiths S, 2015, INT J EAT DISORDER, V48, P775, DOI 10.1002/eat.22413
   Hanna K M, 2000, Issues Compr Pediatr Nurs, V23, P193
   Hookway N, 2008, QUAL RES, V8, P91, DOI 10.1177/1468794107085298
   Iturralde E, 2017, HEALTH PSYCHOL, V36, P236, DOI 10.1037/hea0000445
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Merwin RM, 2015, DIABETES CARE, V38, P2025, DOI 10.2337/dc15-0753
   Micali N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002646
   Miura A, 2007, J COMPUT-MEDIAT COMM, V12, P1452, DOI 10.1111/j.1083-6101.2007.00381.x
   Scheuing N, 2014, DIABETES CARE, V37, P1581, DOI 10.2337/dc13-2156
   Schulte EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117959
   Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6
   Stadler M, 2014, J CLIN ENDOCR METAB, V99, P4523, DOI 10.1210/jc.2014-2701
   Treasure J, 2015, DIABETIC MED, V32, P1541, DOI 10.1111/dme.12839
   Watson A, 2018, CANCER NURS, V41, P117, DOI 10.1097/NCC.0000000000000460
   Wilkinson D, 2011, SOC SCI COMPUT REV, V29, P387, DOI 10.1177/0894439310378979
NR 30
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2018
VL 35
IS 10
BP 1329
EP 1336
DI 10.1111/dme.13700
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GU5ME
UT WOS:000445328800004
PM 29855073
DA 2019-01-08
ER

PT J
AU Ochoa, CY
   Haardorfer, R
   Escoffery, C
   Stein, K
   Alcaraz, KI
AF Ochoa, Carol Y.
   Haardoerfer, Regine
   Escoffery, Cam
   Stein, Kevin
   Alcaraz, Kassandra I.
TI Examining the role of social support and spirituality on the general
   health perceptions of Hispanic cancer survivors
SO PSYCHO-ONCOLOGY
LA English
DT Article
DE cancer; cancer survivors; general health perception; health disparities;
   Hispanics; HRQOL; oncology; quality of life; social support;
   spirituality
ID QUALITY-OF-LIFE; BREAST-CANCER; INTERVIEW SURVEY; UNITED-STATES;
   DISPARITIES; SOCIETY; LATINA; SCALE; CARE; SATISFACTION
AB Objective: Although cancer survival rates continue to improve, overall disparities persist for ethnic minority survivors, who have a disproportionately high risk of experiencing poor quality of life, despite documented higher levels of self-reported spirituality. Yet little is known about the relationship between spirituality and social support and health outcomes among Hispanic survivors. This study examined (1) differences between Hispanic and non-Hispanic white survivors on health, social support, and spirituality and (2) the potential mediating roles of mental health and emotional distress on general health perceptions.
   Methods: We analyzed data (N = 7778) from the American Cancer Society's Study of Cancer Survivors-II, a national cross-sectional study of adult cancer survivors. Preliminary analysis compared sociodemographic and medical characteristics between the 2 groups to identify significant covariates. Structural equation modeling assessed whether mental health and emotional distress mediate the impact of social support and spirituality on Hispanics' general health perceptions.
   Results: Overall, 693 survivors were Hispanic and 7085 were non-Hispanic whites. Hispanics reported poorer health and were more likely to have comorbid conditions such as diabetes and depression compared with non-Hispanic whites. Structural equation modeling indicated that the impact of spirituality on general health perceptions was fully mediated through mental health. Emotional distress did not have a direct effect on general health perceptions nor did it mediate effects of spirituality and social support and on general health perceptions. There was a mediated effect of social support on general health perceptions.
   Conclusions: Spirituality is an important factor in the health of Hispanic survivors. Future studies should explore the impact and effectiveness of spiritual interventions and the beneficial effect for mental health on general health perceptions.
C1 [Ochoa, Carol Y.; Haardoerfer, Regine; Escoffery, Cam; Stein, Kevin] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, 2001 N Soto St, Los Angeles, CA 90033 USA.
   [Ochoa, Carol Y.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.
   [Alcaraz, Kassandra I.] Amer Canc Soc, Behav Res Ctr, Atlanta, GA 30329 USA.
RP Ochoa, CY (reprint author), Univ Southern Calif, Keck Sch Med, Dept Prevent Med, 2001 N Soto St, Los Angeles, CA 90033 USA.
EM caroloch@usc.edu
FU American Cancer Society (ACS) Studies of Cancer Survivors (SCS)
FX The American Cancer Society (ACS) Studies of Cancer Survivors (SCS) were
   funded as an intramural program of research conducted by the ACS
   Behavioral Research. Overall approval for SCS was obtained from the
   Institutional Review Board (IRB) of Emory University and from the IRBs
   and/or regulatory boards for each participating cancer registry. We wish
   to acknowledge the cooperation and efforts of the cancer registries and
   public health departments from the states of Arizona, California
   (Regions 2-6), Colorado, Delaware, Illinois, Iowa, Maine, Massachusetts,
   Michigan, Nebraska, New Jersey, Pennsylvania, Washington, and Wyoming.
   We also thank the staff of the hundreds of hospitals contributing cases
   to the participating cancer registries; their data made this research
   possible. Lastly, we salute the thousands of cancer survivors, their
   physicians, and their loved ones who contributed to the collection of
   these data. The authors assume full responsibility for analyses and
   interpretation of these data.
CR American Cancer Society, 2015, CANC FACTS FIG HISP
   Bai M, 2015, J PALLIAT MED, V18, P286, DOI 10.1089/jpm.2014.0189
   Brady MJ, 1999, PSYCHO-ONCOLOGY, V8, P417, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<417::AID-PON398>3.3.CO;2-W
   Canada AL, 2013, J BEHAV MED, V36, P441, DOI 10.1007/s10865-012-9439-8
   Clarke TC, 2015, ANN EPIDEMIOL, V25, P832, DOI 10.1016/j.annepidem.2015.07.011
   COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310
   Culliford L, 2002, BRIT MED J, V325, P1434, DOI 10.1136/bmj.325.7378.1434
   Eversley R, 2005, ONCOL NURS FORUM, V32, P250, DOI 10.1188/05.ONF.250-256
   Healthy People, 2020, HLTH REL QUAL LIF WE
   IBM Corp., 2015, IBM SPSS STAT WIND V
   Kline R. B., 2015, PRINCIPLES PRACTICE
   Lazarus RS, 1984, FS STRESS APPRAISAL
   Lopez-Class M, 2012, PSYCHO-ONCOLOGY, V21, P115, DOI 10.1002/pon.1998
   Lopez-Class M, 2011, J CANCER EDUC, V26, P724, DOI 10.1007/s13187-011-0249-4
   Luckett T, 2011, LANCET ONCOL, V12, P1240, DOI 10.1016/S1470-2045(11)70212-1
   Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24
   Mukwato K. P., 2010, MED J ZAMBIA, V37, P40
   Muthen L.K., 2012, MPLUS VERSION 7 USER
   Napoles AM, 2017, J COMMUNITY SUPPORT, V15, P20, DOI 10.12788/jcso.0325
   Nelson C, 2009, ANN BEHAV MED, V38, P105, DOI 10.1007/s12160-009-9139-y
   Niu XL, 2013, CANCER MED-US, V2, P403, DOI 10.1002/cam4.84
   Prince P, 2015, J PSYCHOSOC ONCOL, V33, P635, DOI 10.1080/07347332.2015.1082167
   Rim SH, 2016, EXPERT REV PHARM OUT, V16, P579, DOI 10.1080/14737167.2016.1239533
   Ross LE, 2008, J ALTERN COMPLEM MED, V14, P931, DOI 10.1089/acm.2007.0788
   Sammarco A, 2008, ONCOL NURS FORUM, V35, P844, DOI 10.1188/08.ONF.844-849
   Sammarco A, 2010, ONCOL NURS FORUM, V37, P93, DOI 10.1188/10.ONF.93-99
   Short PF, 2006, MED CARE, V44, P16, DOI 10.1097/01.mlr.0000188986.84819.3a
   Smith T, 2007, CANCER, V109, P1, DOI 10.1002/cncr.22387
   Stephens C, 2010, PSYCHO-ONCOLOGY, V19, P376, DOI 10.1002/pon.1566
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Weaver KE, 2012, CANCER EPIDEM BIOMAR, V21, P2108, DOI 10.1158/1055-9965.EPI-12-0740
   Weaver KE, 2010, CANCER-AM CANCER SOC, V116, P3493, DOI 10.1002/cncr.25209
   Wildes KA, 2009, PSYCHO-ONCOLOGY, V18, P831, DOI 10.1002/pon.1475
   Zhao LH, 2009, J PAIN SYMPTOM MANAG, V37, P676, DOI 10.1016/j.jpainsymman.2008.04.011
   ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17
   Zlatar ZZ, 2015, PSYCHO-ONCOLOGY, V24, P241, DOI 10.1002/pon.3600
NR 37
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1057-9249
EI 1099-1611
J9 PSYCHO-ONCOLOGY
JI Psycho-Oncol.
PD SEP
PY 2018
VL 27
IS 9
BP 2189
EP 2197
DI 10.1002/pon.4795
PG 9
WC Oncology; Psychology; Psychology, Multidisciplinary; Social Sciences,
   Biomedical
SC Oncology; Psychology; Biomedical Social Sciences
GA GV5WH
UT WOS:000446175500016
PM 29900621
DA 2019-01-08
ER

PT J
AU Roy, M
   Sengupta, N
   Sahana, PK
   Das, C
   Talukdar, P
   Baidya, A
   Goswami, S
AF Roy, Mukut
   Sengupta, Nilanjan
   Sahana, Pranab Kumar
   Das, Chanchal
   Talukdar, Payel
   Baidya, Arjun
   Goswami, Soumik
TI Type 2 diabetes and influence of diabetes-specific distress on
   depression
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
ID CLINICAL DEPRESSION; GLYCEMIC CONTROL; METAANALYSIS; INVENTORY;
   PREVALENCE; ADULTS; CARE
AB AIMS: Common psycho-social emotional reactions of patients with diabetes may be termed as diabetes-specific distress which is conceptually distinctive from depression. In patients with type 2 diabetes, different screening methods for depression may get influenced by simultaneous presence of diabetes distress. This study was planned to assess magnitude and relationship of depression and diabetes specific distress in patients with type 2 diabetes.
   Methods: Two hundred and fifty (250) adult patients with type 2 diabetes (T2DM) were assessed for depression based on Beck Depression Inventory (BDI) and Diagnostic and Statistical Manual, Fourth edition (DSM IV) criteria. Diabetes specific distress was assessed as per Diabetes Distress Scale (DDS) score.
   Results: Among study population of 250 adult T2DM patients, based on BDI score, 97 (38.8%) patients were found to suffer from depression and based on DSM IV criteria, prevalence of depression was 29.2%. A total of 62 (24.8%) patients were found to suffer from diabetes specific distress based on DDS score. Patients with severe diabetes specific distress had associated matching of symptoms with mild depression based on BDI score which was also statistically significant (p < 0.0001). However, these same individuals were non-depressed as per DSM-IV criteria.
   Conclusion: Recognizing depression with self-administered questionnaires may be influenced by concomitant presence of symptoms due to diabetes specific distress. Therefore, proper diagnosis of depression may be established by structured clinical interview and psycho-social management of type 2 diabetes should possibly include both assessment of depression and diabetes specific distress. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Roy, Mukut] Tripura Med Coll, Dept Med, Agartala 799014, Tripura, India.
   [Roy, Mukut] DRBRAM Teaching Hosp, Agartala 799014, Tripura, India.
   [Roy, Mukut; Sengupta, Nilanjan; Sahana, Pranab Kumar; Baidya, Arjun; Goswami, Soumik] Nilratan Sircar Med Coll, Dept Endocrinol, Kolkata, W Bengal, India.
   [Das, Chanchal] West Bengal Hlth Serv, Kolkata, India.
   [Das, Chanchal; Talukdar, Payel] Nilratan Sircar Med Coll, Dept Psychiat, Kolkata, W Bengal, India.
RP Roy, M (reprint author), Tripura Med Coll, Dept Med, Agartala 799014, Tripura, India.; Roy, M (reprint author), DRBRAM Teaching Hosp, Agartala 799014, Tripura, India.
EM mukutdoc@gmail.com
CR Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-s064, 10.2337/dc12-S064]
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bajaj Sarita, 2012, Indian J Endocrinol Metab, V16, P759, DOI 10.4103/2230-8210.100670
   Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
   First MB, 1995, J PERSONALITY DISORD, V9, P2
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Joseph Nitin, 2013, Indian J Endocrinol Metab, V17, P681, DOI 10.4103/2230-8210.113761
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P24, DOI 10.1097/00006842-199701000-00004
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mathew Cynthia Susan, 2012, Indian J Endocrinol Metab, V16, P764, DOI 10.4103/2230-8210.100671
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Raval A, 2010, INDIAN J MED RES, V132, P195
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Zhang J, 2013, NEUROPSYCH DIS TREAT, V9, P1289, DOI 10.2147/NDT.S49798
NR 23
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2018
VL 143
BP 194
EP 198
DI 10.1016/j.diabres.2018.07.006
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GU2VR
UT WOS:000445129900023
PM 30009934
DA 2019-01-08
ER

PT J
AU Humayun, MA
   Jenkins, E
   Knott, J
   Ryder, J
   Shaban, C
   Weiss, M
   Charman, J
   Cavan, D
   Brooks, A
AF Humayun, Malik Asif
   Jenkins, Emma
   Knott, Julia
   Ryder, Jacky
   Shaban, Clare
   Weiss, Melanie
   Charman, Julie
   Cavan, David
   Brooks, Augustin
TI Intensive structured education for type 1 diabetes management using
   BERTIE: Long-term follow-up to assess impact on glycaemic control and
   quality of life indices
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Structured education; BERTIE
ID ROUTINE CARE; PROGRAM; DISTRESS
AB Aims: Bournemouth Type 1 Intensive Education (BERTIE) is a structured education course delivered 1 day a week for 4 weeks for self-management of type 1 diabetes. BERTIE outcomes were analysed to assess long-term effectiveness: primary outcome assessed impact of BERTIE on glycaemic control, secondary outcomes assessed impact on Problem Area in Diabetes (PAID) scale, severe hypoglycaemia and diabetic ketoacidosis incidence (DKA).
   Methods: Prospectively collected outcome data from attendees included glycated haemoglobin (HbA1c), PAID, severe hypoglycaemia and DKA incidence recorded pre-course, 6 months and 1 year post-attendance, with HbA1c assessed annually at subsequent clinic visits.
   Results: Between 1999 and 2015, 524 people attended BERTIE with 5 year follow-up in 316 (60.3%) attendees. HbA1c was reduced from 74 +/- 17 mmol/mol (8.9 +/- 1.6%) at baseline to 71 +/- 15 mmol/mol (8.6 +/- 1.4%) at 1 year and 70 +/- 15 mmol/mol (8.6 +/- 1.3%) at 5 years (p < 0.0001); severe hypoglycaemia incidence reduced from 0.8 +/- 2.1 to 0.4 +/- 2.2 episodes/person/year at 1 year (p < 0.0001); PAID scale reduced from 23 +/- 16 to 15 +/- 12 (p < 0.0001) at 1 year; DKA incidence was 0.06 +/- 0.34 episodes/person/year pre-course and 0.03 +/- 0.21 at 1 year (p = 0.5271).
   Conclusions: BERTIE outcome data demonstrate favorable biochemical and psychological outcomes supporting recommendations that structured education be provided to adults with type 1 diabetes. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Humayun, Malik Asif; Jenkins, Emma; Knott, Julia; Ryder, Jacky; Shaban, Clare; Weiss, Melanie; Charman, Julie; Cavan, David; Brooks, Augustin] Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Castle Lane East, Bournemouth BH7 7DW, Dorset, England.
RP Brooks, A (reprint author), Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Castle Lane East, Bournemouth BH7 7DW, Dorset, England.
EM Augustin.Brooks@rbch.nhs.uk
OI Humayun, Malik Asif/0000-0003-3313-303X
CR Amiel S, 2002, BRIT MED J, V325, P746
   Bandura A., 1977, SOCIAL LEARNING THEO
   Cooke D, 2013, DIABETES CARE, V36, P270, DOI 10.2337/dc12-0080
   Elliott J, 2014, DIABETIC MED, V31, P847, DOI 10.1111/dme.12441
   Gunn D, 2012, DIABETIC MED, V29, P807, DOI 10.1111/j.1464-5491.2011.03525.x
   Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579
   Lowe J, 2008, DIABETES RES CLIN PR, V80, P439, DOI 10.1016/j.diabres.2008.02.003
   MUHLHAUSER I, 1983, DIABETOLOGIA, V25, P470
   MUHLHAUSER I, 1987, DIABETOLOGIA, V30, P681, DOI 10.1007/BF00296989
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Reas DL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-269
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Speight J, 2010, DIABETES RES CLIN PR, V89, P22, DOI 10.1016/j.diabres.2010.03.017
   Speight J, 2016, DIABETES RES CLIN PR, V112, P65, DOI 10.1016/j.diabres.2015.11.002
NR 14
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2018
VL 143
BP 275
EP 281
DI 10.1016/j.diabres.2018.07.034
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GU2VR
UT WOS:000445129900034
PM 30076871
DA 2019-01-08
ER

PT J
AU Aghili, R
   Ridderstrale, M
   Farshchi, A
   Valojerdi, AE
   Banazadeh, Z
   Malek, M
   Kia, M
   Khamseh, ME
AF Aghili, Rokhsareh
   Ridderstrale, Martin
   Farshchi, Amir
   Valojerdi, Ameneh Ebrahim
   Banazadeh, Zahra
   Malek, Mojtaba
   Kia, Maryam
   Khamseh, Mohammad Ebrahim
TI Psychosocial factors and glycemic control in insulin-naive and
   insulin-experienced people with type 2 diabetes: a path analysis model
SO INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES
LA English
DT Article
DE Diabetes; type 2; Psychosocial; Glycemic control
ID CLINICAL INERTIA; DEPRESSION; BARRIERS; CARE; PREVALENCE; MANAGEMENT;
   KNOWLEDGE; DISTRESS; THERAPY; METAANALYSIS
AB The purpose of this study was to compare the status of psychosocial factors and glycemic control in insulin-naive and insulin-experienced people with type 2 diabetes (T2D). In this observational study on people with T2D, demographic, self-care behavior, resources, and affective variables as well as health-related quality of life were assessed and compared in insulin-naive and insulin-experienced considering the number of oral glucose-lowering drugs (OGLDs). Measured variable path analysis was used to test the association among variables and their effect on HbA1c in both groups. In total, 215 insulin-naive and 165 insulin-experienced patients were recruited in this study. The mean duration of diabetes was 11.7 +/- 7.0years in insulin-experienced and 6.8 +/- 5.4years in insulin-naive (p<0.001). The mean hemoglobin A1c (HbA1c) was significantly higher in insulin-experienced subjects irrespective of the number of OGLDs [68 +/- 20mmol/mol (8.4 +/- 1.8%) vs. 56 +/- 16mmol/mol (7.3 +/- 1.4%); p<0.001]. Moreover, insulin-experienced subjects had significantly higher level of diabetes-related distress (2.2 +/- 0.9 vs. 1.9 +/- 0.8), depression (9.5 +/- 5.5 vs. 8.1 +/- 5.1), anxiety (18.3 +/- 12.0 vs. 15.1 +/- 10.5), and lower knowledge of insulin use considering the results of 9-item insulin-use subscale of Michigan diabetes knowledge test (mean 3.9 +/- 1.8) compared to insulin-naive subjects (p<0.05). Higher levels of distress, depression, and anxiety are found in insulin-experienced people with T2D. Therefore, one should be aware that, at the time of insulin need/initiation, people with T2D have reached a more vulnerable state and this should be taken into consideration when implementing a complex insulin initiation plan.
C1 [Aghili, Rokhsareh; Farshchi, Amir; Valojerdi, Ameneh Ebrahim; Khamseh, Mohammad Ebrahim] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, 10 Firoozeh St,South Vali Asr Ave,Vali Asr Sq, Tehran, Iran.
   [Ridderstrale, Martin] Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, Clin Obes, S-20502 Malmo, Sweden.
   [Banazadeh, Zahra] Iran Univ Med Sci, Lolagar Hosp, Tehran, Iran.
   [Malek, Mojtaba] Iran Univ Med Sci, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran.
   [Kia, Maryam] Univ Tehran Med Sci, Ziaeian Hosp, Dept Internal Med, Tehran, Iran.
RP Khamseh, ME (reprint author), Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, 10 Firoozeh St,South Vali Asr Ave,Vali Asr Sq, Tehran, Iran.
EM aghili.r@tak.iums.ac.ir; martin.ridderstrale@med.lu.se;
   farshchi_a@razi.tums.ac.ir; ebrahimv86@gmail.com;
   zahrabanazadeh@yahoo.com; malek.m@iums.ac.ir; mkia220@gmail.com;
   khamseh.m@iums.ac.ir
RI Khamseh, Mohammad Ebrahim/L-9391-2018
FU Iran University of Medical Sciences [93-02-122-24800]
FX This study was funded and supported by the Iran University of Medical
   Sciences, grant number: 93-02-122-24800. The authors wish to thank all
   people who participated in this study.
CR Abu Hassan H, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-164
   Aghili R, 2016, CAN J DIABETES, V40, P424, DOI 10.1016/j.jcjd.2016.02.014
   American Diabetes A. 6, 2017, DIABETES CARE S1, V40, pS48, DOI DOI 10.2337/DC17-S009
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005
   Byrne B. M., 2013, STRUCTURAL EQUATION
   Camara A, 2015, DIABETES METAB, V41, P62, DOI 10.1016/j.diabet.2014.04.007
   Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Dalal MR, 2017, ADV THER, V34, P2083, DOI 10.1007/s12325-017-0592-x
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   Harris SB, 2010, CAN FAM PHYSICIAN, V56, pE418
   Holmes-Truscott E, 2016, PRIM CARE DIABETES, V10, P75, DOI 10.1016/j.pcd.2015.06.006
   Home P, 2011, DIABETES RES CLIN PR, V94, P352, DOI 10.1016/j.diabres.2011.10.021
   Janes R, 2013, J PRIM HEALTH CARE, V5, P114, DOI 10.1071/HC13114
   Jasper US, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-10
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Kaviani H, 2008, TEHRAN U MED J, V66, P136
   Khamseh ME, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-61
   Khodapanahi MK, 2009, J FAMILY RES, V5, P423
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Limaye TY, 2016, INT J DIABETES DEV C, V36, P263, DOI 10.1007/s13410-015-0367-3
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-125
   Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348
   Pieber TR, 2000, DIABETES CARE, V23, P157, DOI 10.2337/diacare.23.2.157
   Reach G, 2017, DIABETES METAB, V43, P501, DOI 10.1016/j.diabet.2017.06.003
   Reaney M, 2013, DIABETES SPECTR, V26, P236
   Ross SA, 2011, CURR MED RES OPIN, V27, P13, DOI 10.1185/03007995.2011.621416
   Rushforth B, 2016, BRIT J GEN PRACT, V66, pE114, DOI 10.3399/bjgp16X683509
   Russell-Jones D, 2007, DIABETES OBES METAB, V9, P799, DOI 10.1111/j.1463-1326.2006.00686.x
   Tong WT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006407
   van Raalte DH, 2017, DIABETES OBES METAB, V19, P1205, DOI 10.1111/dom.12935
   Vanderlee L, 2016, INT J DIABETES DEV C, V36, P320, DOI 10.1007/s13410-015-0460-7
   Vasheghani-Farahani Ali, 2011, Asian J Sports Med, V2, P106
   Wallace TM, 2000, QJM-MON J ASSOC PHYS, V93, P369, DOI 10.1093/qjmed/93.6.369
   Weinger K, 2010, DIABETES CARE, V33, P450, DOI 10.2337/dc09-2132
NR 43
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0973-3930
EI 1998-3832
J9 INT J DIABETES DEV C
JI Int. Diabetes Dev. Ctries.
PD SEP
PY 2018
VL 38
IS 3
BP 289
EP 297
DI 10.1007/s13410-017-0581-2
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GS8ZZ
UT WOS:000444005700004
DA 2019-01-08
ER

PT J
AU Kilpatrick, M
   Nelson, M
   Palmer, A
   Jose, K
   Venn, A
AF Kilpatrick, Michelle
   Nelson, Mark
   Palmer, Andrew
   Jose, Kim
   Venn, Alison
TI Who discusses reaching a healthy weight with a general practitioner?
   Findings from the 2014-15 Australian National Health Survey
SO OBESITY RESEARCH & CLINICAL PRACTICE
LA English
DT Article
DE Primary care; Obesity; Weight management
ID PRIMARY-CARE; BRIEF INTERVENTION; YOUNG-ADULTS; MANAGEMENT; OBESITY;
   OVERWEIGHT; BEHAVIORS; FUTURE; TRIAL
AB Objective: General practitioners (GPs) can positively impact upon patient intentions to lose weight and weight management, and are important in the referral pathway to specialist weight-loss programs and surgical interventions. The aim of this study was to investigate the characteristics and proportions of Australians who report talking to a GP about weight management.
   Methods: Cross-sectional data from 15,329 participants aged 15 years and over in the 2014-15 Australian National Health Survey were used. Proportions (with 95% confidence intervals (95%CI)) of respondents who reported discussing reaching a healthy weight with a GP in the previous 12 months were estimated, categorised by demographic, social and health characteristics.
   Results: We found that 10.8% (95%CI:9.8-11.8) of overweight participants, 24.4% (95%CI:22.7-26.4) with Class 1 obesity (30 <= BMI < 35 kg/m(2)) and 41.8% (95%CI:38.3-45.3) with Classes II/III obesity (BMI >= 35 kg/m(2)) reported discussing weight with a GP. Higher proportions of respondents with Class II/Class III obesity and poor/fair self-reported health (50.2%, 95%CI:43.3-57.0), or high/very high levels of psychological distress (53.3%, 95%CI:43.7-61.4), or diabetes ( 64.8%, 95%CI:51.9-77.3) reported discussing weight. As age, number of GP visits, or comorbid conditions increased, the proportions of people who discussed their weight with a GP also increased, across all weight classes.
   Conclusions: While discussions are more likely with increasing BMI and comorbidities, most Australians with overweight and obesity appear to be missing opportunities to discuss reaching a healthy weight with their GP. Policies, training and education programs to encourage this dialogue could lead to earlier and more beneficial weight-related interventions. (C) 2018 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.
C1 [Kilpatrick, Michelle; Nelson, Mark; Palmer, Andrew; Jose, Kim; Venn, Alison] Univ Tasmania, Menzies Inst Med Res, Med Sci 1 Bldg,Private Bag 23, Hobart, Tas 7000, Australia.
RP Venn, A (reprint author), Univ Tasmania, Menzies Inst Med Res, Med Sci 1 Bldg,Private Bag 23, Hobart, Tas 7000, Australia.
EM Alison.Venn@utas.edu.au
OI , Mark/0000-0001-9941-7161
FU National Health and Medical Research Council [APP1076899]
FX The research has been supported by a Partnership Project grant
   (APP1076899) from the National Health and Medical Research Council.
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   [Anonymous], 2013, SUMM GUID MAN OV OB
   Ashman Freya, 2016, Int J Family Med, V2016, P8212837, DOI 10.1155/2016/8212837
   Australian Bureau of Statistics, 2015, NAT HLTH SURV 1 RES
   Australian Bureau of Statistics, 2017, NAT HLTH SURV US GUI
   Australian Institute of Health and Welfare, 2017, AUS BURD DIS STUD SE
   Aveyard P, 2016, LANCET, V388, P2492, DOI 10.1016/S0140-6736(16)31893-1
   Beeken RJ, 2017, INT J OBESITY, V41, P246, DOI 10.1038/ijo.2016.206
   Bonney A, 2017, AUST FAM PHYSICIAN, V46, P928
   Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369
   Chauhan BF, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0568-x
   Daly M, 2017, PSYCHOL SCI, V28, P872, DOI 10.1177/0956797617696311
   Dewhurst A, 2017, PATIENT EDUC COUNS, V100, P897, DOI 10.1016/j.pec.2016.12.017
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Galuska DA, 1999, JAMA, V282
   Hayden MJ, 2008, AUST J PRIM HEALTH, V14, P9, DOI 10.1071/PY08031
   Hayes AJ, 2017, INT J OBESITY, V41, P178, DOI 10.1038/ijo.2016.165
   Haynes A, 2018, OBES REV, V19, P347, DOI 10.1111/obr.12634
   Hemmes RA, 2016, CLIN OBES, V6, P202, DOI 10.1111/cob.12143
   Herbert J, 2017, OBES RES CLIN PRACT, V11, P414, DOI 10.1016/j.orcp.2016.12.009
   Jackson SE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003693
   Lanoye A, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0938-4
   LaRose JG, 2013, OBESITY, V21, P449, DOI 10.1002/oby.20053
   Laska MN, 2012, J ADOLESCENT HEALTH, V50, P324, DOI 10.1016/j.jadohealth.2012.01.016
   Lewis AL, 2013, CURR OBES REP, V2, P341, DOI 10.1007/s13679-013-0073-8
   McDonald J, 2008, MED J AUSTRALIA, V188, pS69
   Michie Susan, 2007, Psychol Health Med, V12, P521, DOI 10.1080/13548500701203441
   Rose SA, 2013, INT J OBESITY, V37, P118, DOI 10.1038/ijo.2012.24
   Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263
   Sturgiss E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014314
   Tan D, 2006, MED J AUSTRALIA, V185, P73
   Tang JW, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-31
   Truesdale KP, 2006, INT J OBESITY, V30, P1397, DOI 10.1038/sj.ijo.0803307
   Turner LR, 2015, MED J AUSTRALIA, V202, P370, DOI 10.5694/mja14.00998
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1871-403X
EI 1878-0318
J9 OBES RES CLIN PRACT
JI Obes. Res. Clin. Pract.
PD SEP-OCT
PY 2018
VL 12
IS 5
BP 459
EP 464
DI 10.1016/j.orcp.2018.07.003
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA GT4CD
UT WOS:000444450500010
PM 30033355
DA 2019-01-08
ER

PT J
AU Vesco, AT
   Feldman, MA
   Evans, MA
   Weissberg-Benchell, J
AF Vesco, Anthony T.
   Feldman, Marissa A.
   Evans, Meredyth A.
   Weissberg-Benchell, Jill
TI Parent-Adolescent Dyadic Diabetes Distress: Associations With A1c and
   Diabetes-Related Strengths
SO FAMILIES SYSTEMS & HEALTH
LA English
DT Article
DE adolescent; diabetes mellitus; type 1; emotional stress; family systems
ID QUALITY-OF-LIFE; RESPONSE-SURFACE ANALYSIS; FAMILY SYSTEMS THERAPY;
   GLYCEMIC CONTROL; METABOLIC-CONTROL; SELF-EFFICACY; TYPE-1; PERCEPTIONS;
   MANAGEMENT; CONFLICT
AB Introduction: This study examined concordance and discordance between parent-adolescent report of diabetes-specific emotional distress and associations with A1c and diabetes-related strengths. Diabetes strengths refer to adaptive behaviors and attitudes that enhance resilience in living with diabetes. Method: One thousand two hundred sixteen adolescent-parent dyads completed measures of diabetes distress and adolescent-reported diabetes strengths. Polynomial regression with response surface analysis assessed concordant and discordant reports of adolescent-parent distress and independent associations of each reporter's distress on measures of diabetes strengths and A1c. Results: A1c was lower in concordantly lower distress dyads compared to concordantly higher distress dyads. For discordant dyadic reports, A1c was higher when distress was higher for parents and lower for adolescents compared to low-parent-high-adolescent distress. Greater diabetes-related strengths were reported when distress was concordantly low among dyads and fewer strengths were reported when distress was concordantly higher. Greater strengths were reported when distress was lower for adolescents and higher for parents compared to high-adolescent/low-parent distress. Dyadic distress for both A1c and diabetes strengths were robust when adjusted for significant demographic predictors of outcome including age, race, income, pump use, and continuous glucose monitoring use. Discussion: A1c and diabetes strengths are associated with degree of concordant and discordant reports of diabetes distress among adolescent-parent dyads. Programmatic interventions should target parents and adolescents, particularly when diabetes distress is higher among both adolescents and their parents.
C1 [Vesco, Anthony T.; Feldman, Marissa A.; Evans, Meredyth A.; Weissberg-Benchell, Jill] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Psychiat & Behav Hlth, Chicago, IL 60611 USA.
   [Feldman, Marissa A.; Evans, Meredyth A.; Weissberg-Benchell, Jill] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA.
RP Vesco, AT (reprint author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Psychiat, 225 East Chicago Ave,Mailbox 10A, Chicago, IL 60611 USA.
EM avesco@luriechildrens.org
FU Helmsley Charitable Trust Foundation
FX This research was supported in part by a grant from the Helmsley
   Charitable Trust Foundation.
CR Anderson BJ, 2009, FAM SYST HEALTH, V27, P141, DOI 10.1037/a0015759
   Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713
   Bogenschneider K, 2008, J MARRIAGE FAM, V70, P1015, DOI 10.1111/j.1741-3737.2008.00543.x
   Cook S, 2002, DIABETES EDUCATOR, V28, P115, DOI 10.1177/014572170202800113
   De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498
   Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   Hains AA, 2007, J PEDIATR PSYCHOL, V32, P561, DOI 10.1093/jpepsy/jsl040
   Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079
   Hilliard ME, 2017, J PEDIATR PSYCHOL, V42, P995, DOI 10.1093/jpepsy/jsx086
   Hilliard ME, 2016, AM PSYCHOL, V71, P590, DOI 10.1037/a0040359
   Hilliard ME, 2015, J PEDIATR PSYCHOL, V40, P835, DOI 10.1093/jpepsy/jsv072
   Hilliard ME, 2013, HEALTH PSYCHOL, V32, P388, DOI 10.1037/a0027811
   Hilliard ME, 2012, CURR DIABETES REP, V12, P739, DOI 10.1007/s11892-012-0314-3
   Human LJ, 2016, J YOUTH ADOLESCENCE, V45, P2022, DOI 10.1007/s10964-016-0517-z
   Jaser SS, 2017, ANN BEHAV MED, V51, P30, DOI 10.1007/s12160-016-9825-5
   Jaser SS, 2014, MATERN CHILD HLTH J, V18, P101, DOI 10.1007/s10995-013-1239-4
   Laffel LMB, 2003, DIABETES CARE, V26, P3067, DOI 10.2337/diacare.26.11.3067
   Law GU, 2013, J PSYCHOSOM RES, V74, P334, DOI 10.1016/j.jpsychores.2012.12.009
   Miller VA, 2003, J PEDIATR PSYCHOL, V28, P265, DOI 10.1093/jpepsy/jsg014
   Nouwen A, 2009, PSYCHOL HEALTH, V24, P1071, DOI 10.1080/08870440802254597
   Ohannessian CM, 2000, INT J BEHAV DEV, V24, P362, DOI 10.1080/01650250050118358
   Rybak TM, 2017, J PEDIATR PSYCHOL, V42, P40, DOI 10.1093/jpepsy/jsw071
   Shanock LR, 2010, J BUS PSYCHOL, V25, P543, DOI 10.1007/s10869-010-9183-4
   Vesco AT, 2010, J PEDIATR PSYCHOL, V35, P1168, DOI 10.1093/jpepsy/jsq038
   Weissberg-Benchell J, 2014, AM DIAB ASS 74 SCI S
   Weissberg-Benchell J, 2017, PEDIATR DIABETES, V18, P853, DOI 10.1111/pedi.12499
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Wysocki T, 1996, DIABETES CARE, V19, P119, DOI 10.2337/diacare.19.2.119
   Wysocki T, 2008, BEHAV THER, V39, P33, DOI 10.1016/j.beth.2007.04.001
   Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P928, DOI 10.1093/jpepsy/jsj098
NR 33
TC 0
Z9 0
U1 2
U2 2
PU EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA
SN 1091-7527
EI 1939-0602
J9 FAM SYST HEALTH
JI Fam. Syst. Health
PD SEP
PY 2018
VL 36
IS 3
BP 357
EP 367
DI 10.1037/fsh0000358
PG 11
WC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
SC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
GA GT0LJ
UT WOS:000444131900010
PM 29999340
DA 2019-01-08
ER

PT J
AU Tanaka, N
   Yabe, D
   Murotani, K
   Ueno, S
   Kuwata, H
   Hamamoto, Y
   Kurose, T
   Takahashi, N
   Akashi, T
   Matsuoka, T
   Osonoi, T
   Minami, M
   Shimono, D
   Seino, Y
AF Tanaka, Nagaaki
   Yabe, Daisuke
   Murotani, Kenta
   Ueno, Shinji
   Kuwata, Hitoshi
   Hamamoto, Yoshiyuki
   Kurose, Takeshi
   Takahashi, Nobuo
   Akashi, Tomoyuki
   Matsuoka, Takashi
   Osonoi, Takeshi
   Minami, Masae
   Shimono, Dai
   Seino, Yutaka
CA Positive SMBG Study Grp
TI Mental distress and health-related quality of life among type 1 and type
   2 diabetes patients using self-monitoring of blood glucose: A
   cross-sectional questionnaire study in Japan
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Education; Health-related quality of life; Self-monitoring of blood
   glucose
ID RANDOMIZED CONTROLLED-TRIAL; IMPACT
AB Aims/IntroductionThe present multicenter, cross-sectional survey was initiated to evaluate self-monitoring of blood glucose (SMBG)-associated mental distress among patients with diabetes.
   Materials and MethodsThe survey was carried out in patients with type 1 diabetes and type 2 diabetes using SMBG recruited from 42 medical institutions. Profiles of Mood States 2 and diabetes therapy-related quality of life questionnaires were used to evaluate mood status and health-related quality of life. Two original questionnaires were also developed to evaluate SMBG importance,' painfulness' and confidence' among patients, and to evaluate physician attitudes to SMBG use.
   ResultsQuestionnaires from 517 type 1 diabetes and 1,648 type 2 diabetes patients showed that 46.0% of type 1 diabetes and 37.5% of type 2 diabetes patients reported painfulness,' and that these patients reporting painfulness' showed significantly higher Profiles of Mood States 2 scores, lower diabetes therapy-related quality of life scores and higher glycated hemoglobin compared with those not reporting painfulness,' whereas the number of their daily SMBG tests were comparable. Patients reporting painfulness' also reported that SMBG use was significantly less important. Whether or not patients recognized the importance of SMBG use was well correlated with the frequency of physicians checking patient diaries.
   ConclusionsType 1 diabetes and type 2 diabetes patients reporting painfulness' in SMBG use had more mental distress, lower health-related quality of life and higher glycated hemoglobin regardless of their number of daily SMBG tests. The importance of SMBG use was recognized less by patients experiencing pain, and the importance of SMBG use was recognized more in medical institutions in which physicians regularly checked SMBG diaries to provide meaningful feedback to patients in clinical settings.
C1 [Tanaka, Nagaaki; Yabe, Daisuke; Ueno, Shinji; Kuwata, Hitoshi; Hamamoto, Yoshiyuki; Kurose, Takeshi; Seino, Yutaka] Kansai Elect Power Med Res Inst, Yutaka Seino Distinguished Ctr Diabet Res, Kobe, Hyogo, Japan.
   [Tanaka, Nagaaki; Ueno, Shinji; Kuwata, Hitoshi; Hamamoto, Yoshiyuki; Kurose, Takeshi; Seino, Yutaka] Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Osaka, Japan.
   [Murotani, Kenta] Aichi Med Univ Hosp, Div Biostat, Clin Res Ctr, Nagakute, Aichi, Japan.
   [Hamamoto, Yoshiyuki] Kansai Elect Power Hosp, Ctr Metab & Clin Nutr, Osaka, Japan.
   [Takahashi, Nobuo] Takahashi Family Clin, Nagoya, Aichi, Japan.
   [Akashi, Tomoyuki] Shimada Hosp, Ogori, Japan.
   [Matsuoka, Takashi] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan.
   [Osonoi, Takeshi] Nakakinen Clin, Naka, Ibaraki, Japan.
   [Minami, Masae] Masae Minami Clin, Fukuoka, Japan.
   [Shimono, Dai] Futata Tetsuhiro Clin, Fukuoka, Japan.
RP Seino, Y (reprint author), Kansai Elect Power Med Res Inst, Yutaka Seino Distinguished Ctr Diabet Res, Kobe, Hyogo, Japan.; Seino, Y (reprint author), Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Osaka, Japan.
EM seino.yutaka@e2.kepco.co.jp
OI Yabe, Daisuke/0000-0002-5334-7687
FU Terumo Corporation
FX The authors are grateful to H Abe of Kansai Electric Power Medical
   Research Institute and M Yamane of Kansai Electric Power Hospital for
   secretarial assistance. The authors also deeply thank the patients and
   colleagues who contributed to this study. This study was funded by
   Terumo Corporation.
CR Al Hayek AA, 2017, DIABETES THER, V8, P75, DOI 10.1007/s13300-016-0221-8
   American Diabetes Association, 2017, Diabetes Care, V40, pS33
   Educators AAoD, 2008, DIABETES ED, V2008, P445
   Farmer A, 2007, BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE
   Franciosi M, 2001, DIABETES CARE, V24, P1870, DOI 10.2337/diacare.24.11.1870
   Heinemann Lutz, 2008, J Diabetes Sci Technol, V2, P919
   Heuchert J. P, 2012, PROFILE MOOD STATES
   Iga R, 2017, DIABETES THER, V8, P783, DOI 10.1007/s13300-017-0269-0
   International Diabetes Federation, 2015, IDF DIABETES ATLAS
   Ishii Hitoshi, 2012, J Med Econ, V15, P556, DOI 10.3111/13696998.2012.665111
   Malanda UL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005060.pub3
   Miller KM, 2013, DIABETES CARE, V36, P2009, DOI 10.2337/dc12-1770
   O'Kane MJ, 2008, BRIT MED J, V336, P1174, DOI 10.1136/bmj.39534.571644.BE
   Okada M, 2015, J PHARM HEALTH CARE, V1, DOI 10.1186/s40780-015-0027-2
   Peel E, 2007, BRIT MED J, V335, P493, DOI 10.1136/bmj.39302.444572.DE
   Polonsky WH, 2013, DIABETES CARE, V36, P179, DOI 10.2337/dc12-0731
   Polonsky WH, 2011, DIABETES CARE, V34, P262, DOI 10.2337/dc10-1732
   Russo GT, 2016, DIABETES TECHNOL THE, V18, P421, DOI 10.1089/dia.2015.0358
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Statement AP  Education DS, 2014, DIABETES ED, V33, P45
NR 20
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD SEP
PY 2018
VL 9
IS 5
BP 1203
EP 1211
DI 10.1111/jdi.12827
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GS3YI
UT WOS:000443564400029
PM 29493881
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Ikeda, K
   Fujimoto, S
   Morling, B
   Ayano-Takahara, S
   Harashima, S
   Uchida, Y
   Inagaki, N
AF Ikeda, Kaori
   Fujimoto, Shimpei
   Morling, Beth
   Ayano-Takahara, Shiho
   Harashima, Shin-ichi
   Uchida, Yukiko
   Inagaki, Nobuya
TI Cross-cultural comparison of predictors for self-care behaviors in
   patients with type 2 diabetes
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Cultural psychology; Diabetes self-care; Social psychology
ID SUPPORT; SCALE; INTERVENTIONS; STRATEGIES; AMERICAN; DISTRESS; JAPAN
AB The aim of the present study was to evaluate how culture moderates the behavioral and psychosocial predictors of diabetes self-care activities. Patients with type 2 diabetes were recruited in the outpatient department at two sites: Kyoto University hospital in Japan and the Christiana Care Health System in the USA. The data were collected by survey using questionnaires including questions on the frequency of self-care activities, behavioral and psychosocial predictors, and other background information from 149 Japanese patients and 48 American patients. The cultural impact was observed by multiple regression analyses with interaction terms on the association between emotional support and self-care activities in diet in female patients. The findings of the present study serve as an example of how cultural context can affect patients with diabetes, and lead to a better understanding of culturally sensitive behavioral intervention.
C1 [Ikeda, Kaori; Fujimoto, Shimpei; Ayano-Takahara, Shiho; Harashima, Shin-ichi; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan.
   [Fujimoto, Shimpei] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Kochi, Japan.
   [Morling, Beth] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA.
   [Uchida, Yukiko] Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan.
RP Ikeda, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan.
EM krikeda@kuhp.kyoto-u.ac.jp
OI Ikeda, Kaori/0000-0003-2273-9693
FU Kokoro Research Center Kyoto University; JSPS KAKENHI [15K20698]
FX This study was supported by Kokoro Research Center Kyoto University and
   JSPS KAKENHI Grant Number 15K20698.
CR [Anonymous], 2015, DIABETES CARE, V38, pS20, DOI 10.2337/dc15-S007
   Daitoku Masuko, 2006, Journal of the Japan Diabetes Society, V49, P1
   Ikeda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109323
   Ishii H, 1999, DIABETES, V48, pA319
   Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x
   Kitayama S, 2006, HDB CULTURAL PSYCHOL, P136
   Lirussi F, 2010, DIABETES-METAB RES, V26, P421, DOI 10.1002/dmrr.1105
   MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224
   Morling B, 2003, PERS SOC PSYCHOL B, V29, P1533, DOI 10.1177/0146167203256878
   Morling B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127737
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Powers MA, 2015, DIABETES CARE, V38, P1372, DOI 10.2337/dc15-0730
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Tafarodi RW, 2011, J CROSS CULT PSYCHOL, V42, P155, DOI 10.1177/0022022110386373
   Taylor SE, 2007, PSYCHOL SCI, V18, P831, DOI 10.1111/j.1467-9280.2007.01987.x
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Torenholt R, 2014, DIABETIC MED, V31, P15, DOI 10.1111/dme.12290
   Uchida Y, 2008, PERS SOC PSYCHOL B, V34, P741, DOI 10.1177/0146167208315157
NR 19
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD SEP
PY 2018
VL 9
IS 5
BP 1212
EP 1215
DI 10.1111/jdi.12822
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GS3YI
UT WOS:000443564400030
PM 29453793
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Ozcan, B
   Rutters, F
   Snoek, FJ
   Roosendaal, M
   Sijbrands, EJ
   Elders, PJM
   Holleman, F
   Pijl, H
   Tack, CJ
   Abbink, EJ
   de Valk, HW
   Wolffenbuttel, BHR
   Stehouwer, CDA
   Schaper, NC
   Dekker, JM
   Schram, MT
AF Ozcan, Behiye
   Rutters, Femke
   Snoek, Frank J.
   Roosendaal, Mandy
   Sijbrands, Eric J.
   Elders, Petra J. M.
   Holleman, Frits
   Pijl, Hanno
   Tack, Cees J.
   Abbink, Evertine J.
   de Valk, Harold W.
   Wolffenbuttel, Bruce H. R.
   Stehouwer, Coen D. A.
   Schaper, Nicholas C.
   Dekker, Jacqueline M.
   Schram, Miranda T.
CA Diabet Peart Parelsnoer Initiative
TI High Diabetes Distress Among Ethnic Minorities Is Not Explained by
   Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch
   Diabetes Pearl Cohort
SO DIABETES CARE
LA English
DT Article
ID EMOTIONAL DISTRESS; SELF-MANAGEMENT; CONTROLLED-TRIAL; OLDER-ADULTS;
   DEPRESSION; EFFICACY; PEOPLE; HEALTH; RECOGNITION; HISPANICS
AB OBJECTIVEDiabetes distress among patients from ethnic minorities is still poorly understood. We investigated the association between ethnicity and diabetes distress among ethnic minority groups of people with type 2 diabetes in the Netherlands, focusing on the possible effects of glycemic control, lifestyle factors, cardiovascular risk factors, and diabetes complications.RESEARCH DESIGN AND METHODSCross-sectional data from the Dutch Diabetes Pearl cohort included people with type 2 diabetes from primary, secondary, and tertiary diabetes care programs. We used the 20-item Problem Areas in Diabetes Survey (PAID) scale to assess diabetes distress; a score 40 is considered to represent high distress. Ethnicity was estimated on the basis of country of birth. Sociodemographic and lifestyle data were self-reported; cardiovascular and metabolic data were retrieved from medical charts. Logistic regression analysis determined the association between ethnicity and diabetes distress, with Caucasians as the reference group.RESULTSDiabetes distress scores and ethnicity were available for 4,191 people with type 2 diabetes: 3,684 were Caucasian, 83 were Asian, 51 were Moroccan, 92 were African, 134 were Latin American, 46 were Turkish, and 101 were Hindustani-Surinamese. Overall, participants in minority groups had worse health outcomes than those of Caucasian descent, and diabetes distress was more prevalent (ranging from 9.6 to 31.7%, compared with 5.8% among Caucasians), even after adjusting for age, sex, education level, alcohol use, smoking, BMI, lipid profile, HbA(1c), medication use, and the presence of diabetes complications.CONCLUSIONSAmong people with type 2 diabetes in the Netherlands, ethnicity is independently associated with high diabetes distress. Further research is warranted to explain the higher prevalence of diabetes distress in minority groups and to develop effective interventions.
C1 [Ozcan, Behiye; Sijbrands, Eric J.] Erasmus MC, Rotterdam, Netherlands.
   [Rutters, Femke; Snoek, Frank J.; Elders, Petra J. M.; Dekker, Jacqueline M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.
   [Snoek, Frank J.; Holleman, Frits] Acad Med Ctr, Amsterdam, Netherlands.
   [Roosendaal, Mandy; Stehouwer, Coen D. A.; Schaper, Nicholas C.; Schram, Miranda T.] CARIM, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.
   [Pijl, Hanno] Leiden Univ, Med Ctr, Leiden, Netherlands.
   [Tack, Cees J.; Abbink, Evertine J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands.
   [de Valk, Harold W.] Univ Med Ctr Utrecht, Utrecht, Netherlands.
   [Wolffenbuttel, Bruce H. R.] Univ Med Ctr Groningen, Groningen, Netherlands.
RP Ozcan, B (reprint author), Erasmus MC, Rotterdam, Netherlands.
EM b.ozcan@erasmusmc.nl
OI Sijbrands, Eric/0000-0001-8857-7389; Pijl, Hanno/0000-0002-3076-1551;
   Schram, Miranda/0000-0001-8113-7604
FU Dutch Federation of University Medical Centres; Dutch Government
FX The work described in this study was carried out in the context of the
   Parelsnoer Initiative (PSI). PSI is part of and is funded by the Dutch
   Federation of University Medical Centres and from 2007 to 2011 received
   initial funding from the Dutch Government.
CR Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271
   Cinnirella M, 1999, BRIT J MED PSYCHOL, V72, P505, DOI 10.1348/000711299160202
   Department of Health, 2016, UK CHIEF MED OFF ALC
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2014, DIABETIC MED, V31, P739, DOI 10.1111/dme.12403
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238
   Glasgow RE, 2012, PATIENT EDUC COUNS, V87, P81, DOI 10.1016/j.pec.2011.07.024
   Grzywacz JG, 2012, BEHAV MED, V38, P115, DOI 10.1080/08964289.2012.693976
   Huang ES, 2009, DIABETES CARE, V32, P311, DOI 10.2337/dc08-1307
   Hudson DL, 2013, AM J MANAG CARE, V19, P344
   Ince BU, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0252-5
   Jansen YFM, 2011, NED TIJDSCHR GENEES, V155, pA3117
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   KDOQI, 2007, Am J Kidney Dis, V49, pS12
   Kim G, 2015, J AGING HEALTH, V27, P320, DOI 10.1177/0898264314549662
   Kohinor MJE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-399
   Lavery LA, 1996, DIABETES CARE, V19, P48, DOI 10.2337/diacare.19.1.48
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Loewenthal KM, 2001, BRIT J MED PSYCHOL, V74, P293, DOI 10.1348/000711201160993
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Nouwen A, 2015, DIABETIC MED, V32, P1261, DOI 10.1111/dme.12863
   Peyrot M, 2014, CURR MED RES OPIN, V30, P2241, DOI 10.1185/03007995.2014.947023
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2013, DIABETIC MED, V30, pE25, DOI 10.1111/dme.12031
   Rosal MC, 2003, DIABETES EDUCATOR, V29, P1006, DOI 10.1177/014572170302900611
   Schmidt CB, 2017, J DIABETES RES, DOI 10.1155/2017/1204237
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Stronks K, 2009, J PUBLIC HEALTH-UK, V31, P324, DOI 10.1093/pubmed/fdp070
   Tang TS, 2014, DIABETES CARE, V37, P1525, DOI 10.2337/dc13-2161
   Trief PM, 2009, AGE AGEING, V38, P219, DOI 10.1093/ageing/afn299
   Ujcic-Voortman JK, 2009, EUR J PUBLIC HEALTH, V19, P511, DOI 10.1093/eurpub/ckp096
   van't Riet E, 2012, BMC PUBLIC HLTH, V12, P949
   Weng C, 2000, DIABETIC MED, V17, P612, DOI 10.1046/j.1464-5491.2000.00352.x
   World Health Organization, 2016, GLOB REP DIAB
   YOUNG MJ, 1993, DIABETES RES CLIN PR, V20, P129, DOI 10.1016/0168-8227(93)90006-Q
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 40
TC 1
Z9 1
U1 2
U2 2
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD SEP 1
PY 2018
VL 41
IS 9
BP 1854
EP 1861
DI 10.2337/dc17-2181
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GR1UJ
UT WOS:000442337700009
PM 29945936
DA 2019-01-08
ER

PT J
AU Fisher, L
   Hessler, D
   Polonsky, WH
   Masharani, U
   Guzman, S
   Bowyer, V
   Strycker, L
   Ahmann, A
   Basina, M
   Blumer, I
   Chloe, C
   Kim, S
   Peters, AL
   Shumway, M
   Weihs, K
   Wu, P
AF Fisher, Lawrence
   Hessler, Danielle
   Polonsky, William H.
   Masharani, Umesh
   Guzman, Susan
   Bowyer, Vicky
   Strycker, Lisa
   Ahmann, Andrew
   Basina, Marina
   Blumer, Ian
   Chloe, Charles
   Kim, Sarah
   Peters, Anne L.
   Shumway, Martha
   Weihs, Karen
   Wu, Patricia
TI T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress
   Among Adults With Type 1 Diabetes
SO DIABETES CARE
LA English
DT Article
ID SELF-REGULATION; REGIMEN DISTRESS; TIME; DEPRESSION; MANAGEMENT
AB OBJECTIVETo compare the effectiveness of two interventions to reduce diabetes distress (DD) and improve glycemic control among adults with type 1 diabetes (T1D).RESEARCH DESIGN AND METHODSIndividuals with T1D (n = 301) with elevated DD and HbA(1c) were recruited from multiple settings and randomly assigned to OnTrack, an emotion-focused intervention, or to KnowIt, an educational/behavioral intervention. Each group attended a full-day workshop plus four online meetings over 3 months. Assessments occurred at baseline and 3 and 9 months. Primary and secondary outcomes were change in DD and change in HbA(1c), respectively.RESULTSWith 12% attrition, both groups demonstrated dramatic reductions in DD (effect size d = 1.06; 78.4% demonstrated a reduction of at least one minimal clinically important difference). There were, however, no significant differences in DD reduction between OnTrack and KnowIt. Moderator analyses indicated that OnTrack provided greater DD reduction to those with initially poorer cognitive or emotion regulation skills, higher baseline DD, or greater initial diabetes knowledge than those in KnowIt. Significant but modest reductions in HbA(1c) occurred with no between-group differences. Change in DD was modestly associated with change in HbA(1c) (r = 0.14, P = 0.01), with no significant between-group differences.CONCLUSIONSDD can be successfully reduced among distressed individuals with T1D with elevated HbA(1c) using both education/behavioral and emotion-focused approaches. Reductions in DD are only modestly associated with reductions in HbA(1c). These findings point to the importance of tailoring interventions to address affective, knowledge, and cognitive skills when intervening to reduce DD and improve glycemic control.
C1 [Fisher, Lawrence; Hessler, Danielle; Masharani, Umesh; Bowyer, Vicky; Kim, Sarah; Shumway, Martha] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Polonsky, William H.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Guzman, Susan] Behav Diabet Inst, San Diego, CA USA.
   [Strycker, Lisa] Oregon Res Inst, Eugene, OR 97403 USA.
   [Ahmann, Andrew] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Basina, Marina] Stanford Univ, Stanford, CA 94305 USA.
   [Blumer, Ian] Univ Toronto, Toronto, ON, Canada.
   [Chloe, Charles] Univ Calif San Diego, Vet Affairs San Diego Healthcare Syst, San Diego, CA 92103 USA.
   [Peters, Anne L.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA.
   [Weihs, Karen] Univ Arizona, Coll Med, Tucson, AZ USA.
   [Wu, Patricia] Kaiser Permanente Med Grp, San Diego, CA USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, San Francisco, CA 94143 USA.
EM larry.fisher@ucsf.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases [R01
   DK-094863]
FX This research was supported by the National Institute of Diabetes and
   Digestive and Kidney Diseases (R01 DK-094863).
CR Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504
   Blair C, 2008, DEV PSYCHOPATHOL, V20, P899, DOI 10.1017/S0954579408000436
   Cohen J, 1988, STAT POWER ANAL BEHA
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2018, PATIENT EDUC COUNS, V101, P124, DOI 10.1016/j.pec.2017.06.036
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, PATIENT EDUC COUNS, V86, P372, DOI 10.1016/j.pec.2011.07.002
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fitzgerald JT, 2016, DIABETES EDUCATOR, V42, P178, DOI 10.1177/0145721715624968
   Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Guendelman S, 2017, FRONT PSYCHOL, V8, P1, DOI 10.3389/fpsyg.2017.00220
   Hessler DM, 2017, DIABETIC MED, V34, P1228, DOI 10.1111/dme.13381
   Hessler D, 2015, DIABETES RES CLIN PR, V108, P360, DOI 10.1016/j.diabres.2014.12.017
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hilliard ME, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0761-3
   IBM Corp, 2010, IBM SPSS STAT WIND V
   Lansing AH, 2014, J PEDIATR PSYCHOL, V39, P1091, DOI 10.1093/jpepsy/jsu067
   Leventhal H., 2003, SELF REGULATION HLTH, V1, P42
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Miller W. R., 2013, MOTIVATIONAL INTERVI
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Nigg JT, 2017, J CHILD PSYCHOL PSYC, V58, P361, DOI 10.1111/jcpp.12675
   Polonsky WH, 2017, DIABETES CARE, V40, P736, DOI 10.2337/dc17-0133
   Quoidbach J, 2015, PSYCHOL BULL, V141, P655, DOI 10.1037/a0038648
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Zwarenstein M, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2390
NR 31
TC 3
Z9 3
U1 0
U2 0
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD SEP 1
PY 2018
VL 41
IS 9
BP 1862
EP 1869
DI 10.2337/dc18-0391
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GR1UJ
UT WOS:000442337700010
PM 29976567
DA 2019-01-08
ER

PT J
AU Danne, T
   Cariou, B
   Banks, P
   Brandle, M
   Brath, H
   Franek, E
   Kushner, JA
   Lapuerta, P
   McGuire, DK
   Peters, AL
   Sawhney, S
   Strumph, P
AF Danne, Thomas
   Cariou, Bertrand
   Banks, Phillip
   Brandle, Michael
   Brath, Helmut
   Franek, Edward
   Kushner, Jake A.
   Lapuerta, Pablo
   McGuire, Darren K.
   Peters, Anne L.
   Sawhney, Sangeeta
   Strumph, Paul
TI HbA(1c) and Hypoglycemia Reductions at 24 and 52 Weeks With
   Sotagliflozin in Combination With Insulin in Adults With Type 1
   Diabetes: The European inTandem2 Study
SO DIABETES CARE
LA English
DT Article
ID EXCHANGE CLINIC REGISTRY; PLACEBO-CONTROLLED TRIAL; T1D EXCHANGE;
   DOUBLE-BLIND; AMERICAN ASSOCIATION; GLYCEMIC CONTROL; COMPLICATIONS;
   KETOACIDOSIS; INHIBITORS; MELLITUS
AB OBJECTIVEThe objective of this study was to evaluate the efficacy and safety of the dual sodium-glucose cotransporter 1 and 2 inhibitor sotagliflozin compared with placebo when combined with optimized insulin in adults with type 1 diabetes (T1D).RESEARCH DESIGN AND METHODSIn a double-blind, 52-week, international phase 3 trial, adults with T1D were randomized to placebo (n = 258) or once-daily oral sotagliflozin 200 mg (n = 261) or 400 mg (n = 263) after 6 weeks of insulin optimization. The primary outcome was change in HbA(1c) from baseline to 24 weeks. The first secondary end point was a composite of the proportion of patients with HbA(1c) <7.0%, no episode of severe hypoglycemia, and no episode of diabetic ketoacidosis (DKA) at week 24. Fasting glucose, weight, insulin dose, and safety end points were assessed through 52 weeks.RESULTSAt 24 weeks, placebo-adjusted changes in HbA(1c) from baseline (7.8%) were -0.37% and -0.35% with sotagliflozin 200 and 400 mg, respectively (P < 0.001), and differences were maintained at 52 weeks. At 52 weeks, greater proportions of sotagliflozin-treated patients (200 mg: 25.67%; 400 mg: 26.62%) than placebo-treated patients (14.34%; P 0.001) met the composite end point, and sotagliflozin 400 mg reduced fasting plasma glucose (-0.87 mmol/L; P = 0.008), weight (-2.92 kg; P < 0.001), and total daily insulin dose (-8.2%; P = 0.001). In a 24-week continuous glucose monitoring (CGM) substudy, postprandial glucose decreased (P 0.009) and CGM demonstrated up to 3 h more time in the target range of 3.9-10.0 mmol/L with sotagliflozin. Treatment satisfaction increased and diabetes distress decreased with sotagliflozin (P < 0.05 vs. placebo). The frequency of documented hypoglycemia was lower with sotagliflozin, and severe hypoglycemia occurred by week 52 in 13 patients (5.0%), 13 patients (5.0%), and 6 patients (2.3%) treated with placebo and sotagliflozin 200 and 400 mg, respectively. DKA occurred in 0 of 258 patients, 6 of 261 patients (2.3%), and 9 of 263 patients (3.4%) in these respective groups.CONCLUSIONSIn a 1-year study, sotagliflozin was associated with statistically significant HbA(1c) reductions. More episodes of DKA and fewer episodes of documented and severe hypoglycemia were observed in patients using sotagliflozin relative to those receiving placebo (ClinicalTrials.gov, NCT02421510).
C1 [Danne, Thomas] Hannover Med Sch, Childrens & Youth Hosp Bult, Dept Diabet Endocrinol & Clin Res, Hannover, Germany.
   [Cariou, Bertrand] CHU Nantes, Dept Endocrinol, Inst Thorax, INSERM,CIC 1413, Nantes, France.
   [Banks, Phillip; Lapuerta, Pablo; Sawhney, Sangeeta; Strumph, Paul] Lexicon Pharmaceut Inc, The Woodlands, TX USA.
   [Brandle, Michael] Kantonsspital St Gallen, Dept Internal Med, St Gallen, Switzerland.
   [Brath, Helmut] Hlth Ctr South, Diabet Outpatient Clin, Vienna, Austria.
   [Franek, Edward] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland.
   [Kushner, Jake A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Kushner, Jake A.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [McGuire, Darren K.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX USA.
   [Peters, Anne L.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA.
RP Danne, T (reprint author), Hannover Med Sch, Childrens & Youth Hosp Bult, Dept Diabet Endocrinol & Clin Res, Hannover, Germany.
EM danne@hka.de
OI Kushner, Jake A/0000-0002-3646-1744
FU Lexicon Pharmaceuticals, Inc.; Sanofi
FX This study was supported and conducted by Lexicon Pharmaceuticals, Inc.
   Lexicon Pharmaceuticals, Inc., and Sanofi entered a license agreement
   effective November 2015 and are collaborating on the development and
   commercialization of sotagliflozin.
CR Agiostratidou G, 2017, DIABETES CARE, V40, P1622, DOI 10.2337/dc17-1624
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS144, DOI 10.2337/dc18-S014
   Bode BW, 2016, ENDOCR PRACT, V22, P220, DOI 10.4158/EP15869.RA
   Buse JB, 2018, DIABETES CARE, V41, P1970, DOI [10.2337/dc17-2212, 10.2337/dc18-0343]
   Cariou B, 2015, DIABETES METAB, V41, P116, DOI 10.1016/j.diabet.2014.10.007
   Cariou B, 2015, EXPERT OPIN INV DRUG, V24, P1647, DOI 10.1517/13543784.2015.1100361
   Dandona P, 2017, LANCET DIABETES ENDO, V5, P864, DOI 10.1016/S2213-8587(17)30308-X
   Dobbins RL, 2015, AM J PHYSIOL-GASTR L, V308, pG946, DOI 10.1152/ajpgi.00286.2014
   Ellis SL, 2011, DIABETIC MED, V28, P1176, DOI 10.1111/j.1464-5491.2011.03331.x
   Farsani SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016587
   Garg SK, 2018, NEW ENGL J MED, V378, P967, DOI 10.1056/NEJMc1800394
   Garg SK, 2017, NEW ENGL J MED, V377, P2337, DOI 10.1056/NEJMoa1708337
   Garg SK, 2017, DIABETES TECHNOL THE, V19, P155, DOI 10.1089/dia.2016.0421
   Garg SK, 2013, ENDOCR PRACT, V19, P19, DOI 10.4158/EP12100.OR
   Handelsman Y, 2016, ENDOCR PRACT, V22, P753, DOI 10.4158/EP161292.PS
   Henry RR, 2015, DIABETES CARE, V38, P2258, DOI 10.2337/dc15-1730
   Jonasson JM, 2008, DIABETES CARE, V31, P1536, DOI 10.2337/dc08-0344
   Khunti K, 2016, DIABETES OBES METAB, V18, P907, DOI 10.1111/dom.12689
   Lapuerta P, 2015, DIABETES VASC DIS RE, V12, P101, DOI 10.1177/1479164114563304
   Lyons SK, 2017, DIABETES CARE, V40, pE139, DOI 10.2337/dc17-0403
   Mathieu C, 2016, DIABETES CARE, V39, P1702, DOI 10.2337/dc16-0691
   McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Nathan DM, 2001, DIABETES CARE, V24, P1711
   Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925
   Petrie JR, 2017, LANCET DIABETES ENDO, V5, P597, DOI 10.1016/S2213-8587(17)30194-8
   Pieber T R, 2015, Diabetes Obes Metab, V17, P928, DOI 10.1111/dom.12494
   Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487
   Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474
   Sands AT, 2015, DIABETES CARE, V38, P1181, DOI 10.2337/dc14-2806
   Taylor SI, 2015, J CLIN ENDOCR METAB, V100, P2849, DOI 10.1210/jc.2015-1884
   Weinstock RS, 2016, DIABETES RES CLIN PR, V122, P28, DOI 10.1016/j.diabres.2016.09.024
   Weinstock RS, 2013, J CLIN ENDOCR METAB, V98, P3411, DOI 10.1210/jc.2013-1589
   Zambrowicz B, 2013, CLIN THER, V35
NR 34
TC 6
Z9 6
U1 3
U2 3
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD SEP 1
PY 2018
VL 41
IS 9
BP 1981
EP 1990
DI 10.2337/dc18-0342
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GR1UJ
UT WOS:000442337700024
PM 29937431
DA 2019-01-08
ER

PT J
AU Teufel-Shone, NI
   Jiang, LH
   Rockell, J
   Chang, J
   Beals, J
   Bullock, A
   Manson, SM
AF Teufel-Shone, Nicolette, I
   Jiang, Luohua
   Rockell, Jennifer
   Chang, Jennifer
   Beals, Janette
   Bullock, Ann
   Manson, Spero M.
TI Food choices and distress in reservation-based American Indians and
   Alaska Natives with type 2 diabetes
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE American Indians/Alaska Natives; Type 2 diabetes; Food choice; Diet;
   Distress
ID NONSPECIFIC PSYCHOLOGICAL DISTRESS; DEMONSTRATION PROJECT;
   GENERAL-POPULATION; PHYSICAL-ACTIVITY; SCREENING SCALES;
   NATIONAL-SURVEY; HEART-DISEASE; US ADULTS; STRESS; HEALTH
AB Objective: To examine the association between food choice and distress in a large national sample of American Indians/Alaska Natives (AI/AN) with type 2 diabetes.
   Design: Participants completed a sociodemographic survey, an FFQ and the Kessler-6 Distress Scale. Foods were identified as 'healthy' or 'unhealthy' using a classification grounded in the health education provided by the programme case managers; healthy and unhealthy food scores were calculated using reported intake frequencies. Pearson's correlation coefficients for distress and food scores were calculated for all participants and by gender. Multiple linear regression models stratified by gender assessed the association between distress and food scores, controlling for sociodemogaphics and duration of type 2 diabetes.
   Setting: Rural AI reservations and AN villages.
   Subjects: AI/AN (n 2484) with type 2 diabetes.
   Results: Both males (34.9%) and females (65.1%) had higher healthy food scores than unhealthy scores. In bivariate analysis, distress level had a significant negative correlation with healthy food scores among female participants, but the association was not significant among males. Significant positive correlations between distress and unhealthy food scores were found in both genders. In the final multivariate models, healthy food scores were not significantly related to distress; however, unhealthy food scores showed significant positive relationships with distress for both genders (females: beta = 0.078, P = 0.0007; males: beta = 0.139, P < 0.0001).
   Conclusions: Health professionals working with AI/AN diagnosed with type 2 diabetes should offer food choice strategies during difficult times and recognize that males may be more likely than females to select unhealthy foods when distressed.
C1 [Teufel-Shone, Nicolette, I] No Arizona Univ, Dept Hlth Sci, POB 4065,ARD Bldg,Suite 120, Flagstaff, AZ 86011 USA.
   [Teufel-Shone, Nicolette, I] No Arizona Univ, Ctr Hlth Equ Res, POB 4065,ARD Bldg,Suite 120, Flagstaff, AZ 86011 USA.
   [Jiang, Luohua; Chang, Jennifer] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA.
   [Rockell, Jennifer; Beals, Janette; Manson, Spero M.] Univ Colorado, Ctr Amer Indian & Alaska Nat Hlth, Anschutz Med Ctr, Aurora, CO USA.
   [Bullock, Ann] Indian Hlth Serv, Div Diabet Treatment & Prevent, Rockville, MD USA.
RP Teufel-Shone, NI (reprint author), No Arizona Univ, Dept Hlth Sci, POB 4065,ARD Bldg,Suite 120, Flagstaff, AZ 86011 USA.; Teufel-Shone, NI (reprint author), No Arizona Univ, Ctr Hlth Equ Res, POB 4065,ARD Bldg,Suite 120, Flagstaff, AZ 86011 USA.
EM nicky.teufel@nau.edu
FU Indian Health Service [HHSI242200400049C]; American Diabetes Association
   (ADA) [7-12-CT-36]; National Institute of Diabetes and Digestive and
   Kidney Diseases (NIDDK) [1P30DK092923, R21DK108187]
FX Funding for the SDPI-HH project was provided by the Indian Health
   Service (HHSI242200400049C, S.M. Manson). Manuscript preparation was
   supported in part by American Diabetes Association (ADA #7-12-CT-36, L.
   Jiang), and National Institute of Diabetes and Digestive and Kidney
   Diseases (NIDDK) (1P30DK092923, S.M. Manson and R21DK108187, L. Jiang).
   The IHS contributed to the study design, interpretation of findings and
   the preparation of the manuscript. The ADA had no role in the design,
   analysis or writing of this manuscript.
CR Best LG, 2015, CANCER CAUSE CONTROL, V26, P1551, DOI 10.1007/s10552-015-0648-7
   Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261
   Brewerton TD, 2011, J WOMENS HEALTH, V20, P1133, DOI 10.1089/jwh.2011.3050
   Bryant AN, 2012, AGING MENT HEALTH, V16, P208, DOI 10.1080/13607863.2011.615735
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Choudhary P, 2004, DIABETES RES CLIN PR, V65, pS9, DOI 10.1016/j.diabres.2004.07.003
   Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147
   Dohle S, 2014, PSYCHOL HEALTH, V29, P1062, DOI 10.1080/08870446.2014.909042
   DOHRENWEND BP, 1980, ARCH GEN PSYCHIAT, V37, P1229
   Eisenberg DM, 2015, ACAD MED, V90, P854, DOI 10.1097/ACM.0000000000000682
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024
   Hickman NJ, 2014, TOB CONTROL, V23, P7, DOI 10.1136/tobaccocontrol-2012-050479
   Huyser KR, 2015, ETHNIC DIS, V25, P145
   Jenkins DJA, 2011, DIABETOLOGIA, V54, P271, DOI 10.1007/s00125-010-1927-1
   Kattelmann KK, 2009, J AM DIET ASSOC, V109, P1532, DOI 10.1016/j.jada.2009.06.362
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   King DE, 2009, AM J MED, V122, P528, DOI 10.1016/j.amjmed.2008.11.013
   Li Y, 2017, PSYCHIAT RES, V253, P373, DOI 10.1016/j.psychres.2017.04.020
   Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703
   Mendenhall TJ, 2010, NURS INQ, V17, P359, DOI 10.1111/j.1440-1800.2010.00508.x
   MICHAUD C, 1990, STRESS MEDICINE, V6, P57, DOI 10.1002/smi.2460060112
   Moore K, 2014, AM J PUBLIC HEALTH, V104, pE158, DOI 10.2105/AJPH.2014.302108
   Morton LW, 2007, RURAL REALITIES, V1, P4
   Novotny J, 2003, J AM DIET ASSOC, V103, P1146, DOI [10.1016/S0002-8223(03)00975-1, 10.1053/jada.2003.50568]
   Raghunathan TES, 2002, IVEWARE IMPUTATION V
   Richardson T, 2015, INT J EAT DISORDER, V48, P517, DOI 10.1002/eat.22392
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993
   Saylors K, 2005, J PSYCHOACTIVE DRUGS, V37, P273, DOI 10.1080/02791072.2005.10400520
   Schuz B, 2015, APPETITE, V87, P310, DOI 10.1016/j.appet.2015.01.002
   Teufel-Shone NI, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150266
   Teufel-Shone NI, 2015, ETHNIC HEALTH, V20, P327, DOI 10.1080/13557858.2014.921890
   Teufel-Shone NI, 2009, AM J HEALTH PROMOT, V23, pS8, DOI 10.4278/ajhp.07053151
   Ulrich-Lai YM, 2010, P NATL ACAD SCI USA, V107, P20529, DOI 10.1073/pnas.1007740107
   Veazie M, 2014, AM J PUBLIC HEALTH, V104, pS359, DOI 10.2105/AJPH.2013.301715
   Verhoeven AAC, 2015, APPETITE, V84, P20, DOI 10.1016/j.appet.2014.09.013
   Wallis DJ, 2009, APPETITE, V52, P355, DOI 10.1016/j.appet.2008.11.007
   Wansink B, 2003, PHYSIOL BEHAV, V79, P739, DOI 10.1016/S0031-9384(03)00203-8
   Weidner G, 1996, ANXIETY STRESS COPIN, V9, P123, DOI 10.1080/10615809608249396
   Wethington H, 2014, J PUBLIC HEALTH-UK, V36, P490, DOI 10.1093/pubmed/fdt109
   Yellow Horse Brave Heart M, 2008, J HLTH SOC POLICY, V10, P1
   Zellner DA, 2006, PHYSIOL BEHAV, V87, P789, DOI 10.1016/j.physbeh.2006.01.014
NR 44
TC 0
Z9 0
U1 9
U2 9
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD SEP
PY 2018
VL 21
IS 13
BP 2367
EP 2375
DI 10.1017/S136898018000897
PG 9
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA GP4SM
UT WOS:000440860200003
PM 29681247
DA 2019-01-08
ER

PT J
AU Seligman, HK
   Smith, M
   Rosenmoss, S
   Marshall, MB
   Waxman, E
AF Seligman, Hilary K.
   Smith, Morgan
   Rosenmoss, Sophie
   Marshall, Michelle Berger
   Waxman, Elaine
TI Comprehensive Diabetes Self-Management Support From Food Banks: A
   Randomized Controlled Trial
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID LOW-INCOME PATIENTS; GLYCEMIC CONTROL; HOSPITAL-ADMISSIONS; REGRESSION
   APPROACH; UNITED-STATES; INSECURITY; HYPOGLYCEMIA; EFFICACY;
   INTERVENTION; DISPARITIES
AB Objectives. To determine whether food bank provision of self-management support and diabetes-appropriate food improves glycemic control among clients with diabetes.
   Methods. We screened 5329 adults for diabetes at food pantries (n = 27) affiliated with food banks in Oakland, California; Detroit, Michigan; and Houston, Texas, between October 2015 and September 2016. We individually randomized 568 participants with hemoglobin A1c (HbA1c) 7.5% or greater to waitlist control or 6-month intervention including food, diabetes education, health care referral, and glucose monitoring. The primary outcome was HbA1c at 6 months.
   Results. Food security (relative risk [RR] = 0.85; 95% confidence interval [CI] = 0.73, 0.98), food stability (RR = 0.77; 95% CI = 0.64, 0.93), and fruit and vegetable intake (risk difference [RD] = 0.34; 95% CI = 0.34, 0.34) significantly improved among intervention participants. There were no differences in self-management (depressive symptoms, diabetes distress, self-care, hypoglycemia, self-efficacy) or HbA1c (RD = 0.24; 95% CI = -0.09, 0.58).
   Conclusions. Food banks are ideally situated to provide diabetes-appropriate food to food-insecure households. Effective strategies for food banks to support improvements in diabetes clinical outcomes require additional study.
   Public Health Implications. Moving chronic disease support from clinics into communities expands reach into vulnerable populations. However, it is unclear how community interventions should be integrated with clinical care to improve disease outcomes.
C1 [Seligman, Hilary K.; Rosenmoss, Sophie] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA.
   [Seligman, Hilary K.; Rosenmoss, Sophie] Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA.
   [Seligman, Hilary K.; Smith, Morgan; Marshall, Michelle Berger; Waxman, Elaine] Urban Inst, Washington, DC 20037 USA.
RP Seligman, HK (reprint author), Univ Calif San Francisco, POB 1364, San Francisco, CA 94143 USA.
EM hilary.seligman@ucsf.edu
FU Feeding America; Laura and John Arnold Foundation; Urban Institute via a
   Robert Wood Johnson Foundation grant; National Institute of Diabetes and
   Digestive and Kidney Diseases of the National Institutes of Health
   [P30DK092924]; Centers for Disease Control and Prevention
   [3U48DP004998-01S1]
FX Funding for the Feeding America Intervention Trial for Health-Diabetes
   Mellitus (FAITH-DM) was provided by Feeding America, the Laura and John
   Arnold Foundation, the Urban Institute via a Robert Wood Johnson
   Foundation grant, National Institute of Diabetes and Digestive and
   Kidney Diseases of the National Institutes of Health under award
   P30DK092924, and Centers for Disease Control and Prevention under award
   3U48DP004998-01S1.
CR American Association of Diabetes Educators, 2018, AADE7 SELF CAR BEH
   [Anonymous], 2014, TYP 2 DIAB BASICS CU
   Basu S, 2017, MED CARE, V55, P639, DOI 10.1097/MLR.0000000000000728
   Berkowitz Seth A, 2018, Health Aff (Millwood), V37, P535, DOI 10.1377/hlthaff.2017.0999
   Berkowitz SA, 2015, JAMA INTERN MED, V175, P257, DOI 10.1001/jamainternmed.2014.6888
   Berkowitz SA, 2014, AM J MED, V127, P303, DOI 10.1016/j.amjmed.2014.01.002
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226
   Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223
   Coleman-Jensen A, 2016, STAT HOUSEHOLD FOO S, V72
   Epidemiology and Genomics Research Program National Cancer Institute Division of Cancer Control and Population Sciences, 2015, DIET SCREEN 2005 CHI
   Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x
   Ippolito MM, 2017, PUBLIC HEALTH NUTR, V20, P183, DOI 10.1017/S1368980016001786
   Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007
   KAVANAGH DJ, 1993, J BEHAV MED, V16, P509, DOI 10.1007/BF00844820
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Lyles CR, 2013, DIABETES CARE, V36, P1448, DOI 10.2337/dc12-1961
   Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Peek ME, 2012, HEALTH AFFAIR, V31, P177, DOI 10.1377/hlthaff.2011.1058
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   Seligman HK, 2015, HEALTH AFFAIR, V34, P1956, DOI 10.1377/hlthaff.2015.0641
   Seligman HK, 2014, HEALTH AFFAIR, V33, P116, DOI 10.1377/hlthaff.2013.0096
   Seligman HK, 2012, DIABETES CARE, V35, P233, DOI 10.2337/dc11-1627
   Seligman HK, 2011, ARCH INTERN MED, V171, P1204, DOI 10.1001/archinternmed.2011.287
   Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072
   Smith S, 2018, SOC TEACH FAM MED AN
   Talbot F, 1997, J BEHAV MED, V20, P291, DOI 10.1023/A:1025508928696
   Thom DH, 2013, ANN FAM MED, V11, P137, DOI 10.1370/afm.1443
   UCLA Center for Health Policy Research California Department of Health Services Public Health Institute., 2010, CHIS 2005 AD QUEST V
   United States Department of Agriculture Economic Research Service, 2012, US HOUS FOOD SEC SUR
   University of Chicago, 2018, IMPR DIAB CAR OUTC S
   Weinfield NS, 2014, FEEDING AM HUNGER AM
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 33
TC 0
Z9 0
U1 6
U2 6
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD SEP
PY 2018
VL 108
IS 9
BP 1227
EP 1234
DI 10.2105/AJPH.2018.304528
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP7DZ
UT WOS:000441054400049
PM 30024798
DA 2019-01-08
ER

PT J
AU Zhu, BQ
   Quinn, L
   Kapella, MC
   Bronas, UG
   Collins, EG
   Ruggiero, L
   Park, CG
   Fritschi, C
AF Zhu, Bingqian
   Quinn, Laurie
   Kapella, Mary C.
   Bronas, Ulf G.
   Collins, Eileen G.
   Ruggiero, Laurie
   Park, Chang G.
   Fritschi, Cynthia
TI Relationship between sleep disturbance and self-care in adults with type
   2 diabetes
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Actigraphy; Nocturnal awakening; Self-care; Sleep; Symptom; Type 2
   diabetes
ID PHYSICAL-ACTIVITY; DAYTIME SLEEPINESS; DISTRESS; MELLITUS; SCALE;
   FRAGMENTATION; MANAGEMENT; BEHAVIORS; OUTCOMES; QUALITY
AB Type 2 diabetes (T2D) is a metabolic disorder requiring intensive self-care to maintain optimal glycemic control. Sleep disturbance is common in T2D patients and likely impairs glycemic control. Our aim was to examine the relationship between sleep disturbance and self-care in adults with T2D.
   This study used a correlational design. Sixty-four adults with T2D were recruited. Validated instruments were used to measure self-care, subjective sleep disturbance, and covariates (e.g., diabetes distress, self-efficacy, fatigue, and daytime sleepiness). Over an 8-day period, the ActiGraph-wGT3X was used to measure objective sleep outcomes (e.g., total sleep time and number of awakenings). Bivariate correlation and multiple linear regression analyses were conducted.
   The mean age of the participants was 60.6 (SD 6.8) years (range 50-78), and 51.6% were women. Controlling for covariates, subjective sleep disturbance (beta = - 0.26), diabetes distress (beta = - 0.39), and daytime sleepiness (beta = - 0.21) were strong predictors of diabetes self-care (R (2) = 0.51, p < 0.001). When objective sleep parameters were used, the number of awakenings (beta = - 0.23) also predicted self-care along with diabetes distress, fatigue, and daytime sleepiness (R (2) = 0.57, p < 0.001).
   Subjective sleep disturbance and frequent nocturnal awakenings are associated with worse diabetes self-care in adults with T2D. Healthcare providers are recommended to include comprehensive sleep assessment at every clinical visit. Diabetes educators may consider including sleep-related education in their diabetes self-management classes and/or counseling sessions.
C1 [Zhu, Bingqian; Quinn, Laurie; Kapella, Mary C.; Bronas, Ulf G.; Collins, Eileen G.; Park, Chang G.; Fritschi, Cynthia] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, 845 S Damen Ave,M-C 802, Chicago, IL 60612 USA.
   [Ruggiero, Laurie] Univ Illinois, Sch Publ Hlth, Inst Hlth Res & Policy, Chicago, IL 60612 USA.
   [Ruggiero, Laurie] Univ Delaware, Sch Nursing, Newark, DE USA.
   [Zhu, Bingqian] Shanghai Jiao Tong Univ, Sch Nursing, Shanghai, Peoples R China.
RP Fritschi, C (reprint author), Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, 845 S Damen Ave,M-C 802, Chicago, IL 60612 USA.
EM fritschi@uic.edu
OI Fritschi, Cynthia/0000-0001-5447-8315
FU Midwest Roybal Center for Health Promotion and Translation from the
   National Institute on Aging [P30AG022849]; Institute for Health Research
   and Policy Grant support [Center for Clinical and Translational Science
   (CCTS)] [UL1RR029879]; Chancellor's Graduate Research Award of the
   University of Illinois at Chicago; Provost Award for Graduate Research
   of the University of Illinois at Chicago.; National Institutes of
   Health/National Institute for Nursing Research and Department of
   Veterans Affairs, Research Career Scientist Award [K99 R00 NR012219]
FX This research was supported by the Midwest Roybal Center for Health
   Promotion and Translation from the National Institute on Aging (Grant#
   P30AG022849). This research was also supported by the Institute for
   Health Research and Policy Grant support [Center for Clinical and
   Translational Science (CCTS) UL1RR029879], the Chancellor's Graduate
   Research Award, and the Provost Award for Graduate Research of the
   University of Illinois at Chicago. This research was also supported by
   the National Institutes of Health/National Institute for Nursing
   Research and Department of Veterans Affairs, Research Career Scientist
   Award (EC) [K99 R00 NR012219 (CF)].
CR Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS28, DOI 10.2337/dc18-S003
   American Diabetes Association, 2017, Diabetes Care, V40, pS48
   American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97
   Ancoli-Israel S, 2015, BEHAV SLEEP MED, V13, pS4, DOI 10.1080/15402002.2015.1046356
   Ancoli-Israel S, 2009, SLEEP MED, V10, pS7, DOI 10.1016/j.sleep.2009.07.004
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Beverly EA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0741-7
   Bode Bruce W, 2007, J Diabetes Sci Technol, V1, P405
   BUYSSE DJ, 1991, SLEEP, V14, P331
   Cellini N, 2016, PHYSIOL BEHAV, V157, P79, DOI 10.1016/j.physbeh.2016.01.034
   Chasens ER, 2013, DIABETES EDUCATOR, V39, P74, DOI 10.1177/0145721712467683
   Chasens Eileen R, 2008, Issues Ment Health Nurs, V29, P1134, DOI 10.1080/01612840802319878
   COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461
   Crowley K, 2011, NEUROPSYCHOL REV, V21, P41, DOI 10.1007/s11065-010-9154-6
   Grandner MA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0805-8
   Gupta S, 2016, DIABETES METAB SYND, V10, P213, DOI 10.1016/j.dsx.2016.06.009
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hursel R, 2011, AM J CLIN NUTR, V94, P804, DOI 10.3945/ajcn.111.017632
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Kirk JK, 2015, DIABETES RES CLIN PR, V107, P54, DOI 10.1016/j.diabres.2014.10.005
   Kontopantelis E, 2016, J STAT SOFTW, V74, P1, DOI 10.18637/jss.v074.i12
   Larcher S, 2015, DIABETES METAB, V41, P263, DOI 10.1016/j.diabet.2014.12.004
   Lee SWH, 2017, SLEEP MED REV, V31, P91, DOI 10.1016/j.smrv.2016.02.001
   Lee YJ, 2016, PATIENT EDUC COUNS, V99, P287, DOI 10.1016/j.pec.2015.08.021
   Libman E, 2016, SLEEP DISORD, V2016, P1
   Martins RC, 2008, BRAZ J MED BIOL RES, V41, P180, DOI 10.1590/S0100-879X2006005000194
   Nefs G, 2015, DIABETES RES CLIN PR, V109, P466, DOI 10.1016/j.diabres.2015.07.008
   Ohayon MM, 2010, J PSYCHOSOM RES, V69, P565, DOI 10.1016/j.jpsychores.2010.03.010
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   Pintaudi B, 2015, J PSYCHOSOM RES, V79, P348, DOI 10.1016/j.jpsychores.2015.08.010
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Redeker NS, 2008, J CARDIOVASC NURS, V23, P231, DOI 10.1097/01.JCN.0000305094.20012.76
   Reutrakul S, 2014, ANN NY ACAD SCI, V1311, P151, DOI 10.1111/nyas.12355
   Riegel B, 2009, EUR J CARDIOVASC NUR, V8, P337, DOI 10.1016/j.ejcnurse.2009.06.003
   Rosenberger ME, 2016, MED SCI SPORT EXER, V48, P457, DOI 10.1249/MSS.0000000000000778
   Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004
   Short MA, 2014, SLEEP DEPRIVATION DI, P13
   Slater JA, 2015, SLEEP BIOL RHYTHMS, V13, P172, DOI 10.1111/sbr.12103
   Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Zhuo XH, 2013, AM J PREV MED, V45, P253, DOI 10.1016/j.amepre.2013.04.017
NR 44
TC 0
Z9 0
U1 9
U2 9
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD SEP
PY 2018
VL 55
IS 9
BP 963
EP 970
DI 10.1007/s00592-018-1181-4
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GQ2AC
UT WOS:000441445300010
PM 29931420
DA 2019-01-08
ER

PT J
AU Schmidt, CB
   van Loon, BJP
   Vergouwen, ACM
   Snoek, FJ
   Honig, A
AF Schmidt, C. B.
   van Loon, B. J. Potter
   Vergouwen, A. C. M.
   Snoek, F. J.
   Honig, A.
TI Systematic review and meta-analysis of psychological interventions in
   people with diabetes and elevated diabetes-distress
SO DIABETIC MEDICINE
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; GLYCEMIC CONTROL;
   EMOTIONAL DISTRESS; DEPRESSION; ASSOCIATION; TYPE-1; HBA(1C); HEALTH
AB AimsThe clinical relevance of diabetes-distress is increasingly recognized, but little is known about the efficacy of interventions specifically targeted to treat elevated diabetes-distress. Therefore, this systematic review sought to determine the efficacy of psychological interventions aimed at treating elevated diabetes-distress in people with Type 1 or Type 2 diabetes.
   MethodsWe systematically searched literature from five databases. Randomized controlled trials (RCTs) with an English abstract, describing the results of a psychological intervention in adults with diabetes were included. Articles were eligible for inclusion if the primary outcome was diabetes-distress measured by the Problem Areas in Diabetes Scale (PAID-5/PAID-20) or the Diabetes Distress Scale (DDS-17). Only mean group diabetes-distress values above cut-off at baseline or the results of a subgroup above cut-off (PAID-5 8, PAID-20 40 or DDS-17 3) were included.
   ResultsThe search yielded 8907 articles. After removing 2800 duplicates, 6107 articles remained. Titles and abstracts were screened, leaving 394 potential articles of interest, nine of which were RCTs. In a random-effects meta-analysis, the pooled effect size for diabetes-distress was 0.48 (Cohen's d), Z=3.91, P<0.0001. Statistical heterogeneity was I-2=46.67% (confidence intervals 45.06% to 48.28%). Diabetes-tailored psychological interventions reduced HbA(1c) (Cohen's d=0.57), whereas mindfulness-based interventions did not (Cohen's d=0.11).
   ConclusionsThis systematic review shows that specifically diabetes-tailored psychological interventions are effective in reducing elevated diabetes-distress and HbA(1c). More rigorous studies are warranted to establish the full potential of these interventions. PROSPERO database registration ID: CRD42017075290.
C1 [Schmidt, C. B.; Vergouwen, A. C. M.; Honig, A.] Dept Psychiat, Amsterdam, Netherlands.
   [van Loon, B. J. Potter] OLVG, Dept Internal Med, Amsterdam, Netherlands.
   [Schmidt, C. B.; Snoek, F. J.; Honig, A.] Dept Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.
   [Snoek, F. J.] Acad Med Ctr AMC, Dept Med Psychol, Amsterdam, Netherlands.
   [Snoek, F. J.] Dept Med Psychol, Amsterdam, Netherlands.
   [Honig, A.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.
RP Schmidt, CB (reprint author), Dept Psychiat, Amsterdam, Netherlands.; Schmidt, CB (reprint author), Dept Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.
EM c.schmidt@olvg.nl
OI Schmidt, Charlotte/0000-0002-7852-4264
CR Baumeister H, 2011, PSYCHOTHER PSYCHOSOM, V80, P275, DOI 10.1159/000323404
   Becker L. A., 2000, EFFECT SIZE ES
   Berry E, 2015, POSTGRAD MED J, V91, P278, DOI 10.1136/postgradmedj-2014-133017
   Browne JL, 2016, AUST J PRIM HEALTH, V22, P409, DOI 10.1071/PY15020
   Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475
   Chaimani Anna, 2015, Evid Based Ment Health, V18, P23, DOI 10.1136/eb-2014-102035
   Chew BH, 2017, COCHRANE DB SYST REV, V9
   Elmagarmid A, 2014, EVIDENCE INFORM PUBL
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Friis AM, 2016, DIABETES CARE, V39, P1963, DOI 10.2337/dc16-0416
   Hansen BP, 2017, FAG FORSKNING, V1, P64
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jung HY, 2015, NURS HEALTH SCI, V17, P516, DOI 10.1111/nhs.12229
   Kasteleyn MJ, 2016, DIABETIC MED, V33, P125, DOI 10.1111/dme.12816
   Lamers F, 2011, J ADV NURS, V67, P788, DOI 10.1111/j.1365-2648.2010.05540.x
   Imazu MFM, 2015, REV LAT-AM ENFERM, V23, P200, DOI 10.1590/0104-1169.0247.2543
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nakaya N, 2014, EUR J PUBLIC HEALTH, V24, P45, DOI 10.1093/eurpub/ckt017
   Newby Jill, 2017, J Med Internet Res, V19, pe157, DOI 10.2196/jmir.7274
   Perrin NE, 2017, DIABETIC MED, V34, P1508, DOI 10.1111/dme.13448
   Rees G, 2017, BMJ OPEN DIABETES RE, V5
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Schroevers MJ, 2015, MINDFULNESS, V6, P99, DOI 10.1007/s12671-013-0235-5
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Thorlund K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039471
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   von Hippel PT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0024-z
   Wagner JA, 2016, DIABETES RES CLIN PR, V120, P162, DOI 10.1016/j.diabres.2016.07.022
   Wardian JL, 2018, PATIENT ED COUNS, V23
   Whittemore R, 2004, DIABETES EDUCATOR, V30, P795, DOI 10.1177/014572170403000515
   Wilson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094175
NR 41
TC 0
Z9 0
U1 8
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2018
VL 35
IS 9
BP 1157
EP 1172
DI 10.1111/dme.13709
PG 16
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GP6KX
UT WOS:000440990200003
PM 29896760
DA 2019-01-08
ER

PT J
AU Hayashino, Y
   Okarnura, S
   Tsujii, S
   Ishii, H
AF Hayashino, Yasuaki
   Okarnura, Shintaro
   Tsujii, Satoru
   Ishii, Hitoshi
CA Diabet Distress Care Registry Tenr
TI Association between diabetes distress and all-cause mortality in
   Japanese individuals with type 2 diabetes: a prospective cohort study
   (Diabetes Distress and Care Registry in Tenri [DDCRT 18])
SO DIABETOLOGIA
LA English
DT Article
DE Diabetes distress; Epidemiology; Human; Mortality; Problem Areas in
   Diabetes survey; Type 2 diabetes
ID GLYCEMIC CONTROL; PROBLEM AREAS; DEPRESSION; COMPLICATIONS;
   BENCHMARKING; OUTCOMES; PEOPLE; TRIAL; SCALE
AB Aims/hypothesis The absence of data on the direct association between diabetes-specific distress and all-cause mortality in individuals with diabetes prompted us to examine the temporal association between Problem Areas in Diabetes (PAID) survey scores and the subsequent risk of all-cause mortality in a cohort of individuals with type 2 diabetes.
   Methods Longitudinal data from 3305 individuals with diabetes were obtained from a large Japanese diabetes registry. Independent correlations between quintiles of PAID total scores or PAID scores of >= 40 and all-cause mortality (median follow-up of 6.1 years) were examined using Cox proportional hazards models with adjustment for potential confounders.
   Results The study population included 1280 women and 2025 men with a mean age of 64.9 years, BMI of 24.6 kg/m(2) and HbA(1c) level of 58.7 mmol/mol (7.5%). In the multivariable-adjusted model, compared with the first quintile of PAID scores, the multivariable-adjusted HRs (95% CIs) for all-muse mortality for the second to fifth quintiles were 1.11 (0.77, 1.60; p = 0.56), 0.87 (0.56, 1.35;p = 0.524), 0.95 (0.63, 1.46;p = 0.802) and 1.60 (1.09, 2.36;p = 0.016), respectively. Compared with a PAID score of <40, the multivariable-adjusted HR for all-cause mortality of those with a score of >= 10 was 1.56 (95% CI 1.17, 2.08; p = 0.002). In subgroup analyses, the association between PAID score and all-cause mortality was found in men (HR 1.76; 95% CI 1.26, 2.46) but not in women (HR 1.09; 95% CI 0.60, 2.00), with a significant interaction between diabetes distress and sex (p = 0.0336).
   Conclusions/interpretation We observed a significant positive association between high diabetes distress and all-cause mortality in men with diabetes.
C1 [Hayashino, Yasuaki; Okarnura, Shintaro; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
   [Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara, Japan.
RP Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
EM hayasino-y@umin.net
OI Hayashino, Yasuaki/0000-0002-2932-8478
FU Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of
   Science (JSPS) KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and the Japan Society for the Promotion of Science (JSPS)
   KAKENHI (grant number 25460641). These organisations played no role in
   the study design or conduct, data collection, analysis or
   interpretation, or preparation, review or approval of the manuscript.
CR Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Cuijpers P, 2014, J AFFECT DISORDERS, V161, P47, DOI 10.1016/j.jad.2014.03.003
   Dalsgaard EM, 2014, DIABETOLOGIA, V57, P710, DOI 10.1007/s00125-014-3165-4
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Hayashino Y, 2013, EXP CLIN ENDOCR DIAB, V121, P628, DOI 10.1055/s-0033-1355424
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   International Federation of Clinical Chemistry (IFCC) Working Group, 2010, STAND HBA1C
   Ishii H, 2000, TONYOBYO J JAPAN DIA, V43, P13
   Ismail K, 2017, DIABETOLOGIA, V60, P2092, DOI 10.1007/s00125-017-4367-3
   Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6
   Nakamura J, 2017, J DIABETES INVEST, V8, P397, DOI 10.1111/jdi.12645
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Pintaudi B, 2015, J PSYCHOSOM RES, V79, P348, DOI 10.1016/j.jpsychores.2015.08.010
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Schmitt A, 2014, DIABETIC MED, V31, P1446, DOI 10.1111/dme.12553
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   Ware JE, 2001, SCORE INTERPRET SING
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
NR 23
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD SEP
PY 2018
VL 61
IS 9
BP 1978
EP 1984
DI 10.1007/s00125-018-4657-4
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GO9EP
UT WOS:000440408500010
PM 29947921
OA Bronze
DA 2019-01-08
ER

PT J
AU Caballero, AE
AF Caballero, A. Enrique
TI The "A to Z" of Managing Type 2 Diabetes in Culturally Diverse
   Populations
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Review
DE type 2 diabetes; race; ethnicity; culture; health care disparities;
   social medicine; treatment; vulnerable populations
ID SELF-MANAGEMENT EDUCATION; IMPAIRED GLUCOSE-TOLERANCE; HEALTH-CARE
   PROFESSIONALS; PREDOMINANTLY LOW-INCOME; UNITED-STATES;
   AFRICAN-AMERICAN; GLYCEMIC CONTROL; MEDICATION ADHERENCE;
   INSULIN-RESISTANCE; PHYSICAL-ACTIVITY
AB Type 2 diabetes affects racial/ethnic minorities at an alarming rate in the US and in many countries around the world. The quality of health care provided to these groups is often suboptimal, resulting in worse patient-related outcomes when compared to those in mainstream populations. Understanding the complex biological elements that influence the development and course of the disease in high-risk populations is extremely important but often insufficient to implement effective prevention and treatment plans. Multiple factors must be addressed in routine diabetes clinical care. This paper discusses various key factors, organized in alphabetical order. These are acculturation, biology, clinician's cultural awareness, depression and diabetes-specific emotional distress, educational level, fears, group integration, health literacy, intimacy and sexual dysfunction, judging, knowledge of the disease, language, medication adherence, nutritional preferences, other forms of medicine (alternative), perception of body image, quality of life, religion and faith, socio-economic status, technology, unconscious bias, vulnerable groups, asking why?, exercise, "you are in charge" and zip it! Considering these factors in the development of type 2 diabetes prevention and treatment programs will help improve diabetes-related outcomes in culturally diverse populations and reduce health care disparities.
C1 [Caballero, A. Enrique] Harvard Med Sch, Off External Educ, Boston, MA 02115 USA.
RP Caballero, AE (reprint author), Harvard Med Sch, Off External Educ, Boston, MA 02115 USA.
EM enrique_caballero@hms.harvard.edu
CR Al Sayah F, 2015, J HEALTH COMMUN, V20, P581, DOI 10.1080/10810730.2015.1012235
   Al-Dahir S, 2013, J HEALTH CARE POOR U, V24, P47, DOI 10.1353/hpu.2013.0038
   Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829
   American Diabetes Association, 2017, Diabetes Care, V40, pS6
   Angstman KB, 2015, MED CARE, V53, P32, DOI 10.1097/MLR.0000000000000280
   [Anonymous], 2002, UNEQUAL TREATMENT CO
   Bacha F, 2003, J CLIN ENDOCR METAB, V88, P2534, DOI 10.1210/jc.2002-021267
   Baig AA, 2014, J HEALTH CARE POOR U, V25, P527, DOI 10.1353/hpu.2014.0086
   Baig AA, 2014, ETHNIC DIS, V24, P28
   Beck J, 2017, DIABETES CARE, V40, P1409, DOI 10.2337/dci17-0025
   Betancourt Joseph R, 2006, Consult Pharm, V21, P988, DOI 10.4140/TCP.n.2006.988
   Betancourt JR, 2004, NEW ENGL J MED, V351, P953, DOI 10.1056/NEJMp048033
   Bijlani RL, 2005, J ALTERN COMPLEM MED, V11, P267, DOI 10.1089/acm.2005.11.267
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Blomster JI, 2017, DIABETES RES CLIN PR, V127, P212, DOI 10.1016/j.diabres.2017.03.015
   Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527
   Brown-Riggs C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010028
   Brunton SA, 2017, J FAM PRACTICE, V66, pS46
   Butler M, 2016, 16EHC006EF AHRQ COMP
   Caballero A Enrique, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P151, DOI 10.1097/MED.0b013e32809f9531
   Caballero AE, 2008, DIABETES CARE, V31, P576, DOI 10.2337/dc07-1540
   Caballero A Enrique, 2005, Curr Diab Rep, V5, P217, DOI 10.1007/s11892-005-0012-5
   Caballero A Enrique, 2004, Curr Diab Rep, V4, P237, DOI 10.1007/s11892-004-0074-9
   Caballero AE, 2011, AM J MED, V124, pS10, DOI 10.1016/j.amjmed.2011.07.018
   Caballero A Enrique, 2007, Curr Diab Rep, V7, P321, DOI 10.1007/s11892-007-0052-0
   Caballero AE, 2006, ETHNIC DIS, V16, P559
   Caballero AE, 2007, INSULIN, V2, P81, DOI [10.1016/S1557-0843(07)80019-4, DOI 10.1016/S1557-0843(07)80019-4]
   Caballero AE, 2016, SCI SESS AM DIAB ASS
   Caballero AE, 2005, JOSLINS DIABETES MEL, P505
   Caballero AE, 2017, PRINCIPLES DIABETES, P159
   Caballero E, 2004, DIABETES, V53, pA514
   Capoccia K, 2016, DIABETES EDUCATOR, V42, P34, DOI 10.1177/0145721715619038
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P991
   Chatterjee S, 2018, LANCET DIABETES ENDO, V6, P130, DOI 10.1016/S2213-8587(17)30239-5
   Chesla CA, 2004, DIABETES CARE, V27, P2850, DOI 10.2337/diacare.27.12.2850
   Chiu KC, 2000, DIABETES CARE, V23, P1353, DOI 10.2337/diacare.23.9.1353
   Clark DO, 1997, DIABETES CARE, V20, P1176, DOI 10.2337/diacare.20.7.1176
   Cortes DE, 2013, AM J PREV MED, V44, pS267, DOI 10.1016/j.amepre.2012.11.012
   Coughlin SS, 2018, J HOSP MANAG HLTH PO, V2, DOI [10.21037/jhmhp.2017.12.04, DOI 10.21037/JHMHP.2017.12.04]
   Dai SF, 2015, J PHYS ACT HEALTH, V12, pS128, DOI 10.1123/jpah.2015-0038
   DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028
   Devlin H, 2006, HEALTH PROMOT PRACT, V7, P47, DOI 10.1177/1524839905275395
   Dham Shefali, 2006, Curr Diab Rep, V6, P251, DOI 10.1007/s11892-006-0042-7
   Doshi T, 2016, AM J MED SCI, V352, P36, DOI 10.1016/j.amjms.2016.03.020
   Ferdinand KC, 2014, CARDIORENAL MED, V4, P1, DOI 10.1159/000357236
   Fernandez A, 2011, J GEN INTERN MED, V26, P170, DOI 10.1007/s11606-010-1507-6
   Fisher L, 2000, DIABETES CARE, V23, P267, DOI 10.2337/diacare.23.3.267
   FitzGerald C, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0179-8
   Fox M, 2017, SOC SCI MED, V176, P123, DOI 10.1016/j.socscimed.2017.01.029
   Garrow D, 2006, DIABETES CARE, V29, P15, DOI 10.2337/diacare.29.01.06.dc05-1448
   Glasgow RE, 1997, DIABETES CARE, V20, P556, DOI 10.2337/diacare.20.4.556
   Goran MI, 2002, DIABETES CARE, V25, P2184, DOI 10.2337/diacare.25.12.2184
   Gurka MJ, 2006, OBESITY, V14, P1085, DOI 10.1038/oby.2006.124
   Hahn EA, 2015, J HEALTH COMMUN, V20, P4, DOI [10.1080/10810730.2015.1061071, 10.1097/MLR.0B013E31817A835D]
   Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903
   Han BH, 2016, J NURS SCHOLARSHIP, V48, P48, DOI 10.1111/jnu.12180
   Hansel B, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7947
   Hassanein M, 2017, DIABETES RES CLIN PR, V126, P303, DOI 10.1016/j.diabres.2017.03.003
   Hasson BR, 2015, CURR OBES REP, V4, P241, DOI 10.1007/s13679-015-0150-2
   Heisler M, 2014, ANN INTERN MED, V161, pS13, DOI 10.7326/M13-3012
   Hite RW, 2000, NEW ENGL J MED, V343, P1340
   Hornberger JC, 1996, MED CARE, V34, P845, DOI 10.1097/00005650-199608000-00011
   Horvat L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009405.pub2
   Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441
   Jaam M, 2017, DIABETES RES CLIN PR, V129, P1, DOI 10.1016/j.diabres.2017.04.015
   Jin K, 2017, EUR J PREV CARDIOL, V24, P2000, DOI 10.1177/2047487317736828
   Joo JY, 2014, DIABETES EDUCATOR, V40, P605, DOI 10.1177/0145721714534994
   Gagliardino JJ, 2013, DIABETES-METAB RES, V29, P152, DOI 10.1002/dmrr.2368
   Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182
   Kennedy-Martin T, 2017, PATIENT PREFER ADHER, V11, P1103, DOI 10.2147/PPA.S136639
   Khunti K, 2017, DIABETES CARE, V40, P1588, DOI 10.2337/dc16-1925
   Kim S, 2004, DIABETES CARE, V27, P2980, DOI 10.2337/diacare.27.12.2980
   Kizilay Fuat, 2017, Sex Med Rev, V5, P45, DOI 10.1016/j.sxmr.2016.07.002
   Kouidrat Y, 2017, DIABETIC MED, V34, P1185, DOI 10.1111/dme.13403
   Krass I, 2015, DIABETIC MED, V32, P725, DOI 10.1111/dme.12651
   Kutob RM, 2013, J CONTIN EDUC HEALTH, V33, P164, DOI 10.1002/chp.21181
   Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615
   Lee EH, 2017, J ADV NURS, V73, P2035, DOI 10.1111/jan.13256
   Leonetti Donna L., 1992, Ethnicity and Disease, V2, P326
   Lerman I, 2004, BIOMED PHARMACOTHER, V58, P566, DOI 10.1016/j.biopha.2004.09.003
   Liburd LC, 1999, DIABETES EDUCATOR, V25, P382, DOI 10.1177/014572179902500309
   Lopez L, 2016, J DIABETES COMPLICAT, V30, P554, DOI 10.1016/j.jdiacomp.2015.12.003
   Luscombe F A, 2000, Value Health, V3 Suppl 1, P15
   Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283
   Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167
   Mayberry LS, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0796-5
   McBean AM, 2004, DIABETES CARE, V27, P2317, DOI 10.2337/diacare.27.10.2317
   McCabe MP, 2016, J SEX MED, V13, P153, DOI 10.1016/j.jsxm.2015.12.015
   McCabe M, 2006, DIABETES EDUCATOR, V32, P714, DOI 10.1177/0145721706292101
   Meece J, 2006, DIABETES EDUCATOR, V32, p9S, DOI 10.1177/014572170585638
   Mendivil CO, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-37
   Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029
   Menon K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00263
   Merino J, 2018, ANN NY ACAD SCI, V1411, P140, DOI 10.1111/nyas.13588
   Millan-Ferro Andreina, 2007, Curr Diab Rep, V7, P391, DOI 10.1007/s11892-007-0064-9
   Mitchell MF, 2010, FAM PRACT S1, V27, pi17, DOI 10.1093/fampra/cmp027
   Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x
   Moussa M, 2013, INT J NURS PRACT, V19, P36, DOI 10.1111/ijn.12167
   National Diabetes Statistics, 2005, NAT DIAB INF CLEAR H
   NEEL JV, 1962, AM J HUM GENET, V14, P353
   O'Brien MJ, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140142
   Odgers-Jewell K, 2017, DIABETIC MED, V34, P1027, DOI 10.1111/dme.13340
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Osborn CY, 2013, J NATL MED ASSOC, V105, P51, DOI 10.1016/S0027-9684(15)30085-7
   Osei K, 2004, DIABETES CARE, V27, P1439, DOI 10.2337/diacare.27.6.1439
   Perrin NE, 2017, DIABETIC MED, V34, P1508, DOI 10.1111/dme.13448
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Puckrein GA, 2015, ETHNIC DIS, V25, P521, DOI 10.18865/ed.25.4.521
   Qi L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1798-y
   Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366
   Rasouli N, 2007, J CLIN ENDOCR METAB, V92, P4656, DOI 10.1210/jc.2007-0919
   Reynolds DB, 2015, DIABETES TECHNOL THE, V17, P243, DOI 10.1089/dia.2014.0285
   Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007
   Rodriguez-Gutierrez R, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000482
   Rosal MC, 2004, HEALTH EDUC BEHAV, V31, P388, DOI 10.1177/1090198104263360
   Roux AVD, 2005, CIRCULATION, V112, P1557, DOI 10.1161/CIRCULATIONAHA.104.530147
   Santiago-Torres M, 2016, AM J CLIN NUTR, V103, P366, DOI 10.3945/ajcn.115.119016
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   Saver BG, 2007, J AM BOARD FAM MED, V20, P28, DOI 10.3122/jabfm.2007.01.060026
   Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475
   Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072
   Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057
   Shane-McWhorter Laura, 2005, Curr Diab Rep, V5, P391, DOI 10.1007/s11892-005-0099-8
   Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089
   Snehalatha C, 2003, DIABETES-METAB RES, V19, P329, DOI 10.1002/dmrr.388
   Sohal T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136202
   Sorkin DH, 2015, J AM GERIATR SOC, V63, P2158, DOI 10.1111/jgs.13655
   Stringer Jaime D, 2016, FP Essent, V449, P18
   Strizich G, 2016, DIABETES RES CLIN PR, V117, P64, DOI 10.1016/j.diabres.2016.04.052
   Stuckey HL, 2015, CLIN THER, V37, P1986, DOI 10.1016/j.clinthera.2015.06.010
   Tamhane S, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0688-0
   Tang TS, 2014, DIABETES CARE, V37, P1525, DOI 10.2337/dc13-2161
   Teal CR, 2012, MED EDUC, V46, P80, DOI 10.1111/j.1365-2923.2011.04101.x
   Thackeray R, 2004, DIABETES EDUCATOR, V30, P665, DOI 10.1177/014572170403000418
   Trikkalinou A, 2017, WORLD J DIABETES, V8, P120, DOI 10.4239/wjd.v8.i4.120
   Tucker Katherine L, 2005, J Med Invest, V52 Suppl, P252, DOI 10.2152/jmi.52.252
   US Census Bureau, 2014, US POP PROJ RAC HISP
   van Dijk SEM, 2018, QUAL LIFE RES, V27, P1415, DOI 10.1007/s11136-018-1782-y
   Vongmany J, 2018, DIABETIC MED, V35, P184, DOI 10.1111/dme.13547
   Wachtel MS, 2005, J NATL MED ASSOC, V97, P334
   Walker RJ, 2014, ETHNIC DIS, V24, P349
   Watson KB, 2016, MMWR-MORBID MORTAL W, V65, P954, DOI 10.15585/mmwr.mm6536a3
   Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93
   Weiss R, 2006, DIABETOLOGIA, V49, P571, DOI 10.1007/s00125-005-0109-z
   Weitzman PF, 2013, DIABETES EDUCATOR, V39, P856, DOI 10.1177/0145721713507113
   Welch G, 2006, DIABETES SPECTR, V19, P5, DOI DOI 10.2337/diaspect.19.1.5
   Wen LK, 2004, FAM MED, V36, P423
   Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4
   Wood FG, 2004, J ADV NURS, V45, P190, DOI 10.1046/j.1365-2648.2003.02880.x
   Yazla E, 2018, J RELIG HEALTH, V57, P1010, DOI 10.1007/s10943-017-0504-z
   Zanoveli JM, 2016, CURR DIABETES REV, V12, P165, DOI 10.2174/1573399811666150515125349
   Zhang XX, 2016, PATIENT EDUC COUNS, V99, P186, DOI 10.1016/j.pec.2015.09.006
NR 153
TC 0
Z9 0
U1 6
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD AUG 28
PY 2018
VL 9
AR 479
DI 10.3389/fendo.2018.00479
PG 15
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GR7IE
UT WOS:000442861700001
PM 30233490
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Ponizovsky, AM
   Haklai, Z
   Goldberger, N
AF Ponizovsky, Alexander Michael
   Haklai, Ziona
   Goldberger, Nehama
TI Association between psychological distress and mortality: the case of
   Israel
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
ID NATIONAL-HEALTH SURVEY; CORONARY-HEART-DISEASE; PSYCHOSOCIAL FACTORS;
   MISSILE ATTACKS; MENTAL-HEALTH; GULF-WAR; POPULATION; RISK; CARE;
   DEPRESSION
AB Background Previous studies have demonstrated the association between psychological distress (measured by the 12-item General Health Questionnaire, GHQ-12) and risks of all-cause mortality and deaths from cardiovascular, cancer and other causes. We hypothesised that in the Israeli population permanently exposed to war/terror stressors, this relationship is absent.
   Methods We performed an analysis of data from participants in the Israel National Health Survey conducted in 2003-2004, who died during the follow-up decade. Subjects were assigned to groups based on GHQ-12 score: 0-10 (asymptomatic), 11-14 (subclinically symptomatic), 15-19 (symptomatic) and 20-36 (highly symptomatic). Data were weighted to the total population.
   Results We analysed data from 4843 individuals, median age 40.5 (IQR 28-54); 473 participants died during the follow-up. We found a significant increase in total mortality, cardiovascular and other causes of mortality (but not cancer deaths) with increase in GHQ-12 score (P for linear trend of ungrouped GHQ scores < 0.0001, 0.0015 and < 0.0001, respectively). The age-sex-adjusted HR for the highest GHQ-12 compared with the lowest asymptomatic category was 2.1 (95% CI 1.6 to 2.7) for all-cause deaths, 2.3 (95% CI 1.3 to 4.1) for cardiovascular disease deaths and 2.7 (95% CI 1.9 to 3.9) for other deaths. The HR remained significant after adjustment for education, smoking, alcohol consumption and diabetes. The HR even increased after excluding participants with baseline cardiovascular diseases and cancer.
   Conclusion Contrary to our hypothesis, psychological distress was associated with all-cause and cardiovascular but not cancer mortality. The absence of reverse causality provides evidence for the direct deleterious effects of psychological distress on mortality outcomes.
C1 [Ponizovsky, Alexander Michael] Minist Hlth, Mental Hlth Serv, IL-91000 Jerusalem, Israel.
   [Haklai, Ziona; Goldberger, Nehama] Minist Hlth, Dept Hlth Informat, Jerusalem, Israel.
RP Ponizovsky, AM (reprint author), Minist Hlth, Mental Hlth Serv, IL-91000 Jerusalem, Israel.
EM alexpon8@gmail.com
CR [Anonymous], 1993, ICD 10 CLASS MENT BE
   Batty GD, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j108
   Batty GD, 2014, ATHEROSCLEROSIS, V236, P385, DOI 10.1016/j.atherosclerosis.2014.06.025
   Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1
   Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134
   COX DR, 1972, J R STAT SOC B, V34, P187
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   EASTON JA, 1991, BRIT MED J, V303, P1231, DOI 10.1136/bmj.303.6812.1231
   Goldberg D., 1978, MANUAL GEN HLTH QUES
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   Goldberger N, LEADING CAUSES DEATH
   Gulsvik AK, 2011, EUR J EPIDEMIOL, V26, P221, DOI 10.1007/s10654-010-9535-4
   Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057
   Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002
   HARRIS MD, 1991, J CLIN PATHOL, V44, P862, DOI 10.1136/jcp.44.10.862
   Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460
   HUPPERT FA, 1995, PSYCHOL MED, V25, P1073, DOI 10.1017/S0033291700037569
   Kahan NR, 2018, INT CLIN PSYCHOPHARM, V33, P73, DOI 10.1097/YIC.0000000000000197
   KARK JD, 1995, JAMA-J AM MED ASSOC, V273, P1208, DOI 10.1001/jama.273.15.1208
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Kessler RC, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1353383
   Lerner Y, 1996, PSYCHOL MED, V26, P503, DOI 10.1017/S0033291700035583
   Levav I, 2009, PSYCHIAT BEHAV DISOR
   Levav I, 2006, AM J PSYCHIAT, V163, P1355, DOI 10.1176/appi.ajp.163.8.1355
   Leventer-Roberts M, 2017, STUD HEALTH TECHNOL, V244, P107, DOI 10.3233/978-1-61499-824-2-107
   Levinson D, 2007, ISR J PSYCHIATR REL, V44, P85
   Levinson D, 2007, ISR J PSYCHIATR REL, V44, P79
   Lubin G, 2016, ISR J PSYCHIATR REL, V53, P3
   Neumark YD, 2007, ISR J PSYCHIATR REL, V44, P126
   Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338
   Niskar A, 2009, PREV CHRONIC DIS, V6
   Ponizovsky AM, 2009, CAN J PSYCHIAT, V54, P409, DOI 10.1177/070674370905400608
   Puustinen PJ, 2011, SCAND J PUBLIC HEALT, V39, P577, DOI 10.1177/1403494811414244
   Rasul F, 2005, J EPIDEMIOL COMMUN H, V59, P140, DOI 10.1136/jech.2004.019786
   Robinson KL, 2004, ANN EPIDEMIOL, V14, P467, DOI 10.1016/j.annepidem.2003.11.007
   RUSS TC, 2012, BRIT MED J, V345, DOI [10.1136/bmj.e4933, DOI 10.1136/BMJ.E4933]
   Schmitz N, 1999, SOC PSYCH PSYCH EPID, V34, P360, DOI 10.1007/s001270050156
   Soskolne V, 1996, SOC SCI MED, V42, P1039, DOI 10.1016/0277-9536(95)00215-4
NR 38
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
EI 1470-2738
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD AUG
PY 2018
VL 72
IS 8
BP 726
EP 732
DI 10.1136/jech-2017-210356
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GR3DP
UT WOS:000442469800012
PM 29599386
DA 2019-01-08
ER

PT J
AU Braizat, O
   Feinn, R
   Abbott, G
   Wagner, J
AF Braizat, Omar
   Feinn, Richard
   Abbott, Gina
   Wagner, Julie
TI Relationship style and glycaemic control in women with type 2 diabetes:
   The mediating role of psychological distress
SO STRESS AND HEALTH
LA English
DT Article
DE attachment; continuous glucose monitoring; depression; diabetes;
   diabetes distress; mediation
ID ATTACHMENT STYLE; SOCIAL SUPPORT; DEPRESSION; ADULTS; CARE; ASSOCIATION;
   MORTALITY; OUTCOMES; DISEASE; SCALE
AB This study examined whether depressive symptoms and/or diabetes distress mediate the association between relationship style and glycaemic control in women with diabetes. Seventy-five women with type 2 diabetes completed the Relationship Questionnaire. Participants endorsing secure or preoccupied adult attachment were combined into the interactive relationship style and dismissing/avoidant or fearful adult attachment were combined into the independent relationship style. Glycaemic control was a latent variable composed of A1c and 48-hr continuously measured glucose. Diabetes distress was assessed with the Problem Areas in Diabetes scale and depressive symptoms with the Center for Epidemiological Studies Depression scale. A parallel multiple mediation model with relationship style as the independent variable, glycaemic control as the dependent variable, and Problem Areas in Diabetes and Center for Epidemiological Studies Depression scale as mediators, tested indirect effects. Bias-corrected bootstrap with 10,000 replications was used to construct 95% confidence intervals. The indirect association of relationship style with glycaemic control through diabetes distress was significant (effect=-0.09, p=.036, 95CI=-0.19-0.01), but through depressive symptoms was not. A model testing the indirect association of relationship style with diabetes distress through glycaemic control was not significant. Results suggest that relationship style is associated with glycaemic control through diabetes distress in women with type 2 diabetes.
C1 [Braizat, Omar] Univ Connecticut, Storrs, CT USA.
   [Feinn, Richard] Quinnipiac Univ, Frank Netter Sch Med, North Haven, CT USA.
   [Abbott, Gina] Quinnipiac Univ, Hamden, CT USA.
   [Wagner, Julie] UConn Hlth, Farmington, CT USA.
RP Wagner, J (reprint author), UConn Hlth, Behav Sci & Community Hlth, 263 Farmington Ave, Farmington, CT 06030 USA.
EM juwagner@uchc.edu
FU Foundation for the National Institutes of Health [DK074468]; National
   Institutes of Health [DK074468]
FX Foundation for the National Institutes of Health, Grant/Award Number:
   DK074468; National Institutes of Health, Grant/Award Number: DK074468
CR Ahrens KR, 2012, J PSYCHOSOM RES, V72, P364, DOI 10.1016/j.jpsychores.2012.02.002
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Barry J., 2015, AUSTR I MALE HLTH ST, V4, P63
   BRETHERTON I, 1992, DEV PSYCHOL, V28, P759, DOI 10.1037/0012-1649.28.5.759
   Ciechanowski P, 2004, PSYCHOSOM MED, V66, P720, DOI 10.1097/01.psy.0000138125.59122.23
   Ciechanowski P, 2010, DIABETES CARE, V33, P539, DOI 10.2337/dc09-1298
   Ciechanowski PS, 2006, MED CARE, V44, P283, DOI 10.1097/01.mlr.0000199695.03840.0d
   Ciechanowski PS, 2005, J PSYCHOSOM RES, V58, P139, DOI 10.1016/j.jpsychores.2004.07.009
   Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Griffin D, 1994, ADV PERSONAL RELATIO, P17
   Gross T M, 2000, Diabetes Technol Ther, V2, P49, DOI 10.1089/152091500316737
   Liu LJ, 2011, ANN EPIDEMIOL, V21, P26, DOI 10.1016/j.annepidem.2010.10.012
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Melloni C, 2010, CIRC-CARDIOVASC QUAL, V3, P135, DOI 10.1161/CIRCOUTCOMES.110.868307
   Mondesir FL, 2016, J GERONTOL B-PSYCHOL, V71, P1081, DOI 10.1093/geronb/gbv061
   Muthen L. K., 1998, MPLUS USERS GUIDE
   Olson MM, 2010, INT J PSYCHIAT MED, V40, P289, DOI 10.2190/PM.40.3.e
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Radin MS, 2014, J GEN INTERN MED, V29, P388, DOI 10.1007/s11606-013-2595-x
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rivellese AA, 2010, NUTR METAB CARDIOVAS, V20, P474, DOI 10.1016/j.numecd.2010.01.008
   Saunders R, 2011, ATTACH HUM DEV, V13, P403, DOI 10.1080/14616734.2011.584405
   SCHARFE E, 1994, PERS RELATIONSHIP, V1, P23, DOI DOI 10.1111/J.1475-6811.1994.TB00053.X
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spencer-Bonilla G, 2017, BMJ OPEN, V7
NR 29
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1532-3005
EI 1532-2998
J9 STRESS HEALTH
JI Stress Health
PD AUG
PY 2018
VL 34
IS 3
BP 462
EP 467
DI 10.1002/smi.2795
PG 6
WC Psychology, Applied; Psychiatry; Psychology
SC Psychology; Psychiatry
GA GP9QK
UT WOS:000441251300014
PM 29327498
DA 2019-01-08
ER

PT J
AU Chew, BH
   Vos, RC
   Pouwer, F
   Rutten, GEHM
AF Chew, Boon-How
   Vos, Rimke C.
   Pouwer, Frans
   Rutten, Guy E. H. M.
TI The associations between diabetes distress and self-efficacy, medication
   adherence, self-care activities and disease control depend on the way
   diabetes distress is measured: Comparing the DDS-17, DDS-2 and the
   PAID-5
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes distress; Epidemiologic measurements; Type 2 diabetes mellitus;
   Self-efficacy; Self-care activities; Medication adherence
ID QUALITY-OF-LIFE; EMOTIONAL DISTRESS; PROBLEM AREAS; TYPE-2; HEALTH;
   SCALE; MELLITUS; DEPRESSION; DETERMINANTS; MANAGEMENT
AB Aims: To examine whether diabetes distress (DD), when measured by three different instruments, was associated differently with self-efficacy, self-care activity, medication adherence and disease control in people with Type 2 diabetes mellitus.
   Methods: A cross-sectional study in three health clinics. DD was assessed with the 17-item Diabetes Distress Scale, the 2-item DDS-2 (DDS-2) and the 5-item Problem Areas in Diabetes Scale (PAID-5). Dependent variables included self-efficacy, self-care activities, medication adherence, HbA1c, systolic and diastolic blood pressure (SBP, DBP). Multiple linear and logistic regression were used in analyses.
   Results: In total 338 participants (56% women), with a mean age of 61 years and diabetes duration of 9.8 years, were included. DDS-2 was an independent determinant of SBP (beta = 1.89, 95% CI 0.14, 3.64), DBP (beta = 1.19, 95% CI 0.16, 2.21) and blood pressure target (OR = 2.09, 95% CI 1.12, 3.83). PAID-5 was an independent determinant of medication adherence (adjusted beta = -0.05, 95% CI -0.08, -0.01) and self-care activities (OR = 0.50, 95% CI 0.26, 0.99).
   Conclusions: Associations of DD with important aspects of diabetes care are substantially influenced by confounders and depend on the way DD is measured. Our findings call for a judicious use of different DD measures in clinical practice and research.
   The study is registered on ClinicalTrials.gov (NCT02730754). (C) 2018 Elsevier B.V. All rights reserved.
C1 [Chew, Boon-How] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia.
   [Chew, Boon-How; Vos, Rimke C.; Rutten, Guy E. H. M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Huispost Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.
   [Pouwer, Frans] Univ Southern Denmark, Dept Psychol, Odense, Denmark.
RP Chew, BH (reprint author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia.
EM chewboonhow@upm.edu.my
OI Chew, Boon How/0000-0002-8627-6248
FU Ministry of Higher Education Malaysia [KPT(BS)730928075371]; Universiti
   Putra Malaysia [UPM/TNCPI/RMC/5.1.17/F5(16)]
FX This work was partly supported by the Ministry of Higher Education
   Malaysia (grant numbers KPT(BS)730928075371, 2013) and Universiti Putra
   Malaysia's journal publication awards (award numbers
   UPM/TNCPI/RMC/5.1.17/F5(16)). The funding bodies had no role in the
   design of the study and collection, analysis, and interpretation of data
   and in writing the manuscript.
CR Aghili R, 2016, CAN J DIABETES, V40, P424, DOI 10.1016/j.jcjd.2016.02.014
   Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012
   [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001
   Chew B H, 2015, Malays Fam Physician, V10, P22
   Chew BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152095
   Chew BH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0384-4
   Chew BH, 2015, PATIENT PREFER ADHER, V9, P639, DOI 10.2147/PPA.S81612
   Chew BH, 2015, THER CLIN RISK MANAG, V11, P669, DOI 10.2147/TCRM.S81623
   Chin YW, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0601-9
   Dennick K, 2017, J DIABETES COMPLICAT, V31, P898, DOI 10.1016/j.jdiacomp.2016.12.018
   Devarajooh C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175096
   Fenwick EK, 2018, J HEALTH PSYCHOL, V23, P667, DOI 10.1177/1359105316642006
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Gonzalez JS, 2016, DIABETES CARE, V39, P2182, DOI 10.2337/dc16-1657
   How Chew Boon, 2011, Ment Health Fam Med, V8, P21
   Jannoo Z, 2017, J CLIN TRANSL ENDOCR, V9, P48, DOI 10.1016/j.jcte.2017.07.003
   Jeppesen KM, 2009, ANN FAM MED, V7, P24, DOI 10.1370/afm.919
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lee EH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0142-z
   Lee J, 2015, INT J NURS STUD, V52, P1868, DOI 10.1016/j.ijnurstu.2015.07.004
   Lee YK, 2013, PLOS ONE, V8, P80051
   Luo XP, 2015, INT J ENV RES PUB HE, V12, P11304, DOI 10.3390/ijerph120911304
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Mohd Razali N, 2014, MATH COMPUT METHODS, P200
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Morris Nancy S, 2006, BMC Fam Pract, V7, P21, DOI 10.1186/1471-2296-7-21
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   Pintaudi B, 2015, J PSYCHOSOM RES, V79, P348, DOI 10.1016/j.jpsychores.2015.08.010
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Schmitt A, 2016, DIABETIC MED, V33, P835, DOI 10.1111/dme.12887
   Sharoni SKA, 2012, NURS HEALTH SCI, V14, P38, DOI 10.1111/j.1442-2018.2011.00658.x
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x
   Venkataraman K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136759
   Walker RJ, 2014, GEN HOSP PSYCHIAT, V36, P662, DOI 10.1016/j.genhosppsych.2014.06.011
   Wang RH, 2017, J ADV NURS, V73, P1137, DOI 10.1111/jan.13201
   Winchester RJ, 2016, J DIABETES COMPLICAT, V30, P312, DOI 10.1016/j.jdiacomp.2015.11.010
   Yan J, 2014, J EVAL CLIN PRACT, V20, P311, DOI 10.1111/jep.12125
NR 43
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD AUG
PY 2018
VL 142
BP 74
EP 84
DI 10.1016/j.diabres.2018.05.021
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GO7YL
UT WOS:000440297500009
PM 29802952
DA 2019-01-08
ER

PT J
AU Nichols, J
   Vallis, M
   Boutette, S
   Casey, CG
   Yu, CH
AF Nichols, Jennica
   Vallis, Michael
   Boutette, Stephanie
   Casey, Carolyn Gall
   Yu, Catherine H.
TI A Canadian Cross-Sectional Survey on Psychosocial Supports for Adults
   Living With Type 1 or 2 Diabetes: Health-Care Providers' Awareness,
   Capacity and Motivation
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE Capacity-Opportunity-Motivation Behaviour (COM-B); diabetes; mental
   health psychosocial issues; self-management
ID PSYCHOLOGICAL INSULIN-RESISTANCE; NEEDS 2ND; NATIONAL BENCHMARKING;
   DISTRESS; ATTITUDES; PEOPLE; WISHES; HYPOGLYCEMIA; MANAGEMENT; BARRIERS
AB Objectives: Addressing psychosocial issues is critical for diabetes self-management. This work explores health-care professionals' (HCPs') 1) perceived relevance of various psychosocial issues in diabetes management and 2) confidence in working on these issues within then services.
   Methods: An online cross-sectional survey was developed based on the Capacity-Opportunity-Motivation Behaviour Model. It assessed self-rated confidence in supporting patients with psychosocial issues (capability), perceived relevance of these issues (motivation) and facilitators of skill development (oppor tunity). An e-mail invitation was sent to all Diabetes Canada's professional members, conference delegates and committee members. Qualitative responses were analyzed using thematic analysis.
   Results: Of the 260 responses received (25% response rate), many were Diabetes Canada professional members (83%) and/or certified diabetes educators (66%). The largest professional groups in the sample were registered nurses (44%) and registered dietitians (33%). All psychosocial issues were perceived as somewhat or extremely important by at least 80% of respondents (range, 80% to 97%). However, HCPs were less confident in supporting their patients with these psychosocial issues; significantly fewer respondents reported that they felt somewhat or extremely confident (range, 26% to 62%). Depression (80%) and anxiety (80%) were the issues in which guidance was most desired. Most respondents wanted some form of formal self-management support training (83%). Preferred training methods included in-person workshops (56%), webinars (56%) and conference sessions (51%).
   Conclusions: Motivation to address psychosocial issues in diabetes was high, but capacity to do so and opportunity to learn how were both low. These findings can be used to develop a targeted strategy to help address this gap. (C) 2017 Canadian Diabetes Association.
C1 [Nichols, Jennica; Boutette, Stephanie; Casey, Carolyn Gall] Diabet Canada, Toronto, ON, Canada.
   [Vallis, Michael] Dalhousie Univ, Halifax, NS, Canada.
   [Vallis, Michael] Capital Hlth, Halifax, NS, Canada.
   [Yu, Catherine H.] St Michaels Hosp, Toronto, ON, Canada.
RP Yu, CH (reprint author), St Michaels Hosp, Ctr Diabet & Metab, 30 Bond St, Toronto, ON M5B 1W8, Canada.
EM YuCa@smh.ca
OI Vallis, Michael/0000-0002-0165-5936
CR Battersby MW, 2008, AUST J PRIM HEALTH, V14, P66, DOI 10.1071/PY08009
   Booth G, 2013, CAN J DIABETES, V37, pS4, DOI 10.1016/j.jcjd.2013.01.010
   Braun V., 2008, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2008, CAN J DIABETES S1, V32, pS1, DOI DOI 10.1503/CMAJ.080554
   Canadian Institute for Health Information, 2011, CAN HLTH CAR PROV 19
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Frost MH, 1997, CANCER NURS, V20, P350, DOI 10.1097/00002820-199710000-00006
   Funnell MM, 2008, DIABETES CARE, V31, pS97, DOI 10.2337/dc08-S097
   Glasgow RE, 2006, HEALTH PROMOT INT, V21, P245, DOI 10.1093/heapro/dal017
   Gonder-Frederick LA, 2013, DIABETIC MED, V30, P603, DOI 10.1111/dme.12129
   Greenberg R, 2008, NEW TOOL MOTIVATE PA
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Holmes-Truscott E, 2016, PRIM CARE DIABETES, V10, P75, DOI 10.1016/j.pcd.2015.06.006
   Houlden R, 2003, CAN J DIABETES S2, V27, pS50
   Institute for Healthcare Communication, CHOIC CHANG MOT HEAL
   Kovacs Burns K, 2015, DIABETES RES TREAT, V2, P125
   Kreider KE, 2017, DIABETES THER, V8, P1, DOI 10.1007/s13300-017-0231-1
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42
   Miller W.R., 1995, MOTIVATIONAL ENHANCE
   Miller WR, 2012, MOTIVATIONAL INTERVI
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nouwen A, 2015, DIABETIC MED, V32, P1261, DOI 10.1111/dme.12863
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Pfizer Canada, 2012, 3 MIN EMP
   Polonsky WH, 2015, J DIABETES COMPLICAT, V29, P1171, DOI 10.1016/j.jdiacomp.2015.08.002
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2004, CLIN DIABETES, V22, P147
   Polonsky WH, 2017, DIABETES TECHNOL THE, V19, P131, DOI 10.1089/dia.2016.0366
   Polonsky WH, 2011, CURR MED RES OPIN, V27, P1169, DOI 10.1185/03007995.2011.573623
   Powers MA, 2017, DIABETES EDUCATOR, V43, P105, DOI 10.1177/0145721716680888
   R Core Team, 2016, R LANG ENV STAT COMP
   Robinson DJ, 2013, CAN J DIABETES, V37, pS87, DOI 10.1016/j.jcjd.2013.01.026
   RUBIN RR, 1992, DIABETES CARE, V15, P1640, DOI 10.2337/diacare.15.11.1640
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Stuckey HL, 2014, DIABETES CARE, V37, P2466, DOI 10.2337/dc13-2536
   Vallis M, 2016, CAN J DIABETES, V40, P234, DOI 10.1016/j.jcjd.2015.11.002
   Vallis M, 2014, CURR DIABETES REV, V10, P364, DOI 10.2174/1573399810666141113115026
   von Elm E, 2008, GAC SANIT, V22, P144, DOI 10.1157/13119325
NR 44
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD AUG
PY 2018
VL 42
IS 4
BP 389
EP +
DI 10.1016/j.jcjd.2017.09.004
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GO6XI
UT WOS:000440196700009
PM 29129456
DA 2019-01-08
ER

PT J
AU Hood, KK
   Iturralde, E
   Rausch, J
   Weissberg-Benchell, J
AF Hood, Korey K.
   Iturralde, Esti
   Rausch, Joseph
   Weissberg-Benchell, Jill
TI Preventing Diabetes Distress in Adolescents With Type 1 Diabetes:
   Results 1 Year After Participation in the STePS Program
SO DIABETES CARE
LA English
DT Article
ID AUTOMATIC THOUGHTS QUESTIONNAIRE; GLYCEMIC CONTROL; DEPRESSIVE SYMPTOMS;
   CLINICAL-TRIALS; CHILDREN; GROWTH; INVENTORY; ADULTS; MODEL; YOUTH
AB OBJECTIVE
   The aim is to report 1-year outcomes of the Supporting Teens Problem Solving (STePS) study, a randomized controlled trial comparing a distress and depression prevention program with a diabetes education program for adolescents with type 1 diabetes.
   RESEARCH DESIGN AND METHODS
   With 264 adolescents in two locations (Chicago and San Francisco Bay Area), a randomized controlled trial was conducted comparing the Penn Resilience Program for type 1 diabetes (PRP T1D) to Advanced Diabetes Education. Interventions lasted 4.5 months, and assessments were conducted at baseline, and 4.5, 8, 12, and 16 months. Outcomes of interest were diabetes distress (DD), depressive symptoms, resilience, diabetes self-management, and glycemic control. Latent growth curve modeling was used to test between-group differences over time.
   RESULTS
   Results indicate that there was acceptable randomization and exposure to interventions, and that exposure to PRP T1D was associated with substantial reductions in DD. In addition, stable glycemic control, resilience characteristics, and depressive symptoms were observed 1 year post-treatment. Diabetes management deteriorated in both groups.
   CONCLUSIONS
   Intervening before symptoms of psychological distress start can prevent the development of the DD commonly seen in adolescents with type 1 diabetes. The STePS program represents a promising prevention program, and future reports on 2- and 3-year outcomes will explore benefits over longer periods of time.
C1 [Hood, Korey K.; Iturralde, Esti] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.
   [Rausch, Joseph] Ohio State Univ, Dept Pediat, Res Inst, Nationwide Childrens Hosp, Columbus, OH 43210 USA.
   [Weissberg-Benchell, Jill] Northwestern Univ, Dept Psychiat & Behav Sci, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Hood, KK (reprint author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.
EM kkhood@stanford.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [R01-090030]
FX This study was supported by funding from the National Institute of
   Diabetes and Digestive and Kidney Diseases (grant R01-090030).
CR Feingold A, 2009, PSYCHOL METHODS, V14, P43, DOI 10.1037/a0014699
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Garrison MM, 2005, DIABETES CARE, V28, P2150, DOI 10.2337/diacare.28.9.2150
   Gillham JE, 2006, J ABNORM CHILD PSYCH, V34, P203, DOI 10.1007/s10802-005-9014-7
   Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   HARRELL TH, 1983, J CONSULT CLIN PSYCH, V51, P721, DOI 10.1037//0022-006X.51.5.721
   Hessler DM, 2017, DIABETIC MED, V34, P1228, DOI 10.1111/dme.13381
   Hilliard ME, 2012, CURR DIABETES REP, V12, P739, DOI 10.1007/s11892-012-0314-3
   HOLLON SD, 1980, COGNITIVE THER RES, V4, P383, DOI 10.1007/BF01178214
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Hood KK, 2014, J ADOLESCENT HEALTH, V55, P498, DOI 10.1016/j.jadohealth.2014.03.011
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Jaser SS, 2017, ANN BEHAV MED, V51, P30, DOI 10.1007/s12160-016-9825-5
   Kazdin A. E., 1990, PSYCHOL ASSESSMENT J, V2, P73, DOI DOI 10.1037/1040-3590.2.1.73
   Kovacs M, 2003, CHILDRENS DEPRESSION
   MaydeuOlivares A, 1996, COGNITIVE THER RES, V20, P115, DOI 10.1007/BF02228030
   McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Reivich K., 2005, HDB RESILIENCE CHILD, P223
   Riley AR, 2015, DIABETES CARE, V38, P1435, DOI 10.2337/dc14-2519
   Sandler IN, 2000, CHILD DEV, V71, P1099, DOI 10.1111/1467-8624.00212
   Stull DE, 2008, QUAL LIFE RES, V17, P47, DOI 10.1007/s11136-007-9290-5
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Weissberg-Benchell J, 2014, 74 ANN SCI SESS AM D
   Weissberg-Benchell J, 2016, CONTEMP CLIN TRIALS, V49, P78, DOI 10.1016/j.cct.2016.05.006
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Wu AD, 2010, SOC INDIC RES, V97, P123, DOI 10.1007/s11205-009-9496-8
NR 29
TC 1
Z9 1
U1 2
U2 2
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD AUG 1
PY 2018
VL 41
IS 8
BP 1623
EP 1630
DI 10.2337/dc17-2556
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GN7EC
UT WOS:000439288600012
PM 29921624
DA 2019-01-08
ER

PT J
AU Hartzler, ML
   Shenk, M
   Williams, J
   Schoen, J
   Dunn, T
   Anderson, D
AF Hartzler, Melody L.
   Shenk, McKenzie
   Williams, Julie
   Schoen, James
   Dunn, Thomas
   Anderson, Douglas
TI Impact of Collaborative Shared Medical Appointments on Diabetes Outcomes
   in a Family Medicine Clinic
SO DIABETES EDUCATOR
LA English
DT Article
ID RANDOMIZED-CONTROLLED-TRIAL; SELF-MANAGEMENT EDUCATION; QUALITY-OF-LIFE;
   GROUP VISITS; PRIMARY-CARE; DEPRESSIVE SYMPTOMS; COMORBID DEPRESSION;
   VULNERABLE PATIENTS; FOLLOW-UP; MELLITUS
AB Purpose The purpose of this study is to evaluate the impact of a collaborative diabetes shared medical appointment on patient outcomes in an urban family medicine practice.
   Methods Fifty-nine patients were enrolled to participate in multiple shared medical appointments (SMAs) over 12 months. Baseline data included hemoglobin (A1C), lipids, systolic blood pressure (SBP), weight, adherence to American Diabetes Association (ADA) guidelines, and surveys, including the Problem Areas in Diabetes (PAID-2) scale and the Spoken Knowledge in Low Literacy in Diabetes Scale (SKILLD). A1C and SBP were evaluated at each visit. Lipid control was assessed at baseline and at 6 and 12 months. Adherence to ADA guidelines, SKILLD and PAID-2 survey scores, and number of antihyperglycemic and antihypertensive medications were also evaluated at 12 months.
   Results Thirty-eight patients completed the study. Compared with baseline, A1C and low-density lipoprotein cholesterol (LDL-C) levels decreased significantly over 12 months (P < .001 and P = .004, respectively). More patients became compliant with the ADA guidelines throughout the course of the study. Specifically, more patients achieved the LDL-C goal of 100 mg/dL (2.59 mmol/L; P < .001), were prescribed appropriate antihypertensive medications (P < .001) and aspirin (P < .001), and received the pneumonia vaccine (P < .001). PAID-2 and SKILLD survey scores also significantly improved over the course of the study (P .001 and P = .003, respectively).
   Conclusion Short-term interdisciplinary SMAs decreased A1C and LDL-C, improved patient adherence to ADA guidelines, improved emotional distress related to diabetes, and increased knowledge of diabetes.
C1 [Hartzler, Melody L.; Shenk, McKenzie; Anderson, Douglas] Cedarville Univ, Sch Pharm, 251 N Main St, Cedarville, OH 45314 USA.
   [Williams, Julie] Wright State Univ, Sch Profess Psychol, Dayton, OH 45435 USA.
   [Schoen, James] Grandview Med Ctr, Family Med, Dayton, OH USA.
   [Dunn, Thomas] Kettering Phys Network, Family Med, Dayton, OH USA.
RP Hartzler, ML (reprint author), Cedarville Univ, Sch Pharm, 251 N Main St, Cedarville, OH 45314 USA.
EM mhartzler@cedarville.edu
FU Internal Grant by Cedarville University School of Pharmacy
FX Internal Grant by Cedarville University School of Pharmacy.
CR American Diabetes Association, 2013, EC COSTS DIAB US 201
   American Diabetes Association, 2017, STAT DIAB
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bassett J, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000210
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Brennan J, 2011, AM J LIFESTYLE MED, V5, P69, DOI 10.1177/1559827610378331
   Christie D, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18200
   Clancy DE, 2008, AM J MANAG CARE, V14, P39
   Clancy DE, 2007, J GEN INTERN MED, V22, P620, DOI 10.1007/s11606-007-0150-3
   Cohen LB, 2011, DIABETES EDUCATOR, V37, P801, DOI 10.1177/0145721711423980
   Culhane-Pera KA, 2005, J HEALTH CARE POOR U, V16, P315, DOI 10.1353/hpu.2005.0030
   Dickman K, 2012, J AM ACAD NURSE PRAC, V24, P43, DOI 10.1111/j.1745-7599.2011.00660.x
   Edelman D, 2012, SHARED MED APPOINTME
   Edelman D, 2015, J GEN INTERN MED, V30, P99, DOI 10.1007/s11606-014-2978-7
   Edelman D, 2010, ANN INTERN MED, V152, P689, DOI 10.7326/0003-4819-152-11-201006010-00001
   Eisenstat SA, 2013, CURR DIABETES REP, V13, P177, DOI 10.1007/s11892-012-0349-5
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glasgow RE, 2004, J GEN INTERN MED, V19, P1167, DOI 10.1111/j.1525-1497.2004.30425.x
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Golstein MK, 2007, VET AFF HLTH SERV RE
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Heyworth L, 2014, ANN FAM MED, V12, P324, DOI 10.1370/afm.1660
   Johnson JA, 2014, DIABETES CARE, V37, P3220, DOI 10.2337/dc14-1308
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   Katon W, 2012, ARCH GEN PSYCHIAT, V69, P506, DOI 10.1001/archgenpsychiatry.2011.1548
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Naik AD, 2011, ARCH INTERN MED, V171, P453, DOI 10.1001/archinternmed.2011.70
   Noffsinger E. B., 1999, PERMANENTE J, V3, P58
   Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126
   Pena-Purcell NC, 2011, DIABETES EDUCATOR, V37, P770, DOI 10.1177/0145721711423319
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Ramser KL, 2008, DIABETES SPECTR, V21, P209, DOI DOI 10.2377/DIASPECT.21.3.209
   Ridgeway NA, 1999, SOUTHERN MED J, V92, P667, DOI 10.1097/00007611-199907000-00004
   Rothman RL, 2005, DIABETES EDUCATOR, V31, P215, DOI 10.1177/0145721705275002
   Rygg LO, 2012, PATIENT EDUC COUNS, V86, P98, DOI 10.1016/j.pec.2011.04.008
   Schillinger D, 2009, DIABETES CARE, V32, P559, DOI 10.2337/dc08-0787
   Sikon A, 2010, ANN INTERN MED, V152, P745, DOI 10.7326/0003-4819-152-11-201006010-00012
   Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791
   Sumego M, 2014, ACP J CLUB, V160, P1
   Taveira TH, 2011, ANN PHARMACOTHER, V45, P1346, DOI 10.1345/aph.1Q212
   Taveira TH, 2010, DIABETES EDUCATOR, V36, P109, DOI 10.1177/0145721709352383
   Trento M, 2005, NUTR METAB CARDIOVAS, V15, P293, DOI 10.1016/j.numecd.2004.12.005
   Trento M, 2004, DIABETES CARE, V27, P670, DOI 10.2337/diacare.27.3.670
   Trento M, 2002, DIABETOLOGIA, V45, P1231, DOI 10.1007/s00125-002-0904-8
   Trento M, 2001, DIABETES CARE, V24, P995, DOI 10.2337/diacare.24.6.995
   Trott HW, 2012, THESIS
   Vachon GC, 2007, J NATL MED ASSOC, V99, P1327
   Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wheelock C, 2009, FAM MED, V41, P116
NR 56
TC 0
Z9 0
U1 11
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD AUG
PY 2018
VL 44
IS 4
BP 361
EP 372
DI 10.1177/0145721718776597
PG 12
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA GO0KP
UT WOS:000439617600004
PM 29792133
DA 2019-01-08
ER

PT J
AU Piatt, GA
   Rodgers, EA
   Xue, LS
   Zgibor, JC
AF Piatt, Gretchen A.
   Rodgers, Elizabeth A.
   Xue, Lingshu
   Zgibor, Janice C.
TI Integration and Utilization of Peer Leaders for Diabetes Self-Management
   Support: Results From Project SEED (Support, Education, and Evaluation
   in Diabetes)
SO DIABETES EDUCATOR
LA English
DT Article
ID COMMUNITY-HEALTH WORKERS; RANDOMIZED CONTROLLED-TRIAL; TRAINING-PROGRAM;
   CHRONIC DISEASE; CARE; PREVENTION; MELLITUS; INTERVENTION; OUTCOMES;
   ADULTS
AB Purpose The purpose of the study was to evaluate the effectiveness of a peer leader-led (PL) diabetes self-management support (DSMS) group in achieving and maintaining improvements in A1C, self-monitoring of blood glucose (SMBG), and diabetes distress in individuals with diabetes. Diabetes self-management support is critical; however, effective, sustainable support models are scarce.
   Methods The study was a cluster randomized controlled trial of 221 people with diabetes from 6 primary care practices. Practices and eligible participants (mean age: 63.0 years, 63.8% female, 96.8% white, 28.5% at or below poverty level, 32.5% using insulin, A1C 7%: 54.2%) were randomized to diabetes self-management education (DSME) + PL DSMS (n = 119) or to enhanced usual care (EUC) (DSME + traditional DSMS with no PL; n = 102). Data were collected at baseline, after DSME (6 weeks), after DSMS (6 months), and after telephonic DSMS (12 months).
   Results Decreases in A1C occurred between baseline and post-DSME in both groups. Both groups sustained improvements during DSMS, but A1C levels increased during telephonic DSMS. Improvements in self-monitoring of blood glucose were observed in both groups following DSME and were sustained throughout. At study end, the intervention group was 4.3 times less likely to have diabetes regimen-related distress compared to EUC.
   Conclusions PL DSMS is as effective as traditional DSMS in helping participants to maintain glycemic control and self-monitoring of blood glucose (SMBG) and more effective at improving distress. With increasing diabetes prevalence and shortage of diabetes educators, it is important to integrate and use low-cost interventions in high-risk communities that build on available resources.
C1 [Piatt, Gretchen A.] Univ Michigan, Sch Med, Dept Learning Hlth Sci, Ann Arbor, MI USA.
   [Rodgers, Elizabeth A.] Gateway Hlth Plan, Pittsburgh, PA USA.
   [Rodgers, Elizabeth A.; Xue, Lingshu] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.
   [Zgibor, Janice C.] Univ S Florida, Coll Publ Hlth, Tampa, FL USA.
RP Piatt, GA (reprint author), Univ Michigan, Dept Learning Hlth Sci, 1111 E Catherine St,Room 222, Ann Arbor, MI 48109 USA.
EM piattg@umich.edu
FU educational grant from Eli Lilly and Company
FX Bringing Research in Diabetes to Global Environments and Systems
   (BRiDGES), an International Diabetes Federation project supported by an
   educational grant from Eli Lilly and Company.
CR American Association of Diabetes Educators, 2010, SUST MOD DIAB SELF M
   Anderson G, 2004, PUBLIC HEALTH REP, V119, P263, DOI 10.1016/j.phr.2004.04.005
   Balagopal P, 2012, DIABETES EDUCATOR, V38, P822, DOI 10.1177/0145721712459890
   Beck J, 2017, DIABETES EDUCATOR, V43, P449, DOI 10.1177/0145721717722968
   Cherrington A, 2008, J HEALTH CARE POOR U, V19, P1044, DOI 10.1353/hpu.0.0077
   Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x
   Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5
   Eng Eugenia, 1992, FAM COMMUNITY HEALTH, V15, P24, DOI DOI 10.1097/00003727-199204000-00005
   Fischman Josh, 2005, US News World Rep, V138, P44
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Funnell MM, 2010, FAM PRACT, V27, pI17, DOI 10.1093/fampra/cmp027
   Funnell MM, 2005, DIABETES EDUCATOR, V31, P53, DOI 10.1177/0145721704273166
   Funnell MM, 2005, DIABETES ED, V31, P61
   Funnell MM, 2007, DIABETES SPECTR, V20, P221, DOI DOI 10.2337/DIASPECT.20.4.221
   Harris M. I., 1995, DIABETES AM, P1
   Institute of Medicine, 2001, CROSS QUAL CHASM NEW
   Lasater TM, 1997, ANN EPIDEMIOL, V7, pS46, DOI 10.1016/S1047-2797(97)80007-5
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Millay JM, ACCURATELY MEASURING
   Moskowitz D, 2013, J GEN INTERN MED, V28, P938, DOI 10.1007/s11606-013-2367-7
   National Certification Board for Diabetes Educators, 2017, SUMM 2016 CERT EX RE
   Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2002, AM J PREV MED, V22, P39, DOI 10.1016/S0749-3797(02)00424-5
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   O'Connor A, 2012, PUBLIC HEALTH, V126, P813, DOI 10.1016/j.puhe.2012.05.029
   PADGETT D, 1988, J CLIN EPIDEMIOL, V41, P1007, DOI 10.1016/0895-4356(88)90040-6
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Siminerio L, 2013, DIABETES EDUCATOR, V39, P705, DOI 10.1177/0145721713492570
   Stewart MJ, 1995, INT J NURS STUD, V32, P535, DOI 10.1016/0020-7489(95)00014-9
   Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x
   Tang TS, 2013, DIABETIC MED, V30, P746, DOI 10.1111/dme.12179
   Tang TS, 2014, DIABETES CARE, V37, P1525, DOI 10.2337/dc13-2161
   Tang TS, 2012, DIABETES EDUCATOR, V38, P519, DOI 10.1177/0145721712447982
   Tang TS, 2011, PATIENT EDUC COUNS, V85, P160, DOI 10.1016/j.pec.2010.12.013
   Tang TS, 2011, DIABETES EDUCATOR, V37, P67, DOI 10.1177/0145721710387308
   Thompson JR, 2007, DIABETES EDUCATOR, V33, p159S, DOI 10.1177/01457207304077
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   US Census Bureau, 2015, QUICKFACTS FAYETT CO
   Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334
   2018, DIABETES CARE S1, V41, pS38
   1979, JAMA, V242, P2562
NR 44
TC 1
Z9 1
U1 5
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD AUG
PY 2018
VL 44
IS 4
BP 373
EP 382
DI 10.1177/0145721718777855
PG 10
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA GO0KP
UT WOS:000439617600005
PM 29806788
DA 2019-01-08
ER

PT J
AU Sheikh, MA
AF Sheikh, Mashhood Ahmed
TI Coloring of the past via respondent's current psychological state,
   mediation, and the association between childhood disadvantage and
   morbidity in adulthood
SO JOURNAL OF PSYCHIATRIC RESEARCH
LA English
DT Article
DE Childhood disadvantage; Social epidemiology; Social causation; Life
   course; Anchoring; Recall bias; Measurement error; Differential error;
   Non-differential error; Reliability; Validity
ID RETROSPECTIVE REPORTS; AUTOBIOGRAPHICAL MEMORY; MALTREATMENT RESEARCH;
   REPORTING BEHAVIOR; RECALL BIAS; EXPERIENCES; HEALTH; DISORDERS; ABUSE;
   DISTRESS
AB Objective: Many researchers view retrospective reports with skepticism. Indeed, the observed association between retrospectively-reported childhood disadvantage (CD) and morbidity in adulthood has been criticized as an artefactual correlation driven by the psychological state of the respondent at the time of reporting (current psychological state). The aim of this study was to assess the role of current psychological state in the association between childhood disadvantage and morbidity in adulthood.
   Methods: The present analysis used cross-sectional data collected in 2007-2008 within the framework of the Tromso Study (N = 10,765), a representative study of adult men and women in Norway. The association between CD and the physical health outcomes heart attack, angina pectoris, chronic bronchitis/emphysema/COPD, diabetes mellitus, hypothyroid/low metabolism, migraine, hypertension, and comorbidity (i.e., the sum of these physical health outcomes) was assessed with Poisson regression models. Relative risks (RR) and 95% confidence intervals (CI) were estimated. A wide range of indicators of respondents' current psychological state were included in the models to assess the % attenuation in estimates.
   Results: CD was associated with an increased risk of heart attack, angina pectoris, chronic bronchitis/emphysema/COPD, diabetes mellitus, hypothyroid/low metabolism, migraine, hypertension, and comorbidity (p < 0.05), independent of respondents' current psychological state. A sizeable proportion (23-42%) of the association between CD and physical health outcomes was driven by recall bias or mediation via respondents' current psychological state. Controlling for indicators of current psychological state reduced the strength of associations between CD and physical health outcomes; however, the independent associations remained in the same direction.
   Conclusion: The association between retrospectively-reported CD and physical health outcomes in adulthood is not driven entirely by respondent's current psychological state.
C1 [Sheikh, Mashhood Ahmed] Univ Tromso, Dept Community Med, Tromso, Norway.
RP Sheikh, MA (reprint author), Univ Tromso, Dept Community Med, Tromso, Norway.
EM mashhood.a.sheikh@uit.no
OI Sheikh, Mashhood Ahmed/0000-0002-3212-592X
CR ANESHENSEL CS, 1987, J HEALTH SOC BEHAV, V28, P232, DOI 10.2307/2136843
   Beckett M, 2001, J HUM RESOUR, V36, P593, DOI 10.2307/3069631
   Beckett M, 2000, AM J EPIDEMIOL, V151, P315
   BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037//0003-066X.36.2.129
   BRADBURN NM, 1987, SCIENCE, V236, P157, DOI 10.1126/science.3563494
   Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8
   BREWIN CR, 1988, COGNITIVE FDN CLIN P
   Brown M, 2014, LONGITUD LIFE COURSE, V5, P64, DOI 10.14301/llcs.v5i1.232
   Campbell JA, 2016, AM J PREV MED, V50, P344, DOI 10.1016/j.amepre.2015.07.022
   Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033
   Dube SR, 2004, CHILD ABUSE NEGLECT, V28, P729, DOI 10.1016/j.chiabu.2003.08.009
   Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602
   Falkegard M, 2015, ACTA OBSTET GYN SCAN, V94, P28, DOI 10.1111/aogs.12514
   Femina D, 1990, CHILD ABUSE NEGLECT, V14, P227, DOI DOI 10.1016/0145-2134(90)90033-P
   Fergusson DM, 2011, INT J METH PSYCH RES, V20, P93, DOI 10.1002/mpr.337
   Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111
   FIELD D, 1981, INT J BEHAV DEV, V4, P77, DOI 10.1177/016502548100400106
   Gerlsma C, 1997, PERS INDIV DIFFER, V23, P271, DOI 10.1016/S0191-8869(97)00033-0
   Gilbert D. T., 2006, STUMBLING HAPPINESS
   Goodman G. S., 2016, DEV PSYCHOPATHOLOGY
   Haas SA, 2007, DEMOGRAPHY, V44, P113, DOI 10.1353/dem.2007.0003
   HALVERSON CF, 1988, J PERS, V56, P435, DOI 10.1111/j.1467-6494.1988.tb00895.x
   Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x
   Hardt J, 2010, PSYCHOL REP, V107, P425, DOI 10.2466/02.04.09.10.16.21.PR0.107.5.425-440
   Havari E, 2015, EUR J POPUL, V31, P233, DOI 10.1007/s10680-014-9332-y
   HERZOG AR, 1989, PSYCHOL AGING, V4, P173, DOI 10.1037/0882-7974.4.2.173
   Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049
   Jorgensen RS, 1996, PSYCHOL BULL, V120, P293, DOI 10.1037/0033-2909.120.2.293
   Kendall-Tackett K, 2004, CHILD ABUSE NEGLECT, V28, P723, DOI 10.1016/j.chiabu.2004.02.002
   Krieger N, 1998, AM J EPIDEMIOL, V147, P704
   Kuh D., 2004, LIFE COURSE APPROACH, P371
   LEWINSOHN PM, 1987, J PERS SOC PSYCHOL, V52, P611, DOI 10.1037//0022-3514.52.3.611
   LEWIS M, 1995, J AM ACAD CHILD PSY, V34, P405, DOI 10.1097/00004583-199504000-00007
   Lindsay DS, 2004, MEMORY, V12, P27, DOI 10.1080/09658210244000243
   MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P
   McFarland C, 1998, J PERS SOC PSYCHOL, V75, P1424, DOI 10.1037/0022-3514.75.6.1424
   Memon A., 1997, LEGAL CRIMINOL PSYCH, V2, P131
   Mock S. E., 2011, FRONT PSYCHOL, V1
   Offer D, 2000, J AM ACAD CHILD PSY, V39, P735, DOI 10.1097/00004583-200006000-00012
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   PARKS ED, 1995, PSYCHIATRY, V58, P199, DOI 10.1080/00332747.1995.11024726
   Pinto R, 2014, J FAM VIOLENCE, V29, P431, DOI 10.1007/s10896-014-9602-9
   Pinto RJ, 2013, CHILD ABUSE REV, V22, P354, DOI 10.1002/car.2232
   Raphael Karen G, 2004, Curr Pain Headache Rep, V8, P99, DOI 10.1007/s11916-004-0023-y
   Raphael KG, 2005, CLIN J PAIN, V21, P371, DOI 10.1097/01.ajp.0000149794.70627.18
   RAPHAEL KG, 1994, J CLIN EPIDEMIOL, V47, P555, DOI 10.1016/0895-4356(94)90302-6
   Reuben A, 2016, J CHILD PSYCHOL PSYC, V57, P1103, DOI 10.1111/jcpp.12621
   ROBINS LN, 1985, AM J ORTHOPSYCHIAT, V55, P27, DOI 10.1111/j.1939-0025.1985.tb03419.x
   ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341
   Scott KM, 2011, ARCH GEN PSYCHIAT, V68, P838, DOI 10.1001/archgenpsychiatry.2011.77
   Scott KM, 2008, PSYCHOSOM MED, V70, P1035, DOI 10.1097/PSY.0b013e318187a2fb
   Sheikh MA, 2018, EUR CHILD ADOLES PSY, V27, P481, DOI 10.1007/s00787-017-1090-z
   Sheikh MA, 2018, J PSYCHOSOM RES, V108, P78, DOI 10.1016/j.jpsychores.2018.03.001
   Sheikh MA, 2018, J PSYCHIATR RES, V101, P50, DOI 10.1016/j.jpsychires.2018.02.025
   Sheikh MA, 2018, INT J PUBLIC HEALTH, V63, P181, DOI 10.1007/s00038-017-1021-2
   Sheikh MA, 2018, J AFFECT DISORDERS, V229, P206, DOI 10.1016/j.jad.2017.12.051
   Sheikh MA, 2018, J AFFECT DISORDERS, V226, P21, DOI 10.1016/j.jad.2017.09.015
   Sheikh MA, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312115622857
   Sheikh MA, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-164
   SINGER JA, 1988, CLIN PSYCHOL REV, V8, P211, DOI 10.1016/0272-7358(88)90060-8
   Smith JP, 2009, DEMOGRAPHY, V46, P387, DOI 10.1353/dem.0.0058
   STEELE GP, 1980, PSYCHOL MED, V10, P301, DOI 10.1017/S0033291700044056
   STROMGREN LS, 1977, ACTA PSYCHIAT SCAND, V56, P109, DOI 10.1111/j.1600-0447.1977.tb06670.x
   Sullivan H. S., 1973, CLIN STUDIES PSYCHIA
   Susser E, 2012, SCHIZOPHRENIA BULL, V38, P672, DOI 10.1093/schbul/sbs074
   TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193
   Tietjen GE, 2010, EXPERT REV NEUROTHER, V10, P1625, DOI [10.1586/ern.10.152, 10.1586/ERN.10.152]
   von Fintel D, 2016, SOC INDIC RES, V126, P119, DOI 10.1007/s11205-015-0896-7
   Vuolo M, 2014, DEMOGRAPHY, V51, P1999, DOI 10.1007/s13524-014-0344-3
   Ward MM, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-147
   White HR, 2007, PSYCHOL REP, V101, P1079, DOI 10.2466/PR0.101.4.1079-1094
   Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49
   Widom CS, 2004, CHILD ABUSE NEGLECT, V28, P715, DOI 10.1016/j.chiabu.2004.03.009
   WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037/0022-006X.62.6.1167
   Yarrow M R, 1970, Monogr Soc Res Child Dev, V35, P1
NR 75
TC 3
Z9 3
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3956
EI 1879-1379
J9 J PSYCHIATR RES
JI J. Psychiatr. Res.
PD AUG
PY 2018
VL 103
BP 173
EP 181
DI 10.1016/j.jpsychires.2018.05.027
PG 9
WC Psychiatry
SC Psychiatry
GA GM3LA
UT WOS:000438004900025
PM 29883925
DA 2019-01-08
ER

PT J
AU Wardian, JL
   Tate, J
   Folaron, I
   Graybill, S
   True, M
   Sauerwein, T
AF Wardian, Jana L.
   Tate, Joshua
   Folaron, Irene
   Graybill, Sky
   True, Mark
   Sauerwein, Tom
TI Who's distressed? A comparison of diabetes-related distress by type of
   diabetes and medication
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Diabetes-related distress; Regimen distress; Emotional burden; Type 1
   diabetes; Type 2 diabetes
ID PSYCHOLOGICAL INSULIN-RESISTANCE; EMOTIONAL BURDEN; GLYCEMIC CONTROL;
   SELF-MANAGEMENT; SOCIAL SUPPORT; ADULTS; SCALE; AUSTRALIA; THERAPY;
   IMPACT
AB Objective: We hypothesized that diabetes-related distress would vary by type of diabetes and medication regimen [Type 1 diabetes (T1DM), Type 2 diabetes with insulin use (T2DM-i), Type 2 diabetes without insulin use (T2DM)]. Thus, the aim of this study was to identify groups with elevated diabetes-related distress.
   Methods: We administered the 17-item Diabetes-related Distress Scale (DDS-17) to 585 patients. We collected demographics, medications, and lab results from patient records.
   Results: Patients were categorized by type of diabetes and medication: T1DM (n = 149); T2DM-i (n = 333); and T2DM (n = 103). ANOVA revealed significant differences in sample characteristics. ANCOVA were conducted on all four DDS-17 domains [Emotional Burden (EB); Physician-related Distress (PD); Regimen-related Distress (RD); and Interpersonal Distress (ID)]; covariates included in the models were sex, age, duration of diabetes, BMI, and HbA1c. EB was significantly lower in T1DM than T2DM-i, p < 0.05. In addition, RD was significantly lower in T1DM than either T2DM-i, p < 0.05 and T2DM, p < 0.05.
   Conclusions: EB and RD are higher for those with type 2 diabetes. Thus, interventions to reduce EB and RD need to be considered for patients with type 2 diabetes.
   Implications: DDS-17 is useful in identifying diabetes-related distress in patients with diabetes. Efforts need to be made to reduce EB and RD. Published by Elsevier B.V.
C1 [Wardian, Jana L.; Sauerwein, Tom] Wilford Hall Ambulatory Surg Ctr, Diabet Ctr Excellence, Lackland AFB, TX USA.
   [Tate, Joshua; Folaron, Irene; Graybill, Sky; True, Mark] San Antonio Mil Med Ctr, Serv Endocrinol, Ft Sam Houston, TX 78234 USA.
RP Wardian, JL (reprint author), Wilford Hall Ambulatory Surg Ctr, Diabet Ctr Excellence, 1100 Wilford Hall Loop, Jbsa Lackland AFB, TX 78236 USA.
EM Jana.L.Wardian.ctr@mail.mil
OI Wardian, Jana/0000-0003-3025-686X
CR American Diabetes Association (ADA), 2017, DIAB CAR S1, V40
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Benroubi M, 2011, DIABETES RES CLIN PR, V93, pS97, DOI 10.1016/S0168-8227(11)70021-3
   Bushatz A., 2015, MILITARY DIVORCE RAT
   Fenwick E. K., 2016, J HEALTH PSYCHOL
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gray M, 2017, METHODS MOL BIOL, V1519, P1, DOI 10.1007/978-1-4939-6581-6_1
   Hessler D, 2016, J PEDIATR PSYCHOL, V41, P750, DOI 10.1093/jpepsy/jsw002
   Holmes-Truscott E, 2016, PRIM CARE DIABETES, V10, P75, DOI 10.1016/j.pcd.2015.06.006
   Holmes-Truscott E, 2015, DIABETIC MED, V32, P1297, DOI 10.1111/dme.12729
   Joensen LE, 2016, PRIM CARE DIABETES, V10, P41, DOI 10.1016/j.pcd.2015.06.007
   Joensen LE, 2013, DIABETES RES CLIN PR, V101, P278, DOI 10.1016/j.diabres.2013.07.001
   Jones A, 2016, PRIM CARE DIABETES, V10, P83, DOI 10.1016/j.pcd.2015.03.008
   Karney BR, 2012, J FAM ISSUES, V33, P1572, DOI 10.1177/0192513X12439690
   Phillips Patrick, 2005, Rev Diabet Stud, V2, P35, DOI 10.1900/RDS.2005.2.35
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2011, CURR MED RES OPIN, V27, P1169, DOI 10.1185/03007995.2011.573623
   Ramkisson S, 2016, JEMDSA, V21, P35, DOI 10.1080/16089677.2016.1205822
   Sauerwein TJ, 2016, MIL MED, V181, P407, DOI 10.7205/MILMED-D-15-00007
   Schmitt A, 2016, DIABETIC MED, V33, P835, DOI 10.1111/dme.12887
   Slean GR, 2012, MED CARE, V50, pS69, DOI 10.1097/MLR.0b013e3182641127
   Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   Wardian Jana L, 2017, Clin Diabetes, V35, P329, DOI 10.2337/cd16-0061
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 30
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD AUG
PY 2018
VL 101
IS 8
BP 1490
EP 1495
DI 10.1016/j.pec.2018.03.001
PG 6
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA GL9MH
UT WOS:000437636700021
PM 29525142
DA 2019-01-08
ER

PT J
AU Hessler, DM
   Fisher, L
   Polonsky, WH
   Bowyer, V
   Potter, M
AF Hessler, Danielle M.
   Fisher, L.
   Polonsky, W. H.
   Bowyer, V
   Potter, M.
TI Motivation and attitudes toward changing health (MATCH): A new
   patient-reported measure to inform clinical conversations
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Motivation; Behavior change; Patient reported outcome; Type 2 diabetes;
   Pragmatic measure
ID DIABETES DISTRESS SCALE; SELF-MANAGEMENT; RECOMMENDATIONS; EFFICACY;
   PHQ-9; NEED
AB Objective: To identify and assess patient motivation to initiate or maintain behavior changes.
   Methods: Attitudinal statements were developed from structured patient interviews and translated into 18 survey items. Items were analyzed with exploratory factor analysis (EFA).
   Results: An EFA with 340 type 2 diabetes patients identified three areas of patient attitudes toward changing health behaviors: (1) willingness to make changes (3 items; alpha = 0.69), (2) perceived ability to make or maintain changes (3 items; alpha = 0.74), and (3) and feeling changes are worthwhile (3 items; alpha = 0.61). Greater perceived ability and feelings of worthwhileness were associated with positive psychosocial and behavioral management indicators. All three areas were associated with confidence and attitudes toward making a specific behavioral change (e.g., improve diet).
   Conclusions: MATCH is an internally consistent and valid 9-item scale that provides a profile of factors influencing motivation that can be used in clinical and research settings. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Hessler, Danielle M.; Fisher, L.; Bowyer, V; Potter, M.] Univ Calif San Francisco, Dept Family & Community Med, Box 0900, San Francisco, CA 94143 USA.
   [Polonsky, W. H.] Behav Diabet Inst, San Diego, CA USA.
RP Hessler, DM (reprint author), Univ Calif San Francisco, Dept Family & Community Med, Box 0900, San Francisco, CA 94143 USA.
EM danielle.hessler@ucsf.edu
FU NIH [DK108039]
FX This research was funded by NIH Grant DK108039.
CR Ajzen I., 1985, ACTION CONTROL COGNI, P11, DOI DOI 10.1007/978-3-642-69746-3_2
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   BAGOZZI RP, 1989, SOC PSYCHOL QUART, V52, P266, DOI 10.2307/2786991
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Bandura A., 1997, COGNITIVE THERAPY RE, V1, P287, DOI DOI 10.1007/BF01663995
   Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80
   DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Glasgow RE, 2013, AM J PREV MED, V45, P237, DOI 10.1016/j.amepre.2013.03.010
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Hessler DM, 2012, J HEALTH PSYCHOL, V17, P535, DOI 10.1177/1359105311422120
   Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x
   Jordan JE, 2008, MED J AUSTRALIA, V189, pS9
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lorig K, 1996, OUTCOME MEASURES HLT
   Michie S, 2014, BEHAV CHANGE WHEEL G
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rollnick S., 1992, J MENTAL HLTH, V1, P25, DOI DOI 10.3109/09638239209034509
   Rollnick S, 2007, MOTIVATIONAL INTERVI
   Ruggiero L, 1997, DIABETES CARE, V20, P568, DOI 10.2337/diacare.20.4.568
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052
NR 26
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL
PY 2018
VL 32
IS 7
BP 665
EP 669
DI 10.1016/j.jdiacomp.2018.04.009
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GM1GP
UT WOS:000437814400008
PM 29887299
DA 2019-01-08
ER

PT J
AU Rovner, BW
   Casten, RJ
AF Rovner, Barry W.
   Casten, Robin J.
TI Health Beliefs and Medication Adherence in Black Patients with Diabetes
   and Mild Cognitive Impairment
SO AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
LA English
DT Article
DE Mild cognitive impairment; diabetes; medication adherence; health
   beliefs; blacks
ID DEMENTIA; VALIDITY
AB Objectives: To evaluate determinants of medication adherence and glycemic control in black patients with diabetes and mild cognitive impairment (MCI). Methods: Cross-sectional study of 143 participants with mean age of 68.8 (SD: 6.7) years; 66.4% were women. Results: Eighty-seven participants (60.8%) self-reported medication nonadherence; they had more negative beliefs about medicines, greater diabetes-related distress, and more difficulty with daily living activities and affording medications than adherent participants. There were no group differences in cognition, depressive symptoms, or glycemic control. Glycemic control negatively correlated with regimen distress, emotional burden, interpersonal distress, beliefs that physicians overprescribe medications, and beliefs that medications are harmful. Conclusions: Beliefs about medications, diabetes-related distress, functional disability, and medication affordability are associated with medication nonadherence in black individuals with diabetes and MCI. Interventions that respect personal health beliefs and compensate for impaired cognition may improve medication adherence and glycemic control in this population.
C1 [Rovner, Barry W.] Thomas Jefferson Univ, Dept Neurol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.
   [Rovner, Barry W.] Thomas Jefferson Univ, Dept Psychiat, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.
   [Rovner, Barry W.] Thomas Jefferson Univ, Dept Ophthalmol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.
   [Casten, Robin J.] Thomas Jefferson Univ, Dept Psychiat & Human Behav, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.
RP Rovner, BW (reprint author), Jefferson Hosp Neurosci, 900 Walnut St,Suite 200, Philadelphia, PA 19107 USA.
EM barry.rovner@jefferson.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
   [R01 DK102609-01]
FX This study was supported by the National Institute of Diabetes and
   Digestive and Kidney Diseases (NIDDK; grant R01 DK102609-01).
CR Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829
   Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740
   Galasko D, 2006, ALZ DIS ASSOC DIS, V20, pS152, DOI 10.1097/01.wad.0000213873.25053.2b
   Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92
   National Institute of Diabetes and Digestive and Kidney Diseases, 2005, NIH PUBLICATION, V02-3266
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
NR 10
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1064-7481
EI 1545-7214
J9 AM J GERIAT PSYCHIAT
JI Am. J. Geriatr. Psychiatr.
PD JUL
PY 2018
VL 26
IS 7
BP 812
EP 816
DI 10.1016/j.jagp.2018.03.012
PG 5
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA GL0BZ
UT WOS:000436629200011
PM 29673896
DA 2019-01-08
ER

PT J
AU Spencer, MS
   Kieffer, EC
   Sinco, B
   Piatt, G
   Palmisano, G
   Hawkins, J
   Lebron, A
   Espitia, N
   Tang, T
   Funnell, M
   Heisler, M
AF Spencer, Michael S.
   Kieffer, Edith C.
   Sinco, Brandy
   Piatt, Gretchen
   Palmisano, Gloria
   Hawkins, Jaclynn
   Lebron, Alana
   Espitia, Nicolaus
   Tang, Tricia
   Funnell, Martha
   Heisler, Michele
TI Outcomes at 18 Months From a Community Health Worker and Peer Leader
   Diabetes Self-Management Program for Latino Adults
SO DIABETES CARE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; CHRONIC DISEASE MANAGEMENT;
   AFRICAN-AMERICAN; GLYCEMIC CONTROL; CARE PROFILE; INTERVENTION; SUPPORT;
   DETROIT; RELIABILITY; EDUCATION
AB OBJECTIVEThis study evaluated the effectiveness of a community health worker (CHW) diabetes self-management education (DSME) program, followed by two different approaches to maintain improvements in HbA(1c) and other clinical and patient-centered outcomes over 18 months.RESEARCH DESIGN AND METHODSThe study randomized 222 Latino adults with type 2 diabetes and poor glycemic control from a federally qualified health center to 1) a CHW-led, 6-month DSME program or 2) enhanced usual care (EUC). After the 6-month program, participants randomized to the CHW-led DSME were further randomized to 1) 12 months of CHW-delivered monthly telephone outreach (CHW-only) or 2) 12 months of weekly group sessions delivered by peer leaders (PLs) with telephone outreach to those unable to attend (CHW+PL). The primary outcome was HbA(1c). Secondary outcomes were blood pressure, lipid levels, diabetes distress, depressive symptoms, understanding of diabetes self-management, and diabetes social support. Assessments were conducted at baseline and at 6, 12, and 18 months.RESULTSParticipants in the CHW intervention at the 6-month follow-up had greater decreases in HbA(1c) (-0.45% [95% CI -0.87, -0.03]; P < 0.05) and in diabetes distress (-0.3 points [95% CI -0.6, -0.03]; P < 0.05) compared with EUC. CHW+PL participants maintained HbA(1c) improvements at 12 and 18 months, and CHW-only participants maintained improvements in diabetes distress at 12 and 18 months. CHW+PL participants also had significantly fewer depressive symptoms at 18 months compared with EUC (-2.2 points [95% CI -4.1, -0.3]; P < 0.05). Participants in CHW-led DSME had significant improvements in diabetes social support and in understanding of diabetes self-management at 6 months relative to EUC, but these intervention effects were not sustained at 18 months.CONCLUSIONSThis study demonstrates the effectiveness of a 6-month CHW intervention on key diabetes outcomes and of a volunteer PL program in sustaining key achieved gains. These are scalable models for health care centers in low-resource settings for achieving and maintaining improvements in key diabetes outcomes.
C1 [Spencer, Michael S.; Kieffer, Edith C.; Sinco, Brandy; Piatt, Gretchen; Espitia, Nicolaus; Funnell, Martha; Heisler, Michele] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Palmisano, Gloria] Community Hlth & Social Serv CHASS, Detroit, MI USA.
   [Hawkins, Jaclynn] Michigan State Univ, E Lansing, MI 48824 USA.
   [Lebron, Alana] Univ Calif Irvine, Irvine, CA USA.
   [Tang, Tricia] Univ British Columbia, Vancouver, BC, Canada.
RP Spencer, MS (reprint author), Univ Michigan, Ann Arbor, MI 48109 USA.
EM spencerm1014@gmail.com
FU Peers for Progress grant from the American Association of Family
   Physicians Foundation; National Institute of Diabetes and Digestive and
   Kidney Diseases [P30-DK092926, R18-DK-0785501A1]; Centers for Disease
   Control and Prevention [U50/CCU417409]
FX This research was supported by a Peers for Progress grant from the
   American Association of Family Physicians Foundation, by the National
   Institute of Diabetes and Digestive and Kidney Diseases (grant
   P30-DK092926 to the Michigan Center for Diabetes Translational Research
   and grant R18-DK-0785501A1), and by the Centers for Disease Control and
   Prevention (cooperative agreement no. U50/CCU417409). The funding
   sources had no role in the study design; data collection; administration
   of the interventions; analysis, interpretation, or reporting of data; or
   decision to submit the findings for publication.
CR American Public Health Association, COMM HLTH WORK
   Anderson R., 2003, P 22 ANN S PRINC DIS, P3, DOI 10.1145/872035.872036
   Arsie MP, 2000, ACTA DIABETOL, V37, P1, DOI 10.1007/s005920070028
   Baig AA, 2015, J GEN INTERN MED, V30, P1481, DOI 10.1007/s11606-015-3339-x
   Barrera M, 2002, AM J COMMUN PSYCHOL, V30, P637, DOI 10.1023/A:1016369114780
   de Vries L, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-21
   EDWARDS D, 1987, BIOMETRICS, V43, P913, DOI 10.2307/2531545
   Emmons KM, 2001, AM J PREV MED, V20, P68, DOI 10.1016/S0749-3797(00)00254-3
   Feathers JT, 2007, DIABETES EDUCATOR, V33, P509, DOI 10.1177/0145721707301371
   Feathers JT, 2005, AM J PUBLIC HEALTH, V95, P1552, DOI 10.2105/AJPH.2005.066134
   FISHER RA, 1942, DESIGN EXPT
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Fitzgerald JT, 1998, EVAL HEALTH PROF, V21, P52, DOI 10.1177/016327879802100103
   Funnel MM, 2004, MED MANAGEMENT TYPE, P124
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Haas L, 2012, DIABETES CARE, V35, P2393, DOI 10.2337/dc12-1707
   Kalbfleisch J. D., 2011, STAT ANAL FAILURE TI
   Kieffer EC, 2004, ETHNIC DIS, V14, P27
   Kim K, 2016, AM J PUBLIC HEALTH, V106, pE3, DOI 10.2105/AJPH.2015.302987
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Palmas W, 2014, DIABETES CARE, V37, P963, DOI 10.2337/dc13-2142
   Piatt GA, 2006, DIABETES CARE, V29, P811, DOI 10.2337/diacare.29.04.06.dc05-1785
   Piatt GA, 2010, DIABETES EDUCATOR, V36, P301, DOI 10.1177/0145721710361388
   Piette JD, 2001, EVIDENCE BASED DIABE, P207
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   ROGERS EJ, 1993, CLIN CHEM, V39, P860
   Rubin D., 2004, MULTIPLE IMPUTATION
   Shah M, 2013, CURR DIABETES REP, V13, P163, DOI 10.1007/s11892-012-0359-3
   Spencer MS, 2011, AM J PUBLIC HEALTH, V101, P2253, DOI 10.2105/AJPH.2010.300106
   Tang TS, 2014, DIABETES CARE, V37, P1525, DOI 10.2337/dc13-2161
   Tang TS, 2014, DIABETES EDUCATOR, V40, P223, DOI 10.1177/0145721713520569
   Tang TS, 2012, DIABETES RES CLIN PR, V95, P85, DOI 10.1016/j.diabres.2011.04.003
   Thom DH, 2013, ANN FAM MED, V11, P137, DOI 10.1370/afm.1443
   van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463
   Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569
   Xue L, 2014, EFFECTIVENESS PEER L
NR 39
TC 1
Z9 1
U1 5
U2 5
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUL 1
PY 2018
VL 41
IS 7
BP 1414
EP 1422
DI 10.2337/dc17-0978
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GK2AH
UT WOS:000435926000025
PM 29703724
DA 2019-01-08
ER

PT J
AU Kampling, H
   Mittag, O
   Herpertz, S
   Baumeister, H
   Kulzer, B
   Petrak, F
AF Kampling, Hanna
   Mittag, Oskar
   Herpertz, Stephan
   Baumeister, Harald
   Kulzer, Bernd
   Petrak, Frank
TI Can trajectories of glycemic control be predicted by depression,
   anxiety, or diabetes-related distress in a prospective cohort of adults
   with newly diagnosed type 1 diabetes? Results of a five-year follow-up
   from the German multicenter diabetes cohort study (GMDC-Study)
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Adults; Depression; Longitudinal data; Onset cohort; Glycemic control;
   Type 1 diabetes
ID QUALITY-OF-LIFE; COGNITIVE-BEHAVIORAL THERAPY; EMOTIONAL DISTRESS;
   COMPLICATIONS; PREVALENCE; SYMPTOMS; HBA(1C); EPIDEMIOLOGY; ASSOCIATION;
   DISORDERS
AB Aims: The longitudinal association between glycemic control with depression, anxiety or diabetes-related distress in type 1 diabetes is poorly understood. Therefore, we examined long-term trajectories of HbA1c in a new-onset cohort of adults with type 1 diabetes, and analyzed associations with depression, anxiety, and diabetes-related distress.
   Methods: We included 313 newly diagnosed adults with type 1 diabetes in a prospective multicenter cohort study. Depression, anxiety, and diabetes-related distress were assessed starting with the diabetes diagnosis and at five annual surveys. HbA1c-measurements started with the one-year follow-up. HbA1c trajectories were analyzed applying Growth mixture modeling, while prediction of membership in the trajectories classes was analyzed Onset cohort using multiple regression, and one-way ANOVA/Chi2 to identify differences between Glycemic control classes.
   Results: Average HbA1c increased constantly: follow-up at 1-year 6.5% (48 mmol/mol), 2- years 6.9% (52 mmol/mol), 3-years 7.1% (54 mmol/mol), 4-years 7.1% (54 mmol/mol), and 5-years 7.4% (57 mmol/mol). HbA1c trajectories included one 'good control' and three 'poor control' (52% of patients) classes. At the five-year follow-up, mean HbA1c was 6.3% (45 mmol/mol) in the 'good control' class, and ranging from 7.9% (63 mmol/mol) to 9.0% (75 mmol/mol) in the three 'poor control' classes. Classes were neither predicable, nor differentiated by depression, anxiety, or diabetes-related distress.
   Conclusions: We identified distinct trajectories of glycemic control. Depression and anxiety were highly prevalent but they neither predicted 'poor'/'good' glycemic control trajectories nor were they associated with glycemic control at any assessment point. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Kampling, Hanna; Mittag, Oskar] Univ Freiburg, Fac Med, Med Ctr, Sect Hlth Care Res & Rehabil Res, Hugstetter Str 49, D-79115 Freiburg, Germany.
   [Herpertz, Stephan; Petrak, Frank] Ruhr Univ Bochum, Dept Psychosomat Med & Psychotherapy, LWL Univ Clin Bochum, Alexandrinenstr 1-3, D-44791 Bochum, Germany.
   [Baumeister, Harald] Univ Ulm, Inst Psychol & Educ, Dept Clin Psychol & Psychotherapy, Albert Einstein Allee 47, D-89069 Ulm, Germany.
   [Kulzer, Bernd] Diabet Ctr Mergentheim, Klotzbucher Str 12, D-97980 Bad Mergentheim, Germany.
   [Kulzer, Bernd] Diabet Acad Mergentheim, Res Inst, Klotzbucher Str 12, D-97980 Bad Mergentheim, Germany.
   [Kulzer, Bernd] Otto Friedrich Univ Bamberg, Dept Clin Psychol & Psychotherapy, Markuspl 3, D-96047 Bamberg, Germany.
   [Petrak, Frank] Ctr Psychotherapy Wiesbaden, Sonnenberger Str 20, D-65193 Wiesbaden, Germany.
RP Kampling, H (reprint author), Univ Freiburg, Fac Med, Med Ctr, Sect Hlth Care Res & Rehabil Res, Hugstetter Str 49, D-79106 Freiburg, Germany.
EM hanna.kampling@uniklinik-freiburg.de;
   oskar.mittag@uniklinik-freiburg.de; stephan.herpertz@ruhr-uni-bochum.de;
   harald.baumeister@uni-ulm.de; kulzer@diabetes-zentrum.de;
   mail@dr-frank-petrak.de
OI Petrak, Frank/0000-0001-5985-5845; Kampling, Hanna/0000-0002-5213-0179
FU German Diabetes Association (DDG; Deutsche Diabetes Gesellschaft) in
   Germany; University Medical Centre - Johannes Gutenberg-University Mainz
   in Germany; Novo Nordisk in Germany; Berlin-Chemie AG in Germany
FX The study was supported by the German Diabetes Association (DDG;
   Deutsche Diabetes Gesellschaft), University Medical Centre - Johannes
   Gutenberg-University Mainz, Novo Nordisk, Berlin-Chemie AG, all
   institutions are in Germany.
CR American Diabetes Association, 2017, Diabetes Care, V40, pS11
   American Psychiatric Association APA, 1994, DIAGN STAT MAN MENT
   Asparouhov T, 2014, VARIABLE SPECFIC ENT
   Baumeister H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008381.pub2
   Berge Line Iden, 2013, BMC Res Notes, V6, P543, DOI 10.1186/1756-0500-6-543
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Maia ACCD, 2014, REV ASSOC MED BRAS, V60, P59, DOI 10.1590/1806-9282.60.01.013
   Derogatis L. R., 1995, SYMPTOM CHECKLISTE D
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Franciosi M, 2013, NUTR METAB CARDIOVAS, V23, P606, DOI 10.1016/j.numecd.2012.03.002
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hirsch A, 2000, QUAL LIFE RES, V9, P207, DOI 10.1023/A:1008959810698
   Ismail K, 2017, DIABETOLOGIA, V60, P2092, DOI 10.1007/s00125-017-4367-3
   Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x
   Kampling H, 2017, DIABETOLOGIA, V60, P60, DOI 10.1007/s00125-016-4123-0
   Kong Lulu, 2013, J Biomed Res, V27, P380, DOI 10.7555/JBR.27.20120112
   Korczak DJ, 2011, DIABETOLOGIA, V54, P2483, DOI 10.1007/s00125-011-2240-3
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Luyckx JRK, 2015, HEALTH PSYCHOL, V34, P1058, DOI 10.1037/hea0000212
   Margraf J., 1995, DIAGNOSTIC INTERVIEW
   McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676
   Melin EO, 2013, EUR J ENDOCRINOL, V168, P861, DOI 10.1530/EJE-13-0137
   Miller RG, 2016, DIABETES CARE, V39, P2296, DOI 10.2337/dc16-1162
   Moulton C. D., 2015, ENDOCRINOLOGY, V3, P461, DOI [10.1016/S2213-8587(15)00134-5, DOI 10.1016/S2213-8587(15)00134-5]
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Petrak F, 2003, DIABETES-METAB RES, V19, P216, DOI 10.1002/dmrr.374
   Petrak F, 2015, LANCET DIABETES ENDO, V3, P472, DOI 10.1016/S2213-8587(15)00045-5
   Petrak F, 2015, DIABETES CARE, V38, P767, DOI 10.2337/dc14-1599
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Smith-Palmer J, 2016, CLINICOECONOMIC OUTC, V8, P559, DOI 10.2147/CEOR.S114699
   Snoek FJ, 2008, DIABETIC MED, V25, P1337, DOI 10.1111/j.1464-5491.2008.02595.x
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Strandberg RB, 2015, DIABETIC MED, V32, P1304, DOI 10.1111/dme.12781
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Sultan S, 2008, PSYCHOL HEALTH, V23, P73, DOI 10.1080/14768320701205218
   Tanenbaum ML, 2012, DIABETES EDUCATOR, V38, P695, DOI 10.1177/0145721712452795
   Uher R, 2010, PSYCHOL MED, V40, P1367, DOI 10.1017/S0033291709991528
   Waadt S, 1995, DIABETES PSYCHOL DIA, P17
   World Health Organisation, 2011, US GLYC HAEM HBA1C D
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
NR 45
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUL
PY 2018
VL 141
BP 106
EP 117
DI 10.1016/j.diabres.2018.04.017
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GK8IC
UT WOS:000436462900013
PM 29698712
DA 2019-01-08
ER

PT J
AU Sina, M
   Graffy, J
   Simmons, D
AF Sina, Maryam
   Graffy, Jonathan
   Simmons, David
TI Associations between barriers to self-care and diabetes complications
   among patients with type 2 diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes; Complications; Psychological; Health services
ID GLYCEMIC CONTROL; MULTIETHNIC COMMUNITY; INSULIN INITIATION; MANAGEMENT;
   POPULATION; DEPRESSION; IMPACT; PREVALENCE; DISTRESS; EFFICACY
AB Aims: To determine which barriers to care are associated with type 2 diabetes complications in an area in rural East England.
   Methods: 3649 individuals with type 2 diabetes from 62 general practices were contacted via postal invitation which included a 33 item Barriers-to-Diabetes-Care Survey. Barriers were grouped into five priori major categories: educational, physical, psychological, psychosocial, and systems. The associations of reported barriers, both individually and as a group, with self-reported complications were assessed using logistic regression.
   Results: 39.5% of participants had self-reported diabetes complications. Physical health barriers (OR = 3.3; 95%CI: 2.7, 4.0), systems barriers (OR = 1.6; 95%CI: 1.3, 2.0) and psychological barriers (OR = 1.3 (95%CI: 1.1, 1.5) were associated with diabetes complications. In subcategories, presence of comorbidities (OR = 4.8; 95%CI: 3.9, 5.9), financial difficulties (OR = 1.7; 95%CI: 1.3, 2.1), absence of services (OR = 2.0; 95%CI: 1.4, 3.0), feeling others should bear more financial responsibility for their care (OR = 1.6 (95%CI: 1.1, 2.1), no access to diabetes service (OR = 1.3; 95%CI: 1.1, 1.5), feeling worried about their diabetes (OR = 1.5; 95%CI: 1.2, 2.0) and lack of readiness to exercise (OR = 1.4; 95%CI: 1.2, 1.7) were associated with diabetes complications.
   Conclusions: Barriers to self-care are significantly more common among those with, than those without, diabetes complications. Systematic identification and management of different barriers to self-care could help personalise care for those with diabetes related complications. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Sina, Maryam; Simmons, David] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia.
   [Graffy, Jonathan] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge CB2 0SR, England.
RP Simmons, D (reprint author), Western Sydney Univ, Sch Med, Macarthur Clin Sch, Locked Bag 1797, Campbelltown, NSW 2751, Australia.
EM da.simmons@westernsydney.edu.au
FU Peers for Progress
FX We thank Peers for Progress for funding this work.
CR Aljasem LI, 2001, DIABETES EDUCATOR, V27, P393, DOI 10.1177/014572170102700309
   Ascher-Svanum H, 2015, DIABETES THER, V6, P303, DOI 10.1007/s13300-015-0118-y
   BARR M, 2006, ADV MED HOME PATIENT
   Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4
   Benroubi M, 2011, DIABETES RES CLIN PR, V93, pS97, DOI 10.1016/S0168-8227(11)70021-3
   Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716
   Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258
   Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047
   Comino EJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0666-2
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Dillman D., 2007, MAIL INTERNET SURVEY
   Gao JL, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-66
   Harvey JN, 2015, DIABET METAB SYND OB, V8, P29, DOI 10.2147/DMSO.S44352
   Herbert MS, 2013, DIABETIC MED, V30, P1466, DOI 10.1111/dme.12264
   Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184
   Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2
   Krichbaum K, 2003, DIABETES EDUCATOR, V29, P653, DOI 10.1177/014572170302900411
   Lago RM, 2007, NAT CLIN PRACT ENDOC, V3, P667, DOI 10.1038/ncpendmet0638
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Leyva B, 2011, ETHNIC DIS, V21, P322
   Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189
   Munshi MN, 2013, DIABETES CARE, V36, P543, DOI 10.2337/dc12-1303
   Murray Elizabeth, 2012, Med 2 0, V1, pe3, DOI 10.2196/med20.1741
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Piatt GA, 2011, PATIENT EDUC COUNS, V82, P266, DOI 10.1016/j.pec.2010.04.005
   Robbins I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003178
   SAS Institute, 2013, SAS SYST WIND
   Simmons D, 1998, DIABETIC MED, V15, P958, DOI 10.1002/(SICI)1096-9136(1998110)15:11<958::AID-DIA687>3.0.CO;2-9
   Simmons D, 2001, DIABETES SPECTRUM, V14, P10
   Simmons D, 2007, AUST J RURAL HEALTH, V15, P296, DOI 10.1111/j.1440-1584.2007.00903.x
   Simmons D, 2007, DIABETES CARE, V30, P490, DOI 10.2337/dc06-2338
   Simmons D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120277
   Sparring V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-377
   Strauss K, 2006, J GEN INTERN MED, V21, P378, DOI 10.1111/j.1525-1497.2006.00386.x
   Vanasse A, 2010, RURAL REMOTE HEALTH, V10
   Zgibor JC, 2002, DIABETES CARE, V25, P1772, DOI 10.2337/diacare.25.10.1772
   Zgibor JC, 2001, DIABETES SPECTRUM, V14, P23, DOI DOI 10.2337/DIASPECT.14.1.23
NR 39
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUL
PY 2018
VL 141
BP 126
EP 131
DI 10.1016/j.diabres.2018.04.031
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GK8IC
UT WOS:000436462900015
PM 29689320
DA 2019-01-08
ER

PT J
AU Berry, E
   Davies, M
   Dempster, M
AF Berry, Emma
   Davies, Mark
   Dempster, Martin
TI Managing Type 2 diabetes as a couple: The influence of partners' beliefs
   on diabetes distress over time
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes mellitus; Psychological adjustment; Social support;
   Interpersonal relations
ID RANDOMIZED CLINICAL-TRIAL; PROSTATE-CANCER PATIENTS; ILLNESS
   REPRESENTATIONS; PSYCHOLOGICAL DISTRESS; RELATIONSHIP QUALITY; EMOTIONAL
   DISTRESS; INTERVENTION; DEPRESSION; BEHAVIORS; ADHERENCE
AB Aims: Partners and spouses have an important role in supporting healthy self-care in adults with Type 2 diabetes. While evidence has shown that the beliefs held by people with diabetes influence emotional wellbeing, little is known about the long-term impact of partners' illness beliefs on diabetes distress.
   Methods: Persons with Type 2 diabetes (pwt2d) and their partners completed a questionnaire at baseline (N = 75 couples) and 12 months later (N = 45 couples). Measures included demographic/clinical parameters, the Revised Illness Perception questionnaire, and the Diabetes Distress Scale. A repeated measures ANOVA was used to examine change in measures over time. Multiple regression and moderation analysis were used to explore the indirect influence of partners beliefs on diabetes distress at baseline and follow-up.
   Results: Illness perceptions and diabetes distress in pwt2d and partners did not change overtime. Partners' beliefs about the controllability, chronicity, and predictability of symptoms of diabetes moderated the relationship between the corresponding pwt2d beliefs and diabetes distress. These indirect effects were observed across both time points.
   Conclusions: Conflicting illness perceptions about the controllability and chronicity of diabetes, and congruous negative perceptions about diabetes symptoms among couples sustain distress overtime. Targeting the beliefs of couples to improve communication and understanding may reduce diabetes distress. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Berry, Emma; Dempster, Martin] Queens Univ Belfast, Sch Psychol, David Keir Bldg,18-30 Malone Rd, Belfast BT9 5BN, Antrim, North Ireland.
   [Davies, Mark] Belfast City Hosp, Dept Clin Psychol, Belfast, Antrim, North Ireland.
RP Berry, E (reprint author), Queens Univ Belfast, Sch Psychol, David Keir Bldg,18-30 Malone Rd, Belfast BT9 5BN, Antrim, North Ireland.
EM eberry05@qub.ac.uk; mark.davies@belfasttrust.hscni.net;
   m.dempster@qub.ac.uk
OI , Martin/0000-0001-9499-3186
FU Department of Education and Learning at Queen's University Belfast
FX This study was funded by the Department of Education and Learning at
   Queen's University Belfast.
CR Agren S, 2012, J CARD FAIL, V18, P359, DOI 10.1016/j.cardfail.2012.01.014
   Allison P. D., 1990, SOCIOL METHODOL, P93, DOI DOI 10.2307/271083
   [Anonymous], 2018, TYP 2 DIAB AD MAN, P1
   BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5
   Berry E, 2017, PSYCHOL HEALTH MED, V22, P1118, DOI 10.1080/13548506.2017.1281976
   Berry E, 2017, PATIENT EDUC COUNS, V100, P1287, DOI 10.1016/j.pec.2017.02.015
   Cleal B, 2017, DIABETIC MED, V34, P108, DOI 10.1111/dme.13187
   Cohen J, 1988, STAT POWER ANAL BEHA
   CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297, DOI DOI 10.1007/BF02310555
   Dempster M, 2011, DIABETIC MED, V28, P487, DOI 10.1111/j.1464-5491.2010.03214.x
   Dempster M, 2011, J PSYCHOSOM RES, V70, P432, DOI 10.1016/j.jpsychores.2010.07.007
   Dimitraki G, 2014, INT J BEHAV MED, V21, P230, DOI 10.1007/s12529-013-9296-z
   Ervasti J, 2016, DIABETIC MED, V33, P208, DOI 10.1111/dme.12821
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Pereira MG, 2016, PSYCHOL HEALTH MED, V21, P707, DOI 10.1080/13548506.2015.1118517
   Heinrichs N, 2012, ANN BEHAV MED, V43, P239, DOI 10.1007/s12160-011-9314-9
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Kuijer RG, 2004, PSYCHO-ONCOLOGY, V13, P321, DOI 10.1002/pon.749
   Meltzer D, 2000, Eff Clin Pract, V3, P7
   Miller-Matero LR, 2017, PSYCHOL HEALTH MED, V22, P19, DOI 10.1080/13548506.2016.1191659
   Mishel MH, 2002, CANCER-AM CANCER SOC, V94, P1854, DOI 10.1002/cncr.10390
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Northouse LL, 2007, CANCER, V110, P2809, DOI 10.1002/cncr.23114
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2016, PATIENT PREFER ADHER, V10, P1299, DOI 10.2147/PPA.S106821
   Polonsky WH, 2016, DIABETES TECHNOL THE, V18, P292, DOI 10.1089/dia.2015.0451
   Searle A, 2007, J PSYCHOSOM RES, V63, P175, DOI 10.1016/j.jpyschores.2007.02.006
   Sekhar TVDS, 2013, J CLIN DIAGN RES, V7, P857, DOI 10.7860/JCDR/2013/5726.2958
   Skinner TC, 2011, PSYCHOL HEALTH, V26, P321, DOI 10.1080/08870440903411039
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Trief PM, 2016, DIABETES CARE, V39, P2165, DOI 10.2337/dc16-0035
   Weinman J, 2000, BR J HLTH PSYCHOL, P263
   White P, 2009, DIABETES EDUCATOR, V35, P810, DOI 10.1177/0145721709340930
   Wu LM, 2013, PSYCHOL HEALTH, V28, P355, DOI 10.1080/08870446.2012.722219
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUL
PY 2018
VL 141
BP 244
EP 255
DI 10.1016/j.diabres.2018.05.020
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GK8IC
UT WOS:000436462900029
PM 29775677
DA 2019-01-08
ER

PT J
AU Ruiz-Aranda, D
   Zysberg, L
   Garcia-Linares, E
   Castellano-Guerrero, AM
   Martinez-Brocca, MA
   Gutierrez-Colosia, MR
AF Ruiz-Aranda, Desiree
   Zysberg, Leehu
   Garcia-Linares, Ernesto
   Maria Castellano-Guerrero, Ana
   Asuncion Martinez-Brocca, Maria
   Gutierrez-Colosia, Mencia R.
TI Emotional abilities and HbA1c levels in patients with type 1 diabetes
SO PSYCHONEUROENDOCRINOLOGY
LA English
DT Article
DE Type 1 diabetes mellitus; HbA1c; Emotional abilities; Distress;
   Emotional intelligence
ID SELF-EFFICACY; INTELLIGENCE; HEALTH; ADOLESCENTS; MANAGEMENT; DISTRESS;
   METAANALYSIS; COMPETENCE; DEPRESSION; BEHAVIORS
AB In recent years a growing body of research is focused on the relationships between emotions and health. When it comes to diabetes, findings suggest that distress might play a key role in the acquisition and maintenance of health habits associated with diabetic management. This report describes two studies examining the roles of emotional abilities in diabetic management from two different conceptual points of view using two culturally different samples. In study 1, we examined the relationship between emotional intelligence and HbA1c levels in a sample of eighty-five patients with type 1 diabetes mellitus (DM1) in Israel. In study 2, we examined the relationship between specific emotional regulation strategies and HbA1c in sixty-seven adolescents with DM1, while examining the mediating role of distress in this association. The results showed a negative association between emotional intelligence and HbA1c levels, even after controlling for potential intervening factors. We found that the relationship between difficulties in emotion regulation and HbA1c seemed to be mediated by diabetes-related distress. These findings may aid in the design of psychological models for future research as well as interventions aimed at improving emotional abilities in people with DM1.
C1 [Ruiz-Aranda, Desiree; Gutierrez-Colosia, Mencia R.] Univ Loyola Andalucia, Seville, Spain.
   [Zysberg, Leehu] Gordon Coll Educ, Haifa, Israel.
   [Garcia-Linares, Ernesto] Univ Nacl Educ Distancia, Madrid, Spain.
   [Maria Castellano-Guerrero, Ana; Asuncion Martinez-Brocca, Maria] Hosp Univ Virgen Macarena, UGC Endocrinol & Nutr, Seville, Spain.
   [Asuncion Martinez-Brocca, Maria] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.
RP Gutierrez-Colosia, MR (reprint author), Univ Loyola Andalucia, Seville, Spain.
EM menciaruiz@uloyola.es
RI Ruiz Gutierrez-Colosia, Mencia/N-4515-2014
OI Ruiz Gutierrez-Colosia, Mencia/0000-0002-2631-0205
CR American Diabetes Association [ADA], 2015, FAST FACTS DAT STAT
   Ashraff Suhel, 2013, Oman Med J, V28, P159, DOI 10.5001/omj.2013.46
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Belendez M., 2014, CLIN PRACT, V106, P93
   Berg CA, 2011, J PEDIATR PSYCHOL, V36, P329, DOI 10.1093/jpepsy/jsq088
   Beveridge RM, 2006, J PEDIATR PSYCHOL, V31, P818, DOI 10.1093/jpepsy/jsj094
   Brackett MA, 2006, J PERS SOC PSYCHOL, V91, P780, DOI 10.1037/0022-3514.91.4.780
   Buchberger B, 2016, PSYCHONEUROENDOCRINO, V70, P70, DOI 10.1016/j.psyneuen.2016.04.019
   Coccaro E., 2016, PRIM CARE DIABETES, P334
   Fernandez-Abascal EG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00317
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fortenberry KT, 2009, ANN BEHAV MED, V37, P1, DOI 10.1007/s12160-009-9086-7
   Gemez-Rico I., 2015, AN PEDIAT, V82, P43
   Gonzalez JS, 2016, AM PSYCHOL, V71, P539, DOI 10.1037/a0040388
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94
   Haves G., 2008, CLIN SALUD, V19, P139
   Hughes AE, 2012, J PEDIATR PSYCHOL, V37, P925, DOI 10.1093/jpepsy/jss062
   Hunter CM, 2016, AM PSYCHOL, V71, P515, DOI 10.1037/a0040344
   Janzen-Claude J. A., 2014, J HEALTH PSYCHOL, V9, P312
   Kroger J., 2007, IDENTITY DEV ADOLESC
   Kyngas H, 2000, J CLIN NURS, V9, P549, DOI 10.1046/j.1365-2702.2000.00368.x
   MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4
   Martins A, 2010, PERS INDIV DIFFER, V49, P554, DOI 10.1016/j.paid.2010.05.029
   Mayer J. D, 1997, EMOTIONAL DEV EMOTIO, P3
   Mikolajczak M, 2015, EMOTION, V15, P653, DOI 10.1037/emo0000034
   Naranjo D, 2012, CURR DIABETES REP, V12, P729, DOI 10.1007/s11892-012-0319-y
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   Ryden A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164977
   Sato Asako, 2014, Rinsho Byori, V62, P45
   Schutte NS, 2007, PERS INDIV DIFFER, V42, P921, DOI 10.1016/j.paid.2006.09.003
   Stupiansky NW, 2013, J PEDIATR PSYCHOL, V38, P247, DOI 10.1093/jpepsy/jss110
   Unnikrishnan R., 2016, CLIN DIABETES ENDOCR, V2, P1
   Whittemore R, 2010, NURS OUTLOOK, V58, P242, DOI 10.1016/j.outlook.2010.05.001
   Yalcin BM, 2008, DIABETES EDUCATOR, V34, P1013, DOI 10.1177/0145721708327303
   Zysberg L., 2016, J ENDOCRINOL DIABETE, V3, P1
   Zysberg L, 2017, J HEALTH PSYCHOL, V22, P158, DOI 10.1177/1359105315596373
   Zysberg L, 2011, J PSYCHOEDUC ASSESS, V29, P27, DOI 10.1177/0734282910365059
NR 41
TC 0
Z9 0
U1 1
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4530
J9 PSYCHONEUROENDOCRINO
JI Psychoneuroendocrinology
PD JUL
PY 2018
VL 93
BP 118
EP 123
DI 10.1016/j.psyneuen.2018.04.015
PG 6
WC Endocrinology & Metabolism; Neurosciences; Psychiatry
SC Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry
GA GI8BU
UT WOS:000434747600015
PM 29723781
DA 2019-01-08
ER

PT J
AU Gomez-Peralta, TG
   Gonzalez-Castro, TB
   Fresan, A
   Tovilla-Zarate, CA
   Juarez-Rojop, IE
   Villar-Soto, M
   Hernandez-Diaz, Y
   Lopez-Narvaez, ML
   Ble-Castillo, JL
   Perez-Hernandez, N
   Rodriguez-Perez, JM
AF Guadalupe Gomez-Peralta, Tania
   Beatriz Gonzalez-Castro, Thelma
   Fresan, Ana
   Alfonso Tovilla-Zarate, Carlos
   Esther Juarez-Rojop, Isela
   Villar-Soto, Mario
   Hernandez-Diaz, Yazmin
   Lilia Lopez-Narvaez, Maria
   Ble-Castillo, Jorge L.
   Perez-Hernandez, Nonanzit
   Manuel Rodriguez-Perez, Jose
TI Risk Factors and Prevalence of Suicide Attempt in Patients with Type 2
   Diabetes in the Mexican Population
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE suicide; depression; diabetes; Mexican population
ID BODY-MASS INDEX; QUALITY-OF-LIFE; EMOTIONAL DISTRESS; PROBLEM AREAS;
   CHOLESTEROL; ADULTS; DEPRESSION; IDEATION; MELLITUS; INSULIN
AB Background: It has been proposed that the risk of death by suicide is higher in patients with diabetes than in the general population. Therefore, it is necessary to investigate the risk factors of suicidal behavior in patients with type 2 diabetes. The aim of the present study was to analyze the prevalence of suicide attempt and determine the risk factors of suicide attempt, in patients with type 2 diabetes in a Mexican population. Methods: Clinic characteristics, anthropometric measurements, biochemical levels, depression, and suicidal behavior were evaluated in 185 Mexican patients with type 2 diabetes. A multivariate logistic regression analysis was performed to find predictive factors of suicide attempt. Results: 11.4% of patients reported previous suicide attempts n = 21). Younger patients (OR: 3.63, 95% CI: 1.29-10.19), having depression (OR: 3.33, 95% CI: 1.13-9.76) and normal BMI (OR: 3.14, 95% CI: 1.11-8.83), were predictive factors of suicide attempt. No other variables in the study showed statistical significance. Conclusions: Our results showed a high prevalence of suicidal behavior in patients with type 2 diabetes. We found that younger age, depression and normal BMI could be risk factors of suicide attempt in these patients. Therefore, psychiatric interventions to prevent depression and suicidal behavior in this population are necessary. New studies using larger samples are necessary to replicate and confirm these results.
C1 [Guadalupe Gomez-Peralta, Tania; Alfonso Tovilla-Zarate, Carlos] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco 86025, Tabasco, Mexico.
   [Beatriz Gonzalez-Castro, Thelma; Hernandez-Diaz, Yazmin] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Jalpa de Mendez, Jalpa De Mendez 86200, Tabasco, Mexico.
   [Fresan, Ana] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Subdirecc Invest Clin, Ciudad De Mexico 14370, Mexico.
   [Esther Juarez-Rojop, Isela; Ble-Castillo, Jorge L.] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Salud, Villahermosa 86140, Tabasco, Mexico.
   [Villar-Soto, Mario] Hosp Alta Especialidad Gustavo A Rovirosa Perez, Secretaria Salud, Villahermosa 86140, Tabasco, Mexico.
   [Lilia Lopez-Narvaez, Maria] Hosp Gen Yajalon Dr Manuel Velasco Suarez, Secretaria Salud, Yajalon 29930, Chiapas, Mexico.
   [Perez-Hernandez, Nonanzit; Manuel Rodriguez-Perez, Jose] Inst Nacl Cardiol Ignacio Chavez, Dept Biol Mol, Ciudad De Mexico 14080, Mexico.
RP Tovilla-Zarate, CA (reprint author), Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco 86025, Tabasco, Mexico.; Juarez-Rojop, IE (reprint author), Univ Juarez Autonoma Tabasco, Div Acad Ciencias Salud, Villahermosa 86140, Tabasco, Mexico.
EM tanyperalta93@gmail.com; thelma.glez.castro@gmail.com;
   fresan@imp.edu.mx; alfonso_tovillaz@yahoo.com.mx;
   iselajuarezrojop@hotmail.com; mariovillarsoto@hotmail.com;
   yazmin.hdez.diaz@gmail.com; dralilialonar@yahoo.com.mx;
   jblecastillo@hotmail.com; unicanona@yahoo.com.mx;
   josemanuel_rodriguezperez@yahoo.com.mx
OI Perez-Hernandez, Nonanzit/0000-0003-4786-508X; Hernandez-Diaz,
   Yazmin/0000-0003-1200-2292; Rodriguez-Perez, Jose
   Manuel/0000-0002-3802-0897; BLE-CASTILLO, JORGE L./0000-0002-1376-1461;
   Gonzalez Castro, Thelma Beatriz/0000-0001-8046-6908; Tovilla-Zarate,
   Carlos Alfonso/0000-0001-8170-8171
FU Universidad Juarez Autonoma de Tabasco [UJAT-IB-2105-05]
FX This research was funded by Universidad Juarez Autonoma de Tabasco grant
   number UJAT-IB-2105-05.
CR Apiquian R., 2000, EVALUATION PSYCHOPAT, P49
   Ayyappa KA, 2017, NUTR METAB, V14, DOI 10.1186/s12986-016-0155-1
   Bartoli F, 2017, PROG NEURO-PSYCHOPH, V79, P90, DOI 10.1016/j.pnpbp.2017.06.008
   Bartoli F, 2017, CLIN BIOCHEM, V50, P274, DOI 10.1016/j.clinbiochem.2016.11.035
   Batty GD, 2012, J EPIDEMIOL COMMUN H, V66, P1196, DOI 10.1136/jech-2011-200464corr1
   Beck A.T., 1974, PREDICTION SUICIDE
   Belendez M, 2014, DIABETES RES CLIN PR, V106, pE93, DOI 10.1016/j.diabres.2014.09.012
   Vazquez MB, 2015, GAC SANIT, V29, P300, DOI 10.1016/j.gaceta.2015.02.005
   Bendix M, 2017, PSYCHONEUROENDOCRINO, V81, P1, DOI 10.1016/j.psyneuen.2017.03.019
   Branco JC, 2017, PSYCHOL HEALTH MED, V22, P275, DOI 10.1080/13548506.2016.1164870
   Butwicka A, 2016, DIABETES CARE, V39, P495, DOI 10.2337/dc16-er03
   Cantarelli MD, 2014, PSYCHIAT RES, V220, P745, DOI 10.1016/j.psychres.2014.10.017
   Cheah YK, 2018, PSYCHIAT RES, V261, P319, DOI 10.1016/j.psychres.2017.12.086
   Chung JH, 2014, J PSYCHOSOM RES, V77, P457, DOI 10.1016/j.jpsychores.2014.08.008
   Cohen-Manheim I, 2018, EUR J PUBLIC HEALTH, V28, P496, DOI 10.1093/eurpub/ckx194
   Conti C, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00040
   Davila Cervantes CA, 2015, SALUD COLECT, V11, P471, DOI 10.18294/sc.2015.784
   Davis WA, 2015, INTERN MED J, V45, P976, DOI 10.1111/imj.12853
   Deschenes SS, 2018, J AFFECT DISORDERS, V238, P24, DOI 10.1016/j.jad.2018.05.029
   Dreber H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145273
   Dutton GR, 2013, INT J OBESITY, V37, P1282, DOI 10.1038/ijo.2012.224
   FOSTER HD, 1988, AM J PSYCHIAT, V145, P272
   Gamboa CM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004264
   GOLDSTON DB, 1994, J AM ACAD CHILD PSY, V33, P240, DOI 10.1097/00004583-199402000-00013
   Golomb BA, 2002, J CLIN EPIDEMIOL, V55, P767, DOI 10.1016/S0895-4356(02)00407-9
   Gylfadottir Sandra Sif, 2017, Scand J Pain, V16, P173, DOI 10.1016/j.sjpain.2017.04.026
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   Handley TE, 2016, DIABETIC MED, V33, P1582, DOI 10.1111/dme.13022
   Igwe MN, 2013, AFR HEALTH SCI, V13, P68, DOI 10.4314/ahs.v13i1.10
   INEGI, EST MORT
   Jin H, 2015, METHOD INFORM MED, V54, P553, DOI 10.3414/ME14-02-0009
   Lee EH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0142-z
   Lofman S, 2012, J PSYCHOSOM RES, V73, P268, DOI 10.1016/j.jpsychores.2012.08.002
   Macip SG, 2000, SALUD MENT, V23, P21
   Mantantzis K, 2017, PSYCHOL AGING, V32, P203, DOI 10.1037/pag0000169
   Marklund M, 2017, J NUTR, V147, P2118, DOI 10.3945/jn.117.254250
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Mukamal KJ, 2007, ARCH INTERN MED, V167, P468, DOI 10.1001/archinte.167.5.468
   Mukamal KJ, 2010, EPIDEMIOLOGY, V21, P82, DOI 10.1097/EDE.0b013e3181c1fa2d
   Mukamal KJ, 2009, OBESITY, V17, P532, DOI 10.1038/oby.2008.538
   MULDOON MF, 1990, BRIT MED J, V301, P309, DOI 10.1136/bmj.301.6747.309
   Myers AK, 2017, CURR DIABETES REV, V13, P251, DOI 10.2174/1573399812666161005163618
   Onat A, 2017, TURK KARDIYOL DERN A, V45, P590, DOI 10.5543/tkda.2017.38085
   Ozdemir O, 2017, PSYCHIAT RES, V258, P171, DOI 10.1016/j.psychres.2016.11.043
   Park S, 2018, PSYCHIAT RES, V261, P143, DOI 10.1016/j.psychres.2017.12.055
   Petrak F, 2015, LANCET DIABETES ENDO, V3, P472, DOI 10.1016/S2213-8587(15)00045-5
   Pompili M, 2014, J PSYCHOSOM RES, V76, P352, DOI 10.1016/j.jpsychores.2014.02.009
   Pompili M, 2009, PSYCHOSOMATICS, V50, P16, DOI 10.1176/appi.psy.50.1.16
   Radobuljac MD, 2009, PEDIATR DIABETES, V10, P424, DOI 10.1111/j.1399-5448.2009.00501.x
   Rojas-Martinez R, 2018, SALUD PUBLICA MEXICO, V60, P224, DOI 10.21149/8566
   Sarkar Siddharth, 2014, Indian J Endocrinol Metab, V18, P468, DOI 10.4103/2230-8210.137487
   Song HB, 2016, J AFFECT DISORDERS, V197, P21, DOI 10.1016/j.jad.2016.02.035
   Tabb KM, 2017, J PSYCHOSOM RES, V103, P113, DOI 10.1016/j.jpsychores.2017.10.009
   Tovilla-Zarate C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036887
   Wagner B, 2013, DEPRESS ANXIETY, V30, P975, DOI 10.1002/da.22105
   Wang B, 2017, EUR J ENDOCRINOL, V177, pR169, DOI 10.1530/EJE-16-0952
   Wang Y, 2016, COMPR PSYCHIAT, V71, P11, DOI 10.1016/j.comppsych.2016.08.006
   Webb RT, 2014, DIABETES CARE, V37, P2276, DOI 10.2337/dc14-0005
   Wu SQ, 2016, J PSYCHIATR NEUROSCI, V41, P56, DOI 10.1503/jpn.150079
NR 59
TC 1
Z9 1
U1 6
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2018
VL 15
IS 6
AR 1198
DI 10.3390/ijerph15061198
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GK8SE
UT WOS:000436496900149
PM 29880751
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Mulligan, K
   McBain, H
   Lamontagne-Godwin, F
   Chapman, J
   Flood, C
   Haddad, M
   Jones, J
   Simpson, A
AF Mulligan, Kathleen
   McBain, Hayley
   Lamontagne-Godwin, Frederique
   Chapman, Jacqui
   Flood, Chris
   Haddad, Mark
   Jones, Julia
   Simpson, Alan
TI Barriers to effective diabetes management - a survey of people with
   severe mental illness
SO BMC PSYCHIATRY
LA English
DT Article
DE Diabetes; Severe mental illness; Service users; Self-management;
   Theoretical domains framework
ID RANDOMIZED CONTROLLED-TRIAL; OLDER SCHIZOPHRENIA-PATIENTS; LIFE-STYLE
   INTERVENTION; SELF-MANAGEMENT; MELLITUS; CARE; COMPLICATIONS;
   METAANALYSIS; INDIVIDUALS; MEDICATIONS
AB Background: People with severe mental illnesses (SMI) such as schizophrenia and bipolar disorder have an increased risk of developing type 2 diabetes and have poorer health outcomes than those with diabetes alone. To maintain good diabetes control, people with diabetes are advised to engage in several self-management behaviours. The aim of this study was to identify barriers or enablers of diabetes self-management experienced by people with SMI.
   Methods: Adults with type 2 diabetes and SMI were recruited through UK National Health Service organisations and mental health and diabetes charities. Participants completed an anonymous survey consisting of. Summary of Diabetes Self-Care Activities (SDSCA); CORE-10 measure of psychological distress; a measure of barriers and enablers of diabetes self-management based on the Theoretical Domains Framework; Diabetes UK care survey on receipt of 14 essential aspects of diabetes healthcare. To identify the strongest explanatory variables of SDSCA outcomes, significant variables (p < .05) identified from univariate analyses were entered into multiple regressions.
   Results: Most of the 77 participants had bipolar disorder (42%) or schizophrenia (36%). They received a mean of 7.6 (SD 3.0) diabetes healthcare essentials. Only 28.6% had developed a diabetes care plan with their health professional and only 40% reported receiving specialist psychological support. Engagement in self-management activities was variable. Participants reported taking medication on 6.1 (SD 2.0) days in the previous week but other behaviours were less frequent general diet 4.1 (2.3) days; specific diet 3.6 (1.8) days, taking exercise 2.4 (2.1) days and checking feet on 1.7 (1.8) days. Smoking prevalence was 44%. Participants reported finding regular exercise and following a healthy diet particularly difficult. Factors associated with diabetes self-management included: the level of diabetes healthcare and support received; emotional wellbeing; priority given to diabetes; perceived ability to manage diabetes or establish a routine to do so; and perceived consequences of diabetes self-management.
   Conclusions: Several aspects of diabetes healthcare and self-management are suboptimal in people with SMI. There is a need to improve diabetes self-management support for this population by integrating diabetes action plans into care planning and providing adequate psychological support to help people with SMI manage their diabetes.
C1 [Mulligan, Kathleen; McBain, Hayley; Flood, Chris; Haddad, Mark; Simpson, Alan] City Univ London, Sch Hlth Sci, Myddelton St, London EC1V 0HB, England.
   [Mulligan, Kathleen; Simpson, Alan] East London NHS Fdn Trust, London, England.
   [Lamontagne-Godwin, Frederique] Univ West London, Sch Human & Social Sci, London, England.
   [Chapman, Jacqui] East London NHS Fdn Trust, Diabet Specialist Nursing Serv, London, England.
   [Jones, Julia] Univ Hertfordshire, CRIPACC, Hatfield, Herts, England.
RP Mulligan, K (reprint author), City Univ London, Sch Hlth Sci, Myddelton St, London EC1V 0HB, England.; Mulligan, K (reprint author), East London NHS Fdn Trust, London, England.
EM Kathleen.Mulligan.1@city.ac.uk
FU Barts Charity [477/2314]
FX This study was funded by a grant from Barts Charity, reference number:
   477/2314. The funding body did not have any role in the design of the
   study or collection, analysis, or interpretation of data or in writing
   the manuscript.
CR Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9
   Barkham M, 2012, COUNSELLING PSYCHOTH, V13, P3, DOI DOI 10.1080/14733145.2012.729069
   Becker T, 2011, DIABETES CARE, V34, P398, DOI 10.2337/dc10-1139
   Blixen CE, 2016, AM J HEALTH BEHAV, V40, P194, DOI 10.5993/AJHB.40.2.4
   Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37
   Care Quality Commission, 2016, 2016 COMM MENT HLTH
   Chen SR, 2014, J PSYCHIATR MENT HLT, V21, P414, DOI 10.1111/jpm.12101
   Chrvala CA, 2016, PATIENT EDUC COUNS, V99, P926, DOI 10.1016/j.pec.2015.11.003
   Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309
   Cook JA, 2013, PSYCHIATR REHABIL J, V36, P250, DOI 10.1037/prj0000028
   Cook JA, 2012, SCHIZOPHRENIA BULL, V38, P881, DOI 10.1093/schbul/sbr012
   Corker E, 2016, ACTA PSYCHIAT SCAND, V134, P6, DOI 10.1111/acps.12610
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   De Hert M, 2011, WORLD PSYCHIATRY, V10, P52
   Diabetes UK, 2014, DIAB 15 HEALTHC ESS
   Diabetes UK, 2014, CARE SURVEY RESULTS
   Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4
   Fagard Robert H, 2009, Prim Care Diabetes, V3, P205, DOI 10.1016/j.pcd.2009.09.003
   Garson GD, 2015, MISSING VALUES ANAL
   Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530
   Health and Social Care Information Centre, 2016, SMOKING RATES IN PEO
   Krakow D, 2007, EUR DIABETES NURSING, V4, P106
   Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P428, DOI 10.1093/schbul/sbn106
   Look AHEAD Research Group, 2010, ARCH INTERN MED, V170, P1566
   Mathur R, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653642
   McBain H., 2016, COCHRANE DB SYST REV, V4
   McKibbin CL, 2006, SCHIZOPHR RES, V86, P36, DOI 10.1016/j.schres.2006.05.010
   McKibbin CL, 2010, SCHIZOPHR RES, V121, P203, DOI 10.1016/j.schres.2009.09.039
   Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x
   Mulligan K, 2017, HEALTH EXPECT, V20, P1020, DOI 10.1111/hex.12543
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Office for National Statistics, 2016, AD SMOK HAB UK 2016, P2017
   Office for National Statistics, 2013, GRAD UK LAB MARK 201
   Osborn DPJ, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-84
   Peckham E, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1419-7
   Queen Mary Univeristy of London. Diabetes Research Lay Panel Group, 2017, ENGAGEMENT AND ENTER
   Royal College of Psychiatrists, 2016, IMPR PHYS HLTH AD SE
   Rubin DB, 2009, MULTIPLE IMPUTATION
   Simpson A, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0858-x
   Simpson A, 2014, J PSYCHOSOC NURS MEN, V52, P22, DOI 10.3928/02793695-20131126-04
   Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213
   Stubbs B, 2015, ACTA PSYCHIAT SCAND, V132, P144, DOI 10.1111/acps.12439
   Taylor S, 2014, HLTH SERV DELIV RES, V2, P53, DOI DOI 10.3310/HSDR02530
   Tempelaar WM, 2017, PSYCHOL MED, V47, P776, DOI 10.1017/S0033291716002877
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Vinogradova Y, 2010, BRIT J PSYCHIAT, V197, P272, DOI 10.1192/bjp.bp.109.074674
   Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502
   Ward M, 2015, LANCET PSYCHIAT, V2, P431, DOI 10.1016/S2215-0366(15)00007-3
   Whyte S, 2007, DIABETIC MED, V24, P1442, DOI 10.1111/j.1464-5491.2007.02324.x
   Wu CS, 2015, BRIT J PSYCHIAT, V207, P450, DOI 10.1192/bjp.bp.113.143925
NR 50
TC 1
Z9 1
U1 9
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD JUN 1
PY 2018
VL 18
AR 165
DI 10.1186/s12888-018-1744-5
PG 15
WC Psychiatry
SC Psychiatry
GA GI4AC
UT WOS:000434312300003
PM 29859061
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hansen, UM
   Olesen, K
   Browne, JL
   Skinner, TC
   Willaing, I
AF Hansen, Ulla M.
   Olesen, Kasper
   Browne, Jessica L.
   Skinner, Timothy C.
   Willaing, Ingrid
TI A call for inclusion of work-related diabetes distress in the spectrum
   of diabetes management: Results from a cross-sectional survey among
   working people with type 1 diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes mellitus; Work-related diabetes distress; Well-being;
   Diabetes distress
ID DEPRESSION; ADULTS
AB Aim: Diabetes distress captures a range of emotional responses and reactions to life with diabetes and is considered a part of the experience of managing diabetes and its treatment Given the importance of the social context of work life for people of working age we set out to explore whether work-related diabetes distress is a distinct and important dimension of diabetes-related emotional distress in working people with type 1 diabetes.
   Methods: A questionnaire with self-reported measures of psychosocial health and well-being at work was completed by 1126 working people with type 1 diabetes from a specialist diabetes clinic in Denmark. Work-related diabetes distress was assessed with two questions about worry and exhaustion related to reconciling work life and diabetes. Diabetes-related emotional distress was assessed with the Problem Areas in Diabetes scale (PAID-5), a short form version of the full PAID scale. We performed inter-item correlation analyses, exploratory factor analysis, and hierarchical multiple regression analyses.
   Results: Inter-item correlations and exploratory factor analysis indicated that work-related diabetes distress was distinct from diabetes-related emotional distress. Further, work-related diabetes distress was found to be a unique contributor to work ability, quality of life, intentional hyperglycaemia at work, and absenteeism, after adjusting for covanates and diabetes-related emotional distress.
   Conclusions: The findings suggest that work-related diabetes distress captures an aspect of distress so far unaccounted for in workers with type 1 diabetes Further studies are needed to strengthen the conceptual basis of work-related diabetes distress, explore its clinical usefulness and clarify its risk factors. (c) 2018 Elsevier B.V All rights reserved.
C1 [Hansen, Ulla M.; Olesen, Kasper; Willaing, Ingrid] Steno Diabet Ctr Copenhagen, Gentofte, Denmark.
   [Hansen, Ulla M.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.
   [Browne, Jessica L.] Deakin Univ, Sch Psychol, Geelong, Vic, Australia.
   [Browne, Jessica L.] Diabet Victoria, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Skinner, Timothy C.] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.
RP Hansen, UM (reprint author), Steno Diabet Ctr Copenhagen, Diabet Management Res, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark.
EM Ulla.moeller.hansen@regionh.dk
OI Willaing, Ingrid/0000-0002-3082-8816; Skinner,
   Timothy/0000-0002-0018-6963; Hansen, Ulla Moller/0000-0001-8416-9783
FU Innovation Fund Denmark
FX This work was supported by an unrestricted grant from Innovation Fund
   Denmark.
CR Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS38, DOI 10.2337/dc18-S004
   Balfe MBR, 2014, HEALTH PLACE, V26, P7
   Brown TA, 2015, CONFIRMATORY FACTOR
   Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS
   El Fassi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-305
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Golenbock S, 2017, QUAL LIFE RES, V26, P1839, DOI 10.1007/s11136-017-1523-7
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hakkarainen P, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0099-4
   Hansen UM, 2016, P 48 ANN C NORD ERG, P222
   Hessler DM, 2017, DIABETIC MED, V34, P1228, DOI 10.1111/dme.13381
   Hinder S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-83
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nielsen HB, 2016, DIABETES RES CLIN PR, V121, P62, DOI 10.1016/j.diabres.2016.08.021
   Persson S, 2018, DIABETOLOGIA, V61, P342, DOI 10.1007/s00125-017-4472-3
   Persson S, 2016, ECON HUM BIOL, V23, P180, DOI 10.1016/j.ehb.2016.09.003
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Reddy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i998
   Schulte P, 2010, SCAND J WORK ENV HEA, V36, P422, DOI 10.5271/sjweh.3076
   Sirgy MJ., 2012, WORK QUALITY LIFE ET, P35
   Thurstone LL, 1947, MULTIPLE FACTOR ANAL
   Tuomi K, 1994, WORK ABILITY INDEX
   World Health Organization Quality of Life Group, 1998, PSYCHOL MED, V28, P551, DOI DOI 10.1017/S0033291798006667.
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 27
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUN
PY 2018
VL 140
BP 139
EP 147
DI 10.1016/j.diabres.2018.03.040
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GI1CM
UT WOS:000434107600016
PM 29604390
DA 2019-01-08
ER

PT J
AU Hagiwara, Y
   Kasai, J
   Nakanishi, S
   Saigusa, Y
   Miyagi, E
   Aoki, S
AF Hagiwara, Yuko
   Kasai, Junko
   Nakanishi, Sayuri
   Saigusa, Yusuke
   Miyagi, Etsuko
   Aoki, Shigeru
TI Should the IADPSG criteria be applied when diagnosing early-onset
   gestational diabetes?
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Gestational diabetes mellitus (GDM); 75g oral glucose tolerance test
   (OGTT); Early-onset GDM; The International Association of Diabetes and
   Pregnancy Study Groups (IADPSG) criteria; Pregnancy outcomes
ID GLUCOSE-TOLERANCE TEST; CARDIOVASCULAR-DISEASE; RETROSPECTIVE COHORT;
   PREGNANCY OUTCOMES; MATERNAL OBESITY; MELLITUS; WOMEN; HYPERGLYCEMIA;
   OBSTETRICS; RISK
AB Aims: To investigate whether the broad interpretation of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria with application to the early pregnancy, which is adopted as the standard in Japan, is appropriate.
   Methods: We conducted this investigation by comparing diabetes-related adverse pregnancy outcomes among women treated for gestational diabetes mellitus (GDM) following an early-pregnancy diagnosis (early-onset GDM, n = 528) and those treated for GDM following a mid-pregnancy diagnosis, which is the international standard (Mid-term-onset GDM, n = 147).
   Results: Gestational weight gain was significantly lower in the early-onset GDM group (7.5 kg) than in the mid-term-onset GDM group (8.4 kg). The frequency of hypertensive disorders of pregnancy tended to be lower in the early-onset GDM group (5.6% vs 8.8%, p = 0.085), but infant birth weight did not differ significantly between the groups. No between-group difference was observed in macrosomia, large-for-gestational-age (LGA), small-for-gestational age (SGA), low Apgar score, shoulder dystocia, cesarean delivery, NICU admission, hyperbilirubinemia, neonatal hypoglycemia, or respiratory distress syndrome The frequency of LGA showed a significant association with pre-pregnancy body mass index, but did not differ according to the timing of therapy initiation.
   Conclusions: We could not find the effectiveness of therapeutic interventions initiated after GDM diagnosis in the early pregnancy based on the IADPSG criteria, compared with therapeutic interventions after a mid-pregnancy GDM diagnosis. It was suggested that the IADPSG criteria for diagnosing GDM at 24-28 weeks' gestation should not be applied to Japanese women in the early pregnancy by a broader interpretation. (c) 2018 Elsevier B.V All rights reserved.
C1 [Hagiwara, Yuko; Kasai, Junko; Nakanishi, Sayuri; Aoki, Shigeru] Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonates, Yokohama, Kanagawa, Japan.
   [Saigusa, Yusuke] Yokohama City Univ, Grad Sch Med, Dept Biostat, Yokohama, Kanagawa, Japan.
   [Miyagi, Etsuko] Yokohama City Univ, Sch Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan.
RP Aoki, S (reprint author), Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonate, Minami Ku, 4-57 Urafunecho, Yokohama, Kanagawa 2320024, Japan.
EM smyyaoki@yahoo.co.jp
OI Miyagi, Etsuko/0000-0002-1943-594X
CR American Diabetes Association, 2017, Diabetes Care, V40, pS11
   Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5
   Benhalima K, 2015, DIABETOLOGIA, V58, P1422, DOI 10.1007/s00125-015-3615-7
   Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x
   CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G
   Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305
   Committee on Practice Bulletins--Obstetrics, 2013, Obstet Gynecol, V122, P406, DOI 10.1097/01.AOG.0000433006.09219.f1
   Corrado F, 2012, DIABETES METAB, V38, P458, DOI 10.1016/j.diabet.2012.03.006
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O
   Enomoto K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157081
   HAPO study cooperative research group, 2008, NEW ENGL J MED, V122, P406
   Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361
   Horie I, 2015, DIABETES RES CLIN PR, V107, P400, DOI 10.1016/j.diabres.2014.12.011
   Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862
   KUHL C, 1975, ACTA ENDOCRINOL-COP, V79, P709, DOI 10.1530/acta.0.0790709
   Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430
   Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816
   LIND T, 1973, J OBSTET GYN BR COMM, V80, P1033
   McIntyre HD, 2012, DIABETES CARE, V38, P458
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Meyer WJ, 1996, J REPROD MED, V41, P675
   Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419
   Morikawa M, 2010, DIABETES RES CLIN PR, V90, P339, DOI 10.1016/j.diabres.2010.08.023
   Moyer VA, 2014, ANN INTERN MED, V160, P414, DOI 10.7326/M13-2905
   Pace R, 2017, AM J EPIDEMIOL, V186, P1115, DOI 10.1093/aje/kwx263
   Page KA, 2014, J PEDIATR-US, V164, P807, DOI 10.1016/j.jpeds.2013.11.063
   PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622
   Reece EA, 2004, DIABETES IN WOMEN, P159
   Riskin-Mashiah S, 2009, DIABETES CARE, V32, P1639, DOI 10.2337/dc09-0688
   Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   Seshiah V, 2008, DIABETES RES CLIN PR, V80, P199, DOI 10.1016/j.diabres.2007.12.008
   Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706
   SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611
   SUPER DM, 1991, DIABETES CARE, V14, P288, DOI 10.2337/diacare.14.4.288
   Zhu WW, 2013, DIABETES CARE, V36, P586, DOI 10.2337/dc12-1157
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUN
PY 2018
VL 140
BP 154
EP 161
DI 10.1016/j.diabres.2018.03.048
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GI1CM
UT WOS:000434107600018
PM 29621563
DA 2019-01-08
ER

PT J
AU Ishii, H
   Shin, H
   Tosaki, T
   Haga, T
   Nakajima, Y
   Shiraiwa, T
   Watanabe, N
   Koizumi, M
   Nakajima, H
   Okada, S
   Mashitani, T
   Mohri, T
   Akai, Y
AF Ishii, Hitoshi
   Shin, Hiroki
   Tosaki, Takahiro
   Haga, Tatsuya
   Nakajima, Yoshiki
   Shiraiwa, Toshihiko
   Watanabe, Nobuaki
   Koizumi, Miyuki
   Nakajima, Hiroki
   Okada, Sadanori
   Mashitani, Tsuyoshi
   Mohri, Takako
   Akai, Yasuhiro
TI Reproducibility and Validity of a Questionnaire Measuring Treatment
   Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden
   Questionnaire (DTBQ)
SO DIABETES THERAPY
LA English
DT Article
DE Pharmacotherapy; Questionnaire; Reproducibility; Treatment burden; Type
   2 diabetes mellitus; Validity
ID QUALITY-OF-LIFE; TREATMENT ATTRIBUTES IMPORTANT; TREATMENT SATISFACTION;
   MEDICATION ADHERENCE; GLYCEMIC CONTROL; MELLITUS; THERAPY; PREFERENCES;
   INJECTION; DISTRESS
AB Introduction: To measure the burden of pharmacotherapy on patients with type 2 diabetes mellitus (T2DM), we developed the Diabetes Treatment Burden Questionnaire (DTBQ), a patient-administered questionnaire composed of 18 questions, and evaluated its reproducibility and validity.
   Methods: We enrolled 240 patients with T2DM under pharmacotherapy over 20 years of age at seven institutes in Japan. Their physicians filled out report forms on patient backgrounds, and the patients answered both the DTBQ and the Diabetes Treatment Satisfaction Questionnaire (DTSQ). For evaluation of reproducibility, 48 of the enrolled subjects completed a 2nd DTBQ at home after leaving the medical institutes.
   Results: Statistical analyses were performed for two sets of subjects, the validity analysis set (N = 236) and the reproducibility analysis set (N = 47). Factor analysis found a simple structure in the DTBQ item scores using a three-factor model with varimax rotation; the three subscales were designated as "implementation burden", "flexibility burden", and "blood glucose control burden". All intraclass correlation coefficients for the subscale scores were 0.8 or higher, indicating high reproducibility. Negative correlations were observed between the DTSQ satisfaction score and the DTBQ subscale scores. Moreover, as the dosing frequency of diabetic medicines increased, the DTBQ total score (total burden score) also became higher. Likewise, expected associations were observed between patient backgrounds and DTSQ scores.
   Conclusion: The DTBQ has adequate reproducibility and validity as a measurement scale for treatment burden on T2DM patients.
C1 [Ishii, Hitoshi; Koizumi, Miyuki; Nakajima, Hiroki; Okada, Sadanori; Mashitani, Tsuyoshi; Mohri, Takako; Akai, Yasuhiro] Nara Med Univ, Dept Diabetol, Nara, Japan.
   [Shin, Hiroki] Shin Clin, Tokyo, Japan.
   [Tosaki, Takahiro] TDE Healthcare Corp, TOSAKI Clin Diabet & Endocrinol, Nagoya, Aichi, Japan.
   [Haga, Tatsuya] Haga Diabet Clin, Nagoya, Aichi, Japan.
   [Nakajima, Yoshiki] Nakajima Diabet Clin, Osaka, Japan.
   [Shiraiwa, Toshihiko] Shiraiwa Med Clin, Osaka, Japan.
   [Watanabe, Nobuaki] Watanabe Med Clin, Nishinomiya, Hyogo, Japan.
RP Ishii, H (reprint author), Nara Med Univ, Dept Diabetol, Nara, Japan.
EM hits1@naramed-u.ac.jp
FU Eli Lilly Japan (Kobe, Japan)
FX This study was funded by Eli Lilly Japan (Kobe, Japan). No funding was
   received for the article processing charges and medical
   writing/editorial assistance.
CR Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829
   American Diabetes Association, 2017, Diabetes Care, V40, pS6
   Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x
   Best JH, 2009, DIABETIC MED, V26, P722, DOI 10.1111/j.1464-5491.2009.02752.x
   Blonde L, 2012, ADV THER, V29, P1, DOI 10.1007/s12325-011-0094-1
   Brunton S, 2016, CLIN THER, V38, P582, DOI 10.1016/j.clinthera.2016.01.014
   Burness CB, 2015, BIODRUGS, V29, P407, DOI 10.1007/s40259-015-0143-4
   Confavreux CB, 2012, EUR J ENDOCRINOL, V166, P735, DOI 10.1530/EJE-11-0959
   Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218
   de Climens AR, 2015, CURR MED RES OPIN, V31, P643, DOI 10.1185/03007995.2015.1020364
   Dennick K, 2017, J DIABETES COMPLICAT, V31, P898, DOI 10.1016/j.jdiacomp.2016.12.018
   Donnelly LA, 2007, QJM-INT J MED, V100, P345, DOI 10.1093/qjmed/hcm031
   Evans PMS, 2016, EXPERT OPIN PHARMACO, V17, P1947, DOI 10.1080/14656566.2016.1218472
   Farmer AJ, 2016, DIABETES CARE, V39, P258, DOI 10.2337/dc15-1194
   Garcia-Perez LE, 2013, DIABETES THER, V4, P175, DOI 10.1007/s13300-013-0034-y
   Gelhorn HL, 2016, PATIENT PREFER ADHER, V10, P1337, DOI 10.2147/PPA.S109289
   Gelhorn HL, 2015, PATIENT PREFER ADHER, V9, P1611, DOI 10.2147/PPA.S90842
   Hauber AB, 2016, CURR MED RES OPIN, V32, P251, DOI 10.1185/03007995.2015.1117433
   Hauber AB, 2015, DIABETES THER, V6, P75, DOI 10.1007/s13300-015-0094-2
   Hauber AB, 2013, PATIENT PREFER ADHER, V7, P937, DOI 10.2147/PPA.S43465
   Ishii H, 2008, DIABETES RES CLIN PR, V81, P169, DOI 10.1016/j.diabres.2008.03.020
   Ishii H, 2012, DIABETOL INT, V3, P152, DOI 10.1007/s13340-012-0074-y
   Kaku K, 2015, EXPERT OPIN PHARMACO, V16, P2539, DOI 10.1517/14656566.2015.1099630
   Kirkman MS, 2015, DIABETES CARE, V38, P604, DOI 10.2337/dc14-2098
   Kishimoto H, 2015, ARCH OSTEOPOROS, V10, DOI 10.1007/s11657-015-0231-6
   Lglay K, 2015, CLIN THER, V37, P1813, DOI 10.1016/j.clinthera.2015.05.505
   Nguyen H, 2017, ADV THER, V34, P658, DOI 10.1007/s12325-016-0470-y
   Peron EP, 2015, CLIN GERIATR MED, V31, P17, DOI 10.1016/j.cger.2014.08.017
   Polonsky WH, 2011, DIABETES OBES METAB, V13, P144, DOI 10.1111/j.1463-1326.2010.01327.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2016, PATIENT PREFER ADHER, V10, P1299, DOI 10.2147/PPA.S106821
   Pouwer F, 1998, QUAL LIFE RES, V7, P33
   Qiao Q, 2016, DIABET METAB SYND OB, V9, P201, DOI 10.2147/DMSO.S99732
   Qin L, 2017, DIABETES THER, V8, P335, DOI 10.1007/s13300-017-0237-8
   Qin L, 2017, DIABETES THER, V8, P321, DOI 10.1007/s13300-017-0230-2
   Reaney M, 2015, DIABETES OBES METAB, V17, P896, DOI 10.1111/dom.12527
   Schernthaner G, 2010, DIABETIC MED, V27, P739, DOI 10.1111/j.1464-5491.2010.03000.x
   Thrasher J, 2017, AM J CARDIOL, V120, pS4, DOI 10.1016/j.amjcard.2017.05.009
NR 39
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1869-6953
EI 1869-6961
J9 DIABETES THER
JI Diabetes Ther.
PD JUN
PY 2018
VL 9
IS 3
BP 1001
EP 1019
DI 10.1007/s13300-018-0414-4
PG 19
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GI1ZN
UT WOS:000434169400010
PM 29600503
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Clarke, J
   Proudfoot, J
   Vatiliotis, V
   Verge, C
   Holmes-Walker, DJ
   Campbell, L
   Wilhelm, K
   Moravac, C
   Indu, PS
   Bridgett, M
AF Clarke, Janine
   Proudfoot, Judy
   Vatiliotis, Veronica
   Verge, Charles
   Holmes-Walker, Deborah J.
   Campbell, Lesley
   Wilhelm, Kay
   Moravac, Catherine
   Indu, Pillaveetil S.
   Bridgett, Madeleine
TI Attitudes towards mental health, mental health research and digital
   interventions by young adults with type 1 diabetes: A qualitative
   analysis
SO HEALTH EXPECTATIONS
LA English
DT Article
DE digital interventions; psychosocial support; type 1 diabetes
ID ADOLESCENTS; DEPRESSION; DISTRESS; SERVICES; PEOPLE
AB BackgroundYoung people with type 1 diabetes are at increased risk of mental disorders. Whereas treatment need is high, difficulty recruiting young people with type 1 diabetes into psychosocial studies complicates development, testing and dissemination of these interventions.
   ObjectiveInterviews with young adults with type 1 diabetes were conducted to examine attitudes towards mental health and mental health research, including barriers and motivators to participation in mental health studies and preferred sources of mental health support. The interviews were audio-taped, transcribed and evaluated via thematic analysis.
   Setting and participantsYoung adults with type 1 diabetes were recruited via social media channels of 3 advocacy organizations. A total of 31 young adults (26 females and 5 males) with an average age of 22years were interviewed between October 2015 and January 2016.
   ResultsParticipants were largely unaware of their increased vulnerability to common mental health problems and knew little about mental health research. Major barriers to participation included perceived stigma and lifestyle issues and low levels of trust in researchers. Opportunities to connect with peers and help others were described as key motivators. Psychological distress was considered normal within the context of diabetes. A need for some level of human contact in receiving psychosocial support was expressed.
   Discussion and conclusionFindings provide valuable insights into the complex dynamics of engaging young adults with type 1 diabetes in mental health studies. Interviewees provided practical suggestions to assist investigation and delivery of psychosocial interventions for this vulnerable group.
C1 [Clarke, Janine; Vatiliotis, Veronica] Black Dog Inst, Sydney, NSW, Australia.
   [Proudfoot, Judy] Black Dog Inst, eHlth Implementat & Policy, Sydney, NSW, Australia.
   [Clarke, Janine] UNSW Australia, Sydney, NSW, Australia.
   [Proudfoot, Judy] UNSW Australia, eHlth Implementat & Policy, Sydney, NSW, Australia.
   [Verge, Charles] Sydney Childrens Hosp, Endocrinol, Sydney, NSW, Australia.
   [Verge, Charles] Sydney Childrens Hosp, Sydney, NSW, Australia.
   [Verge, Charles] UNSW Australia, Sch Womens & Childrens Hlth, Endocrinol, Sydney, NSW, Australia.
   [Verge, Charles] UNSW Australia, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.
   [Holmes-Walker, Deborah J.] Westmead Hosp, Dept Diabet & Endocrinol, Westmead, NSW, Australia.
   [Campbell, Lesley] St Vincents Hosp, Dept Endocrinol, Med, Sydney, NSW, Australia.
   [Wilhelm, Kay] St Vincents Hosp, Urban Mental Res Inst, Sydney, NSW, Australia.
   [Moravac, Catherine] Univ Toronto, Toronto, ON, Canada.
   [Indu, Pillaveetil S.] Govt Med Coll, Trivandrum, Kerala, India.
   [Indu, Pillaveetil S.] Govt Med Coll, Community Med, Trivandrum, Kerala, India.
   [Bridgett, Madeleine] 6 St James Hall Chambers, Sydney, NSW, Australia.
RP Clarke, J (reprint author), Black Dog Inst, Sydney, NSW, Australia.
EM janine.clarke@blackdog.org.au
OI Indu, Pillaveetil Sathyadas/0000-0002-2282-7661
FU Australian Rotary Health Research Fund
FX Australian Rotary Health Research Fund
CR Australia D, 2006, YOUNG ADULTS DIABETE
   Australian Bureau of Statistics, 2007, NAT SURV MENT HLTH W
   Balfe M, 2012, CIN-COMPUT INFORM NU, V30, P511, DOI 10.1097/NXN.0b013e31826e4fca
   Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950
   Bradford S, 2014, CHILD ADOL MENT H-UK, V19, P39, DOI 10.1111/camh.12002
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Burns J, 2014, PSYCHOL RES BEHAV MA, V7, P303, DOI 10.2147/PRBM.S49151
   Burns JM, 2010, MED J AUSTRALIA, V192, pS22
   Clarke J, 2016, JMIR MENT HEALTH, V3, DOI 10.2196/mental.4656
   Clarke V., 2014, ENCY CRITICAL PSYCHO, P1947, DOI DOI 10.1007/978-1-4614-5583-7
   Corrigan PW, 2000, CLIN PSYCHOL-SCI PR, V7, P48, DOI 10.1093/clipsy/7.1.48
   Cunradi CB, 2005, SUBST USE MISUSE, V40, P171, DOI 10.1081/JA-200048447
   de Wit M, 2011, PEDIATR DIABETES, V12, P172, DOI 10.1111/j.1399-5448.2010.00673.x
   Ellis L. A., 2014, Clinical Investigation, V4, P881, DOI 10.4155/cli.14.61
   Ellis LA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-119
   Ellis LA, 2012, J MED INTERNET RES, V14, P338, DOI 10.2196/jmir.2291
   Fenner Y, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1978
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fogarty AS, 2017, JMIR MENT HEALTH, V4, DOI 10.2196/mental.7769
   Frew PM, 2010, J CLIN EPIDEMIOL, V63, P1110, DOI 10.1016/j.jclinepi.2009.12.002
   Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013
   Gorman JR, 2014, J ADOLESC YOUNG ADUL, V3, P59, DOI 10.1089/jayao.2013.0031
   Harris MF, 2011, HEALTH POLICY, V101, P140, DOI 10.1016/j.healthpol.2010.10.019
   Krischer Jeffrey, 2017, J Med Internet Res, V19, pe50, DOI 10.2196/jmir.6798
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Miller SM, 2013, PSYCHO-ONCOLOGY, V22, P481, DOI 10.1002/pon.3043
   Newington L, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-10
   Ramo Danielle E, 2014, Internet Interv, V1, P58
   Shaghaghi A, 2011, HEALTH PROMOT PERSPE, V1, P86, DOI 10.5681/hpp.2011.009
   Treweek S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002360
   Weiner B, 1995, JUDGMENTS RESPONSIBI
   White M, 2017, LANCET CHILD ADOLESC, V1, P274, DOI 10.1016/S2352-4642(17)30089-5
NR 33
TC 0
Z9 0
U1 8
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1369-6513
EI 1369-7625
J9 HEALTH EXPECT
JI Health Expect.
PD JUN
PY 2018
VL 21
IS 3
BP 668
EP 677
DI 10.1111/hex.12662
PG 10
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA GI1DY
UT WOS:000434112100013
PM 29319923
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU McLachlan, KJJ
   Gale, CR
AF McLachlan, Kyle J. J.
   Gale, Catharine R.
TI The effects of psychological distress and its interaction with
   socioeconomic position on risk of developing four chronic diseases
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Psychological distress; Depression; Arthritis; Cardiovascular disease;
   Chronic obstructive pulmonary disease; Diabetes
ID CORONARY-HEART-DISEASE; OBSTRUCTIVE PULMONARY-DISEASE; GENERAL-PRACTICE;
   NEIGHBORHOOD COHESION; CARDIOVASCULAR EVENTS; RHEUMATOID-ARTHRITIS;
   INFLAMMATORY MARKERS; PSYCHOSOCIAL FACTORS; ARTERY-DISEASE; DEPRESSION
AB Objective: To examine the relationship between psychological distress and risk of developing arthritis, cardiovascular disease, chronic obstructive pulmonary disease and diabetes across the range of distress severity, investigate the mediating roles of health behaviours and explore whether the associations vary with socioeconomic position.
   Methods: Participants were 16,485 adults from the UK Household Longitudinal Study We examined prospective relationships between psychological distress at baseline (measured using the 12-item General Health Questionnaire) and incidence of arthritis, cardiovascular disease, chronic obstructive pulmonary disease and diabetes (measured using self-report) over 3 years using logistic regression. We then examined the mediating effects of health behaviours and investigated whether the associations varied with socioeconomic position.
   Results: Distress significantly increased risk of incident arthritis, cardiovascular disease and chronic obstructive pulmonary disease in a dose-response pattern after controlling for age, sex, socioeconomic position, neighbourhood cohesion, marital status, BMI and baseline disease. High levels of distress (GHQ 7) increased risk of arthritis (OR 2.22; 1.58-2.13), cardiovascular disease (OR 3.06; 1.89-4.98) and chronic obstructive pulmonary disease (OR 3.25; 1.47-7.18). These associations were partially mediated by smoking status but remained significant after controlling for smoking status, diet and exercise. Distress significantly predicted incident diabetes in manual socioeconomic groups only. Effect sizes did not vary with socioeconomic position for arthritis, cardiovascular disease and chronic obstructive pulmonary disease.
   Conclusion: Psychological distress increases risk of incident arthritis, cardiovascular disease and chronic obstructive pulmonary disease in a dose-response pattern, even at low and moderate distress levels. Future research should investigate the mediating role of inflammatory biomarkers.
C1 [McLachlan, Kyle J. J.] Univ Edinburgh, Edinburgh Med Sch, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland.
   [McLachlan, Kyle J. J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.
   [Gale, Catharine R.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.
   [Gale, Catharine R.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.
RP Gale, CR (reprint author), Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England.
EM crg@mrc.soton.ac.uk
FU MRC; BBSRC part of the cross council Lifelong Health and Wellbeing
   Initiative [MR/K026992/1]
FX CRG is a member of the University of Edinburgh Centre for Cognitive
   Ageing and Cognitive Epidemiology, funded by the MRC and BBSRC part of
   the cross council Lifelong Health and Wellbeing Initiative
   (MR/K026992/1).
CR Aalto AM, 2012, PSYCHIAT RES, V197, P163, DOI 10.1016/j.psychres.2011.09.008
   Atlantis E, 2013, CHEST, V144, P766, DOI 10.1378/chest.12-1911
   Batty G. D., 2017, BMJ, V356
   Batty GD, 2014, ATHEROSCLEROSIS, V236, P385, DOI 10.1016/j.atherosclerosis.2014.06.025
   Bjertness E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-602
   Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1
   Buck N, 2012, LONGITUD LIFE COURSE, V3, P5
   BUCKNER JC, 1988, AM J COMMUN PSYCHOL, V16, P771, DOI 10.1007/BF00930892
   Celiker R, 2001, J MUSCULOSKELET PAIN, V9, P35, DOI 10.1300/J094v09n01_05
   Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC
   CHAN KWA, 1994, ARTHRITIS RHEUM-US, V37, P814, DOI 10.1002/art.1780370606
   Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134
   Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067
   Dixon KE, 2007, HEALTH PSYCHOL, V26, P241, DOI 10.1037/0278-6133.26.3.241
   Do DP, 2010, PSYCHOSOM MED, V72, P613, DOI 10.1097/PSY.0b013e3181e2cca5
   Elliott J, 2014, SOC SCI MED, V107, P44, DOI 10.1016/j.socscimed.2014.02.027
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x
   Goldberg D., 1988, USERS GUIDE GEN HLTH
   Goldberg D., 1978, MANUAL OF THE GHQ
   GOLDBERG DP, 1970, BMJ-BRIT MED J, V2, P439, DOI 10.1136/bmj.2.5707.439
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057
   Hankins Matthew, 2008, Clin Pract Epidemiol Ment Health, V4, P10, DOI 10.1186/1745-0179-4-10
   Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460
   KESSLER RC, 1995, EPIDEMIOL REV, V17, P192, DOI 10.1093/oxfordjournals.epirev.a036176
   Klebanoff MA, 2008, AM J EPIDEMIOL, V168, P355, DOI 10.1093/aje/kwn071
   Knies G., 2014, UNDERSTANDING SOC UK
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0
   Lacasse Y, 1996, LANCET, V348, P1115, DOI 10.1016/S0140-6736(96)04201-8
   Lazzarino AI, 2013, PSYCHOSOM MED, V75, P311, DOI 10.1097/PSY.0b013e3182898e6d
   Lazzarino AI, 2013, JAMA INTERN MED, V173, P22, DOI 10.1001/2013.jamainternmed.951
   Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0
   Linden W, 1996, ARCH INTERN MED, V156, P745, DOI 10.1001/archinte.156.7.745
   Lochner K, 1999, HEALTH PLACE, V5, P259, DOI 10.1016/S1353-8292(99)00016-7
   March LM, 1998, OSTEOARTHR CARTILAGE, V6, P87, DOI 10.1053/joca.1997.0098
   Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mikkelsen RL, 2004, NORD J PSYCHIAT, V58, P65, DOI 10.1080/08039480310000824
   Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5
   Mulder M, 1998, INT J EPIDEMIOL, V27, P199, DOI 10.1093/ije/27.2.199
   Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4
   NICE, 2009, DEPR AD REC MAN
   Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338
   Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967
   Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282
   Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI [10.1016/j.genhosppsych.2008.05.001, 10.1016/j.genhosppsych.2008.05.00l]
   Peckham Stephen, 2011, Qual Prim Care, V19, P317
   Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3
   Pembroke TPI, 2006, J EPIDEMIOL COMMUN H, V60, P789, DOI 10.1136/jech.2005.042150
   Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001
   Rasul F, 2005, J EPIDEMIOL COMMUN H, V59, P140, DOI 10.1136/jech.2004.019786
   ROBERTS RE, 1990, SOC SCI MED, V31, P527, DOI 10.1016/0277-9536(90)90087-9
   Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034
   RUSS TC, 2012, BRIT MED J, V345, DOI [10.1136/bmj.e4933, DOI 10.1136/BMJ.E4933]
   Russ TC, 2015, GASTROENTEROLOGY, V148, P958, DOI 10.1053/j.gastro.2015.02.004
   Sargent-Cox K, 2014, PREV MED, V58, P75, DOI 10.1016/j.ypmed.2013.10.017
   Scott KM, 2011, ARCH GEN PSYCHIAT, V68, P838, DOI 10.1001/archgenpsychiatry.2011.77
   Stansfeld SA, 2002, INT J EPIDEMIOL, V31, P248, DOI 10.1093/ije/31.1.248
   Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45
   STERNE JAC, 2009, BRIT MED J, V339, DOI DOI 10.1136/BMJ.B2393
   Takahashi TU, 2003, RESPIROLOGY, V8, P504, DOI 10.1046/j.1440-1843.2003.00501.x
   UNGER DG, 1985, AM J COMMUN PSYCHOL, V13, P139, DOI 10.1007/BF00905726
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   van Schayck CP, 2002, BRIT MED J, V324, P1370, DOI 10.1136/bmj.324.7350.1370
   Vedsted P, 2005, PUBLIC HEALTH, V119, P118, DOI 10.1016/j.puhe.2004.03.007
NR 69
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD JUN
PY 2018
VL 109
BP 79
EP 85
DI 10.1016/j.jpsychores.2018.04.004
PG 7
WC Psychiatry
SC Psychiatry
GA GH2ZS
UT WOS:000433271100013
PM 29680578
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Lee, AA
   Piette, JD
   Heisler, M
   Rosland, AM
AF Lee, Aaron A.
   Piette, John D.
   Heisler, Michele
   Rosland, Ann-Marie
TI Diabetes Distress and Glycemic Control: The Buffering Effect of Autonomy
   Support From Important Family Members and Friends
SO DIABETES CARE
LA English
DT Article
ID SOCIAL SUPPORT; MEDICATION ADHERENCE; EMOTIONAL DISTRESS; HEALTH;
   ADULTS; LIFE; INTERVENTION; ASSOCIATION; MANAGEMENT; EDUCATION
AB OBJECTIVE
   To examine whether autonomy support (defined as social support for an individual's personal agency) for diabetes management from in formal health supporters (family/friends) reduces the detrimental effects of diabetes distress on glycemic control.
   RESEARCH DESIGN AND METHODS
   Three hundred eight veterans with type 2 diabetes and one or more risk factors for diabetes complications completed a survey that included measures of diabetes distress and perceived autonomy support from their main informal health supporter. Hemoglobin A(1c) (HbA(1c)) data from 12 months before and after the survey were extracted from electronic medical records. Linear mixed modeling examined the main effects and interaction of autonomy support and diabetes distress on repeated measures of HbA(1c) over the 12 months after the survey, controlling for mean prior 12-month HbA(1c), time, insulin use, age, and race/ethnicity.
   RESULTS
   Diabetes distress (B = 0.12 [SE 0.05]; P = 0.023) was associated with higher and autonomy support (B = -0.16 [SE 0.07]; P = 0.032) with lower subsequent HbA(1c) levels. Autonomy support moderated the relationship between diabetes distress and HbA1c (B = -0.13 [SE 0.06]; P = 0.027). Greater diabetes distress was associated with higher HbA(1c) at low (B = 0.21 [SE 07]; P = 0.002) but not high (B = 0.01 [SE 0.07]; P = 0.890) levels of autonomy support.
   CONCLUSIONS
   Autonomy support from main health supporters may contribute to better glycemic control by ameliorating the effects of diabetes distress. Interventions that reduce diabetes distress and enhance the autonomy supportiveness of informal supporters may be effective approaches to improving glycemic control.
C1 [Lee, Aaron A.; Piette, John D.; Heisler, Michele] VA Ctr Clin Management Res, Ann Arbor, MI 48105 USA.
   [Piette, John D.; Heisler, Michele] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.
   [Piette, John D.; Heisler, Michele] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.
   [Heisler, Michele] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA.
   [Rosland, Ann-Marie] VA Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA.
   [Rosland, Ann-Marie] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA USA.
RP Lee, AA (reprint author), VA Ctr Clin Management Res, Ann Arbor, MI 48105 USA.
EM aaronlee@med.umich.edu
FU VA Center for Clinical Management Research; VA Veterans Integrated
   Service Network 11 Patient Aligned Care Team Demonstration Laboratory;
   Michigan Center for Diabetes Translational Research (National Institute
   of Diabetes and Digestive and Kidney Diseases) [P30-DK-092926]
FX This study was supported by the VA Center for Clinical Management
   Research, the VA Veterans Integrated Service Network 11 Patient Aligned
   Care Team Demonstration Laboratory, and the Michigan Center for Diabetes
   Translational Research (National Institute of Diabetes and Digestive and
   Kidney Diseases grant P30-DK-092926). J.D.P. is a VA senior Research
   Career Scientist.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   American Diabetes Association, 2017, Diabetes Care, V40, pS48
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310
   COHEN S, 2004, SOCIAL SUPPORT MEASU, V59, P676, DOI DOI 10.1093/MED:PSYCH/9780195126709.003.0001
   Cramer JA, 2005, DIABETES CARE, V28, P78, DOI 10.2337/diacare.28.1.78
   Du YF, 2014, CLIN INTERV AGING, V9, P1963, DOI 10.2147/CIA.S53482
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Funnell MM, 2007, DIABETES SPECTR, V20, P221, DOI DOI 10.2337/DIASPECT.20.4.221
   GRIFFITH LS, 1990, INT J PSYCHIAT MED, V20, P365, DOI 10.2190/APH4-YMBG-NVRL-VLWD
   Guideline Oversight Group, 2017, TYP 2 DIAB SCREEN TR
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hilliard ME, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0761-3
   Langa KM, 2002, J GERONTOL B-PSYCHOL, V57, pS177, DOI 10.1093/geronb/57.3.S177
   Martire LM, 2007, CURR DIR PSYCHOL SCI, V16, P90, DOI 10.1111/j.1467-8721.2007.00482.x
   Miller TA, 2013, DIABETES METAB SYNDR, V6, P421, DOI 10.2147/DMSO.S36368
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Powers MA, 2015, DIABETES EDUCATOR, V41, P417, DOI 10.1177/0145721715588904
   Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437
   Rosland AM, 2010, CHRONIC ILLN, V6, P22, DOI 10.1177/1742395309354608
   Ryan R. M., 1996, HDB SOCIAL SUPPORT F, P249, DOI DOI 10.1007/978-1-4899-1388-3_11
   Strandberg RB, 2015, DIABETIC MED, V32, P1304, DOI 10.1111/dme.12781
   Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0
   Sullivan M. D., 2012, CLIN DIABETES, V30, P101
   Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592
   Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x
   Wagner JA, 2015, J IMMIGR MINOR HEALT, V17, P566, DOI 10.1007/s10903-013-9948-8
   Williams GC, 2005, PATIENT EDUC COUNS, V57, P39, DOI 10.1016/j.pec.2004.04.001
   Williams GC, 1998, HEALTH PSYCHOL, V17, P269, DOI 10.1037//0278-6133.17.3.269
   WILLIAMS GC, 2006, FAMILIES SYSTEMS HLT, V24, P179, DOI DOI 10.1037/1091-7527.24.2.179
   Williams GC, 2007, HEALTH PSYCHOL, V26, P728, DOI 10.1037/0278-6133.26.6.728
   Williams GC, 2009, DIABETES EDUCATOR, V35, P484, DOI 10.1177/0145721709333856
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 40
TC 1
Z9 1
U1 6
U2 6
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUN 1
PY 2018
VL 41
IS 6
BP 1157
EP 1163
DI 10.2337/dc17-2396
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GG4NI
UT WOS:000432673000020
PM 29599295
DA 2019-01-08
ER

PT J
AU Kumar, S
   Moseson, H
   Uppal, J
   Juusola, JL
AF Kumar, Shefali
   Moseson, Heidi
   Uppal, Jaspreet
   Juusola, Jessie L.
TI A Diabetes Mobile App With In-App Coaching From a Certified Diabetes
   Educator Reduces A1C for Individuals With Type 2 Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID SELF-MANAGEMENT EDUCATION; GLYCEMIC CONTROL; POSITION STATEMENT;
   DISTRESS SCALE; DEPRESSION; ASSOCIATION; MELLITUS; TRIALS; ADULTS; CARE
AB Purpose There are currently many diabetes apps available, but there is limited evidence demonstrating clinical impact. The purpose of this study is to evaluate the impact of a diabetes mobile app with in-app coaching by a certified diabetes educator on glycemic control for individuals with type 2 diabetes.
   Methods A 12 week-long single-arm intent-to-treat trial evaluated the impact of a diabetes mobile app and coaching program (One Drop | Mobile With One Drop | Experts), which facilitated tracking of self-care and included an in-app diabetes education program, on A1C for individuals with type 2 diabetes and an A1C 7.5% (58 mmol/mol). An online study platform (Achievement Studies, Evidation Health Inc, San Mateo, CA) was used to screen, consent, and enroll participants; collect study data; and track participants' progress throughout the study. Baseline and study end A1C measurements as well as questionnaire data from participants were collected.
   Results Participants (n = 146) were 52 9 years old, 71% female, 25% black or Hispanic, diagnosed with diabetes for 11 +/- 7 years, and with a mean baseline A1C of 9.87% +/- 2.0 (84 mmol/mol). In adjusted repeated measures models, mean A1C improved by -0.86% among study completers (n = 127), -0.96% among active users of the app and coaching program (n = 93), and -1.32% among active users with a baseline A1C 9.0% (75 mmol/mol) (n = 53).
   Conclusions This program was associated with a clinically meaningful and significant reduction in A1C and can potentially increase access to effective diabetes self-management education and support for individuals with diabetes.
C1 [Kumar, Shefali; Moseson, Heidi; Uppal, Jaspreet; Juusola, Jessie L.] Evidat Hlth, 167 2nd Ave, San Mateo, CA 94401 USA.
RP Kumar, S (reprint author), Evidat Hlth, 167 2nd Ave, San Mateo, CA 94401 USA.
EM skumar@evidation.com
FU Informed Data Systems, Inc.
FX Informed Data Systems, Inc.
CR Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Cahn A, 2018, J DIABETES, V10, P10, DOI 10.1111/1753-0407.12606
   Centers for Disease Control and Prevention, 2016, DIABETES
   Chrvala CA, 2016, PATIENT EDUC COUNS, V99, P926, DOI 10.1016/j.pec.2015.11.003
   de Groot M, 2012, CURR DIABETES REP, V12, P157, DOI 10.1007/s11892-012-0261-z
   Eng DS, 2013, PEDIATR DIABETES, V14, P231, DOI 10.1111/pedi.12034
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Hood M, 2016, J BEHAV MED, V39, P981, DOI 10.1007/s10865-016-9765-3
   Hou C, 2016, DIABETES CARE, V39, P2089, DOI 10.2337/dc16-0346
   Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956
   Hunt CW, 2015, WORLD J DIABETES, V6, P225, DOI 10.4239/wjd.v6.i2.225
   Kreider KE, 2017, DIABETES THER, V8, P1, DOI 10.1007/s13300-017-0231-1
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Powers MA, 2015, DIABETES EDUCATOR, V41, P417, DOI 10.1177/0145721715588904
   Research2Guidance, 2017, MHEALTH APP DEV EC
   Rosa C, 2015, CONTEMP CLIN TRIALS, V45, P41, DOI 10.1016/j.cct.2015.07.007
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P854, DOI DOI 10.1016/S0140-6736(98)07037-8
   White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 23
TC 2
Z9 2
U1 5
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD JUN
PY 2018
VL 44
IS 3
BP 225
EP 236
DI 10.1177/0145721718765650
PG 12
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA GG7RB
UT WOS:000432894500002
PM 29575982
DA 2019-01-08
ER

PT J
AU Hagger, V
   Hendrieckx, C
   Cameron, F
   Pouwer, F
   Skinner, TC
   Speight, J
AF Hagger, Virginia
   Hendrieckx, Christel
   Cameron, Fergus
   Pouwer, Frans
   Skinner, Timothy C.
   Speight, Jane
TI Diabetes distress is more strongly associated with HbA1c than depressive
   symptoms in adolescents with type 1 diabetes: Results from Diabetes
   MILES Youth-Australia
SO PEDIATRIC DIABETES
LA English
DT Article
DE adolescent; depression; emotions; hemoglobin A1c; type 1 diabetes
ID GLYCEMIC CONTROL; METABOLIC-CONTROL; CONTROLLED-TRIAL; ADULTS; TIME;
   PREDICTORS; DISORDERS; CHILDREN; OUTCOMES; CARE
AB Background: Glycated hemoglobin (HbA1c) is higher during adolescence than at any other life stage. Some research among adolescents indicates that depressive symptoms are associated with suboptimal HbA1c. However, research among adults suggests diabetes distress is a stronger predictor of HbA1c than depressive symptoms.
   Objective: To determine the relative contributions of depressive symptoms and diabetes distress to explain the variance in HbA1c among adolescents with type 1 diabetes.
   Participants and methods: Diabetes MILES Youth Study respondents aged 13 to 19 years completed questionnaires assessing depressive symptoms (Patient Health Questionnaire for Adolescents: PHQA-8), diabetes distress (Problem Areas in Diabetes-Teen version: PAID-T), and self-reported socio-demographic and clinical variables, including their most recent HbA1c. Stepwise hierarchical multiple regression was conducted to examine the contributions of depressive symptoms and diabetes distress to HbA1c.
   Results: Participants (N=450) had a (mean +/- SD) age of 15.7 +/- 1.9 years; diabetes duration of 6.9 +/- 4.3 years; and 38% (n=169) were male. Twenty-one percent (n=96) experienced moderate-to-severe depressive symptoms (PHQA-8 >= 11) and 36% (n=162) experienced high diabetes distress (PAID-T>90). In the final regression model, HbA1c was explained by: diabetes duration (beta =.14, P=.001), self-monitoring of blood glucose (beta=-.20, P<.001), and diabetes distress (beta=.30, P<.001). Following the addition of diabetes distress, depressive symptoms were no longer significantly associated with HbA1c (P=.551). The final model explained 18% of the variance in HbA1c.
   Conclusions: Consistent with evidence from studies among adults, diabetes distress mediated the relationship between depressive symptoms and HbA1c among adolescents with type 1 diabetes. These findings suggest that clinicians need to be aware of diabetes distress.
C1 [Hagger, Virginia; Hendrieckx, Christel; Speight, Jane] Deakin Univ, Sch Psychol, Ctr Social & Early Emot Dev, Geelong, Vic, Australia.
   [Hagger, Virginia; Hendrieckx, Christel; Speight, Jane] Australian Ctr Behav Res Diabet, Diabet Victoria, Melbourne, Vic, Australia.
   [Cameron, Fergus] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Pouwer, Frans] Univ Southern Denmark, Dept Psychol, Odense, Denmark.
   [Skinner, Timothy C.] Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT, Australia.
   [Skinner, Timothy C.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia.
   [Speight, Jane] AHP Res, Hornchurch, England.
RP Hagger, V (reprint author), Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
EM vhagger@acbrd.org.au
OI Speight, Jane/0000-0002-1204-6896; Hagger, Virginia/0000-0003-3845-2814;
   Skinner, Timothy/0000-0002-0018-6963
FU National Diabetes Services Scheme; Deakin University; Diabetes Victoria
FX National Diabetes Services Scheme; Deakin University; Diabetes Victoria
CR AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402
   Anderson BJ, 2009, FAM SYST HEALTH, V27, P141, DOI 10.1037/a0015759
   BLANZ BJ, 1993, DIABETES CARE, V16, P1579, DOI 10.2337/diacare.16.12.1579
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Butwicka A, 2012, DIABETES CARE, V35, P2133, DOI 10.2337/dc12-0160
   Christie D, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000165
   Corathers SD, 2013, PEDIATRICS, V132, pE1395, DOI 10.1542/peds.2013-0681
   Cuijpers P, 2008, EUR CHILD ADOLES PSY, V17, P32, DOI 10.1007/s00787-007-0631-2
   De Wit M, 2008, DIABETES CARE, V31, P1521, DOI 10.2337/dc08-0394
   Ellis DA, 2005, PEDIATRICS, V116, pE826, DOI 10.1542/peds.2005-0638
   Fisher L, 2016, DIABETIC MED, V33, P1590, DOI 10.1111/dme.12973
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Hackorth NJ, 2013, AUST PSYCHOL, V48, P360, DOI [DOI 10.1111/AP.12007, 10.1111/ap.12007]
   Hagger V, 2017, DIABETES CARE, V40, P1462, DOI 10.2337/dc17-0441
   Hagger Virginia, 2016, BMC Psychol, V4, P42, DOI 10.1186/s40359-016-0149-9
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   Handley TE, 2016, DIABETIC MED, V33, P1582, DOI 10.1111/dme.13022
   Heiervang E, 2011, SOC PSYCH PSYCH EPID, V46, P69, DOI 10.1007/s00127-009-0171-9
   Helgeson VS, 2010, J PEDIATR PSYCHOL, V35, P1161, DOI 10.1093/jpepsy/jsq011
   Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079
   Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009
   Herzer M, 2010, J PEDIATR PSYCHOL, V35, P415, DOI 10.1093/jpepsy/jsp063
   Hessler DM, 2017, DIABETIC MED, V34, P1228, DOI 10.1111/dme.13381
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   IDF ISP AD, 2011, GLOB IDF ISPAD GUID
   Iturralde E, 2017, HEALTH PSYCHOL, V36, P236, DOI 10.1037/hea0000445
   Kokkonen J, 1997, NORD J PSYCHIAT, V51, P165, DOI 10.3109/08039489709109091
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Lasaite L, 2016, J DIABETES COMPLICAT, V30, P1500, DOI 10.1016/j.jdiacomp.2016.08.013
   Levine BS, 2001, J PEDIATR-US, V139, P197, DOI 10.1067/mpd.2001.116283
   Lewin AB, 2009, J PEDIATR PSYCHOL, V34, P999, DOI 10.1093/jpepsy/jsp032
   McGrady Meghan E, 2010, Diabetes Res Clin Pract, V88, pe35, DOI 10.1016/j.diabres.2010.03.025
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Plener PL, 2015, PEDIATR DIABETES, V16, P58, DOI 10.1111/pedi.12130
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Richardson LP, 2014, JAMA-J AM MED ASSOC, V312, P809, DOI 10.1001/jama.2014.9259
   Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852
   Serlachius A, 2014, J HEALTH PSYCHOL, V21, P1157
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Wisting L, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000203
NR 42
TC 1
Z9 1
U1 4
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1399-543X
EI 1399-5448
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD JUN
PY 2018
VL 19
IS 4
BP 840
EP 847
DI 10.1111/pedi.12641
PG 8
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA GF5SD
UT WOS:000432027100036
PM 29383803
DA 2019-01-08
ER

PT J
AU Chew, BH
   Vos, RC
   Stellato, RK
   Ismail, M
   Rutten, GEHM
AF Chew, B. H.
   Vos, R. C.
   Stellato, R. K.
   Ismail, M.
   Rutten, G. E. H. M.
TI The effectiveness of an emotion-focused educational programme in
   reducing diabetes distress in adults with Type 2 diabetes mellitus
   (VEMOFIT): a cluster randomized controlled trial
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; SELF-CARE; PSYCHOMETRIC PROPERTIES; GLYCEMIC CONTROL;
   HEALTH; SCALE; DEPRESSION; MANAGEMENT; INTERVENTIONS; METAANALYSIS
AB AimsTo evaluate the effectiveness of a brief, value-based emotion-focused educational programme (VEMOFIT) in Malay adults with Type 2 diabetes mellitus compared with a programme of active listening to participants' emotional experiences, social support and their opinion on the health clinic diabetes care services (attention control).
   MethodsMalay adults with severe diabetes distress [Diabetes Distress Scale (DDS-17) mean score 3] were included. VEMOFIT consisted of four biweekly group sessions, a booster session after 3 months and a follow-up 6 months post intervention. The attention control programme consisted of three sessions over the same period. Outcomes included diabetes distress, depressive symptoms, self-efficacy and disease control. Required total sample size was 165.
   ResultsParticipants (n = 124) were randomized to either VEMOFIT (n = 53) or the attention control programme (n = 71). Participants had a mean (sd) age of 55.7 (9.7) years, median diabetes duration of 7.0 (8.0) years and mean HbA(1c) level of 82 mmol/mol (9.7%). The mean DDS-17 level decreased significantly in both the VEMOFIT and the attention control programmes (3.4 to 2.9 vs. 3.1 to 2.7, respectively). The adjusted between-group DDS-17 difference was not significant [-0.01, 95% confidence interval (CI) -0.38, 0.35]. The proportion of individuals with severe diabetes distress decreased in both groups, from 89% to 47% vs. 69% to 39% (odds ratio 0.88; 95% CI 0.26, 2.90). Other outcomes did not differ between groups.
   ConclusionsBoth interventions decreased diabetes distress significantly. The theory-based VEMOFIT programme was not superior to the attention control programme. The latter approach is a simpler way to decrease severe diabetes distress (Trial registration: NCT02730078; NMRR-15-1144-24803).
C1 [Chew, B. H.] Univ Putra Malaysia, Dept Family Med, Serdang, Selangor, Malaysia.
   [Chew, B. H.; Vos, R. C.; Stellato, R. K.; Rutten, G. E. H. M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Ismail, M.] Hlth Clin Seremban 2, Seremban, Negeri Sembilan, Malaysia.
RP Chew, BH (reprint author), Univ Putra Malaysia, Dept Family Med, Serdang, Selangor, Malaysia.; Chew, BH (reprint author), Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
EM chewboonhow@upm.edu.my
OI Chew, Boon How/0000-0002-8627-6248
FU Malaysian MOH-NIH Research Grant (MRG); Ministry of Higher Education
   Malaysia
FX The trial was supported by the Malaysian MOH-NIH Research Grant (MRG)
   and Ministry of Higher Education Malaysia. These funding sources had no
   role in the design or execution of this study.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Berry E, 2017, PSYCHOL HEALTH MED, V22, P1118, DOI 10.1080/13548506.2017.1281976
   Broadbent E, 2015, PSYCHOL HEALTH, V30, P1361, DOI 10.1080/08870446.2015.1070851
   Chew B H, 2015, Malays Fam Physician, V10, P22
   Chew BH, 2017, COCHRANE DB SYST REV, V9
   Chew BH, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0394-5
   Chew BH, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0172-8
   Chew BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152095
   Chew BH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0384-4
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Harper A, 1998, PSYCHOL MED, V28, P551
   Hasanah C I, 2003, Med J Malaysia, V58, P79
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Martinez K, 2018, PSYCHOL HEALTH MED, V23, P171, DOI 10.1080/13548506.2017.1339892
   NICE guideline NG 28, 2015, TYP 2 DIAB AD MAN
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Sharoni SKA, 2012, NURS HEALTH SCI, V14, P38, DOI 10.1111/j.1442-2018.2011.00658.x
   Sherina M S, 2012, Med J Malaysia, V67, P309
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x
   Yi JP, 2008, BRIT J HEALTH PSYCH, V13, P311, DOI 10.1348/135910707X186994
   Zeh P, 2012, DIABETIC MED, V29, P1237, DOI 10.1111/j.1464-5491.2012.03701.x
   Zhao FF, 2017, J ADV NURS, V73, P812, DOI 10.1111/jan.13163
NR 30
TC 1
Z9 1
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2018
VL 35
IS 6
BP 750
EP 759
DI 10.1111/dme.13615
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GF5DD
UT WOS:000431985000010
PM 29505098
DA 2019-01-08
ER

PT J
AU Lloyd, CE
   Nouwen, A
   Sartorius, N
   Ahmed, HU
   Alvarez, A
   Bahendeka, S
   Basangwa, D
   Bobrov, AE
   Boden, S
   Bulgari, V
   Burti, L
   Chaturvedi, SK
   Cimino, LC
   Gaebel, W
   de Girolamo, G
   Gondek, TM
   de Braude, MG
   Guntupalli, A
   Heinze, MG
   Ji, L
   Hong, X
   Khan, A
   Kiejna, A
   Kokoszka, A
   Kamala, T
   Lalic, NM
   Tosevski, DL
   Mankovsky, B
   Li, M
   Musau, A
   Mussig, K
   Ndetei, D
   Rabbani, G
   Srikanta, SS
   Starostina, EG
   Shevchuk, M
   Taj, R
   Vukovic, O
   Wolwer, W
   Xin, Y
AF Lloyd, C. E.
   Nouwen, A.
   Sartorius, N.
   Ahmed, H. U.
   Alvarez, A.
   Bahendeka, S.
   Basangwa, D.
   Bobrov, A. E.
   Boden, S.
   Bulgari, V.
   Burti, L.
   Chaturvedi, S. K.
   Cimino, L. C.
   Gaebel, W.
   de Girolamo, G.
   Gondek, T. M.
   Guinzbourg de Braude, M.
   Guntupalli, A.
   Heinze, M. G.
   Ji, L.
   Hong, X.
   Khan, A.
   Kiejna, A.
   Kokoszka, A.
   Kamala, T.
   Lalic, N. M.
   Tosevski, D. Lecic
   Mankovsky, B.
   Li, M.
   Musau, A.
   Muessig, K.
   Ndetei, D.
   Rabbani, G.
   Srikanta, S. S.
   Starostina, E. G.
   Shevchuk, M.
   Taj, R.
   Vukovic, O.
   Woelwer, W.
   Xin, Y.
TI Prevalence and correlates of depressive disorders in people with Type 2
   diabetes: results from the International Prevalence and Treatment of
   Diabetes and Depression (INTERPRET-DD) study, a collaborative study
   carried out in 14 countries
SO DIABETIC MEDICINE
LA English
DT Article
ID NEUROPSYCHIATRIC INTERVIEW MINI; EMOTIONAL-PROBLEMS; DISTRESS;
   EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; SYMPTOMS; MELLITUS; VALIDITY;
   CARE
AB AimsTo assess the prevalence and management of depressive disorders in people with Type 2 diabetes in different countries.
   MethodsPeople with diabetes aged 18-65 years and treated in outpatient settings were recruited in 14 countries and underwent a psychiatric interview. Participants completed the Patient Health Questionnaire and the Problem Areas in Diabetes scale. Demographic and medical record data were collected.
   ResultsA total of 2783 people with Type 2 diabetes (45.3% men, mean duration of diabetes 8.8 years) participated. Overall, 10.6% were diagnosed with current major depressive disorder and 17.0% reported moderate to severe levels of depressive symptomatology (Patient Health Questionnaire scores >9). Multivariable analyses showed that, after controlling for country, current major depressive disorder was significantly associated with gender (women) (P<0.0001), a lower level of education (P<0.05), doing less exercise (P<0.01), higher levels of diabetes distress (P<0.0001) and a previous diagnosis of major depressive disorder (P<0.0001). The proportion of those with either current major depressive disorder or moderate to severe levels of depressive symptomatology who had a diagnosis or any treatment for their depression recorded in their medical records was extremely low and non-existent in many countries (0-29.6%).
   ConclusionsOur international study, the largest of this type ever undertaken, shows that people with diabetes frequently have depressive disorders and also significant levels of depressive symptoms. Our findings indicate that the identification and appropriate care for psychological and psychiatric problems is not the norm and suggest a lack of the comprehensive approach to diabetes management that is needed to improve clinical outcomes.
C1 [Lloyd, C. E.; Boden, S.; Guntupalli, A.] Open Univ, Sch Hlth Wellbeing & Social Care, Milton Keynes, Bucks, England.
   [Nouwen, A.] Middlesex Univ, Dept Psychol, London, England.
   [Sartorius, N.] Assoc Improvement Mental Hlth Programmes, Geneva, Switzerland.
   [Ahmed, H. U.] Natl Inst Mental Hlth NIMH, Child Adolescent & Family Psychiat, Dhaka, Bangladesh.
   [Alvarez, A.; Guinzbourg de Braude, M.] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina.
   [Bahendeka, S.; Basangwa, D.] Uganda Martyrs Univ, Mother Kevin Post Grad Med Sch, Kampala, Uganda.
   [Bobrov, A. E.] Fed Med Res Ctr Psychiat & Narcol, Moscow, Russia.
   [Bulgari, V.; de Girolamo, G.] St John God Clin Res Ctr, Psychiat Epidemiol & Evaluat Unit, Brescia, Italy.
   [Bulgari, V.] Univ Cattolica Sacro Cuore, PhD Sch Psychol, Milan, Italy.
   [Burti, L.] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.
   [Chaturvedi, S. K.] Natl Inst Mental Hlth & Neurosci, Bangalore, Karnataka, India.
   [Cimino, L. C.] Indiana Univ, Indiana, PA USA.
   [Gaebel, W.; Woelwer, W.] Heinrich Heine Univ, Fac Med, Dept Psychiat & Psychotherapy, Dusseldorf, Germany.
   [Gondek, T. M.] Wroclaw Med Univ, Dept Psychiat, Wroclaw, Poland.
   [Heinze, M. G.] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico.
   [Ji, L.] Peking Univ, Peoples Hosp, Beijing, Peoples R China.
   [Hong, X.] Chinese Acad Med Sci, Dept Psychol Med, Beijing, Peoples R China.
   [Hong, X.] Peking Union Med Coll, Beijing, Peoples R China.
   [Khan, A.; Taj, R.] Pakistan Inst Med Sci, Islamabad, Pakistan.
   [Kiejna, A.] Univ Lower Silesia, Wroclaw, Poland.
   [Kiejna, A.] Med Univ, Dept Psychiat, Wroclaw, Poland.
   [Kokoszka, A.] Med Univ Warsaw, Dept Psychiat 2, Warsaw, Poland.
   [Kamala, T.] Diabet Ctr, Bangalore, Karnataka, India.
   [Kamala, T.; Srikanta, S. S.] Jnana Sanjeevini Med Ctr, Bangalore, Karnataka, India.
   [Lalic, N. M.] Univ Belgrade, Serbian Acad Sci & Arts, Clin Endocrinol, Sch Med, Belgrade, Serbia.
   [Tosevski, D. Lecic; Vukovic, O.] Univ Belgrade, Serbian Acad Sci & Arts, Inst Mental Hlth, Sch Med, Belgrade, Serbia.
   [Mankovsky, B.] Natl Med Acad Postgrad Educ, Dept Diabetol, Kiev, Ukraine.
   [Li, M.] Peking Univ, Sch Nursing, Beijing, Peoples R China.
   [Musau, A.] Africa Mental Hlth Fdn, Nairobi, Kenya.
   [Muessig, K.] German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.
   [Muessig, K.] Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, Dusseldorf, Germany.
   [Muessig, K.] Heinrich Heine Univ, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany.
   [Muessig, K.] German Ctr Diabet Res DZD, Munich, Germany.
   [Ndetei, D.] Univ Nairobi, Africa Mental Hlth Fdn, Nairobi, Kenya.
   [Rabbani, G.] Popular Med Coll, Dhaka, Bangladesh.
   [Srikanta, S. S.] Samatvam Endocrinol Diabet Ctr, Bangalore, Karnataka, India.
   [Starostina, E. G.] Moscow Reg Clin & Res Inst, Dept Endocrinol, Moscow, Russia.
   [Shevchuk, M.] Natl Med Acad Postgrad Educ, Dept Diabetol, Kiev, Ukraine.
   [Xin, Y.] Peking Univ, Clin Res Ctr, Natl Clin Res Ctr Mental Disorders,Hosp 6, Inst Mental Hlth,Key Lab Mental Hlth,Minist Hlth, Beijing, Peoples R China.
RP Lloyd, CE (reprint author), Open Univ, Sch Hlth Wellbeing & Social Care, Milton Keynes, Bucks, England.
EM Cathy.Lloyd@open.ac.uk
RI Kokoszka, Andrzej/O-7454-2018
OI Kokoszka, Andrzej/0000-0003-4518-5494; Mankovsky,
   Boris/0000-0001-8289-3604; de Girolamo, Giovanni/0000-0002-1611-8324;
   Lloyd, Cathy/0000-0002-8863-3069
FU AIMH; Eli Lilly company; Sanofi company
FX This study was carried out under the aegis of the Association for the
   Improvement of Mental Health Programmes (AIMH) (and supported by AIMH
   and the collaborating institutions). The meetings of the investigators
   and data entry were in part supported by unrestricted grants by Eli
   Lilly and Sanofi companies.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   [Anonymous], 2017, Diabetes Care, V40, pS4
   Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672
   Baumeister H, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858
   Chan J, 2010, DEPRESSION DIABETES, P143
   de Groot M, 2016, DIABETES CARE, V39, P2174, DOI 10.2337/dc16-1145
   Diabetes UK, 15 HEALTHC ESS CAR Y
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hosmer D.W., 2000, APPL LOGISTIC REGRES
   Hossain MD, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0216-9
   Ishizawa K, 2016, J DIABETES COMPLICAT, V30, P597, DOI 10.1016/j.jdiacomp.2016.02.004
   Kirmayer LJ, 2017, SOC SCI MED, V183, P163, DOI 10.1016/j.socscimed.2017.04.034
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lloyd CE, 2015, DIABETIC MED, V32, P925, DOI 10.1111/dme.12719
   Lloyd CE, 2012, J AFFECT DISORDERS, V142, pS22, DOI 10.1016/S0165-0327(12)70005-8
   Lysy Z, 2008, DIABETIC MED, V25, P1133, DOI 10.1111/j.1464-5491.2008.02545.x
   Mander A, 2007, HOTDECK STATA MODULE
   Mendenhall E, 2015, SOC SCI MED, V146, P11, DOI 10.1016/j.socscimed.2015.10.015
   Mommersteeg PMC, 2013, DIABETIC MED, V30, pE208, DOI 10.1111/dme.12193
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nouwen A, 2015, DIABETIC MED, V32, P1261, DOI 10.1111/dme.12863
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Petrak F, 2015, LANCET DIABETES ENDO, V3, P472, DOI 10.1016/S2213-8587(15)00045-5
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   RUBIN DB, 1986, J AM STAT ASSOC, V81, P366, DOI 10.2307/2289225
   Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Van Dornan FEP, 2013, PLOS ONE, V8, pe57
   World Health Organization, 2006, DEF DIAGN DIAB MELL
NR 36
TC 3
Z9 3
U1 16
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2018
VL 35
IS 6
BP 760
EP 769
DI 10.1111/dme.13611
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GF5DD
UT WOS:000431985000011
PM 29478265
DA 2019-01-08
ER

PT J
AU Ju, C
   Shi, R
   Yao, L
   Ye, X
   Jia, M
   Han, J
   Yang, T
   Lu, Q
   Jin, H
   Cai, X
   Yuan, S
   Xie, B
   Yu, X
   Coufal, MM
   Fisher, EB
   Sun, Z
AF Ju, C.
   Shi, R.
   Yao, L.
   Ye, X.
   Jia, M.
   Han, J.
   Yang, T.
   Lu, Q.
   Jin, H.
   Cai, X.
   Yuan, S.
   Xie, B.
   Yu, X.
   Coufal, M. M.
   Fisher, E. B.
   Sun, Z.
TI Effect of peer support on diabetes distress: a cluster randomized
   controlled trial
SO DIABETIC MEDICINE
LA English
DT Article
ID SELF-MANAGEMENT EDUCATION; GLYCEMIC CONTROL; ADULTS; CARE; DEPRESSION;
   COMMUNITY; OUTCOMES
AB AimTo investigate whether peer support would reduce diabetes distress and improve glycaemic control when added to usual diabetes education among adults with Type 2 diabetes in China.
   MethodsWe conducted a cluster randomized trial involving 400 adults with Type 2 diabetes from eight communities in Nanjing. All participants received usual education for an average of 2 h each month from physicians, certified diabetes educators, dieticians, psychologists and podiatric nurses. Peer support was led by trained peer leaders and included diabetes knowledge- and skills-sharing at least once a month, as well as peer-to-peer communication. The primary outcome was diabetes distress measured using the Diabetes Distress Scale at 12 months. Secondary outcomes included fasting plasma glucose, 2-h postprandial glucose and HbA(1c) concentration. Outcome data were collected from all participants at baseline, 6 months and 12 months.
   ResultsFrom 2012 to 2013, there were 200 participants in each study arm at baseline. Compared with the usual education arm, the peer support with usual education arm had greater reductions in regimen-related distress (1.4 0.6 vs 1.2 0.4; P=0.004) and total distress (1.3 0.4 vs 1.2 0.3; P=0.038) at 6 months. At 12 months, the scores for emotional burden (1.2 +/- 0.3 vs 1.4 +/- 0.6; P=0.002), physician-related distress (1.1 +/- 0.3 vs 1.3 +/- 0.4; P=0.001) and total scores (1.2 +/- 0.3 vs 1.3 +/- 0.4; P=0.002) were significantly lower in the peer support with usual education arm than in the usual education arm. Fasting plasma glucose levels were lower in the peer support with usual education arm than in the usual education arm at 6 months (7.5 +/- 1.95 vs 8.0 +/- 2.2; P=0.044) and 12 months (7.0 +/- 2.3 vs 7.6 +/- 1.5; P=0.008).
   ConclusionsBeyond the benefits of usual education, peer support was effective in reducing diabetes distress for Type 2 diabetes mellitus. (Clinical Trials Registry no: NCT02119572)
C1 [Ju, C.; Shi, R.; Yao, L.; Ye, X.; Jia, M.; Han, J.; Yang, T.; Lu, Q.; Jin, H.; Cai, X.; Yuan, S.; Xie, B.; Sun, Z.] Zhongda Hosp, Dept Endocrinol, Sch Med, Inst Diabet, Nanjing, Jiangsu, Peoples R China.
   [Yu, X.] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.
   [Coufal, M. M.] Asian Ctr Hlth Educ, Plano, AS USA.
   [Fisher, E. B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA.
RP Sun, Z (reprint author), Zhongda Hosp, Dept Endocrinol, Sch Med, Inst Diabet, Nanjing, Jiangsu, Peoples R China.
EM sunzilin1963@126.com
FU Jiangsu Provincial Special Programme of Medical Science [BK2014010]
FX This study was supported by the Jiangsu Provincial Special Programme of
   Medical Science (BK2014010).
CR Aghili R, 2016, CAN J DIABETES, V40, P424, DOI 10.1016/j.jcjd.2016.02.014
   Brownson CA, 2009, PATIENT, V2, P5, DOI 10.2165/01312067-200902010-00002
   Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661
   Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x
   Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5
   Due-Christensen M, 2016, PATIENT EDUC COUNS, V99, P1978, DOI 10.1016/j.pec.2016.07.023
   Fisher Edwin B, 2017, Clin Diabetes Endocrinol, V3, P4, DOI 10.1186/s40842-017-0042-3
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   Heisler M, 2010, FAM PRACT, V27, pI23, DOI 10.1093/fampra/cmp003
   Kong Lulu, 2013, J Biomed Res, V27, P380, DOI 10.7555/JBR.27.20120112
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Peyrot M, 2008, DIABETES EDUCATOR, V34, P90, DOI 10.1177/0145721707312399
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694
   Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251
   Tang TS, 2015, DIABETIC MED, V32, P1077, DOI 10.1111/dme.12655
   Tang TS, 2014, DIABETES CARE, V37, P1525, DOI 10.2337/dc13-2161
   Tang TS, 2005, DIABETES EDUCATOR, V31, P91, DOI 10.1177/0145721704273231
   Whittle J, 2014, JAMA INTERN MED, V174, P982, DOI 10.1001/jamainternmed.2014.654
   Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118
   Zhang XX, 2016, PATIENT EDUC COUNS, V99, P186, DOI 10.1016/j.pec.2015.09.006
NR 24
TC 1
Z9 1
U1 5
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2018
VL 35
IS 6
BP 770
EP 775
DI 10.1111/dme.13625
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GF5DD
UT WOS:000431985000012
PM 29574995
DA 2019-01-08
ER

PT J
AU Lum, ZK
   Tsou, KYK
   Lee, JYC
AF Lum, Z. K.
   Tsou, K. Y. K.
   Lee, J. Y-C
TI Mediators of medication adherence and glycaemic control and their
   implications for direct outpatient medical costs: a cross-sectional
   study
SO DIABETIC MEDICINE
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; SELF-MANAGEMENT; DISTRESS; OUTCOMES; MODEL;
   SINGAPORE; BARRIERS; ILLNESS; ADULTS
AB AimsTo investigate the effects of diabetes-related distress and perception of hyperglycaemia on self-reported medication adherence and glycaemic control, as measured by HbA(1c), and to compare the cost outcomes in patients with sub-optimally vs uncontrolled Type 2 diabetes mellitus.
   MethodsWe conducted a retrospective cross-sectional study that involved the review of a chronic disease database in Singapore. Data on clinical characteristics, diabetes-related distress, perception of hyperglycaemia, self-reported medication adherence and costs were obtained from the database. Mediation analyses were conducted using a linear regression-based approach. A final path model was built to illustrate the sequential mediating effects of diabetes-related distress and perception on the association of medication adherence and HbA(1c) concentration.
   ResultsDiabetes-related distress and perception of hyperglycaemia were significantly associated with medication adherence and HbA(1c) concentration. Mediation analyses showed a significant indirect effect of diabetes-related distress and perception of hyperglycaemia on medication adherence and HbA(1c) concentration. People with uncontrolled diabetes were found to incur significantly higher total direct medical costs than those with sub-optimally controlled diabetes (P = 0.034), with medication cost as the main cost driver (66.6%).
   ConclusionsIdentifying the influence of the sequential mediating effects of distress and perception was important in understanding the pathway between medication adherence and glycaemic control. This suggests the importance of a team-based approach to address these mediators and thus improve glycaemic control. Poor glycaemic control was also found to be associated with higher direct medical costs.
C1 [Lum, Z. K.; Lee, J. Y-C] Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore, Singapore.
   [Tsou, K. Y. K.] Natl Univ Polyclin, Singapore, Singapore.
RP Lee, JYC (reprint author), Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore, Singapore.
EM phalycj@nus.edu.sg
FU Health Services Research Competitive Research Grant from the Ministry of
   Health, Singapore [HSRG/11MAY/016]
FX This study was supported by the Health Services Research Competitive
   Research Grant from the Ministry of Health, Singapore (HSRG/11MAY/016).
   The funder was not involved in the design and conduct of the study,
   collection, management, analysis and interpretation of the data,
   preparation, review and approval of the manuscript, or decision to
   submit the manuscript for publication.
CR Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   American Diabetes Association, DIABETES CARE, V40, pS33
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   BRADLEY C, 1990, DIABETIC MED, V7, P445, DOI 10.1111/j.1464-5491.1990.tb01421.x
   Chew BH, 2015, PATIENT PREFER ADHER, V9, P639, DOI 10.2147/PPA.S81612
   Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Gellad WF, 2011, AM J GERIATR PHARMAC, V9, P11, DOI 10.1016/j.amjopharm.2011.02.004
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Krass I, 2015, DIABETIC MED, V32, P725, DOI 10.1111/dme.12651
   Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2
   Lin L-K, 2017, BMJ OPEN DIABETES RE, V5
   Miller-Matero LR, 2017, PSYCHOL HEALTH MED, V22, P19, DOI 10.1080/13548506.2016.1191659
   Ministry of Health Singapore, 2006, DIAB MELL MOH CLIN P
   Ng CS, 2014, DIABETES RES CLIN PR, V105, P151, DOI 10.1016/j.diabres.2014.03.020
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
   Okumura Y, 2013, GEN HOSP PSYCHIAT, V35, P233, DOI 10.1016/j.genhosppsych.2012.12.013
   Pintaudi B, 2015, J PSYCHOSOM RES, V79, P348, DOI 10.1016/j.jpsychores.2015.08.010
   Png ME, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2827-1
   Sapkota S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128581
   Siaw MYL, 2017, J CLIN PHARM THER, V42, P475, DOI 10.1111/jcpt.12536
   Sobel M. E., 1982, SOCIOL METHODOL, P290, DOI DOI 10.2307/270723
   Venkataraman K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136759
   Wang Y, 2012, DIABETIC MED, V29, pE338, DOI 10.1111/j.1464-5491.2012.03733.x
   Wang Y, 2012, THROMB HAEMOSTASIS, V108, P789, DOI 10.1160/TH12-05-0368
   Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z
   Wong LY, 2017, J DIABETES, V9, P65, DOI 10.1111/1753-0407.12384
   Zhao Y, 2015, PATIENT EDUC COUNS, V98, P669, DOI 10.1016/j.pec.2015.02.007
NR 30
TC 2
Z9 2
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2018
VL 35
IS 6
BP 807
EP 815
DI 10.1111/dme.13619
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GF5DD
UT WOS:000431985000016
PM 29532548
DA 2019-01-08
ER

PT J
AU McGill, DE
   Volkening, LK
   Butler, DA
   Harrington, KR
   Katz, ML
   Laffel, LM
AF McGill, Dayna E.
   Volkening, Lisa K.
   Butler, Deborah A.
   Harrington, Kara R.
   Katz, Michelle L.
   Laffel, Lori M.
TI Baseline Psychosocial Characteristics Predict Frequency of Continuous
   Glucose Monitoring in Youth with Type 1 Diabetes
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
DE Continuous glucose monitoring; Depressive symptoms; Diabetes burden;
   Quality of life; Youth; Technology
ID RANDOMIZED CLINICAL-TRIAL; QUALITY-OF-LIFE; GLYCEMIC CONTROL; FOLLOW-UP;
   TIME; ADULTS; CHILDREN; ADOLESCENTS; DEPRESSION; DISTRESS
AB Background: Consistent use of continuous glucose monitoring (CGM) has been associated with improved glycemic control in youth with type 1 diabetes (T1D). There are many barriers to device uptake and continued use. There is a need to understand patient-specific characteristics when considering CGM. We evaluated patterns of CGM use and associations between baseline psychosocial measures and frequency of CGM use over 1 year. Methods: Youth with T1D (n=120), ages 8-18 years, completed questionnaires at CGM initiation and after 6 and 12 months assessing depressive symptoms, diabetes burden, and diabetes-specific and generic quality of life (QOL). Results: Youth (51% male and 95% white) had mean age 12.72.7 years, diabetes duration 6.1 +/- 3.6 years, and glycated hemoglobin (HbA(1c)) 8.0 +/- 0.8%. Over 1 year, 35% of youth used CGM 6 to 7 days per week, 45% used CGM 3-5 days per week, and 20% used CGM only 0-2 days per week. Youth who used CGM 3-7 days per week over 12 months had lower HbA(1c) at months 9 and 12 than youth who used CGM 0-2 days per week (9 months: 7.9 +/- 0.9% vs. 8.5 +/- 1.1%, P=0.006 and 12 months: 8.0 +/- 0.9% vs. 8.5 +/- 1.1%, P=0.02). Those using CGM 0-2 days per week had greater endorsement of depressive symptoms and diabetes burden and reported lower QOL at baseline compared with those using CGM 3-7 days per week. Conclusions: CGM use for 3 or more days per week over 12 months had a protective effect on HbA(1c). Providers should consider addressing psychosocial parameters when initiating CGM to maximize uptake and promote continued use in youth with T1D.
C1 [McGill, Dayna E.; Volkening, Lisa K.; Butler, Deborah A.; Harrington, Kara R.; Katz, Michelle L.; Laffel, Lori M.] Harvard Med Sch, Sect Clin Behav & Outcomes Res, Pediat Adolescent & Young Adult Sect, Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02215 USA.
RP Laffel, LM (reprint author), Harvard Med Sch, Sect Clin Behav & Outcomes Res, Pediat Adolescent & Young Adult Sect, Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02215 USA.
EM lori.laffel@joslin.harvard.edu
FU National Institutes of Health [K12DK094721, T32DK007260, R01DK089349,
   P30DK036836, K23HL125976]; Katherine Adler Astrove Youth Education Fund;
   Maria Griffin Drury Pediatric Fund; Eleanor Chesterman Beatson Fund
FX This research was supported by the National Institutes of Health under
   grants K12DK094721, T32DK007260, R01DK089349, P30DK036836, and
   K23HL125976; the Katherine Adler Astrove Youth Education Fund; the Maria
   Griffin Drury Pediatric Fund; and the Eleanor Chesterman Beatson Fund.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of these organizations. The
   study sponsors were not involved in designing the study; collecting,
   analyzing, or interpreting the data; writing the article; or deciding to
   submit the article for publication. Portions of this article were
   presented as an abstract at the 77th Scientific Sessions of the American
   Diabetes Association, June 9-13, 2017, San Diego, CA.
CR Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975
   Bjornstad P, 2016, DIABETES, V65, pA138
   Chase HP, 2010, DIABETES TECHNOL THE, V12, P507, DOI 10.1089/dia.2010.0021
   Deis D, 2006, DIABETES CARE, V29, P2730, DOI 10.2337/dc06-1134
   FENDRICH M, 1990, AM J EPIDEMIOL, V131, P538, DOI 10.1093/oxfordjournals.aje.a115529
   Fisher L, 2016, DIABETIC MED, V33, P1590, DOI 10.1111/dme.12973
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Giani Elisa, 2017, J Diabetes Sci Technol, V11, P476, DOI 10.1177/1932296816676280
   Hagger V, 2018, PEDIATR DIABETES, V19, P840, DOI 10.1111/pedi.12641
   Hessler DM, 2017, DIABETIC MED, V34, P1228, DOI 10.1111/dme.13381
   Markowitz JT, 2015, DIABETES SCI TECHNOL, V9, P1080
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Phillip M, 2012, PEDIATR DIABETES, V13, P215, DOI 10.1111/j.1399-5448.2011.00849.x
   Pickup JC, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d3805
   Polonsky WH, 2017, DIABETES CARE, V40, P736, DOI 10.2337/dc17-0133
   Polonsky WH, 2013, DIABETES TECHNOL THE, V15, P295, DOI 10.1089/dia.2012.0298
   Scaramuzza AE, 2011, DIABETES TECHNOL THE, V13, P99, DOI 10.1089/dia.2010.0119
   Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017
   Tanenbaum ML, 2017, DIABETES CARE, V40, P181, DOI 10.2337/dc16-1536
   Tansey M, 2011, DIABETIC MED, V28, P1118, DOI 10.1111/j.1464-5491.2011.03368.x
   Van Name MA, 2018, PEDIATR DIABETES, V19, P114, DOI 10.1111/pedi.12525
   Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006
   Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631
   Wong JC, 2014, DIABETES CARE, V37, P2702, DOI 10.2337/dc14-0303
NR 24
TC 0
Z9 0
U1 2
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD JUN
PY 2018
VL 20
IS 6
BP 434
EP 439
DI 10.1089/dia.2018.0037
EA MAY
EY 2018
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GJ8QT
UT WOS:000431467600001
PM 29727245
DA 2019-01-08
ER

PT J
AU Makrilakis, K
   Liatis, S
   Tsiakou, A
   Stathi, C
   Papachristoforou, E
   Perrea, D
   Katsilambros, N
   Kontodimopoulos, N
   Niakas, D
AF Makrilakis, Konstantinos
   Liatis, Stavros
   Tsiakou, Afroditi
   Stathi, Chryssoula
   Papachristoforou, Eleftheria
   Perrea, Despoina
   Katsilambros, Nicholas
   Kontodimopoulos, Nikolaos
   Niakas, Dimitrios
TI Comparison of health-related quality of Life (HRQOL) among patients with
   pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL
   questionnaire in Greece: the DEPLAN study
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Diabetes mellitus; Pre-diabetes; Quality of life; HRQOL-15D
   questionnaire
ID DE-PLAN PROJECT; PSYCHOLOGICAL DISTRESS; NEUROTROPHIC FACTOR;
   PHYSICAL-ACTIVITY; HIGH-RISK; METABOLISM; DEPRESSION; STYLE; POPULATION;
   COHORT
AB Background: Diabetes mellitus is usually preceded by a pre-diabetic stage before the clinical presentation of the disease, the influence of which on persons' quality of life is not adequately elucidated. The purpose of this study was to compare the Health Related Quality of Life (HRQOL) of persons with pre diabetes with that of diabetes or normal glucose tolerance (NGT), using the validated HRQOL-15D questionnaire.
   Methods: The HRQOL-1 5D scores of 172 people with pre-diabetes (108 with Impaired fasting Glucose [ITG], 64 with Impaired Glucose Tolerance [IGT], aged 58.3 +/- 10.3 years) and 198 with NGT (aged 54.4 +/- 10.1 years) from the Greek part of the DEPLAN study (Diabetes in Europe - Prevention using Lifestyle, Physical Activity and Nutritional Intervention), were compared to 100 diabetes patients' scores (aged 60.9 +/- 12.5 years, diabetes duration 17.0 +/- 10.0 years, HbAlc 7.2 +/- 1.2%), derived from the outpatient Diabetes Clinic of a University Hospital.
   Results: The diabetes patients' HRQOL-15D score (0.8605) was significantly lower than the pre-diabetes' (0.9008) and the controls' (0.9092) (p < 0.001). There were no differences in the total score between the controls and the group with pre-diabetes. However, examination of individual parameters of the score showed that people with IGT had lower scores compared to the control group, as related to the parameters of "mobility" and "psychological distress". No differences were found in any component of the HRQOL-15D score between the control group and the IPG group, nor between the two groups with pre-diabetes (IPG vs. IGT).
   Conclusions: Persons with pre diabetes had a similar HRQOL score with healthy individuals, and a higher score than persons with diabetes. Specific components of the score, however, were lower in the IGT group compared to the controls. These findings help clarify the issue of HRQOL of persons with pre-diabetes and its possible impact on prevention.
C1 [Makrilakis, Konstantinos; Liatis, Stavros; Tsiakou, Afroditi; Stathi, Chryssoula; Papachristoforou, Eleftheria; Katsilambros, Nicholas; Niakas, Dimitrios] Univ Athens, Dept Propaedeut Med 1, Med Sch, Laiko Gen Hosp, 17 Ag Thoma St, Athens 11527, Greece.
   [Perrea, Despoina; Katsilambros, Nicholas] Univ Athens, Med Sch, Lab Expt Surg & Surg Res Christeas Hall, Athens, Greece.
   [Kontodimopoulos, Nikolaos; Niakas, Dimitrios] Hellen Open Univ, Patras, Greece.
RP Makrilakis, K (reprint author), Univ Athens, Dept Propaedeut Med 1, Med Sch, Laiko Gen Hosp, 17 Ag Thoma St, Athens 11527, Greece.
EM kmakrila@med.uoa.gr
FU Commission of the European Communities, Directorate C - Public Health
   [2004310]; Bristol-Myers-Squibb, Greece
FX This project was partly funded by the Commission of the European
   Communities, Directorate C - Public Health, grant agreement No. 2004310.
   Under the rules of the agreement, it was also partly co-funded by the
   private sector and in this case it was supported by an unrestricted
   educational grant from Bristol-Myers-Squibb, Greece.
CR Adriaanse MC, 2008, DIABETIC MED, V25, P843, DOI 10.1111/j.1464-5491.2008.02464.x
   Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS13, DOI 10.2337/dc16-S005
   Anagnostopoulos F, 2013, QUAL LIFE RES, V22, P1973, DOI 10.1007/s11136-013-0348-2
   Burroughs TE, 2004, DIABETES SPECTRUM, V17, P41, DOI DOI 10.2337/DIASPECT.17.1.41
   Castren E, 2010, CNS DRUGS, V24, P1, DOI 10.2165/11530010-000000000-00000
   Cederlund RI, 2009, J DIABETES COMPLICAT, V23, P32, DOI 10.1016/j.jdiacomp.2007.09.002
   Chittleborough CR, 2006, QUAL LIFE RES, V15, P687, DOI 10.1007/s11136-005-3570-8
   El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   GREENFIELD S, 1992, MED CARE, V30, pMS23, DOI 10.1097/00005650-199205001-00003
   Hiltunen L, 1999, DIABETES RES CLIN PR, V46, P161, DOI 10.1016/S0168-8227(99)00082-0
   Holt RIG, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0491-3
   Holt RIG, 2012, J AFFECT DISORDERS, V142, pS1, DOI 10.1016/S0165-0327(12)00632-5
   Hunger M, 2014, QUAL LIFE RES, V23, P2515, DOI 10.1007/s11136-014-0689-5
   Kontodimopoulos N, 2012, EUR J HEALTH ECON, V13, P111, DOI 10.1007/s10198-010-0290-y
   Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4
   Li J, 2013, INT J BEHAV MED, V20, P495, DOI 10.1007/s12529-012-9255-0
   Liatis S, 2016, DIABETES RES CLIN PR, V118, P162, DOI 10.1016/j.diabres.2016.06.018
   Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725
   Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006
   Makrilakis K, 2010, DIABETIC MED, V27, P459, DOI 10.1111/j.1464-5491.2010.02918.x
   Marcuello C, 2012, INT J ENDOCRINOL, DOI 10.1155/2012/872305
   Milman S, 2011, MED CLIN N AM, V95, P309, DOI 10.1016/j.mcna.2010.11.004
   Neumann A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0150-z
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   Schwarz PEH, 2008, EXP CLIN ENDOCR DIAB, V116, P167, DOI 10.1055/s-2007-992115
   Seppala T, 2013, PRIM CARE DIABETES, V7, P223, DOI 10.1016/j.pcd.2013.03.001
   Sikdar KC, 2010, QUAL LIFE RES, V19, P781, DOI 10.1007/s11136-010-9641-5
   Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086
   Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18
   Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Tapp R, 2010, DIABETES CARE, V33, P757, DOI 10.2337/dc09-1107
   Tapp RJ, 2006, DIABETES RES CLIN PR, V74, P154, DOI 10.1016/j.diabres.2006.03.012
   Taylor LM, 2010, DIABETES RES CLIN PR, V90, P15, DOI 10.1016/j.diabres.2010.04.011
   Vaatainen S, 2014, QUAL LIFE RES, V23, P1935, DOI 10.1007/s11136-014-0638-3
   Virtanen M, 2014, DIABETES CARE, V37, P2091, DOI 10.2337/dc13-2725
   Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9
   Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955
   Wong E, 2013, LANCET DIABETES ENDO, V1, P106, DOI 10.1016/S2213-8587(13)70046-9
   Cos FX, 2015, DIABETES RES CLIN PR, V109, P149, DOI 10.1016/j.diabres.2015.04.016
NR 42
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD MAY 29
PY 2018
VL 18
AR 32
DI 10.1186/s12902-018-0261-3
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GI0SA
UT WOS:000434078500002
PM 29843700
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Herder, C
   Schmitt, A
   Budden, F
   Reimer, A
   Kulzer, B
   Roden, M
   Haak, T
   Hermanns, N
AF Herder, Christian
   Schmitt, Andreas
   Budden, Florian
   Reimer, Andre
   Kulzer, Bernhard
   Roden, Michael
   Haak, Thomas
   Hermanns, Norbert
TI Longitudinal associations between biomarkers of inflammation and changes
   in depressive symptoms in patients with type 1 and type 2 diabetes
SO PSYCHONEUROENDOCRINOLOGY
LA English
DT Article
DE Inflammation; Biomarkers; Type 1 diabetes; Type 2 diabetes; Depression
ID RECENTLY DIAGNOSED TYPE-1; C-REACTIVE PROTEIN; ANTIINFLAMMATORY
   TREATMENT; GLYCEMIC CONTROL; HS-CRP; METAANALYSIS; ADIPONECTIN; PEOPLE;
   RISK; IL-6
AB Background: Depressive disorders represent a frequent comorbidity of type 1 diabetes (T1D) and type 2 diabetes (T2D). Subclinical inflammation increases the risk of depressive symptoms in the general population, but the relationship appears complex and bidirectional, and longitudinal data from patients with diabetes are lacking. Therefore, this study aimed to analyse associations between changes in depressive symptoms and changes in biomarkers of inflammation in patients with T1D and T2D and to investigate the hypothesis that higher baseline levels of biomarkers of inflammation are related to a less pronounced reduction of depressive symptoms over time.
   Methods: Depressive symptoms and systemic levels of six biomarkers of inflammation were assessed in 168 individuals with T1D and 103 individuals with T2D who participated in baseline and 1-year follow-up examinations. Data were obtained from two matching randomised controlled trials addressing diabetes distress and depressive symptoms. Longitudinal associations between biomarkers and depressive symptoms were estimated using linear regression models adjusting for multiple confounders.
   Results: In patients with T2D, reductions in depressive symptoms were associated with reductions in high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-18 and IL-1 receptor antagonist (IL-1RA) (P <= 0.016), whereas no associations were seen for IL-6, CCL2 and adiponectin. Higher CCL2 levels at baseline were associated with lower subsequent reduction in depressive symptoms (P = 0.018). Neither baseline levels nor changes in biomarkers in subclinical inflammation were associated with changes in depressive symptoms in patients with T1D.
   Conclusions: Reductions of depressive symptoms were longitudinally associated with reductions in biomarkers of inflammation in patients with T2D. Higher baseline CCL2 levels were related with lower reduction of depressive symptoms in this group. No such associations were observed in patients with T1D, suggesting that risk factors and pathomechanisms linking inflammation and depression may differ between diabetes types.
C1 [Herder, Christian; Budden, Florian; Roden, Michael] Heinrich Heine Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
   [Herder, Christian; Schmitt, Andreas; Budden, Florian; Reimer, Andre; Kulzer, Bernhard; Roden, Michael; Hermanns, Norbert] German Ctr Diabet Res DZD, Munich, Germany.
   [Schmitt, Andreas; Reimer, Andre; Kulzer, Bernhard; Haak, Thomas; Hermanns, Norbert] Res Inst Diabet Acad Mergentheim FIDAM, Bad Mergentheim, Germany.
   [Kulzer, Bernhard; Hermanns, Norbert] Otto Friedrich Univ Bamberg, Dept Clin Psychol & Psychotherapy, Bamberg, Germany.
   [Roden, Michael] Heinrich Heine Univ Dusseldorf, Med Fac, Div Endocrinol & Diabetol, Dusseldorf, Germany.
RP Herder, C (reprint author), Heinrich Heine Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
EM christian.herder@ddz.uni-duesseldorf.de; schmitt@diabetes-zentrum.de;
   florian.budden@gmx.de; reimer@diabetes-zentrum.de;
   kulzer@diabetes-zentrum.de; michael.roden@ddz.uni-duesseldorf.de;
   haak@diabetes-zentrum.de; hermanns@diabetes-zentrum.de
OI Schmitt, Andreas/0000-0002-5913-1457
FU German Federal Ministry of Education and Research (BMBF) [FKZ 01G10809,
   FKZ 01GI1107]; German Federal Ministry of Health (BMG); Ministry of
   Culture and Science of the State North Rhine-Westphalia; German Federal
   Ministry of Education and Research (BMBF)
FX This study was supported by the German Federal Ministry of Education and
   Research (BMBF) (FKZ 01G10809 and FKZ 01GI1107). The German Diabetes
   Center is funded by the German Federal Ministry of Health (BMG) and the
   Ministry of Culture and Science of the State North Rhine-Westphalia.
   This study was also supported in part by a grant from the German Federal
   Ministry of Education and Research (BMBF) to the German Center for
   Diabetes Research (DZD e.V.). The funders had no role in study design,
   data collection, data analysis, data interpretation, writing of the
   report and decision to publish the manuscript.
CR Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026
   Baumeister D, 2016, PSYCHOPHARMACOLOGY, V233, P1575, DOI 10.1007/s00213-015-4044-5
   Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-74
   Buchberger B, 2016, PSYCHONEUROENDOCRINO, V70, P70, DOI 10.1016/j.psyneuen.2016.04.019
   Doyle TA, 2013, J PSYCHOSOM RES, V75, P419, DOI 10.1016/j.jpsychores.2013.08.006
   Eyre HA, 2016, PROG NEURO-PSYCHOPH, V68, P1, DOI 10.1016/j.pnpbp.2016.02.006
   Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723
   Hannestad J, 2011, NEUROPSYCHOPHARMACOL, V36, P2452, DOI 10.1038/npp.2011.132
   Hautzinger M, 2012, ADS ALLGEMEINE DEPRE
   Hautzinger M, 1988, DIAGNOSTICA, V34, P167
   Hayashino Y, 2014, DIABETES CARE, V37, P2459, DOI 10.2337/dc13-2312
   Herder C., 2018, TRANSL PSYCHIAT, DOI [10.1038/s41398-017-009-2, DOI 10.1038/S41398-017-009-2]
   Herder C, 2017, ARTERIOSCL THROM VAS, V37, P1222, DOI 10.1161/ATVBAHA.117.309307
   Herder C, 2017, BRAIN BEHAV IMMUN, V61, P137, DOI 10.1016/j.bbi.2016.12.025
   Herder C, 2017, HEART, V103, P63, DOI 10.1136/heartjnl-2015-309181
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hiles SA, 2012, PSYCHOL MED, V42, P2015, DOI 10.1017/S0033291712000128
   Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001
   Holt RIG, 2014, DIABETES CARE, V37, P2067, DOI 10.2337/dc13-2134
   Hood KK, 2012, DIABETES CARE, V35, P2443, DOI 10.2337/dc11-2329
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b
   Imagawa A, 2002, DIABETES CARE, V25, P1665, DOI 10.2337/diacare.25.9.1665
   Ismail K, 2017, DIABETOLOGIA, V60, P2092, DOI 10.1007/s00125-017-4367-3
   Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367
   Kohler O, 2016, CURR NEUROPHARMACOL, V14, P732, DOI 10.2174/1570159X14666151208113700
   Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611
   Korczak DJ, 2011, DIABETOLOGIA, V54, P2483, DOI 10.1007/s00125-011-2240-3
   Laake JPS, 2014, DIABETES CARE, V37, P2186, DOI 10.2337/dc13-2522
   Leslie RDG, 2008, DIABETES-METAB RES, V24, P511, DOI 10.1002/dmrr.877
   Meurs M, 2016, PSYCHOSOM MED, V78, P233, DOI 10.1097/PSY.0000000000000255
   Milaneschi Y, 2009, BIOL PSYCHIAT, V65, P973, DOI [10.1016/j.biopsych.2008.11.01, 10.1016/j.biopsych.2008.11.011]
   Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5
   Moulton C. D., 2015, ENDOCRINOLOGY, V3, P461, DOI [10.1016/S2213-8587(15)00134-5, DOI 10.1016/S2213-8587(15)00134-5]
   Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Pae CU, 2014, PSYCHIAT INVEST, V11, P217, DOI 10.4306/pi.2014.11.3.217
   Pham MN, 2011, DIABETOLOGIA, V54, P1630, DOI 10.1007/s00125-011-2088-6
   Pouwer F, 2017, DIABETOLOGIA, V60, P30, DOI 10.1007/s00125-016-4154-6
   Prossin AR, 2016, MOL PSYCHIATR, V21, P243, DOI 10.1038/mp.2015.110
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Schamarek I, 2016, EUR J ENDOCRINOL, V174, P433, DOI 10.1530/EJE-15-1010
   Schloot NC, 2016, DIABETES CARE, V39, P1932, DOI 10.2337/dc16-0293
   Schmitt A, 2017, J DIABETES COMPLICAT, V31, P1608, DOI 10.1016/j.jdiacomp.2017.08.004
   Strawbridge R, 2015, EUR NEUROPSYCHOPHARM, V25, P1532, DOI 10.1016/j.euroneuro.2015.06.007
   Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001
   Tabak AG, 2014, LANCET DIABETES ENDO, V2, P236, DOI 10.1016/S2213-8587(13)70139-6
   Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004
   Vilagut G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155431
   Zahn D, 2016, DIABETES CARE, V39, pE171, DOI 10.2337/dc16-0710
NR 51
TC 1
Z9 1
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4530
J9 PSYCHONEUROENDOCRINO
JI Psychoneuroendocrinology
PD MAY
PY 2018
VL 91
BP 216
EP 225
DI 10.1016/j.psyneuen.2018.02.032
PG 10
WC Endocrinology & Metabolism; Neurosciences; Psychiatry
SC Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry
GA GK5KT
UT WOS:000436214700026
PM 29525039
DA 2019-01-08
ER

PT J
AU Bak, E
   Marcisz, C
   Krzeminska, S
   Dobrzyn-Matusiak, D
   Foltyn, A
   Drosdzol-Cop, A
AF Bak, Ewelina
   Marcisz, Czeslaw
   Krzeminska, Sylwia
   Dobrzyn-Matusiak, Dorota
   Foltyn, Agnieszka
   Drosdzol-Cop, Agnieszka
TI Does Type 1 Diabetes Modify Sexuality and Mood of Women and Men?
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE sexual disorders; type 1 diabetes; depression; illness acceptance
ID ERECTILE DYSFUNCTION; RISK-FACTORS; PREVALENCE; MELLITUS; DISTRESS;
   COHORT; INDEX
AB Background: Sexual disorders occurring in women and men with type 1 diabetes have not been sufficiently investigated and described until now. This study attempts to evaluate sexuality in women and men. Methods: Altogether, the study comprised 115 patients with type 1 diabetes and 105 healthy people constituting the control group. All the studied persons underwent survey studies determining sexuality using the Female Sexual Function Index (FSFI-19) in women and the International Index of Erectile Function (IIEF-15) in men, and the occurrence of depression using the Beck Depression Inventory. The acceptance of illness among patients with diabetes was examined using the Acceptance of Illness Scale questionnaire. Results: In 35% of the examined women with diabetes, the study demonstrated sexual dysfunction as determined by total FSFI. The point values of all the investigated FSFI domains were significantly lower in women with diabetes than in healthy ones (p < 0.001). Erectile dysfunction occurred in 50% of the studied men with diabetes and in 23% of the control group of men (p = 0.0017). Conclusions: Type 1 diabetes leads to sexual disorders which occur in 1/3 of women and in 1/2 of men. Sexual disorders in patients with diabetes more frequently occur in men, persons with coexisting complications of diabetes, and in those with a concentration of glycated hemoglobin higher than 6.5%.
C1 [Bak, Ewelina] Univ Bielsko Biala, Dept Nursing, Fac Hlth Sci, PL-43309 Bielsko Biala, Poland.
   [Marcisz, Czeslaw] Med Univ Silesia, Sch Hlth Sci, Dept Gerontol & Geriatr Nursing, PL-40752 Katowice, Poland.
   [Krzeminska, Sylwia] Med Univ, Dept Clin Nursing, Fac Hlth Sci, PL-50367 Wroclaw, Poland.
   [Dobrzyn-Matusiak, Dorota] Med Univ Silesia, Sch Hlth Sci, Dept Nursing Propaedeut, PL-40752 Katowice, Poland.
   [Foltyn, Agnieszka] Med Univ Silesia, Sch Hlth Sci, Dept Social & Humanist Studies, Chair Philosophy & Bioeth, PL-40752 Katowice, Poland.
   [Drosdzol-Cop, Agnieszka] Med Univ Silesia, Sch Hlth Sci Katowice, Chair Womans Hlth, PL-40752 Katowice, Poland.
RP Bak, E (reprint author), Univ Bielsko Biala, Dept Nursing, Fac Hlth Sci, PL-43309 Bielsko Biala, Poland.
EM ewelina.bak76@wp.pl; klinwewtychy@poczta.onet.pl; s.krzeminska@wp.pl;
   dorotadobrzyn@op.pl; agnieszka_foltyn@wp.pl; cor111@poczta.onet.pl
OI Dobrzyn-Matusiak, Dorota/0000-0001-6042-8859; Drosdzol-Cop,
   Agnieszka/0000-0003-1249-5840; Bak, Ewelina/0000-0002-2014-3717
CR Abu Ali RM, 2008, DIABETES CARE, V31, P1580, DOI 10.2337/dc08-0081
   Addis IB, 2006, OBSTET GYNECOL, V107, P755, DOI 10.1097/01.AOG.0000202398.27428.e2
   Bak E, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091073
   Basson RJ, 2001, J SEX REPROD MED, V1, P11
   Basu A, 2004, DRUGS, V64, P2667, DOI 10.2165/00003495-200464230-00004
   Beck AT, 1996, BECK DEPRESSION INVE
   Bonierbale M, 2003, CURR MED RES OPIN, V19, P114, DOI 10.1185/030079902125001461
   Brooks M., 1977, MED ASPECTS HUM SEX, V8, P63
   Brown JS, 2005, DIABETES CARE, V28, P177, DOI 10.2337/diacare.28.1.177
   Clayton AH, 2007, J SEX MED, V4, P260, DOI 10.1111/j.1743-6109.2007.00609.x
   Costabile RA, 2003, J UROLOGY, V170, pS35, DOI 10.1097/01.ju.0000077448.31995.99
   Dembe K., 2002, DIABETOL POL, V9, P82
   Dembe K., 2004, SEKSUOLOGIA POLSKA, V2, P51
   Dimitropoulos K, 2012, J SEX MED, V9, P1374, DOI 10.1111/j.1743-6109.2012.02664.x
   Doruk H, 2005, ARCH ANDROLOGY, V51, P1, DOI 10.1080/014850190512798
   Enzlin P, 2003, DIABETES CARE, V26, P409, DOI 10.2337/diacare.26.2.409
   Enzlin P, 1998, DIABETIC MED, V15, P809, DOI 10.1002/(SICI)1096-9136(199810)15:10<809::AID-DIA689>3.0.CO;2-Z
   Enzlin P, 2002, DIABETES CARE, V25, P672, DOI 10.2337/diacare.25.4.672
   Enzlin P, 2009, DIABETES CARE, V32, P780, DOI 10.2337/dc08-1164
   Ferenidou F, 2008, J SEX MED, V5, P631, DOI 10.1111/j.1743-6109.2007.00644.x
   Hatzichristou D, 2004, J SEX MED, V1, P49, DOI 10.1111/j.1743-6109.2004.10108.x
   Hayes RD, 2008, J SEX MED, V5, P1681, DOI 10.1111/j.1743-6109.2008.00838.x
   JENSEN SB, 1986, ARCH SEX BEHAV, V15, P271, DOI 10.1007/BF01550362
   Juczynski Z, 2001, MEASUREMENT TOOLS PR
   KOLODNY RC, 1971, DIABETES, V20, P557, DOI 10.2337/diab.20.8.557
   Kouidrat Y, 2017, DIABETIC MED, V34, P1185, DOI 10.1111/dme.13403
   Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250
   Mazzilli R, 2015, DIABET METAB SYND OB, V8, P97, DOI 10.2147/DMSO.S71376
   Montenero P., 1973, ANNUELLES DIABETOLOG, V11-13, P91
   Muniyappa Ranganath, 2005, Curr Diab Rep, V5, P230, DOI 10.1007/s11892-005-0014-3
   Nowosielski K, 2010, J SEX MED, V7, P723, DOI 10.1111/j.1743-6109.2009.01561.x
   Penson DF, 2009, J SEX MED, V6, P1969, DOI 10.1111/j.1743-6109.2009.01292.x
   Rawa B, 2010, INT MED J, V17, P179
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0
   Salonia A, 2006, DIABETES CARE, V29, P312, DOI 10.2337/diacare.29.02.06.dc05-1067
   SCHIAVI RC, 1995, PSYCHIAT CLIN N AM, V18, P7, DOI 10.1016/S0193-953X(18)30067-4
   Shiften JL, 2008, OBSTET GYNECOL, V112, P970, DOI 10.1097/AOG.0b013e3181898cdb
   Tagliabue M, 2011, J SEX MED, V8, P1694, DOI 10.1111/j.1743-6109.2011.02262.x
   West SL, 2008, ARCH INTERN MED, V168, P1441, DOI 10.1001/archinte.168.13.1441
NR 40
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY
PY 2018
VL 15
IS 5
AR 958
DI 10.3390/ijerph15050958
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GJ3LS
UT WOS:000435197300126
PM 29751592
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Adams, C
   Stears, A
   Savage, D
   Deaton, C
AF Adams, Claire
   Stears, Anna
   Savage, David
   Deaton, Christi
TI "We're stuck with what we've got": The impact of lipodystrophy on body
   image
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE anxiety; body image and sexuality; depression; diabetes; emotional
   distress; endocrine disorders; femininity and daily life; health
   psychology; metabolic syndrome
ID QUALITY-OF-LIFE; HIV; MANAGEMENT; DISFIGUREMENT; PERCEPTIONS; ADHERENCE;
   DIAGNOSIS; DISORDER; RARE
AB Aims and objectivesTo evaluate the impact of lipodystrophy on body image and how this affects patients' daily lives.
   BackgroundLipodystrophy refers to a group of rare conditions characterised by generalised or partial lack of body fat and is associated with severe metabolic problems, for example, severe insulin resistance, diabetes and pancreatitis. In addition to its metabolic effect, lack of adipose tissue may have a major impact on appearance and cause distressing physical changes. While global research has focused on diagnosis and management, there is no published work investigating the psychological effects of lipodystrophy on body image.
   MethodsFollowing ethical approval, participants with lipodystrophy were purposively sampled from the National Severe Insulin Resistance Service in Cambridge, UK, and invited to take part in a semi-structured interview. Eleven (10 female, one male) interviews were conducted and digitally recorded. Data were analysed using an inductive thematic approach.
   ResultsFour main themes were identified in the data set; Always feeling appearance was different, a better understanding of lipodystrophy is needed, feeling accepted and there's more to lipodystrophy than managing symptoms. Participants spoke of distressing cosmetic effects related to lack of fat tissue and other changes related to lipodystrophy, contributing to negative body image. For some, negative body image led to feelings of worthlessness impacting daily life and adherence to treatment. Psychological support was lacking but desired by participants.
   ConclusionLipodystrophy contributes to negative body image affecting patients' daily lives. Patients wanted psychological support alongside medical management. Further research is needed to determine how best to deliver psychological support and to evaluate its impact on well-being and metabolic management.
   Relevance to clinical practiceThe effects of rare diseases such as lipodystrophy on appearance can be distressing for patients. Support beyond medical management is needed to improve patients' daily lives and help them to live well with appearance-altering conditions.
C1 [Adams, Claire; Savage, David] Univ Cambridge, Metab Res Labs, Addenbrookes Treatment Ctr, Wellcome Trust MRC Inst Metab Sci,Addenbrookes Ho, Cambridge, England.
   [Adams, Claire; Stears, Anna] Cambridge Univ Hosp NHS Fdn Trust, Natl Severe Insulin Resistance Serv, Addenbrookes Treatment Ctr, Cambridge, England.
   [Deaton, Christi] Univ Cambridge, Sch Clin Med, Natl Severe Insulin Resistance Serv, Cambridge Inst Publ Hlth, Cambridge, England.
RP Adams, C (reprint author), Univ Cambridge, Metab Res Labs, Addenbrookes Treatment Ctr, Wellcome Trust MRC Inst Metab Sci,Addenbrookes Ho, Cambridge, England.
EM ca337@medschl.cam.ac.uk
FU Addenbrooke's Charitable Trust
FX This research was funded by the Addenbrooke's Charitable Trust and was
   conducted as part of a National Institute of Health Research Masters in
   Clinical Research studentship.
CR Bessell Alyson, 2012, Br J Nurs, V21, P1138
   Bowling A., 2009, RES METHODS HLTH INV
   Braun V., 2008, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Brown RJ, 2016, J CLIN ENDOCR METAB, V101, P4500, DOI 10.1210/jc.2016-2466
   Burgoyne R, 2005, QUAL LIFE RES, V14, P981, DOI 10.1007/s11136-004-2580-2
   Cadogan J., 2012, OXFORD HDB PSYCHOL A, P486
   Calderoni DR, 2011, J PLAST RECONSTR AES, V64, P1248, DOI 10.1016/j.bjps.2011.02.009
   Cash TF, 2005, J PSYCHOSOM RES, V58, P191, DOI 10.1016/j.jpsychores.2004.07.008
   Cash Thomas F, 2004, Body Image, V1, P279, DOI 10.1016/S1740-1445(03)00023-8
   Changing Faces, 2017, DISF UK DISF
   Chiquette Elaine, 2017, Diabetes Metab Syndr Obes, V10, P375, DOI 10.2147/DMSO.S130810
   Clarke A, 2001, PATIENT EDUC COUNS, V43, P305
   Collins E, 2000, AIDS Read, V10, P546
   Green J, 2009, QUALITATIVE METHODS
   Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y
   Grogan S., 2012, OXFORD HDB PSYCHOL A, P581
   Grogan Sara, 2008, BODY IMAGE UNDERSTAN
   Gunter B., 2012, OXFORD HDB PSYCHOL A, P455
   Hale ED, 2015, RHEUMATOLOGY, V54, P1220, DOI 10.1093/rheumatology/keu448
   Halliwell E., 2012, OXFORD HDB PSYCHOL A, P217
   Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272
   Hughes JMF, 2011, J PLAST RECONSTR AES, V64, pE121, DOI 10.1016/j.bjps.2011.01.001
   Huyard C, 2009, HEALTH EXPECT, V12, P361, DOI 10.1111/j.1369-7625.2009.00552.x
   Jackson SNJ, 1997, QJM-INT J MED, V90, P27
   Kelly JS, 2009, AIDS CARE, V21, P1560, DOI 10.1080/09540120902923014
   Lenert LA, 2002, AM J MED, V113, P229, DOI 10.1016/S0002-9343(02)01156-7
   Limb L, 2010, EXPERIENCES RARE DIS
   Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444
   Oette M, 2002, AIDS PATIENT CARE ST, V16, P413, DOI 10.1089/108729102760330254
   Patton M, 2002, QUALITATIVE RES EVAL
   Plankey M, 2009, AIDS BEHAV, V13, P53, DOI 10.1007/s10461-008-9444-7
   Power R, 2003, SEX TRANSM INFECT, V79, P137, DOI 10.1136/sti.79.2.137
   Public Health England, 2015, HIV UK STAT 2015
   QSR International Pty Ltd, 2012, NVIVO QUAL DAT AN SO
   Reynolds NR, 2006, AIDS CARE, V18, P663, DOI 10.1080/09540120500287051
   Robbins AL, 2015, TRENDS MOL MED, V21, P433, DOI 10.1016/j.molmed.2015.04.004
   RUDD NA, 2001, CLOTH TEXT RES J, V19, P120
   Rumsey Nichola, 2004, Body Image, V1, P83, DOI 10.1016/S1740-1445(03)00005-6
   Semple RK, 2010, GENETIC DIAGNOSIS OF ENDOCRINE DISORDERS, P39, DOI 10.1016/B978-0-12-374430-2.00004-3
   Stears A, 2014, CLIN LIPIDOL, V9, P235, DOI 10.2217/CLP.14.13
   Thompson A, 2001, CLIN PSYCHOL REV, V21, P663, DOI 10.1016/S0272-7358(00)00056-8
   Tiggemann M., 2007, PSYCHOL MEN MASCULIN, V8, P15, DOI DOI 10.1037/1524-9220.8.1.15
   Veale D., 2009, OVERCOMING BODY IMAG
   Voelker DK, 2015, ADOLESC HEALTH MED T, V6, P149, DOI 10.2147/AHMT.S68344
   Want SC, 2009, BODY IMAGE, V6, P257, DOI 10.1016/j.bodyim.2009.07.008
NR 45
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD MAY
PY 2018
VL 27
IS 9-10
BP 1958
EP 1968
DI 10.1111/jocn.14342
PG 11
WC Nursing
SC Nursing
GA GI1KB
UT WOS:000434128200021
PM 29516553
DA 2019-01-08
ER

PT J
AU McGavock, J
   Durksen, A
   Wicklow, B
   Malik, S
   Sellers, EAC
   Blydt-Hansen, T
   Chateau, D
   Dart, A
AF McGavock, Jonathan
   Durksen, Anita
   Wicklow, Brandy
   Malik, Sayma
   Sellers, Elizabeth A. C.
   Blydt-Hansen, Tom
   Chateau, Dan
   Dart, Allison
TI Determinants of Readiness for Adopting Healthy Lifestyle Behaviors Among
   Indigenous Adolescents with Type 2 Diabetes in Manitoba, Canada: A
   Cross-Sectional Study
SO OBESITY
LA English
DT Article
ID PHYSICAL-ACTIVITY; SCREENING MEASURE; GLYCEMIC CONTROL; MENTAL-HEALTH;
   DEPRESSIVE SYMPTOMS; PRIMARY-CARE; YOUTH; CHILDREN; INTERVENTION;
   MANAGEMENT
AB ObjectiveThe aim of this study was to determine whether the readiness for adopting healthy lifestyle behaviors was associated with mental health and comorbid conditions in youth with T2D.
   MethodsA cross-sectional comparison of various measures of mental health (distress, stress, resilience) and comorbid conditions (glycated hemoglobin, adiposity, hypertension) was conducted within a cohort of indigenous youth with T2D living in Canada, stratified according to their readiness to adopt healthy lifestyle behaviors based on Prochaska's transtheoretical model.
   ResultsWithin the entire cohort (n=162), only 14% were considered ready to adopt all healthy lifestyle behaviors. The readiness to adopt all lifestyle behaviors was associated with higher positive mental health (47 vs. 39 units; P<0.05) and sense of mastery (40 vs. 37 units; P<0.05), lower perceived stress (27 vs. 29 units; P<0.05) and distress (8 vs. 10 units; P<0.05), and better glycemic control (HbA1c: 8.42.6% vs. 9.7 +/- 2.8%; P<0.05) compared with youth who were not ready to adopt all lifestyle behaviors.
   ConclusionsThe readiness for adopting healthy lifestyle behaviors is low among adolescents with T2D. Being ready to adopt healthy lifestyle behaviors is associated with better mental health and glycemic control.
C1 [McGavock, Jonathan; Wicklow, Brandy; Sellers, Elizabeth A. C.; Dart, Allison] Univ Manitoba, Rady Fac Hlth Sci, Dept Pediat & Child Hlth, Winnipeg, MB, Canada.
   [McGavock, Jonathan; Durksen, Anita; Wicklow, Brandy; Sellers, Elizabeth A. C.; Dart, Allison] Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.
   [McGavock, Jonathan; Wicklow, Brandy; Sellers, Elizabeth A. C.; Dart, Allison] Univ Manitoba, Diabet Res Envisioned & Accomplished Manitoba DRE, Winnipeg, MB, Canada.
   [Malik, Sayma] Univ Manitoba, Dept Clin Psychol, Winnipeg, MB, Canada.
   [Blydt-Hansen, Tom] BC Childrens Hosp, Nephrol Sect, Dept Pediat, Vancouver, BC, Canada.
   [Chateau, Dan] Univ Manitoba, Manitoba Ctr Hlth Policy, Fac Hlth Sci, Winnipeg, MB, Canada.
RP McGavock, J (reprint author), Univ Manitoba, Rady Fac Hlth Sci, Dept Pediat & Child Hlth, Winnipeg, MB, Canada.; McGavock, J (reprint author), Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.; McGavock, J (reprint author), Univ Manitoba, Diabet Res Envisioned & Accomplished Manitoba DRE, Winnipeg, MB, Canada.
EM jmcgavock@chrim.ca
OI Blydt-Hansen, Tom/0000-0002-8864-0197
FU Canadian Diabetes Association; Research Manitoba; Canadian Institutes of
   Child Health; Children's Hospital Research Institute through the
   Diabetes Research Envisioned and Accomplished in Manitoba (DREAM)
   research theme
FX This study was funded by grants from the Canadian Diabetes Association,
   Research Manitoba, the Canadian Institutes of Child Health, and the
   Children's Hospital Research Institute through the Diabetes Research
   Envisioned and Accomplished in Manitoba (DREAM) research theme. JM holds
   a Canadian Institutes of Health Research Applied Public Health Chair in
   Resilience and Obesity in Youth.
CR Anderson BJ, 2011, DIABETES CARE, V34, P2205, DOI 10.2337/dc11-0431
   Berkowitz RI, 2018, PEDIATR DIABETES, V19, P191, DOI 10.1111/pedi.12555
   Copeland KC, 2013, PEDIATRICS, V131, P364, DOI 10.1542/peds.2012-3494
   Dart AB, 2014, CAN J DIABETES, V38, P349, DOI 10.1016/j.jcjd.2014.07.224
   Dray J, 2017, J AM ACAD CHILD PSY, V56, P813, DOI 10.1016/j.jaac.2017.07.780
   Goldenberg R, 2013, CAN J DIABETES, V37, pS8, DOI 10.1016/j.jcjd.2013.01.011
   Hagler AS, 2006, ANN BEHAV MED, V31, P186, DOI 10.1207/s15324796abm3102_11
   Holmen H, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000193
   Hood KK, 2014, J ADOLESCENT HEALTH, V55, P498, DOI 10.1016/j.jadohealth.2014.03.011
   Hood KK, 2012, DIABETES CARE, V35, P2443, DOI 10.2337/dc11-2329
   Huynh E, 2015, CAN J DIABETES, V39, P484, DOI 10.1016/j.jcjd.2015.09.093
   Jones H, 2003, DIABETES CARE, V26, P732, DOI 10.2337/diacare.26.3.732
   Kann L., 2016, MMWR SURVEILL SUMM, V65, P1, DOI DOI 10.15585/MMWR.SS6506A1
   Kramer JR, 2000, ANN BEHAV MED, V22, P17, DOI 10.1007/BF02895164
   Laforge RG, 1999, PREV MED, V28, P61, DOI 10.1006/pmed.1998.0384
   Lamers SMA, 2011, J CLIN PSYCHOL, V67, P99, DOI 10.1002/jclp.20741
   Lawrence JM, 2006, PEDIATRICS, V117, P1348, DOI 10.1542/peds.2005-1398
   Mastellos N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008066.pub3
   McFarlane P, 2013, CAN J DIABETES, V37, pS129, DOI 10.1016/j.jcjd.2013.01.037
   McGavock J, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0568-z
   Meehan C, 2016, J PEDIATR-US, V170, P20, DOI 10.1016/j.jpeds.2015.11.015
   Mitchell CM, 2011, PSYCHOL ASSESSMENT, V23, P752, DOI 10.1037/a0023288
   Mulvaney SA, 2006, DIABETES CARE, V29, P993, DOI 10.2337/dc05-2099
   Mulvaney SA, 2008, DIABETES EDUCATOR, V34, P674, DOI 10.1177/0145721708320902
   Nadeau KJ, 2016, DIABETES CARE, V39, P1635, DOI 10.2337/dc16-1066
   Norcross JC, 2011, J CLIN PSYCHOL, V67, P143, DOI 10.1002/jclp.20758
   Panagiotopoulos C, 2013, CAN J DIABETES, V37, pS163, DOI 10.1016/j.jcjd.2013.01.043
   Patrick K, 2006, ARCH PEDIAT ADOL MED, V160, P128, DOI 10.1001/archpedi.160.2.128
   Plotnikoff RC, 2010, ANN BEHAV MED, V40, P138, DOI 10.1007/s12160-010-9193-5
   Prince-Embury S, 2008, CAN J SCH PSYCHOL, V23, P41, DOI 10.1177/0829573508316592
   Prochaska JJ, 2004, J ADOLESCENT HEALTH, V34, P163, DOI 10.1016/j.jadohealth.2003.07.001
   Prochaska JJ, 2001, ARCH PEDIAT ADOL MED, V155, P554, DOI 10.1001/archpedi.155.5.554
   Prochaska JJ, 2001, PREV MED, V33, P699, DOI 10.1006/pmed.2001.0951
   PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037//0003-066X.47.9.1102
   Protudjer JLP, 2014, CAN J DIABETES, V38, P229, DOI 10.1016/j.jcjd.2014.05.008
   Reinehr T, 2008, HORM RES, V69, P107, DOI 10.1159/000111814
   Robinson DJ, 2013, CAN J DIABETES, V37, pS87, DOI 10.1016/j.jcjd.2013.01.026
   Sellers E, 2000, LANCET, V355, P1156, DOI 10.1016/S0140-6736(00)02067-5
   Silverstein J, 2015, DIABETES CARE, V38, P2341, DOI 10.2337/dc15-0982
   Springer SC, 2013, PEDIATRICS, V131, pE648, DOI 10.1542/peds.2012-3496
   Wilfley DE, 2010, INT J OBESITY, V34, P217, DOI 10.1038/ijo.2009.195
   Wittmeier KDM, 2012, PAED CHILD HEALT-CAN, V17, P129, DOI 10.1093/pch/17.3.129
   Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333
NR 43
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD MAY
PY 2018
VL 26
IS 5
BP 910
EP 915
DI 10.1002/oby.22148
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA GD7GG
UT WOS:000430678000018
PM 29533530
DA 2019-01-08
ER

PT J
AU Hilliard, ME
   De Wit, M
   Wasserman, RM
   Butler, AM
   Evans, M
   Weissberg-Benchell, J
   Anderson, BJ
AF Hilliard, Marisa E.
   De Wit, Maartje
   Wasserman, Rachel M.
   Butler, Ashley M.
   Evans, Meredyth
   Weissberg-Benchell, Jill
   Anderson, Barbara J.
TI Screening and support for emotional burdens of youth with type 1
   diabetes: Strategies for diabetes care providers
SO PEDIATRIC DIABETES
LA English
DT Article
DE ambulatory care; behavioral medicine; diabetes mellitus;
   insulin-dependent; emotional adjustment
ID QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; SHARED DECISION-MAKING;
   MENTAL-HEALTH PROBLEMS; GLYCEMIC CONTROL; DEPRESSIVE SYMPTOMS;
   DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; DELIVERED
   INTERVENTION; MEDICAL APPOINTMENTS
AB Multiple sources of burden for youth with type 1 diabetes (T1D) impact key outcomes including quality of life, self-management, and glycemic control. Professional diabetes organizations recommend diabetes care providers screen for psychosocial and behavioral challenges and implement strategies to support youth with T1D. The purpose of this article is to review the literature and recommend practical strategies medical providers can use for screening and behavioral support for youth with diabetes and their families. As part of their routine medical care, diabetes care providers are well-positioned to identify and intervene to address emotional distress related to the burdens of living with diabetes. In collaboration with multidisciplinary team members, including psychologists and mental health professionals, medical providers may be able to successfully implement brief behavioral strategies for screening and providing emotional support.
C1 [Hilliard, Marisa E.; Wasserman, Rachel M.; Butler, Ashley M.; Anderson, Barbara J.] Baylor Coll Med, Dept Pediat, Psychol Sect, 1102 Bates Ave,Suite 940, Houston, TX 77030 USA.
   [Hilliard, Marisa E.; Wasserman, Rachel M.; Butler, Ashley M.; Anderson, Barbara J.] Texas Childrens Hosp, 1102 Bates Ave,Suite 940, Houston, TX 77030 USA.
   [De Wit, Maartje] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Evans, Meredyth; Weissberg-Benchell, Jill] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Hilliard, ME (reprint author), Baylor Coll Med, Dept Pediat, Psychol Sect, 1102 Bates Ave,Suite 940, Houston, TX 77030 USA.; Hilliard, ME (reprint author), Texas Childrens Hosp, 1102 Bates Ave,Suite 940, Houston, TX 77030 USA.
EM marisa.hilliard@bcm.edu
OI Hilliard, Marisa/0000-0002-8813-629X
FU NIH [K12 DK097696]
FX NIH, Grant/Award number: K12 DK097696
CR American Diabetes Association, 2017, Diabetes Care, V40, pS105
   Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713
   Angold A, 1995, INT J METHOD PSYCH, V5, P237
   Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Boogerd EA, 2015, J CLIN NURS, V24, P2143, DOI 10.1111/jocn.12789
   Boogerd EA, 2014, PEDIATR DIABETES, V15, P394, DOI 10.1111/pedi.12103
   Caccavale LJ, 2015, J PEDIATR PSYCHOL, V40, P500, DOI 10.1093/jpepsy/jsu113
   Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011
   Channon SJ, 2007, DIABETES CARE, V30, P1390, DOI 10.2337/dc06-2260
   Chorpita BF, 1997, BEHAV RES THER, V35, P569, DOI 10.1016/S0005-7967(96)00116-7
   Commissariat PV, 2018, PEDIATR DIABETES, V19, P85, DOI 10.1111/pedi.12523
   Corathers SD, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0664-8
   Corathers SD, 2013, PEDIATRICS, V132, pE1395, DOI 10.1542/peds.2013-0681
   De Brock AJLL, 2006, NOSI R NIJMEEGSE OUD
   de Wit M, 2012, PEDIATR DIABETES, V13, P638, DOI 10.1111/j.1399-5448.2012.00872.x
   de Wit M, 2011, PEDIATR DIABETES, V12, P172, DOI 10.1111/j.1399-5448.2010.00673.x
   de Wit M, 2010, PEDIATR DIABETES, V11, P175, DOI 10.1111/j.1399-5448.2009.00543.x
   De Wit M, 2008, DIABETES CARE, V31, P1521, DOI 10.2337/dc08-0394
   Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191
   Driscoll KA, 2016, CURR DIABETES REP, V16, P1
   Drotar D, 2012, J PEDIATR PSYCHOL, V37, P479, DOI 10.1093/jpepsy/jss065
   Eilander M, 2016, PEDIATR DIABETES, V17, P112, DOI 10.1111/pedi.12237
   Ellis DA, 2005, PEDIATRICS, V116, pE826, DOI 10.1542/peds.2005-0638
   Evans M, 2016, DIABETES S1, V76, P785
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10
   Gardner W, 2002, MED CARE, V40, P812, DOI 10.1097/01.MLR.0000025436.30093.77
   Garvey KC, 2016, DIABETES CARE, V39, P190, DOI 10.2337/dc15-1775
   Gayes LA, 2014, J CONSULT CLIN PSYCH, V82, P521, DOI 10.1037/a0035917
   Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Hapunda G, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0013-6
   Harris MA, 2015, DIABETES CARE, V38, P1427, DOI 10.2337/dc14-2469
   Harris MA, 2014, DIABETES CARE, V37, pE125, DOI 10.2337/dc13-2232
   Haverman L, 2013, PEDIATRICS, V131, pE533, DOI 10.1542/peds.2012-0958
   Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x
   Hilliard ME, 2017, J PEDIATR PSYCHOL, V42, P995, DOI 10.1093/jpepsy/jsx086
   Hilliard ME, 2017, DIABETES, V66, pA225
   Hilliard ME, 2017, DIABETES CARE, V40, P849, DOI 10.2337/dc16-2688
   Hilliard ME, 2016, AM PSYCHOL, V71, P590, DOI 10.1037/a0040359
   Hilliard ME, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0761-3
   Hilliard ME, 2015, DIABETES, V64, pA213
   Hilliard ME, 2013, HEALTH PSYCHOL, V32, P388, DOI 10.1037/a0027811
   Hilliard ME, 2013, J ADOLESCENT HEALTH, V52, P28, DOI 10.1016/j.jadohealth.2012.05.009
   Hilliard ME, 2012, CURR DIABETES REP, V12, P739, DOI 10.1007/s11892-012-0314-3
   Hood KK, 2007, DIABETES CARE, V30, P1764, DOI 10.2337/dc06-2358
   Hood KK, 2014, J ADOLESCENT HEALTH, V55, P498, DOI 10.1016/j.jadohealth.2014.03.011
   Hood KK, 2010, DIABETES CARE, V33, P1658, DOI 10.2337/dc09-2268
   Huston SA, 2016, PEDIATR DIABETES, V17, P623, DOI 10.1111/pedi.12347
   Jaser SS, 2011, CURR DIABETES REP, V11, P480, DOI 10.1007/s11892-011-0222-y
   Jensen SA, 2006, PSYCHOL ASSESSMENT, V18, P346, DOI 10.1037/1040-3590.18.3.346
   Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x
   Johnson JG, 2002, J ADOLESCENT HEALTH, V30, P196, DOI 10.1016/S1054-139X(01)00333-0
   Kazak AE, 2017, J PEDIATR PSYCHOL, V42, P700, DOI 10.1093/jpepsy/jsw110
   Kolko DJ, 2010, J DEV BEHAV PEDIATR, V31, P393, DOI 10.1097/DBP.0b013e3181dff307
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lavigne JV, 2016, J PEDIATR PSYCHOL, V41, P1081, DOI 10.1093/jpepsy/jsw048
   Loeb DF, 2012, J GEN INTERN MED, V27, P945, DOI 10.1007/s11606-012-2005-9
   Lord JH, 2015, J PEDIATR PSYCHOL, V40, P132, DOI 10.1093/jpepsy/jsu078
   Main A, 2014, J PEDIATR PSYCHOL, V39, P1104, DOI 10.1093/jpepsy/jsu062
   Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711
   Mayor S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i394
   Monaghan M, 2015, CLIN PEDIATR, V54, P1346, DOI 10.1177/0009922815581833
   Mullins LL, 2011, J PEDIATR PSYCHOL, V36, P249, DOI 10.1093/jpepsy/jsq080
   National Institutes of Health, 2016, DOM FRAM PROMIS PED
   Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232
   Noser AE, 2017, PEDIATR DIABETES, V18, P614, DOI 10.1111/pedi.12471
   Petrovski G, 2015, DIABETES CARE, V38, pe51, DOI 10.2337/dc14-2487
   Powell PW, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0531-z
   Quittner AL, 2016, THORAX, V71, P26, DOI 10.1136/thoraxjnl-2015-207488
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Raymond Jennifer K, 2015, Diabetes Spectr, V28, P68, DOI 10.2337/diaspect.28.1.68
   Redondo MJ, 2017, DIABETES RES CLIN PR, V129, P203, DOI 10.1016/j.diabres.2017.05.006
   Reynolds KA, 2011, ANN BEHAV MED, V42, P29, DOI 10.1007/s12160-011-9262-4
   Rijswijk C, 2010, PATIENT EDUC COUNS, V79, P351, DOI 10.1016/j.pec.2010.04.016
   Robling M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2359
   Rumburg TM, 2017, PEDIATR DIABETES, V18, P67, DOI 10.1111/pedi.12350
   Sanchez I, 2011, DIABETES EDUCATOR, V37, P381, DOI 10.1177/0145721711401667
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Schwartz DD, 2011, DIABETES CARE, V34, P326, DOI 10.2337/dc10-1553
   Silverstein J, 2015, DIABETES CARE, V38, P2341, DOI 10.2337/dc15-0982
   Siu AL, 2016, ANN INTERN MED, V164, DOI 10.7326/P16-9006
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Tao B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011501
   Thompson D, 2016, JMIR RES PROTOC, V5, P118, DOI 10.2196/resprot.5817
   van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3
   Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006
   Walker Ashby F, 2015, Clin Diabetes, V33, P62, DOI 10.2337/diaclin.33.2.62
   Wei C, 2018, PEDIATR DIABETES, V19, P106, DOI 10.1111/pedi.12519
   Weinger K., 2003, DIABETES SPECTRUM, V16, P104, DOI DOI 10.2337/
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Weitzman C, 2015, PEDIATRICS, V135, P384, DOI 10.1542/peds.2014-3716
   Whittemore R, 2012, NURS RES, V61, P395, DOI 10.1097/NNR.0b013e3182690a29
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Wiley J, 2014, PATIENT PREFER ADHER, V8, P423, DOI 10.2147/PPA.S57707
   Wissow L, 2011, PATIENT EDUC COUNS, V82, P226, DOI 10.1016/j.pec.2010.03.019
   Wolpert HA, 2001, BRIT MED J, V323, P994, DOI 10.1136/bmj.323.7319.994
   Wright DR, 2016, JAMA PEDIATR, V170, P1048, DOI 10.1001/jamapediatrics.2016.1721
   Wyatt KD, 2015, ACAD PEDIATR, V15, P573, DOI 10.1016/j.acap.2015.03.011
   Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P928, DOI 10.1093/jpepsy/jsj098
   Wysocki T, 2016, DIABETES EDUCATOR, V42, P395, DOI 10.1177/0145721716647492
   Wysocki T, 2012, PEDIATR DIABETES, V13, P432, DOI 10.1111/j.1399-5448.2011.00823.x
   Wysocki T, 2009, J PEDIATR PSYCHOL, V34, P869, DOI 10.1093/jpepsy/jsn136
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 105
TC 1
Z9 1
U1 4
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1399-543X
EI 1399-5448
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD MAY
PY 2018
VL 19
IS 3
BP 534
EP 543
DI 10.1111/pedi.12575
PG 10
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA GE0QW
UT WOS:000430921600029
PM 28940936
DA 2019-01-08
ER

PT J
AU Foster, ED
   Bridges, ND
   Feurer, ID
   Eggerman, TL
   Hunsicker, LG
   Alejandro, R
AF Foster, Eric D.
   Bridges, Nancy D.
   Feurer, Irene D.
   Eggerman, Thomas L.
   Hunsicker, Lawrence G.
   Alejandro, Rodolfo
CA Clinical Islet Transplantation Con
TI Improved Health-Related Quality of Life in a Phase 3 Islet
   Transplantation Trial in Type 1 Diabetes Complicated by Severe
   Hypoglycemia
SO DIABETES CARE
LA English
DT Article
ID FALSE DISCOVERY RATE; PANCREAS TRANSPLANTATION; TOTAL PANCREATECTOMY;
   DISTRESS SCALE; FOLLOW-UP; FEAR; MELLITUS; IMPACT; ADULTS; OUTCOMES
AB OBJECTIVE
   Attaining glycemic targets without severe hypoglycemic events (SHEs) is a challenging treatment goal for patients with type 1 diabetes complicated by impaired awareness of hypoglycemia (IAH). The CIT Consortium Protocol 07 (CIT-07) trial showed islet transplantation to be an effective treatment for subjects with IAH and intractable SHEs. We evaluated health-related quality of life (HRQOL), functional health status, and health utility before and after pancreatic islet transplantation in CIT-07 trial participants.
   RESEARCH DESIGN AND METHODS
   Four surveys, the Diabetes Distress Scale (DDS), the Hypoglycemic Fear Survey (HFS), the Short Form 36 Health Survey (SF-36), and the EuroQoL 5 Dimensions (EQ-5D), were administered repeatedly before and after islet transplantation. Summary statistics and longitudinal modeling were used to describe changes in survey scores from baseline and to characterize change in relation to a minimally important difference (MID) threshold of half an SD.
   RESULTS
   Improvements in condition-specific HRQOL met the MID threshold. Reductions from baseline in the DDS total score and its four DDS subscales (all P <= 0.0013) and in the HFS total score and its two subscales (all P < 0.0001) were observed across all time points. Improvements were observed after both 1 and 2 years for the EQ-5D visual analog scale (both P < 0.0001).
   CONCLUSIONS
   In CIT-07, 87.5% of the subjects achieved the primary end point of freedom from SHE along with glycemic control (HbA(1c) < 7% [< 53 mmol/mol]) at 1 year post-initial islet transplantation. The same subjects reported consistent, statistically significant, and clinically meaningful improvements in condition-specific HRQOL as well as self-assessments of overall health.
C1 [Foster, Eric D.; Hunsicker, Lawrence G.] Univ Iowa, Dept Biostat, Clin Trials Stat & Data Management Ctr, Iowa City, IA 52242 USA.
   [Bridges, Nancy D.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Feurer, Irene D.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA.
   [Feurer, Irene D.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA.
   [Feurer, Irene D.] Vanderbilt Transplant Ctr, Nashville, TN USA.
   [Eggerman, Thomas L.] NIDDK, NIH, Bethesda, MD USA.
   [Alejandro, Rodolfo] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.
RP Foster, ED (reprint author), Univ Iowa, Dept Biostat, Clin Trials Stat & Data Management Ctr, Iowa City, IA 52242 USA.
EM eric-foster@uiowa.edu
FU National Institute of Allergy and Infectious Diseases (NIAID); National
   Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIDDK
   at Emory University [NIAID U01-AI-089317]; NIDDK at Northwestern
   University [NIAID U01-AI-089316]; NIDDK at the University of Alberta,
   Edmonton [NIAID U01-AI-065191]; NIDDK at the University of California,
   San Francisco [NIDDK U01-DK-085531]; NIDDK at the University of
   Illinois, Chicago [NIDDK 5U01-DK-070431-10]; NIDDK at the University of
   Iowa [NIDDK U01-DK-070431]; NIDDK at the University of Miami [NIDDK
   U01-DK-070460]; NIDDK at the University of Minnesota [NIAID
   U01-AI-065193]; NIDDK at the University of Pennsylvania [NIDDK
   U01-DK-070430]; NIDDK at Uppsala University [NIAID U01-AI-065192]; Emory
   University [UL1-TR-000454]; Northwestern University [5UL1-RR-025741,
   8UL1-TR-000150]; University of California, San Francisco
   [UL1-TR-000004]; University of Illinois, Chicago [UL1-TR-000050];
   University of Miami [1UL1-TR-000460]; University of Minnesota
   [5M01-RR-000400, UL1-TR-000114]; University of Pennsylvania
   [M01-RR00040, UL1-TR-000003]
FX This research was funded by the National Institute of Allergy and
   Infectious Diseases (NIAID) and the National Institute of Diabetes and
   Digestive and Kidney Diseases (NIDDK), ClinicalTrials.gov no.
   NCT00434811. This research was supported by the following grants from
   the NIAID and the NIDDK: at Emory University, NIAID U01-AI-089317; at
   Northwestern University, NIAID U01-AI-089316; at the University of
   Alberta, Edmonton, NIAID U01-AI-065191; at the University of California,
   San Francisco, NIDDK U01-DK-085531; at the University of Illinois,
   Chicago, NIDDK 5U01-DK-070431-10; at the University of Iowa, NIDDK
   U01-DK-070431; at the University of Miami, NIDDK U01-DK-070460; at the
   University of Minnesota, NIAID U01-AI-065193; at the University of
   Pennsylvania, NIDDK U01-DK-070430; and at Uppsala University, NIAID
   U01-AI-065192. In addition, the study was supported by the following
   General Clinical Research Center grants and Clinical and Translational
   Science Awards: at Emory University, UL1-TR-000454; at Northwestern
   University, 5UL1-RR-025741 and 8UL1-TR-000150; at the University of
   California, San Francisco, UL1-TR-000004; at the University of Illinois,
   Chicago, UL1-TR-000050; at the University of Miami, 1UL1-TR-000460; at
   the University of Minnesota, 5M01-RR-000400 and UL1-TR-000114; and at
   the University of Pennsylvania, M01-RR00040 and UL1-TR-000003.
CR Ahroni JH, 2000, J DIABETES COMPLICAT, V14, P31, DOI 10.1016/S1056-8727(00)00066-0
   [Anonymous], 1997, DIABETES, V46, P271
   Barshes NR, 2005, TRANSPLANTATION, V79, P1727, DOI 10.1097/01.TP.0000160816.21799.F5
   Bellin MD, 2011, CLIN GASTROENTEROL H, V9, P793, DOI 10.1016/j.cgh.2011.04.024
   Benhamou PY, 2009, DIABETIC MED, V26, P617, DOI 10.1111/j.1464-5491.2009.02731.x
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bjorner JB, 2013, VALUE HEALTH, V16, P993, DOI 10.1016/j.jval.2013.06.022
   Bohme P, 2013, DIABETES METAB, V39, P63, DOI 10.1016/j.diabet.2012.10.006
   Chinnakotla S, 2014, J AM COLL SURGEONS, V218, P530, DOI 10.1016/j.jamcollsurg.2013.12.037
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Cryer PE, 2014, DIABETES, V63, P2188, DOI 10.2337/db14-0059
   Cure P, 2008, TRANSPLANTATION, V85, P801, DOI [10.1097/TP.0b013c318166a27b, 10.1097/TP.0b013e318166a27b]
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012
   Hart HE, 2003, QUAL LIFE RES, V12, P1089, DOI 10.1023/A:1026197119569
   Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988
   IRVINE AA, 1992, HEALTH PSYCHOL, V11, P135, DOI 10.1037/0278-6133.11.2.135
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   Janssen MF, 2011, DIABETIC MED, V28, P395, DOI 10.1111/j.1464-5491.2010.03136.x
   Johnson JA, 2004, DIABETES CARE, V27, P624, DOI 10.2337/diacare.27.2.624
   Martyn-Nemeth P, 2016, J DIABETES COMPLICAT, V30, P167, DOI 10.1016/j.jdiacomp.2015.09.003
   Mehrabi A, 2014, PANCREAS, V43, P1190, DOI 10.1097/MPA.0000000000000181
   Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004
   Poggioli R, 2006, AM J TRANSPLANT, V6, P371, DOI 10.1111/j.1600-6143.2005.01174.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2017, DIABETES CARE, V40, P736, DOI 10.2337/dc17-0133
   Radosevich DM, 2013, CLIN TRANSPLANT, V27, pE715, DOI 10.1111/ctr.12265
   Reenen MV, 2015, EQ 5D 3L USER GUIDE
   Ricordi C, 2016, DIABETES, V65, P3418, DOI 10.2337/db16-0234
   Rubin RR, 2012, DIABETES TECHNOL THE, V14, P143, DOI 10.1089/dia.2011.0162
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Scalea JR, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13177
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003
   Speight J, 2010, DIABETIC MED, V27, P812, DOI 10.1111/j.1464-5491.2010.03029.x
   Tharavanij T, 2008, TRANSPLANTATION, V86, P1161, DOI 10.1097/TP.0b013e31818a7f45
   Toso C, 2007, TRANSPLANTATION, V84, P664, DOI 10.1097/01.tp.0000280550.01028.89
   Vanstone Meredith, 2015, Ont Health Technol Assess Ser, V15, P1
   Ware Jr JE, 2000, SF 36 HLTH SURVEY MA, V10, P24
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
NR 41
TC 4
Z9 4
U1 3
U2 7
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD MAY
PY 2018
VL 41
IS 5
BP 1001
EP 1008
DI 10.2337/dc17-1779
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GD4EJ
UT WOS:000430456100020
PM 29563196
DA 2019-01-08
ER

PT J
AU Holmes-Truscott, E
   Browne, JL
   Ventura, AD
   Pouwer, F
   Speight, J
AF Holmes-Truscott, E.
   Browne, J. L.
   Ventura, A. D.
   Pouwer, F.
   Speight, J.
TI Diabetes stigma is associated with negative treatment appraisals among
   adults with insulin-treated Type 2 diabetes: results from the second
   Diabetes MILES - Australia (MILES-2) survey
SO DIABETIC MEDICINE
LA English
DT Article
ID SOCIAL STIGMA; SELF-MANAGEMENT; THERAPY; EXPERIENCES; ADHERENCE;
   ATTITUDES; IMPACT; SCALE; CARE
AB AimTo explore factors associated with negative insulin appraisals among adults with Type 2 diabetes, including perceived and experienced diabetes stigma.
   MethodsThe second Diabetes MILES - Australia study (MILES-2) is a national survey of adults with diabetes, focused on behavioural and psychosocial issues. Subgroup analyses were conducted on the responses of 456 adults with insulin-treated Type 2 diabetes (38% women; mean sd age: 61.2 8.8 years; diabetes duration: 14.5 7.5 years; years using insulin: 6.4 5.5). Participants completed validated measures of perceived and experienced diabetes stigma (Type 2 Diabetes Stigma Assessment Scale), insulin appraisals [Insulin Treatment Appraisal Scale (ITAS)] and known correlates of insulin appraisals: diabetes-specific distress (Problem Areas In Diabetes scale) and diabetes-specific self-efficacy (Confidence in Diabetes Self-care scale). A multiple linear regression was conducted (N = 279) to determine the contribution of those variables found to be associated with ITAS Negative scores.
   ResultsUnivariable analyses revealed negative insulin appraisals were associated with demographic and self-care characteristics (age, employment status, BMI, years using insulin, injections per day), self-efficacy, diabetes-specific distress and diabetes stigma (all P < 0.01). Number of injections per day [regression coefficient [95% confidence interval]: 0.74 [0.08, 1.40]; P = 0.028], self-efficacy [-0.12 [-0.19, -0.06]; P < 0.001] and diabetes stigma [0.39 (0.31, 0.46); P < 0.001) significantly and independently contributed to the final multivariable model, explaining 58% of the variance in ITAS Negative scores. The independent contribution of diabetes-specific distress was suppressed following the inclusion of diabetes stigma.
   ConclusionsThis study represents the first step in understanding the relationship between perceived and experienced diabetes stigma and negative insulin appraisals, and provides quantitative evidence for the strong, independent relationship between these two important constructs.
C1 [Holmes-Truscott, E.; Browne, J. L.; Ventura, A. D.; Speight, J.] Deakin Univ, Sch Psychol, Geelong, Vic, Australia.
   [Holmes-Truscott, E.; Browne, J. L.; Ventura, A. D.; Speight, J.] Diabet Victoria, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Pouwer, F.] Univ Southern Denmark, Dept Psychol, Odense, Denmark.
   [Speight, J.] AHP Res, Hornchurch, England.
RP Holmes-Truscott, E (reprint author), Deakin Univ, Sch Psychol, Geelong, Vic, Australia.; Holmes-Truscott, E (reprint author), Diabet Victoria, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
EM etruscott@acbrd.org.au
OI Holmes-Truscott, Elizabeth/0000-0001-9139-4663; Speight,
   Jane/0000-0002-1204-6896
FU Diabetes Victoria; Deakin University; Sanofi ANZ
FX The key research personnel on the second Diabetes MILES - Australia
   study were supported by core funding provided to The Australian Centre
   for Behavioural Research in Diabetes (ACBRD) by Diabetes Victoria and
   Deakin University. Recruitment activities and the development of the
   study website were funded through an unrestricted educational grant (to
   the ACBRD) from Sanofi ANZ. Sanofi ANZ was not involved in the study
   design, data collection, or data analysis and had no input on the
   preparation of this manuscript or the decision to submit for
   publication.
CR Browne JL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012926
   Browne JL, 2016, DIABETES CARE, V39, P2141, DOI 10.2337/dc16-0117
   Browne JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005625
   Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384
   Davies MJ, 2013, DIABETIC MED, V30, P512, DOI 10.1111/dme.12128
   Holmes-Truscott E, 2015, DIABETIC MED, V32, P1297, DOI 10.1111/dme.12729
   Holmes-Truscott E, 2016, J DIABETES COMPLICAT, V30, P1151, DOI 10.1016/j.jdiacomp.2016.03.027
   Holmes-Truscott E, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-87
   Jenkins N, 2011, DIABETIC MED, V28, P543, DOI 10.1111/j.1464-5491.2010.03200.x
   Lowe J, 2008, DIABETES RES CLIN PR, V80, P439, DOI 10.1016/j.diabres.2008.02.003
   Phelan SM, 2015, OBES REV, V16, P319, DOI 10.1111/obr.12266
   Polinski JM, 2013, DIABETES EDUCATOR, V39, P53, DOI 10.1177/0145721712467696
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Shah RB, 2016, INT J PHARM INVESTIG, V6, P1, DOI 10.4103/2230-973X.176456
   Shiu ATY, 2003, J CLIN NURS, V12, P149, DOI 10.1046/j.1365-2702.2003.00735.x
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Stuckey HL, 2014, DIABETES CARE, V37, P2466, DOI 10.2337/dc13-2536
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
NR 20
TC 1
Z9 1
U1 4
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD MAY
PY 2018
VL 35
IS 5
BP 658
EP 662
DI 10.1111/dme.13598
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GC9LN
UT WOS:000430118900016
PM 29417612
DA 2019-01-08
ER

PT J
AU Castonguay, A
   Miquelon, P
AF Castonguay, Alexandre
   Miquelon, Paule
TI Motivational profiles, accelerometer-derived physical activity, and
   acute diabetes-related symptoms in adults with type 2 diabetes
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Type 2 diabetes; Physical activity behavior; Accelerometer;
   Self-determination theory; Motivational profile; Diabetes-related
   symptoms
ID SELF-DETERMINATION THEORY; DETERMINATION THEORY PERSPECTIVE; POWER
   ANALYSIS PROGRAM; PSYCHOMETRIC EVALUATION; AUTONOMOUS MOTIVATION;
   GLYCEMIC CONTROL; CLUSTER-ANALYSIS; GLUCOSE CONTROL; RISK-FACTORS;
   EXERCISE
AB Background: Using self-determination theory, the objective of this study was to examine, over a one-month period, how physical activity (PA) motivation would influence accelerometer-derived PA behavior, and ultimately, acute diabetes-related symptoms burden among adults with type 2 diabetes (T2D adults). Using both a person and variable-centered approach, this objective was attained by means of: 1) investigating the indirect effect of PA participation on the relationship between PA motivation and acute diabetes-related symptom burden and 2) examining whether participants who met PA recommendations (i.e., 150 min of moderate-to-vigorous PA per week) would experience less acute diabetes-related symptom burden over a one-month period.
   Methods: A two-wave prospective longitudinal design was used. At time 1, participants completed a questionnaire assessing their PA motivation and were asked to wear an ActiGraph GT3x accelerometer for four consecutive weeks. At time 2, they completed a short questionnaire assessing their acute diabetes-related symptoms (i.e., symptoms related to fatigue, cognitive distress, hyperglycemia, and hypoglycemia). The final sample includes 165 adults (89 or 53.61% women) aged from 26 to 75 years (M = 62.05, SD = 8.75) with T2D, which provided at least 21 valid days of accelerometer-derived data.
   Results: First, results of a path analysis demonstrated that over a one-month period, the average number of minutes spent practicing moderate to vigorous PA per week mediated the relationship between intrinsic and external PA motivation and the level of burden associated with the following diabetes-related symptoms: fatigue, cognitive distress, and hyperglycemia. In addition, results of covariance analyses showed that participants meeting PA recommendations also reported significantly less burden associated with these three symptoms over a month period. Then, the existence of four motivational profiles (Self-Determined, High Introjected, Low Motivation, and Non-Self-Determined) was confirmed using a k-means analysis. Results of covariance and chi-square analyses further showed, respectively, that compared to other motivational profiles, the Self-Determined profile was associated with a higher score on weekly PA participation and meeting PA recommendations.
   Conclusions: The results highlight the importance of promoting autonomous motives for PA participation among T2D adults. They also suggest that T2D adults meeting PA recommendations experience less acute diabetes-related symptoms burden, which further support the importance of their PA motivation.
C1 [Castonguay, Alexandre; Miquelon, Paule] Univ Quebec Trois Rivieres, Dept Psychol, 3351 Boul Borges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.
RP Castonguay, A (reprint author), Univ Quebec Trois Rivieres, Dept Psychol, 3351 Boul Borges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.
EM Alexandre.Castonguay@uqtr.ca
FU Fonds de recherche du Quebec - Societe et culture; career research grant
   from the Fonds de recherche du Quebec - Sante
FX This study was supported by a doctoral award from the Fonds de recherche
   du Quebec - Societe et culture to the first author (years 2016-2018) and
   a career research grant from the Fonds de recherche du Quebec - Sante to
   the second author (2012-2016).
CR Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Barrett JE, 2007, DIABETES EDUCATOR, V33, P128, DOI 10.1177/0145721706297453
   Bowen N. K., 2011, STRUCTURAL EQUATION
   Brunet J, 2015, PERS INDIV DIFFER, V84, P2, DOI 10.1016/j.paid.2015.02.034
   Brunet J, 2013, PSYCHO-ONCOLOGY, V22, P2245, DOI 10.1002/pon.3287
   Bryant S., 2016, EMOTIONAL RESPONSE E
   Castonguay A, 2017, HEALTH PSYCHOL BEHAV, V5, P110, DOI 10.1080/21642850.2016.1272416
   Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20
   Chernick M., 2007, BOOTSTRAP METHODS GU
   Chudyk A, 2011, DIABETES CARE, V34, P1228, DOI 10.2337/dc10-1881
   Cohen J, 1988, STAT POWER ANAL BEHA
   Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728
   Colberg Sheri R, 2010, Diabetes Care, V33, pe147, DOI 10.2337/dc10-9990
   Davis CM., 2017, ASS PHYS SELF DISREP
   Deci E. L, 2002, HDB SELF DETERMINATI
   Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01
   Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f
   Efron B, 1993, INTRO BOOTSTRAP
   Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fennell CG., 2016, EFFECTS 16 WEEK EXER
   Fortier MS, 2012, J HEALTH PSYCHOL, V17, P87, DOI 10.1177/1359105311408948
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   Friederichs Stijn Ah, 2015, BMC Psychol, V3, P1, DOI 10.1186/s40359-015-0059-2
   Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322
   Gourlan M, 2016, BEHAV MED, V42, P227, DOI 10.1080/08964289.2014.1001810
   Grace A, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0518-6
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Guerin E., 2012, REV PHENEPS PHENEX J, V4, P1
   Hair J, 2009, MULTIVARIATE DATA AN
   Healey J., 2013, THESIS
   Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Koponen AM, 2017, PSYCHOL HEALTH MED, V22, P332, DOI 10.1080/13548506.2016.1154179
   Krishnan S, 2015, AM J HEALTH BEHAV, V39, P109, DOI 10.5993/AJHB.39.1.12
   Leiter LA, 2013, CAN J DIABETES, V37, P82, DOI 10.1016/j.jcjd.2013.02.055
   Ly TT, 2014, DIABETES CARE, V37, P2310, DOI 10.2337/dc14-0147
   MacKinnon D., 2008, INTRO STAT MEDIATION
   Markland D, 2004, J SPORT EXERCISE PSY, V26, P191, DOI 10.1123/jsep.26.2.191
   Matsumoto H., 2004, INT J SPORT HLTH SCI, V2, P89, DOI DOI 10.5432/IJSHS.2.89
   Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0
   Miquelon P, 2016, INT J SPORT EXERCISE, V15, P1, DOI DOI 10.1080/1612197X.2016.1155637
   Miquelon P, 2016, CAN J DIABETES, V40, P399, DOI 10.1016/j.jcjd.2016.02.009
   Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128
   Naegeli AN, 2010, DIABETES METAB SYNDR, V3, P27, DOI 10.2147/DMSO.S9465
   Patrick H, 2014, PSYCHOL INQ, V25, P101, DOI 10.1080/1047840X.2014.878682
   Phillips LA, 2018, PERS SOC PSYCHOL B, V44, P49, DOI 10.1177/0146167217733068
   Pintrich PR, 2003, J EDUC PSYCHOL, V95, P667, DOI 10.1037/0022-0663.95.4.667
   Plotnikoff RC, 2011, J OBES, DOI 10.1155/2011/561432
   Public Health Agency of Canada, 2002, DIAB CAN
   Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P
   Rea LM, 2014, DESIGNING CONDUCTING
   Scarapicchia TMF, 2014, PREV MED, V66, P45, DOI 10.1016/j.ypmed.2014.05.017
   Sebire SJ, 2011, J SPORT EXERCISE PSY, V33, P175, DOI 10.1123/jsep.33.2.175
   Senecal C, 2000, HEALTH PSYCHOL, V19, P452, DOI 10.1037//0278-6133.19.5.452
   Sigal RJ, 2013, CAN J DIABETES, V37, pS40, DOI 10.1016/j.jcjd.2013.01.018
   Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317
   Standage M, 2008, J SPORT EXERCISE PSY, V30, P337, DOI 10.1123/jsep.30.4.337
   Stephan Y, 2010, PSYCHOL WOMEN QUART, V34, P339, DOI 10.1111/j.1471-6402.2010.01579.x
   Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da
   Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003
   Sweet SN, 2009, PSYCHOL HEALTH MED, V14, P419, DOI 10.1080/13548500903111806
   Tabachnick B. G., 2013, USING MULTIVARIATE S
   Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   Umpierre D, 2013, DIABETOLOGIA, V56, P242, DOI 10.1007/s00125-012-2774-z
   Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576
   Urich-French S, 2009, J SPORT EXERCISE PSY, V31, P358
   Vallerand RJ, 1997, ADV EXP SOC PSYCHOL, V29, P271, DOI 10.1016/S0065-2601(08)60019-2
   Vansteenkiste M, 2009, J EDUC PSYCHOL, V101, P671, DOI 10.1037/a0015083
   Wang CKJ, 2001, J SPORT EXERCISE PSY, V23, P1
   Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58
   Yu C-A, 2015, MOTIVATION PHYS ACTI
NR 73
TC 0
Z9 0
U1 2
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD APR 10
PY 2018
VL 18
AR 469
DI 10.1186/s12889-018-5376-y
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC5TN
UT WOS:000429851700008
PM 29636035
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Bani-issa, W
   Al-Shujairi, AM
   Patrick, L
AF Bani-issa, Wegdan
   Al-Shujairi, Arwa M.
   Patrick, Linda
TI Association between quality of sleep and health-related quality of life
   in persons with diabetes mellitus type 2
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE daytime dysfunction; diabetes mellitus type 2; health-related quality of
   life; sleep quality; subjective sleep quality; use of sleep medication
ID RESTLESS LEGS SYNDROME; GLYCEMIC CONTROL; PEOPLE; ADULTS; APNEA; RISK;
   CARE; DISTURBANCES; DEPRESSION; IMPACT
AB Aim and objectives: To estimate the relationship of sleep quality with health-related quality of life (HRQOL) in persons with diabetes mellitus type 2 (DMT2) living in the United Arab Emirates (UAE).
   Background: DMT2 is an epidemic health condition in the UAE that has enormous impacts on heath, and consequent effects on HRQOL. However, because of an absence of screening for quality of sleep, people with DMT2 who experience poor sleep are likely to go untreated, which may compound the distressing impacts of DMT2 on their HRQOL.
   Design: This is a cross-sectional quantitative research design.
   Methods: A sample of 268 participants with DMT2 were recruited from community healthcare settings in the UAE using cluster sampling. Participants completed questionnaires, including the Pittsburgh Sleep Quality Index (PSQI) and the World Health Organization HRQOL. Data analysis used descriptive and correlational statistics.
   Results: Of the 268 participants, 34% identified as poor sleepers and 55% had poor HRQOL. Poor sleepers showed significantly lower scores for HRQOL than good sleepers. The global PSQI scores were found to be independently predictive of global HRQOL. Subjective perceptions of sleep quality, the use of sleep medications and impaired daytime functioning were the variables found to have the highest correlations with global HRQOL and its four domains.
   Conclusions: This study found that people with DMT2 who indicate experiencing poor quality sleep are more likely to show a negative correlation with HRQOL. Additional research is needed to investigate how poor sleep may impact the health of people with DMT2.
C1 [Bani-issa, Wegdan] Univ Sharjah, Dept Nursing, Coll Hlth Sci, Sharjah, U Arab Emirates.
   [Al-Shujairi, Arwa M.] Univ Sharjah, Res Inst Med & Hlth Sci, Sharjah, U Arab Emirates.
   [Patrick, Linda] Univ Windsor, Fac Nursing, Windsor, CT USA.
RP Bani-issa, W (reprint author), Univ Sharjah, Dept Nursing, Coll Hlth Sci, Sharjah, U Arab Emirates.
EM wbaniissa@sharjah.ac.ae
FU Health Promotion Research Group/Research Institute for Medical and
   Health Sciences Research/University of Sharjah, United Arab Emirates
   [150310]
FX This work was supported by the Health Promotion Research Group/Research
   Institute for Medical and Health Sciences Research/University of
   Sharjah, United Arab Emirates. Grant number: 150310.
CR Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405
   [Anonymous], 2017, Diabetes Care, V40, pS4
   [Anonymous], 1996, PROGR MENT HLTH
   Anothaisintawee T, 2016, SLEEP MED REV, V30, P11, DOI 10.1016/j.smrv.2015.10.002
   BaHammam AS, 2011, ANN THORAC MED, V6, P187, DOI 10.4103/1817-1737.84771
   Bani-Issa W., 2011, Eastern Mediterranean Health Journal, V17, P825
   Silva PAB, 2014, REV SAUDE PUBL, V48, P390, DOI 10.1590/S0034-8910.2014048004912
   Barone MTU, 2011, DIABETES RES CLIN PR, V91, P129, DOI 10.1016/j.diabres.2010.07.011
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Cass AR, 2013, FAM MED, V45, P492
   Chasens Eileen R, 2016, Diabetes Spectr, V29, P20, DOI 10.2337/diaspect.29.1.20
   Chasens ER, 2014, APPL NURS RES, V27, P237, DOI 10.1016/j.apnr.2014.02.006
   Dean A. G., 2016, OPENEPI OPEN SOURCE
   Eljedi A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-268
   Grimaldi D, 2014, DIABETES CARE, V37, P355, DOI 10.2337/dc13-0933
   Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459
   Institute of Medicine, 2006, SLEEP DISORDERS SLEE, DOI [10. 17226/11617, DOI 10.17226/11617]
   Kim TH, 2016, SLEEP MED, V27-28, P72, DOI 10.1016/j.sleep.2016.07.023
   Kuznetsov L, 2015, DIABETES-METAB RES, V31, P69, DOI 10.1002/dmrr.2559
   Lecube A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157579
   Lou PA, 2015, DIABETES RES CLIN PR, V107, P69, DOI 10.1016/j.diabres.2014.09.060
   Lou PA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000956
   Luyster FS, 2011, DIABETES EDUCATOR, V37, P347, DOI 10.1177/0145721711400663
   Maglione JE, 2014, SLEEP, V37, P1179, DOI 10.5665/sleep.3834
   Merlino G, 2010, DIABETES EDUCATOR, V36, P79, DOI 10.1177/0145721709351252
   Nedeltcheva AV, 2014, CURR OPIN ENDOCRINOL, V21, P293, DOI 10.1097/MED.0000000000000082
   Plantinga L, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110244
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Shackman G., 2001, ALB AM STAT ASS ALB
   Shaw JE, 2008, DIABETES RES CLIN PR, V81, P2, DOI 10.1016/j.diabres.2008.04.025
   Sicree R., 2015, GLOBAL BURDEN DIABET
   Siersma V, 2014, DIABETES CARE, V37, P694, DOI 10.2337/dc13-1212
   Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1
   Skomro R. P., 2008, SLEEP QUALITY LIFE C, P461, DOI 10. 1007/978-1-60327-343-5
   Sparring V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-377
   SRIDHAR GR, 1994, DIABETES RES CLIN PR, V23, P183, DOI 10.1016/0168-8227(94)90103-1
   Storgaard H, 2014, DIABETIC MED, V31, P1460, DOI 10.1111/dme.12477
   Suleiman KH, 2010, WESTERN J NURS RES, V32, P250, DOI 10.1177/0193945909348230
   Sullivan P., 2016, CIRCULATION CARDI S2, V9, pA160
   Tang YZ, 2014, CHINESE MED J-PEKING, V127, P3543, DOI 10.3760/cma.j.issn.0366-6999.20141512
   Tsai YW, 2012, FAM PRACT, V29, P30, DOI 10.1093/fampra/cmr041
   Wadden TA, 2014, DIABETES CARE, V37, P1544, DOI 10.2337/dc13-1928
   Wandell PE, 2005, SCAND J PRIM HEALTH, V23, P68, DOI 10.1080/02813430510015296
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
NR 44
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD APR
PY 2018
VL 27
IS 7-8
BP 1653
EP 1661
DI 10.1111/jocn.14221
PG 9
WC Nursing
SC Nursing
GA GD9HZ
UT WOS:000430825100072
PM 29266588
DA 2019-01-08
ER

PT J
AU Kuniss, N
   Muller, UA
   Kloos, C
   Wolf, G
   Kramer, G
AF Kuniss, Nadine
   Mueller, Ulrich Alfons
   Kloos, Christof
   Wolf, Gunter
   Kramer, Guido
TI Reduction of HbA1c and diabetes-related distress after intervention in a
   diabetes day care clinic in people with type 2 diabetes but not with
   type 1 diabetes
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Article
DE diabetes day care clinic; diabetes-related distress; PAID questionnaire
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; INSULIN-TREATMENT;
   TEACHING PROGRAM; EMOTIONAL DISTRESS; PROBLEM AREAS; ROUTINE CARE;
   DEPRESSION; EDUCATION; MANAGEMENT
AB Objective The aim of this prospective, longitudinal study was to assess diabetes-related distress in people with diabetes mellitus type 1 (DM1) and type 2 (DM2) treated for diabetes-related problems and to evaluate, whether distress by diabetes are reduced after intervention in a diabetes day care clinic (DDC).
   Methods Diabetes-related burden was assessed with the "Problem Area In Diabetes (PAID) questionnaire before (T0), directly after (T1) and 6 months after intervention (T2) in the DDC in 72 people (18 DM1, 54 DM2) admitted with a diabetes-specific problem to a DDC in a University department for metabolic diseases. A PAID score of >= 40 was considered as high diabetes-related distress.
   Results The PAID score in people with DM1 was not significantly different between T0, T1 and T2. Furthermore, neither HbA1c nor insulin dose did change at T2. In participants with DM2, the PAID score decreased significantly from T0 to T1 (18.4 +/- 15.9 vs. 15.4 +/- 13.0, p=0.042) and preserved the benefit at T2 (15.0 +/- 13.3). In addition, there was a significant reduction in HbA1c (-1.2%, p<0.001) and body weight (-1.3 kg, p=0.038) between T0 and T2. Insulin dose per day was 15.0 IU/day lower at T1 (p=0.006) and 9.0 IU/day lower at T2 (p=0.212) in comparison to T0.
   Conclusions Diabetes-related distress was reduced after a problem-oriented intervention in a DDC in people with DM2 but not with DM1. Although, all participants at tertiary care level had serious diabetes-specific problems before intervention, mean PAID score was far under the threshold of 40 points thus distress was low.
C1 [Kuniss, Nadine; Mueller, Ulrich Alfons; Kloos, Christof; Wolf, Gunter; Kramer, Guido] Jena Univ Hosp, Dept Internal Med 3, Jena, Germany.
RP Kuniss, N (reprint author), Jena Univ Hosp, Endocrinol & Metab Disorders, Dept Internal Med 3, Klinikum 1, D-07740 Jena, Germany.
EM nadine.kuniss@med.uni-jena.de
CR Amiel S, 2002, BRIT MED J, V325, P746
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Bradley C, 1994, DIABETES TREATMENT S
   Cooke D, 2013, DIABETES CARE, V36, P270, DOI 10.2337/dc12-0080
   Dulon M, 2003, GESUNDHEITSWESEN, V65, P629
   German Diabetes Association (DDG), 2015, GUID REC TREAT I CER
   Gru<ss>er M, 2012, STRUKTURIERTES BEHAN
   Gru<ss>er M, 2009, STRUKTURIERTES BEHAN
   Gruesser M, 1996, PATIENT EDUC COUNS, V29, P123, DOI 10.1016/0738-3991(96)00941-X
   Hagen B, 2015, QUALITY ASSURANCE RE
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Jorgens V, 2011, STRUKTURIERTES BEHAN
   Jorgens V, 2013, STRUKTURIERTES BEHAN
   Kalfhaus J, 2000, DIABETES METAB, V26, P197
   Kulzer BAC, 2013, S2 GUIDELINE PSYCHOS
   Kuniss N, 2016, EXP CLIN ENDOCR DIAB, V124, P307, DOI 10.1055/s-0042-103685
   Kuniss N, 2016, ACTA DIABETOL, V53, P833, DOI 10.1007/s00592-016-0881-x
   MUHLHAUSER I, 1987, DIABETOLOGIA, V30, P681, DOI 10.1007/BF00296989
   Muller UA, 1998, DIABETES METAB, V24, P251
   Petrak F, 2011, DIABETES STOFFWECH H, V20, P7
   PIEBER TR, 1995, DIABETES CARE, V18, P625, DOI 10.2337/diacare.18.5.625
   Pintaudi B, 2015, J PSYCHOSOM RES, V79, P348, DOI 10.1016/j.jpsychores.2015.08.010
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Schumann M., 2013, ELECT MED INFORM SYS
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Speight J, 2016, DIABETES RES CLIN PR, V112, P65, DOI 10.1016/j.diabres.2015.11.002
   STAROSTINA EG, 1994, DIABETOLOGIA, V37, P170, DOI 10.1007/s001250050089
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Trento M, 2017, ACTA DIABETOL, V54, P415, DOI 10.1007/s00592-016-0935-0
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WHO, 1998, INF PACK MAST DEPR P
NR 36
TC 0
Z9 0
U1 1
U2 1
PU JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH
PI STUTTGART
PA RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0947-7349
EI 1439-3646
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PD APR
PY 2018
VL 126
IS 4
BP 242
EP 248
DI 10.1055/s-0043-112862
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GD3YR
UT WOS:000430440200006
PM 28704855
DA 2019-01-08
ER

PT J
AU Hayashino, Y
   Okamura, S
   Mashitani, T
   Tsujii, S
   Ishii, H
AF Hayashino, Yasuaki
   Okamura, Shintaro
   Mashitani, Tsuyoshi
   Tsujii, Satoru
   Ishii, Hitoshi
CA Diabet Distress Care Registry
TI Association of proton pump inhibitor use with the risk of the
   development or progression of albuminuria among Japanese patients with
   diabetes: A prospective cohort study [Diabetes Distress and Care
   Registry at Tenri (DDCRT 16)]
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Proton pump inhibitor; Diabetic nephropathy; Kidney; Renal
   disease; Cohort study; Epidemiology; Adults
ID ACUTE INTERSTITIAL NEPHRITIS; TYPE-2; NEPHROTOXICITY; NEPHROPATHY;
   OMEPRAZOLE; MELLITUS; DISEASE; KIDNEY
AB Aims: We aimed to determine the prospective association between proton pump inhibitor (PPI) use and the subsequent risk of the development or progression of albuminuria or eGFR.
   Methods: Longitudinal data of patients with diabetes were obtained from a large Japanese diabetes registry. To assess the independent correlation between PPI use and the development or progression of urine microalbuminuria, the time-varying Cox proportional hazards model was used with adjustment for potential confounders.
   Results: The mean patient age, body-mass index (BMI), and hemoglobin A1c (HbA1c) levels were 65.7 y, 24.5 kg/m(2), and 7.5% (57.9 mmol/mol), respectively. In 1711 patients without albuminuria, we observed 599 cases with development of albuminuria over median follow-up of 4.0 years, and in 1279 patients with microalbuminuria, 290 cases with urinary albuminuria progression over 4.0 years, and 257 eGFR decline cases over 3.8 years. PPI use was not associated with the development of albuminuria (HR = 0.88; 95% CI, 0.77-1.01; p=.058), progression of albuminuria (HR = 1.24; 95% CI, 0.87-1.79; p=.236), nor eGFR decline (HR = 1.05; 95% CI, 0.81-1.34; p=.973) even in a propensity score-adjusted model with time-varyingly updating PPI use information.
   Conclusions: In conclusion, PPI use was not associated with the subsequent risk of development or progression of albuminuria, or eGFR decline in patients with diabetes. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Hayashino, Yasuaki; Okamura, Shintaro; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
   [Mashitani, Tsuyoshi; Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 6348521, Japan.
RP Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
EM hayasino-y@umin.net
FU Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of
   Science (JSPS) KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and Japan Society for the Promotion of Science (JSPS) KAKENHI
   (Grant No. 25460641); however, they played no role in the study design
   or conduct, data collection, analysis, or interpretation, and the
   preparation, review, or approval of the manuscript.
CR Afghahi H, 2011, NEPHROL DIAL TRANSPL, V26, P1236, DOI 10.1093/ndt/gfq535
   Antoniou Tony, 2015, CMAJ Open, V3, pE166, DOI 10.9778/cmajo.20140074
   Berney-Meyer L, 2014, NEPHROLOGY, V19, P359, DOI 10.1111/nep.12226
   Blank ML, 2014, KIDNEY INT, V86, P837, DOI 10.1038/ki.2014.74
   Brewster UC, 2007, CLIN NEPHROL, V68, P65
   Danziger J, 2013, KIDNEY INT, V83, P692, DOI 10.1038/ki.2012.452
   Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876
   Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE
   Gai ZB, 2016, ANTIMICROB AGENTS CH, V60, P5573, DOI 10.1128/AAC.00907-16
   Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421
   Grant K, 2006, PHARM WORLD SCI, V28, P189, DOI 10.1007/s11096-006-9028-4
   Hacker K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136451
   Hayashino Y, 2014, DIABETES CARE, V37, P2459, DOI 10.2337/dc13-2312
   Ikemura K, 2017, CANCER CHEMOTH PHARM, V79, P943, DOI 10.1007/s00280-017-3296-7
   Lambert AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128004
   Lazarus B, 2016, JAMA INTERN MED, V176, P238, DOI 10.1001/jamainternmed.2015.7193
   Mashitani T, 2015, ACTA DIABETOL, V52, P639, DOI 10.1007/s00592-015-0725-0
   Mashitani T, 2014, DIABETES CARE, V37, P252, DOI 10.2337/dc13-0407
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   Molitch Mark E, 2004, Diabetes Care, V27 Suppl 1, pS79
   Nies AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022163
   Perazella MA, 2015, EXPERT REV CLIN PHAR, V8, P367, DOI 10.1586/17512433.2015.1045489
   Perazella MA, 2010, NAT REV NEPHROL, V6, P461, DOI 10.1038/nrneph.2010.71
   Pham PCT, 2005, CLIN NEPHROL, V63, P429
   Praga M, 2010, KIDNEY INT, V77, P956, DOI 10.1038/ki.2010.89
   Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506
   RUFFENACH SJ, 1992, AM J MED, V93, P472, DOI 10.1016/0002-9343(92)90181-A
   Sakaguchi Y, 2012, DIABETES CARE, V35, P1591, DOI 10.2337/dc12-0226
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   Xie Y, 2016, J AM SOC NEPHROL, V27, P3153, DOI 10.1681/ASN.2015121377
   Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947
NR 31
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD APR
PY 2018
VL 138
BP 1
EP 7
DI 10.1016/j.diabres.2018.01.022
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GD4AS
UT WOS:000430445500001
PM 29382588
DA 2019-01-08
ER

PT J
AU Boden, MT
   Gala, S
AF Boden, Matthew Tyler
   Gala, Sasha
TI Exploring correlates of diabetes-related stress among adults with Type 1
   diabetes in the T1D exchange clinic registry
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Stress; Distress; HbA1c
ID FACTOR SURVEILLANCE SYSTEM; HEALTH INTERVIEW SURVEY; QUALITY-OF-LIFE;
   METABOLIC-CONTROL; GLYCEMIC CONTROL; EMOTIONAL DISTRESS; REGIMEN
   ADHERENCE; NATIONAL-HEALTH; MELLITUS; OUTCOMES
AB Aims: To explore relations between diabetes-related stress and multiple sociodemographic, diabetes health, other health, and treatment-related variables among a large sample of adults with Type 1 Diabetes (T1D).
   Methods: The sample consisted of 10,821 adults (over 18 years old) enrolled in the T1D Exchange Clinic Registry. The T1D Exchange clinic network consists of 67 diabetes clinical centers throughout the United States selected to broadly represent pediatric and adult patients with T1D. Variables were assessed through participant self-report and extraction of clinic chart data. Univariate and multiple linear regression (with simultaneous entry of all predictors) analyses were conducted.
   Results: Robustly associated with increased diabetes-related stress across analyses were multiple sociodemographic (female [vs. male], native Hawaiian/other Pacific islander [vs. white/Caucasian], decreased age and diabetes duration), diabetes health (higher HbA1c), other health (lower general health, presence of major life stress and depression, less physical activity), and treatment related variables (use of injections/pen or combination injection/pen/pump [vs. pump], use of CGM, increased frequency of missing insulin doses and BG checking, decreased frequency of BG checking prior to bolus, receipt of mental health treatment).
   Conclusions: We replicated and extended research demonstrating that diabetes-related stress among people with T1D occurs at higher levels among those with particular sociodemographic characteristics and is associated with a range poorer diabetes health and other health variables, and multiple treatment-related variables. The strong incremental prediction of diabetes-related stress by multiple variables in our study suggests that a multivariable, personalized approach may increase the effectiveness of treatments for diabetes-related stress. Published by Elsevier Ireland Ltd.
C1 [Boden, Matthew Tyler] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Menlo Pk, CA USA.
   [Gala, Sasha] VA Palo Alto Hlth Care Syst, Natl Ctr PTSD, Menlo Pk, CA USA.
RP Boden, MT (reprint author), 795 Willow Rd,152-MPD, Menlo Pk, CA 94025 USA.
EM Matthew.Boden@va.gov
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   AIKENS JE, 1992, J CONSULT CLIN PSYCH, V60, P113, DOI 10.1037/0022-006X.60.1.113
   Cohen J., 2013, APPL MULTIPLE REGRES
   Cox DJ, 1994, HEALTH PSYCHOL, V3, P63
   Dollinger SJ, 2009, J GEN PSYCHOL, V136, P231, DOI 10.3200/GENP.136.3.231-242
   DURBIN J, 1971, BIOMETRIKA, V58, P1
   Eicker F., 1967, P 5 BERK S MATH STAT, V1, P59
   Farrell SP, 2004, J ADOLESCENT HEALTH, V34, P461, DOI 10.1016/S1054-139X(03)00215-5
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Hermanns N, 2009, DIABETES TECHNOL THE, V11, P275, DOI 10.1089/dia.2008.0078
   Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221
   Iturralde E, 2017, HEALTH PSYCHOL, V36, P236, DOI 10.1037/hea0000445
   Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x
   KEMMER FW, 1986, NEW ENGL J MED, V314, P1078, DOI 10.1056/NEJM198604243141704
   Li CY, 2012, PREV MED, V54, P381, DOI 10.1016/j.ypmed.2012.04.003
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lynam DR, 2006, ASSESSMENT, V13, P328, DOI 10.1177/1073191106290562
   Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y
   Pena EA, 2006, J AM STAT ASSOC, V101, P341, DOI 10.1198/016214505000000637
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   R Core Team, 2013, R LANG ENV STAT COMP
   REES WL, 1976, BRIT J PSYCHIAT, V128, P3, DOI 10.1192/bjp.128.1.3
   Riazi A, 2004, DIABETES RES CLIN PR, V66, P237, DOI 10.1016/j.diabres.2004.04.001
   Strandberg RB, 2015, DIABETIC MED, V32, P1304, DOI 10.1111/dme.12781
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Sturt J, 2015, CURR DIABETES REP, V15, P1, DOI DOI 10.1007/S11892-015-0660-Z
   WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037//0033-295X.96.2.234
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
   Zimmerman M, 2006, J CLIN PSYCHIAT, V67, P1536, DOI 10.4088/JCP.v67n1007
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
NR 40
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD APR
PY 2018
VL 138
BP 211
EP 219
DI 10.1016/j.diabres.2017.10.012
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GD4AS
UT WOS:000430445500026
PM 29107758
DA 2019-01-08
ER

PT J
AU Poon, AWC
   Curtis, J
   Ward, P
   Loneragan, C
   Lappin, J
AF Poon, Abner Weng Cheong
   Curtis, Jackie
   Ward, Philip
   Loneragan, Celia
   Lappin, Julia
TI Physical and psychological health of carers of young people with first
   episode psychosis
SO AUSTRALASIAN PSYCHIATRY
LA English
DT Article
DE carer; first episode psychosis; physical health; mental health; youth
ID SCHIZOPHRENIA; CAREGIVERS
AB Objective: Carers of people with psychosis may experience psychological distress and caregiving burden. However, few studies have examined both psychological and physical health of carers of young people with first episode psychosis (FEP).
   Method: A total of 32 young people with FEP and 42 of their carers were recruited from a mental health service. Standardised scales were administered to assess carers' psychological distress and risk for development of Type 2 diabetes. Their body mass index, waist circumference and blood pressure were measured.
   Results: A total of 24% (n = 10) of carers experienced high/very high psychological distress and 39.0% (n = 16) had high risk for Type 2 diabetes. It was common for carers to be overweight (n = 33, 78.6%) and to have hypertension (n = 14, 33.3%). Carers' higher levels of psychological distress were associated with shorter duration of illness in the young person.
   Conclusions: Caring for a young person with FEP is associated with poor physical and psychological health. Findings show the importance of supporting carers' physical and psychological health early in treatment of young people with FEP.
C1 [Poon, Abner Weng Cheong] Univ New South Wales, Sch Social Sci, Morven Brown Bldg, Sydney, NSW 2052, Australia.
   [Curtis, Jackie] South Eastern Sydney Local Hlth Dist, Youth Mental Hlth, Sydney, NSW, Australia.
   [Curtis, Jackie; Loneragan, Celia] Univ New South Wales, Sydney, NSW, Australia.
   [Ward, Philip; Lappin, Julia] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia.
   [Ward, Philip] Univ New South Wales, South Western Sydney Local Hlth Dist, Schizophrenia Res Unit, Sydney, NSW, Australia.
RP Poon, AWC (reprint author), Univ New South Wales, Sch Social Sci, Morven Brown Bldg, Sydney, NSW 2052, Australia.
EM w.poon@unsw.edu.au
OI Poon, Weng Cheong/0000-0003-2863-5916
FU School of Social Sciences, University of New South Wales Australia [SPG
   2015]
FX This research project was supported by the School of Social Sciences,
   University of New South Wales Australia (grant number: SPG 2015 - 13
   July 2015).
CR Addington J, 2003, ACTA PSYCHIAT SCAND, V108, P285, DOI 10.1034/j.1600-0447.2003.00153.x
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE
   Australian Bureau of Statistics, 2015, NAT HLTH SURV 1 RES
   Awad AG, 2008, PHARMACOECONOMICS, V26, P149, DOI 10.2165/00019053-200826020-00005
   Bradford S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0694-4
   Cotton SM, 2013, SCHIZOPHR RES, V146, P118, DOI 10.1016/j.schres.2013.02.008
   Curtis J, 2016, EARLY INTERV PSYCHIA, V10, P267, DOI 10.1111/eip.12230
   Department of Health and Ageing, 2010, AUSTR TYP 2 DIAB RIS
   Gupta S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0547-1
   IBM Corp, 2012, IBM SPSS STAT WINDOW
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Poon AWC, 2017, EPIDEMIOL PSYCH SCI, V26, P265, DOI 10.1017/S2045796015001195
   Sin J, 2016, SOC PSYCH PSYCH EPID, V51, P1247, DOI 10.1007/s00127-016-1222-7
   Tanamas SK, 2013, AUSDIAB 2012 AUSTR D
   Thunyadee C, 2015, NURS HEALTH SCI, V17, P412, DOI 10.1111/nhs.12205
   World Health Organization, 1992, INT CLASS DIS
NR 17
TC 1
Z9 1
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1039-8562
EI 1440-1665
J9 AUSTRALAS PSYCHIATRY
JI Australas. Psychiatry
PD APR
PY 2018
VL 26
IS 2
BP 184
EP 188
DI 10.1177/1039856217748250
PG 5
WC Psychiatry
SC Psychiatry
GA GC4LL
UT WOS:000429755900014
PM 29334229
DA 2019-01-08
ER

PT J
AU Hood, S
   Irby-Shasanmi, A
   de Groot, M
   Martin, E
   LaJoie, AS
AF Hood, Sula
   Irby-Shasanmi, Amy
   de Groot, Mary
   Martin, Elissabeth
   LaJoie, Andrew S.
TI Understanding Diabetes-Related Distress Characteristics and Psychosocial
   Support Preferences of Urban African American Adults Living With Type 2
   Diabetes: A Mixed-Methods Study
SO DIABETES EDUCATOR
LA English
DT Article
ID SELF-MANAGEMENT; DEPRESSION; WOMEN; CARE; SCALE; CHALLENGE; DISEASE;
   PROFILE; IMPACT; STIGMA
AB Purpose The purpose of this study is to understand diabetes-related distress (DRD) characteristics and identify psychosocial support preferences of urban African American adults living with type 2 diabetes (T2DM).
   Methods A 2-phase, mixed-methods sequential explanatory study design was used to gather data. In phase 1, a purposive sample of participants (N = 155) was recruited and asked to complete a written survey. The Diabetes Distress Scale (DDS17) was used to assess DRD, including subscalesemotional burden (EB), regimen distress (RD), interpersonal distress (ID), and physician distress (PD). In phase 2, a subset of phase 1 participants (N = 23) volunteered to attend 1 of 4 gender-stratified follow-up focus groups to contextualize the quantitative survey results.
   Results Survey findings indicate that on average, participants had moderate levels of DRD (aggregate), RD, and EB but had low ID and PD. During follow-up focus groups, participants described RD and EB as their primary distress types and emphasized that clinicians should prioritize the mental health aspects of T2DM similarly to its physical aspects. Participants expressed a desire for culturally appropriate peer support groups as a psychosocial support resource for distress coping and specifically requested the development of gender-stratified groups and groups for young adults.
   Conclusions Results support the need to screen for and address diabetes-related distress among African American patients with T2DM. Findings also inform the development of culturally appropriate psychosocial support resources to facilitate diabetes-related distress coping.
C1 [Hood, Sula] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Social & Behav Sci, Off 6051,1050 Wishard Blvd, Indianapolis, IN 46202 USA.
   [Irby-Shasanmi, Amy] Univ West Georgia, Dept Sociol, Carrollton, GA USA.
   [de Groot, Mary] Indiana Univ Sch Med, Div Endocrinol, Indianapolis, IN 46202 USA.
   [Martin, Elissabeth] Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA.
   [LaJoie, Andrew S.] Univ Louisville, Dept Hlth Promot & Behav Sci, Sch Publ Hlth & Informat Sci, Louisville, KY 40292 USA.
RP Hood, S (reprint author), Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Social & Behav Sci, Off 6051,1050 Wishard Blvd, Indianapolis, IN 46202 USA.
EM sulahood@iu.edu
FU University of Louisville Commission on Diversity and Racial Equality;
   Southern Regional Education Board
FX This research was supported by a Signature Partnership Grant from the
   University of Louisville Commission on Diversity and Racial Equality and
   a Doctoral Scholar Dissertation Award from the Southern Regional
   Education Board. A special thank you to Dr A. O'tayo Lalude of the
   Westside Family Medical Center and Dr Gina Pariser of the Active Steps
   for Diabetes program for assistance with participant recruitment.
CR 100 Black Men of America Inc, WHAT THEY SEE IS WHA
   Aghili R, 2017, PRIM CARE DIABETES, V11, P467, DOI 10.1016/j.pcd.2017.05.001
   Akindana Adeola, 2016, AADE Pract, V4, P44
   Anderson RM, 1996, DIABETES EDUCATOR, V22, P28, DOI 10.1177/014572179602200104
   [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001
   Bogner HR, 2010, DIABETES EDUCATOR, V36, P284, DOI 10.1177/0145721709356115
   Byrd GS, 2011, J NATL MED ASSOC, V103, P480, DOI 10.1016/S0027-9684(15)30361-8
   Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20
   Chlebowy DO, 2010, DIABETES EDUCATOR, V36, P897, DOI 10.1177/0145721710385579
   Conner KO, 2010, AM J GERIAT PSYCHIAT, V18, P531, DOI 10.1097/JGP.0b013e3181cc0366
   Crabtree K, 2015, DIABETES EDUCATOR, V41, P118, DOI 10.1177/0145721714557043
   Creswell J. W., 2011, DESIGNING CONDUCTING
   DeCoster VA, 2003, SOC WORK HEALTH CARE, V36, P79, DOI 10.1300/J010v36n04_05
   Dismuke CE, 2014, INT J PSYCHIAT MED, V48, P135, DOI 10.2190/PM.48.2.f
   Egede LE, 2002, DIABETES EDUCATOR, V28, P258, DOI 10.1177/014572170202800211
   Egede LE, 2006, MED CLIN N AM, V90, P627, DOI 10.1016/j.mcna.2006.04.001
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Feifer C, 1999, PROF PSYCHOL-RES PR, V30, P14, DOI 10.1037//0735-7028.30.1.14
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hausmann LRM, 2010, PATIENT PREFER ADHER, V4, P291, DOI 10.2147/PPA.S12353
   Hawkins JL, 2015, J AGING PHYS ACTIV, V23, P161, DOI 10.1123/japa.2013-0171
   Hessler DM, 2012, J HEALTH PSYCHOL, V17, P535, DOI 10.1177/1359105311422120
   Jones RA, 2008, DIABETES EDUCATOR, V34, P318, DOI 10.1177/0145721708314485
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Lehrer HM, 2017, DIABETES EDUCATOR, V43, P367, DOI 10.1177/0145721717714894
   Lennon-Dearing R, 2008, J HIV-AIDS SOC SERV, V7, P27, DOI 10.1080/15381500802093142
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Miller ST, 2011, J HEALTH CARE POOR U, V22, P1239, DOI 10.1353/hpu.2011.0110
   Pariser G, 2014, DIABETES EDUCATOR, V40, P60, DOI 10.1177/0145721713514281
   Penckofer S, 2007, DIABETES EDUCATOR, V33, P680, DOI 10.1177/0145721707304079
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Saldana J, 2013, CODING MANUAL QUALIT
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Schiotz ML, 2012, DIABETIC MED, V29, P654, DOI 10.1111/j.1464-5491.2011.03485.x
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Stang I., 2008, INT J MENT HEALTH PR, V10, P15, DOI DOI 10.1080/14623730.2008.9721759
   Tang TS, 2011, PATIENT EDUC COUNS, V85, P160, DOI 10.1016/j.pec.2010.12.013
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   US Department of Health and Human Services Office of Minority Health, 2016, DIAB AFR AM
   Verhaak PFM, 2005, SOC SCI MED, V60, P789, DOI 10.1016/j.socscimed.2004.06.012
   Wagner JA, 2009, DIABETES RES CLIN PR, V86, P111, DOI 10.1016/j.diabres.2009.08.004
   Ward EC, 2013, NURS RES, V62, P185, DOI 10.1097/NNR.0b013e31827bf533
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 47
TC 0
Z9 0
U1 2
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD APR
PY 2018
VL 44
IS 2
BP 144
EP 157
DI 10.1177/0145721718754325
PG 14
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA GC7EH
UT WOS:000429955100004
PM 29375023
DA 2019-01-08
ER

PT J
AU Halepian, L
   Saleh, MB
   Hallit, S
   Khabbaz, LR
AF Halepian, Lucine
   Saleh, Mary Bou
   Hallit, Souheil
   Khabbaz, Lydia Rabbaa
TI Adherence to Insulin, Emotional Distress, and Trust in Physician Among
   Patients with Diabetes: A Cross-Sectional Study
SO DIABETES THERAPY
LA English
DT Article
DE Adherence; Diabetes; Emotional distress; Insulin; Trust in physician
ID MEDICATION ADHERENCE; GLYCEMIC CONTROL; SELF-MANAGEMENT; SOCIAL SUPPORT;
   DEPRESSION; CARE; ASSOCIATION; MELLITUS; HEALTH; SCALE
AB Introduction: Type 2 diabetes represents a significant public health issue, with increasing prevalence in developing countries while adherence to insulin treatment remains a challenge. No studies have evaluated the relationship between adherence to insulin, diabetes-related distress, and trust in physician among persons with diabetes. Our objectives were to evaluate treatment adherence to insulin, emotional distress (using the Problem Areas in Diabetes Questionnaire, PAID), trust in physician, and to examine associations between them among Lebanese patients with diabetes.
   Methods: This cross-sectional study, conducted in all districts of Lebanon between August 2016 and April 2017, enrolled 135 adult patients.
   Results: The mean percentage score of adherence to insulin was 79.7 +/- 19.94. A significantly higher mean adherence score was found in non-sedentary (81.96) compared to sedentary patients (67.41) (p = 0.017), with no difference between gender, employment, rural vs non-rural residence, or familial history of diabetes. In addition, no significant relationship was seen between adherence score and education level, smoking, or alcohol intake. A significant positive association was found between trust in physician and adherence scores, whereas a significant but negative one was found between PAID and adherence scores. The results of linear regressions showed that a secondary level of education (beta = -13.48) significantly decreased the trust in physician score, whereas the total number of oral antidiabetics (beta = 0.93) increased it. Having a sedentary lifestyle (beta = -12.73) and smoking < 3 waterpipes/week compared to no smoking (beta = -16.82) significantly decreased the adherence score. Female gender (beta = 10.46), smoking < 3 waterpipes (beta = 27.42) and 3+ waterpipes/week (beta = 17.95) significantly increased the PAID score.
   Conclusion: Trust in physician is associated with an increased adherence and with decreased diabetes-related distress. This distress was also associated with poor adherence in our study.
C1 [Halepian, Lucine; Saleh, Mary Bou; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Pharmacol Clin Pharm & Drug Qual Control Lab, Beirut, Lebanon.
   [Halepian, Lucine; Saleh, Mary Bou; Hallit, Souheil; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon.
RP Khabbaz, LR (reprint author), St Joseph Univ Beirut, Pharmacol Clin Pharm & Drug Qual Control Lab, Beirut, Lebanon.; Hallit, S; Khabbaz, LR (reprint author), St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon.
EM souheilhallit@hotmail.com; Lydia.khabbaz@usj.edu.lb
OI Hallit, Souheil/0000-0001-6918-5689
CR Aikens JE, 2013, DIABETIC MED, V30, P338, DOI 10.1111/dme.12046
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012
   Alazri MH, 2003, DIABETIC MED, V20, P486, DOI 10.1046/j.1464-5491.2003.00957.x
   Alimena S, 2016, MED PROBL PERFORM AR, V31, P166, DOI 10.21091/mppa.2016.3030
   ANDERSON LA, 1990, PSYCHOL REP, V67, P1091, DOI 10.2466/pr0.1990.67.3f.1091
   Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25
   Bell RA, 2013, AM J HEALTH BEHAV, V37, P660, DOI 10.5993/AJHB.37.5.10
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   Dong XQ, 2017, J GERONTOL A-BIOL, V72, pS125, DOI 10.1093/gerona/glx036
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Farsaei S, 2014, PRIM CARE DIABETES, V8, P338, DOI 10.1016/j.pcd.2014.03.001
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Forum for Injection Technique, 2015, UK INJ TECHN REC
   Garfield S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-350
   Golin CE, 2001, DIABETES EDUCATOR, V27, P875, DOI 10.1177/014572170102700613
   He XN, 2017, PATIENT PREFER ADHER, V11, P237, DOI 10.2147/PPA.S123389
   Heisler M, 2007, J GERONTOL A-BIOL, V62, P1435, DOI 10.1093/gerona/62.12.1435
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Kalsingh Maria Jusler, 2017, J Family Med Prim Care, V6, P34, DOI 10.4103/2249-4863.214966
   Kanbara S, 2008, DIABETES RES CLIN PR, V80, P56, DOI 10.1016/j.diabres.2007.12.01S
   Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184
   Kumar Nithin, 2017, J Nat Sci Biol Med, V8, P216, DOI 10.4103/0976-9668.210008
   Lobo CP, 2014, PRIM CARE COMPANION, V16
   Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4
   Maeda U, 2013, INT J BEHAV MED, V20, P88, DOI 10.1007/s12529-011-9215-0
   Manan MM, 2014, J CLIN DIAGN RES, V8, pJC5, DOI 10.7860/JCDR/2014/10481.5309
   Mayer-Davis EJ, 2006, J AM DIET ASSOC, V106, P689, DOI 10.1016/j.jada.2006.02.002
   National Collaborating Centre for Chronic Conditions (UK), 2008, TYP 2 DIAB NAT CLIN
   NICE, 2004, TYP 1 DIAB DIAGN MAN
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
   Polonsky W, 1996, UNDERSTANDING TREATI, P183
   Preston CC, 2000, ACTA PSYCHOL, V104, P1, DOI 10.1016/S0001-6918(99)00050-5
   Ramkisson Samantha, 2017, Afr J Prim Health Care Fam Med, V9, pe1, DOI 10.4102/phcfm.v9i1.1405
   Riaz M, 2014, PAK J MED SCI, V30, P233
   Rodriguez KM, 2013, CLIN THER, V35, P170, DOI 10.1016/j.clinthera.2013.01.002
   Rolfe A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004134.pub3
   Rubin DJ, 2010, ENDOCR PRACT, V16, P408, DOI 10.4158/EP09275.OR
   */* S  11, 2012, DIABETES CARE S1, V35, pS1, DOI DOI 10.2337/DC35-S011
   Sapkota S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128581
   Schiotz ML, 2012, DIABETIC MED, V29, P654, DOI 10.1111/j.1464-5491.2011.03485.x
   Schoenthaler AM, 2012, DIABETES EDUCATOR, V38, P397, DOI 10.1177/0145721712440333
   Shao YC, 2017, J DIABETES RES, DOI 10.1155/2017/2804178
   Slean GR, 2012, MED CARE, V50, pS69, DOI 10.1097/MLR.0b013e3182641127
   Smith SK, 2009, SOC SCI MED, V69, P1805, DOI 10.1016/j.socscimed.2009.09.056
   Solberg LI, 2004, ANN FAM MED, V2, P26, DOI 10.1370/afm.36
   Ulvi Osman Saleem, 2009, JPMA Journal of the Pakistan Medical Association, V59, P798
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   White RO, 2013, J HEALTH CARE POOR U, V24, P1756, DOI 10.1353/hpu.2013.0177
   Wong MCS, 2015, J CLIN PHARMACOL, V55, P279, DOI 10.1002/jcph.408
   World Health Organization, DIABETES
NR 53
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1869-6953
EI 1869-6961
J9 DIABETES THER
JI Diabetes Ther.
PD APR
PY 2018
VL 9
IS 2
BP 713
EP 726
DI 10.1007/s13300-018-0389-1
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GA6UO
UT WOS:000428470000019
PM 29520741
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Hsu, HC
   Lee, YJ
   Wang, RH
AF Hsu, Hui-Chun
   Lee, Yau-Jiunn
   Wang, Ruey-Hsia
TI Influencing Pathways to Quality of Life and HbA1c in Patients With
   Diabetes: A Longitudinal Study That Inform Evidence-Based Practice
SO WORLDVIEWS ON EVIDENCE-BASED NURSING
LA English
DT Article
DE type 2 diabetes mellitus; model testing; hemoglobin A1C; quality of
   life; diabetes distress; social support; self-care behaviors
ID SELF-CARE ACTIVITIES; GLYCEMIC CONTROL; SOCIAL SUPPORT;
   CLINICAL-OUTCOMES; HEALTH LITERACY; PROBLEM AREAS; OLDER-ADULTS;
   DISTRESS; MELLITUS; ASSOCIATIONS
AB BackgroundDetermining possible associated factors and the influencing pathways to hemoglobin A1C (HbA1C) levels and quality of life (QoL) will facilitate the development of effective interventions to improve the physical and psychosocial health of patients with type 2 diabetes mellitus (T2DM).
   ObjectivesTo test a hypothesized model that addressed the pathways among personal characteristics, social support, diabetes distress, and self-care behaviors to HbA1C and QoL.
   MethodsA total of 382 adults with T2DM were recruited. Self-reported questionnaires and medical records were used to collect data regarding personal characteristics, diabetes distress, and social support at baseline. The self-care behaviors characters were collected 6 months later, as well as QoL and HbA1C levels 1 year later.
   ResultsThe 12-month QoL directly affected 12-month HbA1C levels. The 6-month self-care behaviors directly affected 12-month QoL, and indirectly affected 12-month HbA1C levels through 12-month QoL. Baseline diabetes distress directly affected 12-month QoL. Moreover, baseline diabetes distress indirectly affected 12-month HbA1C levels through 12-month QoL. Baseline social support directly affected baseline diabetes distress and 6-month self-care behaviors. In addition, baseline social support indirectly affected 12-month QoL through baseline diabetes distress. Baseline social support also indirectly affected 12-month QoL through 6-month self-care behaviors.
   Linking Evidence to ActionEnhancing QoL is important to improve HbA1C levels. Enhancing self-care behaviors is essential to improve subsequent HbA1C control and QoL. Reducing diabetes distress is crucial to improve subsequent QoL. Improving social support is suggested a favorable strategy to reduce diabetes distress and enhance subsequent self-care behaviors in patients with T2DM.
C1 [Hsu, Hui-Chun] Lees Endocrinol Clin, Dept Diabet Management, Pingtung, Taiwan.
   [Lee, Yau-Jiunn] Lees Endocrinol Clin, Pingtung, Taiwan.
   [Wang, Ruey-Hsia] Kaohsiung Med Univ, Coll Nursing, 100 Shih Chuan,1st Rd, Kaohsiung 807, Taiwan.
   [Wang, Ruey-Hsia] Kaohsiung Med Univ Hosp, Dept Med Res, 100 Shih Chuan,1st Rd, Kaohsiung 807, Taiwan.
RP Wang, RH (reprint author), Kaohsiung Med Univ, Coll Nursing, 100 Shih Chuan,1st Rd, Kaohsiung 807, Taiwan.; Wang, RH (reprint author), Kaohsiung Med Univ Hosp, Dept Med Res, 100 Shih Chuan,1st Rd, Kaohsiung 807, Taiwan.
EM wrhsia@kmu.edu.tw
FU National Science Council, Taiwan [NSC-102-2628-B-037-012-MY3]
FX Study funding was supported by the National Science Council, Taiwan
   (NSC-102-2628-B-037-012-MY3).
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Al Hayek AA, 2014, DIABETES METAB J, V38, P220, DOI 10.4093/dmj.2014.38.3.220
   [Anonymous], 2017, Diabetes Care, V40, pS4
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Bowen PG, 2015, J GERONTOL NURS, V41, P21, DOI 10.3928/00989134-20151008-44
   Chao CY, 2014, OBES RES CLIN PRACT, V8, pE212, DOI 10.1016/j.orcp.2012.07.002
   Cheng JS, 2015, MED CARE, V53, P116, DOI 10.1097/MLR.0000000000000288
   Chew BH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0384-4
   Chew BH, 2014, WORLD J DIABETES, V5, P796, DOI 10.4239/wjd.v5.i6.796
   Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685
   Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532
   Dismuke CE, 2014, INT J PSYCHIAT MED, V48, P135, DOI 10.2190/PM.48.2.f
   DSouza MS, 2015, GSTF J NURSING HLTH, V2, P29
   Egede LE, 2014, ANN PHARMACOTHER, V48, P562, DOI 10.1177/1060028014526362
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Hsu HC, 2013, J NURS RES, V21, P212, DOI 10.1097/01.jnr.0000432048.31921.e2
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Ikeda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109323
   International Diabetes Federation, 2015, IDF DIAB ATL 7, V7
   Kamuhabwa AR, 2014, DRUG HEALTHC PATIENT, V6, P155, DOI 10.2147/DHPS.S68786
   Karlsen B, 2014, INT J NURS STUD, V51, P438, DOI 10.1016/j.ijnurstu.2013.06.016
   Kiadaliri AA, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-54
   Kuznetsov L, 2014, DIABETES RES CLIN PR, V104, P281, DOI 10.1016/j.diabres.2013.12.029
   Laxy M, 2014, DIABETES CARE, V37, P1604, DOI 10.2337/dc13-2533
   Lee EH, 2016, ASIAN NURS RES, V10, P82, DOI 10.1016/j.anr.2016.01.005
   Lee EH, 2012, DIABETES RES CLIN PR, V95, P76, DOI 10.1016/j.diabres.2011.08.022
   Lee YJ, 2016, PATIENT EDUC COUNS, V99, P287, DOI 10.1016/j.pec.2015.08.021
   Ma WY, 2012, J DIABETES COMPLICAT, V26, P296, DOI 10.1016/j.jdiacomp.2012.03.028
   Ministry of Health and Welfare, 2017, 2016 STAT CAUS DEATH
   Ministry of Health and Welfare, 2013, 2013 HLTH PROM ADM A
   Murphy ME, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015135
   Nichols GA, 2014, DIABETES CARE, V37, P167, DOI 10.2337/dc13-1300
   Nicklett EJ, 2013, J GERONTOL B-PSYCHOL, V68, P933, DOI 10.1093/geronb/gbt100
   Osborn CY, 2010, PATIENT EDUC COUNS, V79, P49, DOI 10.1016/j.pec.2009.07.016
   Ouyang CM, 2015, ASIA PAC J CLIN NUTR, V24, P438, DOI 10.6133/apjcn.2015.24.3.03
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   Polit D. F., 2012, NURSING RES GENERATI
   Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199
   Preacher K. J., 2006, COMPUTING POWER MINI
   Rad Ghalmreza Sharfi, 2013, J Educ Health Promot, V2, P62, DOI 10.4103/2277-9531.120864
   Rajasekharan D, 2015, ANN MED HEALTH SCI R, V5, P59, DOI 10.4103/2141-9248.149791
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Saleh F, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-431, 10.1186/1471-2458-14-433]
   Schumacker RE, 2010, BEGINNERS GUIDE STRU
   Sidhu R., 2016, CANADA J DIABETES, V40, pS70
   Ullman JB, 2006, J PERS ASSESS, V87, P35, DOI 10.1207/s15327752jpa8701_03
   Wang RH, 2017, J ADV NURS, V73, P1137, DOI 10.1111/jan.13201
   Wang RH, 2016, PATIENT EDUC COUNS, V99, P1626, DOI 10.1016/j.pec.2016.04.001
   Wang RH, 2011, J ADV NURS, V67, P2658, DOI 10.1111/j.1365-2648.2011.05701.x
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Yu DSF, 2004, RES NURS HEALTH, V27, P135, DOI 10.1002/nur.20008
   Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026
NR 54
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-102X
EI 1741-6787
J9 WORLDV EVID-BASED NU
JI Worldviews Evid.-Based Nurs.
PD APR
PY 2018
VL 15
IS 2
BP 104
EP 112
DI 10.1111/wvn.12275
PG 9
WC Nursing
SC Nursing
GA GB7YN
UT WOS:000429291100004
PM 29443437
DA 2019-01-08
ER

PT J
AU Dogba, MJ
   Dipankui, MT
   Dansokho, SC
   Legare, F
   Witteman, HO
AF Dogba, Maman Joyce
   Dipankui, Mylene Tantchou
   Dansokho, Selma Chipenda
   Legare, France
   Witteman, Holly O.
TI Diabetes-related complications: Which research topics matter to diverse
   patients and caregivers?
SO HEALTH EXPECTATIONS
LA English
DT Article
DE diabetes; diabetes-related complications; participatory research;
   patient engagement; patient involvement; patient-oriented research;
   stakeholder voice; under-represented populations
ID QUALITY-OF-LIFE; VULNERABLE POPULATIONS; MIXED METHODS; RESEARCH
   PRIORITIES; FEAR; TYPE-1; HYPOGLYCEMIA; DISTRESS; INVOLVEMENT;
   PREVALENCE
AB BackgroundDiabetes is a chronic disease with increasing prevalence worldwide. Although research has improved its treatment and management, little is known about which research topics matter to people living with diabetes, particularly among under-represented groups.
   ObjectivesTo explore the importance of research topics among a diverse range of people living with any type of diabetes or caring for someone living with any type of diabetes.
   MethodsWe used a convergent mixed-method design with quantitative and qualitative aspects. We surveyed a national sample of people living with diabetes and caregivers of people with diabetes, asking them to rate the importance of 10 predetermined important research topics. We also held three focus groups in two major cities to explore research concerns of people who are under-represented in research.
   Results469 adults (57% men, 42% women) in Canada completed the online survey, indicating that all 10 areas of research mattered to them, with the highest ratings accorded to preventing and treating kidney, eye and nerve complications. Fourteen individuals participated in three focus groups and similarly noted the importance of research on those three complications. Additionally, focus group participants also noted the importance of research around daily management. No new topics were identified.
   ConclusionsThis study confirmed the importance of research topics among a population of people living with or caring for someone with diabetes. Findings from this study were used to inform the vision for Diabetes Action Canadaa pan-Canadian Strategy for Patient-Oriented Research (SPOR) Network on diabetes and its complications.
C1 [Dogba, Maman Joyce; Dipankui, Mylene Tantchou; Dansokho, Selma Chipenda; Legare, France; Witteman, Holly O.] Univ Laval, Dept Family & Emergency Med, Fac Med, Quebec City, PQ, Canada.
   [Dogba, Maman Joyce; Legare, France; Witteman, Holly O.] Univ Laval, Off Educ & Profess Dev, Fac Med, Quebec City, PQ, Canada.
   [Witteman, Holly O.] CHU Quebec, Res Ctr, Hlth Populat & Best Hlth Practices Axis, Quebec City, PQ, Canada.
RP Dogba, MJ (reprint author), Univ Laval, Dept Family & Emergency Med, Fac Med, Quebec City, PQ, Canada.
EM Joyce-maman.dogba@fmed.ulaval.ca
RI Legare, France/O-6971-2017
FU Canadian Institutes of Health Research [CIHR SCD 139932]
FX This study was funded through a subgrant of the Canadian Institutes of
   Health Research (CIHR SCD 139932)
CR [Anonymous], 2006, AM J MANAG CARE, V12, pS348
   Association Canadienne du Diabete, 2009, UNTS EC COUT DIAB CA
   Barnard KD, 2012, PSYCHOL DIABETES CAR, P1
   Boote J, 2002, HEALTH POLICY, V61, P213, DOI 10.1016/S0168-8510(01)00214-7
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Canadian Diabetes Association, 2011, DIAB CAN TIPP POINT
   Candib LM, 2007, ANN FAM MED, V5, P547, DOI 10.1370/afm.754
   Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1
   Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Creswell JW, 2004, ANN FAM MED, V2, P7, DOI 10.1370/afm.104
   Creswell JW, 2007, DESIGNING CONDUCTING, P58
   Dugas M, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-016-0399-8
   Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Gadsby R, 2012, DIABETIC MED, V29, P1321, DOI 10.1111/j.1464-5491.2012.03755.x
   Green ML, 1989, J PEDIATR PSYCHOL, V15, P9
   Hajos TRS, 2014, DIABETES CARE, V37, P102, DOI 10.2337/dc13-0971
   Hendricks LE, 1998, DIABETES EDUCATOR, V24, P168, DOI 10.1177/014572179802400206
   Irvine A, 1992, HEALTH PSYCHOL, V11, P4
   Jodar-Gimeno E, 2015, REV CLIN ESP, V215, P91, DOI 10.1016/j.rce.2014.07.009
   KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299
   Knoll Megan, 2012, BMC Res Notes, V5, P572, DOI 10.1186/1756-0500-5-572
   Laurance J, 2014, HEALTH AFFAIR, V33, P1627, DOI 10.1377/hlthaff.2014.0375
   Mulhall A, 2003, J ADV NURS, V41, P306, DOI 10.1046/j.1365-2648.2003.02514.x
   Ocloo J, 2016, BMJ QUAL SAF, V25, P626, DOI 10.1136/bmjqs-2015-004839
   Patton M. Q., 2001, QUALITATIVE RES EVAL
   Peyrot M, 2014, CURR MED RES OPIN, V30, P2241, DOI 10.1185/03007995.2014.947023
   Pluye P, 2014, ANNU REV PUBL HEALTH, V35, P29, DOI 10.1146/annurev-publhealth-032013-182440
   POLONSKY WH, 1992, HEALTH PSYCHOL, V11, P199, DOI 10.1037/0278-6133.11.3.199
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Qualtrics, 2015, WORLDS LEAD ENT SURV
   Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399
   Sakane N, 2015, J DIABETES INVEST, V6, P567, DOI 10.1111/jdi.12340
   Shaghaghi A, 2011, HEALTH PROMOT PERSPE, V1, P86, DOI 10.5681/hpp.2011.009
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Stewart RJ, 2011, HEALTH EXPECT, V14, P439, DOI 10.1111/j.1369-7625.2010.00648.x
   Taylor EP, 2005, DIABETES-METAB RES, V21, P264, DOI 10.1002/dmrr.524
   UyBico SJ, 2007, J GEN INTERN MED, V22, P852, DOI 10.1007/s11606-007-0126-3
   Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048
   Vanasse A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0824-1
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Wilson J, 1999, BMJ-BRIT MED J, V319, P771, DOI 10.1136/bmj.319.7212.771
   World Health Organization, 2016, GLOB REP DIAB
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
NR 47
TC 0
Z9 0
U1 4
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1369-6513
EI 1369-7625
J9 HEALTH EXPECT
JI Health Expect.
PD APR
PY 2018
VL 21
IS 2
BP 549
EP 559
DI 10.1111/hex.12649
PG 11
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA GA5VT
UT WOS:000428402700016
PM 29165920
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Fisher, L
   Hessler, D
AF Polonsky, W. H.
   Fisher, L.
   Hessler, D.
TI The impact of non-severe hypoglycemia on quality of life in patients
   with type 2 diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Hypoglycemia; Perceived burden, type 2 diabetes; Quality of life;
   Hypoglycemic fear; Diabetes distress
ID EVENTS; BURDEN; DEPRESSION; MANAGEMENT; DISTRESS; MELLITUS; ADULTS;
   PRODUCTIVITY; WORRY; PHQ-9
AB Aims: To determine the impact of frequency of non-severe hypoglycemic events (NSHE) and the perceived burden of NSHE on quality of life (QOL) over time.
   Methods: T2D adults (n = 424) were re-contacted two years after initial QOL assessment. Responding subjects (n = 290) reported the frequency and burden of NSHE over time and completed six genetic and diabetes-specific QOL measures.
   Results: Most subjects (86%) reported >= one NSHE overtime. Higher frequency of NSHE was significantly associated with decrements in QOL Greater perceived burden of NSHE was significantly linked to decreases in QOL over time for all six QOL measures. Interaction terms indicated that participants with a higher frequency of NSHE and higher perceived burden reported the greatest decrease in QOL; participants who experienced frequent NSHE but did not perceive these events as burdensome evidenced little worsening in QOL over time.
   Conclusions: NSHE have a negative impact on QOL over time in T2D adults. However, it is not just the occurrence of NSHE that affects QOL; it is the individual's felt burden of these events that is critical. The greatest reductions in QOL are seen among those subjects reporting a higher frequency of NSHE and indicating that such events are burdensome. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Polonsky, W. H.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Polonsky, W. H.] Behav Diabet Inst, San Diego, CA USA.
   [Fisher, L.; Hessler, D.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
RP Polonsky, WH (reprint author), POB 2148, Del Mar, CA 92014 USA.
EM whp@behavioraldiabetes.org
FU Merck
FX This investigator-initiated study was supported by Merck.
CR Barendse S, 2012, DIABETIC MED, V29, P293, DOI 10.1111/j.1464-5491.2011.03416.x
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Brod M, 2013, DIABETES OBES METAB, V15, P546, DOI 10.1111/dom.12070
   Brod M, 2013, VALUE HEALTH, V16, P1140, DOI 10.1016/j.jval.2013.09.002
   Brod M, 2013, QUAL LIFE RES, V22, P997, DOI 10.1007/s11136-012-0234-3
   Davis RE, 2005, CURR MED RES OPIN, V21, P1477, DOI 10.1185/030079905X61929
   Fisher I., 2016, DIABET MED, V33
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fulcher Gregory, 2014, J Med Econ, V17, P751, DOI 10.3111/13696998.2014.946992
   Gilet H, 2012, VALUE HEALTH, V15, P1036, DOI 10.1016/j.jval.2012.06.002
   Green AJ, 2012, DIABETES RES CLIN PR, V96, P313, DOI 10.1016/j.diabres.2012.01.002
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hajos TRS, 2014, DIABETES CARE, V37, P102, DOI 10.2337/dc13-0971
   Hessler DM, 2017, DIABETIC MED, V34, P1228, DOI 10.1111/dme.13381
   Irvine A, 1994, HDB PSYCHOL DIABETES
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Marrett Elizabeth, 2011, BMC Res Notes, V4, P251, DOI 10.1186/1756-0500-4-251
   Pedersen-Bjergaard U, 2003, DIABETES-METAB RES, V19, P232, DOI 10.1002/dmrr.377
   Polonsky WH, 2015, J DIABETES COMPLICAT, V29, P1171, DOI 10.1016/j.jdiacomp.2015.08.002
   Polonsky WH, 2014, DIABETIC MED, V31, P40, DOI 10.1111/dme.12275
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Sakane N, 2015, J DIABETES INVEST, V6, P567, DOI 10.1111/jdi.12340
   Sheu WHH, 2012, DIABETES RES CLIN PR, V96, P141, DOI 10.1016/j.diabres.2011.12.027
   Shi LZ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0167-3
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052
   Wieringa TH, 2017, J ENDOCRINOL INVESTI
   Williams SA, 2012, J DIABETES COMPLICAT, V26, P399, DOI 10.1016/j.jdiacomp.2012.05.002
   Williams SA, 2011, DIABETES RES CLIN PR, V91, P363, DOI 10.1016/j.diabres.2010.12.027
NR 29
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD APR
PY 2018
VL 32
IS 4
BP 373
EP 378
DI 10.1016/j.jdiacomp.2018.01.014
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GA5GP
UT WOS:000428361500005
PM 29496364
DA 2019-01-08
ER

PT J
AU Schmitt, A
   Reimer, A
   Kulzer, B
   Icks, A
   Paust, R
   Roelver, KM
   Kaltheuner, M
   Ehrmann, D
   Krichbaum, M
   Haak, T
   Hermanns, N
AF Schmitt, Andreas
   Reimer, Andre
   Kulzer, Bernhard
   Icks, Andrea
   Paust, Rainer
   Roelver, Klaus-Martin
   Kaltheuner, Matthias
   Ehrmann, Dominic
   Krichbaum, Michael
   Haak, Thomas
   Hermanns, Norbert
TI Measurement of psychological adjustment to diabetes with the diabetes
   acceptance scale
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes integration; Illness acceptance; Psychological adjustment; Self
   and identity; Diabetes-related distress
ID QUALITY-OF-LIFE; PERCEPTION QUESTIONNAIRE; SELF-MANAGEMENT; DEPRESSION;
   METAANALYSIS; DISTRESS; MELLITUS; ILLNESS; IDENTITY; PATIENT
AB Aims: To develop a psychometric measure of diabetes acceptance.,
   Methods: An item pool was developed and pilot-tested using a sample of 220 people with diabetes; item selection resulted in the 20-item 'Diabetes Acceptance Scale (DAS)'. 606 people with diabetes were then cross-sectionally assessed with the DAS to evaluate its reliability, validity and clinical utility; concurrent measurements included diabetes-related coping (FQCI), diabetes distress (PAID-5), depressive symptoms (PHQ-9), quality of life (EQ-5D), self-management (DSMQ), glycaemic control (HbA(1c)) and complications.
   Results: Internal reliability was high (Cronbach's alpha = 0.96). Factorial and criterion-related results supported validity. Higher diabetes acceptance scores correlated with more functional coping styles, lower distress and depression levels, higher treatment adherence, better glycaemic control and better quality of life (all P < .001). Persons with low diabetes acceptance (22% of the sample) were four times more likely to have HbA(1c) values over 9.0% (75 mmol/mol), two times more likely to be diagnosed with long-term complications and each over two times more likely to have had episodes of severe hypoglycaemia and ketoacidosis in the past year; the prevalence of major depression in this group was fivefold increased (all P < .05).
   Conclusions: The DAS is a reliable and valid tool to measure diabetes acceptance. It may help identify patients with significant problems of accepting diabetes, a putative high-risk group in need of tailored care and support. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Schmitt, Andreas; Reimer, Andre; Kulzer, Bernhard; Ehrmann, Dominic; Krichbaum, Michael; Haak, Thomas; Hermanns, Norbert] Diabet Acad Mergentheim FIDAM, Res Inst, Johann Hammer Str 24, D-97980 Bad Mergentheim, Germany.
   [Schmitt, Andreas; Reimer, Andre; Kulzer, Bernhard; Ehrmann, Dominic; Krichbaum, Michael; Haak, Thomas; Hermanns, Norbert] Diabet Ctr Mergentheim DZM, Theodor Klotzbuecher Str 12, D-97980 Bad Mergentheim, Germany.
   [Schmitt, Andreas; Reimer, Andre; Kulzer, Bernhard; Icks, Andrea; Hermanns, Norbert] German Ctr Diabet Res DZD, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.
   [Kulzer, Bernhard; Hermanns, Norbert] Otto Friedrich Univ Bamberg, Dept Psychol, Markuspl 3, D-96047 Bamberg, Germany.
   [Icks, Andrea] German Diabet Ctr DDZ, Inst Hlth Serv Res & Hlth Econ, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
   [Icks, Andrea] Heinrich Heine Univ, Inst Hlth Serv Res & Hlth Econ, Fac Med, Moorenstr 5, D-40225 Dusseldorf, Germany.
   [Paust, Rainer] Elisabeth Hosp, Inst Psychosocial Med, Klara Kopp Weg 1, D-45138 Essen, Germany.
   [Roelver, Klaus-Martin] Christian Hosp Quakenbrueck, Diabet Ctr Quakenbrueck, Danziger Str 2, D-49610 Quakenbrueck, Germany.
   [Kaltheuner, Matthias] Specialised Diabet Practice Leverkusen, Kalkstr 117, D-51377 Leverkusen, Germany.
RP Schmitt, A (reprint author), Diabet Ctr Mergentheim, Theodor Klotzbuecher Str 12, D-97980 Bad Mergentheim, Germany.
EM schmitt@diabetes-zentrum.de
OI Krichbaum, Michael/0000-0002-5937-1266; Schmitt,
   Andreas/0000-0002-5913-1457; Ehrmann, Dominic/0000-0002-5794-5596
FU German Center for Diabetes Research (DZD) [82DZD01101]; German Diabetes
   Foundation (DDS) [375.10.15]
FX This work was supported by the German Center for Diabetes Research (DZD)
   [grant number 82DZD01101]; and the German Diabetes Foundation (DDS)
   [grant number 375.10.15]. The funders were not involved in decisions
   regarding study design; collection, analysis and interpretation of data;
   writing of the report; and in the decision to submit the article for
   publication.
CR ANDERSON RM, 1986, DIABETIC MED, V3, P85, DOI 10.1111/j.1464-5491.1986.tb00715.x
   Broadbent E, 2015, PSYCHOL HEALTH, V30, P1361, DOI 10.1080/08870446.2015.1070851
   Cohen GL, 2014, ANNU REV PSYCHOL, V65, P333, DOI 10.1146/annurev-psych-010213-115137
   Dempster M, 2011, DIABETIC MED, V28, P487, DOI 10.1111/j.1464-5491.2010.03214.x
   Dion GA, 1990, THESIS
   Dlugosch GE, 2002, PSYCHODIABETOLOGIE, P150
   Garay-Sevilla ME, 1999, DIABETIC MED, V16, P238, DOI 10.1046/j.1464-5491.1999.00033.x
   Gfeller R., 1987, VERHALTENSMEDIZIN DI, P63
   Gois CJ, 2012, ACTA DIABETOL, V49, pS33, DOI 10.1007/s00592-010-0191-7
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Hardt J, 2003, Z KL PSYCH PSYCHOTH, V32, P41, DOI 10.1026//1616-3443.32.1.41
   Henkel V, 2003, BRIT MED J, V326, P200, DOI 10.1136/bmj.326.7382.200
   Hinz A, 2014, QUAL LIFE RES, V23, P443, DOI 10.1007/s11136-013-0498-2
   Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037//1082-989X.3.4.424
   Isla Pera Pilar, 2008, Endocrinol Nutr, V55, P78
   Kamody RC, 2017, BEHAV MED
   Kiibler-Ross E, 1969, DEATH DYING
   Lewko J, 2007, Adv Med Sci, V52 Suppl 1, P144
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   McDonald Patricia Elaine, 2011, Issues Ment Health Nurs, V32, P416, DOI 10.3109/01612840.2010.551449
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Misra R, 2008, J DIABETES COMPLICAT, V22, P217, DOI 10.1016/j.jdiacomp.2006.09.002
   Oris L, 2016, DIABETES CARE, V39, P757, DOI 10.2337/dc15-2559
   Richardson A, 2001, J ADV NURS, V33, P758, DOI 10.1046/j.1365-2648.2001.01717.x
   Sanden-Eriksson B, 2000, J ADV NURS, V31, P1393, DOI 10.1046/j.1365-2648.2000.01410.x
   Schmitt A, 2016, DIABETIC MED, V33, P835, DOI 10.1111/dme.12887
   Schmitt A, 2013, DIABETES STOFFWECH H, V22, P9
   Schmitt A, 2014, DIABETIC MED, V31, P1446, DOI 10.1111/dme.12553
   Schmitt A, 2017, J DIABETES COMPLICAT, V31, P1608, DOI 10.1016/j.jdiacomp.2017.08.004
   Schmitt A, 2017, J PSYCHOSOM RES, V94, P17, DOI [10.1016/jjpsychores.2016.12.015, 10.1016/j.jpsychores.2016.12.015]
   Schmitt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150774
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   SCHULZ R, 1974, OMEGA-J DEATH DYING, V5, P137, DOI 10.2190/HYRB-7VQK-VU9Y-7L5D
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Sturgeon JA, 2010, CURR PAIN HEADACHE R, V14, P105, DOI 10.1007/s11916-010-0095-9
   Templeton GF, 2011, COMMUN ASSOC INF SYS, V28, P41
   Tilden B, 2005, QUAL HEALTH RES, V15, P312, DOI 10.1177/1049732304272965
   Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585
   Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270
   WELCH G, 1996, MULTIVAR EXP CLIN R, V11, P75
   Wilson AL, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0222-8
NR 44
TC 1
Z9 1
U1 9
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD APR
PY 2018
VL 32
IS 4
BP 384
EP 392
DI 10.1016/j.jdiacomp.2018.01.005
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GA5GP
UT WOS:000428361500007
PM 29439862
DA 2019-01-08
ER

PT J
AU Rhee, TG
   Westberg, SM
   Harris, IM
AF Rhee, Taeho G.
   Westberg, Sarah M.
   Harris, Ila M.
TI Complementary and alternative medicine in US adults with diabetes:
   Reasons for use and perceived benefits
SO JOURNAL OF DIABETES
LA English
DT Article
DE Complementary and alternative medicine (CAM); Diabetes; Health
   promotion; Wellness; Well-being
ID MODERATE MENTAL DISTRESS; MELLITUS; HEALTH; ASSOCIATION; THERAPIES;
   PEOPLE; CARE; CAM
AB BackgroundAlthough complementary and alternative medicine (CAM) is increasingly used, little is known about the reasons for CAM use (treatment, wellness, or both), or the self-reported perceived benefits among US adults with diabetes. In this study we estimated prevalence rates of overall and specific types of CAM, as well as the perceived benefits of CAM, by reason for use among US diabetic adults.
   MethodsCross-sectional data from the 2012 National Health Interview Survey, which represents non-institutionalized adults with diabetes (n=3386 unweighted), were used to estimate prevalence rates of CAM use by reason. Multivariate logistic regression analyses were used to investigate the odds of perceived benefits of CAM by reason for use after controlling for covariates.
   ResultsOf US diabetic adults, 26.2% reported using some form of CAM in the past year. Of these, 56.7% used CAM for both treatment and wellness, 28.3% used CAM for wellness only, and 15.0% used CAM for treatment only. Regardless of reasons for use, most commonly used CAM were herbal therapies (56.9%), followed by chiropractic (25.3%) and massage (20.2%). Those using CAM for a combination of both treatment and wellness had a higher likelihood of self-reporting a better sense of control over their health (P=0.011) and improved overall health and feeling better (P=0.014) than those using CAM for treatment only.
   ConclusionAlthough CAM may be a promising approach to improving health-related quality of life, future research should address efficacy and patient safety.
C1 [Rhee, Taeho G.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.
   [Rhee, Taeho G.; Westberg, Sarah M.; Harris, Ila M.] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Minneapolis, MN 55455 USA.
   [Harris, Ila M.] Univ Minnesota, Sch Med, Dept Family Med & Community Hlth, Minneapolis, MN 55455 USA.
RP Rhee, TG (reprint author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.
EM tgrhee.research@gmail.com
CR American Diabetes Association, 2017, Diabetes Care, V40, pS11
   [Anonymous], 2017, Diabetes Care, V40, pS4
   Barnes P. M., 2008, COMPLEMENTARY ALTERN
   Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20
   Centers for Disease Control and Prevention, 2015, NAT HLTH INT SURV
   Centers for Disease Control and Prevention, 2012, NAT HLTH INT SURV NH
   Chang HY, 2007, J ADV NURS, V58, P307, DOI 10.1111/j.1365-2648.2007.04291.x
   Clarke Tainya C, 2015, Natl Health Stat Report, P1
   Cowan RP, 2014, HEADACHE, V54, P1097, DOI 10.1111/head.12364
   Davis MA, 2011, HEALTH SERV RES, V46, P1402, DOI 10.1111/j.1475-6773.2011.01270.x
   Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011
   Fabian E, 2011, ANN NUTR METAB, V58, P101, DOI 10.1159/000326765
   Garber AJ, 2016, ENDOCR PRACT, V22, P84, DOI 10.4158/EP151126.CS
   Johnson PJ, 2016, MATURITAS, V89, P36, DOI 10.1016/j.maturitas.2016.04.012
   Leach MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007170.pub2
   LIU P., 2004, COCHRANE DB SYST REV, V3
   Nahin RL, 2009, COSTS COMPLEMENTARY
   National Center for Complementary and Integrative Health, 2015, STAT NAT HLTH INT SU
   Odegard PS, 2011, DIABETES EDUCATOR, V37, P419, DOI 10.1177/0145721711401668
   Ooi C.P., 2012, COCHRANE DB SYST REV, V8
   Ooi CP, 2013, COCHRANE DB SYST REV, V9
   Popli U, 2014, ALTERN THER HEALTH M, V20, P24
   Prochaska JJ, 2012, INT J METH PSYCH RES, V21, P88, DOI 10.1002/mpr.1349
   Rhee TG, 2017, COMPLEMENT THER CLIN, V29, P9, DOI 10.1016/j.ctcp.2017.07.003
   Rhee TG, 2017, J PRIM CARE COMMUNIT, V8, P43, DOI 10.1177/2150131916671229
   Rhee TG, 2017, HEADACHE, V57, P97, DOI 10.1111/head.12986
   Roglic G, 2016, GLOB REP DIAB
   Shane-McWhorter L, 2013, DIAB SPECT, V26, P259
   Spinks J, 2013, EUR J INTEGR MED, V5, P44, DOI 10.1016/j.eujim.2012.08.003
   Sridharan K, 2011, COCHRANE DB SYST REV, V12
   Stata Corp, 2013, SURV DAT REF MAN
   Upchurch DM, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0886-y
   Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389
NR 33
TC 3
Z9 3
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1753-0393
EI 1753-0407
J9 J DIABETES
JI J. Diabetes
PD APR
PY 2018
VL 10
IS 4
BP 310
EP 319
DI 10.1111/1753-0407.12607
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GA6JF
UT WOS:000428438500007
PM 28898555
DA 2019-01-08
ER

PT J
AU Whittemore, R
   Delvy, R
   McCarthy, MM
AF Whittemore, Robin
   Delvy, Roberta
   McCarthy, Margaret M.
TI The Experience of Partners of Adults with Type 1 Diabetes: an
   Integrative Review
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Type 1 diabetes; Adults; Partners; Hypoglycemia; Significant others;
   Marriage
ID QUALITY-OF-LIFE; EXCHANGE CLINIC REGISTRY; SELF-MANAGEMENT BEHAVIOR;
   GLYCEMIC CONTROL; MARITAL RELATIONSHIP; SEVERE HYPOGLYCEMIA;
   YOUNG-ADULTS; ASSOCIATION; IMPACT; SPOUSES
AB Purpose of Review The purpose of this review was to synthesize the research on the experience of partners living with adults with type 1 diabetes (T1D).
   Recent Findings Eleven studies were included in the review. Three themes on the experience of living with a person with T1D were identified: the undercurrent of hypoglycemia, partners' involvement in diabetes care, and the impact on partners' lives. Due to considerable fear of hypoglycemia, partners had pervasive and deliberate ways in which they made attempts to minimize hypoglycemia in the person with diabetes and its cascade to a health emergency. As a result, partners of adults with T1D experienced considerable distress and disrupted lives. Partners also expressed a need for more support from family, friends, and health professionals.
   Summary Research is needed on the partner experience across the lifespan and the specific supportive services they need in order to optimize their health outcomes.
C1 [Whittemore, Robin; Delvy, Roberta] Yale Sch Nursing, West Haven, CT 06516 USA.
   [McCarthy, Margaret M.] NYU, Rory Meyers Coll Nursing, New York, NY USA.
RP Whittemore, R (reprint author), Yale Sch Nursing, West Haven, CT 06516 USA.
EM Robin.whittemore@yale.edu
CR American Diabetes A. 6, 2017, DIABETES CARE S1, V40, pS48, DOI DOI 10.2337/DC17-S009
   American Diabetes Association, 2017, Diabetes Care, V40, pS114
   Anderson Barbara J, 2003, Curr Diab Rep, V3, P134, DOI 10.1007/s11892-003-0037-6
   [Anonymous], TYP 1 DIAB FACTS
   Bailey TS, 2016, ENDOCR PRACT, V22, P231, DOI 10.4158/EP151124.CS
   Balfe M, 2014, HEALTH PLACE, V26, P180, DOI 10.1016/j.healthplace.2013.12.016
   Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Barnard Katharine, 2016, J Diabetes Sci Technol, V10, P824, DOI 10.1177/1932296816645365
   Beck RW, 2009, DIABETES CARE, V32, P2047, DOI 10.2337/dc09-0846
   Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485
   Chaytor Naomi S, 2016, Diabetes Spectr, V29, P219
   Critical Appraisal Skills Programme, CASP QUAL CHECKL
   Dhaliwal Ruban, 2014, Diabetes Spectr, V27, P9, DOI 10.2337/diaspect.27.1.9
   DuBose SN, 2016, DIABETES TECHNOL THE, V18, P765, DOI 10.1089/dia.2016.0268
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   GonderFrederick L, 1997, DIABETES CARE, V20, P1543, DOI 10.2337/diacare.20.10.1543
   Hagedoorn M, 2006, DIABETIC MED, V23, P271, DOI 10.1111/j.1464-5491.2006.01794.x
   Joensen LE, 2016, PRIM CARE DIABETES, V10, P41, DOI 10.1016/j.pcd.2015.06.007
   Joensen LE, 2013, DIABETES RES CLIN PR, V101, P278, DOI 10.1016/j.diabres.2013.07.001
   Jorgensen HV, 2003, DIABETES CARE, V26, P1106, DOI 10.2337/diacare.26.4.1106
   Joseph NT, 2014, PSYCHOSOM MED, V76, P347, DOI 10.1097/PSY.0000000000000071
   Jull J, 2016, CAN J DIABETES, V40, P164, DOI 10.1016/j.jcjd.2015.09.080
   King J, 2015, DIABETES EDUCATOR, V41, P698, DOI 10.1177/0145721715606223
   King PS, 2014, HEALTH PSYCHOL, V33, P424, DOI 10.1037/a0032804
   Lawton J, 2014, DIABETES CARE, V37, P109, DOI 10.2337/dc13-1154
   Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425
   Marathe PH, 2017, J DIABETES, V9, P320, DOI 10.1111/1753-0407.12524
   Martyn-Nemeth P, 2017, J DIABETES COMPLICAT, V31, P735, DOI 10.1016/j.jdiacomp.2016.12.015
   McCarthy MM, 2016, DIABETES EDUCATOR, V42, P108, DOI 10.1177/0145721715620021
   McCrimmon RJ, 2010, DIABETES, V59, P2333, DOI 10.2337/db10-0103
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Morris M, 2006, J DIABETES NURSING, V10, P194
   National Heart Lung and Blood Institute, QUAL ASS TOOL OBS CO
   Nefs G, 2015, DIABETIC MED, V32, P1289, DOI 10.1111/dme.12739
   Nielsen HB, 2016, DIABETES RES CLIN PR, V121, P62, DOI 10.1016/j.diabres.2016.08.021
   Peinemann F, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008216.pub4, 10.1371/journal.pmed.1000097, 10.1136/bmj.c869, 10.1136/bmj.b2535, 10.1016/j.jclinepi.2010.02.006, 10.1002/14651858.CD008242.pub3, 10.1016/j.jclinepi.2010.03.004]
   Polonsky WH, 2016, DIABETES TECHNOL THE, V18, P292, DOI 10.1089/dia.2015.0451
   Rajaram SS, 1997, SOCIOL HEALTH ILL, V19, P281, DOI 10.1111/1467-9566.ep11057161
   Rickels MR, 2017, J CLIN ENDOCR METAB
   Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899
   Ritholz MD, 2014, DIABETIC MED, V31, P47, DOI 10.1111/dme.12276
   Schokker MC, 2010, J FAM PSYCHOL, V24, P578, DOI 10.1037/a0021009
   Secrest AM, 2010, DIABETES, V59, P3216, DOI 10.2337/db10-0862
   Snell-Bergeon JK, 2012, J CARDIOVASC TRANSL, V5, P446, DOI 10.1007/s12265-012-9363-x
   Stahl M, 1998, DIABETIC MED, V15, P619, DOI 10.1002/(SICI)1096-9136(199807)15:7<619::AID-DIA619>3.0.CO;2-T
   Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4
   Trief PM, 2017, J HEALTH PSYCHOL, V22, P446, DOI 10.1177/1359105315605654
   Trief PM, 2014, DIABETES CARE, V37, P1563, DOI 10.2337/dc13-1867
   Trief PM, 2013, DIABETES CARE, V36, P2483, DOI 10.2337/dc12-1718
   Trief PM, 2002, DIABETES CARE, V25, P1154, DOI 10.2337/diacare.25.7.1154
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048
   Weinstock RS, 2016, DIABETES CARE, V39, P603, DOI 10.2337/dc15-1426
   Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Wong ND, 2016, DIABETES CARE, V39, P668, DOI 10.2337/dc15-2439
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 57
TC 0
Z9 0
U1 3
U2 8
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD APR
PY 2018
VL 18
IS 4
AR 19
DI 10.1007/s11892-018-0986-4
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FZ9TG
UT WOS:000427953900003
PM 29500739
DA 2019-01-08
ER

PT J
AU Pyatak, EA
   Carandang, K
   Vigen, CLP
   Blanchard, J
   Diaz, J
   Concha-Chavez, A
   Sequeira, PA
   Wood, JR
   Whittemore, R
   Spruijt-Metz, D
   Peters, AL
AF Pyatak, Elizabeth A.
   Carandang, Kristine
   Vigen, Cheryl L. P.
   Blanchard, Jeanine
   Diaz, Jesus
   Concha-Chavez, Alyssa
   Sequeira, Paola A.
   Wood, Jamie R.
   Whittemore, Robin
   Spruijt-Metz, Donna
   Peters, Anne L.
TI Occupational Therapy Intervention Improves Glycemic Control and Quality
   of Life Among Young Adults With Diabetes: the Resilient, Empowered,
   Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial
SO DIABETES CARE
LA English
DT Article
ID SELF-CARE BEHAVIORS; EMERGING ADULTS; MANAGEMENT INTERVENTION;
   TRANSITION PROGRAM; TYPE-1; ADHERENCE; OUTCOMES; SUPPORT; SCALE;
   QUESTIONNAIRE
AB OBJECTIVE
   To assess the efficacy of a manualized occupational therapy (OT) intervention (Resilient, Empowered, Active Living with Diabetes [REAL Diabetes]) to improve glycemic control and psychosocial well-being among ethnically diverse young adults with low socioeconomic status (SES) who have type 1 or type 2 diabetes.
   RESEARCH DESIGN AND METHODS
   Eighty-one young adults (age 22.6 +/- 3.5 years; hemoglobin A(1c) [HbA(1c)] = 10.8%/95 mmol/mol +/- 1.9%/20.8 mmol/mol) were randomly assigned to the REAL Diabetes intervention group (IG) or an attention control group (CG) over 6 months. IG participants received biweekly sessions guided by a manual composed of seven content modules; CG participants received standardized educational materials and biweekly phone calls. Blinded assessors collected data at baseline and 6 months. The primary outcome was HbA(1c); secondary outcomes included diabetes self-care, diabetes-related quality of life (QOL), diabetes distress, depressive symptoms, and life satisfaction. Change scores were analyzed using Wilcoxon rank sum tests.
   RESULTS
   Intent-to-treat analyses showed that IG participants showed significant improvement in HbA(1c) (-0.57%/6.2 mmol/mol vs. +0.36%/3.9 mmol/mol, P = 0.01), diabetes-related QOL (+0.7 vs. +0.15, P = 0.04), and habit strength for checking blood glucose (+3.9 vs. +1.7, P = 0.05) as compared with CG participants. There was no statistically significant effect modification by sex, ethnicity, diabetes type, recruitment site, or SES. No study-related serious adverse events were reported.
   CONCLUSIONS
   The REAL Diabetes intervention improved blood glucose control and diabetes-related QOL among a typically hard-to-reach population, thus providing evidence that a structured OT intervention may be beneficial in improving both clinical and psychosocial outcomes among individuals with diabetes.
C1 [Pyatak, Elizabeth A.; Carandang, Kristine; Vigen, Cheryl L. P.; Blanchard, Jeanine; Diaz, Jesus; Concha-Chavez, Alyssa] Univ Southern Calif, Chan Div Occupat Sci & Occupat Therapy, Los Angeles, CA 90007 USA.
   [Sequeira, Paola A.] Univ Southern Calif, Dept Pediat, Los Angeles, CA USA.
   [Wood, Jamie R.] Childrens Hosp Los Angeles, Los Angeles, CA USA.
   [Whittemore, Robin] Yale Sch Nursing, New Haven, CT USA.
   [Spruijt-Metz, Donna] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA USA.
   [Peters, Anne L.] Univ Southern Calif, Div Endocrinol, Beverly Hills, CA USA.
RP Pyatak, EA (reprint author), Univ Southern Calif, Chan Div Occupat Sci & Occupat Therapy, Los Angeles, CA 90007 USA.
EM beth.pyatak@usc.edu
OI Pyatak, Elizabeth/0000-0003-3280-8912
FU National Institute of Diabetes and Digestive and Kidney Diseases at the
   National Institutes of Health [1K01 DK099202-01A1]
FX This work was supported by the National Institute of Diabetes and
   Digestive and Kidney Diseases at the National Institutes of Health (1K01
   DK099202-01A1).; The content is solely the responsibility of the authors
   and does not represent the official view of the National Institutes of
   Health.
CR Agarwal S, 2017, DIABETES EDUCATOR, V43, P87, DOI 10.1177/0145721716677098
   American Occupational Therapy Association, 2015, AOTA FACT SHEET THE
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Berkowitz RI, 2018, PEDIATR DIABETES, V19, P191, DOI 10.1111/pedi.12555
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004
   Dabelea D, 2017, JAMA-J AM MED ASSOC, V317, P825, DOI 10.1001/jama.2017.0686
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Gardner B, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-102
   Garvey J, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0267-0
   Glasgow RE, 2004, J BEHAV MED, V27, P477, DOI 10.1023/B:JOBM.0000047611.81027.71
   Gonzalez JS, 2016, AM PSYCHOL, V71, P539, DOI 10.1037/a0040388
   Haltiwanger EP, 2012, AM J OCCUP THER, V66, P447, DOI 10.5014/ajot.2012.004457
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hendricks M, 2013, DIABETES EDUCATOR, V39, P195, DOI 10.1177/0145721713475840
   Hollingshead AB, 1975, 4 FACTOR INDEX SOCIA
   Holmes-Walker DJ, 2007, DIABETIC MED, V24, P764, DOI 10.1111/j.1464-5491.2007.02152.x
   Jackson J, 1998, AM J OCCUP THER, V52, P326, DOI 10.5014/ajot.52.5.326
   Johnson B, 2014, DIABETIC MED, V31, P227, DOI 10.1111/dme.12305
   Kibbey KJ, 2013, DIABETIC MED, V30, P878, DOI 10.1111/dme.12227
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Lado JJ, 2016, ENDOCRIN METAB CLIN, V45, P453, DOI 10.1016/j.ecl.2016.01.002
   Markowitz JT, 2012, DIABETIC MED, V29, P522, DOI 10.1111/j.1464-5491.2011.03537.x
   Markowitz Jessica T, 2014, J Diabetes Sci Technol, V8, P1029, DOI 10.1177/1932296814540130
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   O'Toole L, 2013, AUST OCCUP THER J, V60, P30, DOI 10.1111/1440-1630.12008
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Pillay J, 2015, ANN INTERN MED, V163, P836, DOI 10.7326/M15-1399
   Pillay J, 2015, ANN INTERN MED, V163, P848, DOI 10.7326/M15-1400
   Pyatak EA, 2017, CONTEMP CLIN TRIALS, V54, P8, DOI 10.1016/j.cct.2016.12.025
   Pyatak EA, 2015, OTJR-OCCUP PART HEAL, V35, P187, DOI 10.1177/1539449215584310
   Raymond JK, 2016, DIABETES TECHNOL THE, V18, P385, DOI 10.1089/dia.2015.0425
   Rhodes ET, 2012, DIABETIC MED, V29, P453, DOI 10.1111/j.1464-5491.2011.03542.x
   Schwartz JK, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.021006
   Sequeira PA, 2015, DIABETES CARE, V38, P1412, DOI 10.2337/dc14-2577
   Simon AU, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2017.025502
   Smalls BL, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1086-7
   Steinbeck KS, 2015, PEDIATR DIABETES, V16, P634, DOI 10.1111/pedi.12229
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Wood Jamie R, 2012, J Diabetes Sci Technol, V6, P380
   Wood W., 2016, BEHAV SCI POLICY, V2, P71, DOI DOI 10.1353/BSP.2016.0008
NR 43
TC 2
Z9 2
U1 6
U2 11
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD APR 1
PY 2018
VL 41
IS 4
BP 696
EP 704
DI 10.2337/dc17-1634
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GA0JT
UT WOS:000428000000027
PM 29351961
DA 2019-01-08
ER

PT J
AU Vanlalhruaii
   Dasgupta, R
   Ramachandran, R
   Mathews, JE
   Regi, A
   Thomas, N
   Gupta, V
   Visalakshi, P
   Asha, HS
   Paul, T
   Thomas, N
AF Vanlalhruaii
   Dasgupta, Riddhi
   Ramachandran, Roshna
   Mathews, Jiji E.
   Regi, Annie
   Thomas, Niranjan
   Gupta, Vijay
   Visalakshi, P.
   Asha, H. S.
   Paul, Thomas
   Thomas, Nihal
TI How safe is metformin when initiated in early pregnancy? A retrospective
   5-year study of pregnant women with gestational diabetes mellitus from
   India
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
ID POLYCYSTIC-OVARY-SYNDROME; 1ST TRIMESTER; OUTCOMES; INSULIN; BIRTH;
   HYPERGLYCEMIA; INFANTS; RISK
AB Background: The initiation of metformin in early pregnancy in Gestational Diabetes mellitus (GDM) remains controversial. The aim of our study was to assess the influence of Metformin on maternal and fetal outcomes when initiated within the first trimester of pregnancy in GDM.
   Methods and materials: A retrospective analysis of 540 women with diabetes complicating pregnancy (IADPSG criteria) over five years (January 2011 to May 2016) was done. The study population comprised of patients initiated on (a) metformin within the first trimester (Group A:n = 186), (b) metformin after the first trimester (Group B:n = 203) and (c) insulin at any time during their pregnancy (Group C:n = 151). The primary outcomes compared were prematurity, respiratory distress, birth trauma, 5-min APGAR score, neonatal hypoglycaemia and need for phototherapy, while secondary outcomes compared were neonatal anthropometric measurements, maternal glycemic control, maternal hypertensive complications, postpartum glucose tolerance.
   Results: Individual and composite primary or secondary outcomes in group A were similar to Groups B and C, though numerically higher premature births were seen in Group A. There was a 1.3% overall incidence of stillbirths/IUD, while 1.11% congenital anomalies were noted of which 2.15% were in group A and 1.32% were in Group C (p = .16).
   Conclusions: The initiation of metformin within the first trimester of pregnancy has no significant adverse maternal or fetal outcomes. However, vigilance for premature births is recommended in women exposed to metformin in early pregnancy. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Vanlalhruaii; Dasgupta, Riddhi; Ramachandran, Roshna; Asha, H. S.; Paul, Thomas; Thomas, Nihal] CMC, Dept Endocrinol Diabet & Metab, Vellore 632004, Tamil Nadu, India.
   [Mathews, Jiji E.; Regi, Annie] CMC, Dept Obstet & Gynecol, Vellore, Tamil Nadu, India.
   [Thomas, Niranjan; Gupta, Vijay] CMC, Dept Neonatol, Vellore, Tamil Nadu, India.
   [Visalakshi, P.] CMC, Dept Stat, Vellore, Tamil Nadu, India.
RP Dasgupta, R (reprint author), CMC, Dept Endocrinol Diabet & Metab, Vellore 632004, Tamil Nadu, India.
EM riddhi_dg@rediffmail.com
CR Balani J, 2009, DIABETIC MED, V26, P798, DOI 10.1111/j.1464-5491.2009.02780.x
   Ben-Haroush A, 2004, EUR J OBSTET GYN R B, V115, P125, DOI 10.1016/j.ejogrb.2003.11.027
   Blumer I, 2013, J CLIN ENDOCR METAB, V98, P4227, DOI 10.1210/jc.2013-2465
   Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701
   Cassina M, 2014, HUM REPROD UPDATE, V20, P656, DOI 10.1093/humupd/dmu022
   Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006
   George A, 2015, AUST NZ J OBSTET GYN, V55, P47, DOI 10.1111/ajo.12276
   Gilbert CJ, 2005, CAN FAM PHYSICIAN, V51, P1070
   Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585
   Ivan Ngai, 2014, OBSTET GYNECOLOGY, DOI [10.1097/01.AOG.0000447165.22404.99, DOI 10.1097/01.AOG.0000447165.22404.99]
   Kamana KC, 2015, ANN NUTR METAB, V66, P14, DOI 10.1159/000371628
   Kitzmiller JL, 2007, DIABETES CARE, V30, pS225, DOI 10.2337/dc07-s221
   Kock K, 2010, J MATERN-FETAL NEO M, V23, P1004, DOI 10.3109/14767050903551392
   Koren G, 2006, CAN FAM PHYSICIAN, V52, P171
   Lautatzis ME, 2013, METABOLISM, V62, P1522, DOI 10.1016/j.metabol.2013.06.006
   Metzger BE, 1998, DIABETES CARE, V21, pB161
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Poolsup N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109985
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Rowan JA, 2008, NEW ENGL J MED, V358, P2003, DOI 10.1056/NEJMoa0707193
   Seaton SE, 2011, NEONATOLOGY, V100, P398, DOI 10.1159/000325916
   Singh A, 2016, J OBSTET GYN INDIA, V66, P77, DOI 10.1007/s13224-015-0785-7
   Sivalingam VN, 2014, HUM REPROD UPDATE, V20, P853, DOI 10.1093/humupd/dmu037
   Zeng XL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004526
NR 24
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAR
PY 2018
VL 137
BP 47
EP 55
DI 10.1016/j.diabres.2018.01.002
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GC6KZ
UT WOS:000429901700006
PM 29325773
DA 2019-01-08
ER

PT J
AU Trump, LJ
   Novak, JR
   Anderson, JR
   Mendenhall, TJ
   Johnson, MD
   Scheufler, AC
   Wilcox, A
   Lewis, VL
   Robbins, DC
AF Trump, Lisa J.
   Novak, Joshua R.
   Anderson, Jared R.
   Mendenhall, Tai J.
   Johnson, Matthew D.
   Scheufler, Ann C.
   Wilcox, Allison
   Lewis, Virginia L.
   Robbins, David C.
TI Evaluative Coping, Emotional Distress, and Adherence in Couples With
   Type 2 Diabetes
SO FAMILIES SYSTEMS & HEALTH
LA English
DT Article
DE couples; diabetes; evaluative coping; emotional distress; spousal
   support
ID QUALITY-OF-LIFE; SELF-CARE; EXERCISE ADHERENCE; SPOUSAL SUPPORT; CHRONIC
   ILLNESS; MEDICATION ADHERENCE; GENDER-DIFFERENCES; GLUCOSE CONTROL;
   SOCIAL SUPPORT; OLDER-ADULTS
AB Introduction: Spousal support is one of the strongest and most consistent predictors of Type 2 diabetes treatment adherence. However, the effects of both spouses' evaluations of dyadic coping on emotional distress and patients' physical health remain largely unknown. Method: Dyadic data from 117 married couples in which one member is diagnosed with Type 2 diabetes were evaluated in two separate models to explore the associations between (a) patients' and spouses' depression symptoms and patients' adherence to dietary and exercise regimens, and (b) patients' and spouses' acute stress levels and patients' adherence to dietary and exercise regimens. Finally, evaluative dyadic coping was included as a possible moderator between these associations. Results: Results from an actor-partner interdependence model revealed significant actor effects of patients' depression symptoms on patients' adherence to dietary and exercise regimens. Spouses' evaluation of dyadic coping attenuated the direct paths between spouses' depression symptoms and patients' adherence to dietary regimens. No direct pathways were found from patients' or spouses' acute stress to patients' adherence to dietary and exercise regimens. However, spouses' evaluation of dyadic coping attenuated the direct paths between spouses' acute stress and patients' adherence to dietary regimens. Discussion: Tapping into spouses' evaluations of dyadic coping has significant implications for patients' diabetes health outcomes (e.g., adherence to dietary and exercise treatment regimens). Findings from this study highlight the need for systemic interventions targeting both partners.
C1 [Trump, Lisa J.; Mendenhall, Tai J.] Univ Minnesota, Dept Family Social Sci, 290 McNeal Hall,1985 Buford Ave, St Paul, MN 55108 USA.
   [Novak, Joshua R.] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA.
   [Anderson, Jared R.] Kansas State Univ, Dept Family Studies & Human Serv, Manhattan, KS 66506 USA.
   [Johnson, Matthew D.] Univ Alberta, Dept Human Ecol, Edmonton, AB, Canada.
   [Scheufler, Ann C.; Wilcox, Allison; Lewis, Virginia L.; Robbins, David C.] Univ Kansas, Sch Med, Lawrence, KS 66045 USA.
RP Trump, LJ (reprint author), Univ Minnesota, Dept Family Social Sci, 290 McNeal Hall,1985 Buford Ave, St Paul, MN 55108 USA.
EM buch0245@umn.edu
FU CTSA grant from NCRR [UL1TR000001]; NCATS
FX REDCap at University of Kansas Medical Center is supported by CTSA grant
   (Award UL1TR000001) from NCRR and NCATS awarded to the University of
   Kansas Medical Center for Frontiers: The Heartland Institute for
   Clinical and Translational Research.
CR American Diabetes Association, 2014, DEPRESSION
   Anderson JR, 2016, J BEHAV MED, V39, P1020, DOI 10.1007/s10865-016-9796-9
   ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685
   August KJ, 2013, J FAM PSYCHOL, V27, P712, DOI 10.1037/a0034181
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Awadalla AW, 2006, J NATL MED ASSOC, V98, P727
   Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920
   Berg CA, 2009, J FAM PSYCHOL, V23, P521, DOI 10.1037/a0015556
   Beverly EA, 2008, HEALTH EDUC BEHAV, V35, P707, DOI 10.1177/1090198107299787
   Beverly EA, 2010, HEALTH EDUC RES, V25, P211, DOI 10.1093/her/cyn032
   Bodenmann G., 2008, MULTIDIMENSION UNPUB
   Bodenmann G., 2008, DYADIC COPING INVENT
   Bodenmann G, 2011, EUR PSYCHOL, V16, P255, DOI 10.1027/1016-9040/a000068
   Choi SE, 2009, DIABETES EDUCATOR, V35, P978, DOI 10.1177/0145721709349220
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Conger RD, 1999, J PERS SOC PSYCHOL, V76, P54, DOI 10.1037//0022-3514.76.1.54
   Corrigan FM, 2011, J PSYCHOPHARMACOL, V25, P17, DOI 10.1177/0269881109354930
   Denham SA, 2007, FAMILIES SYSTEMS HLT, V25, P36, DOI DOI 10.1037/1091-7527.25.1.36
   Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008
   Dimitraki G, 2014, INT J BEHAV MED, V21, P230, DOI 10.1007/s12529-013-9296-z
   Fisher L, 2002, DIABETES CARE, V25, P1564, DOI 10.2337/diacare.25.9.1564
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Franks MM, 2012, AGING MENT HEALTH, V16, P902, DOI 10.1080/13607863.2012.674486
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gorchoff SM, 2008, PSYCHOL SCI, V19, P1194, DOI 10.1111/j.1467-9280.2008.02222.x
   Heffner KL, 2004, J BEHAV MED, V27, P233, DOI 10.1023/B:JOBM.0000028497.79129.ad
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   International Diabetes Federation, 2015, DIABETES ATLAS
   Johnson MD, 2016, J FAM PSYCHOL, V30, P203, DOI 10.1037/fam0000161
   Johnson MD, 2014, HEALTH PSYCHOL, V33, P841, DOI 10.1037/hea0000054
   Johnson MD, 2013, J FAM PSYCHOL, V27, P722, DOI 10.1037/a0034006
   Jorwal P., 2015, J SOCIAL HLTH DIABET, V3, P95, DOI DOI 10.4103/2321-0656.152806
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Martire LM, 2002, HEALTH PSYCHOL, V21, P167, DOI 10.1037//0278-6133.21.2.167
   Martire LM, 2010, ANN BEHAV MED, V40, P325, DOI 10.1007/s12160-010-9216-2
   Muthen L. K., 1998, MPLUS USERS GUIDE
   National Institute of Mental Health, 2011, DEPRESSION DIABETES
   Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037
   Osborn CY, 2014, WESTERN J NURS RES, V36, P1091, DOI 10.1177/0193945914524639
   Polonsky William H, 2002, Curr Diab Rep, V2, P153, DOI 10.1007/s11892-002-0075-5
   Rook KS, 2016, J HEALTH PSYCHOL, V21, P2538, DOI 10.1177/1359105315581064
   Roper SO, 2009, FAM RELAT, V58, P460, DOI 10.1111/j.1741-3729.2009.00566.x
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief P., 2003, FAMILIES SYSTEMS HLT, V21, P57, DOI [DOI 10.1037/H0089502, 10.1037/h0089502]
   Vassilev I, 2011, CHRONIC ILLN, V7, P60, DOI 10.1177/1742395310383338
   Whittemore R, 2005, J CLIN NURS, V14, P195, DOI 10.1111/j.1365-2702.2004.00937.x
NR 48
TC 0
Z9 0
U1 1
U2 3
PU EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA
SN 1091-7527
EI 1939-0602
J9 FAM SYST HEALTH
JI Fam. Syst. Health
PD MAR
PY 2018
VL 36
IS 1
BP 87
EP 96
DI 10.1037/fsh0000302
PG 10
WC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
SC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
GA GB1YQ
UT WOS:000428848000010
PM 29172625
DA 2019-01-08
ER

PT J
AU Lobo, JM
   Anderson, R
   Stukenborg, GJ
   McCall, A
   Kang, H
   Camacho, F
   Sohn, MW
AF Lobo, Jennifer M.
   Anderson, Roger
   Stukenborg, George J.
   McCall, Anthony
   Kang, Hyojung
   Camacho, Fabian
   Sohn, Min-Woong
TI Disparities in the Use of Diabetes Screening in Appalachia
SO JOURNAL OF RURAL HEALTH
LA English
DT Article
DE Appalachia; diabetes; health disparities; rural; screening
ID CANCER
AB PurposeThe Appalachian region presents disproportionately high rates of chronic disease compared to the rest of the United States. Early diagnosis of diabetes through screening is an important step in reducing diabetes complications. This study examines disparities in the use of diabetes screening in Appalachia.
   MethodsWe analyzed 2009 and 2010 Behavioral Risk Factor Surveillance System data for 96,111 adults aged 45 years from 11 Appalachian states. Based on economic status, Appalachian counties were grouped into distressed (least affluent), at-risk, transitional, and competitive (most affluent). Logistic regression analyses were used to estimate the statistical significance and effect size of factors associated with diabetes screening.
   ResultsCompetitive counties had the highest rate of diabetes screening (65.4%). At-risk counties had the lowest rate (60.3%), about 7.8% lower compared to competitive counties (P < .001). After adjusting for socioeconomic factors, differences in screening rates between county economic levels in Appalachia were not statistically significant. Among respondents 65 years, at-risk counties had an 8.1% lower screening rate compared to competitive counties; this difference was not adequately explained by differences in socioeconomic factors. Screening rates in distressed and transitional counties were not significantly different from competitive counties in unadjusted or adjusted models.
   ConclusionsAt-risk counties had significantly lower screening rates than competitive counties. They should receive more policy attention similar to that received by distressed counties. Social policies that improve socioeconomic status and educational attainment, and health policies that reduce barriers to access to care may reduce disparities in diabetes screening rates in the less affluent Appalachian counties.
C1 [Lobo, Jennifer M.; Anderson, Roger; Stukenborg, George J.; Camacho, Fabian; Sohn, Min-Woong] Univ Virginia, Sch Med, Dept Publ Hlth Sci, 3rd Floor,Rm 3181, Charlottesville, VA 22908 USA.
   [McCall, Anthony] Univ Virginia, Sch Med, Internal Med, Charlottesville, VA 22908 USA.
   [Kang, Hyojung] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA USA.
RP Sohn, MW (reprint author), Univ Virginia, Sch Med, Dept Publ Hlth Sci, 3rd Floor,Rm 3181, Charlottesville, VA 22908 USA.
EM msohn@virginia.edu
FU Agency for Healthcare Research and Quality [R01HS018542]
FX The authors gratefully acknowledge the financial support from the Agency
   for Healthcare Research and Quality (R01HS018542). The paper presents
   the findings and conclusions of the authors; it does not necessarily
   represent the Agency for Healthcare Research and Quality.
CR American Diabetes Association, 2002, DIABETES CARE, V25, pS21
   American Diabetes Association, 2015, AM DIAB ASS DIS SCOP
   Anderson RT, 2014, HEALTH SERV RES, V49, P546, DOI 10.1111/1475-6773.12108
   [Anonymous], 2016, HLTH PEOPL 2020 DIAB
   Appalachian Regional Commission, 2013, COUNTY EC STAT APP
   Appalachian Regional Commission, 2010, MOV APP FORW APP REG
   Ashkenazy R, 2006, J GEN INTERN MED, V21, P386, DOI 10.1111/j.1525-1497.2006.00403.x
   Barker L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-54
   Barker L, 2010, PREV CHRONIC DIS, V7
   Berg AO, 2003, ANN INTERN MED, V138, P212, DOI 10.7326/0003-4819-138-3-200302040-00014
   Crespo R, 2011, HEALTH PROMOT PRACT, V12, P544, DOI 10.1177/1524839910377965
   Denham SA, 2012, APPALACHIAN HEALTH AND WELL-BEING, P131
   Greever C, 2014, PUBLIC HLTH APPALACH, V35, P46
   Health Resources and Services Administration, 2013, AR HLTH RES FIL AHRF
   Hopenhayn C, 2008, CANCER, V113, P2974, DOI 10.1002/cncr.23749
   Johnson CL, 2013, VITAL HLTH STAT, V2, P2013
   Johnson LK, 2015, RURAL REMOTE HEALTH, V15
   Keppel Kenneth, 2005, Vital Health Stat 2, P1
   Mashaw AJ, 2014, AM J CLIN MED, V10, P64
   Misra R, 2016, J DIABETES RES, DOI 10.1155/2016/2456518
   Pedhazur E. J., 1982, MULTIPLE REGRESSION
   Petrocelli JV, 2003, MEAS EVAL COUNS DEV, V36, P9
   Rao J.N.K., 2003, SMALL AREA ESTIMATIO
   Shrestha SS, 2012, OPEN DIABETES J, V5, P29
   Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345
   Tan X, 2016, RES SOC ADM PHARM
   Yao N, 2016, J RURAL HEALTH
   Zhuo XH, 2012, HEALTH AFFAIR, V31, P50, DOI 10.1377/hlthaff.2011.1115
NR 28
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0890-765X
EI 1748-0361
J9 J RURAL HEALTH
JI J. Rural Health
PD SPR
PY 2018
VL 34
IS 2
BP 173
EP 181
DI 10.1111/jrh.12247
PG 9
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA GB8KW
UT WOS:000429325800008
PM 28686786
DA 2019-01-08
ER

PT J
AU Pacanowski, CR
   Linde, JA
   Faulconbridge, LF
   Coday, M
   Safford, MM
   Chen, HY
   Yanovski, SZ
   Ewing, LJ
   Wing, R
   Jeffery, RW
AF Pacanowski, Carly R.
   Linde, Jennifer A.
   Faulconbridge, Lucy F.
   Coday, Mace
   Safford, Monika M.
   Chen, Haiying
   Yanovski, Susan Z.
   Ewing, Linda J.
   Wing, Rena
   Jeffery, Robert W.
TI Psychological Status and Weight Variability Over Eight Years: Results
   From Look AHEAD
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE body weight; mental health; depressive symptoms; binge eating; body
   weight change
ID BINGE-EATING DISORDER; LIFE-STYLE INTERVENTION; HEALTH SURVEY SF-36;
   OBESE PERSONS; LOSS MAINTENANCE; WOMEN; TRIAL; DEPRESSION; INVENTORY;
   CONSEQUENCES
AB Objective: Cross-sectional studies suggest an association between weight cycling and psychological status. Although this is often interpreted as suggesting that weight cycles "cause" psychological distress, the relationship could be bidirectional. This study provides a prospective analysis of the bidirectional association between weight variability and psychological status over an 8-year period in overweight/obese adults with Type 2 diabetes. Method: Data were from the first 8 years of Look AHEAD, a randomized controlled trial comparing health outcomes in individuals with Type 2 diabetes assigned to an intensive lifestyle intervention designed to produce weight loss or a diabetes education and support control group. Psychological status (mental health, depressive symptoms, binge eating) was assessed via surveys and were examined in relation to weight variability at both baseline and year 8. Weight variability was derived from 8 possible annual measurements from participants who had a minimum of 3 consecutive body weight measurements (N = 4,774) and operationalized as the number of year-to-year cycles and the coefficient of variation across all available weight measurements. Results: Controlling for study group, higher baseline scores on mental health (Short Form-36 Mental Component Summary) and lower levels of depressive symptomatology (Beck Depression Inventory) and binge eating (Questionnaire on Eating and Weight Patterns) were associated with significantly less subsequent weight variability. The prospective association between weight variability and psychological status at year 8 was less robust. Conclusions: These results suggest that the cross-sectional relationship between weight variability and psychological status is due primarily to poorer psychological function preceding greater weight instability.
C1 [Pacanowski, Carly R.] Univ Delaware, Dept Behav Hlth & Nutr, 026 North Coll Ave,015 Carpenter Sports Bldg, Newark, DE 19716 USA.
   [Linde, Jennifer A.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.
   [Faulconbridge, Lucy F.] Univ Penn, Pearlman Sch Med, Philadelphia, PA 19104 USA.
   [Coday, Mace] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA.
   [Safford, Monika M.] Cornell Univ, Weill Cornell Med Coll, Dept Med, Ithaca, NY 14853 USA.
   [Chen, Haiying] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat, Winston Salem, NC 27109 USA.
   [Yanovski, Susan Z.] NIDDK, NIH, Bethesda, MD 20892 USA.
   [Ewing, Linda J.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.
   [Wing, Rena] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA.
   [Jeffery, Robert W.] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Minneapolis, MN 55455 USA.
RP Pacanowski, CR (reprint author), Univ Delaware, Dept Behav Hlth & Nutr, 026 North Coll Ave,015 Carpenter Sports Bldg, Newark, DE 19716 USA.
EM cpacanow@udel.edu
OI Pacanowski, Carly/0000-0001-6404-0886
FU  [T32 DK 083250];  [T32 MH 082761]
FX The first author was supported by Grants T32 DK 083250 and T32 MH
   082761.
CR Anderson JW, 2001, AM J CLIN NUTR, V74, P579
   Bartlett SJ, 1996, J CONSULT CLIN PSYCH, V64, P587, DOI 10.1037//0022-006X.64.3.587
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
   BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5
   Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3
   BROWNELL KD, 1994, ARCH INTERN MED, V154, P1325, DOI 10.1001/archinte.154.12.1325
   Casazza K, 2013, NEW ENGL J MED, V368, P446, DOI 10.1056/NEJMsa1208051
   Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383
   Chua JL, 2004, INT J OBESITY, V28, P606, DOI 10.1038/sj.ijo.0802595
   Clark M M, 2000, Eat Behav, V1, P47, DOI 10.1016/S1471-0153(00)00009-X
   Cutter G, 1996, ANN BEHAV MED, V18, P280, DOI 10.1007/BF02895290
   Dalle Grave R, 1996, EAT DISORD, V4, P67
   de Zwaan M, 2015, APPETITE, V91, P336, DOI 10.1016/j.appet.2015.04.064
   Diabetes Prevention Program ( DPP) Research Group, 2002, DIABETES CARE, V25, P2165, DOI DOI 10.2337/DIACARE.25.12.2165
   Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x
   Fairburn CG, 2008, COGNITIVE BEHAV THER
   FOREYT JP, 1995, INT J EAT DISORDER, V17, P263, DOI 10.1002/1098-108X(199504)17:3<263::AID-EAT2260170307>3.0.CO;2-N
   Forman EM, 2016, OBESITY, V24, P2050, DOI 10.1002/oby.21601
   Foster GD, 1996, J CONSULT CLIN PSYCH, V64, P752
   Foster GD, 1997, OBES RES, V5, P474, DOI 10.1002/j.1550-8528.1997.tb00674.x
   French SA, 1994, AM PSYCHOL ASS, V13, P195, DOI DOI 10.1037/0278-6133.13.3.195
   Friedman MA, 1998, J CONSULT CLIN PSYCH, V66, P646, DOI 10.1037/0022-006X.66.4.646
   Gallup, 2014, AM EFF LOS WEIGHT ST
   Geliebter Allan, 2003, Eat Behav, V3, P341, DOI 10.1016/S1471-0153(02)00100-9
   GORMALLY J, 1982, ADDICT BEHAV, V7, P47, DOI 10.1016/0306-4603(82)90024-7
   Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486
   Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001
   JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6
   Kensinger GJ, 1998, J AM DIET ASSOC, V98, P863, DOI 10.1016/S0002-8223(98)00199-0
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   KUEHNEL RH, 1994, INT J EAT DISORDER, V15, P321
   Manikandan S, 2010, J PHARMACOL PHARMACO, V1, P126, DOI 10.4103/0976-500X.72373
   Marchesini G, 2004, INT J OBESITY, V28, P1456, DOI 10.1038/sj.ijo.0802741
   MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006
   McNair D. M, 1981, PROFILE MOOD STATES
   Messier L, 2014, CAN J DIABETES, V38, P456, DOI 10.1016/j.jcjd.2014.01.005
   Montani JP, 2015, OBES REV, V16, P7, DOI 10.1111/obr.12251
   Osborn RL, 2011, ETHNIC DIS, V21, P274
   Sherwood NE, 1999, INT J OBESITY, V23, P485, DOI 10.1038/sj.ijo.0800846
   Simkin-Silverman LR, 1998, INT J EAT DISORDER, V24, P175, DOI 10.1002/(SICI)1098-108X(199809)24:2<175::AID-EAT7>3.0.CO;2-B
   SPITZER RL, 1993, INT J EAT DISORDER, V13, P137
   SPITZER RL, 1992, INT J EAT DISORDER, V11, P191, DOI 10.1002/1098-108X(199204)11:3<191::AID-EAT2260110302>3.0.CO;2-S
   Stein RI, 2007, INT J EAT DISORDER, V40, P195, DOI 10.1002/eat.20352
   Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175
   Stojek MMK, 2017, INT J EAT DISORDER, V50, P551, DOI 10.1002/eat.22636
   Strychar I, 2009, J AM DIET ASSOC, V109, P718, DOI 10.1016/j.jada.2008.12.026
   Venditti EM, 1996, J CONSULT CLIN PSYCH, V64, P400
   Vergnaud AC, 2008, INT J OBESITY, V32, P315, DOI 10.1038/sj.ijo.0803739
   Wadden TA, 2006, OBESITY, V14, p99S, DOI 10.1038/oby.2006.289
   Wadden TA, 2006, OBESITY, V14, P737
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wesche-Thobaben J, 2011, CLIN TRIALS, V8, P320, DOI 10.1177/1740774511405858
NR 53
TC 0
Z9 0
U1 0
U2 3
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD MAR
PY 2018
VL 37
IS 3
BP 238
EP 246
DI 10.1037/hea0000547
PG 9
WC Psychology, Clinical; Psychology
SC Psychology
GA FY6XL
UT WOS:000427006100004
PM 29504788
DA 2019-01-08
ER

PT J
AU Fujita, N
   Yamamoto, Y
   Hayashino, Y
   Kuwata, H
   Okamura, S
   Iburi, T
   Furuya, M
   Kitatani, M
   Yamazaki, S
   Ishii, H
   Tsujii, S
   Inagaki, N
   Fukuhara, S
AF Fujita, Naotaka
   Yamamoto, Yosuke
   Hayashino, Yasuaki
   Kuwata, Hirohito
   Okamura, Shintaro
   Iburi, Tadao
   Furuya, Miyuki
   Kitatani, Masako
   Yamazaki, Shin
   Ishii, Hitoshi
   Tsujii, Satoru
   Inagaki, Nobuya
   Fukuhara, Shunichi
CA Tenri Study Grp
TI Real-life glycemic control in patients with type 2 diabetes treated with
   insulin therapy: A prospective, longitudinal cohort study (Diabetes
   Distress and Care Registry at Tenri [DDCRT 9])
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Cohort study; Insulin therapy; Type 2 diabetes
ID QUALITY-OF-LIFE; JAPANESE PATIENTS; CARDIOVASCULAR-DISEASE; WEIGHT-GAIN;
   MELLITUS; HYPOGLYCEMIA; ASSOCIATION; BASAL; COMPLICATIONS; QUESTIONNAIRE
AB Aims/IntroductionWe investigated the association between four insulin regimens, and increase in glycated hemoglobin (HbA1c) and insulin dose in a real-life clinical setting because there are no data about them among insulin regimens.
   Materials and MethodsParticipants included 757 patients with type 2 diabetes having been treated with insulin therapy for more than 1 year. The four insulin regimens were regimen 1 (long-acting insulin, once daily), regimen 2 (biphasic insulin, twice daily), regimen 3 (biphasic insulin, three times daily) and regimen 4 (basal-bolus therapy). Main outcomes were increases in HbA1c levels >0.5% and increases in daily insulin units after 1 year. We carried out multivariable analyses to examine differences in glycemic control and insulin dose with adjustment for possible confounders.
   ResultsMean HbA1c level and duration of insulin therapy were 7.8% and 11.3 years, respectively. HbA1c levels increased by >0.5% at follow up in 22.8, 24.9, 20.7, and 29.3% of participants using regimen 1, 2, 3 and 4, respectively, with no significant differences between groups. Daily insulin doses increased in 62.3, 68.8, 65.3 and 38.6% of patients, respectively (P < 0.001). Multivariable regression analysis showed that patients who received regimen 4 had significantly lower odds of requiring future insulin dose increases than those who had received regimen 2 (adjusted odds ratio 0.24, 95% confidence interval 0.14-0.41; P < 0.001).
   ConclusionsMany patients receiving insulin therapy showed increases in HbA1c levels and insulin doses 1 year later. The smallest increase in insulin dose was observed in the basal-bolus therapy group compared with other regimens.
C1 [Fujita, Naotaka; Yamamoto, Yosuke; Hayashino, Yasuaki; Yamazaki, Shin; Fukuhara, Shunichi] Kyoto Univ, Dept Healthcare Epidemiol, Sch Publ Hlth, Grad Sch Med, Kyoto, Japan.
   [Fujita, Naotaka; Inagaki, Nobuya] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan.
   [Hayashino, Yasuaki; Kuwata, Hirohito; Okamura, Shintaro; Iburi, Tadao; Furuya, Miyuki; Kitatani, Masako; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, Tenri, Nara, Japan.
   [Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara, Japan.
RP Tsujii, S (reprint author), Tenri Hosp, Dept Endocrinol, Tenri, Nara, Japan.
EM stsujii@tenriyorozu.jp
OI Tsujii, Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]
FX We would like to especially thank Yukari Moritsuji, Yuki Fujita, Noriko
   Nakamura and Yoko Sakamoto for their clerical support. This study was
   partially supported by the Manpei Suzuki Diabetes Foundation and JSPS
   KAKENHI (grant number: 25460641); however, they played no role in the
   study design or conduct; data collection, analysis or interpretation; or
   the preparation, review or approval of the manuscript.
CR Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829
   Buse JB, 2011, DIABETES CARE, V34, P249, DOI 10.2337/dc10-1701
   DANDONA P, 1979, BMJ-BRIT MED J, V1, P1183, DOI 10.1136/bmj.1.6172.1183
   Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   Green AJ, 2012, DIABETES RES CLIN PR, V96, P313, DOI 10.1016/j.diabres.2012.01.002
   Hayashino Y, 2013, EXP CLIN ENDOCR DIAB, V121, P628, DOI 10.1055/s-0033-1355424
   Hayashino Y, 2014, DIABETES CARE, V37, P2947, DOI 10.2337/dc14-1357
   Hayashino Y, 2014, DIABETES CARE, V37, P2459, DOI 10.2337/dc13-2312
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392
   Hotta N, 2010, J DIABETES INVEST, V1, P66, DOI 10.1111/j.2040-1124.2010.00019.x
   International Diabetes Federation, 2015, IDF DIABETES ATLAS
   Inzucchi SE, 2015, DIABETOLOGIA, V58, P429, DOI 10.1007/s00125-014-3460-0
   Ishii H, 2008, DIABETES RES CLIN PR, V81, P169, DOI 10.1016/j.diabres.2008.03.020
   Ishii H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036361
   Ishii Hitoshi, 2012, J Med Econ, V15, P556, DOI 10.3111/13696998.2012.665111
   Jansen HJ, 2014, DIABETES CARE, V37, P2710, DOI 10.2337/dc13-1205
   Japan Diabetes Society, 2014, TREATM GUID DIAB 201, P13
   Kobayashi M, 2006, DIABETES RES CLIN PR, V73, P198, DOI 10.1016/j.diabres.2006.01.013
   Mashitani T, 2015, ACTA DIABETOL, V52, P639, DOI 10.1007/s00592-015-0725-0
   Mashitani T, 2014, DIABETES CARE, V37, P252, DOI 10.2337/dc13-0407
   Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006
   Norhammar A, 2013, DIABETOLOGIA, V56, P1, DOI 10.1007/s00125-012-2694-y
   OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Purnell JQ, 1998, JAMA-J AM MED ASSOC, V280, P140, DOI 10.1001/jama.280.2.140
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   Siegmund T, 2007, EXP CLIN ENDOCR DIAB, V115, P349, DOI 10.1055/s-2007-973082
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Turner RC, 1998, LANCET, V352, P837
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P854, DOI DOI 10.1016/S0140-6736(98)07037-8
   Wu T, 2015, DIABETES THER, V6, P273, DOI 10.1007/s13300-015-0116-0
NR 34
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD MAR
PY 2018
VL 9
IS 2
BP 294
EP 302
DI 10.1111/jdi.12693
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FY2DZ
UT WOS:000426626900011
PM 28494126
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Rathmann, W
   Kuss, O
   Anderson, D
   Busch, S
   Hahn, M
   Engelhard, J
   Zou, M
   Kostev, K
AF Rathmann, Wolfgang
   Kuss, Oliver
   Anderson, Doerte
   Busch, Stefan
   Hahn, Michael
   Engelhard, Johanna
   Zou, Ming
   Kostev, Karel
TI Increased depression symptom score in newly diagnosed type 2 diabetes
   patients
SO PSYCHIATRY RESEARCH
LA English
DT Article
DE Type 2 diabetes; Depression; Primary care; Diabetes distress
ID QUALITY-OF-LIFE; TREATMENT SATISFACTION; ANXIETY DISORDERS; GLYCEMIC
   CONTROL; PRIMARY-CARE; HEALTH; DATABASE; ASSOCIATION; PREVALENCE;
   DISTRESS
AB The aim was to investigate the association between diabetes duration and depressive symptoms in type 2 diabetes. The DIAREG registry used data of a nationwide general medicine practice database (Disease Analyzer, Germany) augmented by prospective data from patient reported outcomes (PRO) including Center of Epidemiological Studies Depression Scale (CES-D: < 16 vs. >= 16) and the SF-36. Multiple logistic regression models were used to investigate the association of diabetes duration with PROs. Overall, 1807 type 2 diabetes patients were registered in 108 practices. From 270 (15%) patients complete PRO could be collected, which were similar with respect to age, sex, body mass index, HbA1c, diabetes duration and treatment to patients with incomplete data (p >= 0.05). Patients with a longer diabetes duration (reference: < 2 years) displayed a significantly increased odds of having no indication of depression (CES-D < 16: 66%) (Odds Ratio, 95%Cl: 2- < 5 years: 5.9, 1.2-29.6; 5- < 10 years: 6.2, 1.3-28.7; >= 10 years: 5.6, 1.2-23.1), after adjusting for age, sex, BMI, diabetes complications, antidepressants and glucose-lowering treatment. Patients with < 2 years diabetes duration also exhibited a significantly decreased mean mental component score (SF-36: < 2 years: 50, 2- < 5 years: 69). In type 2 diabetes with a short duration an increased depressive symptom score was observed.
C1 [Rathmann, Wolfgang; Kuss, Oliver] Heinrich Heine Univ, Inst Biometr & Epidemiol, Leibniz Inst Diabet Res, German Diabet Ctr, Dusseldorf, Germany.
   [Anderson, Doerte; Busch, Stefan] AstraZeneca, Med Dept, Wedel, Germany.
   [Hahn, Michael] Univ Clin, Hamburg, Germany.
   [Engelhard, Johanna; Kostev, Karel] IQVIA, Frankfurt, Germany.
   [Zou, Ming] IQVIA, Basel, Switzerland.
RP Rathmann, W (reprint author), Heinrich Heine Univ, Inst Biometr & Epidemiol, Leibniz Inst Diabet Res, German Diabet Ctr, Dusseldorf, Germany.
EM rathmann@ddz.uni-duesseldorf.de
FU AstraZeneca, Germany
FX The establishment of the DIAREG registry and the present analysis was
   supported by an unlimited grant by AstraZeneca, Germany. AstraZeneca had
   no influence on preparation of the article and in the current study
   design, in the analysis and interpretation of data and in the decision
   to submit the article for publication.
CR Almeida OP, 2016, MATURITAS, V86, P3, DOI 10.1016/j.maturitas.2016.01.003
   Altinok Ali, 2016, J Family Med Prim Care, V5, P302
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arshad AR, 2016, J PAK MED ASSOC, V66, P425
   Bassett J, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000210
   Becher H, 2009, INT J CLIN PHARM TH, V47, P617
   Biderman A, 2009, FAM PRACT, V26, P102, DOI 10.1093/fampra/cmp007
   BRADLEY C, 1994, DIABETIC MED, V11, P510, DOI 10.1111/j.1464-5491.1994.tb00316.x
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Carter J, 2016, J PSYCHOSOM RES, V90, P91, DOI 10.1016/j.jpsychores.2016.09.013
   Carter J, 2016, PSYCHONEUROENDOCRINO, V69, P123, DOI 10.1016/j.psyneuen.2016.04.002
   Chiu CJ, 2017, INT PSYCHOGERIATR, V29, P281, DOI 10.1017/S1041610216001630
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Donald M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-170
   Ellert U, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P1027, DOI 10.1007/s00103-004-0933-1
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Hermanns N, 2013, PRIM CARE DIABETES, V7, P1, DOI 10.1016/j.pcd.2012.11.002
   Holt RIG, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0491-3
   Hood KK, 2014, J ADOLESCENT HEALTH, V55, P498, DOI 10.1016/j.jadohealth.2014.03.011
   Ismail K., 2017, DIABETOL        0803
   Kowall B, 2015, DIABETES CARE, V38, P59, DOI 10.2337/dc14-0977
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lunghi C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003514
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nicolucci A, 2009, NUTR METAB CARDIOVAS, V19, P45, DOI 10.1016/j.numecd.2007.12.005
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rathmann W, 2016, DIABETES OBES METAB, V18, P840, DOI 10.1111/dom.12673
   Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458
   Siegel E. G., 2016, DTSCH GESUNDHEITSBER
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9
NR 34
TC 1
Z9 1
U1 1
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-1781
J9 PSYCHIAT RES
JI Psychiatry Res.
PD MAR
PY 2018
VL 261
BP 259
EP 263
DI 10.1016/j.psychres.2017.12.091
PG 5
WC Psychiatry
SC Psychiatry
GA FX6UK
UT WOS:000426222600042
PM 29329045
DA 2019-01-08
ER

PT J
AU Deary, V
   Hagenaars, SP
   Harris, SE
   Hill, WD
   Davies, G
   Liewald, DCM
   McIntosh, AM
   Gale, CR
   Deary, IJ
AF Deary, V.
   Hagenaars, S. P.
   Harris, S. E.
   Hill, W. D.
   Davies, G.
   Liewald, D. C. M.
   McIntosh, A. M.
   Gale, C. R.
   Deary, I. J.
CA Int Consortium Blood Pressure GWAS
   CHARGE Consortium Aging Lon
   CHARGE Consortium Inflammation Grp
TI Genetic contributions to self-reported tiredness
SO MOLECULAR PSYCHIATRY
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; MULTISYSTEM BIOLOGICAL RISK;
   CHRONIC-FATIGUE-SYNDROME; CANCER-RELATED FATIGUE; UK BIOBANK N=112151;
   MULTIPLE-SCLEROSIS; OLDER-ADULTS; PSYCHOLOGICAL DISTRESS; COGNITIVE
   FUNCTIONS; MENTAL-HEALTH
AB Self-reported tiredness and low energy, often called fatigue, are associated with poorer physical and mental health. Twin studies have indicated that this has a heritability between 6 and 50%. In the UK Biobank sample (N = 108 976), we carried out a genome-wide association study (GWAS) of responses to the question, 'Over the last two weeks, how often have you felt tired or had little energy?' Univariate GCTA-GREML found that the proportion of variance explained by all common single-nucleotide polymorphisms for this tiredness question was 8.4% (s.e. = 0.6%). GWAS identified one genome-wide significant hit (Affymetrix id 1: 64178756_C_T; P = 1.36 x 10(-11)). Linkage disequilibrium score regression and polygenic profile score analyses were used to test for shared genetic aetiology between tiredness and up to 29 physical and mental health traits from GWAS consortia. Significant genetic correlations were identified between tiredness and body mass index (BMI), C-reactive protein, high-density lipoprotein (HDL) cholesterol, forced expiratory volume, grip strength, HbA1c, longevity, obesity, self-rated health, smoking status, triglycerides, type 2 diabetes, waist-hip ratio, attention deficit hyperactivity disorder, bipolar disorder, major depressive disorder, neuroticism, schizophrenia and verbal-numerical reasoning (absolute rg effect sizes between 0.02 and 0.78). Significant associations were identified between tiredness phenotypic scores and polygenic profile scores for BMI, HDL cholesterol, low-density lipoprotein cholesterol, coronary artery disease, C-reactive protein, HbA1c, height, obesity, smoking status, triglycerides, type 2 diabetes, waist-hip ratio, childhood cognitive ability, neuroticism, bipolar disorder, major depressive disorder and schizophrenia (standardised beta's had absolute values < 0.03). These results suggest that tiredness is a partly heritable, heterogeneous and complex phenomenon that is phenotypically and genetically associated with affective, cognitive, personality and physiological processes.
C1 [Deary, V.; Liewald, D. C. M.] Northumbria Univ, Dept Psychol, Newcastle NE1 8ST, England.
   [Hagenaars, S. P.; Harris, S. E.; Hill, W. D.; Davies, G.; Liewald, D. C. M.; Gale, C. R.; Deary, I. J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.
   [Hagenaars, S. P.; Hill, W. D.; Davies, G.; Gale, C. R.; Deary, I. J.] Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.
   [Hagenaars, S. P.; McIntosh, A. M.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland.
   [Harris, S. E.] Univ Edinburgh, Med Genet Sect, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland.
   [Harris, S. E.] Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.
   [Gale, C. R.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.
RP Deary, V (reprint author), Northumbria Univ, Dept Psychol, Newcastle NE1 8ST, England.; Deary, IJ (reprint author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.; Deary, V (reprint author), Northumbria Univ, Dept Psychol, Newcastle NE1 8ST, England.
EM vincent.deary@northumbria.ac.uk; i.deary@ed.ac.uk
RI Deary, Ian/C-6297-2009; McIntosh, Andrew/B-9379-2008
OI Deary, Ian/0000-0002-1733-263X; McIntosh, Andrew/0000-0002-0198-4588;
   Hagenaars, Saskia/0000-0001-9697-8596
FU University of Edinburgh Centre for Cognitive Ageing and Cognitive
   Epidemiology, part of the cross council Lifelong Health and Wellbeing
   Initiative [MR/K026992/1]; BBSRC; Age UK (Disconnected Mind Project);
   Medical Research Council (MRC)
FX This research has been conducted using the UK Biobank Resource. The work
   was undertaken in The University of Edinburgh Centre for Cognitive
   Ageing and Cognitive Epidemiology, part of the cross council Lifelong
   Health and Wellbeing Initiative (MR/K026992/1). Funding from the BBSRC,
   Age UK (Disconnected Mind Project) and Medical Research Council (MRC) is
   gratefully acknowledged.
CR Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Alves G, 2004, NEUROLOGY, V63, P1908, DOI 10.1212/01.WNL.0000144277.06917.CC
   Aristotle, 1999, PHYSICS
   Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262
   Barsevick A, 2010, QUAL LIFE RES, V19, P1419, DOI 10.1007/s11136-010-9757-7
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Booth T, 2013, AM J HUM BIOL, V25, P538, DOI 10.1002/ajhb.22406
   Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127
   Brown PJ, 2014, AM J GERIAT PSYCHIAT, V22, P1083, DOI 10.1016/j.jagp.2013.04.010
   Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406
   Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211
   Bultmann U, 2002, INT ARCH OCC ENV HEA, V75, P259, DOI 10.1007/s00420-001-0294-0
   Clark Gary D, 2015, Enzymes, V38, P37, DOI 10.1016/bs.enz.2015.09.009
   Cullen W, 2002, IRISH J MED SCI, V171, P10, DOI 10.1007/BF03168931
   Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45
   de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219
   de Miguel FJ, 2014, CANCER RES, V74, P1105, DOI 10.1158/0008-5472.CAN-13-1481
   Deary IJ, 2012, GERONTOLOGY, V58, P545, DOI 10.1159/000341157
   Demyttenaere K, 2005, INT J NEUROPSYCHOPH, V8, P93, DOI 10.1017/S1461145704004729
   Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008
   Dolan P., 2013, J GERONTOL B-PSYCHOL, V70, P576
   Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848
   Felger JC, 2012, PSYCHOL MED, V42, P1591, DOI 10.1017/S0033291711002868
   Fernandez-Munoz JJ, 2015, ACTA NEUROL SCAND, V132, P118, DOI 10.1111/ane.12370
   Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404
   Franssen PML, 2003, J PSYCHOSOM RES, V54, P339, DOI 10.1016/S0022-3999(02)00395-1
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021
   Gale CR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.56
   Griffiths L, 2014, DIGEST DIS, V32, P615, DOI 10.1159/000360515
   Hagenaars SP, 2016, MOL PSYCHIATR, V21, P1624, DOI 10.1038/mp.2015.225
   Harris SE, 2016, INT J EPIDEMIOL
   Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450
   Hickie I, 1999, PSYCHOL MED, V29, P259, DOI 10.1017/S0033291798007934
   Hill WD, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.246
   Hoenicka J, 2007, NEUROTOX RES, V11, P61, DOI 10.1007/BF03033483
   Hur YM, 2012, TWIN RES HUM GENET, V15, P720, DOI 10.1017/thg.2012.60
   Jarosz PA, 2014, WOMEN HEALTH ISS, V24, pE447, DOI 10.1016/j.whi.2014.04.005
   Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002
   Kitamura H, 2013, J OCCUP HEALTH, V55, P1
   Klimas NG, 2012, BRAIN BEHAV IMMUN, V26, P1202, DOI 10.1016/j.bbi.2012.06.006
   KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020
   Landmark-Hoyvik H, 2009, PHARMACOGENOMICS J, V9, P333, DOI 10.1038/tpj.2009.27
   Landmark-Hoyvik H, 2010, PM&R, V2, P456, DOI 10.1016/j.pmrj.2010.04.003
   Lasselin J, 2012, BRAIN BEHAV IMMUN, V26, P1211, DOI 10.1016/j.bbi.2012.03.003
   LEWIS G, 1992, J EPIDEMIOL COMMUN H, V46, P92, DOI 10.1136/jech.46.2.92
   Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088
   Meng HD, 2010, J AM GERIATR SOC, V58, P2033, DOI 10.1111/j.1532-5415.2010.03088.x
   Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009
   PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Qi QB, 2012, HUM MOL GENET, V21, P4774, DOI 10.1093/hmg/dds300
   Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a
   Russell B, 2013, GENOME MED, V5, DOI 10.1186/gm420
   Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6
   Schlauch KA, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.208
   Schur E, 2007, TWIN RES HUM GENET, V10, P729, DOI 10.1375/twin.10.5.729
   Seeman T, 2010, AM J HUM BIOL, V22, P463, DOI 10.1002/ajhb.21018
   Skerrett TN, 2006, J PSYCHOSOM RES, V61, P587, DOI 10.1016/j.jpsychores.2006.04.018
   Smith AK, 2011, NEUROPSYCHOBIOLOGY, V64, P183, DOI 10.1159/000326692
   Smith DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075362
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779
   Sugimoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041267
   Sullivan PF, 2005, PSYCHOL MED, V35, P1327, DOI 10.1017/S0033291705005222
   The National Institute of Mental Health, 2016, REQ INF RFI INP PLAN
   Theorell-Haglow J, 2006, SLEEP, V29, P751, DOI 10.1093/sleep/29.6.751
   Tomas C., 2013, ISRN NEUROSCI, V2013, DOI DOI 10.1155/2013/784520
   van Kessel K, 2006, J PSYCHOSOM RES, V61, P583, DOI 10.1016/j.jpsychores.2006.03.006
   van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113
   Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0
   WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037//0033-295X.96.2.234
   Wessely S, 2001, ANN INTERN MED, V134, P838, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00007
   Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608
NR 74
TC 5
Z9 5
U1 7
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD MAR
PY 2018
VL 23
IS 3
BP 609
EP 620
DI 10.1038/mp.2017.5
PG 12
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA FW8MH
UT WOS:000425588100016
PM 28194004
OA Other Gold, Green Published
HC Y
HP N
DA 2019-01-08
ER

PT J
AU Zhu, BQ
   Quinn, L
   Fritschi, C
AF Zhu, Bingqian
   Quinn, Laurie
   Fritschi, Cynthia
TI Relationship and variation of diabetes related symptoms, sleep
   disturbance and sleep-related impairment in adults with type 2 diabetes
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE fatigue; neuropathy; nursing; sleep disturbance; sleep-related
   impairment; symptom; type 2 diabetes
ID PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; GLUCOSE-METABOLISM; BREAST-CANCER;
   OLDER-ADULTS; RISK-FACTORS; MELLITUS; FATIGUE; QUALITY; METAANALYSIS
AB AimThe objective of this study was to examine whether diabetes-related symptoms (e.g. fatigue, neuropathic pain, diabetes distress and depressive symptoms) were related to sleep disturbance and sleep-related impairment in adults with type 2 diabetes while controlling for potential covariates.
   BackgroundIn people with type 2 diabetes, sleep disturbance and sleep-related impairment are common and likely associated with diabetes-related symptoms. However, limited research has investigated the predictive ability of diabetes-related symptoms on sleep.
   DesignA correlational, cross-sectional design was used.
   MethodsData were collected at a large university in the Midwestern United States from September 2013-March 2014. Multiple linear regression analyses were used to examine the relationship of diabetes-related symptoms (fatigue, neuropathic pain, distress and depressive symptoms) to sleep disturbance and sleep-related impairment. The instruments included Patient-Reported Outcomes Measurement Information System instruments, Diabetes Symptom Checklist and Diabetes Distress Scale.
   FindingsIn this study of adults with type 2 diabetes (N=90; 52.2% female, mean age 57.4years), gender, A1C, neuropathic pain and fatigue were significantly related to sleep disturbance when age, diabetes duration, depressive symptoms and distress were controlled. Those variables collectively explained 52% of the variation in sleep disturbance. Fatigue was significantly associated with sleep-related impairment when the same covariates were controlled.
   ConclusionFindings suggested that diabetes-related symptoms, including neuropathic pain and fatigue, are strongly related to sleep disturbance and sleep-related impairment in adults with type 2 diabetes, underscoring the need to include detailed assessments of neuropathic pain and fatigue when evaluating sleep.
C1 [Zhu, Bingqian; Quinn, Laurie; Fritschi, Cynthia] Univ Illinois, Coll Nursing, Chicago, IL USA.
RP Fritschi, C (reprint author), Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL 60607 USA.
EM fritschi@uic.edu
OI Fritschi, Cynthia/0000-0001-5447-8315
FU National Institutes of Health/National Institute for Nursing Research
   [K99 R00 NR012219]
FX This work was supported in part by the National Institutes of
   Health/National Institute for Nursing Research K99 R00 NR012219 (CF).
   The funders had no role in research design, data collection, and
   analysis, or manuscript preparation.
CR American Diabetes Association, 2017, DIABETES CARE S1, V40, pS25, DOI DOI 10.2337/DC17-S006
   Anothaisintawee T, 2016, SLEEP MED REV, V30, P11, DOI 10.1016/j.smrv.2015.10.002
   Arber S, 2009, SOC SCI MED, V68, P281, DOI 10.1016/j.socscimed.2008.10.016
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Barone MTU, 2011, DIABETES RES CLIN PR, V91, P129, DOI 10.1016/j.diabres.2010.07.011
   Bode Bruce W, 2007, J Diabetes Sci Technol, V1, P405
   Bromley LE, 2012, SLEEP, V35, P977, DOI 10.5665/sleep.1964
   Carpenter JS, 2004, ONCOL NURS FORUM, V31, P591, DOI 10.1188/04.ONF.591-598
   Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55
   Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011
   Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP
   Cuellar NG, 2008, J CLIN SLEEP MED, V4, P50
   Dillon HR, 2015, J GERONTOL B-PSYCHOL, V70, P46, DOI 10.1093/geronb/gbu035
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Gupta S, 2016, DIABETES METAB SYND, V10, P213, DOI 10.1016/j.dsx.2016.06.009
   Ho SY, 2015, J PAIN SYMPTOM MANAG, V49, P707, DOI 10.1016/j.jpainsymman.2014.09.009
   Khanna D, 2012, VALUE HEALTH, V15, P128, DOI 10.1016/j.jval.2011.08.006
   Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002
   Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768
   Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962
   Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6
   Lambiase MJ, 2013, MED SCI SPORT EXER, V45, P2362, DOI 10.1249/MSS.0b013e31829e4cea
   Lamond N, 2000, SLEEP, V23, P415
   Lee SWH, 2017, SLEEP MED REV, V31, P91, DOI 10.1016/j.smrv.2016.02.001
   Mahmood WAW, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/341506
   McArdle W. D., 2001, EXERCISE PHYSL, P752
   Nasseri R, 2015, INT J DIABETES DEV C, V35, P454, DOI 10.1007/s13410-015-0314-3
   Nefs G, 2015, DIABETES RES CLIN PR, V109, P466, DOI 10.1016/j.diabres.2015.07.008
   Nerenz DR, 2011, VALUE HEALTH, V14, pA90, DOI 10.1016/j.jval.2011.02.506
   Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255
   Osonoi Y, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0026-1
   Ozturk ZA, 2015, AGING CLIN EXP RES, V27, P533, DOI 10.1007/s40520-014-0293-0
   Parikh RM, 2007, MED HYPOTHESES, V68, P1272, DOI 10.1016/j.mehy.2006.10.038
   Patrick D. L., 2008, COCHRANE HDB SYSTEMA, P531
   Perrin NE, 2017, DIABETIC MED, V34, P1508, DOI 10.1111/dme.13448
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   PROMIS, 2017, PAT REP OUTC MEAS IN
   PROMIS, 2017, INTR PROMIS LIST AUD
   Ramtahal R, 2015, J EPIDEMIOL GLOB HEA, V5, pS35, DOI 10.1016/j.jegh.2015.05.003
   Reutrakul S, 2014, ANN NY ACAD SCI, V1311, P151, DOI 10.1111/nyas.12355
   Shan ZL, 2015, DIABETES CARE, V38, P529, DOI 10.2337/dc14-2073
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Sherrill DL, 1998, ARCH INTERN MED, V158, P1894, DOI 10.1001/archinte.158.17.1894
   Smagula SF, 2016, SLEEP MED REV, V25, P21, DOI 10.1016/j.smrv.2015.01.003
   Sun NQ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012540
   Taylor-Piliae RE, 2006, AM J EPIDEMIOL, V164, P598, DOI 10.1093/aje/kwj248
   Taylor-Piliae RE, 2010, J PHYS ACT HEALTH, V7, P87, DOI 10.1123/jpah.7.1.87
   Tomas-Carus P, 2016, J SPORT MED PHYS FIT, V56, P572
   Trento M, 2008, ACTA DIABETOL, V45, P225, DOI 10.1007/s00592-008-0047-6
   Tsai YW, 2012, FAM PRACT, V29, P30, DOI 10.1093/fampra/cmr041
   Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266
   Zhu BQ, 2017, J CLIN NURS, V26, P4053, DOI 10.1111/jocn.13899
NR 52
TC 0
Z9 0
U1 5
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-2402
EI 1365-2648
J9 J ADV NURS
JI J. Adv. Nurs.
PD MAR
PY 2018
VL 74
IS 3
BP 689
EP 697
DI 10.1111/jan.13482
PG 9
WC Nursing
SC Nursing
GA FV5RK
UT WOS:000424639900019
PM 29114911
DA 2019-01-08
ER

PT J
AU Beach, LB
   Elasy, TA
   Gonzales, G
AF Beach, Lauren B.
   Elasy, Tom A.
   Gonzales, Gilbert
TI Prevalence of Self-Reported Diabetes by Sexual Orientation: Results from
   the 2014 Behavioral Risk Factor Surveillance System
SO LGBT HEALTH
LA English
DT Article
DE Behavioral Risk Factor Surveillance System; bisexual; diabetes; gay;
   health disparities; lesbian
ID PHYSICAL HEALTH; UNITED-STATES; BISEXUAL ADULTS; MENTAL-HEALTH;
   PSYCHOLOGICAL DISTRESS; MINORITY ADOLESCENTS; STRUCTURAL STIGMA;
   NATIONAL-HEALTH; YOUNG-ADULTS; GAY
AB Purpose: This study aimed to compare the prevalence of self-reported diabetes and diabetes risk factors among adult sexual minority and heterosexual populations in the United States. Methods: Data from the 2014 Behavioral Risk Factor Surveillance System for 3776 lesbian, gay, and bisexual (LGB) adults and 142,852 heterosexual adults aged 18 years and older were used to estimate the prevalence of diabetes. Binomial logistic regression models were used to compare the odds of diabetes by sexual orientation. Results: Sexual minorities were younger and more racially diverse than heterosexuals. Gay men less often and lesbian and bisexual women more often reported a body mass index of 30kg/m(2) or higher than heterosexuals. Overall, 14.2% of bisexual men, 11.4% of gay men, and 10.8% of heterosexual men reported a lifetime diabetes diagnosis, as did 8.5% of lesbian women, 5.7% of bisexual women, and 10.2% of heterosexual women. After controlling for multiple factors, gay (odds ratio [OR]=1.50; confidence interval [95% CI]=1.09-2.07) and bisexual men [OR=1.55; 95% CI=1.00-2.07] were more likely to report a lifetime diabetes diagnosis than heterosexual men. Similar differences were not found for lesbian [OR=1.22; 95% CI=0.76-1.95] or bisexual women [OR=0.88; 95% CI=0.62-1.26]. Conclusion: Sexual minorities may be at increased risk for diabetes than their heterosexual peers. This may be due partly to the chronic stressors associated with being a member of a marginalized population. Future research should explore the underlying causes and consequences of LGB diabetes disparities and elucidate best practices to improve diabetes screening and care for these vulnerable patient populations.
C1 [Beach, Lauren B.; Elasy, Tom A.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN USA.
   [Gonzales, Gilbert] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA.
RP Beach, LB (reprint author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol,Med Ctr East, 1161 21st Ave South,Suite 6100, Nashville, TN 37212 USA.
EM lauren.b.beach@vanderbilt.edu
OI Beach, Lauren/0000-0003-3302-5047
FU Vanderbilt University Medical Center Renal Biology Disease Training
   Program; National Institutes of Health/National Institute of Diabetes
   and Digestive and Kidney Diseases (NIH/NIDDK) [T32 5T32DK007569];
   NIH/National Institute on Minority Health and Health Disparities;
   Vanderbilt Center for Diabetes Translation Research [NIH/NIDDK
   5P30DK092986]; Vanderbilt Diabetes Research and Training Center
   [NIH/NIDDK P30DK020593]
FX L.B. and G.G. contributed to the study design, conducted the analyses,
   and wrote the article. T.E. reviewed/edited the article and contributed
   to the study design. L.B. is supported by the Vanderbilt University
   Medical Center Renal Biology Disease Training Program, the National
   Institutes of Health/National Institute of Diabetes and Digestive and
   Kidney Diseases (NIH/NIDDK) T32 5T32DK007569 and a Loan Repayment Award
   from NIH/National Institute on Minority Health and Health Disparities.
   T.E. is supported by the Vanderbilt Center for Diabetes Translation
   Research, NIH/NIDDK 5P30DK092986, and the Vanderbilt Diabetes Research
   and Training Center, NIH/NIDDK P30DK020593. We thank Drs. Kim Unertl and
   Amelia Maiga of Vanderbilt University Medical Center and Dr. Faheemah
   Mustafaa of the University of Michigan for providing helpful comments on
   the article draft. Dr. Lauren Beach takes responsibility for the
   contents of this article.
CR Anyanwagu U, 2016, CLIN PHARMACOL THER, V99, P390, DOI 10.1002/cpt.274
   Blosnich JR, 2014, AM J PREV MED, V46, P337, DOI 10.1016/j.amepre.2013.11.010
   Blosnich JR, 2013, ANN EPIDEMIOL, V23, P448, DOI 10.1016/j.annepidem.2013.04.009
   Bolton SL, 2011, CAN J PSYCHIAT, V56, P35, DOI 10.1177/070674371105600107
   Bostwick WB, 2010, AM J PUBLIC HEALTH, V100, P468, DOI 10.2105/AJPH.2008.152942
   Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179
   Centers for Disease Control and Prevention, 2013, BRFSS DAT US GUID
   Centers for Disease Control and Prevention, 2015, BEH RISK FACT SURV S
   Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53
   Cochran SD, 2007, AM J PUBLIC HEALTH, V97, P2048, DOI 10.2105/AJPH.2006.087254
   Conron KJ, 2010, AM J PUBLIC HEALTH, V100, P1953, DOI 10.2105/AJPH.2009.174169
   Corliss HL, 2011, AM J PUBLIC HEALTH, V101, P1683, DOI 10.2105/AJPH.2011.300155
   Dilley JA, 2010, AM J PUBLIC HEALTH, V100, P460, DOI 10.2105/AJPH.2007.130336
   Djuric Zora, 2008, Open Biomark J, V1, P7, DOI 10.2174/1875318300801010007
   Eliason MJ, 2014, LGBT HEALTH, V1, P259, DOI 10.1089/lgbt.2014.0026
   Everett B, 2013, J COMMUN HEALTH, V38, P588, DOI 10.1007/s10900-013-9655-3
   Fallin A, 2015, PREV MED, V74, P123, DOI 10.1016/j.ypmed.2014.11.026
   Farmer GW, 2013, AM J PUBLIC HEALTH, V103, P1845, DOI 10.2105/AJPH.2013.301258
   Farmer GW, 2013, J EPIDEMIOL COMMUN H, V67, P772, DOI 10.1136/jech-2013-202658
   Fredriksen-Goldsen KI, 2017, AM J PUBLIC HEALTH, V107, P1332, DOI 10.2105/AJPH.2017.303922
   Fredriksen-Goldsen KI, 2013, AM J PUBLIC HEALTH, V103, P1802, DOI 10.2105/AJPH.2012.301110
   Friedman MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087139
   Garland-Forshee RY, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140126
   Goldbach JT, 2014, PREV SCI, V15, P350, DOI 10.1007/s11121-013-0393-7
   Gonzales G, 2016, JAMA INTERN MED, V176, P1344, DOI 10.1001/jamainternmed.2016.3432
   Gruskin EP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-241
   Hammerman A, 2008, ANN PHARMACOTHER, V42, P1316, DOI 10.1345/aph.1L015
   Hatzenbuehler ML, 2016, AM PSYCHOL, V71, P742, DOI 10.1037/amp0000068
   Hatzenbuehler ML, 2014, ANN BEHAV MED, V47, P39, DOI 10.1007/s12160-013-9556-9
   Heidemann DL, 2016, ETHNIC DIS, V26, P85, DOI 10.18865/ed.26.1.85
   Hirshfield S, 2016, AM J MENS HLTH
   Institute of Medicine (US) Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities, 2011, HLTH LESB GAY BISEX
   Joseph JJ, 2017, ANN NY ACAD SCI, V1391, P20, DOI 10.1111/nyas.13217
   Kelly SJ, 2015, ANNU REV PUBL HEALTH, V36, P441, DOI 10.1146/annurev-publhealth-031914-122921
   Lick DJ, 2013, PERSPECT PSYCHOL SCI, V8, P521, DOI 10.1177/1745691613497965
   Lindley LL, 2012, AM J PUBLIC HEALTH, V102, P1177, DOI 10.2105/AJPH.2011.300262
   Lumley T., 2004, J STAT SOFTW, V9, P1, DOI DOI 10.18637/JSS.V009.I08
   Marshal MP, 2013, J YOUTH ADOLESCENCE, V42, P1243, DOI 10.1007/s10964-013-9970-0
   Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674
   Mustanski BS, 2010, AM J PUBLIC HEALTH, V100, P2426, DOI 10.2105/AJPH.2009.178319
   Pierannunzi Carol, 2012, Morbidity and Mortality Weekly Report, V61, P410
   Puckrein GA, 2015, ETHNIC DIS, V25, P521, DOI 10.18865/ed.25.4.521
   R Core Development Team, 2016, R LANG ENV STAT COMP
   Sell RL, 2014, AM J PUBLIC HEALTH, V104, P967, DOI 10.2105/AJPH.2013.301814
   Simoni JM, 2017, J HOMOSEXUAL, V64, P32, DOI 10.1080/00918369.2016.1174021
   Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302
   Tomedi LE, 2013, HLTH INEQUITIES SEXU
   Turi KN, 2017, APPL GEOGR, V85, P62, DOI 10.1016/j.apgeog.2017.05.005
   VanKim NA, 2010, AM J PUBLIC HEALTH, V100, P2392, DOI 10.2105/AJPH.2009.186270
   Ward BW, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150292
NR 50
TC 2
Z9 2
U1 1
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2325-8292
EI 2325-8306
J9 LGBT HEALTH
JI LGBT Health
PD MAR
PY 2018
VL 5
IS 2
BP 121
EP 130
DI 10.1089/lgbt.2017.0091
EA JAN
EY 2018
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FY1GM
UT WOS:000423533400001
PM 29377760
DA 2019-01-08
ER

PT J
AU Schinckus, L
   Dangoisse, F
   Van den Broucke, S
   Mikolajczak, M
AF Schinckus, Louise
   Dangoisse, Florence
   Van den Broucke, Stephan
   Mikolajczak, Moira
TI When knowing is not enough: Emotional distress and depression reduce the
   positive effects of health literacy on diabetes self-management
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Diabetes; Health literacy; Self-efficacy; Depression; Distress
ID GLYCEMIC CONTROL; TYPE-2; OUTCOMES; CARE; ADHERENCE; MELLITUS; ANXIETY;
   WELL; METAANALYSIS; ASSOCIATION
AB Objectives: Adequate self-management activities are important predictors of diabetes outcomes. As diabetes literacy and self-efficacy are strong predictors of diabetes self-care, self-management education programs focus essentially on these factors. This study investigated whether emotional distress or depression moderates the relation between health literacy, self-efficacy and diabetes self-care behaviors.
   Methods: 128 people with type 2 diabetes were recruited in hospitals, through general practitioners and via a diabetes website, and completed a questionnaire assessing health literacy, self-efficacy, diabetes-related distress, depression and self-care behaviors.
   Results: Multiple regression analysis confirms that health literacy and self-efficacy significantly predict reported self-care behaviors. Additional regression analyses reveal that distress or depression do not predict self-care behaviors directly, but moderate the effect of health literacy, which has a weaker impact in patients experiencing distress or depression. In contrast, distress and depression do not moderate the effect of self-efficacy on diabetes self-care behaviors.
   Conclusion: Emotional distress, whether related to diabetes or not, prevents patients from acting on their competence to perform adequate self-management behaviors.
   Practice implications: Diabetes Professionals should pay more attention to the patients' affective state and its influence on self-care. Psychological support should be integrated in the care for people suffering from type 2 diabetes. (C) 2017 Published by Elsevier Ireland Ltd.
C1 [Schinckus, Louise; Dangoisse, Florence; Van den Broucke, Stephan; Mikolajczak, Moira] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.
RP Schinckus, L (reprint author), Catholic Univ Louvain, Psychol Sci Res Inst, 10 Pl Cardinal Mercier,Bte L3-05-01, B-1348 Louvain La Neuve, Belgium.
EM schinckuslouise@gmail.com
OI Mikolajczak, Moira/0000-0002-7333-1578
FU Psychological Sciences Research Institute, Catholic University of
   Louvain, Louvain-la-Neuve, Belgium
FX This work was supported by the Psychological Sciences Research
   Institute, Catholic University of Louvain, Louvain-la-Neuve, Belgium.
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 2011, AADE 7 SELF CAR BEH
   Association Belge du Diabete, 2014, VIV VOTR DIAB TOUT S
   BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L
   BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037//0003-066X.37.2.122
   Barnard K. D., 2012, PSYCHOL DIABETES CAR
   BARTLETT EE, 1986, PATIENT EDUC COUNS, V8, P135, DOI 10.1016/0738-3991(86)90085-6
   Baudrant-Boga M., 2009, THESIS
   Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Brasseur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062635
   Cherrington A, 2010, J BEHAV MED, V33, P81, DOI 10.1007/s10865-009-9233-4
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Hajos TRS, 2011, PATIENT EDUC COUNS, V85, P258, DOI 10.1016/j.pec.2010.08.019
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Heisler M, 2003, DIABETES CARE, V26, P738, DOI 10.2337/diacare.26.3.738
   Ishikawa H, 2008, DIABETES CARE, V31, P874, DOI 10.2337/dc07-1932
   Karahan TF, 2009, TURK KLIN TIP BILIM, V29, P16
   Kotsou I, 2011, J APPL PSYCHOL, V96, P827, DOI 10.1037/a0023047
   Lloyd C. E., 2013, SCREEN DEPRESS PSYCH, P87
   Mann DM, 2009, J BEHAV MED, V32, P278, DOI 10.1007/s10865-009-9202-y
   Millan-Ferro A, 2009, CONTEMP DIABETES, P115, DOI 10.1007/978-1-60327-208-7_8
   Nelis D, 2011, EMOTION, V11, P354, DOI 10.1037/a0021554
   Ngcobo M., 2008, EUR DIABETES NURSING, V11, P133, DOI [10.4314/ajpsy.v11i2.30266, DOI 10.1002/EDN.72]
   Pelikan JM, 2014, MEASURING COMPREHENS
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Powell CK, 2007, DIABETES EDUCATOR, V33, P144, DOI 10.1177/0145721706297452
   Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043
   Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450
   van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x
   Yalcin BM, 2008, DIABETES EDUCATOR, V34, P1013, DOI 10.1177/0145721708327303
NR 41
TC 1
Z9 1
U1 6
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD FEB
PY 2018
VL 101
IS 2
BP 324
EP 330
DI 10.1016/j.pec.2017.08.006
PG 7
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA FX9SQ
UT WOS:000426445700020
PM 28855062
DA 2019-01-08
ER

PT J
AU Masters, RK
   Tilstra, AM
   Simon, DH
AF Masters, Ryan K.
   Tilstra, Andrea M.
   Simon, Daniel H.
TI Explaining recent mortality trends among younger and middle-aged White
   Americans
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE USA; midlife mortality; obesogenic; opiates; despair deaths; mortality
   trends
ID UNITED-STATES; LIFE EXPECTANCY; ANTIRETROVIRAL THERAPY; DISEASE; COHORT;
   INCREASES; PERIOD; WOMEN; DRUG
AB Background: Recent research has suggested that increases in mortality among middle-aged US Whites are being driven by suicides and poisonings from alcohol and drug use. Increases in these 'despair' deaths have been argued to reflect a cohort-based epidemic of pain and distress among middle-aged US Whites.
   Methods: We examine trends in all-cause and cause-specific mortality rates among younger and middle-aged US White men and women between 1980 and 2014, using official US mortality data. We estimate trends in cause-specific mortality from suicides, alcohol-related deaths, drug-related deaths, 'metabolic diseases' (i.e. deaths from heart diseases, diabetes, obesity and/or hypertension), and residual deaths from extrinsic causes (i.e. causes external to the body). We examine variation in mortality trends by gender, age and cause of death, and decompose trends into period-and cohort-based variation.
   Results: Trends in middle-aged US White mortality vary considerably by cause and gender. The relative contribution to overall mortality rates from drug-related deaths has increased dramatically since the early 1990s, but the contributions from suicide and alcohol-related deaths have remained stable. Rising mortality from drug-related deaths exhibit strong period-based patterns. Declines in deaths from metabolic diseases have slowed for middle-aged White men and have stalled for middle-aged White women, and exhibit strong cohort-based patterns.
   Conclusions: We find little empirical support for the pain-and distress-based explanations for rising mortality in the US White population. Instead, recent mortality increases among younger and middle-aged US White men and women have likely been shaped by the US opiate epidemic and an expanding obesogenic environment.
C1 [Masters, Ryan K.; Tilstra, Andrea M.; Simon, Daniel H.] Univ Colorado, Dept Sociol, Boulder, CO 80309 USA.
   [Masters, Ryan K.; Tilstra, Andrea M.; Simon, Daniel H.] Univ Colorado, Inst Behav Sci, Populat Program, Boulder, CO 80309 USA.
RP Masters, RK (reprint author), Univ Colorado, Dept Sociol, Boulder, CO 80309 USA.; Masters, RK (reprint author), Univ Colorado, Inst Behav Sci, Populat Program, Boulder, CO 80309 USA.
EM Ryan.Masters@Colorado.EDU
CR [Anonymous], 1990, Q POP EST 1980 1990
   [Anonymous], 2014, BRIDG RAC POP EST 19
   Boyd MA, 2009, CURR OPIN HIV AIDS, V4, P194, DOI 10.1097/COH.0b013e328329fc8d
   Calcaterra S, 2013, DRUG ALCOHOL DEPEN, V131, P263, DOI 10.1016/j.drugalcdep.2012.11.018
   Carnes BA, 2006, BIOGERONTOLOGY, V7, P183, DOI 10.1007/s10522-006-9020-3
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112
   Cassidy J, 2015, NEW YORKER
   Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366
   Douthat R, 2015, NY TIMES
   Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464
   Gelman A, 2016, P NATL ACAD SCI USA, V113, pE816, DOI 10.1073/pnas.1523465113
   Hedegaard H., 2015, DRUG POISONING DEATH
   Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7
   Kochanek Kenneth D., 2016, EFFECT CHANGES SELEC
   Krugman P, 2015, NY TIMES
   Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9
   Masters RK, 2017, BIODEMOGR SOC BIOL, V63, P31, DOI 10.1080/19485565.2016.1248892
   Masters RK, 2014, DEMOGRAPHY, V51, P2047, DOI 10.1007/s13524-014-0343-4
   Meara E, 2015, P NATL ACAD SCI USA, V112, P15006, DOI 10.1073/pnas.1519763112
   Montez JK, 2014, AM J PUBLIC HEALTH, V104, pE5, DOI 10.2105/AJPH.2014.302146
   National Center for Health Statistics, 2016, Q PROV EST SEL CAUS
   NCHS, 1968, MORT MULT CAUS DEATH
   Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746
   Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743
   Quinones S., 2015, DREAMLAND TRUE TALE
   Reither EN, 2011, HEALTH AFFAIR, V30, P1562, DOI 10.1377/hlthaff.2011.0092
   Rudd RA, 2016, AM J TRANSPLANT, V16, P1323, DOI 10.1111/ajt.13776
   Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849
   Saslow E, 2016, WASHINGTON POST
   Tavernise S., 2016, NY TIMES
   Woolf S. H., 2013, US HLTH INT PERSPECT
   Yang Y, 2008, DEMOGRAPHY, V45, P387, DOI 10.1353/dem.0.0000
   Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714
NR 33
TC 6
Z9 6
U1 2
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD FEB
PY 2018
VL 47
IS 1
BP 81
EP 88
DI 10.1093/ije/dyx127
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FX5UZ
UT WOS:000426148300020
PM 29040539
DA 2019-01-08
ER

PT J
AU Whittemore, R
   Zincavage, RM
   Jaser, SS
   Grey, M
   Coleman, JL
   Collett, D
   Delvy, R
   Ibrahim, BB
   Marceau, LD
AF Whittemore, Robin
   Zincavage, Rebekah M.
   Jaser, Sarah S.
   Grey, Margaret
   Coleman, Julia L.
   Collett, David
   Delvy, Roberta
   Ibrahim, Bridget Basile
   Marceau, Lisa D.
TI Development of an eHealth Program for Parents of Adolescents With Type 1
   Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID PSYCHOSOCIAL ADJUSTMENT; DEPRESSIVE SYMPTOMS; CONTROLLED-TRIAL; GLYCEMIC
   CONTROL; YOUNG-CHILDREN; MOTHERS; FAMILY; YOUTH; INTERVENTION; MELLITUS
AB Purpose The purpose of this study was to understand the experience of parenting an adolescent with type 1 diabetes (T1DM), to develop a prototype of an eHealth program for parents of adolescents with T1DM, and to evaluate the prototype content and acceptability from the perspective of parents and health care providers.
   Methods A multiphase method was used generating both qualitative and quantitative data at multiple time points. There were 27 parents of adolescents aged 12 to 18 years with T1DM and 16 health care providers who participated in semistructured interviews to identify parental challenges; 53 parents and 27 providers evaluated the prototype. Thematic content analysis was used to analyze interview transcripts, and descriptive statistics were used to summarize survey data.
   Results Challenges experienced by parents of adolescents with T1DM included understanding the developmental and hormonal changes of adolescence that affect diabetes care, feeling tension between adolescent independence and parent control, communicating without nagging or conflict, transferring diabetes care responsibility safely, dealing with feelings of stress and distress, and perceiving a lack of resources for T1DM care and insufficient personal time for self-care. In the prototype evaluation, both parents and providers found content to be relevant and provided feedback to guide the development of the full program.
   Conclusions Parents of adolescents with T1DM and providers expressed a need for parents to have more support in transitioning diabetes care from parent to adolescent. eHealth programs offer an ideal way to address these needs and ultimately can be linked to electronic medical records improving quality and efficiency of health care in this population.
C1 [Whittemore, Robin; Grey, Margaret; Collett, David; Delvy, Roberta; Ibrahim, Bridget Basile] Yale Sch Nursing, POB 27399, West Haven, CT 06516 USA.
   [Zincavage, Rebekah M.; Coleman, Julia L.; Marceau, Lisa D.] New England Res Inst, 9 Galen St, Watertown, MA 02172 USA.
   [Jaser, Sarah S.] Vanderbilt Univ, Med Ctr, Nashville, TN USA.
RP Whittemore, R (reprint author), Yale Sch Nursing, POB 27399, West Haven, CT 06516 USA.
EM Robin.whittemore@yale.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [1R43DK098857]
FX This project was funded by a grant (1R43DK098857) from the National
   Institute of Diabetes and Digestive and Kidney Diseases.
CR Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713
   Borus JS, 2010, CURR OPIN PEDIATR, V22, P405, DOI 10.1097/MOP.0b013e32833a46a7
   Bowes S, 2009, J ADV NURS, V65, P992, DOI 10.1111/j.1365-2648.2009.04963.x
   Buckloh LM, 2008, DIABETES CARE, V31, P1516, DOI 10.2337/dc07-2349
   CADMAN D, 1991, PEDIATRICS, V87, P884
   Cameron LD, 2007, J PEDIATR PSYCHOL, V32, P733, DOI 10.1093/jpepsy/jslo53
   Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171
   Eckshtain D, 2010, J PEDIATR PSYCHOL, V35, P426, DOI 10.1093/jpepsy/jsp068
   Ellis DA, 2007, J CONSULT CLIN PSYCH, V75, P168, DOI 10.1037/0022-006X.75.1.168
   Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353
   Green J, 2009, QUALITATIVE METHODS
   Grey M, 2009, RES NURS HEALTH, V32, P405, DOI 10.1002/nur.20336
   Howe CJ, 2012, J PEDIATR NURS, V27, P119, DOI 10.1016/j.pedn.2010.10.006
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Jaser SS, 2010, J PEDIATR PSYCHOL, V35, P738, DOI 10.1093/jpepsy/jsp098
   Jaser SS, 2009, CHILD HEALTH CARE, V38, P91, DOI 10.1080/02739610902813229
   Kaugars AS, 2011, PEDIATR DIABETES, V12, P547, DOI 10.1111/j.1399-5448.2010.00737.x
   Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768
   KOVACS M, 1990, J CONSULT CLIN PSYCH, V58, P189, DOI 10.1037//0022-006X.58.2.189
   Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138
   Landolt MA, 2002, J PEDIATR PSYCHOL, V27, P647, DOI 10.1093/jpepsy/27.7.647
   Leonard Barbara J, 2005, J Pediatr Nurs, V20, P405, DOI 10.1016/j.pedn.2005.03.010
   Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690
   Livingston G., 2009, LATINOS ONLINE 2006
   Lofland John, 1995, ANAL SOCIAL SETTINGS
   Mitchell SJ, 2009, FAM SYST HEALTH, V27, P314, DOI 10.1037/a0018191
   Pew Research Center, 2009, DEM TEEN INT US
   Spencer J, 2010, PEDIATR DIABETES, V11, P364, DOI 10.1111/j.1399-5448.2009.00603.x
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4
   Weinger K, 2001, J ADOLESCENT HEALTH, V29, P330, DOI 10.1016/S1054-139X(01)00270-1
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Wysocki T, 2000, J PEDIATR PSYCHOL, V25, P23, DOI 10.1093/jpepsy/25.1.23
   Young MT, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0546-5
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 35
TC 0
Z9 0
U1 1
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD FEB
PY 2018
VL 44
IS 1
BP 72
EP 82
DI 10.1177/0145721717748606
PG 11
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA FX3SY
UT WOS:000425993800008
PM 29262747
DA 2019-01-08
ER

PT J
AU Purewal, R
   Fisher, PL
AF Purewal, Rebecca
   Fisher, Peter L.
TI The contribution of illness perceptions and metacognitive beliefs to
   anxiety and depression in adults with diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Anxiety; Depression; Metacognitive beliefs; Illness
   perceptions
ID QUALITY-OF-LIFE; EMOTIONAL DISTRESS; GLYCEMIC CONTROL;
   PARKINSONS-DISEASE; GENERAL-POPULATION; SUBSTANCE USE; HEALTH;
   REPRESENTATIONS; ASSOCIATION; DISORDER
AB Aims: Anxiety and depression are highly prevalent in people with diabetes (PwD). The most widely used psychological model to explain anxiety and depression in PwD is the Common-Sense Model, which gives a central role to illness perceptions. The Self-Regulatory Executive Function (S-REF) model proposes metacognitive beliefs are key to understanding the development and maintenance of emotional disorders. To test the potential utility of the S-REF model in PwD, the study explored if metacognitive beliefs explained additional variance in anxiety and depression after controlling for demographic and illness perceptions.
   Methods: 614 adults with either Type 1 (n = 335) or Type 2 (n = 279) diabetes participated in a cross sectional online survey. All participants completed questionnaires on anxiety, depression, illness perceptions and metacognitive beliefs.
   Results: Regression analyses showed that metacognitive beliefs were associated with anxiety and depression in PwD and explained additional variance in both anxiety and depression after controlling for demographics and illness perceptions.
   Conclusions: This is the first study to demonstrate that metacognitive beliefs are associated with anxiety and depression in PwD. The clinical implications of the study are illustrated. Crown Copyright (C) 2017 Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Purewal, Rebecca; Fisher, Peter L.] Univ Liverpool, Psychol Sci, Liverpool, Merseyside, England.
   [Fisher, Peter L.] St Olavs Univ Hosp, Nidaros DPS, Div Psychiat, Trondheim, Norway.
RP Fisher, PL (reprint author), Univ Liverpool, Peter Fisher Inst Psychol Hlth & Soc, Whelan Bldg,Brownlow Hill, Liverpool, Merseyside, England.
EM peter.fisher@liverpool.ac.uk
OI Fisher, Peter/0000-0002-7388-720X
CR Allott R, 2005, BRIT J PSYCHIAT, V187, P182, DOI 10.1192/bjp.187.2.182
   Baumeister H, 2012, COCHRANE DB SYST REV, P12
   Brown RG, 2015, J PSYCHOSOM RES, V78, P143, DOI 10.1016/j.jpsychores.2014.09.021
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Cook SA, 2015, COGNITIVE THER RES, V39, P51, DOI 10.1007/s10608-014-9640-x
   Cook SA, 2015, HEALTH PSYCHOL, V34, P207, DOI 10.1037/hea0000096
   Cook SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107302
   Cukierman-Yaffe T, 2014, DIABETES-METAB RES, V30, P341, DOI 10.1002/dmrr.2507
   Ducat L, 2015, DIABETES CARE, V38, P333, DOI 10.2337/dc14-1383
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hampson SE, 2000, BRIT J HEALTH PSYCH, V5, P27, DOI 10.1348/135910700168748
   Hudson JL, 2014, J PSYCHOSOM RES, V76, P265, DOI 10.1016/j.jpsychores.2014.02.004
   Jeeva F, 2013, INT J TECHNOL ASSESS, V29, P384, DOI 10.1017/S0266462313000445
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Leventhal H, 1980, CONTRIBUTIONS MED PS, V2, P7
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172
   Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Maher-Edwards L, 2012, CLIN PSYCHOL PSYCHOT, V19, P552, DOI 10.1002/cpp.757
   Mollema ED, 2001, J PSYCHOSOM RES, V51, P665, DOI 10.1016/S0022-3999(01)00229-X
   Molosankwe I, 2012, J AFFECT DISORDERS, V142, pS42, DOI 10.1016/S0165-0327(12)70008-3
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Paschalides C, 2004, J PSYCHOSOM RES, V57, P557, DOI 10.1016/j.jpsychores.2004.03.006
   Renn BN, 2011, CLIN PSYCHOL REV, V31, P1239, DOI 10.1016/j.cpr.2011.08.001
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Skinner TC, 2003, DIABETIC MED, V20, P283, DOI 10.1046/j.1464-5491.2003.00923.x
   Sommerfield AJ, 2003, DIABETES CARE, V26, P390, DOI 10.2337/diacare.26.2.390
   Spada MM, 2008, PERS INDIV DIFFER, V45, P238, DOI 10.1016/j.paid.2008.04.005
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Steed L, 2003, PATIENT EDUC COUNS, V51, P5, DOI 10.1016/S0738-3991(02)00213-6
   Stoop CH, 2015, J AFFECT DISORDERS, V184, P269, DOI 10.1016/j.jad.2015.05.063
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Van Steenbergen-Weijenburg KM, 2010, BMC HLTH SERV RES, V10
   Wells A, 2004, BEHAV RES THER, V42, P385, DOI 10.1016/S0005-7967(03)00147-5
   Wells A., 1994, ATTENTION EMOTION CL
   Wells A., 2009, METACOGNITIVE THERAP
   WELLS KB, 1989, AM J PSYCHIAT, V146, P1440
   WELLS KB, 1989, GEN HOSP PSYCHIAT, V11, P320, DOI 10.1016/0163-8343(89)90119-9
NR 43
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD FEB
PY 2018
VL 136
BP 16
EP 22
DI 10.1016/j.diabres.2017.11.029
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FX2GP
UT WOS:000425877900003
PM 29203257
DA 2019-01-08
ER

PT J
AU Hayashino, Y
   Tsujii, S
   Ishii, H
AF Hayashino, Yasuaki
   Tsujii, Satoru
   Ishii, Hitoshi
CA Tenri Study Grp
TI Association of diabetes therapy-related quality of life and physical
   activity levels in patients with type 2 diabetes receiving medication
   therapy: the Diabetes Distress and Care Registry at Tenri (DDCRT 17)
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Diabetes; Physical activity; Diabetes therapy; Quality of life
ID RANDOMIZED CONTROLLED-TRIAL; GLYCEMIC CONTROL; JAPANESE PATIENTS;
   HEALTH; HYPOGLYCEMIA; EXERCISE; MELLITUS; PROGRAM; PEOPLE; ADULTS
AB To examine the association between diabetes therapy-related quality of life (DTR-QOL) and physical activity levels, and identify factors associated with high diabetes therapy-related quality of life.
   Cross-sectional data from 2970 patients with type 2 diabetes in a Japanese diabetes registry were assessed for independent correlations between DTR-QOL (domains 1-4) and high physical activity levels. Data collected by the International Physical Activity Questionnaire were analyzed by logistic regression and adjusted for potential confounders.
   The mean patient age, BMI and HbA1c level were 65.8 years, 24.7 kg/m(2) and 7.6% (58.7 mmol/mol), respectively. Univariate analysis showed that DTR-QOL domain 1, 2 and 4 scores were significantly associated with physical activity levels (p = 0.0046, p = 0.0004 and p < 0.001, respectively, but domain 3 score was not (p = 0.5073). In a multivariable-adjusted logistic regression model, odds ratios (ORs) of DTR-QOL domains 1, 3 and 4 were independently associated with high physical activity (ORs for 2nd to 4th quartile and p for trend; [domain 1] 1.16, 1.56, 1.22, p = 0.032; [domain 3] 1.45, 1.55, 1.38, p = 0.049; [domain 4] 1.09, 1.30, 1.51, p = 0.001, respectively), but domain 2 was not (ORs for 2nd to 4th quartile and p for trend; 1.19, 1.26, 1.23, p = 0.096).
   High diabetes therapy-related QOL scores were associated with high levels of physical activity in patients with type 2 diabetes. Because this is a cross-sectional study, further study is needed to evaluate the causal association between therapy-related QOL and physical activity.
C1 [Hayashino, Yasuaki; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
   [Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 6348521, Japan.
RP Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
EM hayasino-y@umin.net
OI Hayashino, Yasuaki/0000-0002-2932-8478
FU Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and JSPS KAKENHI (Grant Number 25460641). These agencies did
   not participate in the study design or conduct, data collection,
   analysis or interpretation, preparation, review or approval of the
   manuscript. We would like to especially thank Yukari Moritsuji, Yuki
   Fujita, Noriko Nakamura and Yoko Sakamoto (Department of Endocrinology,
   Tenri Hospital) for their clerical support. The authors would like to
   thank Enago (www.enago.jp) for the English language review.
CR Balducci S, 2004, DIABETES CARE, V27, P841, DOI 10.2337/diacare.27.3.841
   Bjorner JB, 2013, VALUE HEALTH, V16, P993, DOI 10.1016/j.jval.2013.06.022
   Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Domgaard M, 2015, POSTGRAD MED, V127, P438, DOI 10.1080/00325481.2015.1045815
   Dunstan DW, 2006, DIABETES CARE, V29, P2586, DOI 10.2337/dc06-1310
   Hakkinen A, 2009, DISABIL REHABIL, V31, P799, DOI 10.1080/08916930802354930
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579
   Hu J, 2010, J COMMUN HEALTH NURS, V27, P70, DOI 10.1080/07370011003704933
   Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0
   Ishii Hitoshi, 2012, J Med Econ, V15, P556, DOI 10.3111/13696998.2012.665111
   Jacobson Alan M, 2004, Endocr Pract, V10, P502
   Kirk A, 2004, DIABETOLOGIA, V47, P821, DOI 10.1007/s00125-004-1396-5
   Kueh YC, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0303-8
   Maddigan SL, 2005, QUAL LIFE RES, V14, P1489, DOI 10.1007/s11136-005-0586-z
   Mashitani T, 2015, ACTA DIABETOL, V52, P639, DOI 10.1007/s00592-015-0725-0
   Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006
   Murata GH, 2004, BIOMED PHARMACOTHER, V58, P551, DOI 10.1016/j.biopha.2004.09.001
   Nakamura A, 2010, J DIABETES INVEST, V1, P208, DOI 10.1111/j.2040-1124.2010.00046.x
   Nicolucci A, 2012, DIABETOLOGIA, V55, P579, DOI 10.1007/s00125-011-2425-9
   Nicolucci A, 2011, ARCH INTERN MED, V171, P1951, DOI 10.1001/archinternmed.2011.561
   Praet SFE, 2008, DIABETOLOGIA, V51, P736, DOI 10.1007/s00125-008-0950-y
   Praet SFE, 2009, ACTA DIABETOL, V46, P263, DOI 10.1007/s00592-009-0129-0
   SCHNEIDER SH, 1992, DIABETES CARE, V15, P1800, DOI 10.2337/diacare.15.11.1800
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Schwartz SS, 2013, DRUGS CONTEXT, V2013
   Seaquist ER, 2013, J CLIN ENDOCR METAB, V98, P1845, DOI 10.1210/jc.2012-4127
   Shi LZ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0167-3
   Shultz JA, 2001, J HEALTH COMMUN, V6, P99, DOI 10.1080/108107301750254457
   Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
   Yong YM, 2015, DIABETES METAB J, V39, P154, DOI 10.4093/dmj.2015.39.2.154
   Zhang P, 2012, DIABETES CARE, V35, P2250, DOI 10.2337/dc11-2478
NR 35
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD FEB
PY 2018
VL 55
IS 2
BP 165
EP 173
DI 10.1007/s00592-017-1080-0
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FW4JM
UT WOS:000425279400007
PM 29188385
DA 2019-01-08
ER

PT J
AU Choi, WH
   Seo, YM
   Ha, Y
AF Choi, Won-Hee
   Seo, Yeong-Mi
   Ha, Yeongmi
TI Evaluation of factors related to glycaemic control among South Korean
   patients with type 2 diabetes
SO INTERNATIONAL JOURNAL OF NURSING PRACTICE
LA English
DT Article
DE diabetes mellitus; glycaemic index; medication adherence; nurses;
   self-care
ID EMOTIONAL DISTRESS; MELLITUS; DEPRESSION; COMPLICATIONS; ASSOCIATIONS;
   ANXIETY; SCALE; LIFE
AB AimsTo examine specific self-care behaviours, depression, and diabetes-related stress among South Korean patients with type 2 diabetes and to evaluate whether these factors are related to glycaemic control.
   MethodsThis cross-sectional study included 171 patients with type 2 diabetes who visited an endocrinology clinic. A structured questionnaire and electronic medical records were used to collect data regarding self-care behaviours, depression, diabetes-related distress, and glycaemic control between May 2015 and July 2015.
   ResultsCompared with the group with good glycaemic control, the group with poor glycaemic control had significantly lower values for medication adherence and significantly greater values for regimen-related distress. Depression was not significantly associated with glycaemic control. In logistic regression analysis, only medication adherence was independently associated with glycaemic control.
   ConclusionsMedication adherence should be continuously emphasized and monitored in clinical practice to effectively manage glycaemic control among patients with type 2 diabetes. Furthermore, consideration of diabetes-related distress may help improve glycaemic control among patients with type 2 diabetes.
C1 [Choi, Won-Hee] Kyungsung Univ, Dept Nursing, Busan, South Korea.
   [Seo, Yeong-Mi] Gyeongnam Natl Univ Sci & Technol, Dept Nursing, 33 Dongjin Ro, Jinju 52725, Gyeongnam, South Korea.
   [Ha, Yeongmi] Gyeongsang Natl Univ, Inst Hlth Sci, Coll Nursing, Jinju, South Korea.
RP Seo, YM (reprint author), Gyeongnam Natl Univ Sci & Technol, Dept Nursing, 33 Dongjin Ro, Jinju 52725, Gyeongnam, South Korea.
EM asfirst@gntech.ac.kr
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   [Anonymous], 2015, DIABETES CARE, V38, pS33, DOI 10.2337/dc15-S009
   [Anonymous], 1995, DIABETES, V44, P968
   Calhoun D, 2010, J DIABETES COMPLICAT, V24, P217, DOI 10.1016/j.jdiacomp.2009.03.005
   Choi E, 2007, THESIS
   Chon K.K., 2001, KOREAN J HLTH PSYCHO, V6, P59
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Feldman BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108145
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Forrest KYZ, 2000, ATHEROSCLEROSIS, V148, P159, DOI 10.1016/S0021-9150(99)00217-8
   GOLDSTON DB, 1995, HEALTH PSYCHOL, V14, P409, DOI 10.1037/0278-6133.14.5.409
   강혜연, 2012, [The Journal of Fundamentals of Nursing, 기본간호학회지], V19, P168
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Ji E. J., 2015, J KOREAN ACAD FUNDAM, V22, P433
   Korean Diabetes Association, 2015, KOR DIAB MELL FACT S
   Ministry of Health and Welfare, 2014, KOR HLTH STAT 2013 K
   Osborn CY, 2016, J CLIN PHARM THER, V41, P256, DOI 10.1111/jcpt.12360
   Parildar H, 2015, PAK J MED SCI, V31, P19, DOI 10.12669/pjms.311.6011
   Park Ju-Young, 2010, [The Korean Academic Society of Adult Nursing, 성인간호학회지], V22, P271
   Park YS, 2005, KOREAN J FAM MED, V26, P744
   Paschalides C, 2004, J PSYCHOSOM RES, V57, P557, DOI 10.1016/j.jpsychores.2004.03.006
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Sekhar TVDS, 2013, J CLIN DIAGN RES, V7, P857, DOI 10.7860/JCDR/2013/5726.2958
   Seo Y. M., 2008, THESIS
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   SURWIT RS, 1992, DIABETES CARE, V15, P1413, DOI 10.2337/diacare.15.10.1413
   Turner RC, 1998, LANCET, V352, P854
   Turner RC, 1998, LANCET, V352, P837
   이주안, 2014, [The Journal of Fundamentals of Nursing, 기본간호학회지], V21, P243, DOI 10.7739/jkafn.2014.21.3.243
   부선주, 2012, [The Korean Academic Society of Adult Nursing, 성인간호학회지], V24, P406
NR 36
TC 0
Z9 0
U1 3
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1322-7114
EI 1440-172X
J9 INT J NURS PRACT
JI Int. J. Nurs. Pract.
PD FEB
PY 2018
VL 24
IS 1
AR e12616
DI 10.1111/ijn.12616
PG 8
WC Nursing
SC Nursing
GA FU8YL
UT WOS:000424142400013
PM 29205693
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Grammes, J
   Schafer, M
   Benecke, A
   Low, U
   Klostermann, AL
   Kubiak, T
   Witthoft, M
AF Grammes, Jennifer
   Schaefer, Manuela
   Benecke, Andrea
   Loew, Ulrike
   Klostermann, Alena-Lynn
   Kubiak, Thomas
   Witthoeft, Michael
TI Fear of hypoglycemia in patients with type 2 diabetes: The role of
   interoceptive accuracy and prior episodes of hypoglycemia
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Fear of hypoglycemia; Heartbeat perception; Hypoglycemia Fear Survey;
   Interoceptive accuracy; Type 2 diabetes mellitus
ID MEDICALLY UNEXPLAINED SYMPTOMS; QUALITY-OF-LIFE; TACTILE PERCEPTUAL
   PROCESSES; POOR GLYCEMIC CONTROL; HEARTBEAT PERCEPTION; PANIC DISORDER;
   SOMATOFORM DISORDERS; HEALTH ANXIETY; SOMATOSENSORY AMPLIFICATION;
   IMPAIRED AWARENESS
AB Objective: Fear of hypoglycemia (FoH) is a limiting factor for diabetes self-management and can have detrimental effects on quality of life. However, relatively little is known about its underlying mechanisms. In line with findings on patients with anxiety disorders, we hypothesized that interoceptive accuracy (IA) might be positively linked to FoH in patients with type 2 diabetes (T2DM).
   Methods: 133 patients with T2DM were screened according to the extreme quartiles of the Hypoglycemia Fear Survey worry subscale (HFS-W). Overall, 66 participants (HFS-W < 4; HFS-W > 17) were included in the present study. Participants completed questionnaires on sociodemographic and diabetes-related measures. Accuracy of heartbeat perception was assessed using the mental tracking task.
   Results: Contrary to expectations, IA did not differ significantly between patients with low and high FoH. A linear regression analysis demonstrated that the experience of mild hypoglycemia (beta = 0.32, p <= 0.01) and its interaction with IA (beta = 0.26, p = 0.040) were significant predictors of FoH, indicating that low IA and a history of experiencing mild hypoglycemia are positively associated with FoH.
   Conclusion: Our findings suggest a positive association of low IA in combination with prior episodes of hypoglycemia and FoH in patients with T2DM. The results are in line with recent findings on IA in patients with chronic somatic symptom distress more generally and contribute to our understanding of the relations between interoception, body related fears, and physical symptom perception.
C1 [Grammes, Jennifer; Kubiak, Thomas] Johannes Gutenberg Univ Mainz, Hlth Psychol, Binger Str 14-16, D-55122 Mainz, Germany.
   [Schaefer, Manuela; Benecke, Andrea; Loew, Ulrike; Klostermann, Alena-Lynn] Johannes Gutenberg Univ Mainz, Outpatient Clin Psychotherapy, Mainz, Germany.
   [Witthoeft, Michael] Johannes Gutenberg Univ Mainz, Clin Psychol Psychotherapy & Expt Psychopathol, Mainz, Germany.
RP Grammes, J (reprint author), Johannes Gutenberg Univ Mainz, Hlth Psychol, Binger Str 14-16, D-55122 Mainz, Germany.
EM jegramme@uni-mainz.de
RI Kubiak, Thomas/D-4655-2009
OI Kubiak, Thomas/0000-0003-0095-9265
CR Al Hayek AA, 2015, MED PRIN PRACT, V24, P222, DOI 10.1159/000375306
   Amiel SA, 2008, DIABETIC MED, V25, P245, DOI 10.1111/j.1464-5491.2007.02341.x
   Anderbro T, 2010, DIABETIC MED, V27, P1151, DOI 10.1111/j.1464-5491.2010.03078.x
   Anderbro T, 2015, ACTA DIABETOL, V52, P581, DOI 10.1007/s00592-014-0694-8
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   ANTONY MM, 1995, J ANXIETY DISORD, V9, P355, DOI 10.1016/0887-6185(95)00017-I
   Barendse S, 2012, DIABETIC MED, V29, P293, DOI 10.1111/j.1464-5491.2011.03416.x
   Barlow D., 1988, INFORM PROCESSING DE
   BARSKY AJ, 1990, BRIT J PSYCHIAT, V157, P404, DOI 10.1192/bjp.157.3.404
   Beck A. T., 1985, ANXIETY DISORDERS PH
   Bornemann B, 2017, PSYCHOPHYSIOLOGY, V54, P469, DOI 10.1111/psyp.12790
   Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4
   Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793
   Ceunen E, 2013, BIOL PSYCHOL, V92, P426, DOI 10.1016/j.biopsycho.2012.09.012
   CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cortina JM, 1998, J APPL PSYCHOL, V83, P798, DOI 10.1037/0021-9010.83.5.798
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Crucianelli L., 2017, CORTEX IN PRESS
   De Berardis D, 2007, PSYCHOSOMATICS, V48, P239, DOI 10.1176/appi.psy.48.3.239
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008
   Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Gonder-Frederick LA, 2006, PEDIATR DIABETES, V7, P215, DOI 10.1111/j.1399-5448.2006.00182.x
   Grammes J, 2017, DIABETIC MED, V34, P1765, DOI 10.1111/dme.13506
   Green AJ, 2012, DIABETES RES CLIN PR, V96, P313, DOI 10.1016/j.diabres.2012.01.002
   Hajos TRS, 2014, DIABETES CARE, V37, P102, DOI 10.2337/dc13-0971
   Hay L C, 2003, Diabetes Technol Ther, V5, P19, DOI 10.1089/152091503763816427
   Henderson JN, 2003, DIABETIC MED, V20, P1016, DOI 10.1046/j.1464-5491.2003.01072.x
   HEPBURN DA, 1993, DIABETIC MED, V10, P231, DOI 10.1111/j.1464-5491.1993.tb00050.x
   HEPBURN DA, 1994, DIABETES CARE, V17, P1273, DOI 10.2337/diacare.17.11.1273
   Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x
   Hermanns N, 2007, DIABETES-METAB RES, V23, P528, DOI 10.1002/dmrr.710
   Irvin A, 1994, HDB PSYCHOL DIABETES, P133
   Jodar-Gimeno E, 2015, REV CLIN ESP, V215, P91, DOI 10.1016/j.rce.2014.07.009
   Katzer A, 2012, J ABNORM PSYCHOL, V121, P530, DOI 10.1037/a0026536
   Katzer A, 2011, J PSYCHOSOM RES, V71, P335, DOI 10.1016/j.jpsychores.2011.03.009
   King P, 1998, DIABETES CARE, V21, P341, DOI 10.2337/diacare.21.3.341
   Krautwurst S, 2016, J ABNORM PSYCHOL, V125, P1179, DOI 10.1037/abn0000210
   Krautwurst S, 2014, J BEHAV THER EXP PSY, V45, P303, DOI 10.1016/j.jbtep.2014.02.001
   Ludewig S, 2005, J PSYCHIATR NEUROSCI, V30, P37
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Martin-Timon I, 2015, WORLD J DIABETES, V6, P912, DOI 10.4239/wjd.v6.i7.912
   Matza L. S., 2007, HLTH QUAL LIFE OUTCO, V5
   NARING GWB, 1995, PSYCHOTHER PSYCHOSOM, V63, P193
   Olatunji BO, 2007, BEHAV THER, V38, P392, DOI 10.1016/j.beth.2006.09.002
   Pennebaker J. W., 1982, PHYSL PHYS SYMPTOMS
   Petersen S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00732
   Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004
   Pollatos O, 2011, J PSYCHOSOM RES, V71, P232, DOI 10.1016/j.jpsychores.2011.03.012
   Polonsky WH, 2015, J DIABETES COMPLICAT, V29, P1171, DOI 10.1016/j.jdiacomp.2015.08.002
   POLONSKY WH, 1992, HEALTH PSYCHOL, V11, P199, DOI 10.1037/0278-6133.11.3.199
   Preacher KJ, 2015, ENCY CLIN PSYCHOL, P1189
   Richards JC, 2003, COGNITIVE THER RES, V27, P447, DOI 10.1023/A:1025476514714
   Richards JC, 2000, J ANXIETY DISORD, V14, P413, DOI 10.1016/S0887-6185(00)00031-1
   Rosendal M, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0592-6
   Sakane N, 2015, J DIABETES INVEST, V6, P567, DOI 10.1111/jdi.12340
   Schachinger H, 2005, J BEHAV MED, V28, P587, DOI 10.1007/s10865-005-9026-3
   SCHACHTER S, 1964, ADV EXP SOC PSYCHOL, V1, P49, DOI 10.1016/S0065-2601(08)60048-9
   Schaefer M, 2014, BIOL PSYCHOL, V101, P69, DOI [10.1016/j.biopsycho.2014.06.012, 10.1016/j.biopsycho.2014.05.012]
   Schaefer M, 2012, J ABNORM PSYCHOL, V121, P719, DOI 10.1037/a0028509
   SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P154
   Shi L. Z., 2014, HLTH QUAL LIFE OUTCO, V12
   SMITH RC, 1991, J GEN INTERN MED, V6, P168, DOI 10.1007/BF02598318
   Stargardt T., 2009, HLTH QUAL LIFE OUTCO, V7
   Sturges LV, 1996, J ANXIETY DISORD, V10, P283, DOI 10.1016/0887-6185(96)00012-6
   ter Braak EWMT, 2000, DIABETES CARE, V23, P1467, DOI 10.2337/diacare.23.10.1467
   Van den Bergh O, 2017, NEUROSCI BIOBEHAV R, V74, P185, DOI 10.1016/j.neubiorev.2017.01.015
   Vexiau P, 2008, DIABETES OBES METAB, V10, P16, DOI 10.1111/j.1463-1326.2008.00883.x
   Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Williams SA, 2011, DIABETES RES CLIN PR, V91, P363, DOI 10.1016/j.diabres.2010.12.027
   Zammitt NN, 2005, DIABETES CARE, V28, P2948, DOI 10.2337/diacare.28.12.2948
   Zoellner LA, 1999, BEHAV RES THER, V37, P1141, DOI 10.1016/S0005-7967(98)00202-2
NR 76
TC 0
Z9 0
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD FEB
PY 2018
VL 105
BP 58
EP 63
DI 10.1016/j.jpsychores.2017.12.010
PG 6
WC Psychiatry
SC Psychiatry
GA FT6HV
UT WOS:000423256000008
PM 29332635
DA 2019-01-08
ER

PT J
AU Inman, M
   Nour, MA
AF Inman, Mark
   Nour, Munier A.
TI Insulin-mediated pseudoacromegaly: a report of two pediatric patients
SO JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
LA English
DT Article
DE acromegaly; diabetes mellitus; insulin resistance; type 2
ID RESISTANCE; HYPERINSULINISM; FIBROBLASTS; RECEPTOR; 3-KINASE; OBESITY
AB Background: Insulin-mediated pseudoacromegaly is a rarely described pediatric phenotype. We present two patients displaying excessive growth associated with marked acanthosis nigricans, hyperinsulinemia and metabolic dysregulation.
   Case presentation: Both patients, of First Nations descent, presented with excessive growth - patient one at 3.92 years (height z-score +3.75) and patient two at 9.0 years (height z-score 5.15). Insulin-like growth factor-1 (IGF-1) levels were normal with appropriate growth hormone suppression, yet marked hyperinsulinemia. Prepubescent growth velocities exceeded 9 cm/year, resulting in final adult height predictions exceeding 3 standard deviations (SDs) of predicted. Clinical courses were complicated by type 2 diabetes, marked acanthosis nigricans and long-standing psychosocial distress.
   Conclusions: Pediatric patients with insulin-mediated pseudoacromegaly are at risk of significant physical, metabolic and psychosocial comorbidities. Unlike adults, the implications in childhood prompt consideration for therapies to decelerate linear growth and avert progression to metabolic dysregulation. Increased recognition of this condition may improve pathophysiological understanding, diagnostic criteria and therapeutic options.
C1 [Inman, Mark; Nour, Munier A.] Univ Saskatchewan, Dept Pediat, 103 Hosp Dr, Saskatoon, SK S7N 0W8, Canada.
RP Inman, M (reprint author), Univ Saskatchewan, Dept Pediat, 103 Hosp Dr, Saskatoon, SK S7N 0W8, Canada.
EM mark.inman@usask.ca
CR Dib K, 1998, J CLIN INVEST, V101, P1111, DOI 10.1172/JCI119884
   FLIER JS, 1993, J CLIN ENDOCR METAB, V76, P1533, DOI 10.1210/jc.76.6.1533
   FRADKIN JE, 1989, NEW ENGL J MED, V320, P640
   Kausch C, 1999, EXP CLIN ENDOCR DIAB, V107, P148, DOI 10.1055/s-0029-1212090
   Kumar S, 1996, J CLIN ENDOCR METAB, V81, P3465, DOI 10.1210/jc.81.10.3465
   Littlejohn EE, 2007, J PEDIATR ENDOCR MET, V20, P41
   Sam AH, 2011, HORM-INT J ENDOCRINO, V10, P156, DOI 10.14310/horm.2002.1306
   Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200
   Srinivasan S, 2003, ARCH DIS CHILD, V88, P332, DOI 10.1136/adc.88.4.332
   Yaqub Abid, 2008, W V Med J, V104, P12
NR 10
TC 0
Z9 0
U1 1
U2 1
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-018X
EI 2191-0251
J9 J PEDIATR ENDOCR MET
JI J. Pediatr. Endocrinol. Metab.
PD FEB
PY 2018
VL 31
IS 2
BP 235
EP 238
DI 10.1515/jpem-2017-0398
PG 4
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA FU2KD
UT WOS:000423677900018
PM 29252200
DA 2019-01-08
ER

PT J
AU Tanenbaum, ML
   Adams, RN
   Gonzalez, JS
   Hanes, SJ
   Hood, KK
AF Tanenbaum, M. L.
   Adams, R. N.
   Gonzalez, J. S.
   Hanes, S. J.
   Hood, K. K.
TI Adapting and validating a measure of diabetes-specific self-compassion
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Self-compassion; Type 1 diabetes; Mindfulness; Scale validation;
   Confirmatory factor analysis
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; STRESS-REDUCTION; GLYCEMIC
   CONTROL; MINDFULNESS; MANAGEMENT; ADOLESCENTS; ACCEPTANCE; THERAPY;
   HEALTH
AB Aims: Self-compassion (SC), or treating oneself with kindness when dealing with personal challenges, has not been rigorously examined in people with T1D. SC has been shown to buffer against negative emotions and to be linked to improved health outcomes, but diabetes-specific SC has not been studied. This study aimed to adapt the Self-Compassion Scale and validate it for a diabetes-specific population.
   Methods: We developed and validated a diabetes-specific version of the Self-Compassion Scale (Neff, 2003) in a sample of adults with T1D (N = 542; 65% female; 97% non-Hispanic White; M age 41, SD = 15.7; M Alc = 73, SD = 1; 72% insulin pump users; 50% continuous glucose monitoring [CCM] users). Confirmatory factor analyses (CFA), and reliability and construct validity analyses were conducted. Validity measures included diabetes distress, diabetes empowerment, diabetes numeracy, and Al c.
   Results: A two-factor bi-factor structure showed best fit, providing support for use of the adapted scale (SCS-D) as a unitary construct The 19-item unidimensional SCS-D demonstrated excellent internal consistency (a = 0.94; range of item-total correlations: 0.52-0.71) and construct validity. As hypothesized, higher SCS-D was associated with less distress, greater empowerment, and lower Aic, and was not associated with numeracy.
   Conclusions: The SCS-D is a reliable and valid measure of diabetes-specific self-compassion in adults with T1D. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Tanenbaum, M. L.; Adams, R. N.; Hanes, S. J.; Hood, K. K.] Stanford Univ, Sch Med, Dept Pediat, 780 Welch Rd, Palo Alto, CA 94304 USA.
   [Gonzalez, J. S.] Yeshiva Univ, Ferkauf Grad Sch Psychol, 1300 Morris Pk Ave,Rousso Bldg, Bronx, NY 10461 USA.
   [Gonzalez, J. S.] Albert Einstein Coll Med, Diabet Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
RP Tanenbaum, ML (reprint author), Stanford Univ, Sch Med, Dept Pediat, 780 Welch Rd, Palo Alto, CA 94304 USA.
EM mollyt@stanford.edu; rnadams@stanford.edu;
   jeffrey.gonzalez@einstein.yu.edu; sjhanes@stanford.edu;
   kkhood@stanford.edu
CR Abernathy P, 2015, WHY I TOLD MY DIABET
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Archer A, 2014, PRACT DIABETES, V31, P102, DOI 10.1002/pdi.1842
   Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Basco M., 1998, DIABETES SPECTRUM, V11, P43
   Brion JM, 2014, J HEALTH PSYCHOL, V19, P218, DOI 10.1177/1359105312467391
   Broom D, 2004, SOC SCI MED, V58, P2371, DOI 10.1016/j.socscimed.2003.09.002
   Costa J, 2016, CLIN PSYCHOL PSYCHOT, V23, P460, DOI 10.1002/cpp.1974
   Davies NJ, 2012, LEARNING SELF COMPAS
   Esbitt SA, 2015, COGN BEHAV PRACT, V22, P393, DOI 10.1016/j.cbpra.2014.02.006
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Folias A, 2014, INVESTIGATION PRESEN
   Friis AM, 2015, DIABETIC MED, V32, P1634, DOI 10.1111/dme.12774
   Friis A. M., 2016, DIABETES CARE
   Friis Anna M, 2015, Diabetes Spectr, V28, P252, DOI 10.2337/diaspect.28.4.252
   Graham CD, 2016, CLIN PSYCHOL REV, V46, P46, DOI 10.1016/j.cpr.2016.04.009
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Grylli V, 2005, J PSYCHOSOM RES, V59, P65, DOI 10.1016/j.jpsychores.2005.02.010
   Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huizinga MM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-96
   Iturralde E, 2017, HEALTH PSYCHOL, V36, P236, DOI 10.1037/hea0000445
   Jaser SS, 2011, CHILD CARE HLTH DEV, V37, P335, DOI 10.1111/j.1365-2214.2010.01184.x
   Joensen LE, 2016, PRIM CARE DIABETES, V10, P41, DOI 10.1016/j.pcd.2015.06.007
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Lopez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132940
   Loucks EB, 2016, AM J HEALTH BEHAV, V40, P258, DOI 10.5993/AJHB.40.2.11
   Loucks EB, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0668-7
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Muthen L. K., 1998, MPLUS USERS GUIDE
   Neff KD, 2017, J PERS ASSESS, P1
   Neff K, 2003, SELF IDENTITY, V2, P85, DOI 10.1080/15298860390129863
   Neff KD, 2016, MINDFULNESS, V7, P264, DOI 10.1007/s12671-015-0479-3
   Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035
   Pinto-Gouveia J, 2014, CLIN PSYCHOL PSYCHOT, V21, P311, DOI 10.1002/cpp.1838
   Raes F, 2011, CLIN PSYCHOL PSYCHOT, V18, P250, DOI 10.1002/cpp.702
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   Schmitt A, 2014, DIABETIC MED, V31, P1446, DOI 10.1111/dme.12553
   Schroevers MJ, 2016, MIND, P1
   Shayeghian Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166599
   Sirois Fuschia M, 2015, Prev Med Rep, V2, P218, DOI 10.1016/j.pmedr.2015.03.006
   Sirois FM, 2015, HEALTH PSYCHOL, V34, P661, DOI 10.1037/hea0000158
   Sirois FM, 2015, SELF IDENTITY, V14, P334, DOI 10.1080/15298868.2014.996249
   Tanenbaum ML, 2016, DIABETES CARE
   Tanenbaum ML, 2017, DIABETES CARE, V40, P181, DOI 10.2337/dc16-1536
   Terry ML, 2013, PERS SOC PSYCHOL B, V39, P911, DOI 10.1177/0146167213488213
   Terry ML, 2011, SELF IDENTITY, V10, P352, DOI 10.1080/15298868.2011.558404
   van Son J, 2014, J PSYCHOSOM RES, V77, P81, DOI 10.1016/j.jpsychores.2014.03.013
   Vanstone Meredith, 2015, Ont Health Technol Assess Ser, V15, P1
   Yi-Frazier JP, 2015, J HEALTH PSYCHOL, V20, P1196, DOI 10.1177/1359105313509846
   Young Laura A, 2009, Pract Diabetes Int, V26, P222, DOI 10.1002/pdi.1380
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 52
TC 1
Z9 1
U1 4
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD FEB
PY 2018
VL 32
IS 2
BP 196
EP 202
DI 10.1016/j.jdiacomp.2017.10.009
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FT8QT
UT WOS:000423419000013
PM 29157869
DA 2019-01-08
ER

PT J
AU Thong, MSY
   Mols, F
   van de Poll-Franse, LV
   Sprangers, MAG
   van der Rijt, CCD
   Barsevick, AM
   Knoop, H
   Husson, O
AF Thong, Melissa S. Y.
   Mols, Floortje
   van de Poll-Franse, Lonneke V.
   Sprangers, Mirjam A. G.
   van der Rijt, Carin C. D.
   Barsevick, Andrea M.
   Knoop, Hans
   Husson, Olga
TI Identifying the subtypes of cancer-related fatigue: results from the
   population-based PROFILES registry
SO JOURNAL OF CANCER SURVIVORSHIP
LA English
DT Article
DE Cancer; Latent class analysis; Fatigue subtypes; Population-based;
   Survivors
ID QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; POSITIVE AFFECT ANHEDONIA;
   PHYSICAL-ACTIVITIES; EVENING FATIGUE; CLINICAL-TRIALS; SURVIVORS;
   INSTRUMENT; BEHAVIOR; QUESTIONNAIRE
AB Little research has been done to identify possible cancer-related fatigue (CRF) subtypes and to classify cancer survivors accordingly. We aimed to identify CRF subtypes in a large population-based sample of (long term) stage I-III colorectal cancer survivors. We also identified factors associated with the CRF subtypes.
   Respondents completed the Multidimensional Fatigue Inventory and other validated questionnaires on anxiety and reduced positive affect (anhedonia), sleep quality, and lifestyle factors (body mass index and physical activity). Latent class analysis was used to derive the CRF subtypes. Factors associated with the derived CRF subtypes were determined with multinomial logistic regression.
   Three CRF classes were identified: class 1 (no fatigue and distress, n = 644, 56%), class 2 (low fatigue, moderate distress, n = 256, 22%), and class 3 (high fatigue, moderate distress, n = 256, 22%). Multinomial logistic regression results show that survivors in class 3 were more likely to be female, were treated with radiotherapy, have comorbid diabetes mellitus, and be overweight/obese than survivors in class 1 (reference). Survivors in classes 2 and 3 were also more likely to have comorbid heart condition, report poorer sleep quality, experience anhedonia, and report more anxiety symptoms when compared with survivors in class 1.
   Three distinct classes of CRF were identified which could be differentiated with sleep quality, anxiety, anhedonia, and lifestyle factors.
   The identification of CRF subtypes with distinct characteristics suggests that interventions should be targeted to the CRF subtype.
C1 [Thong, Melissa S. Y.; Sprangers, Mirjam A. G.; Knoop, Hans] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Med Psychol, Acad Med Ctr, POB 22660, NL-1100 DD Amsterdam, Netherlands.
   [Mols, Floortje; van de Poll-Franse, Lonneke V.] Netherlands Comprehens Canc Org, Utrecht, Netherlands.
   [Mols, Floortje; van de Poll-Franse, Lonneke V.] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, Dept Med & Clin Psychol, Tilburg, Netherlands.
   [van de Poll-Franse, Lonneke V.] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands.
   [van der Rijt, Carin C. D.] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands.
   [Barsevick, Andrea M.] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA.
   [Knoop, Hans] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Med Psychol, Expert Ctr Chron Fatigue,Med Ctr, Amsterdam, Netherlands.
   [Husson, Olga] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, Nijmegen, Netherlands.
RP Thong, MSY (reprint author), Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Med Psychol, Acad Med Ctr, POB 22660, NL-1100 DD Amsterdam, Netherlands.
EM s.y.thong@amc.uva.nl
RI Husson, Olga/L-1339-2015; Knoop, Hans/D-3264-2009
OI Husson, Olga/0000-0002-1387-8686; Knoop, Hans/0000-0001-7763-3517
FU VENI grant from the Netherlands Organization for Scientific Research
   [451-10-041]; Medium Investment Grant from the Netherlands Organisation
   for Scientific Research (NWO), The Hague [480-08-009]; Medium Investment
   Grant from the Netherlands Organisation for Scientific Research (NWO),
   The Netherlands; Dutch Cancer Society [KUN2015-7527]; the Netherlands
   Organization for Scientific Research [451-10-041]
FX The data collection of this study was funded in part by a VENI grant
   from the Netherlands Organization for Scientific Research (#451-10-041)
   awarded to Dr. Floortje Mols, and a Medium Investment Grant from the
   Netherlands Organisation for Scientific Research (NWO#480-08-009), The
   Hague, and The Netherlands. Dr. Olga Husson (KUN2015-7527) is supported
   by a Social Psychology Fellowship from the Dutch Cancer Society, and Dr.
   Floortje Mols is supported by a VENI grant (#451-10-041) from the
   Netherlands Organization for Scientific Research. These funding agencies
   had no further role in study design, in the collection, analysis, and
   interpretation of data, in the writing of the report, and in the
   decision to submit the paper for publication.
CR AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365
   AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080
   Barsevick AM, 2013, JNCI-J NATL CANCER I, V105, P1432, DOI 10.1093/jnci/djt242
   Bennett BK, 2014, PSYCHOSOM MED, V76, P379, DOI 10.1097/PSY.0000000000000061
   Berger AM, 2010, J NATL COMPR CANC NE, V8, P904, DOI 10.6004/jnccn.2010.0067
   Bower JE, 2006, CANCER, V106, P751, DOI 10.1002/cncr.21671
   Bower JE, 2011, J CLIN ONCOL, V29, P3517, DOI 10.1200/JCO.2011.36.1154
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5
   Cheng KKF, 2011, CRIT REV ONCOL HEMAT, V78, P127, DOI 10.1016/j.critrevonc.2010.03.002
   Cramp F, 2012, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD006145
   Damen NL, 2013, EUR J PREV CARDIOL, V20, P127, DOI 10.1177/2047487312436452
   de Raaf PJ, 2013, PSYCHO-ONCOLOGY, V22, P1919, DOI 10.1002/pon.3225
   de Raaf PJ, 2013, CANC RELATED FATIGUE
   de Raaf PJ, 2012, J PAIN SYMPTOM MANAG, V44, P823, DOI 10.1016/j.jpainsymman.2011.12.279
   Dennett AM, 2016, J PHYSIOTHER, V62, P68, DOI 10.1016/j.jphys.2016.02.012
   Denollet J, 2008, J INTERN MED, V263, P203, DOI 10.1111/j.1365-2796.2007.01870.x
   Fayers PM, 1995, BRUSSELS BELG, V11, P1
   Garland SN, 2014, NEUROPSYCH DIS TREAT, V10, P1113, DOI 10.2147/NDT.S47790
   Gielissen MFM, 2006, J CLIN ONCOL, V24, P4882, DOI 10.1200/JCO.2006.06.8270
   Goedendorp MM, 2012, CANCER-AM CANCER SOC, V118, P3833, DOI 10.1002/cncr.26226
   Goedendorp MM, 2009, COCHRANE DB SYST REV, V21, DOI DOI 10.1002/14651858.CD006953.PUB2
   Grimmett C, 2011, QUAL LIFE RES, V20, P1237, DOI 10.1007/s11136-011-9855-1
   Hofman M, 2007, ONCOLOGIST, V12, P4, DOI 10.1634/theoncologist.12-S1-4
   Holzner B, 2002, ANN ONCOL, V13, P965, DOI 10.1093/annonc/mdf122
   Janssen-Heijnen MLG LW, 2005, RESULTS 50 YEARS CAN
   Kim HJ, 2012, CANCER NURS, V35, pE1, DOI 10.1097/NCC.0b013e318233a811
   Koutoukidis DA, 2015, NUTR REV, V73, P399, DOI 10.1093/nutrit/nuu063
   Lengacher CA, 2016, J CLIN ONCOL, V34, P2827, DOI 10.1200/JCO.2015.65.7874
   Magidson Jay, 2004, SAGE HDB QUANTITATIV, P175, DOI DOI 10.4135/9781412986311.N10
   Miaskowski C, 2010, J PAIN SYMPTOM MANAG, V40, P531, DOI 10.1016/j.jpainsymman.2009.12.006
   Mustian K.M., 2017, JAMA ONCOL
   Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46
   Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181
   Prue G, 2006, EUR J CANCER, V42, P846, DOI 10.1016/j.ejca.2005.11.026
   Reeves WC, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-19
   Rich T, 2005, CLIN CANCER RES, V11, P1757, DOI 10.1158/1078-0432.CCR-04-2000
   Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993
   Scott JA, 2011, ONCOL NURS FORUM, V38, P368, DOI 10.1188/11.ONF.E191-E203
   SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O
   Smets EMA, 1996, BRIT J CANCER, V73, P241, DOI 10.1038/bjc.1996.42
   UICC, TNM ATL ILL GUID TNM
   van de Poll-Franse LV, 2011, EUR J CANCER, V47, P2188, DOI 10.1016/j.ejca.2011.04.034
   Vermunt J. K, 2013, LATENT GOLD 5 0 UPGR
   Whitehead L, 2009, J PAIN SYMPTOM MANAG, V37, P107, DOI 10.1016/j.jpainsymman.2007.08.019
   Wright F, 2015, J PAIN SYMPTOM MANAG, V50, P163, DOI 10.1016/j.jpainsymman.2015.02.015
   Wright F, 2015, J PAIN SYMPTOM MANAG, V50, P176, DOI 10.1016/j.jpainsymman.2015.02.016
   Yennurajalingam S, 2014, CANCER J, V20, P319, DOI 10.1097/PPO.0000000000000069
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 51
TC 3
Z9 3
U1 3
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1932-2259
EI 1932-2267
J9 J CANCER SURVIV
JI J. Cancer Surviv.-Res. Pract.
PD FEB
PY 2018
VL 12
IS 1
BP 38
EP 46
DI 10.1007/s11764-017-0641-0
PG 9
WC Oncology; Social Sciences, Biomedical
SC Oncology; Biomedical Social Sciences
GA FU1CJ
UT WOS:000423586600005
PM 28889367
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Wieringa, TH
   de Wit, M
   Twisk, JWR
   Snoek, FJ
AF Wieringa, T. H.
   de Wit, M.
   Twisk, J. W. R.
   Snoek, F. J.
TI Does hypoglycaemia affect the improvement in QoL after the transition to
   insulin in people with type 2 diabetes?
SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
LA English
DT Article
DE Diabetes symptom burden; Emotional well-being; Hypoglycaemia;
   Hypoglycaemia fear; Insulin initiation; Quality of life
ID QUALITY-OF-LIFE; HEALTH-RELATED QUALITY; TREATMENT MODALITIES; GLYCEMIC
   CONTROL; MELLITUS; IMPACT; FREQUENCY; GLARGINE; OUTCOMES; BURDEN
AB Purpose Quality of Life (QoL) of insulin-naive people with type 2 diabetes mellitus (T2DM) improves after transition to insulin. Little is known about the role of hypoglycaemia in this context. Secondary analyses of the Study of the Psychological Impact in Real care of Initiating insulin glargine Treatment (SPIRIT) aimed to investigate the relationship between hypoglycaemia and QoL when transitioning to insulin.
   Methods Insulin-naive Dutch people with T2DM in suboptimal glycaemic control (HbA1c >53 mmol/mol; 7.0%) on maximum dose of oral glucose-lowering medications were included from 363 primary care practices (n = 911). Participants started insulin glargine and completed QoL-questionnaires (WHO-5 Well-being Index (WHO-5; emotional well-being), Hypoglycaemia Fear Survey-worry scale (HFS-w; hypoglycaemia fear) and Diabetes Symptom Checklist-revised (DSC-r; diabetes symptom distress) at baseline, 3 and 6 months follow-up. Linear GEE analyses were used to investigate the association between symptomatic, nocturnal, severe hypoglycaemia (number of episodes during 3 months prior to visit) and QoL over time.
   Results 52.5% men participated, mean age 62.2 years (SD +/- 10.92), and median HbA1c 67 mmol/mol (range 61-77) (8.3%). More symptomatic hypoglycaemic episodes were associated with higher HFS-w and DSC-r scores (P < 0.01). Experiencing multiple nocturnal or severe episodes was related to higher symptom distress as well, when compared to no episodes. These associations did not change significantly over time.
   Conclusions Hypoglycaemia is associated with lower QoL in terms of hypoglycaemia fear and diabetes symptom distress. The transition to insulin does not affect this relationship, suggesting hypoglycaemia in itself has a detrimental effect on diabetes-related QoL independent of treatment regimen.
C1 [Wieringa, T. H.; de Wit, M.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.
   [Wieringa, T. H.; de Wit, M.; Twisk, J. W. R.; Snoek, F. J.] Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.
   [Twisk, J. W. R.] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, De Boelelaan 1089a, NL-1081 HV Amsterdam, Netherlands.
   [Snoek, F. J.] AMC, Dept Med Psychol, Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands.
RP Wieringa, TH (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.; Wieringa, TH (reprint author), Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.
EM t.wieringa@vumc.nl; m.dewit@vumc.nl; jwr.twisk@vumc.nl; fj.snoek@vumc.nl
FU Sanofi
FX This study was supported by an unrestricted grant from Sanofi.
CR Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Barendse S, 2012, DIABETIC MED, V29, P293, DOI 10.1111/j.1464-5491.2011.03416.x
   Boyle PJ, 2007, SOUTH MED J, V100, P175, DOI 10.1097/01.smj.0000242866.81791.70
   Chelliah A, 2004, DRUG AGING, V21, P511, DOI 10.2165/00002512-200421080-00003
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Donnelly LA, 2005, DIABETIC MED, V22, P749, DOI 10.1111/j.1464-5491.2005.01501.x
   Gilet H, 2012, VALUE HEALTH, V15, P1036, DOI 10.1016/j.jval.2012.06.002
   Green AJ, 2012, DIABETES RES CLIN PR, V96, P313, DOI 10.1016/j.diabres.2012.01.002
   Hajos TRS, 2011, DIABETIC MED, V28, P1096, DOI 10.1111/j.1464-5491.2011.03329.x
   Harris S, 2014, CAN J DIABETES, V38, P45, DOI 10.1016/j.jcjd.2013.09.001
   Hartman I, 2008, CLIN MED RES, V6, P54, DOI 10.3121/cmr.2008.793
   Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644
   Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y
   Horvath K, 2007, COCHRANE DB SYST REV
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441
   Marrett Elizabeth, 2011, BMC Res Notes, V4, P251, DOI 10.1186/1756-0500-4-251
   Murata GH, 2004, DIABETES RES CLIN PR, V65, P61, DOI 10.1016/j.diabres.2003.11.013
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   WHO, 1998, WHO M STOCKH SWED 12
   Williams SA, 2012, J DIABETES COMPLICAT, V26, P399, DOI 10.1016/j.jdiacomp.2012.05.002
   Williams SA, 2011, DIABETES RES CLIN PR, V91, P363, DOI 10.1016/j.diabres.2010.12.027
   Zammitt NN, 2005, DIABETES CARE, V28, P2948, DOI 10.2337/diacare.28.12.2948
NR 22
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1720-8386
J9 J ENDOCRINOL INVEST
JI J. Endocrinol. Invest.
PD FEB
PY 2018
VL 41
IS 2
BP 249
EP 258
DI 10.1007/s40618-017-0744-5
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FT8FB
UT WOS:000423387100012
PM 28803366
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Wu, FL
   Wu, EC
   Chang, YC
   Hu, WY
   Juang, JH
   Yeh, MC
AF Wu, Fei-Ling
   Wu, En-Chang
   Chang, Yue-Cune
   Hu, Wen-Yu
   Juang, Jyuhn-Huarng
   Yeh, Mei Chang
TI Factors Affecting the Ability of People With Diabetes to Avoid
   Hypoglycemia
SO JOURNAL OF NURSING RESEARCH
LA English
DT Article
DE problem solving; negative mood; diabetes; hypoglycemia
ID MANAGEMENT
AB Background: Hypoglycemia is recognized as a limiting factor in diabetes management. Fear of experiencing hypoglycemia may lead to lower quality of life, impaired glycemic control, and emotional distress, all of which impair the ability of patients to self-manage their diabetes effectively. Problem solving is central to diabetes self-management and may help patients achieve effective self-care of their disease.
   Purpose: The aim of this study was to investigate the ability of people with diabetes to avoid hypoglycemia and to explore associated factors.
   Methods: A cross-sectional, descriptive design was used for the study. Data were collected using a demographic and disease characteristics datasheet, the Hypoglycemic Problem Solving Scale, and the Disease-Associated Negative Mood Scale.
   Results: Three hundred thirteen participants were recruited, with a mean age of 55.49 years. The average item score for the questions on hypoglycemic problem-solving ability was 2.43 (SD = 0.75). In comparing Hypoglycemic Problem Solving Scale subscales, participants scored highest on the problem orientation subscales and lowest on the problem-solving skills subscales. Multiple regression analysis revealed that being younger and unmarried and having a higher level of education, a diagnosis of Type 1 diabetes, and a lower negative mood score were each significantly associated with greater problem-solving ability as regards hypoglycemic events.
   Conclusions/Implications for Practice: We suggest that patients with diabetes, especially those who are older or with lower levels of education, receive disease-related psychological interventions and that healthcare professionals teach problem-solving abilities in conjunction with hypoglycemia management.
C1 [Wu, Fei-Ling] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan.
   [Wu, En-Chang] Natl Taiwan Univ, Dept Psychol, Taipei, Taiwan.
   [Chang, Yue-Cune] Tamkang Univ, Dept Math, New Taipei, Taiwan.
   [Hu, Wen-Yu; Yeh, Mei Chang] Natl Taiwan Univ, Sch Nursing, Coll Med, Taipei, Taiwan.
   [Juang, Jyuhn-Huarng] Chang Gung Univ, Div Endocrinol & Metab, Dept Internal Med, Chang Gung Mem Hosp, Taoyuan, Taiwan.
   [Juang, Jyuhn-Huarng] Chang Gung Univ, Sch Med, Coll Med, Taoyuan, Taiwan.
RP Yeh, MC (reprint author), 1,Sect 1,Jen Ai Rd, Taipei 10051, Taiwan.
EM mchang@ntu.edu.tw
FU Ministry of Science and Technology [NSC 102-2314-B-255-002-MY3]
FX This research was supported by Grant NSC 102-2314-B-255-002-MY3 from the
   Ministry of Science and Technology.
CR American Association of Diabetes Educators, 2009, AADE7 SELF CAR BEH
   Anderson B. J., 2002, PRACTICAL PSYCHOL DI, P113
   Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744
   Chang F.M., 2014, FORMOSA JOURNAL OF C, V22, P67, DOI [10. 6168/FJCP. 2014. 2202. 01, DOI 10.6168/FJCP.2014.2202.01]
   Cook S, 2001, DIABETES EDUCATOR, V27, P865, DOI 10.1177/014572170102700612
   D'Zurilla T. J., 2007, PROBLEM SOLVING THER
   D'Zurilla TJ, 1998, PERS INDIV DIFFER, V25, P241, DOI 10.1016/S0191-8869(98)00029-4
   DAVIS TM, 2010, THE JOURNAL OF CLINI, V95, P2240
   DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360
   Elliott TR, 2001, J CLIN PSYCHOL MED S, V8, P283, DOI 10.1023/A:1011920914079
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Fitzpatrick SL, 2013, DIABETES RES CLIN PR, V100, P145, DOI 10.1016/j.diabres.2012.12.016
   Health Promotion Administration Taiwan ROC, 2015, 2014 HEALTH PROMOTIO
   Hill-Briggs F, 2007, DIABETES EDUCATOR, V33, P1032, DOI 10.1177/0145721707308412
   Hill-Briggs F, 2011, J GEN INTERN MED, V26, P972, DOI 10.1007/s11606-011-1689-6
   Kerns RD, 2002, ANN BEHAV MED, V24, P100, DOI 10.1207/S15324796ABM2402_06
   Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176
   Leiter LA, 2005, CAN J DIABETES, V29, P186
   Lilly CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130249
   Murata GH, 2004, DIABETES RES CLIN PR, V65, P61, DOI 10.1016/j.diabres.2003.11.013
   Nezu AM, 2004, BEHAV THER, V35, P1, DOI 10.1016/S0005-7894(04)80002-9
   Walls ML, 2014, DIABETES EDUCATOR, V40, P319, DOI 10.1177/0145721714524282
   Wang J, 2012, DIABETES EDUCATOR, V38, P207, DOI 10.1177/0145721712440331
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Wu FL, 2011, J CLIN NURS, V20, P2277, DOI 10.1111/j.1365-2702.2011.03725.x
   WU FL, 2016, THE JOURNAL OF INTER, V44, P592
   Wu Y.C., 2008, RESEARCH GRANT DOH97
   Yeung S, 2007, J CLIN NURS, V16, P344, DOI 10.1111/j.1365-2702.2005.01537.x
NR 29
TC 1
Z9 1
U1 3
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1682-3141
J9 J NURS RES
JI J. Nurs. Res.
PD FEB
PY 2018
VL 26
IS 1
BP 44
EP 51
DI 10.1097/JNR.0000000000000198
PG 8
WC Nursing
SC Nursing
GA FT8ZQ
UT WOS:000423442100007
PM 28079649
DA 2019-01-08
ER

PT J
AU McGill, DE
   Volkening, LK
   Pober, DM
   Muir, AB
   Young-Hyman, DL
   Laffel, LM
AF McGill, Dayna E.
   Volkening, Lisa K.
   Pober, David M.
   Muir, Andrew B.
   Young-Hyman, Deborah L.
   Laffel, Lori M.
TI Depressive Symptoms at Critical Times in Youth With Type 1 Diabetes:
   Following Type 1 Diabetes Diagnosis and Insulin Pump Initiation
SO JOURNAL OF ADOLESCENT HEALTH
LA English
DT Article
DE Type 1 diabetes; Adolescent; Depression; New-onset; Insulin pump;
   Honeymoon; HbA1c
ID GLYCEMIC CONTROL; ADOLESCENTS; CHILDREN; MELLITUS; ASSOCIATION;
   PREVALENCE; MANAGEMENT; DISTRESS; INFUSION; CARE
AB Purpose: Depressive symptoms occur at various times during the life cycle in persons with type 1 diabetes. We investigated depressive symptoms prospectively in youth with new-onset type 1 diabetes and in those beginning pump therapy.
   Methods: Youth with type 1 diabetes (N = 96), ages 10-17 years, completed the Children's Depression Inventory (CDI) at baseline and at 1, 6, and 12 months after diabetes onset or pump start; scores >= 13 indicated clinical elevation. The change in depressive symptoms and the association between CDI score and hemoglobin A1c (HbA1c) level were assessed over 1 year.
   Results: The new-onset group (n = 54) had an HbA1c level of 11.4% +/- 2.5%. The pump group (n = 42) had a diabetes duration of 4.1 +/- 3.4 years and an HbA1c level of 8.3% +/- 1.3%. The baseline median CDI was 5.0 in both groups and remained low over time (ranging from 2.0 to 3.5). Most youth (new onset 72%, pump 81%) scored < 13 at all times. Those with a CDI score of >= 13 in month 1 had 9-fold (95% confidence interval: 3-28) and 11-fold (95% confidence interval: 3-38) higher risks of CDI score of >= 13 at 6 and 12 months, respectively, than those with a CDI score of < 13. New-onset youth with a CDI score of >= 13 in month 1 had a higher HbA1c level at 6 months (8.3% +/- 1.7%) than new-onset youth with a CDI score of < 13 (7.2% +/- 1.6%, p = .04).
   Conclusions: CDI scores over 1 year were similar in the new-onset and pump groups. Youth with elevated CDI in the first month after diagnosis or pump start were significantly more likely to have a CDI score of >= 13 at 6 or 12 months, supporting recommendations to screen for depressive symptoms because of persistence over time. Those with new-onset diabetes and depressive symptoms in the first month had higher HbA1c at 6 months; confirmatory research is needed. (C) 2017 Society for Adolescent Health and Medicine. All rights reserved.
C1 [McGill, Dayna E.; Volkening, Lisa K.; Pober, David M.; Laffel, Lori M.] Harvard Med Sch, Joslin Diabet Ctr, Sect Clin Behav & Outcomes Res, Pediat Adolescent & Young Adult Sect, Boston, MA USA.
   [Muir, Andrew B.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.
   [Young-Hyman, Deborah L.] Georgia Hlth Sci Univ, Georgia Prevent Inst, Augusta, GA USA.
   [Young-Hyman, Deborah L.] NIH, Off Behav & Social Sci Res, Off Director, Bethesda, MD 20892 USA.
RP Laffel, LM (reprint author), Joslin Diabet Ctr, Sect Clin Behav & Outcomes Res, One Joslin Pl, Boston, MA 02215 USA.
EM lori.laffel@joslin.harvard.edu
FU National Institutes of Health [T32DK007260, P30DK036836]; American
   Diabetes Association [07-08-CR66]; Katherine Adler Astrove Youth
   Education Fund; Maria Griffin Drury Pediatric Fund; Eleanor Chesterman
   Beatson Fund
FX This research was supported by the National Institutes of Health under
   grants T32DK007260 and P30DK036836, the American Diabetes Association
   under grant 07-08-CR66, the Katherine Adler Astrove Youth Education
   Fund, the Maria Griffin Drury Pediatric Fund, and the Eleanor Chesterman
   Beatson Fund.
CR American Diabetes Association, 2017, Diabetes Care, V40, pS6
   Boland EA, 1999, DIABETES CARE, V22, P1779, DOI 10.2337/diacare.22.11.1779
   Borus JS, 2010, CURR OPIN PEDIATR, V22, P405, DOI 10.1097/MOP.0b013e32833a46a7
   Center for Behavioral Health Statistics and Quality, 2016, HHS PUBL SMA, VH-51
   Corathers SD, 2013, PEDIATRICS, V132, pE1395, DOI 10.1542/peds.2013-0681
   Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191
   Fisher L, 2016, DIABETIC MED, V33, P1590, DOI 10.1111/dme.12973
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   GREY M, 1995, DIABETES CARE, V18, P1330, DOI 10.2337/diacare.18.10.1330
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   Hirose M, 2012, CURR DIABETES REP, V12, P711, DOI 10.1007/s11892-012-0313-4
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Hood KK, 2014, J ADOLESCENT HEALTH, V55, P498, DOI 10.1016/j.jadohealth.2014.03.011
   Hood KK, 2012, DIABETES CARE, V35, P2443, DOI 10.2337/dc11-2329
   Hood KK, 2011, PEDIATR DIABETES, V12, P718, DOI 10.1111/j.1399-5448.2011.00771.x
   Hosoya T, 2012, INTERNAL MED, V51, P263, DOI 10.2169/internalmedicine.51.5768
   Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160
   Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   KOVACS M, 1990, J PEDIATR PSYCHOL, V15, P619, DOI 10.1093/jpepsy/15.5.619
   KOVACS M, 1985, J PEDIATR-US, V106, P827, DOI 10.1016/S0022-3476(85)80368-1
   Kuczmarski R. J., 2000, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114
   Lichtenberger-Geslin L, 2013, ARCH PEDIATRIE, V20, P248, DOI 10.1016/j.arcped.2012.12.011
   Matlock KA, 2017, J ADOLESCENT HEALTH, V61, P471, DOI 10.1016/j.jadohealth.2017.05.004
   McGrady Meghan E, 2010, Diabetes Res Clin Pract, V88, pe35, DOI 10.1016/j.diabres.2010.03.025
   Mortensen HB, 2009, DIABETES CARE, V32, P1384, DOI 10.2337/dc08-1987
   Moulton C. D., 2015, ENDOCRINOLOGY, V3, P461, DOI [10.1016/S2213-8587(15)00134-5, DOI 10.1016/S2213-8587(15)00134-5]
   Mueller-Godeffroy E, 2009, DIABETIC MED, V26, P493, DOI 10.1111/j.1464-5491.2009.02707.x
   Prager LM, 2009, PEDIATR REV, V30, P199, DOI 10.1542/pir.30-6-199
   Rushton JL, 2002, J AM ACAD CHILD PSY, V41, P199, DOI 10.1097/00004583-200202000-00014
   Silverstein J, 2015, DIABETES CARE, V38, P2341, DOI 10.2337/dc15-0982
   Stahl-Pehe A, 2014, PEDIATR DIABETES, V15, P436, DOI 10.1111/pedi.12096
   Stewart SM, 2005, PEDIATRICS, V115, P1315, DOI 10.1542/peds.2004-1717
   Whittemore Robin, 2002, Pediatr Diabetes, V3, P135, DOI 10.1034/j.1399-5448.2002.30303.x
   Willi SM, 2015, PEDIATRICS, V135, P424, DOI 10.1542/peds.2014-1774
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
   Young-Hyman Deborah L, 2016, J Diabetes Sci Technol, V10, P845, DOI 10.1177/1932296816645118
   Zdunczyk B, 2014, DIABETES-METAB RES, V30, P333, DOI 10.1002/dmrr.2499
NR 38
TC 0
Z9 0
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-139X
EI 1879-1972
J9 J ADOLESCENT HEALTH
JI J. Adolesc. Health
PD FEB
PY 2018
VL 62
IS 2
BP 219
EP 225
DI 10.1016/j.jadohealth.2017.09.017
PG 7
WC Psychology, Developmental; Public, Environmental & Occupational Health;
   Pediatrics
SC Psychology; Public, Environmental & Occupational Health; Pediatrics
GA FS8QV
UT WOS:000422678400016
PM 29212599
DA 2019-01-08
ER

PT J
AU Vallis, M
   Willaing, I
   Holt, RIG
AF Vallis, M.
   Willaing, I.
   Holt, R. I. G.
TI Emerging adulthood and Type 1 diabetes: insights from the DAWN2 Study
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; PATIENT ASSESSMENT; PSYCHOMETRIC PROPERTIES;
   EMPOWERMENT SCALE; SELF-MANAGEMENT; SHORT-FORM; CARE; PEOPLE;
   HYPOGLYCEMIA; VALIDATION
AB Aims To compare clinical, psychological, education and social variables in emerging adults (aged 18-30years) with Type 1 diabetes with their adult counterparts aged >30years.
   Methods A single assessment multinational sample was surveyed as part of the larger second Diabetes Attitudes, Wishes and Needs (DAWN2) study. Participants completed a series of surveys incorporating demographic as well as clinical questions (comorbidities, hypoglycaemia) and validated self-report scales concerning psychosocial (health impact, quality of life, beliefs and attitudes, self-management behaviours, healthcare experience and family support) and diabetes education factors.
   Results Emerging adults differed from adults aged >30years with regard to a number of psychosocial variables. Emerging adults reported better overall quality of life, social support and support from their healthcare team compared with adults aged >30years of age; however, emerging adults experienced greater diabetes-specific distress and were less engaged in self-management. Diabetes education was related to a number of indicators, while experience of discrimination was harmful, but these impacts did not differ between emerging adults and adults aged >30years. An analysis of geographical regions suggested that emerging adults in North America and Europe had better well-being than older adults, while the opposite was observed in Asia.
   Conclusions Emerging adults, particularly those in the later phase (ages 25-30years) are especially at risk in terms of diabetes-specific distress. There is a need for novel interventions to meet the needs of these vulnerable emerging adults more effectively.
C1 [Vallis, M.] Nova Scotia Hlth Author, Behav Change Inst, Halifax, NS, Canada.
   [Vallis, M.] Dalhousie Univ, Halifax, NS, Canada.
   [Willaing, I.] Steno Diabet Ctr, Hlth Promot Res, Diabet Management Res, Copenhagen, Denmark.
   [Holt, R. I. G.] Univ Southampton, Human Dev & Hlth Acad Unit, Fac Med, Southampton, Hants, England.
RP Vallis, M (reprint author), Nova Scotia Hlth Author, Behav Change Inst, Halifax, NS, Canada.; Vallis, M (reprint author), Dalhousie Univ, Halifax, NS, Canada.
EM tvallis@dal.ca
OI Holt, Richard/0000-0001-8911-6744; Vallis, Michael/0000-0002-0165-5936;
   Willaing, Ingrid/0000-0002-3082-8816
FU Novo Nordisk
FX Novo Nordisk funded the DAWN2 study, which was overseen by the DAWN2
   Study Group (see www.dawnstudy.com).
CR Abidi S, 2014, CAN J DIABETES, V38, P205, DOI 10.1016/j.jcjd.2014.03.006
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Barnard KD, 2012, DIABETIC MED, V29, P1358, DOI 10.1111/j.1464-5491.2012.03727.x
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Crowley R, 2011, ARCH DIS CHILD, V96, P548, DOI 10.1136/adc.2010.202473
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c
   Goetz Katja, 2012, Am J Manag Care, V18, pe55
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Harper A, 1998, PSYCHOL MED, V28, P551
   Helgeson VS, 2013, DIABETIC MED, V30, P610, DOI 10.1111/dme.12067
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4
   Lee EH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0142-z
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Parkin T, 2003, DIABETIC MED, V20, P909, DOI 10.1046/j.1464-5491.2003.01056.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rick J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-293
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Sheehan AM, 2015, DIABETIC MED, V32, P440, DOI 10.1111/dme.12639
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   Szende A, 2007, EQ D VALUE SETS INVE
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Vallis M, 2014, CURR DIABETES REV, V10, P364, DOI 10.2174/1573399810666141113115026
   Yu CH, 2016, PATIENT PREFER ADHER, V10, P371, DOI 10.2147/PPA.S102574
NR 32
TC 2
Z9 2
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD FEB
PY 2018
VL 35
IS 2
BP 203
EP 213
DI 10.1111/dme.13554
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FS6IX
UT WOS:000419902200006
PM 29171084
DA 2019-01-08
ER

PT J
AU Elamoshy, R
   Bird, Y
   Thorpe, LU
   Moraros, J
AF Elamoshy, Rasha
   Bird, Yelena
   Thorpe, Lilian Ulrica
   Moraros, John
TI Examining the association between diabetes, depressive symptoms, and
   suicidal ideation among Aboriginal Canadian peoples living off-reserve:
   a cross-sectional, population-based study
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE aboriginal; Canada; diabetes; depression; depressive symptoms; suicidal
   ideation
ID PSYCHOLOGICAL DISTRESS; ALCOHOL-CONSUMPTION; RISK-FACTOR; TYPE-2;
   ANXIETY; HEALTH; MELLITUS; INEQUALITIES; METAANALYSIS; COMORBIDITY
AB Background: Diabetes is a prevalent chronic condition that has been linked to depression and suicidal behavior. The Aboriginal peoples of Canada are known to suffer from significant health disparities and higher burden of physical and mental illnesses. The purpose of this study was to assess whether diabetes is associated with higher depressive symptoms and lifetime suicidal ideation among Aboriginal Canadian peoples living off-reserve.
   Methods: Data were obtained from the Aboriginal Peoples Survey, 2012. Depressive symptoms were evaluated by a modified version of the previously validated K-10 scale, while diabetes and suicidal ideation were self-reported. A secondary analysis was conducted on a weighted sample of 689,860 participants for depressive symptoms (9.25% diabetics) and 694,960 for suicidal ideation (9.39% diabetics). Descriptive statistics and multiple logistic regression analysis were conducted.
   Results : Our study found that the prevalence of depressive symptoms was higher among diabetics (17.53%) compared with nondiabetics (11.12%; OR = 1.70, 95% CI: 1.22-1.61). After adjusting for sociodemographic variables, smoking/alcohol use/drug use, anxiety disorders, and other chronic illnesses, diabetes was still significantly associated with depressive symptoms (aOR = 1.46, 95% CI: 1.03-2.07). Additionally, diabetics (23.86%) were more likely to report suicidal ideation compared with nondiabetics (18.71%; OR = 1.36, 95% CI: 1.05-1.77). Controlling for the effect of sociodemographics and health-related behaviors, diabetes was still associated with higher risk of reporting suicidal ideation (aOR = 1.40, 95% CI: 1.05-1.88).
   Conclusion: Our results suggest that the Aboriginal Canadian diabetic patients living off-reserve are at higher risk of depressive symptoms and suicidal ideation. Culturally appropriate co-screening strategies need to be implemented in primary health care settings to provide the supports necessary for this vulnerable population. Further research is needed to fully elucidate the nature of these associations in order to develop effective intervention and treatment approaches.
C1 [Elamoshy, Rasha; Bird, Yelena; Moraros, John] Univ Saskatchewan, Sch Publ Hlth, 104 Clin Pl, Saskatoon, SK S7N 2Z4, Canada.
   [Thorpe, Lilian Ulrica] Univ Saskatchewan, Community Hlth & Epidemiol Dept, Saskatoon, SK, Canada.
RP Moraros, J (reprint author), Univ Saskatchewan, Sch Publ Hlth, 104 Clin Pl, Saskatoon, SK S7N 2Z4, Canada.
EM john.moraros@usask.ca
OI Thorpe, Lilian/0000-0003-2547-4205
CR Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Armitage A., 1995, COMP POLICY ABORIGIN
   Australian Government, 2001, US KESSL PSYCH DISTR
   Australian Institute of Health and Welfare, 2009, MEAS SOC EM WELLB AB
   Bird Y, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0237-0
   Borges G, 2006, PSYCHOL MED, V36, P1747, DOI 10.1017/S0033291706008786
   BRIEN SE, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D636
   Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17
   Cairney J, 2007, CAN J PSYCHIAT, V52, P111, DOI 10.1177/070674370705200209
   Caldwell TM, 2002, ADDICTION, V97, P583, DOI 10.1046/j.1360-0443.2002.00092.x
   Cameron BL, 2014, ADV NURS SCI, V37, pE1, DOI 10.1097/ANS.0000000000000039
   Canadian Diabetes Association, 2001, DIAB CAN TIPP POINT
   Canadian Diabetes Association, 2018, TYP 2 DIAB AB PEOPL
   Centre for Chronic Disease Prevention and Control Diabetes in Canada: Facts and figures from a public health perspective, 2011, CHRON DIS SURV MON D
   Centre for Suicide Prevention, IND SUIC PREV
   Chaufan C., 2009, HUMANITY SOC, V33, P74, DOI DOI 10.1177/016059760903300106
   Daniel M, 2001, PATIENT EDUC COUNS, V43, P85, DOI 10.1016/S0738-3991(00)00153-1
   Davis TME, 2015, DIABETES RES CLIN PR, V107, P384, DOI 10.1016/j.diabres.2014.12.014
   Elias B, 2012, SOC SCI MED, V74, P1560, DOI 10.1016/j.socscimed.2012.01.026
   Freeman A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3638-0
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Gorrell P., SURVEY ANAL OPTIONS
   Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4
   Graham K, 2007, ALCOHOL CLIN EXP RES, V31, P78, DOI 10.1111/j.1530-0277.2006.00274.x
   GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P197, DOI 10.1016/0376-8716(95)01160-4
   Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938
   Han SJ, 2013, DIABETES RES CLIN PR, V101, pE14, DOI 10.1016/j.diabres.2013.06.012
   Harris SB, 2013, CAN J DIABETES, V37, pS191, DOI 10.1016/j.jcjd.2013.01.046
   Howard HA, 2014, MED ANTHROPOL, V33, P529, DOI 10.1080/01459740.2013.828722
   Joseph B, 2018, INDIAN ACT PASS SYST
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kirmayer LJ, 2009, CURRENT APPROACHES A, P14
   Klonsky ED, 2016, ANNU REV CLIN PSYCHO, V12, P307, DOI 10.1146/annurev-clinpsy-021815-093204
   Loppie Reading C., 2009, HLTH INEQUALITIES SO
   Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Pelletier C, 2012, CHRON DIS INJ CAN, V33, P53
   Pouwer F, 2010, DISCOV MED, V9, P112
   Public Health Agency of Canada, 2011, ARCH HUM FAC MENT HL
   Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P
   Rodgers B, 2000, ADDICTION, V95, P1833, DOI 10.1046/j.1360-0443.2000.9512183312.x
   Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Schierhout G, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-16
   Schilling EA, 2009, J ADOLESCENT HEALTH, V44, P335, DOI 10.1016/j.jadohealth.2008.08.006
   Si DM, 2011, AUST FAM PHYSICIAN, V40, P331
   Singer J, 2014, CLIN OBES, V4, P316, DOI 10.1111/cob.12074
   Skogen JC, 2009, ADDICTION, V104, P1519, DOI 10.1111/j.1360-0443.2009.02659.x
   Statistics Canada. Life expectancy, LIF EXP
   Tabb KM, 2017, J PSYCHOSOM RES, V103, P113, DOI 10.1016/j.jpsychores.2017.10.009
   Thompson EA, 2005, SUICIDE LIFE-THREAT, V35, P14, DOI 10.1521/suli.35.1.14.59266
   Tjepkema M, 2002, HLTH REP S, V13, P73
   Wang B, 2017, EUR J ENDOCRINOL, V177, pR169, DOI 10.1530/EJE-16-0952
   Wang Y, 2016, COMPR PSYCHIAT, V71, P11, DOI 10.1016/j.comppsych.2016.08.006
   World Health Organization, 2018, SOCIAL DETERMINANTS
   Yu CHY, 2007, DIABETES RES CLIN PR, V78, P159, DOI 10.1016/j.diabres.2007.03.022
NR 61
TC 0
Z9 0
U1 1
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2018
VL 11
BP 767
EP 780
DI 10.2147/DMSO.S184058
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA HB8VH
UT WOS:000451368600001
PM 30538514
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Bao, HL
   Liu, JR
   Ye, J
AF Bao, Huilan
   Liu, Junru
   Ye, Jun
TI INFLUENCING FACTORS OF THE DIABETES DISTRESS AMONG CHINESE PATIENTS WITH
   TYPE 2 DIABETES MELLITUS
SO PSYCHIATRIA DANUBINA
LA English
DT Article
DE T2DM; Diabetes Distress; influencing factors
ID EMOTIONAL DISTRESS; PROBLEM AREAS; ADULTS; DEPRESSION; MANAGEMENT;
   SUPPORT; SCALE; SLEEP; PAID
AB Background: Patients with Diabetes Mellitus (DM) are required to have long-term treatment regimen and strict self-management, which thus might lead to the Diabetes Distress (DD). Patients' DD varies in different regions with different levels of medical conditions. For improving the treatment effect of the patients with the Type-2-Diabetes-Mellitus (T2DM), this study explores the influencing factors of the patients' DD in the regions where the medical treatment are at low level.
   Subjects and methods: In this study, 167 adult patients with T2DM were selected from the People's Hospital of Jinhua city, an A-grade hospital of a small-mid-sized city in Eastern China. Based on these samples, the Diabetes Distress Scale with 17 items (DDS17) was adopted to measure the degree of patients' DD, and then regression analyses were carried out to investigate the influencing factors for their DD.
   Results: The T2DM patients with moderate and high levels of DD take up 54.5% of the samples investigated in this study. According to the Spearman correlation analysis, sleep time, physical exercise, diet control, treatment regimen, TG and HbA1c significantly affect the patients' DD. Through the multivariate linear regression analysis, this study shows that (1) sleep time significantly influences the T2DM patients' DD (beta=-0.213, P=0.034); (2) sleep time also impacts emotional burden (beta=-0.379, P=0.027); (3) physical exercise (beta=-0.195, P=0.002), treatment regimen (beta=0.158, P=0.026) and diet control (beta=0.158, P=0.026) are the three major influencing factors for regimen-related distress.
   Conclusion: In the small-mid-sized city where the treatment regimen is not highly advanced, to alleviate the T2DM patients' DD, the medical staff should suggest the patients to improve sleep quality and exercise more, help them positively understand the insulin infusion therapy and take proper diet control.
C1 [Bao, Huilan; Liu, Junru; Ye, Jun] Peoples Hosp Jinhua, Endocrinol Dept, Jinhua 321000, Peoples R China.
RP Bao, HL (reprint author), Peoples Hosp Jinhua, Endocrinol Dept, Jinhua 321000, Peoples R China.
EM huilanbao@outlook.com
CR Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124
   de Vries L, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-21
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Ikeda K, 2014, PLOS ONE, P9
   Ip M, 2007, SLEEP MED CLIN, V2, P19, DOI 10.1016/j.jsmc.2006.12.002
   Jones A, 2016, PRIM CARE DIABETES, V10, P83, DOI 10.1016/j.pcd.2015.03.008
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Nouwen A, 2015, DIABETIC MED, V32, P1261, DOI 10.1111/dme.12863
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Strandberg RB, 2015, DIABETIC MED, V32, P1304, DOI 10.1111/dme.12781
   Thorne SE, 2001, PATIENT EDUC COUNS, V42, P81, DOI 10.1016/S0738-3991(00)00095-1
   Wagner JA, 2007, DIABETIC MED, V24, P211, DOI 10.1111/j.1464-5491.2007.02044.x
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
NR 23
TC 0
Z9 0
U1 3
U2 3
PU MEDICINSKA NAKLADA
PI ZAGREB
PA VLASKA 69, HR-10000 ZAGREB, CROATIA
SN 0353-5053
J9 PSYCHIAT DANUB
JI Psychiatr. Danub.
PY 2018
VL 30
IS 4
BP 459
EP 465
DI 10.24869/psyd.2018.459
PG 7
WC Psychiatry
SC Psychiatry
GA HB3ZN
UT WOS:000450991500011
PM 30439806
DA 2019-01-08
ER

PT J
AU Lacomba-Trejo, L
   Valero-Moreno, S
   Casana-Granell, S
   Prado-Gasco, VJ
   Perez-Marin, M
   Montoya-Castilla, I
AF Lacomba-Trejo, Laura
   Valero-Moreno, Selene
   Casana-Granell, Sara
   Javier Prado-Gasco, Vicente
   Perez-Marin, Marian
   Montoya-Castilla, Inmaculada
TI Questionnaire on adaptation to type 1 diabetes among children and its
   relationship to psychological disorders
SO REVISTA LATINO-AMERICANA DE ENFERMAGEM
LA English
DT Article
DE Adaptive Response; Diabetes Mellitus Type I; Pediatrics; Anxiety;
   Depression; Psychometric
ID HOSPITAL ANXIETY; DEPRESSION SCALE; ADOLESCENTS; PREVALENCE; YOUTH
AB Objective: to study the psychometric properties of an adaptive disease response questionnaire for use with Spanish children with type 1 diabetes; to analyse this response in this sample and to observe the relationship between adaptive response and levels of anxiety-depression. Method: a total of 100 patients with type 1 diabetes aged between nine and 16 years (M=12.28, SD=1.78) participated in the study, of which 59% were children. Data was collected in public hospitals via interviews using the Adaptive Disease Response Questionnaire and Anxiety and Depression Scale. The data was analysed using Pearson correlations, multiple hierarchical linear regressions, Student's t Test for independent samples, and Cohen's d effect size to determine reliability and validity. Result: the instrument was shown to have adequate psychometric properties. Adaptive response was generally high. Adaptive response is negatively related to emotional distress, being a better predictor of depression than of anxiety. There was no association betwee adaptation and sex and age. Conclusion: promoting a better adaptive response appears to reduce emotional distress, especially in the case of depression, regardless of the age or gender of the patients.
C1 [Lacomba-Trejo, Laura; Valero-Moreno, Selene; Casana-Granell, Sara; Javier Prado-Gasco, Vicente; Perez-Marin, Marian; Montoya-Castilla, Inmaculada] Univ Valencia, Fac Psicol, Valencia, Comunidad Valen, Spain.
RP Perez-Marin, M (reprint author), Univ Valencia, Fac Psicol, Valencia, Comunidad Valen, Spain.
EM marian.perez@uv.es
RI Perez Marin, Maria Antonia/G-9394-2011
OI Perez Marin, Maria Antonia/0000-0003-3532-8818
FU Asociacion Espanola de Psicologia Clinica y Psicopatologia; Federacion
   Espanola de Asociaciones de Terapia Familiar; Generalitat Valenciana
   [ACIF17]; Fondo Social Europeo; Instituto de Investigacion La Fe;
   Hospital Universitario y Politecnico La Fe; Universitat de Valencia
   (VLC-BIOMED); Universitat de Valencia
FX Supported by Asociacion Espanola de Psicologia Clinica y Psicopatologia,
   Federacion Espanola de Asociaciones de Terapia Familiar, Instituto de
   Investigacion La Fe, Hospital Universitario y Politecnico La Fe and
   Universitat de Valencia (VLC-BIOMED), initiation grant to research from
   Universitat de Valencia and predoctoral research contract of the
   Generalitat Valenciana (ACIF17) and Fondo Social Europeo.
CR Bilbao-Cercós Ana, 2014, Clínica y Salud, V25, P57, DOI 10.5093/cl2014a5
   Carballal Marino Marta, 2018, An Pediatr (Barc), V89, P153, DOI 10.1016/j.anpedi.2017.10.007
   Cardila F, 2015, EUR J INVEST HEALTH, V5, P267, DOI 10.1989/ejihpe.v5i2.118
   Caro I., 1992, B PSICOL, V36, P43
   Castro-Espinoza José Martín, 2015, Aquichán, V15, P52, DOI 10.5294/aqui.2015.15.1.6
   Chan YF, 2010, QUAL LIFE RES, V19, P865, DOI 10.1007/s11136-010-9645-1
   Conde Barreiro S, 2014, AN PEDIAT, V81, P139, DOI [10.1016/j.anpedi.2013.12.010, DOI 10.1016/J.ANPEDI.2013.12.010]
   Gimenez-Espert MD, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.2018.2969
   Flores-Carvajal D, 2016, REV CHIL PEDIATR-CHI, V87, P169, DOI 10.1016/j.rchipe.2015.08.007
   Garcia A, 2014, CALIDAD VIDA SALUD, V7, P42
   Jacob AA, 2018, J RES MED SCI, V6, P177, DOI [10.18203/2320-6012.ijrms20175716, DOI 10.18203/2320-6012.IJRMS20175716]
   Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x
   Korczak DJ, 2016, J DEPRESS ANXIETY, V217, DOI [10.4200/2167-1044.1000, DOI 10.4200/2167-1044.1000]
   Kristensen LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097543
   Lacomba-Trejo L, 2017, CALID VIDA SALUD, V10, P11
   Markowitz JT, 2015, CURR DIABETES REV, V11, P231, DOI 10.2174/1573399811666150421114146
   Mihalca AM, 2015, PSYCHIATR POL, V49, P1071, DOI 10.12740/PP/38139
   Santos FRM, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-55
   Ortuno-Sierra J, 2014, REV PSIQUIATR SALUD, V7, P121, DOI 10.1016/j.rpsm.2013.12.003
   Perez-Marin M, 2015, ARCH ARGENT PEDIATR, V113, P158, DOI [10.5546/aap.2015.158, 10.5546/aap.2015.eng.158]
   PERRIN JM, 1993, PEDIATRICS, V92, P876
   Portilla L, 1995, REV CUBANA PSICOL, V12, P193
   Quesada AB, 2014, INT J DEV ED PSYCHOL, V4, P569, DOI 10.17060/ijodaep.2014.n1.v4.832
   Quesada-Conde AB, 2016, INT J DEV ED PSYCHOL, V2, P251, DOI [10.17060/ijodaep.2016.n1.v2.215, DOI 10.17060/IJODAEP.2016.N1.V2.215]
   Rasbach L, 2015, DIABETES EDUCATOR, V41, P43, DOI 10.1177/0145721714550254
   Riaz M, 2017, PAK J MED SCI, V33, P1318, DOI 10.12669/pjms.336.13911
   Silverstein J, 2015, DIABETES CARE, V38, P2341, DOI 10.2337/dc15-0982
   Valanzuela C, 2016, QUADERNS DIGITAL, V82, P184
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 29
TC 0
Z9 0
U1 0
U2 0
PU UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO
PI RIBEIRAO PRETO
PA AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL
SN 1518-8345
J9 REV LAT-AM ENFERM
JI Rev. Latino-Am. Enfermagem
PY 2018
VL 26
AR e3088
DI 10.1590/1518-8345.2759.3088
PG 9
WC Nursing
SC Nursing
GA HB2KV
UT WOS:000450870700001
PM 30462792
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Darwish, L
   Beroncal, E
   Sison, MV
   Swardfager, W
AF Darwish, Lina
   Beroncal, Erika
   Sison, Ma Veronica
   Swardfager, Walter
TI Depression in people with type 2 diabetes: current perspectives
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Review
DE type 2 diabetes; depression; mood; complications
ID PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; IMPAIRED GLUCOSE
   REGULATION; EDID RESEARCH CONSORTIUM; SERIOUS MENTAL-ILLNESS; ALL-CAUSE
   MORTALITY; WELL-BEING INDEX; GLYCEMIC CONTROL; MENDELIAN RANDOMIZATION;
   COMORBID DEPRESSION
AB Type 2 diabetes mellitus (T2DM) is associated with depressive symptoms, and comorbid depression in those with T2DM has been associated with adverse clinical profiles. Recognizing and addressing psychological symptoms remain significant clinical challenges in T2DM. Possible mediators of the reciprocal relationship between T2DM and depression may include physical activity levels, effectiveness of self-management, distress associated with a new T2DM diagnosis, and frailty associated with advanced diabetes duration. The latter considerations contribute to a "J-shaped" trajectory from the time of diagnosis. There remain significant challenges to screening for clinical risks associated with psychological symptoms in T2DM; poorer outcomes may be associated with major depressive episodes, isolated (eg, anhedonic), or subsyndromal depressive symptoms, depressive-like symptoms more specific to T2DM (eg, diabetes-related distress), apathy or fatigue. In this review, we discuss current perspectives on depression in the context of T2DM with implications for screening and management of these highly comorbid conditions.
C1 [Darwish, Lina; Beroncal, Erika; Sison, Ma Veronica; Swardfager, Walter] Sunnybrook Res Inst, Hurvitz Brain Sci Program, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.
   [Darwish, Lina; Beroncal, Erika; Sison, Ma Veronica; Swardfager, Walter] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.
   [Darwish, Lina; Beroncal, Erika; Sison, Ma Veronica; Swardfager, Walter] Univ Hlth Network, Cardiac Rehabil Program, Toronto Rehabil Inst, Toronto, ON, Canada.
   [Darwish, Lina; Swardfager, Walter] Canadian Partnership Stroke Recovery, Toronto, ON, Canada.
RP Swardfager, W (reprint author), Sunnybrook Res Inst, Hurvitz Brain Sci Program, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.
EM w.swardfager@utoronto.ca
CR Almeida OP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.79
   Almeida OP, 2008, INT PSYCHOGERIATR, V20, P645, DOI 10.1017/S1041610207006473
   Almeida OP, 2016, MATURITAS, V86, P3, DOI 10.1016/j.maturitas.2016.01.003
   Almeida OP, 2015, J AM MED DIR ASSOC, V16, P296, DOI 10.1016/j.jamda.2014.10.023
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   American Psychiatric Association, 2013, DSM 5
   Anderberg RH, 2016, PSYCHONEUROENDOCRINO, V65, P54, DOI 10.1016/j.psyneuen.2015.11.021
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arshad AR, 2016, J PAK MED ASSOC, V66, P425
   Aujla N, 2010, DIABETIC MED, V27, P896, DOI 10.1111/j.1464-5491.2010.03042.x
   Bauer AM, 2014, J GEN INTERN MED, V29, P1139, DOI 10.1007/s11606-014-2845-6
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5
   Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344
   Brewster P, 2015, GERONTOLOGIST, V55, P525
   Brouwers EPM, 2001, J PSYCHOSOM RES, V51, P659, DOI 10.1016/S0022-3999(01)00245-8
   Bruce DG, 2015, AM J GERIAT PSYCHIAT, V23, P615, DOI 10.1016/j.jagp.2014.09.010
   Carleton RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058067
   Carter J, 2016, J PSYCHOSOM RES, V90, P91, DOI 10.1016/j.jpsychores.2016.09.013
   Carter J, 2016, PSYCHONEUROENDOCRINO, V69, P123, DOI 10.1016/j.psyneuen.2016.04.002
   Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519
   Chiu CJ, 2017, INT PSYCHOGERIATR, V29, P281, DOI 10.1017/S1041610216001630
   Cummings DM, 2016, DIABETES CARE, V39, P101, DOI 10.2337/dc15-1174
   Davis LM, 2009, NEUROENDOCRINOLOGY, V89, P152, DOI 10.1159/000170586
   de Cock ESA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-141
   de Groot M, 1999, J PSYCHOSOM RES, V46, P425, DOI 10.1016/S0022-3999(99)00014-8
   Deschenes SS, 2017, PSYCHOSOM MED, V79, P603, DOI 10.1097/PSY.0000000000000447
   Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y
   Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024
   Goldberg D, 2011, WORLD PSYCHIATRY, V10, P226
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gunzler DD, 2015, STAT MED, V34, P3246, DOI 10.1002/sim.6541
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hartwig FP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32730
   Hermanns N, 2013, PRIM CARE DIABETES, V7, P1, DOI 10.1016/j.pcd.2012.11.002
   Herrera JJ, 2016, EUR J NEUROSCI, V43, P1190, DOI 10.1111/ejn.13193
   Holmes-Truscott E, 2016, PRIM CARE DIABETES, V10, P75, DOI 10.1016/j.pcd.2015.06.006
   Hood KK, 2014, J ADOLESCENT HEALTH, V55, P498, DOI 10.1016/j.jadohealth.2014.03.011
   Hung CF, 2014, BRIT J PSYCHIAT, V205, P24, DOI 10.1192/bjp.bp.113.130419
   Ismail K, 2017, DIABETOLOGIA, V60, P2092, DOI 10.1007/s00125-017-4367-3
   Jahoda M., 1958, CURRENT CONCEPTS POS, V61
   Johnson JA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-258
   Kappelmann N, 2018, MOL PSYCHIATR, V23, P335, DOI 10.1038/mp.2016.167
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363
   Katon WJ, 2010, J GEN INTERN MED, V25, P423, DOI 10.1007/s11606-009-1248-6
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Khamseh ME, 2011, BMC PSYCHIATRY, V22, P1619
   Kivimaki M, 2011, BIOL PSYCHIAT, V70, P978, DOI 10.1016/j.biopsych.2011.07.008
   Laake J-PS, 2014, DIABETES CARE, V1, P1
   Lavretsky H, 2008, INT J GERIATR PSYCH, V23, P1040, DOI 10.1002/gps.2030
   Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x
   Leventhal AM, 2012, AM J HEALTH BEHAV, V36, P860, DOI 10.5993/AJHB.36.6.12
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998
   Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693
   Molina MAL, 2014, PSYCHOL HEALTH MED, V19, P136, DOI 10.1080/13548506.2013.793369
   Lunghi C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003514
   Lustman PJ, 2007, DIABETES CARE, V30, P459, DOI 10.2337/dc06-1769
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P24, DOI 10.1097/00006842-199701000-00004
   Lustman PJ, 2006, ARCH GEN PSYCHIAT, V63, P521, DOI 10.1001/archpsyc.63.5.521
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Madden KM, 2013, DIABETES METAB SYNDR, V6, P233, DOI 10.2147/DMSO.S32951
   Manea L, 2016, J AFFECT DISORDERS, V203, P382, DOI 10.1016/j.jad.2016.06.003
   MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Mendlewicz J, 2006, INT CLIN PSYCHOPHARM, V21, P227, DOI 10.1097/00004850-200607000-00005
   Mommersteeg PMC, 2013, DIABETIC MED, V30, pE208, DOI 10.1111/dme.12193
   Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143
   Morley JE, 2008, CLIN GERIATR MED, V24, P455, DOI 10.1016/j.cger.2008.03.004
   Moskowitz JT, 2008, HEALTH PSYCHOL, V27, pS73, DOI 10.1037/0278-6133.27.1.S73
   Mota-Pereira J, 2011, J PSYCHIATR RES, V45, P1005, DOI 10.1016/j.jpsychires.2011.02.005
   Moulton C. D., 2015, ENDOCRINOLOGY, V3, P461, DOI [10.1016/S2213-8587(15)00134-5, DOI 10.1016/S2213-8587(15)00134-5]
   Naicker K, 2017, PSYCHONEUROENDOCRINO, V84, P116, DOI 10.1016/j.psyneuen.2017.07.002
   Nefs G, 2012, J PSYCHIATR RES, V46, P549, DOI 10.1016/j.jpsychires.2012.01.013
   Nefs G, 2016, BRIT J PSYCHIAT, V209, P142, DOI 10.1192/bjp.bp.114.154781
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   Novak V, 2006, DIABETES CARE, V29, P1529, DOI 10.2337/dc06-0261
   Padala PR, 2018, AM J PSYCHIAT, V175, P159, DOI 10.1176/appi.ajp.2017.17030316
   Park H, 2015, J ADV NURS, V71, P1650, DOI 10.1111/jan.12632
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   Petrak F, 2015, DIABETES CARE, V38, P767, DOI 10.2337/dc14-1599
   Pibernik-Okanovic M, 2005, DIABETIC MED, V22, P942, DOI 10.1111/j.1464-5491.2005.01528.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pruzin JJ, 2017, ALZ DIS ASSOC DIS, V31, P41, DOI 10.1097/WAD.0000000000000172
   Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4
   Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554
   Renn BN, 2011, CLIN PSYCHOL REV, V31, P1239, DOI 10.1016/j.cpr.2011.08.001
   Rethorst CD, 2009, SPORTS MED, V39, P491, DOI 10.2165/00007256-200939060-00004
   Rosenberg PB, 2013, J CLIN PSYCHIAT, V74, P810, DOI 10.4088/JCP.12m08099
   Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022
   Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922
   Sajatovic M, 2016, ARCH PSYCHIAT NURS, V30, P226, DOI 10.1016/j.apnu.2015.11.004
   Sajatovic M, 2015, PSYCHIAT SERV, V66, P197, DOI 10.1176/appi.ps.201300538
   Schmitz N, 2018, BRIT J PSYCHIAT, V212, P96, DOI 10.1192/bjp.2017.26
   Scranton R, 2010, EXPERT OPIN PHARMACO, V11, P269, DOI 10.1517/14656560903501544
   Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001
   Sun JC, 2015, DIABETIC MED, V32, P935, DOI 10.1111/dme.12649
   Swardfager W, 2016, DIABETIC MED, V33, P529, DOI 10.1111/dme.12872
   Swardfager W, 2017, NEUROREHAB NEURAL RE, V31, P48, DOI 10.1177/1545968316656054
   Swardfager W, 2016, NEUROSCI BIOBEHAV R, V64, P148, DOI 10.1016/j.neubiorev.2016.02.017
   Swardfager W, 2011, J CLIN PSYCHIAT, V72, P1181, DOI 10.4088/JCP.09m05810blu
   Tabak AG, 2014, LANCET DIABETES ENDO, V2, P236, DOI 10.1016/S2213-8587(13)70139-6
   Tanenbaum ML, 2013, J AFFECT DISORDERS, V150, P533, DOI 10.1016/j.jad.2013.01.029
   Teresi Jeanne A, 2008, Psychol Sci Q, V50, P538
   Thombs BD, 2016, INT J METH PSYCH RES, V25, P145, DOI 10.1002/mpr.1504
   Tiemeier H, 2002, J NEUROL NEUROSUR PS, V73, P34, DOI 10.1136/jnnp.73.1.34
   Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006
   Tsenkova VK, 2008, HEALTH PSYCHOL, V27, pS163, DOI 10.1037/0278-6133.27.2(Suppl.).S163
   Tuohy A, 2008, BRIT J CLIN PSYCHOL, V47, P153, DOI 10.1348/014466507X238608
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van der Heijden MMP, 2013, DIABETOLOGIA, V56, P1210, DOI 10.1007/s00125-013-2871-7
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   van Dijk SEM, 2018, QUAL LIFE RES, V27, P1415, DOI 10.1007/s11136-018-1782-y
   VANSTEENBERGENWEIJ, 2010, BMC HEALTH SERV RES, V10, DOI DOI 10.1186/1472-6963-10-235
   Wahlqvist ML, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-150
   Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048
   Wang YP, 2013, CLINICS, V68, P1274, DOI 10.6061/clinics/2013(09)15
NR 132
TC 1
Z9 1
U1 3
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2018
VL 11
BP 333
EP 343
DI 10.2147/DMSO.S106797
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GM9RS
UT WOS:000438590800001
PM 30022843
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Sympa, P
   Vlachou, E
   Kazakos, K
   Govina, O
   Stamatiou, G
   Lavdaniti, M
AF Sympa, Paraskevi
   Vlachou, Eugenia
   Kazakos, Kyriakos
   Govina, Ourania
   Stamatiou, George
   Lavdaniti, Maria
TI Depression and Self-Efficacy in Patients with Type 2 Diabetes in
   Northern Greece
SO ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS
LA English
DT Article
DE Depression; anxiety; distress; self-efficacy; diabetes mellitus; Greece
ID BODY-MASS INDEX; GLYCEMIC CONTROL; MELLITUS; ANXIETY; ADULTS; DISORDERS;
   ADHERENCE; DISTRESS
AB Background: Depression represents one of the most common disorders in diabetic patients and frequently complicates the health care of this population. Poor self-efficacy has been associated with increased depressive symptoms as well as poor glycemic control.
   Objective: To assess depression and self-efficacy in adults with type 2 diabetes in Northern Greece and to explore the factors which may affect them in this group of population.
   Method: A descriptive study was conducted in a tertiary hospital in the largest city of Northern Greece. The study group included a convenience sample of 170 adults with type 2 diabetes mellitus who completed the General Health Questionnaire-28 (GHQ-28) and the Diabetes Empowerment Scale- short form (DES) questionnaire.
   Results: The overall rate of diabetic patients showing psychological distress in the present study was 50.6%. Adults with low and moderate income experienced higher levels of depression and anxiety, compared to those with high economical status (p<0,001). Also, adults who graduated elementary education experienced higher levels of depressive and anxiety symptoms than those with a higher educational level (p =0,038). There was a statistically significant difference between age (p<0.001), type of residence (p=0.019), family status (p=0,002), financial status (p<0.001) and self-efficacy. Also, there was a negative correlation between BMI and self-efficacy (r=-0.206, p<0.001) and a negative correlation between depression and self-efficacy scale (r=-0.439, p<0.001)
   Conclusion: The results of the present study highlight the importance of well-planned interventions in order to reduce depression and increase self-efficacy in diabetic adults and to help them further improve their quality of life.
C1 [Sympa, Paraskevi; Kazakos, Kyriakos; Stamatiou, George; Lavdaniti, Maria] Alexander Technol Educ Inst, Nursing Dept, Postgrad Program Diabet Care, Thessaloniki, Greece.
   [Vlachou, Eugenia; Govina, Ourania] Technol Educ Inst Athens, Nursing Dept, Athens, Greece.
RP Lavdaniti, M (reprint author), Alexander Technol Educ Inst Thessaloniki, Thessaloniki, Greece.
EM maria_lavdaniti@yahoo.gr
CR Abazarian Elaheh, 2015, Adv Biomed Res, V4, P112, DOI 10.4103/2277-9175.157830
   Al-Amer R, 2016, ISSUES MENT HEALTH N, V37, P744, DOI 10.1080/01612840.2016.1208692
   Al-Khawaldeh OA, 2012, J DIABETES COMPLICAT, V26, P10, DOI 10.1016/j.jdiacomp.2011.11.002
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   Asuzu CC, 2017, J DIABETES COMPLICAT, V31, P169, DOI 10.1016/j.jdiacomp.2016.09.013
   Cherrington A, 2010, J BEHAV MED, V33, P81, DOI 10.1007/s10865-009-9233-4
   Chew B.H., 2016, PLOS ONE, V22
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062
   Dehghan H, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-016-0285-z
   Demmer RT, 2015, PSYCHOSOM MED, V77, P467, DOI 10.1097/PSY.0000000000000169
   Devarajooh C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175096
   DeVellis BM, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P235
   Giaglis G.D., 2003, GREEK LANGUAGE 8O PA
   Goldberg D., 1978, MANUAL GEN HLTH QUES
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Ikeda K, 2003, PSYCHOL REP, V92, P540, DOI 10.2466/PR0.92.2.540-544
   Ilioudi Stamatia, 2010, Int J Electron Healthc, V5, P327, DOI 10.1504/IJEH.2010.036205
   Indelicato L, 2017, NUTR METAB CARDIOVAS, V27, P300, DOI 10.1016/j.numecd.2017.01.006
   Karaiskos D, 2013, INT J CLIN PRACT, V67, P257, DOI 10.1111/ijcp.12112
   Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409
   Mousleh J., 2000, GERMAN J PSYCHIAT, V3, P1
   Moutzoukis X., 1990, PSYCHIAT HOSP THESSA
   Papathanasiou Athanasia, 2008, Ment Health Fam Med, V5, P85
   Rajput Rajesh, 2016, Indian J Endocrinol Metab, V20, P746
   Sacco WP, 2007, HEALTH PSYCHOL, V26, P693, DOI 10.1037/0278-6133.26.6.693
   Sacco WP, 2005, HEALTH PSYCHOL, V24, P630, DOI 10.1037/0278-6133.6.630
   Shao YC, 2017, NEUROPSYCH DIS TREAT, V13, P855, DOI 10.2147/NDT.S128432
   Trento M, 2015, ACTA DIABETOL, V52, P1157, DOI 10.1007/s00592-015-0806-0
   Willmott SA, 2004, SOC PSYCH PSYCH EPID, V39, P613, DOI 10.1007/s00127-004-0801-1
   World Health Organization, 2016, DIABETES
   Wu SFV, 2013, NURS HEALTH SCI, V15, P213, DOI 10.1111/nhs.12022
NR 33
TC 1
Z9 1
U1 3
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1871-5303
EI 2212-3873
J9 ENDOCR METAB IMMUNE
JI Endocr. Metab. Immune Disord.-Drug Targets
PY 2018
VL 18
IS 4
BP 371
EP 378
DI 10.2174/1871530317666171120154002
PG 8
WC Endocrinology & Metabolism; Immunology; Pharmacology & Pharmacy
SC Endocrinology & Metabolism; Immunology; Pharmacology & Pharmacy
GA GJ5PP
UT WOS:000435434400012
PM 29165096
DA 2019-01-08
ER

PT J
AU Pernomian, L
   Moreira, JD
   Gomes, MS
AF Pernomian, Larissa
   Moreira, Josimar Dornelas
   Gomes, Mayara Santos
TI In the View of Endothelial Microparticles: Novel Perspectives for
   Diagnostic and Pharmacological Management of Cardiovascular Risk during
   Diabetes Distress
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Review
ID CORONARY-ARTERY-DISEASE; CHRONIC MILD STRESS; ANGIOTENSIN-II;
   PSYCHOLOGICAL DISTRESS; MYOCARDIAL-INFARCTION; HYPERTENSIVE PATIENTS;
   VASCULAR DYSFUNCTION; DEPRESSIVE SYMPTOMS; CLINICAL DEPRESSION; GLYCEMIC
   CONTROL
AB Acute or chronic exposure to diabetes-related stressors triggers a specific psychological and behavior stress syndrome called diabetes distress, which underlies depressive symptoms in most diabetic patients. Distressed and/or depressive diabetic adults exhibit higher rates of cardiovascular mortality and morbidity, which have been correlated to macrovascular complications evoked by diabetic behavior stress. Recent experimental findings clearly point out that oxidative stress accounts for the vascular dysfunction initiated by the exposure to life stressors in diabetic conditions. Moreover, oxidative stress has been described as the main autocrine and paracrine mechanism of cardiovascular damage induced by endothelial microparticles (anuclear ectosomal microvesicles released from injured endothelial cells) in diabetic subjects. Such robust relationship between oxidative stress and cardiovascular diseases strongly suggests a critical role for endothelial microparticles as the primer messengers of the redox-dependent vascular dysfunction underlying diabetes distress. Here, we provide novel perspectives opened in the view of endothelial microparticles as promising diagnostic and pharmacotherapeutic biomarkers of cardiovascular risk in distressed diabetic patients.
C1 [Pernomian, Larissa] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Biosci Appl Pharm, Ribeirao Preto, SP, Brazil.
   [Moreira, Josimar Dornelas] Univ Fed Minas Gerais, Fac Pharm, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil.
   [Gomes, Mayara Santos] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Phys & Chem, Ribeirao Preto, SP, Brazil.
RP Pernomian, L (reprint author), Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Biosci Appl Pharm, Ribeirao Preto, SP, Brazil.
EM l.pernomian@usp.br
FU Coordination for the Improvement of Higher Education Personnel (CAPES);
   CAPES (PNPD/CAPES); Sao Paulo Research Foundation (FAPESP, Brazil)
   [2014/17740-0, 2013/08216-2, 2012/00640-7, 2012/09019-3, 2009/01005-0]
FX The authors thank Professor Cristina Ribeiro de Barros Cardoso for her
   scientific support. This work was supported by the Coordination for the
   Improvement of Higher Education Personnel (CAPES), by the National
   Postdoctorate Program of CAPES (PNPD/CAPES), and by the Sao Paulo
   Research Foundation (FAPESP, Brazil, Grant nos. 2014/17740-0,
   2013/08216-2, 2012/00640-7, 2012/09019-3, and 2009/01005-0).
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Burger D, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/5047954
   Chan S, 2018, TOXICOL APPL PHARM, V338, P148, DOI 10.1016/j.taap.2017.11.005
   Chung IM, 2010, ATHEROSCLEROSIS, V213, P109, DOI 10.1016/j.atherosclerosis.2010.08.052
   Coco H, 2017, J PHARM PHARMACOL, V69, P52, DOI 10.1111/jphp.12659
   Cohen S, 2016, PERSPECT PSYCHOL SCI, V11, P456, DOI 10.1177/1745691616646305
   Costa-Ferreira W, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00262
   Dalsgaard EM, 2014, DIABETOLOGIA, V57, P710, DOI 10.1007/s00125-014-3165-4
   Deng F., 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/980202627803933
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Esbitt S. A., 2013, SCREENING DEPRESSION
   Esposito K, 2007, INT J IMPOT RES, V19, P161, DOI 10.1038/sj.ijir.3901500
   Feng B, 2010, ATHEROSCLEROSIS, V208, P264, DOI 10.1016/j.atherosclerosis.2009.06.037
   Fisher EB, 2012, J AFFECT DISORDERS, V142, pS56, DOI 10.1016/S0165-0327(12)70009-5
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Franca CN, 2015, ARQ BRAS CARDIOL, V104, P169, DOI 10.5935/abc.20140210
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Gero D, 2013, DIABETES, V62, P953, DOI [10.2337/db12-0789, 10.2337/db12-0789/-/DC1]
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Groeschel M, 2011, AM J PHYSIOL-RENAL, V300, pF1, DOI 10.1152/ajprenal.00208.2010
   Hackett RA, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0771-4
   Jansen F, 2013, CARDIOVASC RES, V98, P94, DOI 10.1093/cvr/cvt013
   Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72
   Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047
   Kreider KE, 2017, DIABETES THER, V8, P1, DOI 10.1007/s13300-017-0231-1
   Kyritsi EM, 2017, HORM-INT J ENDOCRINO, V16, P42, DOI 10.14310/horm.2002.1718
   Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007
   Lee SK, 2014, THROMB HAEMOSTASIS, V112, P580, DOI 10.1160/TH13-11-0975
   Leroyer AS, 2008, DIABETES METAB, V34, pS27, DOI 10.1016/S1262-3636(08)70100-9
   Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053
   Lichtenauer M, 2017, CLIN HEMORHEOL MICRO, V67, P101, DOI 10.3233/CH-170273
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Matchkov VV, 2015, AM J PHYSIOL-REG I, V309, pR814, DOI 10.1152/ajpregu.00337.2014
   Matsuura N, 2015, AM J PHYSIOL-HEART C, V308, pH1275, DOI 10.1152/ajpheart.00906.2014
   Mobarrez F, 2012, THROMB RES, V129, P95, DOI 10.1016/j.thromres.2011.09.027
   Moreira JD, 2016, EUR J PHARMACOL, V783, P11, DOI 10.1016/j.ejphar.2016.04.050
   Moreira JD, 2015, EUR J PHARMACOL, V765, P503, DOI 10.1016/j.ejphar.2015.09.020
   Morel O, 2003, J THROMB HAEMOST, V1, P171, DOI 10.1046/j.1538-7836.2003.00010.x
   Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26
   Nomura S, 2005, J HUM HYPERTENS, V19, P551, DOI 10.1038/sj.jhh.1001863
   Nomura S, 2007, J HUM HYPERTENS, V21, P38, DOI 10.1038/sj.jhh.1002100
   Nomura S, 2005, J THROMB THROMBOLYS, V18, P177, DOI 10.1007/s11239-005-0343-8
   Nomura S, 2016, J ATHEROSCLER THROMB, V23, P1, DOI 10.5551/jat.32326
   Nomura S, 2009, J ATHEROSCLER THROMB, V16, P83, DOI 10.5551/jat.E091
   Pernomian L, 2012, EUR J PHARMACOL, V678, P15, DOI 10.1016/j.ejphar.2011.12.036
   Puddu Paolo, 2010, Can J Cardiol, V26, P140
   Roohafza H, 2016, ARYA ATHEROSCLER, V12, P166
   Roopan S, 2017, ACTA NEUROPSYCHIATR, V29, P127, DOI 10.1017/neu.2016.54
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005
   Sabatier F, 2002, DIABETES, V51, P2840, DOI 10.2337/diabetes.51.9.2840
   Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   Santilli F, 2016, THROMB HAEMOSTASIS, V116, P220, DOI 10.1160/TH16-03-0176
   Scherrer JF, 2011, DIABETES CARE, V34, P1729, DOI 10.2337/dc11-0031
   Semenkovich K, 2015, DRUGS, V75, P577, DOI 10.1007/s40265-015-0347-4
   Shen JD, 2017, METAB BRAIN DIS, V32, P1163, DOI 10.1007/s11011-017-0017-1
   Suades R, 2013, THROMB HAEMOSTASIS, V110, P366, DOI 10.1160/TH13-03-0238
   Tanenbaum ML, 2012, DIABETES EDUCATOR, V38, P695, DOI 10.1177/0145721712452795
   Tramontano AF, 2004, BIOCHEM BIOPH RES CO, V320, P34, DOI 10.1016/j.bbrc.2004.05.127
   Tushuizen ME, 2007, DIABETES CARE, V30, P728, DOI 10.2337/dc06-1473
   van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15
   Wheatcroft SB, 2013, DIABETES, V62, P698, DOI 10.2337/db12-1530
   Winchester RJ, 2016, J DIABETES COMPLICAT, V30, P312, DOI 10.1016/j.jdiacomp.2015.11.010
   Yang SJ, 2014, J HYPERTENS, V32, P762, DOI 10.1097/HJH.0000000000000083
   Zannas AS, 2017, MOL PSYCHIATR, V22, P640, DOI 10.1038/mp.2017.35
NR 74
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2018
AR 9685205
DI 10.1155/2018/9685205
PG 7
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA GH4WU
UT WOS:000433413000001
PM 29862304
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Gillani, SW
   Ansari, IA
   Zaghloul, HA
   Abdul, MIM
   Sulaiman, SAS
   Baig, MR
   Rathore, HA
AF Gillani, Syed Wasif
   Ansari, Irfan Altaf
   Zaghloul, Hisham A.
   Abdul, Mohi Iqbal Mohammad
   Sulaiman, Syed Azhar Syed
   Baig, Mirza R.
   Rathore, Hassaan Anwar
TI Women with Type 1 Diabetes Mellitus: Effect of Disease and
   Psychosocial-Related Correlates on Health-Related Quality of Life
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID CARE; MANAGEMENT; SUPPORT; INSULIN; SCALE
AB Background. This study is aimed at investigating the various disease-specific and health-related psychosocial concepts of HRQOL among insulin-dependent diabetes mellitus (IDDM) and understanding the gender differences in HRQOL among IDDM patients. Methods. A cross-sectional observational study was conducted to assess the effect of health-related and psychosocial correlates on HRQOL of IDDM patients in Penang, Malaysia. The participants were recruited from five governmental diabetic clinics. Patients with insulin use only, IDDM diagnosed at least 1 year earlier, were identified from clinical registers. The sample was then age stratified for 20-64 years, and severe complications (e. g., end-stage renal failure, hemodialysis, and liver cirrhosis) were excluded; a total of 1003 participants were enrolled in the study. Multivariate regression analysis was used to predict the response. Results. A total of 853 (100%) participants were enrolled and completed the study. Women exhibited significantly higher/ better mental health (p < 0 013) and health perception scores (p < 0 001) despite high prevalence of impaired role (49.2%), social (24.2%), and physical (40.5%) functionings as compared to men. Women with longer diabetes exposure and uncontrolled glycemic levels (HbA1c) have poorer HRQOL. Availability of social support showed no significant association with either HRQOL or diabetes distress levels. Diabetes distress levels remained not associated with social support. Women also showed significantly higher association with health perception (15% versus 13% men, p < 0 001) and mental health (13% versus 11% men, p < 0 001) in diabetes-specific psychosocial factors. Thus, among women alone, diabetes-related specific and psychosocial factors explained 15% and 13% of variations in HRQOL extents, respectively. Conclusion. Women exhibit extensive and significant patterns with health-related factors and diabetes-specific psychosocial factors (self-efficacy, social support, and DLC) to improve HRQOL. Also, women have significantly high reported distress levels and low social functioning compared to men.
C1 [Gillani, Syed Wasif; Zaghloul, Hisham A.; Abdul, Mohi Iqbal Mohammad] Taibah Univ, Coll Pharm, Al Madinah Al Munawarah, Saudi Arabia.
   [Ansari, Irfan Altaf] Taibah Univ, Coll Med, Dept Pathol, Al Madinah Al Munawarah, Saudi Arabia.
   [Sulaiman, Syed Azhar Syed; Rathore, Hassaan Anwar] USM, Sch Pharmaceut Sci, George Town, Malaysia.
   [Baig, Mirza R.] Dubai Pharm Coll, Dubai, U Arab Emirates.
RP Gillani, SW (reprint author), Taibah Univ, Coll Pharm, Al Madinah Al Munawarah, Saudi Arabia.
EM wasifgillani@gmail.com
CR Adejoh SO, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014539966
   [Anonymous], 2017, MED OUTCOMES STUDY H
   Bains SS, 2011, DIABETES TECHNOL THE, V13, P335, DOI 10.1089/dia.2010.0160
   Chao Jingdong, 2005, Res Social Adm Pharm, V1, P508, DOI 10.1016/j.sapharm.2005.09.002
   Domgaard M, 2015, POSTGRAD MED, V127, P438, DOI 10.1080/00325481.2015.1045815
   FERRARO LA, 1987, PSYCHOL REP, V61, P763, DOI 10.2466/pr0.1987.61.3.763
   Garfield S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-149
   Gillani SW, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0325-6
   Gillani SW, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0584-9
   Gillani SW, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0257-6
   Gillani SW, 2017, ACTA PHARMACEUT, V67, P71, DOI 10.1515/acph-2017-0008
   Gillani SW, 2016, CURR PHARM DESIGN, V22, P6469, DOI 10.2174/1381612822666160813235704
   Gillani SW, 2016, CURR DIABETES REV, V12, P279, DOI 10.2174/1573399811666150520094631
   HARRIS R, 1985, SOUTHERN MED J, V78, P162, DOI 10.1097/00007611-198502000-00011
   Hays R. D., RAND CORPORATION MON
   Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4
   International Diabetes Federation (IDF), 2013, AB DIAB 2013
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441
   La Greca AM, 2002, J PEDIATR PSYCHOL, V27, P665, DOI 10.1093/jpepsy/27.8.665
   Osborn CY, 2010, PATIENT EDUC COUNS, V79, P49, DOI 10.1016/j.pec.2009.07.016
   Persell SD, 2004, PREV MED, V39, P746, DOI 10.1016/j.ypmed.2004.02.045
   Santos LM, 2015, SOC SCI RES, V50, P139, DOI 10.1016/j.ssresearch.2014.11.009
   SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179
   Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   von Arx LB, 2014, PATIENT, V7, P283, DOI 10.1007/s40271-014-0057-0
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 27
TC 0
Z9 0
U1 2
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2018
AR 4079087
DI 10.1155/2018/4079087
PG 10
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA GF5PX
UT WOS:000432021100001
PM 29854822
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Aljuaid, MO
   Almutairi, AM
   Assiri, MA
   Almalki, DM
   Alswat, K
AF Aljuaid, Majed O.
   Almutairi, Abdulmajeed M.
   Assiri, Mohammed A.
   Almalki, Dhifallah M.
   Alswat, Khaled
TI Diabetes-Related Distress Assessment among Type 2 Diabetes Patients
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID GLYCEMIC CONTROL; CARE LEVEL; DEPRESSION; MELLITUS; PEOPLE; BURDEN
AB Background and Objectives. Diabetes is one of the most common chronic diseases; it is a debilitating and hard to live with. Diabetes-related distress (DRD) refers to the emotional and behavioral changes caused by diabetes. Our study aims to assess the prevalence of DRD among type 2 diabetes (T2D) patients using Diabetes Distress Scale-17 items (DDS-17) and its relation to complications and treatment modalities. Methods. A cross-sectional study of adult T2D patients with follow-up visits at the Diabetes and Endocrinology Center in Taif, Saudi Arabia, between January and July 2017. We excluded patients with other forms of diabetes, untreated hypothyroidism, and psychiatric illness. The total score of DDS-17 was calculated by summing the 17 items' results and then dividing the total by 17. If the total score was >2, then it was considered as clinically significant results (moderate distress), but if it is >= 3, then it is classified as a high distress. Results. A total of 509 T2D patients with a mean age of 58 +/- 14 years were included. The majority of participants were male, married, not college educated, and reported a sedentary lifestyle. We found 25% of the screened T2D patients have moderate to high DRD. Regarding the DRD components, emotional distress was the most prevalent followed by physician-related distress. HabA1c was significantly higher in those with high combined distress and high emotional distress compared to those with mild/moderate distress (p = 0 015 and 0.030, resp.). Conclusion. Our study shows that DRD is a medically relevant issue that clinicians need to address. Despite observing a low prevalence of DRD compared to other studies, we found significant correlations between DRD scores and HabA1c, triglyceride levels, BMI, T2D duration, and interval between visits.
C1 [Aljuaid, Majed O.; Almutairi, Abdulmajeed M.; Assiri, Mohammed A.; Alswat, Khaled] Taif Univ, Sch Med, At Taif, Saudi Arabia.
   [Almalki, Dhifallah M.] Prince Mansoure Hosp, Diabet & Endocrinol Ctr, At Taif, Saudi Arabia.
RP Alswat, K (reprint author), Taif Univ, Sch Med, At Taif, Saudi Arabia.
EM dr_kswat@hotmail.com
OI Aljuaid, Majed/0000-0001-9529-4803
CR Alvani S. Reza, 2016, PRACTICE CLIN PSYCHO, V3, P167
   Berry E, 2015, POSTGRAD MED J, V91, P278, DOI 10.1136/postgradmedj-2014-133017
   Chew BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152095
   Chew BH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0384-4
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021
   Funnell MM, 2006, CLIN DIABETES, V24, P154
   Gideon E., 2014, P NAT C UND RES NCUR, P204
   Islam MR, 2013, INT J MED BIOMED RES, V2, P113, DOI DOI 10.14194/IJMBR.224
   Kalra S, 2017, J PAK MED ASSOC, V67, P1116
   Kuniss N, 2017, ACTA DIABETOL, V54, P471, DOI 10.1007/s00592-017-0972-3
   Kuniss N, 2016, EXP CLIN ENDOCR DIAB, V124, P307, DOI 10.1055/s-0042-103685
   Kuniss N., 2017, EXPT CLIN ENDOCRINOL
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Reimer A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181218
   Tol A, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-20
   Wong EM, 2017, CAN J DIABETES, V41, P362, DOI 10.1016/j.jcjd.2016.11.006
   Zhou HH, 2017, PSYCHIAT RES, V252, P45, DOI 10.1016/j.psychres.2017.02.049
NR 24
TC 0
Z9 0
U1 1
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2018
AR 7328128
DI 10.1155/2018/7328128
PG 10
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA GC2EO
UT WOS:000429595200001
PM 29770340
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Madva, EN
   Gomez-Bernal, F
   Millstein, RA
   Celano, CM
   Park, ER
   Mastromauro, CA
   Albanese, AM
   Beale, EE
   Huffman, JC
AF Madva, Elizabeth N.
   Gomez-Bernal, Federico
   Millstein, Rachel A.
   Celano, Christopher M.
   Park, Elyse R.
   Mastromauro, Carol A.
   Albanese, Ariana M.
   Beale, Eleanor E.
   Huffman, Jeff C.
TI Magnitude and sources of distress in mid-life adults with chronic
   medical illness: an exploratory mixed-methods analysis
SO PSYCHOLOGY HEALTH & MEDICINE
LA English
DT Article
DE Acute coronary syndrome; chronic medical conditions; diabetes; heart
   failure; mid-life
ID CORONARY-HEART-DISEASE; POSITIVE-AFFECT; PHYSICAL-ACTIVITY; HEALTH
   BEHAVIORS; UNITED-STATES; OLDER-ADULTS; MORTALITY; DEPRESSION; OPTIMISM;
   ANXIETY
AB Most mid-life adults have at least one chronic medical condition (CMC) and are at risk for developing additional CMCs. Stressors specific to this life stage may contribute to CMC development by hindering healthy behaviors. The goal of this study was to compare sources and intensity of distress, as they relate to health behaviors, between mid-life and non-mid-life adults with CMCs. We utilized a mixed-methods approach by analyzing quantitative self-report measures of psychiatric symptoms and psychological well-being, with in-depth, semi-structured qualitative interviews to identify sources of stress in three cohorts of patients with CMCs (heart failure, type 2 diabetes, and coronary artery disease). Between-group differences on self-report measures were compared via independent samples t-tests and relevant themes from interview transcripts were compared via chi-square analysis. We found that mid-life participants (n = 30) reported greater psychological distress (depression/anxiety) than non-mid-life (n = 62) participants (Hospital Anxiety and Depression Scale scores 13.8 [SD 7.3] vs. 10.6 [SD 6.6]; t(90)=2.13; p = .035), and qualitative analysis revealed several specific sources of stress significantly more common (p < .001) in mid-life adults. Interventions targeting the needs of this population could reduce distress, improve health behaviors, and have a major impact on public health.
C1 [Madva, Elizabeth N.; Millstein, Rachel A.; Celano, Christopher M.; Park, Elyse R.; Huffman, Jeff C.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.
   [Madva, Elizabeth N.; Gomez-Bernal, Federico; Millstein, Rachel A.; Celano, Christopher M.; Park, Elyse R.; Mastromauro, Carol A.; Albanese, Ariana M.; Beale, Eleanor E.; Huffman, Jeff C.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.
RP Huffman, JC (reprint author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.; Huffman, JC (reprint author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.
EM jhuffman@partners.org
FU NHLBI NIH HHS [R01 HL113272, K23 HL135277, K23 HL123607]; NIDDK NIH HHS
   [R21 DK109313]
CR Almeida DM, 2004, MAC FDN MEN, P425
   Badley EM, 2010, ARTHRIT CARE RES, V62, P308, DOI 10.1002/acr.20100
   Blackwell DL, 2012, VITAL HLTH STAT, V10, P1
   Boehm JK, 2013, AM J CARDIOL, V111, P1425, DOI 10.1016/j.amjcard.2013.01.292
   Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119
   Bouchard C, 1993, PHYS ACTIVITY FITNES
   Boylan JM, 2015, PSYCHOSOM MED, V77, P548, DOI 10.1097/PSY.0000000000000192
   Brim O. G., 2004, HLTH ARE WE NATL STU
   CDC, 2011, DIAB SUCC OPP POP BA
   CDC, 2009, CTR DIS CONTR PREV C
   CDC, 2012, NAT CTR HLTH STAT HL
   Celano CM, 2013, CURR DIABETES REP, V13, P917, DOI 10.1007/s11892-013-0430-8
   Celano CM, 2013, CIRC-CARDIOVASC QUAL, V6, P498, DOI 10.1161/CIRCOUTCOMES.111.000049
   Charlson FJ, 2016, MENTAL NEUROLOGICAL, V4, P41, DOI [10.1596/978-1-4648-0426-7, DOI 10.1596/978-1-4648-0426-7]
   Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba
   CORYELL W, 1988, PSYCHIAT CLIN N AM, V11, P433
   Dainese SM, 2011, GEROPSYCH, V24, P19, DOI 10.1024/1662-9647/a000032
   Davis JC, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0076-2
   Gathuru I. M., 2016, SOCIAL PHARM J SPJ, V1
   Gillette DB, 2015, J GERIATR PHYS THER, V38, P194, DOI 10.1519/JPT.0000000000000041
   Giltay EJ, 2004, ARCH GEN PSYCHIAT, V61, P1126, DOI 10.1001/archpsyc.61.11.1126
   GRZYWACZ J, 2000, EC NEUROSCI, V2, P41
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   Hevey D, 2014, J BEHAV MED, V37, P300, DOI 10.1007/s10865-012-9487-0
   Huffman J. C., 2015, J DIABETES RES, V2015
   Huffman JC, 2016, J HAPPINESS STUD, V17, P1985, DOI 10.1007/s10902-015-9681-1
   Lachman ME, 2015, INT J BEHAV DEV, V39, P20, DOI 10.1177/0165025414533223
   LINN MW, 1985, AM J PUBLIC HEALTH, V75, P502, DOI 10.2105/AJPH.75.5.502
   McPhail SM, 2014, CLIN INTERV AGING, V9, P2113, DOI 10.2147/CIA.S72731
   Pederson JL, 2016, J HOSP MED, V11, P373, DOI 10.1002/jhm.2547
   Peterson JC, 2012, ARCH INTERN MED, V172, P329, DOI 10.1001/archinternmed.2011.1311
   Piazza JR, 2007, J GERONTOL B-PSYCHOL, V62, pP313, DOI 10.1093/geronb/62.6.P313
   Pratt Laura A, 2014, NCHS Data Brief, P1
   Saint Onge JM, 2014, J GERONTOL B-PSYCHOL, V69, P622, DOI 10.1093/geronb/gbu009
   SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063
   Sin NL, 2015, PSYCHOSOM MED, V77, P1058, DOI 10.1097/PSY.0000000000000238
   Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0
   Steptoe A, 2009, J PERS, V77, P1747, DOI 10.1111/j.1467-6494.2009.00599.x
   Sun Q, 2010, ARCH INTERN MED, V170, P194, DOI 10.1001/archinternmed.2009.503
   Tsenkova VK, 2016, ANN BEHAV MED, V50, P836, DOI 10.1007/s12160-016-9810-z
   Valenstein M, 2001, ANN INTERN MED, V134, P345, DOI 10.7326/0003-4819-134-5-200103060-00007
   Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   White DK, 2012, ARTHRIT CARE RES, V64, P1312, DOI 10.1002/acr.21694
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 45
TC 0
Z9 0
U1 1
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1354-8506
EI 1465-3966
J9 PSYCHOL HEALTH MED
JI Psychol. Health Med.
PY 2018
VL 23
IS 5
BP 555
EP 566
DI 10.1080/13548506.2017.1384554
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GB4NB
UT WOS:000429035800009
PM 28984158
DA 2019-01-08
ER

PT J
AU Pinidiyapathirage, J
   O'Shannessy, M
   Harte, J
   Brumby, S
   Kitchener, S
AF Pinidiyapathirage, Janani
   O'Shannessy, Megan
   Harte, Jane
   Brumby, Susan
   Kitchener, Scott
TI Chronic Disease and Health Risk Behaviors Among Rural Agricultural
   Workforce in Queensland
SO JOURNAL OF AGROMEDICINE
LA English
DT Article
DE Agricultural workers; behavioral risk factors; chronic disease; rural
   Queensland
ID MALE FARMERS; AUSTRALIA
AB Introduction: Little is known of the lifestyle behaviors and prevalence of chronic disease in the Australian agricultural workforce. This study aimed to assess behavioral risk factors and the prevalence of chronic disease among attendees of agricultural events in rural Queensland. Methods: Data on lifestyle risk factors and prevalence of diabetes and cardiovascular diseases were collected from participants in four separate cross-sectional studies in rural southern Queensland. Anthropometric measures, blood pressure, serum cholesterol, and glucose levels of consenting participants were assessed by trained medical students under the supervision of rural clinicians. Data were analyzed using SPSS 22 statistical software package and t-tests and chisquare tests were used to compare differences between groups. Results: A total of 702 attendees participated; the majority were agricultural workers (n = 393). Greater psychological distress was reported among participants from these rural communities (42%) than in the Australian population (31%); however, levels of psychological distress was similar between agricultural workers and others in the sample. Fewer people in these agricultural communities reported smoking (10%), and they reported being more active (86%) than the average Australian, but a greater proportion reported high-risk alcohol consumption (53%) and were found to be hypertensive (31%). These findings were accentuated among agricultural workers. Conclusion: This method of investigation both raises awareness in the community and identifies health risks for further management in a group that has otherwise been poorly defined. Resident agricultural workers have different health risks and behaviors, though psychological distress appears to be borne across these communities.
C1 [Pinidiyapathirage, Janani; Harte, Jane; Kitchener, Scott] Univ Southern Queensland, Agr Hlth & Med Res Grp, Toowoomba, Qld, Australia.
   [O'Shannessy, Megan; Harte, Jane; Kitchener, Scott] Griffith Univ, Rural Hlth Stream, Toowoomba, Qld, Australia.
   [Brumby, Susan] Deakin Univ, Sch Med, Waurn Ponds, Australia.
   [Brumby, Susan] Western Dist Hlth Serv, Natl Ctr Farmer Hlth, Hamilton, Vic, Australia.
RP Kitchener, S (reprint author), Griffith Univ, Rural Stream Campus,POB 2076, Toowoomba, Qld 4350, Australia.
EM s.kitchener@qrme.org.au
FU Queensland Rural Medical Education; Griffith Rural Health Stream
FX This work was supported by the Queensland Rural Medical Education;
   Griffith Rural Health Stream.
CR Australian Bureau of Statistics, 2014, AUSTR HLTH SURV BIOM
   Australian Bureau of Statistics, 2015, NAT HLTH SURV 1 RES
   Australian Institute of Health and Welfare (AIHW), 2008, RURAL HLTH SERIES, V9
   Brumby SA, 2009, RURAL REMOTE HEALTH, V9
   Brumby S, 2013, J RURAL HEALTH, V29, P311, DOI 10.1111/jrh.12001
   Chen L, 2010, MED J AUSTRALIA, V192, P197
   Fragar L, 2011, AUST J RURAL HEALTH, V19, P179, DOI 10.1111/j.1440-1584.2011.01209.x
   HEGNEY D, 1993, AUST J RURAL HEALTH, V1, P27, DOI DOI 10.1111/J.1440-1584.1993.TB00077.X
   Kennedy A, 2014, RURAL REMOTE HEALTH, V14
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146
   Lower T, 2011, J AGROMEDICINE, V16, P292, DOI 10.1080/1059924X.2011.605726
   Miller PG, 2010, AUST J RURAL HEALTH, V18, P110, DOI 10.1111/j.1440-1584.2010.01133.x
   Monaghan N, 2017, J AGROMEDICINE, V22, P100, DOI 10.1080/1059924X.2017.1282907
   Morrissey SA, 2007, AUST J RURAL HEALTH, V15, P120, DOI 10.1111/j.1440-1584.2007.00865.x
   MUELLEMAN RL, 1993, J TRAUMA, V35, P717, DOI 10.1097/00005373-199311000-00011
   National Health and Medical Research Council, 2009, AUSTR GUID RED HLTH
   Roy P, 2013, AUST J RURAL HEALTH, V21, P3, DOI 10.1111/ajr.12008
   Smith KB, 2008, AUST J RURAL HEALTH, V16, P56, DOI 10.1111/j.1440-1584.2008.00953.x
   Sorensen Tony, 2011, International Journal of Foresight and Innovation Policy, V7, P192, DOI 10.1504/IJFIP.2011.040074
   Thomas SL, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-143
   World Health Organisation, 2006, BMI CLASS
NR 22
TC 1
Z9 1
U1 2
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1059-924X
EI 1545-0813
J9 J AGROMEDICINE
JI J. Agromedicine
PY 2018
VL 23
IS 1
BP 32
EP 39
DI 10.1080/1059924X.2017.1387634
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FZ8FJ
UT WOS:000427842100008
PM 28976267
DA 2019-01-08
ER

PT J
AU Dirik, G
   Gocek-Yorulmaz, E
AF Dirik, Gulay
   Gocek-Yorulmaz, Ezgi
TI Positive Sides of the Disease: Posttraumatic Growth in Adults with Type
   2 Diabetes
SO BEHAVIORAL MEDICINE
LA English
DT Article
DE posttraumatic growth; perceived social support; self-efficacy; coping
   and perceived expressed emotions
ID STRESS-RELATED GROWTH; PERCEIVED SOCIAL SUPPORT; EXPRESSED EMOTION;
   BREAST-CANCER; COPING STRATEGIES; SELF-EFFICACY; PREVALENCE;
   DETERMINANTS; METAANALYSIS; SURVIVORS
AB Type 2 diabetes is a chronic disease that can causes positive changes, as well as psychological distress. The aim of the this study is to investigate the posttraumatic growth level of adults with type 2 diabetes and to identify the relationship among perceived social support, coping, diabetes management self-efficacy, perceived expressed emotions, and PTG in diabetes patients from non-western, developing country. The findings revealed that patients experience a moderate level of posttraumatic growth. Regression analyses showed that the severity of the disease, educational level, perceived social support, problem-focused coping, optimistic coping and the criticism/hostility dimension of expressed emotions were associated significantly with posttraumatic growth. In the conclusion part, these findings were consistent with the posttraumatic growth theory. The study reveals that professionals aiming to increase the posttraumatic growth of diabetes patients may need to focus on and facilitate perceived social support, adaptive coping strategies, and perceived expressed emotions to facilitate growth experiences.
C1 [Dirik, Gulay] Dokuz Eylul Univ, Dept Psychol, Izmir, Turkey.
   [Gocek-Yorulmaz, Ezgi] Izmir Univ, Dept Psychol, Izmir, Turkey.
RP Dirik, G (reprint author), Dokuz Eylul Univ, Dept Psychol, Izmir, Turkey.
EM gdirik2@gmail.com
CR American Diabetes Association, 2015, DIAB BAS
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8
   Batu G, 2008, THESIS
   Bellizzi KM, 2006, HEALTH PSYCHOL, V25, P47, DOI 10.1037/0278-6133.25.1.47
   Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008
   Berksun O., 1992, THESIS
   Carver CS, 1998, J SOC ISSUES, V54, P245, DOI 10.1111/0022-4537.641998064
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176
   Dirik G, 2008, J CLIN PSYCHOL MED S, V15, P193, DOI 10.1007/s10880-008-9115-x
   EKER D, 1995, SOC PSYCH PSYCH EPID, V30, P121, DOI 10.1007/BF00802040
   FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150
   Helgeson VS, 2008, J PEDIATR PSYCHOL, V33, P497, DOI 10.1093/jpepsy/jsm081
   Jansen L, 2011, BRIT J CANCER, V105, P1158, DOI 10.1038/bjc.2011.335
   Karanci AN, 2007, STRESS HEALTH, V23, P315, DOI 10.1002/smi.1154
   Karanci NA, 1999, N AM J PSYCHOL, V1, P189
   Karlsen B., 2004, PSYCHOL HEALTH MED, V9, P53
   Kesimci A, 2005, CURR PSYCHOL, V24, P68, DOI 10.1007/s12144-005-1005-x
   King S, 2000, SCHIZOPHR RES, V45, P65, DOI 10.1016/S0920-9964(99)00174-7
   Kirk JK, 2013, EXPERT REV ENDOCRINO, V8, P379, DOI 10.1586/17446651.2013.811895
   Koch T, 2000, J CLIN NURS, V9, P247, DOI 10.1046/j.1365-2702.2000.00341.x
   Kroo A, 2011, J LOSS TRAUMA, V16, P440, DOI 10.1080/15325024.2011.575705
   Lotfi-Kashani F, 2014, IRAN J CANCER PREV, V7, P115
   o Usta-Yeilbalkan, 2001, THESIS
   o Yalcnkaya Alkar, 2014, J COGN BEHAV PSYCHOT, V3, P23
   Polatinsky S, 2000, J TRAUMA STRESS, V13, P709, DOI 10.1023/A:1007870419116
   Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271
   Samuel-Hodge CD, 2008, DIABETES EDUCATOR, V34, P501, DOI 10.1177/0145721708316946
   Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551
   Senol-Durak E, 2014, SOC INDIC RES, V118, P729, DOI 10.1007/s11205-013-0435-3
   Sheikh AI, 2004, J CLIN PSYCHOL MED S, V11, P265, DOI 10.1023/B:JOCS.0000045346.76242.73
   STEVENSON K, 1991, PSYCHOTHER PSYCHOSOM, V55, P170, DOI 10.1159/000288426
   Tedeschi R. G., 1995, TRAUMA TRANSFORMATIO
   Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658
   THOITS PA, 1986, J CONSULT CLIN PSYCH, V54, P416, DOI 10.1037//0022-006X.54.4.416
   Updegraff JA, 2002, PERS SOC PSYCHOL B, V28, P382, DOI 10.1177/0146167202286009
   van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x
   Wearden AJ, 2000, J PSYCHOSOM RES, V49, P125, DOI 10.1016/S0022-3999(00)00141-0
   WILD ND, 2003, J AGGRESS MALTREAT T, V8, P97, DOI DOI 10.1300/J146V08N04_05
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Yamakawa M, 2008, INT J NURS STUD, V45, P1032, DOI 10.1016/j.ijnurstu.2007.05.003
   Yorulmaz H, 2010, PROCD SOC BEHV, V5, P2313, DOI 10.1016/j.sbspro.2010.07.456
   ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2
NR 44
TC 1
Z9 1
U1 3
U2 7
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0896-4289
EI 1940-4026
J9 BEHAV MED
JI Behav. Med.
PY 2018
VL 44
IS 1
BP 1
EP 10
DI 10.1080/08964289.2016.1173635
PG 10
WC Behavioral Sciences; Psychiatry
SC Behavioral Sciences; Psychiatry
GA FX0VU
UT WOS:000425766200001
PM 27115317
DA 2019-01-08
ER

PT J
AU Van Buren, DJ
   Wilfley, DE
   Marcus, MD
   Anderson, B
   Abramson, NW
   Berkowitz, R
   Ievers-Landis, C
   Trief, P
   Yasuda, P
   Hirst, K
AF Van Buren, Dorothy J.
   Wilfley, Denise E.
   Marcus, Marsha D.
   Anderson, Barbara
   Abramson, Natalie Walders
   Berkowitz, Robert
   Ievers-Landis, Carolyn
   Trief, Paula
   Yasuda, Patrice
   Hirst, Kathryn
CA TODAY Study Grp
TI Depressive symptoms and glycemic control in youth with type 2 diabetes
   participating in the TODAY clinical trial
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Adolescent; Depressive symptoms; Type 2 diabetes
ID ADOLESCENTS; DISTRESS; CHILDREN
AB The relationship between depressive symptoms and glycemic control in youth with type 2 diabetes was assessed at baseline (n = 682), 6, and/or 24 months (n = 576). Neither baseline nor persistence of depressive symptoms was significantly associated with maintenance of glycemic control. Nevertheless, depressive symptoms were common, suggesting the importance of repeated screening. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Van Buren, Dorothy J.; Wilfley, Denise E.] Washington Univ, Sch Med, St Louis, MO 63130 USA.
   [Marcus, Marsha D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.
   [Anderson, Barbara] Baylor Coll Med, Houston, TX 77030 USA.
   [Abramson, Natalie Walders] Univ Colorado, Sch Med, Dept Pediat, Boulder, CO 80309 USA.
   [Berkowitz, Robert] Univ Penn, Philadelphia, PA 19104 USA.
   [Ievers-Landis, Carolyn] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.
   [Trief, Paula] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Yasuda, Patrice] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA.
   [Hirst, Kathryn] George Washington Univ, Biostat Ctr, 6110 Execut Blvd,Suite 750, Rockville, MD 20852 USA.
RP Hirst, K (reprint author), George Washington Univ, Biostat Ctr, 6110 Execut Blvd,Suite 750, Rockville, MD 20852 USA.
EM today@bsc.gwu.edu
OI Trief, Paula/0000-0002-2827-5722
FU NIDDK; NIH Office of the Director [U01-DK61212, U01-DK61230,
   U01-DK61239, U01-DK61242, U01-DK61254]; National Center for Research
   Resources (NCRR) General Clinical Research Centers Program
   [M01-RR00036]; NCRR Clinical and Translational Science Awards
   [UL1-RR024992]; Becton; Dickinson and Company; Bristol-Myers Squibb; Eli
   Lilly and Company; GlaxoSmithKline; LifeScan, Inc.; Pfizer; Sanofi
   Aventis
FX This work was completed with funding from NIDDK and the NIH Office of
   the Director through grants U01-DK61212, U01-DK61230, U01-DK61239,
   U01-DK61242, and U01-DK61254; the National Center for Research Resources
   (NCRR) General Clinical Research Centers Program through grants
   M01-RR00036 (Washington University School of Medicine); and from the
   NCRR Clinical and Translational Science Awards through grants
   UL1-RR024992 (Washington University in St. Louis). The content is solely
   the responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. The NIDDK project
   office was involved in all aspects of the study, including: design and
   conduct; collection, management, analysis, and interpretation of the
   data; review and approval of the manuscript; and decision to submit the
   manuscript for publication.; The TODAY Study Group thanks the following
   companies for donations in support of the study's efforts: Becton,
   Dickinson and Company; Bristol-Myers Squibb; Eli Lilly and Company;
   GlaxoSmithKline; LifeScan, Inc.; Pfizer; Sanofi Aventis. We also
   gratefully acknowledge the participation and guidance of the American
   Indian partners associated with the clinical center located at the
   University of Oklahoma Health Sciences Center, including members of the
   Absentee Shawnee Tribe, Cherokee Nation, Chickasaw Nation, Choctaw
   Nation of Oklahoma, and Oklahoma City Area Indian Health Service; the
   opinions expressed in this paper are those of the authors and do not
   necessarily reflect the views of the respective Tribal and Indian Health
   Service Institution Review Boards or their members.
CR [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001
   Beck AT, 1996, BECK DEPRESSION INVE
   Dever M, 2016, J PEDIATR NURS, V31, P117, DOI 10.1016/j.pedn.2015.11.004
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Kovacs M., 1992, CHILDRENS DEPRESSION
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017
   Pinhas-Hamiel O, 2007, PEDIATR DIABETES, V8, P16, DOI 10.1111/j.1399-5448.2007.00330.x
   Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JAN
PY 2018
VL 135
BP 85
EP 87
DI 10.1016/j.diabres.2017.11.008
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FU4ON
UT WOS:000423832500014
PM 29146120
DA 2019-01-08
ER

PT J
AU Lin, CE
   Chen, LF
   Chou, PH
   Chung, CH
AF Lin, Ching-En
   Chen, Li-Fen
   Chou, Po-Han
   Chung, Chi-Hsiang
TI Increased prevalence and risk of anxiety disorders in adults with
   tinnitus: A population-based study in Taiwan
SO GENERAL HOSPITAL PSYCHIATRY
LA English
DT Article
DE Anxiety disorder; Tinnitus; Prevalence; National Health Insurance
   Research Database; NHIRD
ID MAJOR DEPRESSIVE DISORDER; DORSAL COCHLEAR NUCLEUS; PSYCHIATRIC
   COMORBIDITIES; MENIERES-DISEASE; MENTAL-DISORDERS; PANIC DISORDER;
   HEARING-LOSS; FOLLOW-UP; ASSOCIATION; STROKE
AB Objective: Tinnitus is a common disorder that may cause psychological distress and anxiety. The aim of this study was to investigate the association between anxiety disorders (ADs) and tinnitus in a large population.
   Method: We conducted a cross-sectional study using the National Health Insurance Research Database in Taiwan. Study subjects included 14,772 patients with tinnitus and 709,963 people in the general population who sought treatment in 2005. Distributions in ADs, age, sex, and medical comorbidities were compared between groups using chi-squared tests. Multivariate logistic regression models adjusted for age, sex, and medical comorbidities were used to analyze the association between tinnitus and ADs.
   Results: Prevalence of ADs in tinnitus and general population groups was 3.9% and 1.5%, respectively, and this difference was significant (P < 0.001). Diabetes mellitus, hypertension, hyperlipidemia, concussion or head injury, Meniere's disease, sensorineural hearing impairment, renal disease, coronary artery disease, and cerebrovascular disease were significantly more prevalent in the tinnitus group (all P-values < 0.001). Multivariate logistic regression model demonstrated that patients with tinnitus were significantly associated with increased risk of ADs (adjusted OR = 1.99; 95% CI = 1.81-2.19; P < 0.001).
   Conclusion: Because the risk of ADs was significantly higher in patients with tinnitus than in the general population, physicians should be aware of the importance of psychological factors in tinnitus management.
C1 [Lin, Ching-En] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, 289 Jianguo Rd, New Taipei, Taiwan.
   [Lin, Ching-En] Tzu Chi Univ, Sch Med, Hualien, Taiwan.
   [Chen, Li-Fen] Triserv Gen Hosp, Penghu Branch, Taipei, Taiwan.
   [Chen, Li-Fen] Natl Def Med Ctr, Sch Med, Taipei, Taiwan.
   [Chou, Po-Han] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.
   [Chou, Po-Han] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.
   [Chou, Po-Han] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.
   [Chung, Chi-Hsiang] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.
   [Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.
RP Lin, CE (reprint author), Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, 289 Jianguo Rd, New Taipei, Taiwan.; Chou, PH (reprint author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.
EM chingen_lin@tzuchi.com.tw; pchou@hsph.havard.edu
CR Alonso J, 2007, J CLIN PSYCHIAT, V68, P3
   Asnaani A, 2010, J NERV MENT DIS, V198, P551, DOI 10.1097/NMD.0b013e3181ea169f
   Ayerbe L, 2013, AGE AGEING
   Baigi A, 2011, EAR HEARING, V32, P787, DOI 10.1097/AUD.0b013e31822229bd
   Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8
   Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107
   Borghi C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-80
   Chen YH, 2010, CAN J PSYCHIAT, V55, P43, DOI 10.1177/070674371005500107
   Cheng T- M., 2010, SIX COUNTRIES SIX RE, P171
   Chien IC, 2013, J PSYCHOSOM RES, V75, P270, DOI 10.1016/j.jpsychores.2013.06.003
   Chou PH, 2014, PSYCHOSOMATICS, V55, P155, DOI 10.1016/j.psym.2013.06.003
   Chou PH, 2013, EUR CHILD ADOLES PSY, V22, P301, DOI 10.1007/s00787-012-0369-3
   Chou PH, 2012, PSYCHOSOMATICS, V53, P463, DOI 10.1016/j.psym.2012.03.007
   Chung SD, 2015, EUR ARCH OTO-RHINO-L, V272, P2673, DOI 10.1007/s00405-014-3235-8
   Cukor D, 2008, CLIN J AM SOC NEPHRO, V3, P1752, DOI 10.2215/CJN.01120308
   Dortland AKBV, 2010, ACTA PSYCHIAT SCAND, V122, P30, DOI 10.1111/j.1600-0447.2010.01565.x
   Figueiredo RR, 2017, MENIERES DIS TINNITU
   Fure B, 2006, INT J GERIATR PSYCH, V21, P382, DOI 10.1002/gps.1482
   Furukawa M, 2013, ACTA OTO-LARYNGOL, V133, P584, DOI 10.3109/00016489.2012.759274
   Granjeiro RC, 2013, OTOLARYNG HEAD NECK, V148, P658, DOI 10.1177/0194599812473554
   Gul AI, 2015, NEUROPSYCH DIS TREAT, V11, P413, DOI 10.2147/NDT.S77786
   Hafeez F, 1999, J Stroke Cerebrovasc Dis, V8, P217, DOI 10.1016/S1052-3057(99)80070-6
   Ho CH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005269
   Hoffman HJ, 2004, TINNITUS THEORY MANA, P16
   Holmes S, 2008, REV CLIN GERONTOL, V18, P269, DOI 10.1017/S0959259809002883
   Huang CJ, 2011, GEN HOSP PSYCHIAT, V33, P8, DOI 10.1016/j.genhosppsych.2010.10.008
   Jacques D, 2013, PSYCHIAT DANUB, V25, pS102
   Jalessi Maryam, 2013, Acta Med Iran, V51, P886
   Kaltenbach JA, 2006, HEARING RES, V216, P224, DOI 10.1016/j.heares.2006.01.002
   Kaltenbach JA, 2008, AM J AUDIOL, V17, pS148, DOI 10.1044/1059-0889(2008/08-0004)
   Kanzaki J, 2015, ACTA OTO-LARYNGOL, V135, P447, DOI 10.3109/00016489.2014.990581
   Kazmierczak H, 2001, Int Tinnitus J, V7, P54
   Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127578
   Liao SC, 2012, PSYCHOL MED, V42, P1227, DOI 10.1017/S0033291711002364
   Minen MT, 2014, J NEUROL NEUROSUR PS, V85, P1138, DOI 10.1136/jnnp-2013-307339
   Olafiranye O, 2011, Mind Brain, V2, P32
   Pattyn T, 2015, HEARING RES, V30, pe11
   Preljevic VT, 2013, GEN HOSP PSYCHIAT, V35, P619, DOI 10.1016/j.genhosppsych.2013.05.006
   Schmieder RE, 2013, J HYPERTENS, V31, P610, DOI 10.1097/HJH.0b013e32835d6e53
   Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124
   Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015
   Shargorodsky M, 2003, AM J HYPERTENS, V16, P617, DOI 10.1016/S0895-7061(03)00911-7
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   SPSS I, 2013, IBM SPSS STAT 22
   Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038
   Strumila R, 2017, PSYCHIAT QUART, P1
   Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355
   Tyler R. S., 1983, SPEECH HEAR DISORD, V48, P150, DOI [10.1044/jshd.4802.150, DOI 10.1044/JSHD.4802.150]
   VANREEDT DAK, 2013, PSYCHONEUROENDOCRINO, V38, P209, DOI DOI 10.1016/J.PSYNEUEN.2012.05.017
   Wallhausser-Franke E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034583
NR 50
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0163-8343
EI 1873-7714
J9 GEN HOSP PSYCHIAT
JI Gen. Hosp. Psych.
PD JAN-FEB
PY 2018
VL 50
BP 131
EP 136
DI 10.1016/j.genhosppsych.2017.11.006
PG 6
WC Psychiatry
SC Psychiatry
GA FV1RU
UT WOS:000424343000020
PM 29190572
DA 2019-01-08
ER

PT J
AU Fisher, L
   Hessler, D
   Polonsky, W
   Strycker, L
   Guzman, S
   Bowyer, V
   Blumer, I
   Masharani, U
AF Fisher, Lawrence
   Hessler, Danielle
   Polonsky, William
   Strycker, Lisa
   Guzman, Susan
   Bowyer, Vicky
   Blumer, Ian
   Masharani, Umesh
TI Emotion regulation contributes to the development of diabetes distress
   among adults with type 1 diabetes
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Diabetes; Emotion management; Diabetes distress
ID SELF-REGULATION; DEPRESSION; INTERVENTION; ILLNESS; QUESTIONNAIRE;
   MINDFULNESS; VALIDATION; MANAGEMENT; SYMPTOMS; VALIDITY
AB Objective: To demonstrate how maladaptive emotion regulation (ER) can lead to diabetes distress (DD), with subsequent effects on management and metabolic outcomes among adults with type 1 diabetes.
   Methods: Data are based on pre-intervention assessment for a random controlled trial to reduce DD. Patients were recruited in California, Oregon, Arizona and Ontario, Canada. After screening and consent, patients completed an online assessment and released their most recent laboratory HbA1C. Structural equation modeling was used to define an ER measurement model and test for significant pathways.
   Results: Three ER mechanisms combined into a single construct: emotion processing, non-judgment of emotions, non-reactivity to emotions. Models indicated a significant pathway from ER and cognitions to DD to disease management to metabolic control.
   Conclusions: As hypothesized, the three ER mechanisms formed a single, coherent ER construct. Patients with poor ER reported high DD; and high DD was linked to poor diabetes management and poor metabolic control.
   Practice implications: Identifying both the level of DD and the ER mechanisms that lead to high DD should be explored in clinical settings. Helping T1Ds to become more aware, less judgmental and less reactive behaviorally to what they feel about diabetes and its management may reduce DD. Crown Copyright (c) 2017 Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Fisher, Lawrence; Hessler, Danielle; Bowyer, Vicky] UCSF, Dept Family & Community Med, San Francisco, CA USA.
   [Polonsky, William] Univ Calif San Diego, Dept Psychiat, Behav Diabet Inst, San Diego, CA USA.
   [Strycker, Lisa] Oregon Res Inst, Eugene, OR 97403 USA.
   [Guzman, Susan] Behav Diabet Inst, San Diego, CA USA.
   [Blumer, Ian] Charles H Best Diabet Ctr, Whitby, ON, Canada.
   [Masharani, Umesh] UCSF, Dept Med, San Francisco, CA USA.
RP Fisher, L (reprint author), UCSF, Box 0900, San Francisco, CA 94143 USA.
EM larry.fisher@ucsf.edu; Danielle.hessler@ucsf.edu;
   whp@behavioraldiabetes.org; lisas@ori.org; sguzman1@san.rr.com;
   vicky.bowyer@ucsf.edu; ian@ianblumer.com; umesh.masharani@ucsf.edu
FU National Institutes of Health [RO1DK094863, R18DK108039]
FX This work was supported by the National Institutes of Health
   RO1DK094863, R18DK108039.
CR Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504
   Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003
   Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0
   Berking M, 2012, J BEHAV THER EXP PSY, V43, P931, DOI 10.1016/j.jbtep.2011.09.009
   Blair C, 2008, DEV PSYCHOPATHOL, V20, P899, DOI 10.1017/S0954579408000436
   Diedrich A., 2016, PSYCHOL PSYCHOTHER-T, V89, P1
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2015, DIABETIC MED
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, PATIENT EDUC COUNS, V86, P372, DOI 10.1016/j.pec.2011.07.002
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94
   Gross J. J, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.'1080/00140130600971135
   Gu J, 2015, CLIN PSYCHOL REV, V37, P1, DOI 10.1016/j.cpr.2015.01.006
   Guendelman S, 2017, FRONT PSYCHOL, V8, P1, DOI 10.3389/fpsyg.2017.00220
   Jazaieri H, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0531-3
   Joormann J, 2016, BEHAV RES THER, V86, P35, DOI 10.1016/j.brat.2016.07.007
   Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008
   Lansing AH, 2014, J PEDIATR PSYCHOL, V39, P1091, DOI 10.1093/jpepsy/jsu067
   Maes S, 2005, APPL PSYCHOL-INT REV, V54, P267, DOI 10.1111/j.1464-0597.2005.00210.x
   Miller W. R., 2013, MOTIVATIONAL INTERVI
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Neff KD, 2007, J RES PERS, V41, P139, DOI 10.1016/j.jrp.2006.03.004
   Nigg JT, 2017, J CHILD PSYCHOL PSYC, V58, P361, DOI 10.1111/jcpp.12675
   Quoidbach J, 2015, PSYCHOL BULL, V141, P655, DOI 10.1037/a0038648
   Stanton AL, 2000, J PERS SOC PSYCHOL, V78, P1150, DOI 10.1037//0022-3514.78.6.1150
   Stanton K, 2016, J ABNORM PSYCHOL, V125, P960, DOI 10.1037/abn0000208
   Sturt J., 2016, INT DIABETIC NURS, V12, P40
   Tang T. S., 2011, PEER LEADER TRAINING
   Tsjii S., 2012, DIABETIC MED, V29, P1451
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 35
TC 2
Z9 2
U1 2
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD JAN
PY 2018
VL 101
IS 1
BP 124
EP 131
DI 10.1016/j.pec.2017.06.036
PG 8
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA FT9LT
UT WOS:000423474300018
PM 28739179
DA 2019-01-08
ER

PT J
AU Goldberg, A
   Ebraheem, Z
   Freiberg, C
   Ferarro, R
   Chai, S
   Gottfried, OD
AF Goldberg, Alon
   Ebraheem, Zaheera
   Freiberg, Cynthia
   Ferarro, Rachel
   Chai, Sharon
   Gottfried, Orna Dally
TI Sweet and Sensitive: Sensory Processing Sensitivity and Type 1 Diabetes
SO JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES
LA English
DT Article
DE Sensory processing sensitivity; Autoimmune disease; Type 1 diabetes
ID PSYCHOLOGICAL DISTRESS; BEHAVIORAL-INHIBITION; AUTOIMMUNE-DISEASES;
   GLYCEMIC CONTROL; STRESS; DEPRESSION; CHILDHOOD; DISORDER; CHILDREN;
   ANXIETY
AB Objective: Sensory processing sensitivity (SPS) is a recently proposed construct that refers to a genetically influenced tendency to more strongly and deeply process a variety of information. The aim of the study was to examine whether SPS is associated with an autoimmune disease such as type 1 diabetes (T1D).
   Research design and methods: Participants were 128 adolescents (62 with T1D and 66 comparisons [without autoimmune disease]) and their parents who completed the Highly Sensitive Person Scale (HSPS) questionnaire, assessing SPS level.
   Results: Higher levels of SPS were found in the T1D group than in the comparison group. Furthermore, the frequency of SPS trait was significantly higher in the T1D group than in the comparison group.
   Conclusions: T1D is associated with higher levels of SPS. Hence, there is a need to develop interventions, treatments, and care focused on the needs of T1D patients with SPS temperament, aimed at better treatment adherence. Furthermore, longitudinal research is needed to evaluate whether SPS is a risk factor in the development of T1D. (c) 2017 Elsevier Inc. All rights reserved.
C1 [Goldberg, Alon] Tel Hai Coll, Dept Educ, Upper Galilee, Israel.
   [Ebraheem, Zaheera; Ferarro, Rachel] Ziv Hosp, Ctr Juvenile Diabet & Pediat Endocrinol, Safed, Israel.
   [Ebraheem, Zaheera; Ferarro, Rachel] Ziv Hosp, Pediat Outpatient Clin, Safed, Israel.
   [Freiberg, Cynthia] Bar Ilan Univ, Ziv Hosp, Sch Med, Safed, Israel.
   [Chai, Sharon] Tel Hai Coll, Dept Field Practice, Upper Galilee, Israel.
   [Gottfried, Orna Dally] Bar Ilan Univ, Ziv Hosp, Sch Med, Ctr Juvenile Diabet & Pediat Endocrinol, Safed, Israel.
   [Gottfried, Orna Dally] Bar Ilan Univ, Ziv Hosp, Sch Med, Pediat Outpatient Clin, Safed, Israel.
RP Goldberg, A (reprint author), Tel Hai Coll, Dept Educ, Upper Galilee, Israel.
EM goldbergim@gmail.com
CR Acevedo BP, 2014, BRAIN BEHAV, V4, P580, DOI 10.1002/brb3.242
   Aron A, 2010, SOC COGN AFFECT NEUR, V5, P219, DOI 10.1093/scan/nsq028
   Aron EN, 2012, PERS SOC PSYCHOL REV, V16, P262, DOI 10.1177/1088868311434213
   Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345
   Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419
   Benham G, 2006, PERS INDIV DIFFER, V40, P1433, DOI 10.1016/j.paid.2005.11.021
   CARTER WR, 1987, DIABETOLOGIA, V30, P674
   CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319
   Compas BE, 2012, ANNU REV CLIN PSYCHO, V8, P455, DOI 10.1146/annurev-clinpsy-032511-143108
   Cunningham NR, 2011, J PEDIATR PSYCHOL, V36, P196, DOI 10.1093/jpepsy/jsq071
   Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608
   Eysenck H. J, 1991, HDB PERSONALITY, P244
   Gray J. A., 1991, EXPLORATIONS TEMPERA, P105, DOI DOI 10.1007/978-1-4899-0643-4_8
   Hartman S, 2016, FAM PROCESS, V55, P700, DOI 10.1111/famp.12161
   HAWKINS NG, 1957, AM REV TUBERC PULM, V75, P768
   Herrmann M, 2000, RHEUM DIS CLIN N AM, V26, P737, DOI 10.1016/S0889-857X(05)70167-8
   Hofherr SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017076
   Homberg JR, 2016, NEUROSCI BIOBEHAV R, V71, P472, DOI 10.1016/j.neubiorev.2016.09.029
   Jerome EM, 2005, PERS INDIV DIFFER, V38, P1341, DOI 10.1016/j.paid.2004.08.016
   Johnson SL, 2003, J PSYCHOPATHOL BEHAV, V25, P25, DOI 10.1023/A:1022247919288
   Juvenile Diabetes Research Foundation, 2016, TYP 1 DIAB FACTS
   Kagan J, 1997, CHILD DEV, V68, P139, DOI 10.2307/1131931
   Kinnealey M, 1999, OCCUPATIONAL THERAPY, V6, P195, DOI DOI 10.1002/OTI.97
   Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P682, DOI 10.1097/01-chi.0000161645.98022.35
   Liss M, 2005, PERS INDIV DIFFER, V39, P1429, DOI 10.1016/j.paid.2005.05.007
   Liss M, 2008, PERS INDIV DIFFER, V45, P255, DOI 10.1016/j.paid.2008.04.009
   Luyckx K, 2010, DIABETES CARE, V33, P1424, DOI 10.2337/dc09-2017
   Meyer B, 2000, J PERS DISORD, V14, P233, DOI 10.1521/pedi.2000.14.3.233
   Neal JA, 2002, BRIT J CLIN PSYCHOL, V41, P361, DOI 10.1348/014466502760387489
   Persson LO, 1999, SCAND J RHEUMATOL, V28, P137
   Pluess M, 2015, CHILD DEV PERSPECT, V9, P138, DOI 10.1111/cdep.12120
   Pluess M, 2013, PSYCHOL BULL, V139, P901, DOI 10.1037/a0030196
   Renzaho AMN, 2014, EUR J PUBLIC HEALTH, V24, P57, DOI 10.1093/eurpub/ckt007
   Shepshelovich D, 2006, LUPUS, V15, P183, DOI 10.1191/0961203306lu2274rr
   SHOENFELD Y, 1989, IMMUNOL TODAY, V10, P123, DOI 10.1016/0167-5699(89)90245-4
   Shoenfeld Y, 2008, ISR MED ASSOC J, V10, P8
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Stojanovich L, 2008, AUTOIMMUN REV, V7, P209, DOI 10.1016/j.autrev.2007.11.007
   Stojanovich L, 2010, AUTOIMMUN REV, V9, pA271, DOI 10.1016/j.autrev.2009.11.014
   Storch EA, 2004, CLIN PEDIATR, V43, P467, DOI 10.1177/000992280404300508
   Wolfe F, 1999, SCAND J RHEUMATOL, V28, P131, DOI 10.1080/03009749950154185
NR 41
TC 1
Z9 1
U1 4
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0882-5963
J9 J PEDIATR NURS
JI J. Pediatr. Nurs.
PD JAN-FEB
PY 2018
VL 38
BP E35
EP E38
DI 10.1016/j.pedn.2017.10.015
PG 4
WC Nursing; Pediatrics
SC Nursing; Pediatrics
GA FT3GJ
UT WOS:000423035000008
PM 29100650
DA 2019-01-08
ER

PT J
AU Deschenes, SS
   Burns, RJ
   Schmitz, N
AF Deschenes, Sonya S.
   Burns, Rachel J.
   Schmitz, Norbert
TI Trajectories of anxiety symptoms and associations with incident
   cardiovascular disease in adults with type 2 diabetes
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Anxiety; Cardiovascular disease; Latent trajectories; Type 2 diabetes
ID COMORBID ANXIETY; RISK; DEPRESSION; DISORDERS; INDIVIDUALS; MORTALITY;
   DISTRESS; MELLITUS; OUTCOMES; HEALTH
AB Background: Trajectories of anxiety symptoms in people with type 2 diabetes (T2D) and their associations with diabetes health outcomes have not been investigated. This study examined latent longitudinal trajectories of anxiety symptoms in adults with T2D and their associations with incident cardiovascular disease (CVD).
   Methods: Data were from the Evaluation of Diabetes Treatment Study, a community-based cohort study of adults aged 40-76 years with T2D. Anxiety and CVD were assessed by self-report at baseline and at four annual follow-up assessments. N = 832 participants without cardiovascular disease at baseline and 12-month follow-up were included in the present study. Group-based trajectories of anxiety at baseline, 12-month follow-up, and 24 month follow-up were modelled using latent class growth modeling. Associations between anxiety trajectories and CVD reported at 24-, 36-, or 48-month follow-ups were examined with logistic regression analysis adjusted for sociodemographic and lifestyle characteristics.
   Results: Four distinct anxiety trajectories were identified, reflecting chronically low (39.4%), chronically moderate-low (47.4%), chronically moderate-high (11.1%), and chronically high (2.2%) anxiety. The likelihood of CVD was greater for the chronically moderate-low (OR = 2.23, 95% CI = 1.36-3.66), chronically moderate high (OR = 3.05, 95% CI = 1.54-6.02), and chronically high (OR = 3.61, 95% CI = 1.09-12.00) anxiety trajectory groups compared to the chronically low anxiety group.
   Conclusion: The identified latent trajectories reflected three groups with chronic courses of anxiety symptoms at different levels of severity and one group with chronically low levels of anxiety. Chronic anxiety, even at subthreshold levels, was associated with an increased risk of CVD among people with T2D.
C1 [Deschenes, Sonya S.; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada.
   [Deschenes, Sonya S.; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, 6875 Boul Lasalle,Frank B Common Pavil,F2117-2, Montreal, PQ H4H 1R3, Canada.
   [Burns, Rachel J.] Carleton Univ, Dept Psychol, Ottawa, ON, Canada.
   [Schmitz, Norbert] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
RP Deschenes, SS (reprint author), Douglas Mental Hlth Univ Inst, 6875 Boul Lasalle,Frank B Common Pavil,F2117-2, Montreal, PQ H4H 1R3, Canada.
EM sonya.deschenes@mail.mcgill.ca
RI Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323
FU Canadian Institutes of Health Research [MOP-106514]; Canadian Institutes
   of Health Research
FX This work was supported by an Operating Grant from the Canadian
   Institutes of Health Research (MOP-106514). Sonya Deschenes is supported
   by a fellowship from the Canadian Institutes of Health Research.
CR Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011
   Bruce DG, 2016, DEPRESS ANXIETY, V33, P960, DOI 10.1002/da.22523
   Chandola T, 2006, BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80
   Deschenes SS, 2016, J DIABETES, V8, P854, DOI 10.1111/1753-0407.12368
   Edwards LE, 2012, J PSYCHOSOM RES, V73, P418, DOI 10.1016/j.jpsychores.2012.09.018
   Enders CK, 2011, REHABIL PSYCHOL, V56, P267, DOI 10.1037/a0025579
   Fincke BG, 2005, J AMBUL CARE MANAG, V28, P262
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Hasan SS, 2016, PUBLIC HEALTH, V130, P21, DOI 10.1016/j.puhe.2015.07.022
   Holmes S.E., 2017, INT J GERIATR PSYCHI
   Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005
   Jones BL, 2013, SOCIOL METHOD RES, V42, P608, DOI 10.1177/0049124113503141
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Licht CMM, 2009, PSYCHOSOM MED, V71, P508, DOI 10.1097/PSY.0b013e3181a292a6
   Lipscombe C, 2015, J AFFECT DISORDERS, V188, P160, DOI 10.1016/j.jad.2015.08.003
   Baena-Diez JM, 2016, DIABETES CARE, V39, P1987, DOI 10.2337/dc16-0614
   Nagin D, 2005, GROUP BASED MODELING
   Naicker K, 2017, DIABETES CARE, V40, P352, DOI 10.2337/dc16-2018
   Park J, 2014, HEALTH REP, V25, P12
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Schmitz N, 2014, DIABETES CARE, V37, P970, DOI 10.2337/dc13-1832
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Smith KJ, 2013, PSYCHOSOMATICS, V54, P35, DOI 10.1016/j.psym.2012.08.002
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Teesson M, 2011, AUST NZ J PSYCHIAT, V45, P939, DOI 10.3109/00048674.2011.614590
   Tsai MT, 2016, J AFFECT DISORDERS, V202, P178, DOI 10.1016/j.jad.2016.03.060
   Whitworth SR, 2017, DIABETIC MED, V34, P1108, DOI 10.1111/dme.13372
   World Health Organization, 2000, WHO TECHN REP SER
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 30
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD JAN
PY 2018
VL 104
BP 95
EP 100
DI 10.1016/j.jpsychores.2017.11.015
PG 6
WC Psychiatry
SC Psychiatry
GA FT2XW
UT WOS:000423010300014
PM 29275792
DA 2019-01-08
ER

PT J
AU Cohen, A
   Dias, A
   Azariah, F
   Krishna, RN
   Sequeira, M
   Abraham, S
   Cuijpers, P
   Morse, JQ
   Reynolds, CF
   Patel, V
AF Cohen, Alex
   Dias, Amit
   Azariah, Fredric
   Krishna, Revathi N.
   Sequeira, Miriam
   Abraham, Sherin
   Cuijpers, Pim
   Morse, Jennifer Q.
   Reynolds, Charles F., III
   Patel, Vikram
TI Aging and well-being in Goa, India: a qualitative study
SO AGING & MENTAL HEALTH
LA English
DT Article
DE Late-life depression; prevention; Goa; India; qualitative research
ID LATE-LIFE DEPRESSION; PRIMARY-CARE; OLDER-ADULTS; EARLY INTERVENTION;
   SUICIDAL IDEATION; MAJOR DEPRESSION; MENTAL-HEALTH; PREVENTION; TRIAL;
   INEQUALITIES
AB Objectives: The population of India is aging rapidly. This demographic shift brings with it a host of challenges to the health and well-being of older adults, including the increased prevalence of non-communicable diseases, among them depressive disorders. In this paper, we report on qualitative research intended to inform the development of a locally acceptable and appropriate intervention to improve the well-being of older adults in Goa, India and, specifically, to prevent late-life depression.Method: Semi-structured interviews with 20 individuals, aged 60years and older, attending two primary care clinics in Goa, India. Transcripts were reviewed to identify emerging themes, a coding scheme was developed and thematic analyses were conducted.Results: Analyses of the interview transcripts revealed the following key themes: (1) notions of old age tended to be negative and there were widespread fears of becoming widowed or incapacitated; (2) the most frequently reported health conditions were joint pain, diabetes and heart disease; (3) emotional distress was described using the terms tension', stress', worry' and thinking'; (4) family issues often involved financial matters, difficult relationships with daughters-in-law and conflicted feelings about living with the family or independently; (5) other than a pension scheme, participants did not know of community resources available to older adults.Conclusions: Our findings are in general agreement with those of previous research, and with our experiences of working with older adults in Pittsburgh and the Netherlands. This research will inform the development of an intervention to prevent depression in older adults in Goa.
C1 [Cohen, Alex; Patel, Vikram] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London, England.
   [Dias, Amit] Goa Med Coll, Dept Prevent & Social Med, Bambolim, Goa, India.
   [Dias, Amit; Azariah, Fredric; Krishna, Revathi N.; Sequeira, Miriam; Abraham, Sherin; Patel, Vikram] Sangath, Socorro, Goa, India.
   [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Morse, Jennifer Q.] Chatham Univ, Sch Hlth Sci, Grad Psychol Programs, Pittsburgh, PA USA.
   [Reynolds, Charles F., III] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA.
   [Reynolds, Charles F., III] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA.
RP Cohen, A (reprint author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London, England.
EM alex.cohen@lshtm.ac.uk
FU US National Institute of Mental Health [R34MH096997, P30MH90333]
FX This research was supported by funding from the US National Institute of
   Mental Health [R34MH096997 and P30MH90333].
CR Census of India, 2011, POP REL COMM
   Charlson FJ, 2016, LANCET, V388, P376, DOI 10.1016/S0140-6736(16)30590-6
   Cuijpers P, 2014, AM J PSYCHIAT, V171, P453, DOI 10.1176/appi.ajp.2013.13030325
   Diniz BS, 2014, DEPRESS ANXIETY, V31, P787, DOI 10.1002/da.22226
   Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307
   Gilman SE, 2013, SOC PSYCH PSYCH EPID, V48, P59, DOI 10.1007/s00127-012-0575-9
   Gilman SE, 2013, EPIDEMIOLOGY, V24, P14, DOI 10.1097/EDE.0b013e3182762403
   Grover S., 2015, J GERIATRIC MENTAL H, V2, P4, DOI DOI 10.4103/2348-9995.161376
   Haringsma R, 2006, INT PSYCHOGERIATR, V18, P307, DOI 10.1017/S104461020500253X
   He W, 2012, SHADES GRAY CROSS CO
   Institute of Applied Manpower Research Planning Commission Government of India, 2011, IND HUM DEV REP 2011
   Jimenez DE, 2015, AM J GERIAT PSYCHIAT, V23, P548, DOI 10.1016/j.jagp.2014.08.001
   Lakshmi Vijayakumar, 2010, Indian Journal of Psychiatry, V52, P291, DOI 10.4103/0019-5545.69255
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Okereke Olivia I, 2013, Focus (Am Psychiatr Publ), V11, P22
   Onrust S, 2010, DEATH STUD, V34, P777, DOI 10.1080/07481181003761252
   Patel V, 2001, PSYCHOL MED, V31, P29, DOI 10.1017/S0033291799003098
   Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9
   Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5
   Reynolds CF, 2014, PSYCHIAT SERV, V65, P765, DOI 10.1176/appi.ps.201300216
   Reynolds CF, 2012, ANNU REV PUBL HEALTH, V33, P123, DOI 10.1146/annurev-publhealth-031811-124544
   SARTORIUS N, 1993, ARCH GEN PSYCHIAT, V50, P819
   Schoevers RA, 2006, AM J PSYCHIAT, V163, P1611, DOI 10.1176/appi.ajp.163.9.1611
   Smits F, 2008, AM J GERIAT PSYCHIAT, V16, P444, DOI 10.1097/JGP.0b013e3181662ab6
   Stahl ST, 2014, AM J PSYCHIAT, V171, P499, DOI 10.1176/appi.ajp.2013.13101373
   United States Census Bureau, 2016, INT DAT BAS
   van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175
   van't Veer-Tazelaar PJ, 2011, AM J GERIAT PSYCHIAT, V19, P230, DOI 10.1097/JGP.0b013e3181faee4d
   van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555
   Vaz NC, 2011, NATL MED J INDIA, V24, P16
   Zegwaard MI, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-103
NR 31
TC 1
Z9 1
U1 1
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1360-7863
EI 1364-6915
J9 AGING MENT HEALTH
JI Aging Ment. Health
PY 2018
VL 22
IS 2
BP 168
EP 174
DI 10.1080/13607863.2016.1236239
PG 7
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA FS5ZD
UT WOS:000419876800002
PM 27689842
OA Green Published
DA 2019-01-08
ER

PT J
AU Gonzalez-Cantu, A
   Mireles-Zavala, L
   Rodriguez-Romo, A
   Olavide-Aguilar, E
   De la Garza-Hernandez, NE
   Romero-Ibarguengoitia, ME
AF Gonzalez-Cantu, Arnulfo
   Mireles-Zavala, Leonor
   Rodriguez-Romo, Anabel
   Olavide-Aguilar, Elizabeth
   Eloisa De la Garza-Hernandez, Natalia
   Elena Romero-Ibarguengoitia, Maria
TI Eating behaviors and emotional distress are predicted by treatment and
   adverse outcome in patients with type 2 diabetes
SO PSYCHOLOGY HEALTH & MEDICINE
LA English
DT Article
DE Depression; anxiety; type 2 diabetes; eating behaviors
ID PSYCHOMETRIC PROPERTIES; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL;
   DEPRESSION; PREVALENCE; POPULATION; ADULTS; ASSOCIATION; ANXIETY;
   MORTALITY
AB Depression and anxiety are hightly prevalent among patients with Type 2 Diabetes (T2D), however not commonly related to outcomes, treatment and comorbidities. Eating behaviors could also have an implication. To evaluate the relation between mood and eating behaviors with demographic, physical, treatment, biochemical profiles and chronic comorbidities in T2D we conducted this exploratory cross sectional study in a population from Mexico. Hospital Anxiety and Depression Scale and the Three Factor Eating Questionnaire Revised 21 (TFEQ-R21) were correlated with age, gender, blood pressure, treatment and comorbidities (nephropathy, neuropathy, retinopathy and cardiopathy). Multi-linear regression models and 2(k) factorial analyses were conducted. Sixty-one patients (31 male) 55years old (SD 13) with at least 5years of T2D were included. Anxiety correlated with depression (r=0.25, p<0.05). Gender (women) (std B 0.026, p<0.001), insulin therapy (std B 0.3, p=0.11), systolic blood pressure (std B 0.263, p=0.02) and cardiovascular disease (std B 0.232, p=0.035) predicted depression. Insulin therapy had a positive effect in cognitive restraint. (std B 0.32, p=0.001). Age (std B 0.37, p=0.003) and systolic blood pressure (std B 0.237, p=0.048) predicted positively emotional eating (not previously published). 2(k) factorial analyses proved additive interaction between complications and insulin therapy with depression. This study supports the relation between mood disorders and eating behaviors with demographic, physical, treatment, biochemical profiles and chronic comorbidities in T2D and the additive interaction between factors and mood disorders.
C1 [Gonzalez-Cantu, Arnulfo] Ctr Invest Matemat CIMAT, Internal Med, Nuevo Leon, Mexico.
   [Mireles-Zavala, Leonor; Rodriguez-Romo, Anabel; Olavide-Aguilar, Elizabeth] Inst Seguridad & Serv Sociales Trabajadores Estad, Internal Med, Nuevo Leon, Mexico.
   [Elena Romero-Ibarguengoitia, Maria] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Res Dept, Mexico City, DF, Mexico.
RP Romero-Ibarguengoitia, ME (reprint author), Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Res Dept, Mexico City, DF, Mexico.
EM elenaromero83@gmail.com
CR Alegre-Diaz J, 2016, NEW ENGL J MED, V375, P1961, DOI 10.1056/NEJMoa1605368
   Alonso-Moran E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-769
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001
   Berge LI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127161
   Bhat SK, 2017, J HYPERTENS, V35, P1983, DOI [10.1097/HJH.0000000000001410, 10.1097/hjh.0000000000001410]
   Bruce DG, 2016, DEPRESS ANXIETY, V33, P960, DOI 10.1002/da.22523
   Cappelleri JC, 2009, INT J OBESITY, V33, P611, DOI 10.1038/ijo.2009.74
   Cerrelli F, 2005, Eat Weight Disord, V10, P251
   Chaudhary Rupesh, 2017, Indian J Psychol Med, V39, P342, DOI 10.4103/IJPSYM.IJPSYM_35_17
   COLIZZI V, 1979, ANNALES DIMMUNOLOGIE, V100, P659
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Dziemidok P, 2016, PSYCHIATR POL, V50, P407, DOI 10.12740/PP/OnlineFirst/42352
   Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c
   Heckbert SR, 2010, J GEN INTERN MED, V25, P524, DOI 10.1007/s11606-010-1272-6
   Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Jauregui-Lobera I, 2014, NUTRIENTS, V6, P5619, DOI 10.3390/nu6125619
   Jimenez-Cruz A., 2015, NUTR HOSP, V31, P2775, DOI [10.3305/nh.2015.31.6.8845, DOI 10.3305/NH.2015.31.6.8845]
   Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442
   KATON WTHE, 2008, THE AMERICAN JOURNAL, V121, pS8, DOI DOI 10.1016/J.AMJMED.2008.09.008
   Khullar S, 2016, COMMUNITY MENT HLT J, V52, P479, DOI 10.1007/s10597-015-9985-y
   Kimbro LB, 2012, INT J ENDOCRINOL, DOI 10.1155/2012/747460
   Lerman I, 2009, ENDOCR PRACT, V15, P41, DOI 10.4158/EP.15.1.41
   Loffler A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133977
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nichols GA, 2003, DIABETES CARE, V26, P744, DOI 10.2337/diacare.26.3.744
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Rawshani A, 2017, NEW ENGL J MED, V376, P1407, DOI 10.1056/NEJMoa1608664
   Sacco WP, 2007, HEALTH PSYCHOL, V26, P693, DOI 10.1037/0278-6133.26.6.693
   Shah BM, 2015, J DIABETES COMPLICAT, V29, P794, DOI 10.1016/j.jdiacomp.2015.04.009
   Takasaki Keiko, 2016, BMJ Open Diabetes Res Care, V4, pe000310, DOI 10.1136/bmjdrc-2016-000310
   Trento M, 2014, J ENDOCRINOL INVEST, V37, P79, DOI 10.1007/s40618-013-0028-7
   Trento M, 2012, ACTA DIABETOL, V49, P199, DOI 10.1007/s00592-011-0275-z
   Wahlqvist ML, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-150
   Wang LC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1567-y
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Yu MK, 2013, NEPHRON CLIN PRACT, V124, P106, DOI 10.1159/000355551
NR 38
TC 0
Z9 0
U1 3
U2 8
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1354-8506
EI 1465-3966
J9 PSYCHOL HEALTH MED
JI Psychol. Health Med.
PY 2018
VL 23
IS 3
BP 325
EP 336
DI 10.1080/13548506.2017.1363897
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FS6KK
UT WOS:000419906100009
PM 28871828
DA 2019-01-08
ER

PT J
AU Van Gampelaere, C
   Vervoort, T
   Luyckx, K
   De Paepe, A
   Van Aken, S
   Goubert, L
AF Van Gampelaere, Cynthia
   Vervoort, Tine
   Luyckx, Koen
   De Paepe, Annick
   Van Aken, Sara
   Goubert, Liesbet
TI Maternal distress in the context of their child's type 1 diabetes:
   exploring the role of adaptive maternal emotion regulation on child
   outcomes
SO PSYCHOLOGY HEALTH & MEDICINE
LA English
DT Article
DE Pediatric psychology; diabetes mellitus type 1; parental distress;
   cognitive emotion regulation
ID PEDIATRIC PARENTING STRESS; DEPRESSIVE SYMPTOMS; YOUNG-CHILDREN;
   PSYCHOLOGICAL DISTRESS; PSYCHIATRIC-DISORDERS; INTERVENTION TARGETS;
   HOSPITAL ANXIETY; DUTCH VERSION; DOWN-SYNDROME; CHRONIC PAIN
AB Parents of children with Type 1 diabetes (T1D) experience high levels of distress, which may negatively impact child functioning. However, little is known about mechanisms that may buffer the adverse impact of parental distress. The current study explored the possible buffering role of maternal adaptive cognitive emotion regulation (CER) for the relationship between maternal distress and child psychological functioning. Forty-three children with T1D (8-15years) completed measures assessing trait anxiety and depressive symptoms. Their mothers reported on general distress, illness-related parenting stress, and adaptive CER. Maternal illness-related parenting stress (but not general distress) was significantly associated with child psychological functioning. No buffering role for maternal adaptive CER was observed. As the current study is rather preliminary, future research using other methods to examine maternal adaptive CER, and examining other parental variables that may buffer against the negative impact of parental distress is warranted.
C1 [Van Gampelaere, Cynthia; Vervoort, Tine; De Paepe, Annick; Goubert, Liesbet] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.
   [Luyckx, Koen] Univ Leuven, Dept Sch Psychol & Dev Context, Leuven, Belgium.
   [Van Aken, Sara] Univ Hosp Ghent, Dept Pediat, Ghent, Belgium.
RP Van Gampelaere, C (reprint author), Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.
EM Cynthia.VanGampelaere@UGent.be
OI Goubert, Liesbet/0000-0002-7657-5148; De Paepe,
   Annick/0000-0002-9366-3692
FU Fund for Scientific Research - Flanders (FWO, Belgium) [11V9518N]
FX This work was supported by Fund for Scientific Research - Flanders (FWO,
   Belgium), grant number 11V9518N.
CR Aktar E, 2014, J CHILD PSYCHOL PSYC, V55, P77, DOI 10.1111/jcpp.12121
   Bakker F. C., 1989, MANUAL DUTCH VERSION
   Butwicka A, 2016, PSYCHOSOMATICS, V57, P185, DOI 10.1016/j.psym.2015.11.001
   Cameron LD, 2007, J PEDIATR PSYCHOL, V32, P733, DOI 10.1093/jpepsy/jslo53
   Chow ET, 2016, J PAIN, V17, P729, DOI 10.1016/j.jpain.2016.02.014
   Cline GD, 2011, J CLIN PSYCHOL MED S, V18, P416, DOI 10.1007/s10880-011-9266-z
   Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004
   Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6
   Geisbusch CM, 2015, MONATSSCHR KINDERH, V163, P696, DOI 10.1007/s00112-015-3357-0
   Glidden LM, 2006, J INTELL DISABIL RES, V50, P949, DOI 10.1111/j.1365-2788.2006.00929.x
   Goubert L., 2013, OXFORD TXB PEDIAT PA, P95
   Haugstvedt A, 2010, DIABETIC MED, V27, P72, DOI 10.1111/j.1464-5491.2009.02867.x
   Helgeson VS, 2012, J PEDIATR PSYCHOL, V37, P467, DOI 10.1093/jpepsy/jsr110
   Hilliard ME, 2011, CHILD CARE HLTH DEV, V37, P224, DOI 10.1111/j.1365-2214.2010.01162.x
   Hilliard ME, 2015, J PEDIATR PSYCHOL, V40, P835, DOI 10.1093/jpepsy/jsv072
   Hoorelbeke K, 2016, J AFFECT DISORDERS, V195, P96, DOI 10.1016/j.jad.2016.02.001
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Jaser SS, 2014, MATERN CHILD HLTH J, V18, P101, DOI 10.1007/s10995-013-1239-4
   KOVACS M, 1981, ACTA PAEDOPSYCHIATR, V46, P305
   Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36
   Kraaij V, 2015, J CLIN PSYCHOL MED S, V22, P45, DOI 10.1007/s10880-015-9417-8
   Kraaij V, 2012, J ADOLESCENCE, V35, P1593, DOI 10.1016/j.adolescence.2012.06.007
   Lowes L, 2005, J ADV NURS, V50, P253, DOI 10.1111/j.1365-2648.2005.03388.x
   Mullins LL, 2004, CHILD HEALTH CARE, V33, P21, DOI 10.1207/s15326888chc3301_2
   Nieuwesteeg AM, 2016, EUR J PEDIATR, V175, P329, DOI 10.1007/s00431-015-2631-4
   Norizan A, 2010, J INTELL DISABIL RES, V54, P992, DOI 10.1111/j.1365-2788.2010.01324.x
   Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8
   Patton SR, 2008, J CLIN PSYCHOL MED S, V15, P252, DOI 10.1007/s10880-008-9123-x
   Patton SR, 2011, J CLIN PSYCHOL MED S, V18, P345, DOI 10.1007/s10880-011-9256-1
   Roelofs J, 2010, PSYCHOL ASSESSMENT, V22, P866, DOI 10.1037/a0020593
   Sieberg CB, 2011, J PEDIATR PSYCHOL, V36, P1043, DOI 10.1093/jpepsy/jsr043
   Spielberger C. D., 1973, STATE TRAIT ANXIETY
   Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Streisand R, 2008, PATIENT EDUC COUNS, V73, P333, DOI 10.1016/j.pec.2008.06.014
   van der Veek SMC, 2009, INTELLECT DEV DISAB, V47, P295, DOI 10.1352/1934-9556-47.4.295
   Vanderhasselt MA, 2014, J BEHAV THER EXP PSY, V45, P291, DOI 10.1016/j.jbtep.2014.01.003
   Vervoort T, 2011, PSYCHOL REP, V109, P879, DOI 10.2466/07.15.16.21.PR0.109.6.879-895
   Vrijmoet-Wiersma CMJ, 2010, PSYCHO-ONCOLOGY, V19, P368, DOI 10.1002/pon.1571
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Williams LB, 2009, DIABETIC MED, V26, P908, DOI 10.1111/j.1464-5491.2009.02794.x
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 42
TC 0
Z9 0
U1 2
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1354-8506
EI 1465-3966
J9 PSYCHOL HEALTH MED
JI Psychol. Health Med.
PY 2018
VL 23
IS 3
BP 337
EP 346
DI 10.1080/13548506.2017.1394475
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FS6KK
UT WOS:000419906100010
PM 29057673
DA 2019-01-08
ER

PT J
AU Dieter, T
   Lauerer, J
AF Dieter, Taylor
   Lauerer, Joy
TI Depression or Diabetes Distress?
SO PERSPECTIVES IN PSYCHIATRIC CARE
LA English
DT Article
AB PURPOSEThe purpose of this paper is to summarize the need for improved recognition of depression versus diabetes distress and discuss recommendations for appropriate screening tools.
   PRACTICE IMPLICATIONSIn order to assess for both depression and diabetes distress, a combined approach of using both the WHO-5 and the PAID-20 is a simple and reliable method for detecting depression and assisting in determining the focus of specific aspects of diabetes management based on the patient's reported depressive symptoms.
   CONCLUSIONSRoutine screening for depression and diabetes distress is essential for improving quality of life and reducing healthcare cost in patients with diabetes.
C1 [Dieter, Taylor] Med Univ South Carolina, Charleston, SC 29425 USA.
   [Lauerer, Joy] Med Univ South Carolina, Sch Nursing, Charleston, SC USA.
RP Dieter, T (reprint author), Med Univ South Carolina, Charleston, SC 29425 USA.
EM coatest@musc.edu
CR American Diabetes Association, 2016, DIABETES, V39, pS13, DOI DOI 10.2337/DC16-S005
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Balhara Yatan Pal Singh, 2011, Indian J Endocrinol Metab, V15, P274, DOI 10.4103/2230-8210.85579
   Chew BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152095
   Esbitt S., 2013, SCREENING DEPRESSION, V2, P22, DOI 10. 1007/978-0-85729-751-8_2
   Hermanns N, 2013, PRIM CARE DIABETES, V7, P1, DOI 10.1016/j.pcd.2012.11.002
   Holt RIG, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0491-3
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Novo Nordisk, 2006, PROBL AR DIAB QUEST
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Sarkar Siddharth, 2014, Indian J Endocrinol Metab, V18, P468, DOI 10.4103/2230-8210.137487
   Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585
   Twist K, 2013, PSYCHOSOM MED, V75, P791, DOI 10.1097/PSY.0b013e3182a2b108
   World Health Organization, 2016, DEPRESSION
   World Health Organization, 2016, 10 FACTS DIAB
   Wu Shu-Fang Vivienne, 2014, Depress Res Treat, V2014, P239490, DOI 10.1155/2014/239490
NR 16
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0031-5990
EI 1744-6163
J9 PERSPECT PSYCHIATR C
JI Perspect. Psychiatr. Care
PD JAN
PY 2018
VL 54
IS 1
BP 84
EP 87
DI 10.1111/ppc.12203
PG 4
WC Nursing; Psychiatry
SC Nursing; Psychiatry
GA FS4DW
UT WOS:000419738700012
PM 28090642
DA 2019-01-08
ER

PT J
AU Milaniak, I
   Wilczek-Ruzyczka, E
   Wierzbicki, K
   Piatek, J
   Kedziora, A
   Przybylowski, P
AF Milaniak, Irena
   Wilczek-Ruzyczka, Ewa
   Wierzbicki, Karol
   Piatek, Jacek
   Kedziora, Anna
   Przybylowski, Piotr
TI The effect of clinical variables on distress and depressive symptoms
   among heart transplant recipients
SO HEART & LUNG
LA English
DT Article
DE Comorbidities; Stress; Depression; Heart transplantation
ID QUALITY-OF-LIFE; INTERNATIONAL SOCIETY; ORGAN-TRANSPLANTATION;
   PSYCHIATRIC ASPECTS; SHORT-FORM; PREVALENCE; METAANALYSIS; INVENTORY;
   VALIDITY; RISK
AB Background: Heart transplantation (HTx) is the standard treatment for end-stage cardiomyopathy and coronary artery disease. Although major improvements have been made in the prevention and treatment of acute graft rejection, comorbidities still limit the long-term survival of heart transplant recipients. The risk of poor outcome, such us major health status aggravation and death, can stimulate the occurrence of depression and stress in this population. The aim of this study was to determine the impact of comorbidities on depressive symptoms and distress among heart transplant recipients.
   Material/methods: The sample included 131 HTx recipients from one site. Data were collected during a follow-up in-hospital appointment, using the questionnaires assessing depression (Beck Depression Inventory Short Form) and stress (Perceived Stress Scale-10). Statistical analyses included descriptive statistics, Pearson correlations, t-tests, and generalized linear models.
   Results: Study patients were 75.6% (n = 97) male, 100% (n = 131) Caucasian, 74% (n = 89) married, with the mean age of 54 years at time of heart transplantation. Nearly half of the participants (40.5%) presented depression symptoms at the time of evaluation. Severe stress was observed in 30% of individuals. Depression symptoms and severe distress were more commonly observed in patients with many comorbidities, requiring multiple drug therapy, and high NYHA score. Moreover, in a multivariate logistic regression, depression and high distress level occurrence were predicted by the following independent factors: cardiac allograft vasculopathy, cancer, diabetes, higher NYHA score, and comorbidities.
   Conclusions: The prevalence of depression and severe distress is common among heart transplant recipients. Patients with many comorbidities are at higher risk of psychological indisposition. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Milaniak, Irena; Wierzbicki, Karol; Kedziora, Anna] John Paul 2 Hosp, Cardiovasc Surg & Transplantol Dept, Ul Pradnicka 80, PL-31202 Krakow, Poland.
   [Milaniak, Irena] State Higher Vocat Sch, Inst Hlth, Nowysacz, Poland.
   [Milaniak, Irena] Andrzej FryczModrzewski Krakow Univ, Fac Hlth & Med Sci, Krakow, Poland.
   [Wilczek-Ruzyczka, Ewa] Andrzej FryczModrzewski Krakow Univ, Fac Psychol & Humanities, Krakow, Poland.
   [Wierzbicki, Karol] Jagiellonian Univ, Med Coll, Krakow, Poland.
   [Przybylowski, Piotr] Jagiellonian Univ, Med Coll, Chair Gen Surg 1, Krakow, Poland.
   [Przybylowski, Piotr] Silesian Ctr Heart Dis, Zabrze, Poland.
   [Piatek, Jacek] Jagiellonian Univ, John Paul Hosp 2, Coll Med, Dept Cardiovasc Surg & Transplantol, Krakow, Poland.
RP Milaniak, I (reprint author), John Paul 2 Hosp, Cardiovasc Surg & Transplantol Dept, Ul Pradnicka 80, PL-31202 Krakow, Poland.
EM irenem@poczta.onet.pl
OI , IRENA/0000-0002-6649-7545
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   CHIBNALL JT, 1994, CLIN J PAIN, V10, P261, DOI 10.1097/00002508-199412000-00004
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Cristiano YH, 2012, TRANSPLANT J AUSTRAL, V21, P16
   Dew MA, 2001, PSYCHOSOMATICS, V42, P300, DOI 10.1176/appi.psy.42.4.300
   DiMartini A, 2008, CRIT CARE CLIN, V24, P949, DOI 10.1016/j.ccc.2008.05.001
   Dobbels F, 2004, TRANSPLANT INT, V17, P424, DOI 10.1007/s00147-004-0732-5
   Furlanetto LM, 2005, J AFFECT DISORDERS, V86, P87, DOI 10.1016/j.jad.2004.12.011
   HOUSE RM, 1988, JAMA-J AM MED ASSOC, V260, P535, DOI 10.1001/jama.260.4.535
   Hsu RB, 2005, J FORMOS MED ASSOC, V104, P482
   Jalowiec A, 2007, J CARDIOPULM REHABIL, V27, P24
   Kugler C, 2014, J PSYCHOSOM RES, V77, P128, DOI 10.1016/j.jpsychores.2014.06.007
   Lund LH, 2016, J HEART LUNG TRANSPL, V35, P1158, DOI 10.1016/j.healun.2016.08.017
   Mehra MR, 2010, J HEART LUNG TRANSPL, V29, P717, DOI 10.1016/j.healun.2010.05.017
   Moskalewicz J, 2012, EPIDEMIOLOGIA ZABURZ
   Palmer S, 2013, KIDNEY INT, V84, P179, DOI 10.1038/ki.2013.77
   Ravven S, 2013, HARVARD REV PSYCHIAT, V21, P59, DOI 10.1097/HRP.0b013e31828a3612
   Reyes CJ, 2004, J HEART LUNG TRANSPL, V23, P614, DOI 10.1016/S1053-2498(03)00310-3
   Riley A. A., 2009, JNP-J NURSE PRACT, V5, P523, DOI DOI 10.1016/J.NURPRA.2009.03.020
   Ruzyczka EW, 2011, TRANSPL P, V43, P3076, DOI 10.1016/j.transproceed.2011.07.012
   Rybarczyk B, 2007, REHABIL PSYCHOL, V52, P206, DOI 10.1037/0090-5550.52.2.206
   Stiefel P, 2013, J HEALTH PSYCHOL, V18, P680, DOI 10.1177/1359105312454909
NR 22
TC 0
Z9 0
U1 1
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0147-9563
EI 1527-3288
J9 HEART LUNG
JI Heart Lung
PD JAN-FEB
PY 2018
VL 47
IS 1
BP 68
EP 72
DI 10.1016/j.hrtlng.2017.09.008
PG 5
WC Cardiac & Cardiovascular Systems; Nursing; Respiratory System
SC Cardiovascular System & Cardiology; Nursing; Respiratory System
GA FQ2TD
UT WOS:000418210000010
PM 29103660
DA 2019-01-08
ER

PT J
AU Martinez, K
   Lockhart, S
   Davies, M
   Lindsay, JR
   Dempster, M
AF Martinez, Kelly
   Lockhart, Sam
   Davies, Mark
   Lindsay, John R.
   Dempster, Martin
TI Diabetes distress, illness perceptions and glycaemic control in adults
   with type 2 diabetes
SO PSYCHOLOGY HEALTH & MEDICINE
LA English
DT Article
DE Type 2 diabetes; distress; glycaemic control; illness perceptions
ID INTERVENTION; SCALE
AB The emotional distress associated with adjusting to and living with diabetes has been termed diabetes distress. Diabetes distress is associated with glycaemic control but interventions to reduce diabetes distress have failed to consistently improve diabetes control. Various illness perceptions have previously been linked with both diabetes distress and glycaemic control but interrelationships between these features have not been previously investigated. We hypothesised that illness perceptions mediate the relationship between diabetes distress and glycaemia. Participants with type 2 diabetes attending diabetes outpatient clinics (n=84) provided demographic and clinical information and completed the Diabetes Distress Scale-17 and the Brief Illness Perceptions Questionnaire. Using regression analysis we demonstrated that the illness perceptions of personal control, regimen-related distress, socioeconomic status and insulin use were significant contributors in the final model predicting HbA(1c). Higher levels of personal control were associated with better glycaemic control. Conversely, regimen-related distress was associated with hyperglycaemia. Mediation analyses showed that the relationship between regimen-related distress and HbA(1c) was mediated by personal control. Our work suggests that psychological interventions designed to reduce diabetes distress may be more efficacious in improving glycaemic control if they address an individual's perception of personal control.
C1 [Martinez, Kelly; Dempster, Martin] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.
   [Lockhart, Sam] Queens Univ Belfast, Sch Med Dent & Biol Sci, Belfast, Antrim, North Ireland.
   [Davies, Mark] Belfast City Hosp, Dept Psychol, Belfast, Antrim, North Ireland.
   [Lindsay, John R.] Mater Hosp, Belfast, Antrim, North Ireland.
   [Lockhart, Sam] Altnagelvin Hosp, Derry, North Ireland.
RP Lockhart, S (reprint author), Queens Univ Belfast, Sch Med Dent & Biol Sci, Belfast, Antrim, North Ireland.; Lockhart, S (reprint author), Altnagelvin Hosp, Derry, North Ireland.
EM slockhart05@doctors.org.uk
OI Lockhart, Sam/0000-0003-2092-4350; , Martin/0000-0001-9499-3186
CR BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Berry E, 2015, POSTGRAD MED J, V91, P278, DOI 10.1136/postgradmedj-2014-133017
   Bridges HA, 2016, J HEALTH PSYCHOL, V21, P1956, DOI 10.1177/1359105315569094
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Keogh KM, 2011, AM J MANAG CARE, V17, P105
   Leventhal H., 2003, SELF REGULATION HLTH, V1, P42
   Mc Sharry J, 2011, DIABETIC MED, V28, P1300, DOI 10.1111/j.1464-5491.2011.03298.x
   Northern Ireland Statistics and Research Agency, 2010, NO IR MULT DEPR MEAS
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Strandberg RB, 2015, DIABETIC MED, V32, P1304, DOI 10.1111/dme.12781
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   World Health Organization, 2016, GLOB REP DIAB
NR 19
TC 3
Z9 3
U1 3
U2 6
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1354-8506
EI 1465-3966
J9 PSYCHOL HEALTH MED
JI Psychol. Health Med.
PY 2018
VL 23
IS 2
BP 171
EP 177
DI 10.1080/13548506.2017.1339892
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FP4RU
UT WOS:000417604900005
PM 28610449
OA Green Published
DA 2019-01-08
ER

PT J
AU Al-Yateem, N
   Rossiter, R
   Robb, W
   Ahmad, A
   Elhalik, MS
   Albloshi, S
   Slewa-Younan, S
AF Al-Yateem, Nabeel
   Rossiter, Rachel
   Robb, Walter
   Ahmad, Alaa
   Elhalik, Mahmoud Saleh
   Albloshi, Sumaya
   Slewa-Younan, Shameran
TI Mental health literacy among pediatric hospital staff in the United Arab
   Emirates
SO BMC PSYCHIATRY
LA English
DT Article
DE Cross-cultural care; Early intervention; Health literacy; Health
   promotion; Mental health; Professional practice gaps; Pediatric care
ID ADULT SERVICES; BELIEFS; PROFESSIONALS; PSYCHIATRISTS; TRANSITION;
   DISORDERS; KNOWLEDGE; ILLNESS
AB Background: In the United Arab Emirates (UAE) 35% of the population are aged 0-24 years. A significant proportion of these young people are living with chronic conditions (e.g., asthma, type 1 diabetes, cardiac conditions, and geneticallytransmitted conditions such as thalassemia and cystic fibrosis). This group has increased vulnerability to developmental delays and mental health problems, and is increasingly coming to the attention of service providers in mainstream schools, primary healthcare centers, and pediatric hospitals. Despite the government directing attention to improving the mental health of the UAE population, there is concern that mental health services are not growing at the rate needed to meet the mental health needs of children and young people with chronic conditions.
   Method: A cross sectional survey design was used to determine the mental health literacy of nurses and other healthcare professionals working with children with chronic illnesses. Participants completed a culturally-adapted mental health literacy questionnaire comprising three vignettes of fictional characters meeting diagnostic criteria for posttraumatic stress disorder, psychosis, and depression with suicidal thoughts. Participants also completed the Kessler Psychological Distress Scale (K10).
   Results: Participants were 317 healthcare professionals from across the UAE. The majority were nurses. Correct identification of the diagnosis for each vignette was limited, with the highest level of accuracy achieved for the psychosis vignette (n = 113, 54.3%). Accurate identification of appropriate evidence-based interventions was also limited. K10 scores indicated 40% of participants had moderate to high levels of psychological distress.
   Conclusions: These findings are concerning and provide important data to inform the development of undergraduate and continuing education programs for nurses. The K10 scores suggest healthcare professionals are under considerable stress, highlighting the need to support healthcare professionals who experience multiple psychosocial stressors.
C1 [Al-Yateem, Nabeel] Univ Sharjah, Dept Nursing, Coll Hlth Sci, POB 27272, Sharjah, U Arab Emirates.
   [Al-Yateem, Nabeel] Charles Sturt Univ, Sch Nursing Midwifery & Indigenous Hlth, Fac Sci, Orange, NSW, Australia.
   [Al-Yateem, Nabeel] Univ Sharjah, RIMHS, Sharjah, U Arab Emirates.
   [Rossiter, Rachel] Charles Sturt Univ, Sch Nursing Midwifery & Indigenous Hlth, Orange, NSW, Australia.
   [Robb, Walter] Griffith Univ, Menzies Hlth Inst, Brisbane, Qld, Australia.
   [Ahmad, Alaa] SKMC, Abu Dhabi, U Arab Emirates.
   [Elhalik, Mahmoud Saleh] Latifa Hosp, Dept & Neonatol Unit, Dubai, U Arab Emirates.
   [Albloshi, Sumaya] Minist Hlth & Prevent, Dubai, U Arab Emirates.
   [Slewa-Younan, Shameran] Western Sydney Univ, Ctr Hlth Res, Sch Med, Mental Hlth, Sydney, NSW, Australia.
   [Slewa-Younan, Shameran] Univ Melbourne, Ctr Mental Hlth, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.
RP Al-Yateem, N (reprint author), Univ Sharjah, Dept Nursing, Coll Hlth Sci, POB 27272, Sharjah, U Arab Emirates.; Al-Yateem, N (reprint author), Charles Sturt Univ, Sch Nursing Midwifery & Indigenous Hlth, Fac Sci, Orange, NSW, Australia.; Al-Yateem, N (reprint author), Univ Sharjah, RIMHS, Sharjah, U Arab Emirates.
EM Nalyateem@sharjah.ac.ae
OI Rossiter, Rachel/0000-0002-6147-861X
FU AL Jalila Foundation, United Arab Emirates
FX This research was funded by AL Jalila Foundation, United Arab Emirates.
   The funding body had no role in the design of the study, the collection,
   analysis, and interpretation of data, and in writing the manuscript.
CR Al-Darmaki FR, 2015, PSYCHOL INT NEWSL, V2015, P1
   Al-Yateem N, 2016, J SPEC PEDIATR NURS, P1
   Al-Yateem Nabeel, 2013, Nurs Child Young People, V25, P29, DOI 10.7748/ncyp2013.06.25.5.29.e175
   Al-Yateem Nabeel, 2012, Br J Nurs, V21, P850
   Annunziato RA, 2007, PEDIATR TRANSPLANT, V11, P608, DOI 10.1111/j.1399-3046.2007.00689.x
   Annunziato RA, 2013, J PEDIATR-US, V163, P1628, DOI 10.1016/j.jpeds.2013.07.031
   Chikaodiri AN, 2010, MENT ILLN, V2, DOI 10.4081/mi.2010.e1
   CIA, 2016, WORLD FACTBOOK
   Coyne I., 2015, AN INT J PUBLIC PART, V18, P796
   Ekra EMR, 2012, INT J QUAL STUD HEAL, V7, DOI 10.3402/qhw.v7i0.18694
   Ghaffar A, 2010, SUMMARY NATL PRIORIT
   Jones WR, 2013, EUR EAT DISORD REV, V21, P84, DOI 10.1002/erv.2155
   Jorm AF, 1997, MED J AUSTRALIA, V166, P182
   Jorm AF, 2012, AM PSYCHOL, V67, P231, DOI 10.1037/a0025957
   Liu W, 2011, INT NURS REV, V58, P361, DOI 10.1111/j.1466-7657.2011.00883.x
   MacCarthy Dan, 2013, Perm J, V17, P14, DOI 10.7812/TPP/13-033
   Maindonald J., 2006, DATA ANAL GRAPHICS U
   Mayer CH, 2014, INT REV PSYCHIATR, V26, P265, DOI 10.3109/09540261.2013.866076
   Mohamed-Kaloo Z, 2014, SAMJ S AFR MED J, V104, P350, DOI [10.7196/SAMJ.7863, 10.7196/samj.7863]
   Morgan AJ, 2014, AUST NZ J PSYCHIAT, V48, P442, DOI 10.1177/0004867413512686
   Reavley NJ, 2012, EARLY INTERV PSYCHIA, V6, P45, DOI 10.1111/j.1751-7893.2011.00314.x
   Rutishauser C, 2011, EUR J PEDIATR, V170, P865, DOI 10.1007/s00431-010-1364-7
   Sayed MA, 2015, INT J EMERG MENT HLT, V17, P661
   Schumacher K, 2010, TRANSITIONS THEORY M
   Slewa-Younan S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0320-x
   Sulaiman-Hill Cheryl Mr, 2010, BMC Res Notes, V3, P237, DOI 10.1186/1756-0500-3-237
   The American Psychiatric Association, 1995, DIAGN STAT MAN MENT
   US-UAE Business Council, 2014, UAE HEALTHC SECT
NR 28
TC 0
Z9 0
U1 2
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD DEC 8
PY 2017
VL 17
AR 390
DI 10.1186/s12888-017-1556-z
PG 12
WC Psychiatry
SC Psychiatry
GA FP3SK
UT WOS:000417537900001
PM 29216871
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Tanaka, R
   Trief, PM
   Scales, K
   Weinstock, RS
AF Tanaka, Rika
   Trief, Paula M.
   Scales, Kasandra
   Weinstock, Ruth S.
TI "Miscarried Helping" in Adults With Type 2 Diabetes: Helping for Health
   Inventory-Couples
SO FAMILIES SYSTEMS & HEALTH
LA English
DT Article
DE miscarried helping; Type 2 diabetes; marital satisfaction
ID RELATIONSHIP SATISFACTION; MARITAL RELATIONSHIP; SUPPORT;
   OVERPROTECTION; RELIABILITY; ADJUSTMENT; ADHERENCE; DISTRESS; PARTNERS;
   VALIDITY
AB Objective: Family-partner support has been associated with better blood glucose control, self-care adherence, and quality of life in adult patients with Type 2 diabetes (T2D). "Miscarried helping" has described interactions between youth with chronic diseases and their family members, in which a family member is helpful, but efforts are perceived as negative by the patient. Miscarried helping has not, however, been measured in adults with diabetes, which was the purpose of our study. Method: Data from a randomized clinical trial (n = 268) were analyzed to establish the psychometric properties and correlates of an adaptation of a measure of miscarried helping developed in pediatric populations, for use with adults with T2D. Results: The Helping for Health Inventory-Couples Version (HHI-C) was found to have three underlying factors and demonstrated adequate internal consistency across time (alpha at baseline = .86, 4 months = .87, 8 months = .86, and 12 months = .83) and showed high test-retest reliability (p <.01) over a 12-month period. Convergent validity was partially supported, because baseline HHI-C was positively associated with maladaptive conflict resolution strategies (p = .03) and negatively associated with adaptive conflict resolution strategies (p = .04) and diabetes knowledge (p < .01). The HHI-C did not correlate with body mass index or hemoglobin A1c, a measure of glycemic control. The HHI-C was positively associated with diabetes distress (p < .01) and depressive symptoms (p = .01). Discussion: This study is the 1st known reporting of the psychometric properties of a measure of miscarried helping for adults with T2D. This valid measure of miscarried helping could be useful in future studies evaluating novel, relationship-based approaches to assist adults with T2D in disease management.
C1 [Tanaka, Rika] Toronto Gen Hosp, Behav Cardiol Res Unit, 585 Univ Ave,6N-618, Toronto, ON M5G 2C2, Canada.
   [Tanaka, Rika] Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   [Trief, Paula M.; Scales, Kasandra] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.
   [Weinstock, Ruth S.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
RP Tanaka, R (reprint author), Toronto Gen Hosp, Behav Cardiol Res Unit, 585 Univ Ave,6N-618, Toronto, ON M5G 2C2, Canada.
EM rika.tanaka@uhnresearch.ca
FU National Institutes of Health (NIH) [1R18DK080867-01A2]
FX This research was supported in part by National Institutes of Health
   (NIH) Grant 1R18DK080867-01A2. We would like to acknowledge our
   colleagues whose work on the Diabetes Support Project provided the data
   for this article, including Lawrence Fisher and Danielle Hessler of
   University of California, San Francisco; Jonathan Sandberg of Brigham
   Young University; and Jacqueline Dimmock and Patricia Forken of SUNY
   Upstate Medical University. We would also like to thank Michael Harris
   of Oregon Health Sciences University for graciously granting permission
   for us to adapt the Helping for Health Inventory to use with couples.
   Finally, we thank the patients and partners who generously shared their
   time, thoughts, and feelings with us and the diabetes educators who
   provided skilled interventions. The content is solely the responsibility
   of the authors and does not necessarily reflect the official views of
   the National Institutes of Health or its affiliates.
CR ANDERSON BJ, 1991, ADVANCES IN CHILD HEALTH PSYCHOLOGY, P167
   BUSBY DM, 1995, J MARITAL FAM THER, V21, P289, DOI 10.1111/j.1752-0606.1995.tb00163.x
   COYNE JC, 1991, J PERS SOC PSYCHOL, V61, P404, DOI 10.1037/0022-3514.61.3.404
   Davidson N. K., 2012, DEALING DIABETES POL
   DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073
   Fales JL, 2014, J PEDIATR PSYCHOL, V39, P427, DOI 10.1093/jpepsy/jsu003
   Fisher L, 2000, J FAM PRACTICE, V49, P561
   Fisher L., 2006, FAMILIES SYSTEMS HLT, V24, P373, DOI DOI 10.1037/1091-7527.24.4.373
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   GARAYSEVILA ME, 1995, J DIABETES COMPLICAT, V9, P81, DOI 10.1016/1056-8727(94)00021-F
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Hagedoorn M, 2006, DIABETIC MED, V23, P271, DOI 10.1111/j.1464-5491.2006.01794.x
   Harris M. A., 2008, FAMILIES SYSTEMS HLT, V26, P393, DOI [10.1037/a0014232, DOI 10.1037/A0014232]
   Hinnen C, 2008, BRIT J HEALTH PSYCH, V13, P737, DOI 10.1348/135910707X252431
   International Diabetes Federation, 2017, IDF DIAB ATL
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Kuijer RG, 2000, J SOC CLIN PSYCHOL, V19, P256, DOI 10.1521/jscp.2000.19.2.256
   KURDEK LA, 1994, J MARRIAGE FAM, V56, P705, DOI 10.2307/352880
   LOCKE HJ, 1959, MARRIAGE FAM LIVING, V21, P251, DOI 10.2307/348022
   NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602
   Nunnally J. C., 1978, PSYCHOMETRIC THEORY
   Polonsky W.H., 1995, DIABETES FORECAST, V12, P21
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rook KS, 2011, J SOC PERS RELAT, V28, P772, DOI 10.1177/0265407510391335
   Roszler J., 2016, COPING DIABETES POLI
   SCHMALING K, 2000, PSYCHOL COUPLES ILLN
   Schokker MC, 2010, J FAM PSYCHOL, V24, P578, DOI 10.1037/a0021009
   Trief PM, 2017, J HEALTH PSYCHOL, V22, P446, DOI 10.1177/1359105315605654
   Trief PM, 2016, DIABETES CARE, V39, P2165, DOI 10.2337/dc16-0035
   Trief PM, 2011, TRANSL BEHAV MED, V1, P461, DOI 10.1007/s13142-011-0057-8
   Trief PM, 2004, ANN BEHAV MED, V27, P148, DOI 10.1207/s15324796abm2703_2
   Trief PM, 2002, DIABETES CARE, V25, P1154, DOI 10.2337/diacare.25.7.1154
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   Turner RC, 1998, LANCET, V352, P837
   Yang W, 2013, DIABETES CARE, V36, P1033, DOI DOI 10.2337/DC12-2625
   Yang Y, 2013, DIABETES CARE, V36, P978, DOI 10.2337/dc12-0227
NR 36
TC 0
Z9 0
U1 1
U2 2
PU EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA
SN 1091-7527
EI 1939-0602
J9 FAM SYST HEALTH
JI Fam. Syst. Health
PD DEC
PY 2017
VL 35
IS 4
BP 409
EP 419
DI 10.1037/fsh0000289
PG 11
WC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
SC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
GA FR0OR
UT WOS:000418763000003
PM 29283609
DA 2019-01-08
ER

PT J
AU Mora, P
   Buskirk, A
   Lyden, M
   Parkin, CG
   Borsa, L
   Petersen, B
AF Mora, Pablo
   Buskirk, Ann
   Lyden, Maureen
   Parkin, Christopher G.
   Borsa, Lena
   Petersen, Bettina
TI Use of a Novel, Remotely Connected Diabetes Management System Is
   Associated with Increased Treatment Satisfaction, Reduced Diabetes
   Distress, and Improved Glycemic Control in Individuals with
   Insulin-Treated Diabetes: First Results from the Personal Diabetes
   Management Study
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
DE mHealth; Type 1 diabetes; Type 2 diabetes; Insulin; Multiple daily
   injections; Self-monitoring of blood glucose
ID BLOOD-GLUCOSE; CLINICAL INERTIA; MEDICATION NONADHERENCE; PEOPLE;
   IMPACT; CARE; HOSPITALIZATION; MORTALITY; MELLITUS; THERAPY
AB Background: The ability to automatically transfer data to clinicians and receive timely guidance in therapy adjustments through remote and in-office consults can positively impact patients' perceptions about quality of care, which is positively associated with clinical outcomes. We assessed the impact of using the Accu-Chek Connect diabetes management system on treatment satisfaction, diabetes distress, and glycemic control in adults with type 1 diabetes and insulin-treated type 2 diabetes. Subjects and Methods: This 6-month, prospective, multicenter, single-arm study assessed the impact of using the system on treatment satisfaction and glycemic control among 87 adults with insulin-treated diabetes (multiple daily insulin injections and basal only), with 8.8%1.6% glycated hemoglobin (HbA1c) at baseline. The Diabetes Treatment Satisfaction Questionnaire-status (DTSQs) and Diabetes Distress Scale (DDS) were administered at baseline, and the Diabetes Treatment Satisfaction Questionnaire-change (DTSQc) and DDS at 6 months. Changes in HbA1c, average blood glucose (BG), and other metrics were also assessed. Results: Improvements in DTSQc scores were observed at 6 months with a total mean (standard deviation) score of 14.3 +/- 5.1. Significant reductions in total mean DDS scores from baseline to 6 months were also observed, from 2.0 +/- 0.8 to 1.7 +/- 0.7, P<0.0001. A significant reduction in regimen-related distress was notable, from moderate distress (2.4 +/- 1.0) to not distressed (1.9 +/- 0.9), P<0.0001). Significant reductions in mean HbA1c (-0.9 +/- 1.6, P<0.0001) and mean BG (-24.8 +/- 50.8, P<0.0001) were observed. Conclusions: Use of the Accu-Chek Connect diabetes management system is associated with increased treatment satisfaction and improved glycemic control among individuals with insulin-treated diabetes. NCT02600845 (www.clinicaltrials.gov).
C1 [Mora, Pablo] Dallas Diabet Res Ctr, Dallas, TX USA.
   [Buskirk, Ann; Borsa, Lena] Roche Diabet Care, Indianapolis, IN USA.
   [Lyden, Maureen] Biostat Int, Tampa, FL USA.
   [Parkin, Christopher G.] CGParkin Commun Inc, 932 Vista Lago Way, Boulder City, NV 89005 USA.
   [Petersen, Bettina] Roche Diabet Care GmbH, Mannheim, Germany.
RP Parkin, CG (reprint author), CGParkin Commun Inc, 932 Vista Lago Way, Boulder City, NV 89005 USA.
EM chris@cgparkin.org
FU Roche Diabetes Care
FX The authors wish to thank our investigators and their patients for
   participating in this study. The Bluetooth word mark and logos are
   registered trademarks owned by the Bluetooth SIG, Inc., and any use of
   such marks by Roche Diabetes Care is under license. Roche Diabetes Care
   provided funding for the study.
CR Al Shahrani Abeer, 2014, J Family Med Prim Care, V3, P5, DOI 10.4103/2249-4863.130254
   Ali MK, 2013, NEW ENGL J MED, V369, P287, DOI 10.1056/NEJMc1306652
   Auerbach SM, 2002, J BEHAV MED, V25, P17, DOI 10.1023/A:1013585617303
   Bosi E, 2013, DIABETES CARE, V36, P2887, DOI 10.2337/dc13-0092
   Bradley C, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-57
   BRODY DS, 1980, J CHRON DIS, V33, P57, DOI 10.1016/0021-9681(80)90086-7
   Brown JB, 2003, AM J MANAG CARE, V9, P213
   Carls GS, 2016, AM DIAB ASS 76 SCI S
   Currie CJ, 2013, J DIABETES COMPLICAT, V27, P219, DOI 10.1016/j.jdiacomp.2012.10.006
   Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570
   Egede LE, 2014, ANN PHARMACOTHER, V48, P562, DOI 10.1177/1060028014526362
   Faridi Z, 2008, J EVAL CLIN PRACT, V14, P465, DOI 10.1111/j.1365-2753.2007.00881.x
   Fisher L, 2011, CURR MED RES OPIN, V27, P39, DOI 10.1185/03007995.2011.619176
   Franciosi M, 2011, DIABETIC MED, V28, P789, DOI 10.1111/j.1464-5491.2011.03268.x
   Given JE, 2013, DIABETIC MED, V30, P901, DOI 10.1111/dme.12130
   Haynes RB, 1979, COMPLIANCE HLTH CARE
   Hirsch Irl B, 2004, Endocr Pract, V10, P67
   Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836
   Holmen H, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3882
   Kato N, 2013, J DIABETES INVEST, V4, P450, DOI 10.1111/jdi.12072
   Kazlauskaite R, 2009, DIABETES TECHNOL THE, V11, P385, DOI 10.1089/dia.2008.0111
   Khunti K, 2016, DIABETES OBES METAB, V18, P401, DOI 10.1111/dom.12626
   Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331
   Klonoff David C, 2013, J Diabetes Sci Technol, V7, P749
   Lalic Nebojsa M, 2017, J Diabetes Sci Technol, V11, P746, DOI 10.1177/1932296816681323
   LEY P, 1982, BRIT J CLIN PSYCHOL, V21, P241, DOI 10.1111/j.2044-8260.1982.tb00562.x
   Ley P, 1979, RES PSYCHOL MED
   Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x
   Nichols GA, 2007, J GEN INTERN MED, V22, P453, DOI 10.1007/s11606-007-0139-y
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2011, DIABETES TECHNOL THE, V13, P797, DOI 10.1089/dia.2011.0073
   Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af
   World Medical Association, DECLARATION OF HELSI
   Ziemer DC, 2005, DIABETES EDUCATOR, V31, P564, DOI 10.1177/0145721705279050
NR 34
TC 1
Z9 1
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD DEC
PY 2017
VL 19
IS 12
BP 715
EP 722
DI 10.1089/dia.2017.0206
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FQ1XU
UT WOS:000418152000004
PM 29027812
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Capistrant, BD
   Friedemann-Sanchez, G
   Novak, LK
   Zuijdwijk, C
   Ogle, GD
   Pendsey, S
AF Capistrant, Benjamin D.
   Friedemann-Sanchez, Greta
   Novak, Lindsey K.
   Zuijdwijk, Caroline
   Ogle, Graham D.
   Pendsey, Sharad
TI Mental health and well-being among type 1 diabetes caregivers in India:
   Evidence from the IDREAM study
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Depression; Well-being; Caregiver
ID GLYCEMIC CONTROL; DIAGNOSTIC METAANALYSIS; PRIMARY-CARE; CHILDREN;
   DEPRESSION; PARENTS; BURDEN; DISTRESS; STRESS; PHQ-9
AB Aims: Although more than half of the world's children with T1D live in developing countries, still little is known about how caregiving for children with T1D affects the parent/caregivers' health in low-and middle-income country settings.
   Methods: Caregivers of 178 children with T1D from a specialized diabetes clinic in Maharashtra, India were surveyed. Ordered and standard logistic regression models adjusted for caregiver, household and child characteristics, were fit to estimate the association of caregiving burden (objective caregiving burden and subjective caregiving burden (Zarit Burden Inventory - tertiles)) with caregiver depression (Patient Health Questionnaire [PHQ-9]) and well-being (CDC Unhealthy Days) outcomes.
   Results: Caregivers with high subjective caregiving burden had a 41% probability of most severe depression category (probability: 0.41, 95% CI: 0.25, 0.57) and an 39% probability of low well-being (probability: 0.39, 95% CI: 0.27, 0.51), compared to caregivers with low subjective burden. Caregivers with high subjective caregiving burden and high objective direct caregiving burden had an adjusted 30% probability of elevated depressive symptoms (PHQ >= 10).
   Conclusions: Among Indian T1D caregivers, high subjective caregiving burden and objective direct caregiving burden were associated with a high risk for caregiver depression and poorer well-being. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Capistrant, Benjamin D.] Smith Coll, Stat & Data Sci, Burton Hall 115,44 Coll Lane, Northampton, MA 01063 USA.
   [Capistrant, Benjamin D.] Univ Minnesota, Sch Publ Hlth, West Bank Off Bldg,1300 S 2nd St,Suite 300, Minneapolis, MN 55455 USA.
   [Friedemann-Sanchez, Greta] Univ Minnesota, Humphrey Sch Publ Affairs, Humphrey Sch 267, 301 19th Ave South, Minneapolis, MN 55455 USA.
   Colby Coll, Dept Econ, 5237 Mayflower Hill Dr, Waterville, ME USA.
   [Zuijdwijk, Caroline] Childrens Hosp Eastern Ontario, CHEO Res Inst, Div Endocrinol & Metab, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.
   [Ogle, Graham D.] Int Diabet Federat, Life Child, GPO Box 9824, Sydney, NSW 2001, Australia.
   [Pendsey, Sharad] Diabet Res Educ & Management Trust, Shreeniwas Opposite Dhantoli Pk, Nagpur 440012, Maharashtra, India.
RP Capistrant, BD (reprint author), Smith Coll, Stat & Data Sci, Burton Hall 115,44 Coll Lane, Northampton, MA 01063 USA.; Capistrant, BD (reprint author), Univ Minnesota, Sch Publ Hlth, West Bank Off Bldg,1300 S 2nd St,Suite 300, Minneapolis, MN 55455 USA.
EM bcapistrant@smith.edu; gfs@umn.edu; lindsey.novak@colby.edu;
   czuijdwijk@cheo.on.ca; grahamo@diabetesnsw.com.au;
   sharadpendsey2015@g-mail.com
OI Ogle, Graham/0000-0002-2022-0866; Friedemann-Sanchez,
   Greta/0000-0002-0493-7218
FU University of Minnesota [22782]; C-Voter News Services PvT. Ltd.
FX This work was possible by the generous support of a University of
   Minnesota Grant-in-Aid-of-Research, Artistry and Scholarship (GIA)
   #22782 and C-Voter News Services PvT. Ltd.
CR ANDERSON BJ, 1990, J PEDIATR PSYCHOL, V15, P477, DOI 10.1093/jpepsy/15.4.477
   Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6
   Barik D, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00268
   Barile JP, 2013, QUAL LIFE RES, V22, P1201, DOI 10.1007/s11136-012-0246-z
   Barola A, 2016, VALUE HEALTH, V19, pA201, DOI 10.1016/j.jval.2016.03.1291
   Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652
   Berman P., 2010, Economic and Political Weekly, V45, P65
   Bhadada SK, 2011, J GASTROEN HEPATOL, V26, P378, DOI 10.1111/j.1440-1746.2010.06508.x
   Binnendijk E, 2012, TROP MED INT HEALTH, V17, P1376, DOI 10.1111/j.1365-3156.2012.03070.x
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   Butler DA, 2008, PEDIATR DIABETES, V9, P373, DOI 10.1111/j.1399-5448.2008.00370.x
   Control CfD Prevention, 2000, MEAS HLTH DAYS POP A, P40
   Cunningham NR, 2011, J PEDIATR PSYCHOL, V36, P196, DOI 10.1093/jpepsy/jsq071
   DATTA SS, 2002, J LEARN DISABIL, V6, P337, DOI DOI 10.1177/146900470200600401
   Dilworth-Anderson P, 2005, J GERONTOL B-PSYCHOL, V60
   Divan G, 2012, AUTISM RES, V5, P190, DOI 10.1002/aur.1225
   Friedemann-Sanchez G, 2017, PEDIAT DIABETES
   FRIEDEMANNSANCHEZ, 2012, FEMINIST EC, V18, P55, DOI DOI 10.1080/13545701.2012.714471
   Gupta R, 2009, AFFILIA J WOM SOC WO, V24, P69, DOI 10.1177/0886109908326998
   HAUENSTEIN EJ, 1989, DIABETES CARE, V12, P18, DOI 10.2337/diacare.12.1.18
   Haugstvedt A, 2011, PEDIATR DIABETES, V12, P107, DOI 10.1111/j.1399-5448.2010.00661.x
   Helgeson VS, 2007, PEDIAT PSYCHOL, V34
   Kahana S, 2008, J PEDIATR PSYCHOL, V33, P590, DOI 10.1093/jpepsy/jsm128
   Kalra S., 2015, J SOCIAL HLTH DIABET, V3, P56, DOI [10.4103/2321-0656.140896, DOI 10.4103/2321-0656.140896]
   Kalra S, 2014, J SOC HLTH DIABETES, V2, P3
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P682, DOI 10.1097/01-chi.0000161645.98022.35
   Li CY, 2007, DIABETES CARE, V30, P1770, DOI 10.2337/dc06-2571
   Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009
   Minhas A, 2015, INT REV PSYCHIATR, V27, P247, DOI 10.3109/09540261.2015.1049128
   Mitchell AJ, 2016, BJPSYCH OPEN, V2, P127, DOI 10.1192/bjpo.bp.115.001685
   Monaghan M, 2011, PATIENT EDUC COUNS, V82, P271, DOI 10.1016/j.pec.2010.04.007
   Mukama LJ, 2013, PEDIATR DIABETES, V14, P211, DOI 10.1111/pedi.12005
   Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334
   Pearlin L. I., 1999, HDB SOCIOLOGY MENTAL, P395, DOI DOI 10.1007/0-387-36223-1_19
   PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Poongothai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007185
   Rastogi D, 2009, J ASTHMA, V46, P911, DOI 10.3109/02770900903191323
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Streisand R, 2008, PATIENT EDUC COUNS, V73, P333, DOI 10.1016/j.pec.2008.06.014
   Tsiouli E, 2014, EXPLORE-NY, V10, P88, DOI 10.1016/j.explore.2013.12.004
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Zahran Hatice S., 2005, Morbidity and Mortality Weekly Report, V54, P1
NR 46
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD DEC
PY 2017
VL 134
BP 168
EP 177
DI 10.1016/j.diabres.2017.10.009
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FP0TC
UT WOS:000417318700020
PM 29054484
DA 2019-01-08
ER

PT J
AU Hernar, I
   Haltbakk, J
   Brostrom, A
AF Hernar, Ingvild
   Haltbakk, Johannes
   Brostrom, Anders
TI Differences in depression, treatment satisfaction and injection
   behaviour in adults with type 1 diabetes and different degrees of
   lipohypertrophy
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE depressive symptoms; diabetes specialist nurses; health behaviour;
   insulin injection therapy; lipohypertrophy; self-assessment tools;
   self-management of injection technique; treatment satisfaction; type 1
   diabetes
ID PATIENT ACTIVATION; GLYCEMIC CONTROL; EMOTIONAL DISTRESS;
   SELF-MANAGEMENT; D PERSONALITY; PSYCHOMETRIC PROPERTIES; INSULIN;
   HEALTH; PEOPLE; SCALE
AB Aims and objectivesTo assess the prevalence of lipohypertrophy, and to compare differences in external, personal and regimen factors in adults with type 1 diabetes and different degrees of lipohypertrophy.
   BackgroundSuboptimal insulin injection behaviour is associated with lipohypertrophy, which may affect insulin absorption and lead to blood glucose fluctuations. Few, if any studies have investigated how external, personal and regimen factors differ in people with type 1 diabetes and different degrees of lipohypertrophy.
   DesignA cross-sectional study including adults with type 1 diabetes at a diabetes outpatient clinic in a Norwegian university hospital.
   MethodsParticipants (n=215) were included consecutively at scheduled appointments. Sociodemographic, diabetes and insulin treatment data, and self-report questionnaires concerning patient activation (Patient Activation Measure), depression (Patient Health Questionnaire-2), diabetes distress (Diabetes Distress Scale), type D personality (14-item Type D scale), treatment satisfaction (Insulin Treatment Satisfaction Questionnaire) and motivation (Treatment Self-Regulation Questionnaire), were collected. Lipohypertrophic injection sites were identified by palpation by diabetes specialist nurses.
   ResultsLipohypertrophy was present in 53% and was more frequent in insulin pen users (63%) compared to insulin pump users (34%). Participants with two or more lipohypertrophic areas had higher depression scores, lower treatment satisfaction with glycaemic control, higher bolus doses and reported suboptimal injection behaviour compared to those with no lipohypertrophic areas. There were no differences in patient activation, diabetes distress, type D personality or motivation between the groups.
   Discussion and conclusionCompared to pump treatment, pen treatment requires greater awareness of injection technique. Symptoms of depression and lower treatment satisfaction might affect diabetes self-management and glycaemic control, but the association with lipohypertrophy needs further exploration.
   Relevance to clinical practiceLipohypertrophy is more frequent in insulin pen users compared to pump users. Nurses should focus on injection technique education, and should also consider screening for depressive symptoms and treatment satisfaction as these factors could be associated with development of lipohypertrophy.
C1 [Hernar, Ingvild] Haukeland Hosp, Dept Med, Bergen, Norway.
   [Hernar, Ingvild; Haltbakk, Johannes; Brostrom, Anders] Western Norway Univ Appl Sci, Fac Hlth & Social Sci, Dept Nursing, Bergen, Norway.
   [Brostrom, Anders] Jonkoping Univ, Dept Nursing Sci, Jonkoping, Sweden.
   [Brostrom, Anders] Univ Hosp Linkoping, Dept Clin Neurophysiol, Linkoping, Sweden.
RP Hernar, I (reprint author), Western Norway Univ Appl Sci, Bergen, Norway.
EM ingvild.hernar@hvl.no
FU Norwegian Nurses Organisation
FX Ingvild Hernar received a 10,000 NOK scholarship from the Norwegian
   Nurses Organisation for her Master's Programme.
CR Anderson RT, 2004, CLIN THER, V26, P565, DOI 10.1016/S0149-2918(04)90059-8
   Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7
   Barnard KD, 2014, DIABETIC MED, V31, P522, DOI 10.1111/dme.12400
   Bergvik S, 2010, SCAND J PSYCHOL, V51, P334, DOI 10.1111/j.1467-9450.2009.00793.x
   Blanco M, 2013, Diabetes Metab, V39, P445, DOI 10.1016/j.diabet.2013.05.006
   Brod M, 2007, QUAL LIFE RES, V16, P1053, DOI 10.1007/s11136-007-9209-1
   Brod M, 2009, QUAL LIFE RES, V18, P23, DOI 10.1007/s11136-008-9419-1
   De Coninck C, 2010, J DIABETES, V2, P168, DOI 10.1111/j.1753-0407.2010.00077.x
   Deci E. L, 2002, HDB SELF DETERMINATI
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Frid A, 2010, DIABETES METAB, V36, pS3, DOI 10.1016/S1262-3636(10)70002-1
   Garmo A, 2013, DIABETIC MED, V30, P717, DOI 10.1111/dme.12155
   Gentile S, 2011, ACTA DIABETOL, V48, P121, DOI 10.1007/s00592-009-0172-x
   Gin H, 2005, DIABETES METAB, V31, P7, DOI 10.1016/S1262-3636(07)70160-X
   Grassi G, 2014, J CLIN TRANSL ENDOCR, V1, P145, DOI 10.1016/j.jcte.2014.07.006
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hauner H, 1996, EXP CLIN ENDOCR DIAB, V104, P106, DOI 10.1055/s-0029-1211431
   Hendriks M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-393
   Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x
   International Diabetes Federation, 2015, IDF DIABETES ATLAS
   Joensen LE, 2013, DIABETES RES CLIN PR, V101, P278, DOI 10.1016/j.diabres.2013.07.001
   Johansson UB, 2005, DIABETES CARE, V28, P2025, DOI 10.2337/diacare.28.8.2025
   Jones A, 2015, DIABETIC MED, V32, P155, DOI 10.1111/dme.12620
   Jones A., 2016, J DIABETES RES, V2016
   KADIYALA P, 2014, THE BRITISH JOURNAL, V14, P131
   Kordonouri O, 2002, DIABETES CARE, V25, P634, DOI 10.2337/diacare.25.3.634
   Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C
   LAMAR CP, 1950, JAMA-J AM MED ASSOC, V142, P1350, DOI 10.1001/jama.1950.02910350020007
   Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006
   Mapi Research Trust, 2014, PERS COMM REG TRANSL
   Mohn J., 2011, THESIS
   Moljord IEO, 2015, PATIENT EDUC COUNS, V98, P1410, DOI 10.1016/j.pec.2015.06.009
   Mols F, 2010, GEN HOSP PSYCHIAT, V32, P66, DOI 10.1016/j.genhosppsych.2009.09.010
   Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112
   Nefs G, 2015, DIABETES RES CLIN PR, V108, P94, DOI 10.1016/j.diabres.2015.01.015
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Oxford Outcomes, 2014, ICON LANG SERV
   Ozcan S, 2014, DIABETES RES CLIN PR, V106, P35, DOI 10.1016/j.diabres.2014.07.023
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   PHQ Screeners, 2013, PAT HLTH QUEST PHQ S
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Richardson T, 2003, AM J CLIN DERMATOL, V4, P661, DOI 10.2165/00128071-200304100-00001
   Rijken M, 2014, PATIENT EDUC COUNS, V97, P383, DOI 10.1016/j.pec.2014.09.006
   Rogvi S, 2012, DIABETIC MED, V29, pe382, DOI 10.1111/j.1464-5491.2012.03703.x
   Saez-de Ibarra L, 1998, PRACT DIABETES INT, V15, P9
   Saltiel-Berzin R, 2012, DIABETES EDUCATOR, V38, P635, DOI 10.1177/0145721712455107
   Sawatkar GU, 2013, J EUR ACAD DERMATOL, V27, P1321, DOI 10.1111/jdv.12068
   Siemens Healthcare, 2016, DCA VANTAGE ANALYZER
   Skrivarhaug T., 2015, NORWEGIAN CHILDHOOD
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   vansMunster H. E., 2014, EUR DIABETES NURS, V11, P79
   Vardar B, 2007, DIABETES RES CLIN PR, V77, P231, DOI 10.1016/j.diabres.2006.12.023
   Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58
   Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508
NR 58
TC 1
Z9 1
U1 3
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD DEC
PY 2017
VL 26
IS 23-24
BP 4583
EP 4596
DI 10.1111/jocn.13801
PG 14
WC Nursing
SC Nursing
GA FN9AK
UT WOS:000416319600071
PM 28295770
DA 2019-01-08
ER

PT J
AU Levesque, C
AF Levesque, Celia
TI Therapeutic Lifestyle Changes for Diabetes Mellitus
SO NURSING CLINICS OF NORTH AMERICA
LA English
DT Article
DE Diabetes mellitus; Medical nutrition therapy; Physical activity; Smoking
   cessation; Diabetes distress; Diabetes self-management education;
   Diabetes self-management support
ID AMERICAN ASSOCIATION; GLYCEMIC CONTROL; TYPE-2; STATEMENT; EDUCATION;
   RAMADAN
AB Diabetes mellitus is a common chronic disease affecting approximately 9% of the US population. Successful management of diabetes demands constant self-management on the part of the patient. The patient must balance diabetes medications, blood glucose monitoring, food intake, physical activity, and management of diabetes-related acute and chronic complications. The patient is often bombarded with misinformation from friends, relatives, and such sources as the Internet and social media. This article discusses the current recommendations for diabetes self-management education and skills including medical nutrition therapy, physical activity, smoking cessation, and assessment for diabetes distress.
C1 [Levesque, Celia] MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcomb Blvd, Houston, TX 77030 USA.
RP Levesque, C (reprint author), MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcomb Blvd, Houston, TX 77030 USA.
EM clevesqu@mdanderson.org
CR Ahmedani MY, 2016, PAK J MED SCI, V32, P846, DOI 10.12669/pjms.324.9904
   American Diabetes Association, 2017, J DIABETES S1, V40, pS1
   Boucher Jackie L, 2017, Diabetes Spectr, V30, P72, DOI 10.2337/ds16-0074
   Campbell Amy P, 2017, Diabetes Spectr, V30, P76, DOI 10.2337/ds16-0084
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Chong Shanley, 2017, Diabetes Spectr, V30, P43, DOI 10.2337/ds15-0044
   Eid Yara M, 2017, Diabetes Spectr, V30, P36, DOI 10.2337/ds15-0058
   Foster GD, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.3
   Garber AJ, 2016, ENDOCR PRACT, V22, P84, DOI 10.4158/EP151126.CS
   Healy SJ, 2013, DIABETES CARE, V36, P2960, DOI 10.2337/dc13-0108
   Ibrahim M, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000108
   Lessan N, 2015, DIABETES METAB, V41, P28, DOI 10.1016/j.diabet.2014.11.004
   Pan A, 2015, LANCET DIABETES ENDO, V3, P958, DOI 10.1016/S2213-8587(15)00316-2
   Pawlak Roman, 2017, Diabetes Spectr, V30, P82, DOI 10.2337/ds16-0057
   Powers Margaret A, 2017, Diabetes Spectr, V30, P51, DOI 10.2337/ds16-0078
   Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694
   Salas-Salvado J, 2016, J NUTR, V146, p920S, DOI 10.3945/jn.115.218487
NR 17
TC 0
Z9 0
U1 3
U2 8
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0029-6465
EI 1558-1357
J9 NURS CLIN N AM
JI Nurs. Clin. North Am.
PD DEC
PY 2017
VL 52
IS 4
BP 679
EP +
DI 10.1016/j.cnur.2017.07.012
PG 15
WC Nursing
SC Nursing
GA FO1FH
UT WOS:000416501600014
PM 29080584
DA 2019-01-08
ER

PT J
AU Raymaekers, K
   Oris, L
   Prikken, S
   Moons, P
   Goossens, E
   Weets, I
   Luyckx, K
AF Raymaekers, Koen
   Oris, Leen
   Prikken, Sofie
   Moons, Philip
   Goossens, Eva
   Weets, Ilse
   Luyckx, Koen
TI The Role of Peers for Diabetes Management in Adolescents and Emerging
   Adults With Type 1 Diabetes: A Longitudinal Study
SO DIABETES CARE
LA English
DT Article
ID GLYCEMIC CONTROL; METABOLIC-CONTROL; SELF-MANAGEMENT; CARE; SUPPORT;
   INVENTORY; FRIENDS; PARENT; ORIENTATION; DISTRESS
AB OBJECTIVE
   The increasing importance of peers in adolescence and emerging adulthood has been widely acknowledged. However, longitudinal research linking the peer context to diabetes management and outcomes is scarce. The present longitudinal study in a large sample of youths with type 1 diabetes related both positive and negative peer variables to diabetes outcomes over a time interval of 1 year.
   RESEARCH DESIGN AND METHODS
   Our sample consisted of 467 adolescents (14-17 years of age) and emerging adults (18-25 years of age) with type 1 diabetes who participated in a two-wave longitudinal study. Questionnaires tapped into peer support, extreme peer orientation, parental responsiveness, diabetes-related distress, and treatment adherence. HbA(1c) values were obtained from the treating physicians of patients. Cross-lagged analysis from a structural equation modeling approach was performed to assess the directionality of effects.
   RESULTS
   Peer support negatively predicted diabetes-related distress over time. Extreme peer orientation positively predicted treatment distress over time. Parental responsiveness negatively predicted food distress over time. Treatment adherence negatively predicted extreme peer orientation, treatment distress, and HbA(1c) values over time. For emerging adults specifically, there was a reciprocal relationship between HbA(1c) values and extreme peer orientation because they positively predicted each other.
   CONCLUSIONS
   This study highlights the importance of peers in predicting the functioning of youths with type 1 diabetes. Additionally, treatment adherence at baseline was found to negatively predict extreme peer orientation, treatment distress, and worse glycemic control over time. In sum, the current study underscores the importance of the peer context for adolescents and emerging adults with type 1 diabetes.
C1 [Raymaekers, Koen; Oris, Leen; Prikken, Sofie; Moons, Philip; Goossens, Eva; Luyckx, Koen] Univ Leuven, Leuven, Belgium.
   [Oris, Leen; Goossens, Eva] Res Fdn Flanders, Brussels, Belgium.
   [Moons, Philip] Univ Gothenburg, Gothenburg, Sweden.
   [Weets, Ilse] Free Univ Brussels, Brussels, Belgium.
RP Raymaekers, K (reprint author), Univ Leuven, Leuven, Belgium.
EM koen.raymaekers@kuleuven.be
OI Raymaekers, Koen/0000-0002-5571-4081
FU Research Foundation Flanders (FWO) [G.0B35.14N]
FX Funding was provided by Research Foundation Flanders (FWO) through
   Research Project G.0B35.14N to K.L.
CR [Anonymous], 2016, DIABETES CARE S1, V39, pS86
   ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Berg CA, 2008, DIABETES CARE, V31, P678, DOI 10.2337/dc07-1678
   Berlin K. S., 2006, FAMILIES SYSTEMS HLT, V24, P33, DOI DOI 10.1037/1091-7527.24.1.33
   Beyers W, 2003, J YOUTH ADOLESCENCE, V32, P351, DOI 10.1023/A:1024922031510
   BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037//0012-1649.22.6.723
   Brown B. B., 2004, HDB ADOLESCENT PSYCH, V2, P363, DOI DOI 10.1002/9780471726746.CH12
   Carcone AI, 2011, J DEV BEHAV PEDIATR, V32, P581, DOI 10.1097/DBP.0b013e31822c1a27
   Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591
   Doe E., 2016, J HLTH PSYCHOL
   Drew LM, 2010, J FAM PSYCHOL, V24, P299, DOI 10.1037/a0019352
   Enders CK, 2010, APPL MISSING DATA AN
   Enzlin P, 2002, PATIENT EDUC COUNS, V48, P139, DOI 10.1016/S0738-3991(02)00009-5
   Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914
   FULIGNI AJ, 1993, DEV PSYCHOL, V29, P622, DOI 10.1037/0012-1649.29.4.622
   Hains AA, 2007, J PEDIATR PSYCHOL, V32, P561, DOI 10.1093/jpepsy/jsl040
   Hausmann LRM, 2010, PATIENT PREFER ADHER, V4, P291, DOI 10.2147/PPA.S12353
   Helgeson VS, 2015, J PEDIATR PSYCHOL, V40, P359, DOI 10.1093/jpepsy/jsu069
   Helgeson VS, 2014, HEALTH PSYCHOL, V33, P1125, DOI 10.1037/a0033511
   Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079
   Karlsson A, 2008, INT J NURS STUD, V45, P562, DOI 10.1016/j.ijnurstu.2006.08.022
   Kline R. B., 2015, PRINCIPLES PRACTICE
   LAGRECA AM, 1995, J PEDIATR PSYCHOL, V20, P449, DOI 10.1093/jpepsy/20.4.449
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   Luyckx K, 2016, J HEALTH PSYCHOL, V21, P540, DOI 10.1177/1359105314531467
   Luyckx K, 2010, DIABETES CARE, V33, P1424, DOI 10.2337/dc09-2017
   Oris L, 2016, DIABETES CARE, V39, P757, DOI 10.2337/dc15-2559
   Palladino DK, 2012, J PEDIATR PSYCHOL, V37, P591, DOI 10.1093/jpepsy/jss009
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Ramchandani N, 2000, DIABETES EDUCATOR, V26, P656, DOI 10.1177/014572170002600413
   SCHAEFER ES, 1965, CHILD DEV, V36, P413, DOI 10.2307/1126465
   Schumacker RE, 2004, BEGINNERS GUIDE STRU
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Soenens B, 2006, DEV PSYCHOL, V42, P305, DOI 10.1073/0012-1649.42.2.305
   Walker Ashby F, 2015, Clin Diabetes, V33, P62, DOI 10.2337/diaclin.33.2.62
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Weissberg-Benchell J, 2007, DIABETES CARE, V30, P2441, DOI 10.2337/dc07-1249
   Wiebe DJ, 2016, AM PSYCHOL, V71, P526, DOI 10.1037/a0040355
   Wysocki Tim, 2006, Curr Diab Rep, V6, P117, DOI 10.1007/s11892-006-0022-y
NR 41
TC 3
Z9 3
U1 2
U2 8
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD DEC 1
PY 2017
VL 40
IS 12
BP 1678
EP 1684
DI 10.2337/dc17-0643
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FN3AO
UT WOS:000415868000015
PM 29138272
DA 2019-01-08
ER

PT J
AU Dickinson, JK
   Guzman, SJ
   Maryniuk, MD
   O'Brian, CA
   Kadohiro, JK
   Jackson, RA
   D'Hondt, N
   Montgomery, B
   Close, KL
   Funnell, MM
AF Dickinson, Jane K.
   Guzman, Susan J.
   Maryniuk, Melinda D.
   O'Brian, Catherine A.
   Kadohiro, Jane K.
   Jackson, Richard A.
   D'Hondt, Nancy
   Montgomery, Brenda
   Close, Kelly L.
   Funnell, Martha M.
TI The Use of Language in Diabetes Care and Education
SO DIABETES CARE
LA English
DT Article
ID PSYCHOLOGICAL INSULIN-RESISTANCE; WEIGHT BIAS INTERNALIZATION; PATIENTS
   PREFERRED TERMS; PERSON-1ST LANGUAGE; PATIENT EMPOWERMENT; EMOTIONAL
   DISTRESS; DESCRIBING OBESITY; SELF-MANAGEMENT; NEGATIVE-WORDS; CENTERED
   CARE
AB Language is powerful and can have a strong impact on perceptions as well as behavior. A task force, consisting of representatives from the American Association of Diabetes Educators (AADE) and the American Diabetes Association (ADA), convened to discuss language in diabetes care and education. This document represents the expert opinion of the task force. The literature supports the need for a language movement in diabetes care and education. There are effective ways of communicating about diabetes. This article provides recommendations for language used by health care professionals and others when discussing diabetes through spoken or written words-whether directed to people with diabetes, colleagues, or the general public, as well as research questions related to language and diabetes.
C1 [Dickinson, Jane K.] Columbia Univ, Teachers Coll, Dept Hlth & Behav Studies, New York, NY 10027 USA.
   [Guzman, Susan J.] Behav Diabet Inst, Clin Educ Serv, San Diego, CA USA.
   [Maryniuk, Melinda D.] Joslin Diabet Ctr, Clin Educ Programs, Boston, MA 02215 USA.
   [O'Brian, Catherine A.] Amer Assoc Diabet Educ, Dept Sci & Practice, Chicago, IL USA.
   [Kadohiro, Jane K.] Diabet Educ & Support Consulting Serv, Reno, NV USA.
   [Jackson, Richard A.] Grassroots Diabet, Boston, MA USA.
   [D'Hondt, Nancy] Ascens St John Hosp, Detroit, MI USA.
   [Montgomery, Brenda] AstraZeneca, Bothell, WA USA.
   [Close, Kelly L.] Close Concerns & diaTribe Fdn, San Francisco, CA USA.
   [Funnell, Martha M.] Univ Michigan, Med Sch, Ann Arbor, MI USA.
RP Dickinson, JK (reprint author), Columbia Univ, Teachers Coll, Dept Hlth & Behav Studies, New York, NY 10027 USA.
EM dickinson@tc.columbia.edu
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829
   Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001
   [Anonymous], 2001, CROSSING QUALITY CHA
   [Anonymous], 2013, PEOPL 1 LANG OB
   Ayala J, 2014, WESTERN J NURS RES, V36, P1238, DOI 10.1177/0193945913518848
   Barnish M, 2014, OPEN J MOD LINGUIST, V4, P5505
   Benedetti F, 1997, PROG NEUROBIOL, V52, P109, DOI 10.1016/S0301-0082(97)00006-3
   Benedetti F, 2002, EVAL HEALTH PROF, V25, P369, DOI 10.1177/0163278702238051
   Berg FM, 1998, HLTH WEIGHT J, V12, P12
   Beverly EA, 2012, J GEN INTERN MED, V27, P1180, DOI 10.1007/s11606-012-2070-0
   Bissell P, 2004, SOC SCI MED, V58, P851, DOI 10.1016/S0277-9536(03)00259-4
   Bootle S, 2015, DIABETES RES CLIN PR, V109, P6, DOI 10.1016/j.diabres.2015.04.004
   Broom D, 2004, SOC SCI MED, V58, P2371, DOI 10.1016/j.socscimed.2003.09.002
   Brown A, 2016, DO WE REDUCE DIABETE
   Browne JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005625
   Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384
   Brummel-Smith K, 2016, J AM GERIATR SOC, V64, P15, DOI 10.1111/jgs.13866
   CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008
   Chun H, 2007, ADV CONSUM RES, V34, P715
   Collier R, 2012, CAN MED ASSOC J, V184, P1977, DOI 10.1503/cmaj.109-4319
   Dellasega C, 2012, DIABETES RES CLIN PR, V95, P37, DOI 10.1016/j.diabres.2011.08.011
   Diab P, 2012, JEMDSA, V17, P52, DOI 10.1080/22201009.2012.10872274
   Dickinson Jane K, 2017, Diabetes Spectr, V30, P11, DOI 10.2337/ds15-0054
   Dickinson Jane K, 2017, Clin Diabetes, V35, P51, DOI 10.2337/cd16-0014
   Dickinson JK, 2015, DIABETES EDUCATOR, V41, P665, DOI 10.1177/0145721715608952
   Dickinson JK, 2017, DIABETES SPECTR
   Dunn DS, 2015, AM PSYCHOL, V70, P255, DOI 10.1037/a0038636
   Dunning T, 2017, DIABETES EDUCATOR, V43, P18, DOI 10.1177/0145721716683449
   Durso LE, 2008, OBESITY, V16, pS80, DOI 10.1038/oby.2008.448
   Ellis S, 2014, J NUTR EDUC BEHAV, V46, P299, DOI 10.1016/j.jneb.2013.08.006
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fleischman S, 1999, J MED HUMANITIES, V20, P3
   Fleitas J., 2003, MCN-AM J MATERN-CHIL, V28, P389
   Fleitas Joan, 2003, MCN Am J Matern Child Nurs, V28, P384
   Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576
   Funnell MM, 2016, PATIENT EDUC COUNS, V99, P1921, DOI 10.1016/j.pec.2016.10.010
   Glasgow RE, 1999, DIABETES CARE, V22, P2090, DOI 10.2337/diacare.22.12.2090
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gottlieb LN, 2014, AM J NURS, V114, P24, DOI 10.1097/01.NAJ.0000453039.70629.e2
   Gredig D, 2017, HEALTH SOC CARE COMM, V25, P1620, DOI 10.1111/hsc.12376
   Greenfield C, 2011, AUST J RURAL HEALTH, V19, P15, DOI 10.1111/j.1440-1584.2010.01171.x
   Haque M, 2005, SAMJ S AFR MED J, V95, P798
   HARDIN C, 1993, SOC COGNITION, V11, P277, DOI 10.1521/soco.1993.11.3.277
   HOLM S, 1993, J MED ETHICS, V19, P108, DOI 10.1136/jme.19.2.108
   Hoover J, 1980, Diabetes Educ, V6, P9, DOI 10.1177/014572178000600101
   International Diabetes Federation, 2014, INT DIAB FED LANG PH
   Iverson C, 2007, AMA MANUAL STYLE, P416
   Jensen ME, 2013, J AM PSYCHIAT NURSES, V19, P146, DOI 10.1177/1078390313489729
   Jernigan K, 2009, BRAILLE MONITOR
   Kalra S., 2015, J SOCIAL HLTH DIABET, V3, P56, DOI [10.4103/2321-0656.140896, DOI 10.4103/2321-0656.140896]
   Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184
   Kendrick JM, 2005, JOGNN-J OBST GYN NEO, V34, P329, DOI 10.1177/0884217505276306
   Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1
   Liu Nancy F, 2017, Clin Diabetes, V35, P27, DOI 10.2337/cd16-0020
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Lydecker JA, 2016, INT J CLIN PRACT, V70, P682, DOI 10.1111/ijcp.12835
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   Matthews SM, 2009, PATIENT EDUC COUNS, V76, P31, DOI 10.1016/j.pec.2008.11.022
   Meadows A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01527
   Nakar S, 2007, J DIABETES COMPLICAT, V21, P220, DOI 10.1016/j.jdiacomp.2006.02.004
   National Center for Health Statistics, INT CLASS DIS 9 REV
   National Center for Health Statistics Centers for Disease Control and Prevention, INT CLASS DIS 10 REV
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Norman Debbie, 2003, Br J Nurs, V12, P1256
   Ott J, 2012, CLIN J PAIN, V28, P324, DOI 10.1097/AJP.0b013e3182321cc3
   Paget L, 2012, PATIENT CLIN COMMUNI
   Pearl RL, 2017, OBESITY, V25, P317, DOI 10.1002/oby.21716
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2017, DIABETES RES CLIN PR, V127, P265, DOI 10.1016/j.diabres.2017.03.016
   Polonsky WH, 2011, CURR MED RES OPIN, V27, P1169, DOI 10.1185/03007995.2011.573623
   Polonsky WH, 2010, DIABETES EDUCATOR, V36, P828, DOI 10.1177/0145721710378539
   Puhl R, 2013, INT J OBESITY, V37, P612, DOI 10.1038/ijo.2012.110
   Rathert C, 2013, MED CARE RES REV, V70, P351, DOI 10.1177/1077558712465774
   Ritholz MD, 2014, CHRONIC ILLN, V10, P303, DOI 10.1177/1742395314525647
   Ritter A, 2016, HEALTHCARE, V4, P54
   ROSENTHAL R, 1994, CURR DIR PSYCHOL SCI, V3, P176, DOI 10.1111/1467-8721.ep10770698
   Rosenthal Robert, 1968, PYGMALION CLASSROOM
   Saleebey D, 1996, SOC WORK, V41, P296
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Schaffer R, 2016, ENDOCRINE TODAY
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Shiu ATY, 2003, J CLIN NURS, V12, P149, DOI 10.1046/j.1365-2702.2003.00735.x
   Speight J, 2012, DIABETES RES CLIN PR, V97, P425, DOI 10.1016/j.diabres.2012.03.015
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Swift JA, 2013, PATIENT EDUC COUNS, V91, P186, DOI 10.1016/j.pec.2012.12.008
   Texas Department of Aging and Disability Services, 2013, PERS 1 RESP LANG
   Vartanian LR, 2008, J HEALTH PSYCHOL, V13, P131, DOI 10.1177/1359105307084318
   Vishwanath A, 2014, HEALTH COMMUN, V29, P516, DOI 10.1080/10410236.2013.777685
   Volger S, 2012, OBESITY, V20, P147, DOI 10.1038/oby.2011.217
   Wadden TA, 2003, OBES RES, V11, P1140, DOI 10.1038/oby.2003.155
   Wang F, 2008, MINERVA ANESTESIOL, V74, P353
   Ward SH, 2009, J GEN INTERN MED, V24, P579, DOI 10.1007/s11606-009-0922-z
   Weaver J, 2016, J SOC PSYCHOL, V156, P179, DOI 10.1080/00224545.2015.1076761
   Weinger Katie, 2015, Diabetes Spectr, V28, P146, DOI 10.2337/diaspect.28.2.146
   Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502
   Winkley K, 2015, DIABETIC MED, V32, P120, DOI 10.1111/dme.12556
   Yelovich MC, 2016, J EVAL CLIN PRACT, V22, P558, DOI 10.1111/jep.12561
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
   Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc
NR 104
TC 3
Z9 3
U1 1
U2 3
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD DEC 1
PY 2017
VL 40
IS 12
BP 1790
EP 1799
DI 10.2337/dci17-0041
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FN3AO
UT WOS:000415868000030
PM 29042412
OA Bronze
DA 2019-01-08
ER

PT J
AU Nilsson, S
   Hanberger, L
   Olinder, AL
   Forsner, M
AF Nilsson, Stefan
   Hanberger, Lena
   Olinder, Anna Lindholm
   Forsner, Maria
TI The Faces Emotional Coping Scale as a self-reporting instrument for
   coping with needle-related procedures: An initial validation study with
   children treated for type 1 diabetes
SO JOURNAL OF CHILD HEALTH CARE
LA English
DT Article
DE Child; coping; needle-related procedures; pain; pain unpleasantness
ID PAIN SCALES; VENIPUNCTURE; INTENSITY; PARENTS; FEAR; UNPLEASANTNESS;
   ASSOCIATION; PERSPECTIVE; DISTRESS; RATINGS
AB The aim of this study was to determine the concurrent and content validity, sensitivity and inter-rater reliability of the Faces Emotional Coping Scale (FECS) to evaluate the children's anticipation of the level of emotional coping in conjunction with a venepuncture. A total of 153 children with type 1 diabetes and 86 of their parents participated in the study. The age of the children, 76 of whom were boys, ranged from 7 to 18 years. The child and his or her parent reported the child's coping ability, and the child reported the pain intensity and unpleasantness of a venepuncture. The child also wrote a short narrative about his or her experience of the needle procedure. The FECS correlated negatively with the Coloured Analogue Scale and the Facial Affective Scale and positively with the FECS by proxy. The narratives of 90 children correlated negatively with the FECS. Younger children reported significantly lower scores than older children did regarding their ability to cope with a venepuncture. The children's scores on the FECS showed good agreement with the parents' scores. In this study, the FECS was deemed valid for measuring children's ability to cope with their emotions when undergoing needle-related procedures like venepuncture.
C1 [Nilsson, Stefan] Univ Gothenburg, Inst Hlth & Care Sci, Box 457, S-40530 Gothenburg, Sweden.
   [Hanberger, Lena] Linkoping Univ, Div Nursing Sci, Dept Med & Hlth Sci, Linkoping, Sweden.
   [Olinder, Anna Lindholm] Karolinska Inst, Sachs Children & Youths Hosp, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden.
   [Forsner, Maria] Dalarna Univ, Dept Hlth & Social Sci, Caring Sci, Falun, Sweden.
   [Forsner, Maria] Umea Univ, Dept Nursing, Umea, Sweden.
RP Nilsson, S (reprint author), Univ Gothenburg, Inst Hlth & Care Sci, Box 457, S-40530 Gothenburg, Sweden.
EM stefan.nilsson.4@gu.se
FU Diabetes stiftelsen; Novo Nordisk; Ypsomed; Infocare
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by grants from the Diabetes stiftelsen, Novo Nordisk,
   Ypsomed and finally Infocare.
CR Aydin D, 2016, J CLIN NURS, V25, P2328, DOI 10.1111/jocn.13321
   Bulloch B, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e33
   Cemeroglu AP, 2015, ENDOCR PRACT, V21, P46, DOI 10.4158/EP14252.OR
   Duff AJA, 2003, ARCH DIS CHILD, V88, P931, DOI 10.1136/adc.88.10.931
   Fang H, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3613-3
   Ferrari M, 2016, J HLTH PSYCHOL
   Forsner M, 2016, J CHILD HEALTH CARE, V20, P365, DOI 10.1177/1367493515598646
   Goodenough B, 1999, EUR J PAIN-LONDON, V3, P301, DOI 10.1016/S1090-3801(99)90012-5
   Heinrich KH, 2016, VALUE HEALTH, V19, pA199, DOI 10.1016/j.jval.2016.03.1325
   Hodgins MJ, 1997, J PAIN SYMPTOM MANAG, V13, P274, DOI 10.1016/S0885-3924(96)00328-4
   Hofman PL, 2010, DIABETES CARE, V33, P1940, DOI 10.2337/dc10-0871
   Howe CJ, 2011, MCN-AM J MATERN-CHIL, V36, P25, DOI 10.1097/NMC.0b013e3181fc6093
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Jaaniste T, 2016, PAIN, V157, P2399, DOI 10.1097/j.pain.0000000000000666
   Kamper SJ, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0104-0
   Kamsvag-Magnusson T, 2014, ACTA PAEDIATR, V103, P630, DOI 10.1111/apa.12627
   Karlsson K, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23063
   Kennedy RM, 2008, PEDIATRICS, V122, pS130, DOI DOI 10.1542/PEDS.2008-1055E
   King N., 1994, QUALITATIVE METHODS, P14
   Laerd Statistics, 2012, CONC PRED VAL
   Ljusegren G, 2012, CHILD CARE HLTH DEV, V38, P464, DOI 10.1111/j.1365-2214.2011.01262.x
   McCarthy AM, 2010, NURS RES, V59, P407, DOI 10.1097/NNR.0b013e3181f80ed5
   McGrath P, 1996, PAIN, V64, P435, DOI 10.1016/0304-3959(95)00171-9
   McMurtry C Meghan, 2015, Clin J Pain, V31, pS3, DOI 10.1097/AJP.0000000000000272
   Melzack R, 1999, PAIN, pS121
   Nilsson S, 2014, NURS RES PRACT, V2014
   Nilsson Stefan, 2016, Nurs Child Young People, V28, P22, DOI 10.7748/ncyp.28.3.22.s21
   Nilsson S, 2012, NURS RES PRACT, DOI 10.1155/2012/932570
   Nilsson S, 2015, DEV NEUROREHABIL, V18, P162, DOI 10.3109/17518423.2013.801529
   Perrott DA, 2004, EUR J PAIN, V8, P119, DOI 10.1016/S1090-3801(03)00087-9
   Place MA, 2016, J CHILD HEALTH CARE, V20, P55, DOI 10.1177/1367493514551307
   Randall D, 2012, J CHILD HEALTH CARE, V16, P305, DOI 10.1177/1367493512443907
   Reid GJ, 1998, PAIN, V76, P83, DOI 10.1016/S0304-3959(98)00029-3
   Richter M, 2010, PAIN, V148, P198, DOI 10.1016/j.pain.2009.08.009
   Rindstedt Camilla, 2013, Commun Med, V10, P51
   Rzeszut JR, 2011, J PEDIATR NURS, V26, P589, DOI 10.1016/j.pedn.2011.09.003
   Sparapani Valeria de Cassia, 2015, Pediatr Nurs, V41, P17
   Stanford EA, 2006, PAIN, V120, P16, DOI 10.1016/j.pain.2005.10.004
   Streiner DL, 2015, HLTH MEASUREMENT SCA
   Thompson S, 2016, J CHILD HEALTH CARE, V20, P267, DOI 10.1177/1367493515598643
   Tsze DS, 2013, PEDIATRICS, V132, pE971, DOI 10.1542/peds.2013-1509
   Twycross A, 2015, CLIN J PAIN, V31, P707, DOI 10.1097/AJP.0000000000000165
   Uman LS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005179
   Vantaa Benjaminsson M, 2017, CLIN NURSING STUDIES, V5, P13
   Varni JW, 1996, PAIN, V67, P141, DOI 10.1016/0304-3959(96)03077-1
   von Baeyer CL, 2004, J PAIN, V5, P241, DOI 10.1016/j.jpain.2004.05.001
   Walco Gary A, 2008, Pediatrics, V122 Suppl 3, pS125, DOI 10.1542/peds.2008-1055d
   Zhou HQ, 2008, J ADV NURS, V63, P334, DOI 10.1111/j.1365-2648.2008.04694.x
NR 48
TC 0
Z9 0
U1 2
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1367-4935
EI 1741-2889
J9 J CHILD HEALTH CARE
JI J. Child Health Care
PD DEC
PY 2017
VL 21
IS 4
BP 392
EP 403
DI 10.1177/1367493517729041
PG 12
WC Nursing; Pediatrics
SC Nursing; Pediatrics
GA FN4CL
UT WOS:000415950500004
PM 29110524
OA Green Published
DA 2019-01-08
ER

PT J
AU Dickinson, JK
   Guzman, SJ
   Maryniuk, MD
   O'Brian, CA
   Kadohiro, JK
   Jackson, RA
   D'Hondt, N
   Montgomery, B
   Close, KL
   Funnell, MM
AF Dickinson, Jane K.
   Guzman, Susan J.
   Maryniuk, Melinda D.
   O'Brian, Catherine A.
   Kadohiro, Jane K.
   Jackson, Richard A.
   D'Hondt, Nancy
   Montgomery, Brenda
   Close, Kelly L.
   Funnell, Martha M.
TI The Use of Language in Diabetes Care and Education
SO DIABETES EDUCATOR
LA English
DT Article
ID PSYCHOLOGICAL INSULIN-RESISTANCE; WEIGHT BIAS INTERNALIZATION; PATIENTS
   PREFERRED TERMS; PERSON-1ST LANGUAGE; PATIENT EMPOWERMENT; EMOTIONAL
   DISTRESS; DESCRIBING OBESITY; SELF-MANAGEMENT; NEGATIVE-WORDS; SOCIAL
   STIGMA
AB Language is powerful and can have a strong impact on perceptions as well as behavior. A task force, consisting of representatives from the American Association of Diabetes Educators and the American Diabetes Association, convened to discuss language in diabetes care and education. The literature supports the need for a language movement in diabetes care and education. There are effective ways of communicating about diabetes. This article provides recommendations for language used by health care professionals and others when discussing diabetes through spoken or written words, whether directed to people with diabetes, colleagues, or the general public, as well as research questions related to language and diabetes.
C1 [Dickinson, Jane K.] Columbia Univ, Teachers Coll, Box 35,525 West 120th St, New York, NY 10027 USA.
   [Guzman, Susan J.] Behav Diabet Inst, San Diego, CA USA.
   [Maryniuk, Melinda D.] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [O'Brian, Catherine A.] Amer Assoc Diabet Educ, Chicago, IL USA.
   [Kadohiro, Jane K.] Univ Hawaii Manoa, Honolulu, HI 96822 USA.
   [Jackson, Richard A.] Grassroots Diabet, Boston, MA USA.
   [D'Hondt, Nancy] Ascens St John Providence Hosp & Med Ctr, Detroit, MI USA.
   [Montgomery, Brenda] Astra Zeneca, Seattle, WA USA.
   [Close, Kelly L.] Close Concerns, San Francisco, CA USA.
   [Funnell, Martha M.] Michigan Ctr Diabet Translat Res, Ann Arbor, MI USA.
RP Dickinson, JK (reprint author), Columbia Univ, Teachers Coll, Box 35,525 West 120th St, New York, NY 10027 USA.
EM Dickinson@tc.columbia.edu
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829
   Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001
   [Anonymous], 2001, CROSSING QUALITY CHA
   [Anonymous], 2013, PEOPL 1 LANG OB
   [Anonymous], INT CLASS DIS
   Ayala J, 2014, WESTERN J NURS RES, V36, P1238, DOI 10.1177/0193945913518848
   Barnish M, 2014, OPEN J MOD LINGUIST, V4, P5505
   Benedetti F, 1997, PROG NEUROBIOL, V52, P109, DOI 10.1016/S0301-0082(97)00006-3
   Benedetti F, 2002, EVAL HEALTH PROF, V25, P369, DOI 10.1177/0163278702238051
   Berg FM, 1998, HLTH WEIGHT J, V12, P12
   Beverly EA, 2012, J GEN INTERN MED, V27, P1180, DOI 10.1007/s11606-012-2070-0
   Bissell P, 2004, SOC SCI MED, V58, P851, DOI 10.1016/S0277-9536(03)00259-4
   Bootle S, 2015, DIABETES RES CLIN PR, V109, P6, DOI 10.1016/j.diabres.2015.04.004
   Broom D, 2004, SOC SCI MED, V58, P2371, DOI 10.1016/j.socscimed.2003.09.002
   Brown A, 2016, DO WE REDUCE DIABETE
   Browne JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005625
   Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384
   Brummel-Smith K, 2016, J AM GERIATR SOC, V64, P15, DOI 10.1111/jgs.13866
   CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008
   Chun H, 2007, ADV CONSUM RES, V34, P715
   Collier R, 2012, CAN MED ASSOC J, V184, P1977, DOI 10.1503/cmaj.109-4319
   Dellasega C, 2012, DIABETES RES CLIN PR, V95, P37, DOI 10.1016/j.diabres.2011.08.011
   Diab P, 2012, JEMDSA, V17, P52, DOI 10.1080/22201009.2012.10872274
   Dickinson Jane K, 2017, Diabetes Spectr, V30, P11, DOI 10.2337/ds15-0054
   Dickinson Jane K, 2017, Clin Diabetes, V35, P51, DOI 10.2337/cd16-0014
   Dickinson JK, 2015, DIABETES EDUCATOR, V41, P665, DOI 10.1177/0145721715608952
   Dickinson JK, 2017, DIABETES SPECTR
   Dunn DS, 2015, AM PSYCHOL, V70, P255, DOI 10.1037/a0038636
   Dunning T, 2017, DIABETES EDUCATOR, V43, P18, DOI 10.1177/0145721716683449
   Durso LE, 2008, OBESITY, V16, pS80, DOI 10.1038/oby.2008.448
   Ellis S, 2014, J NUTR EDUC BEHAV, V46, P299, DOI 10.1016/j.jneb.2013.08.006
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fleischman S, 1999, J MED HUMANITIES, V20, P3
   Fleitas Joan, 2003, MCN Am J Matern Child Nurs, V28, P384
   Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576
   Funnell MM, 2016, PATIENT EDUC COUNS, V99, P1921, DOI 10.1016/j.pec.2016.10.010
   Glasgow RE, 1999, DIABETES CARE, V22, P2090, DOI 10.2337/diacare.22.12.2090
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gottlieb LN, 2014, AM J NURS, V114, P24, DOI 10.1097/01.NAJ.0000453039.70629.e2
   Gredig D, 2017, HEALTH SOC CARE COMM, V25, P1620, DOI 10.1111/hsc.12376
   Greenfield C, 2011, AUST J RURAL HEALTH, V19, P15, DOI 10.1111/j.1440-1584.2010.01171.x
   Haque M, 2005, SAMJ S AFR MED J, V95, P798
   HARDIN C, 1993, SOC COGNITION, V11, P277, DOI 10.1521/soco.1993.11.3.277
   HOLM S, 1993, J MED ETHICS, V19, P108, DOI 10.1136/jme.19.2.108
   Hoover J, 1980, Diabetes Educ, V6, P9, DOI 10.1177/014572178000600101
   International Diabetes Federation, 2014, INT DIAB FED LANG PH
   Iverson Ch., 2007, AMA MANUAL OF STYLE
   Jensen ME, 2013, J AM PSYCHIAT NURSES, V19, P146, DOI 10.1177/1078390313489729
   Jernigan K, 2009, BRAILLE MONITOR
   Kalra S, 2015, J SOC HLTH DIABETES, V3, P3
   Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184
   Kendrick JM, 2005, JOGNN-J OBST GYN NEO, V34, P329, DOI 10.1177/0884217505276306
   Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1
   Liu Nancy F, 2017, Clin Diabetes, V35, P27, DOI 10.2337/cd16-0020
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Lydecker JA, 2016, INT J CLIN PRACT, V70, P682, DOI 10.1111/ijcp.12835
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   Matthews SM, 2009, PATIENT EDUC COUNS, V76, P31, DOI 10.1016/j.pec.2008.11.022
   Meadows A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01527
   Nakar S, 2007, J DIABETES COMPLICAT, V21, P220, DOI 10.1016/j.jdiacomp.2006.02.004
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Norman Debbie, 2003, Br J Nurs, V12, P1256
   Ott J, 2012, CLIN J PAIN, V28, P324, DOI 10.1097/AJP.0b013e3182321cc3
   Paget L, 2012, PATIENT CLIN COMMUNI
   Pearl RL, 2017, OBESITY, V25, P317, DOI 10.1002/oby.21716
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2017, DIABETES RES CLIN PR, V127, P265, DOI 10.1016/j.diabres.2017.03.016
   Polonsky WH, 2011, CURR MED RES OPIN, V27, P1169, DOI 10.1185/03007995.2011.573623
   Polonsky WH, 2010, DIABETES EDUCATOR, V36, P828, DOI 10.1177/0145721710378539
   Puhl R, 2013, INT J OBESITY, V37, P612, DOI 10.1038/ijo.2012.110
   Rathert C, 2013, MED CARE RES REV, V70, P351, DOI 10.1177/1077558712465774
   Ritholz MD, 2014, CHRONIC ILLN, V10, P303, DOI 10.1177/1742395314525647
   Ritter A, 2016, HEALTHCARE, V4, P54
   ROSENTHAL R, 1994, CURR DIR PSYCHOL SCI, V3, P176, DOI 10.1111/1467-8721.ep10770698
   Rosenthal Robert, 1968, PYGMALION CLASSROOM
   Saleebey D, 1996, SOC WORK, V41, P296
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Schaffer R, 2016, ENDOCR TODAY
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Shiu ATY, 2003, J CLIN NURS, V12, P149, DOI 10.1046/j.1365-2702.2003.00735.x
   Speight J, 2012, DIABETES RES CLIN PR, V97, P425, DOI 10.1016/j.diabres.2012.03.015
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Swift JA, 2013, PATIENT EDUC COUNS, V91, P186, DOI 10.1016/j.pec.2012.12.008
   Texas Department of Aging and Disability Services, 2013, PERS 1 RESP LANG
   Vartanian LR, 2008, J HEALTH PSYCHOL, V13, P131, DOI 10.1177/1359105307084318
   Vishwanath A, 2014, HEALTH COMMUN, V29, P516, DOI 10.1080/10410236.2013.777685
   Volger S, 2012, OBESITY, V20, P147, DOI 10.1038/oby.2011.217
   Wadden TA, 2003, OBES RES, V11, P1140, DOI 10.1038/oby.2003.155
   Wang F, 2008, MINERVA ANESTESIOL, V74, P353
   Ward SH, 2009, J GEN INTERN MED, V24, P579, DOI 10.1007/s11606-009-0922-z
   Weaver J, 2016, J SOC PSYCHOL, V156, P179, DOI 10.1080/00224545.2015.1076761
   Weinger Katie, 2015, Diabetes Spectr, V28, P146, DOI 10.2337/diaspect.28.2.146
   Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502
   Winkley K, 2015, DIABETIC MED, V32, P120, DOI 10.1111/dme.12556
   Yelovich MC, 2016, J EVAL CLIN PRACT, V22, P558, DOI 10.1111/jep.12561
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
   Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc
NR 102
TC 3
Z9 3
U1 4
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD DEC
PY 2017
VL 43
IS 6
BP 551
EP 564
DI 10.1177/0145721717735535
PG 14
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA FM7DJ
UT WOS:000415231200001
PM 29040034
DA 2019-01-08
ER

PT J
AU Heitkemper, EM
   Mamykina, L
   Tobin, JN
   Cassells, A
   Smaldone, A
AF Heitkemper, Elizabeth M.
   Mamykina, Lena
   Tobin, Jonathan N.
   Cassells, Andrea
   Smaldone, Arlene
TI Baseline Characteristics and Technology Training of Underserved Adults
   With Type 2 Diabetes in the Mobile Diabetes Detective (MoDD) Randomized
   Controlled Trial
SO DIABETES EDUCATOR
LA English
DT Article
ID SELF-MANAGEMENT EDUCATION; IMPROVE GLYCEMIC CONTROL; CARE;
   QUESTIONNAIRE; METAANALYSIS; DISPARITIES; NUTRITION; DISTRESS; MELLITUS;
   SUPPORT
AB Purpose The purpose of this study is to describe the characteristics and technology training needs of underserved adults with type 2 diabetes mellitus (T2DM) who participated in a health information technology (HIT) diabetes self-management education (DSME) intervention.
   Methods The baseline physiological, psychosocial, and technology use characteristics for 220 adults with poorly controlled T2DM were evaluated. Intervention participants received a 1-time intervention training, which included basic technology help, introduction to the Mobile Diabetes Detective (MoDD) website and text message features, and account activation that included subject-specific tailoring. Four additional on-site sessions for participants needing computer or Internet access or technology support were made available based on need. Data regarding on-site visits for usual care were collected. Data were analyzed using descriptive statistics and bivariate analysis.
   Results The participants were predominately Hispanic and female with a baseline mean A1C of 10% (86 mmol/mol). Only half of the participants regularly used computers or text messages in daily life. The average introductory MoDD training session lasted 73.6 minutes. Following training, approximately one-third (35%) of intervention participants returned for basic and MoDD-specific technology assistance at their federally qualified health center. The most frequently reported duration for the extra training sessions was 30 to 45 minutes.
   Conclusions Training and support needs were greater than anticipated. Diabetes educators should assess technology abilities prior to implementing health information technology (HIT) diabetes self-management education (DSME) in underserved adults. Future research must invest resources in technology access, anticipate subject training, and develop new training approaches to ensure HIT DSME use and engagement.
C1 [Heitkemper, Elizabeth M.; Smaldone, Arlene] Columbia Univ, Med Ctr, Sch Nursing, New York, NY 10032 USA.
   [Mamykina, Lena] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA.
   [Tobin, Jonathan N.; Cassells, Andrea] Clin Directors Network CDN Inc, New York, NY USA.
   [Tobin, Jonathan N.] Rockefeller Univ, Ctr Clin & Translat Sci, 1230 York Ave, New York, NY 10021 USA.
   [Smaldone, Arlene] Columbia Univ, Coll Dent Med, Med Ctr, Dept Dent Behav Sci, New York, NY 10032 USA.
RP Heitkemper, EM (reprint author), Columbia Univ, Sch Nursing, 617 West 168th St, New York, NY 10032 USA.
EM emh2215@cumc.columbia.edu
FU National Institute of Nursing Research Training [NINR T32NR007969];
   National Institute of Diabetes and Digestive and Kidney Diseases
   [R01DK090372]
FX This work was supported by the National Institute of Nursing Research
   Training grant NINR T32NR007969 and the National Institute of Diabetes
   and Digestive and Kidney Diseases grant R01DK090372
CR American Diabetes Association, 2017, J DIABETES S1, V40, pS1
   [Anonymous], 2012, DIGITAL DIFFERENCES
   Attridge M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub3
   Chatterjee S, 2015, POSTGRAD MED J, V91, P612, DOI 10.1136/postgradmedj-2014-133200
   Cole-Lewis HJ, 2016, INT J MED INFORM, V85, P96, DOI 10.1016/j.ijmedinf.2015.08.003
   Czaja SJ, 2015, HUM FACTORS, V57, P491, DOI 10.1177/0018720814549238
   Ferdinand KC, 2015, CURR MED RES OPIN, V31, P913, DOI 10.1185/03007995.2015.1029894
   Ferguson S, 2015, DIABETES EDUCATOR, V41, P472, DOI 10.1177/0145721715584404
   Glasgow RE, 2004, J BEHAV MED, V27, P477, DOI 10.1023/B:JOBM.0000047611.81027.71
   Glasgow RE, 2007, DIABETES CARE, V30, P33, DOI 10.2337/dc06-1390
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hawthorne K, 2010, DIABETIC MED, V27, P613, DOI 10.1111/j.1464-5491.2010.02954.x
   Heitkemper EM, 2017, J AM MED INFORM ASSN, V24, P1024, DOI 10.1093/jamia/ocx025
   Horigan G, 2017, DIABETIC MED, V34, P14, DOI 10.1111/dme.13120
   Lai Albert M, 2006, AMIA Annu Symp Proc, P459
   Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280
   Li R, 2014, MMWR-MORBID MORTAL W, V63, P1045
   Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x
   Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006
   Mamykina L, 2016, J AM MED INFORM ASSN, V23, P129, DOI 10.1093/jamia/ocv169
   Mamykina L, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P477
   Office of Disease Prevention and Health Promotion Department of Health and Human Services, DIAB OBJ HLTH PEOPL
   Oster Natalia Vukshich, 2006, Dis Manag, V9, P167, DOI 10.1089/dis.2006.9.167
   Pal K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008776.pub2
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694
   Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38
   PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437
   Ricci-Cabello I, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-60
   Ritter PL, 2016, DIABETES EDUCATOR, V42, P167, DOI 10.1177/0145721716628648
   Robinson KS, 2010, CIN-COMPUT INFORM NU, V28, P172, DOI 10.1097/NCN.0b013e3181d785d5
   Rovner AJ, 2012, DIABETES CARE, V35, P1643, DOI 10.2337/dc11-2371
   Shah Viral N, 2015, Clin Diabetes Endocrinol, V1, P16, DOI 10.1186/s40842-015-0016-2
   Shaw K, 2011, DIABETES EDUCATOR, V37, P813, DOI 10.1177/0145721711424618
   Starren J, 2005, CIN-COMPUT INFORM NU, V23, P181, DOI 10.1097/00024665-200507000-00004
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Vincent D, 2008, NURS RES, V57, P101, DOI 10.1097/01.NNR.0000313484.18670.ab
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch G, 2007, ETHNIC DIS, V17, P541
NR 39
TC 0
Z9 0
U1 2
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD DEC
PY 2017
VL 43
IS 6
BP 576
EP 588
DI 10.1177/0145721717737367
PG 13
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA FM7DJ
UT WOS:000415231200003
PM 29059017
OA Green Accepted
DA 2019-01-08
ER

PT J
AU DiNardo, M
   Saba, S
   Greco, CM
   Broyles, L
   Terhorst, L
   Chasens, ER
   Bair, B
   Charron-Prochownik, D
   Cohen, S
AF DiNardo, Monica
   Saba, Shaddy
   Greco, Carol M.
   Broyles, Lauren
   Terhorst, Lauren
   Chasens, Eileen R.
   Bair, Brandi
   Charron-Prochownik, Denise
   Cohen, Susan
TI A Mindful Approach to Diabetes Self-Management Education and Support for
   Veterans
SO DIABETES EDUCATOR
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; STRESS-REDUCTION
   INTERVENTION; GLYCEMIC CONTROL; EMPOWERMENT SCALE; MEDITATION;
   DEPRESSION; DISTRESS; MEDICINE; ADULTS
AB Purpose The purpose of this study is to determine feasibility, satisfaction, and preliminary effects of Mindful Stress Reduction in Diabetes Education (Mind-STRIDE), a mindfulness-based intervention for veterans.
   Methods The study used a single-group pretest-posttest repeated-measures design. The 90-minute Mind-STRIDE training, adapted from Mindfulness Based Stress Reduction (MBSR), was provided as the final component of a half-day diabetes self-management education class at a Veterans Affairs (VA) outpatient diabetes clinic. Following initial training, participants were asked to practice mindfulness at home for 10 minutes each day during the 3-month study. Study recruitment and retention were calculated as rates. Veteran and diabetes educator satisfaction were assessed by rating scales and open-ended comments. Psychosocial-behavioral and metabolic outcomes were assessed at baseline and 3 months after initial training. Bivariate correlations were performed to describe relationships between mindfulness and other outcome variables. Gain scores and Wilcoxon matched-pair signed rank tests were used to assess pre to post changes; Cohen's d was applied to estimate the magnitude of effects.
   Results Twenty-eight of 49 eligible veterans (57%) enrolled in the study. Of those, 11 veterans (39%) demonstrated participation in home practice, and 20 veterans (71%) completed the study. Overall, participants and diabetes educators were highly satisfied with the Mind-STRIDE intervention. Significant improvements were found in diabetes distress, diabetes self-efficacy, diabetes self-management behaviors, mindful-describing, and A1C.
   Conclusion Results suggest feasibility, satisfaction, and positive preliminary effects. Efficacy testing by randomized controlled trial with analysis of covariance structures is warranted.
C1 [DiNardo, Monica; Saba, Shaddy; Broyles, Lauren; Bair, Brandi] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA.
   [Saba, Shaddy] Univ Pittsburgh, Med Ctr, Dept Anesthesiol, Pittsburgh, PA USA.
   [Greco, Carol M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA.
   [Terhorst, Lauren] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Pittsburgh, PA USA.
   [Chasens, Eileen R.; Bair, Brandi; Charron-Prochownik, Denise; Cohen, Susan] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA.
RP DiNardo, M (reprint author), VA Pittsburgh Healthcare Syst, Univ Dr,151C, Pittsburgh, PA 15240 USA.
EM Monica.Dinardo@va.gov
RI Terhorst, Lauren/H-7942-2018
OI Cohen, Susan/0000-0002-3860-4681
FU American Association of Diabetes Educators Education AADE Research
   Foundation; AADE Advanced Practice Community of Interest Scholarship and
   Research Grant [AADE-AP 2012-001]
FX This study was supported by a 2012 American Association of Diabetes
   Educators Education AADE Research Foundation and AADE Advanced Practice
   Community of Interest Scholarship and Research Grant (AADE-AP 2012-001)
   awarded to the principal investigator.
CR Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504
   Bergomi C, 2013, MINDFULNESS, V4, P191, DOI 10.1007/s12671-012-0110-9
   Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077
   Bormann JE, 2014, MED CARE, V52, pS13, DOI 10.1097/MLR.0000000000000200
   Carlson LE, 2005, INT J BEHAV MED, V12, P278, DOI 10.1207/s15327558ijbm1204_9
   Charron-Prochownik D, 2006, DIABETES SPECTR, V19, P220
   Cohen J, 1988, STAT POWER ANAL BEHA
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Diabetes-QUERI Executive Committee, 2013, QUAL ENH RES IN FACT
   Fabian E, 2011, ANN NUTR METAB, V58, P101, DOI 10.1159/000326765
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Friis AM, 2016, DIABETES CARE, V39, P1963, DOI 10.2337/dc16-0416
   Gould CE, 2015, INT J GERIATR PSYCH, V30, P623, DOI 10.1002/gps.4193
   Gregg JA, ACCEPTANCE COMMITMEN
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Gross CR, 2014, WILEY BLACKWELL HANDBOOK OF MINDFULNESS, VOLS I AND II, P898
   Grossman P, 2007, PSYCHOTHER PSYCHOSOM, V76, P226, DOI 10.1159/000101501
   Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343
   Kabat-Zinn J, 1998, PSYCHOSOM MED, V60, P625, DOI 10.1097/00006842-199809000-00020
   Kabat-Zinn J., 1990, FULL CATASTROPHE LIV
   KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3
   Kearney DJ, 2012, J CLIN PSYCHOL, V68, P101, DOI 10.1002/jclp.20853
   Khunti K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2333
   King AP, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00154
   Kligler Benjamin, 2014, Journal of the National Cancer Institute Monographs, P292, DOI 10.1093/jncimonographs/lgu039
   KOENIG RJ, 1976, DIABETES, V25, P230, DOI 10.2337/diabetes.25.3.230
   Lang AJ, 2012, BEHAV MODIF, V36, P759, DOI 10.1177/0145445512441200
   Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350
   Merkes M, 2010, AUST J PRIM HEALTH, V16, P200, DOI 10.1071/PY09063
   Miller CK, 2012, J ACAD NUTR DIET, V112, P1835, DOI 10.1016/j.jand.2012.07.036
   Morone NE, 2008, PAIN, V134, P310, DOI 10.1016/j.pain.2007.04.038
   Mulcahy K, 2003, DIABETES EDUCATOR, V29, P768, DOI 10.1177/014572170302900509
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694
   Pradhan EK, 2007, ARTHRIT RHEUM-ARTHR, V57, P1134, DOI 10.1002/art.23010
   Rosenzweig S, 2010, J PSYCHOSOM RES, V68, P29, DOI 10.1016/j.jpsychores.2009.03.010
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   Shapiro D, 1980, SCI MEDITATION THEOR
   Tacon AM, 2003, FAM COMMUNITY HEALTH, V26, P25, DOI 10.1097/00003727-200301000-00004
   Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037/0022-006X.68.4.615
   Teixeira E, 2010, HOLIST NURS PRACT, V24, P277, DOI 10.1097/HNP.0b013e3181f1add2
   Tilburt JC, 2009, ARCH INTERN MED, V169, P670, DOI 10.1001/archinternmed.2009.49
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   Wahbeh Helane, 2011, Mindfulness (N Y), V2, P219
   Walsh R, 2006, AM PSYCHOL, V61, P227, DOI 10.1037/0003-066X.61.3.227
   Witek-Janusek L, 2008, BRAIN BEHAV IMMUN, V22, P969, DOI 10.1016/j.bbi.2008.01.012
   Young-Hyman D, 2017, DIABETES CARE, V40, P726, DOI 10.2337/dc17-er05
   Youssef NA, 2013, ARCH SUICIDE RES, V17, P106, DOI 10.1080/13811118.2013.776445
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
   Zeidan F, 2010, CONSCIOUS COGN, V19, P597, DOI 10.1016/j.concog.2010.03.014
NR 56
TC 0
Z9 0
U1 7
U2 13
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD DEC
PY 2017
VL 43
IS 6
BP 608
EP 620
DI 10.1177/0145721717738019
PG 13
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA FM7DJ
UT WOS:000415231200006
PM 29078735
DA 2019-01-08
ER

PT J
AU Browne, JL
   Ventura, AD
   Mosely, K
   Speight, J
AF Browne, J. L.
   Ventura, A. D.
   Mosely, K.
   Speight, J.
TI Measuring Type 1 diabetes stigma: development and validation of the Type
   1 Diabetes Stigma Assessment Scale (DSAS-1)
SO DIABETIC MEDICINE
LA English
DT Article
ID NEUROLOGICAL CONDITIONS; PUBLIC-HEALTH; DISTRESS; EPILEPSY; ILLNESS;
   OBESITY; PEOPLE; BIAS; METAANALYSIS; DISORDER
AB Aims To develop and validate a self-report measure designed to assess perceived and experienced stigma for adults with Type 1 diabetes: the Type 1 Diabetes Stigma Assessment Scale (DSAS-1).
   Methods A large item-pool (64 items) was drafted based on qualitative data from interviews with 27 adults with Type 1 diabetes. Eleven adults with Type 1 diabetes completed the draft questionnaire (responding to items using a five-point Likert scale), and participated in cognitive debriefing interviews. Based on their feedback, the item-pool was reduced and refined. Adults with Type 1 diabetes (N=898) completed an online survey including the draft stigma questionnaire (41 items) and other validated measures. Psychometric validation included principal components analysis and confirmatory factor analysis (split samples), internal consistency reliability assessment and Spearman's rho correlations.
   Results Scale reduction techniques resulted in 19 items (alpha=0.93). An unforced three-factor solution suggested three subscales: Treated Differently (six items, alpha=0.89); Blame and Judgement (six items, alpha=0.88); and Identity Concerns (seven items, alpha =0.89). This was corroborated with a confirmatory factor analysis, which demonstrated reasonable model fit with the three factors; less so for a single-factor model. Satisfactory concurrent, convergent and discriminant validity were demonstrated.
   ConclusionsThe 19-item DSAS-1 is a valid and reliable measure of the perceptions and experiences of Type 1 diabetes stigma. This novel, relatively brief measure has satisfactory psychometric properties. The DSAS-1 is now available for investigations into the nature and magnitude of the relationships between diabetes stigma and diabetes self-care behaviours and outcomes.
C1 [Browne, J. L.; Ventura, A. D.; Speight, J.] Deakin Univ, Sch Psychol, Geelong, Vic, Australia.
   [Browne, J. L.; Ventura, A. D.; Speight, J.] Australian Ctr Behav Res Diabet, Diabet Victoria, Melbourne, Vic, Australia.
   [Mosely, K.] BodyMatters Australasia, Sydney, NSW, Australia.
   [Speight, J.] AHP Res, Hornchurch, England.
RP Browne, JL (reprint author), Deakin Univ, Sch Psychol, Geelong, Vic, Australia.; Browne, JL (reprint author), Australian Ctr Behav Res Diabet, Diabet Victoria, Melbourne, Vic, Australia.
EM jbrowne@acbrd.org.au
OI Speight, Jane/0000-0002-1204-6896
FU Diabetes Australia Research Trust grant; Sanofi; Diabetes Victoria;
   Deakin University
FX This design and development of the questionnaire was funded by a
   Diabetes Australia Research Trust grant, while an unrestricted
   educational grant from Sanofi enabled us to enhance the sample size for
   the validation study. Neither of the funding bodies played a role in the
   study design, data collection or analysis, or interpretation or write-up
   of the results. J.L.B. and J.S. were supported by core funding to The
   Australian Centre for Behavioural Research in Diabetes derived from the
   collaboration between Diabetes Victoria and Deakin University.
CR Aikins ADG, 2006, J COMMUNITY APPL SOC, V16, P426, DOI 10.1002/casp.892
   Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x
   Bethlehem J, 2010, INT STAT REV, V78, P161, DOI 10.1111/j.1751-5823.2010.00112.x
   Browne JL, 2016, DIABETES CARE, V39, P2141, DOI 10.2337/dc16-0117
   Browne JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005625
   Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384
   Cataldo Janine K, 2011, Oncol Nurs Forum, V38, pE46, DOI 10.1188/11.ONF.E46-E54
   Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI DOI 10.1316/S0782-051X03024046-9
   Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027
   Della LJ, 2011, J RURAL HEALTH, V27, P3, DOI 10.1111/j.1748-0361.2010.00311.x
   Earnshaw VA, 2013, J BEHAV MED, V36, P270, DOI 10.1007/s10865-012-9422-4
   Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069
   Hayward P, 1997, J MENT HEALTH, V6, P345, DOI DOI 10.1080/09638239718671
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Hutcheson G. D, 1999, MULTIVARIATE SOCIAL
   Jacoby A, 2005, LANCET NEUROL, V4, P171, DOI 10.1016/S1474-4422(05)01014-8
   JACOBY A, 1994, SOC SCI MED, V38, P269, DOI 10.1016/0277-9536(94)90396-4
   Kato A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0179-z
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363
   Livingston JD, 2010, SOC SCI MED, V71, P2150, DOI 10.1016/j.socscimed.2010.09.030
   MacLeod JS, 2003, EPILEPSY BEHAV, V4, P112, DOI 10.1016/S1525-5050(03)00007-6
   Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137
   Mak WWS, 2007, SOC SCI MED, V65, P245, DOI 10.1016/j.socscimed.2007.03.015
   Molina Y, 2013, INT J BEHAV MED, V20, P450, DOI 10.1007/s12529-012-9243-4
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2009, AM DIAB ASS 69 SCI S
   Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108
   Puhl RM, 2008, HEALTH EDUC RES, V23, P347, DOI 10.1093/her/cym052
   Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491
   Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636
   Rao D, 2009, QUAL LIFE RES, V18, P585, DOI 10.1007/s11136-009-9475-1
   Rosenberg M., 1965, SOC ADOLESCENT CHILD
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017
   Valdiserri RO, 2002, AM J PUBLIC HEALTH, V92, P341, DOI 10.2105/AJPH.92.3.341
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Wheaton B, 1977, SOCIOL METHODOL, V8, P84, DOI [10.2307/270754, DOI 10.2307/270754, 10. 2307/270754]
NR 44
TC 2
Z9 2
U1 2
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD DEC
PY 2017
VL 34
IS 12
BP 1773
EP 1782
DI 10.1111/dme.13507
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FM6TJ
UT WOS:000415191800017
PM 28891210
DA 2019-01-08
ER

PT J
AU Weissberg-Benchell, J
   Hessler, D
   Fisher, L
   Russell, SJ
   Polonsky, WH
AF Weissberg-Benchell, Jill
   Hessler, Danielle
   Fisher, Lawrence
   Russell, Steven J.
   Polonsky, William H.
TI Impact of an Automated Bihormonal Delivery System on Psychosocial
   Outcomes in Adults with Type 1 Diabetes
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
DE Bionic pancreas; Psychosocial outcomes; Artificial pancreas
ID EXCHANGE CLINIC REGISTRY; ARTIFICIAL PANCREAS; CLOSED-LOOP;
   PEDIATRIC-PATIENTS; INSULIN DELIVERY; BIONIC PANCREAS; GLUCOSE CONTROL;
   CHILDREN; DISCONTINUATION; ADOLESCENTS
AB Objectives: The study assessed the psychosocial impact of the bihormonal bionic pancreas (BP) on adults in a real-world outpatient setting.
   Research Design and Methods: Thirty-nine adults with type 1 diabetes at four study centers across the U.S. participated in a two-arm, random-order, crossover design study: 11 days with the BP and 11 days with their usual care (UC). Psychosocial questionnaires were administered before the first study arm, at the end of the first study arm, and at the end of the second study arm.
   Results: The mean age of participants was 33 years; mean diabetes duration was 17 years; and 84% were non-Hispanic Caucasian. Significantly greater improvements in psychosocial outcomes were found following the use of BP versus UC; these included reductions in diabetes-related distress (P<0.001) with the greatest drops in distress related to hypoglycemia and to eating constraints, and greater treatment satisfaction (P<0.05). The majority of BP users described their experience as positive with a reduction in worrying about low (72%) and high (69%) blood sugars. The majority reported trusting the device (69%) and feeling less burdened by the BP than their usual method of diabetes care (64%). Concerns about the burden of the BP were also expressed, with >75% of users highlighting the burden of carrying around the equipment and the need to change glucagon daily, and more than half of the participants reporting concerns about wearability, discomfort, the time it took to correct out-of-range numbers, and glitches in the system.
   Conclusions: Overall, participants report substantial psychosocial benefits accruing from the BP relative to their usual method of diabetes care. However, participants also reported a number of burdens associated with the system. Future versions of the BP device should be designed with the goal of addressing these concerns, and studies with larger, more diverse samples, and with more technology-naive participants are needed.
C1 [Weissberg-Benchell, Jill] Ann & Robert H Lurie Childrens Hosp Chicago, 225 East Chicago Ave,Box 10, Chicago, IL 60611 USA.
   [Hessler, Danielle; Fisher, Lawrence; Polonsky, William H.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Russell, Steven J.] Massachusetts Gen Hosp, Diabet Res Ctr, Boston, MA 02114 USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
RP Weissberg-Benchell, J (reprint author), Ann & Robert H Lurie Childrens Hosp Chicago, 225 East Chicago Ave,Box 10, Chicago, IL 60611 USA.
EM jwbenchell@luriechildrens.org
CR Atlas E, 2010, DIABETES CARE, V33, P1072, DOI 10.2337/dc09-1830
   Babar GS, 2009, DIABETES TECHNOL THE, V11, P131, DOI 10.1089/dia.2008.0042
   Bech P, 1999, ACTA ANAESTH SCAND, V43, P893, DOI 10.1034/j.1399-6576.1999.430906.x
   Beck RW, 2012, J CLIN ENDOCR METAB, V97, P4383, DOI 10.1210/jc.2012-1561
   Blauw H, 2013, DIABETES TECHNOL THE, V15, P619, DOI 10.1089/dia.2013.0196
   BRADLEY C, 1990, DIABETIC MED, V7, P445, DOI 10.1111/j.1464-5491.1990.tb01421.x
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   Breton M, 2012, DIABETES, V61, P2230, DOI 10.2337/db11-1445
   Buckingham Bruce, 2005, Diabetes Technol Ther, V7, P440, DOI 10.1089/dia.2005.7.440
   Castle JR, 2010, DIABETES CARE, V33, P1282, DOI 10.2337/dc09-2254
   Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654
   de Vries L, 2011, PEDIATR DIABETES, V12, P506, DOI 10.1111/j.1399-5448.2010.00701.x
   El-Khatib F, 2010, SCI TRANS MED, V4, P1374
   El-Khatib FH, 2017, LANCET, V389, P369, DOI 10.1016/S0140-6736(16)32567-3
   El-Khatib FH, 2014, J CLIN ENDOCR METAB, V99, P1701, DOI 10.1210/jc.2013-4151
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Hofer SE, 2010, PEDIATR DIABETES, V11, P116, DOI 10.1111/j.1399-5448.2009.00546.x
   Hovorka R, 2010, LANCET, V375, P743, DOI 10.1016/S0140-6736(09)61998-X
   Lombardo F, 2012, ACTA DIABETOL, V49, pS99, DOI 10.1007/s00592-011-0344-3
   Mauras N, 2012, DIABETES CARE, V35, P204, DOI 10.2337/dc11-1746
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112
   O'Connell Michele A, 2008, J Diabetes Sci Technol, V2, P91
   Russell SJ, 2016, LANCET DIABETES ENDO, V4, P233, DOI 10.1016/S2213-8587(15)00489-1
   Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474
   Russell SJ, 2012, DIABETES CARE, V35, P2148, DOI [10.2337/dc12-0071, 10.2337/dc12-0071/-/DC1]
   Staehr Johansen K, 1989, MULTICENTRE CONTINUO
   Steil GM, 2006, DIABETES, V55, P3344, DOI 10.2337/db06-0419
   Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967
NR 30
TC 2
Z9 2
U1 0
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD DEC
PY 2017
VL 19
IS 12
BP 723
EP 729
DI 10.1089/dia.2017.0174
EA NOV
EY 2017
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FQ1XU
UT WOS:000414637900001
PM 29106311
DA 2019-01-08
ER

PT J
AU Weissberg-Benchell, J
   Rychlik, K
AF Weissberg-Benchell, Jill
   Rychlik, Karen
TI Diabetes camp matters: Assessing families' views of their diabetes camp
   experience
SO PEDIATRIC DIABETES
LA English
DT Article
DE adaptation; camping; pediatric psychology; psychological; type 1
   diabetes
ID ADOLESCENTS; CHILDREN; CARE
AB BACKGROUNDCamp offers a safe and fun environment for learning new information about diabetes care and for trying new self-care skills. It is a place where children and teens are able to meet with others who also have diabetes and who share their experiences.
   MATERIALS AND METHODSThis study assessed self-reports before and after attending diabetes camp on diabetes-specific emotional distress, diabetes-specific quality of life, and self-care behaviors by surveying campers and their parents from over 42 diabetes-specific summer camps across the United States. Parents (N=413), Teenagers (N=154), and Children (N=116) completed both pre- and post-camp surveys.
   RESULTSParents reported higher levels of diabetes-specific emotional distress than their campers did. Both parents and children reported significant improvements in their own distress after camp. Teens reported improvements in distress but they were not statistically significant. Youth report higher levels of self-care skills than parents believe their children possess. Parents, Teens, and Children all reported significant improvements in the camper's self-care skills after camp. First time campers' and their parents' perspectives regarding self-care skills are consistent with veteran campers after attending camp. Self-reports post-camp reveals that campers and their parents see camp as a place where youth feel they are with others who really understand what it is like to live with diabetes. Respondents also report that camp is a place where youth are exposed to new technologies and where campers can try new self-care tasks.
C1 [Weissberg-Benchell, Jill] Ann & Robert H Lurie Childrens Hosp Chicago, Child & Adolescent Psychiat, 225 East Chicago Ave,Box 10, Chicago, IL 60611 USA.
   [Rychlik, Karen] Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Stat Core, Chicago, IL 60611 USA.
RP Weissberg-Benchell, J (reprint author), Ann & Robert H Lurie Childrens Hosp Chicago, Child & Adolescent Psychiat, 225 East Chicago Ave,Box 10, Chicago, IL 60611 USA.
EM jwbenchell@luriechildrens.org
CR Briery BG, 1999, J PEDIATR PSYCHOL, V24, P183, DOI 10.1093/jpepsy/24.2.183
   de Wit M, 2012, PEDIATR DIABETES, V13, P638, DOI 10.1111/j.1399-5448.2012.00872.x
   Evans M., 2016, 76 ANN SCI SESS AM D
   Evans M, 2016, SOC PED PSYCH ANN C
   Fegan-Bohn K, CURR DIAB R IN PRESS
   Nabors Laura A, 2014, Diabetes Spectr, V27, P257, DOI 10.2337/diaspect.27.4.257
   Odar C, 2013, J PEDIATR PSYCHOL, V38, P398, DOI 10.1093/jpepsy/jss176
   Pihoker C, 2014, PEDIATR DIABETES, V15, P86, DOI 10.1111/pedi.12181
   Redon I, 2014, PEDIATR DIABETES, V15, P329, DOI 10.1111/pedi.12062
   Santiprabhob J, 2008, PATIENT EDUC COUNS, V73, P60, DOI 10.1016/j.pec.2008.05.023
   Wang YCA, 2008, PEDIATR DIABETES, V9, P29, DOI 10.1111/j.1399-5448.2007.00285.x
   Weissberg-Benchell J, 2014, 74 ANN SCI SESS AM D
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Weissberg-Benchell J, 2009, J PEDIATR PSYCHOL, V34, P977, DOI 10.1093/jpepsy/jsp003
NR 14
TC 3
Z9 3
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1399-543X
EI 1399-5448
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD DEC
PY 2017
VL 18
IS 8
BP 853
EP 860
DI 10.1111/pedi.12499
PG 8
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA FM4SP
UT WOS:000415012600027
PM 28156056
DA 2019-01-08
ER

PT J
AU Holmes-Truscott, E
   Furler, J
   Blackberry, I
   O'Neal, DN
   Speight, J
AF Holmes-Truscott, Elizabeth
   Furler, John
   Blackberry, Irene
   O'Neal, David N.
   Speight, Jane
TI Predictors of insulin uptake among adults with type 2 diabetes in the
   Stepping Up Study
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Insulin therapy; Psychological insulin resistance; Attitudes; Primary
   care
ID EUROPEAN ASSOCIATION; STARTING INSULIN; THERAPY; RESISTANCE;
   HYPERGLYCEMIA; MANAGEMENT; INITIATION; STATEMENT; ATTITUDES; PEOPLE
AB Aims: We aimed to investigate predictors of insulin uptake, and change in insulin appraisals, among adults with type 2 diabetes mellitus (T2DM) who participated in the Stepping Up trial.
   Methods: The Stepping Up model of care, supporting timely insulin initiation in primary care, was evaluated in a two-armed cluster-randomised controlled trial. Participants were 266 adults (mean +/- SD age 62 +/- 10 years; 39% women) with T2DM (median (IQR) duration 8.5 (5, 13) years) from 74 primary care practices (Stepping Up intervention: 57%, control 43%). At 12 months, 47% (n = 126) had commenced insulin. Controlling for randomisation, logistic regression was used to explore baseline predictors of insulin uptake, including: demographic and clinical characteristics, emotional wellbeing (depressive symptoms and diabetes-related distress), insulin treatment appraisals, and, 'willingness' to initiate insulin. Two-way analysis of variance examined effects of, and interaction between, randomisation and insulin uptake on 12-month change in insulin appraisals.
   Results: Participants using insulin at 12 months were more likely (all p < 0.05) than those with non-insulin-treated T2DM to report: lower socioeconomic status, higher baseline HbA1c (median difference: 0.3%; 3 mmol/mol), greater willingness to commence insulin (very willing: 27% vs 12%), and less negative and more positive insulin appraisals. All contributed significantly to the final model (chi(2)(8) = 92.1, p < 0.001) except insulin appraisals. Regardless of trial allocation, those initiating insulin reported significantly greater reductions in negative insulin appraisals.
   Conclusions: Controlling for randomisation, 12-month insulin use was predicted by higher baseline HbA1c and 'willingness' to use insulin if recommended. Negative insulin appraisals reduced following insulin initiation. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Holmes-Truscott, Elizabeth; Speight, Jane] Deakin Univ, Sch Psychol, 1 Gheringhap St, Geelong, Vic 3220, Australia.
   [Holmes-Truscott, Elizabeth; Speight, Jane] Australian Ctr Behav Res Diabet, Diabet Victoria, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Furler, John; Blackberry, Irene] Univ Melbourne, Dept Gen Practice, 200 Berkeley St, Carlton, Vic 3052, Australia.
   [Blackberry, Irene] La Trobe Univ, Australian Inst Primary Care & Ageing, John Richards Initiat, POB 821, Wodonga, Vic 3689, Australia.
   [O'Neal, David N.] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Fitzroy, Vic 3065, Australia.
   [Speight, Jane] AHP Res, 16 Walden Way, Hornchurch RM11 2LB, England.
RP Holmes-Truscott, E (reprint author), Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
EM etruscott@acbrd.org.au
OI Holmes-Truscott, Elizabeth/0000-0001-9139-4663; Speight,
   Jane/0000-0002-1204-6896
FU Australian National Health and Medical Research Council [APP1023738];
   Roche Diabetes Care Pty Ltd; RACGP Foundation RACGP/Independent
   Practitioner Network Pty Ltd (IPN); Australian Postgraduate Award/Deakin
   University PhD scholarship; NHMRC/PHCRED Career Development Fellowship;
   Australian Centre for Behavioural Research in Diabetes by Diabetes
   Victoria and Deakin University
FX The Stepping Up trial was funded substantively by the Australian
   National Health and Medical Research Council (Project Grant:
   APP1023738). It was also supported by an unrestricted
   educational/research grant by Roche Diabetes Care Pty Ltd, an RACGP
   Foundation RACGP/Independent Practitioner Network Pty Ltd (IPN) Grant
   and in-kind support from Sanofi. The funders of Stepping Up were not
   involved in trial study design, data collection or analysis,
   interpretation of results or manuscript preparation and submission.; EHT
   is supported by an Australian Postgraduate Award/Deakin University PhD
   scholarship. JF is supported by an NHMRC/PHCRED Career Development
   Fellowship. JS is supported by the core funding provided to The
   Australian Centre for Behavioural Research in Diabetes by Diabetes
   Victoria and Deakin University.
CR [Anonymous], 1995, Diabetes, V44, P1249
   Australian Bureau of Statistics, 2011, SOC EC IND AR 2011
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Bogatean MP, 2004, PRACT DIABETES INT, V21, P247, DOI DOI 10.1002/PDI.670
   Danne T, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0051-0
   Furler J, 2015, ADS ADEA ANN SCI M A
   Furler JS, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-20
   Hermanns N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-113
   Holmes-Truscott E, 2016, DIABETES RES CLIN PR, V114, P126, DOI 10.1016/j.diabres.2015.12.011
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441
   Keij SM, 2016, DIABETIC MED, V33, P170
   Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331
   Khunti S, 2015, BRIT J DIABETES VASC, V15, P65, DOI 10.15277/bjdvd.2015.019
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y
   Nefs G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078865
   Ng CJ, 2015, INT J CLIN PRACT, V69, P1050, DOI 10.1111/ijcp.12691
   Odawara M, 2016, CURR MED RES OPIN, V32, P681, DOI 10.1185/03007995.2015.1136605
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2011, CURR MED RES OPIN, V27, P1169, DOI 10.1185/03007995.2011.573623
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Speight J, 2011, DIABETES MILES AUSTR
   The Royal Australian College of General Practitioners and Diabetes Australia, 2014, GEN PRACT MAN TYP 2
   Turner RC, 1998, LANCET, V352, P837
NR 28
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD NOV
PY 2017
VL 133
BP 204
EP 210
DI 10.1016/j.diabres.2017.01.002
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FM9WU
UT WOS:000415623700025
PM 29122108
DA 2019-01-08
ER

PT J
AU Vileikyte, L
   Crews, RT
   Reeves, ND
AF Vileikyte, Loretta
   Crews, Ryan T.
   Reeves, Neil D.
TI Psychological and Biomechanical Aspects of Patient Adaptation to
   Diabetic Neuropathy and Foot Ulceration
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Diabetic symmetric polyneuropathy; Pain; Unsteadiness; Foot ulcers;
   Depression; Illness cognition and emotion; Offloading adherence;
   Physical activity
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; NORD-TRONDELAG HEALTH;
   CUSTOM-MADE FOOTWEAR; PERIPHERAL NEUROPATHY; OLDER-ADULTS; AEROBIC
   EXERCISE; SINGLE-BLIND; HIGH-RISK; DEPRESSIVE SYMPTOMS
AB Purpose of Review The purpose of this review was to elucidate how psychological and biomechanical factors interrelate in shaping patients' experience with diabetic symmetric polyneuropathy (DSPN) and its sequela-diabetic foot ulceration (DFU).
   Recent Findings Recent findings emphasize the importance not only of neuropathic pain but also of other DSPN symptoms, such as unsteadiness. We highlight the negative spiral between unsteadiness, falls, and psychological distress. Moreover, unsteadiness is a key determinant of non-adherence to offloading resulting in the delayed DFU healing. While depression is an established predictor of incident DFU, findings linking depression and DFU healing remain inconclusive. Examination of physical activity in DFU development and healing represents the most recent application of research to this field.
   Summary Research evidence indicates that DSPN markedly impairs physical and emotional functioning and suggests that there is an unmet need for the development of multifaceted interventions that address both psychological distress and biomechanical challenges experienced by patients with this debilitating complication of diabetes.
C1 [Vileikyte, Loretta] Univ Manchester, Dept Med, Manchester M13 9WL, Lancs, England.
   [Crews, Ryan T.] Rosalind Franklin Univ Med & Sci, William M Scholl Coll Podiatr Med, N Chicago, IL 60064 USA.
   [Reeves, Neil D.] Manchester Metropolitan Univ, Fac Sci & Engn, Sch Healthcare Sci, Manchester M1 5GD, Lancs, England.
RP Vileikyte, L (reprint author), Univ Manchester, Dept Med, Manchester M13 9WL, Lancs, England.
EM lvileikyte@med.miami.edu
OI Reeves, Neil/0000-0001-9213-4580
FU NIH (NIDDK) [R01-DK-071066]
FX We thank the NIH (NIDDK R01-DK-071066) for their generous support of
   some of the studies reported in this review.
CR Ahroni JH, 2000, J DIABETES COMPLICAT, V14, P31, DOI 10.1016/S1056-8727(00)00066-0
   Arts MLJ, 2014, J REHABIL MED, V46, P357, DOI 10.2340/16501977-1272
   Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600
   Brown SJ, 2015, DIABETES CARE, V38, P1116, DOI 10.2337/dc14-1982
   Brownlee S., 2000, HDB SELF REGULATION, P369, DOI DOI 10.1016/B978-012109890-2/50041-X
   Bus SA, 2016, DIABETES-METAB RES, V32, P195, DOI 10.1002/dmrr.2738
   Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x
   Colberg Sheri R, 2010, Diabetes Care, V33, pe147, DOI 10.2337/dc10-9990
   Crews RT, 2016, DIABETES-METAB RES, V32, P791, DOI 10.1002/dmrr.2817
   Crews RT, 2016, DIABETES CARE, V39, P1371, DOI 10.2337/dc15-2373
   Crews Ryan T, 2013, J Aging Res, V2013, P342650, DOI 10.1155/2013/342650
   Crews RT, 2012, CLIN BIOMECH, V27, P725, DOI 10.1016/j.clinbiomech.2012.03.001
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   DeMott TK, 2007, AM J PHYS MED REHAB, V86, P125, DOI 10.1097/PHM.0b013e31802ee1d1
   Dixit S, 2016, AM J PHYS MED REHAB, V95, P516, DOI 10.1097/PHM.0000000000000426
   Dixit S, 2014, QUAL LIFE RES, V23, P1629, DOI 10.1007/s11136-013-0602-7
   Dixit S, 2014, J DIABETES COMPLICAT, V28, P332, DOI 10.1016/j.jdiacomp.2013.12.006
   DUNN JE, 1992, AM J PUBLIC HEALTH, V82, P395, DOI 10.2105/AJPH.82.3.395
   Emery CF, 2005, J GERONTOL A-BIOL, V60, P1432, DOI 10.1093/gerona/60.11.1432
   French DP, 2013, J PSYCHOSOM RES, V74, P327, DOI 10.1016/j.jpsychores.2012.12.008
   Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571
   Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041
   Gonzalez JS, 2011, DIABETOLOGIA, V54, P205, DOI 10.1007/s00125-010-1926-2
   Gonzalez JS, 2010, DIABETOLOGIA, V53, P2241, DOI 10.1007/s00125-010-1821-x
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Goodworth AD, 2014, J PROSTHET ORTHOT, V26, P6
   Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009
   Gore M, 2006, J PAIN, V7, P892, DOI 10.1016/j.jpain.2006.04.013
   Gouin JP, 2011, IMMUNOL ALLERGY CLIN, V31, P81, DOI 10.1016/j.iac.2010.09.010
   Grewal GS, 2015, GERONTOLOGY, V61, P567, DOI 10.1159/000371846
   Handsaker JC, 2016, DIABETIC MED, V33, P97, DOI 10.1111/dme.12841
   Hazari A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3405-9
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Iversen MM, 2015, J DIABETES COMPLICAT, V29, P20, DOI 10.1016/j.jdiacomp.2014.09.006
   Iversen MM, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-18
   Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e
   Kanchanasamut W, 2017, DIABET FOOT ANKLE, V8, DOI 10.1080/2000625X.2017.1287239
   Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363
   Kelly C, 2013, J AM PODIAT MED ASSN, V103, P480, DOI 10.7547/1030480
   Keylock KT, 2008, AM J PHYSIOL-REG I, V294, pR179, DOI 10.1152/ajpregu.00177.2007
   Kluding PM, 2015, PHYS THER, V95, P223, DOI 10.2522/ptj.20140108
   Kluding PM, 2012, J DIABETES COMPLICAT, V26, P424, DOI 10.1016/j.jdiacomp.2012.05.007
   Lavery L A, 1998, Ostomy Wound Manage, V44, P26
   Marchettini P, 2016, EUR J PAIN, V20, P472, DOI 10.1002/ejp.763
   McKee KJ, 2002, DISABIL REHABIL, V24, P327, DOI 10.1080/09638280110093686
   Mendes R, 2013, POSTGRAD MED J, V89, P715, DOI 10.1136/postgradmedj-2013-132222
   Monami M, 2008, J AM PODIAT MED ASSN, V98, P130, DOI 10.7547/0980130
   Morrison S, 2014, J DIABETES COMPLICAT, V28, P715, DOI 10.1016/j.jdiacomp.2014.04.007
   Mueller MJ, 2013, ARCH PHYS MED REHAB, V94, P829, DOI 10.1016/j.apmr.2012.12.015
   Najafi B, 2016, J DIABETES SCI TECHN, V11, P657
   Otto M, 2007, EUR J PAIN, V11, P572, DOI 10.1016/j.ejpain.2006.08.003
   Padua L, 2001, EUR NEUROL, V45, P214, DOI 10.1159/000052132
   Pence BD, 2014, ADV WOUND CARE, V3, P71, DOI 10.1089/wound.2012.0377
   Pence BD, 2012, MED SCI SPORT EXER, V44, P1846, DOI 10.1249/MSS.0b013e31825a5971
   Perrin BM, 2014, DIABETIC MED, V31, P102, DOI 10.1111/dme.12287
   Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042
   Razjouyan Javad, 2017, J Diabetes Sci Technol, V11, P685, DOI 10.1177/1932296817705397
   Reeves ND, 2017, PRELIMINARY OBS DIAB, V40, pe51
   Schwartz AV, 2008, DIABETES CARE, V31, P391, DOI 10.2337/dc07-1152
   Schwenk M, 2013, J AM PODIAT MED ASSN, V103, P534, DOI 10.7547/1030534
   Selvarajah D, 2014, DIABETES VASC DIS RE, V11, P218, DOI 10.1177/1479164114522135
   Singleton JR, 2015, ANN NEUROL, V77, P146, DOI 10.1002/ana.24310
   Tan MP, 2016, GERIATR GERONTOL INT, V16, P111, DOI 10.1111/ggi.12446
   Tesfaye S, 2011, DIABETES-METAB RES, V27, P629, DOI 10.1002/dmrr.1225
   van Deursen R, 2008, DIABETES-METAB RES, V24, pS96, DOI 10.1002/dmrr.827
   VanRoss ER, 2009, ARCH PHYS MED REHAB, V90, P610, DOI 10.1016/j.apmr.2008.10.026
   Vedhara K, 2010, DIABETOLOGIA, V53, P1590, DOI 10.1007/s00125-010-1743-7
   Vickrey BG, 2000, NEUROREHAB NEURAL RE, V14, P93, DOI 10.1177/154596830001400202
   Vileikyte L, 2005, DIABETES CARE, V28, P2378, DOI 10.2337/diacare.28.10.2378
   Vileikyte L, 2003, DIABETES CARE, V26, P2549, DOI 10.2337/diacare.26.9.2549
   Vileikyte L, 2009, DIABETOLOGIA, V52, P1265, DOI 10.1007/s00125-009-1363-2
   Vileikyte L, 2006, DIABETES CARE, V29, P2617, DOI 10.2337/dc06-1550
   Vileikyte L, 2017, DIABETES, V66, pA168
   Vinik Etta J, 2005, Diabetes Technol Ther, V7, P497, DOI 10.1089/dia.2005.7.497
   Waaijman R, 2013, DIABETES CARE, V36, P1613, DOI 10.2337/dc12-1330
   Williams LH, 2010, AM J MED, V123, P748, DOI 10.1016/j.amjmed.2010.01.023
   Winkley K, 2012, DIABETOLOGIA, V55, P303, DOI 10.1007/s00125-011-2359-2
   Yoo M, 2015, PAIN MED, V16, P1482, DOI 10.1111/pme.12743
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 79
TC 0
Z9 1
U1 2
U2 9
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD NOV
PY 2017
VL 17
IS 11
AR 109
DI 10.1007/s11892-017-0945-5
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FJ9BZ
UT WOS:000413064200009
PM 28942488
DA 2019-01-08
ER

PT J
AU Hagger, V
   Hendrieckx, C
   Cameron, F
   Pouwer, F
   Skinner, TC
   Speight, J
AF Hagger, Virginia
   Hendrieckx, Christel
   Cameron, Fergus
   Pouwer, Frans
   Skinner, Timothy C.
   Speight, Jane
TI Cut Points for Identifying Clinically Significant Diabetes Distress in
   Adolescents With Type 1 Diabetes Using the PAID-T: Results From Diabetes
   MILES Youth-Australia
SO DIABETES CARE
LA English
DT Article
ID PROBLEM-AREAS; SCALE; ADULTS; RELIABILITY; DISORDERS; VALIDITY
AB OBJECTIVE
   To establish cut point(s) for the Problem Areas in Diabetes-teen version (PAID-T) scale to identify adolescents with clinically meaningful, elevated diabetes distress.
   RESEARCH DESIGN AND METHODS
   Data were available from the Diabetes Management and Impact for Long-term Empowerment and Success (MILES) Youth-Australia Study, a national survey assessing various psychosocial indicators among self-selected National Diabetes Services Scheme registrants. Participants in the current study (n = 537) were (mean SD) 16 2 years old, had type 1 diabetes for 6 +/- 4 years, and 62% (n = 334) were girls. They completed measures of diabetes distress (PAID-T) and depressive symptoms (Patient Health Questionnaire for Adolescents) and self-reported their most recent HbA(1c) and frequency of self-monitoring of blood glucose (SMBG). Relationships between the PAID-T and the psychological and clinical variables were examined to identify a clinically meaningful threshold for elevated diabetes distress. ANOVA was used to test whether these variables differed by levels of distress.
   RESULTST
   wo cut points distinguished none-to-mild (<70), moderate (70-90), and high (>90) diabetes distress. Moderate distress was experienced by 18% of adolescents and high distress by 36%. Mean depressive symptoms, self-reported HbA(1c), and SMBG differed significantly across the three levels of diabetes distress (all P < 0.001), with moderate-to-large effect sizes.
   CONCLUSIONS
   Using the PAID-T, this study defined two clinically meaningful cut points to distinguish none-to-mild, moderate, and high diabetes distress in adolescents (aged 13-19). Based on these cut points, most respondents experienced at least moderate diabetes distress, which was clinically significant. Establishing thresholds for elevated diabetes distress will aid clinicians and researchers to interpret PAID-T scores, prompt discussion and intervention for those with unmet needs, and enable the effectiveness of interventions to be evaluated.
C1 [Hagger, Virginia; Hendrieckx, Christel; Speight, Jane] Deakin Univ, Sch Psychol, Ctr Social & Early Emot Dev, Geelong, Vic, Australia.
   [Hagger, Virginia; Hendrieckx, Christel; Speight, Jane] Diabet Victoria, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Cameron, Fergus] Royal Childrens Hosp, Melbourne, Vic, Australia.
   [Cameron, Fergus] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Pouwer, Frans] Univ Southern Denmark, Dept Psychol, Odense, Denmark.
   [Skinner, Timothy C.] Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT, Australia.
   [Skinner, Timothy C.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia.
   [Speight, Jane] Appl Hlth Psychol Res, Hornchurch, Essex, England.
RP Hagger, V (reprint author), Deakin Univ, Sch Psychol, Ctr Social & Early Emot Dev, Geelong, Vic, Australia.
EM vhagger@acbrd.org.au
OI Skinner, Timothy/0000-0002-0018-6963; Hagger,
   Virginia/0000-0003-3845-2814; Speight, Jane/0000-0002-1204-6896
FU NDSS, an initiative of the Australian Government; Diabetes Victoria;
   Deakin University; Diabetes Australia
FX The Diabetes MILES Youth-Australia 2014 Survey was funded by the NDSS,
   an initiative of the Australian Government administered with assistance
   from Diabetes Australia. C.H. and J.S. are supported by core funding to
   The Australian Centre for Behavioural Research in Diabetes derived from
   the collaboration between Diabetes Victoria and Deakin University.
CR Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Australian Bureau of Statistics, 2011, CENS POP HOUS SOC IN
   Butwicka A, 2012, DIABETES CARE, V35, P2133, DOI 10.2337/dc12-0160
   Chae M, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-14
   Cohen J., 1992, CURRENT DIRECTIONS P, V1, P98, DOI [10.1111/1467-8721.ep10768783, DOI 10.1111/1467-8721.EP10768783]
   Fisher L, 2016, DIABETIC MED, V33, P1590, DOI 10.1111/dme.12973
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hackorth NJ, 2013, AUST PSYCHOL, V48, P360, DOI [DOI 10.1111/AP.12007, 10.1111/ap.12007]
   Hagger Virginia, 2016, BMC Psychol, V4, P42, DOI 10.1186/s40359-016-0149-9
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   Handley TE, 2016, DIABETIC MED, V33, P1582, DOI 10.1111/dme.13022
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns Norbert, 2007, Diabetes Care, V30, pe101, DOI 10.2337/dc07-1019
   Iturralde E, 2017, HEALTH PSYCHOL, V36, P236, DOI 10.1037/hea0000445
   Johnson JG, 2002, J ADOLESCENT HEALTH, V30, P196, DOI 10.1016/S1054-139X(01)00333-0
   Kibbey KJ, 2013, DIABETIC MED, V30, P878, DOI 10.1111/dme.12227
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Lasaite L, 2016, J DIABETES COMPLICAT, V30, P1500, DOI 10.1016/j.jdiacomp.2016.08.013
   Lewin AB, 2009, J PEDIATR PSYCHOL, V34, P999, DOI 10.1093/jpepsy/jsp032
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   ROSE G, 1978, BRIT MED J, V2, P873, DOI 10.1136/bmj.2.6141.873
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 29
TC 2
Z9 2
U1 1
U2 2
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD NOV 1
PY 2017
VL 40
IS 11
BP 1462
EP 1468
DI 10.2337/dc17-0441
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FK5RE
UT WOS:000413557200014
PM 28882887
DA 2019-01-08
ER

PT J
AU Perrin, NE
   Davies, MJ
   Robertson, N
   Snoek, FJ
   Khunti, K
AF Perrin, N. E.
   Davies, M. J.
   Robertson, N.
   Snoek, F. J.
   Khunti, K.
TI The prevalence of diabetes-specific emotional distress in people with
   Type 2 diabetes: a systematic review and meta-analysis
SO DIABETIC MEDICINE
LA English
DT Review
ID PROBLEM AREAS; GLYCEMIC CONTROL; DEPRESSION; ADULTS; PAID; RECOGNITION;
   ASSOCIATION; ADHERENCE; SYMPTOMS; VALIDITY
AB AimsPsychological comorbidity, such as depression and/or diabetes-specific emotional distress (diabetes distress), is widespread in people with Type 2 diabetes and is associated with poorer treatment outcomes. Although extensive research into the prevalence of depression has been conducted, the same attention has not been given to diabetes distress. The aim of this systematic review was to determine the overall prevalence of diabetes distress in people with Type 2 diabetes. MethodsSeven databases were searched to identify potentially relevant studies; eligible studies (adult population aged > 18 years with Type 2 diabetes and an outcome measure of diabetes distress) were selected and appraised independently by two reviewers. Multiple fixed- and random-effects meta-analyses were performed to synthesize the data; with primary analyses to determine the overall prevalence of diabetes distress in people with Type 2 diabetes, and secondary meta-analyses and meta-regression to explore the prevalence across different variables.
   ResultsFifty-five studies (n = 36 998) were included in the meta-analysis and demonstrated an overall prevalence of 36% for diabetes distress in people with Type 2 diabetes. Prevalence of diabetes distress was significantly higher in samples with a higher prevalence of comorbid depressive symptoms and a female sample majority.
   ConclusionsDiabetes distress is a prominent issue in people with Type 2 diabetes that is associated with female gender and comorbid depressive symptoms. It is important to consider the relationship between diabetes distress and depression, and the significant overlap between conditions. Further work is needed to explore psychological comorbidity in Type 2 diabetes to better understand how best to identify and appropriately treat individuals.
C1 [Perrin, N. E.; Davies, M. J.; Khunti, K.] Univ Leicester, Coll Med Biol Sci & Psychol, Diabet Res Ctr, Leicester, Leics, England.
   [Robertson, N.] Univ Leicester, Coll Med Biol Sci & Psychol, Sch Psychol, Leicester, Leics, England.
   [Snoek, F. J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Acad Med Ctr Amsterdam, Amsterdam, Netherlands.
RP Perrin, NE (reprint author), Univ Leicester, Coll Med Biol Sci & Psychol, Diabet Res Ctr, Leicester, Leics, England.
EM n.e.perrin@gmail.com
OI Davies, Melanie/0000-0002-9987-9371
FU National Institute for Health Research Collaboration for Leadership in
   Applied Health Research and Care - Leicestershire, Northamptonshire and
   Rutland (NIHR CLAHRC - LNR); Leicester Clinical Trials Unit; NIHR
   Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical
   Research Unit; University Hospitals of Leicester NHS Trust; Loughborough
   University; University of Leicester
FX We acknowledge support from the National Institute for Health Research
   Collaboration for Leadership in Applied Health Research and Care -
   Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR), the
   Leicester Clinical Trials Unit and the NIHR Leicester-Loughborough Diet,
   Lifestyle and Physical Activity Biomedical Research Unit which is a
   partnership between University Hospitals of Leicester NHS Trust,
   Loughborough University and the University of Leicester.
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Adriaanse MC, 2005, QUAL LIFE RES, V14, P1501, DOI 10.1007/s11136-004-0028-3
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Asghar S, 2007, DIABETIC MED, V24, P872, DOI 10.1111/j.1464-5491.2007.02136.x
   Center for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS
   Charmaz K., 1995, MENS HLTH ILLNESS GE, P266
   Dennick K, 2015, INT DIABETES NURS, V12, P93
   Doyal L, 2000, SOC SCI MED, V51, P931, DOI 10.1016/S0277-9536(00)00072-1
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Holt RIG, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0491-3
   Hudson DL, 2013, AM J MANAG CARE, V19, P344
   Katon WJ, 2004, MED CARE, V42, P1222, DOI 10.1097/00005650-200412000-00009
   Loney P L, 1998, Chronic Dis Can, V19, P170
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Moulton CD, 2015, LANCET DIABETES ENDO, V3, P461, DOI 10.1016/S2213-8587(15)00134-5
   Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Schmitt A, 2016, DIABETIC MED, V33, P835, DOI 10.1111/dme.12887
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   World Health Organization, 2017, WHO MEMB STAT 6 REG
NR 50
TC 8
Z9 9
U1 3
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2017
VL 34
IS 11
BP 1508
EP 1520
DI 10.1111/dme.13448
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FK0JC
UT WOS:000413165100004
PM 28799294
OA Bronze
DA 2019-01-08
ER

PT J
AU Ferrari, M
   Dal Cin, M
   Steele, M
AF Ferrari, M.
   Dal Cin, M.
   Steele, M.
TI Self-compassion is associated with optimum self-care behaviour, medical
   outcomes and psychological well-being in a cross-sectional sample of
   adults with diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; GLYCEMIC CONTROL; METABOLIC-CONTROL;
   DEPRESSION; LOCUS; ADHERENCE; INTERVENTION; METAANALYSIS; DISTRESS;
   SUPPORT
AB AimTo investigate the role of self-compassion in diabetes outcomes. Self-compassion is a construct which may be relevant to chronic conditions, given its focus on compassion toward oneself, especially in times of difficulty.
   MethodsIn this cross-sectional study we collected data online from 310 adults diagnosed with diabetes. The questionnaire measured three primary outcomes: self-management behaviours; HbA(1c) levels and psychological well-being. Potential predictors were also assessed, including self-compassion, locus of control, social support and demographics.
   ResultsMultiple regression analyses showed that self-compassion had the most consistent association with better outcomes, including all forms of self-management behaviour, HbA(1c) levels and psychological well-being. Self-compassion was independently associated with 55.1% of the variance in well-being. Internal locus of control was also significantly associated with better well-being and HbA(1c) outcomes. Chance and external locus of control and social support were generally associated with poorer outcomes.
   ConclusionsHigher levels of self-compassion are typically associated with improved self-management behaviour, medical outcomes and psychological well-being in adults with diabetes mellitus. The present findings suggest that self-compassion may be a parsimonious and suitable intervention target. Future interventions and consultations with medical professionals may benefit from fostering self-compassion in adults with diabetes mellitus.
   What's new?
   In a cross-sectional study in adults diagnosed with diabetes mellitus (N = 310) we found that self-compassion was consistently associated with better behavioural (self-management behaviours, exercise, blood glucose checking and healthcare use), metabolic (HbA(1c)) and psychological (well-being) outcomes. Independently, self-compassion accounted for a large proportion of variance in the outcomes compared with other known predictors, such as locus of control, social support and demographic variables (age, gender, education and relationship status). Our findings demonstrate the relevance of self-compassion to health behaviour in adults with diabetes mellitus, and empirically support the development of holistic psychological interventions targeting self-compassion for adults with diabetes mellitus.
C1 [Ferrari, M.; Dal Cin, M.] Australian Catholic Univ, Sch Psychol, Strathfield, NSW, Australia.
   [Ferrari, M.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia.
   [Steele, M.] Australian Catholic Univ, Sch Allied Hlth, Brisbane, Qld, Australia.
RP Ferrari, M (reprint author), Australian Catholic Univ, Sch Psychol, Strathfield, NSW, Australia.; Ferrari, M (reprint author), Univ Sydney, Sch Psychol, Sydney, NSW, Australia.
EM m.ferrari037@gmail.com
OI Steele, Michael/0000-0001-9628-3057
CR BRADLEY C, 1994, HDB PSYCHOL DIABETES, P89
   DeCoster VA, 2003, SOC WORK HEALTH CARE, V36, P79, DOI 10.1300/J010v36n04_05
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   FERRARO LA, 1987, PSYCHOL REP, V61, P763, DOI 10.2466/pr0.1987.61.3.763
   Friis AM, 2015, DIABETIC MED, V32, P1634, DOI 10.1111/dme.12774
   Friis AM, 2016, DIABETES CARE, V39, P1963, DOI 10.2337/dc16-0416
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Houle J, 2015, DIABETIC MED, V32, P1247, DOI 10.1111/dme.12686
   Hunter CM, 2016, AM PSYCHOL, V71, P515, DOI 10.1037/a0040344
   Indelicato L, 2017, DIABETIC MED, V34, P691, DOI 10.1111/dme.13321
   Jaacks LM, 2016, BEST PRACT RES CL EN, V30, P331, DOI 10.1016/j.beem.2016.05.003
   Janowski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063920
   Knittle K, 2016, ARTHRIT CARE RES, V68, P203, DOI 10.1002/acr.22647
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   MacBeth A, 2012, CLIN PSYCHOL REV, V32, P545, DOI 10.1016/j.cpr.2012.06.003
   Neff KD, 2007, J RES PERS, V41, P908, DOI 10.1016/j.jrp.2006.08.002
   Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035
   Neff KD, 2009, J PERS, V77, P23, DOI 10.1111/j.1467-6494.2008.00537.x
   Pfattheicher S, 2017, EUR J PERSONALITY, V31, P160, DOI 10.1002/per.2097
   Powers MA, 2015, DIABETES EDUCATOR, V41, P417, DOI 10.1177/0145721715588904
   Przezdziecki A, 2013, PSYCHO-ONCOLOGY, V22, P1872, DOI 10.1002/pon.3230
   Raes F, 2011, CLIN PSYCHOL PSYCHOT, V18, P250, DOI 10.1002/cpp.702
   Russo GT, 2016, DIABETES TECHNOL THE, V18, P421, DOI 10.1089/dia.2015.0358
   SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Sirois FM, 2015, HEALTH PSYCHOL, V34, P661, DOI 10.1037/hea0000158
   Stenstrom U, 1998, BRIT J HEALTH PSYCH, V3, P15, DOI 10.1111/j.2044-8287.1998.tb00552.x
   Tabachnick B. G., 2007, USING MULTIVARIATE S
   Wren AA, 2012, J PAIN SYMPTOM MANAG, V43, P759, DOI 10.1016/j.jpainsymman.2011.04.014
NR 30
TC 1
Z9 1
U1 4
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2017
VL 34
IS 11
BP 1546
EP 1553
DI 10.1111/dme.13451
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FK0JC
UT WOS:000413165100008
PM 28799282
OA Bronze
DA 2019-01-08
ER

PT J
AU Khan, S
   Yao, Z
   Shah, BR
AF Khan, S.
   Yao, Z.
   Shah, B. R.
TI Gestational diabetes care and outcomes for refugee women: a
   population-based cohort study
SO DIABETIC MEDICINE
LA English
DT Article
ID PREGNANCY OUTCOMES; BIRTH OUTCOMES; UNITED-STATES; HEALTH-STATUS;
   RISK-FACTORS; PREVALENCE; IMMIGRANTS; CANADA; MELLITUS; DISEASE
AB AimTo determine the prevalence of adverse clinical outcomes, the rates of healthcare utilization, and the incidence of post-partum Type 2 diabetes in refugees with gestational diabetes (GDM), compared with other immigrants and non-immigrants.
   MethodsA population-based cohort study was conducted using healthcare databases in Ontario, Canada. Over 40000 women with GDM having singleton live births between 2002 and 2014 were identified. We identified GDM adverse outcomes such as macrosomia, pre-eclampsia and respiratory distress syndrome. Antenatal and newborn healthcare utilization were ascertained. Women were then followed for diagnosis of diabetes post-partum.
   ResultsBoth refugees and other immigrants had a lower rate than non-immigrants of many adverse GDM outcomes, including pre-eclampsia [relative risk (RR) 0.65, 95% confidence interval (95% CI) 0.44-0.95 and 0.61, 95% CI 0.52-0.72, respectively], preterm birth (RR 0.87, 95% CI 0.75-0.995 and 0.85, 95% CI 0.80-0.91, respectively), and respiratory distress syndrome (RR 0.83, 95% CI 0.70-0.97 and 0.78, 95% CI 0.72-0.84, respectively). However, refugees were less likely to attend well-baby care in time for the first routine vaccination (RR 0.92, 95% CI 0.88-0.95). Incidence of post-partum diabetes was high in all groups, but refugee women were at increased risk (hazard ratio 1.23, 95% CI 1.11-1.37).
   ConclusionsDespite different circumstances leading to migration, refugees have a similar healthy immigrant effect' to other immigrants, with respect to adverse GDM outcomes. However, newborns of refugees were less likely to have well-baby care, and refugee women were also at especially high risk of developing diabetes post-partum. These are both important public health issues.
C1 [Khan, S.; Shah, B. R.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Yao, Z.; Shah, B. R.] Inst Clin Evaluat Sci, Toronto, ON, Canada.
   [Shah, B. R.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada.
RP Shah, BR (reprint author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Shah, BR (reprint author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Shah, BR (reprint author), Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada.
EM baiju.shah@ices.on.ca
FU Ontario Ministry of Health and Long-Term Care (MOHLTC)
FX The study relied on data and information compiled and provided by the
   Canadian Institute of Health Information (CIHI). The Institute for
   Clinical Evaluative Sciences (ICES) is a non-profit research institute
   funded by the Ontario Ministry of Health and Long-Term Care (MOHLTC).
   The opinions, results and conclusions reported in this paper are those
   of the authors. No endorsement by CIHI, ICES or MOHLTC is intended or
   should be inferred.
CR Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2
   Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5
   Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989
   Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Glazier R. H., 2007, NEIGHBOURHOOD ENV RE
   Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512
   Janevic T, 2011, SOC SCI MED, V73, P429, DOI 10.1016/j.socscimed.2011.05.041
   Kandasamy T, 2014, J OBSTET GYNAECOL CA, V36, P296, DOI 10.1016/S1701-2163(15)30604-6
   McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Miller LS, 2016, MATERN CHILD HLTH J, V20, P484, DOI 10.1007/s10995-015-1846-3
   Mukerji G, 2012, DIABETOLOGIA, V55, P2148, DOI 10.1007/s00125-012-2549-6
   Newbold B, 2009, ETHNIC HEALTH, V14, P315, DOI 10.1080/13557850802609956
   Ng Edward, 2011, Health Rep, V22, P25
   Okrainec K, 2015, AM HEART J, V170, P123, DOI 10.1016/j.ahj.2015.04.009
   Pottie K, 2011, CAN MED ASSOC J, V183, pE824, DOI 10.1503/cmaj.090313
   Redditt VJ, 2015, CAN FAM PHYSICIAN, V61, pE310
   Shah BR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-42
   Statistics Canada, 2013, IMM ETHN DIV 2011 NA
   UNHCR, UNHCR VIEWP REF MIGR
   Vang Z, 2015, POPULATION CHANGE LI, V3, P6
   Wanigaratne S, 2016, MATERN CHILD HLTH J, V20, P2189, DOI 10.1007/s10995-016-2047-4
   Wanigaratne S, 2016, J EPIDEMIOL COMMUN H, V70, P622, DOI 10.1136/jech-2015-206529
   WASSE H, 1994, AM J PUBLIC HEALTH, V84, P1505, DOI 10.2105/AJPH.84.9.1505
   Yeung RO, 2017, J DIABETES COMPLICAT, V31, P529, DOI 10.1016/j.jdiacomp.2016.10.016
   Yun K, 2012, J IMMIGR MINOR HEALT, V14, P933, DOI 10.1007/s10903-012-9618-2
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 28
TC 2
Z9 2
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2017
VL 34
IS 11
BP 1608
EP 1614
DI 10.1111/dme.13440
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FK0JC
UT WOS:000413165100016
PM 28779484
DA 2019-01-08
ER

PT J
AU Quiles, NN
   Ciccolo, JT
   Garber, CE
AF Quiles, Norberto N.
   Ciccolo, Joseph T.
   Garber, Carol Ewing
TI Association Between Physical Activity, Depression, and Diabetes in
   Urban-Dwelling People Living with HIV
SO JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE
LA English
DT Article
DE cardiovascular disease; exercise; mental health; metabolic disease
ID CARDIOVASCULAR-DISEASE; DRUG-USERS; EXERCISE; ADULTS; RISK; VALIDITY;
   COHORT; TIME
AB Physical activity (PA) may improve physical and mental health in people living with HIV (PLWH). However, the associations between PA participation and physical and mental health problems of PLWH in urban settings remain largely unknown. Our objective was to determine the relationships between PA and physical and mental health in urban-dwelling PLWH. There were 289 adult PLWH who responded to an electronic survey including questions on PA and current physical and mental health. The associations between physical and mental health and PA were investigated using linear and logistic regression. A large proportion of participants met recommended volumes of PA. Eighty-three percent of respondents reported symptoms of severe mental distress. Diabetes mellitus was associated with a lower total volume of PA (p = .035). Similarly, depression was negatively associated with muscle-strengthening exercise participation (p = .030). Sufficient amounts of aerobic activity and/or muscle strengthening exercise are associated with better physical and mental health. Copyright (C) 2017 Association of Nurses in AIDS Care
C1 [Quiles, Norberto N.] CUNY Queens Coll, Dept Family Nutr & Exercise Sci, Flushing, NY 11367 USA.
   [Ciccolo, Joseph T.; Garber, Carol Ewing] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.
RP Quiles, NN (reprint author), CUNY Queens Coll, Dept Family Nutr & Exercise Sci, Flushing, NY 11367 USA.
EM norberto.quilesgonzalez@qc.cuny.edu
FU Teachers College Deans Grant for Student Research
FX This project was supported in part by the Teachers College Deans Grant
   for Student Research. All authors declare no financial interests or
   potential conflicts of interest. We thank Abdulaziz Alnafesah for his
   assistance conducting this study.
CR Arseniou S, 2014, PSYCHIAT CLIN NEUROS, V68, P96, DOI 10.1111/pcn.12097
   Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003
   Blashill AJ, 2013, ANN BEHAV MED, V46, P149, DOI 10.1007/s12160-013-9489-3
   Centers for Disease Control and Prevention, 2014, STAT IND REP PHYS AC
   Centers for Disease Control and Prevention, 2013, BEH RISK FACT SURV S
   Centers for Disease Control and Prevention, 2013, HIV SURV REP
   Clingerman Evelyn M, 2003, J Assoc Nurses AIDS Care, V14, P59, DOI 10.1177/1055329003255284
   Codella R., 2005, SPORT SCI HLTH, V1, P81
   Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c
   Cossman Ronald E, 2008, J Health Hum Serv Adm, V30, P503
   De Socio GV, 2014, AM J HYPERTENS, V27, P222, DOI 10.1093/ajh/hpt182
   Della Justina LB, 2014, REV SOC BRAS MED TRO, V47, P30, DOI 10.1590/0037-8682-0240-2013
   Fahimi Mansour, 2008, Prev Chronic Dis, V5, pA80
   Fillipas S., 2013, J AIDS CLIN RES, V9, P2
   Fillipas S, 2010, J ASSOC NURSE AIDS C, V21, P173, DOI 10.1016/j.jana.2009.11.003
   Gavrila A, 2003, CLIN INFECT DIS, V36, P1593, DOI 10.1086/375225
   Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462
   Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421
   International Physical Activity Questionnaire, 2005, GUID DAT PROC AN INT
   Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x
   Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Korkiakangas EE, 2009, HEALTH PROMOT INT, V24, P416, DOI 10.1093/heapro/dap031
   Segatto AFM, 2011, REV SOC BRAS MED TRO, V44, P420, DOI 10.1590/S0037-86822011000400004
   Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x
   Pellowski JA, 2013, AM PSYCHOL, V68, P197, DOI 10.1037/a0032694
   Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO
   Pierannunzi C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-49
   Pilu Alessandra, 2007, Clin Pract Epidemiol Ment Health, V3, P8, DOI 10.1186/1745-0179-3-8
   Ramirez-Marrero FA, 2004, J ASSOC NURSE AIDS C, V15, P68, DOI 10.1177/1055329003261966
   Ramirez-Marrero FA, 2008, J ASSOC NURSE AIDS C, V19, P283, DOI 10.1016/j.jana.2008.04.003
   Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002
   Schuelter-Trevisol F, 2012, CURR HIV RES, V10, P487, DOI 10.2174/157016212802429794
   Smit E, 2006, AIDS CARE, V18, P1040, DOI 10.1080/09540120600580926
   Spies G, 2009, AIDS CARE, V21, P1163, DOI 10.1080/09540120902729965
   Tang AM, 2010, AM J DRUG ALCOHOL AB, V36, P78, DOI 10.3109/00952990903544851
   U.S. Census Bureau, 2015, SEL RAC SEX ED INC C
   U.S. Department of Health and Human Services, 2016, ANN UPD HLTH HUM SER
   Willig AL, 2014, CURR HIV-AIDS REP, V11, P35, DOI 10.1007/s11904-013-0191-7
   Wyker B., 2013, SELF REPORTED ACCELE
   Yore MM, 2007, MED SCI SPORT EXER, V39, P1267, DOI 10.1249/mss.0b013e3180618bbe
NR 41
TC 0
Z9 0
U1 2
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1055-3290
EI 1552-6917
J9 J ASSOC NURSE AIDS C
JI J. Assoc. Nurses Aids Care
PD NOV-DEC
PY 2017
VL 28
IS 6
BP 838
EP 848
DI 10.1016/j.jana.2017.06.015
PG 11
WC Nursing
SC Nursing
GA FL4RR
UT WOS:000414218900002
PM 28743495
DA 2019-01-08
ER

PT J
AU Clapin, H
   Hop, L
   Ritchie, E
   Jayabalan, R
   Evans, M
   Browne-Cooper, K
   Peter, S
   Vine, J
   Jones, TW
   Davis, EA
AF Clapin, H.
   Hop, L.
   Ritchie, E.
   Jayabalan, R.
   Evans, M.
   Browne-Cooper, K.
   Peter, S.
   Vine, J.
   Jones, T. W.
   Davis, E. A.
TI Home-based vs inpatient education for children newly diagnosed with type
   1 diabetes
SO PEDIATRIC DIABETES
LA English
DT Article
DE ambulatory; education; pediatric; randomized-controlled trial; type 1
   diabetes mellitus
ID YOUNG-PEOPLE; MANAGEMENT; CHILDHOOD; OUTPATIENT; EXPERIENCE; DISTRESS;
   FAMILIES; OUTCOMES; PARENTS; CARE
AB Background: Initial management of children diagnosed with type 1 diabetes (T1D) varies worldwide with sparse high quality evidence regarding the impact of different models of care.
   Aim: To compare the inpatient model of care with a hybrid home-based alternative, examining metabolic and psychosocial outcomes, diabetes knowledge, length of stay, and patient satisfaction.
   Subjects and Methods: The study design was a randomized-controlled trial. Inclusion criteria were: newly diagnosed T1D, aged 3 to 16 years, living within approximately 1 hour of the hospital, English-speaking, access to transport, absence of significant medical or psychosocial comorbidity. Patients were randomized to standard care with a 5 to 6 day initial inpatient stay or discharge after 2 days for home-based management. All patients received practical skills training in the first 48 hours. The intervention group was visited twice/day by a nurse for 2 days to assist with injections, then a multi-disciplinary team made 3 home visits over 2 weeks to complete education. Patients were followed up for 12 months. Clinical outcomes included HbA1c, hypoglycemia, and diabetes-related readmissions. Surveys measured patient satisfaction, diabetes knowledge, family impact, and quality of life.
   Results: Fifty patients were recruited, 25 to each group. There were no differences in medical or psychosocial outcomes or diabetes knowledge. Average length of admission was 1.9 days shorter for the intervention group. Families indicated that with hindsight, most would choose home-over hospital-based management.
   Conclusions: With adequate support, children newly diagnosed with T1D can be safely managed at home following practical skills training.
C1 [Clapin, H.; Hop, L.; Ritchie, E.; Jayabalan, R.; Evans, M.; Browne-Cooper, K.; Jones, T. W.; Davis, E. A.] Princess Margaret Hosp Children, Dept Endocrinol & Diabet, GPO Box D184, Perth, WA 6840, Australia.
   [Clapin, H.; Evans, M.; Jones, T. W.; Davis, E. A.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.
   [Peter, S.; Vine, J.] Princess Margaret Hosp Children, Hosp Home, Perth, WA, Australia.
RP Clapin, H (reprint author), Princess Margaret Hosp Children, Dept Endocrinol & Diabet, GPO Box D184, Perth, WA 6840, Australia.
EM helen.clapin@health.wa.gov.au
FU PMH Foundation; WA Department of Health; Paediatric Medicine Clinical
   Care Unit of PMH
FX PMH Foundation; WA Department of Health; Paediatric Medicine Clinical
   Care Unit of PMH
CR AIHW, 2010, DIAB SER
   CHASE HP, 1992, CLIN PEDIATR, V31, P450, DOI 10.1177/000992289203100801
   Clar C, 2007, COCHRANE DB SYST REV, V2
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Dougherty G, 1999, PEDIATRICS, V103, P122, DOI 10.1542/peds.103.1.122
   Eigenmann CA, 2011, PRACT DIABETES, V28, P166, DOI 10.1002/pdi.1586
   Funnel MM, 2009, DIABETES CARE, V32, pS87, DOI 10.2337/dc09-S087
   Grey M, 2011, MCN-AM J MATERN-CHIL, V36, P214, DOI 10.1097/NMC.0b013e3182184c8f
   Haynes A, 2004, DIABETOLOGIA, V47, P866, DOI 10.1007/s00125-004-1385-8
   Ingersoll G M, 1991, Diabetes Educ, V17, P114, DOI 10.1177/014572179101700219
   Jasinski CF, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-55
   KAZAK A, 2001, FAMILIES SYSTEMS HLT, V19, P303, DOI DOI 10.1037/H0089454
   Koizumi S, 1992, J Pediatr Nurs, V7, P154
   Konrad K, 2016, PEDIATR DIABETES, V17, P483, DOI 10.1111/pedi.12330
   Lee P D, 1992, Tex Med, V88, P64
   Lowes L, 2004, ARCH DIS CHILD, V89, P934, DOI 10.1136/adc.2003.035949
   Lowes L, 2004, DIABETIC MED, V21, P531, DOI 10.1111/j.1464-5491.2004.01193.x
   Markowitz JT, 2012, DIABETIC MED, V29, P526, DOI 10.1111/j.1464-5491.2011.03434.x
   Morgan-Trimmer S, 2016, DIABETIC MED, V33, P119, DOI 10.1111/dme.12891
   Pai ALH, 2008, J PEDIATR PSYCHOL, V33, P50, DOI 10.1093/jpepsy/jsm053
   Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Samuelsson U, 2014, PEDIATR DIABETES, V15, P229, DOI 10.1111/pedi.12085
   Scott A, 2001, DIABETIC MED, V18, P861, DOI 10.1046/j.1464-5491.2001.00627.x
   SIMELL T, 1993, DIABETIC MED, V10, P855, DOI 10.1111/j.1464-5491.1993.tb00180.x
   Siminerio LM, 1999, DIABETES EDUCATOR, V25, P895, DOI 10.1177/014572179902500607
   Srinivasan S, 2004, MED J AUSTRALIA, V180, P277
   SWIFT PGF, 1993, BRIT MED J, V307, P96, DOI 10.1136/bmj.307.6896.96
   Tiberg I, 2014, EUR DIABETES NURSING, V11, P70
   Tonyushkina KN, 2014, PEDIATR DIABETES, V15, P135, DOI 10.1111/pedi.12069
   Townson JK, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-7
   Wennick A, 2006, J FAM NURS, V12, P368, DOI 10.1177/1074840706296724
NR 32
TC 1
Z9 1
U1 5
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1399-543X
EI 1399-5448
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD NOV
PY 2017
VL 18
IS 7
BP 579
EP 587
DI 10.1111/pedi.12466
PG 9
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA FK2XY
UT WOS:000413348000011
PM 27807908
DA 2019-01-08
ER

PT J
AU Forsander, G
   Bogelund, M
   Haas, J
   Samuelsson, U
AF Forsander, Gun
   Bogelund, Mette
   Haas, Josephine
   Samuelsson, Ulf
TI Adolescent life with diabetes-Gender matters for level of distress.
   Experiences from the national TODS study
SO PEDIATRIC DIABETES
LA English
DT Article
DE adolescent; diabetes; distress; female; gender
ID METABOLIC-CONTROL; GLYCEMIC CONTROL; CHILDREN; RISK; COMPLICATIONS;
   MORTALITY; BRAIN; SEX; AGE; DIAGNOSIS
AB Objective: To examine the relationship between diabetes distress and gender, and the association with glycemic control, social support, health behaviors, and socio-economic status.
   Methods: All adolescents, aged 15 to 18 years, in the national, pediatric diabetes registry SWE-DIABKIDS with type 1 diabetes were invited to complete an online questionnaire. A total of 2112 teenagers were identified.
   Results: 453 complete responses were valid for analyses. Young women scored significantly higher on the distress-screening instrument DDS-2. Almost half of the female respondents exhibited moderate to severe diabetes distress-more than twice the proportion than among male respondents (44% vs 19%). Females reported twice as high scores on the fear of hypoglycemia scale (P < 0.0001) and had a higher HbA1c value than males (P < 0.0001). Gender was highly correlated with distress level even when controlling for multiple factors that may affect distress (parameter(female) = 0.4, P = 0.0003). Particular social problems were highly significant, that is, those who trust that their parents can handle their diabetes when necessary were significantly less distressed than others (P = 0.018). Higher HbA1c levels were associated with higher distress scores (P = 0.0005 [female], P = 0.0487 [male]).
   Conclusions: Diabetes-related distress is a great burden for adolescents living with diabetes. Actively involved family and friends may reduce diabetes distress, but female adolescents appear to be particularly vulnerable and may need extra focus and support. Our findings indicate that pediatric diabetes teams working with teenagers must intensify the care during this vulnerable period of life in order to reduce the risk of both psychological and vascular complications in young adults.
C1 [Forsander, Gun] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, S-41685 Gothenburg, Sweden.
   [Forsander, Gun] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, S-41685 Gothenburg, Sweden.
   [Bogelund, Mette] Incentive, Holte Stationsvej 14,1, DK-2840 Holte, Denmark.
   [Haas, Josephine] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden.
   [Samuelsson, Ulf] Linkoping Univ, Div Pediat, Dept Clin & Expt Med, Linkoping, Sweden.
RP Bogelund, M (reprint author), Incentive, Holte Stationsvej 14,1, DK-2840 Holte, Denmark.
EM mb@incentive.dk
FU NovoNordisk
FX NovoNordisk
CR Akesson K, 2015, PEDIATR DIABETES, V16, P581, DOI 10.1111/pedi.12219
   Arbelaez AM, 2013, PEDIATR DIABETES, V14, P541, DOI 10.1111/pedi.12088
   Benitez-Aguirre P, 2015, INVEST OPHTH VIS SCI, V56, P571, DOI 10.1167/iovs.14-15147
   Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010
   Chaplin JE, 2009, ACTA PAEDIATR, V98, P361, DOI 10.1111/j.1651-2227.2008.01066.x
   Cho YH, 2014, PEDIATR DIABETES, V15, P18, DOI 10.1111/pedi.12112
   Colver A, 2013, ARCH DIS CHILD, V98, P902, DOI 10.1136/archdischild-2013-303945
   Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Gallego PH, 2008, BRIT MED J, V337, DOI 10.1136/bmi.a918
   Graue M, 2004, DIABETES CARE, V27, P1313, DOI 10.2337/diacare.27.6.1313
   Hanberger L, 2008, DIABETES CARE, V31, P927, DOI 10.2337/dc07-1863
   Hochhauser CJ, 2008, PEDIATR DIABETES, V9, P303, DOI 10.1111/j.1399-5448.2008.00395.x
   Holl RW, 1999, DIABETES CARE, V22, P1555, DOI 10.2337/diacare.22.9.1555
   Holl RW, 2003, EUR J PEDIATR, V162, P22, DOI 10.1007/s00431-002-1037-2
   HOLMES CS, 1992, J CONSULT CLIN PSYCH, V60, P698, DOI 10.1037/0022-006X.60.5.698
   Huston SA, 2016, PEDIATR DIABETES, V17, P623, DOI 10.1111/pedi.12347
   Huxley RR, 2015, LANCET DIABETES ENDO, V3, P198, DOI 10.1016/S2213-8587(14)70248-7
   Jeffery AN, 2014, PEDIATR DIABETES, V15, P599, DOI 10.1111/pedi.12125
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Kyngas H, 2001, J CLIN NURS, V10, P767, DOI 10.1046/j.1365-2702.2001.00538.x
   LAGRECA AM, 1995, CHILD HEALTH CARE, V24, P61, DOI 10.1207/s15326888chc2401_6
   Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6
   Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214
   Nationella Diabetesregistret (NDR), SWED
   Nylander C, 2014, ACTA PAEDIATR, V103, P194, DOI 10.1111/apa.12461
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Samuelsson U, 2016, J DIABETES COMPLICAT, V30, P917, DOI 10.1016/j.jdiacomp.2016.02.007
   Schoenaker DAJM, 2014, J CLIN ENDOCR METAB, V99, P800, DOI 10.1210/jc.2013-2824
   Schoenle EJ, 2002, DIABETOLOGIA, V45, P108, DOI 10.1007/s125-002-8250-6
   Schwab KO, 2010, PEDIATR DIABETES, V11, P357, DOI 10.1111/j.1399-5448.2010.00665.x
   Setoodeh A, 2012, INDIAN J PEDIATR, V79, P896, DOI 10.1007/s12098-011-0613-8
   Statistics Sweden, 2012, WOM MEN SWED FACTS F
   Sundberg F, 2012, ACTA PAEDIATR, V101, P1164, DOI 10.1111/j.1651-2227.2012.02803.x
NR 34
TC 2
Z9 2
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1399-543X
EI 1399-5448
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD NOV
PY 2017
VL 18
IS 7
BP 651
EP 659
DI 10.1111/pedi.12478
PG 9
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA FK2XY
UT WOS:000413348000021
PM 28004484
DA 2019-01-08
ER

PT J
AU Vancampfort, D
   Koyanagi, A
   Ward, PB
   Veronese, N
   Carvalho, AF
   Solmi, M
   Mugisha, J
   Rosenbaum, S
   De Hert, M
   Stubbs, B
AF Vancampfort, Davy
   Koyanagi, Ai
   Ward, Philip B.
   Veronese, Nicola
   Carvalho, Andre F.
   Solmi, Marco
   Mugisha, James
   Rosenbaum, Simon
   De Hert, Marc
   Stubbs, Brendon
TI Perceived Stress and Its Relationship With Chronic Medical Conditions
   and Multimorbidity Among 229,293 Community-Dwelling Adults in 44 Low-
   and Middle-Income Countries
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE chronic conditions; low- and middle-income countries; multimorbidity;
   perceived stress; poverty
ID RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSIVE EPISODES; HEALTH-CARE
   UTILIZATION; CULTURALLY ADAPTED CBT; CHRONIC DISEASES; ASSOCIATION;
   DISTRESS; EXPENDITURES; POPULATION; TRANSITION
AB In this study, we assessed the association of chronic medical conditions and multimorbidity with perceived stress among community-dwelling adults in 44 low- and middle-income countries. Data from the World Health Survey (2002-2004), including 229,293 adults, were analyzed. A perceived stress score (range, 0 (lowest stress)-100 (highest stress)) was computed on the basis of 2 questions from the Perceived Stress Scale. Eleven chronic conditions were assessed. Multivariable linear regression analyses were conducted to explore the associations. All chronic conditions were associated with significantly higher mean perceived stress scores, with the exception of edentulism. The associations were particularly strong for depression (beta = 14.71, 95% confidence interval (CI): 13.68, 15.74), visual impairment (beta = 10.66, 95% CI: 8.09, 13.23), and schizophrenia (beta = 9.98, 95% CI: 7.71, 12.24). Compared with no chronic conditions, the beta coefficients for perceived stress with the presence of 1, 2, 3, and >= 4 chronic conditions were 5.58 (95% CI: 4.94, 6.23), 9.58 (95% CI: 8.67, 10.49), 14.15 (95% CI: 12.63, 15.67), and 20.17 (95% CI: 18.29, 22.05), respectively. The associations with perceived stresswere significantly stronger among the poorest individuals for arthritis, asthma, diabetes, edentulism, and >= 4 chronic conditions. Our data suggest that a range of chronic conditions and multimorbidity are associated with greatly increased perceived stress among people in low- and middle-income countries, and that the poorest persons may be a particularly vulnerable group.
C1 [Vancampfort, Davy] Katholieke Univ Leuven, Dept Rehabil Sci, Biomed Sci Grp, Leuven, Belgium.
   [Vancampfort, Davy; De Hert, Marc] Katholieke Univ Leuven, Univ Psychiat Ctr, Leuven Kortenberg, Belgium.
   [Koyanagi, Ai] Univ Barcelona, Res & Dev Unit, Fundacio St Joan de Deu, Parc Sanitari St Joan de Deu, Barcelona, Spain.
   [Koyanagi, Ai] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Monforte De Lemos, Spain.
   [Koyanagi, Ai] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid, Spain.
   [Ward, Philip B.] Univ New South Wales, Sch Psychiat, Fac Med, Sydney, NSW, Australia.
   [Ward, Philip B.] Ingham Inst Appl Med Res, Schizophrenia Res Unit, Liverpool, Merseyside, England.
   [Veronese, Nicola] Univ Padua, Inst Clin Res & Educ Med, Geriatr Div, Dept Med, Padua, Italy.
   [Veronese, Nicola] Inst Clin Res & Educ Med, Padua, Italy.
   [Carvalho, Andre F.] Univ Fed Ceara, Translat Psychiat Res Grp, Fac Med, Fortaleza, Ceara, Brazil.
   [Carvalho, Andre F.] Univ Fed Ceara, Dept Clin Med, Fac Med, Fortaleza, Ceara, Brazil.
   [Solmi, Marco] Univ Padua, Dept Neurosci, Padua, Italy.
   [Mugisha, James] Kyambogo Univ, Dept Sociol & Social Sci, Kampala, Uganda.
   [Mugisha, James] Butabika Natl Referral & Mental Hlth Hosp, Kampala, Uganda.
   [Rosenbaum, Simon] Univ New South Wales, Sch Med Sci, Exercise Physiol Dept, Sydney, NSW, Australia.
   [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, London, England.
   [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England.
RP Vancampfort, D (reprint author), Katholieke Univ Leuven, Univ Psychiat Ctr, Leuvensesteenweg 517, B-3070 Kortenberg, Belgium.
EM Davy.Vancampfort@kuleuven.be
RI Stubbs, Brendon/X-1904-2018; Koyanagi, Ai/D-3833-2018; Ward,
   Philip/E-3959-2010
OI Stubbs, Brendon/0000-0001-7387-3791; Koyanagi, Ai/0000-0002-9565-5004;
   Ward, Philip/0000-0002-5779-7722
FU National Institute for Health Research Collaboration for Leadership in
   Applied Health Research and Care (United Kingdom).; Miguel Servet
   contract [CP13/00150, PI15/00862]; Instituto de Salud Carlos III
   (General Branch Evaluation and Promotion of Health Research); European
   Regional Development Fund; Society for Mental Health Research
   (Australia); Research Foundation-Flanders
FX There was no funding for the current work. B.S. receives financial
   support from the National Institute for Health Research Collaboration
   for Leadership in Applied Health Research and Care (United Kingdom).
   A.K.'s work was supported by a Miguel Servet contract (projects
   CP13/00150 and PI15/00862), integrated into the National Research,
   Development, and Innovation program and funded by the Instituto de Salud
   Carlos III (General Branch Evaluation and Promotion of Health Research)
   and the European Regional Development Fund. S.R. was supported by a
   Society for Mental Health Research (Australia) Early Career Fellowship.
   D.V. was supported by the Research Foundation-Flanders.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Cifuentes M, 2008, SOC SCI MED, V67, P529, DOI 10.1016/j.socscimed.2008.04.003
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   DeVylder JE, 2016, SCHIZOPHRENIA BULL, V42, P1353, DOI 10.1093/schbul/sbw044
   Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208
   Errisuriz VL, 2016, EAT BEHAV, V22, P211, DOI 10.1016/j.eatbeh.2016.06.008
   Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51
   Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337
   Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063315
   Gallo JJ, 2016, J GEN INTERN MED, V31, P380, DOI 10.1007/s11606-015-3524-y
   Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238
   Goldstein DS, 2002, STRESS, V5, P54, DOI 10.1080/10253890290012345
   Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821
   Lavoie KL, 2010, CHEST, V137, P1324, DOI 10.1378/chest.09-1979
   Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004
   Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580
   Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403
   Loerbroks A, 2012, INT J EPIDEMIOL, V41, P1436, DOI 10.1093/ije/dys123
   Makinen M, 2000, B WORLD HEALTH ORGAN, V78, P55
   McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.07t
   McEwen BS, 2015, METABOLISM, V64, pS2, DOI 10.1016/j.metabol.2014.10.029
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   Naeem F, 2014, J AFFECT DISORDERS, V156, P224, DOI 10.1016/j.jad.2013.10.051
   Naeem F, 2015, SCHIZOPHR RES, V164, P143, DOI 10.1016/j.schres.2015.02.015
   Nuevo R, 2012, SCHIZOPHRENIA BULL, V38, P475, DOI 10.1093/schbul/sbq099
   Oni T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-575
   Pandey KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155293
   Pati S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-451
   Phillips A. C., 2013, ENCY BEHAV MED, P1453
   Prior A, 2016, AM J EPIDEMIOL, V184, P199, DOI 10.1093/aje/kwv324
   ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645
   RUSS TC, 2012, BRIT MED J, V345, DOI [10.1136/bmj.e4933, DOI 10.1136/BMJ.E4933]
   Salisbury C, 2012, LANCET, V380, P7, DOI 10.1016/S0140-6736(12)60482-6
   Santiago T, 2015, CURR PHARM DESIGN, V21, P257
   Sladek MR, 2016, BIOL PSYCHOL, V117, P8, DOI 10.1016/j.biopsycho.2016.02.003
   Stults-Kolehmainen MA, 2014, SPORTS MED, V44
   Swartz JA, 2014, AM J PUBLIC HEALTH, V104, P2350, DOI 10.2105/AJPH.2014.302165
   Tola HH, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29019
   Tomasdottir MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130591
   Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
   World Health Organization, HLTH STAT INF SYST
   Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972
   Yoon SJ, 2016, ASIA PAC J CLIN NUTR, V25, P316, DOI 10.6133/apjcn.2016.25.2.23
NR 47
TC 6
Z9 6
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD OCT 15
PY 2017
VL 186
IS 8
BP 979
EP 989
DI 10.1093/aje/kwx159
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FJ5NK
UT WOS:000412798300011
PM 28637230
DA 2019-01-08
ER

PT J
AU Ognean, L
   Boanta, O
   Visa, G
   Grosu, F
   Sofariu, C
   Gafencu, M
   Matei, C
   Iurian, S
AF Ognean, L.
   Boanta, O.
   Visa, G.
   Grosu, F.
   Sofariu, C.
   Gafencu, M.
   Matei, C.
   Iurian, S.
TI HYDROCEPHALY, SCHIZENCEPHALY, SPONDYLOCOSTAL DYSPLASIA, AND
   HYPOPARATHYROIDISM IN AN INFANT OF A DIABETIC MOTHER
SO ACTA ENDOCRINOLOGICA-BUCHAREST
LA English
DT Article
DE diabetic mother; infant; hydrocephaly; hypoparathyroidism;
   schizencephaly; spondylocostal dysplasia
ID NEWBORN-INFANTS; BIRTH-DEFECTS; PREGNANCY; MELLITUS; POPULATION; WOMEN;
   OUTCOMES; TYPE-1; PREVALENCE; ANOMALIES
AB Context. Diabetes mellitus is the most frequent chronic complication in pregnancy and continues to contribute to increased perinatal morbidity and mortality in newborns. Macrosomia, respiratory distress syndrome, metabolic and electrolytic disturbances, and increased rates of congenital structural defects are well-known neonatal complications associated with maternal diabetes, even if well-controlled.
   Case report. A macrosomic infant born from an insulin-dependent mother, with uncontrolled diabetes and lack of adequate prenatal care, prenatally diagnosed with hydrocephaly showed a complicated postnatal course. Initial respiratory distress syndrome and transient hypoglycemia, rapidly corrected under treatment, were followed by persistent hypocalcemia and hyperphosphatemia due to hypoparathyroidism and evolving hydrocephaly. Ventriculoperitoneal shunting was followed by resolution of hypocalcemia, but seizures associated with schizencephaly and recurrent respiratory tract infections, aggravated by spondylocostal dysplasia, concurred to infant's demise at the age of 5 months.
   Conclusions. The reported case is rare due to multiple aspects: persistent hypoparathyroidism, uncommon association of schizencephaly, and even rarely association with spondylocostal dysplasia, all these conditions requiring a multidisciplinary therapeutic approach. Also, the reported case is evocative for challenges associated with infants born from diabetic mothers.
C1 [Ognean, L.; Boanta, O.] Lucian Blaga Univ, Fac Med, Dept Neonatol, Sibiu, Romania.
   [Grosu, F.] Lucian Blaga Univ, Fac Med, Dept Radiol, Sibiu, Romania.
   [Matei, C.] Lucian Blaga Univ, Fac Med, Dept Neurosurg, Sibiu, Romania.
   [Iurian, S.] Lucian Blaga Univ, Fac Med, Pediat Hosp, Sibiu, Romania.
   [Visa, G.] Clin Hosp Pediat, Dept Neurol, Sibiu, Romania.
   [Sofariu, C.] Clin Hosp Pediat, Childrens Neurol Dis Res Ctr & Telemed CEFORATEN, Sibiu, Romania.
   [Gafencu, M.] Victor Babes Univ Med & Pharm, Dept Pediat, Timisoara, Romania.
   [Gafencu, M.] Louis Turcanu Emergency Children Peritoneal Dialy, Timisoara, Romania.
RP Gafencu, M (reprint author), Victor Babes Univ Med & Pharm, Dept Nephrol, 2nd E Murgu Square, Timisoara 300350, Timis, Romania.
EM mgafencu@umft.ro
CR Allen VM, 2007, J OBSTET GYNAECOL CA, V29, P927, DOI 10.1016/S1701-2163(16)32653-6
   BECERRA JE, 1990, PEDIATRICS, V85, P1
   Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410
   Bodmer-Roy S, 2012, OBSTET GYNECOL, V120, P746, DOI 10.1097/AOG.0b013e31826994ec
   BUCHANAN TA, 1994, ANNU REV MED, V45, P245
   Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275
   Ceausu I, 2016, ACTA ENDOCRINOL-BUCH, V12, P500, DOI 10.4183/aeb.2016.500
   Celik O, 2011, ACTA ENDOCRINOL-BUCH, V7, P545, DOI 10.4183/aeb.2011.545
   Chen YZ, 2009, POPUL HEALTH MANAG, V12, P165, DOI 10.1089/pop.2009.12303
   Cohen RS, 2012, NEOREVIEWS, V13, pe486
   Das S, 2009, ARCH DIS CHILD-FETAL, V94, pF419, DOI 10.1136/adc.2008.156026
   Das SU, 2012, J NEONATOLOGY RES, V2, P130
   DEMARINI S, 1994, OBSTET GYNECOL, V83, P918, DOI 10.1097/00006250-199406000-00003
   Gheorman L, 2011, ROM J MORPHOL EMBRYO, V52, P1127
   Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99
   HILLMAN LS, 1977, PEDIATR RES, V11, P739, DOI 10.1203/00006450-197706000-00009
   Jain A, 2010, INDIAN J PEDIATR, V77, P1123, DOI 10.1007/s12098-010-0176-0
   Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345
   LOUGHEAD JL, 1991, J AM COLL NUTR, V10, P123
   Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE
   McFarland M B, 1998, J Matern Fetal Med, V7, P292
   Nold JL, 2004, PEDIATR CLIN N AM, V51, P619, DOI 10.1016/j.pcl.2004.01.003
   Oakley GP, 2012, AM J OBSTET GYNECOL, V206, P179, DOI 10.1016/j.ajog.2011.12.019
   Ozkinay F, 1996, TURKISH J PEDIATR, V38, P381
   Panaitescu AM, 2016, ACTA ENDOCRINOL-BUCH, V12, P331, DOI 10.4183/aeb.2016.331
   Patil MB, 2012, INDIAN PEDIATR, V49, P670
   PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330
   Persson B, 1998, DIABETES CARE, V21, pB79
   Persson M, 2011, DIABETES CARE, V34, P1145, DOI 10.2337/dc10-2406
   Prabha FCS, 2010, CURR PEDIAT RES, V14, P83
   Rafiq W., 2015, INT J CONT PEDIAT, V2, P114, DOI [10.5455/2349-3291.ijcp20150510, DOI 10.5455/2349-3291.IJCP20150510]
   Rosenn B, 1996, PEDIATR ANN, V25, P215, DOI 10.3928/0090-4481-19960401-09
   ROSENN B, 1991, ANN CLIN LAB SCI, V21, P153
   Rozance PJ, 2006, BIOL NEONATE, V90, P74, DOI 10.1159/000091948
   Schwartz R, 2000, SEMIN PERINATOL, V24, P120, DOI 10.1053/sp.2000.6363
   Stoll BJ, 2003, NELSON TXB PAEDIAT, P614
   Tyrala EE, 1996, OBSTET GYN CLIN N AM, V23, P221, DOI 10.1016/S0889-8545(05)70253-9
   Ullmo S, 2007, EUR HEART J, V28, P1319, DOI 10.1093/eurheartj/ehl416
   WIDNESS JA, 1990, DIABETOLOGIA, V33, P378, DOI 10.1007/BF00404643
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Yang J, 2006, OBSTET GYNECOL, V108, P644, DOI 10.1097/01.AOG.0000231688.08263.47
NR 41
TC 0
Z9 0
U1 2
U2 4
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 1841-0987
EI 1843-066X
J9 ACTA ENDOCRINOL-BUCH
JI Acta Endocrinol.
PD OCT-DEC
PY 2017
VL 13
IS 4
BP 494
EP 501
DI 10.4183/aeb.2017.494
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FT4QQ
UT WOS:000423140200015
DA 2019-01-08
ER

PT J
AU Halliday, JA
   Hendrieckx, C
   Busija, L
   Browne, JL
   Nefs, G
   Pouwer, F
   Speight, J
AF Halliday, Jennifer A.
   Hendrieckx, Christel
   Busija, Lucy
   Browne, Jessica L.
   Nefs, Giesje
   Pouwer, Francois
   Speight, Jane
TI Validation of the WHO-5 as a first-step screening instrument for
   depression in adults with diabetes: Results from Diabetes MILES -
   Australia
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes mellitus; Depression; Surveys and questionnaires;
   Psychometrics; Factor analysis; statistical; ROC curve
ID WELL-BEING-INDEX; PRIMARY-CARE; OUTPATIENTS; PEOPLE; ASSOCIATION;
   DISTRESS; VALIDITY; QUALITY; TOOLS; PHQ-9
AB Aims: Screening for depression is recommended internationally. The World Health Organization's 5-item Well-being Index (WHO-5) is used clinically to screen for depression but its empirical suitability for this purpose is not well documented. We investigated the psychometric properties of the WHO-5 and its suitability for identifying likely depression in Australian adults with diabetes.
   Methods: The Diabetes MILES -Australia study dataset provided a sample of N = 3249 who completed the WHO-5 (positively-worded 5-item measure of emotional well-being) and the PHQ-9 (9-item measure of depressive symptoms). Analyses were conducted for the full sample, and separately by diabetes type and treatment (type 1, non-insulin-treated type 2, and insulin-treated type 2 diabetes). Construct (convergent and factorial) validity and reliability of the WHO-5 were examined. ROC analyses were used to examine the sensitivity and specificity of the WHO-5 as a depression screening instrument, comparing two commonly used WHO-5 cut-off values (<= 7 and < 13) with the PHQ-9.
   Results: For the whole sample, the WHO-5 demonstrated satisfactory internal consistency reliability (a = 0.90) and convergent validity with the PHQ-9 (r = -0.73, p < 0.001). Confirmatory factor analysis partially supported factorial validity:.2(5) = 834.94, p < 0.001; RMSEA = 0.23, 90% CI 0.21-0.24; CFI = 0.98, TLI = 0.96; factor loadings = 0.78-0.92. The AUC was 0.87 (95% CI: 0.86-0.89, p < 0.001). The sensitivity/specificity of the WHO-5 for detecting likely depression was 0.44/ 0.96 for the <= 7 cut-off, and 0.79/ 0.79 for the < 13 cut-off, with similar findings by diabetes type and treatment.
   Conclusions: These findings support use of a WHO-5 cut-point of <13 to identify likely depression in Australian adults with diabetes, regardless of type/treatment. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Halliday, Jennifer A.; Hendrieckx, Christel; Browne, Jessica L.; Speight, Jane] Deakin Univ, Sch Psychol, 1 Geringhap St, Geelong, Vic 3220, Australia.
   [Halliday, Jennifer A.; Hendrieckx, Christel; Browne, Jessica L.; Speight, Jane] Australian Ctr Behav Res Diabet, Diabet Victoria, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Busija, Lucy] Australian Catholic Univ, Inst Hlth & Ageing, Level 6,215 Spring St, Melbourne, Vic 3000, Australia.
   [Nefs, Giesje] Tilburg Univ, Ctr Res Psychol & Somat Disorders CoRPS, Dept Med & Clin Psychol, POB 90153, NL-5000 LE Tilburg, Netherlands.
   [Nefs, Giesje] Ctr Pediat & Adolescent Diabet Care & Res, Blaak 6, NL-3011 TA Rotterdam, Netherlands.
   [Pouwer, Francois] Univ Southern Denmark, Dept Psychol, Campusvej 55, DK-5230 Odense M, Denmark.
   [Speight, Jane] AHP Res, Hornchurch, Essex, England.
RP Halliday, JA (reprint author), Deakin Univ, Sch Psychol, 1 Geringhap St, Geelong, Vic 3220, Australia.
EM j.halliday@deakin.edu.au
RI Nefs, Giesje/C-9992-2018
OI Speight, Jane/0000-0002-1204-6896
FU National Diabetes Services Scheme (NDSS) Strategic Development Grant;
   Sanofi-Aventis; NDSS Mental Health and Diabetes Priority Area; Diabetes
   Victoria; Deakin University
FX The Diabetes MILES - Australia 2011 Survey was funded by a National
   Diabetes Services Scheme (NDSS) Strategic Development Grant. The NDSS is
   an initiative of the Australia Government administered with the
   assistance of Diabetes Australia. The Diabetes MILES Study was also
   supported by an unrestricted educational grant from Sanofi-Aventis. The
   funding sources had no role in the design, data collection, analysis or
   interpretation of the study, or in the decision to submit the manuscript
   for publication. JH was funded by the NDSS Mental Health and Diabetes
   Priority Area. The contributions of JS, CH and JB are supported by core
   funding provided by Diabetes Victoria and Deakin University to The
   Australian Centre for Behavioural Research in Diabetes.
CR Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x
   Bech P., 2004, QUALITY LIFE NEWSLET, V32, P15
   Browne MW, 2002, PSYCHOL METHODS, V7, P403, DOI 10.1037//1082-989X.7.4.403
   Byrne JL, 2017, DIABETIC MED, V34, P1074, DOI 10.1111/dme.13334
   Cohen J, 1988, STAT POWER ANAL BEHA
   Davies MJ, 2007, PRACT DIAB INT, V24, P483
   de Wit M, 2007, DIABETES CARE, V30, P2003, DOI 10.2337/dc07-0447
   Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Furuya M, 2013, ACTA DIABETOL, V50, P117, DOI 10.1007/s00592-010-0219-z
   Hajos TRS, 2012, DIABETIC MED, V30, pe63
   Halliday JA, 2015, DIABETIC MED, V32, P1393, DOI 10.1111/dme.12768
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Hendrieckx C, 2012, AUSTR DIAB SOC AUSTR
   Hendrieckx C, 2016, HDB HLTH PROFESSIONA
   Henkel V, 2004, GEN HOSP PSYCHIAT, V26, P190, DOI 10.1016/j.genhosppsych.2004.02.003
   Hochberg G, 2012, DIABETES METAB, V38, P515, DOI 10.1016/j.diabet.2012.06.002
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lamers F, 2008, J CLIN EPIDEMIOL, V61, P679, DOI 10.1016/j.jclinepi.2007.07.018
   Lloyd CE, 2012, DIABETIC MED, V29, P140, DOI 10.1111/j.1464-5491.2011.03481.x
   Lloyd CE, 2013, SCREENING DEPRESSION
   Lombardo P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-114
   Mosely K, 2010, DIABETES RES CLIN PR, V87, P11
   Muthen B, 1997, PSYCHOMETRIKA, V1, P1
   Novo Nordisk, 2015, THE DAWN PROGR
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Pouwer F, 2013, SCREENING DEPRESSION, P199
   Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Psychiatric Research Unit at the Mental Health Centre, 2014, WHO 5 WELL BEING IND
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Shea S, 2003, DIABETOLOGIA, V46, pA85
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Speight J, 2012, BEHALF DIABETES MILE
   Speight J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-120
   Spitzer RL, INSTRUCTION MANUAL I
   Tarolla E, 2012, RIV PSICHIATR, V47, P304, DOI 10.1708/1139.12557
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   The Royal Australian College of General Practitioners, 2016, GEN PRACT MAN TYP 2
   Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585
   VANSTEENBERGENWEIJ, 2010, BMC HEALTH SERV RES, V10, DOI DOI 10.1186/1472-6963-10-235
   West SG, 1995, STRUCTURAL EQUATION, P56, DOI DOI 10.1016/J.STUEDUC.2012.09.001
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
   Yu C. Y., 2002, EVALUATING CUTOFF CR
NR 49
TC 2
Z9 2
U1 4
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD OCT
PY 2017
VL 132
BP 27
EP 35
DI 10.1016/j.diabres.2017.07.005
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FM6WQ
UT WOS:000415202800004
PM 28783530
DA 2019-01-08
ER

PT J
AU Raymond, KL
   Kannis-Dymand, L
   Lovell, GP
AF Raymond, Karren-Lee
   Kannis-Dymand, Lee
   Lovell, Geoff P.
TI A graduated food addiction classifications approach significantly
   differentiates depression, anxiety and stress among people with type 2
   diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes mellitus; Depression; Anxiety; Stress; Processed food
   addiction; Severity levels; Processed food use disorder
ID BODY-MASS INDEX; SUBSTANCE USE; MULTIMORBIDITY; DISORDERS; HEALTH;
   ADULTS; RISK; PREVALENCE; VALIDATION; DISTRESS
AB Aims: To examine differences in depression, anxiety, and stress across people with type 2 diabetes mellitus (t2d) classified according to a four level processed food addiction (PFA) severity indicator dichotomy.
   Methods: Four hundred and eight participants with a t2d diagnoses completed an online survey including the Yale Food Addiction Scale (YFAS) and the DASS-21. Based on YFAS symptom counts participants were classified as either: non-PFA; mild-PFA; moderatePFA; or severe-PFA.
   Results: Multivariate, lambda = 0.422, F(9,978.51) = 46.286, p < 0.001, n(p)(2) = 0.250, and univariate analyses of variance demonstrated that depression F(3,408) = 159.891, p < 0.001, n(p)(2) = 0.543, anxiety F(3,408) = 127.419, p < 0.001, np 2 = 0.486, and stress scores F(3,408) = 129.714, p < 0.001, n(p)(2) = 0.491, significantly and meaningfully increased from one PFA classification level to the next. Furthermore, the proportion of participants with more severe classifications of depression chi(2) (12) = 297.820, p < 0.001, anxiety chi(2) (12) = 271.805, p < 0.001, and stress chi(2) (12) = 240.875, p < 0.001, were significantly higher in the more severe PFA groupings.
   Conclusion: For people with t2d, PFA is an important and meaningful associate of depression, anxiety, and stress, and that the adopted four level PFA severity indicator dichotomy is valid and useful. (C) 2017 Elsevier B. V. All rights reserved.
C1 [Raymond, Karren-Lee; Kannis-Dymand, Lee; Lovell, Geoff P.] Univ Sunshine Coast, Sch Social Sci, Locked Bag 4, Maroochydore, Qld 4558, Australia.
RP Raymond, KL (reprint author), Univ Sunshine Coast, Sch Social Sci, Locked Bag 4, Maroochydore, Qld 4558, Australia.
EM karren-lee.raymond@research.usc.edu.au; lkannisd@usc.edu.au;
   glovell@usc.edu.au
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Begin C., 2012, HEALTH, V4, P1492, DOI DOI 10.4236/HEALTH.2012.412A214
   Bener A, 2011, ONCOL REV, V5, P5, DOI 10.1007/s12156-010-0061-0
   Bruinsma K, 1999, J AM DIET ASSOC, V99, P1249, DOI 10.1016/S0002-8223(99)00307-7
   Burmeister JM, 2013, APPETITE, V60, P103, DOI 10.1016/j.appet.2012.09.013
   Chien IC, 2016, J PSYCHOSOM RES, V86, P47, DOI 10.1016/j.jpsychores.2016.05.003
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Diabetes Australia, 2016, DIAB GLOB
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fortin M, 2007, BMJ-BRIT MED J, V334
   Gearhardt AN, 2013, EAT BEHAV, V14, P508, DOI 10.1016/j.eatbeh.2013.07.002
   Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003
   Global Burden of Disease, 2015, LANCET
   Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016
   Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657
   Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442
   Ifland JR, 2009, MED HYPOTHESES, V72, P518, DOI 10.1016/j.mehy.2008.11.035
   Kelly TM, 2012, ADDICT BEHAV, V37, P11, DOI 10.1016/j.addbeh.2011.09.010
   Lai HMX, 2015, DRUG ALCOHOL DEPEN, V154, P1, DOI 10.1016/j.drugalcdep.2015.05.031
   Lian J, 2014, CURR MED RES OPIN, V30, P2233, DOI 10.1185/03007995.2014.952716
   Lovibond SH, 1995, MANUAL DEPRESSION AN
   Lerma-Cabrera JM, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0124-6
   Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020
   Meule A, 2012, DIAGNOSTICA, V58, P115, DOI 10.1026/0012-1924/a000047
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3
   Moubarac JC, 2014, CURR OBES REP, V3, P256, DOI 10.1007/s13679-014-0092-0
   Murphy CM, 2014, APPETITE, V73, P45, DOI 10.1016/j.appet.2013.10.008
   Pelchat ML, 2009, J NUTR, V139, P620, DOI 10.3945/jn.108.097816
   Pivarunas B, 2015, EAT BEHAV, V19, P9, DOI 10.1016/j.eatbeh.2015.06.007
   Quello Susan B, 2005, Sci Pract Perspect, V3, P13
   Raymond K-L, 2016, J HEALTH PSYCHOL, P1
   Raymond KL, 2016, J DIABETES COMPLICAT, V30, P651, DOI 10.1016/j.jdiacomp.2016.01.020
   Schult EM, 2016, APPETITE
   Schulte EM, 2015, PLOS ONE
   Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030
   Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032
   Tann SS, 2007, AM INDIAN ALASKA NAT, V14, P1
   Tolliver BK, 2015, DIALOGUES CLIN NEURO, V17, P181
   Tovilla-Zarate C, 2011, PLOS ONE, V7, P5
   Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093
   van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715
   Whiteford HA, GLOBAL BURDEN DIS AT
   Whitworth SR, 2016, DIABETES RES CLIN PR, V122, P190, DOI 10.1016/j.diabres.2016.10.023
   Wu LT, 2015, DRUG ALCOHOL DEPEN, V156, P162, DOI 10.1016/j.drugalcdep.2015.09.003
NR 49
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD OCT
PY 2017
VL 132
BP 95
EP 101
DI 10.1016/j.diabres.2017.07.028
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FM6WQ
UT WOS:000415202800011
PM 28826026
DA 2019-01-08
ER

PT J
AU Hoogendoorn, CJ
   Roy, JF
   Gonzalez, JS
AF Hoogendoorn, Claire J.
   Roy, Juan F.
   Gonzalez, Jeffrey S.
TI Shared Dysregulation of Homeostatic Brain-Body Pathways in Depression
   and Type 2 Diabetes
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Type 2 diabetes; Depression; Biological pathways;
   Hypothalamic-pituitary-adrenal axis; Brain-gut-microbiome axis
ID RANDOMIZED CONTROLLED-TRIALS; MIDDLE-AGED MEN; GUT MICROBIOTA; HPA AXIS;
   GLUCOSE-METABOLISM; INSULIN-RESISTANCE; MAJOR DEPRESSION; IMMUNE-SYSTEM;
   SECRETORY PATTERN; CIRCADIAN-RHYTHM
AB Purpose of Review The purpose of this review is to provide an overview of shared dysregulation of the hypothalamic-pituitary-adrenal (HPA) and brain-gut-microbiome (BGM) axes associated with depression and type 2 diabetes (T2D). Clinical implications and future research are also discussed.
   Recent Findings Both depression and T2D are associated with dysregulation of the HPA and BGM axes. These pathways regulate immune function, glucose metabolism, and sleep, which are altered in both illnesses. Dysregulation of homeostatic brain-body pathways may be positively influenced through different therapeutic actions, including psychotherapy, healthy eating, physical activity, sleep promotion, and certain anti-inflammatory or antidepressant medications.
   Summary While the causal nature of the relationship between depression and T2D remains unclear, these conditions share dysregulation of homeostatic brain-body pathways that are central to mental and physical health. Better understanding of this dysregulation may provide opportunities for interventions that could benefit both conditions. Future research should examine the additive burden of depression and T2D on HPA and BGM dysregulation and better differentiate depression from emotional distress.
C1 [Hoogendoorn, Claire J.; Roy, Juan F.; Gonzalez, Jeffrey S.] Yeshiva Univ, Ferkauf Grad Sch Psychol, 1165 Morris Pk Ave,Rousso Bldg, Bronx, NY 10461 USA.
   [Gonzalez, Jeffrey S.] Albert Einstein Coll Med, Dept Med Endocrinol, Bronx, NY 10467 USA.
RP Hoogendoorn, CJ (reprint author), Yeshiva Univ, Ferkauf Grad Sch Psychol, 1165 Morris Pk Ave,Rousso Bldg, Bronx, NY 10461 USA.
EM Claire.hoogendoorn@yu.edu; juan.roy-delgado@yu.edu;
   jeffrey.gonzalez@einstein.yu.edu
FU National Institutes of Health [R18 DK098742, R01 DK104845, P30
   DK111022]; Drs. David and Jane Willner Bloomgarden Family Fellowship
   Fund
FX Dr. Gonzalez's effort is partialy supported by grants from the National
   Institutes of Health: R18 DK098742, R01 DK104845 and P30 DK111022.
   Support was also provided by The Drs. David and Jane Willner Bloomgarden
   Family Fellowship Fund.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Aronsohn RS, 2010, AM J RESP CRIT CARE, V181, P507, DOI 10.1164/rccm.200909-1423OC
   Baganz NL, 2013, ACS CHEM NEUROSCI, V4, P48, DOI 10.1021/cn300186b
   Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09
   Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298
   Bhaskar Swapna, 2016, J Family Med Prim Care, V5, P780, DOI 10.4103/2249-4863.201153
   Blalock JE, 2005, J INTERN MED, V257, P126, DOI 10.1111/j.1365-2796.2004.01441.x
   Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a
   Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29
   Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038
   Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003
   Chan O, 2003, Minerva Endocrinol, V28, P87
   Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816
   Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109
   Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346
   DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   de Groot M, 2012, CURR DIABETES REP, V12, P157, DOI 10.1007/s11892-012-0261-z
   de Jonge P, 2006, DIABETOLOGIA, V49, P2627, DOI 10.1007/s00125-006-0442-x
   de Weerth C, 2003, EARLY HUM DEV, V73, P39, DOI 10.1016/S0378-3782(03)00074-4
   Desan PH, 2000, AM J MED GENET, V96, P418, DOI 10.1002/1096-8628(20000612)96:3<418::AID-AJMG34>3.0.CO;2-S
   Deuschle M, 2013, CURR OPIN PSYCHIATR, V26, P60, DOI 10.1097/YCO.0b013e32835a4206
   Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188
   Dinan TG, 2013, NEUROGASTROENT MOTIL, V25, P713, DOI 10.1111/nmo.12198
   Dinan TG, 1996, LIFE SCI, V58, P1683, DOI 10.1016/0024-3205(96)00066-5
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033
   Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520
   Eskandari F, 2002, ANN NY ACAD SCI, V966, P20, DOI 10.1111/j.1749-6632.2002.tb04198.x
   Ferrari E, 2001, BRAIN RES REV, V37, P294, DOI 10.1016/S0165-0173(01)00133-3
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Franchimont DP, 2008, NEUROIMMUNE, V7, P349
   Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094
   Guseva D, 2014, INFLAMM BOWEL DIS, V20, P1516, DOI 10.1097/MIB.0000000000000150
   Hawrelak Jason A, 2004, Altern Med Rev, V9, P180
   Hiller-Sturmhofel S, 1998, ALCOHOL HEALTH RES W, V22, P153
   Himmerich H, 2006, BIOL PSYCHIAT, V60, P882, DOI 10.1016/j.biopsych.2006.03.075
   HOLDEMAN LV, 1976, APPL ENVIRON MICROB, V31, P359
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6
   Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442
   Kasinska MA, 2015, POL ARCH MED WEWN, V125, P803, DOI 10.20452/pamw.3156
   Kaye J, 2004, J NEUROENDOCRINOL, V16, P256, DOI 10.1111/j.0953-8194.2004.01158.x
   Kivimaki M, 2010, DIABETES CARE, V33, P2611, DOI 10.2337/dc10.1187
   Knowles SR, 2008, BIOL PSYCHOL, V77, P132, DOI 10.1016/j.biopsycho.2007.09.010
   Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002
   Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009
   Laake JPS, 2014, DIABETES CARE, V37, P2186, DOI 10.2337/dc13-2522
   Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175
   Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x
   Magouliotis DE, 2017, OBES SURG, P1
   Manber R, 2011, J CLIN SLEEP MED, V7, P645, DOI 10.5664/jcsm.1472
   McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3
   McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x
   Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184
   Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25
   Moreno-Indias I, 2015, EUR RESPIR J, V45, P1055, DOI 10.1183/09031936.00184314
   Moulton CD, 2015, LANCET DIABETES ENDO, V3, P461, DOI 10.1016/S2213-8587(15)00134-5
   Murri MB, 2014, PSYCHONEUROENDOCRINO, V41, P46, DOI 10.1016/j.psyneuen.2013.12.004
   Naseribafrouei A, 2014, NEUROGASTROENT MOTIL, V26, P1155, DOI 10.1111/nmo.12378
   National Institutes of Mental Health, MENTAL HLTH
   Naughton M, 2000, HUM PSYCHOPHARM CLIN, V15, P397, DOI 10.1002/1099-1077(200008)15:6<397::AID-HUP212>3.3.CO;2-C
   Nemeroff CB, 2004, CNS SPECTRUMS, V9, P23, DOI 10.1017/S1092852900025475
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027
   Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X
   Pirbaglou M, 2016, NUTR RES, V36, P889, DOI 10.1016/j.nutres.2016.06.009
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006
   Reutrakul S, 2014, ANN NY ACAD SCI, V1311, P151, DOI 10.1111/nyas.12355
   Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35
   Rosmond R, 2000, OBES RES, V8, P445, DOI 10.1038/oby.2000.55
   Rosmond R, 2003, MED SCI MONITOR, V9, P35
   Roy Monique, 1991, Journal of Diabetic Complications, V5, P218, DOI 10.1016/0891-6632(91)90079-5
   Rubin RR, 2008, DIABETES CARE, V31, P420, DOI 10.2337/dc07-182T
   Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55
   Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Steptoe A, 2003, PSYCHOL MED, V33, P667, DOI 10.1017/S0033291702007250
   Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b
   Swain MG, 2000, CLIN SCI, V99, P1, DOI 10.1042/CS19990372
   Trinder M, 2015, UNIV TOR MED J, V92, P52
   Tsatsoulis A, 2006, ANN NY ACAD SCI, V1083, P196, DOI 10.1196/annals.1367.020
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Vedder H, 2008, NEUROIMMUNE, V7, P17
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455
   Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047
   Zhang JP, 2006, PSYCHOSOM MED, V68, P718, DOI 10.1097/01.psy.0000228343.89466.11
NR 100
TC 2
Z9 2
U1 2
U2 12
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD OCT
PY 2017
VL 17
IS 10
AR 90
DI 10.1007/s11892-017-0923-y
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FJ9BY
UT WOS:000413063800009
PM 28815394
DA 2019-01-08
ER

PT J
AU Kuwata, H
   Okamura, S
   Hayashino, Y
   Tsujii, S
   Ishii, H
AF Kuwata, Hirohito
   Okamura, Shintaro
   Hayashino, Yasuaki
   Tsujii, Satoru
   Ishii, Hitoshi
CA Tenri Study Grp
TI Serum uric acid levels are associated with increased risk of newly
   developed diabetic retinopathy among Japanese male patients with type 2
   diabetes: A prospective cohort study (diabetes distress and care
   registry at Tenri [DDCRT 13])
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Article
DE cohort; diabetic retinopathy; epidemiology; human; type 2 diabetes; uric
   acid
ID KIDNEY-DISEASE PROGRESSION; CARDIOVASCULAR MORTALITY; ATHEROSCLEROSIS;
   COMPLICATIONS; HYPERURICEMIA; ALBUMINURIA; PREVALENCE; ADULTS
AB Objective: We assessed the prospective association between baseline serum uric acid levels and consequent risk of developing diabetic retinopathy.
   Research Design and Methods: Data for 1839 type 2 diabetes patients without diabetic retinopathy were obtained from a Japanese diabetes registry. A Cox proportional hazards model with time-varying exposure information by sex was used and adjusted for potential confounders to assess the independent correlations between baseline serum uric acid levels and incidence rate of diabetic retinopathy.
   Results: Newly developed diabetic retinopathy was recognized in 188 patients (10.2%) during the observation period of 2years. Compared to the first serum uric acid quartile level, the multivariate adjusted hazards ratio for diabetic retinopathy development in male patients was 1.97 (95% CI, 1.14-3.41; P=.015), 1.92 (95% CI, 1.18-3.13; P=.008), and 2.17 (95% CI, 1.40-3.37; P=.001) for the second, third, and fourth serum uric acid quartile levels, respectively. But this was not the case with female patients.
   Conclusion: Higher serum uric acid levels were associated with increased risk of developing diabetic retinopathy in male patients with type 2 diabetes, but not in female patients. Serum uric acid may be a useful biomarker for predicting the future risk of developing diabetic retinopathy in male patients with type 2 diabetes.
C1 [Kuwata, Hirohito; Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara, Japan.
   [Okamura, Shintaro; Hayashino, Yasuaki; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
RP Tsujii, S (reprint author), Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
EM stsujii@tenriyorozu.jp
OI Tsujii, Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]
FX Manpei Suzuki Diabetes Foundation and JSPS KAKENHI, Grant/Award Number:
   25460641
CR AKIZUKI S, 1982, ANN RHEUM DIS, V41, P272, DOI 10.1136/ard.41.3.272
   Bjornstad P, 2014, ACTA DIABETOL, V51, P783, DOI 10.1007/s00592-014-0611-1
   Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010
   Cai XL, 2006, CHINESE MED J-PEKING, V119, P822
   De Cosmo S, 2015, CLIN J AM SOC NEPHRO, V10, P1921, DOI 10.2215/CJN.03140315
   Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404
   Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885
   Fenwick E, 2012, CLIN EXP OPHTHALMOL, V40, P27, DOI 10.1111/j.1442-9071.2011.02599.x
   Filiopoulos V, 2012, RENAL FAILURE, V34, P510, DOI 10.3109/0886022X.2011.653753
   Fong DS, 1999, AM J OPHTHALMOL, V127, P137, DOI 10.1016/S0002-9394(98)00309-2
   FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479
   Fu CC, 2009, ACTA DIABETOL, V46, P127, DOI 10.1007/s00592-008-0069-0
   FUKUDA M, 1983, Tohoku Journal of Experimental Medicine, V141, P331
   Fukui M, 2008, METABOLISM, V57, P625, DOI 10.1016/j.metabol.2007.12.005
   Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210
   Hakoda M, 2005, J RHEUMATOL, V32, P906
   Hayashino Y, 2016, ACTA DIABETOL, V53, P599, DOI 10.1007/s00592-015-0825-x
   Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x
   KABASAKALIAN P, 1973, Clinical Chemistry, V19, P522
   Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0
   KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010
   Krizova L, 2011, OPHTHALMIC RES, V46, P73, DOI 10.1159/000322994
   Kushiyama A, 2012, ARTERIOSCL THROM VAS, V32, P291, DOI 10.1161/ATVBAHA.111.234559
   Kuwata H, 2016, DIABETOL INT, V7, P352, DOI 10.1007/s13340-016-0254-2
   Lee JJ, 2014, DIABETES RES CLIN PR, V106, P366, DOI 10.1016/j.diabres.2014.07.027
   LEVINE W, 1989, J CLIN EPIDEMIOL, V42, P257, DOI 10.1016/0895-4356(89)90061-9
   Maahs DM, 2013, CURR DIABETES REP, V13, P550, DOI 10.1007/s11892-013-0381-0
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   Mercuro G, 2004, AM J CARDIOL, V94, P932, DOI 10.1016/j.amjcard.2004.06.032
   OLUKOGA AO, 1991, DIABETES RES CLIN PR, V14, P99, DOI 10.1016/0168-8227(91)90115-T
   REUNANEN A, 1982, ACTA MED SCAND, P49
   ROUBENOFF R, 1990, RHEUM DIS CLIN N AM, V16, P539
   Sakata K, 2001, EUR J EPIDEMIOL, V17, P461, DOI 10.1023/A:1013735717961
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   Tomita M, 2000, J Epidemiol, V10, P403
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   YANKO L, 1983, BRIT J OPHTHALMOL, V67, P759, DOI 10.1136/bjo.67.11.759
NR 37
TC 2
Z9 2
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-7560
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD OCT
PY 2017
VL 33
IS 7
AR e2905
DI 10.1002/dmrr.2905
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FI7GU
UT WOS:000412165800002
PM 28444955
DA 2019-01-08
ER

PT J
AU van Beers, CAJ
   de Wit, M
   Kleijer, SJ
   Geelhoed-Duijvestijn, PH
   DeVries, JH
   Kramer, MHH
   Diamant, M
   Serne, EH
   Snoek, FJ
AF van Beers, Cornelis A. J.
   de Wit, Maartje
   Kleijer, Susanne J.
   Geelhoed-Duijvestijn, Petronella H.
   DeVries, J. Hans
   Kramer, Mark H. H.
   Diamant, Michaela
   Serne, Erik H.
   Snoek, Frank J.
TI Continuous Glucose Monitoring in Patients with Type 1 Diabetes and
   Impaired Awareness of Hypoglycemia: Also Effective in Patients with
   Psychological Distress?
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
DE Type 1 diabetes; Continuous glucose monitoring; Impaired awareness of
   hypoglycemia; Psychological distress
ID QUALITY-OF-LIFE; RANDOMIZED CLINICAL-TRIAL; PUMP THERAPY; ADULTS; TIME;
   FEAR; INTERVENTION; PREVALENCE; MELLITUS; OUTCOMES
AB The aim of this study was to evaluate whether psychological distress modifies the effect of continuous glucose monitoring (CGM) in patients with type 1 diabetes (T1D) and impaired awareness of hypoglycemia. Fifty-two patients with T1D and impaired awareness of hypoglycemia participated in an earlier reported randomized crossover trial with two 16-week intervention periods comparing CGM with self-monitoring of blood glucose (SMBG). During the CGM phase, time spent in euglycemia (4-10mmol/L), the primary outcome, was 9.6% higher compared with the SMBG phase (P<0.0001). Psychological distress was operationalized as low emotional well-being (World Health Organization Well-being Index 5 [WHO-5] < 50), high diabetes-related distress (Problem Areas in Diabetes 5 [PAID-5] 8), and/or high fear of hypoglycemia (Hypoglycemia Fear Survey [HFS] Worry > mean HFS Worry score +1 standard deviation). Modifying effects were assessed by analyzing psychological distress scorexinterventioninteraction effects. Results showed that both the low emotional well-being group and normal emotional well-being group had equal glycemic outcomes during the CGM phase. High diabetes distress and elevated fear of hypoglycemia did not result in significant interaction effects for glycemic outcomes. This study demonstrated that CGM is equally effective in terms of glycemic improvements in high versus low distressed patients with T1D and impaired awareness of hypoglycemia.
C1 [van Beers, Cornelis A. J.; Kleijer, Susanne J.; Kramer, Mark H. H.; Diamant, Michaela; Serne, Erik H.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands.
   [de Wit, Maartje; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Geelhoed-Duijvestijn, Petronella H.] Med Ctr Haaglanden, Dept Internal Med, The Hague, Netherlands.
   [DeVries, J. Hans] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol, Amsterdam, Netherlands.
   [Snoek, Frank J.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
RP van Beers, CAJ (reprint author), Vrije Univ Amsterdam, Med Ctr, Diabet Ctr, Dept Internal Med, Room ZH-4A63,Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.
EM c.vanbeers@vumc.nl
FU Eli Lilly; Sanofi; AstraZeneca; Boehringer Ingelheim; Novo Nordisk;
   Abbott; Dexcom; Medtronic; Roche Diabetes Care; Senseonics
FX This research received funding from Eli Lilly and Sanofi. Medtronic
   provided continuous glucose monitoring devices. Through M.H.H.K. and
   M.D., the VU University Medical Center received research grants from
   AstraZeneca, Boehringer Ingelheim, Novo Nordisk, and Sanofi. J.H.D. or
   his institution received research support and speaker's fees from
   Abbott, Dexcom, Medtronic, Roche Diabetes Care, and Senseonics.
   P.H.G.-D. received speaker's fees from Abbott and Medtronic and is a
   member of the advisory board of Medtronic.
CR Barendse S, 2012, DIABETIC MED, V29, P293, DOI 10.1111/j.1464-5491.2011.03416.x
   Beck RW, 2010, DIABETES CARE, V33, P2175, DOI 10.2337/dc10-0331
   Choudhary P, 2013, DIABETES CARE, V36, P4160, DOI 10.2337/dc13-0939
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hajos TRS, 2014, DIABETES CARE, V37, P102, DOI 10.2337/dc13-0971
   Hermanides J, 2011, DIABETIC MED, V28, P1158, DOI 10.1111/j.1464-5491.2011.03256.x
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Ly TT, 2013, JAMA-J AM MED ASSOC, V310, P1240, DOI 10.1001/jama.2013.277818
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Peters AL, 2016, J CLIN ENDOCR METAB, V101, P3922, DOI 10.1210/jc.2016-2534
   Pickup JC, 2015, DIABETES CARE, V38, P544, DOI 10.2337/dc14-1855
   Pickup JC, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d3805
   Polonsky WH, 2017, DIABETES CARE, V40, P736, DOI 10.2337/dc17-0133
   Ritholz MD, 2010, DIABETIC MED, V27, P1060, DOI 10.1111/j.1464-5491.2010.03061.x
   Rondags SMPA, 2016, DIABETES CARE, V39, P2190, DOI 10.2337/dc16-1614
   Rubin RR, 2012, DIABETES TECHNOL THE, V14, P143, DOI 10.1089/dia.2011.0162
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Tanenbaum ML, 2017, DIABETES CARE, V40, P181, DOI 10.2337/dc16-1536
   van Beers CAJ, 2016, LANCET DIABETES ENDO, V4, P893, DOI 10.1016/S2213-8587(16)30193-0
   van Beers CAJ, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0040-3
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
NR 27
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD OCT
PY 2017
VL 19
IS 10
BP 595
EP 599
DI 10.1089/dia.2017.0141
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FK1XT
UT WOS:000413277600009
PM 28836833
DA 2019-01-08
ER

PT J
AU Sominsky, L
   Hodgson, DM
   McLaughlin, EA
   Smith, R
   Wall, HM
   Spencer, SJ
AF Sominsky, Luba
   Hodgson, Deborah M.
   McLaughlin, Eileen A.
   Smith, Roger
   Wall, Hannah M.
   Spencer, Sarah J.
TI Linking Stress and Infertility: A Novel Role for Ghrelin
SO ENDOCRINE REVIEWS
LA English
DT Review
ID POLYCYSTIC-OVARY-SYNDROME; GONADOTROPIN-RELEASING-HORMONE; IN-VITRO
   FERTILIZATION; PITUITARY-ADRENAL AXIS; GESTATIONAL DIABETES-MELLITUS;
   DES-ACYL GHRELIN; MAJOR DEPRESSIVE DISORDER; MESSENGER-RNA EXPRESSION;
   FEMALE RHESUS-MONKEYS; QUALITY-OF-LIFE
AB Infertility affects a remarkable one in four couples in developing countries. Psychological stress is a ubiquitous facet of life, and although stress affects us all at some point, prolonged or unmanageable stress may become harmful for some individuals, negatively impacting on their health, including fertility. For instance, women who struggle to conceive are twice as likely to suffer from emotional distress than fertile women. Assisted reproductive technology treatments place an additional physical, emotional, and financial burden of stress, particularly on women, who are often exposed to invasive techniques associated with treatment. Stress-reduction interventions can reduce negative affect and in some cases to improve in vitro fertilization outcomes. Although it has been well-established that stress negatively affects fertility in animal models, human research remains inconsistent due to individual differences and methodological flaws. Attempts to isolate single causal links between stress and infertility have not yet been successful due to their multifaceted etiologies. In this review, we will discuss the current literature in the field of stress-induced reproductive dysfunction based on animal and human models, and introduce a recently unexplored link between stress and infertility, the gut-derived hormone, ghrelin. We also present evidence from recent seminal studies demonstrating that ghrelin has a principal role in the stress response and reward processing, as well as in regulating reproductive function, and that these roles are tightly interlinked. Collectively, these data support the hypothesis that stress may negatively impact upon fertility at least in part by stimulating a dysregulation in ghrelin signaling.
C1 [Sominsky, Luba; Wall, Hannah M.; Spencer, Sarah J.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic 3083, Australia.
   [Hodgson, Deborah M.] Univ Newcastle, Sch Psychol, Fac Sci & IT, Callaghan, NSW 2308, Australia.
   [McLaughlin, Eileen A.] Univ Auckland, Sch Biol Sci, Fac Sci, Auckland 1010, New Zealand.
   [McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Fac Sci & IT, Callaghan, NSW 2308, Australia.
   [Smith, Roger] Hunter Med Res Inst, Mothers & Babies Res Ctr, Lookout Rd, New Lambton Hts, NSW 2305, Australia.
   [Smith, Roger] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW 2308, Australia.
RP Sominsky, L (reprint author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic 3083, Australia.
EM luba.sominsky@rmit.edu.au
RI Spencer, Sarah/D-5777-2018
OI McLaughlin, Eileen/0000-0002-5837-3876; Sominsky,
   Luba/0000-0002-0674-8824
FU Australian Research Council (ARC) [DP130100508]
FX This work is supported by a Discovery Project Grant from the Australian
   Research Council (ARC) to S.J.S. (DP130100508). S.J.S. is an ARC Future
   Fellow (FT110100084) and an RMIT University VC Senior Research Fellow.
CR Abizaid A, 2011, NEUROSCIENCE, V192, P500, DOI 10.1016/j.neuroscience.2011.06.001
   Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867
   Abu El-Magd M, 2016, GEN COMP ENDOCR, V237, P131, DOI 10.1016/j.ygcen.2016.08.016
   Abu-Musa AA, 2007, FERTIL STERIL, V88, P1579, DOI 10.1016/j.fertnstert.2007.01.067
   Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004
   Acromite Michael, 2004, Hormones (Athens), V3, P46
   Aghajanova L, 2010, REPROD SCI, V17, P823, DOI 10.1177/1933719110371683
   AGUADO LI, 1984, ENDOCRINOLOGY, V114, P1845, DOI 10.1210/endo-114-5-1845
   AGUADO LI, 1982, ENDOCRINOLOGY, V110, P1124, DOI 10.1210/endo-110-4-1124
   Aiken C. E., 2015, NATURE SCI REPORTS, V5, P16175, DOI DOI 10.1038/SREP16175)
   Akema T, 2005, J NEUROENDOCRINOL, V17, P672, DOI 10.1111/j.1365-2826.2005.01358.x
   Allas S, 2016, DIABETES OBES METAB, V18, P868, DOI 10.1111/dom.12675
   ALTEMUS M, 1995, J CLIN ENDOCR METAB, V80, P2954, DOI 10.1210/jc.80.10.2954
   Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321
   Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564
   Ananth CV, 2010, EPIDEMIOLOGY, V21, P118, DOI 10.1097/EDE.0b013e3181c297af
   Anderheim L, 2005, HUM REPROD, V20, P2969, DOI 10.1093/humrep/dei219
   Anderson K, 2010, AUST NZ J OBSTET GYN, V50, P8, DOI 10.1111/j.1479-828X.2009.01119.x
   Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009
   Angelidis G, 2012, REPROD SCI, V19, P903, DOI 10.1177/1933719112443880
   Arck PC, 2008, REPROD BIOMED ONLINE, V17, P101, DOI 10.1016/S1472-6483(10)60300-8
   Arusoglu G, 2013, J CLIN ENDOCR METAB, V98, P4475, DOI 10.1210/jc.2013-1526
   Arvat E, 2001, J CLIN ENDOCR METAB, V86, P1169, DOI 10.1210/jc.86.3.1169
   Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680
   Aydin S, 2008, J PHYSIOL BIOCHEM, V64, P51, DOI 10.1007/BF03168234
   Aydin S, 2006, PEPTIDES, V27, P878, DOI 10.1016/j/peptides.2005.08.006
   Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028
   Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827
   BARBARINO A, 1989, METABOLISM, V38, P504, DOI 10.1016/0026-0495(89)90208-4
   Barbazanges A, 1996, J NEUROSCI, V16, P3943
   Barber TM, 2008, EUR J ENDOCRINOL, V158, P511, DOI 10.1530/EJE-07-0683
   Barim AO, 2009, CLIN BIOCHEM, V42, P1076, DOI 10.1016/j.clinbiochem.2009.02.020
   Barreiro ML, 2004, ENDOCRINOLOGY, V145, P4825, DOI 10.1210/en.2004-0732
   Barreiro ML, 2003, BIOL REPROD, V68, P1631, DOI 10.1095/biolreprod.102.008862
   Barreiro ML, 2002, BIOL REPROD, V67, P1768, DOI 10.1095/biolreprod.102.006965
   Bayliss JA, 2016, J NEUROCHEM, V137, P460, DOI 10.1111/jnc.13576
   BENJONATHAN N, 1985, ENDOCR REV, V6, P564, DOI 10.1210/edrv-6-4-564
   Bernuci MP, 2008, ENDOCRINOLOGY, V149, P2907, DOI 10.1210/en.2007-1254
   Bertoldi ML, 2011, HORM METAB RES, V43, P494, DOI 10.1055/s-0031-1277228
   Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972
   Bhongade MB, 2015, ANDROLOGIA, V47, P336, DOI 10.1111/and.12268
   Bideci A, 2008, J OBSTET GYNAECOL RE, V34, P578, DOI 10.1111/j.1447-0756.2008.00819.x
   Bigelow PL, 1998, FERTIL STERIL, V69, P11, DOI 10.1016/S0015-0282(97)00437-8
   Bilger M, 2001, ENDOCRINOLOGY, V142, P2102, DOI 10.1210/en.142.5.2102
   BLACKBURN JR, 1992, PROG NEUROBIOL, V39, P247, DOI 10.1016/0301-0082(92)90018-A
   Bock J, 2015, BIOL PSYCHIAT, V78, P315, DOI 10.1016/j.biopsych.2015.02.036
   Bodnar LM, 2005, ANN EPIDEMIOL, V15, P475, DOI 10.1016/j.annepidem.2004.12.008
   BOIVIN J, 1995, FERTIL STERIL, V64, P802, DOI 10.1016/S0015-0282(16)57858-3
   Boivin J, 2005, FERTIL STERIL, V83, P1745, DOI 10.1016/j.fertnstert.2004.12.039
   Boivin J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d223
   Boivin J, 2003, SOC SCI MED, V57, P2325, DOI 10.1016/S0277-9536(03)00138-2
   Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2
   Breen KM, 2007, ENDOCRINOLOGY, V148, P1882, DOI 10.1210/en.2006-0973
   Breen KM, 2012, MOL ENDOCRINOL, V26, P1716, DOI 10.1210/me.2011-1327
   Breen KM, 2004, ENDOCRINOLOGY, V145, P2739, DOI 10.1210/en.2004-0123
   Breen KM, 2004, ENDOCRINOLOGY, V145, P692, DOI 10.1210/en.2003-1114
   Briggs DI, 2014, ENDOCRINOLOGY, V155, P2411, DOI 10.1210/en.2013-1861
   Briggs DI, 2013, ENDOCRINOLOGY, V154, P709, DOI 10.1210/en.2012-1421
   Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556
   Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964
   Brugh VM, 2004, MED CLIN N AM, V88, P367, DOI 10.1016/S0025-7125(03)00150-0
   Brugo-Olmedo Santiago, 2001, Reprod Biomed Online, V2, P41
   Brunner RL, 2005, ARCH INTERN MED, V165, P1976, DOI 10.1001/archinte.165.17.1976
   Buller K, 2001, NEUROENDOCRINOLOGY, V73, P129, DOI 10.1159/000054629
   Buller KM, 2003, STRESS, V6, P11, DOI 10.1080/1025389031000092313
   Burkett JP, 2012, PSYCHOPHARMACOLOGY, V224, P1, DOI 10.1007/s00213-012-2794-x
   Cabral A, 2014, J NEUROENDOCRINOL, V26, P542, DOI 10.1111/jne.12168
   Cabral A, 2016, PSYCHONEUROENDOCRINO, V67, P27, DOI 10.1016/j.psyneuen.2016.01.027
   Cabral A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031462
   Cai G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21097
   Camina JP, 2006, J NEUROENDOCRINOL, V18, P65, DOI 10.1111/j.1365-2826.2005.01379.x
   Caminos JE, 2003, ENDOCRINOLOGY, V144, P5089, DOI 10.1210/en.2003-0529
   Caminos JE, 2003, ENDOCRINOLOGY, V144, P1594, DOI 10.1210/en.2002-221058
   Campagne DM, 2006, HUM REPROD, V21, P1651, DOI 10.1093/humrep/del078
   Cannon W. B., 1929, BODILY CHANGES PAIN
   Cannon WB, 1935, AM J MED SCI, V189, P1
   Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337
   Cates PS, 2004, STRESS, V7, P113, DOI 10.1080/102589042000218988
   Catherino WH, 2011, FERTIL STERIL, V95, P2462, DOI 10.1016/j.fertnstert.2011.05.067
   Cesur G, 2012, J PHYSIOL SCI, V62, P185, DOI 10.1007/s12576-012-0193-z
   Chan CB, 2004, FEBS LETT, V577, P147, DOI 10.1016/j.febslet.2004.08.088
   Chan KA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124149
   Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596
   Chen T, 2008, J ENDOCRINOL, V199, P253, DOI 10.1677/JOE-08-0325
   Christo K, 2008, CLIN ENDOCRINOL, V69, P628, DOI 10.1111/j.1365-2265.2008.03237.x
   Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a
   Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660
   Chuang Jen-Chieh, 2010, Int J Pept, V2010, DOI 10.1155/2010/460549
   Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x
   Clifford PS, 2012, ADDICT BIOL, V17, P956, DOI 10.1111/j.1369-1600.2011.00339.x
   COHENBECKER IR, 1986, NEUROENDOCRINOLOGY, V42, P328, DOI 10.1159/000124459
   Collden G, 2015, MOL METAB, V4, P15, DOI 10.1016/j.molmet.2014.10.003
   Cordoba-Chacon J, 2011, ENDOCRINOLOGY, V152, P4800, DOI 10.1210/en.2011-1542
   Cortelazzi D, 2003, EUR J ENDOCRINOL, V149, P111, DOI 10.1530/eje.0.1490111
   Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009
   Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006
   CUMMING DC, 1983, J CLIN ENDOCR METAB, V57, P671, DOI 10.1210/jcem-57-3-671
   Currie PJ, 2012, BEHAV BRAIN RES, V226, P96, DOI 10.1016/j.bbr.2011.08.037
   Currie PJ, 2010, PHARMACOL BIOCHEM BE, V97, P152, DOI 10.1016/j.pbb.2010.05.027
   Currie PJ, 2005, AM J PHYSIOL-REG I, V289, pR353, DOI 10.1152/ajpregu.00756.2004
   Daniells S, 2003, DIABETES CARE, V26, P385, DOI 10.2337/diacare.26.2.385
   Day TA, 2005, PROG NEURO-PSYCHOPH, V29, P1195, DOI 10.1016/j.pnpbp.2005.08.005
   Dayas CV, 1999, EUR J NEUROSCI, V11, P2312, DOI 10.1046/j.1460-9568.1999.00645.x
   Dayas CV, 2001, EUR J NEUROSCI, V14, P1143, DOI 10.1046/j.0953-816x.2001.01733.x
   de Jonge J, 2000, SOC SCI MED, V50, P1317, DOI 10.1016/S0277-9536(99)00388-3
   de Klerk C, 2008, HUM REPROD, V23, P112, DOI 10.1093/humrep/dem357
   de Liz TM, 2005, HUM REPROD, V20, P1324, DOI 10.1093/humrep/deh743
   De Souza MJ, 2004, J CLIN ENDOCR METAB, V89, P3536, DOI 10.1210/jc.2003-032007
   De Vriendt T, 2009, NUTR METAB CARDIOVAS, V19, P511, DOI 10.1016/j.numecd.2009.02.009
   De Vriese C, 2004, ENDOCRINOLOGY, V145, P4997, DOI 10.1210/en.2004-0569
   Delhanty PJD, 2014, FRONT HORM RES, V42, P163, DOI 10.1159/000358345
   Delhanty PJD, 2013, FASEB J, V27, P1690, DOI 10.1096/fj.12-221143
   Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456
   Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749
   DEMYTTENAERE K, 1992, PSYCHONEUROENDOCRINO, V17, P655, DOI 10.1016/0306-4530(92)90024-2
   Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656
   Dickson SL, 2010, NEUROSCIENCE, V171, P1180, DOI 10.1016/j.neuroscience.2010.10.005
   Diedrich K, 2007, HUM REPROD UPDATE, V13, P365, DOI 10.1093/humupd/dmm011
   Disse E, 2010, PHYSIOL BEHAV, V101, P277, DOI 10.1016/j.physbeh.2010.05.017
   DiVall SA, 2010, J CLIN INVEST, V120, P2900, DOI 10.1172/JCI41069
   Domar AD, 2000, FERTIL STERIL, V73, P805, DOI 10.1016/S0015-0282(99)00493-8
   Domar AD, 2015, FERTIL STERIL, V104, P440, DOI 10.1016/j.fertnstert.2015.05.009
   Donarelli Zaira, 2016, Reprod Biomed Soc Online, V3, P16, DOI 10.1016/j.rbms.2016.10.001
   Dorfman A, 2003, BIOL REPROD, V68, P2038, DOI 10.1095/biolreprod.102.008318
   Douglas AJ, 2003, ENDOCRINOLOGY, V144, P5268, DOI 10.1210/en.2003-0461
   Dovolou E, 2014, THERIOGENOLOGY, V81, P565, DOI 10.1016/j.theriogenology.2013.11.009
   Du C, 2010, REPROD DOMEST ANIM, V45, P92, DOI 10.1111/j.1439-0531.2008.01259.x
   Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774
   Dundar NO, 2010, PEDIATR INT, V52, P622, DOI 10.1111/j.1442-200X.2010.03100.x
   Dunn AJ, 2004, ANN NY ACAD SCI, V1018, P25, DOI 10.1196/annals.1296.003
   Ebbesen SMS, 2009, HUM REPROD, V24, P2173, DOI 10.1093/humrep/dep185
   Egecioglu E, 2016, ADDICT BIOL, V21, P348, DOI 10.1111/adb.12202
   Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x
   Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536
   El-Eshmawy MM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-153
   Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432
   Entringer S, 2013, NESTLE NUTR WORKS SE, V74, P107, DOI 10.1159/000348454
   Entringer S, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.006
   Eugster A, 2004, J PSYCHOSOM OBST GYN, V25, P57, DOI 10.1080/01674820410001737441
   Evans JJ, 1999, ENDOCR REV, V20, P46, DOI 10.1210/er.20.1.46
   Faron-Gorecka A, 2014, BRAIN RES, V1555, P48, DOI 10.1016/j.brainres.2014.01.031
   Fassnacht M, 2003, J CLIN ENDOCR METAB, V88, P2760, DOI 10.1210/jc.2002-021875
   Fenster L, 1997, J ANDROL, V18, P194
   Ferguson AV, 2008, EXPERT OPIN THER TAR, V12, P717, DOI [10.1517/14728220802138252, 10.1517/14728222.12.6.717 ]
   Fernandez-Fernandez R, 2005, NEUROENDOCRINOLOGY, V82, P245, DOI 10.1159/000092753
   Fernandez-Fernandez R, 2005, ENDOCRINOLOGY, V146, P3018, DOI 10.1210/en.2004-1622
   Fernandez-Fernandez R, 2004, NEUROSCI LETT, V362, P103, DOI 10.1016/j.neulet.2004.03.003
   Fernandez-Fernandez R, 2007, REPRODUCTION, V133, P1223, DOI 10.1530/REP-06-0227
   Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206
   Feuer S, 2012, BIRTH DEFECTS RES C, V96, P299, DOI 10.1002/bdrc.21022
   Forbes S, 2009, NEUROSCI LETT, V460, P143, DOI 10.1016/j.neulet.2009.05.060
   Frazao R, 2014, AM J PHYSIOL-ENDOC M, V306, pE606, DOI 10.1152/ajpendo.00211.2013
   Frederiksen Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006592
   Fuglsang J, 2005, CLIN ENDOCRINOL, V62, P554, DOI 10.1111/j.1365-2265.2005.02257.x
   Furness JB, 2011, NEUROSCIENCE, V193, P1, DOI 10.1016/j.neuroscience.2011.07.063
   Furuta M, 2001, BIOCHEM BIOPH RES CO, V288, P780, DOI 10.1006/bbrc.2001.5854
   Gambineri A, 2003, J ENDOCRINOL INVEST, V26, P629, DOI 10.1007/BF03347020
   Gameiro S, 2015, HUM REPROD, V30, P2476, DOI 10.1093/humrep/dev177
   Gao Y, 2016, REPROD SCI, V23, P1148, DOI 10.1177/1933719116630416
   Garcia JM, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129759
   Garcia MC, 2007, REPRODUCTION, V133, P531, DOI 10.1530/REP-06-0249
   Garcia-Rudaz C, 1998, CLIN ENDOCRINOL, V49, P221, DOI 10.1046/j.1365-2265.1998.00511.x
   Gaytan F, 2005, J CLIN ENDOCR METAB, V90, P1798, DOI 10.1210/jc.2004-1532
   Gaytan F, 2004, J CLIN ENDOCR METAB, V89, P400, DOI 10.1210/jc.2003-031375
   Gaytan F, 2003, J CLIN ENDOCR METAB, V88, P879, DOI 10.1210/jc.2002-021196
   Gelbaya TA, 2014, OBSTET GYNECOL SURV, V69, P109, DOI 10.1097/OGX.0000000000000043
   Geraghty AC, 2015, ELIFE, V4, DOI 10.7554/eLife.04316
   Gibson W, 2010, METABOLISM, V59, P841, DOI 10.1016/j.metabol.2009.09.033
   Glintborg D, 2006, EUR J ENDOCRINOL, V155, P337, DOI 10.1530/eje.1.02207
   Glynn LM, 2007, EARLY HUM DEV, V83, P675, DOI 10.1016/j.earlhumdev.2007.01.003
   Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988
   Goldstone AP, 2009, EUR J NEUROSCI, V30, P1625, DOI 10.1111/j.1460-9568.2009.06949.x
   Gollenberg AL, 2010, FERTIL STERIL, V93, P1104, DOI 10.1016/j.fertnstert.2008.12.018
   Gonzalez R, 2010, REPROD TOXICOL, V29, P198, DOI 10.1016/j.reprotox.2009.10.009
   GORDON M, 1982, J PEDIATR-US, V101, P477, DOI 10.1016/S0022-3476(82)80093-0
   Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521
   Gourounti K, 2011, WOMEN HEALTH, V51, P321, DOI 10.1080/03630242.2011.574791
   Govic A, 2008, BEHAV BRAIN RES, V190, P140, DOI 10.1016/j.bbr.2008.02.013
   Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x
   Greil AL, 2010, SOCIOL HEALTH ILL, V32, P140, DOI 10.1111/j.1467-9566.2009.01213.x
   Grey KR, 2013, PSYCHONEUROENDOCRINO, V38, P1178, DOI 10.1016/j.psyneuen.2012.11.002
   GROSSMAN A, 1981, CLIN ENDOCRINOL, V14, P41, DOI 10.1111/j.1365-2265.1981.tb00363.x
   Gualillo O, 2001, ENDOCRINOLOGY, V142, P788, DOI 10.1210/en.142.2.788
   Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105
   Hammerli K, 2009, HUM REPROD UPDATE, V15, P279, DOI 10.1093/humupd/dmp002
   Hahn JD, 2003, J NEUROENDOCRINOL, V15, P732, DOI 10.1046/j.1365-2826.2003.01056.x
   Han SK, 2002, ENDOCRINOLOGY, V143, P1459, DOI 10.1210/en.143.4.1459
   Handa RJ, 2012, NEUROENDOCRINOLOGY, V96, P111, DOI 10.1159/000338397
   Hansson C, 2011, NEUROSCIENCE, V180, P201, DOI 10.1016/j.neuroscience.2011.02.002
   Hansson C, 2013, PSYCHIAT RES, V206, P22, DOI 10.1016/j.psychres.2012.09.051
   Harrison JL, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-25
   Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311
   HECKERT L, 1993, RECENT PROG HORM RES, V48, P61
   Hehir MP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.040
   Heider U, 2001, FERTIL STERIL, V75, P1141, DOI 10.1016/S0015-0282(01)01805-2
   Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729
   HERBISON AE, 1991, EXP BRAIN RES, V87, P345
   Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006
   Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001
   HERNANDEZ ER, 1988, ENDOCRINOLOGY, V122, P1592, DOI 10.1210/endo-122-4-1592
   Hernandez-Diaz S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2255
   Herod SM, 2011, AM J PHYSIOL-ENDOC M, V300, pE19, DOI 10.1152/ajpendo.00224.2010
   Hjollund NHI, 2004, EPIDEMIOLOGY, V15, P114, DOI 10.1097/01.ede.0000100290.908884a
   Hjollund NHI, 2004, EPIDEMIOLOGY, V15, P21, DOI 10.1097/01.edu.0000100289.82156.8b
   Hlatky MA, 2002, JAMA-J AM MED ASSOC, V287, P591, DOI 10.1001/jama.287.5.591
   Hoffman Elizabeth R, 2011, Expert Rev Obstet Gynecol, V6, P403
   Hoffman S, 2000, HEALTH PSYCHOL, V19, P535, DOI 10.1037/0278-6133.19.6.535
   Homan P, 2013, PSYCHONEUROENDOCRINO, V38, P1545, DOI 10.1016/j.psyneuen.2012.12.024
   Hou GL, 2014, J SEX MED, V11, P653, DOI 10.1111/jsm.12416
   Houjeghani S, 2012, INT J FERTIL STERIL, V6, P117
   Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974
   Hu GX, 2008, STEROIDS, V73, P1018, DOI 10.1016/j.steroids.2007.12.020
   Hu L, 2008, MOL ENDOCRINOL, V22, P2250, DOI 10.1210/me.2008-0192
   Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018
   Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002
   Ikezaki A, 2002, DIABETES, V51, P3408, DOI 10.2337/diabetes.51.12.3408
   Ilcol YO, 2007, ACTA PAEDIATR, V96, P1632, DOI 10.1111/j.1651-2227.2007.00493.x
   Inal HA, 2016, J ENDOCRINOL INVEST, V39, P431, DOI 10.1007/s40618-015-0392-6
   Inhoff T, 2008, PEPTIDES, V29, P2159, DOI 10.1016/j.peptides.2008.09.014
   Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016
   Inoue Y, 2010, BIOCHEM BIOPH RES CO, V393, P455, DOI 10.1016/j.bbrc.2010.02.022
   Iqbal J, 2006, ENDOCRINOLOGY, V147, P510, DOI 10.1210/en.2005-1048
   Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140
   Ishikawa T, 2007, J ANDROL, V28, P320, DOI 10.2164/jandrol.106.000810
   Ishitobi Y, 2012, NEUROPSYCHOBIOLOGY, V66, P185, DOI 10.1159/000339948
   Iwasa T, 2014, HORM BEHAV, V66, P309, DOI 10.1016/j.yhbeh.2014.06.007
   Janevic T, 2014, FERTIL STERIL, V102, P530, DOI 10.1016/j.fertnstert.2014.04.021
   Jaremka LM, 2014, PSYCHONEUROENDOCRINO, V48, P178, DOI 10.1016/j.psyneuen.2014.06.018
   Jarrell H, 2008, PHYSIOL BEHAV, V93, P807, DOI 10.1016/j.physbeh.2007.11.042
   JARRY H, 1988, ACTA ENDOCRINOL-COP, V118, P573, DOI 10.1530/acta.0.1180573
   Jasoni CL, 2005, NEUROENDOCRINOLOGY, V82, P320, DOI 10.1159/000093155
   Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x
   Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010
   Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7
   Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106
   JIMENA P, 1992, ACTA ENDOCRINOL-COP, V127, P403, DOI 10.1530/acta.0.1270403
   Joachim R, 2003, STEROIDS, V68, P931, DOI 10.1016/j.steroids.2003.08.010
   Johnstone HA, 2000, J NEUROENDOCRINOL, V12, P811, DOI 10.1046/j.1365-2826.2000.00525.x
   Johnstone LE, 2005, STRESS, V8, P59, DOI 10.1080/10253890500095283
   Julien M, 2012, EUR J PHARM SCI, V47, P625, DOI 10.1016/j.ejps.2012.07.014
   Kageyama K, 2012, PEPTIDES, V33, P149, DOI 10.1016/j.peptides.2011.11.020
   Kammerer M., 2002, BMC PREGNANCY CHILDB, V2, P8, DOI DOI 10.1186/1471-2393-2-8
   Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442
   Kanayama N, 1997, J HYPERTENS, V15, P383, DOI 10.1097/00004872-199715040-00009
   Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x
   Kawakami A, 2008, STRESS, V11, P363, DOI 10.1080/10253890701820257
   Kawamura K, 2003, ENDOCRINOLOGY, V144, P2623, DOI 10.1210/en.2003-0033
   Keen KL, 1999, ENDOCRINOLOGY, V140, P5257, DOI 10.1210/en.140.11.5257
   Keen-Rhinehart E, 2009, MOL PSYCHIATR, V14, P37, DOI 10.1038/mp.2008.91
   Kenny R, 2013, AM J PHYSIOL-REG I, V304, pR980, DOI 10.1152/ajpregu.00594.2012
   Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038
   Khatun S, 1999, EUR J OBSTET GYN R B, V86, P89, DOI 10.1016/S0301-2115(99)00050-0
   Kheradmand A, 2009, ANDROLOGIA, V41, P335, DOI 10.1111/j.1439-0272.2009.00932.x
   Kheradmand A, 2009, TISSUE CELL, V41, P311, DOI 10.1016/j.tice.2009.01.002
   Kheradmand A, 2009, TISSUE CELL, V41, P105, DOI 10.1016/j.tice.2008.07.006
   Kheradmand A, 2011, REGUL PEPTIDES, V167, P97, DOI 10.1016/j.regpep.2010.12.002
   Kierson JA, 2006, ACTA PAEDIATR, V95, P991, DOI 10.1080/08035250600669769
   Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862
   Kinsey-Jones JS, 2009, J NEUROENDOCRINOL, V21, P20, DOI 10.1111/j.1365-2826.2008.01807.x
   Kirby ED, 2009, P NATL ACAD SCI USA, V106, P11324, DOI 10.1073/pnas.0901176106
   Kishimoto I, 2012, J CARDIOL, V59, P8, DOI 10.1016/j.jjcc.2011.11.002
   Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8
   Kluge M, 2007, J CLIN ENDOCR METAB, V92, P3202, DOI 10.1210/jc.2007-0593
   Kluge M, 2013, J PSYCHIATR RES, V47, P1236, DOI 10.1016/j.jpsychires.2013.05.010
   Kluge M, 2012, REPROD SCI, V19, pNP3, DOI 10.1177/1933719112459242
   Kluge M, 2012, J CLIN ENDOCR METAB, V97, pE448, DOI 10.1210/jc.2011-2607
   Kluge M, 2011, J PSYCHIATR RES, V45, P421, DOI 10.1016/j.jpsychires.2010.09.002
   Kluge M, 2009, CYTOKINE GROWTH F R, V20, P339, DOI 10.1016/j.cytogfr.2009.07.003
   Kluge M, 2009, CLIN ENDOCRINOL, V70, P920, DOI 10.1111/j.1365-2265.2008.03440.x
   Kluge M, 2009, NEUROPSYCHOBIOLOGY, V59, P199, DOI 10.1159/000223731
   KNOBIL E, 1988, HUM REPROD, V3, P29, DOI 10.1093/oxfordjournals.humrep.a136647
   Kodomari I, 2009, NEUROCHEM INT, V54, P222, DOI 10.1016/j.neuint.2008.11.006
   KOIKE K, 1991, HORM RES, V35, P5, DOI 10.1159/000181921
   Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230
   Komarowska H, 2013, NEUROENDOCRINOL LETT, V34, P669
   Komesaroff PA, 1999, J CLIN ENDOCR METAB, V84, P606, DOI 10.1210/jc.84.2.606
   KONONEN J, 1993, MOL CELL ENDOCRINOL, V93, P97, DOI 10.1016/0303-7207(93)90144-9
   Korek E, 2013, PRZ GASTROENTEROL, V8, P383, DOI 10.5114/pg.2013.39922
   Kristenssson E, 2006, REGUL PEPTIDES, V134, P114, DOI 10.1016/j.regpep.2006.02.003
   Krsmanovic LZ, 2009, TRENDS ENDOCRIN MET, V20, P402, DOI 10.1016/j.tem.2009.05.002
   Krsmanovic LZ, 2003, P NATL ACAD SCI USA, V100, P2969, DOI 10.1073/pnas.05305708100
   Krsmanovic LZ, 1996, TRENDS ENDOCRIN MET, V7, P56, DOI 10.1016/1043-2760(96)00007-0
   KRSMANOVIC LZ, 1993, P NATL ACAD SCI USA, V90, P3908, DOI 10.1073/pnas.90.9.3908
   Ku JM, 2016, CLIN SCI, V130, P1545, DOI 10.1042/CS20160077
   Ku JM, 2015, ENDOCRINOLOGY, V156, P280, DOI 10.1210/en.2014-1415
   Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X
   Kurt E, 2007, NEUROSCI LETT, V426, P49, DOI 10.1016/j.neulet.2007.08.018
   Lanfranco F, 2008, J CLIN ENDOCR METAB, V93, P3633, DOI 10.1210/jc.2008-0049
   Lappas M, 2015, J DIABETES, V7, P506, DOI 10.1111/1753-0407.12209
   LARA HE, 1990, ENDOCRINOLOGY, V126, P364, DOI 10.1210/endo-126-1-364
   Larson-Meyer DE, 2010, AM J CLIN NUTR, V91, P366, DOI 10.3945/ajcn.2009.28616
   Laszlo KD, 2013, HYPERTENSION, V62, P183, DOI 10.1161/HYPERTENSIONAHA.111.00550
   Latendresse G, 2009, J MIDWIFERY WOM HEAL, V54, P8, DOI 10.1016/j.jmwh.2008.08.001
   Lewicka S, 2003, HUM REPROD, V18, P1613, DOI 10.1093/humrep/deg352
   Li LY, 2011, FERTIL STERIL, V96, P1116, DOI 10.1016/j.fertnstert.2011.08.017
   LI PS, 1983, BIOL REPROD, V29, P25, DOI 10.1095/biolreprod29.1.25
   Li W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.223
   Li XF, 2006, J NEUROENDOCRINOL, V18, P602, DOI 10.1111/j.1365-2826.2006.01450.x
   Li XF, 2011, J NEUROENDOCRINOL, V23, P3, DOI 10.1111/j.1365-2826.2010.02071.x
   Li XF, 2009, STRESS, V12, P259, DOI 10.1080/10253890802379922
   Li XF, 2005, ENDOCRINOLOGY, V146, P318, DOI 10.1210/en.2004-0950
   Li XF, 2004, ENDOCRINOLOGY, V145, P1556, DOI 10.1210/en.2003-1609
   Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334
   Li XF, 2015, J MOL ENDOCRINOL, V55, P9, DOI 10.1530/JME-15-0084
   Lin YS, 2012, J NEUROENDOCRINOL, V24, P477, DOI 10.1111/j.1365-2826.2011.02270.x
   Lin YS, 2011, ENDOCRINOLOGY, V152, P545, DOI 10.1210/en.2010-1003
   Lindsay JR, 2005, ENDOCR REV, V26, P775, DOI 10.1210/er.2004-0025
   Lintsen AME, 2009, HUM REPROD, V24, P1092, DOI 10.1093/humrep/den491
   LIU JH, 1990, AM J OBSTET GYNECOL, V163, P1732, DOI 10.1016/0002-9378(90)91437-H
   Lockie SH, 2015, PSYCHONEUROENDOCRINO, V62, P114, DOI 10.1016/j.psyneuen.2015.08.004
   Lorenzi T, 2009, CYTOKINE GROWTH F R, V20, P137, DOI 10.1016/j.cytogfr.2009.02.003
   Louis GMB, 2011, FERTIL STERIL, V95, P2184, DOI 10.1016/j.fertnstert.2010.06.078
   Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139
   Lydon K, 2012, Ir Med J, V105, P26
   Lynch CD, 2014, HUM REPROD, V29, P1067, DOI 10.1093/humrep/deu032
   Macfarlane MS, 2000, ANIM REPROD SCI, V63, P167, DOI 10.1016/S0378-4320(00)00179-2
   MACLUSKY NJ, 1988, BRAIN RES, V439, P391, DOI 10.1016/0006-8993(88)91501-6
   Magiakou MA, 1996, CLIN ENDOCRINOL, V44, P419, DOI 10.1046/j.1365-2265.1996.683505.x
   Magiakou MA, 1996, J CLIN ENDOCR METAB, V81, P1912, DOI 10.1210/jc.81.5.1912
   Maheshwari A, 2008, HUM REPROD, V23, P538, DOI 10.1093/humrep/dem431
   Makino Y, 2002, HYPERTENSION, V39, P781, DOI 10.1161/hy0302.105221
   Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007
   Mao YJ, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0622-5
   Martin JR, 2011, ENDOCRINOLOGY, V152, P2060, DOI 10.1210/en.2010-1485
   Martin SA, 2014, J SEX MED, V11, P1136, DOI 10.1111/jsm.12483
   Martini AC, 2006, ENDOCRINOLOGY, V147, P2374, DOI 10.1210/en.2005-1422
   Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356
   Matsuo K, 2012, BRAIN RES, V1473, P185, DOI 10.1016/j.brainres.2012.07.027
   MATSUZAKI T, 1994, FERTIL STERIL, V62, P1143
   Matthiesen SMS, 2011, HUM REPROD, V26, P2763, DOI 10.1093/humrep/der246
   Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055
   McGovern-Gooch KR, 2016, ENDOCRINOLOGY, V157, P4330, DOI 10.1210/en.2016-1657
   McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415
   McLaughlin T, 2004, J CLIN ENDOCR METAB, V89, P1630, DOI 10.1210/jc.2003-031572
   MELIS GB, 1987, J CLIN ENDOCR METAB, V65, P237, DOI 10.1210/jcem-65-2-237
   MERARI D, 1992, J ASSIST REPROD GEN, V9, P161, DOI 10.1007/BF01203757
   Luque EM, 2014, REPRODUCTION, V148, P159, DOI 10.1530/REP-14-0129
   Messini CI, 2011, J ENDOCRINOL INVEST, V34, P276, DOI 10.3275/7102
   Meyer RM, 2014, MOL PSYCHIATR, V19, P1284, DOI 10.1038/mp.2013.135
   MICHAEL AE, 1993, CLIN ENDOCRINOL, V38, P641, DOI 10.1111/j.1365-2265.1993.tb02147.x
   Michael AE, 2008, HUM REPROD UPDATE, V14, P497, DOI 10.1093/humupd/dmn021
   Michopoulos V, 2013, NEUROSCIENCE, V250, P300, DOI 10.1016/j.neuroscience.2013.07.002
   Michopoulos V, 2011, PHYSIOL BEHAV, V102, P382, DOI 10.1016/j.physbeh.2010.11.031
   Michopoulos V, 2010, ENDOCRINE, V38, P227, DOI 10.1007/s12020-010-9378-5
   Michopoulos V, 2009, BIOL REPROD, V81, P1154, DOI 10.1095/biolreprod.109.079038
   Micic D, 2007, J ENDOCRINOL INVEST, V30, P820, DOI 10.1007/BF03349222
   Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032
   Miller DW, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-60
   Mircea CN, 2007, J OBSTET GYNAECOL CA, V29, P887, DOI 10.1016/S1701-2163(16)32661-5
   Mitkov M, 2008, GYNECOL ENDOCRINOL, V24, P625, DOI 10.1080/09513590802302233
   Monteleone P, 2012, NEUROPSYCHOBIOLOGY, V66, P230, DOI 10.1159/000341877
   Moran LJ, 2004, J CLIN ENDOCR METAB, V89, P3337, DOI 10.1210/jc.2003-031583
   Moretti E, 2014, ANDROLOGIA, V46, P979, DOI 10.1111/and.12183
   Muccioli G, 2011, PEPTIDES, V32, P2514, DOI 10.1016/j.peptides.2011.10.020
   Nakahara K, 2006, ENDOCRINOLOGY, V147, P1333, DOI 10.1210/en.2005-0708
   Nakashima K, 2008, PSYCHIAT GENET, V18, P257, DOI 10.1097/YPG.0b013e328306c979
   Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587
   Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025
   Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103
   Nepomnaschy PA, 2004, AM J HUM BIOL, V16, P523, DOI 10.1002/ajhb.20057
   Nepomnaschy PA, 2007, ANN NY ACAD SCI, V1113, P350, DOI 10.1196/annals.1391.028
   Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Ng PC, 2005, CLIN ENDOCRINOL, V63, P217, DOI 10.1111/j.1365-2265.2005.02328.x
   Nonoshita A, 2010, PLACENTA, V31, P358, DOI 10.1016/j.placenta.2010.02.013
   NORMAN RL, 1992, NEUROENDOCRINOLOGY, V55, P405, DOI 10.1159/000126151
   Nouri K, 2011, FERTIL STERIL, V96, P69, DOI 10.1016/j.fertnstert.2011.04.063
   O'Brien M, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-55
   Ochi M, 2008, LIFE SCI, V82, P862, DOI 10.1016/j.lfs.2008.01.020
   Ohkawa N, 2010, ACTA PAEDIATR, V99, P37, DOI 10.1111/j.1651-2227.2009.01516.x
   Ohkura S, 2009, PEPTIDES, V30, P49, DOI 10.1016/j.peptides.2008.08.004
   Olivius C, 2004, FERTIL STERIL, V81, P258, DOI 10.1016/j.fertnster.2003.06.029
   Orio F, 2003, J CLIN ENDOCR METAB, V88, P942, DOI 10.1210/jc.2002-021451
   Orr ST, 2002, AM J EPIDEMIOL, V156, P797, DOI 10.1093/aje/kwf131
   Orr ST, 2007, PSYCHOSOM MED, V69, P566, DOI 10.1097/PSY.0b013e3180cac25d
   Otto B, 2001, EUR J ENDOCRINOL, V145, pR5
   Ozcan B, 2014, EUR J ENDOCRINOL, V170, P799, DOI 10.1530/EJE-13-0347
   Ozsoy S, 2014, PSYCHIAT INVEST, V11, P167, DOI 10.4306/pi.2014.11.2.167
   Pacifico L, 2009, BONE, V45, P274, DOI 10.1016/j.bone.2009.04.204
   Pagotto U, 2002, J CLIN ENDOCR METAB, V87, P5625, DOI 10.1210/jc.2002-020776
   Palik E, 2007, DIABETES RES CLIN PR, V76, P351, DOI 10.1016/j.diabres.2006.09.005
   Panidis D, 2005, HUM REPROD, V20, P2127, DOI 10.1093/humrep/dei055
   Pantham P, 2015, PLACENTA, V36, P709, DOI 10.1016/j.placenta.2015.04.006
   Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184
   Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803
   Paredes A, 1998, ENDOCRINE, V8, P309, DOI 10.1385/ENDO:8:3:309
   Parker VJ, 2010, J REPROD IMMUNOL, V85, P86, DOI 10.1016/j.jri.2009.10.011
   Patel SS, 2007, J OBSTET GYNAECOL, V27, P455, DOI 10.1080/01443610701406125
   Patterson ZR, 2010, EUR J NEUROSCI, V32, P632, DOI 10.1111/j.1460-9568.2010.07310.x
   PEARCE GP, 1988, J REPROD FERTIL, V83, P413
   Pearson S, 2010, DIABETES CARE, V33, P1128, DOI 10.2337/dc09-1940
   PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969
   Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638
   Pfaus JG, 2009, J SEX MED, V6, P1506, DOI 10.1111/j.1743-6109.2009.01309.x
   Pinar M, 2008, PROG NEURO-PSYCHOPH, V32, P135, DOI 10.1016/j.pnpbp.2007.07.028
   Pinheiro AP, 2007, INT J EAT DISORDER, V40, P424, DOI 10.1002/eat.20388
   Pitchers KK, 2010, GENES BRAIN BEHAV, V9, P831, DOI 10.1111/j.1601-183X.2010.00621.x
   Pitchers KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034700
   Pitchers KK, 2010, BIOL PSYCHIAT, V67, P872, DOI 10.1016/j.biopsych.2009.09.036
   PRADER A, 1975, CLIN ENDOCRINOL META, V4, P143, DOI 10.1016/S0300-595X(75)80037-5
   Prieto-Garcia L, 2015, PSYCHONEUROENDOCRINO, V62, P392, DOI 10.1016/j.psyneuen.2015.09.009
   Qiu CF, 2009, AM J HYPERTENS, V22, P397, DOI 10.1038/ajh.2008.366
   Quant HS, 2013, J ASSIST REPROD GEN, V30, P1451, DOI 10.1007/s10815-013-0098-7
   Rajkhowa M, 2006, HUM REPROD, V21, P358, DOI 10.1093/humrep/dei355
   Rak A, 2009, GROWTH HORM IGF RES, V19, P68, DOI 10.1016/j.ghir.2008.08.006
   Rak-Mardyla A, 2012, THERIOGENOLOGY, V77, P1505, DOI 10.1016/j.theriogenology.2011.11.017
   Rak-Mardyla A, 2015, REPROD SCI, V22, P469, DOI 10.1177/1933719114549854
   Rak-Mardyla A, 2010, REPROD BIOL, V10, P159, DOI 10.1016/S1642-431X(12)60058-8
   Rannikko A, 1996, J ENDOCRINOL, V151, P29, DOI 10.1677/joe.0.1510029
   Raso GM, 2007, J ENDOCRINOL, V194, P611, DOI 10.1677/JOE-07-0159
   Raspopow K, 2014, APPETITE, V74, P35, DOI 10.1016/j.appet.2013.11.018
   Raspopow K, 2010, HORM BEHAV, V58, P677, DOI 10.1016/j.yhbeh.2010.06.003
   Rediger A, 2011, J BIOL CHEM, V286, P39623, DOI 10.1074/jbc.M111.287607
   Reding K, 2012, HORM BEHAV, V62, P612, DOI 10.1016/j.yhbeh.2012.09.010
   Reichenbach A, 2012, ENDOCRINOLOGY, V153, P5452, DOI 10.1210/en.2012-1622
   Richardson AC, 2007, OBSTET GYN CLIN N AM, V34, P213, DOI 10.1016/j.ogc.2007.04.001
   Riedl M, 2007, J INTERN MED, V262, P458, DOI 10.1111/j.1365-2796.2007.01832.x
   RIVEST S, 1991, ENDOCRINOLOGY, V129, P2049, DOI 10.1210/endo-129-4-2049
   RIVIER C, 1984, ENDOCRINOLOGY, V114, P914, DOI 10.1210/endo-114-3-914
   Rivier C, 2002, NEUROIMMUNOMODULAT, V10, P17, DOI 10.1159/000064411
   RIVIER C, 1991, BIOL REPROD, V45, P523, DOI 10.1095/biolreprod45.4.523
   Rizwan MZ, 2012, ENDOCRINOLOGY, V153, P3770, DOI 10.1210/en.2012-1133
   Roa J, 2010, MOL CELL ENDOCRINOL, V324, P87, DOI 10.1016/j.mce.2009.12.018
   Roney JR, 2015, ADAPT HUM BEHAV PHYS, V1, P30, DOI 10.1007/s40750-014-0004-2
   Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010
   Rubinfeld H, 2004, EUR J ENDOCRINOL, V151, P787, DOI 10.1530/eje.0.1510787
   Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001
   Sagsoz N, 2009, FERTIL STERIL, V92, P660, DOI 10.1016/j.fertnstert.2008.07.008
   Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001
   Sandberg DE, 2002, BEST PRACT RES CL EN, V16, P449, DOI 10.1053/beem.2002.0211
   Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55
   Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925
   Schanze A, 2008, NEUROPSYCHOBIOLOGY, V57, P126, DOI 10.1159/000138915
   Schellekens H, 2013, VITAM HORM, V91, P285, DOI 10.1016/B978-0-12-407766-9.00013-4
   Schellekens H, 2013, J BIOL CHEM, V288, P181, DOI 10.1074/jbc.M112.382473
   Schellekens H, 2012, PHARMACOL THERAPEUT, V135, P316, DOI 10.1016/j.pharmthera.2012.06.004
   Schliep KC, 2015, EPIDEMIOLOGY, V26, P177, DOI 10.1097/EDE.0000000000000238
   Schmid DA, 2006, NEUROPSYCHOPHARMACOL, V31, P832, DOI 10.1038/sj.npp.1300923
   Schmid DA, 2005, NEUROPSYCHOPHARMACOL, V30, P1187, DOI 10.1038/sj.npp.1300670
   Schneider LF, 2008, FERTIL STERIL, V90, P121, DOI 10.1016/j.fertnstert.2007.06.002
   Schofl C, 2002, J CLIN ENDOCR METAB, V87, P4607, DOI 10.1210/jc.2002-020505
   SCHREIBER JR, 1982, STEROIDS, V39, P569, DOI 10.1016/0039-128X(82)90057-5
   SCHULTE HM, 1990, CLIN ENDOCRINOL, V33, P99, DOI 10.1111/j.1365-2265.1990.tb00470.x
   SCHWARTZ R, 1994, DIABETES CARE, V17, P640, DOI 10.2337/diacare.17.7.640
   SCOTT CJ, 1993, ENDOCRINOLOGY, V133, P2904, DOI 10.1210/en.133.6.2904
   Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230
   SELYE H, 1946, J CLIN ENDOCR METAB, V6, P117, DOI 10.1210/jcem-6-2-117
   Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322
   Sen TA, 2011, J PEDIATR ADOL GYNEC, V24, P211, DOI 10.1016/j.jpag.2011.02.007
   Sen Tolta Altug, 2010, J Clin Res Pediatr Endocrinol, V2, P117, DOI 10.4274/jcrpe.v2i3.117
   Sepa A, 2005, DIABETES CARE, V28, P290, DOI 10.2337/diacare.28.2.290
   Shah SN, 2010, HORM BEHAV, V57, P291, DOI 10.1016/j.yhbeh.2009.12.010
   Shalitin S, 2003, INT J OBESITY, V27, P869, DOI 10.1038/sj.ijo.0802328
   Shansky RM, 2010, CEREB CORTEX, V20, P2560, DOI 10.1093/cercor/bhq003
   Shansky RM, 2004, MOL PSYCHIATR, V9, P531, DOI 10.1038/sj.mp.4001435
   Sheiner EK, 2002, J OCCUP ENVIRON MED, V44, P1093, DOI 10.1097/01.jom.0000044116.59147.64
   Shepard JD, 2000, BRAIN RES, V861, P288, DOI 10.1016/S0006-8993(00)02019-9
   Shibata K, 2004, PEPTIDES, V25, P279, DOI 10.1016/j.peptides.2004.01.011
   Shimbara T, 2004, NEUROSCI LETT, V369, P75, DOI 10.1016/j.neulet.2004.07.060
   Sibai BM, 2006, SEMIN PERINATOL, V30, P16, DOI 10.1053/j.semperi.2006.01.008
   SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611
   Simon C, 2000, BEST PRACT RES CL OB, V14, P815, DOI 10.1053/beog.2000.0121
   Simon C, 1998, J REPROD IMMUNOL, V39, P117, DOI 10.1016/S0165-0378(98)00017-5
   Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016
   Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x
   Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896
   Smeenk JMJ, 2004, FERTIL STERIL, V81, P262, DOI 10.1016/j.fertnstert.2003.09.027
   Smeenk JMJ, 2001, HUM REPROD, V16, P1420, DOI 10.1093/humrep/16.7.1420
   Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435
   Smith JT, 2013, PEPTIDES, V47, P45, DOI 10.1016/j.peptides.2013.06.012
   Smith JT, 2013, ADV EXP MED BIOL, V784, P275, DOI 10.1007/978-1-4614-6199-9_13
   Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488
   SMITH R, 1981, CLIN ENDOCRINOL, V15, P291, DOI 10.1111/j.1365-2265.1981.tb00668.x
   Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621
   Sominsky L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173498
   Sominsky L, 2017, NEUROPHARMACOLOGY, V113, P21, DOI 10.1016/j.neuropharm.2016.09.023
   Sominsky L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00434
   Sominsky L, 2012, HORM BEHAV, V62, P345, DOI 10.1016/j.yhbeh.2012.02.005
   Soriano-Guillen L, 2004, J PEDIATR-US, V144, P30, DOI 10.1016/j.jpeds.2003.08.050
   Soriano-Guillen L, 2004, J PEDIATR-US, V144, P36, DOI 10.1016/j.jpeds.2003.10.036
   Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145
   Spencer SJ, 2015, BIOL PSYCHIAT, V78, P19, DOI 10.1016/j.biopsych.2014.10.021
   Spencer SJ, 2012, BIOL PSYCHIAT, V72, P457, DOI 10.1016/j.biopsych.2012.03.010
   Spencer SJ, 2011, STRESS, V14, P233, DOI 10.3109/10253890.2010.534831
   STALKER A, 1989, AM J ANAT, V186, P369, DOI 10.1002/aja.1001860406
   Stark R, 2016, ENDOCRINOLOGY, V157, P3946, DOI 10.1210/en.2016-1306
   Steculorum SM, 2015, J CLIN INVEST, V125, P846, DOI 10.1172/JCI73688
   Stengel A, 2011, PEPTIDES, V32, P2208, DOI 10.1016/j.peptides.2011.07.002
   Sullivan EC, 2011, DEV PSYCHOBIOL, V53, P96, DOI 10.1002/dev.20483
   SUTER DE, 1989, BIOL REPROD, V41, P1091, DOI 10.1095/biolreprod41.6.1091
   SUTER DE, 1985, ENDOCRINOLOGY, V117, P849, DOI 10.1210/endo-117-3-849
   SUTER DE, 1988, AM J PHYSIOL, V254, pE595
   Suzuki H, 2010, REPROD DOMEST ANIM, V45, P927, DOI 10.1111/j.1439-0531.2009.01352.x
   Sverrisdottir YB, 2008, AM J PHYSIOL-ENDOC M, V294, pE576, DOI 10.1152/ajpendo.00725.2007
   Szczepankiewicz D, 2010, J PHYSIOL PHARMACOL, V61, P443
   Taati M, 2012, J PHYSIOL BIOCHEM, V68, P91, DOI 10.1007/s13105-011-0122-2
   Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908
   Takiuti NH, 2002, AM J OBSTET GYNECOL, V186, P544, DOI 10.1067/mob.2002.121102
   Tanaka K, 2003, J CLIN ENDOCR METAB, V88, P2335, DOI 10.1210/jc.2002-021024
   Vulliemoz NR, 2004, J CLIN ENDOCR METAB, V89, P5718, DOI 10.1210/jc.2004-1244
   Traslavina GAA, 2012, ENDOCRINOLOGY, V153, P4838, DOI 10.1210/en.2012-1333
   Tanaka M, 2003, PSYCHONEUROENDOCRINO, V28, P829, DOI 10.1016/S0306-4530(02)00066-5
   Tawadros N, 2007, MOL HUM REPROD, V13, P483, DOI 10.1093/molehr/gam029
   Taylor BD, 2015, HYPERTENSION, V65, P594, DOI 10.1161/HYPERTENSIONAHA.114.03979
   Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41
   Telejko B, 2010, EXP CLIN ENDOCR DIAB, V118, P87, DOI 10.1055/s-0029-1238313
   Tena-Sempere M, 2004, NEUROENDOCRINOLOGY, V79, P133, DOI 10.1159/000077271
   Tena-Sempere M, 2002, ENDOCRINOLOGY, V143, P717, DOI 10.1210/en.143.2.717
   Tetsuka M, 1999, BIOL REPROD, V60, P330, DOI 10.1095/biolreprod60.2.330
   Tham E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1093, DOI 10.1152/ajpendo.90866.2008
   THEORELL T, 1990, J INTERN MED, V227, P31, DOI 10.1111/j.1365-2796.1990.tb00115.x
   THIERING P, 1993, J PSYCHOSOM RES, V37, P481, DOI 10.1016/0022-3999(93)90004-Y
   Tilbrook AJ, 2002, STRESS, V5, P83, DOI 10.1080/10253890290027912
   Tilbrook AJ, 1999, J ENDOCRINOL, V160, P469, DOI 10.1677/joe.0.1600469
   Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/revreprod/5.2.105
   Tolle V, 2003, J CLIN ENDOCR METAB, V88, P109, DOI 10.1210/jc.2002-020645
   Torner L, 2002, EUR J NEUROSCI, V15, P1381, DOI 10.1046/j.1460-9568.2002.01965.x
   Torner L, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00025
   Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638
   Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707
   Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090
   Tsilchorozidou T, 2003, J CLIN ENDOCR METAB, V88, P5907, DOI 10.1210/jc.2003-030240
   Tuncel OK, 2016, J CHILD ADOL PSYCHOP, V26, P733, DOI 10.1089/cap.2015.0149
   Turgut A, 2015, CLIN EXP OBSTET GYN, V42, P473
   Turner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063743
   Ubuka T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008400
   VADAKKADATH MS, 2005, CELL MOL LIFE SCI, V62, P257, DOI DOI 10.1007/S00018-004-4381-3
   VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699
   Van Merris V, 2007, REPROD TOXICOL, V23, P32, DOI 10.1016/j.reprotox.2006.08.008
   Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U
   Varnagy A, 2013, J REPROD MED, V58, P305
   Vassiliadi DA, 2009, J CLIN ENDOCR METAB, V94, P3558, DOI 10.1210/jc.2009-0837
   Verhaak CM, 2001, FERTIL STERIL, V76, P525, DOI 10.1016/S0015-0282(01)01931-8
   Viani I, 2008, J CLIN ENDOCR METAB, V93, P1476, DOI 10.1210/jc.2007-2063
   Vianna P, 2011, MED HYPOTHESES, V77, P188, DOI 10.1016/j.mehy.2011.04.007
   Vidal C, 2008, HUM REPROD, V23, P958, DOI 10.1093/humrep/den020
   Visser-van Balen H, 2006, ARCH DIS CHILD, V91, P433, DOI 10.1136/adc.2005.086942
   Vitalis EA, 2000, P NATL ACAD SCI USA, V97, P1861, DOI 10.1073/pnas.040545197
   von Borell E, 2007, HORM BEHAV, V52, P130, DOI 10.1016/j.yhbeh.2007.03.014
   Vulliemoz NR, 2008, ENDOCRINOLOGY, V149, P869, DOI 10.1210/en.2007-1350
   Wahab F, 2015, J ENDOCRINOL, V225, pR49, DOI 10.1530/JOE-14-0688
   Wahab F, 2008, LIFE SCI, V83, P633, DOI 10.1016/j.lfs.2008.09.001
   Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp
   Walker AK, 2011, BRAIN BEHAV IMMUN, V25, P674, DOI 10.1016/j.bbi.2011.01.004
   Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148
   Wang JW, 2015, EXP THER MED, V9, P1909, DOI 10.3892/etm.2015.2341
   Wang ZG, 2013, THERIOGENOLOGY, V79, P695, DOI 10.1016/j.theriogenology.2012.11.026
   Wasko R, 2004, HORM METAB RES, V36, P170, DOI 10.1055/s-2004-814341
   Wellman PJ, 2008, REGUL PEPTIDES, V146, P33, DOI 10.1016/j.regpep.2007.07.007
   Wellman PJ, 2011, REGUL PEPTIDES, V172, P77, DOI 10.1016/j.regpep.2011.08.014
   Whatmore AJ, 2003, CLIN ENDOCRINOL, V59, P649, DOI 10.1046/j.1365-2265.2003.01903.x
   Wigger A, 1999, ENDOCRINOLOGY, V140, P2843, DOI 10.1210/en.140.6.2843
   WILLIAMS CL, 1990, NEUROENDOCRINOLOGY, V52, P133, DOI 10.1159/000125563
   Williams DL, 2005, J NUTR, V135, P1320
   Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443
   Wischmann TH, 2003, J ASSIST REPROD GEN, V20, P485, DOI 10.1023/B:JARG.0000013648.74404.9d
   Wood GE, 1998, P NATL ACAD SCI USA, V95, P4066, DOI 10.1073/pnas.95.7.4066
   Wu LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052331
   Wu LM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093468
   Wu M, 2009, J PHYSIOL-LONDON, V587, P1401, DOI 10.1113/jphysiol.2008.166447
   Wu WG, 2015, PREGNANCY HYPERTENS, V5, P263, DOI 10.1016/j.preghy.2015.09.002
   Xiao EN, 2007, ENDOCRINOLOGY, V148, P841, DOI 10.1210/en.2006-1074
   Yang H, 2008, BRAIN BEHAV IMMUN, V22, P1138, DOI 10.1016/j.bbi.2008.06.003
   Yang JG, 1999, BIOL REPROD, V60, P929, DOI 10.1095/biolreprod60.4.929
   Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017
   Yap BK, 1996, J CHROMATOGR B, V687, P117, DOI 10.1016/S0378-4347(96)00017-5
   Yazawa H, 2000, HUM REPROD, V15, P1917, DOI 10.1093/humrep/15.9.1917
   Yazawa H, 1999, HUM REPROD, V14, P1806, DOI 10.1093/humrep/14.7.1806
   YEN SSC, 1970, J CLIN ENDOCR METAB, V30, P435, DOI 10.1210/jcem-30-4-435
   Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103
   Yu Y., 2013, AM J OBSTET GYNECOL, V209, p438 e431
   Zhang K, 2007, J REPROD DEVELOP, V53, P647, DOI 10.1262/jrd.18140
   Zhang SC, 2013, OBSTET GYNECOL SURV, V68, P825, DOI 10.1097/OGX.0000000000000001
   ZHANG SM, 1995, BRIT MED J, V311, P1139, DOI 10.1136/bmj.311.7013.1139
   Zhu CC, 2013, FERTIL STERIL, V99, P918, DOI 10.1016/j.fertnstert.2012.11.022
   Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200
   Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823
   Zorn B, 2002, HUM REPROD, V17, P3173, DOI 10.1093/humrep/17.12.3173
   Zorn B, 2008, INT J ANDROL, V31, P557, DOI 10.1111/j.1365-2605.2007.00806.x
NR 579
TC 1
Z9 1
U1 4
U2 21
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0163-769X
EI 1945-7189
J9 ENDOCR REV
JI Endocr. Rev.
PD OCT 1
PY 2017
VL 38
IS 5
BP 432
EP 467
DI 10.1210/er.2016-1133
PG 36
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FJ5EJ
UT WOS:000412769300002
PM 28938425
DA 2019-01-08
ER

PT J
AU van de Pavert, I
   Sunderland, M
   Luijten, M
   Slade, T
   Teesson, M
AF van de Pavert, Iris
   Sunderland, Matthew
   Luijten, Maartje
   Slade, Tim
   Teesson, Maree
TI The general relationship between internalizing psychopathology and
   chronic physical health conditions: a population-based study
SO SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
LA English
DT Article
DE Internalizing; Comorbidity; Physical health; Obesity; Tobacco use;
   Latent variable models
ID SUBSTANCE USE DISORDERS; MENTAL-DISORDERS; EMOTIONAL DISORDERS;
   DIABETES-MELLITUS; META-STRUCTURE; DSM-IV; DEPRESSION; COMORBIDITY;
   OBESITY; ADULTS
AB Studies have consistently demonstrated a reciprocal relationship between internalizing disorders and several chronic physical health conditions. Yet, much of the extant literature fails to take into account the role of comorbidity among internalizing disorders when examining the relationship with poor physical health. The current study applied latent variable modelling to investigate the shared and specific relationships between internalizing (fear and distress factors) and a range of physical health conditions. Data comprised 8841 respondents aged 16-85 years who took part in the 2007 Australian National Survey of Mental Health and Wellbeing. Multiple indicator, multiple causes models were used to parse the shared and specific relationships between internalizing disorders and variables associated with poor physical health. The study found that several physical conditions were significantly related to mean levels of fear and distress. The results were broadly similar but minor differences emerged depending on whether lifetime or past 12 months indicators of mental disorders and physical conditions were utilized in the model. Finally, the results demonstrated that the association between individual mental disorders and physical health conditions are better accounted for by indirect relationships with broad transdiagnostic dimensions rather than including additional disorder-specific relationships. The results indicate that researchers should focus on common mechanisms across multiple internalizing disorders and poor physical health when developing prevention and treatment initiatives.
C1 [van de Pavert, Iris; Luijten, Maartje] Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Netherlands.
   [Sunderland, Matthew; Slade, Tim; Teesson, Maree] UNSW Sydney, Ctr Res Excellence Mental Hlth & Subst Use, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.
RP Sunderland, M (reprint author), UNSW Sydney, Ctr Res Excellence Mental Hlth & Subst Use, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.
EM Matthews@unsw.edu.au
OI Sunderland, Matthew/0000-0001-8452-364X
CR Andrews G, 2009, PSYCHOL MED, V39, P1993, DOI 10.1017/S0033291709990250
   [Anonymous], 2009, NAT SURV MENT HLTH W
   Baumeister D, 2014, SOC PSYCH PSYCH EPID, V49, P841, DOI 10.1007/s00127-014-0887-z
   Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038
   Clarke DM, 2009, MED J AUSTRALIA, V190, pS52
   Conway CC, 2012, J ABNORM PSYCHOL, V121, P754, DOI 10.1037/a0027457
   Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414
   Crane PK, 2009, GLOBAL PERSPECTIVES, P239
   Degenhardt L, 2001, Nicotine Tob Res, V3, P225
   Eaton NR, 2013, J ABNORM PSYCHOL, V122, P86, DOI 10.1037/a0029598
   Farchione TJ, 2012, BEHAV THER, V43, P666, DOI 10.1016/j.beth.2012.01.001
   Goldberg DP, 2009, PSYCHOL MED, V39, P2043, DOI 10.1017/S0033291709990298
   Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258
   Krueger RF, 2001, PERS INDIV DIFFER, V30, P1245, DOI 10.1016/S0191-8869(00)00106-9
   Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921
   Krueger RE, 2006, ANNU REV CLIN PSYCHO, V2, P111, DOI 10.1146/annurev.clinpsy.2.022305.095213
   Kruse J, 2003, DIABETES CARE, V26, P1841, DOI 10.2337/diacare.26.6.1841
   Lahey BB, 2014, JAMA PSYCHIAT, V71, P989, DOI 10.1001/jamapsychiatry.2014.359
   Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606
   Markon KE, 2004, BEHAV GENET, V34, P593, DOI 10.1007/s10519-004-5587-0
   McLaughlin KA, 2011, BEHAV RES THER, V49, P186, DOI 10.1016/j.brat.2010.12.006
   Muthen LK, 2015, MPLUS USERS GUIDE
   O'Connor KA, 2003, BRAIN RES, V991, P123, DOI 10.1016/j.brainres.2003.08.006
   Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063
   Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006
   Saydah SH, 2003, DIABETES-METAB RES, V19, P202, DOI 10.1002/dmrr.353
   Scott KM, 2008, INT J OBESITY, V32, P192, DOI 10.1038/sj.ijo.0803701
   Slade T, 2007, SOC PSYCH PSYCH EPID, V42, P554, DOI 10.1007/s00127-007-0200-5
   Slade T, 2006, PSYCHOL MED, V36, P1593, DOI 10.1017/S0033291706008452
   Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011
   Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008
   Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245
   Teesson M, 2011, AUST NZ J PSYCHIAT, V45, P939, DOI 10.3109/00048674.2011.614590
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
   Wright AGC, 2013, J ABNORM PSYCHOL, V122, P281, DOI 10.1037/a0030133
NR 40
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0933-7954
EI 1433-9285
J9 SOC PSYCH PSYCH EPID
JI Soc. Psychiatry Psychiatr. Epidemiol.
PD OCT
PY 2017
VL 52
IS 10
BP 1257
EP 1265
DI 10.1007/s00127-017-1422-9
PG 9
WC Psychiatry
SC Psychiatry
GA FJ2IH
UT WOS:000412548200006
PM 28744565
DA 2019-01-08
ER

PT J
AU Aghili, R
   Ridderstrale, M
   Kia, M
   Valojerdi, AE
   Malek, M
   Farshchi, A
   Khamseh, ME
AF Aghili, Rokhsareh
   Ridderstrale, Martin
   Kia, Maryam
   Valojerdi, Ameneh Ebrahim
   Malek, Mojtaba
   Farshchi, Amir
   Khamseh, Mohammad Ebrahim
TI The challenge of living with diabetes in women and younger adults: A
   structural equation model
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Diabetes; Type 2; Age; Gender; Psychosocial factors
ID PHYSICAL-DISABILITY; GENDER; EDUCATION; MEN; AGE
AB Background: Attitudes toward diabetes care are different between genders and age-groups. Furthermore, diabetes related challenges may cause psychosocial problems. Therefore, we were to compare the psychosocial status and glycemic control in women and men with type 2 diabetes (T2D) in different age-groups.
   Methods: 441 adults with T2D were recruited. Demographic, self-care behavior, resources and affective variables as well as the health related quality of life (HRQoL) were measured. The median age of 55 was used as the cut-off for the age comparison. Structured equation modeling (SEM) investigated the relationship between age, gender, psychosocial factors and glycemic control.
   Results: Finally, 203 women and 177 men completed the study (86.1%). There was no significant difference in mean duration of T2D, or glycemic control between genders or age-groups. Women, especially those below the median age of 55, had significantly higher level of diabetes-related distress (2.16 +/- 1 0.94 vs. 1.92 +/- 0.81), depression (9.67 +/- 5.37 vs. 7.54 +/- 5.06), and anxiety (19.81 +/- 12.04 vs. 12.81 +/- 9.04, P < 0.05 for all comparisons), while people above the age of 55 reported better self-management and patient-physician relationship. HRQoL was lower in women compared to men (0.77 +/- 0.23 vs. 0.81 +/- 0.18, P=0.02). The final SEM suggested that the effect (standardized beta coefficient) of gender and age on affective variables was 0.25 and -0.19 (P < 0.05), respectively, though psychosocial factors did not directly influence HbA1c.
   Conclusions: This study shows that psychosocial factors are associated with age and gender in patients with T2D; with younger women demonstrating higher level of depressive symptoms, anxiety, and diabetes-related distress independent of status of glycemic control. (C) 2017 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Aghili, Rokhsareh; Valojerdi, Ameneh Ebrahim; Farshchi, Amir; Khamseh, Mohammad Ebrahim] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran.
   [Ridderstrale, Martin] Lund Univ, Skane Univ Hosp Malmo, Clin Obes, Dept Clin Sci, S-20502 Malmo, Sweden.
   [Kia, Maryam] Univ Tehran Med Sci, Ziaeian Hosp, Dept Internal Med, Tehran, Iran.
   [Malek, Mojtaba] Iran Univ Med Sci, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran.
   [Farshchi, Amir] Univ Tehran Med Sci, Sch Pharm, Dept Pharmacoecon & Pharmaceut Adm, Tehran, Iran.
RP Khamseh, ME (reprint author), Valadi St,Behafarin St,Karimkhan Ave,Vali Asr Sq, Tehran, Iran.
EM aghili.r@tak.iums.ac.ir; martin.ridderstrale@med.lu.se;
   mkia220@gmail.com; ebrahimv86@gmail.com; malek.m@iums.acir;
   farshchi_a@razi.tums.ac.ir; khamseh.m@iums.ac.ir
RI Khamseh, Mohammad Ebrahim/L-9391-2018
FU Iran University of Medical Sciences [93-02-122-24800]
FX This study was funded and supported by Iran University of Medical
   Sciences; grant number: 93-02-122-24800. The authors wish to thank all
   people who participated in this study.
CR Aamir Sayed, 2012, MIDDLE E J PSYCHIAT, V3, P16
   Aghili R, 2013, INT NURS REV, V60, P267, DOI 10.1111/inr.12007
   Aghili R, 2016, CAN J DIABETES, V40, P424, DOI 10.1016/j.jcjd.2016.02.014
   Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS23, DOI 10.2337/dc16-S006
   Bruce DG, 2005, DIABETES CARE, V28, P2441, DOI 10.2337/diacare.28.10.2441
   Chiu CJ, 2011, ANN BEHAV MED, V41, P71, DOI 10.1007/s12160-010-9226-0
   Chiu CJ, 2011, GERONTOLOGIST, V51, P51, DOI 10.1093/geront/gnq069
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Gao J, 2013, J CHEM-NY, DOI 10.1155/2013/719179
   Gucciardi E, 2008, CAN FAM PHYSICIAN, V54, P219
   HIBBARD JH, 1983, SOC SCI MED, V17, P129, DOI 10.1016/0277-9536(83)90246-0
   Maggi S, 2004, DIABETOLOGIA, V47, P1957, DOI 10.1007/s00125-004-1555-8
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Ponzo MG, 2006, BEHAV MED, V31, P153, DOI 10.3200/BMED.31.4.153-160
   Pound N, 1996, DIABETIC MED, V13, P510, DOI 10.1002/(SICI)1096-9136(199606)13:6<510::AID-DIA122>3.0.CO;2-W
   Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899
   SASISEKHAR TVD, 2013, IOSR JDMS, V4, P48
   Schieman S, 2002, J AGING HEALTH, V14, P260, DOI 10.1177/089826430201400205
   Shalev V, 2005, PUBLIC HEALTH, V119, P45, DOI 10.1016/j.puhe.2004.03.004
   Siddiqui Muhammad A, 2013, Mater Sociomed, V25, P140, DOI 10.5455/msm.2013.25.140-142
   Sriram V., 2001, INT J DIABETES DEV C, V21
   Stofan JR, 1998, AM J PUBLIC HEALTH, V88, P1807, DOI 10.2105/AJPH.88.12.1807
   Trief PM, 2003, AGE AGEING, V32, P613, DOI 10.1093/ageing/afg105
   Wray LA, 2005, J GERONTOL A-BIOL, V60, P1206, DOI 10.1093/gerona/60.9.1206
NR 24
TC 2
Z9 2
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD OCT
PY 2017
VL 11
IS 5
BP 467
EP 473
DI 10.1016/j.pcd.2017.05.001
PG 7
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA FI3HO
UT WOS:000411848800009
PM 28579058
DA 2019-01-08
ER

PT J
AU Vloemans, AF
   van Beers, CAJ
   de Wit, M
   Cleijne, W
   Rondags, SM
   Geelhoed-Duijvestijn, PH
   Kramer, MHH
   Serne, EH
   Snoek, FJ
AF Vloemans, A. F.
   van Beers, C. A. J.
   de Wit, M.
   Cleijne, W.
   Rondags, S. M.
   Geelhoed-Duijvestijn, P. H.
   Kramer, M. H. H.
   Serne, E. H.
   Snoek, F. J.
TI Keeping safe. Continuous glucose monitoring (CGM) in persons with Type 1
   diabetes and impaired awareness of hypoglycaemia: a qualitative study
SO DIABETIC MEDICINE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; ADULTS; MANAGEMENT; BENEFITS
AB AimTo further our understanding of individual use and experience of continuous glucose monitoring (CGM) in adults with Type 1 diabetes and impaired awareness of hypoglycaemia, we conducted a qualitative study supplementary to a randomized controlled trial, using semi-structured interviews.
   MethodsTwenty-three participants of the IN CONTROL trial were interviewed within 4weeks after the last study visit. The interview centred around experiences of CGM, taking into account the person's expectations prior to the trial. The interview was semi-structured, using open-ended questions and, if needed, prompts were offered to elicit further responses. Using thematic analysis, the interview transcripts were coded independently by three members of the research team. The consolidated criteria for reporting qualitative research (COREQ) were followed.
   ResultsOverall, CGM was experienced as helpful in gaining more insight into glucose variability, and temporarily improved sense of control, reduced distress and made participants less dependent on others. However, some participants experienced confrontation with CGM output as intrusive, while some reported frustration due to failing technique and difficulty trusting the device. Participants reported active and passive self-management behaviours mirroring individual differences in attitudes and coping styles.
   ConclusionsIn adults with Type 1 diabetes at risk of recurrent hypoglycaemia due to impaired awareness of hypoglycaemia, CGM use enhances a sense of control and safety for most, but not all. Future studies should further explore differential use of CGM in this population in the context of active and passive self-management styles.
C1 [Vloemans, A. F.; de Wit, M.; Cleijne, W.; Rondags, S. M.; Snoek, F. J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [van Beers, C. A. J.; Kramer, M. H. H.; Serne, E. H.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands.
   [Geelhoed-Duijvestijn, P. H.] Med Ctr Haaglanden, Dept Internal Med, The Hague, Netherlands.
   [Snoek, F. J.] Univ Amsterdam, Dept Med Psychol, Acad Med Ctr, Amsterdam, Netherlands.
RP van Beers, CAJ (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands.
EM c.vanbeers@vumc.nl
FU Eli Lilly; Sanofi
FX The IN CONTROL trial received funding from Eli Lilly and Sanofi.
   Medtronic supplied CGM devices.
CR Beck RW, 2010, DIABETES CARE, V33, P2175, DOI 10.2337/dc10-0331
   Bergenstal RM, 2016, JAMA-J AM MED ASSOC, V316, P1407, DOI 10.1001/jama.2016.11708
   Bolinder J, 2016, LANCET, V388, P2254, DOI 10.1016/S0140-6736(16)31535-5
   Borges Uirassu Jr, 2016, J Diabetes Sci Technol, V10, P633, DOI 10.1177/1932296816634736
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Choudhary P, 2013, DIABETES CARE, V36, P4160, DOI 10.2337/dc13-0939
   Cox DJ, 2001, DIABETES CARE, V24, P637, DOI 10.2337/diacare.24.4.637
   Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9
   Hermanides J, 2011, DIABETIC MED, V28, P1158, DOI 10.1111/j.1464-5491.2011.03256.x
   Kubiak Thomas, 2016, J Diabetes Sci Technol, V10, P859, DOI 10.1177/1932296816651450
   Litchman ML, 2017, J DIABETES SCI TECHN
   Ly TT, 2013, JAMA-J AM MED ASSOC, V310, P1240, DOI 10.1001/jama.2013.277818
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Pickup JC, 2015, DIABETES CARE, V38, P544, DOI 10.2337/dc14-1855
   Pickup JC, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d3805
   Polonsky WH, 2013, DIABETES TECHNOL THE, V15, P295, DOI 10.1089/dia.2012.0298
   Ritholz MD, 2014, DIABETIC MED, V31, P47, DOI 10.1111/dme.12276
   Ritholz MD, 2010, DIABETIC MED, V27, P1060, DOI 10.1111/j.1464-5491.2010.03061.x
   Rondags SMPA, 2016, DIABETES CARE, V39, P2190, DOI 10.2337/dc16-1614
   Russell Cynthia K, 2003, Evid Based Nurs, V6, P36
   Schmidt Signe, 2012, J Diabetes Sci Technol, V6, P986
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   van Beers CAJ, 2016, LANCET DIABETES ENDO, V4, P893, DOI 10.1016/S2213-8587(16)30193-0
   Yeoh E, 2015, DIABETES CARE, V38, P1592, DOI 10.2337/dc15-0102
NR 24
TC 3
Z9 3
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2017
VL 34
IS 10
BP 1470
EP 1476
DI 10.1111/dme.13429
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FH3DP
UT WOS:000411025300021
PM 28731509
DA 2019-01-08
ER

PT J
AU Castensoe-Seidenfaden, P
   Teilmann, G
   Kensing, F
   Hommel, E
   Olsen, BS
   Husted, GR
AF Castensoe-Seidenfaden, Pernille
   Teilmann, Grete
   Kensing, Finn
   Hommel, Eva
   Olsen, Birthe Susanne
   Husted, Gitte Reventlov
TI Isolated thoughts and feelings and unsolved concerns: adolescents' and
   parents' perspectives on living with type 1 diabetes - a qualitative
   study using visual storytelling
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE adolescence; qualitative methods; self-management; transition; type 1
   diabetes; visual storytelling
ID DETERMINATION-YOUTH INTERVENTION; GLYCEMIC CONTROL; EMOTIONAL DISTRESS;
   SELF-MANAGEMENT; EMERGING ADULTS; LIFE SKILLS; CHILDREN; CARE;
   HYPOGLYCEMIA; FEAR
AB Aims and objectivesTo explore and describe the experiences of adolescents and their parents living with type 1 diabetes, to identify their needs for support to improve adolescents' self-management skills in the transition from child- to adulthood.
   BackgroundAdolescents with type 1 diabetes often experience deteriorating glycaemic control and distress. Parents are important in adolescents' ability to self-manage type 1 diabetes, but they report anxiety and frustrations. A better understanding of the challenges adolescents and parents face, in relation to the daily self-management of type 1 diabetes, is important to improve clinical practice.
   DesignA qualitative explorative study using visual storytelling as part of individual interviews.
   MethodsA purposive sample of nine adolescents and their parents (seven mothers, six fathers) took photographs illustrating their experiences living with type 1 diabetes. Subsequently, participants were interviewed individually guided by participants' photographs and a semistructured interview guide. Interviews were analysed using thematic analysis.
   ResultsFour major themes were consistent across adolescents and their parents: (1) striving for safety, (2) striving for normality, (3) striving for independence and (4) worrying about future. Although adolescents and parents had same concerns and challenges living with type 1 diabetes, they were experienced differently. Their thoughts and feelings mostly remained isolated and their concerns and challenges unsolved.
   ConclusionsThe concerns and challenges adolescents and their parents face in the transition from child- to adulthood are still present despite new treatment modalities. Parents are fundamental in supporting the adolescents' self-management-work; however, the parties have unspoken concerns and challenges.
   Relevance to clinical practiceHealthcare providers should address the parties' challenges and concerns living with type 1 diabetes to diminish worries about future including fear of hypoglycaemia, the burden of type 1 diabetes and the feeling of being incompetent in diabetes self-management. It is important to focus on supporting both adolescents and their parents, and to provide a shared platform for communication.
C1 [Castensoe-Seidenfaden, Pernille; Teilmann, Grete] Nordsjaellands Hosp, Pediat & Adolescent Dept, Dyrehavevej 29, DK-3400 Hillerod, Denmark.
   [Kensing, Finn] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark.
   [Hommel, Eva] Steno Diabet Ctr, Gentofte, Denmark.
   [Olsen, Birthe Susanne] Herlev Hosp, Dept Pediat, Herlev, Denmark.
   [Husted, Gitte Reventlov] Steno Diabet Ctr, Hlth Promot Res, Gentofte, Denmark.
RP Castensoe-Seidenfaden, P (reprint author), Nordsjaellands Hosp, Pediat & Adolescent Dept, Dyrehavevej 29, DK-3400 Hillerod, Denmark.
EM pernille.castensoee-seidenfaden@regionh.dk
FU Nordsjaellands Hospital, University of Copenhagen; Regionradets
   Foundation for Particularly Vulnerable Citizens, the Capital Region,
   Denmark
FX This study was funded by a Research Grant from Nordsjaellands Hospital,
   University of Copenhagen and Regionradets Foundation for Particularly
   Vulnerable Citizens, the Capital Region, Denmark.
CR Babler E, 2015, DIABETES EDUCATOR, V41, P351, DOI 10.1177/0145721715579108
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Burke K, 2012, J ADOLESCENCE, V35, P1315, DOI 10.1016/j.adolescence.2012.05.002
   Cardwell CR, 2005, ARCH DIS CHILD, V90, P468, DOI 10.1136/adc.2004.061150
   Carroll AE, 2006, DIABETIC MED, V23, P1222, DOI 10.1111/j.1464-5491.2006.01961.x
   Cheung Ruth, 2006, J Sch Nurs, V22, P53
   Collier J., 1986, VISUAL ANTHR PHOTOGR
   Court JM, 2009, PEDIATR DIABETES, V10, P185, DOI 10.1111/j.1399-5448.2009.00586.x
   Crowley R, 2011, ARCH DIS CHILD, V96, P548, DOI 10.1136/adc.2010.202473
   Denzin NK, 2000, HDB QUALITATIVE RES
   Drew SE, 2010, QUAL HEALTH RES, V20, P1677, DOI 10.1177/1049732310377455
   Freckleton E, 2014, INT J BEHAV MED, V21, P804, DOI 10.1007/s12529-013-9360-8
   Freeborn D, 2013, J CLIN NURS, V22, P1890, DOI 10.1111/jocn.12046
   Gallagher J. M., 1981, LEARNING THEORY PIAG
   Garvey K, 2015, PEDIATR CLIN N AM, V62, P873, DOI 10.1016/j.pcl.2015.04.005
   Glindorf M, 2014, PAID 1 IS VALUABLE T
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Hampson SE, 2000, DIABETES CARE, V23, P1416, DOI 10.2337/diacare.23.9.1416
   Hanna K M, 2001, Issues Compr Pediatr Nurs, V24, P209
   Haugstvedt A, 2010, DIABETIC MED, V27, P72, DOI 10.1111/j.1464-5491.2009.02867.x
   Haugstvedt A, 2011, PEDIATR DIABETES, V12, P107, DOI 10.1111/j.1399-5448.2010.00661.x
   Husted GR, 2014, J ADV NURS, V70, P2634, DOI 10.1111/jan.12413
   Husted GR, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-321
   Huus Karina, 2007, Paediatr Nurs, V19, P29
   Inzucchi SE, 2009, CECIL MED, P1727
   Joensen LE, 2016, PATIENT PREFER ADHER, V10, P1443, DOI 10.2147/PPA.S111696
   Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36
   Luyckx K, 2008, J ADOLESCENT HEALTH, V43, P451, DOI 10.1016/j.jadohealth.2008.04.005
   Luyckx K, 2009, DIABETES CARE, V32, P797, DOI 10.2337/dc08-1990
   Marshall M, 2009, J CLIN NURS, V18, P1703, DOI 10.1111/j.1365-2702.2008.02737.x
   Mattelmaki T, 2005, APPL PROBES FROM INS
   NICE, 2016, TRANS CHILDR AD SERV
   Olsson E, 2015, ACTION RES-LONDON, V13, P9, DOI 10.1177/1476750314566216
   Palmer DL, 2011, J PEDIATR PSYCHOL, V36, P596, DOI 10.1093/jpepsy/jsq019
   Patton M., 1990, QUALITATIVE EVALUATI
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Pillay J, 2015, ANN INTERN MED, V163, P836, DOI 10.7326/M15-1399
   Rasmussen B, 2011, J CLIN NURS, V20, P1981, DOI 10.1111/j.1365-2702.2010.03657.x
   Sakane N, 2015, J DIABETES INVEST, V6, P567, DOI 10.1111/jdi.12340
   Schilling LS, 2002, J ADV NURS, V37, P87, DOI 10.1046/j.1365-2648.2002.02061.x
   Schilling LS, 2009, NURS RES, V58, P228, DOI 10.1097/NNR.0b013e3181ac142a
   Stuckey HL, 2015, CLIN THER, V37, P1986, DOI 10.1016/j.clinthera.2015.06.010
   Tsiouli E, 2013, CAN FAM PHYSICIAN, V59, P143
   Vallis M, 2014, CURR DIABETES REV, V10, P364, DOI 10.2174/1573399810666141113115026
   Van Ryzin MJ, 2012, DEV PSYCHOPATHOL, V24, P1139, DOI 10.1017/S0954579412000582
   Viklund G, 2009, J CLIN NURS, V18, P3262, DOI 10.1111/j.1365-2702.2009.02963.x
   Young MT, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0546-5
NR 47
TC 4
Z9 4
U1 2
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD OCT
PY 2017
VL 26
IS 19-20
BP 3018
EP 3030
DI 10.1111/jocn.13649
PG 13
WC Nursing
SC Nursing
GA FG6YI
UT WOS:000410546400019
PM 27865017
DA 2019-01-08
ER

PT J
AU Ismail, K
   Moulton, CD
   Winkley, K
   Pickup, JC
   Thomas, SM
   Sherwood, RA
   Stahl, D
   Amiel, SA
AF Ismail, Khalida
   Moulton, Calum D.
   Winkley, Kirsty
   Pickup, John C.
   Thomas, Stephen M.
   Sherwood, Roy A.
   Stahl, Daniel
   Amiel, Stephanie A.
TI The association of depressive symptoms and diabetes distress with
   glycaemic control and diabetes complications over 2 years in newly
   diagnosed type 2 diabetes: a prospective cohort study
SO DIABETOLOGIA
LA English
DT Article
DE Depressive symptoms; Diabetes distress; Glycaemic control; Inflammation;
   Macrovascular complications; Microvascular complications; Type 2
   diabetes
ID EMOTIONAL DISTRESS; CONTROLLED-TRIAL; CARDIOVASCULAR COMPLICATIONS;
   PROBLEM AREAS; MISSING DATA; FOLLOW-UP; MELLITUS; CARE; METAANALYSIS;
   MORTALITY
AB Aims/hypothesis We examined the associations between depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years, after diagnosis of type 2 diabetes.
   Methods In a multi-ethnic, primary care cohort (n = 1735) of adults, all with recent (< 6 months) diagnosis of type 2 diabetes, we measured the associations between depressive symptoms (Patient Health Questionnaire-9 [PHQ-9] score = 10) and diabetes distress (Problem Areas in Diabetes [PAID] score = 40), with change in 2 year HbA(1c) as the primary outcome and with incident rates of diabetes complications as secondary outcomes. Multivariate models were used to account for potential confounders.
   Results Of the 1651 participants (95.2%) of the total primary care cohort with available baseline PHQ-9 and PAID scores, mean +/- SD age was 56.2 +/- 11.1 years, 55.1% were men and 49.1% were of non-white ethnicity; 232 (14.1%) and 111 (6.7%) had depressive symptoms and diabetes distress, respectively. After adjustment for confounders, depressive symptoms were not associated with worsening HbA(1c). After adjustment for age, sex, ethnicity, vascular risk factors and diabetes treatments, depressive symptoms were associated with increased risk of incident macrovascular complications (OR 2.78 [95% CI 1.19, 6.49], p = 0.018) but notmicrovascular complications. This was attenuated (p = 0.09) after adjustment for IL-1 receptor antagonist concentration. Diabetes distress was not associated with worsening HbA1c or incident complications.
   Conclusions/interpretation In the first 2 years of type 2 diabetes, the effect of depressive symptoms and diabetes distress on glycaemic control is minimal. There was, however, an association between depressive symptoms and incidence of macrovascular complications. Elevated innate inflammation may be common to both depression and macrovascular diabetes complications, but these findings require replication.
C1 [Ismail, Khalida; Moulton, Calum D.; Winkley, Kirsty] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London SE5 9RJ, England.
   [Pickup, John C.; Amiel, Stephanie A.] Kings Coll London, Div Diabet & Nutr Sci, Fac Life Sci & Med, London, England.
   [Thomas, Stephen M.] Guys & St Thomas NHS Fdn Trust, Dept Endocrinol & Diabet, London, England.
   [Sherwood, Roy A.] Kings Coll Hosp NHS Fdn Trust, Dept Clin Biochem, London, England.
   [Stahl, Daniel] Kings Coll London, Dept Biostat, Inst Psychiat Psychol & Neurosci, London, England.
RP Ismail, K (reprint author), Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London SE5 9RJ, England.
EM khalida.2.ismail@kcl.ac.uk
RI Stahl, Daniel/B-9713-2011
OI Stahl, Daniel/0000-0001-7987-6619; Winkley, Kirsty/0000-0002-1725-6040;
   ismail, khalida/0000-0001-6084-449X
FU National Institute for Health Research (NIHR) under its Programme Grants
   for Applied Research scheme [RP-PG-0606-1142]; NIHR Biomedical Research
   Centre at South London and South London and Maudsley NHS Foundation
   Trust; EFSD/Lilly Mental Health in Diabetes Programme; NIHR Biomedical
   Research Centre for Mental Health at the South London and Maudsley NHS
   Foundation Trust; Institute of Psychiatry, Psychology and Neuroscience,
   King's College London; Royal College of Physicians of Edinburgh
FX This report presents independent research funded by the National
   Institute for Health Research (NIHR) under its Programme Grants for
   Applied Research scheme (RP-PG-0606-1142) and part-funded by the NIHR
   Biomedical Research Centre at South London and South London and Maudsley
   NHS Foundation Trust. Additional funding was received from the
   EFSD/Lilly Mental Health in Diabetes Programme (2010) and the NIHR
   Biomedical Research Centre for Mental Health at the South London and
   Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology
   and Neuroscience, King's College London. The views expressed in this
   publication are those of the authors and not necessarily those of the
   NHS, the NIHR or the Department of Health. CM receives salary support
   from a fellowship funded by the Royal College of Physicians of
   Edinburgh. The study sponsor was not involved in the design of the
   study; the collection, analysis, and interpretation of data; writing the
   report; or the decision to submit the report for publication.
CR Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3
   Chiu CJ, 2010, SOC PSYCH PSYCH EPID, V45, P67, DOI 10.1007/s00127-009-0043-3
   Cummings DM, 2016, DIABETES CARE, V39, P101, DOI 10.2337/dc15-1174
   Dalsgaard EM, 2014, DIABETOLOGIA, V57, P710, DOI 10.1007/s00125-014-3165-4
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Department for Communities and Local Government DCLG, 2010, ENGL IND DEPR 2010
   Dirmaier J, 2010, PSYCHOTHER PSYCHOSOM, V79, P172, DOI 10.1159/000296135
   Fenwick EK, 2018, J HEALTH PSYCHOL, V23, P667, DOI 10.1177/1359105316642006
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Herder C, 2015, TRENDS ENDOCRIN MET, V26, P551, DOI 10.1016/j.tem.2015.08.001
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363
   Katon WJ, 2004, J GEN INTERN MED, V19, P1192, DOI 10.1111/j.1525-1497.2004.30405.x
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Laake JPS, 2014, DIABETES CARE, V37, P2186, DOI 10.2337/dc13-2522
   Lustman PJ, 2006, ARCH GEN PSYCHIAT, V63, P521, DOI 10.1001/archpsyc.63.5.521
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Palta P, 2014, J DIABETES COMPLICAT, V28, P798, DOI 10.1016/j.jdiacomp.2014.06.014
   Pickup JC, 2003, DIABETIC MED, V20, P723, DOI 10.1046/j.1464-5491.2003.00990.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RAYMOND MR, 1986, EVAL HEALTH PROF, V9, P395, DOI 10.1177/016327878600900401
   Roth PL, 1999, ORGAN RES METHODS, V2, P211, DOI 10.1177/109442819923001
   Schmitt A, 2014, DIABETIC MED, V31, P1446, DOI 10.1111/dme.12553
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Ting RZ, J AFFECT DISORD, V149, P129
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Twist K, 2013, PSYCHOSOM MED, V75, P791, DOI 10.1097/PSY.0b013e3182a2b108
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Winkley K, 2013, DIABETOLOGIA, V56, P1272, DOI 10.1007/s00125-013-2873-5
   Winkley K, 2012, DIABETOLOGIA, V55, P303, DOI 10.1007/s00125-011-2359-2
NR 43
TC 4
Z9 5
U1 2
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD OCT
PY 2017
VL 60
IS 10
BP 2092
EP 2102
DI 10.1007/s00125-017-4367-3
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FF3BK
UT WOS:000408770300026
PM 28776084
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Gamble, S
   Mawokomatanda, T
   Xu, F
   Chowdhury, PP
   Pierannunzi, C
   Flegel, D
   Garvin, W
   Town, M
AF Gamble, Sonya
   Mawokomatanda, Tebitha
   Xu, Fang
   Chowdhury, Pranesh P.
   Pierannunzi, Carol
   Flegel, David
   Garvin, William
   Town, Machell
TI Surveillance for Certain Health Behaviors and Conditions Among States
   and Selected Local Areas - Behavioral Risk Factor Surveillance System,
   United States, 2013 and 2014
SO MMWR SURVEILLANCE SUMMARIES
LA English
DT Article
ID AMERICAN-HEART-ASSOCIATION; JOINT CONSENSUS STATEMENT; SLEEP RESEARCH
   SOCIETY; MENTAL DISTRESS STATUS; SERVICES TASK-FORCE; RECOMMENDED
   AMOUNT; ADULTS; DISEASE; US; CARE
AB Problem: Chronic diseases and conditions (e.g., heart diseases, stroke, arthritis, and diabetes) are the leading causes of morbidity and mortality in the United States. These conditions are costly to the U.S. economy, yet they are often preventable or controllable. Behavioral risk factors (e.g., excessive alcohol consumption, tobacco use, poor diet, frequent mental distress, and insufficient sleep) are linked to the leading causes of morbidity and mortality. Adopting positive health behaviors (e.g., staying physically active, quitting tobacco use, obtaining routine physical checkups, and checking blood pressure and cholesterol levels) can reduce morbidity and mortality from chronic diseases and conditions. Monitoring the health risk behaviors, chronic diseases and conditions, access to health care, and use of preventive health services at multilevel public health points (states, territories, and metropolitan and micropolitan statistical areas [MMSA]) can provide important information for development and evaluation of health intervention programs.
   Reporting Period: 2013 and 2014.
   Description of the System: The Behavioral Risk Factor Surveillance System (BRFSS) is an ongoing, state-based, random-digitdialed telephone survey of noninstitutionalized adults aged >= 18 years residing in the United States. BRFSS collects data on health risk behaviors, chronic diseases and conditions, access to health care, and use of preventive health services and practices related to the leading causes of death and disability in the United States and participating territories. This is the first BRFSS report to include age-adjusted prevalence estimates. For 2013 and 2014, these age-adjusted prevalence estimates are presented for all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, Guam, and selected MMSA.
   Results: Age-adjusted prevalence estimates of health status indicators, health care access and preventive practices, health risk behaviors, chronic diseases and conditions, and cardiovascular conditions vary by state, territory, and MMSA. Each set of proportions presented refers to the range of age-adjusted prevalence estimates of selected BRFSS measures as reported by survey respondents. The following are estimates for 2013. Adults reporting frequent mental distress: 7.7%-15.2% in states and territories and 6.3%-19.4% in MMSA. Adults with inadequate sleep: 27.6%-49.2% in states and territories and 26.5%-44.4% in MMSA. Adults aged 18-64 years having health care coverage: 66.9%-92.4% in states and territories and 60.5%-97.6% in MMSA. Adults identifying as current cigarette smokers: 10.1%-28.8% in states and territories and 6.1%-33.6% in MMSA. Adults reporting binge drinking during the past month: 10.5%-25.2% in states and territories and 7.2%-25.3% in MMSA. Adults with obesity: 21.0%-35.2% in states and territories and 12.1%-37.1% in MMSA. Adults aged >= 45 years with some form of arthritis: 30.6%-51.0% in states and territories and 27.6%-52.4% in MMSA. Adults aged >= 45 years who have had coronary heart disease: 7.4%-17.5% in states and territories and 6.2%-20.9% in MMSA. Adults aged >= 45 years who have had a stroke: 3.1%-7.5% in states and territories and 2.3%-9.4% in MMSA. Adults with high blood pressure: 25.2%-40.1% in states and territories and 22.2%-42.2% in MMSA. Adults with high blood cholesterol: 28.8%-38.4% in states and territories and 26.3%-39.6% in MMSA.
   The following are estimates for 2014. Adults reporting frequent physical distress: 7.8%-16.0% in states and territories and 6.2%-18.5% in MMSA. Women aged 21-65 years who had a Papanicolaou test during the past 3 years: 67.7%-87.8% in states and territories and 68.0%-94.3% in MMSA. Adults aged 50-75 years who received colorectal cancer screening on the basis of the 2008 U.S. Preventive Services Task Force recommendation: 42.8%-76.7% in states and territories and 49.1%-79.6% in MMSA. Adults with inadequate sleep: 28.4%-48.6% in states and territories and 25.4%-45.3% in MMSA. Adults reporting binge drinking during the past month: 10.7%-25.1% in states and territories and 6.7%-26.3% in MMSA. Adults aged >= 45 years who have had coronary heart disease: 8.0%-17.1% in states and territories and 7.6%-19.2% in MMSA. Adults aged >= 45 years with some form of arthritis: 31.2%-54.7% in states and territories and 28.4%-54.7% in MMSA. Adults with obesity: 21.0%-35.9% in states and territories and 19.7%-42.5% in MMSA.
   Interpretation: Prevalence of certain chronic diseases and conditions, health risk behaviors, and use of preventive health services varies among states, territories, and MMSA. The findings of this report highlight the need for continued monitoring of health status, health care access, health behaviors, and chronic diseases and conditions at state and local levels.
   Public Health Action: State and local health departments and agencies can continue to use BRFSS data to identify populations at risk for certain unhealthy behaviors and chronic diseases and conditions. Data also can be used to design, monitor, and evaluate public health programs at state and local levels.
C1 [Gamble, Sonya; Mawokomatanda, Tebitha; Xu, Fang; Chowdhury, Pranesh P.; Pierannunzi, Carol; Garvin, William; Town, Machell] CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Populat Hlth, Atlanta, GA 30333 USA.
   [Flegel, David] Northrop Grumman Corp, Atlanta, GA USA.
RP Mawokomatanda, T (reprint author), CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Populat Hlth, Atlanta, GA 30333 USA.
EM chn4@cdc.gov
CR American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C
   Barbour KE, 2017, MMWR-MORBID MORTAL W, V66, P246, DOI 10.15585/mmwr.mm6609e1
   Benard VB, 2014, MMWR-MORBID MORTAL W, V63, P1004
   Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045
   CDC, 2012, CHRON DIS OV
   CDC, 2016, TABL SUMM HLTH STAT
   CDC, 2017, ARTHR AW MONTH
   CDC, 2011, STRAT PREV OB OTH CH
   *CDC, 2000, MEAS HLTH DAYS POP A
   CDC, 2017, FACT SHEETS BING DRI
   CDC, 2016, BEH RISK FACT SURV S
   CDC, 2015, BEH RISK FACT SURV S
   CDC Centers for Disease Control and Prevention, 2016, PHYS ACTIVITY HLTH
   CDC National Center for Chronic Disease Prevention and Health Promotion, 2014, HLTH CONSMOK 50 YE
   Centers for Disease Control, 2016, AD OB FACTS
   Centers for Disease Control and Prevention (CDC), 2014, BEH RISK FACT SURV S
   Chowdhury PP, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6504a1
   Dwyer-Lindgren L, 2015, AM J PUBLIC HEALTH, V105, P1120, DOI 10.2105/AJPH.2014.302313
   Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
   Fox J. B., 2010, Morbidity and Mortality Weekly Report, V59, P1448
   Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1
   Hoffman C, 2008, ANN NY ACAD SCI, V1136, P149, DOI 10.1196/annals.1425.007
   Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14
   King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207
   Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881
   Kochanek KD, 2014, NATL VITAL STAT REPO, V65, P1
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9
   Li C, 2012, PREV MED, V54, P381
   LIU Y, 2009, ELECTRON J DIFF 0112
   May AL, 2013, MMWR SUPPL S3, V62
   Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424
   Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Pew Research Center, 2016, MOB FACT SHEET
   Pierannunzi C, 2004, BMC MED RES METHODOL, V2013, P13, DOI DOI 10.1186/1471-2288-13-49
   Pierannunzi C, 2015, AM ASS PUBL OP RES A
   Sherry B., 2010, Morbidity and Mortality Weekly Report, V59, P951
   Simon JG, 2005, EUR J PUBLIC HEALTH, V15, P200, DOI 10.1093/eurpub/cki102
   Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015
   Strine TW, 2004, PREV MED, V39, P191, DOI 10.1016/j.ypmed.2004.01.022
   Strine TW, 2004, AM J PREV MED, V26, P213, DOI 10.1016/j.amepre.2003.11.002
   US Centers for Disease Control and Prevention (CDC), 2010, TOB SMOK CAUS DIS BI
   US Department of Health and Human Services, 2001, HLTH PEOPL 2010 AG A
   Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886
   Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
   World Health Organization [WHO], 2013, WHO REP GLOB TOB EP
   Xu J, 2013, NATL VITAL STAT REP, V64, P1
   Xuan ZM, 2015, AM J PUBLIC HEALTH, V105, P816, DOI 10.2105/AJPH.2014.302112
   Zack MM, 2004, PUBLIC HEALTH REP, V119, P493, DOI 10.1016/j.phr.2004.07.007
   Zack MM, 2013, MMWR SUPPL S3, V62
   Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244
NR 52
TC 5
Z9 5
U1 1
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-8636
J9 MMWR SURVEILL SUMM
JI MMWR Surv. Summ.
PD SEP 15
PY 2017
VL 66
IS 16
BP 1
EP 139
PG 139
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FM4IG
UT WOS:000414978200001
PM 28910267
OA Bronze, Green Published
DA 2019-01-08
ER

PT J
AU Assari, S
   Lee, DB
   Nicklett, EJ
   Lankarani, MM
   Piette, JD
   Aikens, JE
AF Assari, Shervin
   Lee, Daniel B.
   Nicklett, Emily Joy
   Lankarani, Maryam Moghani
   Piette, John D.
   Aikens, James E.
TI Racial Discrimination in Health Care Is Associated with Worse Glycemic
   Control among Black Men but Not Black Women with Type 2 Diabetes
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE Blacks; African-Americans; gender; racial discrimination; diabetes
ID AFRICAN-AMERICAN MEN; SELF-RATED HEALTH; STRESSFUL LIFE EVENTS;
   SICKLE-CELL-DISEASE; PERCEIVED DISCRIMINATION; DEPRESSIVE SYMPTOMS;
   UNITED-STATES; PSYCHOLOGICAL DISTRESS; CULTURAL COMPETENCE;
   GENDER-DIFFERENCES
AB Background: A growing body of research suggests that racial discrimination may affect the health of Black men and Black women differently.
   Aims: This study examined Black patients with diabetes mellitus (DM) in order to test gender differences in (1) levels of perceived racial discrimination in health care and (2) how perceived discrimination relates to glycemic control.
   Methods: A total of 163 Black patients with type 2 DM (78 women and 85 men) provided data on demographics (age and gender), socioeconomic status, perceived racial discrimination in health care, self-rated health, and hemoglobin A1c (HbA1c). Data were analyzed using linear regression.
   Results: Black men reported more racial discrimination in health care than Black women. Although racial discrimination in health care was not significantly associated with HbA1c in the pooled sample (b = 0.20, 95% CI = -0.41 -0.80), gender-stratified analysis indicated an association between perceived discrimination and higher HbA1c levels for Black men (b = 0.86, 95% confidence intervals (CI) = 0.01-1.73) but not Black women (b = -0.31, 95% CI = -1.17 to -0.54).
   Conclusion: Perceived racial discrimination in diabetes care may be more salient for glycemic control of Black men than Black women. Scholars and clinicians should take gender into account when considering the impacts of race-related discrimination experiences on health outcomes. Policies should reduce racial discrimination in the health care.
C1 [Assari, Shervin; Lankarani, Maryam Moghani] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.
   [Assari, Shervin] Univ Michigan, Sch Publ Hlth, Ctr Res Ethn Culture & Hlth, Ann Arbor, MI 48109 USA.
   [Lee, Daniel B.; Piette, John D.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.
   [Lee, Daniel B.] Univ Michigan, Sch Publ Hlth, Prevent Res Ctr, Ann Arbor, MI 48109 USA.
   [Nicklett, Emily Joy] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA.
   [Piette, John D.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA.
   [Piette, John D.] Michigan Med, Dept Internal Med, Ann Arbor, MI USA.
   [Aikens, James E.] Michigan Med, Dept Family Med, Ann Arbor, MI USA.
RP Assari, S (reprint author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.; Assari, S (reprint author), Univ Michigan, Sch Publ Hlth, Ctr Res Ethn Culture & Hlth, Ann Arbor, MI 48109 USA.
EM assari@umich.edu
FU National Institutes of Health [R01DK066016]; Heinz C. Prechter Bipolar
   Research Fund; Richard Tam Foundation at the University of Michigan
   Depression Center; Eunice Kennedy Shriver National Institute of Child
   Health and Development (NICHD) [T32 HD 79350-2]
FX This study was funded by the National Institutes of Health
   (R01DK066016). SA is supported by the Heinz C. Prechter Bipolar Research
   Fund and the Richard Tam Foundation at the University of Michigan
   Depression Center. Second author is supported by a grant from the Eunice
   Kennedy Shriver National Institute of Child Health and Development
   (NICHD) (T32 HD 79350-2).
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Anderson LM, 2003, AM J PREV MED, V24, P68, DOI 10.1016/S0749-3797(02)00657-8
   Assari S, 2018, J RACIAL ETHN HEALTH, V5, P243, DOI 10.1007/s40615-017-0364-y
   Assari S, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116666975
   Assari S, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4020014
   Assari S, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00023
   Assari S, 2016, IRAN J PSYCHIATRY BE, V10, DOI 10.17795/ijpbs-3458
   Assari S, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.31475
   Assari S, 2016, J RACIAL ETHN HEALTH, V3, P349, DOI 10.1007/s40615-015-0160-5
   Assari S, 2016, ANN EPIDEMIOL, V26, P106, DOI 10.1016/j.annepidem.2015.11.006
   Assari S, 2015, J RACIAL ETHN HEALTH, V2, P200, DOI 10.1007/s40615-014-0064-9
   Assari S, 2015, INT J PREVENTIVE MED, V6, DOI [10.4103/2008-7802.17043, 10.4103/2008-7802.170431]
   Assari S, 2015, SOCIETIES, V5, P151, DOI 10.3390/soc5010151
   Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-36
   Banks KH, 2006, COMMUNITY MENT HLT J, V42, P555, DOI 10.1007/s10597-006-9052-9
   Bertakis KD, 2000, J FAM PRACTICE, V49, P147
   BOWMAN PJ, 1985, J AM ACAD CHILD PSY, V24, P134, DOI 10.1016/S0002-7138(09)60438-6
   Brodish Amanda B, 2011, Race Soc Probl, V3, P160
   Broman C.L., 2000, J BLACK PSYCHOL, V26, P165, DOI DOI 10.1177/0095798400026002003
   Brondolo E, 2008, J SOC CLIN PSYCHOL, V27, P150, DOI 10.1521/jscp.2008.27.2.150
   Brondolo E, 2009, J BEHAV MED, V32, P64, DOI 10.1007/s10865-008-9193-0
   BROWN TN, 2000, RACE SOC, V0002
   Browne I, 2003, ANNU REV SOCIOL, V29, P487, DOI 10.1146/annurev.soc.29.010202.100016
   Caldwell CH, 2013, PSYCHOL MEN MASCULIN, V14, P47, DOI 10.1037/a0029105
   Canady RB, 2008, WOMEN HEALTH ISS, V18, P292, DOI 10.1016/j.whi.2008.04.003
   Carter JS, 1996, ANN INTERN MED, V125, P221, DOI 10.7326/0003-4819-125-3-199608010-00011
   Caughy MO, 2004, AM J PUBLIC HEALTH, V94, P2118, DOI 10.2105/AJPH.94.12.2118
   Chen FM, 2005, ANN FAM MED, V3, P138, DOI 10.1370/afm.282
   Clark R, 1999, AM PSYCHOL, V54, P805, DOI 10.1037//0003-066X.54.10.805
   Clifford A, 2015, INT J QUAL HEALTH C, V27, P89, DOI 10.1093/intqhc/mzv010
   Coard S. J., 2004, J CHILD FAM STUD, V13, P277, DOI DOI 10.1023/B:JCFS.0000022035.07171.F8
   Cook CB, 2000, DIABETES CARE, V23, P319, DOI 10.2337/diacare.23.3.319
   Davis JE, 2003, URBAN EDUC, V38, P515, DOI 10.1177/0042085903256220
   Forsyth J, 2014, PSYCHOSOM MED, V76, P229, DOI 10.1097/PSY.0000000000000043
   Foynes MM, 2013, CULT DIVERS ETHN MIN, V19, P111, DOI 10.1037/a0030567
   Gallagher RW, 2015, NURS EDUC TODAY, V35, P333, DOI 10.1016/j.nedt.2014.10.021
   Hammond WP, 2012, AM J PUBLIC HEALTH, V102, pS232, DOI 10.2105/AJPH.2011.300485
   Hammond WP, 2010, J GEN INTERN MED, V25, P1300, DOI 10.1007/s11606-010-1481-z
   Hammond WP, 2010, AM J COMMUN PSYCHOL, V45, P87, DOI 10.1007/s10464-009-9280-6
   Harnois CE, 2011, ETHNIC RACIAL STUD, V34, P1006, DOI 10.1080/01419870.2010.516836
   Hausmann LRM, 2010, ETHNIC DIS, V20, P40
   Hawkins J, 2017, AM J MENS HEALTH, V11, P344, DOI 10.1177/1557988316681125
   Haywood C, 2014, J PAIN SYMPTOM MANAG, V48, P934, DOI 10.1016/j.jpainsymman.2014.02.002
   Haywood C, 2014, J GEN INTERN MED, V29, P1657, DOI 10.1007/s11606-014-2986-7
   Himmelstein MS, 2015, PSYCHOL HEALTH, V30, P253, DOI 10.1080/08870446.2014.966104
   Honora DT, 2002, ADOLESCENCE, V37, P301
   Horvat L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009405.pub2
   Hudson DL, 2012, J MENS HEALTH, V9, P127, DOI 10.1016/j.jomh.2012.03.006
   Infatunji M., 2016, SOCIOL RACE ETHN, V2, P263, DOI [10.1177/2332649215613532, DOI 10.1177/2332649215613532]
   Jackson J. S, 1995, ETHNIC DIS, V6, P132
   Jackson JS, 2010, AM J PUBLIC HEALTH, V100, P933, DOI 10.2105/AJPH.2008.143446
   Kelly MM, 2008, DEPRESS ANXIETY, V25, P839, DOI 10.1002/da.20341
   Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349
   Krieger N, 1996, AM J PUBLIC HEALTH, V86, P1370, DOI 10.2105/AJPH.86.10.1370
   KRIEGER N, 1990, SOC SCI MED, V30, P1273, DOI 10.1016/0277-9536(90)90307-E
   Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544
   Landrine H., 1996, J BLACK PSYCHOL, V22, P144, DOI DOI 10.1177/00957984960222002
   Lie DA, 2011, J GEN INTERN MED, V26, P317, DOI 10.1007/s11606-010-1529-0
   Mayor E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00779
   McLaughlin KA, 2010, AM J PUBLIC HEALTH, V100, P1477, DOI 10.2105/AJPH.2009.181586
   Mezuk B, 2013, SOC MENT HEALTH, V3, P79, DOI 10.1177/2156869313480892
   Nam C., 1983, SOCIOECONOMIC APPROA
   Neblett EW, 2016, COGN BEHAV PRACT, V23, P385, DOI 10.1016/j.cbpra.2016.05.002
   Noguera PA, 2003, URBAN EDUC, V38, P431, DOI 10.1177/0042085903254969
   Odom EC, 2010, J MARRIAGE FAM, V72, P346, DOI 10.1111/j.1741-3737.2010.00704.x
   Ong AD, 2009, J PERS SOC PSYCHOL, V96, P1259, DOI 10.1037/a0015335
   Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059
   Peek ME, 2011, MED CARE, V49, P618, DOI 10.1097/MLR.0b013e318215d925
   Piette JD, 2006, PATIENT EDUC COUNS, V60, P41, DOI 10.1016/j.pec.2004.12.001
   Roderick M, 2003, URBAN EDUC, V38, P538, DOI 10.1177/0042085903256221
   Ryan AM, 2008, J HEALTH CARE POOR U, V19, P149, DOI 10.1353/hpu.2008.0005
   Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933
   Schulz AJ, 2006, AM J PUBLIC HEALTH, V96, P1265, DOI 10.2105/AJPH.2005.064543
   Seaton EK, 2011, CHILD DEV, V82, P1850, DOI 10.1111/j.1467-8624.2011.01651.x
   Sellers RM, 2006, J RES ADOLESCENCE, V16, P187, DOI 10.1111/j.1532-7795.2006.00128.x
   Sellers RM, 2003, J HEALTH SOC BEHAV, V44, P302, DOI 10.2307/1519781
   Sellers RM, 2003, J PERS SOC PSYCHOL, V84, P1079, DOI 10.1037/0022-3514.84.5.1079
   SIMPSON AW, 1983, AM EDUC RES J, V20, P183, DOI 10.2307/1162593
   Singh-Manoux A, 2006, J EPIDEMIOL COMMUN H, V60, P364, DOI 10.1136/jech.2005.039883
   Slaughter-Acey JC, 2013, WOMEN HEALTH ISS, V23, pE381, DOI 10.1016/j.whi.2013.08.001
   Smalls C, 2007, J BLACK PSYCHOL, V33, P299, DOI 10.1177/0095798407302541
   Swanson DP, 2003, URBAN EDUC, V38, P608, DOI 10.1177/0042085903256218
   Thomas A., 2016, J MEN STUD, V24, P185, DOI DOI 10.1177/1060826516641104
   Torres L, 2010, CULT DIVERS ETHN MIN, V16, P561, DOI 10.1037/a0020652
   Trivedi AN, 2006, J GEN INTERN MED, V21, P553, DOI 10.1111/j.1525-1497.2006.00413.x
   Utsey SO, 2008, J COUNS PSYCHOL, V55, P49, DOI 10.1037/0022-0167.55.1.49
   Varner F, 2013, CHILD DEV, V84, P875, DOI 10.1111/cdev.12021
   Wagner J, 2007, DIABETES CARE, V30, P364, DOI 10.2337/dc06-1756
   Walker RL, 2014, SUICIDE LIFE-THREAT, V44, P548, DOI 10.1111/sltb.12089
   Wang JJ, 2013, INT J PALLIAT NURS, V19, P347, DOI 10.12968/ijpn.2013.19.7.347
   Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0
   Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200
NR 96
TC 4
Z9 4
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD SEP 12
PY 2017
VL 5
AR UNSP 235
DI 10.3389/fpubh.2017.00235
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FH2ME
UT WOS:000410972700001
PM 28955703
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Lin, KK
   Park, C
   Li, MZ
   Wang, XD
   Li, XS
   Li, W
   Quinn, L
AF Lin, Keke
   Park, Chang
   Li, Mingzi
   Wang, Xiudong
   Li, Xiushu
   Li, Wei
   Quinn, Laurie
TI Effects of depression, diabetes distress, diabetes self-efficacy, and
   diabetes self-management on glycemic control among Chinese population
   with type 2 diabetes mellitus
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Glycemic control; Diabetes self-management; Diabetes
   self-efficacy; Depression; Diabetes distress
ID SOCIAL DETERMINANTS; HEALTH; ADULTS; CARE; VALIDATION; ADHERENCE;
   OUTCOMES; WOMEN
AB Aim: To examine the direct and indirect effects of depression, diabetes distress, diabetes self-efficacy and diabetes self-management on glycemic control among a group of T2DM patients in China.
   Method: A convenience sample of 254 participants were selected from three outpatient departments in Beijing, China. They were surveyed using a self-administered questionnaire. Diabetes-related information was retrieved from their medical records. Descriptive statistics, independent student t tests, Chi-square tests, correlation analyses and Generalized Structural Equation Modeling were used.
   Results: Only 91 (35.82%) participants achieved optimal glycemic control of HbA1c < 7.0% (53 mmol/mol). Only diabetes self-management had a direct effect on glycemic control (OR = 0.95, P < 0.001). Depression and diabetes distress had only indirect effects on glycemic control through both diabetes self-efficacy and diabetes self-management. Diabetes selfefficacy only had an indirect effect on glycemic control through diabetes self-management.
   Conclusions: Glycemic control among Chinese population with T2DM was suboptimal. Future interventions should focus on decreasing depressive symptoms and diabetes distress levels, and, therefore, improve diabetes self-efficacy and self-management practices and, ultimately, reach the optimal goal of glycemic control. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Lin, Keke; Park, Chang; Quinn, Laurie] Univ Illinois, Coll Nursing, Chicago, IL USA.
   [Lin, Keke; Li, Mingzi] Peking Univ, Hlth Sci Ctr, Sch Nursing, 38 Xueyuan Rd, Beijing 100191, Peoples R China.
   [Wang, Xiudong] Beijing Jingmei Grp Gen Hosp, Dept Endocrinol, Beijing, Peoples R China.
   [Li, Xiushu] Peking Univ, Peoples Hosp, Emergency Room, Beijing, Peoples R China.
   [Li, Wei] Peking Univ, Dept Endocrinol, Hosp 1, Beijing, Peoples R China.
RP Li, MZ (reprint author), Peking Univ, Hlth Sci Ctr, Sch Nursing, 38 Xueyuan Rd, Beijing 100191, Peoples R China.
EM limingzi@bjmu.edu.cn
CR Ahmad NS, 2014, J DIABETES INVEST, V5, P563, DOI 10.1111/jdi.12175
   Al-Khawaldeh OA, 2012, J DIABETES COMPLICAT, V26, P10, DOI 10.1016/j.jdiacomp.2011.11.002
   American Diabetes Association, STAND MED CAR DIAB 2
   Asuzu CC, 2016, J DIABETES COMPLICAT
   Chen R, 2015, MED SCI MONITOR, V21, P1440, DOI 10.12659/MSM.892246
   Ciccone MM, 2010, VASC HEALTH RISK MAN, V6, P297
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Cosansu G, 2014, J TRANSCULT NURS, V25, P51, DOI 10.1177/1043659613504112
   Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gao JL, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-66
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Guo XH, 2012, CHINESE MED J-PEKING, V125, P4175, DOI 10.3760/cma.j.issn.0366-6999.2012.23.003
   International Diabetes Federation, IDF DIABETES ATLAS
   [嵇加佳 Ji Jiajia], 2014, [中华护理杂志, Chinese Journal of Nursing], V49, P617
   Ji LN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-602
   Li MZ., 2012, STUDY APPL DEPRESSIO
   Liu Ming, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P782
   Lu JM, 2014, PATIENT PREFER ADHER, V8, P1161, DOI 10.2147/PPA.S66915
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Qteishat RR, 2015, DIABETES METABOL SYN
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Shiu ATY, 2003, DIABETES CARE, V26, P2817, DOI 10.2337/diacare.26.10.2817
   [孙胜男 Sun Shengnan], 2011, [中华护理杂志, Chinese Journal of Nursing], V46, P229
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Turner RC, 1998, LANCET, V352, P837
   Walker RJ, 2015, DIABETES RES CLIN PR, V110, P193, DOI 10.1016/j.diabres.2015.09.007
   Walker RJ, 2015, DIABETES TECHNOL THE, V17, P80, DOI 10.1089/dia.2014.0166
   Walker RJ, 2014, GEN HOSP PSYCHIAT, V36, P662, DOI 10.1016/j.genhosppsych.2014.06.011
   Walker RJ, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-82
   Xu Y, 2008, RES NURS HEALTH, V31, P613, DOI 10.1002/nur.20293
   Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118
   Yeung A, 2008, COMPR PSYCHIAT, V49, P211, DOI 10.1016/j.comppsych.2006.06.002
NR 36
TC 2
Z9 3
U1 2
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2017
VL 131
BP 179
EP 186
DI 10.1016/j.diabres.2017.03.013
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FM6VC
UT WOS:000415197900020
PM 28756132
DA 2019-01-08
ER

PT J
AU Massetti, GM
   Thomas, CC
   King, J
   Ragan, K
   Lunsford, NB
AF Massetti, Greta M.
   Thomas, Cheryll C.
   King, Jessica
   Ragan, Kathleen
   Lunsford, Natasha Buchanan
TI Mental Health Problems and Cancer Risk Factors Among Young Adults
SO AMERICAN JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Article
ID SERVICES TASK-FORCE; PHYSICAL HEALTH; CERVICAL-CANCER; UNITED-STATES;
   ILLNESS; METAANALYSIS; DEPRESSION; DISORDERS; MORTALITY; SYMPTOMS
AB Introduction: Chronic mental health problems often emerge in young adulthood, when adults begin to develop lifelong health behaviors and access preventive health services. The associations between mental health problems and modifiable cancer risk factors in young adulthood are not well understood.
   Methods: In 2016, the authors analyzed 2014 Behavioral Risk Factor Surveillance System data on demographic characteristics, health service access and use, health status, and cancer risk factors (tobacco use, alcohol use, overweight or obesity, physical activity, and sleep) for 90,821 young adults aged 18-39 years with mental health problems (depressive disorder or frequent mental distress) compared to other young adults.
   Results: Mental health problems were associated with white race; less than a high school education; lower income; being out of work or unable to work; being uninsured (for men only); poor health; previous diagnosis of asthma, skin cancer, or diabetes; and not having a recent checkup. After controlling for demographic characteristics, health service use, and health status, mental health problems among young adults were associated with smoking, binge drinking, inadequate sleep, having no leisure time physical activity, and being overweight or obese (among women only). Cervical cancer screening was not associated with mental health problems after controlling for demographic characteristics, health service use, and health status.
   Conclusions: Mental health problems in young adulthood were associated with potentially modifiable factors and behaviors that increase risk for cancer. Efforts to prevent cancer and promote health must attend to mental health disparities to meet the needs of young adults. Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.
C1 [Massetti, Greta M.; Thomas, Cheryll C.; King, Jessica; Ragan, Kathleen; Lunsford, Natasha Buchanan] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway,NE MS F-76, Atlanta, GA 30341 USA.
RP Massetti, GM (reprint author), Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway,NE MS F-76, Atlanta, GA 30341 USA.
EM gmassetti@cdc.gov
FU U.S. Centers for Disease Control and Prevention (CDC), an Agency of the
   U.S. Department of Health and Human Services [200-2017-M-94637]
FX Publication of this article was supported by the U.S. Centers for
   Disease Control and Prevention (CDC), an Agency of the U.S. Department
   of Health and Human Services, under contract number: 200-2017-M-94637.
   The findings and conclusions in this article are those of the authors
   and do not necessarily represent the official position of CDC. n.
CR BEEKMAN ATF, 1995, SOC PSYCH PSYCH EPID, V30, P32, DOI 10.1007/BF00784432
   Brown DW, 2003, J OCCUP ENVIRON MED, V45, P1159, DOI 10.1097/01.jom.0000094994.09.655.0f
   Center for Behavioral Health Statistics and Quality, HHS PUBL
   Charara R, 2016, PREV MED, V89, P292, DOI 10.1016/j.ypmed.2016.06.011
   Chesher NJ, 2012, AM J ADDICTION, V21, P1, DOI 10.1111/j.1521-0391.2011.00196.x
   Clarke TC, 2015, EARLY RELEASE SELECT
   Eaton WW, 1997, ARCH GEN PSYCHIAT, V54, P993
   Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x
   Gardner MJ, BR MED J CLIN RES ED, P746
   Gfroerer J, 2013, MMWR-MORBID MORTAL W, V62, P81
   Lando James, 2006, Prev Chronic Dis, V3, pA61
   Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37
   Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424
   National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE, P458
   O'Connor E, 2016, JAMA-J AM MED ASSOC, V315, P388, DOI 10.1001/jama.2015.18948
   Office of Disease Prevention and Health Promotion, HLTH PEOPL 2020
   Robson D, 2007, INT J NURS STUD, V44, P457, DOI 10.1016/j.ijnurstu.2006.07.013
   Schottenfeld D., 2006, CANC EPIDEMIOLOGY PR
   Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392
   Stanley SL, 2014, J COMMUN HEALTH, V39, P400, DOI 10.1007/s10900-013-9778-6
   Vanhoof JMM, 2014, J HEART LUNG TRANSPL, V33, P800, DOI 10.1016/j.healun.2014.04.003
   Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502
NR 22
TC 2
Z9 2
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0749-3797
EI 1873-2607
J9 AM J PREV MED
JI Am. J. Prev. Med.
PD SEP
PY 2017
VL 53
IS 3
SU 1
SI SI
BP S30
EP S39
DI 10.1016/j.amepre.2017.04.023
PG 10
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA FM6TN
UT WOS:000415192400005
PM 28818243
OA Other Gold
DA 2019-01-08
ER

PT J
AU Trump, LJ
   Mendenhall, TJ
AF Trump, Lisa J.
   Mendenhall, Tai J.
TI Community Health Workers in Diabetes Care: A Systematic Review of
   Randomized Controlled Trials
SO FAMILIES SYSTEMS & HEALTH
LA English
DT Review
DE chronic illness; community health workers; diabetes; type II diabetes
ID AFRICAN-AMERICAN ADULTS; SELF-MANAGEMENT; MEXICAN-AMERICANS; GLYCEMIC
   CONTROL; SOCIAL SUPPORT; INTERVENTION; LATINOS; EDUCATION; OUTCOMES;
   PROGRAM
AB Introduction: Maintaining optimal self-care in managing Type 2 diabetes is a common struggle for patients due to several barriers, including access to quality services, financial insecurity and/or lack of insurance, and emotional distress. Consequently, morbidity and mortality rates are high, alongside rising health care costs. Alternative approaches that address common barriers require further investigation. This systematic review of randomized controlled trials examines the effectiveness of using community health workers (CHWs) in Type 2 diabetes care. This effort is warranted to orient practitioners and researchers to the state of existing knowledge, and to direct clinical practice and future research. Method: Data were extracted from 17 peer-reviewed articles; they were examined with respect to theory integration, CHW intervention design, outcome variables, and findings. Results: Approximately one-third of articles explicitly integrated theory into their research conceptualization and design. There was great variation across intervention dosages, attrition rates, and methods of CHW training. Main foci across studies' findings suggest that a CHW intervention has significant impacts on physical health outcomes, diabetes knowledge, self-care behaviors, and emotional distress and well-being. Discussion: Principal implications relate to the need for more research regarding CHW intervention types and methods, and further investigation about the mechanisms of change within a CHW-delivered intervention. Findings support the case for more CHWs in treatment teams to bridge patients with the medical system. This research will serve to better equip providers in the support of patients managing Type 2 diabetes and advance the Triple Aim of health care.
C1 [Trump, Lisa J.; Mendenhall, Tai J.] Univ Minnesota, Dept Family Social Sci, 1985 Buford Ave,290 McNeal Hall, St Paul, MN 55108 USA.
RP Trump, LJ (reprint author), Univ Minnesota, Dept Family Social Sci, 1985 Buford Ave,290 McNeal Hall, St Paul, MN 55108 USA.
EM buch0245@umn.edu; mend0009@umn.edu
CR Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829
   Anderson R. M., 2005, ART EMPOWERMENT STOR
   Babamoto KS, 2009, HEALTH EDUC BEHAV, V36, P113, DOI 10.1177/1090198108325911
   Bandura A, 2001, MEDIA PSYCHOL, V3, P265, DOI 10.1207/S1532785XMEP0303_03
   Batts ML, 2001, DIABETES EDUCATOR, V27, P405, DOI 10.1177/014572170102700310
   Bureau of Labor Statistics, 2015, OCC EMPL STAT
   Carolan-Olah MC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-447
   Corkery E, 1997, DIABETES CARE, V20, P254, DOI 10.2337/diacare.20.3.254
   Dumville JC, 2006, BMJ-BRIT MED J, V332, P969, DOI 10.1136/bmj.332.7547.969
   Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316
   Gary TL, 2003, PREV MED, V37, P23, DOI 10.1016/S0091-7435(03)00040-9
   GREEN LW, 1991, HLTH PROMOTION PLANN, P22
   Heisler M, 2014, ANN INTERN MED, V161, pS13, DOI 10.7326/M13-3012
   Katon WJ, 2013, J PSYCHOSOM RES, V74, P533, DOI 10.1016/j.jpsychores.2013.04.005
   Kelly M, 2010, FAM PRACT, V27, P285, DOI 10.1093/fampra/cmp077
   Kenya S, 2014, CLIN THER, V36, P485, DOI 10.1016/j.clinthera.2013.12.009
   Kollannoor-Samuel G, 2016, AM J PUBLIC HEALTH, V106, P1059, DOI 10.2105/AJPH.2016.303091
   Little TV, 2012, CURR DIABETES REP, V14, P558, DOI 10.1007/s11892-014-0558-1
   Lyles CM, 2007, AM J PUBLIC HEALTH, V97, P133, DOI 10.2105/AJPH.2005.076182
   Mayo Foundation for Medical Education and Research, 2016, TEST ID HBA1C HEM AL
   McDermott RA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0695-5
   McEwen MM, 2010, PUBLIC HEALTH NURS, V27, P310, DOI 10.1111/j.1525-1446.2010.00860.x
   Miller W. R., 1991, MOTIVATIONAL INTERVI
   National Institute of Mental Health, 2011, DEPRESSION DIABETES
   Navaneethan SD, 2010, NEPHROLOGY, V15, P732, DOI 10.1111/j.1440-1797.2010.01428.x
   Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x
   Palmas W, 2014, DIABETES CARE, V37, P963, DOI 10.2337/dc13-2142
   Perez-Escamilla R, 2015, DIABETES CARE, V38, P197, DOI 10.2337/dc14-0327
   Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354
   Prezio EA, 2013, DIABETES RES CLIN PR, V100, P19, DOI 10.1016/j.diabres.2013.01.027
   Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38
   PROCHASKA JO, 2002, HLTH BEHAV HLTH ED T
   Rosen L, 2006, AM J PUBLIC HEALTH, V96, P1181, DOI 10.2105/AJPH.2004.061713
   Rothschild SK, 2014, AM J PUBLIC HEALTH, V104, P1540, DOI 10.2105/AJPH.2013.301439
   Santos-Longhurst A., 2014, TYPE 2 DIABETES STAT
   Spencer Michael S, 2013, Race Soc Probl, V5, P137
   Spencer MS, 2011, AM J PUBLIC HEALTH, V101, P2253, DOI 10.2105/AJPH.2010.300106
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   Tang TS, 2014, DIABETES CARE, V37, P1525, DOI 10.2337/dc13-2161
   Wagner J, 2015, TRANSL BEHAV MED, V5, P415, DOI 10.1007/s13142-015-0332-1
   Wagner JA, 2016, DIABETES RES CLIN PR, V120, P162, DOI 10.1016/j.diabres.2016.07.022
   Whittemore R, 2005, J CLIN NURS, V14, P195, DOI 10.1111/j.1365-2702.2004.00937.x
   Zgibor JC, 2001, DIABETES SPECTRUM, V14, P23, DOI DOI 10.2337/DIASPECT.14.1.23
NR 43
TC 3
Z9 3
U1 1
U2 1
PU EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA
SN 1091-7527
EI 1939-0602
J9 FAM SYST HEALTH
JI Fam. Syst. Health
PD SEP
PY 2017
VL 35
IS 3
BP 320
EP 340
DI 10.1037/fsh0000283
PG 21
WC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
SC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
GA FK9LW
UT WOS:000413833700007
PM 28639794
DA 2019-01-08
ER

PT J
AU Yi-Frazier, JP
   Fladeboe, K
   Klein, V
   Eaton, L
   Wharton, C
   McCauley, E
   Rosenberg, AR
AF Yi-Frazier, Joyce P.
   Fladeboe, Kaitlyn
   Klein, Victoria
   Eaton, Lauren
   Wharton, Claire
   McCauley, Elizabeth
   Rosenberg, Abby R.
TI Promoting Resilience in Stress Management for Parents (PRISM-P): An
   Intervention for Caregivers of Youth With Serious Illness
SO FAMILIES SYSTEMS & HEALTH
LA English
DT Article
DE caregiver stress; resilience; Type 1 diabetes; cancer
ID RANDOMIZED CONTROLLED-TRIALS; FAMILY RESILIENCE; MENTAL-HEALTH;
   GENERAL-POPULATION; PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL CARE; PEDIATRIC
   CANCER; YOUNG-ADULTS; CHILDREN; SCALE
AB Introduction: It is well-known that parental stress and coping impacts the well-being of children with serious illness. The current study aimed to evaluate the feasibility and satisfaction of a novel resilience promoting intervention, the Promoting Resilience in Stress Management Intervention for Parents (PRISM-P) among parents of adolescents and young adults with Type 1 diabetes or cancer. Secondary analyses explored the effect of the PRISM-P on parent-reported resilience and distress. Method: The PRISM-P includes 4 short skills-based modules, delivered in either 2 or 4 separate, individual sessions. English-speaking parents of adolescents with cancer or Type 1 diabetes were eligible. Feasibility was conservatively defined as a completion rate of 80%; satisfaction was qualitatively evaluated based upon parent feedback regarding intervention content, timing, and format. Resilience and distress were assessed pre- and postintervention with the Connor Davidson Resilience Scale and the Kessler-6 Psychological Distress Scale. Results: Twelve of 24 caregivers of youth with diabetes (50%) and 13 of 15 caregivers of youth with cancer (87%) agreed to participate. Nine of 12 (75%) and 9 of 13 (64%) completed all PRISM-P modules, respectively. Among those who completed the intervention, qualitative satisfaction was high. Parent-reported resilience and distress scores improved after the intervention. Effect sizes for both groups indicated a moderate intervention effect. Discussion: Ultimately, the PRISM-P intervention was well accepted and impactful among parents who completed it. However, attrition rates were higher than anticipated, suggesting alternative or less time-intensive formats may be more feasible.
C1 [Yi-Frazier, Joyce P.; Fladeboe, Kaitlyn; Klein, Victoria; Eaton, Lauren; Wharton, Claire; Rosenberg, Abby R.] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA USA.
   [McCauley, Elizabeth] Seattle Childrens Res Inst, Ctr Child Hlth & Behav, Seattle, WA USA.
   [McCauley, Elizabeth; Rosenberg, Abby R.] Univ Washington, Sch Med, Dept Psychiat & Behav Med, Seattle, WA 98195 USA.
   [Rosenberg, Abby R.] Univ Washington, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Seattle, WA 98195 USA.
RP Rosenberg, AR (reprint author), Seattle Childrens Hosp Canc & Blood Disorders Ctr, 4800 Sand Point Way NE,M-S MB 8-501, Seattle, WA 98115 USA.
EM abby.rosenberg@seattlechildrens.org
FU Seattle Children's Hospital's Center for Clinical and Translational
   Research (Pilot Grant Program); National Institutes of Health Center for
   Translational Science of the University of Washington Institute of
   Translational Health Science [UL1 TR000423]; St. Baldrick's Foundation;
   CureSearch for Children's Cancer; National Center for Advancing
   Translational Sciences of the National Institutes of Health
   [KL2TR000421]
FX This research was supported by Seattle Children's Hospital's Center for
   Clinical and Translational Research (Pilot Grant Program to Joyce P.
   Yi-Frazier and Abby R. Rosenberg) and in part by the National Institutes
   of Health Center for Translational Science Awards Grant UL1 TR000423 of
   the University of Washington Institute of Translational Health Science.
   In addition, Abby R. Rosenberg was supported by the St. Baldrick's
   Foundation, CureSearch for Children's Cancer, and the National Center
   for Advancing Translational Sciences of the National Institutes of
   Health (KL2TR000421).
CR Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058
   Bradshaw BG, 2007, DIABETES EDUCATOR, V33, P650, DOI 10.1177/0145721707303809
   Bruwer B, 2008, COMPR PSYCHIAT, V49, P195, DOI 10.1016/j.comppsych.2007.09.002
   Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001
   Carver CS, 2005, CANCER, V104, P2602, DOI 10.1002/cncr.21247
   Connor KM, 2007, PSYCHIAT RES, V151, P249, DOI 10.1016/j.psychres.2006.11.008
   Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113
   Davidson J. R., 2006, US PSYCH MENT HLTH C
   Eilertsen ME, 2016, ACTA PAEDIATR, V105, pE30, DOI 10.1111/apa.13232
   Ewald H, 2014, J PUBLIC HEALTH-UK, V36, P476, DOI 10.1093/pubmed/fdt108
   Fergus S, 2005, ANNU REV PUBL HEALTH, V26, P399, DOI 10.1146/annurev.publhealth.26.021304.144357
   Fisher L, 2000, J FAM PRACTICE, V49, P561
   Fjorback LO, 2011, ACTA PSYCHIAT SCAND, V124, P102, DOI 10.1111/j.1600-0447.2011.01704.x
   Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3
   Folkman S, 2000, PSYCHO-ONCOL, V9, P11, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<11::AID-PON424>3.3.CO;2-Q
   Fraser E, 2009, PSYCHOL HEALTH MED, V14, P573, DOI 10.1080/13548500903193820
   Green JG, 2010, INT J METH PSYCH RES, V19, P23, DOI 10.1002/mpr.314
   Henry M, 2010, PSYCHO-ONCOLOGY, V19, P1340, DOI 10.1002/pon.1764
   Hilliard ME, 2015, J PEDIATR PSYCHOL, V40, P835, DOI 10.1093/jpepsy/jsv072
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   IBM Corp, 2010, IBM SPSS STAT WIND V
   Jacobsen PB, 2012, J CLIN ONCOL, V30, P1151, DOI 10.1200/JCO.2011.41.4078
   Jang M, 2015, J PEDIATR NURS, V30, P877, DOI 10.1016/j.pedn.2015.05.004
   Karlson CW, 2009, J PEDIATR PSYCHOL, V34, P782, DOI 10.1093/jpepsy/jsn122
   Kazak AE, 2015, ACTA ONCOL, V54, P574, DOI 10.3109/0284186X.2014.995774
   Kearney JA, 2015, PEDIATR BLOOD CANCER, V62, pS632, DOI 10.1002/pbc.25761
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310
   Kim S., 2016, J APPL GERONTOLOGY
   Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P682, DOI 10.1097/01-chi.0000161645.98022.35
   Landolt MA, 2002, J PEDIATR PSYCHOL, V27, P647, DOI 10.1093/jpepsy/27.7.647
   Lyon ME, 2009, PEDIATRICS, V123, pE199, DOI 10.1542/peds.2008-2379
   McCarty C. A., 2011, DEPRESSION RES TREAT
   McMillan Susan C, 2003, Oncol Nurs Forum, V30, P123, DOI 10.1188/03.ONF.123-129
   Miller KA, 2017, PEDIATR BLOOD CANCER, V64, P358, DOI 10.1002/pbc.26209
   PERRIN EC, 1993, J DEV BEHAV PEDIATR, V14, P94
   Rew Lynn, 2003, J Pediatr Nurs, V18, P379, DOI 10.1016/S0882-5963(03)00162-3
   Robinson KE, 2007, J PEDIATR PSYCHOL, V32, P400, DOI 10.1093/jpepsy/Jsl038
   Rohan JM, 2015, J PEDIATR PSYCHOL, V40, P956, DOI 10.1093/jpepsy/jsv061
   Rosenberg AR, 2016, J PEDIATR PSYCHOL, V41, P506, DOI 10.1093/jpepsy/jsw018
   Rosenberg AR, 2015, J PEDIATR PSYCHOL, V40, P992, DOI 10.1093/jpepsy/jsv004
   Rosenberg AR, 2014, PEDIATR BLOOD CANCER, V61, P552, DOI 10.1002/pbc.24854
   Rosenberg AR, 2013, JAMA PEDIATR, V167, P537, DOI 10.1001/jamapediatrics.2013.628
   Sahler OJZ, 2013, J CLIN ONCOL, V31, P1329, DOI 10.1200/JCO.2011.39.1870
   Saltzman WR, 2016, FAM PROCESS, V55, P647, DOI 10.1111/famp.12250
   Saltzman WR, 2016, FAM PROCESS, V55, P633, DOI 10.1111/famp.12238
   Sottile PD, 2016, CRIT CARE MED, V44, pE721, DOI 10.1097/CCM.0000000000001673
   Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338
   Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942
   Svoren BM, 2003, PEDIATRICS, V112, P914, DOI 10.1542/peds.112.4.914
   Tan L, 2013, CLIN CHILD PSYCHOL P, V18, P300, DOI 10.1177/1359104512455182
   Van Schoors M, 2015, J PEDIATR PSYCHOL, V40, P856, DOI 10.1093/jpepsy/jsv055
   Walsh F, 2003, FAM PROCESS, V42, P1, DOI 10.1111/j.1545-5300.2003.00001.x
   Walsh F, 2016, STRENGTHENING FAMILY
NR 55
TC 4
Z9 4
U1 1
U2 13
PU EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA
SN 1091-7527
EI 1939-0602
J9 FAM SYST HEALTH
JI Fam. Syst. Health
PD SEP
PY 2017
VL 35
IS 3
BP 341
EP 351
DI 10.1037/fsh0000281
PG 11
WC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
SC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
GA FK9LW
UT WOS:000413833700008
PM 28541057
DA 2019-01-08
ER

PT J
AU Walls, ML
   Sittner, KJ
   Aronson, BD
   Forsberg, AK
   Whitbeck, LB
   al'Absi, M
AF Walls, Melissa L.
   Sittner, Kelley J.
   Aronson, Benjamin D.
   Forsberg, Angie K.
   Whitbeck, Les B.
   al'Absi, Mustafa
TI Stress Exposure and Physical, Mental, and Behavioral Health among
   American Indian Adults with Type 2 Diabetes
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE American Indian; diabetes; stress; Native American
ID COMORBIDITY SURVEY REPLICATION; DSM-IV DISORDERS; SCALE; LIFE;
   PREVALENCE; DISTRESS; NONADHERENCE; DEPRESSION; EVENTS; CARE
AB American Indian ( AI) communities experience disproportionate exposure to stressors and health inequities including type 2 diabetes. Yet, we know little about the role of psychosocial stressors for AI diabetes-related health outcomes. We investigated associations between a range of stressors and psychological, behavioral, and physical health for AIs with diabetes. This community-based participatory research with 5 AI tribes includes 192 AI adult type 2 diabetes patients recruited from clinical records at tribal clinics. Data are from computer-assisted interviews and medical charts. We found consistent bivariate relationships between chronic to discrete stressors and mental and behavioral health outcomes; several remained even after accounting for participant age, gender, and income. Fewer stressors were linked to physical health. We also document a dose-response relationship between stress accumulation and worse health. Findings underscore the importance of considering a broad range of stressors for comprehensive assessment of stress burden and diabetes. Policies and practices aimed at reducing stress exposure and promoting tools for stress management may be mechanisms for optimal health for AI diabetes patients.
C1 [Walls, Melissa L.; Forsberg, Angie K.; al'Absi, Mustafa] Univ Minnesota, Sch Med, Dept Family Med & Biobehav Hlth, Duluth Campus,1035 Univ Dr,235 SMed, Duluth, MN 55812 USA.
   [Sittner, Kelley J.] Oklahoma State Univ, Dept Sociol, Stillwater, OK 74078 USA.
   [Aronson, Benjamin D.] Ohio Northern Univ, Dept Pharm Practice, Ada, OH 45810 USA.
   [Whitbeck, Les B.] Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA.
RP Walls, ML (reprint author), Univ Minnesota, Sch Med, Dept Family Med & Biobehav Hlth, Duluth Campus,1035 Univ Dr,235 SMed, Duluth, MN 55812 USA.
EM mlwalls@d.umn.edu; kelley.sittner@okstate.edu; b-aronson.1@onu.edu;
   aforsber@d.umn.edu; lwhitbeck2@unl.edu; malabsi@d.umn.edu
OI Aronson, Benjamin/0000-0001-9739-6221
FU National Institute of Diabetes and Digestive and Kidney Diseases of the
   National Institutes of Health [DK091250]
FX We gratefully acknowledge the dedicated Community Research Council and
   Clinical Project Members of the Gathering for Health team: Sidnee
   Kellar, Rose Barber, Robert Miller, Tweed Shuman, Lorraine Smith, Sandy
   Zeznanski, Patty Subera, Tracy Martin, Geraldine Whiteman, Lisa Perry,
   Trisha Prentice, Alexis Mason, Charity Prentice-Pemberton, Kathy Dudley,
   Romona Nelson, Eileen Miller, Geraldine Brun, Murphy Thomas, Mary
   Sikora-Petersen, Tina Handeland, GayeAnn Allen, Frances Whitfield,
   Phillip Chapman, Sr., Hope Williams, Betty Jo Graveen, Daniel Chapman,
   Jr., Doris Isham, Stan Day, Jane Villebrun, Beverly Steel, Muriel
   Deegan, Peggy Connor, Michael Connor, Ray E. Villebrun, Sr., Pam Hughes,
   Cindy McDougall, Melanie McMichael, Robert Thompson, and Sandra Kier.
   Research reported in this manuscript is supported by the National
   Institute of Diabetes and Digestive and Kidney Diseases of the National
   Institutes of Health under Award Number DK091250 (M. Walls, PI). The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Acton KJ, 2003, JAMA-J AM MED ASSOC, V290, P1571
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Benyshek D C, 2001, Med Anthropol, V20, P25
   Chae DH, 2009, AM J PUBLIC HEALTH, V99, pS144, DOI 10.2105/AJPH.2007.126003
   de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026
   DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536
   Egede LE, 2014, ANN PHARMACOTHER, V48, P562, DOI 10.1177/1060028014526362
   Elm J., 2017, SOURCES STR IN PRESS
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hill DL, 2006, ARCH PSYCHIAT NURS, V20, P210, DOI 10.1016/j.apnu.2006.04.003
   HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4
   Jiang LH, 2008, DIABETES CARE, V31, P427, DOI 10.2337/dc07-2044
   Kahn JR, 2006, J HEALTH SOC BEHAV, V47, P17, DOI 10.1177/002214650604700102
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   KOHN PM, 1992, J BEHAV MED, V15, P221, DOI 10.1007/BF00848327
   LEE ET, 1992, DIABETES CARE, V15, P1620, DOI 10.2337/diacare.15.11.1620
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   O'Connell J, 2010, DIABETES CARE, V33, P1463, DOI 10.2337/dc09-1652
   PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676
   Pearlin LI, 1997, J HEALTH SOC BEHAV, V38, P223, DOI 10.2307/2955368
   Scarton L.J., 2016, HEALTH EDUC BEHAV, V44, P70
   Shields CG, 1994, FAM SYST MED, V12, P361, DOI [10. 1037/h0089289, DOI 10.1037/H0089289]
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   STAHN RM, 1993, DIABETES CARE, V16, P244, DOI 10.2337/diacare.16.1.244
   Sue DW, 2007, AM PSYCHOL, V62, P271, DOI 10.1037/0003-066X.62.4.271
   SURWIT RS, 1992, DIABETES CARE, V15, P1413, DOI 10.2337/diacare.15.10.1413
   Tiedt J.A., 2014, J THEORY CONSTR TEST, V18, P22
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   TOOBERT DJ, 1994, HDB PSYCHOL DIABETES, P351
   Turner J., 2009, UNDERSTANDING HLTH D, P3
   Turner RJ, 2003, J HEALTH SOC BEHAV, V44, P488, DOI 10.2307/1519795
   TURNER RJ, 1995, AM SOCIOL REV, V60, P104, DOI 10.2307/2096348
   Walders-Abramson N, 2014, J PEDIATR-US, V165, P504, DOI 10.1016/j.jpeds.2014.05.020
   Walters KL, 2002, AM J PUBLIC HEALTH, V92, P520, DOI 10.2105/AJPH.92.4.520
   Wheaton B., 1999, HDB STUDY MENTAL HLT, P171
   Wheaton B., 1994, STRESS MENTAL HLTH C, P77, DOI DOI 10.1007/978-1-4899-1106-3
   Xu J, 2016, NATL VITAL STAT REP, V64, P2
NR 41
TC 0
Z9 0
U1 3
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD SEP
PY 2017
VL 14
IS 9
AR 1074
DI 10.3390/ijerph14091074
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FH9YO
UT WOS:000411574400126
PM 28926940
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Darawad, MW
   Hammad, S
   Samarkandi, OA
   Hamdan-Mansour, AM
   Khalil, AA
AF Darawad, Muhammad W.
   Hammad, Sawsan
   Samarkandi, Osama A.
   Hamdan-Mansour, Ayman M.
   Khalil, Amani A.
TI Evaluating the Psychometric Properties of the Arabic Version of the
   Diabetes Distress Scale
SO JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES
LA English
DT Article
ID SELF-MANAGEMENT PRACTICES; EMOTIONAL DISTRESS; LONGITUDINAL
   RELATIONSHIP; DEPRESSIVE SYMPTOMS; GLYCEMIC CONTROL; PROBLEM AREAS;
   RISK-FACTORS; ADULTS; PREVALENCE; HEALTH
AB The current study evaluated the psychometric properties of the Arabic version of the Diabetes Distress Scale (DDS-A) among Arab patients with diabetes mellitus (DM) using a descriptive cross-sectional design. Participants' DDS-A total scores significantly correlated with depressive symptoms (r = 0.288, p = 0.000) as well as two subscales, emotional burden (r = 0.276, p = 0.000) and regimen distress (r = 0.265, p = 0.000). Participants' DDS-A scores had significant negative correlations with income, DM self-management, and knowledge (r = -0.184, p = 0.008; r = -0.310, p = 0.000; r = -0.174, p = 0.003, respectively) and a positive correlation with HbA1c level (r = 0.153, p = 0.018). Factor analysis revealed a four-factor solution that retained all items and explained a variance of 65.59%. Cronbach's alpha was 0.822 for the total scale and 0.778 to 0.881 for the subscales, indicating a high internal consistency. The DDS-A was found to be a psychometrically sound measure to evaluate DM-related distress among Arab patients.
C1 [Darawad, Muhammad W.; Hammad, Sawsan; Hamdan-Mansour, Ayman M.; Khalil, Amani A.] Univ Jordan, Sch Nursing, Amman 11942, Jordan.
   [Samarkandi, Osama A.] King Saud Univ, Prince Sultan bin Abdulaziz Coll Emergency Med Se, Riyadh, Saudi Arabia.
RP Darawad, MW (reprint author), Univ Jordan, Sch Nursing, Amman 11942, Jordan.
EM m.darawad@ju.edu.jo
RI Samarkandi, Osama/J-1482-2017
OI Samarkandi, Osama/0000-0003-2698-7176
FU University of Jordan
FX The authors thank the University of Jordan for funding this study, as
   well as the patients and directors of nursing at the participating
   hospitals who granted access to participants in their organizations.
CR Ajlouni K, 2008, J DIABETES COMPLICAT, V22, P317, DOI 10.1016/j.jdiacomp.2007.01.004
   Al-Amer RM, 2011, J DIABETES COMPLICAT, V25, P247, DOI 10.1016/j.jdiacomp.2011.03.001
   Bani-issa WA, 2014, J TRANSCULT NURS, V25, P42, DOI 10.1177/1043659613503873
   Baradaran HR, 2013, INT J PREVENTIVE MED, V4, P580
   Boutayeb A., 2012, OPEN J EPIDEMIOL, V2, P55, DOI DOI 10.4236/0JEPI.2012.22009
   Darawad MW, 2018, CLIN NURS RES, V27, P890, DOI 10.1177/1054773816683504
   Darawad MW, 2017, IRAN J PUBLIC HEALTH, V46, P771
   de Villiers L., 2015, INT J RES NURSING, V6, P30, DOI [10.3844/ijrnsp.2015.30.41, DOI 10.3844/IJRNSP.2015.30.41]
   Department of Statistics, 2012, JORD ANN CENS
   DUNN SM, 1986, DIABETES CARE, V9, P480, DOI 10.2337/diacare.9.5.480
   Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Gazmararian JA, 2009, DIABETES EDUCATOR, V35, P778, DOI 10.1177/0145721709338527
   Gorsuch R, 1983, FACTOR ANAL
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N
   Hammad S, 2015, IRAN J PUBLIC HEALTH, V44, P1482
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   International Diabetes Federation, 2012, DIABETES ATLAS
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kong Lulu, 2013, J Biomed Res, V27, P380, DOI 10.7555/JBR.27.20120112
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   Polit D.F., 2014, ESSENTIALS NURSING R
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rogvi S, 2012, DIABETIC MED, V29, pe382, DOI 10.1111/j.1464-5491.2012.03703.x
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Shakibazadeh E, 2011, IRAN J PUBLIC HEALTH, V40, P146
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Stankovic Z, 2013, VOJNOSANIT PREGL, V70, P1138, DOI 10.2298/VSP1312138S
   Strandberg RB, 2015, DIABETIC MED, V32, P1304, DOI 10.1111/dme.12781
   Tabachnick B. G., 2007, USING MULTIVARIATE S
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Yacoub MI, 2014, INT NURS REV, V61, P255, DOI 10.1111/inr.12090
   Yacoub MI, 2015, J CONTIN EDUC NURS, V46, P128, DOI [10.3928/00220124-20150220-16, 10.3928/00220124-20150126-02]
   Zulman DM, 2012, PATIENT EDUC COUNS, V87, P74, DOI 10.1016/j.pec.2011.07.013
NR 43
TC 0
Z9 0
U1 0
U2 5
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0279-3695
EI 1938-2413
J9 J PSYCHOSOC NURS MEN
JI J. Psychosoc. Nurs. Ment. Health Serv.
PD SEP
PY 2017
VL 55
IS 9
BP 43
EP 51
DI 10.3928/02793695-20170818-12
PG 9
WC Nursing
SC Nursing
GA FG6WR
UT WOS:000410539300006
PM 28850650
DA 2019-01-08
ER

PT J
AU Hessler, DM
   Fisher, L
   Polonsky, WH
   Masharani, U
   Strycker, LA
   Peters, AL
   Blumer, I
   Bowyer, V
AF Hessler, D. M.
   Fisher, L.
   Polonsky, W. H.
   Masharani, U.
   Strycker, L. A.
   Peters, A. L.
   Blumer, I.
   Bowyer, V.
TI Diabetes distress is linked with worsening diabetes management over time
   in adults with Type 1 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID POOR SELF-CARE; EMOTIONAL DISTRESS; GLYCEMIC CONTROL; DEPRESSIVE
   SYMPTOMS; REGIMEN DISTRESS; ASSOCIATIONS; MELLITUS; HBA(1C); TRIAL
AB AimTo determine the cross-sectional and longitudinal associations between diabetes distress and diabetes management.
   MethodsIn a non-interventional study, 224 adults with Type 1 diabetes were assessed for diabetes distress, missed insulin boluses, hypoglycaemic episodes, and HbA(1c) at baseline and 9 months.
   ResultsAt baseline, greater distress was associated with higher HbA(1c) and a greater percentage of missed insulin boluses. Longitudinally, elevated baseline distress was related to increased missed insulin boluses, and decreases in distress were associated with decreases in HbA(1c). In supplementary analyses, neither depression symptoms nor a diagnosis of major depressive disorder was associated with missed insulin boluses, HbA(1c) or hypoglycaemic episodes in cross-sectional or longitudinal analyses.
   ConclusionsSignificant cross-sectional and longitudinal associations were found between diabetes distress and management; in contrast, no parallel associations were found for major depressive disorder or depression symptoms. Findings suggest that elevated distress may lead to more missed insulin boluses over time, suggesting a potential intervention target. The covarying association between distress and HbA(1c) points to the complex and likely interactive associations between these constructs. Findings highlight the need to address distress as an integral part of diabetes management in routine care.
C1 [Hessler, D. M.; Fisher, L.; Bowyer, V.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Polonsky, W. H.] Univ Calif San Francisco, Behav Diabet Inst, San Francisco, CA 94143 USA.
   [Masharani, U.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Strycker, L. A.] Oregon Res Inst, Eugene, OR 97403 USA.
   [Peters, A. L.] Univ Southern Calif, Los Angeles, CA USA.
   [Blumer, I.] Charles H Best Diabet Ctr, Whitby, ON, Canada.
RP Hessler, DM (reprint author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
EM Danielle.Hessler@ucsf.edu
FU NIH [DK094863]
FX This research was funded by NIH Grant DK094863.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2016, DIABETES CARE, V39, P2182, DOI 10.2337/dc16-1657
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hessler D, 2015, DIABETES RES CLIN PR, V108, P360, DOI 10.1016/j.diabres.2014.12.017
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Strandberg RB, 2015, DIABETIC MED, V32, P1304, DOI 10.1111/dme.12781
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
NR 24
TC 8
Z9 8
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2017
VL 34
IS 9
BP 1228
EP 1234
DI 10.1111/dme.13381
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FD9CA
UT WOS:000407819200007
PM 28498610
DA 2019-01-08
ER

PT J
AU Sudhir, PM
AF Sudhir, Paulomi M.
TI Advances in psychological interventions for lifestyle disorders:
   overview of interventions in cardiovascular disorder and type 2 diabetes
   mellitus
SO CURRENT OPINION IN PSYCHIATRY
LA English
DT Review
DE cardiovascular disorders; psychological interventions; self-management;
   type 2 diabetes
ID RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE;
   COGNITIVE-BEHAVIORAL THERAPY; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL;
   SELF-REGULATION; CLINICAL-TRIAL; ADULTS; DEPRESSION; MANAGEMENT
AB Purpose of reviewThe present review examines the recent advances in psychological interventions for two major lifestyle disorders in adults namely, type 2 diabetes mellitus and cardiovascular disorders. The review summarizes findings from studies carried out between the years 2015 and 2017.Recent findingsThe effectiveness of psychological interventions in the management of lifestyle disorders has been examined with respect to adaptation, self-care, adherence, negative emotions and improving quality of life. There is an increasing recognition that psychological interventions are important for prevention of lifestyle disorders and promotion of health. Key psychological interventions include self-management and educational interventions based on learning and motivational principles, patient empowerment, cognitive behaviour therapy, behavioural skills and coaching. Recent developments also include the use of information technology to deliver these interventions through internet, mobile applications and text messages. Another significant development is that of mindfulness-based interventions within the third-generation behaviour therapy approaches to reduce distress and increase acceptance. In addition, family and couples interventions have also been emphasised as necessary in maintenance of healthy behaviours.SummaryStudies examining psychological interventions in cardiovascular and type 2 diabetes mellitus support the efficacy of these interventions in bringing about changes in biochemical / physiological parameters and in psychological outcomes such as self-efficacy, knowledge, quality of life and a sense of empowerment.
C1 [Sudhir, Paulomi M.] Natl Inst Mental Hlth, Dept Clin Psychol, Neurosci, Bangalore, Karnataka, India.
RP Sudhir, PM (reprint author), Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore, Karnataka, India.
EM paulomi.sudhir@gmail.com
CR Abdi S, 2015, BMC NUTR, V1, P37
   Abughosh SM, 2016, J MANAG CARE SPEC PH, V22, P63, DOI 10.18553/jmcp.2016.22.1.63
   Alsaleh E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3313-5
   Bardideh K, 2017, GLOBAL J HLTH SCI, V9, P163
   Blumenthal JA, 2016, CIRCULATION, V133, P1341, DOI 10.1161/CIRCULATIONAHA.115.018926
   Chamany S, 2015, AM J PREV MED, V49, P832, DOI 10.1016/j.amepre.2015.04.016
   Chapman A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1358-x
   Chrvala CA, 2016, PATIENT EDUC COUNS, V99, P926, DOI 10.1016/j.pec.2015.11.003
   de Groot Mary, 2010, Diabetes Spectr, V23, P15, DOI 10.2337/diaspect.23.1.15
   de Hoog N, 2016, HEALTH EDUC RES, V31, P350, DOI 10.1093/her/cyv100
   Doering LV, 2016, EUR J CARDIOVASC NUR, V15, P417, DOI 10.1177/1474515115592292
   Ebert DD, 2017, DIABETIC MED, V34, P99, DOI 10.1111/dme.13173
   Fard AD, 2016, IJHCS, P271
   Figueroa C, 2016, PSYCHOLOGY, V07, P374
   Fitzpatrick SL, 2016, DIABETES CARE, V39, P2149, DOI 10.2337/dc16-0941
   Friis AM, 2016, DIABETES CARE, V39, P1963, DOI 10.2337/dc16-0416
   Gomez-Pardo E, 2016, J AM COLL CARDIOL, V67, P476, DOI 10.1016/j.jacc.2015.10.033
   Haenen S, 2016, J PSYCHOSOM RES, V85, P44, DOI 10.1016/j.jpsychores.2016.04.006
   Hofmann M, 2016, J DIABETES RES, DOI 10.1155/2016/1476384
   Holmen H, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000193
   Hu J, 2016, DIABETES EDUCATOR, V42, P299, DOI 10.1177/0145721716636961
   Islam SMS, 2015, DIABETES CARE, V38, pE112, DOI 10.2337/dc15-0505
   Johnston N, 2016, AM HEART J, V178, P85, DOI 10.1016/j.ahj.2016.05.005
   Kaltman S, 2016, DIABETES EDUCATOR, V42, P87, DOI 10.1177/0145721715617536
   Kashani Mariam, 2016, Glob J Health Sci, V8, P55119, DOI 10.5539/gjhs.v8n9p322
   Kleinman NJ, 2016, DIABETES CARE, V39, pE169, DOI 10.2337/dc16-0869
   Lv JF, 2016, INT HEART J, V57, P167, DOI 10.1536/ihj.15-259
   Mayberry LS, 2016, J DIABETES RES, DOI 10.1155/2016/7586385
   McClintock HFD, 2016, AM J HEALTH BEHAV, V40, P503, DOI 10.5993/AJHB.40.4.12
   Mendis S, 2011, GLOBAL ATLAS CARDIOV
   Nanditha A, 2016, DIABETES CARE, V39, P472, DOI 10.2337/dc15-1536
   Nelson Lyndsay A, 2016, JMIR Hum Factors, V3, pe13, DOI 10.2196/humanfactors.5177
   Norlund F, 2017, EUR J PREV CARDIOL
   Olson EA, 2015, J BEHAV MED, V38, P886, DOI 10.1007/s10865-015-9660-3
   Onyechi KCN, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004444
   Park LG, 2016, PROG CARDIOVASC DIS, V58, P639, DOI 10.1016/j.pcad.2016.03.002
   Pibernik-Okanovic M, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0833-8
   Redfern J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163929
   Rees G, 2017, BMJ OPEN DIABETES RE, V5
   Rondags SMPA, 2016, DIABETES CARE, V39, P2190, DOI 10.2337/dc16-1614
   Schneider KL, 2016, BEHAV THER, V47, P198, DOI 10.1016/j.beth.2015.10.005
   Shayeghian Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166599
   Sherwood A, 2017, AM HEART J, V183, P85, DOI 10.1016/j.ahj.2016.10.011
   Silfee V, 2016, PSYCHOL HEALTH MED, V21, P715, DOI 10.1080/13548506.2016.1139144
   Sultan S, 2016, PAK HEART J, V49, P9
   Trief PM, 2016, DIABETES CARE, V39, P2165, DOI 10.2337/dc16-0035
   Tully PJ, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1109-z
   Uchendu C, 2017, DIABETIC MED, V34, P328, DOI 10.1111/dme.13195
   Wilczynska M, 2016, CONTEMP CLIN TRIALS, V49, P116, DOI 10.1016/j.cct.2016.06.013
   Winter SJ, 2016, PROG CARDIOVASC DIS, V58, P605, DOI 10.1016/j.pcad.2016.02.005
   Wolever RQ, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000201
   Wu Y, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6522
   Younge JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143843
NR 53
TC 2
Z9 2
U1 5
U2 32
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7367
EI 1473-6578
J9 CURR OPIN PSYCHIATR
JI Curr. Opin. Psychiatr.
PD SEP
PY 2017
VL 30
IS 5
BP 346
EP 351
DI 10.1097/YCO.0000000000000348
PG 6
WC Psychiatry
SC Psychiatry
GA FB9OD
UT WOS:000406467700005
PM 28682800
DA 2019-01-08
ER

PT J
AU Murri, MB
   Mamberto, S
   Briatore, L
   Mazzucchelli, C
   Amore, M
   Cordera, R
AF Murri, Martino Belvederi
   Mamberto, Sara
   Briatore, Lucia
   Mazzucchelli, Chiara
   Amore, Mario
   Cordera, Renzo
TI The interplay between diabetes, depression and affective temperaments: A
   structural equation model
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Depression; Diabetes; Distress; Temperament; Personality; Glycemic
   control
ID MEDICATION ADHERENCE; RISK-FACTOR; ASSOCIATION; METAANALYSIS; SYMPTOMS;
   DISTRESS; MELLITUS; INVARIANCE; GENDER; ISSUES
AB Background: Diabetes and depression are reciprocally linked, but few studies modeled their interplay considering the influence of affective temperaments (AT) and demographic factors.
   Methods: Participants with type 1 and type 2 diabetes (T1DM and T2DM, n = 279) recruited from Diabetes Units were assessed with the Beck Depression Inventory (BDI), Temperament Evaluation of Memphis, Pisa, Paris and San Diego-autoquestionnaire version (TEMPS-A), Morisky Medication Adherence Scale (MMAS), Diabetes Distress Scale (DDS) and Cumulative Illness Rating Scales (CIRS). Glycosylated hemoglobin levels (HBA1C) was used as index of glycemic control. The bi-directional association between glycemic control, depression and candidate mediators was examined with Structural Equation Modeling, testing the impact of moderator variables (AT, diabetes type, age and gender) with multigroup comparison.
   Results: The association between HBA1C and depressive symptoms was mediated by diabetes-related distress,, while there was no definite evidence of depression influencing HBA1C through changes of adherence, tiredness, appetite, alcohol intake or smoking. Among individuals with AT, distress was unrelated to HBA1C and had a higher impact on depression; adherence was inversely association with HBA1C. Moreover, physical comorbidities impacted on depression. While diabetes type had a moderation role, age and gender did not affect the model.
   Limitations: Cross sectional design, lack of objective measures of diet and physical activity.
   Conclusions: Glycemic control seem to influence the severity of depressive symptoms, but the reciprocal association seems non-significant. AT and diabetes type may shape this relationship influencing distress and adherence to medications. Findings may aid interventions aimed at improving patients' care and quality of life.
C1 [Murri, Martino Belvederi; Amore, Mario] Univ Genoa, Sect Psychiat, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.
   [Murri, Martino Belvederi] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.
   [Mamberto, Sara; Cordera, Renzo] Univ Genoa, Dept Internal Med, Genoa, Italy.
   [Briatore, Lucia] Pietra Ligure Hosp, ASL 2 Savonese, Internal Med Unit, Genoa, Italy.
   [Mazzucchelli, Chiara] Osped Imperia, ASL 1 Imperiese, Diabet Unit, Imperia, Italy.
RP Murri, MB (reprint author), Univ Genoa, Sect Psychiat, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.
EM martino.belvederi@gmail.com
RI Belvederi Murri, Martino/G-8781-2011
OI Belvederi Murri, Martino/0000-0002-7262-3528; cordera,
   renzo/0000-0002-5280-9691
CR Akiskal HS, 2005, J AFFECT DISORDERS, V85, P1, DOI 10.1016/j.jad.2004.12.003
   Alexopoulos GS, 2011, INT J GERIATR PSYCH, V26, P1109, DOI 10.1002/gps.2672
   Almeida OP, 2016, MATURITAS, V86, P3, DOI 10.1016/j.maturitas.2016.01.003
   Bartoli F, 2016, INT J GERIATR PSYCH, V31, P829, DOI 10.1002/gps.4397
   Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13
   Buchberger B, 2016, PSYCHONEUROENDOCRINO, V70, P70, DOI 10.1016/j.psyneuen.2016.04.019
   Bullock HE, 1994, STRUCT EQU MODELING, V1, P253, DOI 10.1080/10705519409539977
   Byrne BM, 2004, STRUCT EQU MODELING, V11, P272, DOI 10.1207/s15328007sem1102_8
   Chen SG, 2016, ENDOCRINE, V53, P35, DOI 10.1007/s12020-016-0869-x
   Chiu CJ, 2010, SOC PSYCH PSYCH EPID, V45, P67, DOI 10.1007/s00127-009-0043-3
   Demakakos P, 2014, PSYCHOSOM MED, V76, P555, DOI 10.1097/PSY.0000000000000082
   Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861
   Eliasson B, 2003, PROG CARDIOVASC DIS, V45, P405, DOI 10.1053/pcad.2003.00103
   Fernandez-Aranda F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104534
   Gaskin J., 2011, MULTIGROUP MODERATIO, P25
   Gois C, 2012, J AFFECT DISORDERS, V143, P1, DOI 10.1016/j.jad.2012.05.028
   Gois C, 2012, J AFFECT DISORDERS, V142, pS67, DOI 10.1016/S0165-0327(12)70010-1
   Gois C, 2011, J AFFECT DISORDERS, V134, P52, DOI 10.1016/j.jad.2011.05.021
   Hair J., 2010, MULTIVARIATE DATA AN
   Hall PA, 2009, J PSYCHOSOM RES, V67, P297, DOI 10.1016/j.jpsychores.2009.05.015
   Hasan SS, 2013, ASIAN J PSYCHIATR, V6, P460, DOI 10.1016/j.ajp.2013.09.008
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Kaikkonen JE, 2015, SCAND J CLIN LAB INV, V75, P133, DOI 10.3109/00365513.2014.992945
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Lasserre A. M., 2016, MOL PSYCHIAT
   Mezuk B, 2015, PSYCHOSOM MED, V77, P559, DOI 10.1097/PSY.0000000000000182
   MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N
   Molfenter T. D., 2014, GEN MED LOS ANGEL, P2
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Murri MB, 2014, PSYCHONEUROENDOCRINO, V41, P46, DOI 10.1016/j.psyneuen.2013.12.004
   Nau DP, 2007, GENDER MED, V4, P205, DOI 10.1016/S1550-8579(07)80041-6
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Pietraszek A, 2010, NUTR METAB CARDIOVAS, V20, P366, DOI 10.1016/j.numecd.2010.05.001
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Preti A, 2013, J AFFECT DISORDERS, V151, P995, DOI [10.1010/j.jad.2013.08.025, 10.1016/j.jad.2013.08.025]
   Shamsi A, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0096-z
   Shi LZ, 2010, PHARMACOECONOMICS, V28, P1097, DOI 10.2165/11537400-000000000-00000
   Tabak AG, 2014, LANCET DIABETES ENDO, V2, P236, DOI 10.1016/S2213-8587(13)70139-6
   van Dooren FEP, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0722-z
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Zhang YY, 2015, J DIABETES, V7, P800, DOI 10.1111/1753-0407.12238
NR 42
TC 0
Z9 0
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD SEP
PY 2017
VL 219
BP 64
EP 71
DI 10.1016/j.jad.2017.05.018
PG 8
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FB9MQ
UT WOS:000406463600009
PM 28525822
DA 2019-01-08
ER

PT J
AU Silveira, MSVM
   Bovi, TG
   Oliveira, PF
   Pavin, EJ
   Fisher, L
AF Silveira, M. S. V. M.
   Bovi, T. G.
   Oliveira, P. F.
   Pavin, E. J.
   Fisher, L.
TI Translation and cultural adaptation into Brazilian culture of type 1
   diabetes distress scale
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Diabetes mellitus type 1; Emotional distress; Translating
ID EMOTIONAL DISTRESS; GLYCEMIC CONTROL; YOUNG-ADULTS; DEPRESSION;
   PREVALENCE
AB Background: Diabetes related distress is common in type 1 diabetes patients (T1D). High levels of diabetes distress are related to poor metabolic control. An instrument to evaluate diabetes distress in T1D patients is "type 1 diabetes scale-T1DDS". The aim of this study was to translate and culturally adapt the T1DDS into Brazilian culture.
   Methods: T1DDS scale was translated into Portuguese. Back translation was performed and evaluated by a specialists committee. Pre-test was performed with 40 T1D outpatients at State University of Campinas hospital. Internal consistency, external consistency and re-test were performed.
   Results: 72% women, mean age: 32, 1 +/- 9, 7 years, mean diabetes duration: 15, 8 +/- 9, 1 years, mean scholarity: 11, 5 +/- 3, 6, glycosylated hemoglobin mean: 9 +/- 2%. Internal consistency: Cronbach alpha of T1DDS Brazilian version was 0.93. External consistency: Spearman's coefficient between T1DDS and PAID, Brazilian version, was 0.7781; ( p < 0.0001).
   Conclusions: The T1DDS Brazilian version is a reliable tool to evaluate diabetes distress in T1D patients in the Brazilian Population. This tool can be useful in clinical care and to identify patiens at risk and in need for psychosocial intervention.
C1 [Silveira, M. S. V. M.; Bovi, T. G.] Univ Estadual Campinas, Fac Med Sci, Internal Med Postgrad Program, Campinas, SP, Brazil.
   [Oliveira, P. F.] Univ Estadual Campinas, Fac Med Sci, Stat Res Ctr, Campinas, SP, Brazil.
   [Silveira, M. S. V. M.; Pavin, E. J.] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Endocrinol Div, Rua Vital Brasil 251, BR-13083970 Campinas, SP, Brazil.
   [Fisher, L.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
RP Silveira, MSVM (reprint author), Univ Estadual Campinas, Fac Med Sci, Internal Med Postgrad Program, Campinas, SP, Brazil.; Silveira, MSVM (reprint author), Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Endocrinol Div, Rua Vital Brasil 251, BR-13083970 Campinas, SP, Brazil.
EM msvms@uol.com.br
CR [Anonymous], 2002, SAS SYST WIND STAT A
   Bachle C, 2015, PSYCHONEUROENDOCRINO, V55, P48, DOI 10.1016/j.psyneuen.2015.01.026
   Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Conover W., 1999, PRACTICAL NONPARAMET
   Fisher L, 2016, DIABETIC MED, V33, P1590, DOI 10.1111/dme.12973
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2012, PATIENT EDUC COUNS, V86, P372, DOI 10.1016/j.pec.2011.07.002
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gomes MB, 2012, DIABETES RES CLIN PR, V97, P63, DOI 10.1016/j.diabres.2012.02.008
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nunnally JC, 1967, PSYCHOMETRIC THEORY
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977
NR 20
TC 0
Z9 0
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD AUG 7
PY 2017
VL 9
AR 61
DI 10.1186/s13098-017-0260-y
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FD7MQ
UT WOS:000407710600001
PM 28794803
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Burke, LA
   Rosenfeld, AG
   Daya, MR
   Vuckovic, KM
   Zegre-Hemsey, JK
   Diaz, MF
   Santos, JTD
   Mirzaei, S
   DeVon, HA
AF Burke, Larisa A.
   Rosenfeld, Anne G.
   Daya, Mohamud R.
   Vuckovic, Karen M.
   Zegre-Hemsey, Jessica K.
   Diaz, Maria Felix
   Santos, Josemare Tosta Daiube
   Mirzaei, Sahereh
   DeVon, Holli A.
TI Impact of comorbidities by age on symptom presentation for suspected
   acute coronary syndromes in the emergency department
SO EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING
LA English
DT Article
DE Acute coronary syndrome; comorbidities; symptoms; age; cardiovascular
   conditions; emergency medicine
ID AMIS PLUS REGISTRY; INDEX; ADULTS; WOMEN; SEX; QUESTIONNAIRE; SERVICES;
   OUTCOMES; DISEASE; STROKE
AB Background: It is estimated half of acute coronary syndrome (ACS) patients have one or more associated comorbid conditions.
   Aims: Aims were to: 1) examine the prevalence of comorbid conditions in patients presenting to the emergency department with symptoms suggestive of ACS; 2) determine if comorbid conditions influence ACS symptoms; and 3) determine if comorbid conditions predict the likelihood of receiving an ACS diagnosis.
   Methods: A total of 1064 patients admitted to five emergency departments were enrolled in this prospective study. Symptoms were measured on presentation to the emergency department. The Charlson Comorbidity Index (CCI) was used to evaluate group differences in comorbidity burden across demographic traits, risk factors, clinical presentation, and diagnosis.
   Results: The most prominent comorbid conditions were prior myocardial infarction, diabetes without target organ damage, and chronic lung disease. In younger ACS patients, higher CCI predicted less chest pain, chest discomfort, unusual fatigue and a lower number of symptoms. In older ACS patients, higher CCI predicted more chest discomfort, upper back pain, abrupt symptom onset, and greater symptom distress. For younger non-ACS patients, higher CCI predicted less chest pain and symptom distress. Higher CCI was associated with a greater likelihood of receiving an ACS diagnosis for younger but not older patients with suspected ACS.
   Conclusions: Younger patients with ACS and higher number of comorbidities report less chest pain, putting them at higher risk for delayed diagnosis and treatment since chest pain is a hallmark symptom for ACS.
C1 [Burke, Larisa A.; Vuckovic, Karen M.; Diaz, Maria Felix; Santos, Josemare Tosta Daiube; Mirzaei, Sahereh; DeVon, Holli A.] Univ Illinois, Coll Nursing, Dept Biobehav Sci, 845 South Damen Ave M-C 802, Chicago, IL 60612 USA.
   [Rosenfeld, Anne G.] Univ Arizona, Coll Nursing, Biobehav Hlth Sci Div, Tucson, AZ 85721 USA.
   [Daya, Mohamud R.] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA.
   [Zegre-Hemsey, Jessica K.] Univ N Carolina, Sch Nursing, Chapel Hill, NC USA.
RP Burke, LA (reprint author), Univ Illinois, Coll Nursing, Dept Biobehav Sci, 845 South Damen Ave M-C 802, Chicago, IL 60612 USA.
EM laburke@uic.edu
OI Zegre-Hemsey, Jessica/0000-0002-5650-0464; DeVon,
   Holli/0000-0002-4526-9631
FU National Institute of Nursing Research [R01NR012012]
FX This work was supported by the National Institute of Nursing Research
   (grant number R01NR012012).
CR Alfredsson J, 2016, CLIN GERIATR MED, V32, P291, DOI 10.1016/j.cger.2016.01.009
   Bourassa MG, 2000, AM J CARDIOL, V85, P548, DOI 10.1016/S0002-9149(99)90809-3
   Boyd CM, 2011, J AM GERIATR SOC, V59, P797, DOI 10.1111/j.1532-5415.2011.03391.x
   Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199
   Chen Han-Yang, 2013, Clin Epidemiol, V5, P439, DOI 10.2147/CLEP.S49485
   Chen SY, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-80
   de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1
   DeVon HA, 2003, NURS RES, V52, P108, DOI 10.1097/00006199-200303000-00007
   DeVon HA, 2008, AM J CRIT CARE, V17, P14
   DeVon HA, 2017, J CARDIOVASC NURS, V32, P383, DOI 10.1097/JCN.0000000000000351
   DeVon HA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000586
   DeVon HA, 2013, J EMERG NURS, V39, P6, DOI 10.1016/j.jen.2012.08.012
   DeVon HA, 2010, RES NURS HEALTH, V33, P386, DOI 10.1002/nur.20395
   Fassa AA, 2010, CARDIOVASC MED, V13, P155
   Francisco AR, 2010, REV PORT CARDIOL, V29, P7
   Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c
   Hess EP, 2012, CIRC-CARDIOVASC QUAL, V5, P251, DOI 10.1161/CIRCOUTCOMES.111.964791
   HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7
   Hollander JE, 2004, ACAD EMERG MED, V11, P1331, DOI 10.1197/j.aem.2004.08.033
   Katz DA, 2008, ANN EMERG MED, V51, P561, DOI 10.1016/j.annemergmed.2007.05.016
   Krantz DS, 2006, J WOMENS HEALTH, V15, P1214, DOI 10.1089/jwh.2006.15.1214
   Maeder MT, 2014, HEART, V100, P268, DOI 10.1136/heartjnl-2013-305104
   McManus David D, 2012, Clin Epidemiol, V4, P115, DOI 10.2147/CLEP.S30883
   Oka RK, 1996, AM J CARDIOL, V77, P159, DOI 10.1016/S0002-9149(96)90588-3
   Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781
   Radovanovic D, 2014, HEART, V100, P288, DOI 10.1136/heartjnl-2013-304588
   RICKHAM PP, 1964, BRIT MED J, V2, P173
   Rosengren A, 2004, EUR HEART J, V25, P663, DOI 10.1016/j.ehj.2004.02.023
   Sanchis J, 2011, MAYO CLIN PROC, V86, P291, DOI 10.4065/mcp.2010.0702
   Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993
   Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89
   Scheuermeyer FX, 2014, CAN J EMERG MED, V16, P106, DOI 10.2310/8000.2013.130938
   Schmidt M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e356
   Tessier A, 2008, ARCH PHYS MED REHAB, V89, P1276, DOI 10.1016/j.apmr.2007.11.049
   Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035
   Radovanovic CAT, 2014, REV LAT-AM ENFERM, V22, P547, DOI 10.1590/0104-1169.3345.2450
NR 36
TC 1
Z9 1
U1 1
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1474-5151
EI 1873-1953
J9 EUR J CARDIOVASC NUR
JI Eur. J. Cardiovasc. Nurs.
PD AUG
PY 2017
VL 16
IS 6
BP 511
EP 521
DI 10.1177/1474515117693891
PG 11
WC Cardiac & Cardiovascular Systems; Nursing
SC Cardiovascular System & Cardiology; Nursing
GA FH8ZY
UT WOS:000411496500008
PM 28198635
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Matsunaga, S
   Tanaka, S
   Fujihara, K
   Horikawa, C
   Iimuro, S
   Kitaoka, M
   Sato, A
   Nakamura, J
   Haneda, M
   Shimano, H
   Akanuma, Y
   Ohashi, Y
   Sone, H
AF Matsunaga, Satoshi
   Tanaka, Shiro
   Fujihara, Kazuya
   Horikawa, Chika
   Iimuro, Satoshi
   Kitaoka, Masafumi
   Sato, Asako
   Nakamura, Jiro
   Haneda, Masakazu
   Shimano, Hitoshi
   Akanuma, Yasuo
   Ohashi, Yasuo
   Sone, Hirohito
TI Association between all-cause mortality arid severity of depressive
   symptoms in patients with type 2 diabetes: Analysis from the Japan
   Diabetes Complications Study (JDCS)
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Diabetes mellitus, type 2; Depressive disorder; Death; Hypoglycemia
ID SEVERE HYPOGLYCEMIA; COMORBID DEPRESSION; EXCESS MORTALITY; SLEEP
   DURATION; METAANALYSIS; RISK; COHORT; ADULTS; COMMUNITY; DISTRESS
AB Objective: The aims of this study are to confirm whether the excess mortality caused by depressive symptoms is independent of severe hypoglycemia in patients with type 2 diabetes mellitus (T2DM) and to evaluate the association between all-cause mortality and degrees of severity of depressive symptoms in Japanese patients with T2DM.
   Methods: A total of 1160 Japanese patients with T2DM were eligible for this analysis. Participants were followed prospectively for 3 years and their depressive states were evaluated at baseline by the Center for Epidemiologic Studies Depression Scale (CES-D). Cox proportional hazards model was used to evaluate the relative risk of all cause mortality and was adjusted by possible confounding factors, including severe hypoglycemia, all of which are known as risk factors for both depression and mortality.
   Results: After adjustment for severe hypoglycemia, each 5-point increase in the CES-D score was significantly associated with excess all-cause mortality (hazard ratio 1.69 [95% CI 1.26-2.17]). The spline curve of HRs for mortality according to total CES-D scores showed that mortality risk was slightly increased at lower scores but was sharply elevated at higher scores.
   Conclusion: A high score on the CES-D at baseline was significantly associated with all-cause mortality in patients with T2DM after adjusting for confounders including severe hypoglycemia. However, only a small effect on mortality risk was found at relatively lower levels of depressive symptoms in this population. Further research is needed to confirm this relationship between the severity of depressive symptoms and mortality in patients with T2DM.
C1 [Matsunaga, Satoshi; Fujihara, Kazuya; Sone, Hirohito] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan.
   [Tanaka, Shiro] Kyoto Univ, Grad Sch Med, Dept Pharmacoepidemiol, Kyoto, Japan.
   [Horikawa, Chika] Univ Niigata Prefecture, Fac Human Life Studies, Dept Hlth & Nutr, Niigata, Japan.
   [Iimuro, Satoshi] Teikyo Univ, Teikyo Acad Res Ctr, Tokyo, Japan.
   [Kitaoka, Masafumi] Showa Gen Hosp, Div Endocrinol & Metab, Tokyo, Japan.
   [Sato, Asako] Tokyo Womens Med Univ, Clin Lab, Tokyo, Japan.
   [Nakamura, Jiro] Aichi Med Univ, Dept Internal Med, Div Diabet, Sch Med, Nagakute, Aichi, Japan.
   [Haneda, Masakazu] Asahikawa Med Univ, Dept Med, Div Metab & Biosyst Sci, Asahikawa, Hokkaido, Japan.
   [Shimano, Hitoshi] Univ Tsukuba, Fac Med, Div Endocrinol & Metab, Dept Internal Med, Tsukuba, Ibaraki, Japan.
   [Akanuma, Yasuo] Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan.
   [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo, Japan.
RP Sone, H (reprint author), Niigata Univ, Dept Hematol Endocrinol & Metab, Chuo Ku, 757 Asahimachi Dori, Niigata 9518510, Japan.
EM sone@med.niigata-u.ac.jp
FU Ministry of Health, Labor and Welfare
FX This study was supported by grants from the Ministry of Health, Labor
   and Welfare. The sponsor had no role in the design and conduct of the
   study.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
   Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344
   Bonds DE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b4909
   Bush DE, 2001, AM J CARDIOL, V88, P337, DOI 10.1016/S0002-9149(01)01675-7
   Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585
   Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878
   Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X
   Cuijpers P, 2014, AM J PSYCHIAT, V171, P453, DOI 10.1176/appi.ajp.2013.13030325
   Cuijpers P, 2013, BRIT J PSYCHIAT, V202, P22, DOI 10.1192/bjp.bp.112.112169
   Da Silva MA, 2014, J SLEEP RES, V23, P94, DOI 10.1111/jsr.12077
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Forsblom CM, 1998, DIABETOLOGIA, V41, P1253, DOI 10.1007/s001250051062
   Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533
   Ishizawa K, 2016, J DIABETES COMPLICAT, V30, P597, DOI 10.1016/j.jdiacomp.2016.02.004
   Katon W, 2009, PSYCHOSOM MED, V71, P965, DOI 10.1097/PSY.0b013e3181bd8f55
   Katon WJ, 2013, ANN FAM MED, V11, P245, DOI 10.1370/afm.1501
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Kimbro LB, 2014, J AM GERIATR SOC, V62, P1017, DOI 10.1111/jgs.12833
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Russ TC, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4933
   Shima S, 1985, CLIN PSYCHIATR, V27, P717, DOI DOI 10.11477/MF.1405203967
   Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791
   Tanaka S, 2014, INT J EPIDEMIOL, V43, P1054, DOI 10.1093/ije/dyt057
   Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303
   Wada K, 2007, AM J IND MED, V50, P8, DOI 10.1002/ajim.20403
   White J, 2015, PSYCHOL MED, V45, P2771, DOI 10.1017/S0033291715000732
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   Zhang YY, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0580-0
   Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795
NR 33
TC 1
Z9 1
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD AUG
PY 2017
VL 99
BP 34
EP 39
DI 10.1016/j.jpsychores.2017.05.020
PG 6
WC Psychiatry
SC Psychiatry
GA FB7ZA
UT WOS:000406357300006
PM 28712428
DA 2019-01-08
ER

PT J
AU Wong, EM
   Afshar, R
   Qian, H
   Zhang, M
   Elliott, TG
   Tang, TS
AF Wong, Evelyn M.
   Afshar, Rowshanak
   Qian, Hong
   Zhang, Mira
   Elliott, Thomas G.
   Tang, Tricia S.
TI Diabetes Distress, Depression and Glycemic Control in a Canadian-Based
   Specialty Care Setting
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE depression; diabetes distress; type 2 diabetes mellitus; psychosocial
   outcomes; tertiary care setting
ID EMOTIONAL DISTRESS; CLINICAL DEPRESSION; TYPE-2; ASSOCIATIONS;
   PREVALENCE; AMERICANS; ANXIETY
AB Objectives: The objectives of this study were to determine rates of diabetes distress and depression in patients with type 2 diabetes in a tertiary care setting, to examine the relationship among glycemic control, diabetes distress and depression, and to identify predictors of diabetes distress and depression on the basis of demographic and clinical characteristics.
   Methods: We recruited 148 adults with type 2 diabetes who were presenting to a specialty diabetes clinic in Vancouver, British Columbia, Canada. Participants completed a questionnaire measuring diabetes distress, depressive symptoms and demographic backgrounds. The Diabetes Distress Scale was used to assess overall distress as well as 4 distinct distress dimensions, including emotional burden, physician-related, regimen-related and interpersonal distress. The Personal Health Questionnaire-9 was used to assess depressive symptoms. Glycated hemoglobin (A1C) data were also collected.
   Results: The prevalence of diabetes distress and depression was 39% and 12% in our population, respectively. A1C levels emerged as a significant predictor of emotional burden (p=0.03) and regimen-related distress (p=0.01); higher A1C levels were associated with increased distress regarding emotional functioning and regimen adherence. A1C levels (p=0.02) and education levels (p=0.03) emerged as predictors of physician-related distress, with higher A1C levels associated with decreased distress regarding confidence in physicians.
   Conclusions: Our findings reveal that the rate of diabetes distress for patients in a tertiary care setting is high. Furthermore, diabetes distress, particularly emotion- and self-care-related distress, plays a significant role in glycemic control, whereas depression does not. Routine screening for diabetes distress as part of an initial specialty clinic evaluation should be explored. (C) 2017 Canadian Diabetes Association.
C1 [Wong, Evelyn M.] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada.
   [Afshar, Rowshanak; Tang, Tricia S.] Univ British Columbia, Dept Med, Div Endocrinol, Vancouver, BC, Canada.
   [Qian, Hong] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.
   [Zhang, Mira; Elliott, Thomas G.] BC Diabet, Vancouver, BC, Canada.
RP Wong, EM (reprint author), Toronto Gen Hosp, 200 Elizabeth St,Eaton North 7th Floor,Room 234, Toronto, ON M5G 2C4, Canada.
EM evelyn.mm.wong@gmail.com
FU BC Diabetes
FX Thanks to Paige Kendall, Alex Dang and Jas Sidhu for data entry. This
   work was supported by BC Diabetes.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Black SA, 1999, DIABETES CARE, V22, P56, DOI 10.2337/diacare.22.1.56
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fleer J, 2013, DIABETIC MED, V30, P88, DOI 10.1111/dme.12001
   Gariepy G, 2013, J PSYCHOSOM RES, V75, P147, DOI 10.1016/j.jpsychores.2013.05.009
   Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G
   Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nichols GA, 2003, DIABETES CARE, V26, P744, DOI 10.2337/diacare.26.3.744
   Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Rogvi S, 2012, DIABETIC MED, V29, pe382, DOI 10.1111/j.1464-5491.2012.03703.x
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Wu SFV, 2011, INT J NURS STUD, V48, P1376, DOI 10.1016/j.ijnurstu.2011.04.008
   Zhang CX, 2008, DIABETES RES CLIN PR, V79, P523, DOI 10.1016/j.diabres.2007.10.014
NR 24
TC 4
Z9 4
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD AUG
PY 2017
VL 41
IS 4
BP 362
EP 365
DI 10.1016/j.jcjd.2016.11.006
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FB3BQ
UT WOS:000406018000005
PM 28462795
DA 2019-01-08
ER

PT J
AU Bai, JW
   Lovblom, LE
   Cardinez, M
   Weisman, A
   Farooqi, MA
   Halpern, EM
   Boulet, G
   Eldelekli, D
   Lovshin, JA
   Lytvyn, Y
   Keenan, HA
   Brent, MH
   Paul, N
   Bril, V
   Cherney, DZI
   Perkins, BA
AF Bai, Johnny-Wei
   Lovblom, Leif E.
   Cardinez, Marina
   Weisman, Alanna
   Farooqi, Mohammed A.
   Halpern, Elise M.
   Boulet, Genevieve
   Eldelekli, Devrim
   Lovshin, Julie A.
   Lytvyn, Yuliya
   Keenan, Hillary A.
   Brent, Michael H.
   Paul, Narinder
   Bril, Vera
   Cherney, David Z. I.
   Perkins, Bruce A.
TI Neuropathy and presence of emotional distress and depression in
   longstanding diabetes: Results from the Canadian study of longevity in.
   type 1 diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Type 1 diabetes; Complications; Neuropathy; Depression; Distress;
   Psychology
ID PERIPHERAL NEUROPATHY; GLYCEMIC CONTROL; SELF-CARE; COMPLICATIONS;
   SYMPTOMS; ADULTS; SCALE; METAANALYSIS; DISEASE; INTERVENTIONS
AB Aim: To determine the association of neuropathy and other complications with emotional distress and depression among patients with longstanding type 1 diabetes (T1DM).
   Methods: Canadians with >= 50 years of T1DM completed a questionnaire including assessment of distress and depression by the Problem Areas in Diabetes Scale (PAID) and Geriatric Depression Scale (GDS), respectively. Complications were determined using the Michigan Neuropathy Screening Instrument (Questionnaire Component), fundoscopy reports, renal function tests, and self-reported peripheral-(PVD) and cardiovascular (CVD) disease. Associations were analyzed by Poisson regression.
   Results: Among 323 participants, 137 (42.4%) had neuropathy, 113 (36.5%) nephropathy, 207 (69.5%) retinopathy, 95 (29.4%) CVD, and 31 (9.8%) PVD. The neuropathy subgroup had higher prevalence of distress (13 (9.5%) vs. 6 (3.3%), p = 0.029) and depression (34 (24.9%) vs. 12 (6.5%), p < 0.001). Adjusting for diabetes complications, neuropathy was associated with higher PAID (adjusted RR 1.44 (95% CI 1.14-1.82), p = 0.003) and GDS scores (adjusted RR1.57 (1.18-2.11), p = 0.002). Independent of potential confounders, neuropathy remained associated with higher PAID (adjusted RR 1.39 (1.10-1.76), p = 0.006) and GDS scores (adjusted RR 137 (1.03-1.83), p = 0.032). Associations with neuropathy were not fully explained by neuropathic pain.
   Conclusion: Compared to other complications, neuropathy had the greatest association with distress and depression in longstanding T1DM, independent of pain. Strategies beyond pain management are needed to improve quality of life in diabetic neuropathy. (C) 2017 Published by Elsevier Inc.
C1 [Bai, Johnny-Wei; Lovblom, Leif E.; Cardinez, Marina; Weisman, Alanna; Farooqi, Mohammed A.; Halpern, Elise M.; Boulet, Genevieve; Eldelekli, Devrim; Lovshin, Julie A.; Perkins, Bruce A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.
   [Lytvyn, Yuliya; Cherney, David Z. I.] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada.
   [Keenan, Hillary A.] Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.
   [Brent, Michael H.] Univ Toronto, Dept Med, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.
   [Paul, Narinder] Univ Hlth Network, Div Cardiothorac Radiol, Joint Dept Med Imaging, Toronto, ON, Canada.
   [Bril, Vera] Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Div Neurol,Krembil Neurosci Ctr,Dept Med, Toronto, ON, Canada.
   [Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada.
RP Perkins, BA (reprint author), Univ Toronto, Leadership Sinai Ctr Diabet, Mt Sinai Hosp, Endocrinol & Metab, L5-210,60 Murray St,Mail Box 16, Toronto, ON M5T 3L9, Canada.
EM BPerkins@mtsinai.on.ca
RI Perkins, Bruce/L-3726-2017
OI Farooqi, Mohammed/0000-0001-5282-4034; Lovblom, Leif
   Erik/0000-0002-6774-8924
FU JDRF Canada (Juvenile Diabetes Research Foundation) [17-2013-312]; JDRF
   Canadian Clinical Trial Network; Medtronic; Boehringer Ingelheim;
   AstraZeneca; Merck
FX We are grateful to the support of JDRF Canada (Juvenile Diabetes
   Research Foundation operating grant 17-2013-312), its Canadian Clinical
   Trial Network and to the Canadian Diabetes Association for their
   non-financial support with study advertisement. We greatly appreciate
   our distinguished study participants, who have inspired our team and
   spent considerable time participating in this study. A.W. has received a
   post -doctoral fellowship award from the JDRF Canadian Clinical Trial
   Network. B.A.P has received speaker honoraria from Medtronic Inc.,
   Johnson and Johnson, Roche, Glaxo Smith Kline Canada, Novo Nordisk and
   Sanofi; has received research grant support from Medtronic and
   Boehringer Ingelheim; and serves as a consultant for Neurometrix.
   D.Z.I.C. has received speaker honoraria from Janssen, AstraZeneca,
   Boehringer Ingelheim, Lilly and Merck and has received research grant
   support from AstraZeneca, Merck and Boehringer Ingelheim.
CR Aalto AM, 2000, EUR J PUBLIC HEALTH, V10, P68, DOI 10.1093/eurpub/10.1.68
   Allison P. D., 1999, LOGISTIC REGRESSION
   American Psychiatric, 2013, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bai JW, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-015-0318-9
   Bain SC, 2003, DIABETIC MED, V20, P808, DOI 10.1046/j.1464-5491.2003.01029.x
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Chew BH, 2014, WORLD J DIABETES, V5, P796, DOI 10.4239/wjd.v5.i6.796
   Conradsson M, 2013, AGING MENT HEALTH, V17, P638, DOI 10.1080/13607863.2012.758231
   D'Amato C, 2016, DIAB VASC DIS RES
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   de Groot M, 2012, CURR DIABETES REP, V12, P157, DOI 10.1007/s11892-012-0261-z
   Dhaliwal Ruban, 2014, Diabetes Spectr, V27, P9, DOI 10.2337/diaspect.27.1.9
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009
   Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x
   Ishizawa K, 2016, J DIABETES COMPLICAT, V30, P597, DOI 10.1016/j.jdiacomp.2016.02.004
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449
   Marc LG, 2008, AM J GERIAT PSYCHIAT, V16, P914, DOI 10.1097/JGP.0b013e318186bd67
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Pallayova Maria, 2014, Diabetes Spectr, V27, P143, DOI 10.2337/diaspect.27.2.143
   Prior SL, 2011, DIABETES RES CLIN PR, V91, pE71, DOI 10.1016/j.diabres.2010.12.007
   Robinson DJ, 2013, CAN J DIABETES, V37, pS87, DOI 10.1016/j.jcjd.2013.01.026
   Selvarajah D, 2014, DIABETES VASC DIS RE, V11, P218, DOI 10.1177/1479164114522135
   SHEIKH J I, 1986, Clinical Gerontologist, V5, P165
   Sherifali D, 2015, DIABETIC MED, V32, P1404, DOI 10.1111/dme.12780
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Sun JK, 2011, DIABETES CARE, V34, P968, DOI 10.2337/dc10-1675
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   TURKINGTON RW, 1980, JAMA-J AM MED ASSOC, V243, P1147, DOI 10.1001/jama.243.11.1147
   Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Vileikyte L, 2005, DIABETES CARE, V28, P2378, DOI 10.2337/diacare.28.10.2378
   Weintraub D, 2006, AM J GERIAT PSYCHIAT, V14, P169, DOI 10.1097/01.JGP.0000192488.66049.4b
   Weisman A, 2016, DIABETES CARE, V39, pE67, DOI 10.2337/dc16-0102
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
NR 40
TC 3
Z9 3
U1 4
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD AUG
PY 2017
VL 31
IS 8
BP 1318
EP 1324
DI 10.1016/j.jdiacomp.2017.05.002
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FB3ZL
UT WOS:000406081200014
PM 28599823
DA 2019-01-08
ER

PT J
AU Hermanns, N
   Ehrmann, D
   Schall, S
   Maier, B
   Haak, T
   Kulzer, B
AF Hermanns, N.
   Ehrmann, D.
   Schall, S.
   Maier, B.
   Haak, T.
   Kulzer, B.
TI The effect of an education programme (MEDIAS 2 BSC) of non-intensive
   insulin treatment regimens for people with Type2 diabetes: a randomized,
   multi-centre trial
SO DIABETIC MEDICINE
LA English
DT Article
ID SELF-MANAGEMENT EDUCATION; GLYCEMIC CONTROL; THERAPY; ADULTS;
   HYPOGLYCEMIA; METAANALYSIS; ASSOCIATION; DISTRESS; SCALE
AB AimsA self-management oriented education programme (MEDIAS2BSC) for people with Type2 diabetes who are on a non-intensive insulin treatment regimen was developed. In a randomized, multi-centre trial, the effect of MEDIAS2BSC was compared with an established education programme that acted as a control group.
   MethodsThe primary outcome was the impact of MEDIAS2BSC on glycaemic control. Secondary outcomes included the incidence of severe hypoglycaemia, hypoglycaemia unawareness, diabetes-related distress, diabetes knowledge, quality of life and self-care behaviour.
   ResultsIn total, 182 participants were randomized to the control group or MEDIAS2BSC [median age 64.0 (interquartile range 58.0-68.5) vs. 63.5 (57.0-70.0)years; HbA(1c) 62.812.7mmol/mol vs. 63.714.0mmol/mol; 7.9%1.2% vs. 8.0%1.3%]. After a 6-month follow-up, there was a mean decrease in HbA(1c) of 3.5mmol/mol (0.32%) in the control group and 6.7mmol/mol (0.61%) in MEDIAS2BSC. After adjusting for baseline differences and study centre, the mean difference between the groups was -3.3mmol/mol [95% confidence interval (CI) -0.54 to -5.90mmol/mol] [-0.30% (95% CI -0.05 to -0.54)] in favour of MEDIAS2BSC (P=0.018). There were no increases in severe hypoglycaemia or hypoglycaemia unawareness. The education programmes had no significant effects on psychosocial outcome variables.
   ConclusionMEDIAS2BSC was more effective in lowering HbA(1c) than the control condition. MEDIAS2BSC is a safe educational tool that improves glycaemic control without increasing the risk for hypoglycaemia. (Clinical Trials Registry No; NCT 02748239)
C1 [Hermanns, N.; Ehrmann, D.; Schall, S.; Maier, B.; Haak, T.; Kulzer, B.] Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.
   [Hermanns, N.; Maier, B.; Haak, T.; Kulzer, B.] Diabet Ctr Mergentheim, Bad Mergentheim, Germany.
   [Hermanns, N.; Ehrmann, D.; Kulzer, B.] Otto Friedrich Univ Bamberg, Dept Clin Psychol, Bamberg, Germany.
RP Hermanns, N (reprint author), Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.; Hermanns, N (reprint author), Diabet Ctr Mergentheim, Bad Mergentheim, Germany.; Hermanns, N (reprint author), Otto Friedrich Univ Bamberg, Dept Clin Psychol, Bamberg, Germany.
EM hermanns@diabetes-zentrum.de
OI Ehrmann, Dominic/0000-0002-5794-5596
CR Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008
   Berger M, 1989, STRUCTURED TREATMENT
   Bundesaerztekammer (BAEK) Kassenaerztliche Bundesvereinigung (KBV) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), 2013, NAT GUID THERP TYP 2
   Chrvala CA, 2016, PATIENT EDUC COUNS, V99, P926, DOI 10.1016/j.pec.2015.11.003
   CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Didjurgeit U, 2011, STRUCTURED TREATMENT
   Greiner W, 2007, HLTH EC EVALUATION, P403
   Hautzinger M, 1993, GERMAN VERSION CTR E
   Hermanns N, 2007, DIABETES-METAB RES, V23, P528, DOI 10.1002/dmrr.710
   Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009
   Hermanns N, 2012, PATIENT EDUC COUNS, V86, P226, DOI 10.1016/j.pec.2011.05.017
   Hermanns N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-113
   Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392
   Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479
   Kulzer B, 2007, DIABETIC MED, V24, P415, DOI 10.1111/j.1464-5491.2007.02089.x
   Kulzer B, 2015, MEDIAS 2 MORE DIABET
   Muhlhauser I, 2002, DIABETOLOGIA, V45, P1723, DOI 10.1007/s00125-002-0987-2
   Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Peyrot M, 2012, DIABETES OBES METAB, V14, P1081, DOI 10.1111/j.1463-1326.2012.01636.x
   Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 30
TC 1
Z9 1
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD AUG
PY 2017
VL 34
IS 8
BP 1084
EP 1091
DI 10.1111/dme.13346
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FA7CK
UT WOS:000405602000009
PM 28257159
DA 2019-01-08
ER

PT J
AU Al Sayah, F
   Qiu, WY
   Xie, F
   Johnson, JA
AF Al Sayah, Fatima
   Qiu, Weiyu
   Xie, Feng
   Johnson, Jeffrey A.
TI Comparative performance of the EQ-5D-5L and SF-6D index scores in adults
   with type 2 diabetes
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE EQ-5D-5L; SF-6D; Discriminative validity; Responsiveness; Diabetes
ID QUALITY-OF-LIFE; EUROQOL-5 DIMENSION EQ-5D; FUNCTIONAL DISABILITY;
   GENERAL-POPULATION; PATIENT GROUPS; HEALTH; VALIDITY; RESPONSIVENESS;
   QUESTIONNAIRE; INSTRUMENTS
AB To explore the comparative performance including discriminative and longitudinal validity of EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.
   Data from an on-going cohort study of adults with type 2 diabetes in Alberta, Canada, were used. Known-groups approach was used to examine discriminative validity. Correlation and agreement indices and scatter and Bland-Altman plots were used to examine the relationship between the two measures. Longitudinal validity was explored using Wilcoxon signed-rank test, effect size, and standardized response mean.
   In 1832 participants at baseline (age 64.3, standard deviation 10.6 years; 45% female), median EQ-5D-5L score was 0.85 [interquartile range (IQR) 0.17], and floor and ceiling effects of 0.1 and 16.1%, respectively; median SF-6D score was 0.72 (IQR 0.24), and floor and ceiling effects of 0.1 and 3.2%, respectively. EQ-5D-5L and SF-6D index scores were significantly correlated with an overall Spearman correlation coefficient of 0.73, and an ICC of 0.62 (95% CI 0.42-0.74). Both EQ-5D-5L and SF-6D scores demonstrated statistically significant differences in self-reported chronic conditions, depressive symptoms, and diabetes-related distress, and were able to detect changes in depressive symptoms and diabetes distress across all change groups.
   Both EQ-5D-5L and SF-6D index scores provide valid measurement in this patient population. Considerable overlap between the measures means it is not necessary to include both in surveys, however, the advantages and disadvantages of each should be considered.
C1 [Al Sayah, Fatima; Qiu, Weiyu] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.
   [Xie, Feng] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
   [Xie, Feng] St Josephs Healthcare Hamilton, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada.
   [Xie, Feng] Program Hlth Econ & Outcome Measures, Hamilton, ON, Canada.
   [Johnson, Jeffrey A.] Univ Alberta, Sch Publ Hlth, Li Ka Shing Ctr Hlth Res Innovat 2 040, Edmonton, AB T6G 2E1, Canada.
RP Johnson, JA (reprint author), Univ Alberta, Sch Publ Hlth, Li Ka Shing Ctr Hlth Res Innovat 2 040, Edmonton, AB T6G 2E1, Canada.
EM jeff.johnson@ualberta.ca
OI Johnson, Jeffrey/0000-0001-8290-2857
FU Alberta Health; CIHR - CIHR Institute of Nutrition, Metabolism and
   Diabetes (INMD) [OTG- 88588]
FX This work was supported by grant from Alberta Health, and a CIHR Team
   Grant to the Alliance for Canadian Health Outcomes Research in Diabetes
   (reference #: OTG- 88588), sponsored by the CIHR Institute of Nutrition,
   Metabolism and Diabetes (INMD).
CR Agborsangaya CB, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-74
   Al Sayah Fatima, 2015, Can J Diabetes, V39 Suppl 3, pS113, DOI 10.1016/j.jcjd.2015.05.005
   Biering K, 2015, CLIN EPIDEMIOL, V7, P91, DOI 10.2147/CLEP.S72247
   Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866
   Brazier J, 1999, HEALTH TECHNOL ASSES, V3, P1
   Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d
   Bryan Stirling, 2005, Eur J Health Econ, V6, P253, DOI 10.1007/s10198-005-0299-9
   Cicchetti D., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]
   Cohen J, 1988, STAT POWER ANAL BEHA
   De Smedt D, 2014, VALUE HEALTH, V17, P84, DOI 10.1016/j.jval.2013.10.010
   Drummond M, 2001, ANN MED, V33, P344, DOI 10.3109/07853890109002088
   Drummond M. F., 1997, METHODS EC EVALUATIO
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338
   Garratt A., 2002, BMJ-BRIT MED J, V324, P1471
   Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015
   Gregg EW, 2002, DIABETES CARE, V25, P61, DOI 10.2337/diacare.25.1.61
   Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x
   Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4
   Kontodimopoulos N, 2012, EUR J HEALTH ECON, V13, P111, DOI 10.1007/s10198-010-0290-y
   Kontodimopoulos N, 2009, QUAL LIFE RES, V18, P87, DOI 10.1007/s11136-008-9420-8
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Maddigan SL, 2006, AM J PUBLIC HEALTH, V96, P1649, DOI 10.2105/AJPH.2005.067728
   Maddigan SL, 2005, QUAL LIFE RES, V14, P1311, DOI 10.1007/s11136-004-6640-4
   Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829
   Marrero D, 2014, QUAL LIFE RES, V23, P75, DOI 10.1007/s11136-013-0436-3
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Mukaka MM, 2012, MALAWI MED J, V24, P69
   Mulhern B, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-42
   Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004
   Obradovic M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-110
   Pattanaphesaj J, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-014-0203-3
   Petrou S, 2005, HEALTH ECON, V14, P1169, DOI 10.1002/hec.1006
   Revicki DA., 2002, STAT METHODS QUALITY, P103
   Royston P, 2011, J STAT SOFTW, V45, P1
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Simon Pickard A, 2005, QUAL LIFE RES, V14, P207, DOI 10.1007/s11136-004-3928-3
   van Stel HF, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-20
   Wee HL, 2007, VALUE HEALTH, V10, P256, DOI 10.1111/j.1524-4733.2007.00174.x
   Whitehurst DGT, 2011, MED DECIS MAKING, V31, pE34, DOI 10.1177/0272989X11421529
   Wu J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0156-6
   Xie F, 2007, ARTHRIT RHEUM-ARTHR, V57, P1043, DOI 10.1002/art.22883
   Xie F, 2016, MED CARE, V54, P98, DOI 10.1097/MLR.0000000000000447
   Yordanova S, 2014, BIOTECHNOL BIOTEC EQ, V28, P769, DOI 10.1080/13102818.2014.935572
NR 44
TC 2
Z9 2
U1 1
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
EI 1573-2649
J9 QUAL LIFE RES
JI Qual. Life Res.
PD AUG
PY 2017
VL 26
IS 8
BP 2057
EP 2066
DI 10.1007/s11136-017-1559-8
PG 10
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA FA8XC
UT WOS:000405728800007
PM 28364183
DA 2019-01-08
ER

PT J
AU Ehrmann, D
   Schmitt, A
   Reimer, A
   Haak, T
   Kulzer, B
   Hermanns, N
AF Ehrmann, Dominic
   Schmitt, Andreas
   Reimer, Andre
   Haak, Thomas
   Kulzer, Bernhard
   Hermanns, Norbert
TI The affective and somatic side of depression: subtypes of depressive
   symptoms show diametrically opposed associations with glycemic control
   in people with type 1 diabetes
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Depressive symptoms; Glycemic control; Subtypes; Psychosocial aspects
ID CO-MORBID DEPRESSION; ADULTS; METAANALYSIS; DISTRESS; CLUSTERS;
   MELLITUS; PREVALENCE; TRIAL; PHQ-9
AB Aims While depression has been linked to serious adverse outcomes in diabetes, associations with glycemic control are not conclusive. Inconsistencies could be due to the complex symptomatology of depression. Aim of this study was to analyze the associations of depressive subtypes with glycemic control in people with type 1 and type 2 diabetes.
   Methods Patients completed the Center for Epidemiological Studies-Depression scale which comprises affective, somatic, and anhedonic symptoms. These subtypes were analyzed in a joint linear regression analysis with glycemic control as a dependent variable. Subtype scores were calculated as mean item scores. Separate analyses for people with type 1 and type 2 diabetes were conducted. All analyses were controlled for demographic and medical confounders.
   Results The sample comprised 604 patients with type 1 and 382 patients with type 2 diabetes. In people with type 1 diabetes, the somatic and affective subtype showed diametrically opposed associations with glycemic control (somatic: beta =+0.23, p < .05; affective: beta = -0.23, p < .05). Anhedonia was not significantly associated with glycemic control. In people with type 2 diabetes, none of the depressive subtypes was significantly associated with glycemic control.
   Conclusions For people with type 1 diabetes, the distinction of subtypes offered a detailed picture of the associations of depressive symptoms with glycemic control. However, due to the cross-sectional design, inferences about the direction of these associations cannot be made. In clinical practice, instead of focusing on overall depression, healthcare providers should examine the nature of depressive symptoms and how they might be related to having diabetes.
C1 [Ehrmann, Dominic; Schmitt, Andreas; Reimer, Andre; Haak, Thomas; Kulzer, Bernhard; Hermanns, Norbert] Diabet Acad Mergentheim FIDAM, Res Inst, Johann Hammer Str 24, D-97980 Bad Mergentheim, Germany.
   [Ehrmann, Dominic; Kulzer, Bernhard; Hermanns, Norbert] Otto Friedrich Univ Bamberg, Dept Clin Psychol & Psychotherapy, Markuspl 3, D-96047 Bamberg, Germany.
   [Schmitt, Andreas; Reimer, Andre; Haak, Thomas; Kulzer, Bernhard; Hermanns, Norbert] Diabet Clin Mergentheim, Theodor Klotzbuecher Str 12, D-97980 Bad Mergentheim, Germany.
RP Ehrmann, D (reprint author), Diabet Acad Mergentheim FIDAM, Res Inst, Johann Hammer Str 24, D-97980 Bad Mergentheim, Germany.; Ehrmann, D (reprint author), Otto Friedrich Univ Bamberg, Dept Clin Psychol & Psychotherapy, Markuspl 3, D-96047 Bamberg, Germany.
EM ehrmann@fidam.de
OI Schmitt, Andreas/0000-0002-5913-1457; Ehrmann,
   Dominic/0000-0002-5794-5596
CR Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Asuzu CC, 2017, J DIABETES COMPLICAT, V31, P169, DOI 10.1016/j.jdiacomp.2016.09.013
   Bachle C, 2015, PSYCHONEUROENDOCRINO, V55, P48, DOI 10.1016/j.psyneuen.2015.01.026
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Baumeister H, 2014, DIABETIC MED, V31, P773, DOI 10.1111/dme.12452
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   de Groot M, 1999, J PSYCHOSOM RES, V46, P425, DOI 10.1016/S0022-3999(99)00014-8
   de Jonge P, 2011, J PSYCHOSOM RES, V71, P59, DOI 10.1016/j.jpsychores.2010.12.013
   Denic-Roberts H, 2016, DIABETES RES CLIN PR, V119, P1, DOI 10.1016/j.diabres.2016.06.013
   Ehrmann D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147581
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Gonzalez JS, 2016, DIABETES CARE, V39, P2182, DOI 10.2337/dc16-1657
   Hawkins MAW, 2014, PSYCHOSOM MED, V76, P38, DOI 10.1097/PSY.0000000000000023
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hermanns N, 2012, PATIENT EDUC COUNS, V86, P226, DOI 10.1016/j.pec.2011.05.017
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   King DE, 2003, DIABETES CARE, V26, P1535, DOI 10.2337/diacare.26.5.1535
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lux V, 2010, PSYCHOL MED, V40, P1679, DOI 10.1017/S0033291709992157
   Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009
   McGrady ME, 2009, DIABETES CARE, V32, P804, DOI 10.2337/dc08-2111
   Melin EO, 2013, EUR J ENDOCRINOL, V168, P861, DOI 10.1530/EJE-13-0137
   Nefs G, 2012, J PSYCHIATR RES, V46, P549, DOI 10.1016/j.jpsychires.2012.01.013
   Nefs G, 2015, PSYCHOSOMATICS, V56, P662, DOI 10.1016/j.psym.2015.06.006
   Petrak F, 2015, DIABETES CARE, V38, P767, DOI 10.2337/dc14-1599
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Reutrakul S, 2016, SLEEP MED, V23, P26, DOI 10.1016/j.sleep.2016.03.019
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213
   Stewart JC, 2012, CIRCULATION, V126, P410, DOI 10.1161/CIRCULATIONAHA.112.094946
   Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011
   Surwit RS, 2005, DIABETES RES CLIN PR, V69, P78, DOI 10.1016/j.diabres.2004.11.002
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
NR 42
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD AUG
PY 2017
VL 54
IS 8
BP 749
EP 756
DI 10.1007/s00592-017-1006-x
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FA2UX
UT WOS:000405297400004
PM 28555338
DA 2019-01-08
ER

PT J
AU Rautio, N
   Varanka-Ruuska, T
   Vaaramo, E
   Palaniswamy, S
   Nedelec, R
   Miettunen, J
   Karppinen, J
   Auvinen, J
   Jarvelin, MR
   Keinanen-Kiukaanniemi, S
   Sebert, S
   Ala-Mursula, L
AF Rautio, Nina
   Varanka-Ruuska, Tuulia
   Vaaramo, Eeva
   Palaniswamy, Saranya
   Nedelec, Rozenn
   Miettunen, Jouko
   Karppinen, Jaro
   Auvinen, Juha
   Jarvelin, Marjo-Riitta
   Keinanen-Kiukaanniemi, Sirkka
   Sebert, Sylvain
   Ala-Mursula, Leena
TI Accumulated exposure to unemployment is related to impaired glucose
   metabolism in middle-aged men: A follow-up of the Northern Finland Birth
   Cohort 1966
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Type 2 diabetes; Pre-diabetes; Unemployment
ID DIABETES-MELLITUS; PSYCHOLOGICAL DISTRESS; RISK-FACTORS; LIFE-STYLE;
   TYPE-2; HEALTH; TOLERANCE; WOMEN; WORK; POPULATION
AB Aims: We explored whether registered unemployment is associated with impaired glucose metabolism in general population.
   Methods: Based on Northern Finland Birth Cohort 1966 at 46 years, we analyzed the oral glucose tolerance tests of 1970 men and 2544 women in relation to their preceding three-year employment records in three categories of unemployment exposure: no (employed), low (<= 1-year) and high exposure (>1-year).
   Results: Among men, pre-diabetes was found in 19.2% of those with no unemployment, 23.0% with low and 27.0% with high exposure, the corresponding figures for screen-detected type 2 diabetes were 3.8%, 3.8% and 9.2% (p < 0.01). Among women, analogous figures for pre-diabetes were 10.0%, 12.6% and 16.2% and for screen-detected type 2 diabetes 1.7%, 3.4% and 3.6% (p < 0.01). Men with high exposure to unemployment had a higher risk for pre-diabetes (OR 1.61, CI 95% 1.03-2.51) and screen-detected type 2 diabetes (OR 2.58 95% CI 1.23-5.44) than employed men, after adjustment for education, smoking, alcohol intake, physical activity and body mass index. Among women, associations were attenuated in the adjusted models.
   Conclusions: High exposure to unemployment may predispose to type 2 diabetes in middle-aged men. For clinicians, awareness of the patient's unemployment status may be helpful in recognizing undiagnosed cases. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.
C1 [Rautio, Nina; Varanka-Ruuska, Tuulia; Vaaramo, Eeva; Palaniswamy, Saranya; Nedelec, Rozenn; Miettunen, Jouko; Karppinen, Jaro; Auvinen, Juha; Jarvelin, Marjo-Riitta; Keinanen-Kiukaanniemi, Sirkka; Sebert, Sylvain; Ala-Mursula, Leena] Univ Oulu, Ctr Life Course Hlth Res, POB 5000, FIN-90014 Oulu, Finland.
   [Rautio, Nina; Auvinen, Juha; Jarvelin, Marjo-Riitta; Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Unit Primary Hlth Care, OYS, POB 20, Oulu 90029, Finland.
   [Varanka-Ruuska, Tuulia] Kallio Primary Hlth Care Unit, Kirkkotie 4, Ylivieska 84100, Finland.
   [Miettunen, Jouko; Karppinen, Jaro; Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Med Res Ctr Oulu, POB 5000, Oulu 90014, Finland.
   [Miettunen, Jouko; Karppinen, Jaro; Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, POB 5000, Oulu 90014, Finland.
   [Karppinen, Jaro] Finnish Inst Occupat Hlth, Aapistie 1, Oulu 90220, Finland.
   [Jarvelin, Marjo-Riitta] Imperial Coll London, MRC PHE Ctr Environm & Hlth, Praed St Wing,St Marys Campus, London W2 1PG, England.
   [Palaniswamy, Saranya; Nedelec, Rozenn; Jarvelin, Marjo-Riitta; Sebert, Sylvain] Univ Oulu, Bioctr Oulu, POB 5000, Oulu 90014, Finland.
   [Sebert, Sylvain] Imperial Coll London, Dept Genom, South Kensington Campus, London SW7, England.
RP Rautio, N (reprint author), Univ Oulu, Ctr Life Course Hlth Res, POB 5000, FIN-90014 Oulu, Finland.
EM nina.rautio@oulu.fi; tuulia.varanka-ruuska@oulu.fi;
   eeva.vaaramo@oulu.fi; saranya.palaniswamy@oulu.fi;
   rozenn.nedelec@oulu.fi; jouko.miettunen@oulu.fi; jaro.karppinen@oulu.fi;
   juha.auvinen@oulu.fi; sirkka.keinanen-kiukaanniemi@oulu.fi;
   sylvain.sebert@oulu.fi; leena.ala-mursula@oulu.fi
OI Sebert, Sylvain/0000-0001-6681-6983
FU University of Oulu [24000692]; Oulu University Hospital [24301140]; ERDF
   European Regional Development Fund [539/2010 A31592]; Academy of Finland
   [268336]; European Union's Horizon 2020 research and innovation program
   for the DynaHEALTH action [633595]
FX NFBC1966 received financial support from University of Oulu [Grant no.
   24000692]; Oulu University Hospital [Grant no. 24301140] and ERDF
   European Regional Development Fund [Grant no. 539/2010 A31592]. This
   project has received funding from the Academy of Finland [#268336] and
   the European Union's Horizon 2020 research and innovation program [under
   grant agreement No. 633595] for the DynaHEALTH action.
CR [Anonymous], 2015, UNEMPLOYMENT STAT
   [Anonymous], 2015, SECURITY EVENT DISAB
   BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333
   Centers for Disease Control and Prevention, 2011, DISTR AG DIAGN DIAB
   Chung HR, 2009, NUTR RES PRACT, V3, P286, DOI 10.4162/nrp.2009.3.4.286
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Eriksson AK, 2013, DIABETES CARE, V36, P2683, DOI 10.2337/dc12-1738
   Heianza Y, 2013, DIABETES CARE, V36, P4007, DOI 10.2337/dc13-1048
   Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132
   JAHODA M, 1981, AM PSYCHOL, V36, P184, DOI 10.1037/0003-066X.36.2.184
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Laakso M, 2007, TYPE 2 DIABETES PRIN, P1
   Lundin A, 2010, J EPIDEMIOL COMMUN H, V64, P22, DOI 10.1136/jech.2008.079269
   Martikainen PT, 1998, AM J PUBLIC HEALTH, V88, P1859, DOI 10.2105/AJPH.88.12.1859
   McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307
   Morikawa Y, 2005, SCAND J WORK ENV HEA, V31, P179, DOI 10.5271/sjweh.867
   Muller G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002601
   Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037
   Nyberg ST, 2014, DIABETES CARE, V37, P2268, DOI 10.2337/dc13-2936
   Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x
   Saaristo TE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-423
   Sabanayagam C, 2009, ASIA-PAC J PUBLIC HE, V21, P385, DOI 10.1177/1010539509343958
   Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9
   Stumvoll M., 2007, TYPE 2 DIABETES PRIN, P13
   Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   van der Noordt M, 2014, OCCUP ENVIRON MED, V71, P730, DOI 10.1136/oemed-2013-101891
   Virtanen M, 2014, DIABETES CARE, V37, P2091, DOI 10.2337/dc13-2725
   World Health Organization, 1999, 992 WORLD HLTH ORG
NR 30
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD AUG
PY 2017
VL 11
IS 4
BP 365
EP 372
DI 10.1016/j.pcd.2017.03.010
PG 8
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA FA0VR
UT WOS:000405155200007
PM 28456438
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Bennich, BB
   Roder, ME
   Overgaard, D
   Egerod, I
   Munch, L
   Knop, FK
   Vilsboll, T
   Konradsen, H
AF Bennich, Birgitte B.
   Roder, Michael E.
   Overgaard, Dorthe
   Egerod, Ingrid
   Munch, Lene
   Knop, Filip K.
   Vilsboll, Tina
   Konradsen, Hanne
TI Supportive and non-supportive interactions in families with a type 2
   diabetes patient: an integrative review
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Review
DE Family; Interaction; Literature review; Support; Type 2 diabetes;
   Involvement
ID QUALITATIVE CONTENT-ANALYSIS; CROSS-NATIONAL BENCHMARKING;
   SELF-MANAGEMENT BEHAVIORS; SOCIAL-CONTROL; CHRONIC ILLNESS; NEEDS 2ND;
   INTERVENTIONS; ADHERENCE; HEALTH; ADULTS
AB Background: Type 2 diabetes and its management affect the patient and the close family potentially causing either psychological distress or increased sense of responsibility and collaboration in these families. Interactions between patient and family play an important role in maintaining lifestyle changes and diabetes self-management. The purpose of this integrative review was to summarise and assess published studies on the intra-family perspective of supportive and non-supportive interactions in families with a type 2 diabetes patient.
   Methods: Included in the review were published qualitative and quantitative studies that examined the intra-family perspective on supportive and non-supportive interactions. We searched the literature from 2000 to 2016 and the search strategy comprised the following databases: Cochrane, PubMed, CINAHL, Web of Science, PsycINFO and Psyc-ARTICLES as well as hand searching of reference lists. Quality assessment, data extraction and analysis were undertaken on all included studies.
   Results: We identified five eligible research papers. Employing content analysis three categories describing interactions were refined: Impact of practical action, impact of emotional involvement, and impact of communication content. Supportive interactions included encouraging communication and family collaboration in managing diet, medications, and blood glucose checking. Non-supportive interactions were visible irritation, nagging behaviour and refusing to share the burden of living with diabetes.
   Conclusion: The findings stress the importance of including both patient and family in clinical practice to target diabetes self-management adherence and well-being of the whole family. The majority of self-management occurs within the family environment. Therefore, the intra-family perspective of supportive and non-supportive interactions should be understood and addressed as the family members are interdependent and affected by each other. Future research assessing the impact of professional support and the family function will have the potential to improve the daily life and well-being of patients with type 2 diabetes as well as the whole family.
C1 [Bennich, Birgitte B.; Roder, Michael E.; Munch, Lene; Knop, Filip K.; Vilsboll, Tina] Univ Copenhagen, Gentofte Hosp, Ctr Diabet Res, Hellerup, Denmark.
   [Bennich, Birgitte B.; Overgaard, Dorthe; Munch, Lene] Metropolitan Univ Coll, Inst Nursing, Copenhagen N, Denmark.
   [Egerod, Ingrid] Copenhagen Univ Hosp, Intens Care Unit, Rigshosp, Copenhagen, Denmark.
   [Egerod, Ingrid] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.
   [Knop, Filip K.; Vilsboll, Tina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark.
   [Knop, Filip K.] Univ Copenhagen, Fac Hlth & Med Sci, NNF Ctr Basic Metab Res, Copenhagen, Denmark.
   [Vilsboll, Tina] Univ Copenhagen, Steno Diabet Ctr Copenhagen, Copenhagen, Denmark.
   [Konradsen, Hanne] Karolinska Inst, NVS, Dept Neurobiol Care Sci & Soc, Alfred Nobels Alle 23, S-14152 Hundinge, Sweden.
RP Konradsen, H (reprint author), Karolinska Inst, NVS, Dept Neurobiol Care Sci & Soc, Alfred Nobels Alle 23, S-14152 Hundinge, Sweden.
EM hanne.konradsen@ki.se
OI Konradsen, Hanne/0000-0002-7477-125X; Egerod, Ingrid/0000-0002-9576-4390
FU Research Foundation in the Capital Region of Denmark; Jascha Foundation
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: Financial
   support for this research was provided by the Research Foundation in the
   Capital Region of Denmark and the Jascha Foundation.
CR August KJ, 2013, J FAM PSYCHOL, V27, P712, DOI 10.1037/a0034181
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Baig AA, 2015, ANN NY ACAD SCI, V1353, P89, DOI 10.1111/nyas.12844
   Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   Chesla CA, 2010, J FAM NURS, V16, P355, DOI 10.1177/1074840710383145
   Costa V., 2012, EUROPEAN DIABETES NU, V9, P81
   Cowell JM, 2012, J SCH NURS, V28, P326, DOI 10.1177/1059840512458666
   Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x
   Daley B. J., 2010, HUMAN RESOURCES DEVE, V9, P357, DOI [DOI 10.1177/1534484310379101, 10.1177/1534484310379101]
   Dalton JM, 2014, SELF CARE DEPEND CAR, V21, P12
   de Lima Santos Aliny, 2014, Invest. educ. enferm, V32, P260, DOI 10.17533/udea.iee.v32n2a09
   Denham SA, 2011, DIABETES EDUCATOR, V37, P528, DOI 10.1177/0145721711411312
   Dimitraki G, 2014, INT J BEHAV MED, V21, P230, DOI 10.1007/s12529-013-9296-z
   Franks MM, 2006, J FAM PSYCHOL, V20, P311, DOI 10.1037/0893-3200.20.2.311
   GLASGOW RE, 1988, DIABETES CARE, V11, P377, DOI 10.2337/diacare.11.5.377
   Glasgow RE, 2014, TRANSL BEHAV MED, V4, P26, DOI 10.1007/s13142-013-0232-1
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Gunn KL, 2012, HEALTH SOC CARE COMM, V20, P591, DOI 10.1111/j.1365-2524.2012.01073.x
   Hartmann M, 2010, PSYCHOTHER PSYCHOSOM, V79, P136, DOI 10.1159/000286958
   Hornsten A, 2004, J ADV NURS, V47, P174, DOI 10.1111/j.1365-2648.2004.03076.x
   Houston-Barrett RA, 2014, J MARITAL FAM THER, V40, P92, DOI 10.1111/j.1752-0606.2012.00322.x
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   International Diabetes Federation, IDF DIABETES ATLAS
   Joanna Briggs Institute reviewers' manual, 2011, REV MAN
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kaufman G, 1998, J MARRIAGE FAM, V60, P924, DOI 10.2307/353635
   Kelly JB, 2007, FAM PROCESS, V46, P35, DOI 10.1111/j.1545-5300.2006.00190.x
   Kerr ME, 2000, PRIMER BOWEN THEORY
   King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746
   Kylma Jari, 2009, Palliat Support Care, V7, P365, DOI 10.1017/S1478951509990307
   Laranjo L, 2015, EUR J GEN PRACT, V21, P103, DOI 10.3109/13814788.2014.1000855
   Leong A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-12
   Lerman I, 2005, ARCH MED RES, V36, P300, DOI 10.1016/j.arcmed.2004.12.001
   Lewinski AA, 2015, CHRONIC ILLN
   Martire LM, 2010, ANN BEHAV MED, V40, P325, DOI 10.1007/s12160-010-9216-2
   Mayberry LS, 2015, J BEHAV MED, V38, P363, DOI 10.1007/s10865-014-9611-4
   Mayberry LS, 2014, PATIENT EDUC COUNS, V97, P418, DOI 10.1016/j.pec.2014.09.011
   Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029
   Miller TA, 2013, DIABETES METAB SYNDR, V6, P421, DOI 10.2147/DMSO.S36368
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   National Collaborating Centre for Methods and Tools: Critical Appraisal Skills Programme (CASP), 2014, CRIT APPR SKILLS PRO
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Oftedal B., 2014, EUR DIABETES NURS, V11, P43, DOI DOI 10.1002/EDN.247
   Okun MA, 2007, BASIC APPL SOC PSYCH, V29, P185, DOI 10.1080/01973530701332245
   Orvik E., 2010, EUR DIABETES NURS, V7, P63
   Ostlund U, 2014, J FAM NURS, V20, P259, DOI 10.1177/1074840714542962
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Rosland AM, 2010, CHRONIC ILLN, V6, P22, DOI 10.1177/1742395309354608
   Rosland AM, 2008, J GEN INTERN MED, V23, P1992, DOI 10.1007/s11606-008-0814-7
   Rubin RR, 2005, AM J MED, V118, P27, DOI 10.1016/j.amjmed.2005.04.012
   Sandberg J, 2006, J COUPLE RELATSH THE, V5, P23, DOI 10.1300/J398v05n02_02
   Stephens MAP, 2013, HEALTH PSYCHOL, V32, P1029, DOI 10.1037/a0030018
   Stephens MAP, 2009, HEALTH PSYCHOL, V28, P48, DOI 10.1037/a0012385
   Torenholt R, 2014, DIABETIC MED, V31, P15, DOI 10.1111/dme.12290
   Torge C. J., 2013, QUALITATIVE STUDIES, V4, P100
   Trief P., 2003, FAMILIES SYSTEMS HLT, V21, P57, DOI [DOI 10.1037/H0089502, 10.1037/h0089502]
   Trief P, 2011, FAM SYST HEALTH, V29, P253, DOI 10.1037/a0024564
   Tucker JS, 2001, J APPL SOC PSYCHOL, V31, P467, DOI 10.1111/j.1559-1816.2001.tb02051.x
   Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x
   Wright DDB, 2012, NURSES FAMILIES GUID
   Wright L. M., 1999, J FAMILY NURSING, V5, P259, DOI DOI 10.1177/107484079900500302
   Zoffmann V, 2005, QUAL HEALTH RES, V15, P750, DOI 10.1177/1049732304273888
NR 63
TC 5
Z9 5
U1 1
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD JUL 21
PY 2017
VL 9
AR 57
DI 10.1186/s13098-017-0256-7
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FC1HV
UT WOS:000406588900001
PM 28736580
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Paula, JS
   Braga, LD
   Moreira, RO
   Kupfer, R
AF Paula, Juliana Santos
   Braga, Leticia Dinis
   Moreira, Rodrigo Oliveira
   Kupfer, Rosane
TI Correlation between parameters of self-monitoring of blood glucose and
   the perception of health-related quality of life in patients with type 1
   diabetes mellitus
SO ARCHIVES OF ENDOCRINOLOGY METABOLISM
LA English
DT Article
DE Type 1 diabetes mellitus; hypoglycemia; self-monitoring of blood
   glucose; quality of life
ID GLYCEMIC CONTROL; SCALE; HYPOGLYCEMIA; DISTRESS; COHORT; AGENTS; TRIAL
AB Objective: The aim of this study was to evaluate how different parameters of short-term glycemic control would correlate with the perception of health-related quality of life (HRQoL) in patients with type 1 diabetes mellitus (T1D). Subjects and methods: A total of 50 T1D patients aged 18 to 50 years were evaluated with the questionnaires Problem Areas in Diabetes (PAID) scale and Diabetes Quality of Life (DQOL) measure after 30 days of self-monitoring of blood glucose (SMBG). Glycemic control was evaluated using glycated hemoglobin (HbA(1c)), mean glucose levels (MGL) in the prior month's data from SMBG (Accu-Check 360 degrees), number of hypoglycemic episodes (< 70 mg/dL and < 50 mg/dL), and glycemic variability (GV). Results: PAID correlated positively with MGL (r = 0.52; p < 0.001) and HbA(1c) (r = 0.36; p < 0.0097), but not with GV (r = 0.17; p = 0.23) or number of hypoglycemic episodes (r = 0.15; p = 0.17 for glucose < 70 mg/dL and r = 0.02; p = 0.85 for glucose < 50 mg/dL). After multiple linear regression, only MGL remained independently related to PAID scores. DQOL scores had a positive correlation with MGL (r = 0.45; p = 0.001), but not with HbA(1c) (r = 0.23; p = 0.09), GV (r = 0.20; p = 0.16), or number of hypoglycemic episodes (r = 0.06 p = 0.68). Conclusion: In T1D patients, MGL, but not HbA(1c) or number hypoglycemic episodes, was the glycemic control parameter that best correlated with short-term perception of HRQoL.
C1 [Paula, Juliana Santos; Braga, Leticia Dinis; Moreira, Rodrigo Oliveira; Kupfer, Rosane] Inst Estadual Diabet & Endocrinol Luiz Capriglion, Serv Diabet, Rio De Janeiro, RJ, Brazil.
RP Moreira, RO (reprint author), Inst Estadual Diabet & Endocrinol, Rua Moncorvo Filho 90, BR-20211340 Rio De Janeiro, RJ, Brazil.
EM rom_br@yahoo.com
CR Alcubierre N, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0131-2
   [Anonymous], 2015, DIABETES ATLAS
   CAREY MP, 1991, J BEHAV MED, V14, P43, DOI 10.1007/BF00844767
   de Souza ACCB, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0396-0
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Felicio JS, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0081-9
   Fenwick EK, 2011, BRIT J OPHTHALMOL, V95, P774, DOI 10.1136/bjo.2010.191312
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   Gusmai LD, 2015, REV ESC ENFERM USP, V49, P832, DOI 10.1590/S0080-623420150000500019
   Hermanns N, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0279-4
   Johnson SR, 2013, DIABETIC MED, V30, P1126, DOI 10.1111/dme.12247
   Jones A, 2016, PRIM CARE DIABETES, V10, P83, DOI 10.1016/j.pcd.2015.03.008
   Kuznetsov L, 2015, DIABETES-METAB RES, V31, P69, DOI 10.1002/dmrr.2559
   Kuznetsov L, 2014, DIABETES RES CLIN PR, V104, P281, DOI 10.1016/j.diabres.2013.12.029
   Maia Frederico F.R., 2004, Arq Bras Endocrinol Metab, V48, P261, DOI 10.1590/S0004-27302004000200009
   Matziou V, 2011, J DIABETES, V3, P82, DOI 10.1111/j.1753-0407.2010.00106.x
   Papelbaum M, 2010, DIABETES RES CLIN PR, V89, P227, DOI 10.1016/j.diabres.2010.05.024
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   */* S  81, 2014, DIABETES CARE S1, V37, pS8, DOI DOI 10.2337/DC14-S081
   Schunk M, 2015, J DIABETES COMPLICAT, V29, P203, DOI 10.1016/j.jdiacomp.2014.11.010
   Sheu WHH, 2012, DIABETES RES CLIN PR, V96, P141, DOI 10.1016/j.diabres.2011.12.027
   Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021
   Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306
   Aguiar CCT, 2008, ARQ BRAS ENDOCRINOL, V52, P931, DOI 10.1590/S0004-27302008000600004
   Vanstone Meredith, 2015, Ont Health Technol Assess Ser, V15, P1
   WHOQL Group, 1997, PROGR MENT HLTH
   Wikblad K, 1996, QUAL LIFE RES, V5, P123, DOI 10.1007/BF00435977
NR 27
TC 1
Z9 1
U1 0
U2 1
PU SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
PI RIO DE JANEIRO, RJ
PA RUA HUMAITA, 85 CJ 501, RIO DE JANEIRO, RJ, 22261-000, BRAZIL
SN 2359-3997
EI 2359-4292
J9 ARCH ENDOCRIN METAB
JI Arch. Endocrinol. Metab.
PD JUL-AUG
PY 2017
VL 61
IS 4
BP 343
EP 347
DI 10.1590/2359-3997000000222
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FN4UW
UT WOS:000416003200007
PM 27901179
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Deeb, A
AF Deeb, Asma
TI Challenges of Diabetes Management in Toddlers
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Review
DE Toddlers; Hypoglycemia; Glucose monitoring; Insulin pumps; Psychology
ID SUBCUTANEOUS INSULIN INFUSION; YOUNG-CHILDREN; GLYCEMIC CONTROL; PUMP
   THERAPY; MELLITUS; HYPOGLYCEMIA; ADOLESCENTS; ASSOCIATION; CHILDHOOD;
   COMPLICATIONS
AB Toddlers with type 1 diabetes have distinctive combination of challenges to their families and healthcare providers. A major factor is the difficulty in achieving metabolic control without risking hypoglycemia. The rising incidence of type 1 diabetes in toddlers increases the magnitude of the problem and creates a greater need for providing specialized service to cater for this age group's unique need. Type 1 has a specific disease nature in younger children and its clinical presentation mimics common childhood diseases. Symptoms and signs in the newly presented toddler with diabetes might be unspecific causing diagnosis to be missed or delayed. With the low cognitive ability and immature communication, toddlers might not be able to express their ill-feeling resulting from hypoglycemia or hyperglycemia. Hypoglycemia fear is common, which aggravates stress and reduces adherence to strict metabolic control. Nocturnal hypoglycemia is more common in toddlers and can be undiagnosed unless continuous glucose monitoring is used. Insulin administration and adjustment can be challenging due to pain, fear, refusal, and frequent intercurrent illness. Glucose monitoring is crucial. However, it can be distressing to the child and difficult to adhere to due to commitment or financial reasons. Insulin pump therapy is proven to be an effective and a safe method of treatment for toddlers, but it requires intensive training, resources, and long-term support. Provision of multidisciplinary team with special expertise in managing toddlers with diabetes is essential. Providing more physiological insulin regimes and customized technology is required to improve treatment compliance and diabetes control.
C1 [Deeb, Asma] Mafraq Hosp, Paediat Endocrinol Dept, Abu Dhabi 2951, U Arab Emirates.
RP Deeb, A (reprint author), Mafraq Hosp, Paediat Endocrinol Dept, Abu Dhabi 2951, U Arab Emirates.
EM adeeb@mafraqhospital.ae
CR Abul-Ainine AA, 2014, PEDIATR DIABETES, V15, P319, DOI 10.1111/pedi.12087
   Adolfsson P, 2017, PEDIATR DIABETES, V18, P255, DOI 10.1111/pedi.12491
   Alharfi IM, 2014, PEDIATR EMERG CARE, V30, P485, DOI 10.1097/PEC.0000000000000167
   AMAN J, 1988, ACTA PAEDIATR SCAND, V77, P548, DOI 10.1111/j.1651-2227.1988.tb10698.x
   American DA, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   Anderson B, 1997, J PEDIATR-US, V130, P257, DOI 10.1016/S0022-3476(97)70352-4
   Anderson BJ, 2001, J PEDIATR ENDOCR MET, V14, P645
   [Anonymous], 2016, NICE GUID DIAB TYP 1
   Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x
   Braun M, 2016, J DIABETES RES, DOI 10.1155/2016/5490258
   Ceriello A, 2013, DIABETES CARE, V36, pS272, DOI 10.2337/dcS13-2030
   Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140
   Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9
   Daneman D, 1999, Paediatr Child Health, V4, P57
   Davis EA, 1998, ARCH DIS CHILD, V78, P111, DOI 10.1136/adc.78.2.111
   Deiss D, 2001, DIABETIC MED, V18, P337, DOI 10.1046/j.1464-5491.2001.00429-3.x
   Desrocher M, 2004, CHILD NEUROPSYCHOL, V10, P36, DOI 10.1076/chin.10.1.36.26241
   Diabetes Australia, INF PAR KIDS AG 0 2
   Doyle Boland EA, 2005, DIABETES ED, V31, P584
   Doyle FJ, 2014, DIABETES CARE, V37, P1191, DOI 10.2337/dc13-2108
   DRAELOS MT, 1995, AM J MED, V98, P135, DOI 10.1016/S0002-9343(99)80397-0
   Flanagan SE, 2014, CELL METAB, V19, P146, DOI 10.1016/j.cmet.2013.11.021
   Frank M, 1986, CLIN DIABETES, V4, P121
   Fuld K, 2010, DIABETES TECHNOL THE, V12, pS67, DOI 10.1089/dia.2009.0182
   Gardner SG, 1997, BMJ-BRIT MED J, V315, P712
   Garg SK, 2017, DIABETES TECHNOL THE, V19, P155, DOI 10.1089/dia.2016.0421
   Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1
   HATTON DL, 1995, J ADV NURS, V22, P569, DOI 10.1046/j.1365-2648.1995.22030569.x
   HELLER SR, 1991, DIABETES, V40, P223, DOI 10.2337/diabetes.40.2.223
   Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303
   Katte JC, 2015, PAN AFR MED J, V24, P293
   Kaufman FR, 2002, J PEDIATR-US, V141, P625, DOI 10.1067/mpd.2002.129175
   Komulainen J, 1999, DIABETES CARE, V22, P1950, DOI 10.2337/diacare.22.12.1950
   Kushion W, 1991, Diabetes Educ, V17, P107, DOI 10.1177/014572179101700217
   Lang EG, 2017, PEDIATR DIABETES, V18, P26, DOI 10.1111/pedi.12357
   Littom J, 2002, J PEDIATR-US, V141, P490, DOI 10.1067/mpd.2002.127500
   Mack-Fogg JE, 2005, PEDIATR DIABETES, V6, P17, DOI 10.1111/j.1399-543X.2005.00090.x
   Muhammad J, 1999, ARCH DIS CHILD, V80, P367, DOI 10.1136/adc.80.4.367
   Nordfeldt S, 1999, ACTA PAEDIATR, V88, P1184, DOI 10.1080/080352599750030275
   Northam EA, 1998, DIABETES CARE, V21, P379, DOI 10.2337/diacare.21.3.379
   Patton SR, 2006, J DEV BEHAV PEDIATR, V27, P202, DOI 10.1097/00004703-200606000-00004
   Patton Susana R, 2017, J Diabetes Sci Technol, V11, P87, DOI 10.1177/1932296816658901
   Patton SR, 2017, DIABETES TECHNOL THE, V19, P103, DOI 10.1089/dia.2016.0389
   Paul P, 2005, ARCH DIS CHILD, V90, pA19
   Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759
   Peters A., 2013, AM DIABETES ASS JDRF
   Porter PA, 1999, J PEDIAT, V130, P366
   Raine JE, 2006, PRACTICAL ENDOCRINOL, P1
   Rewers M, 2004, TYPE 1 DIABETES CELL
   Rubio-Cabezas O, 2013, HORM RES PAEDIAT, V80, P137, DOI 10.1159/000354219
   Rutledge KS, 1997, PEDIATRICS, V100, P968, DOI 10.1542/peds.100.6.968
   Ryan CM, 1999, J PEDIAT, V117, P32
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977
   Tsalikian Eva, 2012, Pediatr Diabetes, V13, P301, DOI 10.1111/j.1399-5448.2011.00837.x
   Villafuerte QB, 2017, ENDOCRINOL DIABETES, V64, P198
   Virk SA, 2016, J CLIN ENDOCR METAB, V101, P3257, DOI 10.1210/jc.2015-3604
   Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568
   WYSOCKI T, 1989, DIABETES CARE, V12, P524, DOI 10.2337/diacare.12.8.524
NR 59
TC 1
Z9 1
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD JUL
PY 2017
VL 19
IS 7
BP 383
EP 390
DI 10.1089/dia.2017.0130
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FB3JE
UT WOS:000406038000001
PM 28686045
DA 2019-01-08
ER

PT J
AU Gomez, AM
   Carrillo, LFM
   Correa, CMA
   Velandia, OMM
   Sepulveda, MAR
   Herrera, JLS
   Carrillo, DCH
AF Gomez, Ana Maria
   Marin Carrillo, Lisseth Fernanda
   Arevalo Correa, Carol M.
   Munoz Velandia, Oscar Mauricio
   Rondon Sepulveda, Martin Alonso
   Silva Herrera, Jaime Luis
   Henao Carrillo, Diana Cristina
TI Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in
   Sensor-Augmented Insulin Pump Therapy
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
DE Sensor-augmented pump therapy-Low-glucose suspension; Continuous glucose
   monitoring; Pregnancy; Type 1 diabetes mellitus; Severe hypoglycemia and
   maternal-fetal outcomes
ID INFUSION; HYPOGLYCEMIA; KETOACIDOSIS; DELIVERY; CARE
AB Background: Pregnancy in women with type 1 diabetes (T1D) is associated with increased risk of maternal complications and neonatal morbidity and mortality. Optimizing glycemic control improves these outcomes.
   Objective: To describe the experience of using sensor-augmented insulin pump therapy (SAPT) and SAPT + low-glucose suspension (LGS) on pregnant women with T1D, including neonatal and maternal outcomes.
   Methods: A prospective observational study was conducted in women with T1D who started SAPT and SAPT + LGS before or during pregnancy at the San Ignacio University Hospital Diabetes Center in Bogota',Colombia. The main indication was severe hypoglycemia (SH) and poor glycemic control. Glycated hemoglobin (A1c), hypoglycemia, and maternal and fetal outcomes were assessed.
   Results: Thirty-four pregnant women with T1D on SAPT and SAPT + LGS were included. Sixteen patients started therapy during pregnancy at a mean gestational age of 17.6 +/- 8.3 weeks. Mean preconceptional A1c was 8.24%+/- 2.02%. Absolute reduction ofA1c level from prepregnancy to third trimesterwas -1.63% (P<0.0001), with a significant clinical and statistical reduction in both groups, women who initiated SAPT before or during pregnancy. 52.9% of patients in second trimester and 66.6% in third trimester achieved A1c <6.5%, respectively. 91.1% underwent cesarean section. The main reasons were iterative cesarean (30%), fetal distress (20%), and preeclampsia (16%). The median gestational age at delivery was 37 weeks and 15 pregnancies resulted in preterm delivery. There was neither maternal-fetal mortality nor severe hypoglycemic episodes. Two patients had diabetic ketoacidosis.
   Conclusions: In pregnant patients with T1D and high risk of hypoglycemia, SAPT and SAPT + LGS should be considered as a therapeutic alternative for A1c reduction with a low risk of SH. However, additional studies are required to evaluate the efficacy and safety of this therapy during pregnancy.
C1 [Gomez, Ana Maria; Marin Carrillo, Lisseth Fernanda; Arevalo Correa, Carol M.; Henao Carrillo, Diana Cristina] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Div Endocrinol, Bogota, Colombia.
   [Munoz Velandia, Oscar Mauricio] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Internal Med, Bogota, Colombia.
   [Munoz Velandia, Oscar Mauricio; Rondon Sepulveda, Martin Alonso] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Clin Epidemiol & Stat, Bogota, Colombia.
   [Silva Herrera, Jaime Luis] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Dept Gynecol & Obstet, Bogota, Colombia.
RP Gomez, AM (reprint author), Hosp Univ San Ignacio, Endocrinol Unit, Carrera 7 40-62, Bogota 110231, Colombia.
EM amgomezm5@gmail.com
OI Henao-Carrillo, Diana Cristina/0000-0002-1353-148X; SILVA HERRERA, JAIME
   LUIS/0000-0001-6822-0374; Gomez-Medina, Ana Maria/0000-0002-8907-3470
FU Novo Nordisk; Elli Lilly; MSD; Novartis; Medtronic; Abbott
FX The authors declared the following potential conflicts of interest with
   respect to research, authorship, and/or publication of this article:
   A.M.G. reports speaker fees from Novo Nordisk, Elli Lilly, MSD,
   Novartis, and Medtronic and research grants from Medtronic, Novartis,
   Novo Nordisk, and Abbott. C.M.A. receives fees for insulin pump patient
   training with Medtronic. D.C.H.C. reports speaker fees from Novo Nordisk
   and research grants from Novo Nordisk. No other potential conflicts are
   reported.
CR Bergenstal RM, 2013, DIABETES TECHNOL THE, V15, P198, DOI 10.1089/dia.2013.0051
   Bruttomesso D, 2011, DIABETES METAB, V37, P426, DOI 10.1016/j.diabet.2011.02.002
   Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016
   Dalfra MG, 2016, J MATERN-FETAL NEO M, V29, P2889, DOI 10.3109/14767058.2015.1107903
   Evers IN, 2004, BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE
   Farrar D, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005542.pub3
   Fresa R, 2013, DIABETES TECHNOL THE, V15, P328, DOI 10.1089/dia.2012.0260
   Medina AMG, 2011, AV DIABETOL, V27, P143, DOI 10.1016/j.avdiab.2011.08.003
   Kallas-Koeman MM, 2014, DIABETOLOGIA, V57, P681, DOI 10.1007/s00125-014-3163-6
   Maresh MJA, 2015, DIABETES CARE, V38, P34, DOI 10.2337/dc14-1755
   Gomez AM, 2017, DIABETES TECHNOL THE, V19, P109, DOI 10.1089/dia.2016.0332
   Mukhopadhyay A, 2007, AM J OBSTET GYNECOL, V197, P447, DOI 10.1016/j.ajog.2007.03.062
   Neff KJ, 2014, IRISH J MED SCI, V183, P397, DOI 10.1007/s11845-013-1027-6
   Nielsen LR, 2008, DIABETES CARE, V31, P9, DOI 10.2337/dc07-1066
   Petrovski G, 2011, DIABETES TECHNOL THE, V13, P1109, DOI 10.1089/dia.2011.0081
   Polsky S, 2016, POSTGRAD MED, V128, P418, DOI 10.1080/00325481.2016.1159910
   Stewart ZA, 2016, NEW ENGL J MED, V375, P644, DOI 10.1056/NEJMoa1602494
NR 17
TC 2
Z9 2
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD JUL
PY 2017
VL 19
IS 7
BP 417
EP 422
DI 10.1089/dia.2017.0030
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FB3JE
UT WOS:000406038000006
PM 28731823
DA 2019-01-08
ER

PT J
AU Dahal, KA
   Premji, S
   Patel, AB
   Williamson, T
   Peng, MK
   Metcalfe, A
AF Dahal, Kamala Adhikari
   Premji, Shahirose
   Patel, Alka B.
   Williamson, Tyler
   Peng, Mingkai
   Metcalfe, Amy
TI Variation in Maternal Co-morbidities and Obstetric Interventions across
   Area-Level Socio-economic Status: A Cross-Sectional Study
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Article
DE area-level socio-economic status; maternal co-morbidities; obstetric
   interventions; prolonged hospital stay
ID PSYCHOLOGICAL DISTRESS; ADMINISTRATIVE DATA; MULTILEVEL ANALYSIS;
   CESAREAN-SECTIONS; OUTCOMES; HEALTH; COMORBIDITY; ASSOCIATION;
   PREGNANCY; CANADA
AB Background: Multiple studies indicate a significant association between area-level socio-economic status (SES) and adverse maternal health outcomes; however, the impact of area-level SES on maternal co-morbidities and obstetric interventions has not been examined.
   Objective: To examine the variation in maternal co-morbidities and obstetric interventions across area-level SES.
   Methods: This study used data from the Discharge Abstract Database that comprised birth data in Alberta between 2005-2007 (n = 120 285). Co-morbidities and obstetric interventions were identified using validated case-definitions. Material deprivation index was obtained for each dissemination area through linkage of hospitalisation and census data. Multilevel logistic regression was used to analyse the data adjusting for potential confounding variables.
   Results: The prevalence of any co-morbidity varied across area-level SES. Drug abuse odds ratio (OR) 2.5 (95% confidence interval (CI) 1.8, 3.5), pre-existing diabetes OR 1.7 (95% CI 1.1, 2.6), and prolonged hospital stay OR 1.5 (95% CI 1.4, 1.6) were significantly more likely to occur in the most deprived areas compared to the least deprived areas. In contrast, caesarean delivery OR 0.9 (95% CI 0.8, 0.9) was less likely to occur in the most deprived areas compared to the least deprived areas. Area-level deprivation explained area-level variance of drug abuse, HIV, and other mental diseases only.
   Conclusion: Many co-morbidities and obstetric interventions vary at the area-level, but only some are associated with area-level SES, and few of them vary due to the area-level SES. This indicates that other area-level factors, in addition to area-level SES, need to be considered when investigating maternal health and use of health interventions.
C1 [Dahal, Kamala Adhikari; Premji, Shahirose; Patel, Alka B.; Williamson, Tyler; Peng, Mingkai; Metcalfe, Amy] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.
   [Premji, Shahirose] Univ Calgary, Fac Nursing, Calgary, AB, Canada.
   [Patel, Alka B.] Alberta Hlth Serv, Appl Res & Evaluat Serv Primary Hlth Care, Calgary, AB, Canada.
   [Metcalfe, Amy] Univ Calgary, Dept Obstet & Gynecol, Calgary, AB, Canada.
RP Metcalfe, A (reprint author), Foothills Med Ctr, Calgary, AB, Canada.
EM amy.metcalfe@albertahealthservices.ca
CR Alberta Reproductive Health Report Working Group, 2011, ALB REPR HLTH PREGN
   Alberta Services Services, 2016, US PAMP DEPR IND ALB
   [Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb
   Auger N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-67
   BARROS FC, 1991, LANCET, V338, P167, DOI 10.1016/0140-6736(91)90149-J
   Comstock EE, 2016, J ASSOC NURSE AIDS C, V27, P98, DOI 10.1016/j.jana.2015.08.006
   Fairley L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-330
   Fiest KM, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0289-5
   Fridman M, 2014, AM J PUBLIC HEALTH, V104, pS49, DOI 10.2105/AJPH.2013.301583
   GOULD JB, 1989, NEW ENGL J MED, V321, P233, DOI 10.1056/NEJM198907273210406
   *HLTH CAN, 2000, PER HLTH IND CAN RES
   Hu WS, 2016, CLIN EXP OBSTET GYN, V43, P212
   Joseph KS, 2010, J OBSTET GYNAECOL CA, V32, P837, DOI 10.1016/S1701-2163(16)34655-2
   KAWACHI I, 2003, NEIGHBORHOOD HLTH
   KESSLER RC, 1979, J HEALTH SOC BEHAV, V20, P259, DOI 10.2307/2136450
   Leeb Kira, 2005, Healthc Policy, V1, P48
   Marrie RA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-16
   Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310
   Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454
   Metcalfe A, 2015, BJOG-INT J OBSTET GY, V122, P1748, DOI 10.1111/1471-0528.13254
   Metcalfe A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012007
   Metcalfe A, 2011, PAEDIATR PERINAT EP, V25, P236, DOI 10.1111/j.1365-3016.2011.01192.x
   Nagahawatte NT, 2008, ANN NY ACAD SCI, V1136, P80, DOI 10.1196/annals.1425.016
   Pampalon R, 2000, Chronic Dis Can, V21, P104
   Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P900, DOI 10.1136/jech.2004.023036
   Roos NP, 1997, MILBANK Q, V75, P89, DOI 10.1111/1468-0009.00045
   Saint-Jacques N, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0094-2
   Southern DA, 2005, MED CARE, V43, P1116, DOI 10.1097/01.mlr.0000182517.57235.6d
   Statistics Canada, TABL 102 4516 LIV BI
   Statistics Canada, 2016, 2011 NAT HOUS SURV C
   Statistics Canada, POP GROWTH AG STRUCT
   Tough S, 2006, CLIN MED RES, V4, P97, DOI 10.3121/cmr.4.2.97
   Wen SW, 2005, CAN MED ASSOC J, V173, P759, DOI 10.1503/cmaj.045156
   Yang SM, 2015, MATERN CHILD HLTH J, V19, P1142, DOI 10.1007/s10995-014-1623-8
   Zhao YJ, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-79
NR 35
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD JUL
PY 2017
VL 31
IS 4
BP 274
EP 283
DI 10.1111/ppe.12370
PG 10
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA FB0HY
UT WOS:000405827300005
PM 28590511
DA 2019-01-08
ER

PT J
AU Corathers, SD
   Mara, CA
   Chundi, PK
   Kichler, JC
AF Corathers, Sarah D.
   Mara, Constance A.
   Chundi, Pavan K.
   Kichler, Jessica C.
TI Psychosocial Patient-Reported Outcomes in Pediatric and Adolescent
   Diabetes: a Review and Case Example
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Psychosocial; Patient-reported outcome (PRO); Adolescent; Diabetes
ID QUALITY-OF-LIFE; ROUTINE CLINICAL-PRACTICE; SELF-CARE;
   METABOLIC-CONTROL; PSYCHOMETRIC PROPERTIES; POSITION STATEMENT;
   CONTROLLED-TRIAL; SOCIAL SUPPORT; SCREENING TOOL; TYPE-1
AB Purpose of Review The purpose of this review is to define psychosocial patient-reported outcomes (PROs) relevant to pediatric and adolescent diabetes populations. Potential domains for PROs include a spectrum of emotional, behavioral, social, physical, overall health, and/or care management areas. A literature review of potential PRO measures, selection criteria, and implementation strategies including a case example will be presented.
   Recent Findings Among the pediatric, adolescent, and emerging adult populations, research indicates a relative higher risk for distress, depression, anxiety, and eating disorders as compared to peers without diabetes. Use of PRO measures can expand providers' focus beyond glycemic control, or simply hemoglobin A1c, to better appreciate the impact of diabetes on the whole child/adolescent, and provide services that address patients' individually identified needs, which are most salient to them.
   Summary Successful selection and implementation of psychosocial PRO measures should be designed to include pathways for real-time provider interaction with the patient and respective PRO data to guide clinical care.
C1 [Corathers, Sarah D.] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, 3333 Burnet Ave,MLC 7012, Cincinnati, OH 45229 USA.
   [Corathers, Sarah D.; Chundi, Pavan K.] Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA.
   [Mara, Constance A.; Kichler, Jessica C.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA.
RP Corathers, SD (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, 3333 Burnet Ave,MLC 7012, Cincinnati, OH 45229 USA.; Corathers, SD (reprint author), Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA.
EM sarah.corathers@cchmc.org; constance.mara@cchmc.org;
   pavan.chundi@cchmc.org; jessica.kichler@cchmc.org
CR Allgaier AK, 2012, J PSYCHOSOM RES, V73, P369, DOI 10.1016/j.jpsychores.2012.08.016
   Almario CV, 2016, AM J GASTROENTEROL, V111, P1546, DOI 10.1038/ajg.2016.305
   [Anonymous], 2017, DIABETES CARE S1, V40, pS4
   Berwick DM, 2016, JAMA-J AM MED ASSOC, V315, P1329, DOI 10.1001/jama.2016.1509
   BROWNLEEDUFFECK M, 1987, J CONSULT CLIN PSYCH, V55, P139, DOI 10.1037//0022-006X.55.2.139
   Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140
   Corathers SD, 2013, PEDIATRICS, V132, pE1395, DOI 10.1542/peds.2013-0681
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   de Wit M, 2010, PEDIATR DIABETES, V11, P175, DOI 10.1111/j.1399-5448.2009.00543.x
   De Wit M, 2008, DIABETES CARE, V31, P1521, DOI 10.2337/dc08-0394
   Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191
   Forrest CB, 2014, QUAL LIFE RES, V23, P1221, DOI 10.1007/s11136-013-0581-8
   Garvey KC, 2016, DIABETES CARE
   GREEN LB, 1990, J PEDIATR PSYCHOL, V15, P633, DOI 10.1093/jpepsy/15.5.633
   Greenhalgh J, 2005, SOC SCI MED, V60, P833, DOI 10.1016/j.socscimed.2004.06.022
   Hilliard ME, 2013, DIABETES CARE, V36, P1891, DOI 10.2337/dc12-1708
   Hilliard ME, 2011, DIABETES RES CLIN PR, V94, P39, DOI 10.1016/j.diabres.2011.05.027
   Hood KK, 2007, DIABETES CARE, V30, P1764, DOI 10.2337/dc06-2358
   Iturralde E, 2016, HLTH PSYCHOL
   Kamps JL, 2005, J PEDIATR PSYCHOL, V30, P287, DOI 10.1093/jpepsy/jsi038
   Kovacs M, 2003, CHILDRENS DEPRESSION
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   La Greca AM, 2002, J PEDIATR PSYCHOL, V27, P665, DOI 10.1093/jpepsy/27.8.665
   Langley GJ, 2009, IMPROVEMENT GUIDE PR, pxxi
   Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690
   Lohr K, 2009, QUAL LIFE RES, V18, P99, DOI 10.1007/s11136-008-9413-7
   Markowitz JT, 2010, DIABETES CARE, V33, P495, DOI 10.2337/dc09-1890
   MELAMED S, 1992, BEHAV MED, V18, P53, DOI 10.1080/08964289.1992.9935172
   Modi AC, 2012, PEDIATRICS, V129, pE473, DOI 10.1542/peds.2011-1635
   Mulvaney SA, 2011, DIABETES RES CLIN PR, V94, P77, DOI 10.1016/j.diabres.2011.06.010
   Owens JA, 2000, SLEEP, V23, P1043
   Owens JA, 2000, ARCH PEDIAT ADOL MED, V154, P549, DOI 10.1001/archpedi.154.6.549
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   PROCIDANO ME, 1983, AM J COMMUN PSYCHOL, V11, P1, DOI 10.1007/BF00898416
   Pyatak EA, 2017, J ADOLESCENT HEALTH, V60, P212, DOI 10.1016/j.jadohealth.2016.09.004
   Rodbard HW, 2017, DIABETES CARE, V40, P171, DOI 10.2337/dc16-1353
   Rose M, 2009, QUAL LIFE RES, V18, P125, DOI 10.1007/s11136-008-9436-0
   RUBIN RR, 1989, DIABETES CARE, V12, P673, DOI 10.2337/diacare.12.10.673
   Santana MJ, 2015, QUAL LIFE RES, V24, P1707, DOI 10.1007/s11136-014-0903-5
   SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Sharifi A, 2016, DIABETES TECHNOL THE, V18, P772, DOI 10.1089/dia.2016.0288
   Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155
   Tanenbaum ML, 2017, DIABETES CARE, V40, P181, DOI 10.2337/dc16-1536
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55
   Varni JW, 2015, J PEDIATR PSYCHOL, V40, P591, DOI 10.1093/jpepsy/jsv005
   Varni JW, 2013, QUAL LIFE RES, V22, P2169, DOI 10.1007/s11136-012-0339-8
   Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006
   Tran VT, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-109
   Weissberg-Benchell Jill, 2016, J Diabetes Sci Technol, V10, P799, DOI 10.1177/1932296815619637
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 59
TC 2
Z9 2
U1 1
U2 15
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD JUL
PY 2017
VL 17
IS 7
AR 45
DI 10.1007/s11892-017-0872-5
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EZ2KM
UT WOS:000404538200001
PM 28508255
DA 2019-01-08
ER

PT J
AU Swoboda, CM
   Miller, CK
   Wills, CE
AF Swoboda, Christine M.
   Miller, Carla K.
   Wills, Celia E.
TI Impact of a goal setting and decision support telephone coaching
   intervention on diet, psychosocial, and decision outcomes among people
   with type 2 diabetes
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Type 2 diabetes mellitus; Decision support; Goal setting; Self-efficacy;
   Telephone coaching; Randomized controlled trial
ID PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; SELF-MANAGEMENT; DISTRESS SCALE;
   MULTIPLE; BEHAVIOR; ADULTS; CARE; COACTION; SINGLE
AB Objective: Evaluate a 16-week decision support and goal-setting intervention to compare diet quality, decision, and diabetes-related outcomes to a control group.
   Methods: Adults with type 2 diabetes (n = 54) were randomly assigned to an intervention or control group. Intervention group participants completed one in-person motivational interviewing and decision support session followed by seven biweekly telephone coaching calls. Participants reported previous goal attempts and set diet-and/or physical activity-related goals during coaching calls. Control group participants received information about local health care resources on the same contact schedule.
   Results: There was a significant difference between groups for diabetes empowerment (p = 0.045). A significant increase in diet quality, diabetes self-efficacy, and diabetes empowerment, and a significant decrease in diabetes distress and depressive symptoms (all p <= 0.05) occurred in the intervention group. Decision confidence to achieve diet-related goals significantly improved from baseline to week 8 but then declined at study end (both p <= 0.05).
   Conclusions: Setting specific diet-related goals may promote dietary change, and telephone coaching can improve psychosocial outcomes related to diabetes self-management.
   Practice implications: Informed shared decision making can facilitate progressively challenging yet attainable goals tailored to individuals' lifestyle. Decision coaching may empower patients to improve self-management practices and reduce distress. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Swoboda, Christine M.] Ohio State Univ, Dept Human Sci, Human, Nutr, Columbus, OH 43210 USA.
   [Miller, Carla K.] Ohio State Univ, Human Nutr, Dept Human Sci, 1787 Neil Ave,325 Campbell Hall, Columbus, OH 43210 USA.
   [Wills, Celia E.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA.
   [Swoboda, Christine M.] Ohio State Univ, Dept Family Med, Columbus, OH 43210 USA.
RP Miller, CK (reprint author), Ohio State Univ, Human Nutr, Dept Human Sci, 1787 Neil Ave,325 Campbell Hall, Columbus, OH 43210 USA.
EM miller.4453@osu.edu
OI Miller, Carla/0000-0002-1002-7288; Swoboda,
   Christine/0000-0002-2085-2126
FU Ohio State University Department of Human Sciences
FX Funding for this research was provided by The Ohio State University
   Department of Human Sciences, which had no role in study design,
   analyses or interpretation.
CR Alden Dana L, 2013, Hawaii J Med Public Health, V72, P396
   American Diabetes Association, 2017, Diabetes Care, V40, pS75
   American Diabetes Association, 2017, Diabetes Care, V40, pS33
   American Diabetes Association, 2017, Diabetes Care, V40, pS48
   Anderson AR, 2010, DIABETES SPECTRUM, V23, P97, DOI [10.2337/diaspect.23.2.97, DOI 10.2337/DIASPECT.23.2.97]
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Bailey RA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1262-4
   Baldoni N.R., 2016, PRIM CARE DIABETES
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741
   Corser W, 2007, DIABETES EDUCATOR, V33, P700, DOI 10.1177/0145721707304086
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glasgow RE, 1996, DIABETES CARE, V19, P835, DOI 10.2337/diacare.19.8.835
   Graham I, 1995, USER MANUAL PREPARAT
   Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016
   Guenther PM, 2010, J NUTR, V2014, P399, DOI DOI 10.3945/
   Gunathilake Waruna, 2013, J Diabetes Sci Technol, V7, P653
   HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114
   Horner NK, 2002, AM J CLIN NUTR, V76, P766
   Johnson SS, 2014, HEALTH PSYCHOL, V33, P475, DOI 10.1037/a0034215
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Lafata JE, 2013, PATIENT EDUC COUNS, V92, P94, DOI 10.1016/j.pec.2013.01.016
   Lakerveld J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-17
   Locke E. A., 1990, THEORY GOAL SETTING
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Mathers N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001469
   Miller CK, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0509-x
   Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293
   Naik AD, 2011, ARCH INTERN MED, V171, P453, DOI 10.1001/archinternmed.2011.70
   O' Connor A. M, 1995, USER MANUAL DECISION
   O'Connor AM, 1998, PATIENT EDUC COUNS, V33, P267, DOI 10.1016/S0738-3991(98)00026-3
   OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105
   OConnor AM, 2000, USER MANUAL STAGE DE
   Paiva AL, 2012, PREV MED, V54, P331, DOI 10.1016/j.ypmed.2012.02.017
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Price AE, 2013, J AGING PHYS ACTIV, V21, P348, DOI 10.1123/japa.21.3.348
   Stacey D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub4
   Sweet SN, 2010, INT J ENV RES PUB HE, V7, P1720, DOI 10.3390/ijerph7041720
   Swoboda CM, 2016, DIABETES EDUCATOR, V42, P429, DOI 10.1177/0145721716650043
   Tanenbaum ML, 2016, J DIABETES COMPLICAT, V30, P1060, DOI 10.1016/j.jdiacomp.2016.04.023
   Volk R., 2012, 2012 IPDAS BACKGROUN
   Wills Celia E, 2003, Health Expect, V6, P149, DOI 10.1046/j.1369-6513.2003.00220.x
NR 45
TC 3
Z9 3
U1 4
U2 24
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD JUL
PY 2017
VL 100
IS 7
BP 1367
EP 1373
DI 10.1016/j.pec.2017.02.007
PG 7
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA FA2LI
UT WOS:000405272500016
PM 28215827
DA 2019-01-08
ER

PT J
AU Chiu, CJ
   Tseng, YH
   Hsu, YC
   Wu, ST
AF Chiu, Ching-Ju
   Tseng, Yu-Hsuan
   Hsu, Yu-Ching
   Wu, Shang-Te
TI Depressive symptom trajectories in the first 10 years of diabetes
   diagnosis: antecedent factors and link with future disability in Taiwan
SO SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
LA English
DT Article
DE Diabetes; Depressive symptoms; Long-term trajectories; Middle-aged and
   older adults
ID COMORBID DEPRESSION; SELF-CARE; MEDICATION ADHERENCE; ADULTS;
   PREVALENCE; MELLITUS; METAANALYSIS; COMMUNITY; IMPACT
AB ion, less This study identified depressive symptom trajectories in the years after diabetes diagnosis, examined factors that predict the probability for people following a specific trajectory, and investigated how the trajectories are associated with subsequent disability.
   We drew data from a nationally representative survey in Taiwan to identify adults aged 50 and older diagnosed with diabetes; 487 patients newly diagnosed with diabetes during 1996-2007 were included. Time axis was set to zero when diabetes was first reported in any given wave in the survey, and data related to depressive symptoms after that were recorded. We used group-based semi-parametric mixture models to identify trajectories of depressive symptoms and multinomial logistic regressions to examine factors associated with the trajectories.
   Older adults with newly diagnosis of diabetes in Taiwan follow different trajectories of depressive symptoms over time. Being female, lower educated, not married/partnered, with lower self-rated health, hospitalizations, more limitations in physical funct regular exercise before diagnosis, and not regularly using anti-diabetic medication at the beginning of their diagnosis were factors associated with increasing or high stable depressive symptom trajectories. Those who experienced high depressive symptoms were more likely than individuals with stable depressive symptoms to have physical limitations in the last follow-up interview.
   Depressive symptom trajectories after diabetes diagnosis were associated with select sociodemographic, health, and lifestyle factors before diagnosis, and also predicted subsequent disability. Risk groups identified in the present study may be used for personalized diabetes care that prevents diabetes-related distress and future disability.
C1 [Chiu, Ching-Ju] Natl Cheng Kung Univ, Inst Gerontol, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan.
   [Tseng, Yu-Hsuan] Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan 70101, Taiwan.
   [Hsu, Yu-Ching] Tainan Hosp, Dept Chinese Med, Minist Hlth & Welf, Tainan 70043, Taiwan.
   [Wu, Shang-Te] Kao Gen Hosp, Dept Neurol, Tainan 70054, Taiwan.
RP Chiu, CJ (reprint author), Natl Cheng Kung Univ, Inst Gerontol, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan.
EM cjchiu@mail.ncku.edu.tw
FU Ministry of Science and Technology [MOST 102-2314-B-006-075]
FX This work was supported by a Grant from the Ministry of Science and
   Technology (PI: Ching-Ju Chiu, MOST 102-2314-B-006-075).
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Chiu CJ, 2011, DIABETES RES CLIN PR, V91, P413, DOI 10.1016/j.diabres.2010.12.003
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   D'Unger AV, 1998, AM J SOCIOL, V103, P1593, DOI 10.1086/231402
   de Jonge P, 2006, DIABETOLOGIA, V49, P2627, DOI 10.1007/s00125-006-0442-x
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895(02)00580-2
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Khan MA, 2014, JCPSP-J COLL PHYSICI, V24, P770, DOI 10.2014/JCPSP.770771
   Limongi F, 2014, DIABETES METAB, V40, P373, DOI 10.1016/j.diabet.2014.05.001
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lipscombe C, 2015, J AFFECT DISORDERS, V188, P160, DOI 10.1016/j.jad.2015.08.003
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   Maraldi C, 2007, ARCH INTERN MED, V167, P1137, DOI 10.1001/archinte.167.11.1137
   NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677
   Nagin D, 2005, GROUP BASED MODELING
   Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037//1082-989X.4.2.139
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   POPKIN MK, 1988, ARCH GEN PSYCHIAT, V45, P64
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Schmitz N, 2013, J PSYCHOSOM RES, V74, P128, DOI 10.1016/j.jpsychores.2012.09.021
   Shaw JL, 2013, J COMMUN HEALTH, V38, P86, DOI 10.1007/s10900-012-9585-5
   Thomasouli MA, 2013, SLEEP BREATH, V17, P925, DOI 10.1007/s11325-013-0806-7
   Tsai YF, 2005, INT J GERIATR PSYCH, V20, P315, DOI 10.1002/gps.1281
   Tseng CH, 2006, DIABETOLOGIA, V49, P1755, DOI 10.1007/s00125-006-0314-4
NR 31
TC 1
Z9 1
U1 3
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0933-7954
EI 1433-9285
J9 SOC PSYCH PSYCH EPID
JI Soc. Psychiatry Psychiatr. Epidemiol.
PD JUL
PY 2017
VL 52
IS 7
BP 829
EP 836
DI 10.1007/s00127-016-1314-4
PG 8
WC Psychiatry
SC Psychiatry
GA FA3AV
UT WOS:000405314200008
PM 27878580
DA 2019-01-08
ER

PT J
AU Mashitani, T
   Hayashino, Y
   Okamura, S
   Kitatani, M
   Furuya, M
   Iburi, T
   Tsujii, S
   Ishii, H
AF Mashitani, Tsuyoshi
   Hayashino, Yasuaki
   Okamura, Shintaro
   Kitatani, Masako
   Furuya, Miyuki
   Iburi, Tadao
   Tsujii, Satoru
   Ishii, Hitoshi
CA Diabetes Distress Care Registry Te
TI Association between dipstick hematuria and decline in estimated
   glomerular filtration rate among Japanese patients with type 2 diabetes:
   A prospective cohort study [Diabetes Distress and Care Registry at Tenri
   (DDCRT 14)]
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes; Hematuria; eGFR decline; Diabetic nephropathy; Albuminuria
ID STAGE RENAL-DISEASE; MICROSCOPIC HEMATURIA; CLINICAL-FEATURES; OVERT
   PROTEINURIA; KIDNEY-FUNCTION; NEPHROPATHY; RISK; PROGRESSION;
   RETINOPATHY; PREVALENCE
AB Aims: To assess the association between dipstick hematuria and estimated glomerular filtration rate (eGFR) decline in Japanese patients with type 2 diabetes.
   Methods: Longitudinal data were obtained from 3068 Japanese patients with type 2 diabetes. To assess the independent association between dipstick hematuria and eGFR decline, we used Cox proportional hazard model adjusted for potential confounders.
   Results: Median follow-up period was 699.7 days. Mean age, body mass index (BMI), and HbAlc level were 65.7 years, 24.6 kg/m(2), and 7.5% (58.1 mmol/mol), respectively. Positive dipstick hematuria was significantly associated with baseline eGFR and severity of albuminuria (p < 0.001). The multivariable-adjusted hazard ratio for eGFR decline in patients with dipstick hematuria compared with those without dipstick hematuria was 2.19 [95% confidence interval (CI): 1.22-3.91]; this association remained significant even after the exclusion of patients who did not have diabetic retinopathy (hazard ratio: 239; 95% CI: 1.13-5.04).
   Conclusion: Positive dipstick hematuria was associated with severity of albuminuria and renal function. A significant association was found between dipstick hematuria and increased risk of eGFR decline among patients with type 2 diabetes. Therefore, our results suggest that dipstick hematuria is perhaps indicative of more severe diabetic nephropathy. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Mashitani, Tsuyoshi; Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 6348521, Japan.
   [Mashitani, Tsuyoshi] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara 6348521, Japan.
   [Hayashino, Yasuaki; Okamura, Shintaro; Kitatani, Masako; Furuya, Miyuki; Iburi, Tadao; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, Tenri, Nara 6328552, Japan.
RP Mashitani, T (reprint author), Nara Med Univ, Dept Diabetol, 840 Shijo Cho, Kashihara, Nara 6348552, Japan.
EM mashiyan@gmail.com
OI Tsujii, Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and JSPS KAKENHI (grant 25460641).
CR Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x
   Akimoto T, 2008, NEPHRON CLIN PRACT, V109, pC119, DOI 10.1159/000145454
   American Diabetes A, 2011, DIABETES CARE S1, V34, pS11
   Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694
   Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001
   Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634
   DEFARIA JBL, 1988, CLIN NEPHROL, V30, P117
   DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716
   Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0
   Gale DP, 2013, PEDIATR NEPHROL, V28, P1183, DOI 10.1007/s00467-012-2399-y
   GALL MA, 1993, DIABETOLOGIA, V36, P1071, DOI 10.1007/BF02374501
   Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273
   Greene T, 2014, AM J KIDNEY DIS, V64, P867, DOI 10.1053/j.ajkd.2014.08.019
   Hayashino Y, 2016, ACTA DIABETOL, V53, P599, DOI 10.1007/s00592-015-0825-x
   Hayashino Y, 2014, DIABETES CARE, V37, P2947, DOI 10.2337/dc14-1357
   Iseki K, 1996, KIDNEY INT, V49, P800, DOI 10.1038/ki.1996.111
   Kido R, 2010, AM J TRANSPLANT, V10, P1597, DOI 10.1111/j.1600-6143.2010.03077.x
   Liang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064184
   Mashitani T, 2015, ACTA DIABETOL, V52, P639, DOI 10.1007/s00592-015-0725-0
   Mashitani T, 2014, DIABETES CARE, V37, P252, DOI 10.2337/dc13-0407
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x
   Molitch Mark E, 2004, Diabetes Care, V27 Suppl 1, pS79
   Moriya T, 2013, DIABETES CARE, V36, P2803, DOI 10.2337/dc12-2327
   Oh SW, 2012, DIABETES RES CLIN PR, V97, P418, DOI 10.1016/j.diabres.2012.03.016
   Okada T, 2013, NEPHROLOGY, V18, P563, DOI 10.1111/nep.12104
   Palmer SC, 2011, AM J KIDNEY DIS, V58, P335, DOI 10.1053/j.ajkd.2011.06.006
   Pham TT, 2007, AM J NEPHROL, V27, P322, DOI 10.1159/000102598
   Sakata M, 2013, DIABETES RES CLIN PR, V100, pE39, DOI 10.1016/j.diabres.2013.01.031
   SAMAK MJ, 2003, CIRCULATION, V108, P2154, DOI DOI 10.1161/01.CIR.0000095676.90936.80
   Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x
   Sheen YJ, 2014, WORLD J DIABETES, V5, P835, DOI 10.4239/wjd.v5.i6.835
   Shen FC, 2012, DIABETIC MED, V29, P1178, DOI 10.1111/j.1464-5491.2012.03608.x
   Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298
   Tone A, 2005, DIABETES RES CLIN PR, V69, P237, DOI 10.1016/j.diabres.2005.02.009
   Vivante A, 2011, JAMA-J AM MED ASSOC, V306, P729, DOI 10.1001/jama.2011.1141
   Yokoyama H, 2009, CLIN J AM SOC NEPHRO, V4, P1432, DOI 10.2215/CJN.06511208
   Yuste C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128575
   Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711
NR 39
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL
PY 2017
VL 31
IS 7
BP 1079
EP 1084
DI 10.1016/j.jdiacomp.2017.04.016
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EY6JK
UT WOS:000404088700003
PM 28499960
DA 2019-01-08
ER

PT J
AU Secinti, E
   Thompson, EJ
   Richards, M
   Gaysina, D
AF Secinti, Ekin
   Thompson, Ellen J.
   Richards, Marcus
   Gaysina, Darya
TI Research Review: Childhood chronic physical illness and adult emotional
   health - a systematic review and meta-analysis
SO JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
LA English
DT Review
DE Depression; anxiety; chronic disorders; meta-analysis; paediatrics
ID QUALITY-OF-LIFE; ACUTE LYMPHOBLASTIC-LEUKEMIA; LONG-TERM SURVIVORS;
   YOUNG-ADULTS; PSYCHOLOGICAL DISTRESS; POSTTRAUMATIC STRESS; PSYCHOSOCIAL
   OUTCOMES; PSYCHIATRIC-DISORDERS; ADOLESCENT SURVIVORS; DEPRESSIVE
   SYMPTOMS
AB Background: Childhood chronic physical illness is associated with a greater vulnerability for emotional problems (i.e. depression and anxiety) in childhood. However, little is known about life-long effects of childhood chronic physical illness on mental health. The present study aims to systematically review evidence for associations between eight chronic physical illnesses with childhood onset (arthritis, asthma, cancer, chronic renal failure, congenital heart disease, cystic fibrosis, type 1 diabetes, and epilepsy) and adult emotional problems. Methods: A database search of MEDLINE, PsycARTICLES, PsycINFO, and ScienceDirect was undertaken, and random effects meta-analyses were used to synthesise evidence from eligible studies. Results: In total, 37 studies were eligible for the systematic review (n = 45,733) and of these, 34 studies were included in the meta-analyses (n = 45,358). There were overall associations between childhood chronic physical illness and adult depression (OR = 1.31; 95% CI [1.12, 1.54]) and anxiety(OR = 1.47; 95% CI [1.13, 1.92]). Separate meta-analyses for childhood asthma, type 1 diabetes and cancer were also conducted, with cancer being significantly associated with adult depression (OR = 1.19; 95% CI [1.00, 1.42]). Conclusions: The effects of childhood chronic physical illness on the risk of emotional problems persist beyond childhood and adolescence. Mental health prevention and intervention strategies targeting children with chronic physical illnesses can have long-term benefits.
C1 [Secinti, Ekin; Thompson, Ellen J.; Gaysina, Darya] Univ Sussex, Sch Psychol, EDGE Lab, Pevensey 1, Brighton BN1 9QH, E Sussex, England.
   [Secinti, Ekin] Indiana Univ Purdue Univ, Dept Psychol, Indianapolis, IN 46205 USA.
   [Richards, Marcus] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England.
RP Gaysina, D (reprint author), Univ Sussex, Sch Psychol, EDGE Lab, Pevensey 1, Brighton BN1 9QH, E Sussex, England.
EM D.Gaysina@sussex.ac.uk
OI Secinti, Ekin/0000-0001-7794-8500
FU Medical Research Council [MC_UU_12019/3]
CR Alwash RH, 2000, SEIZURE-EUR J EPILEP, V9, P412, DOI 10.1053/seiz.2000.0427
   Baca CB, 2015, QUAL LIFE RES, V24, P1379, DOI 10.1007/s11136-014-0867-5
   Baldin E, 2015, EPILEPSIA, V56, P1623, DOI 10.1111/epi.13123
   BLAIR C, 1994, THORAX, V49, P798, DOI 10.1136/thx.49.8.798
   BLANZ BJ, 1993, DIABETES CARE, V16, P1579, DOI 10.2337/diacare.16.12.1579
   Borenstein M., 2009, INTRO METAANALYSIS
   Brinkman TM, 2013, BRIT J CANCER, V109, P1373, DOI 10.1038/bjc.2013.428
   Brown RT, 2003, J TRAUMA STRESS, V16, P309, DOI 10.1023/A:1024465415620
   Chaney JM, 1999, J PEDIATR PSYCHOL, V24, P259, DOI 10.1093/jpepsy/24.3.259
   Chen MH, 2014, J AFFECT DISORDERS, V156, P232, DOI 10.1016/j.jad.2013.10.053
   Eddington AR, 2010, J ASTHMA, V47, P14, DOI 10.3109/02770900903427003
   Fedele DA, 2009, J ASTHMA, V46, P835, DOI 10.3109/02770900903184229
   Ferro MA, 2016, J ASTHMA, V53, P282, DOI 10.3109/02770903.2015.1104694
   Ferro MA, 2015, HEALTH PSYCHOL, V34, P820, DOI 10.1037/hea0000226
   Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733
   Gianinazzi ME, 2013, PSYCHO-ONCOLOGY, V22, P2051, DOI 10.1002/pon.3249
   Gledhill J, 2000, ARCH DIS CHILD, V83, P104, DOI 10.1136/adc.83.2.104
   Gunn ME, 2013, J CANCER SURVIV, V7, P404, DOI 10.1007/s11764-013-0285-7
   Harila MJ, 2011, J PEDIAT HEMATOL ONC, V33, P194, DOI 10.1097/MPH.0b013e3181ff0e2e
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Huurre TM, 2002, EUR CHILD ADOLES PSY, V11, P85, DOI 10.1007/s007870200015
   Kamibeppu K, 2010, J CANCER SURVIV, V4, P303, DOI 10.1007/s11764-010-0124-z
   Kazak AE, 2010, J CLIN ONCOL, V28, P2002, DOI 10.1200/JCO.2009.25.9564
   Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c
   Kokkonen ER, 2001, NORD J PSYCHIAT, V55, P237
   Kremer A. L., 2016, INT J ADOLESCENT MED
   Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639
   Ly TT, 2011, DIABETES CARE, V34, P2192, DOI 10.2337/dc11-0697
   Mackie E, 2000, LANCET, V355, P1310, DOI 10.1016/S0140-6736(00)02112-7
   Maunsell E, 2006, J CLIN ONCOL, V24, P2527, DOI 10.1200/JCO.200503.9297
   Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534
   Muller J, 2013, INT J CARDIOL, V165, P142, DOI 10.1016/j.ijcard.2011.08.005
   Musliner KL, 2016, J AFFECT DISORDERS, V192, P199, DOI 10.1016/j.jad.2015.12.030
   Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232
   Palladino DK, 2013, J PEDIATR PSYCHOL, V38, P506, DOI 10.1093/jpepsy/jst002
   Perrin JM, 2007, JAMA-J AM MED ASSOC, V297, P2755, DOI 10.1001/jama.297.24.2755
   Pike NA, 2012, J CARDIOVASC NURS, V27, P539, DOI 10.1097/JCN.0b013e31822ce5f6
   Pinquart M, 2011, J PEDIATR PSYCHOL, V36, P1003, DOI 10.1093/jpepsy/jsr042
   Pinquart M, 2011, J PEDIATR PSYCHOL, V36, P375, DOI 10.1093/jpepsy/jsq104
   Pinquart M, 2011, ACTA PAEDIATR, V100, P1069, DOI 10.1111/j.1651-2227.2011.02223.x
   PLESS IB, 1993, PEDIATRICS, V91, P1131
   Purdy Jana, 2013, Yale Journal of Biology and Medicine, V86, P15
   R Core Team, 2013, R LANG ENV STAT COMP
   Schwartz L, 2006, J PEDIATR PSYCHOL, V31, P356, DOI 10.1093/jpepsy/jsj018
   Seitz DCM, 2010, EUR J CANCER, V46, P1596, DOI 10.1016/j.ejca.2010.03.001
   Servitzoglou M, 2008, SUPPORT CARE CANCER, V16, P29, DOI 10.1007/s00520-007-0278-z
   Sivertsen B, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-83
   Stam H, 2006, PSYCHO-ONCOL, V15, P31, DOI 10.1002/pon.920
   STEIN REK, 1993, J PEDIATR-US, V122, P342, DOI 10.1016/S0022-3476(05)83414-6
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sundberg KK, 2010, PEDIATR BLOOD CANCER, V55, P337, DOI 10.1002/pbc.22492
   TEBBI CK, 1990, DIABETES CARE, V13, P98, DOI 10.2337/diacare.13.2.98
   TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X
   Tluczek A, 2014, J CYST FIBROS, V13, P227, DOI 10.1016/j.jcf.2013.10.001
   van der Lee JH, 2007, JAMA-J AM MED ASSOC, V297, P2741, DOI 10.1001/jama.297.24.2741
   Verhoof E. J. A., 2014, CHILD ADOLESCENT PSY, V8, P1
   von Elm E, 2007, BRIT MED J, V335, P806
   Zahn-Waxler C, 2000, DEV PSYCHOPATHOL, V12, P443, DOI 10.1017/S0954579400003102
   Zeltzer LK, 1997, J CLIN ONCOL, V15, P547, DOI 10.1200/JCO.1997.15.2.547
   Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541
NR 60
TC 4
Z9 4
U1 2
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9630
EI 1469-7610
J9 J CHILD PSYCHOL PSYC
JI J. Child Psychol. Psychiatry
PD JUL
PY 2017
VL 58
IS 7
BP 753
EP 769
DI 10.1111/jcpp.12727
PG 17
WC Psychology, Developmental; Psychiatry; Psychology
SC Psychology; Psychiatry
GA EX7CG
UT WOS:000403404000002
PM 28449285
OA Bronze
DA 2019-01-08
ER

PT J
AU Tan, ML
   Tan, CS
   Griva, K
   Lee, YS
   Lee, J
   Tai, ES
   Khoo, EY
   Wee, HL
AF Tan, Maudrene L.
   Tan, Chuen S.
   Griva, Konstadina
   Lee, Yung S.
   Lee, Jeannette
   Tai, E. S.
   Khoo, Eric Y.
   Wee, Hwee-Lin
TI Factors associated with diabetes-related distress over time among
   patients with T2DM in a tertiary hospital in Singapore
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Diabetes-related distress; Diabetes; Longitudinal; Excessive daytime
   sleepiness
ID OBSTRUCTIVE SLEEP-APNEA; QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS;
   DEPRESSIVE SYMPTOMS; DAYTIME SLEEPINESS; TYPE-2; MELLITUS; ADULTS;
   QUESTIONNAIRES; POPULATION
AB Background: Persistent diabetes-related distress (DRD) is experienced by patients with Type 2 Diabetes Mellitus. Knowing factors associated with persistent DRD will aid clinicians in prioritising interventions efforts.
   Methods: A total of 216 patients were recruited from a tertiary hospital in Singapore, an Asian city state, and followed for 1.5 years (2011-2014). Data was collected by self-completed questionnaires assessing DRD (measured by the Problem Areas in Diabetes score) and other psychosocial aspects such as social support, presenteeism, depression, health-related quality of life (HRQoL) and excessive daytime sleepiness (EDS) at three time points. Clinical data (body-mass-index and glycated haemoglobin) was obtained from medical records. Change score was calculated for each clinical and psychosocial variable to capture changes in these variables from baseline. Generalized Linear Model with Generalized Estimating Equation method was used to assess whether baseline and change scores in clinical and psychosocial are associated with DRD over time.
   Results: Complete data was available for 73 patients, with mean age 44 (SD 12.5) years and 67% males. Persistent DRD was experienced by 210% of the patients. In the final model, baseline HRQoL (OR = 0.56, p < 0.05) and change score of EDS (OR = 1.22, p < 0.05) was significantly associated with DRD over time.
   Conclusions: EDS might be a surrogate marker for persistent DRD and should be explored in larger samples of population to confirm the findings from this study.
C1 [Tan, Maudrene L.; Tan, Chuen S.; Lee, Jeannette; Tai, E. S.; Wee, Hwee-Lin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Griva, Konstadina] Natl Univ Singapore, Dept Psychol, Singapore, Singapore.
   [Lee, Yung S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore, Singapore.
   [Lee, Yung S.] Natl Univ Hlth Syst, Khoo Teck Puat Natl Univ Childrens Med Inst, Div Paediat Endocrinol & Diabet, Singapore, Singapore.
   [Lee, Yung S.] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.
   [Tai, E. S.; Khoo, Eric Y.] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore.
   [Wee, Hwee-Lin] Natl Univ Singapore, Dept Pharm, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
RP Wee, HL (reprint author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Wee, HL (reprint author), Natl Univ Singapore, Dept Pharm, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM phawhl@nus.edu.sg
RI Wee, Hwee-Lin/D-4126-2012; Griva, Konstadina/A-6549-2018; Lee, Yung
   Seng/F-2169-2014
OI Wee, Hwee-Lin/0000-0002-7150-1801; Lee, Yung Seng/0000-0002-1253-0557;
   Tan, Chuen Seng/0000-0002-6513-2309
FU Ministry of Education Singapore Academic Research Fund [FY2011-FRC3-007]
FX This work was supported by the Ministry of Education Singapore Academic
   Research Fund Tier 1 (Grant No.: FY2011-FRC3-007).
CR Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Burns RJ, 2015, DIABETIC MED, V32, P1272, DOI 10.1111/dme.12860
   Chasens Eileen R, 2008, Issues Ment Health Nurs, V29, P1134, DOI 10.1080/01612840802319878
   Co MA, 2015, J DIABETES COMPLICAT, V29, P378, DOI 10.1016/j.jdiacomp.2015.01.009
   Dixon JB, 2007, OBESITY, V15, P2504, DOI 10.1038/oby.2007.297
   Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   FIFE BL, 1994, SOC SCI MED, V38, P309, DOI 10.1016/0277-9536(94)90400-6
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Keskin A, 2015, CHINESE MED J-PEKING, V128, P3292, DOI 10.4103/0366-6999.171415
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Koutsourelakis I, 2008, J SLEEP RES, V17, P437, DOI 10.1111/j.1365-2869.2008.00667.x
   Lipscombe C, 2015, J AFFECT DISORDERS, V188, P160, DOI 10.1016/j.jad.2015.08.003
   Lopes LA, 2005, DIABETES CARE, V28, P2633, DOI 10.2337/diacare.28.11.2633
   Medeiros C, 2013, ARQ BRAS ENDOCRINOL, V57, P425, DOI 10.1590/S0004-27302013000600003
   Pamidi S, 2011, SLEEP MED, V12, P827, DOI 10.1016/j.sleep.2011.08.003
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006
   Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702
   Stewart A., 1992, MEASURING FUNCTIONIN
   Tan LSM, 2015, QUAL LIFE RES, V24, P153, DOI 10.1007/s11136-014-0747-z
   WHOQOL Group, 1998, WHOQOL BREF INTR ADM
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 27
TC 0
Z9 0
U1 1
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD JUN 23
PY 2017
VL 17
AR 36
DI 10.1186/s.12902-017-0184-4
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EZ0QD
UT WOS:000404409700001
PM 28645273
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Yoda, T
   Yokoyama, K
   Suzuki, H
   Hirao, T
AF Yoda, Takeshi
   Yokoyama, Katsunori
   Suzuki, Hiromi
   Hirao, Tomohiro
TI Relationship Between Long-term Flooding and Serious Mental Illness After
   the 2011 Flood in Thailand
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE flood victims; serious mental illness; psychological distress; risk
   factors
ID EPIDEMIOLOGIC EVIDENCE; HEALTH; IMPACTS
AB Objective: The present study aimed to evaluate the long-term psychological effects of the 2011 flood in Thailand on flood victims and unaffected residents, taking into account risk factors such as floodwater levels in the house, period of flooding, and disruption to essential services.
   Methods: Surveys were conducted in Salaya and Nakhon Chaisri subdistrict, Nakhonpatom Province, from May to June 2012. Approximately 400 households were selected. Measures of sociodemographic variables, exposure to flooding, incidents (eg, disruption of services), and outcome variables (Kessler 10) were recorded.
   Results: A total of 407 respondents completed the survey. The results of the univariate analysis showed that possible serious mental illness was approximately 1.5 times higher in flood victims than in unaffected respondents. After adjustment for potential confounding factors, significant associations were found for disruption of essential services and hypertension or diabetes with possible serious mental illness.
   Conclusions: Disruption of essential services and chronic illness may affect psychological distress among flood victims. Public health agencies should develop and evaluate strategies to improve risk communication and psychological support for flood victims.
C1 [Yoda, Takeshi; Yokoyama, Katsunori; Suzuki, Hiromi; Hirao, Tomohiro] Kagawa Univ, Dept Publ Hlth, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.
RP Yoda, T (reprint author), Kagawa Univ, Dept Publ Hlth, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.
EM tyoda@med.kagawa-u.ac.jp
FU MIU memorial foundation [H23]
FX We thank Orada Anotaipaiboon and Piyachatr Tragoolvongse for their
   assistance in the questionnaire research and Orawan Quansri for her
   friendly support. This research was supported by funding from the MIU
   memorial foundation grant number H23.
CR Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004
   Ginexi EM, 2000, AM J COMMUN PSYCHOL, V28, P495, DOI 10.1023/A:1005188515149
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Mason V, 2010, PSYCHOL HEALTH MED, V15, P61, DOI 10.1080/13548500903483478
   Ohl CA, 2000, BRIT MED J, V321, P1167, DOI 10.1136/bmj.321.7270.1167
   Paranjothy S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-145
   Piyaphanee W, 2012, SE ASIAN J TROP MED, V43, P1193
   Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x
   Bich TH, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6356
   Wisitwong A, 2010, NURS HEALTH SCI, V12, P4, DOI 10.1111/j.1442-2018.2009.00504.x
NR 10
TC 0
Z9 0
U1 1
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD JUN
PY 2017
VL 11
IS 3
BP 300
EP 304
DI 10.1017/dmp.2016.148
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FA7WM
UT WOS:000405658100005
PM 27927268
DA 2019-01-08
ER

PT J
AU Roberts, DP
   Ward, BM
   Russell, DJ
   O'Sullivan, BG
AF Roberts, Diane Patricia
   Ward, Bernadette Maree
   Russell, Deborah Jane
   O'Sullivan, Belinda Gabrielle
TI Accessibility and outcomes from a rural diabetes nurse-educator led
   self-management program
SO AUSTRALIAN JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE access; diabetes nurse educator; diabetes self-management; health
   outcomes; rural; primary health care
ID RESIDENTS
AB Objective
   To investigate factors associated with access to, and health outcomes of, a diabetes nurse-educator led self-management program for rural Australians with diabetes.
   Design
   Retrospective cohort study
   Setting
   A rural community-health service with a dispersed catchment of 10,000 population.
   Subjects
   Clients diagnosed with type 2 diabetes mellitus and referred to the program between April 2008 and December 2012.
   Intervention
   A diabetes self-management program comprising an initial assessment, a group education session, and 3, 6, and 12 month clinical reviews.
   Main outcome measures
   Program attendance after referral; and achievement of management goals for HbA1c, BMI, total cholesterol, quality of life and psychological distress.
   Results
   Ninety-four percent (n= 219/232) of referred clients attended at least once. Multivariate logistic regression showed that attending at least once was significantly associated with living within 25km of the service. Non-smokers/former smokers, general practitioner-referred clients and those with diabetes management plans were significantly more likely to attend three or more sessions. At 12 months clients showed significant improvements in cholesterol, BMI, quality of life and psychological distress.
   Conclusion
   This study demonstrates that diabetes nurse-educator led self-management programs which adapt to their rural contexts - including geographically dispersed catchment populations and resource constraints - provide highly accessible services meeting the needs of most. Nevertheless, some groups (cigarette smokers, those living furthest from the service) may remain marginalised and less able to access services. Improvements in health outcomes for these clients may require further adaptation of models of care to better target their health care needs.
C1 [Roberts, Diane Patricia; Ward, Bernadette Maree; Russell, Deborah Jane] Monash Univ, Monash Rural Hlth, Ctr Res Excellence CRE Rural & Remote Primary Hlt, POB 666, Bendigo, Vic, Australia.
   [O'Sullivan, Belinda Gabrielle] Monash Univ, Monash Rural Hlth, POB 666, Bendigo, Vic, Australia.
RP Roberts, DP (reprint author), Monash Univ, Monash Rural Hlth, Ctr Res Excellence CRE Rural & Remote Primary Hlt, POB 666, Bendigo, Vic, Australia.
EM diane.p.roberts@monash.edu; bernadette.ward@monash.edu;
   deborah.russell@monash.edu; belinda.osullivan@monash.edu
FU Australian Government Department of Health and Ageing
FX The research reported in this paper was a project of the Australian
   Primary Health Care Research Institute which was supported by a grant
   from the Australian Government Department of Health and Ageing.
CR Arcury TA, 2005, HEALTH SERV RES, V40, P135, DOI 10.1111/j.1475-6773.2005.00346.x
   Australian Bureau of Statistics Microdata, 2011, AUSTR HLTH SURV COR
   Australian Institute for Primary Care & Ageing, 2012, IMM CLIENT OUTC COMM
   Australian Institute of Health and Welfare, 2008, IND CHRON DIS THEIR
   Australian Institute of Health and Welfare, 2012, AUSTR HLTH 2012
   Australian Institute of Health and Welfare, 2009, KEY IND PROGR CHRON
   Colagiuri R., 2009, NATL EVIDENCE BASED
   Hawthorne G, 2013, AUST NZ J PUBL HEAL, V37, P7
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   McGrail MR, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0880-6
   National Health and Medical Research Council, 2001, NAT EV BAS GUID MAN
   Primary Health Care Research and Information Service, 2012, NAT PERF IND DIV GEN
   Russell DJ, 2013, AUST J RURAL HEALTH, V21, P61, DOI 10.1111/ajr.12023
   Travaglia J, 2009, CLIN AUDIT COMPREHEN
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   World Health Organisation: Obesity: Preventing and Managing a Global Epidemic Geneva: World Health Organisation, 2000, TECHNICAL REPORT SER, V894
NR 17
TC 0
Z9 0
U1 1
U2 5
PU AUSTRALIAN NURSING FEDERATION
PI KINGSTON
PA PO BOX 4239, KINGSTON, ACT 2604, AUSTRALIA
SN 0813-0531
EI 1447-4328
J9 AUST J ADV NURS
JI Aust. J. Adv. Nurs.
PD JUN-AUG
PY 2017
VL 34
IS 4
BP 26
EP 33
PG 8
WC Nursing
SC Nursing
GA FA0LG
UT WOS:000405125400003
DA 2019-01-08
ER

PT J
AU Li, DN
   Elliott, T
   Klein, G
   Ur, E
   Tang, TS
AF Li, Danni
   Elliott, Tom
   Klein, Gerri
   Ur, Ehud
   Tang, Tricia S.
TI Diabetes Nurse Case Management in a Canadian Tertiary Care Setting:
   Results of a Randomized Controlled Trial
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE diabetes nurse case manager; randomized controlled trial; tertiary care
   setting; diabetes distress; psychosocial outcomes
ID CARDIOVASCULAR RISK-FACTORS; SELF-CARE; GLYCEMIC CONTROL; DISEASE;
   DISTRESS; DEPRESSION; PROGRAMS; VALIDITY; SCALE; LIFE
AB Objectives: To examine the effects of a 6-month nurse case manager (NCM) intervention compared to standard care (SC) on glycemic control and diabetes distress in a Canadian tertiary-care setting.
   Methods: We recruited 140 adults with type 2 diabetes and glycated hemoglobin (AlC) levels >8% (64 mmol/mol) from 2 tertiary care facilities and randomized them to: 1) a 6-month NCM intervention in addition to SC or 2) SC by the primary endocrinologists. Assessments were conducted at baseline and at 6 months. Primary outcomes included AlC levels and diabetes distress scores (DDS). Secondary outcomes included body mass index, blood pressure, diabetes-related behaviour measures, depressive symptoms, self-motivation and perception of support.
   Results: At the 6-month follow up, the NCM group experienced larger reductions in AlC levels of -0.73% compared to the SC group (p=0.027; n=134). The NCM group also showed an additional reduction of -0.40 (26% reduction) in DDS compared to those in the SC group (p=0.001; n=134). The NCM group had lower blood pressure, ate more fruit and vegetables, exercised more, checked their feet more frequently, were more motivated, were less depressed and perceived more support. There were no changes and no group differences in terms of body mass index, medication compliance or frequency of testing.
   Conclusions: Compared to SC, NCM intervention was more effective in improving glycemic control and reducing diabetes distress. It is, therefore, a viable adjunct to standard diabetes care in the tertiary care setting, particularly for patients at high risk and with poor control. (C) 2017 Canadian Diabetes Association.
C1 [Li, Danni; Elliott, Tom; Klein, Gerri; Ur, Ehud; Tang, Tricia S.] Univ British Columbia, Dept Med, Div Endocrinol, Vancouver, BC, Canada.
   [Elliott, Tom; Klein, Gerri] BC Diabet, Vancouver, BC, Canada.
RP Tang, TS (reprint author), Univ British Columbia, 2775 Laurel St,Suite 10211, Vancouver, BC V5Z 1M9, Canada.
EM tricia.tang@vch.ca
FU British Columbia Endocrine Research Foundation (Sanofi-Aventis Canada);
   Sanofi; NovoNordisk; Boehringer-Ingelheim; Astra-Zeneca; Merck
FX This study was supported by the British Columbia Endocrine Research
   Foundation (itself supported by a grant from Sanofi-Aventis Canada).
   Clinical trial registry #NCT01659294, clinicaltrials.gov. Dr. Tom
   Elliott has received funding for giving lectures and symposia and
   attending advisory boards for the following companies: Sanofi,
   NovoNordisk, Boehringer-Ingelheim and Astra-Zeneca. Dr. Ehud Ur has
   received funding for giving lectures and symposia and attending advisory
   boards for the following companies: Sanofi, NovoNordisk,
   Boehringer-Ingelheim, Merck and Astra-Zeneca.
CR Arsie MP, 2000, ACTA DIABETOL, V37, P1, DOI 10.1007/s005920070028
   Bernard S, 2013, UNDERSTAND YOUR DIAB
   Braga MFB, 2010, CAN J CARDIOL, V26, P297, DOI 10.1016/S0828-282X(10)70393-7
   Couch Carl, 2003, Proc (Bayl Univ Med Cent), V16, P336
   Drabik A, 2012, DIABETES RES CLIN PR, V95, P194, DOI 10.1016/j.diabres.2011.09.015
   Fanning EL, 2004, DIABETES CARE, V27, P1638, DOI 10.2337/diacare.27.7.1638
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Funnell M, 2004, CLIN DIABETES, V223, P123
   Gabbay RA, 2013, J DIABETES, V5, P349, DOI 10.1111/1753-0407.12030
   Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x
   Ishani A, 2011, DIABETES CARE, V34, P1689, DOI 10.2337/dc10-2121
   Joo JY, 2012, PROF CASE MANAG, V17, P72, DOI 10.1097/NCM.0b013e318243d473
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Leyva B, 2011, ETHNIC DIS, V21, P322
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   Paula A, 2011, CONTEMP NURSE, V39, P157, DOI 10.5172/conu.2011.157
   Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Saxena S, 2007, J AMBUL CARE MANAG, V30, P218
   Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Sutherland D, 2009, J CLIN NURS, V18, P2978, DOI 10.1111/j.1365-2702.2009.02900.x
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]
   Thompson DM, 1999, CAN MED ASSOC J, V161, P959
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Welch G, 2010, DIABETES RES CLIN PR, V88, P1, DOI 10.1016/j.diabres.2009.12.026
NR 29
TC 0
Z9 0
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD JUN
PY 2017
VL 41
IS 3
BP 297
EP 304
DI 10.1016/j.jcjd.2016.10.012
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EY9LG
UT WOS:000404319500007
PM 28318938
DA 2019-01-08
ER

PT J
AU Daniels, J
   Turner-Cobb, JM
AF Daniels, J.
   Turner-Cobb, J. M.
TI Adjuvant psychological therapy in long-term endocrine conditions
SO CLINICAL ENDOCRINOLOGY
LA English
DT Article
DE adjuvant; long-term endocrinological conditions; psychological; therapy
ID QUALITY-OF-LIFE; ADRENAL INSUFFICIENCY; HEALTH ANXIETY; STRESS; DISEASE;
   MODEL; DEPRESSION; CHALLENGE; BEHAVIOR
AB Consideration of psychological distress in long-term endocrine conditions is of vital importance given the prevalence of anxiety and depression in such disorders. Poor mental health can lead to compromised self-care, higher utilization of health services, lower rates of adherence, reduced quality of life and ultimately poorer outcomes. Adjuvant psychological therapy offers an effective resource to reduce distress in-endocrine conditions. While the vast majority of work in this area has focused on-psychological screening and intervention in diabetes, identification and recognition of psychological distress are equally important in other endocrinological conditions, with supportive evidence in polycystic ovary syndrome and Addison's disease. Referral pathways and recommendations set out by UK guidelines and the Department of Health mandate requires greater attention across a wider range of long-term endocrine conditions to facilitate improved quality of life and health outcome.
C1 [Daniels, J.] Univ Bath, Dept Psychol, Bath, Avon, England.
   [Turner-Cobb, J. M.] Bournemouth Univ, Res Ctr Behav Change, Dept Psychol, Bournemouth, Dorset, England.
RP Daniels, J (reprint author), Univ Bath, Dept Psychol, Bath, Avon, England.
EM j.daniels@bath.ac.uk
CR Aulinas A, 2014, EXPERT REV PHARM OUT, V14, P873, DOI 10.1586/14737167.2014.963559
   Bleicken B, 2010, CLIN ENDOCRINOL, V72, P297, DOI 10.1111/j.1365-2265.2009.03596.x
   Care Quality Commission, 2016, MY DIAB MY CAR
   Daniels J, 2017, PSYCHOL PSYCHOTHER-T, V90, P502, DOI 10.1111/papt.12118
   Daniels J, 2017, BEHAV COGN PSYCHOTH, V45, P419, DOI 10.1017/S1352465817000182
   Department of Health, 2013, MAND GOV NHS ENGL AP
   Department of Health, 2011, TALK THER 4 YEAR PLA
   ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460
   European Commission, STAT MENT HLTH EUR U
   Fischer S, 2016, PSYCHONEUROENDOCRINO, V63, P68, DOI 10.1016/j.psyneuen.2015.09.018
   Golden SH, 2007, CURR DIABETES REV, V3, P252, DOI 10.2174/157339907782330021
   Henningsen P, 2015, J PSYCHOSOM RES, V79, P362, DOI 10.1016/j.jpsychores.2015.09.003
   Kaye JM, 2006, CLIN ENDOCRINOL, V65, P282, DOI 10.1111/j.1365-2265.2006.02589.x
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   LEVENTHAL H, 1983, HEALTH EDUC QUART, V10, P3, DOI 10.1177/109019818301000101
   Lutgendorf SK, 2003, BRAIN BEHAV IMMUN, V17, P225, DOI 10.1016/S0889-1591(03)00033-3
   McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x
   Mental Health Task Force, 2016, 5 YEAR FORW VIEW MEN
   Morrison V, 2016, INTRO HLTH PSYCHOL
   National Institute for Care and health Excellence, 2015, TYP 1 DIAB AD DIAGN
   Naylor C., 2012, LONG TERM CONDITIONS
   Naylor S, 2016, BRINGING TOGETHER PH
   Nishikawa T, 2014, INTERNAL MED, V53, P169, DOI 10.2169/internalmedicine.53.1527
   Power M, 1998, SOC SCI MED, V46, P1569
   Press MJ, 2017, NEW ENGL J MED, V376, P405, DOI 10.1056/NEJMp1614134
   Rofey DL, 2009, J PEDIATR PSYCHOL, V34, P156, DOI 10.1093/jpepsy/jsn057
   Sage S, 2008, CBT CHRONIC ILLNESS
   Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822
   Sepa A, 2005, DIABETES CARE, V28, P290, DOI 10.2337/diacare.28.2.290
   Sonino N, 2004, PSYCHOTHER PSYCHOSOM, V73, P78, DOI 10.1159/000075538
   Sonino N, 2015, J ROY COLL PHYS EDIN, V45, P55, DOI [10.4997/JRCPE.2015.413, 10.4997/JRCPE.2015.113]
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Sterling P, 1988, HDB LIFE STRESS COGN, P629, DOI [10.1016/0005-7967(90)90076-U, DOI 10.1016/0005-7967(90)90076-U]
   Tyrer P, 2014, LANCET, V383, P219, DOI 10.1016/S0140-6736(13)61905-4
   Tyrer P, 2011, J PSYCHOSOM RES, V71, P392, DOI 10.1016/j.jpsychores.2011.07.004
   Uchendu C, 2017, DIABETIC MED, V34, P328, DOI 10.1111/dme.13195
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   White CA, 2001, COGNITIVE BEHAV THER
   World Health Organization, 2017, EUR MENT HLTH ACT PL
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 40
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-0664
EI 1365-2265
J9 CLIN ENDOCRINOL
JI Clin. Endocrinol.
PD JUN
PY 2017
VL 86
IS 6
BP 772
EP 777
DI 10.1111/cen.13341
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EY1GM
UT WOS:000403714100002
PM 28370206
DA 2019-01-08
ER

PT J
AU Zhou, HH
   Zhu, JY
   Liu, L
   Li, F
   Fish, AF
   Chen, T
   Lou, QQ
AF Zhou, Huanhuan
   Zhu, Junya
   Liu, Lin
   Li, Fan
   Fish, Anne F.
   Chen, Tao
   Lou, Qingqing
TI Diabetes-related distress and its associated factors among patients with
   type 2 diabetes mellitus in China
SO PSYCHIATRY RESEARCH
LA English
DT Article
DE Chinese; Diabetes; Diabetes-related distress; Self-efficacy; Sleep
   timep, Insulin, Physical activity
ID QUALITY-OF-LIFE; EMOTIONAL DISTRESS; GLYCEMIC CONTROL; SLEEP QUALITY;
   INSULIN THERAPY; PROBLEM AREAS; DEPRESSION; SCALE; CARE; ADULTS
AB Diabetes-related distress is one of the psychological disorders affecting patients with diabetes, yet there are few studies about diabetes-related distress in Chinese patients. To assess the level of psychological distress and examine its associated factors, we conducted a cross-sectional analysis of patients with type 2 diabetes mellitus from a Chinese tertiary hospital. The Diabetes Distress Scale (DDS) and the General Self-Efficacy Scale (GSES) were administered. There were 210 (57.85%) patients with little or no diabetes-related distress, 84 (23.14%) with moderate diabetes-related distress and 69 (19.01%) with high diabetes-related distress. Stepwise multiple linear regression showed that sleep time was significantly related to the DDS total score and the subscale scores of emotional burden (EB) (beta=-0.190, -0.379), respectively. GSES was associated with the DDS total score (beta=-0.128) and the EB score (beta=-0.153). Oral medication plus insulin was significantly related to regimen-related distress (RD) (beta=0.137), physician-related distress (PD) (beta=0.152) and interpersonal distress (ID) (beta=0.103). Physical activity (beta=-0.185) and making meal plan with health care professionals(HCP) (beta=-0.169) were associated with RD. The prevalence of diabetes-related distress among patients with type 2 diabetes mellitus was high in China. DDS and EB were associated with poorer sleep time and lower self-efficacy. Interventions to improve sleep are needed. Qualitative and longitudinal studies are required to understand why type 2 diabetic patients are not getting enough sleep.
C1 [Zhou, Huanhuan; Liu, Lin; Li, Fan; Lou, Qingqing] Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Jiangsu, Peoples R China.
   [Zhou, Huanhuan; Liu, Lin; Li, Fan; Lou, Qingqing] Jiangsu Prov Acad Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.
   [Zhou, Huanhuan] Nanjing Univ Chinese Med, Nursing Coll, Nanjing, Jiangsu, Peoples R China.
   [Zhu, Junya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 North Broadway, Baltimore, MD USA.
   [Fish, Anne F.] Univ Missouri, Coll Nursing, ISP Program, St Louis, MO 63121 USA.
   [Chen, Tao] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
RP Lou, QQ (reprint author), Jiangsu Prov Acad Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.
EM lqq188@yahoo.com
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829
   American Diabetes Association, 2016, DIABETES CARE S1, V39, pS13, DOI DOI 10.2337/DC16-S005
   Brieler JA, 2016, FAM PRACT, V33, P30, DOI 10.1093/fampra/cmv100
   Chew BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152095
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Demirci H, 2010, DAN MED BULL, V57
   Fenwick EK, 2016, J HLTH PSYCHOL
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479
   Karlsen B, 2014, INT J NURS STUD, V51, P438, DOI 10.1016/j.ijnurstu.2013.06.016
   KAWADA T, 2016, AM J PUBLIC HLTH, V106
   Kong Lulu, 2013, J Biomed Res, V27, P380, DOI 10.7555/JBR.27.20120112
   Luyster FS, 2011, DIABETES EDUCATOR, V37, P347, DOI 10.1177/0145721711400663
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Munhoz TN, 2016, J AFFECT DISORDERS, V192, P226, DOI 10.1016/j.jad.2015.12.038
   Najafian J, 2013, NIGER J CLIN PRACT, V16, P59, DOI 10.4103/1119-3077.106756
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   Park Chan Young, 2015, Osong Public Health Res Perspect, V6, P224, DOI 10.1016/j.phrp.2015.05.004
   Polinski JM, 2013, DIABETES EDUCATOR, V39, P53, DOI 10.1177/0145721712467696
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Reutrakul S, 2015, CHRONOBIOL INT, V32, P1469, DOI 10.3109/07420528.2015.1105812
   Schwarzer R, 1997, WORLD PSYCHOL, V3, P177
   Stankovic Z, 2013, VOJNOSANIT PREGL, V70, P1138, DOI 10.2298/VSP1312138S
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   Wong S, 2011, DIABETIC MED, V28, P206, DOI 10.1111/j.1464-5491.2010.03195.x
   Yang Q., 2010, J NURSING CHINA, V17, P8
   Zhang J, 2013, NEUROPSYCH DIS TREAT, V9, P1289, DOI 10.2147/NDT.S49798
   ZHANG JX, 1995, PSYCHOLOGIA, V38, P174
   Zhang P, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0435-x
   Zhao J, 2016, EUR REV MED PHARMACO, V20, P3087
NR 38
TC 4
Z9 4
U1 2
U2 19
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-1781
J9 PSYCHIAT RES
JI Psychiatry Res.
PD JUN
PY 2017
VL 252
BP 45
EP 50
DI 10.1016/j.psychres.2017.02.049
PG 6
WC Psychiatry
SC Psychiatry
GA EX3FX
UT WOS:000403119100007
PM 28246057
DA 2019-01-08
ER

PT J
AU McCarthy, MM
   Whittemore, R
   Gholson, G
   Grey, M
AF McCarthy, Margaret M.
   Whittemore, Robin
   Gholson, Georica
   Grey, Margaret
TI Self-management of physical activity in adults with type 1 diabetes
SO APPLIED NURSING RESEARCH
LA English
DT Article
ID CARDIOVASCULAR-DISEASE; BARRIERS; RISK; MELLITUS; CARE; ASSOCIATION;
   DEPRESSION; MORTALITY; STATEMENT; DISTRESS
C1 [McCarthy, Margaret M.] NYU, Coll Nursing, 433 First Ave 404, New York, NY 10010 USA.
   [Whittemore, Robin; Grey, Margaret] Yale Sch Nursing, Orange, CT USA.
   [Gholson, Georica] Kimberly M Brooks & Associates, Bowie, MD USA.
RP McCarthy, MM (reprint author), NYU, Coll Nursing, 433 First Ave 404, New York, NY 10010 USA.
EM mmm529@nyu.edu
FU Multidisciplinary Behavioral Research Training in Type 1 Diabetes [MPI1
   T32 DK 097718-01]; Sigma Theta Tau International, Delta Mu Chapter
FX Multidisciplinary Behavioral Research Training in Type 1 Diabetes Grant
   # MPI1 T32 DK 097718-01 and the Sigma Theta Tau International, Delta Mu
   Chapter.
CR American Diabetes Association, 2016, STAT DIAB
   American Diabetes Association, 2016, DIABETES CARE S1, V39, pS60, DOI DOI 10.2337/DC16-S011
   Ashrafian H, 2016, OBES SURG, V26, P1697, DOI 10.1007/s11695-015-1999-6
   Balfe M, 2014, HEALTH PLACE, V26, P180, DOI 10.1016/j.healthplace.2013.12.016
   Bohn B, 2015, DIABETES CARE, V38, P1536, DOI 10.2337/dc15-0030
   Brazeau AS, 2012, DIABETES METAB, V38, P164, DOI 10.1016/j.diabet.2011.10.005
   Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720
   Cerin E., 2016, MED SCI SPORTS EXERC
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Clemes SA, 2012, MED SCI SPORT EXER, V44, P1097, DOI 10.1249/MSS.0b013e318242a377
   Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728
   Corson K, 2004, AM J MANAG CARE, V10, P839
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   de Ferranti SD, 2014, DIABETES CARE, V37, P2843, DOI 10.2337/dc14-1720
   Duca L, 2013, CURR DIABETES REP, V13, P350, DOI 10.1007/s11892-013-0380-1
   ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Galassetti P, 2013, COMPR PHYSIOL, V3, P1309, DOI 10.1002/cphy.c110040
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Halford J, 2010, DIABETES TECHNOL THE, V12, P201, DOI 10.1089/dia.2009.0121
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Martyn-Nemeth P, 2016, J DIABETES COMPLICAT, V30, P167, DOI 10.1016/j.jdiacomp.2015.09.003
   McCarthy M, 2015, NURS RES, V64, P320, DOI 10.1097/NNR.0000000000000098
   McCarthy MM, 2016, DIABETES EDUCATOR, V42, P108, DOI 10.1177/0145721715620021
   Moon D. H., 2016, J SPORTS SCI, P1
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Mulcahy K, 2003, DIABETES EDUCATOR, V29, P768, DOI 10.1177/014572170302900509
   Mulcahy K, 2003, DIABETES ED, V29, P773, DOI DOI 10.1177/014572170302900509
   Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423
   Peterson JC, 2012, ANN RHEUM DIS, V71, P635, DOI 10.1136/annrheumdis-2011-200473
   Pinsker J. E., 2016, CANADIAN J DIABETES
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Prime Group for JDRF, 2015, TYP 1 DIAB FACTS
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9
   Secrest AM, 2010, DIABETES, V59, P3216, DOI 10.2337/db10-0862
   Snell-Bergeon JK, 2012, J CARDIOVASC TRANSL, V5, P446, DOI 10.1007/s12265-012-9363-x
   Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553
   Tielemans SMAJ, 2013, DIABETOLOGIA, V56, P82, DOI 10.1007/s00125-012-2743-6
   Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133
   Tudor-Locke C, 2009, RES Q EXERCISE SPORT, V80, P175, DOI 10.1080/02701367.2009.10599551
   Wasserman LI, 2006, SPAN J PSYCHOL, V9, P75, DOI 10.1017/S1138741600005990
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
NR 45
TC 1
Z9 1
U1 2
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0897-1897
EI 1532-8201
J9 APPL NURS RES
JI Appl. Nurs. Res.
PD JUN
PY 2017
VL 35
BP 18
EP 23
DI 10.1016/j.apnr.2017.02.010
PG 6
WC Nursing
SC Nursing
GA EW8QZ
UT WOS:000402784500004
PM 28532721
DA 2019-01-08
ER

PT J
AU Montgomery, J
   Lu, J
   Ratliff, S
   Mezuk, B
AF Montgomery, Joshua
   Lu, Juan
   Ratliff, Scott
   Mezuk, Briana
TI Food Insecurity and Depression Among Adults With Diabetes: Results From
   the National Health and Nutrition Examination Survey (NHANES)
SO DIABETES EDUCATOR
LA English
DT Article
ID LOW-INCOME PATIENTS; NEIGHBORHOOD CHARACTERISTICS; SOCIAL DETERMINANTS;
   DISTRESS; MELLITUS; SAFETY; COSTS; RISK
AB Purpose While both food insecurity and depression have been linked to risk of type 2 diabetes, little is known about the relationship between food insecurity and depression among adults with diabetes.
   Research Design and Methods Cross-sectional analyses of the National Health and Nutrition Examination Survey (2011-2014), a nationally representative, population-based survey. Analytic sample was limited to adults aged 20 with diabetes determined by either fasting plasma glucose (126 mg/dL) or self-report (n = 1724) and adults age 20 with prediabetes determined by fasting plasma glucose (100-125 mg/dL) or self-report (n = 2004). Food insecurity was measured using the US Food Security Survey Module. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Logistic regression was used to assess the relationship between food insecurity and depression while accounting for sociodemographic characteristics and health behaviors.
   Results Approximately 10% of individuals with diabetes and 8.5% of individuals with prediabetes had severe food insecurity in the past year; an additional 20.3% of individuals with diabetes and 14.3% of those with prediabetes had mild food insecurity. Among individuals with diabetes, both mild and severe food insecurity were associated with elevated odds of depression These relationships were similar in magnitude among individuals with prediabetes.
   Conclusions Food insecurity is significantly associated with depressive symptoms in people with diabetes and prediabetes. Results point to the need to address economic issues in conjunction with psychosocial issues for comprehensive diabetes care.
C1 [Montgomery, Joshua; Lu, Juan; Ratliff, Scott; Mezuk, Briana] Virginia Commonwealth Univ, Sch Med, Div Epidemiol, Dept Family Med & Populat Hlth, POB 980212, Richmond, VA 23298 USA.
   [Ratliff, Scott; Mezuk, Briana] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Mezuk, Briana] Univ Michigan, Inst Social Res, Ann Arbor, MI USA.
RP Mezuk, B (reprint author), Virginia Commonwealth Univ, Sch Med, Div Epidemiol, Dept Family Med & Populat Hlth, POB 980212, Richmond, VA 23298 USA.
EM bmezuk@vcu.edu
FU America Diabetes Association [1-16-ICTS-082]; National Center for Health
   Statistics;  [K01-MH093642];  [P60-MD002249];  [R25-GM089614]
FX B. Mezuk is supported by K01-MH093642, B. Mezuk and S. Ratliff are
   supported by P60-MD002249, and J. Montgomery was supported by
   R25-GM089614. Additional support provided by the America Diabetes
   Association (1-16-ICTS-082). The National Health and Nutrition
   Examination Survey (NHANES) is supported by the National Center for
   Health Statistics. The sponsors had no role in the design,
   interpretation, or decision to publish this study. There is no conflict
   of interest to report.
CR American DA, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   American Diabetes Association, 2016, DIABETES CARE S1, V39, pS59
   ANDERSON SA, 1990, J NUTR, V120, P1559, DOI 10.1093/jn/120.suppl_11.1555
   Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x
   Bickel G, 2000, GUIDE MEASURING HOUS
   Centers for Disease Control and Prevention, 2012, NAT HLTH NUTR EX SUR
   Christine PJ, 2015, JAMA INTERN MED, V175, P1311, DOI 10.1001/jamainternmed.2015.2691
   Chung WT, 2012, J URBAN HEALTH, V89, P407, DOI 10.1007/s11524-011-9633-y
   Drewnowski A, 2005, J NUTR, V135, P900
   Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
   Garg A, 2016, JAMA-J AM MED ASSOC, V316, P813, DOI 10.1001/jama.2016.9282
   Gucciardi E., 2014, Current Nutrition Reports, V3, P324
   Hallahan B, 2016, BRIT J PSYCHIAT, V209, P192, DOI 10.1192/bjp.bp.114.160242
   Hamelin AM, 1999, J NUTR, V129, p525S, DOI 10.1093/jn/129.2.525S
   Hosmer DW, 2000, INTRO LOGISTIC REGRE
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lewis JH, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0526-8
   Lopez A., 2012, Diabetes Spectrum, V25, P14, DOI 10.2337/diaspect.25.1.14
   LUSTMAN PJ, 1987, COMPR PSYCHIAT, V28, P22, DOI 10.1016/0010-440X(87)90040-X
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mezuk B, 2013, HEALTH PLACE, V23, P63, DOI 10.1016/j.healthplace.2013.05.004
   Parker ED, 2010, ANN EPIDEMIOL, V20, P364, DOI 10.1016/j.annepidem.2010.02.009
   Sanchez-Villegas A, 2012, PUBLIC HEALTH NUTR, V15, P424, DOI 10.1017/S1368980011001856
   Sanchez-Villegas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016268
   Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6
   Seligman HK, 2012, DIABETES CARE, V35, P233, DOI 10.2337/dc11-1627
   Seligman HK, 2011, ARCH INTERN MED, V171, P1204, DOI 10.1001/archinternmed.2011.287
   Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573
   Siefert K, 2001, WOMEN HEALTH, V32, P159, DOI 10.1300/J013v32n01_08
   Silverman J, 2015, J GEN INTERN MED, V30, P1476, DOI 10.1007/s11606-015-3351-1
   Singh A, 2013, ERR173
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Stuff JE, 2004, J NUTR, V134, P2330
   Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x
   Weissman Judith F, 2015, NCHS Data Brief, P1
   Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239
NR 38
TC 2
Z9 2
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD JUN
PY 2017
VL 43
IS 3
BP 260
EP 271
DI 10.1177/0145721717699890
PG 12
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA EV4SU
UT WOS:000401753100003
PM 28436293
OA Green Accepted
DA 2019-01-08
ER

PT J
AU McEwen, MM
   Pasvogel, A
   Murdaugh, C
   Hepworth, J
AF McEwen, Marylyn Morris
   Pasvogel, Alice
   Murdaugh, Carolyn
   Hepworth, Joseph
TI Effects of a Family-based Diabetes Intervention on Behavioral and
   Biological Outcomes for Mexican American Adults
SO DIABETES EDUCATOR
LA English
DT Article
ID SELF-MANAGEMENT EDUCATION; GLYCEMIC CONTROL; CARE BEHAVIORS; STARR
   COUNTY; TYPE-2; HEALTH; DISTRESS; SUPPORT; MEMBERS; SCALE
AB Purpose The purpose of the study was to investigate the effects of a family-based self-management support intervention for adults with type 2 diabetes (T2DM).
   Methods Using a 2-group, experimental repeated measures design, 157 dyads (participant with T2DM and family member) were randomly assigned to an intervention (education, social support, home visits, and telephone calls) or a wait list control group. Data were collected at baseline, postintervention (3 months), and 6 months postintervention. A series of 2 x 3 repeated measures ANOVAs were used to test the hypotheses with interaction contrasts to assess immediate and sustained intervention effects.
   Results Significant changes over time were reported in diet self-management, exercise self-management, total self-management, diabetes self-efficacy for general health and total diabetes self-efficacy, physician distress, regimen distress, interpersonal distress, and total distress. There were likewise sustained effects for diet self-management, total self-management, diabetes self-efficacy for general health, total self-efficacy, physician distress, regimen distress, and interpersonal distress.
   Conclusions Results support and extend prior research documenting the value of culturally relevant family-based interventions to improve diabetes self-management and substantiate the need for intensive, longer, tailored interventions to achieve glycemic control.
C1 [McEwen, Marylyn Morris; Pasvogel, Alice; Murdaugh, Carolyn; Hepworth, Joseph] Univ Arizona, Coll Nursing, Community & Hlth Syst Sci Div, 1305 N Martin Ave,Room 411 POB 201203, Tucson, AZ 85721 USA.
RP McEwen, MM (reprint author), Univ Arizona, Coll Nursing, Community & Hlth Syst Sci Div, 1305 N Martin Ave,Room 411 POB 201203, Tucson, AZ 85721 USA.
EM marylynm@email.arizona.edu
FU National Institute for Minority Health and Health Disparities
   [R01MD005837]
FX Grant Support: R01MD005837, National Institute for Minority Health and
   Health Disparities.
CR Agency for Healthcare Research and Quality, 2011, 2010 NAT HEALTHC DIS
   American Diabetes Association, 2016, LIV DIAB COMPL
   American Diabetes Association, 2014, DIAB HISP ALL AR NOT
   [Anonymous], 2016, DIABETES CARE S1, V39, pS11
   Arizona Department of Health Services, 2011, AR DIAB BURD REP
   Baig AA, 2015, ANN NY ACAD SCI, V1353, P89, DOI 10.1111/nyas.12844
   Berry E, 2015, POSTGRAD MED J, V91, P278, DOI 10.1136/postgradmedj-2014-133017
   Block G, 2000, AM J PREV MED, V18, P284, DOI 10.1016/S0749-3797(00)00119-7
   Boren SA, 2007, DIABETES EDUCATOR, V33, P1053, DOI 10.1177/0145721707309809
   Brown SA, 2016, PATIENT EDUC COUNS, V99, P1558, DOI 10.1016/j.pec.2016.03.020
   Brown SA, 2014, DIABETES EDUCATOR, V40, P476, DOI 10.1177/0145721714531336
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   Carter JS, 1996, DIABETES CARE, V19, P764, DOI 10.2337/diacare.19.7.764
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Ortiz LGC, 2016, CLIN NURS RES, V25, P120, DOI 10.1177/1054773815586542
   Creamer J, 2016, DIABETIC MED, V33, P169, DOI 10.1111/dme.12865
   CUELLAR I, 1995, HISPANIC J BEHAV SCI, V17, P275, DOI 10.1177/07399863950173001
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Dominguez K, 2015, MMWR-MORBID MORTAL W, V64, P469
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fortmann AL, 2011, HEALTH PSYCHOL, V30, P251, DOI 10.1037/a0022850
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Garcia-Solano B, 2015, SAGE OPEN MED, V3
   Pereira MG, 2014, FAM SYST HEALTH, V32, P198, DOI 10.1037/fsh0000029
   Haas L, 2013, DIABETES CARE, V36, pS100, DOI 10.2337/dc13-S100
   Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898
   Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442
   Hu J, 2016, DIABETES EDUCATOR, V42, P299, DOI 10.1177/0145721716636961
   Hu J, 2013, DIABETES EDUCATOR, V39, P494, DOI 10.1177/0145721713486200
   McEwen MM, 2014, DIABETES EDUCATOR, V40, P488, DOI 10.1177/0145721714528996
   National Alliance for Hispanic Health, 2010, STAT DIAB HISP
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Powers MA, 2015, DIABETES EDUCATOR, V41, P417, DOI 10.1177/0145721715588904
   Rosland AM, 2010, CHRONIC ILLN, V6, P22, DOI 10.1177/1742395309354608
   Stark CS, 2013, DIABETES CARE, V36, P2271, DOI DOI 10.2337/DC12-2258
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief PM, 2016, DIABETES CARE, V39, P2165, DOI 10.2337/dc16-0035
   Vaccaro J. A., 2014, J NUTR HLTH, V2, P1, DOI DOI 10.12691/JNH-2-1-1
   Vincent D, 2013, DIABETES EDUCATOR, V39, P222, DOI 10.1177/0145721713475842
   Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405
NR 42
TC 4
Z9 4
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD JUN
PY 2017
VL 43
IS 3
BP 272
EP 285
DI 10.1177/0145721717706031
PG 14
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA EV4SU
UT WOS:000401753100004
PM 28447545
DA 2019-01-08
ER

PT J
AU Tully, C
   Shneider, C
   Monaghan, M
   Hilliard, ME
   Streisand, R
AF Tully, Carrie
   Shneider, Caitlin
   Monaghan, Maureen
   Hilliard, Marisa E.
   Streisand, Randi
TI Peer Coaching Interventions for Parents of Children with Type 1 Diabetes
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Diabetes; Peer mentor; Parent coach; Parents; Child; Psychosocial
ID FAMILY SYSTEMS THERAPY; RANDOMIZED-TRIAL; SOCIAL SUPPORT;
   YOUNG-CHILDREN; PSYCHOLOGICAL DISTRESS; SELF-MANAGEMENT; EMPOWER
   PARENTS; OUTCOMES; ADOLESCENTS; MOTHERS
AB Purpose of Review Peer support is a promising model of providing psychosocial support to parents of children with type 1 diabetes. This review seeks to discuss the findings of the existing literature in peer coaching as it relates to parents and diabetes as well as to identify gaps in knowledge for future intervention development and implementation.
   Recent Findings Peer support programs vary widely with regard to recruitment, training, and delivery protocols. Across most programs, ongoing support and supervision are provided to peer coaches. Despite inconsistent effects on psychosocial and child health outcomes, parent coaching is consistently a highly acceptable and feasible intervention with parents of children with T1D. Current evidence supports use of parent coaching as part of a multicomponent intervention or program to increase patient satisfaction, but more research is needed to determine if it can stand alone as an active mechanism for behavior change.
   Summary The use of peer coach interventions for parents of young children with diabetes is feasible to implement and highly acceptable. However, more research is needed to understand the enduring impact for target parents and peer coaches alike, as well as impact on child outcomes.
C1 [Tully, Carrie; Shneider, Caitlin; Monaghan, Maureen; Streisand, Randi] Childrens Natl Med Ctr, Ctr Translat Sci, 111 N Michigan Ave NW, Washington, DC 20010 USA.
   [Monaghan, Maureen; Streisand, Randi] George Washington Univ, Sch Med & Hlth Sci, 2300 Eye St NW, Washington, DC 20037 USA.
   [Hilliard, Marisa E.] Baylor Coll Med, 1102 Bates Ave,Suite 940, Houston, TX 77030 USA.
   [Hilliard, Marisa E.] Texas Childrens Hosp, 1102 Bates Ave,Suite 940, Houston, TX 77030 USA.
RP Tully, C (reprint author), Childrens Natl Med Ctr, Ctr Translat Sci, 111 N Michigan Ave NW, Washington, DC 20010 USA.
EM ctully1@childrensnational.org; ceshneider@childrensnational.org;
   mmonagha@childrensnational.org; marisa.hilliard@bcm.edu;
   rstreis@childrensnational.org
OI Hilliard, Marisa/0000-0002-8813-629X
FU National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK)/National Institutes of Health (NIH) [R01DK102561-02]; NIDDK [DP3
   DK103998-01, K12DK097696, K23DK099250]
FX Randi Streisand, Marisa Hilliard, Maureen Monaghan, Carrie Tully, and
   Caitlin Shneider report grants from the National Institute of Diabetes
   and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health
   (NIH): R01DK102561-02.; Randi Streisand and Carrie Tully report
   additional grant support from NIDDK: DP3 DK103998-01. Marisa Hilliard
   reports additional grant support from NIDDK: K12DK097696 (PI: B
   Anderson). Maureen Monaghan reports additional grant support NIDDK:
   K23DK099250.
CR Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713
   Channon S, 2016, DIABETES EDUCATOR, V42, P462, DOI 10.1177/0145721716644673
   Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x
   Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5
   Donegan A, 2016, INFLAMM BOWEL DIS, V22, P1151, DOI 10.1097/MIB.0000000000000733
   Flores G, 2009, PEDIATRICS, V124, P1522, DOI 10.1542/peds.2009-0230
   Freeman Kurt A, 2013, J Diabetes Sci Technol, V7, P727
   Grey Margaret, 2004, Curr Diab Rep, V4, P126, DOI 10.1007/s11892-004-0068-7
   Grey M, 2013, DIABETES CARE, V36, P2475, DOI 10.2337/dc12-2199
   Hebert M., 2008, PSYCHOL SERV, V5, P216, DOI [10.1037/1541-1559.5.3.216, DOI 10.1037/1541-1559.5.3.216]
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   Hilliard ME, 2016, AM PSYCHOL, V71, P590, DOI 10.1037/a0040359
   Horsch A, 2007, J TRAUMA STRESS, V20, P881, DOI 10.1002/jts.20247
   Ireys HT, 2001, ARCH PEDIAT ADOL MED, V155, P771, DOI 10.1001/archpedi.155.7.771
   Jaser SS, 2014, MATERN CHILD HLTH J, V18, P101, DOI 10.1007/s10995-013-1239-4
   Jaser SS, 2010, J PEDIATR PSYCHOL, V35, P738, DOI 10.1093/jpepsy/jsp098
   Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003
   Lorig KR, 2015, FRONT PUBLIC HLTH, V2, P253
   Maas-van Schaaijk NM, 2013, J PEDIATR PSYCHOL, V38, P30, DOI 10.1093/jpepsy/jss096
   Mackey Eleanor Race, 2016, Clin Pract Pediatr Psychol, V4, P35
   Mellin AE, 2004, J PEDIATR PSYCHOL, V29, P221, DOI 10.1093/jpepsy/jsh023
   Monaghan M, 2015, HEALTH PSYCHOL, V34, P794, DOI 10.1037/hea0000204
   Monaghan M, 2011, PATIENT EDUC COUNS, V82, P271, DOI 10.1016/j.pec.2010.04.007
   Moskowitz D, 2013, J GEN INTERN MED, V28, P938, DOI 10.1007/s11606-013-2367-7
   Rearick EM, 2011, DIABETES EDUCATOR, V37, P508, DOI 10.1177/0145721711412979
   Shilling V, 2013, DEV MED CHILD NEUROL, V55, P602, DOI 10.1111/dmcn.12091
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Streisand R, 2008, PATIENT EDUC COUNS, V73, P333, DOI 10.1016/j.pec.2008.06.014
   Sullivan-Bolyai S, 2004, DIABETES EDUCATOR, V30, P476, DOI 10.1177/014572170403000319
   Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4
   Sullivan-Bolyai S, 2011, MCN-AM J MATERN-CHIL, V36, P224, DOI 10.1097/NMC.0b013e3182183bf5
   Sullivan-Bolyai S, 2011, DIABETES EDUCATOR, V37, P35, DOI 10.1177/0145721710392248
   Sullivan-Bolyai S, 2010, DIABETES EDUCATOR, V36, P88, DOI 10.1177/0145721709352384
   Tang T, 2011, DIABETES SPECTR, V24, P85, DOI DOI 10.2337/DIASPECT.24.2.85
   Tang TS, 2011, PEER LEADER MANUAL
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Williams LB, 2009, DIABETIC MED, V26, P908, DOI 10.1111/j.1464-5491.2009.02794.x
   Wysocki T, 2008, BEHAV THER, V39, P33, DOI 10.1016/j.beth.2007.04.001
   Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613
NR 39
TC 3
Z9 3
U1 3
U2 12
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD JUN
PY 2017
VL 17
IS 6
AR 39
DI 10.1007/s11892-017-0870-7
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EV4DA
UT WOS:000401707300004
PM 28434144
DA 2019-01-08
ER

PT J
AU Linetzky, B
   Jiang, DF
   Funnell, MM
   Curtis, BH
   Polonsky, WH
AF Linetzky, Bruno
   Jiang, Dingfeng
   Funnell, Martha M.
   Curtis, Bradley H.
   Polonsky, William H.
TI Exploring the role of the patient-physician relationship on insulin
   adherence and clinical outcomes in type 2 diabetes: Insights from the
   MOSAIc study
SO JOURNAL OF DIABETES
LA English
DT Article
DE medication adherence; patient-physician relationships; type 2 diabetes
ID INTERPERSONAL PROCESSES; HEALTH-CARE; BARRIERS; COMMUNICATION;
   ATTITUDES; ASSOCIATION; PERSPECTIVE; CONCORDANCE; MANAGEMENT; LANGUAGE
AB Background: The 2-year prospective MOSAIc (Multinational Observational Study assessing Insulin use: understanding the challenges associated with progression of therapy) study is investigating whether patient-, physician-, and health system-related factors affect outcomes in patients with type 2 diabetes (T2D). This baseline subanalysis investigated how aspects of the patientphysician relationship are associated with diabetes-related distress, insulin adherence, and glycemic control.
   Methods: Patients with T2D taking insulin for >= 3 months were recruited at primary care and specialty practice sites in 18 countries. Physicians provided usual care. Clinical history and most recent HbA1c values were collected; patients were surveyed regarding their perception of physician interactions, diabetes-related distress level, and insulin adherence.
   Results: The analysis population comprised 4341 patients. Four (of six) domains showed a significant relationship with total diabetes-related distress (P < 0.01). Poor insulin adherence was associated with greater diabetes-related distress (adjusted odds ratio [aOR] 1.14; 95% confidence interval [CI] 1.06-1.22), higher Discrimination (aOR 1.13; 95% CI 1.02-1.27) and Hurried Communication (aOR 1.35; 95% CI 1.20-1.53) scores, and a lower Explained Results score (aOR 0.86; 95% CI 0.77-0.97). Poor insulin adherence was associated with a 0.43% increase in HbA1c, whereas a 1-unit increase in total diabetes-related distress and Hurried Communication scores was associated with a 0.171% and 0.145% increase in HbA1c, respectively.
   Conclusions: Patients distressed about living with T2D, and dissatisfied with aspects of their interactions with physicians, exhibited poor insulin adherence. Perceived physician inattention and lack of engagement (and diabetes-related distress) directly affect insulin adherence and glycemic control.
C1 [Linetzky, Bruno] Eli Lilly & Co, Tronador 4890,Piso 12,C1430DNN, Buenos Aires, DF, Argentina.
   [Jiang, Dingfeng; Curtis, Bradley H.] Eli Lilly & Co, Indianapolis, IN 46285 USA.
   [Funnell, Martha M.] Univ Michigan, Med Sch, Ann Arbor, MI USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Polonsky, William H.] Univ Calif San Diego, San Diego, CA 92103 USA.
RP Linetzky, B (reprint author), Eli Lilly & Co, Tronador 4890,Piso 12,C1430DNN, Buenos Aires, DF, Argentina.
EM linetzky_bruno@lilly.com
FU Eli Lilly and Company
FX The MOSAIc study was sponsored by Eli Lilly and Company. Medical writing
   assistance was provided by Lucy Rutherford and Andrew Sakko (inVentiv
   Health Clinical, Sydney, NSW, Australia) and editorial assistance was
   provided by Jeanne Claypoole (inVentiv Health Clinical, Princeton, NJ,
   USA), sponsored by Eli Lilly and Company.
CR Forum for Injection Technique, 2015, UK INJECTION TECHNIQ
   GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921
   Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x
   Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242
   Inzucchi SE, 2015, DIABETOLOGIA, V58, P429, DOI 10.1007/s00125-014-3460-0
   Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184
   Kerse N, 2004, ANN FAM MED, V2, P455, DOI 10.1370/afm.139
   Lee YY, 2009, SOC SCI MED, V68, P1060, DOI 10.1016/j.socscimed.2008.12.033
   Mayberry LS, 2014, DIABETES CARE, V37, P1246, DOI 10.2337/dc13-1828
   Nam Soohyun, 2014, J Contemp Diabetes Res, V1, P1
   Napoles AM, 2009, HEALTH SERV RES, V44, P1326, DOI 10.1111/j.1475-6773.2009.00965.x
   Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x
   Piette JD, 2005, ARCH INTERN MED, V165, P1749, DOI 10.1001/archinte.165.15.1749
   Piette JD, 2003, J GEN INTERN MED, V18, P624, DOI 10.1046/j.1525-1497.2003.31968.x
   Polinski JM, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0044-z
   Polinski JM, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-20
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2015, P EUR ASS STUD DIAB
   Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   Schmittdiel JA, 2009, J WOMENS HEALTH, V18, P2065, DOI 10.1089/jwh.2009.1406
   Stewart AL, 2007, HEALTH SERV RES, V42, P1235, DOI 10.1111/j.1475-6773.2006.00637.x
   Traylor AH, 2010, J GEN INTERN MED, V25, P1172, DOI 10.1007/s11606-010-1424-8
   Weinger K, 2010, DIABETES CARE, V33, P450, DOI 10.2337/dc09-2132
NR 24
TC 8
Z9 8
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1753-0393
EI 1753-0407
J9 J DIABETES
JI J. Diabetes
PD JUN
PY 2017
VL 9
IS 6
BP 596
EP 605
DI 10.1111/1753-0407.12443
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EV6AZ
UT WOS:000401853200008
PM 27368146
OA Other Gold
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Hessler, D
   Ruedy, KJ
   Beck, RW
AF Polonsky, William H.
   Hessler, Danielle
   Ruedy, Katrina J.
   Beck, Roy W.
CA DIAMOND Study Grp
TI The Impact of Continuous Glucose Monitoring on Markers of Quality of
   Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND
   Randomized Clinical Trial
SO DIABETES CARE
LA English
DT Article
ID GLYCEMIC CONTROL; HYPOGLYCEMIA; MULTICENTER; INJECTIONS; AWARENESS;
   DISTRESS
AB OBJECTIVE
   Continuous glucose monitoring (CGM) improves glycemic control, but data are inconclusive about its influence on quality of life (QOL). We investigated the impact of 24 weeks of CGM use on QOL in adults with type 1 diabetes (T1D) who use multiple daily insulin injections.
   RESEARCH DESIGN AND METHODS DIAMOND
   (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) was a prospective randomized trial that assessed CGM versus self-monitoring of blood glucose (SMBG) only in 158 adults with poorly controlled T1D. At baseline and study end, participants completed QOL measures that assessed overall well-being (WHO-5), health status (EQ-5D-5L), diabetes distress (DDS), hypoglycemic fear (worry subscale of the HFS-II), and hypoglycemic confidence (HCS). At study end, CGM participants completed the CGM Satisfaction Survey. Linear regression analyses compared treatment group changes in QOL outcomes over time. Associations between CGM satisfaction and change in QOL outcomes and in glycemic control indices were assessed.
   RESULTS
   The CGM group demonstrated a greater increase in hypoglycemic confidence (P = 0.01) and a greater decrease in diabetes distress (P = 0.01) than the SMBG group. No significant group differences in well-being, health status, or hypoglycemic fear were observed. CGM satisfaction was not significantly associated with glycemic changes but was associated with reductions in diabetes distress (P < 0.001) and hypoglycemic fear (P = 0.02) and increases in hypoglycemic confidence (P < 0.001) and well-being (P = 0.01).
   CONCLUSIONS
   CGM contributes to significant improvement in diabetes-specific QOL (i.e., diabetes distress, hypoglycemic confidence) in adults with T1D, but not with QOL measures not specific to diabetes (i.e., well-being, health status). CGM satisfaction was associated with most of the QOL outcomes but not with glycemic outcomes.
C1 [Polonsky, William H.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA 92121 USA.
   [Hessler, Danielle] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Ruedy, Katrina J.; Beck, Roy W.] Jaeb Ctr Hlth Res, Tampa, FL USA.
RP Polonsky, WH (reprint author), Univ Calif San Diego, San Diego, CA 92103 USA.; Polonsky, WH (reprint author), Behav Diabet Inst, San Diego, CA 92121 USA.
EM whp@behavioraldiabetes.org
FU Dexcom, Inc.; Dexcom and Abbott Diabetes Care
FX Dexcom, Inc. provided funding for the study to the Behavioral Diabetes
   Institute and to the Jaeb Center for Health Research. W.H.P. reports
   consulting fees from Dexcom and Abbott Diabetes Care. R.W.B. reports
   that his institution has received supplies for research studies from
   Dexcom and Abbott Diabetes Care. No other potential conflicts of
   interest relevant to this article were reported.
CR Bailey Timothy S, 2015, J Diabetes Sci Technol, V9, P209, DOI 10.1177/1932296814559746
   Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975
   Beck RW, 2010, DIABETES CARE, V33, P2175, DOI 10.2337/dc10-0331
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bolinder J, 2016, LANCET, V388, P2254, DOI 10.1016/S0140-6736(16)31535-5
   Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hirsch IB, 2010, DIABETES TECHNOL THE, V12, P679, DOI 10.1089/dia.2010.0015
   Irvin A, 1994, HDB PSYCHOL DIABETES, P133
   Little SA, 2014, DIABETES CARE, V37, P2114, DOI 10.2337/dc14-0030
   Pickup JC, 2015, DIABETES CARE, V38, P544, DOI 10.2337/dc14-1855
   Polonsky WH, 2015, J DIABETES COMPLICAT, V29, P1171, DOI 10.1016/j.jdiacomp.2015.08.002
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2017, DIABETES TECHNOL THE, V19, P131, DOI 10.1089/dia.2016.0366
   Polonsky William H, 2016, J Diabetes Sci Technol, V10, P892, DOI 10.1177/1932296816643542
   Polonsky WH, 2013, DIABETES TECHNOL THE, V15, P295, DOI 10.1089/dia.2012.0298
   Riveline JP, 2012, DIABETES CARE, V35, P965, DOI 10.2337/dc11-2021
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   van Beers CAJ, 2016, LANCET DIABETES ENDO, V4, P893, DOI 10.1016/S2213-8587(16)30193-0
   Vigersky RA, 2012, DIABETES CARE, V35, P32, DOI 10.2337/dc11-1438
NR 21
TC 29
Z9 29
U1 2
U2 15
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUN 1
PY 2017
VL 40
IS 6
BP 736
EP 741
DI 10.2337/dc17-0133
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EV4AC
UT WOS:000401699500008
PM 28389582
OA Bronze
HC Y
HP N
DA 2019-01-08
ER

PT J
AU Nieuwesteeg, A
   Hartman, E
   Emons, W
   van Bakel, H
   Aanstoot, HJ
   van Mil, E
   Pouwer, F
AF Nieuwesteeg, A.
   Hartman, E.
   Emons, W.
   van Bakel, H.
   Aanstoot, H. -J.
   van Mil, E.
   Pouwer, F.
TI Paediatric parenting stress in fathers and mothers of young children
   with Type 1 diabetes: a longitudinal study
SO DIABETIC MEDICINE
LA English
DT Article
ID PATERNAL INVOLVEMENT; DISEASE MANAGEMENT; CHRONIC ILLNESS; ASSOCIATIONS;
   MULTICENTER; CAREGIVERS; INVENTORY; AMERICAN; MELLITUS; OUTCOMES
AB AimTo compare levels of paediatric parenting stress in the fathers and mothers of young children with Type 1 diabetes and study the variation in this stress over time.
   MethodsOne hundred and twelve parents (56 mothers and 56 fathers) of young children (0-7 years) with Type 1 diabetes participated in this study. They completed the Pediatric Inventory for Parents to assess paediatric parenting stress (frequency and difficulty scores on the Communication, Emotional Distress, Medical Care and Role Functioning subscales and Total Score); 44 mothers (79%) and 31 fathers (55%) completed the questionnaire again, 1 year later. Independent and paired sample t-tests were used to examine the differences between fathers and mothers and the changes over time. Cohen's d effect sizes were also calculated.
   ResultsMothers scored significantly higher than fathers on the stress subscales for Communication frequency and difficulty, Emotional Distress frequency and difficulty, Medical Care frequency and Total Score frequency and difficulty (d ranged from -0.44 to -0.56). Furthermore, fathers reported a decrease in Medical Care frequency (d = 0.10) and an increase in Emotional Distress difficulty (d = -0.32) and Total Score difficulty (d = -0.29), whereas mothers reported a decrease in Emotional Distress frequency, Medical Care frequency and Total Score frequency (d ranged from 0.31 to 0.66) over a 1-year period.
   ConclusionsThese results show that within families with a young child with Type 1 diabetes, the burden of care increases in fathers and decreases in mothers, suggesting that fathers assume more responsibility for care of their child with Type 1 diabetes as the child grows.
C1 [Nieuwesteeg, A.; Hartman, E.; Emons, W.; Pouwer, F.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, Tilburg, Netherlands.
   [Emons, W.] Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands.
   [van Bakel, H.] Tilburg Univ, Dept Tranzo, Sci Ctr Care & Welf, Tilburg, Netherlands.
   [van Mil, E.] Jeroen Bosch Hosp, Kidz & Ko, sHertogenbosch, Netherlands.
RP Hartman, E (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, Tilburg, Netherlands.
EM e.e.hartman@tilburguniversity.edu
CR [Anonymous], 1995, LANCET, V1, P1
   Brown RT, 2008, J PEDIATR PSYCHOL, V33, P408, DOI 10.1093/jpepsy/jsm079
   Cohen BH., 1988, STAT POWER ANAL BEHA
   Cousino MK, 2013, J PEDIATR PSYCHOL, V38, P809, DOI [10.1093/jpepsy/jsto49, 10.1093/jpepsy/jst049]
   Cunningham NR, 2011, J PEDIATR PSYCHOL, V36, P196, DOI 10.1093/jpepsy/jsq071
   Dashiff Carol, 2008, J Pediatr Nurs, V23, P101, DOI 10.1016/j.pedn.2007.08.007
   Eccleston C, 2015, COCHRANE DB SYST REV, V4
   Gavin L, 2006, J PEDIATR PSYCHOL, V31, P481, DOI 10.1093/jpepsy/jsj043
   Goldbeck L, 2006, QUAL LIFE RES, V15, P1121, DOI 10.1007/s11136-006-0068-y
   Hansen JA, 2012, FAM SYST HEALTH, V30, P47, DOI 10.1037/a0027519
   Hilliard ME, 2011, CHILD CARE HLTH DEV, V37, P224, DOI 10.1111/j.1365-2214.2010.01162.x
   Hullmann SE, 2010, J CLIN PSYCHOL MED S, V17, P357, DOI 10.1007/s10880-010-9213-4
   Iwamoto V, 2008, J PEDIAT, V84, P91, DOI [10.2223/JPED.1738, 10.1590/S0021-75572008000100015]
   Lewin A. B., 2005, FAMILIES SYSTEMS HLT, V23, P56, DOI DOI 10.1037/1091-7527.23.1.56
   Mitchell SJ, 2009, FAM SYST HEALTH, V27, P314, DOI 10.1037/a0018191
   Monaghan M, 2011, PATIENT EDUC COUNS, V82, P271, DOI 10.1016/j.pec.2010.04.007
   Monaghan MC, 2009, FAM SYST HEALTH, V27, P28, DOI 10.1037/a0014770
   Mueller-Godeffroy E, 2009, DIABETIC MED, V26, P493, DOI 10.1111/j.1464-5491.2009.02707.x
   Nieuwesteeg A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-145
   Nieuwesteeg AM, 2016, EUR J PEDIATR, V175, P329, DOI 10.1007/s00431-015-2631-4
   Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7
   Patton SR, 2011, J CLIN PSYCHOL MED S, V18, P345, DOI 10.1007/s10880-011-9256-1
   Romano MC, 2007, SOC INDIC RES, V84, P97, DOI 10.1007/s11205-006-9077-z
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Stallwood Lynda, 2005, J Pediatr Health Care, V19, P293, DOI 10.1016/j.pedhc.2005.04.003
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155
   Streisand R, 2008, PATIENT EDUC COUNS, V73, P333, DOI 10.1016/j.pec.2008.06.014
   Sullivan-Bolyai S, 2006, MCN-AM J MATERN-CHIL, V31, P24, DOI 10.1097/00005721-200601000-00007
   Svavarsdottir EK, 2003, J NURS SCHOLARSHIP, V35, P351, DOI 10.1111/j.1547-5069.2003.00351.x
   Vrijmoet-Wiersma CMJ, 2010, PSYCHO-ONCOLOGY, V19, P368, DOI 10.1002/pon.1571
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Wu YP, 2010, DIABETES RES CLIN PR, V89, P121, DOI 10.1016/j.diabres.2010.04.010
NR 33
TC 6
Z9 6
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2017
VL 34
IS 6
BP 821
EP 827
DI 10.1111/dme.13300
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EU9CJ
UT WOS:000401334700012
PM 27973688
DA 2019-01-08
ER

PT J
AU Stoop, CH
   Nefs, G
   Pop, VJ
   Pouwer, F
AF Stoop, Corinne H.
   Nefs, Giesje
   Pop, Victor J.
   Pouwer, Francois
TI Screening for and subsequent participation in a trial for depression and
   anxiety in people with type 2 diabetes treated in primary care: Who do
   we reach?
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Diabetes; Depression; Anxiety; Trial participation; Screening
ID RANDOMIZED CONTROLLED-TRIAL; CO-MORBID DEPRESSION; ILL ELDERLY-PATIENTS;
   EMOTIONAL DISTRESS; PROSPECTIVE COHORT; METAANALYSIS; PREVALENCE;
   DISEASE; INTERVENTION; MELLITUS
AB Aims: This study investigated (factors related to) (a) the response to a screening procedure for depression and anxiety in people with type 2 diabetes in primary care, and (b) participation in a subsequent randomised controlled trial targeting depressive or anxiety symptoms.
   Methods: People with type 2 diabetes (n=1837) received a screening questionnaire assessing depressive symptoms (PHQ-9) and anxiety symptoms (GAD-7). Eligible persons who scored above the cut-off score (PHQ-9 >= 7 or GAD-7 >= 8) were offered to participate in the trial.
   Results: In total, 798 people (43%) returned the screening questionnaire. Non-responders were more often female (53% vs 44%, p <0.001), had higher LDL cholesterol levels (Cohen's d = 0.17, p = 0.001) and a higher albumin/creatinine ratio (Cohen's d = 0.08, p = 0.01). In total, 130 people (18%) reported elevated depressive or anxiety symptoms. Twenty-seven persons agreed to participate in the trial. Factors related to participation were a high education level, a higher level of diabetes distress and a history of psychological problems.
   Conclusions: Using screening as recruitment resulted in a small number of participants in a treatment trial for anxiety and depression. Research is needed to investigate whether screening is also followed by a low uptake of treatment in primary care outside a RCT setting. (C) 2017 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Stoop, Corinne H.; Nefs, Giesje; Pop, Victor J.; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders CoRPS, POB 90153, NL-5000 LE Tilburg, Netherlands.
   [Stoop, Corinne H.] PoZOB, POB 312, NL-5500 AH Veldhoven, Netherlands.
RP Nefs, G (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders CoRPS, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM g.m.nefs@tilburguniversity.edu
RI Nefs, Giesje/C-9992-2018
FU ZonMw The Netherlands Organisation for Health Research and Development,
   the Hague, the Netherlands [300020015]; CoRPS, Tilburg University
FX This study has been funded by ZonMw The Netherlands Organisation for
   Health Research and Development, the Hague, the Netherlands, grant
   number 300020015, and CoRPS, Tilburg University. The funding sources
   were not involved in the design, data collection, analysis and
   interpretation of data or in the writing of this article.
CR Ajdukovic D., 2012, INT J ENDOCRINOL, V2012
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011
   [Anonymous], 2005, IDF CLIN GUID TASK F
   Baas KD, 2009, BRIT J PSYCHIAT, V194, P399, DOI 10.1192/bjp.bp.107.046052
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cuijpers P, 2009, BRIT J GEN PRACT, V59, P120, DOI 10.3399/bjgp09X395139
   Fleer J, 2013, DIABETIC MED, V30, P88, DOI 10.1111/dme.12001
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Koopmans B, 2009, DIABETOLOGIA, V52, P2056, DOI 10.1007/s00125-009-1460-2
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004
   Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613
   Lamers F, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-161
   Lamers F, 2008, J CLIN EPIDEMIOL, V61, P679, DOI 10.1016/j.jclinepi.2007.07.018
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Manea L., 2012, CMAJ, V184
   National Collaborating Centre for Mental Health National Institute for Health and Clinical Excellence, 2010, DEPR AD CHRON PHYS H
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Nouwen A., 2010, DIABETOLOGIA, P1
   Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2011, DIABETOLOGIA, V54, P741, DOI 10.1007/s00125-010-2033-0
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Sluiter AC, 2012, HUISARTS WET, V55, P1
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Stoop CH, 2015, J AFFECT DISORDERS, V184, P269, DOI 10.1016/j.jad.2015.05.063
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Stoop CH, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-139
   Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x
   Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   VANVLIET IM, 2000, MINI INT NEUROPSYCHI
   Yu MK, 2013, NEPHRON CLIN PRACT, V124, P106, DOI 10.1159/000355551
NR 42
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD JUN
PY 2017
VL 11
IS 3
BP 273
EP 280
DI 10.1016/j.pcd.2017.02.006
PG 8
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA EU7JJ
UT WOS:000401210800008
PM 28330680
DA 2019-01-08
ER

PT J
AU Carmichael, AG
   Hulswit, BB
   Moe, EJ
   Jayaratne, TE
   Yashar, BM
AF Carmichael, Alicia G.
   Hulswit, Bailey B.
   Moe, Emily J.
   Jayaratne, Toby Epstein
   Yashar, Beverly M.
TI A Qualitative Study of Anticipated Decision Making around Type 2
   Diabetes Genetic Testing: the Role of Scientifically Concordant and
   Discordant Expectations
SO JOURNAL OF GENETIC COUNSELING
LA English
DT Article
DE Diabetes; Genetic testing; Decision-making; Qualitative research
ID RANDOMIZED CONTROLLED-TRIAL; RISK-FACTORS; INTERVENTIONS; METAANALYSIS;
   PREVENTION; DISORDERS; FRAMEWORK; ATTITUDES
AB Type 2 diabetes mellitus (T2DM) genetic testing is undergoing clinical trials to measure the efficacy of genetic counseling for behavior-based risk reduction. The expectations patients bring to the testing process may play an important role in individual outcomes. We conducted a qualitative exploration of anticipated decision-making and expectations around T2DM genetic testing. Semi-structured interviews were completed with Mexican Americans (n = 34), non-Hispanic Black Americans (n = 39), and non-Hispanic White Americans (n = 39) at risk for T2DM. Transcripts were analyzed for themes. Most participants would accept T2DM genetic testing in order to motivate risk-reducing behaviors or apprise family members of their risk. Participants who would decline testing wished to avoid emotional distress or believed the test would not reveal new risk information. Non-Hispanic Whites and those with college education declined genetic testing more often than other groups. Those without college education were more likely to have testing expectations that were discordant with current science, such as conflating genetic testing with common 'blood tests.' Understanding expectations and decision-making factors around T2DM genetic testing will better prepare healthcare professionals to counsel their patients. This may lead to a higher efficacy of T2DM genetic testing and counseling.
C1 [Carmichael, Alicia G.] Univ Michigan, Inst Social Res, BioSocial Methods Collaborat, Res Ctr Grp Dynam, 426 Thompson St, Ann Arbor, MI 48109 USA.
   [Hulswit, Bailey B.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA.
   [Moe, Emily J.] Childrens Hosp Wisconsin, Genet & Genom Program, Milwaukee, WI 53201 USA.
   [Jayaratne, Toby Epstein] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.
   [Yashar, Beverly M.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.
RP Carmichael, AG (reprint author), Univ Michigan, Inst Social Res, BioSocial Methods Collaborat, Res Ctr Grp Dynam, 426 Thompson St, Ann Arbor, MI 48109 USA.
EM almagior@umich.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases of the
   National Institutes of Health [R01DK083347]; Michigan Center for
   Diabetes Translational Research from the National Institute of Diabetes
   and Digestive and Kidney Diseases [P30DK092926]
FX The authors thank Hannah M. Curtis and Alix H. Bernholtz for assistance
   with qualitative coding, and Ji Qi for help with data management. This
   project was funded by the National Institute of Diabetes and Digestive
   and Kidney Diseases of the National Institutes of Health under award
   number R01DK083347 (to T.E.J.). Additional support was provided by the
   Michigan Center for Diabetes Translational Research under award number
   P30DK092926 from the National Institute of Diabetes and Digestive and
   Kidney Diseases. The content of this publication is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
CR Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5
   [Anonymous], 2015, DIABETES CARE, V38, pS5, DOI 10.2337/dc15-S004
   Becker F, 2011, EUR J HUM GENET, V19, pS6, DOI 10.1038/ejhg.2010.249
   Cameron LD, 2008, BRIT J HEALTH PSYCH, V13, P215, DOI 10.1348/135910708X288800
   Cardona-Morrell M, 2010, BMC PUBLIC HEALTH, V10, P1
   Centre d'Etudes, 2012, VAL PRED RISK EQ TYP
   Christensen KD, 2010, PUBLIC HEALTH GENOM, V13, P467, DOI 10.1159/000293287
   de Miguel-Yanes JM, 2011, DIABETES CARE, V34, P121, DOI 10.2337/dc10-1265
   Grant David, 2013, GEN RISK HLTH COACH
   Grant RW, 2009, DIABETOLOGIA, V52, P2299, DOI 10.1007/s00125-009-1512-7
   Grant RW, 2013, DIABETES CARE, V36, P13, DOI 10.2337/dc12-0884
   Haga SB, 2013, GENET TEST MOL BIOMA, V17, P327, DOI 10.1089/gtmb.2012.0350
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   IDF. International Diabetes Federation, 2013, IDF DIABETES ATLAS
   Klitzman RL, 2010, J GENET COUNS, V19, P430, DOI 10.1007/s10897-010-9307-z
   Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6
   Lanie Angela D, 2004, J Genet Couns, V13, P305, DOI 10.1023/B:JOGC.0000035524.66944.6d
   Lea DH, 2011, PUBLIC HEALTH GENOM, V14, P279, DOI 10.1159/000294191
   Lombard M., 2002, HUMAN COMMUNICATION, V28, P1468
   MACQUEEN, 1998, CULTURAL ANTHR METHO, V10, P31, DOI DOI 10.1177/1525822X980100020301
   Markowitz SM, 2011, DIABETES CARE, V34, P568, DOI 10.2337/dc10-1960
   McAndrew LM, 2008, BRIT J HEALTH PSYCH, V13, P195, DOI 10.1348/135910708X295604
   Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742
   Mills R, 2015, J GENET COUNS, V24, P58, DOI 10.1007/s10897-014-9736-1
   Nishigaki M, 2014, J GENET COUNS, V23, P762, DOI 10.1007/s10897-013-9680-5
   Nishigaki M, 2007, DIABETES CARE, V30, P3033, DOI 10.2337/dc07-0688
   Nishigaki Masakazu, 2011, Adv Prev Med, V2011, P365132, DOI 10.4061/2011/365132
   O'Daniel JM, 2010, J GENET COUNS, V19, P315, DOI 10.1007/s10897-010-9302-4
   Persky S, 2007, GENET MED, V9, P727, DOI 10.1097/GIM.0b013e318159a344
   Proove Bioscience Inc., 2015, STUD IMP GEN TEST CL
   Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007
   Tessaro I., 2005, PREVENTING CHRONIC D, V2, P1
   U. S. Department of Health and Human Services, 2008, U0036 US DEP HLTH HU
   Vassy JL, 2013, J COMMUN GENET, V4, P263, DOI 10.1007/s12687-013-0140-6
   Vassy JL, 2012, MED DECIS MAKING, V32, P606, DOI 10.1177/0272989X11431608
   Voils CI, 2015, J GEN INTERN MED, V30, P1591, DOI 10.1007/s11606-015-3315-5
   Waxler JL, 2012, J GENET COUNS, V21, P684, DOI 10.1007/s10897-012-9486-x
   Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249
   WHO Department of Health Statistics and Information Systems, 2013, GHE YLL GLOB 2000 20
   Wright C. F., 2009, HUM GENET, V127, P125
   Yates T, 2009, POSTGRAD MED J, V85, P475, DOI 10.1136/pgmj.2008.076166
NR 41
TC 1
Z9 1
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-7700
EI 1573-3599
J9 J GENET COUNS
JI J. Genet. Couns.
PD JUN
PY 2017
VL 26
IS 3
BP 469
EP 479
DI 10.1007/s10897-016-9999-9
PG 11
WC Genetics & Heredity; Health Policy & Services; Social Sciences,
   Biomedical
SC Genetics & Heredity; Health Care Sciences & Services; Biomedical Social
   Sciences
GA ET8RQ
UT WOS:000400568900009
PM 27465809
DA 2019-01-08
ER

PT J
AU Terracciano, A
   Stephan, Y
   Luchetti, M
   Albanese, E
   Sutin, AR
AF Terracciano, Antonio
   Stephan, Yannick
   Luchetti, Martina
   Albanese, Emiliano
   Sutin, Angelina R.
TI Personality traits and risk of cognitive impairment and dementia
SO JOURNAL OF PSYCHIATRIC RESEARCH
LA English
DT Article
DE Personality; Dementia; Cognitive impairment; Prospective study
ID ALZHEIMERS-DISEASE; 5-FACTOR MODEL; PSYCHOLOGICAL DISTRESS; FOLLOW-UP;
   HEALTH; METAANALYSIS; DECLINE; OLDER; RETIREMENT; MECHANISMS
AB We investigated the association between five factor model personality traits (neuroticism, extraversion, openness, agreeableness, and conscientiousness) and risk of dementia, cognitive impairment not dementia (CIND), and conversion from CIND to dementia in a large national cohort. Participants from the Health and Retirement Study (N > 10,000) completed a personality scale in 2006-2008 and their cognitive status was tracked for up to 8 years using the modified Telephone Interview for Cognitive Status (TICSm). Adjusting for age, sex, education, race, and ethnicity, lower conscientiousness and agreeableness and higher neuroticism were independently associated with increased risk of dementia. These associations remained significant after adjusting for other risk factors for dementia, including income, wealth, smoking, physical inactivity, obesity, diabetes, hypertension, and blood biomarkers. These associations were not modified by age, sex, race, ethnicity, and education, suggesting that the associations of personality with risk of dementia were similar across demographic groups. Neuroticism and conscientiousness were also associated with risk of CIND. Low conscientiousness predicted conversion from CIND to dementia. Using brief assessments of personality and cognition, we found robust evidence that personality is associated with risk of cognitive impairment and dementia in a large national sample. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Terracciano, Antonio; Luchetti, Martina; Sutin, Angelina R.] Florida State Univ, Coll Med, 1115 West Call St, Tallahassee, FL 32306 USA.
   [Stephan, Yannick] Univ Montpellier, Montpellier, France.
   [Albanese, Emiliano] Univ Geneva, Dept Psychiat, Geneva, Switzerland.
RP Terracciano, A (reprint author), Florida State Univ, Coll Med, Dept Geriatr, 1115 West Call St, Tallahassee, FL 32306 USA.
EM antonio.terracciano@med.fsu.edu
RI Luchetti, Martina/A-4530-2017
OI Luchetti, Martina/0000-0002-7370-8443
FU NIA NIH HHS [R01 AG053297, R03 AG051960]
CR Baumgart M, 2015, ALZHEIMERS DEMENT, V11, P718, DOI 10.1016/j.jalz.2015.05.016
   Booth T, 2014, HEALTH PSYCHOL, V33, P1477, DOI 10.1037/hea0000012
   Clark D. O., 2013, ALZ DIS ASSOC DIS, V27, P372
   Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048
   Davydow DS, 2015, PSYCHOSOM MED, V77, P200, DOI 10.1097/PSY.0000000000000136
   Duberstein PR, 2011, PSYCHOL AGING, V26, P351, DOI 10.1037/a0021377
   Duchek JM, 2007, J GERONTOL B-PSYCHOL, V62, pP353, DOI 10.1093/geronb/62.6.P353
   Duron E, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00195
   Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127
   Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Jackson J, 2011, NEUROBIOL AGING, V32, P2162, DOI 10.1016/j.neurobiolaging.2009.12.009
   Johansson L, 2014, NEUROLOGY, V83, P1538, DOI 10.1212/WNL.0000000000000907
   Jokela M, 2014, HEALTH PSYCHOL, V33, P1618, DOI 10.1037/hea0000003
   Kolanowski A, 2011, J AM GERIATR SOC, V59, P1032, DOI 10.1111/j.1532-5415.2011.03449.x
   Lachman M. E., 1997, MIDLIFE DEV INVENTOR
   Lai MKP, 2010, NEUROREPORT, V21, P1111, DOI 10.1097/WNR.0b013e3283407204
   Luchetti M, 2016, J GERONTOL B-PSYCHOL, V71, P591, DOI 10.1093/geronb/gbu184
   Luchetti M, 2014, PSYCHONEUROENDOCRINO, V50, P181, DOI 10.1016/j.psyneuen.2014.08.014
   MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x
   Orfei MD, 2010, AM J GERIAT PSYCHIAT, V18, P1133, DOI 10.1097/JGP.0b013e3181dd1c50
   Pocnet C, 2011, CAN J PSYCHIAT, V56, P408, DOI 10.1177/070674371105600704
   Prince M., 2014, DEMENTIA RISK REDUCT
   Ramakers IHGB, 2015, J ALZHEIMERS DIS, V46, P805, DOI 10.3233/JAD-142493
   Rankin KP, 2005, J NEUROL NEUROSUR PS, V76, P632, DOI 10.1136/jnnp.2004.042879
   Rapp MA, 2008, AM J GERIAT PSYCHIAT, V16, P168, DOI 10.1097/JGP.0b013e31816029ec
   Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37
   Saczynski JS, 2015, AM J MED, V128, P739, DOI 10.1016/j.amjmed.2015.01.007
   Skogen JC, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0020-5
   Stephan Y., 2016, J GERONTOLOGY B
   Sutin AR, 2016, J RES PERS, V63, P22, DOI 10.1016/j.jrp.2016.05.001
   Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286
   Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x
   Terracciano A, 2014, ALZHEIMERS DEMENT, V10, P179, DOI 10.1016/j.jalz.2013.03.002
   Terracciano A, 2013, NEUROBIOL AGING, V34, P1045, DOI 10.1016/j.neurobiolaging.2012.08.008
   Terracciano A, 2011, PSYCHOSOM MED, V73, P638, DOI 10.1097/PSY.0b013e3182306a4f
   Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P1204, DOI 10.1001/archpsyc.64.10.1204
   Wilson RS, 2005, NEUROLOGY, V64, P380, DOI 10.1212/01.WNL.0000149525.53525.E7
   Yaffe K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7051
NR 39
TC 16
Z9 16
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3956
EI 1879-1379
J9 J PSYCHIATR RES
JI J. Psychiatr. Res.
PD JUN
PY 2017
VL 89
BP 22
EP 27
DI 10.1016/j.jpsychires.2017.01.011
PG 6
WC Psychiatry
SC Psychiatry
GA ES9AD
UT WOS:000399847400004
PM 28153642
DA 2019-01-08
ER

PT J
AU Lee, SH
   Shin, DS
   Kim, JR
   Kim, H
AF Lee, Sun Hee
   Shin, Dong-Soo
   Kim, Jong Ran
   Kim, Hyunjung
TI Factors associated with mortality risk in critical care patients treated
   with veno-arterial extracorporeal membrane oxygenation
SO HEART & LUNG
LA English
DT Article
DE Extracorporeal membrane oxygenation; Mortality; Intensive care unit;
   Risk factors; Simplified acute physiology score
ID RESPIRATORY-DISTRESS-SYNDROME; ADULT PATIENTS; FAILURE; SUPPORT; SCORE;
   ECMO; COMPLICATIONS; EXPERIENCE; OUTCOMES
AB Objectives: To identify factors associated with mortality in patients treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and to validate the discrimination of the risk assessment tools to predict mortality.
   Background: VA-ECMO is a rescue therapy for patients with life-threatening cardiac failure, but mortality remains high.
   Methods: In this retrospective study, we reviewed the medical records of adult patients who underwent VA-ECMO in an intensive care unit of a university hospital, between 2009 and 2013.
   Results: VA-ECMO was performed in 89 patients, with a median duration of 116 h. The survival rate until hospital discharge was 27%. The pre-ECMO simplified acute physiology score (SAPS) II and diabetes mellitus were significant predictors of hospital mortality. The optimal prognostic SAPS II score was 81 overall, 80 in patients with diabetes, and 84 in those without diabetes.
   Conclusions: Our findings indicate that high pre-ECMO SAPS II score and diabetes are risk factors for mortality in patients who undergo VA-ECMO. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Lee, Sun Hee; Kim, Jong Ran] Hallym Univ, Sacred Heart Hosp, Dept Nursing, 22 Gwanpyeong Ro 170 Beon Gil, Anyang Si 14068, Gyeonggi Do, South Korea.
   [Shin, Dong-Soo; Kim, Hyunjung] Hallym Univ, Res Inst Nursing Sci, Div Nursing, 1 Hallymdaehak Gil, Chunchon 24252, Gangwon Do, South Korea.
RP Kim, H (reprint author), Hallym Univ, Res Inst Nursing Sci, Div Nursing, 1 Hallymdaehak Gil, Chunchon 24252, Gangwon Do, South Korea.
EM hjkim97@hallym.ac.kr
CR Aubron C, 2013, CRIT CARE, V17, DOI 10.1186/cc12681
   Aziz F, 2014, ANN VASC SURG, V28, P178, DOI 10.1016/j.avsg.2013.03.011
   Beurtheret S, 2012, EUR J CARDIO-THORAC, V41, P691, DOI 10.1093/ejcts/ezr082
   Brogan TV, 2009, INTENS CARE MED, V35, P2105, DOI 10.1007/s00134-009-1661-7
   Choi H, 1992, KOREAN J ANESTHEOL, V25, P424
   Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Enger TB, 2014, CRIT CARE, V18, DOI 10.1186/cc13824
   Guttendorf J, 2014, AM J CRIT CARE, V23, P365, DOI 10.4037/ajcc2014115
   Huh JW, 2015, KOREAN ACAD TUBERC R, V78, P149
   Kim KI, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0135-x
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Kumar TKS, 2010, J THORAC CARDIOV SUR, V140, P330, DOI 10.1016/j.jtcvs.2010.02.034
   Lafc G, 2014, HEART LUNG CIRC, V23, P10, DOI 10.1016/j.hlc.2013.08.009
   Lan CC, 2010, ARTIF ORGANS, V34, pE59, DOI 10.1111/j.1525-1594.2009.00909.x
   Lin CY, 2007, ANN THORAC SURG, V84, P1256, DOI 10.1016/j.athoracsur.2007.05.045
   Lindskov C, 2013, ACTA ANAESTH SCAND, V57, P303, DOI 10.1111/aas.12050
   Paden ML, 2013, ASAIO J, V59, P202, DOI 10.1097/MAT.0b013e3182904a52
   Pappalardo F, 2013, INTENS CARE MED, V39, P275, DOI 10.1007/s00134-012-2747-1
   Peigh G, 2015, J SURG RES, V198, P273, DOI 10.1016/j.jss.2015.04.044
   Prakash P, 2006, J INDIAN ACAD CLIN M, V7, P202
   Roch A, 2014, INTENS CARE MED, V40, P74, DOI 10.1007/s00134-013-3135-1
   Schmidt M, 2013, INTENS CARE MED, V39, P1704, DOI 10.1007/s00134-013-3037-2
   ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193
NR 24
TC 2
Z9 2
U1 1
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0147-9563
EI 1527-3288
J9 HEART LUNG
JI Heart Lung
PD MAY-JUN
PY 2017
VL 46
IS 3
BP 137
EP 142
DI 10.1016/j.hrtlng.2017.02.003
PG 6
WC Cardiac & Cardiovascular Systems; Nursing; Respiratory System
SC Cardiovascular System & Cardiology; Nursing; Respiratory System
GA EX4IF
UT WOS:000403197500002
PM 28318620
DA 2019-01-08
ER

PT J
AU Wang, RH
   Hsu, HC
   Kao, CC
   Yang, YM
   Lee, YJ
   Shin, SJ
AF Wang, Ruey-Hsia
   Hsu, Hui-Chun
   Kao, Chia-Chan
   Yang, Yung-Mei
   Lee, Yau-Jiunn
   Shin, Shyi-Jang
TI Associations of changes in psychosocial factors and their interactions
   with diabetes distress in patients with type 2 diabetes: a longitudinal
   study
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE diabetes distress; interaction; nurses; patient empowerment; prospective
   study; resilience; self-efficacy; self-management; social support; type
   2 diabetes
ID SELF-MANAGEMENT PRACTICES; HEALTH LITERACY; PSYCHOLOGICAL DISTRESS;
   EMOTIONAL DISTRESS; PERCEIVED SUPPORT; SOCIAL SUPPORT; EMPOWERMENT;
   RESILIENCE; OUTCOMES; DEPRESSION
AB Aim. To assess the associations of changes in self-management behaviours, diabetes self-efficacy, resilience, social support, patient empowerment and their interactions with changes in diabetes distress in patients with type 2 diabetes mellitus.
   Background. Many patients with type 2 diabetes mellitus experience diabetes distress. Few longitudinal studies have investigated the associations of changes in various psychosocial factors with changes in diabetes distress in patients with type 2 diabetes mellitus.
   Design. This study adopted a longitudinal design. Data were collected at baseline and 12 months later.
   Methods. Overall, 304 patients with type 2 diabetes were recruited from four hospitals in southern Taiwan by convenience sampling. A self-report questionnaire and medical record were used to collect demographic data, clinical indicators, self-management behaviours, diabetes self-efficacy, resilience, social support, patient empowerment, and diabetes distress. Data were collected from February 2014-March 2015.
   Results/Findings. An increase in resilience or diabetes self-efficacy significantly associated with a decrease in diabetes distress, whereas an increase in patient empowerment significantly associated with an increase in diabetes distress. The interactions between increase in patient empowerment and increase in self-management behaviours significantly associated with decrease in diabetes distress.
   Conclusion. Nurses could endeavour to improve the diabetes self-efficacy and resilience to reducing diabetes distress. Arbitrarily empowering patients may increase diabetes distress. Increasing self-care management behaviours and patient empowerment might need to be simultaneously addressed to reduce the diabetes distress in patients with type 2 diabetes.
C1 [Wang, Ruey-Hsia; Yang, Yung-Mei] Kaohsiung Med Univ, Coll Nursing, Kaohsiung, Taiwan.
   [Hsu, Hui-Chun] Lees Endocrinol Clin, Dept Diabet Management, Pingtung, Taiwan.
   [Kao, Chia-Chan] I Shou Univ, Dept Healthcare Adm, Kaohsiung, Taiwan.
   [Lee, Yau-Jiunn] Lees Endocrinol Clin, Pingtung, Taiwan.
   [Shin, Shyi-Jang] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan.
RP Wang, RH (reprint author), Kaohsiung Med Univ, Coll Nursing, Kaohsiung, Taiwan.
EM wrhsia@kmu.edu.tw
FU National Science Council, Taiwan [NSC-102-2628-B-037-012-MY3]
FX Studying funding was supported by the National Science Council, Taiwan.
   (NSC-102-2628-B-037-012-MY3).
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   American Diabetes Association, 2016, DIABETES CARE S1, V39, pS4, DOI DOI 10.2337/DC16-S003
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   Bandura A., 1997, SELF EFFICACY EXERCI
   Brugge D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-354
   Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271
   Cochran J, 2008, DIABETES EDUCATOR, V34, P815, DOI 10.1177/0145721708323640
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Hsu HC, 2013, J NURS RES, V21, P212, DOI 10.1097/01.jnr.0000432048.31921.e2
   International Diabetes Federation, 2015, IDF DIAB ATL 7
   Karlsen B, 2014, INT J NURS STUD, V51, P438, DOI 10.1016/j.ijnurstu.2013.06.016
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kim G, 2015, J AGING HEALTH, V27, P320, DOI 10.1177/0898264314549662
   Lee YJ, 2016, PATIENT EDUC COUNS, V99, P287, DOI 10.1016/j.pec.2015.08.021
   Li JH, 2015, ASIAN J PSYCHIATR, V14, P22, DOI 10.1016/j.ajp.2015.01.011
   Livneh H., 2007, COPING CHRONIC ILLNE
   Londono AMM, 2015, PATIENT EDUC COUNS, V98, P908, DOI 10.1016/j.pec.2015.03.003
   Min JA, 2013, SUPPORT CARE CANCER, V21, P2469, DOI 10.1007/s00520-013-1807-6
   [Ministry of Health and Welfare Retrieved from], 2014, PREV DIAB YEARS
   Ministry of Health and Welfare, 2015, ANN STAT REP DEATH
   National Health Insurance (NHI), 2013, RES DAT ROC
   Padesky CA, 2012, CLIN PSYCHOL PSYCHOT, V19, P283, DOI 10.1002/cpp.1795
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Rose V, 2009, PATIENT EDUC COUNS, V77, P260, DOI 10.1016/j.pec.2009.03.026
   Rossi MC, 2015, PATIENT EDUC COUNS, V98, P1142, DOI 10.1016/j.pec.2015.05.012
   Schulz PJ, 2013, PATIENT EDUC COUNS, V90, P4, DOI 10.1016/j.pec.2012.09.006
   Sigurdardottir AK, 2008, SCAND J CARING SCI, V22, P284, DOI 10.1111/j.1471-6712.2007.00506.x
   Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961
   Su D, 2012, ARCH GERONTOL GERIAT, V55, P564, DOI 10.1016/j.archger.2012.06.006
   Taylor S, 2006, HLTH PSYCHOL
   Tian XH, 2016, GEN HOSP PSYCHIAT, V39, P86, DOI 10.1016/j.genhosppsych.2015.12.004
   Wang WR, 2013, QUAL LIFE RES, V22, P1965, DOI 10.1007/s11136-012-0345-x
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   WHO, 2014, GLOB STAT REP NONC D
   Yang J, 2009, J CLIN NURS, V18, P1295, DOI 10.1111/j.1365-2702.2008.02703.x
   Zulman DM, 2012, PATIENT EDUC COUNS, V87, P74, DOI 10.1016/j.pec.2011.07.013
NR 40
TC 5
Z9 5
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-2402
EI 1365-2648
J9 J ADV NURS
JI J. Adv. Nurs.
PD MAY
PY 2017
VL 73
IS 5
BP 1137
EP 1146
DI 10.1111/jan.13201
PG 10
WC Nursing
SC Nursing
GA EX3CQ
UT WOS:000403110000013
PM 27862194
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Capehorn, M
   Belton, A
   Down, S
   Alzaid, A
   Gamerman, V
   Nagel, F
   Lee, J
   Edelman, S
AF Polonsky, William H.
   Capehorn, Matthew
   Belton, Anne
   Down, Susan
   Alzaid, Aus
   Gamerman, Victoria
   Nagel, Friedericke
   Lee, Jisoo
   Edelman, Steven
TI Physician-patient communication at diagnosis of type 2 diabetes and its
   links to patient outcomes: New results from the global IntroDia (R)
   study
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes; Physician-patient communication; Patient survey;
   Psychological well-being; Patient-reported outcomes
ID SELF-CARE; PROVIDER COMMUNICATION; ATTITUDES; MANAGEMENT; SCALE; NEEDS;
   PERCEPTIONS; WISHES
AB Aims: To investigate patient experiences during the diagnosis of type 2 diabetes mellitus (T2DM), focusing on how physician-patient communication at diagnosis influences patients' psychosocial stress and subsequent self-management and outcomes.
   Methods: We surveyed adults with T2DM in 26 countries in a large cross-national study of physician-patient communication during early T2DM treatment (IntroDia (R)). The self-report questionnaire assessed retrospectively patient experiences during diagnosis conversations (focusing on 43 possible conversational elements, and communication quality) and potential effects on patient-reported outcomes.
   Results: Data from 3628 people with T2DM who had been prescribed oral treatment at diagnosis were analysed. Exploratory factor analyses of the conversational elements yielded four coherent, meaningful factors: Encouraging (Cronbach's alpha = 0.86); Collaborative (alpha = 0.88); Recommending Other Resources (alpha = 0.75); and Discouraging (alpha = 0.72). Patient-perceived communication quality (PPCQ) at diagnosis was positively associated with Encouraging (beta = +1.764, p < 0.001) and Collaborative (beta = +0.347, p < 0.001), negatively associated with Discouraging (beta = -1.181, beta < 0.001) and not associated with Recommending Other Resources (beta = +0.087, p = 0.096), using a stable path model. PPCQ was associated with less current diabetes distress, greater current well-being and better current self-care. Conversation elements comprising factors associated with better PPCQ (Encouraging and Collaborative) were recalled more frequently by patients than elements associated with poor PPCQ (Discouraging).
   Conclusions: Better physician-patient communication at T2DM diagnosis may contribute to subsequent greater patient well-being and self-care, and may be enhanced by greater physician use of Collaborative and Encouraging conversation elements. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Polonsky, William H.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Polonsky, William H.] Behav Diabet Inst, 5405 Oberlin Dr,Suite 100, San Diego, CA 92121 USA.
   [Capehorn, Matthew] Rotherham Inst Obes, Rotherham S65 1DA, S Yorkshire, England.
   [Capehorn, Matthew] Clifton Med Ctr, Rotherham S65 1DA, S Yorkshire, England.
   [Belton, Anne] UHN, Michener Inst Educ, 222 St Patrick St, Toronto, ON M5T 1V4, Canada.
   [Down, Susan] Somerset Partnership NHS Fdn Trust, Mallard Court, 2nd Floor,Express Pk,Bristol Rd, Bridgwater TA6 4RN, England.
   [Alzaid, Aus] Prince Sultan Mil Med City, POB 7897, Riyadh 11159, Saudi Arabia.
   [Gamerman, Victoria] Boehringer Ingelheim Pharmaceut Inc, 900 Ridgebury Rd,POB 368, Ridgefield, CT 06877 USA.
   [Nagel, Friedericke; Lee, Jisoo] Boehringer Ingelheim Pharma GmbH & Co KG, Binger Str 173, D-55216 Ingelheim, Germany.
   [Edelman, Steven] Univ Calif San Diego, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Edelman, Steven] Vet Affairs Med Ctr, 3350 La Jolla Village Dr, La Jolla, CA 92161 USA.
RP Polonsky, WH (reprint author), 5405 Oberlin Dr,Suite 100, San Diego, CA 92121 USA.
EM whp@behavioraldiabetes.org
FU Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance
FX This study was sponsored by the Boehringer Ingelheim & Eli Lilly and
   Company Diabetes Alliance.
CR Adriaanse MC, 2002, DIABETIC MED, V19, P406
   Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829
   Anderson LA, PSYCHOL REP
   Beeney LJ, 1996, PATIENT EDUC COUNS, V29, P109, DOI 10.1016/0738-3991(96)00939-1
   Bundesmann R, 2011, PATIENT EDUC COUNS, V85, P143, DOI 10.1016/j.pec.2010.09.025
   Capehorn M, 2017, CHALLENGES FACED PHY
   Cattell RB, 1952, FACTOR ANAL
   Council of American Survey Research Organizations, CASRO COD STAND ETH
   Crofton C, 1998, AHCPR PUB
   Dietrich UC, 1996, PATIENT EDUC COUNS, V29, P13, DOI 10.1016/0738-3991(96)00930-5
   European Pharmaceutical Market Research Association, EPHMRA CODE COND
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hays RD, 1999, MED CARE, V37, pMS22, DOI 10.1097/00005650-199903001-00003
   Heisler M, 2003, J GEN INTERN MED, V18, P893, DOI 10.1046/j.1525-1497.2003.21132.x
   International Chamber of Commerce/ European Society for Opinion and Marketing Research, ICC ESOMAR INT CODE
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116
   Lawson VL, 2008, DIABETIC MED, V25, P482, DOI 10.1111/j.1464-5491.2008.02394.x
   Ohtaki S, 2003, FAM PRACT, V20, P276, DOI 10.1093/fampra/cmg308
   Parry O, 2004, FAM PRACT, V21, P131, DOI 10.1093/fampra/cmh203
   Peel E, 2004, PATIENT EDUC COUNS, V53, P269, DOI 10.1016/j.pec.2003.07.010
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   PibernikOkanovic M, 1996, DIABETES RES CLIN PR, V34, P99, DOI 10.1016/S0168-8227(96)01342-3
   Piette JD, 2003, J GEN INTERN MED, V18, P624, DOI 10.1046/j.1525-1497.2003.31968.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2010, DIABETES EDUCATOR, V36, P828, DOI 10.1177/0145721710378539
   Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216
   Sastre MTM, 2011, HEALTH COMMUN, V26, P649, DOI 10.1080/10410236.2011.561919
   Stewart AL, 2007, HEALTH SERV RES, V42, P1235, DOI 10.1111/j.1475-6773.2006.00637.x
   Thom DH, 1999, MED CARE, V37, P510, DOI 10.1097/00005650-199905000-00010
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   World Health Organization (n.d), PROC TRANSL AD INSTR
NR 34
TC 3
Z9 3
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAY
PY 2017
VL 127
BP 265
EP 274
DI 10.1016/j.diabres.2017.03.016
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EW4JT
UT WOS:000402468500030
PM 28407552
DA 2019-01-08
ER

PT J
AU Holland-Carter, L
   Tuerk, PW
   Wadden, TA
   Fujioka, KN
   Becker, LE
   Miller-Kovach, K
   Hollander, PL
   Garvey, WT
   Weiss, D
   Rubino, DM
   Kushner, RF
   Malcolm, RJ
   Raum, WJ
   Hermayer, KL
   Veliko, JL
   Rost, SL
   Sora, ND
   Salyer, JL
   O'Neil, PM
AF Holland-Carter, Lauren
   Tuerk, Peter W.
   Wadden, Thomas A.
   Fujioka, Ken N.
   Becker, Lynne E.
   Miller-Kovach, Karen
   Hollander, Priscilla L.
   Garvey, W. Timothy
   Weiss, Daniel
   Rubino, Domenica M.
   Kushner, Robert F.
   Malcolm, Robert J.
   Raum, William J.
   Hermayer, Kathie L.
   Veliko, Jan L.
   Rost, Stephanie L.
   Sora, Nicoleta D.
   Salyer, Jonny L.
   O'Neil, Patrick M.
TI Impact on psychosocial outcomes of a nationally available weight
   management program tailored for individuals with type 2 diabetes:
   Results of a randomized controlled trial
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes; Weight loss; Psychosocial; Diabetes distress; Commercial
   weight loss programs; Quality of life
ID QUALITY-OF-LIFE; GLYCEMIC CONTROL; DISTRESS SCALE; HEALTH SURVEY;
   RISK-FACTORS; DEPRESSION; ADULTS; METAANALYSIS; OVERWEIGHT; SYMPTOMS
AB Aims: Type 2 diabetes mellitus (T2DM) can substantially decrease quality of life (QOL). This study examined the effects on QOL-relevant psychosocial measures of a widely available commercial weight loss program enhanced for individuals with T2DM.
   Methods: A year-long multi-site randomized clinical trial compared the Weight Watchers (WW) approach, supplemented with phone and email counseling with a certified diabetes educator (CDE), to brief standard diabetes nutrition counseling and education (Standard Care; SC). Participants were 400 women and 163 men (N = 279 WW; 284 SC) with T2DM [mean ( +/- SD) HbA(1c) 8.32 +/- 1%; BMI = 37.1 +/- 5.7 kg/m(2); age = 55.1 +/- 9.1 years]. Psychosocial outcomes were assessed at baseline, month 6, and month 12 using a diabetes specific psychosocial measure (Diabetes Distress Scale [DDS]), Impact of Weight on Quality of Life-Lite scale (IWQOL), a generic QOL measure (SF-36), and a depression screen (PHQ-9).
   Results: WW participants showed significantly greater improvements than did SC participants on all DDS subscales and total score and on IWQOL total score and physical function, sex life and work domains (all ps < .05). There was no significant treatment effect on SF-36 scores or PHQ-9.
   Conclusions: WW enhanced for individuals with T2DM was superior to SC in improving psychosocial outcomes most specific to T2DM and obesity. Available commercial WL programs, combined with scalable complementary program-specific diabetes counseling, may have benefits that extend to diabetes-related distress and weight-relevant QOL. (C) 2017 The Authors. Published by Elsevier Inc.
C1 [Holland-Carter, Lauren; Tuerk, Peter W.; Becker, Lynne E.; Malcolm, Robert J.; O'Neil, Patrick M.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Weight Management Ctr, 67 President St,Suite 410 South, Charleston, SC 29425 USA.
   [Tuerk, Peter W.] Ralph H Johnson VA Med Ctr, Mental Hlth Serv, 109 Bee St, Charleston, SC 29401 USA.
   [Wadden, Thomas A.] Univ Penn, Perelman Sch Med, Dept Psychiat, Ctr Weight & Eating Disorders, 3535 Market St,Suite 3029, Philadelphia, PA 19104 USA.
   [Fujioka, Ken N.] Scripps Clin Res, 11025 N Torrey Pines Rd,Suite 200, La Jolla, CA 92037 USA.
   [Miller-Kovach, Karen; Veliko, Jan L.; Rost, Stephanie L.] Weight Watchers Int, 11 Madison Ave 17th Floor, New York, NY 10010 USA.
   [Hollander, Priscilla L.] Baylor Endocrine Ctr, 3600 Gaston Ave,Wadley Tower,Suite 656, Dallas, TX 75246 USA.
   [Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, 1675 Univ Blvd, Birmingham, AL 35294 USA.
   [Garvey, W. Timothy] Birmingham Vet Adm Med Ctr, Birmingham, AL USA.
   [Weiss, Daniel] Your Diabet Endocrine Nutr Grp, 8300 Tyler Blvd Suite 102, Mentor, OH 44060 USA.
   [Rubino, Domenica M.] Washington Ctr Weight Management & Res, 2800 S Shirlington Rd, Arlington, VA 22206 USA.
   [Kushner, Robert F.] Northwestern Univ, Feinberg Sch Med, Rubloff Bldg 10th Floor,750 N Lake Shore Dr, Chicago, IL 60611 USA.
   [Raum, William J.] Oregon Weight Loss Surg, 1040 NW 22nd Ave,Suite 500, Portland, OR 97210 USA.
   [Hermayer, Kathie L.; Sora, Nicoleta D.] Med Univ South Carolina, Div Endocrinol Diabet & Med Genet, Coll Med, Clin Sci Bldg,8th Floor,96 Jonathan Lucas St, Charleston, SC 29425 USA.
   [Salyer, Jonny L.] Lovelace Sci Resources, 2441 Ridgecrest Dr,SE, Albuquerque, NM 87108 USA.
RP O'Neil, PM (reprint author), Med Univ South Carolina, Weight Management Ctr, 67 President St,Suite 410 South, Charleston, SC 29425 USA.
EM holland@musc.edu; tuerk@musc.edu; wadden@mail.med.upenn.edu;
   fujiolca.ken@scrippshealth.org; lynne.e.becker@gmail.com;
   kmillerkovach@gmail.com; priscilh@baylorhealth.edu; garveyt@uab.edu;
   drdanweiss@ameritech.net; drubino@wtmgmt.com; rkushner@northwestern.edu;
   wraum@oregonwls.com; hermayer@musc.edu; jvelikocde@yahoo.com;
   schoemers@gmail.com; sora@musc.edu; oneilp@musc.edu
OI Rubino, Domenica/0000-0002-3072-2819
FU Weight Watchers International (WWI)
FX This work was supported by a grant from Weight Watchers International
   (WWI) to the Medical University of South Carolina (MUSC).
CR ADA, 2016, DIABETES CARE, V39, P2126
   Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829
   Bjorner JB, 2013, VALUE HEALTH, V16, P993, DOI 10.1016/j.jval.2013.06.022
   Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041
   Centers for Disease Control and Prevention (CDC), 2014, NAT DIAB STAT REP ES
   Crosby RD, 2004, J CLIN EPIDEMIOL, V57, P1153, DOI 10.1016/j.jclinepi.2004.04.004
   Dall TM, 2014, DIABETES CARE, V37, P3172, DOI 10.2337/dc14-1036
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Engel SG, 2003, OBES RES, V11, P1207, DOI 10.1038/oby.2003.166
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Foster GD, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.3
   Fujioka K, 2010, DIABETES OBES METAB, V12, P186, DOI 10.1111/j.1463-1326.2009.01155.x
   GONDERFREDERICK LA, 1989, HEALTH PSYCHOL, V8, P45, DOI 10.1037//0278-6133.8.1.45
   Gonzalez JS, 2011, PSYCHOLOGICAL CO-MORBIDITIES OF PHYSICAL ILLNESS: A BEHAVIORAL MEDICINE PERSPECTIVE, P73, DOI 10.1007/978-1-4419-0029-6_2
   Greenberg I, 2009, J AM COLL NUTR, V28, P159, DOI 10.1080/07315724.2009.10719767
   Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Kolotkin AL, 2001, OBESITY, V9, P564
   Kolotkin RL, 2002, QUAL LIFE RES, V11, P157, DOI 10.1023/A:1015081805439
   Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Maruish ME, 2011, USERS MANUAL SF 36V2
   Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029
   Mezuk B, 2013, HEALTH PSYCHOL, V32, P254, DOI 10.1037/a0029014
   Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024
   O'Neil PM, 2016, OBESITY, V24, P2269, DOI 10.1002/oby.21616
   O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Robbins JM, 2008, DIABETES CARE, V31, P655, DOI [10.2337/dc07-1871, 10.2337/dc07-187]
   Rock CL, 2014, DIABETES CARE, V37, P1573, DOI 10.2337/dc13-2900
   Steed L, 2003, PATIENT EDUC COUNS, V51, P5, DOI 10.1016/S0738-3991(02)00213-6
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   Vettor R, 2005, DIABETES CARE, V28, P942, DOI 10.2337/diacare.28.4.942
   Wadden TA, 2014, DIABETES CARE, V37, P1544, DOI 10.2337/dc13-1928
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   White R, 2004, OBESITY, V12, P949
   Williamson DA, 2009, ARCH INTERN MED, V169, P163, DOI 10.1001/archinternmed.2008.544
   Winchester RJ, 2016, J DIABETES COMPLICAT, V30, P312, DOI 10.1016/j.jdiacomp.2015.11.010
   Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415
NR 42
TC 1
Z9 1
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD MAY
PY 2017
VL 31
IS 5
BP 891
EP 897
DI 10.1016/j.jdiacomp.2017.01.022
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EV3UC
UT WOS:000401683600020
PM 28319001
OA Other Gold
DA 2019-01-08
ER

PT J
AU Dennick, K
   Sturt, J
   Speight, J
AF Dennick, Kathryn
   Sturt, Jackie
   Speight, Jane
TI What is diabetes distress and how can we measure it? A narrative review
   and conceptual model
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Review
DE Diabetes distress; Patient-reported outcome measures; Validity;
   Narrative review; Conceptual model
ID QUALITY-OF-LIFE; EMOTIONAL DISTRESS; PROBLEM AREAS; SELF-CARE;
   PERCEPTION QUESTIONNAIRE; PSYCHOMETRIC VALIDATION; PROFESSIONAL SUPPORT;
   SYMPTOM CHECKLIST; GLYCEMIC CONTROL; CHRONIC ILLNESS
AB Background: Diabetes distress is the negative emotional impact of living with diabetes. It has tangible clinical importance, being associated with sub-optimal self-care and glycemic control. Diabetes distress has been operationalized in various ways and several measures exist. Measurement clarity is needed for both scientific and clinical reasons.
   Objectives: To clarify the conceptualization and operationalization of diabetes distress, identify and distinguish relevant measures, and evaluate their appropriateness for this purpose.
   Results: Six measures were identified: Problem Areas in Diabetes (PAID) scale, Diabetes Distress Scale (DDS); Type I Diabetes Distress Scale (T1-DDS), Diabetes-specific Quality of Life Scale Revised (DSQoLs-R) 'Burden and Restrictions-Daily Hassles' sub-scale, Well-being Questionnaire 28 (W-BQ 28) 'Diabetes Well-being' sub-scale, and Illness Perceptions Questionnaire Revised (IPQ-R) 'Emotional Representations' sub-scale. Across these measures a broad spectrum of diabetes distress is captured, including distress associated with treatment regimen, food/eating, future/complications, hypoglycemia, social/interpersonal relationships, and healthcare professionals. No single measure appears fully comprehensive. Limited detail of the qualitative work informing scale design is reported, raising concerns about content validity.
   Conclusions: Across the available measures diabetes distress is seemingly comprehensively assessed and measures should be considered in terms of their focus and scope to ensure the foci of interventions are appropriately targeted. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Dennick, Kathryn; Sturt, Jackie] Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, 57 Waterloo Rd, London SE1 8WA, England.
   [Speight, Jane] Deakin Univ, Sch Psychol, 1 Gheringhap St, Geelong, Vic 3220, Australia.
   [Speight, Jane] Australian Ctr Behav Res Diabet, Diabet Victoria, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Speight, Jane] AHP Res, 16 Walden Way, Hornchurch, Essex, England.
   [Dennick, Kathryn] UCL, Res Dept Clin Educ & Hlth Psychol, Room 209,Hunter St Hlth Ctr,8 Hunter St, London WC1N 1BN, England.
RP Dennick, K (reprint author), Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, 57 Waterloo Rd, London SE1 8WA, England.; Dennick, K (reprint author), UCL, Res Dept Clin Educ & Hlth Psychol, Room 209,Hunter St Hlth Ctr,8 Hunter St, London WC1N 1BN, England.
EM kdennick@ucl.ac.uk
OI Speight, Jane/0000-0002-1204-6896
FU Florence Nightingale Faculty of Nursing and Midwifery; King's College
   London; Diabetes Victoria; Deakin University
FX This research did not receive any specific grant from funding agencies
   in the public, commercial, or not-for-profit sectors.JSt and KD were
   supported by core funding provided by Florence Nightingale Faculty of
   Nursing and Midwifery, King's College London. JSp is supported by the
   core funding provided to the Australian Centre for Behavioural Research
   in Diabetes by Diabetes Victoria and Deakin University.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS25
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Bott U, 1998, DIABETES CARE, V21, P757, DOI 10.2337/diacare.21.5.757
   Boyer JG, 1997, MED CARE, V35, P440, DOI 10.1097/00005650-199705000-00003
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Bradley G, 2000, DIABETES CARE, V23, P875
   CAREY MP, 1991, J BEHAV MED, V14, P43, DOI 10.1007/BF00844767
   Cooke D, 2013, DIABETES CARE, V36, P1117, DOI 10.2337/dc12-0076
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Dennidc K, 2016, INT DIABETES NURS
   DURAN G, 1995, PSYCHOL REP, V76, P515, DOI 10.2466/pr0.1995.76.2.515
   Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x
   El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020
   Esbitt SA, 2013, SCREENING DEPRESSION, P27
   European Medicines Agency Committee for Medicinal Products for Human Use, REFL PAP REG GUID US
   Fenwick EK, 2016, J HLTH PSYCHOL
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2014, 74 SCI SESS AM DIAB
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fonda Stephanie J, 2009, J Diabetes Sci Technol, V3, P117
   Furler J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-214
   Garratt AM, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.2002.00650.x
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   Henry SL, 2013, J HEALTH PSYCHOL, V18, P1550, DOI 10.1177/1359105312465913
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Hirsch A, 2000, QUAL LIFE RES, V9, P207, DOI 10.1023/A:1008959810698
   Johnson L. N., 2013, THESIS
   Kempf K, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-57
   Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002
   Luscombe F A, 2000, Value Health, V3 Suppl 1, P15
   Mannucci E, 1996, DIABETES NUTR METAB, V9, P89
   Markowitz JT, 2012, DIABETIC MED, V29, P526, DOI 10.1111/j.1464-5491.2011.03434.x
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Meadows K, 1996, QUAL LIFE RES, V5, P242, DOI 10.1007/BF00434746
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Peeples M, 2007, DIABETES EDUCATOR, V33, P794, DOI 10.1177/0145721707307615
   Peyrot M, 2005, DIABETES CARE, V28, P53, DOI 10.2337/diacare.28.1.53
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36
   Polonsky WH, 2016, DIABETES TECHNOL THE, V18, P292, DOI 10.1089/dia.2015.0451
   Rubin RR, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-32
   Schmitt A, 2015, DIABET MED
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Speight J, 2012, DIABETIC MED, V29, pE345, DOI 10.1111/j.1464-5491.2012.03702.x
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   Speight J, 2011, BEHALF DIABETES MILE
   Speight J, 2002, DIAB UK PROF C
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Sturt J, 2015, INT DIABETES NURS, P1
   Sturt J, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0660-z
   Talbot F, 1997, J BEHAV MED, V20, P291, DOI 10.1023/A:1025508928696
   Tanenbaum ML, 2016, J DIABETES COMPLICAT, V30, P1060, DOI 10.1016/j.jdiacomp.2016.04.023
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   Taylor EP, 2005, DIABETES-METAB RES, V21, P264, DOI 10.1002/dmrr.524
   Thorne SE, 2001, PATIENT EDUC COUNS, V42, P81, DOI 10.1016/S0738-3991(00)00095-1
   US Department of Health and Human Services & Food and Drug Administration, 2009, GUID IND PAT REP OUT
   Watkins K, 2004, PHARMACOECONOMICS, V22, P1109, DOI 10.2165/00019053-200422170-00002
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 79
TC 4
Z9 4
U1 2
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD MAY
PY 2017
VL 31
IS 5
BP 898
EP 911
DI 10.1016/j.jdiacomp.2016.12.018
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EV3UC
UT WOS:000401683600021
PM 28274681
DA 2019-01-08
ER

PT J
AU Rechenberg, K
   Grey, M
   Sadler, L
AF Rechenberg, Kaitlyn
   Grey, Margaret
   Sadler, Lois
TI Stress and Posttraumatic Stress in Mothers of Children With Type 1
   Diabetes
SO JOURNAL OF FAMILY NURSING
LA English
DT Article
DE stress; posttraumatic stress; chronic illness; maternal attachment; type
   1 diabetes
ID PSYCHOLOGICAL DISTRESS; PATERNAL INVOLVEMENT; DEPRESSIVE SYMPTOMS;
   YOUNG-CHILDREN; PARENTS; ADJUSTMENT; ADOLESCENTS; ASSOCIATION; DISORDER;
   FATHERS
AB The onset of acute and chronic illness in children frequently triggers episodes of stress and posttraumatic stress symptoms (PTSS) in mothers. Mothers of children with type 1 diabetes (T1D) consistently report high levels of stress and PTSS. The purpose of this integrative review was to review and synthesize the published empirical research. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used to conduct this integrative literature review. A total of 19 studies were identified from a sample of 128. Stress and PTSS were prevalent in mothers of youth with T1D. While PTSS was most severe at disease onset, symptoms often persisted 1 to 5 years after diagnosis. The diagnosis of T1D in a child was traumatic for mothers. Stress and PTSS in mothers adversely affected children's health. Management of stress symptoms in mothers may lead to improved behavioral and metabolic outcomes in children.
C1 [Rechenberg, Kaitlyn; Grey, Margaret; Sadler, Lois] Yale Sch Nursing, 400 West Campus Dr, Orange, CT 06577 USA.
RP Rechenberg, K (reprint author), Yale Sch Nursing, 400 West Campus Dr, Orange, CT 06577 USA.
EM Kaitlyn.rechenberg@yale.edu
FU NCATS NIH HHS [UL1 TR001863]; NIDDK NIH HHS [T32 DK097718]; NINR NIH HHS
   [P30 NR008999]
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011]
   Athaseri S., 2010, THAI J NURSING RES, V12, P55
   Balluffi Andrew, 2004, Pediatr Crit Care Med, V5, P547, DOI 10.1097/01.PCC.0000137354.19807.44
   Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058
   Berg CA, 2007, J PEDIATR PSYCHOL, V32, P995, DOI 10.1093/jpepsy/jsm043
   Beveridge RM, 2006, J PEDIATR PSYCHOL, V31, P818, DOI 10.1093/jpepsy/jsj094
   Bodenmann G, 2005, COUPLES COPING STRES
   Butler JM, 2007, J PEDIATR PSYCHOL, V32, P1227, DOI 10.1093/jpepsy/jsm065
   Cameron FJ, 2007, DIABETES CARE, V30, P2716, DOI 10.2337/dc07-0603
   Chaney JM, 1997, J PEDIATR PSYCHOL, V22, P229
   Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140
   Critical Apprasial Skills Program (CASP), 2004, APPR TOOL QUAL RES
   Genuth S, 2001, J PEDIATR-US, V139, P804, DOI 10.1067/mpd.2001.118887
   Hall E, 2006, J PEDIATR PSYCHOL, V31, P403, DOI 10.1093/jpepsy/jsj016
   Hannonen R, 2015, ACTA PAEDIATR, V104, P1144, DOI 10.1111/apa.13144
   Hansen JA, 2012, FAM SYST HEALTH, V30, P47, DOI 10.1037/a0027519
   Helgeson VS, 2012, J PEDIATR PSYCHOL, V37, P467, DOI 10.1093/jpepsy/jsr110
   Herzer M, 2010, J PEDIATR PSYCHOL, V35, P415, DOI 10.1093/jpepsy/jsp063
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hoff A. L., 2005, FAMILIES SYSTEMS HLT, V23, P329, DOI DOI 10.1037/1091-7527.23.3.329
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Horsch A, 2007, J TRAUMA STRESS, V20, P881, DOI 10.1002/jts.20247
   Horsch A, 2014, J HEALTH PSYCHOL, V19, P987, DOI 10.1177/1359105313482169
   Horsch A, 2012, BEHAV COGN PSYCHOTH, V40, P400, DOI 10.1017/S1352465812000112
   Horton TV, 2001, REHABIL PSYCHOL, V46, P382, DOI 10.1037/0090-5550.46.4.382
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Jaser SS, 2009, CHILD HEALTH CARE, V38, P91, DOI 10.1080/02739610902813229
   KAGER VA, 1992, J PEDIATR PSYCHOL, V17, P491, DOI 10.1093/jpepsy/17.4.491
   Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022
   Koizumi S, 1992, J Pediatr Nurs, V7, P154
   Kokkonen J, 1997, NORD J PSYCHIAT, V51, P165, DOI 10.3109/08039489709109091
   Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P682, DOI 10.1097/01-chi.0000161645.98022.35
   Landolt MA, 2002, J PEDIATR PSYCHOL, V27, P647, DOI 10.1093/jpepsy/27.7.647
   Landolt MA, 2012, J CHILD PSYCHOL PSYC, V53, P767, DOI 10.1111/j.1469-7610.2011.02520.x
   Levine B., 2014, MILITARY BEHAV HLTH, V2, P59, DOI [10.1080/21635781.2013.845070, DOI 10.1080/21635781.2013.845070]
   Lewin A. B., 2005, FAMILIES SYSTEMS HLT, V23, P56, DOI DOI 10.1037/1091-7527.23.1.56
   Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690
   Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011
   Mitchell SJ, 2009, FAM SYST HEALTH, V27, P314, DOI 10.1037/a0018191
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   National Institutes of Health & National Heart Lung and Blood Institute, 2014, QUAL ASS TOOL OBS CO
   Pisula E, 2010, EUR J MED RES, V15, P115
   Stewart M J, 1994, Can J Nurs Res, V26, P61
   Streisand R, 2008, PATIENT EDUC COUNS, V73, P333, DOI 10.1016/j.pec.2008.06.014
   Streisand R, 2010, MATERN CHILD HLTH J, V14, P612, DOI 10.1007/s10995-009-0497-7
   Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4
   Sullivan-Bolyai S, 2016, J FAM NURS, V22, P579, DOI 10.1177/1074840716676589
   Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959
   Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P501, DOI 10.1093/jpepsy/jsj042
NR 53
TC 0
Z9 0
U1 1
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1074-8407
EI 1552-549X
J9 J FAM NURS
JI J. Fam. Nurs.
PD MAY
PY 2017
VL 23
IS 2
BP 201
EP 225
DI 10.1177/1074840716687543
PG 25
WC Family Studies; Nursing
SC Family Studies; Nursing
GA EV1OX
UT WOS:000401517000003
PM 28795899
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Kuniss, N
   Rechtacek, T
   Kloos, C
   Muller, UA
   Roth, J
   Burghardt, K
   Kramer, G
AF Kuniss, N.
   Rechtacek, T.
   Kloos, C.
   Mueller, U. A.
   Roth, J.
   Burghardt, K.
   Kramer, G.
TI Diabetes-related burden and distress in people with diabetes mellitus at
   primary care level in Germany
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Diabetes-related distress; PAID questionnaire; Type 2 diabetes
ID EMOTIONAL DISTRESS; PROBLEM AREAS; SELF-MANAGEMENT; DEPRESSION;
   ASSOCIATION; SCALE; HYPOGLYCEMIA; ADHERENCE; UTILITY; DUTCH
AB Aims The importance of diabetes-related distress for the treatment of diabetes is emphasised in national and international guidelines recommending routinely screening for psychosocial problems. Data of investigations regarding diabetes-related distress on primary care are rare in Germany though most people with diabetes are treated without insulin therapy at primary care level.
   Methods Three hundred and forty-five people with diabetes mellitus type 2 (DM2, n = 336, 229 without and 107 with insulin therapy) and type 1 (DM1, n = 9) were interviewed with the PAID questionnaire in the period from 1 October 2015 to 31 December 2015 in a general practice. A PAID score >= 40 (range 0-100) was considered as high diabetes-related distress.
   Results The mean PAID score of all participants was 3.9 +/- 7.0 (DM2 without insulin 2.7 +/- 6.3, DM2 with insulin therapy 6.0 +/- 8.0, DM1 6.8 +/- 4.9) and far below the threshold of 40 points. Only 1.2% of all responders showed high diabetes-related distress (score >= 40). People on insulin therapy with HbA1c > 7.5% and with diagnosed depression prior to the study scored significantly higher. Furthermore, there are weak correlations between the PAID score and HbA1c (r = 0.253, p < 0.001), duration of diabetes (r = 0.169, p = 0.002), insulin dosage (r = 0.283, p < 0.001) and age (r = -0.129, p = 0.016).
   Conclusions Only 1.2% of our outpatients with diabetes on primary care level showed high diabetes-related distress. Higher rates in the current literature are probably due to not investigating on primary care level. Guidelines should consider this.
C1 [Kuniss, N.; Kloos, C.; Mueller, U. A.; Roth, J.; Burghardt, K.; Kramer, G.] Jena Univ Hosp, Dept Internal Med Endocrinol & Metab Disorder 3, Klinikum 1, D-07740 Jena, Germany.
RP Kuniss, N (reprint author), Jena Univ Hosp, Dept Internal Med Endocrinol & Metab Disorder 3, Klinikum 1, D-07740 Jena, Germany.
EM nadine.kuniss@med.uni-jena.de
CR American Diabetes Association, 2015, DIABETES CARE, V38
   Bohm BO, EVIDENCE BASED GUIDE
   Bundesarztekammer (BAK) Kassenarztliche Bundesvereinigung (KBV) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), 2013, NAT VERS LEITL THER, DOI 10.6101/AXQ/0UU213
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   German Diabetes Association (DDG), 2015, GUID REC TREATM I CE
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Hagen B, 2015, QUALITATSBERICHT 201
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   International Diabetes Federation Guideline Development Group, 2014, DIABETES RES CLIN PR, V104, P1, DOI DOI 10.1016/J.DIABRES.2012.10.001
   Joensen LE, 2013, DIABETES RES CLIN PR, V101, P278, DOI 10.1016/j.diabres.2013.07.001
   Kovacs BK, 2013, DIABETIC MED, V30, P778, DOI DOI 10.1111/DME.12239
   Kulzer BAC, 2013, S2 GUIDELINE PSYCHOS
   Kuniss N, 2016, EXP CLIN ENDOCR DIAB, V124, P307, DOI 10.1055/s-0042-103685
   Kuniss N, 2016, ACTA DIABETOL
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Petrak F, 2011, DIABETES STOFFWECH H, V20, P7
   Pettersson B, 2011, DIABETES RES CLIN PR, V92, P19, DOI 10.1016/j.diabres.2010.12.005
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
NR 29
TC 3
Z9 3
U1 1
U2 12
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD MAY
PY 2017
VL 54
IS 5
BP 471
EP 478
DI 10.1007/s00592-017-0972-3
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA ER2DD
UT WOS:000398603300007
PM 28210870
DA 2019-01-08
ER

PT J
AU Chew, BH
   Vos, RC
   Ghazali, SS
   Shamsuddin, NH
   Fernandez, A
   Mukhtar, F
   Ismail, M
   Ahad, AM
   Sundram, NN
   Ali, SZM
   Rutten, GEHM
AF Chew, Boon-How
   Vos, Rimke C.
   Ghazali, Sazlina Shariff
   Shamsuddin, Nurainul Hana
   Fernandez, Aaron
   Mukhtar, Firdaus
   Ismail, Mastura
   Ahad, Azainorsuzila Mohd
   Sundram, Narayanan N.
   Ali, Siti Zubaidah Mohd
   Rutten, Guy E. H. M.
TI The effectiveness of a value-based EMOtion-cognition-Focused educatIonal
   programme to reduce diabetes-related distress in Malay adults with Type
   2 diabetes (VEMOFIT): study protocol for a cluster randomised controlled
   trial
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Diabetes-related distress; Self-care; Depression; Diabetes education;
   Quality of life; Type 2 diabetes mellitus; HbA1c; Blood pressure;
   LDL-cholesterol
ID SELF-MANAGEMENT BEHAVIORS; QUALITY-OF-LIFE; PRIMARY-CARE; ILLNESS
   REPRESENTATIONS; GLYCEMIC CONTROL; TREATMENT FIDELITY; ANXIETY
   DISORDERS; HEALTH-CARE; DEPRESSION; OUTCOMES
AB Background: Type 2 diabetes mellitus (T2DM) patients experience many psychosocial problems related to their diabetes. These often lead to emotional disorders such as distress, stress, anxiety and depression, resulting in decreased self-care, quality of life and disease control. The purpose of the current study is to evaluate the effectiveness of a brief value-based emotion-focused educational programme in adults with T2DM on diabetes-related distress (DRD), depressive symptoms, illness perceptions, quality of life, diabetes self-efficacy, self-care and clinical outcomes.
   Methods: A cluster randomised controlled trial will be conducted in 10 public health clinics in Malaysia, all providing diabetes care according to national clinical practice guidelines. Patients' inclusion criteria: Malay, >= 18 years with T2DM for at least 2 years, on regular follow-up with one of three biomarkers HbA1c, systolic blood pressure and LDL-cholesterol sub-optimally controlled, and with a mean 17-item Diabetes Distress Scale (DDS-17) score >= 3. The intervention consists of four sessions and one booster over a period of 4 months that provide information and skills to assist patients in having proper perceptions of their T2DM including an understanding of the treatment targets, understanding and managing their emotions and goal-setting. The comparator is an attention-control group with three meetings over a similar period. With an estimated intra-cluster correlation coefficient. of 0.015, a cluster size of 20 and 20% non-completion, the trial will need to enroll 198 patients. Primary outcome: the between groups difference in proportion of patients achieving a mean DDS-17 score < 3 (non-significant distress) at 6 months post-intervention. Secondary outcomes will be the differences in the above mentioned variables between groups.
   Discussion: We hypothesize that primary and secondary outcomes will improve significantly after the intervention compared to the comparator group. The results of this study can contribute to better care for T2DM patients with DRD.
C1 [Chew, Boon-How; Ghazali, Sazlina Shariff; Shamsuddin, Nurainul Hana] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia.
   [Chew, Boon-How; Vos, Rimke C.; Rutten, Guy E. H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Gen Practice, Huispost Str 6-131,POB 855003508 GA, Utrecht, Netherlands.
   [Fernandez, Aaron; Mukhtar, Firdaus] Univ Putra Malaysia, Dept Psychiat, Fac Med & Hlth Sci, Serdang 43400, Selangor, Malaysia.
   [Ismail, Mastura] Hlth Clin Seremban 2, Jalan S2,A2,Seremban 2, Seremban 27300, Negeri Sembilan, Malaysia.
   [Ahad, Azainorsuzila Mohd] Hlth Clin Port Dickson, KM 1,Jalan Seremban Port Dickson, Port Dickson 71000, Negeri Sembilan, Malaysia.
   [Sundram, Narayanan N.] Hlth Clin Nilai, Port Dickson 71000, Negeri Sembilan, Malaysia.
   [Ali, Siti Zubaidah Mohd] Hlth Clin Seremban, Jalan Rasah, Seremban 70300, Negeri Sembilan, Malaysia.
RP Chew, BH (reprint author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia.; Chew, BH (reprint author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Gen Practice, Huispost Str 6-131,POB 855003508 GA, Utrecht, Netherlands.
EM chewboonhow@gmail.com
RI Chew, Boon How/B-2385-2010
OI Chew, Boon How/0000-0002-8627-6248; Fernandez, Aaron/0000-0002-9834-472X
FU Malaysian MOH-NIH Research Grant (MRG)
FX The trial is funded by the Malaysian MOH-NIH Research Grant (MRG). This
   funding source had no role in the design of this study and will not have
   any role during its execution, analyses, interpretation of the data, or
   decision to submit results. MRG can be contacted at the Secretariat
   National Institutes of Health (NIH) Ministry of Health Malaysia, c/o
   Institut Pengurusan Kesihatan Jalan Rumah Sakit Bangsar 59000 Kuala
   Lumpur; telephone: 03 - 2287 4032/2282 0491/2282 9085/2282 9082; fax :
   03 2287 4030/2282 8072, and email: nihsec@nih.gov.my.
CR Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L
   Barnes L, 2004, NZ MED J, V117, P743
   Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443
   Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852
   Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008
   Bradshaw BG, 2007, DIABETES EDUCATOR, V33, P650, DOI 10.1177/0145721707303809
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Cameron LDLH, 2003, SELF REGULATION HLTH
   Campbell NC, 2007, BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE
   Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586
   Chew BH, 2016, PRIM CARE DIABETES, V10, P383, DOI 10.1016/j.pcd.2016.07.003
   Chew BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152095
   Chew BH, 2014, WORLD J DIABETES, V5, P796, DOI 10.4239/wjd.v5.i6.796
   Collins J, 2004, RADIOGRAPHICS, V24, P1483, DOI 10.1148/rg.245045020
   Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062
   De Maeseneer J, 2008, BRIT J GEN PRACT, V58, P806, DOI 10.3399/bjgp08X342697
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   Dimitraki G, 2014, INT J BEHAV MED, V21, P230, DOI 10.1007/s12529-013-9296-z
   Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2002, DIABETES CARE, V25, P1564, DOI 10.2337/diacare.25.9.1564
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Franks MM, 2012, FAM SYST HEALTH, V30, P154, DOI 10.1037/a0028614
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Glasgow RE, 2014, TRANSL BEHAV MED, V4, P26, DOI 10.1007/s13142-013-0232-1
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Harper A, 1998, PSYCHOL MED, V28, P551
   Harvey JN, 2009, DIABETIC MED, V26, P5, DOI 10.1111/j.1464-5491.2008.02628.x
   Hayes E, 2008, J AM ACAD NURSE PRAC, V20, P155, DOI 10.1111/j.1745-7599.2007.00297.x
   Health Quality Ontario, 2009, Ont Health Technol Assess Ser, V9, P1
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lau R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009993
   Lewis F M, 1997, Oncol Nurs Forum, V24, P1695
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Low LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147127
   Lynch CP, 2012, DIABETES EDUCATOR, V38, P427, DOI 10.1177/0145721712440335
   Ministry of Health Malaysia, 2015, CLIN PRACT GUID MAN
   Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1
   Myers DG, 2000, AM PSYCHOL, V55, P56, DOI 10.1037//0003-066X.55.1.56
   Naik AD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-37
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   Paschalides C, 2004, J PSYCHOSOM RES, V57, P557, DOI 10.1016/j.jpsychores.2004.03.006
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Ramli AS, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0557-1
   Rasmussen NH, 2013, PRIM CARE DIABETES, V7, P213, DOI 10.1016/j.pcd.2013.04.006
   Reuben E, 2009, CAN WE TEACH EMOTION
   Rosland AM, 2012, J BEHAV MED, V35, P221, DOI 10.1007/s10865-011-9354-4
   Russell S. S., 2006, UROLOGIC NURSING, V26, P370
   Rutten GEHM, 2014, LANCET DIABETES ENDO, V2, P191, DOI 10.1016/S2213-8587(13)70122-0
   Searle A, 2007, J PSYCHOSOM RES, V63, P175, DOI 10.1016/j.jpyschores.2007.02.006
   Sharoni SKA, 2012, NURS HEALTH SCI, V14, P38, DOI 10.1111/j.1442-2018.2011.00658.x
   Sherina M S, 2012, Med J Malaysia, V67, P309
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   Skinner TC, 2014, DIABETIC MED, V31, P1260, DOI 10.1111/dme.12484
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Sturt Jackie, 2006, BMC Fam Pract, V7, P70, DOI 10.1186/1471-2296-7-70
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x
   Walker RJ, 2012, GEN HOSP PSYCHIAT, V34, P598, DOI 10.1016/j.genhosppsych.2012.07.005
   Wallace AS, 2009, PATIENT EDUC COUNS, V75, P328, DOI 10.1016/j.pec.2008.12.017
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   WHO Consultation, 1999, 992 WHO
   Willaing I, 2013, DIABETIC MED, V30, pe139, DOI 10.1111/dme.12121
   Wu SFV, 2008, INT J NURS STUD, V45, P534, DOI 10.1016/j.ijnurstu.2006.08.020
   Xu Y, 2008, J TRANSCULT NURS, V19, P234, DOI 10.1177/1043659608319239
   Yi-Frazier JP, 2010, STRESS HEALTH, V26, P51, DOI 10.1002/smi.1258
   Zeh P, 2012, DIABETIC MED, V29, P1237, DOI 10.1111/j.1464-5491.2012.03701.x
NR 85
TC 3
Z9 3
U1 1
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD APR 4
PY 2017
VL 17
AR 22
DI 10.1186/s12902-017-0172-8
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EQ6VZ
UT WOS:000398223200001
PM 28376921
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Mutai, H
   Furukawa, T
   Houri, A
   Suzuki, A
   Hanihara, T
AF Mutai, Hitoshi
   Furukawa, Tomomi
   Houri, Ayumi
   Suzuki, Akihito
   Hanihara, Tokiji
TI Factors associated with multidimensional aspect of post-stroke fatigue
   in acute stroke period
SO ASIAN JOURNAL OF PSYCHIATRY
LA English
DT Article
DE Post-stroke fatigue; Stroke; Anxiety; Depression
ID DEPRESSIVE SYMPTOMS; INVENTORY MFI; ACUTE-PHASE; INFARCTS; ANXIETY;
   DISEASE; COHORT; RISK
AB Background: Post-stroke fatigue (PSF) is a frequent and distressing consequence of stroke, and can be both acute and long lasting. We aimed to investigate multidimensional aspects of acute PSF and to determine the clinical factors relevant to acute PSF.
   Methods: We collected data of 101 patients admitted to the hospital for acute stroke. PSF was assessed using the Multidimensional Fatigue Inventory within 2 weeks of stroke. Measures included Mini-Mental State Examination, Hospital Anxiety and Depression Scale, and Functional Independence Measure. Stroke character, lesion location, and clinical variables that potentially influence PSF were also collected.
   Results: The prevalence of pathological fatigue is 56.4% within 2 weeks of stroke. Binary logistic regression analysis revealed that anxiety was the only predictor for presence of PSF (OR = 1.32, 95% CI: 1.13-1.53, P < 0.001). Multivariate stepwise regression analysis showed anxiety, right lesion side, thalamus, and/or brainstem were independently associated with general fatigue, right lesion side, depression, diabetes mellitus, and anxiety with physical fatigue, depression with reduced activity, depression, and BMI with reduced motivation, depression, and diabetes mellitus with mental fatigue.
   Conclusions: PSF was highly prevalent in the acute phase, and specific factors including lesion location (right side lesion, thalamic and brainstem lesion), anxiety, and depression were independently associated with multidimensional aspects of PSF. Further study is needed to elucidate how specific structural lesions and anxiety symptoms relate to the development of early fatigue following stroke. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mutai, Hitoshi; Furukawa, Tomomi; Houri, Ayumi; Suzuki, Akihito] Azumino Red Cross Hosp, Dept Rehabil, 5685 Toyoshina, Azumino, Nagano 3998292, Japan.
   [Mutai, Hitoshi; Hanihara, Tokiji] Shinshu Univ, Sch Med, Sch Hlth Sci, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.
   [Hanihara, Tokiji] Nagano Prefectural Mental Wellness Ctr Komagane, 2901 Shimodaira, Komagane, Nagano 3994101, Japan.
RP Hanihara, T (reprint author), Nagano Prefectural Mental Wellness Ctr, Komagane, Japan.
EM qhaniha@shinshu-u.ac.jp
CR Astrom M, 1996, STROKE, V27, P270, DOI 10.1161/01.STR.27.2.270
   Burton CA Campbell, 2013, INT J STROKE, V8, P545, DOI [doi:10.1111/j.1747-4949.2012.00906.x, DOI 10.1111/J.1747-4949.2012.00906.X]
   Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2
   CHINO N, 1994, JPN J REHABIL MED, V31, P119, DOI DOI 10.2490/JJRM1963.31.119
   Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784
   Choi-Kwon S, 2011, INT J STROKE, V6, P328, DOI 10.1111/j.1747-4949.2011.00624.x
   Christensen D, 2008, CEREBROVASC DIS, V26, P134, DOI 10.1159/000139660
   Duncan F, 2015, STROKE, V46, P1052, DOI 10.1161/STROKEAHA.114.008079
   Elbers RG, 2012, PARKINSONISM RELAT D, V18, P532, DOI 10.1016/j.parkreldis.2012.01.024
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6
   GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005
   Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8
   Kutlubaev MA, 2013, CEREBROVASC DIS EXTR, V3, P26, DOI 10.1159/000347113
   Lerdal A, 2013, NEUROLOGY, V81, P1581, DOI 10.1212/WNL.0b013e3182a9f471
   Lerdal A, 2011, DISABIL REHABIL, V33, P334, DOI 10.3109/09638288.2010.490867
   Manes F, 1999, J NERV MENT DIS, V187, P707, DOI 10.1097/00005053-199912000-00001
   Naess H, 2010, J NEUROL, V257, P1446, DOI 10.1007/s00415-010-5539-y
   Radman N, 2012, NEUROLOGY, V79, P1422, DOI 10.1212/WNL.0b013e31826d5f3a
   Sagen U, 2010, GEN HOSP PSYCHIAT, V32, P80, DOI 10.1016/j.genhosppsych.2009.10.001
   Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005
   SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O
   Snaphaan L, 2011, EUR J NEUROL, V18, P611, DOI 10.1111/j.1468-1331.2010.03217.x
   Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685
   Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2
   van der Werf SP, 2001, EUR NEUROL, V45, P28, DOI 10.1159/000052085
   Whyte EM, 2002, BIOL PSYCHIAT, V52, P253, DOI 10.1016/S0006-3223(02)01424-5
   Wu SM, 2015, STROKE, V46, P893, DOI 10.1161/STROKEAHA.114.006647
   Wu SM, 2014, STROKE, V45, P1778, DOI 10.1161/STROKEAHA.113.004584
NR 30
TC 2
Z9 2
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-2018
EI 1876-2026
J9 ASIAN J PSYCHIATR
JI Asian J. Psychiatr.
PD APR
PY 2017
VL 26
BP 1
EP 5
DI 10.1016/j.ajp.2016.12.015
PG 5
WC Psychiatry
SC Psychiatry
GA EY8ZO
UT WOS:000404288300002
PM 28483068
DA 2019-01-08
ER

PT J
AU Clarke, TK
   Obsteter, J
   Hall, LS
   Hayward, C
   Thomson, PA
   Smith, BH
   Padmanabhan, S
   Hocking, LJ
   Deary, IJ
   Porteous, DJ
   McIntosh, AM
AF Clarke, Toni-Kim
   Obsteter, Jana
   Hall, Lynsey S.
   Hayward, Caroline
   Thomson, Pippa A.
   Smith, Blair H.
   Padmanabhan, Sandosh
   Hocking, Lynne J.
   Deary, Ian J.
   Porteous, David J.
   McIntosh, Andrew M.
TI Investigating Shared Aetiology Between Type 2 Diabetes and Major
   Depressive Disorder in a Population Based Cohort
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
LA English
DT Article
DE depression; type 2 diabetes; genetics; polygenic
ID GENETIC ARCHITECTURE; ASSOCIATION; EPIDEMIOLOGY; METAANALYSIS; HEALTH;
   TWIN
AB Type II diabetes (T2D) and major depressive disorder (MDD) are often co-morbid. The reasons for this co-morbidity are unclear. Some studies have highlighted the importance of environmental factors and a causal relationship between T2D and MDD has also been postulated. In the present study we set out to investigate the shared aetiology between T2D and MDD using Mendelian randomization in a population based sample, Generation Scotland: the Scottish Family Health Study (N = 21,516). Eleven SNPs found to be associated with T2D were tested for association with MDD and psychological distress (General Health Questionnaire scores). We also assessed causality and genetic overlap between T2D and MDD using polygenic risk scores (PRS) assembled from the largest available GWAS summary statistics to date. No single T2D risk SNP was associated with MDD in the MR analyses and we did not find consistent evidence of genetic overlap between MDD and T2D in the PRS analyses. Linkage disequilibrium score regression analyses supported these findings as no genetic correlation was observed between T2D and MDD(rG = 0.0278 (S.E. 0.11), P-value = 0.79). As suggested by previous studies, T2D and MDD covariance may be better explained by environmental factors. Future studies would benefit from analyses in larger cohorts where stratifying by sex and looking more closely at MDD cases demonstrating metabolic dysregulation is possible. (C) 2016 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Published by Wiley Periodicals, Inc.
C1 [Clarke, Toni-Kim; Obsteter, Jana; McIntosh, Andrew M.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland.
   [Hall, Lynsey S.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Hayward, Caroline; Thomson, Pippa A.] Univ Edinburgh, Inst Genet & Mol Med, Western Gen Hosp, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland.
   [Hayward, Caroline; Porteous, David J.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet, Edinburgh, Midlothian, Scotland.
   [Thomson, Pippa A.; Deary, Ian J.; Porteous, David J.; McIntosh, Andrew M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.
   [Smith, Blair H.] Univ Dundee, Div Populat Hlth Sci, Dundee, Scotland.
   [Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.
   [Hocking, Lynne J.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland.
   [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.
RP Clarke, TK (reprint author), Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland.
EM toni.clarke@ed.ac.uk
RI Deary, Ian/C-6297-2009; McIntosh, Andrew/B-9379-2008
OI Deary, Ian/0000-0002-1733-263X; McIntosh, Andrew/0000-0002-0198-4588
FU Wellcome Trust [104036/Z/14/Z]; Scottish Government Health Department,
   Chief Scientist Office [CZD/16/6]; Dr. Mortimer and Theresa Sackler
   Foundation; Wellcome Trust [104036/Z/14/Z]; Scottish Government Health
   Department, Chief Scientist Office [CZD/16/6]; Dr. Mortimer and Theresa
   Sackler Foundation; Chief Scientist Office [CZD/16/6/4]; Medical
   Research Council [1292844, MR/K026992/1, MC_PC_U127561128]
FX Grant sponsor: Wellcome Trust Through a Strategic Award; Grant number:
   104036/Z/14/Z; Grant sponsor: Scottish Government Health Department,
   Chief Scientist Office; Grant number: CZD/16/6; Grant sponsor: Dr.
   Mortimer and Theresa Sackler Foundation.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Anwar H, 2011, DIABETIC MED, V28, P1514, DOI 10.1111/j.1464-5491.2011.03432.x
   Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211
   Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659
   Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
   First M. B, 1997, STRUCTURED CLIN INTE
   GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Goodwin Guy M, 2006, Dialogues Clin Neurosci, V8, P259
   Kan C, 2016, MOL PSYCHIATR, V21, P903, DOI 10.1038/mp.2016.28
   Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409
   Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711
   Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897
   Mezuk B, 2015, PSYCHOSOM MED, V77, P559, DOI 10.1097/PSY.0000000000000182
   Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383
   Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Samaan Z, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.113
   Scherrer JF, 2011, TWIN RES HUM GENET, V14, P169, DOI 10.1375/twin.14.2.169
   Schmitz N, 2016, MOL PSYCHIAT
   Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48
   Smith BH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-74
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21
NR 25
TC 5
Z9 5
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4841
EI 1552-485X
J9 AM J MED GENET B
JI Am. J. Med. Genet. B
PD APR
PY 2017
VL 174
IS 3
BP 227
EP 234
DI 10.1002/ajmg.b.32478
PG 8
WC Genetics & Heredity; Psychiatry
SC Genetics & Heredity; Psychiatry
GA EV1PF
UT WOS:000401517800005
PM 27480393
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Indelicato, L
   Dauriz, M
   Santi, L
   Bonora, F
   Negri, C
   Cacciatori, V
   Targher, G
   Trento, M
   Bonora, E
AF Indelicato, L.
   Dauriz, M.
   Santi, L.
   Bonora, F.
   Negri, C.
   Cacciatori, V.
   Targher, G.
   Trento, M.
   Bonora, E.
TI Psychological distress, self-efficacy and glycemic control in type 2
   diabetes
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Type 2 diabetes; Self-efficacy; Glycemic control; Anxiety; Depression
ID ANXIETY DISORDERS; RISK-FACTORS; DEPRESSION; ADULTS; PREVALENCE;
   METAANALYSIS; SYMPTOMS; ASSOCIATION; ADHERENCE; CARE
AB Aim: To investigate the association of glycemic control with depression, anxiety, self-efficacy and other diabetes-specific psychological measures in a cohort of adult patients with type 2 diabetes (T2D) free of severe chronic diabetes-related complications.
   Methods and Results: In 172 T2D outpatients consecutively recruited at the Diabetes Center of Verona City Hospital, we performed a standard medical assessment and completed the Beck Depression Inventory-II (BDI-II), the Beck Anxiety Inventory (BAI) and the Multidimensional Diabetes Questionnaire (MDQ) Age, body mass index (BMI) and glycosylated hemoglobin (HbA1c) were (median [IQR]): 64.0 [58.0-69.0] years, 31.0 [28.0-34.4] kg/m(2), and 7.3 [6.7 -8.0] %, respectively. The overall prevalence of anxiety and depression was 14.5% and 18.6%, respectively. Higher levels of HbA1c were significantly (p < 0.001) associated with a number of MDQ dimensions, such as higher perceived interference with daily activities (Spearman's rho coefficient = 0.33), higher perceived diabetes severity (rho = 0.28) and lower self-efficacy (rho = -0.27), but not with depression or anxiety. These three variables were also independent predictors of higher HbA1c levels, when entered in a multivariable stepwise-forward regression model that also included age, BMI, diabetes duration and diabetes-specific social support as covariates.
   Conclusion: Lower self-efficacy and higher diabetes distress were closely associated with poorer glycemic control. No direct association between HbA1c and clinical psychological symptoms was detected. These results highlight that a number of diabetes-specific psychological variables may play a role amidst psychological distress and glycemic control. Further studies are needed to elucidate the relevance of diabetes distress and self-efficacy to the achievement of individual glycemic targets. (C) 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
C1 [Indelicato, L.; Dauriz, M.; Santi, L.; Bonora, F.; Negri, C.; Cacciatori, V.; Targher, G.; Bonora, E.] Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, Piazzale Stefani 1, I-37126 Verona, Italy.
   [Indelicato, L.; Dauriz, M.; Santi, L.; Bonora, F.; Negri, C.; Cacciatori, V.; Targher, G.; Bonora, E.] Hosp Trust Verona, Piazzale Stefani 1, I-37126 Verona, Italy.
   [Trento, M.] Univ Turin, Dept Med Sci, Lab Clin Pedag, Turin, Italy.
RP Indelicato, L; Dauriz, M (reprint author), Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, Piazzale Stefani 1, I-37126 Verona, Italy.; Indelicato, L; Dauriz, M (reprint author), Hosp Trust Verona, Piazzale Stefani 1, I-37126 Verona, Italy.
EM liliana.indelicato@univr.it; marco.dauriz@univr.it
RI Dauriz, Marco/S-5843-2016
OI Dauriz, Marco/0000-0002-5542-5941; TRENTO, Marina/0000-0003-3764-3539
FU Fondazione Diabete Ricerca (Fo.Di.Ri, Rome, Italy)
FX This study was supported by Fondazione Diabete Ricerca (Fo.Di.Ri, Rome,
   Italy). The support of the administrative and clinical personnel of the
   Verona Diabetes Center (University and General Hospital of Verona,
   Verona, Italy) is gratefully acknowledged.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arshad AR, 2016, J PAK MED ASSOC, V66, P425
   Beck AT, MANUAL BECK ANXIETY
   Beck AT, 1996, MANUAL BECK DEPRESSI
   Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782
   Cherrington A, 2010, J BEHAV MED, V33, P81, DOI 10.1007/s10865-009-9233-4
   Chlebowy DO, 2006, DIABETES EDUCATOR, V32, P777, DOI 10.1177/0145721706291760
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2000, DIABETES CARE, V23, P267, DOI 10.2337/diacare.23.3.267
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Ghisi M, BDI 2 BECK DEPRESSIO
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Henderson AS, 1998, PSYCHOL MED, V28, P1321, DOI 10.1017/S0033291798007570
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Lazzari D, 2009, PSICOTER COGN COMPOR, V15, P171
   LUDLOW AP, 1995, CANADIAN J DIABETES, V19, P10
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Rees G, 2016, JAMA OPHTHALMOL, V134, P1007, DOI 10.1001/jamaophthalmol.2016.2213
   Sacco WP, 2005, HEALTH PSYCHOL, V24, P630, DOI 10.1037/0278-6133.6.630
   Talbot F, 1997, J BEHAV MED, V20, P291, DOI 10.1023/A:1025508928696
   Trento M, 2012, ACTA DIABETOL, V49, P199, DOI 10.1007/s00592-011-0275-z
   Williams JW, 2004, ANN INTERN MED, V140, P1015, DOI 10.7326/0003-4819-140-12-200406150-00012
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
NR 32
TC 2
Z9 2
U1 2
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD APR
PY 2017
VL 27
IS 4
BP 300
EP 306
DI 10.1016/j.numecd.2017.01.006
PG 7
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition
   & Dietetics
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism;
   Nutrition & Dietetics
GA ET7GA
UT WOS:000400461300003
PM 28274728
OA Green Published
DA 2019-01-08
ER

PT J
AU Sandberg, J
   Yorgason, JB
   Fisher, L
   Weinstock, RS
   Hessler, D
   Dimmock, J
   Trief, PM
AF Sandberg, Jonathan
   Yorgason, Jeremy B.
   Fisher, Lawrence
   Weinstock, Ruth S.
   Hessler, Danielle
   Dimmock, Jacqueline
   Trief, Paula M.
TI Does Length of Relationship or Gender Predict Response to Behavioral
   Diabetes Intervention? Generating Hypotheses From Secondary Analysis of
   a Randomized Trial
SO DIABETES EDUCATOR
LA English
DT Article
ID MARITAL QUALITY; OLDER-ADULTS; COUPLES; HEALTH; MANAGEMENT; ADHERENCE;
   DISTRESS; MARRIAGE; OUTCOMES; SPOUSES
AB Purpose
   The purpose of the study was to determine, through secondary analysis, whether the length of a couple's relationship and the participants' gender are associated with glycemic response to a type 2 diabetes (T2D) behavioral couples-based intervention.
   Methods
   A randomized trial was conducted to test the impact of a couples-level, telephone-based behavioral intervention on hemoglobin A1C in patients with T2D. One hundred and four patients and partners participated in the couples intervention arm, and 94 individuals participated in the individual arm. A1C levels were measured at baseline and 1-year follow-up.
   Results
   Results of the regression analysis showed that for men with T2D (n = 35) in the couples intervention group, longer length of relationship was associated with lower A1C at 1-year follow-up, after controlling for baseline A1C, diabetes duration, and income. Length of relationship was not significantly related to follow-up glycemic measures for women or men with T2D in the individual intervention.
   Conclusions
   Study findings suggests that for men with T2D in a couples- - based intervention, those in longer relationships may be more likely to benefit from the intervention. More research is needed to better understand factors that contribute to successful couples- based behavioral approaches to help adults with T2D improve their glycemic control.
C1 [Sandberg, Jonathan; Yorgason, Jeremy B.] Brigham Young Univ, Sch Family Life, 266 TLRB, Provo, UT 84602 USA.
   [Weinstock, Ruth S.; Dimmock, Jacqueline; Trief, Paula M.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Fisher, Lawrence; Hessler, Danielle] Univ Calif San Francisco, San Francisco, CA 94143 USA.
RP Sandberg, J (reprint author), Brigham Young Univ, Sch Family Life, 266 TLRB, Provo, UT 84602 USA.
EM jgs@byu.edu
OI Yorgason, Jeremy/0000-0002-4208-7306
FU National Institutes of Health (NIDDK) [1R18DK080867-01A2]
FX Funding for this study was provided by the National Institutes of Health
   (NIDDK) No. 1R18DK080867-01A2.
CR Bandura A, 1978, SOCIAL LEARNING THEO
   Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258
   Clark CD, 2008, DISS ABSTR INT, V68, P4619
   Donato S, 2015, J SOC PERS RELAT, V32, P580, DOI 10.1177/0265407514541071
   Fisher L, 2000, J FAM PRACTICE, V49, P561
   Fisher L, 2000, FAM PROCESS, V39, P403, DOI 10.1111/j.1545-5300.2000.39402.x
   Franks MM, 2012, FAM SYST HEALTH, V30, P154, DOI 10.1037/a0028614
   Franks MM, 2010, FAM RELAT, V59, P599, DOI 10.1111/j.1741-3729.2010.00626.x
   HAMPSON SE, 1995, DIABETES EDUCATOR, V21, P300, DOI 10.1177/014572179502100407
   Hemphill RC, 2013, PSYCHOL HEALTH, V28, P139, DOI 10.1080/08870446.2012.685740
   Iida M, 2010, PERS SOC PSYCHOL B, V36, P780, DOI 10.1177/0146167210369897
   Kang CM, 2010, INT J NURS STUD, V47, P1363, DOI 10.1016/j.ijnurstu.2010.03.009
   Kelley H. H., 1978, INTERPERSONAL RELATI
   Keogh KM, 2011, AM J MANAG CARE, V17, P105
   Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472
   Landis M, 2013, GEROPSYCH, V26, P39, DOI 10.1024/1662-9647/a000077
   LEVENSON RW, 1994, J PERS SOC PSYCHOL, V67, P56, DOI 10.1037//0022-3514.67.1.56
   Lin WF, 2016, J HAPPINESS STUD, V17, P757, DOI 10.1007/s10902-015-9621-0
   Lister Z, 2013, CONTEMP FAM THER, V35, P613, DOI 10.1007/s10591-013-9250-x
   Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599
   Martire LM, 2014, HEALTH PSYCHOL, V33, P501, DOI 10.1037/hea0000103
   Padula C, 1996, WESTERN J NURS RES, V18, P675, DOI 10.1177/019394599601800605
   Pasupathi M, 1999, J NONVERBAL BEHAV, V23, P173, DOI 10.1023/A:1021439627043
   Rentscher KE, 2013, J FAM PSYCHOL, V27, P691, DOI 10.1037/a0034184
   Robles TF, 2014, CURR DIR PSYCHOL SCI, V23, P427, DOI 10.1177/0963721414549043
   Rohrbaugh MJ, 2008, J CONSULT CLIN PSYCH, V76, P781, DOI 10.1037/a0013238
   Sandberg J, 2006, J COUPLE RELATSH THE, V5, P23, DOI 10.1300/J398v05n02_02
   Seidel AJ, 2012, FAM RELAT, V61, P698, DOI 10.1111/j.1741-3729.2012.00719.x
   Trief PM, 2016, DIABETES CARE, V39, P2165, DOI 10.2337/dc16-0035
   Trief PM, 2011, TRANSL BEHAV MED, V1, P461, DOI 10.1007/s13142-011-0057-8
   Trief PM, 2004, ANN BEHAV MED, V27, P148, DOI 10.1207/s15324796abm2703_2
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   United Kingdom Prospective Diabetes Study Group, 1998, LANCET, V352, P837
   Whisman MA, 2014, HEALTH PSYCHOL, V33, P832, DOI 10.1037/hea0000064
   Yang W, 2013, DIABETES CARE, V36, P1033, DOI DOI 10.2337/DC12-2625
NR 35
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD APR
PY 2017
VL 43
IS 2
BP 216
EP 222
DI 10.1177/0145721717691147
PG 7
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA EQ3NX
UT WOS:000397980900008
PM 28162037
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Billionnet, C
   Mitanchez, D
   Weill, A
   Nizard, J
   Alla, F
   Hartemann, A
   Jacqueminet, S
AF Billionnet, Cecile
   Mitanchez, Delphine
   Weill, Alain
   Nizard, Jacky
   Alla, Francois
   Hartemann, Agnes
   Jacqueminet, Sophie
TI Gestational diabetes and adverse perinatal outcomes from 716,152 births
   in France in 2012
SO DIABETOLOGIA
LA English
DT Article
DE Cardiac malformation; Gestational diabetes mellitus; Macrosomia;
   Perinatal death; Pre-eclampsia; Preterm
ID GLUCOSE-TOLERANT WOMEN; IMMORTAL TIME BIAS; BODY-MASS INDEX;
   INTERNATIONAL ASSOCIATION; CONGENITAL-MALFORMATIONS; ATLANTIC-DIP;
   PREGNANCY; MELLITUS; HYPERGLYCEMIA; RISK
AB Aims/hypothesis The aim of this study was to assess the risk of adverse perinatal outcomes in gestational diabetes mellitus (GDM) in a large national cohort.
   Methods All deliveries taking place after 22 weeks in France in 2012 were included by extracting data from the hospital discharge database and the national health insurance system. The diabetic status of mothers was determined by the use of glucose-lowering agents and by hospital diagnosis. Outcomes were analysed according to the type of diabetes and, in the GDM group, whether or not diabetes was insulin-treated.
   Results The cohort of 796,346 deliveries involved 57,629 (7.24%) mothers with GDM. Mother-infant linkage was obtained for 705,198 deliveries. The risks of adverse outcomes were much lower with GDM than with pregestational diabetes. After limiting the analysis to deliveries after 28 weeks to reduce immortal time bias, the risks of preterm birth (OR 1.3 [95% CI 1.3, 1.4]), Caesarean section (OR 1.4 [95% CI 1.4, 1.4]), pre-eclampsia/eclampsia (OR 1.7 [95% CI 1.6, 1.7]), macrosomia (OR 1.8 [95% CI 1.7, 1.8]), respiratory distress (OR 1.1 [95% CI 1.0, 1.3]), birth trauma (OR 1.3 [95% CI 1.1, 1.5]) and cardiac malformations (OR 1.3 [95% CI 1.1, 1.4]) were increased in women with GDM compared with the non-diabetic population. Higher risks were observed in women with insulin-treated GDMthan those with diet-treated GDM. After limiting the analysis to term deliveries, an increased risk of perinatal mortality was observed. After excluding women suspected to have undiagnosed pregestational diabetes, the risk remained moderately increased only for those with diet-treated GDM (OR 1.3 [95% CI 1.0, 1.6]).
   Conclusions/interpretation GDM is associated with a moderately increased risk of adverse perinatal outcomes, which is higher in insulin-treated GDM than in non-insulintreated GDM for most outcomes.
C1 [Billionnet, Cecile; Weill, Alain; Alla, Francois] Natl Hlth Insurance, Dept Publ Hlth Studies, Div Stat Strateg Res & Dev, Paris, France.
   [Mitanchez, Delphine] Armand Trousseau Hosp, AP HP, Dept Perinatol, Div Neonatol, Paris, France.
   [Mitanchez, Delphine; Nizard, Jacky; Hartemann, Agnes] UPMC Univ Paris 06, Sorbonne Univ, Paris, France.
   [Nizard, Jacky] Grp Hosp Pitie Salpetriere, Dept Obstet & Gynaecol, APHP CNRS UMR 7222, Inserm U1150, Paris, France.
   [Hartemann, Agnes; Jacqueminet, Sophie] Hop La Pitie Salpetriere, AP HP, Inst Cardiometab & Nutr, Paris, France.
   [Hartemann, Agnes; Jacqueminet, Sophie] Hop La Pitie Salpetriere, Diabet & Metab Dis Dept, 83 Blvd Hop, F-75013 Paris, France.
RP Jacqueminet, S (reprint author), Hop La Pitie Salpetriere, AP HP, Inst Cardiometab & Nutr, Paris, France.; Jacqueminet, S (reprint author), Hop La Pitie Salpetriere, Diabet & Metab Dis Dept, 83 Blvd Hop, F-75013 Paris, France.
EM sophie.jacqueminet@aphp.fr
OI alla, francois/0000-0002-5793-7190
CR [Anonymous], 2010, Diabetes Metab, V36, P695, DOI 10.1016/j.diabet.2010.11.019
   Becquet O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008192
   Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039
   Charles MA, 2008, OBESITY, V16, P2180, DOI [10.1038/oby.2008.285, 10.1038/oby.2008.286]
   Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a
   Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x
   Dennedy MC, 2012, J CLIN ENDOCR METAB, V97, pE608, DOI 10.1210/jc.2011-2674
   Fadl HE, 2010, DIABETIC MED, V27, P436, DOI 10.1111/j.1464-5491.2010.02978.x
   Feig DS, 2014, DIABETES CARE, V37, P1590, DOI 10.2337/dc13-2717
   Fong A, 2014, J DIABETES COMPLICAT, V28, P29, DOI 10.1016/j.jdiacomp.2013.08.009
   Garcia-Patterson A, 2004, DIABETOLOGIA, V47, P509, DOI 10.1007/s00125-004-1337-3
   Hutcheon JA, 2013, EPIDEMIOLOGY, V24, P787, DOI 10.1097/EDE.0b013e3182a6d9aa
   Lepercq J, 2010, J GYNECOL OBST BIO R, V39, pS141, DOI 10.1016/S0368-2315(10)70042-9
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Mitanchez D, 2010, DIABETES METAB, V36, P617, DOI 10.1016/j.diabet.2010.11.013
   Mitanchez D, 2014, J PEDIATR-US, V164, P445, DOI 10.1016/j.jpeds.2013.10.076
   Moses RG, 2016, AUST NZ J OBSTET GYN, V56, P341, DOI 10.1111/ajo.12447
   Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009
   O'Sullivan EP, 2011, DIABETOLOGIA, V54, P1670, DOI 10.1007/s00125-011-2150-4
   Ogunleye OK, 2016, J MATERN-FETAL NEO M, V30, P1
   Owens LA, 2010, DIABETES CARE, V33, P577, DOI 10.2337/dc09-0911
   Oyen N, 2016, CIRCULATION, V133, P2243, DOI 10.1161/CIRCULATIONAHA.115.017465
   Pierron A, 2015, REV EPIDEMIOL SANTE, V63, P237, DOI 10.1016/j.respe.2015.05.001
   Piper JM, 2002, SEMIN PERINATOL, V26, P206, DOI 10.1053/sper.2002.33969
   Quantin C, 2014, J GYNECOL OBST BIO R, V43, P680, DOI 10.1016/j.jgyn.2013.09.004
   Reece EA, 2012, CURR DIABETES REP, V12, P24, DOI 10.1007/s11892-011-0251-6
   Rosenstein MG, 2012, AM J OBSTET GYNECOL, V206
   Schaefer-Graf UM, 2000, AM J OBSTET GYNECOL, V182, P313, DOI 10.1016/S0002-9378(00)70217-1
   Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324
NR 30
TC 27
Z9 28
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD APR
PY 2017
VL 60
IS 4
BP 636
EP 644
DI 10.1007/s00125-017-4206-6
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EQ4KS
UT WOS:000398046400005
PM 28197657
OA Other Gold
DA 2019-01-08
ER

PT J
AU Li, C
   Xu, D
   Hu, MY
   Tan, YF
   Zhang, P
   Li, GC
   Chen, L
AF Li, Chen
   Xu, Duo
   Hu, Mingyue
   Tan, Yongfei
   Zhang, Ping
   Li, Guichen
   Chen, Li
TI A systematic review and meta-analysis of randomized controlled trials of
   cognitive behavior therapy for patients with diabetes and depression
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Review
DE Diabetes mellitus; Depression; Cognitive behavior therapy; Meta-analysis
ID QUALITY-OF-LIFE; MOTIVATIONAL ENHANCEMENT THERAPY; GLYCEMIC CONTROL;
   TYPE-1; SYMPTOMS; ANXIETY; INTERVENTION; PREVALENCE; MELLITUS; ADULTS
AB Objective: The aim of this meta-analysis was to systematically examine the efficacy of cognitive behavior therapy (CBT) for diabetic patients who have comorbid depression and to identify which aspects can be improved through intervention.
   Methods: A systematic literature review was performed using multiple databases. The inclusion criteria included randomized controlled trials (RCTs) of CBT that were conducted with diabetes patients with clinically relevant depression. Review Manager version 5.3 was used to obtain pooled results.
   Results: Ten RCTs, with a total sample size of 998 participants, met the inclusion criteria. Compared with control groups, the CBT groups had statistically significant, long-term improvements in depression (standardized mean differences [SMD] = -0.65, 95% confidence interval [CI] (-0.98 to -031), P = 0.0002), quality of life (SMD = 0.29, 95%CI (0.08 to 0.51), P = 0.007), fasting glucose (SMD = 0.21, 95%CI (0.04 to 037), P = 0.01) and anxiety (SMD = -0.49, 95%CI (-0.88 to -0.10), P = 0.01). No improvements were found in glycemic control or in diabetes-related distress.
   Conclusions: The results of this meta-analysis showed that CBT can be effective in reducing depression symptoms and fasting glucose in diabetes patients with comorbid depression as well as in improving quality of life and anxiety in the long-term. The results showed that CBT can serve as a promising treatment alternative for diabetes patients with comorbid depression. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Li, Chen; Xu, Duo; Hu, Mingyue; Zhang, Ping; Li, Guichen; Chen, Li] Jilin Univ, Sch Nursing, 965 Xinjiang St, Changchun 130021, Jilin, Peoples R China.
   [Tan, Yongfei] Jilin Univ, Coll Basic Med Sci, 126 Xinmin St, Changchun 130021, Jilin, Peoples R China.
RP Chen, L (reprint author), Jilin Univ, Sch Nursing, 965 Xinjiang St, Changchun 130021, Jilin, Peoples R China.
EM chen_care@126.com
CR Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Baumeister H, 2014, DIABETIC MED, V31, P773, DOI 10.1111/dme.12452
   Baumeister H., 2012, PSYCHOL PHARM INTERV
   Beck A. T., 1976, COGNITIVE THERAPY EM
   Bogner HR, 2016, J GEN INTERN MED, V31, P594, DOI 10.1007/s11606-016-3675-5
   Bot M, 2010, DIABETIC MED, V27, P1295, DOI 10.1111/j.1464-5491.2010.03119.x
   Browne JL, 2015, DIABETIC MED, V32, P133, DOI 10.1111/dme.12566
   Carper MM, 2014, J BEHAV MED, V37, P501, DOI 10.1007/s10865-013-9505-x
   Chapman A., 2015, FRONT PUBLIC HLTH, V3
   COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186
   Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1
   Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   DOBSON KS, 1989, J CONSULT CLIN PSYCH, V57, P414, DOI 10.1037/0022-006X.57.3.414
   Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Ekers D, 2008, PSYCHOL MED, V38, P611, DOI 10.1017/S0033291707001614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Ghasemzadeh H., 2001, COGNITIVE BEHAV THER
   Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4
   Herder C, 2013, DIABETES CARE, V36, P3663, DOI 10.2337/dc13-0382
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Higgins J, 2008, COCHRANE HDB SYSTEMA, P187, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hind D, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-5
   Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1
   Huang CY, 2016, QUAL LIFE RES, V25, P1275, DOI 10.1007/s11136-015-1165-6
   Huang YG, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-92
   International Diabetes Federation, 2013, IDF DIABETES ATLAS
   Ismail K, 2008, ANN INTERN MED, V149, P708, DOI 10.7326/0003-4819-149-10-200811180-00005
   Johansson R, 2012, EXPERT REV NEUROTHER, V12, P861, DOI [10.1586/ern.12.63, 10.1586/ERN.12.63]
   Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Koffel EA, 2015, SLEEP MED REV, V19, P6, DOI 10.1016/j.smrv.2014.05.001
   Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002
   Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36
   Lawrence JM, 2006, PEDIATRICS, V117, P1348, DOI 10.1542/peds.2005-1398
   Lenze EJ, 2000, AM J PSYCHIAT, V157, P722, DOI 10.1176/appi.ajp.157.5.722
   Li Liuzhi, 2008, INT J NURS, V27, P295
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   De la Roca-Chiapas JM, 2013, REV INVEST CLIN, V65, P209
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Marks I., 2007, HANDS ON HELP COMPUT
   Matthews EE, 2013, SLEEP MED REV, V17, P453, DOI 10.1016/j.smrv.2013.01.001
   Mosaku K, 2008, J NATL MED ASSOC, V100, P73, DOI 10.1016/S0027-9684(15)31178-0
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Paschalides C, 2004, J PSYCHOSOM RES, V57, P557, DOI 10.1016/j.jpsychores.2004.03.006
   Peinemann F, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008216.pub4, 10.1371/journal.pmed.1000097, 10.1136/bmj.c869, 10.1136/bmj.b2535, 10.1016/j.jclinepi.2010.02.006, 10.1002/14651858.CD008242.pub3, 10.1016/j.jclinepi.2010.03.004]
   Penckofer SM, 2012, ANN BEHAV MED, V44, P192, DOI 10.1007/s12160-012-9377-2
   Petrak F, 2015, DIABETES CARE, V38, P767, DOI 10.2337/dc14-1599
   Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9
   Pignone M, 2008, CLIN DIABETES, V26, P15
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Sharif Farkhondeh, 2014, Iran J Nurs Midwifery Res, V19, P529
   Simos G., 2014, COGNITIVE BEHAV THER
   Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392
   Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944
   Tarrier Nicholas, 2010, Clin Schizophr Relat Psychoses, V4, P176, DOI 10.3371/CSRP.4.3.4
   Titov N, 2015, BEHAV THER, V46, P193, DOI 10.1016/j.beth.2014.09.008
   Tovote KA, 2014, DIABETES CARE, V37, P2427, DOI 10.2337/dc13-2918
   Uchendu C., 2016, DIABET MED
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Wagner B, 2014, J AFFECT DISORDERS, V152, P113, DOI 10.1016/j.jad.2013.06.032
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
   Zhang Junqing, 2014, CHINA J POSTGRAD MED, V31, P58
   Zheng AS Y., 2016, AUST NZ J OBSTET GYN
NR 71
TC 2
Z9 2
U1 6
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD APR
PY 2017
VL 95
BP 44
EP 54
DI 10.1016/j.jpsychores.2017.02.006
PG 11
WC Psychiatry
SC Psychiatry
GA EP4OZ
UT WOS:000397361100007
PM 28314548
DA 2019-01-08
ER

PT J
AU Wang, RH
AF Wang, Ruey-Hsia
TI Psychological Care for Patients With Diabetes - Present and Future
SO JOURNAL OF NURSING RESEARCH
LA English
DT Article
ID DISTRESS; PEOPLE; OUTCOMES; DEPRESSION.; ATTITUDES; WISHES; TRIAL; 2ND
C1 [Wang, Ruey-Hsia] Kaohsiung Med Univ, Coll Nursing, Kaohsiung, Taiwan.
   [Wang, Ruey-Hsia] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.
RP Wang, RH (reprint author), 100 Shin Chuan 1st Rd, Kaohsiung 80708, Taiwan.
EM wrhsia@kmu.edu.tw
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   American Diabetes Association, 2017, DIABETES CARE S1, V40, pS4
   Chapman Anna, 2015, Front Public Health, V3, P252, DOI 10.3389/fpubh.2015.00252
   Chapman A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1358-x
   Dalsgaard EM, 2014, DIABETOLOGIA, V57, P710, DOI 10.1007/s00125-014-3165-4
   DuBois Christina M, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.15m01902
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Friis AM, 2016, DIABETES CARE, V39, P1963, DOI 10.2337/dc16-0416
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Hsu HC, 2013, J NURS RES, V21, P212, DOI 10.1097/01.jnr.0000432048.31921.e2
   Kok JLA, 2015, INT J NURS STUD, V52, P1625, DOI 10.1016/j.ijnurstu.2015.05.012
   Mommersteeg PMC, 2013, DIABETIC MED, V30, pE208, DOI 10.1111/dme.12193
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022
   Stuckey HL, 2014, DIABETES CARE, V37, P2466, DOI 10.2337/dc13-2536
   Tanenbaum ML, 2016, J DIABETES COMPLICAT, V30, P1060, DOI 10.1016/j.jdiacomp.2016.04.023
   van Dijk-de Vries A., 2016, INT J NURS STUD, V63, P58, DOI [10.1016/j.ijnurstu.2016.08.018, DOI 10.1016/J.IJNURSTU.2016.08.018]
   Wang RH, 2017, J ADV NURS, V73, P1137, DOI 10.1111/jan.13201
   Wang RH, 2011, J ADV NURS, V67, P2658, DOI 10.1111/j.1365-2648.2011.05701.x
NR 22
TC 1
Z9 1
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1682-3141
J9 J NURS RES
JI J. Nurs. Res.
PD APR
PY 2017
VL 25
IS 2
BP 86
EP 89
DI 10.1097/jnr.0000000000000207
PG 4
WC Nursing
SC Nursing
GA EN3ZX
UT WOS:000395947700001
PM 28277388
DA 2019-01-08
ER

PT J
AU Green, MJ
   Espie, CA
   Popham, F
   Robertson, T
   Benzeval, M
AF Green, Michael J.
   Espie, Colin A.
   Popham, Frank
   Robertson, Tony
   Benzeval, Michaela
TI Insomnia symptoms as a cause of type 2 diabetes Incidence: a 20 year
   cohort study
SO BMC PSYCHIATRY
LA English
DT Article
DE Insomnia; Sleep; Type 2 Diabetes; Longitudinal; Confounding; Causal
   Effects; Marginal Structural Models
ID MARGINAL STRUCTURAL MODELS; COLLIDER-STRATIFICATION BIAS;
   SOCIOECONOMIC-STATUS; PROPENSITY SCORE; HEALTH BEHAVIORS; SLEEP; RISK;
   QUALITY; METAANALYSIS; DISTRESS
AB Background: Insomnia symptoms are associated with type 2 diabetes incidence but are also associated with a range of potential time-varying covariates which may confound and/or mediate associations. We aimed to assess whether cumulative exposure to insomnia symptoms has a causal effect on type 2 diabetes incidence.
   Methods: A prospective cohort study in the West of Scotland, following respondents for 20 years from age 36. 996 respondents were free of diabetes at baseline and had valid data from up to four follow-up visits. Type 2 diabetes was assessed at the final visit by self-report, taking diabetic medication, or blood-test (HbA(1c) >= 6.5% or 48 mmol/mol). Effects of cumulative insomnia exposure on type 2 diabetes incidence were estimated with traditional regression and marginal structural models, adjusting for time-dependent confounding (smoking, diet, physical inactivity, obesity, heavy drinking, psychiatric distress) as well as for gender and baseline occupational class.
   Results: Traditional regression yielded an odds ratio (OR) of 1.34 (95% CI: 1.06-1.70) for type 2 diabetes incidence for each additional survey wave in which insomnia was reported. Marginal structural models adjusted for prior covariates (assuming concurrently measured covariates were potential mediators), reduced this OR to 1.20 (95% CI: 0.98-1.46), and when concurrent covariates were also included (viewing them as potential confounders) this dropped further to 1.08 (95% CI: 0.85-1.37).
   Conclusions: The association between cumulative experience of insomnia and type 2 diabetes incidence appeared confounded. Evidence for a residual causal effect depended on assumptions as to whether concurrently measured covariates were confounders or mediators.
C1 [Green, Michael J.; Popham, Frank] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, 200 Renfield St, Glasgow G2 3QB, Lanark, Scotland.
   [Espie, Colin A.] Univ Oxford, Sleep & Circadian Neurosci Inst, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.
   [Robertson, Tony] Univ Stirling, Fac Hlth Sci & Sport, Stirling FK9 4LA, Scotland.
   [Benzeval, Michaela] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England.
   [Benzeval, Michaela] Univ Glasgow, Inst Hlth & Wellbeing, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.
RP Green, MJ (reprint author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, 200 Renfield St, Glasgow G2 3QB, Lanark, Scotland.
EM michael.green@glasgow.ac.uk
OI Green, Michael/0000-0003-3193-2452; Robertson, Tony/0000-0002-1962-5874;
   Popham, Frank/0000-0002-7263-7954
FU UK Medical Research Council [MC_UU_12017/13, MC_A540_53462]; Chief
   Scientist Office, Scottish Government Health Directorates [SPHSU 13];
   University of Essex; UK Economic and Social Research Council
FX MJG and FP are supported by the UK Medical Research Council
   (MC_UU_12017/13) and the Chief Scientist Office, Scottish Government
   Health Directorates (SPHSU 13). MB has support from the University of
   Essex and the UK Economic and Social Research Council. The Twenty-07
   Study is funded by the UK Medical Research Council (MC_A540_53462).
CR Agardh EE, 2004, DIABETES CARE, V27, P716, DOI 10.2337/diacare.27.3.716
   Ali MS, 2013, EUR J EPIDEMIOL, V28, P291, DOI 10.1007/s10654-013-9766-2
   Anothaisintawee T, 2016, SLEEP MED REV, V30, P11, DOI 10.1016/j.smrv.2015.10.002
   Asparouhov T., 2010, TECHNICAL REPORT
   Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786
   Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124
   Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164
   Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173
   Demakakos P, 2012, EUR J EPIDEMIOL, V27, P367, DOI 10.1007/s10654-012-9688-4
   Der G, 1998, MRC MED SOCIOLOGY UN, V60
   Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531
   Goldberg D., 1988, USERS GUIDE GEN HLTH
   Green MJ, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-152
   Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009
   Kaufman JS, 2010, EPIDEMIOLOGY, V21, P490, DOI 10.1097/EDE.0b013e3181e00730
   Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078
   Lucassen EA, 2012, ANN NY ACAD SCI, V1264, P110, DOI 10.1111/j.1749-6632.2012.06655.x
   Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167
   Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109
   Moodie EEM, 2008, INT J BIOSTAT, V4, P13
   Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134
   Muthen L. K., 1998, MPLUS USERS GUIDE
   Office of Population Censuses and Surveys, 1980, CLASS OCC
   Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009
   PHILLIPS BA, 1995, ARCH INTERN MED, V155, P734, DOI 10.1001/archinte.155.7.734
   Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011
   Royal Colleges of Physicians P.a.G.P., 1995, ALC HEART PERSP SENS
   Schmid SM, 2015, LANCET DIABETES ENDO, V3, P52, DOI 10.1016/S2213-8587(14)70012-9
   Schmid SM, 2011, SLEEP, V34, P371, DOI 10.1093/sleep/34.3.371
   Seaman S, 2011, WORKING PAPER, V27
   Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x
   Sherrill DL, 1998, ARCH INTERN MED, V158, P1894, DOI 10.1001/archinte.158.17.1894
   Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8
   Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003
   Suarez D, 2011, EPIDEMIOLOGY, V22, P586, DOI 10.1097/EDE.0b013e31821d0507
   Tanaka T, 2012, EUR J PUBLIC HEALTH, V22, P310, DOI 10.1093/eurpub/ckr050
   Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284
   Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4
NR 40
TC 3
Z9 3
U1 1
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD MAR 16
PY 2017
VL 17
AR 94
DI 10.1186/s12888-017-1268-4
PG 8
WC Psychiatry
SC Psychiatry
GA EO5WT
UT WOS:000396764400001
PM 28302102
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Conti, C
   Mennitto, C
   Di Francesco, G
   Fraticelli, F
   Vitacolonna, E
   Fulcheri, M
AF Conti, Chiara
   Mennitto, Chiara
   Di Francesco, Giulia
   Fraticelli, Federica
   Vitacolonna, Ester
   Fulcheri, Mario
TI Clinical Characteristics of Diabetes Mellitus and Suicide Risk
SO FRONTIERS IN PSYCHIATRY
LA English
DT Review
DE diabetes mellitus; suicidal behavior; suicidal ideation; suicide
   attempt; depression
ID CO-MORBID DEPRESSION; IDEATION; ADULTS; PREVALENCE; ADOLESCENTS;
   DISORDERS; REGIMEN; HEALTH
AB Background: Diabetes mellitus (DM) is a chronic illness with impaired health-related quality of life and a high risk of psychiatric disorders. We carried out a systematic review analyzing the relationship between DM and suicide by providing a qualitative data synthesis of the studies.
   Methods: We conducted, in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic search of the literature in PubMed, Scopus, ISI Web of Science, PsycINFO, Google Scholar, and ScienceDirect. Search terms were "suicid*" combined with the Boolean "AND" operator with "diabetes."
   Results: The initial search identified 568 citations. A total of 17 research reports met the predefined inclusion criteria and were analyzed. DM was found to be significantly associated with a marked increase in suicidal behaviors and suicidal ideation (SI), especially in patients with depressive symptoms. Insulin therapy, DM of long duration, and unsatisfactory glycemic control were identified as risk factors for SI in Type 1 (T1DM) and Type 2 (T2DM).
   Conclusion: Health-care professionals need to be aware of the higher suicidal risk in patient subgroups based on the clinical characteristics of DM; thus, patients with these characteristics warrant special attention. In this regard, clinical management should include efforts to manage emotional distress in DM care.
C1 [Conti, Chiara; Mennitto, Chiara; Di Francesco, Giulia; Fulcheri, Mario] Univ G Annunzio Chieti Pescara, Dept Psychol Hlth & Territorial Sci, Chieti, Italy.
   [Fraticelli, Federica; Vitacolonna, Ester] Univ G Annunzio Chieti Pescara, Dept Med & Aging, Chieti, Italy.
RP Conti, C (reprint author), Univ G Annunzio Chieti Pescara, Dept Psychol Hlth & Territorial Sci, Chieti, Italy.
EM cconti@unich.it
OI Fulcheri, Mario/0000-0002-2389-9800
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Amer NRY, 2014, ISSUES MENT HEALTH N, V35, P864, DOI 10.3109/01612840.2014.917752
   [Anonymous], 2016, DIABETES CARE S1, pS1, DOI DOI 10.2337/DC16-S001
   Ausili Davide, 2014, Prof Inferm, V67, P180, DOI 10.7429/pi.2014.673180
   Avci D, 2013, RENAL FAILURE, V35, P863, DOI 10.3109/0886022X.2013.801299
   Bai YM, 2013, J AFFECT DISORDERS, V150, P57, DOI 10.1016/j.jad.2013.02.019
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Ceretta LB, 2012, ACTA DIABETOL, V49, pS227, DOI 10.1007/s00592-012-0435-9
   Chung JH, 2014, J PSYCHOSOM RES, V77, P457, DOI 10.1016/j.jpsychores.2014.08.008
   Conti C, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00113
   Corathers SD, 2013, PEDIATRICS, V132, pE1395, DOI 10.1542/peds.2013-0681
   Davis WA, 2015, INTERN MED J, V45, P976, DOI 10.1111/imj.12853
   Fornaro M, 2010, WORLD J BIOL PSYCHIA, V11, P991, DOI 10.3109/15622975.2010.491126
   Fuller-Thomson Esme, 2009, Diabetes Res Clin Pract, V83, pe9, DOI 10.1016/j.diabres.2008.10.004
   Gois C, 2012, J AFFECT DISORDERS, V142, pS67, DOI 10.1016/S0165-0327(12)70010-1
   Goldston DB, 1997, J AM ACAD CHILD PSY, V36, P1528, DOI 10.1016/S0890-8567(09)66561-8
   Han SJ, 2013, DIABETES RES CLIN PR, V101, pE14, DOI 10.1016/j.diabres.2013.06.012
   Handley TE, 2016, DIABETIC MED, V33, P1582, DOI 10.1111/dme.13022
   Lee HY, 2014, J PSYCHOSOM RES, V76, P275, DOI [10.1016/j.jpsychores2014.02.003, 10.1016/j.jpsychores.2014.02.003]
   Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006
   Lofman S, 2012, J PSYCHOSOM RES, V73, P268, DOI 10.1016/j.jpsychores.2012.08.002
   Martino M, 2012, CURR NEUROPHARMACOL, V10, P97, DOI 10.2174/157015912800604542
   Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006
   Myers AK, 2013, PSYCHONEUROENDOCRINO, V38, P2810, DOI 10.1016/j.psyneuen.2013.06.013
   Pompili M, 2009, PSYCHOSOMATICS, V50, P16, DOI 10.1176/appi.psy.50.1.16
   Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002
   Radobuljac MD, 2009, PEDIATR DIABETES, V10, P424, DOI 10.1111/j.1399-5448.2009.00501.x
   Roy A, 2010, PSYCHIAT RES, V179, P53, DOI 10.1016/j.psychres.2010.06.004
   Sarkar P, 2006, Indian J Psychiatry, V48, P78, DOI 10.4103/0019-5545.31594
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Westling S, 2004, PSYCHIAT RES, V129, P249, DOI 10.1016/j.psychres.2004.09.004
   World Health Organization, 2012, PUBL HLTH ACT PREV S
NR 32
TC 3
Z9 3
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-0640
J9 FRONT PSYCHIATRY
JI Front. Psychiatry
PD MAR 13
PY 2017
VL 8
AR 40
DI 10.3389/fpsyt.2017.00040
PG 7
WC Psychiatry
SC Psychiatry
GA EN4PP
UT WOS:000395989700001
PM 28348533
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Delaney, G
   Newlyn, N
   Pamplona, E
   Hocking, SL
   Glastras, SJ
   McGrath, RT
   Fulcher, GR
AF Delaney, Grace
   Newlyn, Neroli
   Pamplona, Elline
   Hocking, Samantha L.
   Glastras, Sarah J.
   McGrath, Rachel T.
   Fulcher, Gregory R.
TI Identification of Patients With Diabetes Who Benefit Most From a Health
   Coaching Program in Chronic Disease Management, Sydney, Australia, 2013
SO PREVENTING CHRONIC DISEASE
LA English
DT Article
ID QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT; DISTRESS
   SCALE; GLYCEMIC CONTROL; EMPOWERMENT; MELLITUS; PEOPLE; INTERVENTIONS;
   COMPLICATIONS
AB Introduction
   Chronic disease management programs (CDMPs) that include health coaching can facilitate and coordinate diabetes management. The aim of this study was to assess changes in patients' general knowledge of diabetes, self-reported health status, diabetes distress, body mass index (BMI), and glycemic control after enrollment in a face-to-face CDMP group health coaching session (with telephone follow-up) compared with participation in telephone-only health coaching, during a 12-month period.
   Methods
   Patients with diabetes were enrolled in a health coaching program at Royal North Shore Hospital, Sydney, Australia, in 2013. Questionnaires were administered at baseline and at 3, 6, and 12 months, and the results were compared with baseline. Glycemic control, measured with glycated hemoglobin A(1c) (HbA(1c)) and BMI, were measured at baseline and 12 months.
   Results
   Overall, 238 patients attended a face-to-face CDMP session with telephone follow-up (n = 178) or participated in telephone-only health coaching (n = 60). We found no change in BMI in either group; however, HbA(1c) levels in patients with baseline above the current recommended target (>7%) decreased significantly from 8.5% (standard deviation [SD], 1.0%) to 7.9% (SD, 1.0%) (P = .03). Patients with the lowest self-reported health status at baseline improved from 4.4 (SD, 0.5) to 3.7 (SD, 0.9) (P = .001). Diabetes knowledge improved in all patients (24.4 [SD, 2.4] to 25.2 [SD, 2.4]; P <.001), and diabetes distress decreased among those with the highest levels of distress at baseline (3.0 [SD, 0.4] vs 3.8 [SD, 0.6]; P = .003).
   Conclusion
   Diabetes health coaching programs can improve glycemic control and reduce diabetes distress in patients with high levels of these at baseline.
C1 [Delaney, Grace; Newlyn, Neroli; Pamplona, Elline; Hocking, Samantha L.; Glastras, Sarah J.; McGrath, Rachel T.; Fulcher, Gregory R.] Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, Level 3,Acute Serv Bldg, Sydney, NSW 2065, Australia.
   [Hocking, Samantha L.; McGrath, Rachel T.; Fulcher, Gregory R.] Univ Sydney, Royal North Shore Hosp, Northern Clin Sch, St Leonards, NSW 2065, Australia.
   [Hocking, Samantha L.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.
   [Glastras, Sarah J.; McGrath, Rachel T.] Univ Sydney, Kolling Inst Med Res, Royal North Shore Hosp, St Leonards, NSW 2065, Australia.
RP McGrath, RT (reprint author), Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, Level 3,Acute Serv Bldg, Sydney, NSW 2065, Australia.
EM rachel.mcgrath@sydney.edu.au
OI McGrath, Rachel/0000-0003-3453-058X; Hocking,
   Samantha/0000-0002-2514-9392; Glastras, Sarah/0000-0002-9317-1348
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Beverly EA, 2013, DIABETES CARE, V36, P1501, DOI 10.2337/dc12-2110
   Davis TME, 2012, DIABETES CARE, V35, P2005, DOI 10.2337/dc12-0225
   Dennis SM, 2013, AUST HEALTH REV, V37, P381, DOI 10.1071/AH13005
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Forlani G, 2006, J ENDOCRINOL INVEST, V29, P405, DOI 10.1007/BF03344123
   Glasgow RE, 2001, DIABETES SPECTRUM, V14, P33, DOI DOI 10.2337/DIASPECT.14.1.33
   HealthStats NSW, SOC IND AR SEIFA LOC
   Hill-Briggs F, 2005, DIABETES CARE, V28, P443, DOI 10.2337/diacare.28.2.443
   Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2
   Kueh YC, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0303-8
   Lai PSM, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-18
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   NSW Agency for Clinical Innovation, NSW CHRON DIS MAN PR
   Pibernik-Okanovic M, 2004, PATIENT EDUC COUNS, V52, P193, DOI 10.1016/S0738-3991(03)00038-7
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Schmitt A, 2016, DIABETIC MED, V33, P835, DOI 10.1111/dme.12887
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Steed L, 2003, PATIENT EDUC COUNS, V51, P5, DOI 10.1016/S0738-3991(02)00213-6
   The Australian Government Department of Health, CHRON DIS MAN
   Trento M, 2004, DIABETES CARE, V27, P670, DOI 10.2337/diacare.27.3.670
   University of Adelaide, 2011, N W AD HLTH STUD HLT
   Wattana C, 2007, NURS HEALTH SCI, V9, P135, DOI 10.1111/j.1442-2018.2007.00315.x
   Wayne N, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4871
   Wong-Rieger D, 2013, CAN J DIABETES, V37, P41, DOI 10.1016/j.jcjd.2013.01.001
NR 28
TC 3
Z9 3
U1 2
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-1151
J9 PREV CHRONIC DIS
JI Prev. Chronic Dis.
PD MAR
PY 2017
VL 14
AR E21
DI 10.5888/pcd14.160504
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EW4IQ
UT WOS:000402465600002
PM 28253473
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Cummings, DM
   Lutes, LD
   Littlewood, K
   Solar, C
   Hambidge, B
   Gatlin, P
AF Cummings, Doyle M.
   Lutes, Lesley D.
   Littlewood, Kerry
   Solar, Chelsey
   Hambidge, Bertha
   Gatlin, Peggy
TI IMPACT OF DISTRESS REDUCTION ON BEHAVIORAL CORRELATES AND A1C IN AFRICAN
   AMERICAN WOMEN WITH UNCONTROLLED TYPE 2 DIABETES: RESULTS FROM EMPOWER
SO ETHNICITY & DISEASE
LA English
DT Article
DE Diabetes-related Distress; A1C; Glycemic Control; Self-Care;
   Self-Efficacy
ID GLYCEMIC CONTROL; MEDICATION ADHERENCE; DEPRESSIVE SYMPTOMS; SCALE;
   TRIAL; MELLITUS; PROGRAM; STRESS
AB Objective: Symptoms of emotional distress related to diabetes have been associated with inadequate self-care behaviors, medication non-adherence, and poor glycemic control that may predispose patients to premature death. African American women, in whom diabetes is more common and social support is often insufficient, may be at particularly high risk. The objective of this study was to examine the impact of lowering diabetes-related emotional distress on glycemic control and associated behavioral correlates in rural African American women with uncontrolled type 2 diabetes (T2D).
   Design: Post-hoc analysis of prospective, randomized, controlled trial.
   Setting: Rural communities in the southeastern United States.
   Patients: 129 rural middle-aged African American women with uncontrolled type 2 diabetes (T2D)(A1C >= 7.0).
   Primary Independent Variable: Diabetesrelated distress.
   Main Outcome Measures: Changes from baseline to 12-month follow-up in diabetesrelated distress, and associated changes in medication adherence, self-care activities, self-efficacy, and glycemic control (A1C).
   Results: Patients with a reduction in diabetes- related distress (n= 79) had significantly greater improvement in A1C, medication adherence, self-care activities, and self-efficacy compared with those in whom diabetes distress worsened or was unchanged (n= 50). Changes in distress were also significantly and inversely correlated with improvements in medication adherence, self-care activities, and self-efficacy.
   Conclusions: Among rural African American women, reductions in diabetes-related distress may be associated with lower A1C and improvements in self-efficacy, self-care behaviors, and medication adherence.
C1 [Cummings, Doyle M.; Hambidge, Bertha; Gatlin, Peggy] East Carolina Univ, Dept Family Med, Greenville, NC USA.
   [Cummings, Doyle M.; Hambidge, Bertha; Gatlin, Peggy] East Carolina Univ, Dept Publ Hlth, Greenville, NC USA.
   [Cummings, Doyle M.; Hambidge, Bertha; Gatlin, Peggy] East Carolina Univ, Ctr Hlth Dispar, Greenville, NC USA.
   [Lutes, Lesley D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.
   [Littlewood, Kerry] Univ S Florida, Sch Social Work, Tampa, FL USA.
   [Solar, Chelsey] East Carolina Univ, Dept Psychol, Greenville, NC 27858 USA.
RP Cummings, DM (reprint author), East Carolina Univ, Brody Sch Med, Berbecker Distinguished Prof Rural Med, Dept Family Med, 101 Heart Dr,MS 654, Greenville, NC 27834 USA.
EM cummingsd@ecu.edu
OI CUMMINGS, DOYLE/0000-0002-8237-7885
FU Bristol-Myers Squibb Foundation's Together on Diabetes Initiative
FX The authors acknowledge the generous financial support of Bristol-Myers
   Squibb Foundation's Together on Diabetes Initiative that funded this
   study. The authors also acknowledge the substantial contributions of our
   peer advisors: Ms. J. Royal-Burgess; Ms. J. Jordan; Ms. F. Parker;, Ms.
   E. Roberson-Morning; and Ms. S. Taylor; as well as staff member Ms. T.
   Kono; research assistants: Ms. J. King; Mr. K. Quinn; Mr. E. Soto; Ms.
   L. Vines; and Ms. S. Williamson; our clinical lab assistants Mr. B.
   Gilpin; Ms. T. Davis; Ms. B. Whitehurst; Ms. N. Johnson; and Ms. J.
   Sanderson; our Research Division supporters: Ms. C. Kennedy and Ms. W.
   Wynne; and our community participants.
CR American Diabetes Association, 2016, DIABETES CARE S1, V39, pS52, DOI DOI 10.2337/DC16-S010
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Cummings DM, 2016, DIABETES CARE, V39, P101, DOI 10.2337/dc15-1174
   Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532
   Cummings DM, 2013, CONTEMP CLIN TRIALS, V36, P147, DOI 10.1016/j.cct.2013.06.006
   Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861
   Faulenbach M, 2012, DIABETIC MED, V29, P128, DOI 10.1111/j.1464-5491.2011.03431.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Littlewood K, 2015, ETHNIC DIS, V25, P193
   Lorig K, 1996, OUTCOME MEASURES HLT
   Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
NR 18
TC 0
Z9 0
U1 0
U2 6
PU INT SOC HYPERTENSION BLACKS-ISHIB
PI ATLANTA
PA 100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA
SN 1049-510X
EI 1945-0826
J9 ETHNIC DIS
JI Ethn. Dis.
PD SPR
PY 2017
VL 27
IS 2
BP 155
EP 160
DI 10.18865/ed.27.2.155
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ES8UC
UT WOS:000399831400012
PM 28439186
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Ohira, T
   Nakano, H
   Nagai, M
   Yumiya, Y
   Zhang, W
   Uemura, M
   Sakai, A
   Hashimoto, S
AF Ohira, Tetsuya
   Nakano, Hironori
   Nagai, Masato
   Yumiya, Yui
   Zhang, Wen
   Uemura, Mayu
   Sakai, Akira
   Hashimoto, Shigeatsu
CA Fukushima Hlth Management Survey
TI Changes in Cardiovascular Risk Factors After the Great East Japan
   Earthquake: A Review of the Comprehensive Health Check in the Fukushima
   Health Management Survey
SO ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH
LA English
DT Review
DE epidemiology; non-communicable diseases; population studies; social
   determinants of health; psychological/behavioral medicine
ID POWER-PLANT ACCIDENT; PSYCHOLOGICAL DISTRESS; EVACUATION; DISASTER;
   HYPERTENSION; RESIDENTS; RADIATION; DISEASE
AB The Great East Japan Earthquake occurred on March 11, 2011, and was followed by a nuclear accident at the Fukushima Daiichi Nuclear Power Plant. The government ordered a mandatory evacuation from the high radioactive concentration area in Fukushima. This evacuation may have forced many evacuees to change specific aspects of their lifestyles such as diet and physical activity, which in turn may lead to future incidence of lifestyle diseases such as cardiovascular diseases (CVDs). To address this concern, the association between the evacuation and changes in CVD risk factors before and after the disaster was examined in the Fukushima Health Management Survey. In the present study, we reviewed the results of longitudinal studies in the Fukushima Health Management Survey. The proportion of overweight/obese people and those with hypertension, diabetes mellitus, dyslipidemia, liver dysfunction, atrial fibrillation, and polycythemia increased after the disaster. Furthermore, the evacuation was associated with an increase of these cardiovascular risk factors. Therefore, evacuees may be more disposed to CVDs such as myocardial infarction and stroke after the disaster. The prevention of future CVDs among evacuees from Fukushima requires ongoing preventive programs for obesity, hypertension, diabetes mellitus, and dyslipidemia, in collaboration with local governments and communities.
C1 [Ohira, Tetsuya; Nakano, Hironori; Nagai, Masato; Yumiya, Yui; Zhang, Wen; Uemura, Mayu; Sakai, Akira; Hashimoto, Shigeatsu] Fukushima Med Univ, Fukushima, Japan.
   [Nagai, Masato] Tohoku Univ, Sendai, Miyagi, Japan.
RP Ohira, T (reprint author), Fukushima Med Univ, Sch Med, Dept Epidemiol, Hikarigaoka 1, Fukushima 9601295, Japan.
EM teoohira@fmu.ac.jp
FU National Health Fund for Children and Adults Affected by the Nuclear
   Incident
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the National Health Fund for Children and Adults
   Affected by the Nuclear Incident for the research, authorship, and/or
   publication of this article.
CR Aoki T, 2012, EUR HEART J, V33, P2796, DOI 10.1093/eurheartj/ehs288
   Batelaan NM, 2016, BRIT J PSYCHIAT, V208, P223, DOI 10.1192/bjp.bp.114.156554
   Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0
   Hashimoto S, 2017, J ATHEROSCLER THROMB, V24, P327, DOI 10.5551/jat.35824
   Kario K, 1998, J Epidemiol, V8, P131
   Kario K, 2012, CIRC J, V76, P553, DOI 10.1253/circj.CJ-11-1510
   Kitamura T, 2013, NEW ENGL J MED, V369, P2165, DOI 10.1056/NEJMc1306058
   Kunii Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158821
   Nagai Masato, 2016, Nihon Koshu Eisei Zasshi, V63, P3, DOI 10.11236/jph.63.1_3
   Nishina M, 2011, J ATHEROSCLER THROMB, V18, P396, DOI 10.5551/jat.6692
   Noda H, 2005, J AM COLL CARDIOL, V46, P1761, DOI 10.1016/j.jacc.2005.07.038
   Nozaki E, 2013, INT HEART J, V54, P247, DOI 10.1536/ihj.54.247
   Oe M, 2016, PSYCHIAT CLIN NEUROS, V70, P245, DOI 10.1111/pcn.12387
   Ohira T, 2016, HYPERTENSION, V68, P558, DOI 10.1161/HYPERTENSIONAHA.116.07499
   Ohira T, 2016, AM J PREV MED, V50, P553, DOI 10.1016/j.amepre.2015.10.008
   Ohira T, 2010, J EPIDEMIOL, V20, P185, DOI 10.2188/jea.JE20100011
   Sakai A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1318
   Satoh H, 2015, J DIABETES RES, V2015, DOI DOI 10.1155/2015/627390
   Satoh H, 2016, INTERNAL MED, V55, P1967, DOI 10.2169/internalmedicine.55.6030
   Suzuki H, 2015, INT J CARDIOL, V198, P102, DOI 10.1016/j.ijcard.2015.06.151
   Suzuki Y, 2015, B WORLD HEALTH ORGAN, V93, P598, DOI 10.2471/BLT.14.146498
   Swerdel JN, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001354
   Takahashi A, J EPIDEMIOL, DOI [10.1016/j.je.2016.05.006, DOI 10.1016/J.JE.2016.05.006]
   Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1
   Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105
   Yoshimura E, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0203-8
NR 26
TC 7
Z9 8
U1 2
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1010-5395
EI 1941-2479
J9 ASIA-PAC J PUBLIC HE
JI Asia-Pac. J. Public Health
PD MAR
PY 2017
VL 29
SU 2
BP 47S
EP 55S
DI 10.1177/1010539517695436
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ER7ZD
UT WOS:000399033600007
PM 28330394
DA 2019-01-08
ER

PT J
AU Iturralde, E
   Weissberg-Benchell, J
   Hood, KK
AF Iturralde, Esti
   Weissberg-Benchell, Jill
   Hood, Korey K.
TI Avoidant Coping and Diabetes-Related Distress: Pathways to Adolescents'
   Type 1 Diabetes Outcomes
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE Type 1 diabetes; adolescents; diabetes distress; avoidant coping;
   longitudinal mediation
ID METABOLIC-CONTROL; GLYCEMIC CONTROL; COMMITMENT THERAPY; LONGITUDINAL
   DATA; SELF-CARE; CHILDREN; INTERVENTIONS; ADAPTATION; TRIAL; ASSOCIATION
AB Objective: Adolescents with Type 1 diabetes (T1D) are vulnerable to diabetes-related distress and often struggle to complete self-management tasks needed to maintain blood glucose values in target range. One way that youth with T1D handle problems is through avoidant coping. The current study examined cross-time associations between avoidant coping style and diabetes outcomes and tested the possible mediating role of diabetes-related distress. Method: Adolescents with T1D (N = 264) were assessed 4 times over 1 year to measure avoidant coping style, diabetes-related distress, adherence (on the basis of glucometer data and self-report), and glycemic control (hemoglobin A1c). Mediation and direct effects were tested across time using time-lagged autoregressive path models, making use of the repeated measurement of all constructs. Results: The hypothesized mediation effect was found for all 3 diabetes outcomes. Higher levels of avoidant coping style were associated with greater diabetes-related distress at the subsequent time point, which was related in turn to fewer blood glucose checks, less frequent self-care behaviors, and poorer glycemic control (higher A1c) at the next assessment. Conclusions: In the context of diabetes, an avoidant coping style may contribute to greater diabetes-specific distress followed by deterioration in self-management and glycemic control over time. Maladaptive coping styles are modifiable factors that offer an entry point into intervention before further difficulties can take hold.
C1 [Iturralde, Esti; Hood, Korey K.] Stanford Univ, Sch Med, Dept Pediat, 780 Welch Rd,MC 5776, Palo Alto, CA 94304 USA.
   [Weissberg-Benchell, Jill] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA.
   [Hood, Korey K.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA USA.
RP Hood, KK (reprint author), Stanford Univ, Sch Med, Dept Pediat, 780 Welch Rd,MC 5776, Palo Alto, CA 94304 USA.
EM kkhood@stanford.edu
OI Iturralde, Esti/0000-0001-6837-4998
FU National Institutes of Health [NIH R01 DK 090030]
FX We are grateful to the adolescents who generously participated in the
   study. We also thank the following staff members who worked tirelessly
   to enroll and retain participants: Sarah Hanes, Aneta Jedraszko, Paige
   Staudenmaier, and Sarah Woods. This research was supported by (National
   Institutes of Health) NIH R01 DK 090030 (Jill Weissberg-Benchell, Korey
   K. Hood, PIs).
CR American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS33, DOI 10.2337/dc15-S009
   Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558
   Corathers SD, 2013, PEDIATRICS, V132, pE1395, DOI 10.1542/peds.2013-0681
   D'Zurilla T., 2002, SOCIAL PROBLEM SOLVI
   Davidson M, 2004, APPL NURS RES, V17, P72, DOI 10.1016/j.apnr.2004.02.006
   DELAMATER AM, 1987, J DEV BEHAV PEDIATR, V8, P136
   Graue M, 2004, DIABETES CARE, V27, P1313, DOI 10.2337/diacare.27.6.1313
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   GREY M, 1991, NURS RES, V40, P144
   Hadlandsmyth K, 2013, INT J BEHAV CONSULTA, V7, P12, DOI DOI 10.1037/H0100960
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   HANSON CL, 1989, J CONSULT CLIN PSYCH, V57, P644, DOI 10.1037//0022-006X.57.5.644
   Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006
   Hill-Briggs F, 2006, J BEHAV MED, V29, P69, DOI 10.1007/s10865-005-9037-0
   Hilliard ME, 2011, DIABETES RES CLIN PR, V94, P39, DOI 10.1016/j.diabres.2011.05.027
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Hood KK, 2010, DIABETES CARE, V33, P1658, DOI 10.2337/dc09-2268
   Hood KK, 2009, PEDIATRICS, V124, pE1171, DOI 10.1542/peds.2009-0207
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huang IC, 2014, QUAL LIFE RES, V23, P747, DOI 10.1007/s11136-013-0607-2
   Jaser SS, 2011, CHILD CARE HLTH DEV, V37, P335, DOI 10.1111/j.1365-2214.2010.01184.x
   Jaser SS, 2014, J PEDIATR PSYCHOL, V39, P306, DOI 10.1093/jpepsy/jst081
   Jaser SS, 2012, ANN BEHAV MED, V43, P311, DOI 10.1007/s12160-012-9343-z
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Mortensen HB, 1997, DIABETES CARE, V20, P714, DOI 10.2337/diacare.20.5.714
   Murphy HR, 2006, DIABETIC MED, V23, P935, DOI 10.1111/j.1464-5491.2005.01816.x
   Muthen L. K., 2012, MPLUS USERS GUIDE
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   REID GJ, 1994, J DEV BEHAV PEDIATR, V15, P327
   Seiffge-Krenke I, 2003, J ADOLESCENT HEALTH, V33, P180, DOI 10.1016/S1054-139X(02)00707-3
   Selig JP, 2009, RES HUM DEV, V6, P144, DOI 10.1080/15427600902911247
   Serlachius AS, 2016, J HEALTH PSYCHOL, V21, P1157, DOI 10.1177/1359105314547940
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   Siu AL, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4467
   Swain J, 2015, J CONTEXT BEHAV SCI, V4, P73, DOI 10.1016/j.jcbs.2015.02.001
   Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520
   The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, 2000, NEW ENGL J MED, V342L, P381, DOI DOI 10.1056/NEJM200002103420603
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977
   Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Weissberg-Benchell J, 2016, CONTEMP CLIN TRIALS, V49, P78, DOI 10.1016/j.cct.2016.05.006
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   WEISSBERGBENCHELL J, 1995, DIABETES CARE, V18, P77, DOI 10.2337/diacare.18.1.77
   Whittemore R, 2010, NURS OUTLOOK, V58, P242, DOI 10.1016/j.outlook.2010.05.001
   Wicksell RK, 2015, CURR OPIN PSYCHOL, V2, P1, DOI 10.1016/j.copsyc.2014.12.029
   Wysocki T, 2008, J PEDIATR PSYCHOL, V33, P875, DOI 10.1093/jpepsy/jsn024
   Wysocki Tim, 2006, Curr Diab Rep, V6, P117, DOI 10.1007/s11892-006-0022-y
NR 47
TC 10
Z9 10
U1 2
U2 11
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD MAR
PY 2017
VL 36
IS 3
BP 236
EP 244
DI 10.1037/hea0000445
PG 9
WC Psychology, Clinical; Psychology
SC Psychology
GA EN4UN
UT WOS:000396002500006
PM 27808528
DA 2019-01-08
ER

PT J
AU Siaw, MYL
   Tai, BWB
   Lee, JYC
AF Siaw, Melanie Yee Lee
   Tai, Bik-Wai Bilvick
   Lee, Joyce Yu-Chia
TI Psychometric properties of the Chinese version of the Problem Areas in
   Diabetes scale (SG-PAID-C) among high-risk polypharmacy patients with
   uncontrolled type 2 diabetes in Singapore
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Quality of life; Type 2 diabetes mellitus; Validation studies
ID EMOTIONAL DISTRESS; VALIDITY; QUESTIONNAIRE; RELIABILITY; DEPRESSION;
   ANXIETY; STRESS; HEALTH
AB Aims/Introduction: Undetected diabetes distress is a cause of concern. However, the lack of a validated questionnaire is a barrier to screening for diabetes distress. The aim of the present study was to examine the validity and reliability of the Chinese version of the Problem Areas in Diabetes scale (SG-PAID-C), and its association with sociodemographic and clinical parameters in patients with type 2 diabetes.
   Materials and Methods: This cross-sectional study was carried out in four outpatient healthcare institutions in Singapore. Chinese-speaking patients with uncontrolled type 2 diabetes, polypharmacy, and multiple comorbidities were administered the SG-PAID-C and European Quality of Life-5 Dimensions questionnaires as quality of life measures. The factorial construct, convergent validity and internal consistency of SG-PAID-C were evaluated.
   Results: The exploratory factor analysis resulted in a three-factor structure of SG-PAID-C with subscales on emotional-and management-related problem (11 items), ability to cope with diabetes problem (3 items) and support-related problem (2 items). The findings also showed good model fit in the confirmatory factor analysis, and provided support for the construct and convergent validity of SG-PAID-C. Overall, the internal consistency of SG-PAID-C was good (Cronbach's alpha = 0.900). Sex and duration of diabetes were positively associated with the 16-item SG-PAID-C, whereas age and type of antidiabetic agents were inversely associated with the 16-item SG-PAID-C.
   Conclusions: The 16-item SG-PAID-C is a valid and reliable instrument for use among patients with uncontrolled type 2 diabetes in Singapore. Future studies on its clinical utility should be carried out.
C1 [Siaw, Melanie Yee Lee; Lee, Joyce Yu-Chia] Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore, Singapore.
   [Tai, Bik-Wai Bilvick] Caritas Bianchi Coll Careers, Sch Hlth Sci, Caritas Inst Higher Educ, Hong Kong, Hong Kong, Peoples R China.
RP Lee, JYC (reprint author), Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore, Singapore.; Tai, BWB (reprint author), Caritas Bianchi Coll Careers, Sch Hlth Sci, Caritas Inst Higher Educ, Hong Kong, Hong Kong, Peoples R China.
EM btai@cihe.edu.hk; phalycj@nus.edu.sg
OI Siaw, Melanie/0000-0003-0546-0287; Tai, Bik-Wai
   Bilvick/0000-0002-4017-334X
FU Health Service Research Competitive Research Grant from Singapore
   Ministry of Health [HSRG/11MAY/016]
FX The authors thank Yii-Jen Lew, Elaine Tan and Soo Chung Chan for their
   support in the study. This study was funded by a Health Service Research
   Competitive Research Grant from Singapore Ministry of Health (grant
   number: HSRG/11MAY/016).
CR Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Ascher-Svanum H, 2015, DIABETES THER, V6, P303, DOI 10.1007/s13300-015-0118-y
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Denneboom W, 2006, BRIT J GEN PRACT, V56, P504
   Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222
   Field A., 2009, DISCOVERING STAT USI
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   Huis v EM, 2011, CARDIOVASC PSYCHIAT, V2011
   International Diabetes Federation, 2015, IDF DIABETES ATLAS
   Lee KH, 2015, ANN OCCUP ENVIRON ME, V27, DOI 10.1186/s40557-015-0075-y
   Lim MCC, 2008, ANN ACAD MED SINGAP, V37, P753
   Luo N, 2003, ANN ACAD MED SINGAP, V32, P685
   Luo N, 2014, PHARMACOECONOMICS, V32, P495, DOI 10.1007/s40273-014-0142-1
   Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003
   Miller ST, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-70
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   Papathanasiou A, 2014, J PSYCHIATR MENT HLT, V21, P345, DOI 10.1111/j.1365-2850.2012.01875.x
   Phan TP, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000012
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110
   Schmitt A, 2016, DIABETIC MED, V33, P835, DOI 10.1111/dme.12887
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Sperlich S, 2015, SOC SCI MED, V131, P58, DOI 10.1016/j.socscimed.2015.03.001
   Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd
   Tol Azar, 2015, J Educ Health Promot, V4, P9, DOI 10.4103/2277-9531.151903
   Vathsala A, 2007, ANN ACAD MED SINGAP, V36, P157
   Venkataraman K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136759
   West Christina, 2002, Br J Community Nurs, V7, P606
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 37
TC 1
Z9 1
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD MAR
PY 2017
VL 8
IS 2
BP 235
EP 242
DI 10.1111/jdi.12556
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EQ4PB
UT WOS:000398059100016
PM 27461266
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Uchendu, C
   Blake, H
AF Uchendu, C.
   Blake, H.
TI Effectiveness of cognitive-behavioural therapy on glycaemic control and
   psychological outcomes in adults with diabetes mellitus: a systematic
   review and meta-analysis of randomized controlled trials
SO DIABETIC MEDICINE
LA English
DT Review
ID GROUP TRAINING CBGT; PANIC DISORDER; DEPRESSION; INTERVENTION; ANXIETY;
   PREVALENCE; CBT; PSYCHOTHERAPY; MANAGEMENT; LIFE
AB Aim Diabetes is a chronic progressive condition presenting physical, social and psychological challenges that increase the risk of comorbid mental health problems. Cognitive-behavioural therapy (CBT) is effective in treating a variety of psychological disorders, and may potentially improve glycaemic control and psychological outcomes in diabetes. This systematic review and meta-analysis aims to establish the effectiveness of CBT on glycaemic control and comorbid diabetes-related distress, depression, anxiety and quality of life in the short, medium and longer term among adults with diabetes.
   Method An electronic search was conducted in PubMed, Embase, MEDLINE, PsycINFO, CINAHL, Web of Knowledge, Cochrane Central Register of Controlled Trials and references in reviews. Twelve randomized controlled trials (RCTs) were identified that evaluated the effectiveness of CBT on at least one of: glycaemic control, diabetes-related distress, anxiety, depression or quality of life in adults with Type 1 or Type 2 diabetes. The Cochrane Risk of Bias Tool and Review Manager version 5.3 were used for risk of bias assessment and meta-analysis, respectively.
   Results CBT is effective in reducing short-term and medium-term glycaemic control, although no significant effect was found for long-term glycaemic control. CBT improved short-and medium-term anxiety and depression, and long-term depression. Mixed results were found for diabetes-related distress and quality of life.
   Conclusion CBT is beneficial in improving depression for adults with diabetes. It may have benefits for improving glycaemic control and other aspects of psychological health, although the findings are inconclusive.
C1 [Uchendu, C.; Blake, H.] Univ Nottingham, Sch Hlth Sci, Nottingham, England.
RP Uchendu, C (reprint author), Univ Nottingham, Sch Hlth Sci, Nottingham, England.
EM ntxcou@nottingham.ac.uk
CR Alam R, 2009, PATIENT EDUC COUNS, V75, P25, DOI 10.1016/j.pec.2008.08.026
   Ali Naseer, 2013, J Assoc Physicians India, V61, P619
   Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andrews G, 2011, AUST NZ J PSYCHIAT, V45, P337, DOI 10.3109/00048674.2010.538840
   [Anonymous], 2015, LANCET DIABETES ENDO, V3, P393
   Balhara Yatan Pal Singh, 2011, Indian J Endocrinol Metab, V15, P274, DOI 10.4103/2230-8210.85579
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Beltman MW, 2010, BRIT J PSYCHIAT, V197, P11, DOI 10.1192/bjp.bp.109.064675
   Bergstrom J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-54
   Borkovec TD, 2001, J CLIN PSYCHIAT, V62, P37
   Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003
   Chen SM, 2012, INT J NURS STUD, V49, P637, DOI 10.1016/j.ijnurstu.2011.11.011
   Chew BH, 2014, WORLD J DIABETES, V5, P796, DOI 10.4239/wjd.v5.i6.796
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Davazdahemamy M, 2009, IRAN J ENDOCRIN META, V11, P385
   Davazdahemamy MH, 2012, IRAN J CLIN PSYCHOL, V1
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Elliott S, 2012, PRACT DIABETES, V29, P67, DOI 10.1002/pdi.1661
   Fairburn CG, 2003, BEHAV RES THER, V41, P509, DOI 10.1016/S0005-7967(02)00088-8
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Gois C, 2014, CLIN PSYCHOL PSYCHOT, V21, P39, DOI 10.1002/cpp.1817
   Gois CJ, 2012, ACTA DIABETOL, V49, pS33, DOI 10.1007/s00592-010-0191-7
   Granath Jens, 2006, Cognitive Behaviour Therapy, V35, P3, DOI 10.1080/16506070500401292
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Henry JL, 1997, PSYCHOL HEALTH MED, V2, P109
   Higgins JP, 2011, COCHRANE HDB SYSTEMA
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008
   Kiropoulos LA, 2008, J ANXIETY DISORD, V22, P1273, DOI 10.1016/j.janxdis.2008.01.008
   Kroenke K, 2003, INT J METH PSYCH RES, V12, P34, DOI 10.1002/mpr.140
   Llorente MD, 2007, PSYCHIAT DISORDERS D
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   National Institute for Health and Care Excellence (NICE), 2007, DEPR MAN DEPR PRIM S
   Paschalides C, 2004, J PSYCHOSOM RES, V57, P557, DOI 10.1016/j.jpsychores.2004.03.006
   Penckofer SM, 2012, ANN BEHAV MED, V44, P192, DOI 10.1007/s12160-012-9377-2
   Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9
   Polit D.F., 2014, ESSENTIALS NURSING R
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   Simon GE, 2010, PSYCHIAT SERV, V61, P684, DOI 10.1176/ps.2010.61.7.684
   Simos G., 2014, COGNITIVE BEHAV THER
   Snoek FJ, 2008, DIABETIC MED, V25, P1337, DOI 10.1111/j.1464-5491.2008.02595.x
   Snoek F. J., 1999, DIABETES SPECTRUM, V12, P147
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Turner J., 2010, J DIABETES NURSING, V14, P86
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   Wampold BE, 2002, J AFFECT DISORDERS, V68, P159, DOI 10.1016/S0165-0327(00)00287-1
   Wang MY, 2008, J CLIN NURS, V17, P2524, DOI 10.1111/j.1365-2702.2008.02301.x
   Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502
   Welschen LMC, 2013, J BEHAV MED, V36, P556, DOI 10.1007/s10865-012-9451-z
   Welschen LMC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-74
   Westbrook D., 2008, INTRO COGNITIVE BEHA
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
NR 56
TC 8
Z9 9
U1 4
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD MAR
PY 2017
VL 34
IS 3
BP 328
EP 339
DI 10.1111/dme.13195
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EP5FK
UT WOS:000397404200004
PM 27472405
DA 2019-01-08
ER

PT J
AU Schmitt, A
   Reimer, A
   Hermanns, N
   Kulzer, B
   Ehrmann, D
   Krichbaum, M
   Huber, J
   Haak, T
AF Schmitt, Andreas
   Reimer, Andre
   Hermanns, Norbert
   Kulzer, Bernhard
   Ehrmann, Dominic
   Krichbaum, Michael
   Huber, Jorg
   Haak, Thomas
TI Depression is linked to hyperglycaemia via suboptimal diabetes
   self-management: A cross-sectional mediation analysis
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Depressive symptoms; Mood disorder; HbA(1c); Hyperglycaemia Diabetes
   self-care; Mediation
ID CO-MORBID DEPRESSION; GLYCEMIC CONTROL; CLINICAL DEPRESSION; SYMPTOMS;
   DISTRESS; METAANALYSIS; TYPE-1; ADULTS; ASSOCIATION; PREVALENCE
AB Objective: To analyse if the association between depressive symptoms and hyperglycaemia is mediated by diabetes self-management.
   Methods: 430 people with diabetes (57.7% type 1, 42.3% type 2) were cross-sectionally assessed using validated self-report scales for depressive symptoms (Center for Epidemiologic Studies Depression Scale (CES-D)) and diabetes self-management (Diabetes Self-Management Questionnaire (DSMQ)); HbA(1c) was analysed simultaneously in a central laboratory. Structural equation modelling was used to test if the association between depressive symptoms and hyperglycaemia (HbA(1c)) was mediated by suboptimal self-management in people with type 1 and type 2 diabetes.
   Results: The hypothesised model of depressive symptoms, diabetes self-management and hyperglycaemia fit the data well for both diabetes types (SRMR <= 0.04, TLI >= 0.99, CFI > 0.99, RMSEA <= 0.02 for both models). In both the type I and type 2 diabetes group, higher depressive symptoms were associated with lower self-management (P < 0.001) and lower self-management was associated with higher HbAi, (P < 0.001). Results indicated that the association between depressive symptoms and hyperglycaemia was significantly mediated by suboptimal diabetes self-management in both type 1 and type 2 diabetes patients (P < 0.001). Significant direct associations between depressive symptoms and hyperglycaemia, not mediated by self-management, could not be observed.
   Conclusions: This study provides good evidence supporting that depression is linked to hyperglycaemia via suboptimal diabetes self-management in both major diabetes types.(C) 2016 Elsevier Inc All rights reserved.
C1 [Schmitt, Andreas; Reimer, Andre; Hermanns, Norbert; Kulzer, Bernhard; Ehrmann, Dominic; Krichbaum, Michael; Haak, Thomas] Res Inst Diabet Acad Mergentheim FIDAM, Johann Hammer Str 24, D-97980 Bad Mergentheim, Germany.
   [Schmitt, Andreas; Reimer, Andre; Hermanns, Norbert; Kulzer, Bernhard; Ehrmann, Dominic; Krichbaum, Michael; Haak, Thomas] Diabet Ctr Mergentheim DZM, Theodor Klotzbucher Str 12, D-97980 Bad Mergentheim, Germany.
   [Schmitt, Andreas; Reimer, Andre; Hermanns, Norbert; Kulzer, Bernhard] German Ctr Diabet Res DZD, D-85764 Munich, Germany.
   [Hermanns, Norbert; Kulzer, Bernhard] Otto Friedrich Univ Bamberg, Dept Psychol, Markuspl 3, D-96047 Bamberg, Germany.
   [Huber, Jorg] Univ Brighton, Ctr Hlth Res, Falmer BN1 9PH, England.
RP Schmitt, A (reprint author), Diabet Acad Mergentheim FIDAM, Res Inst, Theodor Klotzbuecher Str 12, D-97980 Bad Mergentheim, Germany.
EM schmitt@diabetes-zentrum.de; reimer@diabetes-zentrum.de;
   hermanns@diabetes-zentrum.de; kulzer@diabetes-zentrum.de;
   ehrmann@diabetes-zentrum.de; krichbaum@diabetes-zentrum.de;
   J.Huber@brighton.ac.uk; haak@diabetes-zentrum.de
OI Ehrmann, Dominic/0000-0002-5794-5596; Krichbaum,
   Michael/0000-0002-5937-1266; Schmitt, Andreas/0000-0002-5913-1457
FU Federal Ministry of Education and Research [01G11107]; German Center for
   Diabetes Research (DZD) [82DZD01101]
FX This work was supported by the "Kompetenznetz Diabetes mellitus
   (Competence Network for Diabetes mellitus)" of the Federal Ministry of
   Education and Research [grant number 01G11107] and the German Center for
   Diabetes Research (DZD) [grant number 82DZD01101].
CR Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Chiu CJ, 2010, SOC PSYCH PSYCH EPID, V45, P67, DOI 10.1007/s00127-009-0043-3
   Clouse RE, 2003, PSYCHOSOM MED, V65, P376, DOI 10.1097/01.PSY.0000041624.96580.1F
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Cole DA, 2007, PSYCHOL METHODS, V12, P381, DOI 10.1037/1082-989X.12.4.381
   Dirmaier J, 2010, PSYCHOTHER PSYCHOSOM, V79, P172, DOI 10.1159/000296135
   Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356
   Egede LE, 2010, DIABETES EDUCATOR, V36, P276, DOI 10.1177/0145721710361389
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gohel MG, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-56
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hautzinger M, 2012, ADS ALLGEMEINE DEPRE
   Hofmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079809
   Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037//1082-989X.3.4.424
   Kenny D. A., 2016, MEDIATION
   Laake JPS, 2014, DIABETES CARE, V37, P2186, DOI 10.2337/dc13-2522
   Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037//0882-7974.12.2.277
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lustman PJ, 2005, PSYCHOSOM MED, V67, P195, DOI 10.1097/01.psy.0000155670.88919.ad
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McGrady ME, 2009, DIABETES CARE, V32, P804, DOI 10.2337/dc08-2111
   Osborn CY, 2010, DIABETES TECHNOL THE, V12, P913, DOI 10.1089/dia.2010.0058
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   Pibernik-Okanovic M, 2008, DIABETIC MED, V25, P1252, DOI 10.1111/j.1464-5491.2008.02553.x
   Richardson LK, 2008, GEN HOSP PSYCHIAT, V30, P509, DOI 10.1016/j.genhosppsych.2008.07.001
   Schmitt A., 2014, P 50 EASD ANN M SEP
   Schmitt A., 2013, DIABETOLOGIE STOF S1, V8, P77
   Schmitt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150774
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001
   Templeton GF, 2011, COMMUN ASSOC INF SYS, V28, P41
   TOOBERT DJ, 1994, HDB PSYCHOL DIABETES, P351
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
NR 41
TC 9
Z9 10
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD MAR
PY 2017
VL 94
BP 17
EP 23
DI 10.1016/jjpsychores.2016.12.015
PG 7
WC Psychiatry
SC Psychiatry
GA EL4AK
UT WOS:000394562100003
PM 28183398
DA 2019-01-08
ER

PT J
AU Yoong, RKL
   Mooppil, N
   Khoo, EYH
   Newman, SP
   Lee, VYW
   Kang, AWC
   Griva, K
AF Yoong, Russell K. L.
   Mooppil, Nandakumar
   Khoo, Eric Y. H.
   Newman, Stanton P.
   Lee, Vanessa Y. W.
   Kang, Augustine W. C.
   Griva, Konstadina
TI Prevalence and determinants of anxiety and depression in end stage renal
   disease (ESRD). A comparison between ESRD patients with and without
   coexisting diabetes mellitus
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Anxiety; Depression; Diabetes mellitus; End-stage renal disease
ID PSYCHOLOGICAL DISTRESS; PERITONEAL-DIALYSIS; SYMPTOMS; METAANALYSIS;
   INTERVENTION; HEMODIALYSIS; MORTALITY; OUTCOMES; ADULTS
AB Objective: To compare anxiety and/or depressive symptoms between patients with end-stage renal disease with and without comorbid diabetes and identify factors associated with symptoms of distress in this population.
   Methods: Data from two studies (conducted between 2010 and 2014) were pooled. A total of 526 patients on hemodialysis (68.8% with diabetes) completed the Hospital Anxiety and Depression Scale (HADS). Elevated symptoms were defined as HADS-Anxiety or HADS-Depression >= 8. Univariate and multivariate logistic regressions were used to estimate associations between diabetic status, and other socio-demographic and clinical factors with baseline clinical anxiety and depression.
   Results: A total of 233 (45.4%) reported elevated anxiety symptoms and 256 (49.9%) reported elevated depressive symptoms sufficient for caseness. Rates were not different between patients with and without diabetes. Risk for clinical depression was higher in patients who were single/unpartnered (OR = 1.828), Chinese vs. Malay (OR = 2.05), or had lower albumin levels (OR = 0.932). None of the parameters were associated with anxiety caseness.
   Conclusion: Sociocultural factors rather than comorbid burden may help identify patients at risk for depression. The high rates of anxiety and depression underlie the importance for monitoring and intervention in dialysis care. (C) 2017 Elsevier Inc.All rights reserved.
C1 [Yoong, Russell K. L.; Lee, Vanessa Y. W.; Kang, Augustine W. C.; Griva, Konstadina] Natl Univ Singapore, Dept Psychol, Singapore, Singapore.
   [Mooppil, Nandakumar] Natl Kidney Fdn Singapore, Singapore, Singapore.
   [Khoo, Eric Y. H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
   [Khoo, Eric Y. H.] Natl Univ Hlth Syst, Univ Med Cluster, Div Endocrinol, Singapore, Singapore.
   [Newman, Stanton P.] City Univ London, London, England.
RP Griva, K (reprint author), Natl Univ Singapore, Dept Psychol, Singapore, Singapore.
EM psygk@nus.edu.sg
RI Griva, Konstadina/A-6549-2018
FU Venerable Yen Pei National Kidney Foundation Research Fund
   [NKFRC2008/07/24, NKFRC2013/01/20]; Ministry of Education - NUS Academic
   Research Fund [FY2007-FRC5-006]
FX This research was supported by grants from the Venerable Yen Pei
   National Kidney Foundation Research Fund (NKFRC2008/07/24 and
   NKFRC2013/01/20) and the Ministry of Education - NUS Academic Research
   Fund (FY2007-FRC5-006). The authors also thank Dr. Tonia Griva, the NKF
   Health Care Professionals, Senior Renal Nurse Clinicians and Medical
   Social Workers from the Care and Counselling department and all
   respondents for their support in the programme.
CR Alavi NM, 2009, TRANSPL P, V41, P3693, DOI 10.1016/j.transproceed.2009.06.217
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BENTELSPACHER CE, 1994, FAM SOC-J CONTEMP H, V75, P287, DOI 10.1177/104438949407500504
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Blake M., 1992, GROWING OLD MALAY CO, DOI [10.1080/21650993.1993.9755647., DOI 10.1080/21650993.1993.9755647]
   Bossola M, 2010, GEN HOSP PSYCHIAT, V32, P125, DOI 10.1016/j.genhosppsych.2009.10.009
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Cheung E., 1986, PSYCHOL CHINESE PEOP, P171
   Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008
   Feng L, 2013, AM J GERIAT PSYCHIAT, V21, P570, DOI 10.1016/j.jagp.2012.12.020
   Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528
   Gould CE, 2016, INT J GERIATR PSYCH, V31, P1105, DOI 10.1002/gps.4532
   Griva K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007253
   Griva K, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-4
   Griva K, 2010, J PSYCHOSOM RES, V69, P363, DOI 10.1016/j.jpsychores.2010.04.008
   Griva K, 2014, PSYCHOSOM MED, V76, pA84
   Hudson JL, 2015, CARDIO RENAL CLIN CH, P227, DOI [10.1007/978-3-319-09162-4_22, DOI 10.1007/978-3-319-09162-4_22]
   Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7
   National Registry of Diseases Office, 2014, TRENDS CHRON KIDN FA
   NEFF JA, 1993, J COMMUNITY PSYCHOL, V21, P3, DOI 10.1002/1520-6629(199301)21:1<3::AID-JCOP2290210102>3.0.CO;2-9
   Palmer S, 2013, KIDNEY INT, V84, P179, DOI 10.1038/ki.2013.77
   Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055
   Salsberg E, 2015, US NEPHROLOGY WORKFO
   Tanvir S., 2013, PREVALENCE DEPRESSIO
   Turkistani I, 2014, RENAL FAILURE, V36, P1510, DOI 10.3109/0886022X.2014.949761
   van Dijk S, 2013, J PSYCHOSOM RES, V74, P511, DOI 10.1016/j.jpsychores.2013.03.001
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Willingham F, 2012, J REN CARE, V38, P40, DOI 10.1111/j.1755-6686.2012.00283.x
   Ye XQ, 2008, J PSYCHOSOM RES, V65, P157, DOI 10.1016/j.jpsychores.2008.04.007
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 30
TC 6
Z9 6
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD MAR
PY 2017
VL 94
BP 68
EP 72
DI 10.1016/jjpsychores.2017.01.009
PG 5
WC Psychiatry
SC Psychiatry
GA EL4AK
UT WOS:000394562100010
PM 28183405
DA 2019-01-08
ER

PT J
AU Garvey, KC
   Foster, NC
   Agarwal, S
   DiMeglio, LA
   Anderson, BJ
   Corathers, SD
   Desimone, ME
   Libman, IM
   Lyons, SK
   Peters, AL
   Raymond, JK
   Laffel, LM
AF Garvey, Katharine C.
   Foster, Nicole C.
   Agarwal, Shivani
   DiMeglio, Linda A.
   Anderson, Barbara J.
   Corathers, Sarah D.
   Desimone, Marisa E.
   Libman, Ingrid M.
   Lyons, Sarah K.
   Peters, Anne L.
   Raymond, Jennifer K.
   Laffel, Lori M.
TI Health Care Transition Preparation and Experiences in a US National
   Sample of Young Adults With Type 1 Diabetes
SO DIABETES CARE
LA English
DT Article
ID EMERGING ADULTS; ADOLESCENTS; MELLITUS; SYSTEMS; DISTRESS; PEOPLE;
   COHORT; YOUTH
AB OBJECTIVE
   Young adults with type 1 diabetes transitioning from pediatric to adult care are at risk for adverse outcomes. We developed a survey to evaluate transition experiences in two groups of young adults with type 1 diabetes, before (PEDS) and after (ADULT) transition to adult care.
   RESEARCH DESIGN AND METHODS
   We fielded an electronic survey to young adults (18 to < 30 years) at 60 T1D Exchange Clinic Registry centers.
   RESULTS
   Surveys were completed by 602 young adults, 303 in the PEDS group (60% female, age 20 6 2 years) and 299 in the ADULT group (62% female, age 24 6 3 years). In the PEDS group, mean anticipated transition age was 22 62 years; 64% remained in pediatric care because of emotional attachment to the provider. The ADULT group transitioned at age 19 6 2 years, mainly after pediatric provider recommendation. More than 80% of respondents reported receiving counseling on type 1 diabetes self-management and screening tests from pediatric providers, but less than half (43% PEDS and 33% ADULT) reported discussing reproductive health. In the PEDS group, half had discussed transfer with pediatric providers. Of the ADULT participants, 63% received an adult provider referral, and 66% felt mostly/ completely prepared to transition. ADULT participants with fewer pretransition pediatric visits orwho felt unprepared for transition had increased odds of gaps > 6 months between pediatric and adult care. Receipt of transition preparation counseling was not associated with self-reported hemoglobin A1c < 7.0% in either group.
   CONCLUSIONS
   These results support the need for intensive efforts to integrate transition preparation counseling and care coordination into pediatric type 1 diabetes care.
C1 [Garvey, Katharine C.] Boston Childrens Hosp, Boston, MA USA.
   [Foster, Nicole C.] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA.
   [Agarwal, Shivani] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [DiMeglio, Linda A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
   [Anderson, Barbara J.; Lyons, Sarah K.] Baylor Coll Med, Houston, TX 77030 USA.
   [Corathers, Sarah D.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.
   [Corathers, Sarah D.] Univ Cincinnati, Cincinnati, OH USA.
   [Desimone, Marisa E.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Libman, Ingrid M.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA.
   [Peters, Anne L.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA.
   [Raymond, Jennifer K.] Barbara Davis Ctr Diabet, Aurora, CO USA.
   [Laffel, Lori M.] Joslin Diabet Ctr, Boston, MA 02215 USA.
RP Foster, NC (reprint author), Jaeb Ctr Hlth Res, Tampa, FL 33647 USA.
EM t1dstats@jaeb.org
OI Lyons, Sarah/0000-0002-3686-0112
FU Leona M. and Harry B. Helmsley Charitable Trust; National Institute for
   Diabetes and Digestive and Kidney Diseases [K23-DK-102655,
   K12-DK-094721]
FX Funding was provided by The Leona M. and Harry B. Helmsley Charitable
   Trust. K.C.G.'s work on this study was also supported by the National
   Institute for Diabetes and Digestive and Kidney Diseases (K23-DK-102655
   and K12-DK-094721).
CR Agarwal S, 2016, PEDIAT DIABETES, DOI [10.1111/pedi.12436, DOI 10.1111/PEDI.12436]
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Beck RW, 2012, J CLIN ENDOCR METAB, V97, P4383, DOI 10.1210/jc.2012-1561
   BLUM RW, 1993, J ADOLESCENT HEALTH, V14, P570, DOI 10.1016/1054-139X(93)90143-D
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536
   Busse FP, 2007, HORM RES, V67, P132, DOI 10.1159/000096583
   Cadario F, 2009, CLIN ENDOCRINOL, V71, P346, DOI 10.1111/j.1365-2265.2008.03467.x
   Charron-Prochownik D, 2006, DIABETES EDUCATOR, V32, P235, DOI 10.1177/0145721706286895
   Cooley WC, 2011, PEDIATRICS, V128, P182, DOI DOI 10.1542/PEDS.2011-0969
   Fernandes SM, 2014, J PEDIATR REHAB MED, V7, P43, DOI 10.3233/PRM-140269
   Garvey KC, 2012, DIABETES CARE, V35, P1716, DOI 10.2337/dc11-2434
   Helgeson VS, 2013, DIABETIC MED, V30, P610, DOI 10.1111/dme.12067
   Hilliard ME, 2014, DIABETES CARE, V37, P346, DOI 10.2337/dc13-1346
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Holmes-Walker DJ, 2007, DIABETIC MED, V24, P764, DOI 10.1111/j.1464-5491.2007.02152.x
   Jacobson AM, 1997, J PEDIATR-US, V131, P727, DOI 10.1016/S0022-3476(97)70101-X
   Kipps S, 2002, DIABETIC MED, V19, P649, DOI 10.1046/j.1464-5491.2002.00757.x
   La Greca AM, 1988, 9 ANN SESS SOC BEH M, pA42
   LAGRECA AM, 2003, HDB PEDIAT PSYCHOL, P119
   Laing SP, 2005, DIABETES CARE, V28, P1618, DOI 10.2337/diacare.28.7.1618
   Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x
   Lotstein DS, 2013, PEDIATRICS, V131, pE1062, DOI 10.1542/peds.2012-1450
   Lotstein DS, 2010, PEDIATRICS, V126, pS129, DOI 10.1542/peds.2010-1466F
   Nakhla M, 2009, PEDIATRICS, V124, pE1134, DOI 10.1542/peds.2009-0041
   Pacaud D, 2005, CAN J DIABETES, V29, P13, DOI DOI 10.2337/DC07-1249
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Raymond Jennifer K, 2013, Diabetes Manag (Lond), V3, DOI 10.2217/dmt.13.27
   Ritholz MD, 2014, DIABETES EDUCATOR, V40, P40, DOI 10.1177/0145721713513177
   Sawicki GS, 2011, PEDIATRICS, V128, pE521, DOI 10.1542/peds.2010-3017
   Van Walleghem N, 2008, DIABETES CARE, V31, P1529, DOI 10.2337/dc07-2247
   Waitzfelder B, 2011, PEDIATRICS, V128, P531, DOI 10.1542/peds.2010-3641
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Weissberg-Benchell J, 2007, DIABETES CARE, V30, P2441, DOI 10.2337/dc07-1249
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wills CJ, 2003, BRIT MED J, V327, P260, DOI 10.1136/bmj.327.7409.260
NR 37
TC 8
Z9 8
U1 1
U2 5
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2017
VL 40
IS 3
BP 317
EP 324
DI 10.2337/dc16-1729
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EM7UZ
UT WOS:000395519100010
PM 28007779
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Paika, V
   Andreoulakis, E
   Ntountoulaki, E
   Papaioannou, D
   Kotsis, K
   Siafaka, V
   Fountoulakis, KN
   Pargament, KI
   Carvalho, AF
   Hyphantis, T
AF Paika, Vassiliki
   Andreoulakis, Elias
   Ntountoulaki, Elisavet
   Papaioannou, Dimitra
   Kotsis, Konstantinos
   Siafaka, Vassiliki
   Fountoulakis, Konstantinos N.
   Pargament, Kenneth I.
   Carvalho, Andre F.
   Hyphantis, Thomas
CA ASSERT-DEP Study Grp
TI The Greek-Orthodox version of the Brief Religious Coping (B-RCOPE)
   instrument: psychometric properties in three samples and associations
   with mental disorders, suicidality, illness perceptions, and quality of
   life
SO ANNALS OF GENERAL PSYCHIATRY
LA English
DT Article
DE Religious coping; Religiousness; Mental disorder; Depression; Anxiety;
   Suicidal risk; Illness perceptions; Quality of life; Psychometric
   properties; Chronic illness
ID ILL ELDERLY-PATIENTS; PSYCHOLOGICAL DISTRESS; EMERGENCY-DEPARTMENT;
   OLDER-ADULTS; SPIRITUAL STRUGGLE; INITIAL VALIDATION; MEDICAL
   CONDITIONS; ANXIETY DISORDERS; LIKERT VARIABLES; ADVANCED CANCER
AB Background: The B-RCOPE is a brief measure assessing religious coping. We aimed to assess the psychometric properties of its Greek version in people with and without long-term conditions (LTCs). Associations between religious coping and mental illness, suicidality, illness perceptions, and quality of life were also investigated.
   Methods: The B-RCOPE was administered to 351 patients with diabetes, chronic pulmonary obstructive disease (COPD), and rheumatic diseases attending either the emergency department (N = 74) or specialty clinics (N = 302) and 127 people without LTCs. Diagnosis of mental disorders was established by the MINI. Associations with depressive symptom severity (PHQ-9), suicidal risk (RASS), illness perceptions (B-IPQ), and health-related quality of life (WHOQOL-BREF) were also investigated.
   Results: The Greek version of B-RCOPE showed a coherent two-dimensional factor structure with remarkable stability across the three samples corresponding to the positive (PRC) and negative (NRC) religious coping dimensions. Cronbach's alphas were 0.91-0.96 and 0.77-0.92 for the PRC and NRC dimensions, respectively. Furthermore, NRC was associated with poorer mental health, greater depressive symptom severity and suicidality, and impaired HRQoL. In patients with LTCs, PRC correlated with lower perceived illness timeline, while NRC was associated with greater perceived illness consequences, lower perceived treatment control, greater illness concern, and lower illness comprehensibility.
   Conclusions: These findings indicate that the Greek-Orthodox B-RCOPE version may reliably assess religious coping. In addition, negative religious coping (i.e., religious struggle) is associated with adverse illness perceptions, and thus may detrimentally impact adaptation to medical illness. These findings deserve replication in prospective studies.
C1 [Paika, Vassiliki; Ntountoulaki, Elisavet; Papaioannou, Dimitra; Kotsis, Konstantinos; Hyphantis, Thomas] Univ Ioannina, Fac Med, Sch Hlth Sci, Dept Psychiat, GR-45110 Ioannina, Greece.
   [Andreoulakis, Elias; Fountoulakis, Konstantinos N.] Aristotle Univ Thessaloniki, Sch Med, Dept Psychiat 3, Thessaloniki, Greece.
   [Siafaka, Vassiliki] Technol Educ Inst Epirus, Dept Speech & Language Therapy, Ioannina, Greece.
   [Pargament, Kenneth I.] Bowling Green State Univ, Dept Psychol, Bowling Green, OH 43403 USA.
   [Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
RP Hyphantis, T (reprint author), Univ Ioannina, Fac Med, Sch Hlth Sci, Dept Psychiat, GR-45110 Ioannina, Greece.
EM tyfantis@cc.uoi.gr
RI Fountoulakis, Konstantinos/N-6990-2017
OI Andreoulakis, Elias/0000-0001-7067-9467; Hyphantis,
   Thomas/0000-0002-7647-4312
FU European Economic Area (EEA) Financial Mechanism [EEA GR07/3767];
   National funds, program "Dissimilarity, Inequality and Social
   Integration" [132324/I4-25/8/2015]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq; Brazil)
FX The project "ASSessing and Enhancing Resilience To DEPression in people
   with long term medical conditions in the era of the current Greek social
   and financial crisis (ASSERT-DEP)" has been co-financed by the European
   Economic Area (EEA) Financial Mechanism 2009-2014 (EEA GR07/3767) and
   National funds as part of the program "Dissimilarity, Inequality and
   Social Integration" (Grant number: 132324/I4-25/8/2015). The funding
   source had no involvement in study design; in the collection, analysis,
   and interpretation of data; in the writing of the report; and in the
   decision to submit the article for publication.; AFC is supported by a
   research scholarship award from the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq; Brazil).
CR Abiary M, 2010, CONT PSYCHOLY, V93, P81
   Ai AL, 2009, PSYCHOL RELIG SPIRIT, V1, P112, DOI 10.1037/a0015775
   Ai AL, 2010, J HEALTH PSYCHOL, V15, P186, DOI 10.1177/1359105309345556
   Al-Hadethe A, 2014, J RELIG HLTH J RELIG, V55, P16
   ALTMAN DG, 1991, PRACTICAL STAT MED R, P285
   Ano GG, 2005, J CLIN PSYCHOL, V61, P461, DOI 10.1002/jclp.20049
   Bay PS, 2008, J RELIG HEALTH, V47, P57, DOI 10.1007/s10943-007-9131-4
   Berger D, 2015, SPAN J PSYCHOL, V19, pE3
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Broadbent E, 2015, PSYCHOL HEALTH, V30, P1361, DOI 10.1080/08870446.2015.1070851
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Ford D, 2010, CHEST, V138, P59, DOI 10.1378/chest.09-2124
   Fountoulakis KN, 2012, J AFFECT DISORDERS, V138, P449, DOI 10.1016/j.jad.2011.12.045
   Freitas TH, 2015, REV BRAS PSIQUIATR, V37, P219, DOI 10.1590/1516-4446-2014-1507
   Ginieri-Coccossis M, 2012, Psychiatriki, V23, P130
   Goulia P, 2012, J PSYCHOSOM RES, V72, P120, DOI 10.1016/j.jpsychores.2011.11.011
   Hill PC, 2003, AM PSYCHOL, V58, P64, DOI 10.1037/0003-066X.58.1.64
   Hyphantis T, 2015, J AFFECT DISORDERS, V176, P155, DOI 10.1016/j.jad.2015.01.062
   Hyphantis T, 2014, COMPR PSYCHIAT, V55, P1950, DOI 10.1016/j.comppsych.2014.08.042
   Hyphantis T, 2011, ARTHRIT CARE RES, V63, P1313, DOI 10.1002/acr.20505
   Ibrahim N, 2012, ASIAN SOCIAL SCI, V8, P23, DOI [10.5539/ass.v8n9p23, DOI 10.5539/ASS.V8N9P23]
   Ironson G, 2016, J GEN INTERN MED, V31, P1068, DOI 10.1007/s11606-016-3668-4
   Khalaf DR, 2015, J RELIG HEALTH, V54, P1438, DOI 10.1007/s10943-014-9981-5
   Koenig HG, 2010, RELIGIONS, V1, P78, DOI 10.3390/rel1010078
   Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502
   Koenig HG, 1998, J NERV MENT DIS, V186, P513, DOI 10.1097/00005053-199809000-00001
   Lawrence RE, 2016, ARCH SUICIDE RES, V20, P1, DOI 10.1080/13811118.2015.1004494
   Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219
   Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753
   Lorenzo-Seva U, 1999, MULTIVAR BEHAV RES, V34, P347, DOI 10.1207/S15327906MBR3403_3
   Lorenzo-Seva U, 2013, APPL PSYCH MEAS, V37, P497, DOI 10.1177/0146621613487794
   Moreira-Almeida A, 2006, REV BRAS PSIQUIATR, V28, P242, DOI 10.1590/S1516-44462006000300018
   MUTHEN B, 1985, BRIT J MATH STAT PSY, V38, P171, DOI 10.1111/j.2044-8317.1985.tb00832.x
   MUTHEN B, 1992, BRIT J MATH STAT PSY, V45, P19, DOI 10.1111/j.2044-8317.1992.tb00975.x
   Ng GC, 2016, J RELIG HLTH, V10, P1
   Ntountoulaki E, 2016, COMPR PSYCHIAT, V69, P193, DOI 10.1016/j.comppsych.2016.06.010
   Papadimitriou GN, 2004, GREEK TRANSLATION MI
   Pargament K. I., 1997, PSYCHOL RELIG COPING
   Pargament K. I., 2005, INT J PSYCHOL RELIG, V15, P179, DOI [10.1207/s15327582ijpr1503_1, DOI 10.1207/S15327582IJPR1503_1]
   Pargament K, 2011, RELIGIONS, V2, P51, DOI 10.3390/rel2010051
   Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.3.CO;2-T
   Pargament KI, 1998, J SCI STUD RELIG, V37, P710, DOI 10.2307/1388152
   Pargament KI, 2004, SOUTH MED J, V97, P1201, DOI 10.1097/01.SMJ.0000146508.14898.E2
   Pargament KI, 2004, J HEALTH PSYCHOL, V9, P713, DOI 10.1177/1359105304045366
   Pargament KI, 2001, ARCH INTERN MED, V161, P1881, DOI 10.1001/archinte.161.15.1881
   Pargament KI, 2012, RELIG COPING CURRENT
   Pearce MJ, 2006, J HEALTH PSYCHOL, V11, P743, DOI 10.1177/1359105306066629
   Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871
   Piderman KM, 2007, AM J ADDICTION, V16, P232, DOI 10.1080/10550490701375616
   Ramirez SP, 2012, J PSYCHOSOM RES, V72, P129, DOI 10.1016/j.jpsychores.2011.11.012
   Rosen E., 1958, TRANSLATION ADAPTATI
   Rosmarin DH, 2013, PSYCHIAT RES, V210, P182, DOI 10.1016/j.psychres.2013.03.023
   Rosmarin DH, 2009, J CLIN PSYCHOL, V65, P670, DOI 10.1002/jclp.20574
   Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249
   Schanowitz JY, 2006, J BEHAV MED, V29, P191, DOI 10.1007/s10865-005-9034-3
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   Shreve-Neiger AK, 2004, CLIN PSYCHOL REV, V24, P379, DOI 10.1016/j.cpr.2004.02.003
   Simonsen E., 1990, J PERSONALITY DISORD, V4, P290
   Talik EB, 2013, J RELIG HEALTH, V52, P143, DOI 10.1007/s10943-011-9464-x
   Tarakeshwar N, 2006, J PALLIAT MED, V9, P646, DOI 10.1089/jpm.2006.9.646
   Tarakeshwar N, 2003, J COMMUNITY PSYCHOL, V31, P607, DOI 10.1002/jcop.10071
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   Thune-Boyle IC, 2006, SOC SCI MED, V63, P151, DOI 10.1016/j.socscimed.2005.11.055
   Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353
   Trevino KM, 2014, PSYCHO-ONCOLOGY, V23, P936, DOI 10.1002/pon.3505
NR 65
TC 1
Z9 1
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1744-859X
J9 ANN GEN PSYCHIATR
JI Ann. Gen. Psychiatr.
PD FEB 16
PY 2017
VL 16
AR 13
DI 10.1186/s12991-017-0136-4
PG 13
WC Psychiatry
SC Psychiatry
GA EL2RF
UT WOS:000394466400001
PM 28239407
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Joensen, LE
   Willaing, I
   Holt, RIG
   Wens, J
   Skovlund, S
   Peyrot, M
AF Joensen, Lene E.
   Willaing, Ingrid
   Holt, Richard I. G.
   Wens, Johan
   Skovlund, Soren
   Peyrot, Mark
TI Household composition and psychological health: Results of the Second
   Diabetes Attitudes, Wishes and Needs (DAWN2) study
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes; Psychological health; Household composition; Social network;
   Social support
ID QUALITY-OF-LIFE; MARITAL-STATUS; GLYCEMIC CONTROL; BARRIERS; NETWORK;
   SUPPORT
AB Aims: 1) To explore the effect of household composition on the psychological health of adults with diabetes by comparing those living with other adult(s) including a partner with those living with neither partner nor other adult(s); 2) to examine potential mediation of social support in the association between household composition and psychological health.
   Methods: The study is part of the DAWN2 study conducted in 17 countries. The population comprised 8596 people with diabetes (PWD). Multiple regression models (linear and binary) were applied.
   Results: People living with 'other adult(s) but no partner' experienced significantly lower well-being, higher diabetes distress and worried more frequently about hypoglycaemic events than those with a partner or those not co-habiting with another adult. However, participants living with 'other adult(s) but no partner' were more empowered compared to the other household composition groups. The association between household composition and psychological health was not mediated by diabetes-specific social support.
   Conclusions: The study indicates the psychological vulnerability of respondents living without a partner but with other adult(s). Appropriate support interventions must be developed and tested in order to enhance psychological health in people with diabetes living with other adults such as adult children, but with no partner. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Joensen, Lene E.; Willaing, Ingrid] Steno Diabet Ctr, Gentofte, Denmark.
   [Holt, Richard I. G.] Univ South Hampton, Southampton, Hants, England.
   [Wens, Johan] Univ Antwerp, Antwerp, Belgium.
   [Skovlund, Soren] Novo Nordisk, Copenhagen, Denmark.
   [Peyrot, Mark] Loyola Univ Maryland, Baltimore, MD USA.
RP Joensen, LE (reprint author), Niels Steensens Vej 6, DK-2820 Gentofte, Denmark.
EM ljoe@steno.dk
OI Holt, Richard/0000-0001-8911-6744; Wens, Johan/0000-0002-0229-9064;
   Joensen, Lene Eide/0000-0002-4790-8759; Willaing,
   Ingrid/0000-0002-3082-8816
FU Novo Nordisk A/S
FX The DAWN2 study is funded by Novo Nordisk A/S.
CR August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Bei kman LF, 1979, AM J EPIDEMIOL, V109, P186
   Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   Due P, 1999, SOC SCI MED, V48, P661, DOI 10.1016/S0277-9536(98)00381-5
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Eller M, 2008, INT J PUBLIC HEALTH, V53, P188, DOI 10.1007/s00038-008-7091-4
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   GOVE WR, 1983, J HEALTH SOC BEHAV, V24, P122, DOI 10.2307/2136639
   Hart HE, 2003, QUAL LIFE RES, V12, P1089, DOI 10.1023/A:1026197119569
   Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889
   Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458
   Leonard Barbara J, 2005, J Pediatr Nurs, V20, P405, DOI 10.1016/j.pedn.2005.03.010
   LLOYD CE, 1993, DIABETES RES CLIN PR, V21, P187, DOI 10.1016/0168-8227(93)90068-G
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Metayer C, 1996, EUR J EPIDEMIOL, V12, P573, DOI 10.1007/BF00499455
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nilsson PM, 2005, SCAND J PUBLIC HEALT, V33, P412, DOI 10.1080/14034940510005905
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Weinger K, 2001, J ADOLESCENT HEALTH, V29, P330, DOI 10.1016/S1054-139X(01)00270-1
   WIKBY A, 1991, DIABETES RES CLIN PR, V13, P53, DOI 10.1016/0168-8227(91)90033-A
NR 27
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD FEB
PY 2017
VL 31
IS 2
BP 340
EP 346
DI 10.1016/j.jdiacomp.2016.07.006
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA ES3NA
UT WOS:000399435100008
PM 27491452
DA 2019-01-08
ER

PT J
AU Dunning, T
   Speight, J
   Bennett, C
AF Dunning, Trisha
   Speight, Jane
   Bennett, Craig
TI Language, the "Diabetes Restricted Code/Dialect," and What It Means for
   People With Diabetes and Clinicians
SO DIABETES EDUCATOR
LA English
DT Article
ID POSITION STATEMENTS
AB Purpose
   The purpose of the paper is to explore the notion of a diabetes language restricted code or "dialect" and its effect on people with diabetes. Language is a complex phenomenon comprising verbal and nonverbal components used to communicate in human interactions.
   Methods
   Information was collected from a literature review, during clinical consultations, and from an email survey.
   Results
   Language and the way clinicians use language affect motivation, behaviors, and outcomes of people with diabetes. Language is influenced by culture, experience, and familiarity with words and their use and is idiosyncratic. "Diabetes" is a particular restricted code or dialect that people with diabetes gradually learn to speak, usually after they are diagnosed with diabetes. The diabetes dialect contains many metric and target words and very few positive, encouraging words, and it is often discriminatory, negative, judgmental, labelling, distressing, and stigmatizing: for example, victim, sufferer, and lifestyle disease.
   Conclusion
   Language codes/dialects can compound the already high levels of emotional distress and self-care burden associated with living with diabetes and can affect outcomes. The information presented in this article will be useful for clinicians caring for people with diabetes and will be helpful for professionals who develop information for people with diabetes and those who create policies and guidelines.
C1 [Dunning, Trisha] Deakin Univ, Sch Nursing & Midwifery, Geelong, Vic, Australia.
   [Dunning, Trisha] Barwon Hlth, Geelong, Vic, Australia.
   [Speight, Jane] Deakin Univ, Sch Psychol, Burwood, Vic, Australia.
   [Speight, Jane] AHP Res, Hornchurch, Essex, England.
   [Speight, Jane; Bennett, Craig] Diabet Victoria, Melbourne, Vic, Australia.
RP Dunning, T (reprint author), Deakin Univ, Kitchener House,Ryrie St,POB 281, Geelong, Vic 3220, Australia.; Dunning, T (reprint author), C Univ Hosp Geelong, Barwon Hlth, Kitchener House,Ryrie St,POB 281, Geelong, Vic 3220, Australia.
EM trisha.dunning@barwonhealth.org.au
OI Speight, Jane/0000-0002-1204-6896
CR Fain JA, 2003, DIABETES EDUCATOR, V29, P880, DOI 10.1177/014572170302900601
   Fain JA, 2002, DIABETES EDUCATOR, V28, P650, DOI 10.1177/014572170202800501
   Fain JA, 2012, DIABETES EDUCATOR, V38, P14, DOI 10.1177/0145721711435220
   Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, 2011, CLIN PRACTICE GUIDEL
NR 4
TC 3
Z9 3
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD FEB
PY 2017
VL 43
IS 1
BP 18
EP 26
DI 10.1177/0145721716683449
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA EL8VB
UT WOS:000394897300002
PM 28072923
OA Bronze
DA 2019-01-08
ER

PT J
AU Powers, MA
   Richter, SA
   Ackard, DM
   Craft, C
AF Powers, Margaret A.
   Richter, Sara A.
   Ackard, Diann M.
   Craft, Cheryl
TI Diabetes Distress Among Persons With Type 1 Diabetes Associations With
   Disordered Eating, Depression, and Other Psychological Health Concerns
SO DIABETES EDUCATOR
LA English
DT Article
ID EDUCATION; CARE; SIMULATION; ADOLESCENTS; MANAGEMENT; VIGNETTE;
   CHILDREN; PARENTS; INTERVENTION; OUTCOMES
AB Purpose
   The purpose of this study is to evaluate associations between diabetes distress and a range of psychological health behaviors and concerns among persons with type 1 diabetes for the benefit of enhancing early identification and intervention of at-risk individuals.
   Methods
   Persons with type 1 diabetes (n = 268; 57.1% female, 91.0% white, 76.8% < 18 years of age, average A1C 8.4%) completed the 2-item Diabetes Distress Screening Scale (DDS2) and a battery of psychometrically sound instruments measuring satisfaction with life, self-esteem, self-efficacy, depression, perfectionism, body image satisfaction, dietary restraint and eating, and shape and weight concerns. Each subscale score was compared within age groups (< 18 years vs = 18 years) between groups (diabetes distress level [low, moderate, high]) using analysis of variance (with Bonferroni correction or the Kruskal-Wallis test if the variables were not normally distributed).
   Results
   For both age groups, high diabetes distress was independently associated with greater A1C values, higher depression scores and eating, and shape and weight concerns than those with low or moderate distress. For patients < 18 years of age, those with high diabetes distress scored lower on measures of satisfaction with life, self-esteem, and self-efficacy and higher on dietary restraint and several areas of perfectionism than those with low or moderate distress.
   Conclusions
   Individuals with type 1 diabetes who have high diabetes distress also report higher A1C values and poorer psychological health concerns. A brief diabetes distress questionnaire can help to identify those who need additional screening, education and support, and treatment for overall health and well-being.
C1 [Powers, Margaret A.] Int Diabet Ctr Pk Nicollet, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.
   [Powers, Margaret A.; Richter, Sara A.; Craft, Cheryl] Hlth Partners Inst, Minneapolis, MN USA.
   [Richter, Sara A.] Profess Data Analysts Inc, Minneapolis, MN USA.
   [Ackard, Diann M.] Off Diann M Ackard, Minneapolis, MN USA.
   [Ackard, Diann M.] Pk Nicollet Melrose Ctr, Minneapolis, MN USA.
RP Powers, MA (reprint author), Int Diabet Ctr Pk Nicollet, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.
EM margaret.powers@parknicollet.com
FU Park Nicollet Foundation
FX This work was supported by the Park Nicollet Foundation. The study is
   registered through Clinical Trials (NCT00948311;
   https://clinicaltrials.gov).
CR Ayling K, 2015, PSYCHOL HEALTH, V30, P85, DOI 10.1080/08870446.2014.953528
   Berlin KS, 2002, DIABETES EDUCATOR, V28, P809, DOI 10.1177/014572170202800521
   Bova C, 2016, NURS RES IN PRESS
   Cant R, 2013, INT J NURS PRACT, V19, P163, DOI 10.1111/ijn.12053
   Grant RW, 2009, J AM BOARD FAM MED, V22, P513, DOI 10.3122/jabfm.2009.05.080232
   Greenhalgh Trisha, 2006, Psychol Health Med, V11, P432, DOI 10.1080/13548500500429379
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Hughes P, 2015, DIABETES EDUCATOR, V41, P452, DOI 10.1177/0145721715587743
   Jiwa M, 2012, DIABETES RES CLIN PR, V95, P326, DOI 10.1016/j.diabres.2011.11.004
   Johnson M, 2005, HEALTH EXPECT, V8, P324, DOI 10.1111/j.1369-7625.2005.00344.x
   Lange K, 2014, PEDIATR DIABETES, V15, P77, DOI 10.1111/pedi.12187
   Levett-Jones Tracy, 2014, Nurse Educ Today, V34, pe58, DOI 10.1016/j.nedt.2013.09.020
   Maguire LL, 2015, DIABETES EDUCATOR, V41, P678, DOI 10.1177/0145721715607982
   Martin D, 2012, PEDIATR DIABETES, V13, P20, DOI 10.1111/j.1399-5448.2012.00909.x
   Ramchandani N, 2016, PATIENT EDUC COUNS, V99, P1362, DOI 10.1016/j.pec.2016.03.019
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Simon ACR, 2015, DIABETIC MED, V32, P69, DOI 10.1111/dme.12586
   Sullivan-Bolyai S, 2015, DIABETES EDUCATOR, V41, P537, DOI 10.1177/0145721715598383
   Sullivan-Bolyai S, 2014, ADV NURS SCI, V37, P340, DOI 10.1097/ANS.0000000000000050
   Sullivan-Bolyai S, 2012, DIABETES EDUCATOR, V38, P50, DOI 10.1177/0145721711432457
   Williamson C, 2014, POSTGRAD MED, V126, P145, DOI 10.3810/pgm.2014.05.2764
   Willis DG, 2016, WESTERN J NURS RES, V38, P1185, DOI 10.1177/0193945916645499
   Woodring B C, 2000, Pediatr Nurs, V26, P505
   Wysocki T, 2008, J PEDIATR PSYCHOL, V33, P875, DOI 10.1093/jpepsy/jsn024
NR 24
TC 1
Z9 1
U1 3
U2 16
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD FEB
PY 2017
VL 43
IS 1
BP 105
EP 113
DI 10.1177/0145721716680888
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA EL8VB
UT WOS:000394897300010
PM 27932687
DA 2019-01-08
ER

PT J
AU Jimenez, K
   Vargas, C
   Garcia, K
   Guzman, H
   Angulo, M
   Billimek, J
AF Jimenez, Krystal
   Vargas, Cristina
   Garcia, Karla
   Guzman, Herlinda
   Angulo, Marco
   Billimek, John
TI Evaluating the Validity and Reliability of the Beliefs About Medicines
   Questionnaire in Low-Income, Spanish-Speaking Patients With Diabetes in
   the United States
SO DIABETES EDUCATOR
LA English
DT Article
ID MENTAL-HEALTH ISSUES; POSITION STATEMENT; EMOTIONAL DISTRESS; GLYCEMIC
   CONTROL; EDE-Q; TYPE-1; ASSOCIATION; SCALE; CARE; ADOLESCENTS
AB Purpose
   The purpose of this study was to examine the reliability and validity of a Spanish version of the Beliefs about Medicines Questionnaire (BMQ) as a measure to evaluate beliefs about medications and to differentiate adherent from nonadherent patients among low-income Latino patients with diabetes in the United States.
   Methods
   Seventy-three patients were administered the BMQ and surveyed for evidence of medication nonadherence. Internal consistency of the BMQ was assessed by Cronbach's alpha along with performing a confirmatory factor analysis. Criterion validity was assessed by comparing mean scores on 3 subscales of the BMQ (General Overuse, General Harm, and Specific NecessityConcerns difference score) between adherent patients and patients reporting nonadherence for 3 different reasons (unintentional nonadherence, cost-related nonadherence, and nonadherence due to reasons other than cost) using independent samples t tests.
   Results
   The BMQ is a reliable instrument to examine beliefs about medications in this Spanish-speaking population. Construct validity testing shows nearly identical factor loading as the original construct map. General Overuse scores were significantly more negative for patients reporting each reason for nonadherence compared with their adherent counterparts. Necessity-Concerns difference scores were significantly more negative for patients reporting nonadherence for reasons other than cost compared with those who did not report this reason for nonadherence.
   Conclusion
   The Spanish version of the BMQ is appropriate to assess beliefs about medications in Latino patients with type 2 diabetes in the United States and may help identify patients who become nonadherent to medications for reasons other than out-of-pocket costs.
C1 [Jimenez, Krystal; Vargas, Cristina; Garcia, Karla; Guzman, Herlinda; Billimek, John] Univ Calif Irvine, Hlth Policy Res Inst, 100 Theory,Suite 110, Irvine, CA 92697 USA.
   [Billimek, John] Univ Calif Irvine, Dept Med, Div Gen Internal Med & Primary Care, Sch Med, Irvine, CA 92697 USA.
   [Billimek, John] Univ Calif Irvine, Dept Family Med, Sch Med, Irvine, CA 92697 USA.
RP Billimek, J (reprint author), Univ Calif Irvine, Hlth Policy Res Inst, 100 Theory,Suite 110, Irvine, CA 92697 USA.
EM jbillime@uci.edu
FU National Center for Research Resources; National Center for Advancing
   Translational Sciences, National Institutes of Health (NIH) [UL1
   TR001414]
FX The project described was supported by the National Center for Research
   Resources and the National Center for Advancing Translational Sciences,
   National Institutes of Health (NIH), through Grant UL1 TR001414. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIH. All authors have no
   conflicts of interest to report. Dr Billimek had full access to all of
   the data in the study and takes responsibility for the integrity of the
   data and the accuracy of the data analysis.
CR Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950
   Colton P., 2009, Diabetes Spectrum, V22, P138, DOI 10.2337/diaspect.22.3.138
   Daneman D., 2002, Diabetes Spectrum, V15, P83, DOI 10.2337/diaspect.15.2.83
   de Wit M, 2014, J CLIN PSYCHOL MED S, V21, P190, DOI 10.1007/s10880-014-9395-2
   Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Ducat L, 2015, DIABETES CARE, V38, P333, DOI 10.2337/dc14-1383
   Esbitt SA, 2013, SCREENING DEPRESSION, P27
   Fairburn C. G., 2008, COGNITIVE BEHAV THER, P308
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967
   Goebel-Fabbri AE, 2008, DIABETES CARE, V31, P415, DOI 10.2337/dc07-2026
   Goebel-Fabbri AE, 2011, DIABETES CARE, V34, P545, DOI 10.2337/dc10-1547
   Hackorth NJ, 2013, AUST PSYCHOL, V48, P360, DOI [DOI 10.1111/AP.12007, 10.1111/ap.12007]
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003
   Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Powers MA, J HLTH PSYCHOL
   Powers MA, 2016, DIABETES CARE, V39, P2101, DOI 10.2337/dc16-2085
   Powers MA, 2016, EAT DISORD, V24, P271, DOI 10.1080/10640266.2015.1090866
   Powers MA, 2015, DIABETES CARE, V38, P1372, DOI 10.2337/dc15-0730
   Powers MA, 2013, DIABETES EDUCATOR, V39, P387, DOI 10.1177/0145721713482737
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Reas DL, 2012, EAT DISORD, V20, P437, DOI 10.1080/10640266.2012.715523
   Robinson DJ, 2013, CAN J DIABETES, V37, pS87, DOI 10.1016/j.jcjd.2013.01.026
   Rose JS, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-42
   Rosenberg M, 1965, SOC ADOLESCENT SELF
   Schwarzer R, 2005, SELF EFFICACY BELIEF, P139
   Schwarzer R, 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000
   Schwarzer R., 1993, MEASUREMENT PERCEIVE
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053
   Young-Hyman DL, 2010, DIABETES CARE, V33, P683, DOI 10.2337/dc08-1077
NR 41
TC 0
Z9 1
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD FEB
PY 2017
VL 43
IS 1
BP 114
EP 124
DI 10.1177/0145721716675740
PG 11
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA EL8VB
UT WOS:000394897300011
PM 27831521
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Kreider, KE
AF Kreider, Kathryn Evans
TI Diabetes Distress or Major Depressive Disorder? A Practical Approach to
   Diagnosing and Treating Psychological Comorbidities of Diabetes
SO DIABETES THERAPY
LA English
DT Article
DE Chronic care management; Depression; Diabetes distress; Major
   depressive; disorder
ID GLYCEMIC CONTROL; TRIAL; CARE; EPIDEMIOLOGY; METAANALYSIS; SYMPTOMS;
   THERAPY; PEOPLE; ADULTS; TYPE-1
AB The presence of major depressive disorder (MDD) in people with diabetes may be up to three times more common than in the general population. People with diabetes and major depressive disorder have worse health outcomes and higher mortality rates. Diabetes distress refers to an emotional state where people experience feelings such as stress, guilt, or denial that arise from living with diabetes and the burden of self-management. Diabetes distress has also been linked to worse health outcomes. There are multiple treatment options for MDD including pharmacotherapy and cognitive behavioral approaches. Providers treating patients with diabetes must be aware of the frequent comorbidity of diabetes, diabetes distress, and depression and manage patients using a multidisciplinary team approach. This article discusses the epidemiology, pathophysiology, and bi-directional relationship of diabetes and depression and provides a practical, patient-centered approach to diagnosis and management.
C1 [Kreider, Kathryn Evans] Duke Univ, Sch Nursing, Durham, NC 27708 USA.
   [Kreider, Kathryn Evans] Duke Univ, Med Ctr, Durham, NC 27706 USA.
RP Kreider, KE (reprint author), Duke Univ, Sch Nursing, Durham, NC 27708 USA.; Kreider, KE (reprint author), Duke Univ, Med Ctr, Durham, NC 27706 USA.
EM kathryn.evans@duke.edu
CR Aikens JE, 2008, DIABETIC MED, V25, P1324, DOI 10.1111/j.1464-5491.2008.02590.x
   American Diabetes Association, 2017, DIABETES CARE S1, V40, pS39
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   de Vries M, 2016, AM J HEALTH BEHAV, V40, P503
   Egede LE, 2009, GEN HOSP PSYCHIAT, V31, P422, DOI 10.1016/j.genhosppsych.2009.06.007
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hermanns N, 2013, PRIM CARE DIABETES, V7, P1, DOI 10.1016/j.pcd.2012.11.002
   Hollander P, 2013, DIABETES CARE, V36, P4022, DOI 10.2337/dc13-0234
   Holt RG, 2014, CURRENT DIABETES REP, V14, P1
   Huang Y, 2013, INT J ADV MANUF TECH, V2013, P1
   Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lloyd CE, 2012, J AFFECT DISORDERS, V142, pS22, DOI 10.1016/S0165-0327(12)70005-8
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   McIntyre Roger S, 2007, Ann Clin Psychiatry, V19, P257, DOI 10.1080/10401230701653377
   National Collaborating Centre for Mental Health (Great Britain) and Royal College of Psychiatrists, 2011, COMM MENT HLTH DIS I
   O'Connor PJ, 2012, DIABETES CARE, V35, P1479, DOI 10.2337/dc11-1868
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rossom RC, 2017, GEN HOSP PSYCHIAT, V44, P77, DOI 10.1016/j.genhosppsych.2016.05.006
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Ye Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021551
NR 37
TC 5
Z9 6
U1 1
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1869-6953
EI 1869-6961
J9 DIABETES THER
JI Diabetes Ther.
PD FEB
PY 2017
VL 8
IS 1
BP 1
EP 7
DI 10.1007/s13300-017-0231-1
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EL0WO
UT WOS:000394342700001
PM 28160185
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Palar, K
   Napoles, T
   Hufstedler, LL
   Seligman, H
   Hecht, FM
   Madsen, K
   Ryle, M
   Pitchford, S
   Frongillo, EA
   Weiser, SD
AF Palar, Kartika
   Napoles, Tessa
   Hufstedler, Lee L.
   Seligman, Hilary
   Hecht, Fredrick M.
   Madsen, Kimberly
   Ryle, Mark
   Pitchford, Simon
   Frongillo, Edward A.
   Weiser, Sheri D.
TI Comprehensive and Medically Appropriate Food Support Is Associated with
   Improved HIV and Diabetes Health
SO JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
LA English
DT Article
DE Food; Nutrition; HIV; Diabetes; Community-based; Food security; Food
   support; Food-assistance; Intervention; Medically tailored
ID ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; SAN-FRANCISCO;
   SOCIOECONOMIC DISPARITIES; CARE UTILIZATION; GLYCEMIC CONTROL;
   SELF-MANAGEMENT; CHRONIC DISEASE; UNITED-STATES; DIET-QUALITY
AB Food insecurity is associated with negative chronic health outcomes, yet few studies have examined how providing medically appropriate food assistance to food-insecure individuals may improve health outcomes in resource-rich settings. We evaluated a communitybased food support intervention in the San Francisco Bay Area for people living with HIV and/or type 2 diabetes mellitus (T2DM) to determine the feasibility, acceptability, and potential impact of the intervention on nutritional, mental health, disease management, healthcare utilization, and physical health outcomes. The 6-month intervention provided meals and snacks designed to comprise 100% of daily energy requirements and meet nutritional guidelines for a healthy diet. We assessed paired outcomes at baseline and 6 months using validated measures. Paired t tests and McNemar exact tests were used with continuous and dichotomous outcomes, respectively, to compare pre-post changes. Fifty-two participants (out of 72 initiators) had both baseline and follow-up assessments, including 23 with HIV, 24 with T2DM, and 7 with both HIVand T2DM. Median food pick-up adherence was 93%. Comparing baseline to follow-up, very low food security decreased from 59.6% to 11.5% (p < 0.0001). Frequency of consumption of fats (p= 0.003) decreased, while frequency increased for fruits and vegetables (p = 0.011). Among people with diabetes, frequency of sugar consumption decreased (p = 0.006). We also observed decreased depressive symptoms (p = 0.028) and binge drinking (p =0.008). At follow-up, fewer participants sacrificed food for healthcare (p = 0.007) or prescriptions (p = 0.046), or sacrificed healthcare for food (p = 0.029). Among people with HIV, 95% adherence to antiretroviral therapy increased from 47 to 70% (p = 0.046). Among people with T2DM, diabetes distress (p < 0.001), and perceived diabetes self-management (p = 0.007) improved. Comprehensive, medically appropriate food support is feasible and may improve multiple health outcomes for food-insecure individuals living with chronic health conditions. Future studies should formally test the impact of medically appropriate food support interventions for food-insecure populations through rigorous, randomized controlled designs.
C1 [Palar, Kartika; Napoles, Tessa; Hufstedler, Lee L.; Hecht, Fredrick M.; Weiser, Sheri D.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA.
   [Seligman, Hilary] UCSF, San Francisco Gen Hosp, Dept Med, Div Gen Internal Med, San Francisco, CA USA.
   [Madsen, Kimberly; Ryle, Mark] Project Open Hand, San Francisco, CA USA.
   [Pitchford, Simon] Homebridge Inc, San Francisco, CA USA.
   [Frongillo, Edward A.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.
   [Weiser, Sheri D.] UCSF, Ctr AIDS Prevent Studies, San Francisco, CA USA.
   [Hufstedler, Lee L.] Univ Calif Berkeley, Sch Publ Hlth, Univ Calif Berkeley Univ Calif San Francisco Join, Berkeley, CA 94720 USA.
RP Palar, K (reprint author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA.
EM Kartika.Palar@ucsf.edu
FU Project Open Hand (POH); Burke Global Health; NIH/NIDDK [K01DK107335];
   NIH/NIMH [R01MH095683]
FX Project Open Hand (POH) provided funding for this study as an external
   evaluation, but had no role in data collection or analysis, nor in
   scientific interpretation of the data. Funding from Burke Global Health
   supported student and intern participation in data collection. The
   authors acknowledge the following sources of salary support: NIH/NIDDK
   K01DK107335 (Dr. Palar) and NIH/NIMH R01MH095683 (Dr. Weiser).
CR Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557
   [Anonymous], 2016, FOOD MED ACH TRIPL A
   [Anonymous], 2015, CAL 2015 STAT HLTH P
   Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015
   Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011
   Bickel G, 2000, GUIDE MEASURING HOUS
   Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x
   Bunn JY, 2007, AIDS EDUC PREV, V19, P198, DOI 10.1521/aeap.2007.19.3.198
   Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2
   Coleman-Jensen A, 2016, ERR215 US DEP AGR EC
   Crum-Cianflone N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010106
   Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027
   DiSantis KI, 2013, AM J PUBLIC HEALTH, V103, P516, DOI 10.2105/AJPH.2012.301149
   Drewnowski A., 2012, AM J PUBLIC HEALTH, V102, P74, DOI DOI 10.2105/AJPH.2012.300660
   Ellwood M, 2014, FOOD IS MED OPPORTUN
   GARCIA DOP, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI DOI 10.1097/00042560-200205010-00014
   Gurvey J, 2013, J PRIM CARE COMMUNIT, V4, P311, DOI 10.1177/2150131913490737
   Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10
   Ivers L., 2015, FOOD INSECURITY PUBL
   Kalichman S, 2010, J URBAN HEALTH, V87, P1
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Li R, 2013, AM J MANAG CARE, V19, P421
   Martin KS, 2013, AM J PREV MED, V45, P569, DOI 10.1016/j.amepre.2013.06.012
   Martinez H, 2014, AIDS BEHAV, V18, pS566, DOI 10.1007/s10461-014-0786-z
   McMahon JH, 2011, JAIDS-J ACQ IMM DEF, V58, P60, DOI 10.1097/QAI.0b013e318227f8dd
   Nelson K, 1998, JAMA-J AM MED ASSOC, V279, P1211, DOI 10.1001/jama.279.15.1211
   Palar K, 2016, AIDS, V30, P1457, DOI 10.1097/QAD.0000000000001095
   Palar K, 2015, AIDS CARE, V27, P409, DOI 10.1080/09540121.2014.983041
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6
   Seligman HK, 2015, HEALTH AFFAIR, V34, P1956, DOI 10.1377/hlthaff.2015.0641
   Seligman HK, 2012, DIABETES CARE, V35, P233, DOI 10.2337/dc11-1627
   Seligman HK, 2010, J HEALTH CARE POOR U, V21, P1227, DOI 10.1353/hpu.2010.0921
   Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072
   Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573
   Shannon K, 2011, AIDS, V25, P2037, DOI 10.1097/QAD.0b013e32834b35c9
   Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977
   Thompson FE, 2004, PUBLIC HEALTH NUTR, V7, P1097, DOI 10.1079/PHN2004642
   Trenkamp B, 2007, SOCIAL SECURITY B, V67
   Vogenthaler NS, 2012, AIDS BEHAV, P1
   Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y
   Wang EA, 2011, J GEN INTERN MED, V26, P1012, DOI 10.1007/s11606-011-1723-8
   Weinfield NS, 2014, HUNGER AM 2014 NATL
   Weiser S. D., 2015, FOOD INSECURITY PUBL, P23
   Weiser SD, 2013, AIDS, V27, P2953, DOI 10.1097/01.aids.0000432538.70088.a3
   Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4
   Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37
   Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070
   Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2
   Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5
   Whittle HJ, 2015, SOC SCI MED, V143, P154, DOI 10.1016/j.socscimed.2015.08.027
NR 51
TC 5
Z9 5
U1 2
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1099-3460
EI 1468-2869
J9 J URBAN HEALTH
JI J. Urban Health
PD FEB
PY 2017
VL 94
IS 1
BP 87
EP 99
DI 10.1007/s11524-016-0129-7
PG 13
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA EP5GD
UT WOS:000397406100009
PM 28097614
OA Green Published
DA 2019-01-08
ER

PT J
AU Sidhu, R
   Tang, TS
AF Sidhu, Rawel
   Tang, Tricia S.
TI Diabetes Distress and Depression in South Asian Canadians with Type 2
   Diabetes
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE depression; diabetes distress; South Asia; type 2 diabetes mellitus
AB Objectives: South Asians are disproportionately affected by diabetes compared to some other ethnic groups in Canada. Although depression and diabetes distress are psychological issues well studied in the general population of those with diabetes, they have not been investigated in South Asian Canadians with type 2 diabetes. We sought to identify the rates of depression and diabetes distress in South Asian adults with type 2 diabetes and to explore the relationship among glycemic control, depression and diabetes distress.
   Methods: We recruited 41 South Asian adults with type 2 diabetes for this study. Glycated hemoglobin (A1C) levels were collected via venous puncture. We utilized the Diabetes Distress Scale to assess total diabetes distress and its subscales (emotional distress, interpersonal distress, regimen-related distress and physician distress) and the Personal Health Questionnaire-9 to assess depressive symptoms.
   Results: The rate of depression was 15%, and the rate of total diabetes distress was 52.5%. Although neither measure was found to be correlated with A1C levels, depression had a moderate positive correlation with total diabetes distress (r=0.696; p< 0.001); subscales of regimen distress and emotional burden emerged as the strongest correlates.
   Conclusions: This is the first study to report that diabetes distress is a serious concern for South Asian Canadians with type 2 diabetes. Given that depression and diabetes distress are linked, studies recruiting a larger and more diverse sample of South Asian Canadians should be conducted to better understand the psychological issues that may impact diabetes self-management in this community. (C) 2016 Canadian Diabetes Association.
C1 [Sidhu, Rawel] Univ British Columbia, Fac Sci, Dept Med, Vancouver, BC, Canada.
   [Tang, Tricia S.] Univ British Columbia, Div Endocrinol, Vancouver, BC, Canada.
RP Sidhu, R (reprint author), 7675 Prince Albert St, Vancouver, BC V5X 3Z3, Canada.
EM rawel95@gmail.com
FU Vancouver General Hospital University of British Columbia Foundation
   Grant; Azad and Yasmin Shamji family
FX This study was supported by a Vancouver General Hospital University of
   British Columbia Foundation Grant and was financially sponsored by the
   Azad and Yasmin Shamji family.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Ali S, 2009, POSTGRAD MED J, V85, P238, DOI 10.1136/pgmj.2008.074641
   Aujla N, 2010, DIABETIC MED, V27, P896, DOI 10.1111/j.1464-5491.2010.03042.x
   Aujla N, 2009, PLOS ONE, V411, pe7755
   Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2013, DIAB MENT HLTH
   Clayton D, 2013, CAN J DIABETES, V37, pS69, DOI 10.1016/j.jcjd.2013.01.022
   Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551
   Ell K, 2015, GEN HOSP PSYCHIAT, V37, P414, DOI 10.1016/j.genhosppsych.2015.05.010
   Fisher L, 2007, DIABETES CARE, V30, P2746, DOI 10.2337/dc07-1166
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Hessler D, 2015, DIABETES RES CLIN PR, V108, P360, DOI 10.1016/j.diabres.2014.12.017
   Imran SA, 2013, CAN J DIABETES, V37, pS31, DOI 10.1016/j.jcjd.2013.01.016
   Islam MR, 2013, INT J MED BIOMED RES, V2, P113, DOI DOI 10.14194/IJMBR.224
   Ke C, 2015, DIABETIC MED, V32, P487, DOI 10.1111/dme.12657
   Leyva B, 2011, ETHNIC DIS, V21, P322
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   Pinkington FB, 2010, CAN J DIABETES, V342, P119
   RAPHAEL D, 2003, LEADERSHIP HLTH SERV, V16, P10
   Rastogi PP, 2014, ASIAN J PSYCHIAT, V71, P15
   Shah BR, 2008, J PUBLIC HEALTH-UK, V30, P327, DOI 10.1093/pubmed/fdn042
   Statistics Canada, 2011, IMM ETHN DIV CAN
   Tang T, 2014, CAN J DIABETES, V385, pS31
   Williams ED, 2015, PSYCHOL MED, V45, P1861, DOI 10.1017/S0033291714002967
NR 24
TC 3
Z9 3
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD FEB
PY 2017
VL 41
IS 1
BP 69
EP 72
DI 10.1016/j.jcjd.2016.07.008
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EO7VY
UT WOS:000396899400011
PM 27745846
DA 2019-01-08
ER

PT J
AU Strandberg, RB
   Graue, M
   Wentzel-Larsen, T
   Peyrot, M
   Wahl, AK
   Rokne, B
AF Strandberg, Ragnhild B.
   Graue, Marit
   Wentzel-Larsen, Tore
   Peyrot, Mark
   Wahl, Astrid K.
   Rokne, Berit
TI The relationships among fear of hypoglycaemia, diabetes-related quality
   of life and psychological well-being in Norwegian adults with Type 1
   diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes-related quality of life; Fear of hypoglycaemia; Psychological
   well-being; Type 1 diabetes; Mediation analysis
ID DEPRESSIVE SYMPTOMS; DISTRESS; PERCEPTIONS; MEDIATION; SUBSCALE;
   VERSION; ISSUES; IMPACT
AB Aims: To examine the associations among fear of hypoglycaemia, diabetes- related quality of life and psychological well- being, and determine whether diabetes- related quality of life is a mediator of the relationship between fear of hypoglycaemia and psychological wellbeing in adults with Type 1 diabetes.
   Methods: A total of 235 of 319 invited adults (8-69 years) with Type 1 diabetes agreed to participate. Hierarchical linear regression was applied to 188 individuals with complete data. Mediation analysis was used to determine whether diabetes- related quality of life mediated the relationship between fear of hypoglycaemia and psychological well-being.
   Results: Fear of hypoglycaemia was significantly associated with diabetes-related quality of life and psychological well-being. The behaviour and worry components of fear of hypoglycaemia were significantly associated with diabetes-related quality of life (behaviour component: unstandardised coefficient = -0.04, p < 0.001, standardised coefficient = -0.40; worry component: unstandardised coefficient = -0.01, p = 0.041, standardised coefficient = -0.18). Fear of hypoglycaemia worry had a significant independent association with psychological well-being (unstandardised coefficient = -0.28, p = 0.009, standardised coefficient = -0.25), whereas fear of hypoglycaemia behaviour did not. Diabetes-related quality of life mediated approximately half of the association between fear of hypoglycaemia worry and psychological well-being.
   Conclusions: Hypoglycaemic episodes can have serious consequences, and assessing fear of hypoglycaemia might help health care providers offer suitable care strategies to individuals with Type 1 diabetes. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Strandberg, Ragnhild B.; Graue, Marit; Peyrot, Mark] Bergen Univ Coll, Ctr Evidence Based Practice, POB 7030, N-5020 Bergen, Norway.
   [Strandberg, Ragnhild B.; Rokne, Berit] Univ Bergen, Fac Med & Dent, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
   [Graue, Marit] Haukeland Hosp, Dept Paediat, Bergen, Norway.
   [Wentzel-Larsen, Tore] Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway.
   [Wentzel-Larsen, Tore] Ctr Child & Adolescent Mental Hlth, Eastern & Southern Norway, Oslo, Norway.
   [Wentzel-Larsen, Tore] Haukeland Hosp, Clin Res Ctr, Bergen, Norway.
   [Peyrot, Mark] Loyola Univ Maryland, Dept Sociol, Baltimore, MD USA.
   [Wahl, Astrid K.] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway.
   [Rokne, Berit] Haukeland Hosp, Dept Res & Dev, Bergen, Norway.
RP Strandberg, RB (reprint author), Bergen Univ Coll, Ctr Evidence Based Practice, POB 7030, N-5020 Bergen, Norway.
EM Ragnhild.Bjarkoy.Strandberg@hib.no
FU Bergen University College
FX The data collection was funded by Bergen University College. The funding
   source had no involvement in the study design, the data collection,
   analysis, interpretation and writing, or in the decision to submit the
   article for publication.
CR Anderbro T, 2008, PATIENT EDUC COUNS, V73, P127, DOI 10.1016/j.pec.2008.03.022
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   Bohme P, 2013, DIABETES METAB, V39, P63, DOI 10.1016/j.diabet.2012.10.006
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Burns RJ, 2015, DIABETIC MED, V32, P1272, DOI 10.1111/dme.12860
   Buuren S, 2011, R J STAT SOFTWARE, V45, P3, DOI DOI 10.18637/JSS.V045.I03
   Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902
   Ducat L, 2015, DIABETES CARE, V38, P333, DOI 10.2337/dc14-1383
   Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonder-Frederick LA, 2013, DIABETIC MED, V30, P603, DOI 10.1111/dme.12129
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Graue M., 2013, Norsk Epidemiologi, V23, P75
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hofmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079809
   Huang H, 2012, PSYCHOSOMATICS, V53, P21, DOI 10.1016/j.psym.2011.07.001
   Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761
   Iversen MM, 2013, QUAL LIFE RES, V22, P2809, DOI 10.1007/s11136-013-0413-x
   MacDonald IA, 2007, HYPOGLYCEMIA
   Martyn-Nemeth P, 2016, J DIABETES COMPLICAT, V30, P167, DOI 10.1016/j.jdiacomp.2015.09.003
   Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23
   Nefs G, 2015, DIABETIC MED, V32, P1289, DOI 10.1111/dme.12739
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348
   Shi LZ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0167-3
   Shiu ATY, 2002, J ADV NURS, V39, P155
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Tingley D, 2014, J STAT SOFTW, P59
   Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585
   Vallis M, 2014, CURR DIABETES REV, V10, P364, DOI 10.2174/1573399810666141113115026
   Van Buuren S, 2012, FLEXIBLE IMPUTATION
   WHO, THE WHO 5 WEBS
NR 35
TC 3
Z9 3
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD FEB
PY 2017
VL 124
BP 11
EP 19
DI 10.1016/j.diabres.2016.12.018
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EO7NZ
UT WOS:000396878700002
PM 28081448
DA 2019-01-08
ER

PT J
AU Maiorino, MI
   Bellastella, G
   Castaldo, F
   Petrizzo, M
   Giugliano, D
   Esposito, K
AF Maiorino, M. I.
   Bellastella, G.
   Castaldo, F.
   Petrizzo, M.
   Giugliano, D.
   Esposito, K.
TI Sexual function in young women with type 1 diabetes: the METRO study
SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
LA English
DT Article
DE Female sexual dysfunction; Type 1 diabetes; Female sexual function
   index; Multiple daily insulin injections; Continuous subcutaneous
   insulin infusion
ID QUALITY-OF-LIFE; UNITED-STATES; TREATMENT SATISFACTION; INDEX FSFI;
   DYSFUNCTION; FEMALE; PREVALENCE; HEALTH; DISTRESS; ADULTS
AB Purpose The aim of this study was to evaluate the prevalence and risk factors associated with female sexual dysfunction (FSD) in young women with type 1 diabetes treated with different intensive insulin regimens.
   Methods Type 1 diabetic women aged 18-35 years were included in this study if they had stable couple relationship and no oral contraceptive use. All women were asked to complete the Female Sexual Function Index (FSFI) and other validated multiple-choice questionnaires assessing sexual-related distress (Female Sexual Distress Scale, FSDS), quality of life (SF-36 Health Survey), physical activity (International Physical Activity Questionnaire), depressive symptoms (Zung Self-Rating Depression Scale, SRDS) and diabetes-related problems (Diabetes Integration Scale ATT-19). FSD was diagnosed according to a FSFI score higher than 26.55 and a FSDS score lower than 15.
   Results The overall prevalence of FSD in diabetic and control women was 20 and 15 %, respectively (P = 0.446). Compared with the continuous subcutaneous insulin infusion group and control women, diabetic women on multiple daily injections (MDI) had lower global FSFI score (P = 0.007), FSDS score (P = 0.045) and domains such as arousal (P = 0.006), lubrication and satisfaction scores (P < 0.001 for both). In the multiple regression analysis, only the mental component summary (P = 0.047) and the SRDS score (P = 0.042) were independent predictors of FSFI score in the overall diabetic women.
   Conclusion Young women with type 1 diabetes wearing an insulin pump show a prevalence of sexual dysfunction similar to that of healthy age-matched women, but sexual function was significantly impaired in diabetic women on MDI therapy. Depression and the mental health status were independent predictors for FSD in diabetic women.
C1 [Maiorino, M. I.; Bellastella, G.; Castaldo, F.; Giugliano, D.; Esposito, K.] Univ Naples 2, Diabet Unit, Piazza L Miraglia 2, I-80138 Naples, Italy.
   [Petrizzo, M.; Esposito, K.] Univ Naples 2, Dept Med Surg Neurol Metab Sci & Aging, Diabet Unit, Piazza L Miraglia 2, I-80138 Naples, Italy.
RP Maiorino, MI (reprint author), Univ Naples 2, Diabet Unit, Piazza L Miraglia 2, I-80138 Naples, Italy.
EM mariaida.maiorino@unina2.it
CR Abu Ali RM, 2008, DIABETES CARE, V31, P1580, DOI 10.2337/dc08-0081
   American Diabetes Association, 2016, DIABETES CARE S1, V39, pS52, DOI DOI 10.2337/DC16-S010
   Baser RE, 2012, CANCER, V15, P4606
   Bultrini A, 2004, J SEX MED, V1, P337, DOI 10.1111/j.1743-6109.04048.x
   Cherubini V, 2014, ACTA DIABETOL, V51, P43, DOI 10.1007/s00592-013-0466-x
   Ciocca G, 2015, J ENDOCRINOL INVEST, V38, P999, DOI 10.1007/s40618-015-0286-7
   Ciocca G, 2015, ACTA DIABETOL, V52, P513, DOI 10.1007/s00592-014-0686-8
   Cortelazzi D, 2013, ACTA DIABETOL, V50, P911, DOI 10.1007/s00592-013-0482-x
   Derogatis LR, 2002, J SEX MARITAL THER, V28, P317, DOI 10.1080/00926230290001448
   Dimitropoulos K, 2012, J SEX MED, V9, P1374, DOI 10.1111/j.1743-6109.2012.02664.x
   Enzlin P, 2003, DIABETES CARE, V26, P409, DOI 10.2337/diacare.26.2.409
   Enzlin P, 2009, DIABETES CARE, V32, P780, DOI 10.2337/dc08-1164
   Esposito K, 2008, INT J IMPOT RES, V20, P358, DOI 10.1038/ijir.2008.9
   Esposito K, 2007, INT J IMPOT RES, V19, P353, DOI 10.1038/sj.ijir.3901548
   Esposito K, 2010, INT J IMPOT RES, V22, P179, DOI 10.1038/ijir.2010.6
   IPAQ Research Committee, GUID DAT PROC AN INT
   Isidori AM, 2010, J SEX MED, V7, P1139, DOI 10.1111/j.1743-6109.2009.01635.x
   KOKKONEN J, 1995, NORD J PSYCHIAT, V49, P175, DOI 10.3109/08039489509011903
   Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250
   Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537
   Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423
   Maiorino MI, 2014, ENDOCRINE, V46, P256, DOI 10.1007/s12020-013-0060-6
   Maiorino MI, 2014, DIABET METAB SYND OB, V7, P95, DOI 10.2147/DMSO.S36455
   Maseroli E, 2016, J ENDOCRINOL INVEST, V39, P401, DOI 10.1007/s40618-015-0378-4
   McCabe MP, 2016, J SEX MED, V13, P135, DOI 10.1016/j.jsxm.2015.12.019
   Meston CM, 2002, J SEX MARITAL THER, V28, P155, DOI 10.1080/00926230252851276
   Nicolucci A, 2008, DIABETIC MED, V25, P213, DOI 10.1111/j.1464-5491.2007.02346.x
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Pontiroli AE, 2013, J SEX MED, V10, P1044, DOI 10.1111/jsm.12065
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   Salonia A, 2006, DIABETES CARE, V29, P312, DOI 10.2337/diacare.29.02.06.dc05-1067
   Shiften JL, 2008, OBSTET GYNECOL, V112, P970, DOI 10.1097/AOG.0b013e3181898cdb
   Tagliabue M, 2011, J SEX MED, V8, P1694, DOI 10.1111/j.1743-6109.2011.02262.x
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Welch G., 1994, HDB PSYCHOL DIABETES, P223
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
NR 37
TC 6
Z9 6
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1720-8386
J9 J ENDOCRINOL INVEST
JI J. Endocrinol. Invest.
PD FEB
PY 2017
VL 40
IS 2
BP 169
EP 177
DI 10.1007/s40618-016-0542-5
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EO7OR
UT WOS:000396880500007
PM 27613610
DA 2019-01-08
ER

PT J
AU Cheng, L
   Sit, JWH
   Choi, KC
   Chair, SY
   Li, XM
   He, XL
AF Cheng, Li
   Sit, Janet W. H.
   Choi, Kai-chow
   Chair, Sek-ying
   Li, Xiaomei
   He, Xiao-le
TI Effectiveness of Interactive Self-Management Interventions in
   Individuals With Poorly Controlled Type 2 Diabetes: A Meta-Analysis of
   Randomized Controlled Trials
SO WORLDVIEWS ON EVIDENCE-BASED NURSING
LA English
DT Article
DE meta-analysis; interactive; self-management; intervention; type 2
   diabetes; poor control
ID IMPROVE GLYCEMIC CONTROL; BEHAVIORAL INTERVENTION; GENERAL-PRACTICE;
   CLINICAL-TRIAL; BLOOD-GLUCOSE; ADULTS; SUPPORT; EDUCATION; CARE;
   AMERICANS
AB Aims: To identify, assess, and summarize available scientific evidence on the effectiveness of interactive self-management interventions on glycemic control and patient-centered outcomes in individuals with poorly controlled type 2 diabetes.
   Methods: Major English and Chinese electronic databases including Medline, EMBASE, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, and WanFang Data were searched to identify randomized controlled trials that reported the effectiveness of interactive self-management interventions in individuals with poorly controlled type 2 diabetes (glycated hemoglobin [HbA1c] >= 7.5% or 58 mmol/mol), from inception to June 2015. Data extraction and risk-of-bias assessment were performed by two reviewers independently. Meta-analysis was performed using Review Manager 5.3.
   Results: A total of 16 trials with 3,545 participants were included in the meta-analysis. Interactive self-management interventions could have a beneficial effect in individuals with poorly controlled type 2 diabetes in reducing HbA1c (mean difference: -0.43%, 95% CI: -0.67% to -0.18%), improving diabetes knowledge (standardized mean difference [SMD]: 0.30, 95% CI: 0.03 to 0.58), enhancing self-efficacy (SMD: 0.29, 95% CI: 0.14 to 0.44), and reducing diabetes-related distress (SMD: -0.21, 95% CI: -0.39 to -0.04). Self-management interventions supported with theory and structured curriculum showed desirable results in glycemic control. The behavioral change techniques, including providing feedback on performance, problem-solving, and action planning, were associated with a significant reduction in HbA1c.
   Linking Evidence to Action: Individuals with poorly controlled type 2 diabetes could benefit from interactive self-management interventions. Interventions targeting patients with poorly controlled diabetes, those who are at the greatest risk of developing complications, should be prioritized. Our findings indicate that providing feedback on performance, problem-solving, and action planning are promising behavioral change techniques specifically for individuals with poor glycemic control.
C1 [Cheng, Li; Sit, Janet W. H.; Choi, Kai-chow; Chair, Sek-ying] Chinese Univ Hong Kong, Nethersole Sch Nursing, Fac Med, Shatin, Hong Kong, Peoples R China.
   [Li, Xiaomei; He, Xiao-le] Xi An Jiao Tong Univ, Sch Nursing, Xian, Peoples R China.
RP Cheng, L (reprint author), Chinese Univ Hong Kong, Nethersole Sch Nursing, Room 821,Esther Lee Bldg, Shatin, Hong Kong, Peoples R China.
EM lilycheng@link.cuhk.edu.hk
RI Chair, Sek Ying/G-9965-2016; Sit, Janet/A-5159-2015; Choi, Kai
   Chow/F-1398-2018
OI Chair, Sek Ying/0000-0003-2387-7035; Sit, Janet/0000-0002-4714-5915;
   Choi, Kai Chow/0000-0001-7157-8668
CR AgursCollins TD, 1997, DIABETES CARE, V20, P1503, DOI 10.2337/diacare.20.10.1503
   American Diabetes Association, 2016, DIABETES CARE S1, V39, pS4, DOI DOI 10.2337/DC16-S003
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Blackberry ID, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5272
   Bolen SD, 2014, J GEN INTERN MED, V29, P1166, DOI 10.1007/s11606-014-2855-4
   Cattaneo LB, 2010, AM PSYCHOL, V65, P646, DOI 10.1037/a0018854
   Cotter AP, 2014, J DIABETES COMPLICAT, V28, P243, DOI 10.1016/j.jdiacomp.2013.07.003
   Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2
   Farmer A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-30
   Frosch DL, 2011, ARCH INTERN MED, V171, P2011, DOI 10.1001/archinternmed.2011.497
   Heinrich E, 2010, EUR DIAB NURSING, V7, P71, DOI DOI 10.1002/EDN.160
   Higgins J. P., 2008, COCHRANE HDB SYSTEMA, V5
   International Diabetes Federation Guideline Development Group, 2014, DIABETES RES CLIN PR, V104, P1
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Kim MT, 2009, DIABETES EDUCATOR, V35, P986, DOI 10.1177/0145721709345774
   Krein SL, 2004, AM J MED, V116, P732, DOI 10.1016/j.amjmed.2003.11.028
   [李蒙 Li Meng], 2014, [中华护理杂志, Chinese Journal of Nursing], V49, P6
   Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x
   Litwak L, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-57
   Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Monasta L, 2011, OBES REV, V12, pe107, DOI 10.1111/j.1467-789X.2010.00774.x
   Naik AD, 2011, ARCH INTERN MED, V171, P453, DOI 10.1001/archinternmed.2011.70
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Pal K, 2014, DIABETES CARE, V37, P1759, DOI 10.2337/dc13-1386
   Philis-Tsimikas A, 2011, DIABETES CARE, V34, P1926, DOI 10.2337/dc10-2081
   Powers MA, 2015, DIABETES EDUCATOR, V41, P417, DOI 10.1177/0145721715588904
   Quinn CC, 2011, DIABETES CARE, V34, P1934, DOI 10.2337/dc11-0366
   Rickheim PL, 2002, DIABETES CARE, V25, P269, DOI 10.2337/diacare.25.2.269
   Riddle MC, 2013, DIABETES OBES METAB, V15, P819, DOI 10.1111/dom.12096
   Schwedes U, 2002, DIABETES CARE, V25, P1928, DOI 10.2337/diacare.25.11.1928
   Sherifali D, 2015, DIABETIC MED, V32, P1404, DOI 10.1111/dme.12780
   Slingerland AS, 2013, DIABETES CARE, V36, P3054, DOI 10.2337/dc12-1865
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   Tang PC, 2013, J AM MED INFORM ASSN, V20, P526, DOI 10.1136/amiajnl-2012-001263
   Tshiananga JKT, 2012, DIABETES EDUCATOR, V38, P108, DOI 10.1177/0145721711423978
   Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9
   Urrechaga E, 2012, AM J CLIN PATHOL, V138, P448, DOI 10.1309/AJCPVYW9QZ9EVFXI
   Walker EA, 2011, DIABETES CARE, V34, P2, DOI 10.2337/dc10-1005
   Welch G, 2015, DIABETES CARE, V38, P561, DOI 10.2337/dc14-1412
   Welch G, 2011, DIABETES RES CLIN PR, V91, P54, DOI 10.1016/j.diabres.2010.09.036
   Welch G, 2010, DIABETES RES CLIN PR, V88, P1, DOI 10.1016/j.diabres.2009.12.026
   Williams ED, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-602
   Woodcock AJ, 2001, QUAL LIFE RES, V10, P661, DOI 10.1023/A:1013837709224
NR 44
TC 7
Z9 7
U1 5
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-102X
EI 1741-6787
J9 WORLDV EVID-BASED NU
JI Worldviews Evid.-Based Nurs.
PD FEB
PY 2017
VL 14
IS 1
BP 65
EP 73
DI 10.1111/wvn.12191
PG 9
WC Nursing
SC Nursing
GA EP2KI
UT WOS:000397211500008
PM 27984672
DA 2019-01-08
ER

PT J
AU Tanenbaum, ML
   Hanes, SJ
   Miller, KM
   Naranjo, D
   Bensen, R
   Hood, KK
AF Tanenbaum, Molly L.
   Hanes, Sarah J.
   Miller, Kellee M.
   Naranjo, Diana
   Bensen, Rachel
   Hood, Korey K.
TI Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake
   and Potential Intervention Targets
SO DIABETES CARE
LA English
DT Article
ID SUBCUTANEOUS INSULIN INFUSION; EXCHANGE CLINIC REGISTRY; PUMP THERAPY;
   PSYCHOSOCIAL FACTORS; GLYCEMIC CONTROL; SELF-MANAGEMENT; GLUCOSE; CARE;
   TECHNOLOGY; TRANSITION
AB OBJECTIVE Diabetes devices (insulin pumps, continuous glucose monitors [CGMs]) are associated with benefits for glycemic control, yet uptake of these devices continues to be low. Some barriers to device uptake may be modifiable through psychosocial intervention, but little is known aboutwhich barriers andwhich patients to target.
   RESEARCH DESIGN AND METHODS We surveyed 1,503 adult T1D Exchange participants (mean age 35.3 [SD 14.8] years, mean diagnosis duration 20.4 [SD 12.5] years) to investigate barriers to device uptake, understand profiles of device users versus nonusers, and explore differences by age and sex. Scales used were the Diabetes Distress Scale, Technology Use Attitudes (General and Diabetes-Specific), and Barriers to Device Use and Reasons for Discontinuing Devices.
   RESULTS Most commonly endorsed modifiable barriers were related to the hassle of wearing devices (47%) and disliking devices on one's body (35%). CGM users (37%) were older than nonusers (mean 38.3 vs. 33.5 years), had diabetes for longer (22.9 vs. 18.8 years), had more positive technology attitudes (22.6-26.0 vs. 21.4-24.8), and reported fewer barriers to using diabetes technology than nonusers (3.3 vs. 4.3). The youngest age-group (18-25 years) had the lowest CGM (26% vs. 40-48%) and insulin pump (64% vs. 69-77%) uptake, highest diabetes distress (2.2 vs. 1.8-2.1), and highest HbA1c levels (8.3% [67 mmol/ mol] vs. 7.2- 7.4% [ 55-57 mmol/ mol]).
   CONCLUSIONS Efforts to increase device use need to target physical barriers to wearing devices. Because young adults had the lowest device uptake rates, highest distress, and highest HbA1c compared with older age- groups, they should be the focus of future interventions to increase device use.
C1 [Tanenbaum, Molly L.; Hanes, Sarah J.; Bensen, Rachel; Hood, Korey K.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA.
   [Miller, Kellee M.] Jaeb Ctr Hlth Res, Tampa, FL USA.
   [Naranjo, Diana] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.
RP Hood, KK (reprint author), Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA.
EM kkhood@stanford.edu
FU Leona M. and Harry B. Helmsley Charitable Trust
FX This study was made possible with the support of The Leona M. and Harry
   B. Helmsley Charitable Trust.
CR Amer Assoc Diabetes Educ, 2003, DIABETES EDUCATOR, V29, P97
   [Anonymous], 2016, THE DIABETES TIMES
   Barnard KD, 2015, DIABETES TECHNOL THE, V17, P311, DOI 10.1089/dia.2014.0316
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bode BW, 2002, DIABETES-METAB RES, V18, pS14, DOI 10.1002/dmrr.205
   Bruttomesso D, 2009, DIABETES-METAB RES, V25, P99, DOI 10.1002/dmrr.931
   Cortina S, 2010, PEDIATR DIABETES, V11, P337, DOI 10.1111/j.1399-5448.2009.00593.x
   de Vries L, 2011, PEDIATR DIABETES, V12, P506, DOI 10.1111/j.1399-5448.2010.00701.x
   Deis D, 2006, DIABETES CARE, V29, P2730, DOI 10.2337/dc06-1134
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Floyd BD, 2017, PEDIATR DIABETES, V18, P204, DOI 10.1111/pedi.12373
   Garvey K, 2011, DIABETES SPECTRUM, V24, P22, DOI [10.2337/diaspect.24.1.22, DOI 10.2337/DIASPECT.24.1.22]
   Garvey KC, 2012, CURR DIABETES REP, V12, P533, DOI 10.1007/s11892-012-0311-6
   Hermanides J, 2011, DIABETES CARE, V34, pS197, DOI 10.2337/dc11-s219
   Hill-Briggs F, 2007, DIABETES EDUCATOR, V33, P1032, DOI 10.1177/0145721707308412
   HILLBRIGGS F, 2007, DIABETES ED, V33, P1051
   Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231
   Liberman A, 2014, DIABETES TECHNOL THE, V16, pS110, DOI 10.1089/dia.2014.1513
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Modi AC, 2012, PEDIATRICS, V129, pE473, DOI 10.1542/peds.2011-1635
   Norgaard K, 2013, DIABETES TECHNOL THE, V15, P273, DOI 10.1089/dia.2012.0288
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922
   PICKUP JC, 1978, BRIT MED J, V1, P204, DOI 10.1136/bmj.1.6107.204
   Raymond Jennifer K, 2015, Diabetes Spectr, V28, P68, DOI 10.2337/diaspect.28.1.68
   Ritholz MD, 2007, DIABETES CARE, V30, P549, DOI 10.2337/dc06-1755
   Ronsin O, 2005, DIABETES METAB, V31, P90, DOI 10.1016/S1262-3636(07)70173-8
   Rubin Richard R, 2009, J Diabetes Sci Technol, V3, P1402
   Scheiner G., 2009, DIABETES ED S2, V35, p42S
   Scheiner G., 2009, DIABETES ED S2, V35, p28S
   Scheiner G, 2009, DIABETES EDUCATOR, V35, p29S, DOI 10.1177/0145721709333493
   Shalitin S, 2010, DIABETIC MED, V27, P339, DOI 10.1111/j.1464-5491.2009.02925.x
   Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017
   TAMBORLANE WV, 1979, NEW ENGL J MED, V300, P573, DOI 10.1056/NEJM197903153001101
   Weissberg-Benchell J, 2007, DIABETES CARE, V30, P2441, DOI 10.2337/dc07-1249
   Wong JC, 2014, DIABETES CARE, V37, P2702, DOI 10.2337/dc14-0303
NR 36
TC 18
Z9 19
U1 0
U2 4
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD FEB
PY 2017
VL 40
IS 2
BP 181
EP 187
DI 10.2337/dc16-1536
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EL2ZL
UT WOS:000394489300015
PM 27899489
OA Bronze
DA 2019-01-08
ER

PT J
AU Rumburg, TM
   Lord, JH
   Savin, KL
   Jaser, SS
AF Rumburg, Tamara M.
   Lord, Jadienne H.
   Savin, Kimberly L.
   Jaser, Sarah S.
TI Maternal diabetes distress is linked to maternal depressive symptoms and
   adolescents' glycemic control
SO PEDIATRIC DIABETES
LA English
DT Article
DE adolescents; diabetes distress; family functioning; parenting; type 1
   diabetes
ID TYPE-1; VALIDITY; SCALE; YOUTH
AB Objective: Mothers of youth with type 1 diabetes experience increased levels of stress and depression related to the burden of diabetes management, but the concept of diabetes distress, or distress linked specifically to diabetes and its management, has not been applied to mothers. The current study examined diabetes distress in relation to maternal depressive symptoms and adolescents' glycemic control.
   Research Design and Methods: Mothers of youth with type 1 diabetes (age: 10-16) completed a measure of depressive symptoms and diabetes distress as part of a screening questionnaire. Adolescents' glycosylated hemoglobin (HbA1c) was obtained from medical records.
   Results: Mothers' diabetes distress was strongly related to maternal depressive symptoms, and relationship-related diabetes distress was significantly associated with adolescents' HbA1c. In multivariate analyses, maternal depression was the only significant predictor of glycemic control.
   Conclusions: Given the links between mothers' diabetes distress, maternal depressive symptoms, and adolescents' glycemic control, diabetes distress may be important to consider when targeting both maternal and adolescent adjustment to type 1 diabetes.
C1 [Rumburg, Tamara M.; Lord, Jadienne H.; Savin, Kimberly L.; Jaser, Sarah S.] Vanderbilt Univ, Dept Pediat, 2200 Childrens Way, DOT 11136, Nashville, TN 37232 USA.
RP Jaser, SS (reprint author), Vanderbilt Univ, Dept Pediat, 2200 Childrens Way, DOT 11136, Nashville, TN 37232 USA.
EM sarah.jaser@vanderbilt.edu
OI Savin, Kimberly/0000-0003-1658-1228
FU Center for Diabetes Translation Research from the National Institute of
   Diabetes and Digestive and Kidney Diseases [P30 DK092986]
FX Funding for this study was provided by the Center for Diabetes
   Translation Research (P30 DK092986) from the National Institute of
   Diabetes and Digestive and Kidney Diseases.
CR American Diabetes, 2015, CLIN DIABETES, V33, P97, DOI DOI 10.2337/DIACLIN.33.2.97
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hessler D., 2012, SCI SESS AM DIAB ASS
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Maas-van Schaaijk NM, 2013, J PEDIATR PSYCHOL, V38, P30, DOI 10.1093/jpepsy/jss096
   Mackey ER, 2014, HEALTH PSYCHOL, V33, P783, DOI 10.1037/hea0000066
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959
   Zamora I., 2014, AUTISM RES TREAT, V2014
NR 14
TC 4
Z9 4
U1 2
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1399-543X
EI 1399-5448
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD FEB
PY 2017
VL 18
IS 1
BP 67
EP 70
DI 10.1111/pedi.12350
PG 4
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA EK4OY
UT WOS:000393907700009
PM 26712240
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Fisher, L
   Hessler, D
   Edelman, SV
AF Polonsky, William H.
   Fisher, Lawrence
   Hessler, Danielle
   Edelman, Steven V.
TI Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
DE Hypoglycemia; Confidence; Type 1 diabetes; Type 2 diabetes
ID ADULTS; FEAR; DISTRESS; IMPACT
AB Background: While research designed to understand the concerns about hypoglycemia among patients with diabetes has been primarily focused on the investigation of fear and anxiety, recent evidence suggests a potentially important and conceptually distinct element-hypoglycemic confidence. To investigate this dimension, we developed the Hypoglycemic Confidence Scale (HCS); herein, we describe the construction and validation of the HCS and examine how key patient factors are associated with hypoglycemic confidence.
   Methods: Items were developed from interviews with six type 1 diabetes (T1D) adults, six insulin-using type 2 diabetes (T2D) adults, and seven diabetes healthcare professionals, resulting in nine self-report items. Separate exploratory factor analyses (EFAs) were conducted with T1D adults (N=326), with T2D adults using both basal and prandial insulins (T2D-BP, N=145) and with T2D adults using only basal insulin (T2D-BO, N=82). Construct validity for the HCS was established with overall well-being (World Health Organization-5), diabetes distress (Diabetes Distress Scale), global anxiety (Generalized Anxiety Disorder), hypoglycemic fear (Hypoglycemic Fear Survey-II), and glycemic control (self-reported A1C). Hierarchical regression analyses examined the unique contribution of HCS scores, independent of hypoglycemic fear, on key psychosocial constructs and A1C.
   Results: EFAs of the nine HCS items yielded a single factor solution for each of the three subject samples, accounting for 50.8%, 65.1%, and 73.7% of the variance for the T1D, T2D-BP, and T2D-BO groups, respectively. Construct validity was established by significant correlations with criterion variables. The HCS was associated with well-being and diabetes distress in the T1D (in both cases, P < 0.001) and T2D-BP groups (in both cases, P < .05) and for self-reported A1C in the T2D-BP group (P < .05) independent of hypoglycemic fear.
   Conclusions: Hypoglycemic confidence is a unique dimension of patient experience, different from hypoglycemic fear, and is deserving of further study. The HCS is a reliable valid measure of hypoglycemic confidence for adults with T1D and insulin-using T2D.
C1 [Polonsky, William H.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Fisher, Lawrence; Hessler, Danielle] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Edelman, Steven V.] Univ Calif San Diego, Div Endocrinol & Metab, San Diego, CA 92103 USA.
   [Edelman, Steven V.] Vet Affairs Med Ctr, San Diego, CA 92161 USA.
RP Polonsky, WH (reprint author), POB 2148, Del Mar, CA 92014 USA.
EM whp@behavioraldiabetes.org
FU Dexcom
FX This investigator-initiated study was supported by Dexcom.
CR COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Domgaard M, 2015, POSTGRAD MED, V127, P438, DOI 10.1080/00325481.2015.1045815
   Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Gonder-Frederick L., 2013, DIABETIC HYPOGLYCEMI, V5, P3
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Irvine A, 1994, HDB PSYCHOL DIABETES
   Polonsky WH, 2015, J DIABETES COMPLICAT, V29, P1171, DOI 10.1016/j.jdiacomp.2015.08.002
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Sheeran P, 2016, HEALTH PSYCHOL, V35, P1178, DOI 10.1037/hea0000387
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Wong ND, 2013, DIABETES VASC DIS RE, V10, P505, DOI 10.1177/1479164113496828
NR 13
TC 6
Z9 6
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD FEB
PY 2017
VL 19
IS 2
BP 131
EP 136
DI 10.1089/dia.2016.0366
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EI9JG
UT WOS:000392823500012
PM 27997217
DA 2019-01-08
ER

PT J
AU Shin, JK
   Poltavskiy, E
   Kim, TN
   Hasan, A
   Bang, HJ
AF Shin, Jinah K.
   Poltavskiy, Eduard
   Kim, Tae Nyun
   Hasan, Abdullah
   Bang, Heejung
TI Help-seeking behaviors for serious psychological distress among
   individuals with diabetes mellitus: The California Health Interview
   Survey, 2011-2012
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Diabetes mellitus; Help-seeking behaviors; Perceived needs; Serious
   psychological distress
ID COMORBID DEPRESSION; PERCEIVED NEED; SUICIDAL IDEATION; ADULTS; CARE;
   PREVALENCE; METAANALYSIS; ASSOCIATION; POPULATION; SERVICES
AB Aim: To investigate patterns of and factors associated with help-seeking behaviors among individuals with diabetes mellitus (DM) and/or serious psychological distress (SPD).
   Methods: The analysis was conducted with the California Health Interview Survey (CHIS) 2011-2012 of 40,803 adults. Logistic regression was used to examine the associations between the multiple facilitating/preventing factors and outcome, guided by the Andersen's Health Care Utilization Model.
   Results: The prevalence of DM and SPD were 10.9% and 3.4%, respectively, among participants in the survey. The participants with DM were more likely to experience SPD than those without DM (OR 1.46, 95% CI = 1.11-1.91, p = 0.006). Participants with combined DM and SPD, the most underserved, were less likely to perceive the need for mental health services and less likely to seek help, compared to those with only SPD. Need factors (SPD status and perceived need) were significantly associated with help-seeking behaviors for mental health, along with predisposing factors (age, gender, obesity, race, and employment), and enabling factors (insurance, English proficiency).
   Conclusions: Perceptions about need for seeking help seem to play an important role in receiving mental health services in addition to other predisposing or enabling factors. Identification of these factors may improve clinical outcomes related to DM and SPD. (C) 2016 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Shin, Jinah K.; Hasan, Abdullah] Elmhurst Hosp New York, Dept Psychiat, 79-01 Broadway, Elmhurst, NY 11373 USA.
   [Poltavskiy, Eduard] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Grad Grp Epidemiol, Davis, CA 95616 USA.
   [Kim, Tae Nyun] Inje Univ, Haeundae Paik Hosp, Sch Med, Dept Internal Med,Div Endocrinol & Metab, Busan, South Korea.
   [Bang, Heejung] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA.
EM jshin124@hotmail.com
FU National Center for Advancing Translational Sciences, National
   Institutes of Health [UL1 TR000002]
FX H. Bang was partly supported by the National Center for Advancing
   Translational Sciences, National Institutes of Health, through grant
   number UL1 TR000002. The authors declare that they have no conflict of
   interest.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284
   Andersen RM, 2001, CHANGING US HLTH CAR, P3
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   California Health Interview Survey, 2014, CHIS 2011 2012 METH
   Chung JH, 2014, J PSYCHOSOM RES, V77, P457, DOI 10.1016/j.jpsychores.2014.08.008
   Codony M, 2009, PSYCHIAT SERV, V60, P1051, DOI 10.1176/appi.ps.60.8.1051
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Dhingra SS, 2010, PSYCHIAT SERV, V61, P524, DOI 10.1176/appi.ps.61.5.524
   Dismuke CE, 2011, GEN HOSP PSYCHIAT, V33, P311, DOI 10.1016/j.genhosppsych.2011.03.014
   Edlund MJ, 2006, SOC PSYCH PSYCH EPID, V41, P480, DOI 10.1007/s00127-006-0047-1
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Han SJ, 2013, DIABETES RES CLIN PR, V101, pE14, DOI 10.1016/j.diabres.2013.06.012
   Hochhausen L., 2009, COMMUNITY MENT HLTH, V47, P14
   Huang CJ, 2011, GEN HOSP PSYCHIAT, V33, P8, DOI 10.1016/j.genhosppsych.2010.10.008
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Li C, 2007, DIABETES CARE, V33, P1061, DOI DOI 10.2337/DC09-1515]
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Meadows G, 2002, PSYCHOL MED, V32, P299, DOI 10.1017/S0033291701004913
   Mechanic D, 2002, HEALTH AFFAIR, V21, P137, DOI 10.1377/hlthaff.21.3.137
   Mojtabai R, 2002, ARCH GEN PSYCHIAT, V59, P77, DOI 10.1001/archpsyc.59.1.77
   Shin JK, 2012, DIABETES RES CLIN PR, V95, P406, DOI 10.1016/j.diabres.2011.10.043
   Subramaniam M, 2009, GEN HOSP PSYCHIAT, V31, P220, DOI 10.1016/j.genhosppsych.2009.01.001
   Surood S, 2010, CAN J PUBLIC HEALTH, V101, P176
   Vamos EP, 2009, PSYCHOSOM MED, V71, P501, DOI 10.1097/PSY.0b013e3181a5a7ad
   Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089
NR 30
TC 0
Z9 0
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD FEB
PY 2017
VL 11
IS 1
BP 63
EP 70
DI 10.1016/j.pcd.2016.07.007
PG 8
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA EI7LK
UT WOS:000392679200009
PM 27492797
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Huang, SY
   Huang, WC
   Chen, YC
   Tsai, CY
   Lee, IK
AF Huang, Shi-Yu
   Huang, Wen-Chi
   Chen, Yi-Chun
   Tsai, Ching-Yen
   Lee, Ing-Kit
TI Increased Mortality in Seasonal H3N2 Patients Compared with those with
   Pandemic 2009 H1N1 in Taiwan, 2009-2010
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VIRUS-INFECTION; INFLUENZA INFECTION; ADULT PATIENTS; CALIFORNIA;
   THERAPY; HUMANS
AB We conducted a retrospective study to compare clinical and laboratory findings between 1) severe influenza A and mild influenza A and 2) pandemic 2009 H1N1 (pdm09 A/H1) and seasonal H3N2 (A/H3) from 2009 to 2010. A total of 526 (mean age, 13.6 years; 447 pdm09 A/H1, 79 seasonal A/H3) patients were included, 41 (7.8%) with severe influenza (mean age, 28.1 years; 26 pdm09 A/H1, 15 seasonal A/H3). Influenza-associated complications were pneumonia (75.6%), meningoencephalitis (14.6%), acute kidney injury (14.6%), and acute respiratory distress syndrome (12.2%). Patients with seasonal A/H3 were significantly less likely to experience sore throat (P < 0.001), malaise (P < 0.001), and muscle pain (P < 0.001); they were significantly more likely to have hypertension (P < 0.001), diabetes mellitus (P = 0.001), and chronic obstructive pulmonary disease (P < 0.001), delayed hospital presentation (P = 0.001), delayed oseltamivir treatment (P < 0.001), and higher in-hospital mortality (P = 0.02) than patients with pdm09 A/H1. Further comparison between severe pdm09 A/H1 and severe seasonal A/H3 revealed that severe seasonal A/H3 patients (median age, 71 years) were significantly older than patients with severe pdm09 A/H1 (median age, 7 years) (P < 0.001). Comparison between severe influenza and mild influenza, regardless of influenza A subtypes, by multivariate analysis, found that tachypnea (odds ratio [OR] = 44.3,95% confidence interval [CI] = 15.7-124.6) and delayed oseltamivir therapy >= 48 hours after illness onset (OR = 3.7, 95% CI = 1.3-10.5) were independent risk factors for severe influenza. The findings of this study will improve the understanding of the clinical differences between pdm09 A/H1 and seasonal A/H3, and of influenza-associated complications and predictors for severe outcomes that can help to direct clinicians toward the most effective management of influenza patients to reduce the preventable mortality and morbidity.
C1 [Huang, Shi-Yu] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung, Taiwan.
   [Huang, Wen-Chi; Chen, Yi-Chun; Tsai, Ching-Yen; Lee, Ing-Kit] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 833, Taiwan.
   [Lee, Ing-Kit] Chang Gung Univ, Coll Med, Taoyuan, Taiwan.
RP Lee, IK (reprint author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 833, Taiwan.
EM sarawah@ms28.hinet.net; heteyland@cgmh.org.tw; sonice83@cgmh.org.tw;
   greenswallow822@yahoo.com.tw; leee@cgmh.org.tw
FU Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan [CMRPG8E0691]
FX This work was partly supported by a grant from the Kaohsiung Chang Gung
   Memorial Hospital (CMRPG8E0691), Kaohsiung, Taiwan.
CR [Anonymous], 2009, Wkly Epidemiol Rec, V84, P185
   Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449
   Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467
   Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536
   Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003
   Chang YS, 2010, MED J AUSTRALIA, V192, P90
   Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296
   Glaser CA, 2012, CLIN INFECT DIS, V55, P514, DOI 10.1093/cid/cis454
   Gordon A, 2010, CLIN INFECT DIS, V50, P1462, DOI 10.1086/652647
   Kelly HA, 2009, MED J AUSTRALIA, V191, P146
   Lee IK, 2012, INFLUENZA OTHER RESP, V6, pe152, DOI 10.1111/j.1750-2659.2012.00410.x
   Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051
   Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083
   Martin S, 2017, FRONT MED, V4, DOI 10.3389/fmed.2017.00020
   Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC
   McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584
   Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906
   Monto AS, 2009, CLIN INFECT DIS, V48, pS20, DOI 10.1086/591853
   Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243
   Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007
   Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558
   Sivadon-Tardy V, 2009, CLIN INFECT DIS, V48, P48, DOI 10.1086/594124
   STANLEY TV, 1994, NEW ZEAL MED J, V107, P382
   Taiwan CDC, 2009, GLOB INFL A H1N1 PAN
   Tang JWT, 2010, ARCH INTERN MED, V170, P861, DOI 10.1001/archinternmed.2010.108
   Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   WELLS DL, 1991, JAMA-J AM MED ASSOC, V265, P478, DOI 10.1001/jama.265.4.478
   *WHO, 2009, INFL LIK ILLN US MEX
   World Health Organization, 2009, CDC PROT REAL TIM RT
   World Health Organization, INFL UPD
   World Health Organization, 2010, PAND H1N1 2009 UPD 1
   World Health Organization, 2009, CLIN MAN HUM INF PAN
NR 35
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 6
BP 1945
EP 1951
DI 10.4269/ajtmh.17-0172
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5ZI
UT WOS:000423231800056
PM 29016325
DA 2019-01-08
ER

PT J
AU Alam, U
   Fawwad, A
   Shaheen, F
   Tahir, B
   Basit, A
   Malik, RA
AF Alam, Uazman
   Fawwad, Asher
   Shaheen, Fariha
   Tahir, Bilal
   Basit, Abdul
   Malik, Rayaz A.
TI Improvement in Neuropathy Specific Quality of Life in Patients with
   Diabetes after Vitamin D Supplementation
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID PERIPHERAL NEUROPATHY; D DEFICIENCY; PAIN; ASSOCIATION; PREVALENCE;
   PREGABALIN; MELLITUS; HEALTH; SLEEP; RISK
AB Objective. To assess the effect of vitamin D supplementation on neuropathy specific quality of life (NeuroQoL) in patients with painful diabetic neuropathy. Methods. This prospective, open label study was conducted between June 2012 and April 2013. Patients with symptomatic diabetic neuropathy were given a single dose of 600,000 IU intramuscular vitamin D, and NeuroQol was assessed at baseline and at five follow-up visits every 4 weeks. Results. Of 143 participants, 41.3% were vitamin D deficient (vitamin D < 20 ng/ml). Treatment with vitamin D resulted in a significant increase in 25(OH)D (P < 0.0001) and a significant improvement in the NeuroQoL subscale score for emotional distress (P = 0.04), with no significant change in the other NeuroQoL domains of painful symptoms and paresthesia, loss of temperature and touch sensation, unsteadiness, limitation in daily activities, and interpersonal problems. There was a significant reduction in patient perception about foot problems on QoL of "quite a lot" (P < 0.05) and "very much" (P < 0.0001) with a significant reduction in the baseline response of having a "poor" QoL from 5.2% to 0.7% (P < 0.0001) and an increase in the response of an "excellent QoL" from 1.5% to 7.4% (P < 0.0001). Conclusion. Vitamin D is effective in improving quality of life in patients with painful diabetic neuropathy.
C1 [Alam, Uazman] Univ Liverpool, Dept Eye & Vis Sci, Inst Ageing & Chron Dis, Liverpool, Merseyside, England.
   [Alam, Uazman] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England.
   [Alam, Uazman] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Sch Med Sci, Manchester, Lancs, England.
   [Fawwad, Asher; Shaheen, Fariha; Tahir, Bilal; Basit, Abdul] Baqai Inst Diabetol & Endocrinol, Karachi, Pakistan.
   [Fawwad, Asher] Baqai Med Univ, Karachi, Pakistan.
   [Malik, Rayaz A.] Weill Cornell Med Qatar, Doha, Qatar.
   [Malik, Rayaz A.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England.
   [Malik, Rayaz A.] Cent Manchester Hosp Fdn Trust, Manchester, Lancs, England.
   [Malik, Rayaz A.] Manchester Metropolitan Univ, Manchester, Lancs, England.
RP Malik, RA (reprint author), Weill Cornell Med Qatar, Doha, Qatar.; Malik, RA (reprint author), Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England.; Malik, RA (reprint author), Cent Manchester Hosp Fdn Trust, Manchester, Lancs, England.; Malik, RA (reprint author), Manchester Metropolitan Univ, Manchester, Lancs, England.
EM ram2045@qatar-med.cornell.edu
OI Malik, Rayaz/0000-0002-7188-8903; Alam, Uazman/0000-0002-3190-1122
CR Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108
   Alam U, 2012, DIABETIC MED, V29, P1343, DOI 10.1111/j.1464-5491.2012.03692.x
   Alam U., 2016, J DIABETES RES, V2016, DOI DOI 10.1155/2016/6156217.NUTRES.2015.11.008
   Alam U, 2016, DIABETES THER, V7, P11, DOI 10.1007/s13300-016-0159-x
   Alam U, 2014, J DIABETES COMPLICAT, V28, P66, DOI 10.1016/j.jdiacomp.2013.09.003
   Ali A, 2013, PAK J MED SCI, V29, P899, DOI 10.12669/pjms.294.3704
   Almurdhi MM, 2016, DIABETES CARE, V39, P441, DOI 10.2337/dc15-0995
   Arabi A, 2010, NAT REV ENDOCRINOL, V6, P550, DOI 10.1038/nrendo.2010.146
   Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831
   Basit A, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000148
   Benbow SJ, 1998, QJM-MON J ASSOC PHYS, V91, P733, DOI 10.1093/qjmed/91.11.733
   Bondor C. I., 2016, J DIABETES RES, V2016, DOI DOI 10.1155/2016/5439521
   Boyd Amanda, 2011, J Diabetes Sci Technol, V5, P714
   Boyle J, 2012, DIABETES CARE, V35, P2451, DOI 10.2337/dc12-0656
   Celikbilek A, 2015, ACTA NEUROL BELG, V115, P47, DOI 10.1007/s13760-014-0304-0
   Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6
   Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009
   He R, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2820
   Huang W, 2013, CLIN J PAIN, V29, P341, DOI 10.1097/AJP.0b013e318255655d
   Humble MB, 2010, J PHOTOCH PHOTOBIO B, V101, P142, DOI 10.1016/j.jphotobiol.2010.08.003
   Jawaid SA, 2006, PAK J MED SCI, V22, P97
   Lee P, 2008, ARCH INTERN MED, V168, P771, DOI 10.1001/archinte.168.7.771
   Lv WS, 2015, J ENDOCRINOL INVEST, V38, P513, DOI 10.1007/s40618-014-0210-6
   Marchettini P, 2016, EUR J PAIN, V20, P472, DOI 10.1002/ejp.763
   Moore A, 2014, JAMA-J AM MED ASSOC, V312, P182, DOI 10.1001/jama.2014.6336
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Sadosky A, 2013, DIABETES METAB SYNDR, V6, P79, DOI 10.2147/DMSO.S37415
   Shehab D, 2015, MED PRIN PRACT, V24, P250, DOI 10.1159/000375304
   Shehab D, 2012, DIABETIC MED, V29, P43, DOI 10.1111/j.1464-5491.2011.03510.x
   Sheikh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033452
   Skalli S, 2012, EUR J INTERN MED, V23, pE67, DOI 10.1016/j.ejim.2011.11.008
   Smith SC, 2012, DIABETES RES CLIN PR, V96, P261, DOI 10.1016/j.diabres.2011.11.013
   Soderstrom LH, 2012, DIABETIC MED, V29, P50, DOI 10.1111/j.1464-5491.2011.03379.x
   Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004
   Veresiu AI, 2015, J DIABETES COMPLICAT, V29, P644, DOI 10.1016/j.jdiacomp.2015.04.001
   Vileikyte L, 2005, DIABETES CARE, V28, P2378, DOI 10.2337/diacare.28.10.2378
   Vileikyte L, 2003, DIABETES CARE, V26, P2549, DOI 10.2337/diacare.26.9.2549
   Vinik A, 2013, CLIN THER, V35, P612, DOI 10.1016/j.clinthera.2013.03.008
   Wang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106935
NR 39
TC 0
Z9 0
U1 1
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2017
AR 7928083
DI 10.1155/2017/7928083
PG 7
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA FS0XD
UT WOS:000419496400001
PM 29445752
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Eilander, MMA
   Snoek, FJ
   Rotteveel, J
   Aanstoot, HJ
   Bakker-van Waarde, WM
   Houdijk, ECAM
   Nuboer, R
   Winterdijk, P
   de Wit, M
AF Eilander, Minke M. A.
   Snoek, Frank J.
   Rotteveel, Joost
   Aanstoot, Henk-Jan
   Bakker-van Waarde, Willie M.
   Houdijk, Euphemia C. A. M.
   Nuboer, Roos
   Winterdijk, Per
   de Wit, Maartje
TI Parental Diabetes Behaviors and Distress Are Related to Glycemic Control
   in Youth with Type 1 Diabetes: Longitudinal Data from the DINO Study
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID QUALITY-OF-LIFE; MATERNAL DEPRESSIVE SYMPTOMS; METABOLIC-CONTROL;
   PSYCHOLOGICAL DISTRESS; ADOLESCENTS; CHILDREN; MOTHERS; CARE;
   RESPONSIBILITY; DISCREPANCIES
AB Objective. To evaluate (1) the longitudinal relationship between parental well-being and glycemic control in youth with type 1 diabetes and (2) if youth's problem behavior, diabetes parenting behavior, and parental diabetes-distress influence this relationship. Research Design and Methods. Parents of youth 8-15 yrs (at baseline) (N = 174) participating in the DINO study completed questionnaires at three time waves (1 yr interval). Using generalized estimating equations, the relationship between parental well-being (WHO-5) and youth's HbA1c was examined. Second, relationships between WHO-5, Strength and Difficulties Questionnaire (SDQ), Diabetes Family Behavior Checklist (DFBC), Problem Areas In Diabetes-Parent Revised (PAID-Pr) scores, and HbA1c were analyzed. Results. Low well-being was reported by 32% of parents. No relationship was found between parents' WHO-5 scores and youth's HbA1c (beta = -0 052, p = 0 650). WHO-5 related to SDQ (beta = -0 219, p < 0 01), DFBC unsupportive scale (beta = -0 174, p < 0 01), and PAID-Pr (beta = -0 666, p < 0 01). Both DFBC scales (supportive beta = -0 259, p = 0 01; unsupportive beta = 0 383, p = 0 017), PAID-Pr (beta = 0 276, p < 0 01), and SDQ (beta = 0 424, p < 0 01) related to HbA1c.Conclusions. Over time, reduced parental well-being relates to increased problem behavior in youth, unsupportive parenting, and parental distress, which negatively associate with HbA1c. More unsupportive diabetes parenting and distress relate to youth's problem behavior.
C1 [Eilander, Minke M. A.; Snoek, Frank J.; de Wit, Maartje] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, De Boelenlaan 1117, NL-1081 HV Amsterdam, Netherlands.
   [Eilander, Minke M. A.; Snoek, Frank J.; Rotteveel, Joost; de Wit, Maartje] Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
   [Eilander, Minke M. A.; Aanstoot, Henk-Jan; Winterdijk, Per] Diabeter, Ctr Pediat & Adolescent Diabet Care & Res, Blaak 6, NL-3011 TA Rotterdam, Netherlands.
   [Snoek, Frank J.] Acad Med Ctr, Dept Med Psychol, Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands.
   [Rotteveel, Joost] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, De Boelelaan 1118, NL-1081 HV Amsterdam, Netherlands.
   [Bakker-van Waarde, Willie M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
   [Houdijk, Euphemia C. A. M.] Juliana Childrens Hosp, Haga Hosp, Dept Pediat, Els Borst Eilerspl 275, NL-2545 AA The Hague, Netherlands.
   [Nuboer, Roos] Meander Med Ctr, Dept Pediat, Maatweg 3, NL-3813 TZ Amersfoort, Netherlands.
RP Eilander, MMA (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, De Boelenlaan 1117, NL-1081 HV Amsterdam, Netherlands.; Eilander, MMA (reprint author), Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.; Eilander, MMA (reprint author), Diabeter, Ctr Pediat & Adolescent Diabet Care & Res, Blaak 6, NL-3011 TA Rotterdam, Netherlands.
EM m.eilander@vumc.nl
FU Dutch Diabetes Foundation [2009.80.103]
FX Minke M. A. Eilander collected and researched the data, wrote the
   manuscript, and is a guarantor of the work. Frank J. Snoek, Joost
   Rotteveel, Henk-Jan Aanstoot, Willie M. Bakker-van Waarde, Euphemia C.
   A. M. Houdijk, Per Winterdijk, and Maartje de Wit reviewed and edited
   the manuscript. The authors would like to thank Professor Jos Twisk of
   the Department of Epidemiology and Biostatistics of the VU University
   Medical Center for his advisory role in the statistical analyses. This
   work was supported by the Dutch Diabetes Foundation (Grant no.
   2009.80.103).
CR ANDERSON BL, 1991, ADV CHILD HLTH PSYCH
   Armstrong B, 2011, J PEDIATR PSYCHOL, V36, P1052, DOI 10.1093/jpepsy/jsr039
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   CBS, 2017, WELZ REL GEZ LEEFST
   De Wit M, 2008, DIABETES CARE, V31, P1521, DOI 10.2337/dc08-0394
   Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191
   Driscoll KA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0762-2
   Duke DC, 2008, J PEDIATR PSYCHOL, V33, P719, DOI 10.1093/jpepsy/jsn012
   Eccleston C, 2015, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD009660.PUB3
   Eilander M. M. A., 2016, J DIABETES RES, V2016
   Eilander M, 2016, PEDIATR DIABETES, V17, P112, DOI 10.1111/pedi.12237
   Eilander MMA, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0400-1
   Hannonen R, 2015, ACTA PAEDIATR, V104, P1144, DOI 10.1111/apa.13144
   Hassan K, 2006, J PEDIATR-US, V149, P526, DOI 10.1016/j.jpeds.2006.05.039
   Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079
   Hoey H, 2009, PEDIATR DIABETES, V10, P9, DOI 10.1111/j.1399-5448.2009.00609.x
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Jaser SS, 2014, MATERN CHILD HLTH J, V18, P101, DOI 10.1007/s10995-013-1239-4
   Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138
   Law GU, 2013, J PSYCHOSOM RES, V74, P334, DOI 10.1016/j.jpsychores.2012.12.009
   Lohan A, 2015, CHILD CARE HLTH DEV, V41, P803, DOI 10.1111/cch.12278
   Lopez-Perez B, 2015, J EXP CHILD PSYCHOL, V139, P249, DOI 10.1016/j.jecp.2015.06.006
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   Maas-van Schaaijk NM, 2013, J PEDIATR PSYCHOL, V38, P30, DOI 10.1093/jpepsy/jss096
   Mackey ER, 2014, HEALTH PSYCHOL, V33, P783, DOI 10.1037/hea0000066
   Markowitz JT, 2012, DIABETIC MED, V29, P526, DOI 10.1111/j.1464-5491.2011.03434.x
   Rumburg TM, 2017, PEDIATR DIABETES, V18, P67, DOI 10.1111/pedi.12350
   SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179
   Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585
   van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3
   Verweij A., 2008, SCHOLING OPLEIDING I
   Wiebe DJ, 2014, J PEDIATR PSYCHOL, V39, P532, DOI 10.1093/jpepsy/jsu006
   Wu YP, 2013, DIABETIC MED, V30, P596, DOI 10.1111/dme.12117
   Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613
   Young MT, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0546-5
NR 35
TC 0
Z9 0
U1 2
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2017
AR 1462064
DI 10.1155/2017/1462064
PG 7
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA FR2OS
UT WOS:000418907200001
PM 29376080
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Berry, E
   Davies, M
   Dempster, M
AF Berry, Emma
   Davies, Mark
   Dempster, Martin
TI Illness perception clusters and relationship quality are associated with
   diabetes distress in adults with Type 2 diabetes
SO PSYCHOLOGY HEALTH & MEDICINE
LA English
DT Article
DE Type 2 diabetes mellitus; emotional adjustment; illness perceptions;
   interpersonal relations
ID DEPRESSIVE SYMPTOMS; EMOTIONAL DISTRESS; SCALE; REPRESENTATIONS;
   ADJUSTMENT; ADHERENCE; MELLITUS; TRIAL
AB This report aims to augment what is already known about emotional distress in Type 2 diabetes, by assessing the predictive value of illness perception clusters and relationship quality on four subcategories of Diabetes Distress.162 individuals with Type 2 diabetesresponded to a postal questionnaireassessing demographics, depression, diabetes distress, illness perceptions and relationship quality. Long-term blood glucose was retrievedfrom participants' General Practitioner. Three illness perception clusters emerged from the data,capturing three subgroups of participants sharing similar illness perception schemas. Regression analyses were performed across eachdiabetes distress subscale, with demographics, illness perception clusters, and relationship variables entered into three blocks.Covariates explained 51.1% of the variance in emotional burden, 41% of the variance in regimen-related distress, 20% of the variance in interpersonal distress, and 8.6% of the variance in physician-related distress. Cluster membership was strongly associated with emotional burden, regimen-related distress, and to a lesser degree interpersonal distress, but was not associated with physician-related distress. Relationship quality most strongly predicted regimen-related distress. Illness perception schemas and interpersonal issuesinfluence emotional adjustment in diabetes. This study provides direction for the content of a novel approach to identifying and reducing diabetes distress in people with Type 2 diabetes.
C1 [Berry, Emma; Dempster, Martin] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.
   [Davies, Mark] Belfast City Hosp, Clin Psychol, Belfast, Antrim, North Ireland.
RP Berry, E (reprint author), Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.
EM eberry05@qub.ac.uk
OI , Martin/0000-0001-9499-3186
FU Queen's University Belfast; Department of Education and Learning
FX This work was supported by Queen's University Belfast; and the
   Department of Education and Learning.
CR Beck AT, 1996, BECK DEPRESSION INVE
   Burns RJ, 2015, DIABETIC MED, V32, P1272, DOI 10.1111/dme.12860
   BUSBY DM, 1995, J MARITAL FAM THER, V21, P289, DOI 10.1111/j.1752-0606.1995.tb00163.x
   Dempster M, 2011, DIABETIC MED, V28, P487, DOI 10.1111/j.1464-5491.2010.03214.x
   Ebrahimi H, 2016, PRIM CARE DIABETES, V10, P129, DOI 10.1016/j.pcd.2015.09.003
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Garcia-Huidobro D, 2011, FAM PRACT, V28, P4, DOI 10.1093/fampra/cmq069
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Hosoya T, 2012, INTERNAL MED, V51, P263, DOI 10.2169/internalmedicine.51.5768
   Hudson JL, 2014, J PSYCHOSOM RES, V76, P265, DOI 10.1016/j.jpsychores.2014.02.004
   Islam MR, 2013, INT J MED BIOMED RES, V2, P113, DOI DOI 10.14194/IJMBR.224
   Johnson MD, 2015, BRIT J HEALTH PSYCH, V20, P360, DOI 10.1111/bjhp.12105
   Karlsen B, 2014, INT J NURS STUD, V51, P438, DOI 10.1016/j.ijnurstu.2013.06.016
   Miller D, 2005, J NUTR EDUC BEHAV, V37, P226, DOI 10.1016/S1499-4046(06)60276-5
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Ngcobo M., 2008, EUR DIABETES NURSING, V11, P133, DOI [10.4314/ajpsy.v11i2.30266, DOI 10.1002/EDN.72]
   NICE National Institute for Health and Clinical Excellence, 2015, CLIN GUID NG28 TYP 2
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Skinner TC, 2011, PSYCHOL HEALTH, V26, P321, DOI 10.1080/08870440903411039
   Strandberg RB, 2015, DIABETIC MED, V32, P1304, DOI 10.1111/dme.12781
NR 23
TC 2
Z9 2
U1 1
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1354-8506
EI 1465-3966
J9 PSYCHOL HEALTH MED
JI Psychol. Health Med.
PY 2017
VL 22
IS 9
BP 1118
EP 1126
DI 10.1080/13548506.2017.1281976
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FB6FU
UT WOS:000406237700011
PM 28103702
OA Green Published
DA 2019-01-08
ER

PT J
AU Ippolito, MM
   Lyles, CR
   Prendergast, K
   Marshall, MB
   Waxman, E
   Seligman, HK
AF Ippolito, Matthew M.
   Lyles, Courtney R.
   Prendergast, Kimberly
   Marshall, Michelle Berger
   Waxman, Elaine
   Seligman, Hilary Kessler
TI Food insecurity and diabetes self-management among food pantry clients
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Food security; Food pantries; Diabetes self-management
ID LOW-INCOME PATIENTS; GLYCEMIC CONTROL; MEDICATION ADHERENCE;
   MENTAL-HEALTH; SOCIOECONOMIC-STATUS; WELFARE RECIPIENTS; HEMOGLOBIN
   A(1C); DEPRESSION; DISTRESS; INSUFFICIENCY
AB Objective: To examine the association between level of food security and diabetes self-management among food pantry clients, which is largely not possible using clinic-based sampling methods.
   Design: Cross-sectional descriptive study.
   Setting: Community-based food pantries in California, Ohio and Texas, USA, from March 2012 through March 2014.
   Subjects: Convenience sample of adults with diabetes queuing at pantries (n 1237; 83 % response). Sampled adults were stratified as food secure, low food secure or very low food secure. We used point-of-care glycated Hb (HbA(1c)) testing to determine glycaemic control and captured diabetes self-management using validated survey items.
   Results: The sample was 70 % female, 55 % Latino/Hispanic, 25 % white and 10 % black/African American, with a mean age of 56 years. Eighty-four per cent were food insecure, one-half of whom had very low food security. Mean HbA(1c) was 8.1 % and did not vary significantly by food security status. In adjusted models, very-low-food-secure participants, compared with both low-food-secure and food-secure participants, had poorer diabetes self-efficacy, greater diabetes distress, greater medication non-adherence, higher prevalence of severe hypoglycaemic episodes, higher prevalence of depressive symptoms, more medication affordability challenges, and more food and medicine or health supply trade-offs.
   Conclusions: Few studies of the health impact of food security have been able to examine very low food security. In a food pantry sample with high rates of food insecurity, we found that diabetes self-management becomes increasingly difficult as food security worsens. The efficacy of interventions to improve diabetes self-management may increase if food security is simultaneously addressed.
C1 [Ippolito, Matthew M.] Johns Hopkins Univ, Sch Med, Dept Med, 1830 East Monument St,Room 450B, Baltimore, MD 21287 USA.
   [Lyles, Courtney R.; Seligman, Hilary Kessler] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Lyles, Courtney R.; Seligman, Hilary Kessler] San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94110 USA.
   [Prendergast, Kimberly; Marshall, Michelle Berger] Feeding Amer, Chicago, IL USA.
   [Waxman, Elaine] Urban Inst, Washington, DC 20037 USA.
RP Ippolito, MM (reprint author), Johns Hopkins Univ, Sch Med, Dept Med, 1830 East Monument St,Room 450B, Baltimore, MD 21287 USA.
EM mippolito@jhu.edu
FU NIH/NCRR/OD UCSF-CTSI [KL2 RR024130]; AHRQ Career Development Award
   [R00HS022408]; The Bristol-Myers Squibb Foundation; National Institute
   of General Medical Sciences of the National Institutes of Health
   [T32GM066691]
FX This work was supported by NIH/NCRR/OD UCSF-CTSI Grant Number KL2
   RR024130, AHRQ Career Development Award R00HS022408, and The
   Bristol-Myers Squibb Foundation. Research reported in this publication
   was supported by the National Institute of General Medical Sciences of
   the National Institutes of Health under award number T32GM066691. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. Funders had no role in the design, analysis or writing of this
   article.
CR Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   Anater AS, 2011, J HUNGER ENVIRON NUT, V6, P27, DOI 10.1080/19320248.2011.549368
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Baronberg S, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130113
   Berkowitz SA, 2013, DIABETES CARE, V36, P3093, DOI 10.2337/dc13-0570
   Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344
   Bunnell R, 2012, J COMMUN HEALTH, V37, P1081, DOI 10.1007/s10900-012-9542-3
   Centers for Disease Control and Prevention, 2014, MEAN MED AIC AD DIAG
   Coleman-Jensen Alisha, 2012, 141 US DEP AGR EC RE
   Corcoran M, 2001, WELFARE WORK WELLBEI, P159
   County Health Rankings and Roadmaps, 2016, HLTH FOOD IN FOOD BA
   Dammann KW, 2009, J NUTR EDUC BEHAV, V41, P242, DOI [10.1016/j.jneb.2008.07.003, 10.1016/j.neb.2008.07.003]
   Drewnowski A, 2005, J NUTR, V135, P900
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gaskin DJ, 2014, AM J PUBLIC HEALTH, V104, P2147, DOI 10.2105/AJPH.2013.301420
   Glasgow RE, 2005, ANN FAM MED, V3, P73, DOI 10.1370/afm.261
   Gross R, 2005, J GEN INTERN MED, V20, P460, DOI 10.1111/j.1525-1497.2005.30003.x
   Hanson KL, 2012, J HEALTH CARE POOR U, V23, P1174, DOI 10.1353/hpu.2012.0116
   Heflin CM, 2005, SOC SCI MED, V61, P1971, DOI 10.1016/j.socscimed.2005.04.014
   Herman DR, 2008, AM J PUBLIC HEALTH, V98, P98, DOI 10.2105/AJPH.2005.079418
   Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007
   KAVANAGH DJ, 1993, J BEHAV MED, V16, P509, DOI 10.1007/BF00844820
   Krapek K, 2004, ANN PHARMACOTHER, V38, P1357, DOI 10.1345/aph.1D612
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lyles CR, 2013, DIABETES CARE, V36, P1448, DOI 10.2337/dc12-1961
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   National Research Council, 2006, FOOD INS HUMG US ASS
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6
   Seligman HK, 2015, HEALTH AFFAIR, V34, P1956, DOI 10.1377/hlthaff.2015.0641
   Seligman HK, 2014, HEALTH AFFAIR, V33, P116, DOI 10.1377/hlthaff.2013.0096
   Seligman HK, 2012, DIABETES CARE, V35, P233, DOI 10.2337/dc11-1627
   Seligman HK, 2011, ARCH INTERN MED, V171, P1204, DOI 10.1001/archinternmed.2011.287
   Seligman HK, 2010, J HEALTH CARE POOR U, V21, P1227, DOI 10.1353/hpu.2010.0921
   Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072
   Siefert K, 2004, J HEALTH SOC BEHAV, V45, P171, DOI 10.1177/002214650404500204
   Siefert K, 2001, WOMEN HEALTH, V32, P159, DOI 10.1300/J013v32n01_08
   Silverman J, 2015, J GEN INTERN MED, V30, P1476, DOI 10.1007/s11606-015-3351-1
   Talbot F, 1997, J BEHAV MED, V20, P291, DOI 10.1023/A:1025508928696
   Wang EA, 2011, J GEN INTERN MED, V26, P1012, DOI 10.1007/s11606-011-1723-8
   Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239
NR 45
TC 4
Z9 4
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JAN
PY 2017
VL 20
IS 1
BP 183
EP 189
DI 10.1017/S1368980016001786
PG 7
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA FA1LN
UT WOS:000405201100020
PM 27406399
OA Bronze
DA 2019-01-08
ER

PT J
AU Otieno, CFF
   Kanu, JE
   Karari, EM
   Okech-Helu, V
   Joshi, MD
   Mutai, K
AF Otieno, C. F. Frederick
   Kanu, Joseph E.
   Karari, Emma M.
   Okech-Helu, Violet
   Joshi, Mark D.
   Mutai, Kenn
TI Glucose-lowering therapies, adequacy of metabolic control, and their
   relationship with comorbid depression in outpatients with type 2
   diabetes in a tertiary hospital in Kenya
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE type 2 diabetes; comorbid depression; insulin therapy and poor glycemic
   control
ID GLYCEMIC CONTROL; MEDICATION ADHERENCE; CLINICAL DEPRESSION; SELF-CARE;
   DISTRESS; MELLITUS; METAANALYSIS; MANAGEMENT; SYMPTOMS; ADULTS
AB Background: Depression and diabetes mellitus are important comorbid conditions with serious health consequences. When depression and diabetes are comorbid, depression negatively affects self-management activities of diabetes with serious consequences. Relationship between treatment regimens of diabetes, the adequacy of glycemic control, and occurrence of comorbid depression is not known among our patients.
   Patients and methods: This was a cross-sectional descriptive study at the outpatient diabetes clinic of the Kenyatta National Hospital where 220 ambulatory patients with type 2 diabetes on follow-up were systematically sampled. Sociodemographic data and clinical information were documented. The Patient Health Questionnaire-9 (PHQ-9) was used to assess depression. Ethylenediaminetetraacetic acid-anticoagulated blood was used for glycated hemoglobin (HbA(1C)) assay on automated system, COBAS INTEGRA machine.
   Results: Two hundred twenty patients with type 2 diabetes were enrolled. The prevalence of comorbid depression by PHQ-9 was 32.3% (95% confidence interval: 26.4%-38.6%). The majority, 69.5%, had poor glycemic control, HbA(1C)> 7.0%, mean HbA(1C) was 8.9%+/- 2.4%. Half, 50.4%, of the study subjects were on insulin-containing regimens. Over 8% (84.5%) of the participants with comorbid depression had poor glycemic control, which worsened with increasing severity of depression. There was significant correlation between comorbid depression and poor glycemic control, which is more consistent in the insulin-treated patients. However, patients on oral agents only, both with and without comorbid depression, were similar in their glycemic control.
   Conclusion: Among our type 2 diabetic population with comorbid depression, a large proportion had poor glycemic control, which worsened with increasing severity of depression. The insulin treatment increased the odds of comorbid depression and poor glycemic control in patients. It is justifiable to screen for comorbid depression in patients with type 2 diabetes who are in poor glycemic control, especially the insulin-treated, and then provide specific and appropriate interventions that are necessary to optimize their metabolic outcomes.
C1 [Otieno, C. F. Frederick; Kanu, Joseph E.; Karari, Emma M.; Joshi, Mark D.] Univ Nairobi, Dept Clin Med & Therapeut, Nairobi, Kenya.
   [Okech-Helu, Violet; Mutai, Kenn] Kenyatta Natl Hosp, Nairobi, Kenya.
RP Otieno, CFF (reprint author), Univ Nairobi, Dept Clin Med & Therapeut, Nairobi, Kenya.
EM cfotieno@gmail.com
CR Aikens JE, 2008, DIABETIC MED, V25, P1324, DOI 10.1111/j.1464-5491.2008.02590.x
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Albright TL, 2001, FAM MED, V33, P354
   American Diabetes Association, 2015, DIABETES CARE S1, V38, pS1, DOI DOI 10.2337/DC15-S001
   Ascher-Svanum H, 2015, DIABETES THER, V6, P303, DOI 10.1007/s13300-015-0118-y
   Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344
   Chao Jingdong, 2005, Res Social Adm Pharm, V1, P508, DOI 10.1016/j.sapharm.2005.09.002
   Cochran WG., 1977, SAMPLING TECHNIQUES
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   DSouza MS, 2015, GSTF J NURSING HLTH, V2, P29
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gramer JA, 2005, DIABETES CARE, V28, P78
   Huang YF, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-260
   International Obesity Task Force of WHO 2000, 2004, INT J OBESITY, V28, P152
   Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427
   Katon W, 2009, PSYCHOSOM MED, V71, P965, DOI 10.1097/PSY.0b013e3181bd8f55
   Lee HJ, 2009, J AM ACAD NURSE PRAC, V21, P214, DOI 10.1111/j.1745-7599.2009.00396.x
   Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Niraula K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-309
   Otieno C F, 2005, East Afr Med J, V82, pS184
   Otieno C F, 2003, East Afr Med J, V80, P406
   Paul SK, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0260-x
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Tan MY, 2008, PATIENT EDUC COUNS, V72, P252, DOI 10.1016/j.pec.2008.03.017
   Teklay G, 2013, J MED SCI, V13, P578
   U. K. Prospective Diabetes Study Group, 1995, DIABETES, V44, P1249
   Vijan S, 2005, J GEN INTERN MED, V20, P479, DOI 10.1111/j.1525-1497.2005.0117.x
   Zafar A, 2010, PRIM CARE DIABETES, V4, P203, DOI 10.1016/j.pcd.2010.07.003
NR 42
TC 1
Z9 1
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2017
VL 10
DI 10.2147/DMSO.S124473
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA ET7YH
UT WOS:000400514900001
PM 28496345
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Asuzu, CC
   Walker, RJ
   Williams, JS
   Egede, LE
AF Asuzu, Christopher C.
   Walker, Rebekah J.
   Williams, Joni Strom
   Egede, Leonard E.
TI Pathways for the relationship between diabetes distress, depression,
   fatalism and glycemic control in adults with type 2 diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes; Depression; Diabetes distress; Fatalism; HbA1c
ID SELF-CARE; SOCIAL DETERMINANTS; MEDICATION ADHERENCE; METAANALYSIS;
   HEALTH; OUTCOMES; SCALE; PREVALENCE; MANAGEMENT; VALIDITY
AB Background: The aim of this study was to examine the mechanism by which depressive symptoms, diabetes distress, and diabetes fatalism together influence diabetes outcomes using structured equation modeling.
   Methods: 615 adults with type 2 diabetes were recruited from two primary care clinics in the southeastern United States. Psychosocial factors found to be associated with diabetes outcomes were measured using validated questionnaires. Structured equation modeling (SEM) was used to investigate the relationship between diabetes fatalism, depressive symptoms, diabetes distress, self-care and glycemic control.
   Results: The final model (chi(2)(903) = 24,088.91, p < 0.0001, R-2 = 0.93, RMSEA = 0.05 and CFI = 0.90) showed that higher diabetes distress was directly significantly related to a decreased self-care (r = -0.69, p < 0.001) and increased HbA1c (r = 0.69, p < 0.001). There was no significant direct association between depressive symptoms or fatalism, and glycemic control or self-care. There was, however, an indirect association between increased depressive symptoms and increased fatalism, explained through the direct association with diabetes distress in that higher depressive symptoms (0.76, p < 0.001) and higher fatalism (0.11, p < 0.001) were significantly associated with higher diabetes distress.
   Conclusion: Diabetes distretc-serves as a pathway through which depressive symptoms and fatalism impact both glycemic control and self-care. In addition, pathways between diabetes distress and both self-care behaviors and glycemic control in patients with type 2 diabetes remained separate, suggesting the need to address both psychological and behavioral factors in standard diabetes care, rather than focusing on psyChological care primarily through support for self-management and treatment of depression. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Asuzu, Christopher C.] Med Univ South Carolina, Coll Med, Charleston, SC USA.
   [Walker, Rebekah J.; Williams, Joni Strom; Egede, Leonard E.] Med Univ South Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.
   [Walker, Rebekah J.; Williams, Joni Strom; Egede, Leonard E.] Ralph H Johnson VAMC, Charleston VA HSR&D COIN, HEROIC, Charleston, SC USA.
   [Walker, Rebekah J.; Williams, Joni Strom; Egede, Leonard E.] Med Univ South Carolina, Dept Med, Div Gen Internal Med & Geriatr, Charleston, SC USA.
RP Egede, LE (reprint author), Med Univ South Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280, Charleston, SC 29425 USA.
EM egedel@musc.edu
FU National Institute of Diabetes and Digestive and Kidney Disease
   [K24DK093699]
FX This study was supported by grant K24DK093699 from The National
   Institute of Diabetes and Digestive and Kidney Disease (PI: Leonard
   Egede).
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Centers for Disease Control and Prevention, 2015, NAT DIAB STAT REP ES
   Chailson M. E., 1987, J CHRON DIS, V40, P373
   Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI DOI 10.1316/S0782-051X03024046-9
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Egede LE, 2003, DIABETES EDUCATOR, V29, P105, DOI 10.1177/014572170302900115
   Egede LE, 2010, J GEN INTERN MED, V25, P61, DOI 10.1007/s11606-009-1168-5
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAMILY MED, V6
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Foundations of Care, 2014, DIABETES CARE S1, V38, pS20
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.1016/J.INFBEH.2006.11.010
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Marmot M, 2014, AM J PUBLIC HEALTH, V104, pS517, DOI 10.2105/AJPH.2014.302200
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   National Center for Health Statistics, 2004, SURV QUEST NAT HLTH
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003
   Schumacker RE, 2010, BEGINNERS GUIDE STRU
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker RJ, 2014, GEN HOSP PSYCHIAT, V36, P662, DOI 10.1016/j.genhosppsych.2014.06.011
   Walker RJ, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-82
   Walker RJ, 2014, ENDOCRINE, V47, P29, DOI 10.1007/s12020-014-0195-0
   Walker RJ, 2012, GEN HOSP PSYCHIAT, V34, P598, DOI 10.1016/j.genhosppsych.2012.07.005
   World Health Organization, 2015, CONCEPTUAL FRAMEWORK
   Zulman DM, 2012, PATIENT EDUC COUNS, V87, P74, DOI 10.1016/j.pec.2011.07.013
NR 34
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JAN
PY 2017
VL 31
IS 1
BP 169
EP 174
DI 10.1016/j.jdiacomp.2016.09.013
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA ES3MZ
UT WOS:000399435000025
PM 27746088
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Chernyak, N
   Julich, F
   Kasperidus, J
   Stephan, A
   Begun, A
   Kaltheuner, M
   Icks, A
AF Chernyak, Nadja
   Juelich, Fabian
   Kasperidus, Julia
   Stephan, Astrid
   Begun, Alexander
   Kaltheuner, Matthias
   Icks, Andrea
TI Time cost of diabetes: Development of a questionnaire to assess time
   spent on diabetes self-care
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Patient time; Time measurement; Recall questionnaire; Self-care;
   Diabetes
ID HEALTH STATE VALUATIONS; SILENCE; LEISURE; INCOME; SCALE
AB Background: Methods to measure patient time spent on health-related activities are currently not well elaborated or standardized.
   Aim: The purpose of this study was to develop a recall questionnaire measuring patient time devoted to diabetes self-care and to examine its feasibility and validity under field conditions.
   Methods: The initial questionnaire was developed on the basis of instruments frequently used to assess self-care behavior in patients with diabetes, evaluated in two focus groups with patients with type 2 diabetes (N = 15) and tested in a random sample of patients with type 2 diabetes (N = 178). To assess the validity of the questionnaire, four hypotheses about expected differences in self-care time across various patient sub-groups were tested.
   Results: The final questionnaire includes thirteen items estimating time spent on regular diabetes-related activities undertaken in the previous seven days. 78% of respondents completed the questionnaire without item non-response or other evident problems. As hypothesized, respondents receiving insulin treatment, those with poor self-rated health and those with diabetes-related emotional distress (PAID-5 score >= 8) reported spending more time on diabetes self-care than the rest of the sample. Contrary to our assumption, no differences in time spent on diabetes self-care between employed and retired individuals were detected by the questionnaire.
   Conclusion: The recall questionnaire measuring patient time devoted to a broad range of regular diabetes self-care activities was developed and its feasibility was proved under field conditions. Ideally, the questionnaire should be further validated within a variety of populations. Exploration of the convergent validity between the recall method and prospective diary may be also useful. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Chernyak, Nadja; Juelich, Fabian; Kasperidus, Julia; Stephan, Astrid; Icks, Andrea] Heinrich Heine Univ Dusseldorf, Fac Med, Inst Hlth Serv Res & Hlth Econ, Mooren Str 5, D-40225 Dusseldorf, Germany.
   [Begun, Alexander; Icks, Andrea] Heinrich Heine Univ Dusseldorf, German Diabet Ctr, Inst Biometr & Epidemiol, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
   [Icks, Andrea] German Ctr Diabet Res DZD eV, Partner Dusseldorf, Dusseldorf, Germany.
RP Chernyak, N (reprint author), Heinrich Heine Univ Dusseldorf, Fac Med, Inst Hlth Serv Res & Hlth Econ, Mooren Str 5, D-40225 Dusseldorf, Germany.
EM Nadja.Chernyak@uni-duesseldorf.de; fabian-juelich@gmx.de;
   juliakasperidus@gmx.de; astrid.stephan@uni-duesseldorf.de;
   Alexander.Begun@ddz.uni-duesseldorf.de; m.kaltheuner@web.de;
   Andrea.lcks@uni-duesseldorf.de
FU German Research Foundation (DFG) [701 010 607]; German Federal Ministry
   of Education and Research (BMBF)
FX The study was funded by the German Research Foundation (DFG, 701 010
   607) and supported in part by a grant from the German Federal Ministry
   of Education and Research (BMBF) to the German Center for Diabetes
   Research (DZD e.V.)
CR Brouwer WBF, 2003, HEALTH ECON, V12, P629, DOI 10.1002/hec.764
   Brouwer WBF, 2009, MED DECIS MAKING, V29, P503, DOI 10.1177/0272989X09336161
   Ettner SL, 2009, HEALTH ECON, V18, P645, DOI 10.1002/hec.1394
   Gold MR, 1996, COST EFFECTIVENESS H
   Jowsey T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1044
   JUSTER FT, 1991, J ECON LIT, V29, P471
   Kamble S, 2013, MED DECIS MAKING, V33, P215, DOI 10.1177/0272989X12464824
   McEwen LN, 2011, DIABETES CARE, V34, P1180, DOI 10.2337/dc10-2038
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Russell LB, 2005, J FAM PRACTICE, V54, P52
   Russell LB, 2009, MED CARE, V47, pS89, DOI 10.1097/MLR.0b013e31819bc077
   Safford MM, 2005, J AM BOARD FAM PRACT, V18, P262, DOI 10.3122/jabfm.18.4.262
   Sendi P, 2005, HEALTH ECON, V14, P643, DOI 10.1002/hec.971
   Streiner DL, 2003, HLTH MEASUREMENT SCA
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Yen L, 2013, CHRONIC ILLN, V9, P268, DOI 10.1177/1742395313476720
   Yen LE, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-33
NR 20
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JAN
PY 2017
VL 31
IS 1
BP 260
EP 266
DI 10.1016/j.jdiacomp.2016.06.016
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA ES3MZ
UT WOS:000399435000040
PM 27411888
DA 2019-01-08
ER

PT J
AU Schmidt, CB
   van Loon, BJP
   Torensma, B
   Snoek, FJ
   Honig, A
AF Schmidt, Charlotte B.
   van Loon, Bert Jan Potter
   Torensma, Bart
   Snoek, Frank J.
   Honig, Adriaan
TI Ethnic Minorities with Diabetes Differ in Depressive and Anxiety
   Symptoms and Diabetes-Distress
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
DE Objective. To determine the association between ethnicity;
   diabetes-distress; and depressive and anxiety symptoms in adult;
   outpatients with diabetes. Research Design and Methods.
   Diabetes-distress (Problem Areas in Diabetes Scale; PAID5); depressive
   and; anxiety symptoms ( Extended Kessler-10; EK10); and quality of life
   (Short-Form12; SF12) were assessed in an ethnic diverse diabetes;
   outpatient population of a teaching hospital in Amsterdam. Descent of
   one's parents and self-classified ethnicity were obtained to; define
   ethnicity. HbA1c; clinical data; and socioeconomic status were derived
   from the medical charts. Based on established cut-offs; for PAID5; and
   EK10; scores; emotional distress was dichotomized for the purpose of
   logistic regression analyses. Results. Of 1007; consecutive patients
   approached; 575 participated. Forty-nine percent were of non-Dutch
   ethnicity and 24.7% had type 1 diabetes.; Diabetes-distress was reported
   by 12.5% of the native Dutch patients and by 22.0%; 34.5%; and 42.6% of
   the Surinamese; Turkish; and Moroccan patients; respectively. Prevalence
   of depressive symptoms was 9.4% in native Dutch patients and 20.4%;
   34.5%; and; 27.3% in the other groups mentioned. Diabetes-distress and
   Moroccan origin were significantly associated (OR=3.60; p < .01) as;
   well as depressive symptoms and Turkish origin (OR=4.23; p =.04).
   Conclusions. Different ethnic minorities with diabetes vary; in their
   vulnerability for emotional distress; warranting clinical attention.
   Future research should elucidate explanatory factors and; opportunities
   for tailored interventions.
ID EMOTIONAL DISTRESS; RISK-FACTORS; SOCIOECONOMIC-STATUS; COMORBID
   DEPRESSION; MENTAL-DISORDERS; SECONDARY CARE; PREVALENCE; POPULATION;
   MOROCCAN; TURKISH
AB Objective. To determine the association between ethnicity, diabetes-distress, and depressive and anxiety symptoms in adult outpatients with diabetes. Research Design and Methods. Diabetes-distress (Problem Areas in Diabetes Scale, PAID5), depressive and anxiety symptoms (Extended Kessler-10, EK10), and quality of life (Short-Form12, SF12) were assessed in an ethnic diverse diabetes outpatient population of a teaching hospital in Amsterdam. Descent of one's parents and self-classified ethnicity were obtained to define ethnicity. HbA1c, clinical data, and socioeconomic status were derived from the medical charts. Based on established cut-offs for PAID5- and EK10-scores, emotional distress was dichotomized for the purpose of logistic regression analyses. Results. Of 1007 consecutive patients approached, 575 participated. Forty-nine percent were of non-Dutch ethnicity and 24.7% had type 1 diabetes. Diabetes-distress was reported by 12.5% of the native Dutch patients and by 22.0%, 34.5%, and 42.6% of the Surinamese, Turkish, and Moroccan patients, respectively. Prevalence of depressive symptoms was 9.4% in native Dutch patients and 20.4%, 34.5%, and 27.3% in the other groups mentioned. Diabetes- distress and Moroccan origin were significantly associated (OR = 3.60, p < .01) as well as depressive symptoms and Turkish origin ( OR = 4.23, p =.04). Conclusions. Different ethnic minorities with diabetes vary in their vulnerability for emotional distress, warranting clinical attention. Future research should elucidate explanatory factors and opportunities for tailored interventions.
C1 [Schmidt, Charlotte B.; Honig, Adriaan] OLVG, Dept Psychiat, Amsterdam, Netherlands.
   [Schmidt, Charlotte B.; Snoek, Frank J.] Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.
   [van Loon, Bert Jan Potter] OLVG, Dept Internal Med, Amsterdam, Netherlands.
   [Torensma, Bart] OLVG, Dept Epidemiol & Biostat, Amsterdam, Netherlands.
   [Snoek, Frank J.] AMC, Dept Med Psychol, Amsterdam, Netherlands.
   [Snoek, Frank J.] VU Univ Med Ctr VUMC, Dept Med Psychol, Amsterdam, Netherlands.
   [Honig, Adriaan] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.
RP Schmidt, CB (reprint author), OLVG, Dept Psychiat, Amsterdam, Netherlands.; Schmidt, CB (reprint author), Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.
EM c.schmidt@olvg.nl
OI Schmidt, Charlotte/0000-0002-7852-4264
FU Innovation Fund of OLVG-W
FX The authors thank all people that participated in this study and Saskia
   Gorter-de Vries, Trudy Nieuwint, Nabila Chaara, Patrick Bonestroo, Leni
   Telleman, Renee Elsas, Inge de Vlieger, and Evert van der Poest Clement
   (all from OLVG) for valuable contributions. The authors also thank the
   personnel of the Internal Medicine Outpatient Department for assistance
   in data collection. This study was supported by the Innovation Fund of
   OLVG-W.
CR Al-Krenawi A, 2005, ISRAEL J PSYCHIAT, V42, P71
   Ali S, 2009, POSTGRAD MED J, V85, P238, DOI 10.1136/pgmj.2008.074641
   [Anonymous], 1985, INT DEMOGRAPHICS, V4, P1
   [Anonymous], 2014, AOF FONDS HUIS ACHT
   Bambra C, 2010, J EPIDEMIOL COMMUN H, V64, P284, DOI 10.1136/jech.2008.082743
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Baumeister H, 2011, PSYCHOTHER PSYCHOSOM, V80, P275, DOI 10.1159/000323404
   Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466
   Brazier J, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18340
   Cinnirella M, 1999, BRIT J MED PSYCHOL, V72, P505, DOI 10.1348/000711299160202
   Danesh J, 1999, BRIT MED J, V318, P843, DOI 10.1136/bmj.318.7187.843
   de Wit MAS, 2008, SOC PSYCH PSYCH EPID, V43, P905, DOI 10.1007/s00127-008-0382-5
   Donker T, 2010, PSYCHIAT RES, V176, P45, DOI 10.1016/j.psychres.2009.01.012
   Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hair J., 1995, MULTIVARIATE DATA AN
   Hans E, 2013, J CONSULT CLIN PSYCH, V81, P75, DOI 10.1037/a0031080
   Haverkamp GLG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130961
   Ince BU, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0252-5
   Kamperman A. M., 2003, TIJDSCHR PSYCHIAT, V45, P315
   Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   Loewenthal KM, 2001, BRIT J MED PSYCHOL, V74, P293, DOI 10.1348/000711201160993
   Maurischat C, 2008, PSYCHOL SCI Q, V50, P7
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Muntaner C, 2004, EPIDEMIOL REV, V26, P53, DOI 10.1093/epirev/mxh001
   Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3
   Peyrot M, 2014, CURR MED RES OPIN, V30, P2241, DOI 10.1185/03007995.2014.947023
   Pouwer F, 2013, DIABETIC MED, V30, pE25, DOI 10.1111/dme.12031
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Sobel M. E., 1982, SOCIOL METHODOL, P290, DOI DOI 10.2307/270723
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206
   Uitewaal PJM, 2004, PREV MED, V39, P1068, DOI 10.1016/j.ypmed.2004.04.009
   Ujcic-Voortman JK, 2009, EUR J PUBLIC HEALTH, V19, P511, DOI 10.1093/eurpub/ckp096
   Unsal A, 2011, INT J NURS PRACT, V17, P411, DOI 10.1111/j.1440-172X.2011.01949.x
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van der Wurff FB, 2004, J AFFECT DISORDERS, V83, P33, DOI 10.1016/j.jad.2004.04.009
   Ware J, 1995, SF 12 SCORE SF 12 PH
   Yuan Y, 2005, MULTIPLE IMPUTATION
   Zimmerman FJ, 2005, HEALTH ECON, V14, P1197, DOI 10.1002/hec.1011
NR 52
TC 2
Z9 2
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2017
AR 1204237
DI 10.1155/2017/1204237
PG 11
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA EQ9IH
UT WOS:000398397600001
PM 28373992
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Feng, XQ
   Astell-Burt, T
AF Feng, Xiaoqi
   Astell-Burt, Thomas
TI Impact of a type 2 diabetes diagnosis on mental health, quality of life,
   and social contacts: a longitudinal study
SO BMJ OPEN DIABETES RESEARCH & CARE
LA English
DT Article
ID PSYCHOLOGICAL DISTRESS; ETHNIC-DIFFERENCES; SCREENING SCALES;
   RISK-FACTOR; DEPRESSION; METAANALYSIS; MELLITUS; STIGMA; ADULTS;
   PREVENTION
AB Aims: The aim was to examine whether a type 2 diabetes mellitus (T2DM) diagnosis increases the odds of psychological distress, a worsening in overall quality of life, and a potential reduction in social contacts.
   Method: Longitudinal data were obtained from the 45 and Up Study (baseline 2006-2008; 3.4 +/- 0.95 years follow-up time). Fixed effects logistic and negative binomial regression models were fitted on a complete case on outcome sample that did not report T2DM at baseline (N=26 344), adjusted for time-varying confounders. The key exposure was doctor-diagnosed T2DM at follow-up. Outcome variables examined included the Kessler Psychological Distress Scale, self-rated quality of life, and four indicators of social contacts.
   Results: A modest increase in the odds of psychological distress associated with T2DM diagnosis (OR= 1.30) was not statistically significant (95% CI 0.75 to 2.25). A T2DM diagnosis was associated with a fivefold increase in the odds of a participant reporting that their quality of life had become significantly poorer (OR 5.49, 95% CI 1.26 to 23.88). T2DM diagnosis was also associated with a reduction in times spent with friends and family (RR 0.88, 95% CI 0.82 to 0.95), contacts by telephone (RR 0.95, 95% CI 0.87 to 1.02), attendance at social clubs or religious groups (RR 0.82, 95% CI 0.73 to 0.91), and the number of people nearby but outside the home that participants felt they could rely on (RR 0.92, 95% CI 0.86 to 0.98).
   Conclusions: A T2DM diagnosis can have important impacts on quality of life and on social contacts, which may have negative impacts on mental health and T2DM management in the longer term.
C1 [Feng, Xiaoqi; Astell-Burt, Thomas] Univ Wollongong, Fac Social Sci, Sch Hlth & Soc, Populat Wellbeing & Environm Res Lab PowerLab, Wollongong, NSW, Australia.
   [Feng, Xiaoqi; Astell-Burt, Thomas] Univ Wollongong, Fac Social Sci, Early Start Res Inst, Wollongong, NSW, Australia.
   [Feng, Xiaoqi; Astell-Burt, Thomas] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.
RP Feng, XQ (reprint author), Univ Wollongong, Fac Social Sci, Sch Hlth & Soc, Populat Wellbeing & Environm Res Lab PowerLab, Wollongong, NSW, Australia.; Feng, XQ (reprint author), Univ Wollongong, Fac Social Sci, Early Start Res Inst, Wollongong, NSW, Australia.; Feng, XQ (reprint author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.
EM xfeng@uow.edu.au
OI Feng, Xiaoqi/0000-0002-3421-220X; Astell-Burt,
   Thomas/0000-0002-1498-4851
FU National Health and Medical Research Council [1101065]; Vanguard grant
   from the National Heart Foundation of Australia [101460]; National Heart
   Foundation of Australia Postdoctoral Fellowship [100948]
FX This work was supported by a project grant from the National Health and
   Medical Research Council (grant number #1101065) and a Vanguard grant
   from the National Heart Foundation of Australia (grant number #101460).
   Dr Feng's contribution was also supported by a National Heart Foundation
   of Australia Postdoctoral Fellowship: grant number #100948.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Allison P. D., 2005, FIXED EFFECTS REGRES
   *AUSTR BUR STAT, 2003, INF PAP US KESSL PSY
   Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184
   Barkow K, 2001, EUR ARCH PSY CLIN N, V251, P21, DOI 10.1007/BF03035122
   Browne JL, 2013, DIABETIC MED, V30, P620, DOI 10.1111/dme.12078
   Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384
   Chapple A, 2004, BRIT MED J, V328, P1470, DOI 10.1136/bmj.38111.639734.7C
   Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183
   Colagiuri S, 2012, DIABETES OBES METAB, V14, P3, DOI 10.1111/j.1463-1326.2011.01506.x
   Colagiuri S, 2014, MED J AUSTRALIA, V201, P501, DOI 10.5694/mja14.01307
   Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305
   Ducat L, 2014, JAMA-J AM MED ASSOC, V312, P691, DOI 10.1001/jama.2014.8040
   Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3
   Feng XQ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002713
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221
   Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403
   Jimenez DE, 2013, J AM GERIATR SOC, V61, P18, DOI 10.1111/jgs.12063
   Johnson Joy L, 2007, Proc Am Thorac Soc, V4, P680, DOI 10.1513/pats.200706-084SD
   Jutagir DR, 2016, ETHNIC HEALTH, V21, P411, DOI 10.1080/13557858.2015.1066494
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Kawachi I., 2008, SOCIAL CAPITAL HLTH
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3
   Kuh D., 2004, LIFE COURSE APPROACH
   Marrero D, 2014, QUAL LIFE RES, V23, P75, DOI 10.1007/s11136-013-0436-3
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Narayan KMV, 2012, HEALTH AFFAIR, V31, P84, DOI 10.1377/hlthaff.2011.1040
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Room R, 2005, DRUG ALCOHOL REV, V24, P143, DOI 10.1080/0959230500102434
   ROSENBAUM M, 1990, LEARNED RESOURCEFULN, P3, DOI DOI 10.1016/S0005-7894(80)80040-2
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Semenkovich K, 2015, DRUGS, V75, P577, DOI 10.1007/s40265-015-0347-4
   Shaw J, 2012, DIABETES SILENT PAND
   Skaff MM, 2009, HEALTH PSYCHOL, V28, P265, DOI 10.1037/a0014429
   Speight J, 2016, MED J AUSTRALIA, V205, P149, DOI 10.5694/mja16.00556
   Stewart-Brown S, 2011, J EPIDEMIOL COMMU S2, V11, DOI [10.1136/jech.2011.143586.86, DOI 10.1136/JECH.2011.143586.86]
   Zacks S, 2006, J CLIN GASTROENTEROL, V40, P220, DOI 10.1097/00004836-200603000-00009
   Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8
NR 42
TC 0
Z9 0
U1 2
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2052-4897
J9 BMJ OPEN DIAB RES CA
JI BMJ Open Diab. Res. Care
PD JAN
PY 2017
VL 5
IS 1
DI 10.1136/bmjdrc-2016-000198
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EO9VX
UT WOS:000397037300001
PM 28243446
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Rees, G
   O'Hare, F
   Saeed, M
   Sudholz, B
   Sturrock, BA
   Xie, J
   Speight, J
   Lamoureux, EL
AF Rees, Gwyneth
   O'Hare, Fleur
   Saeed, Marian
   Sudholz, Bronwyn
   Sturrock, Bonnie A.
   Xie, Jing
   Speight, Jane
   Lamoureux, Ecosse L.
TI Problem-solving therapy for adults with diabetic retinopathy and
   diabetesspecific distress: a pilot randomized controlled trial
SO BMJ OPEN DIABETES RESEARCH & CARE
LA English
DT Article
ID GLYCEMIC CONTROL; DEPRESSION; ASSOCIATION; CARE; COMPLICATIONS;
   METAANALYSIS; TYPE-1; SCALE
AB Objective: To provide preliminary evidence for the impact of problem-solving therapy for diabetes ( PST-D) in adults with diabetic retinopathy ( DR) and diabetes distress. Research design and methods: In a pilot randomized controlled trial, 40 participants with DR and diabetes distress were allocated to the PST-D or control groups. Diabetes distress ( DDS), depressive symptoms ( PHQ-9), self-care activities ( SDSCA), and HbA1c were assessed at baseline, and 3 and 6-month follow-ups. Results: At the 6-month follow-up, the PST-D group showed significant improvements relative to the control group, in `regimen-related distress' ( PST-D: - 1.3 +/- 1.4; control: - 0.4 +/- 1.1), depressive symptoms (PST-D: - 4.3 +/- 6.1; control: - 0.3 +/- 4.6), and HbA1c (PST-D: -1.2%+/- 1.01; control: 0.2%+/- 1.2%) (all p<0.05). In multiple regression analysis, adjusting for baseline values and sociodemographic factors, PST- D was associated with significant improvement in `regimenrelated distress', depressive symptoms, and HbA1c at the 6-month follow-up (p<0.05). Conclusions: PST- D is a promising intervention for improving psychological outcomes and glycemic control. A fully powered study is required to confirm these findings and examine mechanisms of change in HbA1c. Trial registration number: ACTRN12616001010482; results.
C1 [Rees, Gwyneth; O'Hare, Fleur; Saeed, Marian; Sturrock, Bonnie A.; Xie, Jing; Lamoureux, Ecosse L.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.
   [Sudholz, Bronwyn] Deakin Univ, IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.
   [Sudholz, Bronwyn; Speight, Jane] Deakin Univ, Sch Psychol, Geelong, Vic, Australia.
   [Speight, Jane] Australian Ctr Behav Res Diabet, Diabet Victoria, Melbourne, Vic, Australia.
   [Speight, Jane] AHP Res, Hornchurch, England.
   [Lamoureux, Ecosse L.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore, Singapore.
   [Lamoureux, Ecosse L.] Duke NUS Med Sch, Singapore, Singapore.
RP Rees, G (reprint author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.
EM grees@unimelb.edu.au
OI Speight, Jane/0000-0002-1204-6896
FU Australian Research Council [LP0884108]
FX Australian Research Council (grant number LP0884108).
CR Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.0.CO;2-1
   Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Early Treatment Diabetic Retinopathy Study Research Group, 1991, OPHTHALMOLOGY, V98, P786
   Fenwick EK, 2016, J HLTH PSYCHOL
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2012, PATIENT EDUC COUNS, V86, P372, DOI 10.1016/j.pec.2011.07.002
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Hegel M, 1999, PROBLEM SOLVING TREA
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Kinder LS, 2006, J GEN INTERN MED, V21, P1036, DOI 10.1111/j.1525-1497.2006.00552.x
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lipscombe C, 2016, J DIABETES, V8, P269, DOI 10.1111/1753-0407.12298
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Roy MS, 2007, PSYCHOSOM MED, V69, P537, DOI 10.1097/PSY.0b013e3180df84e2
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
NR 21
TC 0
Z9 0
U1 2
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2052-4897
J9 BMJ OPEN DIAB RES CA
JI BMJ Open Diab. Res. Care
PD JAN
PY 2017
VL 5
IS 1
DI 10.1136/bmjdrc-2016-000307
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EO9VX
UT WOS:000397037300010
PM 28243448
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Shibuta, T
   Waki, K
   Tomizawa, N
   Igarashi, A
   Yamamoto-Mitani, N
   Yamaguchi, S
   Fujita, H
   Kimura, S
   Fujiu, K
   Waki, H
   Izumida, Y
   Sasako, T
   Kobayashi, M
   Suzuki, R
   Yamauchi, T
   Kadowaki, T
   Ohe, K
AF Shibuta, Tomomi
   Waki, Kayo
   Tomizawa, Nobuko
   Igarashi, Ayumi
   Yamamoto-Mitani, Noriko
   Yamaguchi, Satoko
   Fujita, Hideo
   Kimura, Shigeko
   Fujiu, Katsuhito
   Waki, Hironori
   Izumida, Yoshihiko
   Sasako, Takayoshi
   Kobayashi, Masatoshi
   Suzuki, Ryo
   Yamauchi, Toshimasa
   Kadowaki, Takashi
   Ohe, Kazuhiko
TI Willingness of patients with diabetes to use an ICT-based
   self-management tool: a cross-sectional study
SO BMJ OPEN DIABETES RESEARCH & CARE
LA English
DT Article
ID GLYCEMIC CONTROL; MICROVASCULAR COMPLICATIONS; PROBLEM AREAS; CARE;
   SCALE; DISTRESS; MELLITUS; ASSOCIATION; OLDER
AB Objectives: To examine the prevalence of the willingness of patients with diabetes to use a selfmanagement tool based on information and communication technology (ICT) such as personal computers, smartphones, and mobile phones; and to examine the patient characteristics associated with that willingness. Research design and methods: We conducted a cross-sectional interview survey of 312 adults with diabetes at a university hospital in an urban area in Japan. Participants were classified into 2 groups: those who were willing to use an ICT-based self-management tool and those who were unwilling. Multiple logistic regression analysis was used to identify factors associated with the willingness, including clinical and social factors, current use of ICT, self-management practices, self-efficacy, and diabetes-related emotional distress. Results: The mean age of the 312 participants was 66.3 years (SD=11.5) and 198 (63%) were male. Most of the participants (93%) had type 2 diabetes. Although only 51 (16%) currently used ICT-based selfmanagement tools, a total of 157 (50%) expressed the willingness to use such a tool. Factors associated with the willingness included: not having nephropathy (OR=2.02, 95% CI 1.14 to 3.58); outpatient visits once a month or more (vs less than once a month, OR=2.13, 95% CI 1.13 to 3.99); current use of personal computers and/or smartphones (OR=4.91, 95% CI 2.69 to 8.98); and having greater diabetesrelated emotional distress (OR=1.10, 95% CI 1.01 to 1.20). Conclusions: Approximately half of the patients showed interest in using an ICT-based selfmanagement tool. Willing patients may expect ICTbased self-management tools to complement outpatient visits and to make self-management easier. Starting with patients who display the willingness factors might optimize programs based on such tools.
C1 [Shibuta, Tomomi; Igarashi, Ayumi; Yamamoto-Mitani, Noriko] Univ Tokyo, Grad Sch Med, Sch Hlth Sci & Nursing, Tokyo, Japan.
   [Waki, Kayo; Tomizawa, Nobuko; Yamaguchi, Satoko; Fujita, Hideo; Kimura, Shigeko; Fujiu, Katsuhito] Univ Tokyo, Grad Sch Med, Dept Ubiquitous Hlth Informat, Tokyo, Japan.
   [Waki, Kayo; Waki, Hironori; Izumida, Yoshihiko; Sasako, Takayoshi; Kobayashi, Masatoshi; Suzuki, Ryo; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan.
   [Ohe, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Biomed Informat, Tokyo, Japan.
RP Waki, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Ubiquitous Hlth Informat, Tokyo, Japan.; Waki, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan.
EM kwaki-tky@umin.ac.jp
OI Shibuta, Tomomi/0000-0001-8867-4656
FU NTT DOCOMO; Japan Society for Promotion of Science KAKENHI grant
   [26460858]
FX This study was funded by NTT DOCOMO and was partly supported by Japan
   Society for Promotion of Science KAKENHI grant numbers 26460858 to KW.
CR Akao A., 2011, Journal of the Japan Diabetes Society, V54, P128
   Akimoto M, 2004, PSYCHOSOMATICS, V45, P343, DOI 10.1176/appi.psy.45.4.343
   Amante DJ, 2014, DIABETES TECHNOL THE, V16, P784, DOI 10.1089/dia.2014.0078
   Arnhold M, 2014, J MED INTERNET RES, V16, P34, DOI 10.2196/jmir.2968
   Coyle ME, 2013, AUST HEALTH REV, V37, P513, DOI 10.1071/AH13060
   Daitoku Masuko, 2006, Journal of the Japan Diabetes Society, V49, P1
   Franks MM, 2012, AGING MENT HEALTH, V16, P902, DOI 10.1080/13607863.2012.674486
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   International Diabetes Federation, 2015, IDF DIABETES ATLAS
   Jennings CA, 2014, PREV MED, V60, P33, DOI 10.1016/j.ypmed.2013.12.011
   Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x
   Lim S, 2011, DIABETES METAB J, V35, P50, DOI 10.4093/dmj.2011.35.1.50
   Lim S, 2011, DIABETES CARE, V34, P308, DOI 10.2337/dc10-1447
   Morrison F, 2011, ARCH INTERN MED, V171, P1542, DOI 10.1001/archinternmed.2011.400
   Nijland N, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1603
   OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K
   Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310
   Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037//0003-066X.47.9.1102
   Ramadas A, 2011, INT J MED INFORM, V80, P389, DOI 10.1016/j.ijmedinf.2011.02.002
   Sarkar U, 2011, J AM MED INFORM ASSN, V18, P318, DOI [10.1136/jamia.2010.006015, 10.1136/amiajnl.2010.006015]
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Tang PC, 2013, J AM MED INFORM ASSN, V20, P526, DOI 10.1136/amiajnl-2012-001263
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Waki Kayo, 2014, J Diabetes Sci Technol, V8, P209
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Zickuhr K., 2010, GENERATIONS 2010
NR 30
TC 1
Z9 1
U1 2
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2052-4897
J9 BMJ OPEN DIAB RES CA
JI BMJ Open Diab. Res. Care
PD JAN
PY 2017
VL 5
IS 1
DI 10.1136/bmjdrc-2016-000322
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EO9VX
UT WOS:000397037300014
PM 28243450
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Gerlanc, NM
   Cai, J
   Tkacz, J
   Bolge, SC
   Brady, BL
AF Gerlanc, Nicole M.
   Cai, Jennifer
   Tkacz, Joseph
   Bolge, Susan C.
   Brady, Brenna L.
TI The association of weight loss with patient experience and outcomes in a
   population of patients with type 2 diabetes mellitus prescribed
   canagliflozin
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE T2DM; patient outcomes; diabetes self-management; SGLT2 inhibitor;
   weight management
ID QUALITY-OF-LIFE; TREATMENT SATISFACTION; CENTERED APPROACH; GLYCEMIC
   CONTROL; HEALTH; CARE; MANAGEMENT; COMPLICATIONS; EFFICACY; ADULTS
AB Objective: Type 2 diabetes mellitus (T2DM) is a chronic condition complicated by being overweight or obese. This study used a patient survey to assess health, satisfaction, and diabetes self-management in relation to weight management.
   Methods: A survey including the Current Health Satisfaction Questionnaire, Diabetes Distress Scale, and Diabetes Treatment Satisfaction Questionnaire was administered using an online platform to a sample of 205 patients with T2DM prescribed canagliflozin. Patients were placed into 5 groups based on their self-reported weight change since initiation of canagliflozin: Lost >10 lbs, Lost 5-10 lbs, Lost <5 lbs, No Change, and Gained Weight. One-way ANOVAs, Kruskall-Wallis tests, and multivariable regression were used to explore differences between weight loss groups.
   Results: The majority of patients (66.8%) reported losing weight. Compared to other groups, patients who lost >10 lbs were more likely to be engaged in a weight loss program for at least 6 months. Patients in the Lost >10 lbs and Lost 5-10 lbs groups reported the greatest satisfaction with canagliflozin (p<0.05 for both). Multivariable analyses controlling for patient demographic and treatment characteristics revealed that losing >10 lbs was associated with reduced diabetes distress, improved A1c and blood glucose levels, and decreased perceived frequency of hyperglycemia (p<0.05).
   Conclusion: Increased positive patient outcomes, engagement in diabetes self-management, and medication satisfaction were observed among patients who reported weight loss. These findings suggest that a T2DM regimen that includes canagliflozin as part of a weight loss regimen can help improve patient outcomes and experiences with T2DM.
C1 [Gerlanc, Nicole M.; Tkacz, Joseph; Brady, Brenna L.] Hlth Analyt LLC, 9200 Rumsey Rd,Suite 215, Columbia, MD 21045 USA.
   [Cai, Jennifer; Bolge, Susan C.] Janssen Sci Affairs LLC, Titusville, NJ USA.
RP Brady, BL (reprint author), Hlth Analyt LLC, 9200 Rumsey Rd,Suite 215, Columbia, MD 21045 USA.
EM bbrady@healthanalytic.com
FU Janssen Scientific Affairs, LLC
FX Janssen Scientific Affairs, LLC, funded this study.
CR A. American Diabetes, 2013, DIABETES CARE, V36, P1033, DOI DOI 10.2337/DC12-2625
   American Association of Diabetes Educators, AADE7 SELFC BEH
   American Diabetes Association, 2016, CLIN DIABETES, V34, P3, DOI DOI 10.2337/DIACLIN.34.1.3
   Bash LD, 2008, ARCH INTERN MED, V168, P2440, DOI 10.1001/archinte.168.22.2440
   Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570
   Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759
   Bradley C., 1994, HDB PSYCHOL DIABETES
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Fu AZ, 2009, DIABETES CARE, V32, P2187, DOI 10.2337/dc09-1128
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Guisasola FA, 2008, DIABETES OBES METAB, V10, P25, DOI 10.1111/j.1463-1326.2008.00882.x
   Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061
   Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499
   Idris I, 2009, DIABETES OBES METAB, V11, P79, DOI 10.1111/j.1463-1326.2008.00982.x
   Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413
   Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552
   Klein S, 2004, DIABETES CARE, V27, P2067, DOI 10.2337/diacare.27.8.2067
   Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005
   Lau DCW, 2013, CAN J DIABETES, V37, P128, DOI 10.1016/j.jcjd.2013.03.023
   Look ARG, 2007, DIABETES CARE, V30, P1374, DOI DOI 10.2337/DC07-0048]
   Norris SL, 2004, ARCH INTERN MED, V164, P1395, DOI 10.1001/archinte.164.13.1395
   Pi-Sunyer FX, 2009, POSTGRAD MED, V121, P94, DOI 10.3810/pgm.2009.09.2056
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458
   Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010
   Schernthaner G, 2013, DIABETES CARE, V36, P2508, DOI 10.2337/dc12-2491
   Shetty Sharashchandra, 2005, J Manag Care Pharm, V11, P559
   Stenlof K, 2013, DIABETES OBES METAB, V15, P372, DOI 10.1111/dom.12054
   Stenlof K, 2014, CURR MED RES OPIN, V30, P163, DOI 10.1185/03007995.2013.850066
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599
   Tchicaya A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0348-8
   Traina S, 2014, POSTGRAD MED, V126, P7, DOI 10.3810/pgm.2014.05.2752
   Traina SB, 2015, DIABETES THER, V6, P611, DOI 10.1007/s13300-015-0145-8
   Traina SB, 2015, PATIENT-RELAT OUTCOM, V6, P103, DOI 10.2147/PROM.S79368
   Wandell PE, 2005, SCAND J PRIM HEALTH, V23, P68, DOI 10.1080/02813430510015296
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
   Zhuo XH, 2013, AM J PREV MED, V45, P253, DOI 10.1016/j.amepre.2013.04.017
NR 39
TC 2
Z9 2
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2017
VL 10
BP 89
EP 99
DI 10.2147/DMSO.S129824
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EO6NZ
UT WOS:000396811100001
PM 28360528
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Mina, TH
   Lahti, M
   Drake, AJ
   Raikkonen, K
   Minnis, H
   Denison, FC
   Norman, JE
   Reynolds, RM
AF Mina, T. H.
   Lahti, M.
   Drake, A. J.
   Raikkonen, K.
   Minnis, H.
   Denison, F. C.
   Norman, J. E.
   Reynolds, R. M.
TI Prenatal exposure to very severe maternal obesity is associated with
   adverse neuropsychiatric outcomes in children
SO PSYCHOLOGICAL MEDICINE
LA English
DT Article
DE Affective; attention deficit; externalizing; hyperactivity;
   neurodevelopmental; obesity; prenatal; sleep
ID BODY-MASS INDEX; AUTISM SPECTRUM DISORDERS; DIFFICULTIES QUESTIONNAIRE;
   PRESCHOOL-CHILDREN; MENTAL-DISORDERS; UNITED-STATES; PREGNANCY;
   BEHAVIOR; SYMPTOMS; COHORT
AB Background. Prenatal maternal obesity has been linked to adverse childhood neuropsychiatric outcomes, including increased symptoms of attention deficit hyperactivity disorder (ADHD), internalizing and externalizing problems, affective disorders and neurodevelopmental problems but few studies have studied neuropsychiatric outcomes among offspring born to very severely obese women or assessed potential familial confounding by maternal psychological distress.
   Method. We evaluated neuropsychiatric symptoms in 112 children aged 3-5 years whose mothers had participated in a longitudinal study of obesity in pregnancy (50 very severe obesity, BMI >= 40 kg/m(2), obese class III and 62 lean, BMI 18.5-25 kg/m(2)). The mothers completed the Conners' Hyperactivity Scale, Early Symptomatic Syndrome Eliciting Neurodevelopmental Clinical Examination Questionnaire (ESSENCE-Q), Child's Sleep Habits Questionnaire (CSHQ), Strengths and Difficulties Questionnaire (SDQ), and Child Behavior Checklist (CBCL) to assess child neuropsychiatric symptoms. Covariates included child's sex, age, birthweight, gestational age, socioeconomic deprivation levels, maternal age, parity, smoking status during pregnancy, gestational diabetes and maternal concurrent symptoms of anxiety and depression assessed using State Anxiety of Spielberger State-Trait Anxiety Index (STAI) and General Health Questionnaire (GHQ), respectively.
   Results. Children exposed to prenatal maternal very severe obesity had significantly higher scores in the Conners' Hyperactivity Scale; ESSENCE-Q; total sleep problems in CSHQ; hyperactivity, conduct problems and total difficulties scales of the SDQ; higher externalizing and total problems, anxious/depressed, aggressive behaviour and other problem syndrome scores and higher DSM-oriented affective, anxiety and ADHD problems in CBCL. Prenatal maternal very severe obesity remained a significant predictor of child neuropsychiatric problems across multiple scales independent of demographic factors, prenatal factors and maternal concurrent symptoms of anxiety and depression.
   Conclusions. Prenatal maternal very severe obesity is a strong predictor of increased neuropsychiatric problems in early childhood.
C1 [Mina, T. H.; Lahti, M.; Drake, A. J.; Reynolds, R. M.] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Queens Med Res Inst, 47 Little France, Edinburgh EH16 4TJ, Midlothian, Scotland.
   [Mina, T. H.; Denison, F. C.; Norman, J. E.; Reynolds, R. M.] Univ Edinburgh, Tommys Ctr Maternal & Fetal Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland.
   [Lahti, M.; Raikkonen, K.] Univ Helsinki, Inst Behav Sci, Helsinki, Finland.
   [Minnis, H.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.
   [Denison, F. C.; Norman, J. E.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.
RP Reynolds, RM (reprint author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Queens Med Res Inst, 47 Little France, Edinburgh EH16 4TJ, Midlothian, Scotland.
EM r.reynolds@ed.ac.uk
RI Reynolds, Rebecca/C-3044-2008
OI Raikkonen, Katri/0000-0003-3124-3470; Denison,
   Fiona/0000-0003-0371-2014; Lahti-Pulkkinen, Marius/0000-0002-5244-5525
FU Tommy's the Baby Charity; University of Edinburgh, Scotland; Academy of
   Finland; University of Helsinki Funds; Scottish Senior Clinical
   Fellowship [SCD/09]; British Heart Foundation; Medical Research Council
   [G0501904]
FX We acknowledge funding from Tommy's the Baby Charity. THM is funded by
   Principal Development Scholarship, Charles Darwin Scholarship and Global
   Research Scholarship, University of Edinburgh, Scotland. M.L. is funded
   by the Academy of Finland and University of Helsinki Funds. A.J.D. was
   supported by Scottish Senior Clinical Fellowship (SCD/09). T.H.M.,
   A.J.D. and R.M.R. acknowledge the support of the British Heart
   Foundation.
CR Achenbach T., 2000, MANUAL ASEBA PRESCHO
   Antoniou EE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005974
   Atladottir HO, 2015, EUR CHILD ADOLES PSY, V24, P173, DOI 10.1007/s00787-014-0553-8
   Bilbo SD, 2012, FRONT NEUROENDOCRIN, V33, P267, DOI 10.1016/j.yfrne.2012.08.006
   Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989
   Brion MJ, 2011, PEDIATRICS, V127, pE202, DOI 10.1542/peds.2010-0651
   Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197
   Buescher AVS, 2014, JAMA PEDIATR, V168, P721, DOI 10.1001/jamapediatrics.2014.210
   Buss C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037758
   Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033
   Chen Q, 2014, INT J EPIDEMIOL, V43, P83, DOI 10.1093/ije/dyt152
   Chu SY, 2009, MATERN CHILD HLTH J, V13, P614, DOI 10.1007/s10995-008-0388-3
   Croft S, 2015, PEDIATRICS, V135, pE1210, DOI 10.1542/peds.2014-2920
   Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004
   Erhart M, 2008, EUR CHILD ADOLES PSY, V17, P106, DOI 10.1007/s00787-008-1012-1
   Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015
   Gardner RM, 2015, INT J EPIDEMIOL, V44, P870, DOI 10.1093/ije/dyv081
   Gillberg C, 2010, RES DEV DISABIL, V31, P1543, DOI 10.1016/j.ridd.2010.06.002
   Goodlin-Jones BL, 2008, J DEV BEHAV PEDIATR, V29, P82, DOI 10.1097/DBP.0b013e318163c39a
   Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x
   Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1
   Heinrich A, 2015, BEHAV GENET, V45, P529, DOI 10.1007/s10519-015-9721-y
   Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250
   Jo H, 2015, PEDIATRICS, V135, pE1198, DOI 10.1542/peds.2014-3058
   Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583
   Le HH, 2014, EUR CHILD ADOLES PSY, V23, P587, DOI 10.1007/s00787-013-0477-8
   Li YM, 2016, J AUTISM DEV DISORD, V46, P95, DOI 10.1007/s10803-015-2549-8
   Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7
   Madigan S, 2016, PSYCHOL BULL, V142, P367, DOI 10.1037/bul0000029
   McLoone P, 2004, CARSTAIRS SCORES SCO
   Mina TH, 2015, PSYCHOL MED, V45, P3133, DOI 10.1017/S0033291715001087
   Molyneaux E, 2014, OBSTET GYNECOL, V123, P857, DOI 10.1097/AOG.0000000000000170
   Norman JE, 2011, P NUTR SOC, V70, P450, DOI 10.1017/S0029665111003077
   Parade SH, 2016, CHILD DEV, V87, P86, DOI 10.1111/cdev.12484
   Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476
   Pihlakoski L, 2006, EUR CHILD ADOLES PSY, V15, P409, DOI 10.1007/s00787-006-0548-1
   Pugh SJ, 2016, BJOG-INT J OBSTET GY, V123, P2094, DOI 10.1111/1471-0528.13909
   Raikkonen K, 2015, PSYCHOL MED, V45, P3217, DOI 10.1017/S003329171500121X
   Reising MM, 2013, J CHILD FAM STUD, V22, P335, DOI 10.1007/s10826-012-9582-4
   Rescorla LA, 2011, J CLIN CHILD ADOLESC, V40, P456, DOI 10.1080/15374416.2011.563472
   Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539
   Robinson M, 2013, J DEV ORIG HLTH DIS, V4, P42, DOI 10.1017/S2040174412000578
   Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741
   Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x
   Simpkin CT, 2014, J SLEEP RES, V23, P397, DOI 10.1111/jsr.12142
   Van Batenburg-Eddes T, 2013, J CHILD PSYCHOL PSYC, V54, P591, DOI 10.1111/jcpp.12023
   Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P259, DOI 10.1016/j.neubiorev.2004.10.010
   van der Heijden KB, 2013, CHRONOBIOL INT, V30, P919, DOI 10.3109/07420528.2013.790041
   Van Lieshout RJ, 2013, CHILD PSYCHIAT HUM D, V44, P382, DOI 10.1007/s10578-012-0332-z
   Yap MBH, 2015, J AFFECT DISORDERS, V175, P424, DOI 10.1016/j.jad.2015.01.050
NR 50
TC 13
Z9 13
U1 8
U2 33
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0033-2917
EI 1469-8978
J9 PSYCHOL MED
JI Psychol. Med.
PD JAN
PY 2017
VL 47
IS 2
BP 353
EP 362
DI 10.1017/S0033291716002452
PG 10
WC Psychology, Clinical; Psychiatry; Psychology
SC Psychology; Psychiatry
GA EG8PU
UT WOS:000391320100014
PM 27776561
DA 2019-01-08
ER

PT J
AU Ebert, DD
   Nobis, S
   Lehr, D
   Baumeister, H
   Riper, H
   Auerbach, RP
   Snoek, F
   Cuijpers, P
   Berking, M
AF Ebert, D. D.
   Nobis, S.
   Lehr, D.
   Baumeister, H.
   Riper, H.
   Auerbach, R. P.
   Snoek, F.
   Cuijpers, P.
   Berking, M.
TI The 6-month effectiveness of Internet-based guided self-help for
   depression in adults with Type 1 and 2 diabetes mellitus
SO DIABETIC MEDICINE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; WEB-BASED
   INTERVENTION; MOBILE PHONE SUPPORT; COMORBID DEPRESSION; MAJOR
   DEPRESSION; METAANALYSIS; CARE; EFFICACY; ACCEPTANCE
AB Aim The aim of this research is to examine the 6-month effects of an Internet-based guided self-help intervention for comorbid depressive symptoms in people with diabetes.
   Methods Participants (n = 260) with Type 1 or 2 diabetes and elevated depressive symptoms [Center for Epidemiological Studies Depression Scale (CES-D) >= 23] were randomly assigned to a guided Internet-based self-help intervention or a control condition (treatment as usual + online psychoeducation about depression). The primary outcome was a change in depressive symptom severity (CES-D) from baseline to 6-month follow-up. The secondary outcomes included numbers of people achieving treatment response (reliable change of depressive symptoms) and remission (CES-D = 16), as well as the effects on glycaemic control, diabetes-related emotional distress and diabetes acceptance. Repeated measures analysis of variance examined between-group differences using intent-to-treat principles.
   Results Both conditions showed improvements in depression severity: intervention condition, d = 1.48 [95% confidence interval (95% CI): 1.21 to 1.76]; control condition d = 0.55 (95% CI: 0.30 to 0.80). Changes were significantly greater in the intervention condition with a large between-group effect size (d = 0.83, 95% CI: 0.57 to 1.08). Accordingly, effects on response [relative risk (RR) = 2.60 (95% CI: 2.01 to 3.36), P < 0.001] and remission [RR = 3.36 (95% CI: 2.98 to 5.44), P < 0.001] were in favour of the intervention group, as were differences in change in diabetes emotional distress (d = 0.50, 95% CI: 0.04 to 0.54), and physical and mental functioning [Short Form Health Survey (SF-12) Physical d = 0.27 (95% CI: 0.01 to 0.51) and SF-12 Mental d = 0.68 (95% CI: 0.11 to 0.40)]. The intervention group was not superior with regard to glycaemic control, diabetes self-management and diabetes acceptance.
   Conclusions The trial indicates that Internet-based guided self-help treatments for depression in people with diabetes can have sustained effects on depressive symptoms, well-being and emotional distress associated with diabetes.
C1 [Ebert, D. D.; Berking, M.] Friedrich Alexander Univ Erlangen Nuremberg, Dept Clin Psychol & Psychotherapy, Erlangen, Germany.
   [Ebert, D. D.; Nobis, S.; Lehr, D.; Riper, H.; Cuijpers, P.; Berking, M.] Leuphana Univ, Div Online Hlth Trainings, Innovat Incubator, Luneburg, Germany.
   [Ebert, D. D.] Harvard Univ, Dept Hlth Care Policy, Boston, MA 02115 USA.
   [Baumeister, H.] Univ Ulm, Inst Psychol & Educ, Dept Clin Psychol & Psychotherapy, Ulm, Germany.
   [Riper, H.; Cuijpers, P.] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Auerbach, R. P.] Harvard Med Sch, McLean Hosp, Dept Psychiat, Belmont, MA USA.
   [Snoek, F.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Snoek, F.] Acad Med Ctr, Amsterdam, Netherlands.
   [Snoek, F.] Vrije Univ Amsterdam, Med Ctr, Inst Hlth & Care Res EMGO, Amsterdam, Netherlands.
RP Ebert, DD (reprint author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Clin Psychol & Psychotherapy, Erlangen, Germany.
EM David.Ebert@fau.de
OI Ebert, David Daniel/0000-0001-6820-0146
FU BARMER GEK; European Union [EU EFRE: ZW6-80119999, CCI 2007DE161PR001]
FX The BARMER GEK and the European Union funded this study (EU EFRE:
   ZW6-80119999, CCI 2007DE161PR001).
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 2017, DIABET MED, V34, P99
   Baumeister H, 2014, DIABETES RES CLIN PR, V105, P30, DOI 10.1016/j.diabres.2014.04.031
   Baumeister H, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Cuijpers P, 2014, J AFFECT DISORDERS, V159, P118, DOI 10.1016/j.jad.2014.02.026
   Donker T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-79
   Ebert DD, 2015, HEALTH PSYCHOL, V34, P1240, DOI 10.1037/hea0000277
   Ebert DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119895
   Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hautzinger M, 1993, ALLGEMEINE DEPRESSIO
   Huang YF, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-260
   Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037//0022-006X.59.1.12
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2004, MED CARE, V42, P1222, DOI 10.1097/00005650-200412000-00009
   Lamers F, 2010, PSYCHOTHER PSYCHOSOM, V79, P217, DOI 10.1159/000313690
   Lee EH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0142-z
   Lustman PJ, 1998, GEN HOSP PSYCHIAT, V20, P302, DOI 10.1016/S0163-8343(98)00039-5
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Nobis S, 2015, DIABETES CARE, V38, P776, DOI 10.2337/dc14-1728
   Nobis S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-306
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Petrak F, 2015, LANCET DIABETES ENDO, V3, P472, DOI 10.1016/S2213-8587(15)00045-5
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   Schmitt A, 2013, DIABETES STOFFWECH H, V22, P9
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Sharif Farkhondeh, 2014, Iran J Nurs Midwifery Res, V19, P529
   vansBastelaar KMP, 2011, DIABETES CARE, V34, P320
NR 31
TC 12
Z9 12
U1 3
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JAN
PY 2017
VL 34
IS 1
BP 99
EP 107
DI 10.1111/dme.13173
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EF9SF
UT WOS:000390669800013
PM 27334444
DA 2019-01-08
ER

PT J
AU Gibbons, E
   Casey, AF
   Brewster, KZ
AF Gibbons, Emma
   Casey, Amanda Faith
   Brewster, Keith Z.
TI Bariatric surgery and intellectual disability: Furthering evidence-based
   practice
SO DISABILITY AND HEALTH JOURNAL
LA English
DT Review
DE Weight loss; Scoping review; Prader-Willi syndrome; Obesity
ID PRADER-WILLI-SYNDROME; BILIOPANCREATIC DIVERSION; COGNITIVE FUNCTION;
   GASTRIC BYPASS; WEIGHT-LOSS; MORBID-OBESITY; GASTROPLASTY; MANAGEMENT;
   PATIENT; SUPPORT
AB Background: Rates of morbid obesity are higher for individuals with intellectual disability (ID). Individuals with ID may find nutritional guidelines difficult to follow and many face personal and environmental barriers for physical activity. Bariatric surgery may reduce obesity related health comorbidities while promoting sustained weight loss in diverse populations. Yet no study has reviewed the feasibility of conducting bariatric surgery on individuals with ID.
   Objectives: To conduct a scoping review of literature on bariatric procedures performed on individuals with D.
   Methods: Authors searched electronic database via PubMED, Science Direct, Wiley and Medline (1975-2014). Extracted articles were evaluated independently following scoping reviews guidelines.
   Results: Reviewers included sixteen studies. Nine surgical interventions were reported on 49 patients with ID. Studies followed either case report or case series design. The most common procedure patients received was biliopancreatic diversion (n = 24) followed by Roux en -Y Gastric Bypass (n = 12). Degree of weight loss was the primary outcome in each study. Excess weight loss (%EWL) ranged from 12% to 86%. Further benefits included improved quality of life, decreased psychological tension within family and resolution of sleep apnea, hypertension, respiratory distress and type II diabetes. Six studies included a post-operative follow-up period below two years.
   Conclusions: Bariatric surgery may be a viable option to treat obesity in individuals with ID but there is no consensus which procedure is preferred and which associated interventions should be in place to warrant long lasting results. Further research featuring randomized control trials may be beneficial. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Gibbons, Emma; Casey, Amanda Faith] St Francis Xavier Univ, Dept Human Kinet, POB 5000, Antigonish, NS B2G 2W5, Canada.
   [Brewster, Keith Z.] Okanagan Bariatr Surg Ctr, Patient Serv, Kelowna, BC, Canada.
   [Brewster, Keith Z.] Sch Hlth & Exercise Sci, Kelowna, BC, Canada.
RP Casey, AF (reprint author), St Francis Xavier Univ, Dept Human Kinet, POB 5000, Antigonish, NS B2G 2W5, Canada.
EM acasey@stfx.ca
CR Alosco ML, 2014, AM J SURG, V207, P870, DOI 10.1016/j.amjsurg.2013.05.018
   ANDERSON AE, 1980, J PEDIATR SURG, V15, P876, DOI 10.1016/S0022-3468(80)80297-1
   Antal SC, 1996, OBES SURG, V6, P58, DOI 10.1381/096089296765557286
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Bauchowitz AU, 2005, PSYCHOSOM MED, V67, P825, DOI 10.1097/01.psy.0000174173.32271.01
   Bertoli S, 2006, NUTR METAB CARDIOVAS, V16, P100, DOI 10.1016/j.numecd.2005.05.007
   Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724
   Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041
   Casey AF, 2013, DISABIL HEALTH J, V6, P2, DOI 10.1016/j.dhjo.2012.09.002
   Chelala E, 2014, SURG ENDOSC, V11, P268
   Chow A, 2016, J OBES, V2016
   de Almeida MQ, 2005, OBES SURG, V15, P901, DOI 10.1381/0960892054222885
   DOUSEI T, 1992, OBES SURG, V2, P189, DOI 10.1381/096089292765560411
   Fong AKW, 2012, OBES SURG, V22, P1742, DOI 10.1007/s11695-012-0725-x
   FONKALSRUD EW, 1981, J PEDIATR SURG, V16, P888, DOI 10.1016/S0022-3468(81)80841-X
   Grugni G, 2000, OBES SURG, V10, P179, DOI 10.1381/096089200321668631
   Heinberg LJ, 2014, SURG OBES RELAT DIS, P1
   Kobayashi J, 2003, OBES SURG, V13, P803, DOI 10.1381/096089203322509453
   Laurent-Jaccard 17. A, 1991, OBES SURG, V1, P83
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
   Livhits M, 2011, OBES REV, V12, P142, DOI 10.1111/j.1467-789X.2010.00720.x
   Marinari GM, 2001, OBES SURG, V11, P491, DOI 10.1381/096089201321209404
   MASON EE, 1995, OBES SURG, V5, P23, DOI 10.1381/096089295765558114
   Mechanick JI, 2013, SURG OBES RELAT DIS, V9, P159, DOI 10.1016/j.soard.2012.12.010
   Musella M, 2014, J INVEST SURG, V27, P102, DOI 10.3109/08941939.2013.832824
   Papavramidis ST, 2006, J PEDIATR SURG, V41, P1153, DOI 10.1016/j.jpedsurg.2006.01.065
   Rimmer JH, 2010, J INTELL DISABIL RES, V54, P787, DOI 10.1111/j.1365-2788.2010.01305.x
   Rimmer JH, 2012, LANCET, V380, P193, DOI 10.1016/S0140-6736(12)61028-9
   Rimmer JH, 2005, AM J HEALTH PROMOT, V19, P327, DOI 10.4278/0890-1171-19.5.327
   Spanos D, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-132
   Spitznagel MB, 2013, SURG OBES RELAT DIS, V9, P765, DOI 10.1016/j.soard.2013.04.011
   Spitznagel MB, 2013, SURG OBES RELAT DIS, V9, P580, DOI 10.1016/j.soard.2013.04.007
   TOUQUET VLR, 1983, BRIT J SURG, V70, P180, DOI 10.1002/bjs.1800700314
   Votruba Kristen, 2014, Curr Psychiatry Rep, V16, P448, DOI 10.1007/s11920-014-0448-x
   Yamaki K, 2005, MENT RETARD, V43, P1, DOI 10.1352/0047-6765(2005)43<1:BWSAAW>2.0.CO;2
   2013, SURG OBES RELAT DIS, V9, P159, DOI DOI 10.1016/J.SOARD.2012.12.010
NR 36
TC 2
Z9 2
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1936-6574
EI 1876-7583
J9 DISABIL HEALTH J
JI Disabil. Health J.
PD JAN
PY 2017
VL 10
IS 1
BP 3
EP 10
DI 10.1016/j.dhjo.2016.09.005
PG 8
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health; Rehabilitation
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; Rehabilitation
GA EF4KB
UT WOS:000390293100002
PM 27720223
DA 2019-01-08
ER

PT J
AU Kampling, H
   Petrak, F
   Farin, E
   Kulzer, B
   Herpertz, S
   Mittag, O
AF Kampling, Hanna
   Petrak, Frank
   Farin, Erik
   Kulzer, Bernd
   Herpertz, Stephan
   Mittag, Oskar
TI Trajectories of depression in adults with newly diagnosed type 1
   diabetes: results from the German Multicenter Diabetes Cohort Study
SO DIABETOLOGIA
LA English
DT Article
DE Adults; Depression; Growth mixture modelling; Longitudinal data; Onset
   cohort; Psychological outcomes; Type 1 diabetes
ID GLYCEMIC CONTROL; COMORBID DEPRESSION; PREVALENCE; SYMPTOMS;
   INDIVIDUALS; DISORDERS; DISTRESS; THERAPY; TRIAL; CARE
AB There is a paucity of longitudinal data on type 1 diabetes and depression, especially in adults. The present study prospectively analysed trajectories of depressive symptoms in adults during the first 5 years of living with type 1 diabetes. We aimed to identify distinct trajectories of depressive symptoms and to examine how they affect diabetes outcome.
   We reanalysed data from a prospective multicentre observational cohort study including 313 adults with newly diagnosed type 1 diabetes. At baseline and in annual postal surveys over 5 consecutive years, we gathered patient characteristics and behavioural and psychosocial data (e.g. Symptom Checklist-90-R [SCL-90-R]). Medical data (e.g. HbA(1c) levels) was obtained from the treating physicians. We applied growth mixture modelling (GMM) to identify distinct trajectories of depression over time.
   Five years after diagnosis, 7.8% (n = 20) of patients were moderately depressed and 10.2% (n = 26) were severely depressed. GMM statistics identified three possible models of trajectories (class 1, 'no depressive symptoms'; class 2, 'worsening depressive symptoms that improve after 2 years'; class 3, 'worsening depressive symptoms'). Severity of depression symptoms at baseline (subscale of the SCL-90-R questionnaire) significantly predicted membership of classes 2 and 3 vs class 1. After 5 years, higher HbA(1c) values were detected in class 3 patients (mean = 8.2%, 66 mmol/mol) compared with class 1 and class 2 (both: mean = 7.2%, 55 mmol/mol).
   We identified distinct trajectories of depressive symptoms that are also relevant for diabetes outcome. Patients with worsening depressive symptoms over time exhibited poor glycaemic control after the first 5 years of living with diabetes. They also exhibited a reduced quality of life and increased diabetes-related distress.
C1 [Kampling, Hanna; Farin, Erik; Mittag, Oskar] Univ Freiburg, Sect Hlth Care Res & Rehabil Res, Med Ctr, Fac Med, Hugstetterstr 49, D-79106 Freiburg, Germany.
   [Petrak, Frank; Herpertz, Stephan] Ruhr Univ Bochum, LWL Univ Clin Bochum, Dept Psychosomat Med & Psychotherapy, Bochum, Germany.
   [Petrak, Frank] Ctr Psychotherapy Wiesbaden, Wiesbaden, Germany.
   [Kulzer, Bernd] Diabet Ctr Mergentheim, Bad Mergentheim, Germany.
   [Kulzer, Bernd] Res Inst Diabet Acad Mergentheim, Bad Mergentheim, Germany.
   [Kulzer, Bernd] Otto Friedrich Univ Bamberg, Dept Clin Psychol & Psychotherapy, Bamberg, Germany.
RP Kampling, H (reprint author), Univ Freiburg, Sect Hlth Care Res & Rehabil Res, Med Ctr, Fac Med, Hugstetterstr 49, D-79106 Freiburg, Germany.
EM hanna.kampling@uniklinik-freiburg.de
OI Kampling, Hanna/0000-0002-5213-0179
FU German Diabetes Association (DDG); Johannes Gutenberg-University Mainz;
   Novo Nordisk and Berlin-Chemie
FX The study was funded by the German Diabetes Association (DDG), Johannes
   Gutenberg-University Mainz, Novo Nordisk and Berlin-Chemie (all German
   institutions).
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   AYMANNS P, 1992, KREBSERKRANKUNG FAMI
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Baumeister H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008381.pub2
   Berge Line Iden, 2013, BMC Res Notes, V6, P543, DOI 10.1186/1756-0500-6-543
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Maia ACCD, 2014, REV ASSOC MED BRAS, V60, P59, DOI 10.1590/1806-9282.60.01.013
   de Ornelas Maia Ana Claudia C, 2013, Clin Pract Epidemiol Ment Health, V9, P136, DOI 10.2174/1745017901309010136
   Derogatis L. R., 1995, SYMPTOM CHECKLISTE D
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Hirsch A, 2000, QUAL LIFE RES, V9, P207, DOI 10.1023/A:1008959810698
   Korczak DJ, 2011, DIABETOLOGIA, V54, P2483, DOI 10.1007/s00125-011-2240-3
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Luyckx JRK, 2015, HEALTH PSYCHOL, V34, P1058, DOI 10.1037/hea0000212
   Margraf J, 2015, DIAGNOSTIC INTERVIEW
   Melin EO, 2013, EUR J ENDOCRINOL, V168, P861, DOI 10.1530/EJE-13-0137
   Moulton CD, 2015, LANCET DIABETES ENDO, V3, P461, DOI 10.1016/S2213-8587(15)00134-5
   Nefs G, 2015, DIABETIC MED, V32, P1289, DOI 10.1111/dme.12739
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Petrak F, 2003, DIABETES-METAB RES, V19, P216, DOI 10.1002/dmrr.374
   Petrak F, 2015, LANCET DIABETES ENDO, V3, P472, DOI 10.1016/S2213-8587(15)00045-5
   Petrak F, 2015, DIABETES CARE, V38, P767, DOI 10.2337/dc14-1599
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Roy MS, 2007, PSYCHOSOM MED, V69, P537, DOI 10.1097/PSY.0b013e3180df84e2
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Tanenbaum ML, 2012, DIABETES EDUCATOR, V38, P695, DOI 10.1177/0145721712452795
   Tovote KA, 2014, DIABETES CARE, V37, P2427, DOI 10.2337/dc13-2918
   Trief PM, 2014, DIABETES CARE, V37, P1563, DOI 10.2337/dc13-1867
   Uher R, 2010, PSYCHOL MED, V40, P1367, DOI 10.1017/S0033291709991528
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Waadt S, 1995, DIABETES PSYCHOL DIA, P17
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
NR 35
TC 4
Z9 4
U1 1
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD JAN
PY 2017
VL 60
IS 1
BP 60
EP 68
DI 10.1007/s00125-016-4123-0
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EE5GQ
UT WOS:000389634000009
PM 27787619
OA Bronze
DA 2019-01-08
ER

PT J
AU Due-Christensen, M
   Hommel, E
   Ridderstrale, M
AF Due-Christensen, M.
   Hommel, E.
   Ridderstrale, M.
TI Potential positive impact of group-based diabetes dialogue meetings on
   diabetes distress and glucose control in people with type 1 diabetes
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Patient education; Patient participation; Peer support; Disease specific
   distress; Type 1 diabetes; Chronic disease
ID RANDOMIZED CONTROLLED-TRIAL; GLYCEMIC CONTROL; SELF-MANAGEMENT; PEER
   SUPPORT; EDUCATION; OUTCOMES; INTERVENTION; BEHAVIOR; THERAPY; BURDEN
AB Objective: To evaluate the effect of group-based diabetes dialogue meetings (DDMs) on diabetes distress, perceived competence and glycaemic control.
   Methods: Patients with type 1 diabetes (T1D) were invited to DDMs with peers and healthcare professionals. The impact of participation was evaluated by change in diabetes distress measured by Problem Areas in Diabetes (PAID), diabetes competence measured by Perceived Competence in Diabetes (PCD), change in HbA1c before and one year after the DDMs.
   Results: 120 patients with T1D participated in at least one DDM: 75% female, mean age 50 years (range 21-76), mean diabetes duration 23 years (range 0-64); 39% of all participants had a baseline PAID score >= 33, indicating high levels of distress. After one year, both PAID (from 30.4 +/- 16.6 to 27.4 +/- 17.1; n = 81, p = 0.03), and mean HbA1c (61.6 +/- 10.2 to 58.8 +/- 9.9; n = 120, p < 0.0001) had improved significantly. PCD showed no change. Meanwhile, the benefit from participating was rated high with a median of four out of five and the major gain being the possibility to share experiences with peers.
   Conclusion: Group-based DDMs were highly appreciated by participants and associated with significant improvements in diabetes distress and HbA1c.
   Practice implications: DDMs target a large group of patients using few staff resources. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Due-Christensen, M.; Hommel, E.; Ridderstrale, M.] Steno Diabet Ctr, Niels Steensens Vej 6, D-2820 Gentofte, Denmark.
   [Due-Christensen, M.] Kings Coll London, Fac Nursing & Midwifery, London, England.
RP Due-Christensen, M (reprint author), Steno Diabet Ctr, Niels Steensens Vej 6, D-2820 Gentofte, Denmark.
EM Mtdc@steno.dk
OI Due-Christensen, Mette/0000-0003-2604-3730; Hommel,
   Eva/0000-0001-7570-5919
FU Steno Diabetes Center
FX We would like to thank the people with type 1 diabetes who took part in
   the study and Anette Hougaard and Anne Skouboe who helped facilitate the
   meetings. We also thank Caroline Horness for helping with data
   management in regards to the surveys. Steno Diabetes Center funded the
   research.
CR Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1
   Berry E, 2015, POSTGRAD MED J, V91, P278, DOI 10.1136/postgradmedj-2014-133017
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Colagiuri R, 2009, DIABETIC MED, V26, P442, DOI 10.1111/j.1464-5491.2009.02700.x
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x
   Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5
   Due-Christensen M, 2012, DIABETIC MED, V29, P251, DOI 10.1111/j.1464-5491.2011.03521.x
   Fisher EB, 2007, DIABETES ED, V33, P6
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Funnell MM, 2007, DIABETES SPECTR, V20, P221, DOI DOI 10.2337/DIASPECT.20.4.221
   Haas L, 2014, DIABETES CARE, V37, pS144, DOI 10.2337/dc14-S144
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N., 2015, DIABETES CARE
   Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009
   Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579
   Joensen LE, 2016, PRIM CARE DIABETES, V10, P41, DOI 10.1016/j.pcd.2015.06.007
   Joensen LE, 2013, DIABETES RES CLIN PR, V101, P278, DOI 10.1016/j.diabres.2013.07.001
   Krichbaum K, 2003, DIABETES EDUCATOR, V29, P653, DOI 10.1177/014572170302900411
   Luyckx K, 2015, PSYCHOL HEALTH MED, V20, P77, DOI 10.1080/13548506.2014.902482
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rane K, 2011, DIABETES RES CLIN PR, V93, P371, DOI 10.1016/j.diabres.2011.05.009
   Schmitt A., 2014, J BEHAV MED, P1
   Simmons D, 2012, DIABETES MANAGEMENT, V3, P61
   Strandberg R. Bjarkoy, 2015, DIABETES MED, V130, P4
   Sturt J, 2015, CURR DIABETES REP, V15, P1, DOI DOI 10.1007/S11892-015-0660-Z
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
   Zoffmann V., 2015, DIABETIC MED, V123, P9
   Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017
NR 30
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD DEC
PY 2016
VL 99
IS 12
BP 1978
EP 1983
DI 10.1016/j.pec.2016.07.023
PG 6
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA EG7JM
UT WOS:000391223200008
PM 27444233
DA 2019-01-08
ER

PT J
AU Trief, PM
   Fisher, L
   Sandberg, J
   Cibula, DA
   Dimmock, J
   Hessler, DM
   Forken, P
   Weinstock, RS
AF Trief, Paula M.
   Fisher, Lawrence
   Sandberg, Jonathan
   Cibula, Donald A.
   Dimmock, Jacqueline
   Hessler, Danielle M.
   Forken, Patricia
   Weinstock, Ruth S.
TI Health and Psychosocial Outcomes of a Telephonic Couples Behavior Change
   Intervention in Patients With Poorly Controlled Type 2 Diabetes: A
   Randomized Clinical Trial
SO DIABETES CARE
LA English
DT Article
ID SELF-MANAGEMENT EDUCATION; SUPPORT PROJECT; CHRONIC ILLNESS; FAMILY;
   INTERDEPENDENCE; METAANALYSIS; MEDICINE; CONTEXT; ADULTS
AB OBJECTIVE
   To compare glycemic control and secondary outcomes of a 4-month telephonic couples behavioral intervention to individual intervention, and to education, for adults with type 2 diabetes.
   RESEARCH DESIGN AND METHODS
   A randomized trial with the following three arms: couples calls (CC) (n = 104); individual calls (IC) (n = 94); and diabetes education (DE) (n = 82). All arms had self-management education (two calls). CC and IC had 10 additional behavior change calls. CC addressed collaboration and relationships/communication. Participants consisted of 280 couples, among whom one partner had type 2 diabetes and an A1C level >= 7.5%. Blinded assessments occurred at 4, 8, and 12 months. The primary outcome was change in A1C; and secondary outcomes were BMI, waist circumference, blood pressure, depressive symptoms, diabetes self-efficacy, and diabetes distress.
   RESULTS
   Patients had a mean age of 56.8 years; 61.6% were male, and 30.4% were minorities. The baseline mean A1C level was 9.1%. Intention-to-treat analyses found significant A1C reductions for all (12 months: CC -0.47%, IC -0.52%, DE -0.57%), with no differences between arms. Preplanned within-arm analyses were stratified by baseline A1C tertiles: lowest tertile (7.5-8.2%), no change from baseline; middle tertile (8.3-9.2%), only CC led to significantly lower A1C level; and highest tertile (>= 9.3%), significant improvement for all interventions. For BMI, CC showed significant improvement, and CC and DE led to decreased waist circumference. The IC group showed greater blood pressure improvement. Results for secondary psychosocial outcomes favored the CC group.
   CONCLUSIONS
   In adults with poorly controlled type 2 diabetes, a collaborative couples intervention resulted in significant, lasting improvement in A1C levels, obesity measures, and some psychosocial outcomes. For those with exceedingly high A1C levels, education alone was beneficial, but additional intervention is needed to achieve glycemic targets.
C1 [Trief, Paula M.; Dimmock, Jacqueline; Forken, Patricia] SUNY Upstate Med Univ, Dept Psychiat & Behav Neurosci, Syracuse, NY 13210 USA.
   [Trief, Paula M.; Weinstock, Ruth S.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Fisher, Lawrence; Hessler, Danielle M.] Univ Calif San Francisco, Dept Family Med, San Francisco, CA 94143 USA.
   [Sandberg, Jonathan] Brigham Young Univ, Sch Family Life, Provo, UT 84602 USA.
   [Cibula, Donald A.] SUNY Upstate Med Univ, Dept Publ Hlth & Prevent Med, Syracuse, NY 13210 USA.
RP Trief, PM (reprint author), SUNY Upstate Med Univ, Dept Psychiat & Behav Neurosci, Syracuse, NY 13210 USA.; Trief, PM (reprint author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
EM triefp@upstate.edu
OI Trief, Paula/0000-0002-2827-5722
FU National Institutes of Health (NIH) [1R18-DK-080867-01A2]; NIH
FX This study was supported by National Institutes of Health (NIH) grant
   1R18-DK-080867-01A2. The first year of the study was funded by an NIH
   Diversity Fellowship Supplement.
CR Agency for Healthcare Research and Quality, 2014, BEH PROGR DIAB MELL
   Bandura A, 1978, SOCIAL LEARNING THEO
   BLACK DR, 1990, HEALTH PSYCHOL, V9, P330, DOI 10.1037//0278-6133.9.3.330
   Campbell TA, 2002, EFFECTIVENESS RES MA, P311
   Chamany S, 2015, AM J PREV MED, V49, P832, DOI 10.1016/j.amepre.2015.04.016
   DEVOOGD JN, 1993, J MUSCULOSKELET PAIN, V1, P273
   Duncan I, 2009, DIABETES EDUCATOR, V35, P752, DOI 10.1177/0145721709343609
   Eakin EG, 2007, AM J PREV MED, V32, P419, DOI 10.1016/j.amepre.2007.01.004
   Fisher L, 2000, J FAM PRACTICE, V49, P561
   Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Haas L, 2012, DIABETES CARE S1, V37, pS144
   Kang CM, 2010, INT J NURS STUD, V47, P1363, DOI 10.1016/j.ijnurstu.2010.03.009
   Kelley H. H., 1978, INTERPERSONAL RELATI
   Keogh KM, 2011, AM J MANAG CARE, V17, P105
   Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Laurenceau JP, 2004, J CONSULT CLIN PSYCH, V72, P933, DOI 10.1037/0022-006X.72.6.933
   Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006
   Li R, 2014, MMWR-MORBID MORTAL W, V63, P1045
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599
   Martire LM, 2014, HEALTH PSYCHOL, V33, P501, DOI 10.1037/hea0000103
   NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Palmer C. A., 2000, PSYCHOL COUPLES ILLN, P311
   PIANTADOSI S, 1997, CLIN TRIALS METHODOL
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Powers MA, 2015, DIABETES CARE, V38, P1372, DOI 10.2337/dc15-0730
   Rook KS, 2011, J SOC PERS RELAT, V28, P772, DOI 10.1177/0265407510391335
   Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059
   Stark CS, 2013, DIABETES CARE, V36, P2271, DOI DOI 10.2337/DC12-2258
   Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213
   Stokols D, 1996, AM J HEALTH PROMOT, V10, P282, DOI 10.4278/0890-1171-10.4.282
   Torenholt R, 2014, DIABETIC MED, V31, P15, DOI 10.1111/dme.12290
   Trief P. M., 2006, FAMILIES SYSTEMS HLT, V24, P318, DOI [10.1037/1091-7527.24.3.318, DOI 10.1037/1091-7527.24.3.318]
   Trief P, 2011, FAM SYST HEALTH, V29, P253, DOI 10.1037/a0024564
   Trief PM, 2011, TRANSL BEHAV MED, V1, P461, DOI 10.1007/s13142-011-0057-8
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   Yang W, 2013, DIABETES CARE, V36, P1033, DOI DOI 10.2337/DC12-2625
NR 42
TC 12
Z9 12
U1 0
U2 4
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2016
VL 39
IS 12
BP 2165
EP 2173
DI 10.2337/dc16-0035
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EG1IF
UT WOS:000390785000021
PM 27456837
OA Bronze, Green Published
DA 2019-01-08
ER

PT J
AU Gonzalez, JS
   Kane, NS
   Binko, DH
   Shapira, A
   Hoogendoorn, CJ
AF Gonzalez, Jeffrey S.
   Kane, Naomi S.
   Binko, Deborah H.
   Shapira, Amit
   Hoogendoorn, Claire J.
TI Tangled Up in Blue: Unraveling the Links Between Emotional Distress and
   Treatment Adherence in Type 2 Diabetes
SO DIABETES CARE
LA English
DT Article
ID RATING-SCALE MADRS; MEDICATION ADHERENCE; DEPRESSIVE SYMPTOMS;
   SELF-CARE; CLINICAL DEPRESSION; SOMATIC SYMPTOMS; GLYCEMIC CONTROL;
   ADULTS; METAANALYSIS; OUTCOMES
AB OBJECTIVE
   We conducted comprehensive assessments of emotional distress to examine relations with diabetes medication adherence over time.
   RESEARCH DESIGN AND METHODS
   Ethnically and socioeconomically diverse adults treated for type 2 diabetes completed validated self-reports (SRs) for diabetes distress and depression, were administered semistructured depression interviews, and provided blood samples for A1C. Medication adherence among 104 participants was electronically monitored (EM) over the subsequent 3 months; validated SRs of medication adherence were also obtained. Hierarchical linear regression evaluated independent effects of diabetes distress and depression on adherence.
   RESULTS
   Mean +/- SD 3-month medication adherence was 76.1% +/- 25.7% for EM and 83.7% +/- 21.9% for SR. Higher levels of SR (P < 0.001) and interview-based (P < 0.05) depressive symptom severity (P < 0.05) and diabetes-related distress (P < 0.01) showed a significant bivariate association with EM and SR nonadherence. Regression models showed baseline diabetes distress was a significant independent predictor of EM (beta = -0.29; P = 0.001) and SR adherence (beta = -0.24; P < 0.02) at follow-up. SR depression was an independent predictor of EM and SR adherence and reduced the effects of diabetes distress to nonsignificance. Subsequent models indicated this effect was driven by somatic rather than cognitive-affective symptoms of depression. Results were consistent but weaker for interview-based depressive symptoms.
   CONCLUSIONS
   Findings support diabetes-related distress and depression symptom severity as risk factors for type 2 diabetes medication nonadherence. Somatic symptoms captured by depression measures, but not cognitive-affective symptoms, independently predict nonadherence and should be further investigated as a potential link between emotional distress and nonadherence.
C1 [Gonzalez, Jeffrey S.; Kane, Naomi S.; Binko, Deborah H.; Shapira, Amit; Hoogendoorn, Claire J.] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA.
   [Gonzalez, Jeffrey S.] Albert Einstein Coll Med, Dept Med Endocrinol, Bronx, NY 10467 USA.
   [Gonzalez, Jeffrey S.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.
RP Gonzalez, JS (reprint author), Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA.; Gonzalez, JS (reprint author), Albert Einstein Coll Med, Dept Med Endocrinol, Bronx, NY 10467 USA.; Gonzalez, JS (reprint author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.
EM jeffrey.gonzalez@einstein.yu.edu
FU Albert Einstein Diabetes Research Center; National Institutes of Health
   (NIH) [P60 DK020541]; National Institute of Diabetes and Digestive and
   Kidney Diseases [R18 DK09872, R01 DK104845, P30 DK11022]; Drs. David and
   Jane Willner Bloomgarden Family Fellowship Fund
FX This work was partially supported by a pilot and feasibility grant from
   the Albert Einstein Diabetes Research Center, which was supported at the
   time of data collection by National Institutes of Health (NIH) grant P60
   DK020541. J.S.G. is additionally supported by grants R18 DK09872, R01
   DK104845, and P30 DK11022 from the National Institute of Diabetes and
   Digestive and Kidney Diseases. C.J.H. is supported by The Drs. David and
   Jane Willner Bloomgarden Family Fellowship Fund.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Azevedo RD, 2014, PSYCHOL MED, V44, P2689, DOI 10.1017/S0033291714000063
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Gonzalez JS, 2013, DIABETES CARE, V36, P831, DOI 10.2337/dc12-0410
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hofmann M, 2013, PLOS ONE, V8
   Hwang B, 2015, PSYCHOSOM MED, V77, P798, DOI 10.1097/PSY.0000000000000221
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423
   Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McIntyre RS, 2006, J PSYCHOSOM RES, V60, P279, DOI 10.1016/j.jpsychores.2005.09.010
   Michal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072014
   MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
   Muller MJ, 2003, J AFFECT DISORDERS, V77, P255, DOI 10.1016/S0165-0327(02)00120-9
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Reijnders JSAM, 2010, J PSYCHOSOM RES, V68, P561, DOI 10.1016/j.jpsychores.2009.10.006
   Roest AM, 2016, HEALTH PSYCHOL, V35, P413, DOI 10.1037/hea0000256
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1
   Tanenbaum ML, 2013, J AFFECT DISORDERS, V150, P533, DOI 10.1016/j.jad.2013.01.029
   Twist K, 2013, PSYCHOSOM MED, V75, P791, DOI 10.1097/PSY.0b013e3182a2b108
   Williams JBW, 2008, BRIT J PSYCHIAT, V192, P52, DOI 10.1192/bjp.bp.106.032532
   Wiltink J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105499
NR 39
TC 7
Z9 7
U1 2
U2 13
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2016
VL 39
IS 12
BP 2182
EP 2189
DI 10.2337/dc16-1657
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EG1IF
UT WOS:000390785000023
PM 27797932
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Rondags, SMPA
   de Wit, M
   Twisk, JW
   Snoek, FJ
AF Rondags, Stefanie M. P. A.
   de Wit, Maartje
   Twisk, Jos W.
   Snoek, Frank J.
TI Effectiveness of HypoAware, a Brief Partly Web-Based Psychoeducational
   Intervention for Adults With Type 1 and Insulin-Treated Type 2 Diabetes
   and Problematic Hypoglycemia: A Cluster Randomized Controlled Trial
SO DIABETES CARE
LA English
DT Article
ID AWARENESS; FREQUENCY; DUTCH; RISK
AB OBJECTIVE
   To establish the effectiveness of a brief, partly web-based group intervention, HypoAware, in patients with problematic hypoglycemia, in terms of the reduction of severe hypoglycemic episodes, impaired hypoglycemia awareness, and worries.
   RESEARCH DESIGN AND METHODS
   A two-arm, cluster randomized controlled trial was conducted in insulin-treated patients with problematic hypoglycemia in eight Dutch clinics comparing HypoAware with care as usual. Primary outcomes included self-reported severe hypoglycemia, impaired hypoglycemia awareness (Gold score), and worries and distress about hypoglycemia (Hypoglycemia Fear Survey-II/Problem Areas In Diabetes scale hypo-item), assessed at baseline, and at 2, 4, and 6 months of follow-up. We used t tests, nonparametric tests, and intention-to-treat generalized estimation equation (GEE) analyses with linear, logistic, and Poisson or negative binomial models.
   RESULTS
   We enrolled 137 participants. Adjusted GEE analyses over four time points showed a nonsignificant 33% fewer episodes of severe hypoglycemia in the HypoAware group compared with the control group (relative risk [RR] 0.67 [95% CI 0.39-1.16], P = 0.150); a significant reduced odds of impaired awareness (odds ratio 0.38 [95% CI 0.15-0.95], P = 0.038), a trend toward 20% fewer worries about hypoglycemia (RR 0.80 [95% CI 0.64-1.01], P = 0.059), and a significant 30% less hypo-distress (RR 0.70 [95% CI 0.56-0.88], P = 0.002). Over the 6-month study duration, participants experienced a median of 2.5 events of severe hypoglycemia (interquartile range [IQR] 1-10) in the control condition versus 1 event (IQR 0-6.5) in the HypoAware group (P = 0.030). There was no significant change in HbA(1c) level within and between both groups.
   CONCLUSIONS
   HypoAware resulted in fewer severe hypoglycemic episodes, significantly improved hypoglycemia awareness, and less hypo-distress in comparison with usual care, and deserves further dissemination.
C1 [Rondags, Stefanie M. P. A.; de Wit, Maartje; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Rondags, Stefanie M. P. A.; de Wit, Maartje; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Twisk, Jos W.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands.
   [Snoek, Frank J.] Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
RP Snoek, FJ (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.; Snoek, FJ (reprint author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.; Snoek, FJ (reprint author), Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
EM fj.snoek@vumc.nl
FU ZonMw, Dutch Organisation for Health Research and Development
   [837001406]; Novo Nordisk; Agis Achmea; VU University Medical Center
FX The study and manuscript preparation are funded by ZonMw (837001406),
   the Dutch Organisation for Health Research and Development. The authors
   have received unrestricted cofunding from Novo Nordisk, Agis Achmea (a
   Dutch health care insurer), and VU University Medical Center.
CR Broers S, 2002, DIABETIC MED, V19, P157, DOI 10.1046/j.1464-5491.2002.00682.x
   Cox DJ, 2001, DIABETES CARE, V24, P637, DOI 10.2337/diacare.24.4.637
   Cox DJ, 2006, DIABETES SPECTRUM, V19, P43, DOI DOI 10.2337/DIASPECT.19.1.43
   Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084
   DCCT Res Grp, 1991, AM J MED, V90, P450
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   GonderFrederick L, 1997, DIABETES CARE, V20, P661, DOI 10.2337/diacare.20.4.661
   Gruden G, 2012, DIABETES CARE, V35, P1598, DOI 10.2337/dc11-1531
   Ha WC, 2012, DIABETES METAB J, V36, P280, DOI 10.4093/dmj.2012.36.4.280
   Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y
   Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Oyer DS, 2013, CURR DIABETES REV, V9, P195, DOI 10.2174/15733998113099990059
   Pedersen-Bjergaard U, 2004, DIABETES-METAB RES, V20, P479, DOI 10.1002/dmrr.482
   Pedersen-Bjergaard U, 2003, DIABETES-METAB RES, V19, P232, DOI 10.1002/dmrr.377
   Rondags SMPA, 2016, DIABETIC MED, V33, P184, DOI 10.1111/dme.12876
   Rondags SMPA, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0035-0
   Schachinger H, 2005, J BEHAV MED, V28, P587, DOI 10.1007/s10865-005-9026-3
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Snoek FJ, 2014, HYPOGLYCAEMIA CLIN D, P323
   Twisk J. W. R, 2006, APPL MULTILEVEL ANAL
   Unger J, 2011, POSTGRAD MED, V123, P81, DOI 10.3810/pgm.2011.07.2307
   van Beers CAJ, 2016, LANCET DIABETES ENDO, V4, P893, DOI 10.1016/S2213-8587(16)30193-0
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Yeoh E, 2015, DIABETES CARE, V38, P1592, DOI 10.2337/dc15-0102
   Zammitt NN, 2005, DIABETES CARE, V28, P2948, DOI 10.2337/diacare.28.12.2948
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 28
TC 13
Z9 13
U1 0
U2 3
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2016
VL 39
IS 12
BP 2190
EP 2196
DI 10.2337/dc16-1614
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EG1IF
UT WOS:000390785000024
PM 27797931
OA Bronze
DA 2019-01-08
ER

PT J
AU Nyklicek, I
   van Son, J
   Pop, VJ
   Denollet, J
   Pouwer, F
AF Nyklicek, Ivan
   van Son, Jenny
   Pop, Victor J.
   Denollet, Johan
   Pouwer, Francois
TI Does Mindfulness-Based Cognitive Therapy benefit all people with
   diabetes and comorbid emotional complaints equally? Moderators in the
   DiaMind trial
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Diabetes; Mindfulness-Based Cognitive Therapy; Moderator; Personality;
   Randomized trial
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; NEGATIVE AFFECTIVITY;
   BEHAVIORAL THERAPY; STRESS REDUCTION; D PERSONALITY; DEPRESSION;
   ANXIETY; INTERVENTION; DISTRESS
AB Objectives: Research has shown the effectiveness of mindfulness-based interventions for a variety of emotional problems in different samples, but it is unknown which factors influence this effectiveness. Therefore, the aim of the current study was: which factors (demographic, personality, and baseline levels of mindfulness skills) moderate the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT)?
   Methods: Outpatients with diabetes (type I or type 2; N = 139) and an elevated level of emotional distress participated in the Diabetes and Mindfulness (DiaMind) trial. They were randomized into MBCT (N = 70) or a control group (N = 69) that received treatment as usual and that was offered the intervention 6 months later. Primary outcomes were anxiety, depressive symptoms, and perceived stress at post-intervention and at 6-month follow-up.
   Results: Mixed models analyses showed that sex, extraversion, and baseline acting with awareness were significant moderators of effectiveness. In the MBCT group, women showed larger decreases in anxiety and depression across time (large effects) compared to men (medium to small effects). For extraversion divided into quartiles, the three lowest quartiles generally exhibited large decreases in symptoms, whereas the high extraversion group showed medium (perceived stress) to small (depression) decreases.
   Conclusion: MBCT seems to be effective to decrease symptoms of anxiety, depression, and perceived stress for a broad range of person characteristics in patients with diabetes. However, men and those high in extraversion showed considerably lower effectiveness compared to the other groups. The small effect in high extraverts may be due to the large dropout in this subgroup. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Nyklicek, Ivan; van Son, Jenny; Pop, Victor J.; Denollet, Johan; Pouwer, Francois] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med & Clin Psychol, Tilburg, Netherlands.
RP Nyklicek, I (reprint author), Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med & Clin Psychol, Tilburg, Netherlands.; Nyklicek, I (reprint author), P Box 90153, NL-5000 LE Tilburg, Netherlands.
EM I.Nyklicek@tilburguniversity.edu
FU Dutch Diabetes Research Foundation or 'Diabetesfonds' [2008.13.005];
   Tilburg University, Center of Research on Psychology in Somatic diseases
   (CoRPS)
FX The study is supported by grants from 1) the Dutch Diabetes Research
   Foundation or 'Diabetesfonds' (project number 2008.13.005, awarded to
   Dr. I. Nyklicek) and 2) Tilburg University, Center of Research on
   Psychology in Somatic diseases (CoRPS).
CR Arch JJ, 2013, BEHAV RES THER, V51, P434, DOI 10.1016/j.brat.2013.04.004
   ASENDORPF JB, 1993, EMOTION INHIBITION H, P80
   Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504
   Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003
   Beck AT, 1979, COGNITIVE THERAPY DE
   Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077
   Blom MBJ, 2007, J AFFECT DISORDERS, V104, P119, DOI 10.1016/j.jad.2007.03.010
   Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   de Vibe M, 2015, MINDFULNESS, V6, P281, DOI 10.1007/s12671-013-0258-y
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Eysenck HJ, 1991, MANUAL EYSENCK PERSO
   Grossman P, 2008, J PSYCHOSOM RES, V64, P405, DOI 10.1016/j.jpsychores.2008.02.001
   Hoekstra H.A., 2003, HANDLEIDING NEO PERS
   Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555
   Kabat-Zinn J., 1990, FULL CATASTROPHE LIV
   KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3
   Kadengye DT, 2012, BEHAV RES METHODS, V44, P516, DOI 10.3758/s13428-011-0157-x
   Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005
   Kiekens G, 2015, EUR PSYCHIAT, V30, P743, DOI 10.1016/j.eurpsy.2015.06.007
   Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877
   Kupper N, 2014, INT J BEHAV MED, V21, P496, DOI 10.1007/s12529-013-9350-x
   Nyklicek I, 2008, ANN BEHAV MED, V35, P331, DOI 10.1007/s12160-008-9030-2
   Nyklicek I, 2014, J BEHAV MED, V37, P135, DOI 10.1007/s10865-012-9475-4
   Nyklicek I, 2009, PSYCHOL ASSESSMENT, V21, P32, DOI 10.1037/a0014418
   Okumura Y, 2014, J AFFECT DISORDERS, V164, P155, DOI 10.1016/j.jad.2014.04.023
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Quilty LC, 2008, J AFFECT DISORDERS, V108, P241, DOI 10.1016/j.jad.2007.10.022
   SANDERMAN R, 1991, PSYCHOL REP, V69, P1091, DOI 10.2466/PR0.69.8.1091-1096
   Segal Z., 2002, MINDFULNESS BASED CO
   Shapiro SL, 2011, J CLIN PSYCHOL, V67, P267, DOI 10.1002/jclp.20761
   Spek V, 2008, J AFFECT DISORDERS, V105, P137, DOI 10.1016/j.jad.2007.05.001
   Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382
   van Son J, 2014, J PSYCHOSOM RES, V77, P81, DOI 10.1016/j.jpsychores.2014.03.013
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   van Son J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-131
   WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037//0033-295X.96.2.234
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 38
TC 5
Z9 5
U1 3
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD DEC
PY 2016
VL 91
BP 40
EP 47
DI 10.1016/j.jpsychores.2016.10.009
PG 8
WC Psychiatry
SC Psychiatry
GA EE6PY
UT WOS:000389735900007
PM 27894461
DA 2019-01-08
ER

PT J
AU Robinson, EM
   Weaver, P
   Chen, R
   Streisand, R
   Holmes, CS
AF Robinson, Elizabeth M.
   Weaver, Patrick
   Chen, Rusan
   Streisand, Randi
   Holmes, Clarissa S.
TI A Model of Parental Distress and Factors That Mediate Its Link With
   Parental Monitoring of Youth Diabetes Care, Adherence, and Glycemic
   Control
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE type 1 diabetes; adherence; adolescence; parental monitoring; parental
   distress
ID MATERNAL DEPRESSIVE SYMPTOMS; METABOLIC-CONTROL; SELF-EFFICACY;
   YOUNG-CHILDREN; ILLNESS MANAGEMENT; REGIMEN ADHERENCE; FAMILY CONFLICT;
   HEALTH OUTCOMES; DISEASE CARE; FIT INDEXES
AB Objective: Parental monitoring of adolescents' diabetes self-care is associated with better adherence and glycemic control (A1c). A number of parent-level factors are associated with higher levels of parental monitoring, including lower levels of parental distress (depressive symptoms, stress, anxiety), as well as higher levels of parental self-efficacy for diabetes management and authoritative parenting. Often studied in isolation, these factors may be best considered simultaneously as they are interrelated and are associated with parental monitoring and youth adherence. Method: Structural equation modeling with a cross-sectional sample of 257 parent/youth (aged 11-14) dyads: (a) examined a broad model of parental factors (i.e., parental distress, parental diabetes self-efficacy, authoritative parenting), and (b) assessed their relation to parental monitoring, youth adherence, and A1c. Post hoc analyses of variance (ANOVAs) evaluated clinical implications of daily parental monitoring. Results: Parental distress was not related directly to parental monitoring. Instead less distress related indirectly to more monitoring via higher parental self-efficacy and more authoritative parenting which, in turn, related to better adherence and A1c. Higher parental self-efficacy also related directly to better youth adherence and then to better A1c. Clinically, more parental monitoring related to more daily blood glucose checks and to better A1c (8.48% vs. 9.17%). Conclusions: A broad model of parent-level factors revealed more parental distress was linked only indirectly to less monitoring via lower parental self-efficacy and less authoritative parenting. Behaviorally, more parental monitoring related to better adherence and to clinically better A1c in adolescents. Further study of parent-level factors that relate to parental distress and monitoring of adherence appears warranted.
C1 [Robinson, Elizabeth M.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA.
   [Weaver, Patrick] Eastern Michigan Univ, Dept Psychol, Ypsilanti, MI 48197 USA.
   [Chen, Rusan] Georgetown Univ, Ctr New Designs Learning & Scholarship, Washington, DC 20057 USA.
   [Streisand, Randi] Childrens Natl Med Ctr, Dept Psychiat & Behav Sci, Div Behav Med & Clin Psychol, Washington, DC 20010 USA.
   [Streisand, Randi] George Washington Univ, Dept Pediat, Washington, DC 20052 USA.
   [Holmes, Clarissa S.] Virginia Commonwealth Univ, Dept Pediat, Richmond, VA 23284 USA.
   [Holmes, Clarissa S.] Georgetown Univ, Dept Psychiat, Washington, DC 20057 USA.
RP Robinson, EM (reprint author), Childrens Hosp Philadelphia, 3401 Civ Ctr Blvd,Room 11400-03, Philadelphia, PA 19104 USA.
EM robinson.elizabeth.m@gmail.com
FU National Institute of Diabetes and Digestive and Kidney Diseases at the
   National Institutes of Health [5R01DK070917]
FX This work was supported by the National Institute of Diabetes and
   Digestive and Kidney Diseases at the National Institutes of Health
   (Grant 5R01DK070917) awarded to CH.
CR ABIDIN RR, 1992, J CLIN CHILD PSYCHOL, V21, P407, DOI 10.1207/s15374424jccp2104_12
   AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402
   Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   BAUMRIND D, 1967, GENET PSYCHOL MONOGR, V75, P43
   Beck AT, 1996, MANUAL BECK DEPRESSI
   BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.1111/j.1467-8624.1984.tb00275.x
   BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170
   Carcone AI, 2012, J DEV BEHAV PEDIATR, V33, P343, DOI 10.1097/DBP.0b013e31824eaac8
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140
   Clarke WL, 1998, J PEDIATR ENDOCR MET, V11, P189
   Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330
   Driscoll KA, 2010, J PEDIATR PSYCHOL, V35, P814, DOI 10.1093/jpepsy/jsp138
   Eckshtain D, 2010, J PEDIATR PSYCHOL, V35, P426, DOI 10.1093/jpepsy/jsp068
   Ellis DA, 2008, J ADOLESCENT HEALTH, V42, P146, DOI 10.1016/j.jadohealth.2007.08.012
   Ellis DA, 2007, J PEDIATR PSYCHOL, V32, P907, DOI 10.1093/jpepsy/jsm009
   EVANS CL, 1987, J PSYCHOSOM RES, V31, P367, DOI 10.1016/0022-3999(87)90057-2
   GILLIS JS, 1993, PSYCHOL REP, V72, P1355, DOI 10.2466/pr0.1993.72.3c.1355
   Glatz T, 2015, J FAM PSYCHOL, V29, P427, DOI 10.1037/fam0000076
   Greene MS, 2010, DIABETES EDUCATOR, V36, P326, DOI 10.1177/0145721710361270
   Grey M, 2001, J ADOLESCENT HEALTH, V28, P377, DOI 10.1016/S1054-139X(00)00211-1
   Helgeson VS, 2012, J PEDIATR PSYCHOL, V37, P467, DOI 10.1093/jpepsy/jsr110
   Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079
   Hilliard ME, 2013, HEALTH PSYCHOL, V32, P388, DOI 10.1037/a0027811
   Hilliard ME, 2011, ARCH PEDIAT ADOL MED, V165, P624, DOI 10.1001/archpediatrics.2011.86
   Hollingshead A. A., 1975, 4 FACTOR INDEX UNPUB
   Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P5, DOI 10.1093/jpepsy/27.1.5
   Holmes CS, 2006, J PEDIATR PSYCHOL, V31, P770, DOI 10.1093/jpepsy/jsj083
   Holmes CS, 2014, DIABETES CARE, V37, P1535, DOI 10.2337/dc13-1053
   Horsch A, 2007, J TRAUMA STRESS, V20, P881, DOI 10.1002/jts.20247
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037//1082-989X.3.4.424
   Iannotti RJ, 2006, J DEV BEHAV PEDIATR, V27, P98, DOI 10.1097/00004703-200604000-00003
   Iannotti RJ, 2006, DIABETES CARE, V29, P2263, DOI 10.2337/dc06-0685
   IRVINE AA, 1992, HEALTH PSYCHOL, V11, P135, DOI 10.1037/0278-6133.11.2.135
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Jaser SS, 2010, J PEDIATR PSYCHOL, V35, P738, DOI 10.1093/jpepsy/jsp098
   JOHNSON SB, 1986, HEALTH PSYCHOL, V5, P545, DOI 10.1037/0278-6133.5.6.545
   JOHNSON SB, 1992, J PEDIATR PSYCHOL, V17, P537, DOI 10.1093/jpepsy/17.5.537
   Johnson SR, 2013, DIABETOLOGIA, V56, P2392, DOI 10.1007/s00125-013-3007-9
   Jones TL, 2005, CLIN PSYCHOL REV, V25, P341, DOI 10.1016/j.cpr.2004.12.004
   KENNY DA, 1995, PERS RELATIONSHIP, V2, P67, DOI 10.1111/j.1475-6811.1995.tb00078.x
   King PS, 2014, HEALTH PSYCHOL, V33, P424, DOI 10.1037/a0032804
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Leonard B J, 1998, J Pediatr Nurs, V13, P224, DOI 10.1016/S0882-5963(98)80049-3
   MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201
   Mackey ER, 2014, HEALTH PSYCHOL, V33, P783, DOI 10.1037/hea0000066
   MacKinnon D., 2008, INTRO STAT MEDIATION
   Marrero DG, 1997, DIABETES EDUCATOR, V23, P281, DOI 10.1177/014572179702300306
   McGrady ME, 2009, DIABETES CARE, V32, P804, DOI 10.2337/dc08-2111
   Mlynarczyk Susan M, 2013, Pediatr Nurs, V39, P181
   Monaghan M, 2012, J CLIN PSYCHOL MED S, V19, P255, DOI 10.1007/s10880-011-9284-x
   Monaghan MC, 2009, FAM SYST HEALTH, V27, P28, DOI 10.1037/a0014770
   Muthen L. K., 1998, MPLUS USERS GUIDE
   Patton SR, 2007, PEDIATR DIABETES, V8, P362, DOI 10.1111/j.1399-5448.2007.00242.x
   Patton SR, 2011, J CLIN PSYCHOL MED S, V18, P345, DOI 10.1007/s10880-011-9256-1
   Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163
   Snorer M, 2011, DIABETES CARE, V34, P1735, DOI 10.2337/dc10-1602
   STEINBERG L, 1994, CHILD DEV, V65, P754, DOI 10.1111/j.1467-8624.1994.tb00781.x
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   Wiebe DJ, 2011, J PEDIATR PSYCHOL, V36, P837, DOI 10.1093/jpepsy/jsr002
   Wiebe DJ, 2010, J PEDIATR PSYCHOL, V35, P1152, DOI 10.1093/jpepsy/jsq012
   Wiebe DJ, 2005, J PEDIATR PSYCHOL, V30, P167, DOI 10.1093/jpepsy/jsi004
   WYSOCKI T, 1992, DIABETES CARE, V15, P43, DOI 10.2337/diacare.15.1.43
NR 67
TC 3
Z9 3
U1 0
U2 18
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD DEC
PY 2016
VL 35
IS 12
BP 1373
EP 1382
DI 10.1037/hea0000406
PG 10
WC Psychology, Clinical; Psychology
SC Psychology
GA ED3MD
UT WOS:000388752300010
PM 27513476
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Das, A
AF Das, Aniruddha
TI Psychosocial distress and inflammation: Which way does causality flow?
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Inflammation; Psychosocial distress; Older adults; NSHAP
ID C-REACTIVE PROTEIN; NATIONAL SOCIAL-LIFE; MARGINAL STRUCTURAL MODELS;
   TYPE-2 DIABETES-MELLITUS; CORONARY-HEART-DISEASE; AGING PROJECT;
   CARDIOVASCULAR-DISEASE; OLDER-ADULTS; DEPRESSIVE SYMPTOMS; METABOLIC
   SYNDROME
AB Objectives: This study queried causal direction in linkages of inflammation with psychosocial distress.
   Methods: Data were from the 2005-2006 and 2010-2011 waves of the U.S. National Social Life, Health, and Aging Project. Inflammation was indicated by C-reactive protein, and distress by depression, anxiety, as well as stress. Autoregressive cross-lagged panel models were used to examine causal direction.
   Results: Rather than being an outcome of psychosocial distress, inflammation was a predictor of it. Linkages were gender differentiated, with inflammation seeming to induce depression among men but stress among women.
   Discussion: Contrary to previous literature, inflammation may not be a mechanism through which psychosocial distress gets "under the skin" to cause cardiovascular and metabolic issues. Rather, it may be a node through which social pathologies and life events influence both mental health and physiological problems. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Das, Aniruddha] McGill Univ, Dept Sociol, Room 712,Leacock Bldg,855 Sherbrooke St West, Montreal, PQ H3A 2T7, Canada.
RP Das, A (reprint author), McGill Univ, Dept Sociol, Room 712,Leacock Bldg,855 Sherbrooke St West, Montreal, PQ H3A 2T7, Canada.
EM aniruddha.das@mcgill.ca
CR Baune BT, 2012, PSYCHONEUROENDOCRINO, V37, P1521, DOI 10.1016/j.psyneuen.2012.02.006
   Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200
   Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100
   Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014
   Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159
   CARR D, 2002, AGEING INT, V0027
   Chiu HM, 2008, AM J GASTROENTEROL, V103, P2317, DOI 10.1111/j.1572-0241.2008.01952.x
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Cole SR, 2005, AM J EPIDEMIOL, V162, P471, DOI 10.1093/aje/kwi216
   Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164
   Copeland WE, 2012, BIOL PSYCHIAT, V71, P15, DOI 10.1016/j.biopsych.2011.09.023
   Cuijpers P, 2014, AM J PSYCHIAT, V171, P453, DOI 10.1176/appi.ajp.2013.13030325
   CURRAN PJ, 2000, MULT APPL BK SER, P1
   Danesh J, 2000, BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199
   Deverts DJ, 2010, PSYCHOSOM MED, V72, P734, DOI 10.1097/PSY.0b013e3181ec4b98
   Duivis HE, 2011, AM J PSYCHIAT, V168, P913, DOI 10.1176/appi.ajp.2011.10081163
   Elwert F, 2006, AM SOCIOL REV, V71, P16, DOI 10.1177/000312240607100102
   Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010
   Fuente-Martin E, 2013, REV ENDOCR METAB DIS, V14, P331, DOI 10.1007/s11154-013-9263-7
   Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723
   Glassman AH, 2007, BIOL PSYCHIAT, V62, P280, DOI 10.1016/j.biopsych.2007.05.032
   Gouin JP, 2012, ANN BEHAV MED, V44, P287, DOI 10.1007/s12160-012-9386-1
   Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536
   Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6
   Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205
   Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005
   Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012
   Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137
   Kiecolt-Glaser JK, 2015, AM J PSYCHIAT, V172, P1075, DOI 10.1176/appi.ajp.2015.15020152
   Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003
   Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100
   KiecoltGlaser JK, 1997, PSYCHOSOM MED, V59, P339, DOI 10.1097/00006842-199707000-00001
   Lagraauw HM, 2015, BRAIN BEHAV IMMUN, V50, P18, DOI 10.1016/j.bbi.2015.08.007
   Lancaster GI, 2014, TRENDS IMMUNOL, V35, P262, DOI 10.1016/j.it.2014.02.008
   Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005
   Lykken D, 1996, PSYCHOL SCI, V7, P186, DOI 10.1111/j.1467-9280.1996.tb00355.x
   Matthews KA, 2010, BRAIN BEHAV IMMUN, V24, P96, DOI 10.1016/j.bbi.2009.08.005
   McDade TW, 2013, BRAIN BEHAV IMMUN, V31, P23, DOI 10.1016/j.bbi.2012.08.010
   McDade TW, 2012, P NATL ACAD SCI USA, V109, P17281, DOI 10.1073/pnas.1202244109
   McDade TW, 2009, BIODEMOGR SOC BIOL, V55, P159, DOI 10.1080/19485560903382478
   McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64
   McDade TW, 2004, CLIN CHEM, V50, P652, DOI 10.1373/clinchem.2003.029488
   Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050
   Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327
   Milaneschi Y, 2009, BIOL PSYCHIAT, V65, P973, DOI [10.1016/j.biopsych.2008.11.01, 10.1016/j.biopsych.2008.11.011]
   Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084
   Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029
   Mukamal KJ, 2006, ALCOHOL RES HEALTH, V29, P199
   Muthen L. K., 1998, MPLUS USERS GUIDE
   O'Muircheartaigh C., 2007, NSHAP NATL SOCIAL LI
   O'Muircheartaigh C, 2014, J GERONTOL B-PSYCHOL, V69, pS15, DOI 10.1093/geronb/gbu053
   Owen N, 2003, BRAIN BEHAV IMMUN, V17, P286, DOI 10.1016/S0889-1591(03)00058-8
   Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009
   Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Qato DM, 2009, J GERONTOL B-PSYCHOL, V64, pI86, DOI 10.1093/geronb/gbp036
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Raison CL, 2013, BRAIN BEHAV IMMUN, V31, P1, DOI 10.1016/j.bbi.2013.04.009
   Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0
   Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006
   Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05
   Schnittker J, 2008, AM J SOCIOL, V114, pS233, DOI 10.1086/592424
   Schultze-Florey CR, 2012, BRAIN BEHAV IMMUN, V26, P1066, DOI 10.1016/j.bbi.2012.06.009
   Shaffer JA, 2011, PSYCHOSOM MED, V73, P370, DOI 10.1097/PSY.0b013e31821deafd
   Shelton RC, 2010, PROG NEUROBIOL, V91, P275, DOI 10.1016/j.pneurobio.2010.04.004
   Shiovitz-Ezra S, 2009, J GERONTOL B-PSYCHOL, V64, pI30, DOI 10.1093/geronb/gbn020
   Simanek AM, 2014, PSYCHONEUROENDOCRINO, V50, P139, DOI 10.1016/j.psyneuen.2014.08.002
   Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302
   Slopen N, 2015, PSYCHONEUROENDOCRINO, V51, P403, DOI 10.1016/j.psyneuen.2014.10.016
   Smith S, 2009, J GERONTOL B-PSYCHOL, V64, pI20, DOI 10.1093/geronb/gbn013
   Stata Corp, 2014, STATA REL 14 0
   Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b
   Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004
   WEINSTEIN M, 2007, BIOSOCIAL SURVEYS
   Williams SR, 2009, J GERONTOL B-PSYCHOL, V64, pI67, DOI 10.1093/geronb/gbn015
   Williams SR, 2009, J GERONTOL B-PSYCHOL, V64, pI131, DOI 10.1093/geronb/gbn022
   Willson AE, 2007, AM J SOCIOL, V112, P1886, DOI 10.1086/512712
   Yudkin JS, 2003, INT J OBESITY, V27, pS25, DOI 10.1038/sj.ijo.0802496
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 79
TC 18
Z9 18
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD DEC
PY 2016
VL 170
BP 1
EP 8
DI 10.1016/j.socscimed.2016.10.001
PG 8
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA ED8FZ
UT WOS:000389108700001
PM 27728857
DA 2019-01-08
ER

PT J
AU Han, Y
   Zheng, YL
   Wu, AM
   Liu, HB
   Su, JB
   Lu, XY
   Han, YW
   Ji, NL
   Ji, JH
   Shi, Y
AF Han, Yun
   Zheng, Yan-li
   Wu, Ai-min
   Liu, Hong-bin
   Su, Jian-bin
   Lu, Xiao-yan
   Han, Yu-wen
   Ji, Jin-long
   Ji, Ju-hua
   Shi, Yue
TI Effects of management in gestational diabetes mellitus with normal
   prepregnancy body mass index on pregnancy outcomes and placental
   ultrastructures: a prospective cohort study
SO ENDOCRINE
LA English
DT Article
DE Gestational diabetes mellitus; Pregnancy outcome; Placenta;
   Ultrastructure; Management
ID WEIGHT-GAIN; DIAGNOSTIC-CRITERIA; NEONATAL OUTCOMES; WOMEN;
   RECOMMENDATIONS; ASSOCIATION; GLUCOSE; TRIAL; BIRTH
AB A great quantity of gestational diabetes mellitus with normal prepregnancy body mass index have emerged with the new criteria of gestational diabetes mellitus in China based on the International Diabetes in Pregnancy Consensus group criteria, and understanding placental changes and how they affect outcomes are necessary in order to develop effective management approach. The aim of this study was to prospectively explore the effect of active management starting from the late second trimester in gestational diabetes mellitus women with normal prepregnancy body mass index on pregnancy outcomes and placental ultrastructures, and to provide scientific evidences for optimizing the management of gestational diabetes mellitus in China. Gestational diabetes mellitus women with normal prepregnancy body mass index in the same period of this prospective cohort study were divided into intervention group (n = 51) and control group (n = 55). The intervention group was managed rigorously, while the control group received conventional prenatal cares. The glucose profile, gestational weight gain and pregnancy outcomes were followed up and placental ultrastructures were observed and recorded by transmission electron microscopy. The blood glucose level and gestational weight gain in intervention group were significantly better controlled than those in control group (P < 0.01). The incidences of fetal distress, cesarean section and large for gestational age were significantly lower in intervention group than in control group (P < 0.05). There was a significant reduction in the incidence of abnormal placental ultrastructure in the intervention group (P < 0.01). After adjustment for confounding factors, the undesirable glycemic control and conventional management were related to abnormal placental ultrastructure (P < 0.05). Meanwhile, the undesirable glycemic control, abnormal placental ultrastructure and conventional management made sense in the incidence of fetal distress (P < 0.05), and the target glycemic control, recommend weight gain and active management were associated with reductions in the prevalence of cesarean delivery and large for gestational age (P < 0.05). The active management of gestational diabetes mellitus women with normal prepregnancy body mass index can improve pregnancy outcomes and placental ultrastructures, and the abnormal placental ultrastructure might be closely associated with the undesirable glycemic control and adverse pregnancy outcomes.
C1 [Han, Yun; Zheng, Yan-li; Wu, Ai-min; Lu, Xiao-yan; Han, Yu-wen; Ji, Jin-long] Nantong Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China.
   [Liu, Hong-bin] Nantong Univ, Affiliated Hosp 2, Dept Pathol, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China.
   [Su, Jian-bin] Nantong Univ, Affiliated Hosp 2, Dept Endocrinol, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China.
   [Ji, Ju-hua] Nantong Univ, Affiliated Hosp 2, Dept Pediat, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China.
   [Shi, Yue] Johns Hopkins Med, 1013 N Wolfe St, Baltimore, MD 21205 USA.
RP Zheng, YL (reprint author), Nantong Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China.
EM gaoshan1189@sina.com
OI Su, Jian-bin/0000-0002-2138-0263
FU National Natural Science Foundation of China [81501258]; Maternal and
   Children Health Research Project of Jiangsu Province [F201329]; Jiangsu
   Provincial Commission of Health and Family Planning Youth Research
   Project [Q201512]
FX The study was partly supported by National Natural Science Foundation of
   China (81501258), Maternal and Children Health Research Project of
   Jiangsu Province (F201329) and Jiangsu Provincial Commission of Health
   and Family Planning Youth Research Project (Q201512).
CR Abenhaim Haim A., 2007, Archives of Gynecology and Obstetrics, V275, P39, DOI 10.1007/s00404-006-0219-y
   ALOKAIL MS, 1994, ENDOCR J, V41, P355, DOI 10.1507/endocrj.41.355
   Berggren EK, 2015, AM J PERINAT, V32, P251, DOI 10.1055/s-0034-1383848
   Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741
   Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1
   Bonomo M, 2005, DIABETIC MED, V22, P1536, DOI 10.1111/j.1464-5491.2005.01690.x
   Casey BM, 2015, AM J PERINAT, V32, P93, DOI 10.1055/s-0034-1374815
   Derbyshire E, 2006, J HUM NUTR DIET, V19, P267, DOI 10.1111/j.1365-277X.2006.00705.x
   Dzakpasu S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-106
   Gabbay-Benziv R., 2014, CLIN OBSTET GYNAECOL, V29, P150, DOI [10.1016/j.bpobgyn.2014.04.025, DOI 10.1016/J.BPOBGYN.2014.04.025]
   Gasim Turki, 2012, Oman Med J, V27, P140, DOI 10.5001/omj.2012.29
   Getahun D, 2007, AM J OBSTET GYNECOL, V196, pe1
   Greuter MJE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-58
   Hadar E, 2009, J PERINAT MED, V37, P447, DOI 10.1515/JPM.2009.114
   Hartling L, 2014, DIABETIC MED, V31, P319, DOI 10.1111/dme.12357
   Institute of Medicine, 2009, WEIGHT GAIN PREGNANC
   JONES CJP, 1976, OBSTET GYNECOL, V48, P274
   Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430
   Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039
   Langer O, 2010, J MATERN-FETAL NEO M, V23, P196, DOI 10.3109/14767050903550634
   McGiveron A, 2015, J HUM NUTR DIET, V28, P29, DOI 10.1111/jhn.12240
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Shen Cai-xia, 2011, Chinese Journal of Pathology, V40, P856, DOI 10.3760/cma.j.issn.0529-5807.2011.12.018
   Strom-Roum EM, 2013, ACTA OBSTET GYN SCAN, V92, P783, DOI 10.1111/aogs.12104
   Turok DK, 2003, AM FAM PHYSICIAN, V68, P1767
   Yang HX, 2012, CHINESE MED J-PEKING, V125, P1212, DOI 10.3760/cma.j.issn.0366-6999.2012.07.004
   Yang Yan-dong, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P646
   Zhu WW, 2013, DIABETES CARE, V36, P586, DOI 10.2337/dc12-1157
NR 28
TC 0
Z9 0
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD DEC
PY 2016
VL 54
IS 3
BP 691
EP 699
DI 10.1007/s12020-016-1064-9
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EC5TA
UT WOS:000388197900014
PM 27481362
DA 2019-01-08
ER

PT J
AU Kurajoh, M
   Kadoya, M
   Morimoto, A
   Naka, M
   Miyoshi, A
   Kanzaki, A
   Kakutani-Hatayama, M
   Hamamoto, K
   Shoji, T
   Moriwaki, Y
   Yamamoto, T
   Inaba, M
   Namba, M
   Koyama, H
AF Kurajoh, Masafumi
   Kadoya, Manabu
   Morimoto, Akiko
   Naka, Mariko
   Miyoshi, Akio
   Kanzaki, Akinori
   Kakutani-Hatayama, Mild
   Hamamoto, Kae
   Shoji, Takuhito
   Moriwaki, Yuji
   Yamamoto, Tetsuya
   Inaba, Masaaki
   Namba, Mitsuyoshi
   Koyama, Hidenori
TI Plasma leptin concentration is associated with fatigue severity in
   patients with cardiovascular risk factors - HSCAA study
SO PSYCHONEUROENDOCRINOLOGY
LA English
DT Article
DE Fatigue; Leptin; Cardiovascular risk factor
ID OBSTRUCTIVE SLEEP-APNEA; PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS;
   AUTONOMIC FUNCTION; CHOLESTEROL LEVELS; DOPAMINE NEURONS; ALCOHOL;
   QUALITY; BRAIN; DISEASE
AB Fatigue induced by complex dysfunctions of the central nervous system is frequently complained by patients with cardiovascular risk factors. Although leptin is considered to regulate the central nervous system, there are no reports regarding its association with fatigue in those patients. This cross-sectional study included 347 patients with cardiovascular risk factors. Fatigue score and plasma leptin concentration were measured. In addition, abdominal fat accumulation, systemic inflammation, sleep condition, and functions of hypothalamus-pituitary axis and autonomic system were estimated. Plasma leptin concentration (natural logarithm transformed) was significantly and positively (r= 0.222, p < 0.001) associated with fatigue score, and significantly (p <0.001) higher in the moderately-fatigued group (2.32 +/- 10.75 ng/ml, mean +/- SD, n = 52) than in the normally-fatigued group (1.85 +/- 1.02 ng/ml, mean +/- SD, n=295). Multiple logistic regression analysis showed that plasma leptin concentration was significantly and independently associated with a moderately-fatigued condition independent of other factors, including age, gender, presence of diabetes, hypertension, dyslipidemia, alcohol consumption habit, urinary free cortisol, serum high-sensitive CRP concentration, visceral and subcutaneous fat area, apnea/hypopnea index, sleep efficiency, and heart rate variability. Hyperleptinemia may contribute to fatigue severity in patients with cardiovascular risk factors. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Kurajoh, Masafumi; Kadoya, Manabu; Morimoto, Akiko; Naka, Mariko; Miyoshi, Akio; Kanzaki, Akinori; Kakutani-Hatayama, Mild; Hamamoto, Kae; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Namba, Mitsuyoshi; Koyama, Hidenori] Hyogo Coll Med, Div Diabet Endocrinol & Metab, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.
   [Kurajoh, Masafumi; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Endocrinol Metab & Mol Med, Osaka, Japan.
RP Kurajoh, M (reprint author), Hyogo Coll Med, Div Diabet Endocrinol & Metab, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.
EM mkurajoh@hyo-med.ac.jp
CR Atmaca M, 2002, NEUROPSYCHOBIOLOGY, V46, P176, DOI 10.1159/000067809
   BAILEY SP, 1993, INT J SPORTS MED, V14, P330, DOI 10.1055/s-2007-1021187
   Bardwell WA, 2003, AM J PSYCHIAT, V160, P350, DOI 10.1176/appi.ajp.160.2.350
   Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8
   Brewerton TD, 2000, PSYCHONEUROENDOCRINO, V25, P649, DOI 10.1016/S0306-4530(00)00016-0
   Bultmann U, 2002, J OCCUP ENVIRON MED, V44, P116
   Bunevicius A, 2012, PSYCHOSOM MED, V74, P848, DOI 10.1097/PSY.0b013e318268e7f0
   Burguera B, 2000, NEUROENDOCRINOLOGY, V71, P187, DOI 10.1159/000054536
   Calapi G, 1999, J CLIN INVEST, V104, P975, DOI 10.1172/JCI5867
   Camm AJ, 1996, EUR HEART J, V17, P354
   Cho HJ, 2009, BIOL PSYCHIAT, V66, P871, DOI 10.1016/j.biopsych.2009.06.008
   Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2001-0014
   Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775
   Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y
   Eckert ED, 1998, J CLIN ENDOCR METAB, V83, P791, DOI 10.1210/jc.83.3.791
   Farr OM, 2015, METABOLISM, V64, P114, DOI 10.1016/j.metabol.2014.07.004
   Fujii H, 2013, J RENAL NUTR, V23, P340, DOI 10.1053/j.jrn.2012.12.008
   Holliday EB, 2016, RADIOTHER ONCOL, V118, P105, DOI 10.1016/j.radonc.2015.12.015
   Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023
   Jarosz PA, 2014, WOMEN HEALTH ISS, V24, pE447, DOI 10.1016/j.whi.2014.04.005
   Jow GM, 2006, J AFFECT DISORDERS, V90, P21, DOI 10.1016/j.jad.2005.09.015
   Kadoya M, 2015, ATHEROSCLEROSIS, V238, P409, DOI 10.1016/j.atherosclerosis.2014.12.032
   Kadoya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105977
   King AC, 2011, ARCH GEN PSYCHIAT, V68, P389, DOI 10.1001/archgenpsychiatry.2011.26
   Koyama H, 2010, CLIN J AM SOC NEPHRO, V5, P659, DOI 10.2215/CJN.08151109
   Kuppuswamy A, 2015, J NEUROL NEUROSUR PS, V86, P902, DOI 10.1136/jnnp-2015-310431
   Kurajoh M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0280-6
   Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011
   Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575
   Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836
   Lim WJ, 2005, ARCH INTERN MED, V165, P910, DOI 10.1001/archinte.165.8.910
   Loppenthin K, 2015, CLIN RHEUMATOL, V34, P2029, DOI 10.1007/s10067-015-2875-4
   Macdonald JH, 2012, AM J KIDNEY DIS, V60, P930, DOI 10.1053/j.ajkd.2012.06.021
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   McKenzie R, 1998, JAMA-J AM MED ASSOC, V280, P1061, DOI 10.1001/jama.280.12.1061
   MORRISS R, 1993, BRIT MED J, V306, P1161, DOI 10.1136/bmj.306.6886.1161
   Neu D, 2007, NEUROPSYCHOBIOLOGY, V56, P40, DOI 10.1159/000110727
   Nicolas JM, 2001, ALCOHOL CLIN EXP RES, V25, P83
   PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763
   PERSSON LO, 1980, PSYCHOPHARMACOLOGY, V68, P295, DOI 10.1007/BF00428119
   Piche T, 2002, GUT, V51, P434, DOI 10.1136/gut.51.3.434
   Piche T, 2007, EUR J GASTROEN HEPAT, V19, P237, DOI 10.1097/01.meg.0000252627.50302.b4
   Rizo C, 2011, J AFFECT DISORDERS, V130, P290, DOI 10.1016/j.jad.2010.07.027
   Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579
   Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490
   Schrieks IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126421
   Schwartz MW, 1997, DIABETES CARE, V20, P1476, DOI 10.2337/diacare.20.9.1476
   Stringer EA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-93
   Stubbs B, 2016, PSYCHONEUROENDOCRINO, V63, P144, DOI 10.1016/j.psyneuen.2015.09.026
   Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370
   Wiese JG, 2000, ANN INTERN MED, V132, P897, DOI 10.7326/0003-4819-132-11-200006060-00008
   WILSON WM, 1992, EXP PHYSIOL, V77, P921, DOI 10.1113/expphysiol.1992.sp003660
   Woolley J, 2004, J PSYCHOSOM RES, V56, P203, DOI 10.1016/S0022-3999(03)00077-1
   Wu MN, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0112-1
   Zhuang XX, 1999, NEUROPSYCHOPHARMACOL, V21, pS52, DOI 10.1038/sj.npp.1395371
   Zupancic ML, 2011, PSYCHOSOM MED, V73, P407, DOI 10.1097/PSY.0b013e31821a196f
NR 56
TC 2
Z9 2
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4530
J9 PSYCHONEUROENDOCRINO
JI Psychoneuroendocrinology
PD DEC
PY 2016
VL 74
BP 7
EP 12
DI 10.1016/j.psyneuen.2016.08.016
PG 6
WC Endocrinology & Metabolism; Neurosciences; Psychiatry
SC Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry
GA EB6VW
UT WOS:000387524700002
PM 27567116
DA 2019-01-08
ER

PT J
AU Lasaite, L
   Dobrovolskiene, R
   Danyte, E
   Stankute, I
   Razanskaite-Virbickiene, D
   Schwitzgebel, V
   Marciulionyte, D
   Verkauskiene, R
AF Lasaite, Lina
   Dobrovolskiene, Rimante
   Danyte, Evalda
   Stankute, Ingrida
   Razanskaite-Virbickiene, Dovile
   Schwitzgebel, Valerie
   Marciulionyte, Dalia
   Verkauskiene, Rasa
TI Diabetes distress in males and females with type 1 diabetes in
   adolescence and emerging adulthood
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes distress; Type 1 diabetes; Adolescence; Emerging adulthood;
   Gender-specific differences
ID PROBLEM-AREAS; EMOTIONAL DISTRESS; GLYCEMIC CONTROL; GLYCOSYLATED
   HEMOGLOBIN; METABOLIC-CONTROL; DEPRESSION; SCALE; COMPLICATIONS;
   CHILDREN; HEALTH
AB Background: Age and gender are important factors in the adjustment and psychological well-being of patients with chronic physical illness.
   Aim: To explore the gender and age differences in diabetes distress between adolescents and emerging adults with type 1 diabetes (T1D).
   Subjects and methods: Diabetes distress was compared in 255 adolescents and 283 emerging adults with T1D using Problem Areas in Diabetes scale.
   Results: High diabetes distress level was found in 22.8% of participants. Lack of confidence in self-care (6.0 vs 3.0,p = 0.002), negative emotional consequences (10.0 vs 6.0,p = 0.004), and overall score (18.75 vs 11.25, p = 0.002) were higher in adult than in adolescent males, when adjusted for age at T1D onset. Negative emotional consequences (13.0 vs 10.0, p = 0.005) and overall score (25.0 vs 20.0, p = 0.016) were higher in adult compared to adolescent females, when adjusted for age at T1D onset. Lack of confidence in self-care (6.0 vs 3.0,p = 0.002), negative emotional consequences (10.0 vs 6.0,p = 0.015), and overall score (20.0 vs 11.2, p = 0.005) were higher in adolescent females compared to males, when adjusted for age at T1D onset. Negative emotional consequences score was higher in adult females compared to males (13.0 vs 10.0, p = 0.029), when adjusted for age at T1D onset.
   In conclusion, our findings show that patients with TID have greater burden of diabetes distress in emerging adulthood than in adolescence and add to evidence suggesting the importance of addressing diabetes distress in clinical care and the necessity of wider picture beyond the physical manifestation of diabetes to be taken into consideration. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Lasaite, Lina; Danyte, Evalda; Razanskaite-Virbickiene, Dovile; Marciulionyte, Dalia; Verkauskiene, Rasa] Lithuanian Univ Hlth Sci, Inst Endocrinol, Kaunas, Lithuania.
   [Dobrovolskiene, Rimante; Stankute, Ingrida] Hosp Lithuanian Univ Hlth Sci Kauno Klinikos, Dept Endocrinol, Kaunas, Lithuania.
   [Schwitzgebel, Valerie] Univ Hosp Geneva, Dept Child & Adolescent, Geneva, Switzerland.
   [Schwitzgebel, Valerie] Univ Geneva, Diabet Ctr, Fac Med, Geneva, Switzerland.
RP Lasaite, L (reprint author), Lithuanian Univ Hlth Sci, Inst Endocrinol, Kaunas, Lithuania.
EM linlasla@yahoo.com
FU Lithuanian Research Council Lithuanian Swiss program "Research and
   Development" [CH-3-SMM-01/09]; Swiss National Science Foundation
   [CR33I3_140655]
FX This study was supported by a grant of Lithuanian Research Council
   Lithuanian Swiss program "Research and Development", CH-3-SMM-01/09, and
   the Swiss National Science Foundation (grant No. CR33I3_140655 to VMS).
CR Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Arnett J. J., 2007, HDB SOCIALIZATION TH, P208, DOI DOI 10.1093/ACPROF:OSO/9780199757176.001.0001
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Barry CM, 2009, J ADULT DEV, V16, P209, DOI 10.1007/s10804-009-9067-x
   BERN SL, 1974, J CONSULT CLIN PSYCH, V42, P155
   Byrne DG, 2007, J ADOLESCENCE, V30, P393, DOI 10.1016/j.adolescence.2006.04.004
   de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8
   DELAMATER AM, 1987, J DEV BEHAV PEDIATR, V8, P136
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   GAFVELS C, 1993, DIABETIC MED, V10, P768, DOI 10.1111/j.1464-5491.1993.tb00162.x
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   GORTMAKER SL, 1990, PEDIATRICS, V85, P267
   Graber JA, 2004, HDB ADOLESCENT PSYCH, V2
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   Helgeson VS, 2014, J PSYCHOSOM RES, V77, P484, DOI 10.1016/j.jpsychores.2014.09.013
   Helgeson VS, 2010, HEALTH PSYCHOL, V29, P153, DOI 10.1037/a0018163
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hessler D. M., 2010, DIABETES S1, V59, P1435
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Holmbeck G. N., 2006, BEHAV EMOTIONAL DISO, P21
   Holt RIG, 2014, DIABETES CARE, V37, P2067, DOI 10.2337/dc13-2134
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Kendler KS, 2005, AM J PSYCHIAT, V162, P250, DOI 10.1176/appi.ajp.162.2.250
   Kessler RC, 2004, MAC FDN MEN, P227
   Lasaite L, 2016, J DIABETES COMPLICAT, V30, P133, DOI 10.1016/j.jdiacomp.2015.09.012
   Luecken L. J, 2010, HDB ADULT RESILIENCE, P238
   Luyckx K, 2009, DIABETES CARE, V32, P797, DOI 10.2337/dc08-1990
   MANN NP, 1982, ARCH DIS CHILD, V57, P434, DOI 10.1136/adc.57.6.434
   Matthews S, 1999, SOC SCI MED, V48, P49, DOI 10.1016/S0277-9536(98)00288-3
   METSCH J, 1995, INT J BEHAV MED, V2, P104, DOI 10.1207/s15327558ijbm0202_2
   Miller ST, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-70
   Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x
   Pintaudi B, 2015, J PSYCHOSOM RES, V79, P348, DOI 10.1016/j.jpsychores.2015.08.010
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601
   Schmitt A, 2016, DIABETIC MED, V33, P835, DOI 10.1111/dme.12887
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Schultz CJ, 1999, DIABETES CARE, V22, P495, DOI 10.2337/diacare.22.3.495
   Simmons JH, 2013, DIABETES CARE, V36, P3573, DOI 10.2337/dc12-2643
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   *WHO, 1989, REPR HLTH AD STRAT A, P1
   Wolpert HA, 2001, DIABETES CARE, V24, P1513, DOI 10.2337/diacare.24.9.1513
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
NR 61
TC 7
Z9 8
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD NOV-DEC
PY 2016
VL 30
IS 8
BP 1500
EP 1505
DI 10.1016/j.jdiacomp.2016.08.013
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA ES3MY
UT WOS:000399434900016
PM 27613444
DA 2019-01-08
ER

PT J
AU Pelizza, L
   Pupo, S
AF Pelizza, Lorenzo
   Pupo, Simona
TI Brittle diabetes: Psychopathology and personality
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Brittle diabetes; Glycaemic instability; Personality disorder;
   Psychopathology; Assessment
ID HYPOGLYCEMIA; PREVALENCE; NEUROPATHY; MELLITUS
AB The term "brittle" is used to describe an uncommon subgroup of patients with type I diabetes whose lives are disrupted by severe glycaemic instability with repeated and prolonged hospitalization. Psychosocial problems are the major perceived underlying causes of brittle diabetes. Aim of this study is a systematic psychopathological and personological assessment of patients with brittle diabetes in comparison with subjects without brittle diabetes, using specific parameters of general psychopathology and personality disorders following the multi-axial format of the current DSM-IV-TR (Diagnostic and Statistical manual of Mental Disorders - IV Edition - Text Revised) diagnostic criteria for mental disorders. Patients comprised 42 subjects with brittle diabetes and a case-control group of 42 subjects with stable diabetes, matched for age, gender, years of education, and diabetes duration. General psychopathology and the DSM-IV-TR personality disorders were assessed using the Symptom Checklist-90-Revised (SCL-90-R) and the Structured Clinical Interview for axis II personality Disorders (SCID-II). The comparison for SCL-90-R parameters revealed no differences in all primary symptom dimensions and in the three global distress indices between the two groups. However, patients with brittle diabetes showed higher percentages in borderline, histrionic, and narcissistic personality disorder. In this study, patients with brittle diabetes show no differences in terms of global severity of psychopathological distress and specific symptoms of axis I DSM-IV-TR psychiatric diagnoses in comparison with subjects without brittle diabetes. Differently, individuals with brittle diabetes are more frequently affected by specific DSM-IV-TR cluster B personality disorders. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Pelizza, Lorenzo] Reggio Emilia Mental Hlth Dept, Guastalla Psychiat Outpatients Serv, Via Salvo DAcquisto 7, I-42016 Guastalla, RE, Italy.
   [Pupo, Simona] Guastalla Civil Hosp, Reggio Emilia Hlth Care Serv, Intens Care Unit, Via Donatori Sangue 1, I-42016 Guastalla, RE, Italy.
RP Pelizza, L (reprint author), CSM Guastalla, Via Salvo DAcquisto 7, I-42016 Guastalla, RE, Italy.
EM anolino@yahoo.it
RI Pelizza, Lorenzo/W-4951-2017
OI Pelizza, Lorenzo/0000-0003-4746-2061
CR American PsychiatricAssociation, 2001, DIAGNOSTIC STAT MANU
   Bertuzzi F, 2007, CURR MED CHEM, V14, P1739
   BHATNAGAR D, 1988, BRIT J HOSP MED, V40, P140
   Brosig B, 2001, PSYCHOTHER PSYCH MED, V51, P232, DOI 10.1055/s-2001-14301
   Cartwright A, 2011, QJM-INT J MED, V104, P575, DOI 10.1093/qjmed/hcr010
   Conti L, 1999, REPERTORIO SCALE VAL
   Derogatis L., 1977, SCL 90 R ADM SCORING
   Dutour A, 1996, PSYCHONEUROENDOCRINO, V21, P525, DOI 10.1016/S0306-4530(96)00014-5
   First M. B, 1997, STRUCTURED CLIN INTE
   Gill G, 1999, DIABETES METAB, V25, P308
   Gill G, 1986, Diabet Med, V3, P284
   GILL GV, 1985, DIABETOLOGIA, V28, P579, DOI 10.1007/BF00281992
   Gill GV, 1996, QJM-MON J ASSOC PHYS, V89, P839, DOI 10.1093/qjmed/89.11.839
   GILL GV, 1992, J ROY SOC MED, V85, P259
   HEPBURN DA, 1990, DIABETIC MED, V7, P711, DOI 10.1111/j.1464-5491.1990.tb01475.x
   KENT LA, 1994, LANCET, V344, P778, DOI 10.1016/S0140-6736(94)92340-X
   Leweke F, 2004, PRAX KINDERPSYCHOL K, V53, P347
   PICKUP J, 1983, DIABETES CARE, V6, P279, DOI 10.2337/diacare.6.3.279
   Schade D S, 1995, Adv Endocrinol Metab, V6, P289
   STEEL JM, 1987, BRIT MED J, V294, P859, DOI 10.1136/bmj.294.6576.859
   TATTERSALL R, 1985, BRIT MED J, V291, P555, DOI 10.1136/bmj.291.6495.555
   TATTERSALL R, 1991, BRIT MED J, V302, P1240, DOI 10.1136/bmj.302.6787.1240
   TATTERSALL R, 1977, CLIN ENDOCRINOL META, V6, P403, DOI 10.1016/S0300-595X(77)80045-5
   Tattersall RB, 1997, DIABETIC MED, V14, P99, DOI 10.1002/(SICI)1096-9136(199702)14:2<99::AID-DIA320>3.3.CO;2-9
   TATTERSALL RB, 1981, BRIT J PSYCHIAT, V139, P485, DOI 10.1192/bjp.139.6.485
   Vantyghem MC, 2006, ANN ENDOCRINOL-PARIS, V67, P287, DOI 10.1016/S0003-4266(06)72600-2
   Voulgari C, 2012, DIABETES TECHNOL THE, V14, P835, DOI 10.1089/dia.2012.0058
NR 27
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD NOV-DEC
PY 2016
VL 30
IS 8
BP 1544
EP 1547
DI 10.1016/j.jdiacomp.2016.07.028
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA ES3MY
UT WOS:000399434900024
PM 27524279
DA 2019-01-08
ER

PT J
AU Stenberg, U
   Haaland-Overby, M
   Fredriksen, K
   Westermann, KF
   Kvisvik, T
AF Stenberg, Una
   Haaland-Overby, Mette
   Fredriksen, Kari
   Westermann, Karl Fredrik
   Kvisvik, Toril
TI A scoping review of the literature on benefits and challenges of
   participating in patient education programs aimed at promoting
   self-management for people living with chronic illness
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Review
DE Patient education; Patient participation; Disease management; Self
   efficacy; Chronic disease
ID RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES MELLITUS.; CHRONIC DISEASE;
   MENTAL-ILLNESS; PRIMARY-CARE; DECISION-MAKING; SOCIAL SUPPORT;
   HEALTH-STATUS; SHORT-FORM; FOLLOW-UP
AB Objective: To give a comprehensive overview of benefits and challenges from participating in group based patient education programs that are carried out by health care professionals and lay participants, aimed at promoting self-management for people living with chronic illness.
   Methods: We searched 8 literature databases. Full text articles meeting the inclusion criteria were retrieved and reviewed. Arksey and O'Malley's framework for scoping studies guided the review process and thematic analysis was undertaken to synthesize extracted data.
   Results: Of the 5935 titles identified, 47 articles were included in this review. The participants experienced the programs as beneficial according to less symptom distress and greater awareness of their own health, improved self-management strategies, peer support, learning and hope.
   Conclusion: A substantial evidence base supports the conclusion that group based self-management patient education programs in different ways have been experienced as beneficial, but more research is needed.
   Practice implications: The insights gained from this review can enable researchers, health care professionals, and participants to understand the complexity in evaluating self-management patient education programs, and constitute a basis for a more standardized and systematic evaluation. The results may also encourage health care professionals in planning and carrying out programs in cooperation with lay participants. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Stenberg, Una; Haaland-Overby, Mette; Westermann, Karl Fredrik] Oslo Univ Hosp, Norwegian Natl Advisory Unit Learning & Mastery H, Postboks 4959, N-0424 Oslo, Norway.
   [Stenberg, Una] Oslo Univ Hosp, Ctr Shared Decis Making & Collaborat Care Res, Postboks 4959, N-0424 Oslo, Norway.
   [Fredriksen, Kari] Stavanger Univ Hosp, Learning & Mastery Ctr, Postboks 8100, N-4068 Stavanger, Norway.
   [Kvisvik, Toril] More & Romsdal Hosp, Patient Educ Resource Ctr, Herman Dohlens Vei 1, N-6508 Kristiansand, Norway.
RP Stenberg, U (reprint author), Oslo Univ Hosp, Norwegian Natl Advisory Unit Learning & Mastery H, Postboks 4959, N-0424 Oslo, Norway.
EM una.stenberg@mestring.no; mette.haaland-overby@gmail.com;
   kari.fredriksen@sus.no; karl.fredrik.westermann@gmail.com;
   toril.kvisvik@helse-mr.no
FU Norwegian National Advisory Unit on Learning and Mastery in Health, Oslo
   University Hospital, Norway
FX This work was funded by Norwegian National Advisory Unit on Learning and
   Mastery in Health, Oslo University Hospital, Norway. We would like to
   thank all our colleagues for daily support in this work, with special
   thanks to Andre Vagan for reading abstracts and Ann Britt Sandvin Olsson
   for reading and giving us feedback on the manuscript. Thanks to Bente
   Schjodt-Osmo for quality assurance of literature searches and Margaret
   Forbes for language editing.
CR AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365
   Abraham C, 2009, PSYCHOL HEALTH, V24, P1153, DOI 10.1080/08870440802521110
   Ackerman IN, 2012, J RHEUMATOL, V39, P1047, DOI 10.3899/jrheum.111358
   Albert Hanne B, 2003, Ugeskr Laeger, V165, P1875
   Altuntas YE, 2012, EUR J CANCER CARE, V21, P776, DOI 10.1111/j.1365-2354.2012.01360.x
   Ambrosio L, 2015, J CLIN NURS, V24, P2357, DOI 10.1111/jocn.12827
   Andenaes R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-95
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   Antonovsky A., 1987, UNRAVELING MYSTERY H
   Arksey H.L.O.M., 2005, INT J SOC RES METHOD, V8, P13
   Attridge M, 2014, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD006424.PUB3
   Austevoll-Dahlgren A.N., 2011, EFFECT GROUP ED PATI
   Barlow J, 2009, PSYCHOL HEALTH, V24, P1167, DOI 10.1080/08870440802040277
   Beattie J, 2013, PSYCHIATR REHABIL J, V36, P306, DOI 10.1037/prj0000031
   BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469
   Bonsaksen T, 2015, J HEALTH PSYCHOL, V20, P942, DOI 10.1177/1359105313504235
   Bonsaksen T, 2014, PSYCHOL HEALTH, V29, P350, DOI 10.1080/08870446.2013.856432
   Bonsaksen T, 2014, INT J CHRONIC OBSTR, V9, P41, DOI 10.2147/COPD.S52700
   Borge L, 2012, SYKEPLEIEN FORSKNING, V7, P14
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Brady TJ, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120112
   Brashers DE, 1999, HEALTH COMMUN, V11, P97, DOI 10.1207/s15327027hc1102_1
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Brown JPR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008895.pub2
   Cade JE, 2009, DIABETIC MED, V26, P1048, DOI 10.1111/j.1464-5491.2009.02808.x
   Carmack CL, 2011, CANCER-AM CANCER SOC, V117, P4993, DOI 10.1002/cncr.26110
   CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267
   Chin WW, 1999, SMALL GR RES, V30, P751, DOI 10.1177/104649649903000605
   Christensen KS, 2005, FAM PRACT, V22, P448, DOI 10.1093/fampra/cmi025
   Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940
   Cook JA, 2010, PSYCHIATR REHABIL J, V34, P113, DOI 10.2975/34.2.2010.113.120
   Cook JA, 2009, PSYCHIAT SERV, V60, P246, DOI 10.1176/ps.2009.60.2.246
   Cooper LA, 2000, GEN HOSP PSYCHIAT, V22, P163
   Corbin J. M., 1988, UNENDING WORK CARE M
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Derogatis LR, 2001, BSI 18 ADM SCORING P
   Elg E.J.M., 2012, J SERV MANAGE, V23, P16
   Fagermoen MS, 2015, J MULTIDISCIP HEALTH, V8, P157, DOI 10.2147/JMDH.S77763
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7
   Giffort DA, 1995, CONSTRUCTION SCALE M
   Goldberg D., 1988, USERS GUIDE GEN HLTH
   Goldsmith MR, 2007, J EPIDEMIOL COMMUN H, V61, P262, DOI 10.1136/jech.2006.046110
   Green CA, 2013, PSYCHIAT SERV, V64, P1211, DOI 10.1176/appi.ps.201200546
   Harrison M, 2011, PATIENT EDUC COUNS, V85, pE39, DOI 10.1016/j.pec.2010.10.026
   Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x
   Jarvis J, 2010, DIABETES OBES METAB, V12, P12, DOI 10.1111/j.1463-1326.2009.01098.x
   JOHNSTON M, 1995, MEASURES HLTH PSYCHO
   Johnston S, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-65
   Jones N, 2013, PSYCHIATR REHABIL J, V36, P209, DOI 10.1037/prj0000008
   JONES PW, 2003, ST GEORGES RESP QUES
   Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073
   Jormfeldt Henrika, 2012, Issues Ment Health Nurs, V33, P209, DOI 10.3109/01612840.2011.653041
   Gagliardino JJ, 2013, DIABETES-METAB RES, V29, P152, DOI 10.1002/dmrr.2368
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Kroon FP, 2014, COCHRANE DB SYST REV, V1, DOI [DOI 10.1002/14651858.CD008963.PUB2, 10.1002/14651858.CD008963.pub2]
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
   Lomundal BK, 2012, INT J CHRONIC OBSTR, V7, P87, DOI 10.2147/COPD.S27352
   LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107
   Lorig K, 1996, OUTCOME MEASURES HLT
   Lorig K, 2014, COMMUNITY MENT HLT J, V50, P96, DOI 10.1007/s10597-013-9615-5
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01
   Lucksted A, 2013, ACTA PSYCHIAT SCAND, V127, P279, DOI 10.1111/j.1600-0447.2012.01901.x
   Ludman E, 2003, PSYCHOL MED, V33, P1061, DOI 10.1017/S003329170300816X
   Mahler C, 2010, J EVAL CLIN PRACT, V16, P574, DOI 10.1111/j.1365-2753.2009.01169.x
   MAYS N., 2001, STUDYING ORG DELIVER, P188
   Mehlsen M, 2015, PATIENT EDUC COUNS, V98, P677, DOI 10.1016/j.pec.2015.01.008
   MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8
   Mustafa M, 2013, COCHRANE DB SYST REV, V6
   Nossum R, 2013, SCAND J PUBLIC HEALT, V41, P429, DOI 10.1177/1403494813480279
   Nunez DE, 2009, WORLDV EVID-BASED NU, V6, P130, DOI 10.1111/j.1741-6787.2009.00157.x
   Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658
   Osborne RH, 2011, NURS CLIN N AM, V46, P255, DOI 10.1016/j.cnur.2011.05.010
   Pace R, 2012, INT J NURS STUD, V49, P47, DOI 10.1016/j.ijnurstu.2011.07.002
   Packer TL, 2012, PATIENT EDUC COUNS, V87, P93, DOI 10.1016/j.pec.2011.09.007
   Pallaveshi L, 2014, COMMUNITY MENT HLT J, V50, P388, DOI 10.1007/s10597-013-9612-8
   Parahoo K., 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD008529.PUB3
   PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011
   Pettman TL, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-53
   Pham MT, 2014, RES SYNTH METHODS, V5, P371, DOI 10.1002/jrsm.1123
   Pickett SA, 2012, COMMUNITY MENT HLT J, V48, P420, DOI 10.1007/s10597-012-9507-0
   Pickett SA, 2010, PSYCHIATR REHABIL J, V34, P96, DOI 10.2975/34.2.2010.96.103
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Quinones AR, 2014, PATIENT EDUC COUNS, V95, P3, DOI 10.1016/j.pec.2013.12.021
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Radloff L. S., 1986, COMMUNITY SURVEYS PS, P177
   Rise MB, 2014, INT J SOC PSYCHIATR, V60, P387, DOI 10.1177/0020764013491739
   Rise MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064009
   Rogers A, 2009, CHRONIC ILLN, V5, P305, DOI 10.1177/1742395309350384
   Rogers ES, 1997, PSYCHIATR SERV, V48, P1042
   ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004
   ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350
   Rosenberg M, 1965, SOC ADOLESCENT SELF
   Rygg LO, 2012, PATIENT EDUC COUNS, V86, P98, DOI 10.1016/j.pec.2011.04.008
   Sallinen M, 2011, PATIENT EDUC COUNS, V85, pE126, DOI 10.1016/j.pec.2011.02.011
   Sandelowski M, 2012, J MIX METHOD RES, V6, P317, DOI 10.1177/1558689811427913
   SARASON IG, 1982, J PERS, V50, P331, DOI 10.1111/j.1467-6494.1982.tb00754.x
   Sharma S, 2013, PATIENT EDUC COUNS, V90, P38, DOI 10.1016/j.pec.2012.09.002
   Shaya FT, 2014, J EPIDEMIOL COMMUN H, V68, P326, DOI 10.1136/jech-2013-203274
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Smeulders ESTF, 2010, PATIENT EDUC COUNS, V81, P214, DOI 10.1016/j.pec.2010.01.003
   Snaith RP, 1994, HOSP ANXIETY DEPRESS
   SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570
   Sohanpal R, 2012, CHRON RESP DIS, V9, P163, DOI 10.1177/1479972312444630
   Spielberger C. D., 1983, STAI MANUAL STAIT TR
   Steigman PJ, 2014, J NERV MENT DIS, V202, P193, DOI 10.1097/NMD.0000000000000098
   Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213
   Stewart A., 1992, MEASURING FUNCTIONIN
   Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524
   Taylor SJC, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656829
   Tjelta M, 2013, NORDISK SYGEPLEJEFOR, V3, P193
   Van Metre Laura, 2011, Issues Ment Health Nurs, V32, P408, DOI 10.3109/01612840.2011.553771
   Ware JE, 2001, SCORE INTERPRET SING
   Webel AR, 2010, AIDS CARE, V22, P1029, DOI 10.1080/09540120903214389
   Webel AR, 2009, J ASSOC NURSE AIDS C, V20, P458, DOI 10.1016/j.jana.2009.05.003
   Whitfield K, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-19
   World Health Organization, GLOBAL HLTH AGING
   Wu CJ, 2012, INT NURS REV, V59, P345, DOI 10.1111/j.1466-7657.2012.00998.x
   Zangi HA, 2011, PATIENT EDUC COUNS, V85, P419, DOI 10.1016/j.pec.2010.12.032
NR 123
TC 11
Z9 11
U1 0
U2 20
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD NOV
PY 2016
VL 99
IS 11
BP 1759
EP 1771
DI 10.1016/j.pec.2016.07.027
PG 13
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA EG7JC
UT WOS:000391222100003
PM 27461944
DA 2019-01-08
ER

PT J
AU Bolge, SC
   Flores, NM
   Phan, JH
AF Bolge, Susan C.
   Flores, Natalia M.
   Phan, Jennifer H.
TI The Burden of Poor Mental Well-being Among Patients With Type 2 Diabetes
   Mellitus: Examining Health Care Resource Use and Work Productivity Loss
SO JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
LA English
DT Article
ID DEPRESSIVE SYMPTOMS; SELF-CARE; UNITED-STATES; SOCIOECONOMIC
   DISPARITIES; EMOTIONAL DISTRESS; MAJOR DEPRESSION; COSTS; DISABILITY;
   ADHERENCE; RISK
AB Objective:The aim of this study was to evaluate the association of mental well-being with outcomes among patients with type 2 diabetes mellitus (T2DM).Methods:Seven thousand eight hundred fifty-two adults with T2DM were identified from a national, Internet-based study. Mental well-being [SF-36v2 mental component summary (MCS)] was categorized as good (MCS 50), poor (40 MCS < 50), and very poor (MCS < 40). Outcomes included past 6 months of health care resource use and lost productivity (Work Productivity and Activity Impairment questionnaire).Results:Respondents with very poor/poor versus good mental well-being were more likely to visit the emergency room (27%/18% vs 11%, P<0.001) or be hospitalized (19%/14% vs 9%, P<0.001). Among labor force participants, those with very poor/poor versus good mental well-being experienced greater overall work impairment (43.7/26.0 vs 10.7, P<0.001).Conclusions:Greater resource use and work productivity impairment associated with poorer mental well-being among patients with T2DM has cost implications.
C1 [Bolge, Susan C.; Phan, Jennifer H.] Janssen Sci Affairs LLC, Raritan, NJ USA.
   [Flores, Natalia M.] Kantar Hlth, Foster City, CA USA.
   [Phan, Jennifer H.] Anthem Inc, New York, NY USA.
RP Flores, NM (reprint author), 393 Vintage Pk Dr, Foster City, CA 94404 USA.
EM Natalia.Flores@KantarHealth.com
FU Janssen Scientific Affairs, LLC.
FX The study was funded by Janssen Scientific Affairs, LLC.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Alegria M, 2008, PSYCHIAT SERV, V59, P1264, DOI 10.1176/appi.ps.59.11.1264
   Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bolge SC, 2010, MENOPAUSE, V17, P80, DOI 10.1097/gme.0b013e3181b4c286
   Bosmans JE, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-46
   Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082
   Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8
   Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384
   Center for Financing Access and Cost Trends Agency for Healthcare Research and Quality: Medical Expenditure Panel Survey, 2012, TABL 5 HOSP INP SERV
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Control CfD Prevention, 2014, NAT DIAB STAT REP ES
   Davydow DS, 2013, J GEN INTERN MED, V28, P921, DOI 10.1007/s11606-013-2336-1
   Davydow DS, 2011, PSYCHOSOMATICS, V52, P117, DOI 10.1016/j.psym.2010.12.020
   DiBonaventura Marco DaCosta, 2010, J Med Econ, V13, P709, DOI 10.3111/13696998.2010.535576
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Finkelstein EA, 2011, J OCCUP ENVIRON MED, V53, P1025, DOI 10.1097/JOM.0b013e318229aae4
   Flores NM, 2015, VALUE HEALTH, V3, pA110
   Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017
   Gonzalez HM, 2010, ARCH GEN PSYCHIAT, V67, P37, DOI 10.1001/archgenpsychiatry.2009.168
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Grandy S, 2008, INT J CLIN PRACT, V62, P562, DOI 10.1111/j.1742-1241.2008.01703.x
   Huang H, 2012, PSYCHOSOMATICS, V53, P21, DOI 10.1016/j.psym.2011.07.001
   Hudson JL, 2014, J PSYCHOSOM RES, V76, P265, DOI 10.1016/j.jpsychores.2014.02.004
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Nozaki T, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-4
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529
   Park H, 2004, J CLIN EPIDEMIOL, V57, P978, DOI 10.1016/j.jclinepi.2004.01.015
   REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006
   Shim RS, 2011, J AM BOARD FAM MED, V24, P33, DOI 10.3122/jabfm.2011.01.100121
   Simon GE, 2005, GEN HOSP PSYCHIAT, V27, P344, DOI 10.1016/j.genhosppsych.2005.04.008
   Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65
   Strine T.W., 2015, PSYCHIAT SERV
   US Bureau of Labor Statistics, 2013, BLS REP HIGHL WOM EA
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 2008, USERS MANUAL SF 36V2
   Zulman DM, 2010, J GEN INTERN MED, V25, P408, DOI 10.1007/s11606-009-1232-1
NR 45
TC 1
Z9 1
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1076-2752
EI 1536-5948
J9 J OCCUP ENVIRON MED
JI J. Occup. Environ. Med.
PD NOV
PY 2016
VL 58
IS 11
BP 1121
EP 1126
DI 10.1097/JOM.0000000000000874
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EB3OD
UT WOS:000387273800016
PM 27820762
OA Green Published
DA 2019-01-08
ER

PT J
AU Friis, AM
   Johnson, MH
   Cutfield, RG
   Consedine, NS
AF Friis, Anna M.
   Johnson, Malcolm H.
   Cutfield, Richard G.
   Consedine, Nathan S.
TI Kindness Matters: A Randomized Controlled Trial of a Mindful
   Self-Compassion Intervention Improves Depression, Distress, and HbA(1c)
   Among Patients With Diabetes
SO DIABETES CARE
LA English
DT Article
ID GLYCEMIC CONTROL; METAANALYSIS; STRESS; HEALTH; INTERLEUKIN-6;
   MANAGEMENT; THERAPY; PROGRAM; ANXIETY; VALUES
AB OBJECTIVE
   Mood difficulties are common among patients with diabetes and are linked to poor blood glucose control and increased complications. Evidence on psychological treatments that improve both mood and metabolic outcomes is limited. Greater self-compassion predicts better mental and physical health in both healthy and chronically ill populations. Thus, the purpose of this randomized controlled trial (RCT) was to evaluate the effects of self-compassion training on mood and metabolic outcomes among patients with diabetes.
   RESEARCH DESIGN AND METHODS
   This RCT tested the effects of a standardized 8-week mindful self-compassion (MSC) program (n = 32) relative to a wait-list control condition (n = 31) among patients with type 1 and type 2 diabetes. Measures of self-compassion, depressive symptoms, diabetes-specific distress, and HbA(1c) were taken at baseline (preintervention), at week 8 (postintervention), and at 3-month follow-up.
   RESULTS
   Repeated-measures ANOVA using intention to treat showed that MSC training increased self-compassion and produced statistically and clinically significant reductions in depression and diabetes distress in the intervention group, with results maintained at 3-month follow-up. MSC participants also averaged a clinically and statistically meaningful decrease in HbA(1c) between baseline and follow-up of >10 mmol/mol (nearly 1%). There were no overall changes for the wait-list control group.
   CONCLUSIONS
   This initial report suggests that learning to be kinder to oneself (rather than being harshly self-critical) may have both emotional and metabolic benefits among patients with diabetes.
C1 [Friis, Anna M.; Johnson, Malcolm H.; Consedine, Nathan S.] Univ Auckland, Auckland, New Zealand.
   [Cutfield, Richard G.] Waitemata Dist Hlth Board, Auckland, New Zealand.
RP Friis, AM (reprint author), Univ Auckland, Auckland, New Zealand.
EM a.friis@auckland.ac.nz
FU New Zealand Society for the Study of Diabetes; New Zealand Diabetes
   Foundation
FX This study was made possible with the support of the New Zealand Society
   for the Study of Diabetes and the New Zealand Diabetes Foundation.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Basco M., 1998, DIABETES SPECTRUM, V11, P43
   Breines JG, 2014, BRAIN BEHAV IMMUN, V37, P109, DOI 10.1016/j.bbi.2013.11.006
   Derr R, 2003, DIABETES CARE, V26, P2728, DOI 10.2337/diacare.26.10.2728
   Dodds SE, 2015, SUPPORT CARE CANCER, V23, P3599, DOI 10.1007/s00520-015-2888-1
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Friis AM, 2015, DIABETIC MED, V32, P1634, DOI 10.1111/dme.12774
   Gilbert P, 2005, COMPASSION CONCEPTUA, P263
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114
   Lenters-Westra E, 2014, NETH J MED, V72, P462
   Lowe B, 2004, MED CARE, V42, P1194
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Neff KD, 2015, MINDFULNESS, V7, P1
   Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035
   Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923
   Noordali F, 2017, J HEALTH PSYCHOL, V22, P965, DOI 10.1177/1359105315620293
   Pauley G, 2010, PSYCHOL PSYCHOTHER-T, V83, P129, DOI 10.1348/147608309X471000
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009
   Rockliff H., 2008, J CLIN NEUROPSYCHOLO, V5, P132
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   Terry ML, 2013, PERS SOC PSYCHOL B, V39, P911, DOI 10.1177/0146167213488213
   Tovote KA, 2014, DIABETES CARE, V37, P2427, DOI 10.2337/dc13-2918
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   Young Laura A, 2009, Pract Diabetes Int, V26, P222, DOI 10.1002/pdi.1380
   Zessin U, 2015, APPL PSYCHOL-HLTH WE, V7, P340, DOI 10.1111/aphw.12051
NR 39
TC 24
Z9 24
U1 5
U2 31
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD NOV
PY 2016
VL 39
IS 11
BP 1963
EP 1971
DI 10.2337/dc16-0416
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EA1BZ
UT WOS:000386328800027
PM 27335319
OA Bronze
DA 2019-01-08
ER

PT J
AU Handley, TE
   Ventura, AD
   Browne, JL
   Rich, J
   Attia, JR
   Reddy, P
   Pouwer, F
   Speight, J
AF Handley, T. E.
   Ventura, A. D.
   Browne, J. L.
   Rich, J.
   Attia, J. R.
   Reddy, P.
   Pouwer, F.
   Speight, J.
TI Suicidal ideation reported by adults with Type 1 or Type 2 diabetes:
   results from Diabetes MILESAustralia
SO DIABETIC MEDICINE
LA English
DT Article
ID CO-MORBID DEPRESSION; QUALITY-OF-LIFE; GENERAL-POPULATION; AUSTRALIAN
   ADULTS; HEALTH OUTCOMES; NATIONAL-SURVEY; PRIMARY-CARE; RISK-FACTORS;
   PREVALENCE; DISTRESS
AB AimsTo examine the prevalence and correlates of suicidal ideation (SI) in a community-based sample of adults with Type 1 or Type 2 diabetes.
   MethodsParticipants were 3338 adults aged 18-70 years with Type 1 diabetes (n = 1376) or Type 2 diabetes (non-insulin: n = 1238; insulin: n = 724) from a national survey administered to a random sample registered with the National Diabetes Services Scheme. Depression and SI were assessed using the Patient Health Questionnaire, and diabetes-specific distress with the Problem Areas In Diabetes scale. Separate logistic regression analyses by diabetes type/treatment were used to determine relative contribution to SI.
   ResultsOverall, we observed a SI rate of 14% in our sample. Participants with Type 2 diabetes using insulin reported more frequent depressive symptoms, and were more likely to report recent SI (19%) compared with those with either Type 1 diabetes or Type 2 diabetes not using insulin (14 and 12%, respectively). After controlling for depression, there was little difference in the prevalence of SI between diabetes types/treatments, but higher diabetes-specific distress significantly increased the odds of SI.
   ConclusionsAs SI is a significant risk factor for a suicide attempt, the findings have implications for healthcare professionals, pointing to the importance of adequate screening and action plans for appropriate follow-up of those reporting depression. Our findings are also indicative of the psychological toll of diabetes more generally, and the need to integrate physical and mental healthcare for people with diabetes.
C1 [Handley, T. E.; Rich, J.; Attia, J. R.; Reddy, P.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia.
   [Handley, T. E.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Randwick, NSW, Australia.
   [Ventura, A. D.; Browne, J. L.; Speight, J.] Australian Ctr Behav Res Diabet, Diabet Victoria, Melbourne, Vic, Australia.
   [Ventura, A. D.; Browne, J. L.; Speight, J.] Deakin Univ, Sch Psychol, Ctr Social & Early Emot Dev, Burwood, Vic, Australia.
   [Attia, J. R.] Hunter Med Res Inst, New Lambton, NSW, Australia.
   [Pouwer, F.] Tilburg Univ, CoRPS, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands.
   [Speight, J.] AHP Res, Hornchurch, England.
RP Handley, TE (reprint author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia.; Handley, TE (reprint author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Randwick, NSW, Australia.
EM tonelle.handley@newcastle.edu.au
OI Speight, Jane/0000-0002-1204-6896
FU National Diabetes Services Scheme (NDSS) Strategic Development Grant;
   Sanofi Aventis
FX The Diabetes MILES-Australia 2011 Survey was funded by a National
   Diabetes Services Scheme (NDSS) Strategic Development Grant. The NDSS is
   an initiative of the Australian Government administered by Diabetes
   Australia. In addition, Diabetes MILES-Australia received sponsorship
   from Sanofi Aventis to support the development of the study website
   http://www.diabetesMILES.org and related activities.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Bauer AM, 2013, J GEN INTERN MED, V28, P363, DOI 10.1007/s11606-012-2194-2
   Beyondblue, 2013, BEYONDBL GUID MAN DE
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Browne JL, 2015, DIABETES RES CLIN PR, V108, pE5, DOI 10.1016/j.diabres.2015.01.021
   Ceretta LB, 2012, ACTA DIABETOL, V49, pS227, DOI 10.1007/s00592-012-0435-9
   Engum A, 2005, DIABETES CARE, V28, P1904, DOI 10.2337/diacare.28.8.1904
   Fuller-Thomson Esme, 2009, Diabetes Res Clin Pract, V83, pe9, DOI 10.1016/j.diabres.2008.10.004
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Goodwin RD, 2003, PSYCHOSOM MED, V65, P501, DOI 10.1097/01.PSY.0000041544.14277.EC
   Han SJ, 2013, DIABETES RES CLIN PR, V101, pE14, DOI 10.1016/j.diabres.2013.06.012
   Handley TE, 2014, AM J GERIAT PSYCHIAT, V22, P1325, DOI 10.1016/j.jagp.2013.05.009
   Handley TE, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-105
   Handley TE, 2012, SOC PSYCH PSYCH EPID, V47, P1281, DOI 10.1007/s00127-011-0436-y
   Hintikka J, 2009, SOC PSYCH PSYCH EPID, V44, P29, DOI 10.1007/s00127-008-0401-6
   Johnston AK, 2009, AUST NZ J PSYCHIAT, V43, P635, DOI 10.1080/00048670902970874
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Ladwig KH, 2008, PSYCHIAT RES, V161, P248, DOI 10.1016/j.psychres.2008.03.011
   LEMPERS JD, 1989, CHILD DEV, V60, P25, DOI 10.1111/j.1467-8624.1989.tb02692.x
   Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998
   ORCHARD TJ, 1991, DIABETES CARE, V14, P55
   Organisation for Economic Co-operation and Development, 2011, HLTH AT A GLANC
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pompili M, 2009, PSYCHOSOMATICS, V50, P16, DOI 10.1176/appi.psy.50.1.16
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002
   Roy T, 2012, J AFFECTIVE DISORD S, V142, pS8
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Speight J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-120
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   ten Have M, 2009, CAN J PSYCHIAT, V54, P824
   vansDam HA, 2005, PATIENT EDUC COUNS, V59, P1
   vansDooren FE, 2013, PLOS ONE, V8
   Wu SF, 2014, DEPRESS RES TREAT
NR 39
TC 13
Z9 13
U1 1
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2016
VL 33
IS 11
BP 1582
EP 1589
DI 10.1111/dme.13022
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DZ7FB
UT WOS:000386029200021
PM 26525943
DA 2019-01-08
ER

PT J
AU Fisher, L
   Hessler, DM
   Polonsky, WH
   Masharani, U
   Peters, AL
   Blumer, I
   Strycker, LA
AF Fisher, L.
   Hessler, D. M.
   Polonsky, W. H.
   Masharani, U.
   Peters, A. L.
   Blumer, I.
   Strycker, L. A.
TI Prevalence of depression in Type 1 diabetes and the problem of
   over-diagnosis
SO DIABETIC MEDICINE
LA English
DT Article
ID EXCHANGE CLINIC REGISTRY; DISTRESS; ADULTS; SEVERITY; VALIDITY;
   OUTCOMES; PHQ-9
AB AimsTo determine the prevalence of depression and diabetes distress in adults with Type 1 diabetes and the rate of false-positives when compared with rates of major depressive disorder.
   MethodsThe sample consisted of 368 individuals with Type 1 diabetes, aged 19 years. Individuals completed: the eight-item Patient Health Questionnaire depression scale (PHQ8), which was coded using four scoring criteria (scores 10, 12 and 15, and Diagnostic and Statistical Manual of Mental Disorders 5 (DSM) algorithm scores); the Type 1 Diabetes Distress Scale; and the Structured Clinical Interview for DSM Disorders (SCID) to assess major depressive disorder.
   ResultsThe prevalence rates of depression according to the eight-item Patient Health Questionnaire were: score10, 11.4%; score 12, 7.1%; score 15, 3.8%; and positive algorithm result, 4.6%. The prevalence of major depressive disorder was 3.5%; and the prevalence of at least moderate diabetes distress was 42.1%. Depending on the criterion used, the false-positive rate when using the Patient Health Questionnaire compared with the results when using the SCID varied from 52 to 71%. Of those classified as depressed on the PHQ-8 or Structured Clinical Interview for DSM Disorders, between 92.3 and 96.2% also reported elevated diabetes distress. No significant association was found between any group classed as having depression according to the PHQ8 or the SCID and HbA(1c) concentration. Depression was significantly associated with more other life stress, more complications and a lower level of education.
   ConclusionsWe found an unexpectedly low rate of current depression and major depressive disorder in this diverse sample of adults with Type 1 diabetes, and a very high rate of false-positive results using the Patient Health Questionnaire. Considering the high prevalence of diabetes distress, much of what has been considered depression in adults with Type 1 diabetes may be attributed to the emotional distress associated with managing a demanding chronic disease and other life stressors and not necessarily to underlying psychopathology.
C1 [Fisher, L.; Hessler, D. M.] UCSF, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Polonsky, W. H.] Behav Diabet Inst, San Diego, CA USA.
   [Masharani, U.] UCSF, Dept Med, San Francisco, CA USA.
   [Peters, A. L.] Univ So Calif, Los Angeles, CA USA.
   [Blumer, I.] Charles H Best Diabet Ctr, Whitby, ON, Canada.
   [Strycker, L. A.] Oregon Res Inst, Eugene, OR 97403 USA.
RP Fisher, L (reprint author), UCSF, Dept Family & Community Med, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
OI Peters, Anne/0000-0003-0520-0776
FU National Institutes of Health [DK094863]
FX This research was funded by National Institutes of Health grant
   DK094863.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andreoulakis E, 2012, HIPPOKRATIA, V16, P205
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Beck RW, 2012, J CLIN ENDOCR METAB, V97, P4383, DOI 10.1210/jc.2012-1561
   Biometric Research Department, STRUCT CLIN INT DSM
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P1229
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Harris L.R., 2010, PRACTICAL ASSESSMENT, V15, P1
   Katon W, 2010, DEPRESSION DIABETES
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154
   PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676
   Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Snoek FJ, 2015, LANCET DIABETES ENDO, V858, P135
   Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791
   Trief PM, 2014, DIABETES CARE, V37, P1563, DOI 10.2337/dc13-1867
NR 28
TC 14
Z9 15
U1 1
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2016
VL 33
IS 11
BP 1590
EP 1597
DI 10.1111/dme.12973
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DZ7FB
UT WOS:000386029200022
PM 26433004
DA 2019-01-08
ER

PT J
AU van Dijk-de Vries, A
   van Bokhoven, MA
   de Jong, S
   Metsemakers, JFM
   Verhaak, PPM
   van der Weijden, T
   van Eijk, JTM
AF van Dijk-de Vries, Anneke
   van Bokhoven, Marloes A.
   de Jong, Sabine
   Metsemakers, Job F. M.
   Verhaak, Peter P. M.
   van der Weijden, Trudy
   van Eijk, Jacques Th. M.
TI Patients' readiness to receive psychosocial care during nurse-led
   routine diabetes consultations in primary care: A mixed methods study
SO INTERNATIONAL JOURNAL OF NURSING STUDIES
LA English
DT Article
DE Diabetes mellitus; Family practices; Mixed methods; Primary care
   nursing; Psychosocial; Self-management
ID SELF-MANAGEMENT SUPPORT; QUALITATIVE EVALUATION; DEPRESSION; PEOPLE;
   ILLNESS
AB Background: Patients with type 2 diabetes mellitus face several emotional and social consequences of their chronic illness in their everyday life. Symptoms of distress and depression are prevalent. For providing psychosocial self-management support, nurses in primary care were trained to identify patients with psychosocial problems during routine medically-shaped diabetes consultations. However, detection rates appeared to be strikingly low.
   Objectives: Our study aimed to examine patients' readiness to discuss psychosocial problems with nurses during diabetes consultations.
   Design: A mixed methods design was used in which qualitative data collection was followed up by quantitative data collection.
   Setting: Diabetes care in a regional group of family practices in the south of the Netherlands.
   Participants: Type 2 diabetes patients with psychosocial problems, determined by a self-administered questionnaire.
   Methods: First, in-depth interviews (n=12) were conducted about patients' experiences with routine diabetes consultations and their perspective on a biopsychosocial care approach. Based on a qualitative content analysis, a structured questionnaire was designed to further explore the findings among a larger group of patients. This questionnaire was completed by 205 patients. The questionnaire included 14 items measuring patients' agreement with statements about diabetes care and the role of the nurse to focus on patients' emotional and social functioning.
   Results: The interviews showed that patients view a diabetes consultation primarily as a biomedical check-up, and do not perceive discussion of psychosocial well-being as an integral part of diabetes management. More than 90% of the sample showed a positive attitude towards current diabetes consultations. Patients' intentions and perceived needs regarding a biopsychosocial care approach of the nurse were variable. Younger patients seemed more open to discussing psychosocial problems with the nurse than patients over 65. Patients' openness to discussing psychosocial problems was not significantly (p < 0.05) associated with the nurses being trained in the biopsychosocial self-management approach.
   Conclusion: Patients see primary care nurses primarily as specialists regarding the biomedical management of diabetes. Although patients seemed to support the ideal of integrated care, they did not expect a discussion about psychosocial problems in diabetes consultations. The incorporation of systematic detection of patients with psychosocial problems in diabetes care requires endeavours to make patients acquainted with the new role of the nurse. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [van Dijk-de Vries, Anneke; van Bokhoven, Marloes A.; de Jong, Sabine; Metsemakers, Job F. M.; van der Weijden, Trudy] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands.
   [van Dijk-de Vries, Anneke; van Eijk, Jacques Th. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Social Med, Maastricht, Netherlands.
   [Verhaak, Peter P. M.] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.
   [Verhaak, Peter P. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.
RP van Dijk-de Vries, A (reprint author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands.; van Dijk-de Vries, A (reprint author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Social Med, Maastricht, Netherlands.
EM anneke.vandijk@maastrichtuniversity.nl;
   loes.vanbokhoven@maastrichtuniversity.nl; sabinedejong88@gmail.com;
   job.metsemakers@maastrichtuniversity.nl; p.verhaak@nivel.nl;
   trudy.vanderweijden@maastrichtuniversity.nl;
   j.vaneijk@maastrichtuniversity.nl
FU Dutch Diabetes Research Foundation (Diabetes Fonds) [2010.13.1366];
   'Annadal Foundation' in Maastricht
FX We wish to thank all patients who participated in this study. We
   received funding from the Dutch Diabetes Research Foundation (Diabetes
   Fonds) under grant no. 2010.13.1366 (Voice of the Patient programme),
   and a financial contribution from the 'Annadal Foundation' in
   Maastricht, an independent financial support fund for healthcare.
CR Alderson S.L., 2014, BMJ OPEN, V4
   Alderson SL, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-37
   Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0
   Bentley M., 2016, J ADV NURS
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Braam C, 2009, J OCCUP REHABIL, V19, P231, DOI 10.1007/s10926-009-9178-z
   Caracelli V. J., 1989, EDUC EVAL POLICY AN, V11, P255, DOI DOI 10.3102/01623737011003255
   Chew-Graham CA, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-103
   EDMONDS W. A., 2013, APPL REFERENCE GUIDE
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Elissen A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-117
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Franek J, 2013, Ont Health Technol Assess Ser, V13, P1
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Grund J, 2012, J PRIM CARE COMMUNIT, V3, P230, DOI 10.1177/2150131911435263
   Halcomb EJ, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-26
   Heiligers PJM, 2012, KENNISVRAAG PRAKTIJK
   Hinder S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-83
   IBM Corp, 2012, IBM SPSS STAT WIND V
   IDF Clinical Guidelines Task Force, 2012, GLOB GUID TYP 2 DIAB
   Jakimowicz S, 2015, J CLIN NURS, V24, P19, DOI 10.1111/jocn.12676
   Knowles SE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0246-5
   Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2
   Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01
   Mulder BC, 2015, PATIENT EDUC COUNS, V98, P156, DOI 10.1016/j.pec.2014.11.006
   Netherlands Diabetes Federation, 2007, NDF CAR STAND TRANSP
   Pearce MJ, 2013, J AM ASSOC NURSE PRA, V25, P578, DOI 10.1002/2327-6924.12035
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Raaijmakers LGM, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-114
   Struijs J., 2012, BUNDL PAYM DIAB CAR
   The Dutch College of General Practitioners (NHG), 2011, COR VAL GEN PRACT FA
   Townsend A, 2006, CHRONIC ILLN, V2, P185, DOI 10.1179/174592006X129518
   Van de Laar FA, 2013, HUISARTS WET, V56, P512
   van Dijk-de Vries A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007014
   van Dijk-de Vries A, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-77
NR 35
TC 1
Z9 1
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7489
EI 1873-491X
J9 INT J NURS STUD
JI Int. J. Nurs. Stud.
PD NOV
PY 2016
VL 63
BP 58
EP 64
DI 10.1016/j.ijnurstu.2016.08.018
PG 7
WC Nursing
SC Nursing
GA DZ1LS
UT WOS:000385600500008
PM 27597730
DA 2019-01-08
ER

PT J
AU Fatani, SH
   Saleh, SAK
   Adly, HM
   Abdulkhaliq, AA
AF Fatani, Sameer H.
   Saleh, Saleh A. K.
   Adly, Heba M.
   Abdulkhaliq, Altaf A.
TI Trace Element Alterations in the Hair of Diabetic and Obese Women
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE Hair; Trace elements; Obesity; Diabetes mellitus; Women; Saudi Arabia
ID BODY-MASS INDEXES; BIOLOGICAL SAMPLES; MELLITUS PATIENTS; FEMALE HAIR;
   COPPER; IRON; ZINC; MAGNESIUM; SELENIUM; ADOLESCENTS
AB Alterations in the trace element content can induce metabolic disorders as these elements are involved in the regulation of metabolism. Obesity increases the likelihood of various diseases, particularly cardiovascular disease and type 2 diabetes, and is more prevalent in Saudi Arabia, especially in women. This study explored the potential of alterations in hair trace elements as long-term markers in diabetic and/or obese Saudi females. In total, 65 diabetic obese women, 47 non-diabetic obese women, and 70 normal-weight women were recruited. Clinical and familial history and anthropometric variables were recorded. Hair Se, Zn, Cu, Mn, and Fe levels were analyzed. Fasting blood sugar (FBS), glycated hemoglobin (HbA1c), and lipid profile were analyzed. Our findings revealed a marked decrease of hair Zn, Mn, and Fe and elevated Se and Cu levels in obese women. In addition, Zn and Fe levels were decreased in diabetic women. Thus, the metabolic distress occurring in obesity and hyperglycemia may affect trace element status by increasing the excretion and decreasing the bioavailability of trace elements or redistributing them among various pools. Hair trace elements can serve as important long-term markers for metabolic disorders; however, larger prospective studies are warranted to validate their diagnostic and follow-up utilities.
C1 [Fatani, Sameer H.; Saleh, Saleh A. K.; Adly, Heba M.; Abdulkhaliq, Altaf A.] Umm Al Qura Univ, Dept Biochem, Fac Med, POB 715, Mecca 21955, Saudi Arabia.
RP Saleh, SAK (reprint author), Umm Al Qura Univ, Dept Biochem, Fac Med, POB 715, Mecca 21955, Saudi Arabia.
EM sameer_fatani2003@yahoo.co.uk; Saleh-A-S@hotmail.com;
   Hebamadly@hotmail.com; dr.altaf@gmail.com
FU Institute of Scientific Research and Revival of Islamic Culture, Umm
   Al-Qura University, Makkah, Saudi Arabia [43209016]
FX The authors thank the Institute of Scientific Research and Revival of
   Islamic Culture, Umm Al-Qura University, Makkah, Saudi Arabia, for
   funding this project (Project number 43209016).
CR Afridi HI, 2008, DIABETES RES CLIN PR, V80, P280, DOI 10.1016/j.diabres.2007.12.021
   Al-Nozha MM, 2005, SAUDI MED J, V26, P824
   Al-Othaimeen A. I., 2007, Eastern Mediterranean Health Journal, V13, P441
   Al-Saleh E, 2006, BIOL TRACE ELEM RES, V113, P113, DOI 10.1385/BTER:113:2:113
   Alzaid AA, 1997, ANN SAUDI MED, V17, P154, DOI 10.5144/0256-4947.1997.154
   Anetor J I, 2002, Nutr Health, V16, P291
   Boosalis MG, 2008, NUTR CLIN PRACT, V23, P152, DOI 10.1177/0884533608314532
   Chojnacka K, 2010, ENVIRON TOXICOL PHAR, V3, P52
   CLOUET P, 1986, BIOCHEM J, V239, P103, DOI 10.1042/bj2390103
   Dambal SS, 2011, IJABPT, V2, P280
   Griffith H, 1995, COMPLETE GUIDE VITAM, P100
   Groop LC, 1999, DIABETES OBES METAB, V1, pS1
   Institute for Health Metrics and Evaluation, 2013, GBD COMP CAUS DIS IN
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y
   KORC M, 1983, AM J PHYSIOL, V245, pG628
   Lima SCVC, 2006, BIOL TRACE ELEM RES, V114, P19, DOI 10.1385/BTER:114:1:19
   Mehra R, 2005, J SCI IND RES INDIA, V64, P119
   Nead KG, 2004, PEDIATRICS, V114, P104, DOI 10.1542/peds.114.1.104
   Neymotin F, 2011, OBESITY, V19, P191, DOI 10.1038/oby.2010.112
   Ozturk P, 2014, J TRACE ELEM MED BIO, V28, P266, DOI 10.1016/j.jtemb.2014.03.003
   Pinhas-Hamiel O, 2003, INT J OBESITY, V27, P416, DOI [10.1038/sj.ijo.0802224, 10.1038/sj.ijo.802224]
   Rashed MN, 2011, J TRACE ELEM MED BIO, V25, P181, DOI 10.1016/j.jtemb.2011.07.001
   REGAN L, 1993, ANNU REV BIOPH BIOM, V22, P257, DOI 10.1146/annurev.bb.22.060193.001353
   Rungby J, 2010, DIABETOLOGIA, V53, P1549, DOI 10.1007/s00125-010-1793-x
   Skalnaya MG, 2007, J TRACE ELEM MED BIO, V21, P59, DOI 10.1016/j.jtemb.2007.09.019
   Steinbrenner H, 2011, J CLIN BIOCHEM NUTR, V48, P40, DOI 10.3164/jcbn.11-002FR
   Stranges S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-564
   Tungtrongchitr Rungsunn, 2003, Journal of the Medical Association of Thailand, V86, P543
   Viktorinova A, 2009, METABOLISM, V58, P1477, DOI 10.1016/j.metabol.2009.04.035
   Wang CT, 2005, CLIN CHEM LAB MED, V43, P389, DOI 10.1515/CCLM.2005.070
   Wang CT, 2005, J HEALTH SCI, V51, P70, DOI 10.1248/jhs.51.70
   WANG CT, 1994, EUR J CLIN CHEM CLIN, V32, P107
   Warsy A S, 1999, East Mediterr Health J, V5, P1236
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Wiernsperger N, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-70
   Zargar AH, 2002, SAUDI MED J, V23, P539
NR 37
TC 2
Z9 2
U1 2
U2 8
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
EI 1559-0720
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD NOV
PY 2016
VL 174
IS 1
BP 32
EP 39
DI 10.1007/s12011-016-0691-6
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA DY5IG
UT WOS:000385132300005
PM 27075547
DA 2019-01-08
ER

PT J
AU Wagner, JA
   Bermudez-Millan, A
   Damio, G
   Segura-Perez, S
   Chhabra, J
   Vergara, C
   Feinn, R
   Perez-Escamilla, R
AF Wagner, Julie Ann
   Bermudez-Millan, Angela
   Damio, Grace
   Segura-Perez, Sofia
   Chhabra, Jyoti
   Vergara, Cunegundo
   Feinn, Richard
   Perez-Escamilla, Rafael
TI A randomized, controlled trial of a stress management intervention for
   Latinos with type 2 diabetes delivered by community health workers:
   Outcomes for psychological wellbeing, glycemic control, and cortisol
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Latinos; Community health workers; Depression; Anxiety
ID DEPRESSION; IMPLEMENTATION; METAANALYSIS; PREVALENCE; PEOPLE; ADULTS
AB Aims: To test the efficacy of a community health worker (CHW) delivered stress management (SM) intervention on psychosocial, glycemic, and cortisol outcomes among U.S. Latinos with type 2 diabetes.
   Methods: A randomized, controlled trial compared CHW-delivered diabetes education (DE; one group session) to DE plus CHW-delivered SM (DE + SM; 8 group sessions). Psychosocial variables and urinary cortisol were measured at baseline and posttreatment. HbA1c was measured at baseline, posttreatment, and 3-month follow-up.
   Results: In intent to treat analysis, compared to DE (n = 46), DE + SM (n = 61) showed significantly improved symptoms of depression, anxiety, and self-reported health status. There were no significant group effects for HbA1c, diabetes distress, or urinary cortisol. However, there was a dose response effect for HbA1c and diabetes distress; increasing attendance at SM sessions was associated with greater improvements in HbA1c and diabetes distress.
   Conclusions: This is the first randomized, controlled trial demonstrating that CHWs can improve psychological symptoms and self-reported health among Latinos with type 2 diabetes. Efforts to increase intervention attendance may improve HbA1c and diabetes distress. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Wagner, Julie Ann; Bermudez-Millan, Angela] UConn Hlth, 263 Farmington Ave, Farmington, CT 06030 USA.
   [Damio, Grace; Segura-Perez, Sofia] Hispan Hlth Council, Hartford, CT USA.
   [Chhabra, Jyoti; Vergara, Cunegundo] Hartford Hosp, Hartford, CT 06115 USA.
   [Feinn, Richard] Quinnipiac Univ, Sch Med, Hamden, CT USA.
   [Perez-Escamilla, Rafael] Yale Sch Publ Hlth, New Haven, CT USA.
RP Wagner, JA (reprint author), UConn Hlth, 263 Farmington Ave, Farmington, CT 06030 USA.
EM juwagner@uchc.edu
FU NIH Minority Health and Health Disparities Institute [5 R01 MD005879];
   Yale Center for Clinical Investigation through Clinical and Translation
   Science Award from the National Center for Advancing Translational
   Sciences, a component of NIH [UL1-TR-000142]
FX CALMS-D was funded by the NIH Minority Health and Health Disparities
   Institute (Grant No. 5 R01 MD005879 to J.W. and R.P.-E., principal
   investigators). R.P.-E. received funding support for this publication
   from the Yale Center for Clinical Investigation through Clinical and
   Translation Science Award grant UL1-TR-000142 from the National Center
   for Advancing Translational Sciences, a component of NIH. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Center on Minority Health
   and Health Disparities or the National Institutes of Health (NIH).
CR Al-Zoairy R, 2013, CURR DIABETES REV, V9, P362, DOI 10.2174/15733998113099990067
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bermudez-Millan A, 2008, NOTICIA SALUD OFFICI, V3, P4
   Bermudez-Millan A, 2015, J HLTH PSYCHOL
   Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527
   Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Chapman DJ, 2012, ADV NUTR, V3, P95, DOI 10.3945/an.111.001016
   Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481
   de Vibe M, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-107
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Feathers JT, 2007, DIABETES EDUCATOR, V33, P509, DOI 10.1177/0145721707301371
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Global Health Workforce Alliance World Health Organization, 2010, COUNTR CAS STUD REC
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   International Diabetes Federation, 2015, DIABETES ATLAS
   International Labour Organization, 2008, INT STAND CLASS OCC
   Little TV, 2014, CURR DIABETES REP, V14
   McGee DL, 1999, AM J EPIDEMIOL, V149, P41
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Naranjo D, 2012, CURR DIABETES REP, V12, P729, DOI 10.1007/s11892-012-0319-y
   Pallas SW, 2013, AM J PUBLIC HEALTH, V103, pE74, DOI 10.2105/AJPH.2012.301102
   Palmas W, 2015, J GEN INTERN MED, V30, P1004, DOI 10.1007/s11606-015-3247-0
   Perez-Escamilla R., 2010, J HISP HIGH EDUC, V9, P43, DOI DOI 10.1177/1538192709349917
   Perez-Escamilla R, 2015, DIABETES CARE, V38, P197, DOI 10.2337/dc14-0327
   Roman LA, 2009, ARCH WOMEN MENT HLTH, V12, P379, DOI 10.1007/s00737-009-0083-4
   Segura-Perez S, 2011, IMPACT PROMOTORES SA
   Shah M, 2013, CURR DIABETES REP, V13, P163, DOI 10.1007/s11892-012-0359-3
   Snijders A.B., 2012, MULTILEVEL ANAL INTR
   UKPDS Study Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   van Son J, 2014, J PSYCHOSOM RES, V77, P81, DOI 10.1016/j.jpsychores.2014.03.013
   Vincent D, 2008, NURS RES, V57, P101, DOI 10.1097/01.NNR.0000313484.18670.ab
   Wagner J, 2015, INT J BEHAV MED, V5, P2
   Wagner J, 2015, CURR DIABETES REP, V15
   Wagner J, 2015, TRANSL BEHAV MED, V5, P415, DOI 10.1007/s13142-015-0332-1
   Weber B, 2000, EXP CLIN ENDOCR DIAB, V108, P187, DOI 10.1055/s-2000-7742
   Welch G, 2007, ETHNIC DIS, V17, P541
   Wennerstrom A, 2015, J AMBUL CARE MANAG, V38, P263, DOI 10.1097/JAC.0000000000000087
   World Health Organization, 2007, TASK SHIFT TACKL HLT
   WULSIN L, 2002, PRIM CARE COMPANION, V4, P191, DOI DOI 10.4088/PCC.V04N0504
NR 41
TC 13
Z9 14
U1 0
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD OCT
PY 2016
VL 120
BP 162
EP 170
DI 10.1016/j.diabres.2016.07.022
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EA6PK
UT WOS:000386750900022
PM 27568646
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Jaser, SS
   Lord, JH
   Simmons, JH
   Malow, BA
AF Jaser, Sarah S.
   Lord, Jadienne H.
   Simmons, Jill H.
   Malow, Beth A.
TI Brief report: Sleep disturbances in young children with type 1 diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Sleep; Psychological stress; Type 1 diabetes mellitus; Parenting
ID BEHAVIORS; PARENTS; YOUTH
AB This multi-method study, including actigraphy, sleep diaries, and questionnaires, indicated significant sleep disturbances in young children with type 1 diabetes (age 3-5) and insufficient sleep duration in children and their parents. Results provide initial support for sleep as a potential target to improve both diabetes outcomes and parental distress. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Jaser, Sarah S.; Lord, Jadienne H.; Simmons, Jill H.; Malow, Beth A.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Jaser, SS (reprint author), Vanderbilt Univ, Dept Pediat, 2200 Childrens Way,DOT 11136, Nashville, TN 37232 USA.
EM sarah.jaser@vanderbilt.edu
FU CTSA Award from the National Center for Advancing Translational Sciences
   [UL1TR000455]
FX This study was supported by CTSA Award UL1TR000455 from the National
   Center for Advancing Translational Sciences.
CR Adkins KW, 2012, BEHAV SLEEP MED, V10, P138, DOI 10.1080/15402002.2011.596598
   American Diabetes Association, 2016, DIABETES CARE S1, V39, pS1 , DOI DOI 10.2337/DC13-S011
   Donga E, 2010, DIABETES CARE, V33, P1573, DOI 10.2337/dc09-2317
   Goodlin-Jones BL, 2008, J DEV BEHAV PEDIATR, V29, P82, DOI 10.1097/DBP.0b013e318163c39a
   Meltzer LJ, 2008, J PEDIATR PSYCHOL, V33, P279, DOI 10.1093/jpepsy/jsm118
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Mindell JA, 2006, SLEEP, V29, P1263
   Monaghan M, 2012, CHILD HEALTH CARE, V41, P246, DOI 10.1080/02739615.2012.685385
   Monaghan MC, 2009, FAM SYST HEALTH, V27, P28, DOI 10.1037/a0014770
   National Sleep Foundation, MUCH SLEEP DO WE REA
   Owens JA, 2000, SLEEP, V23, P1043
   Perfect MM, 2012, SLEEP, V35, P81, DOI 10.5665/sleep.1590
   Smaldone A, 2011, J PEDIATR HEALTH CAR, V25, P87, DOI 10.1016/j.pedhc.2009.09.003
   Vehik K, 2007, DIABETES CARE, V30, P503, DOI 10.2337/dc06-1837
NR 14
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD OCT
PY 2016
VL 120
BP 232
EP 234
DI 10.1016/j.diabres.2016.08.012
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EA6PK
UT WOS:000386750900033
PM 27599087
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Aghili, R
   Polonsky, WH
   Valojerdi, AE
   Malek, M
   Keshtkar, AA
   Esteghamati, A
   Heyman, M
   Khamseh, ME
AF Aghili, Rokhsareh
   Polonsky, William H.
   Valojerdi, Ameneh Ebrahim
   Malek, Mojtaba
   Keshtkar, Abbas Ali
   Esteghamati, Alireza
   Heyman, Mark
   Khamseh, Mohammad Ebrahim
TI Type 2 Diabetes: Model of Factors Associated with Glycemic Control
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE diabetes mellitus; distress; glycemic control; psychosocial; type 2
   diabetes
ID QUALITY-OF-LIFE; SELF-MANAGEMENT; DEPRESSIVE SYMPTOMS; EMOTIONAL
   DISTRESS; CLINICAL DEPRESSION; SOCIAL SUPPORT; CARE; PATIENT; HEALTH;
   METAANALYSIS
AB Objectives: The purpose of this study was to evaluate the related factors and their intercorrelated impacts on glycemic control in people with type 2 diabetes mellitus.
   Methods: Patients with type 2 diabetes were recruited for this study during their regular clinic visits at a major medical centre in Iran. Glycated hemoglobin (A1C) levels were used as the indicator of glycemic control. Regression analysis was used to determine the relationships between glycemic control and demographics, self-care behaviours, resources and affective variables. Moreover, the associations between diabetes related distress and measured variables were tested.
   Results: Three hundred eighty people with type 2 diabetes completed the study. The mean duration of diabetes was 8.94 +/- 6.57 years, and the mean A1C levels were 7.78%+/- 1.7%. Diabetes-related distress was significantly associated with A1C levels, controlling for all other variables (p=0.01). On the other hand, depression (p<0.001), self-management (p<0.001), anxiety (p<0.001) and patient-physician relationship (p=0.023) were significantly associated with diabetes-related distress.
   Conclusions: Diabetes-related distress was found to be associated with glycemic control in people with type 2 diabetes, whereas age, depression, anxiety, self-management and family and social support may affect glycemic control indirectly through diabetes-related distress. Thus, it is important to assess and, if appropriate, treat people with diabetes for diabetes-related distress in order to identify and help them overcome barriers to optimal glycemic control. (C) 2016 Canadian Diabetes Association.
C1 [Aghili, Rokhsareh; Valojerdi, Ameneh Ebrahim; Khamseh, Mohammad Ebrahim] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Malek, Mojtaba] Iran Univ Med Sci, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran.
   [Keshtkar, Abbas Ali] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Osteoporosis Res Ctr, Tehran, Iran.
   [Esteghamati, Alireza] Univ Tehran Med Sci, Vali Asr Hosp, Endocrinol & Metab Res Ctr EMRC, Tehran, Iran.
   [Heyman, Mark] UCSD Sch Med, Dept Psychiat, San Diego, CA USA.
RP Khamseh, ME (reprint author), Inst Endocrinol & Metab, 10 Firouzeh St,South Vali Asr Ave,Vali Asr Sq, Tehran, Iran.
EM khamseh.m@iums.ac.ir
RI Khamseh, Mohammad Ebrahim/L-9391-2018
FU Iran University of Medical Sciences [93-02-122-24800]
FX This study was funded and supported by Iran University of Medical
   Sciences, grant number 93-02-122-24800. The authors thank all the people
   who participated in this study.
CR Aghili R, 2013, INT NURS REV, V60, P267, DOI 10.1111/inr.12007
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   [Anonymous], 2015, DIABETES CARE S, V38, pS1
   Baradaran HR, 2013, INT J PREVENTIVE MED, V4, P580
   Brown JB, 2002, FAM PRACT, V19, P344, DOI 10.1093/fampra/19.4.344
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   Davis RE, 2005, CURR MED RES OPIN, V21, P1477, DOI 10.1185/030079905X61929
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   Farshchi A, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-42
   Fisher L, 2007, DIABETES CARE, V30, P2746, DOI 10.2337/dc07-1166
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hessler D, 2015, DIABETES RES CLIN PR, V108, P360, DOI 10.1016/j.diabres.2014.12.017
   Jones A, 2016, PRIM CARE DIABETES, V10, P83, DOI 10.1016/j.pcd.2015.03.008
   Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363
   KAVIANI H, 2008, TEHRAN U MED J, V66, P136
   Khamseh ME, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-61
   Khodapanahi MK, 2010, J FAM RES, V5, P423
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Peyrot M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-125
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky William H, 2002, Curr Diab Rep, V2, P153, DOI 10.1007/s11892-002-0075-5
   Robinson DJ, 2013, CAN J DIABETES, V37, pS87, DOI 10.1016/j.jcjd.2013.01.026
   Rosland AM, 2008, J GEN INTERN MED, V23, P1992, DOI 10.1007/s11606-008-0814-7
   Stark CS, 2013, DIABETES CARE, V36, P2271, DOI DOI 10.2337/DC12-2258
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Tong WT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006407
   Vasheghani-Farahani Ali, 2011, Asian J Sports Med, V2, P106
   Wang RH, 2011, J ADV NURS, V67, P2658, DOI 10.1111/j.1365-2648.2011.05701.x
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   Weinger K, 2010, DIABETES CARE, V33, P450, DOI 10.2337/dc09-2132
   Zhang CX, 2009, DIABETIC MED, V26, P1282, DOI 10.1111/j.1464-5491.2009.02840.x
NR 47
TC 12
Z9 12
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD OCT
PY 2016
VL 40
IS 5
BP 424
EP 430
DI 10.1016/j.jcjd.2016.02.014
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EC6ML
UT WOS:000388250300013
PM 27291886
DA 2019-01-08
ER

PT J
AU Cheng, L
   Sit, JWH
   Leung, DYP
   Li, XM
AF Cheng, Li
   Sit, Janet W. H.
   Leung, Doris Y. P.
   Li, Xiaomei
TI The Association Between Self-Management Barriers and Self-Efficacy in
   Chinese Patients with Type 2 Diabetes: The Mediating Role of Appraisal
SO WORLDVIEWS ON EVIDENCE-BASED NURSING
LA English
DT Article
DE diabetes; self-management barriers; appraisal; self-efficacy; mediating
   effect; knowledge; decision making
ID EMOTIONAL DISTRESS; PERCEIVED BARRIERS; BEHAVIOR-CHANGE; LOW-INCOME;
   STRESS; MODEL; PEOPLE; PERFORMANCE; DEPRESSION; ADHERENCE
AB Background: Patients with higher levels of self-management barriers are more likely to exhibit a lower level of self-efficacy. However, the theoretically meaningful mechanisms underlying the association between the two variables have not yet been established.
   Aims: Informed by the Transactional Model of Stress and Coping, this study aimed to examine the potential role of diabetes appraisal on the association of self-management barriers and self-efficacy in patients with type 2 diabetes mellitus.
   Methods: This article presents the secondary data analyses of a multicenter, cross-sectional study. A sample of 346 adults with type 2 diabetes was interviewed, using the Personal Diabetes Questionnaire, the Appraisal of Diabetes scale, the Diabetes Empowerment Scale-Short Form, and the Summary of Diabetes Self-Care Activities. Structure equation modeling was performed with 10,000 bootstrap samples using Mplus 7.
   Results: The hypothesized model provided a good fit to the data (chi(2) = 22.975, df = 33; p = .1144; CFI = 0.989; SRMR = 0.036; RMSEA = 0.042). The mediating effect of diabetes appraisal on the association of self-management barriers and self-efficacy was significant (beta = -0.521; 95% CI: -0.865, -0.283), explaining 44.82% of the total effect of barriers on self-efficacy. Significant associations were also detected between diet knowledge and diabetes appraisal (beta = 0.148, p = .047).
   Linking Evidence to Action: Diabetes appraisal plays a mediating role in the association between self-management barriers and self-efficacy in patients with type 2 diabetes. Reflecting on patients' appraisal of diabetes can help to develop evidence-based and patient-centered interventions. Interventions that enhance individuals' positive appraisal of diabetes have the potential to buffer the negative effects of self-management barriers on self-efficacy.
C1 [Cheng, Li; Sit, Janet W. H.; Leung, Doris Y. P.] Chinese Univ Hong Kong, Fac Med, Nethersole Sch Nursing, Shatin, Hong Kong, Peoples R China.
   [Li, Xiaomei] Xi An Jiao Tong Univ, Fac Med, Sch Nursing, Xian, Peoples R China.
RP Cheng, L (reprint author), Chinese Univ Hong Kong, Nethersole Sch Nursing, Room 806,Esther Lee Bldg, Shatin, Hong Kong, Peoples R China.
EM lilycheng@link.cuhk.edu.hk
RI Leung, Doris/K-4878-2014; Sit, Janet/A-5159-2015
OI Leung, Doris/0000-0003-0138-8839; Sit, Janet/0000-0002-4714-5915
CR Abubakari A-R, 2011, J NURS HEALTHC CHRON, V3, P245, DOI DOI 10.1111/J.1752-9824.2011.01098.X
   Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Arbuckle J. L., 2013, IBM SPSS AMOS 22 USE
   Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Baumann LC, 2012, NURSE PRACT, V37, P32, DOI DOI 10.1097/01.NPR.0000411104.12617.64
   Breland JY, 2013, DIABETES CARE, V36, P2895, DOI 10.2337/dc12-1632
   Burner Elizabeth, 2013, J Diabetes Sci Technol, V7, P111
   CAREY MP, 1991, J BEHAV MED, V14, P43, DOI 10.1007/BF00844767
   Carpenter R. D., 2008, THESIS
   Carpenter R, 2012, J HEALTH CARE POOR U, V23, P726, DOI 10.1353/hpu.2012.0049
   Cattaneo LB, 2010, AM PSYCHOL, V65, P646, DOI 10.1037/a0018854
   Chen X P, 2011, J MANAGE, P796
   Cheng L, 2014, CHIN J NUR, V49, P749
   Cheng L, 2016, PATIENT PREFER ADHER, V10, DOI 10.2147/PPA.S94275
   [程丽 Cheng Li], 2013, [中华护理杂志, Chinese Journal of Nursing], V48, P707
   Enders CK, 2001, EDUC PSYCHOL MEAS, V61, P713, DOI 10.1177/00131640121971482
   Garland E, 2009, EXPLORE-NY, V5, P37, DOI 10.1016/j.explore.2008.10.001
   Ho AYK, 2010, NURS HEALTH SCI, V12, P259, DOI 10.1111/j.1442-2018.2010.00517.x
   [胡贝贝 Hu Beibei], 2011, [中华护理杂志, Chinese Journal of Nursing], V46, P225
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   JanzenClaude JA, 2014, J HEALTH PSYCHOL, V19, P312, DOI DOI 10.1177/1359105312470157
   Jung SY, 2015, ASIAN NURS RES, V9, P73, DOI 10.1016/j.anr.2014.11.002
   Kidd LA, 2014, HEALTH EXPECT, V17, P565, DOI 10.1111/j.1369-7625.2012.00785.x
   Kuo CC, 2014, WORLDV EVID-BASED NU, V11, P301, DOI 10.1111/wvn.12066
   Lazarus R. S., 1987, EUROPEAN J PERSONALI, V1, P141, DOI DOI 10.1002/PER.2410010304
   Li Y., 2011, MOD HOSP, V11, P148
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Mansyur CL, 2013, J BEHAV MED, V36, P75, DOI 10.1007/s10865-012-9403-7
   Marcy Todd R, 2011, Diabetes Ther, V2, P9, DOI 10.1007/s13300-010-0012-6
   McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430
   McGuire AM, 2014, COLLEGIAN, V21, P301, DOI 10.1016/j.colegn.2013.07.001
   Mika A, 2012, BEHAV NEUROSCI, V126, P605, DOI 10.1037/a0029642
   Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   Nicholls AR, 2012, PSYCHOL SPORT EXERC, V13, P263, DOI 10.1016/j.psychsport.2011.12.003
   Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Shah BM, 2012, STRESS HEALTH, V28, P111, DOI 10.1002/smi.1410
   Shansky RM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00123
   Sharma M., 2011, THEORETICAL FDN HLTH
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   Smalls BL, 2012, GEN HOSP PSYCHIAT, V34, P385, DOI 10.1016/j.genhosppsych.2012.03.018
   Stetson B, 2011, DIABETES RES CLIN PR, V91, P321, DOI 10.1016/j.diabres.2010.12.002
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
NR 48
TC 2
Z9 3
U1 3
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-102X
EI 1741-6787
J9 WORLDV EVID-BASED NU
JI Worldviews Evid.-Based Nurs.
PD OCT
PY 2016
VL 13
IS 5
BP 356
EP 362
DI 10.1111/wvn.12159
PG 7
WC Nursing
SC Nursing
GA EC7HL
UT WOS:000388307700004
PM 27074413
DA 2019-01-08
ER

PT J
AU Bajaj, HS
   Venn, K
   Ye, CL
   Aronson, R
AF Bajaj, Harpreet S.
   Venn, Karri
   Ye, Chenglin
   Aronson, Ronnie
TI Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool
   (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE
   Trial)
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; GLUCOSE-LOWERING DRUGS; SELF-TITRATION;
   HYPOGLYCEMIA; DETEMIR; 52-WEEK; PEOPLE
AB Background: Basal insulin titration in the real world is often unsuccessful. LTHome, a web tool, applies a rules engine-based algorithm providing insulin titration advice directly to the patient. Methods: This pilot, randomized trial evaluates basal insulin glargine titration by LTHome compared to enhanced usual therapy ([EUT]diabetes education program) over 12 weeks. Important inclusion criteria: 18-75 years, type 2 diabetes, computer literacy, and HbA1c >7.0%. Trial protocol was approved by ethics board. Results: We randomized 139 subjects. The achievement of primary composite outcome (four out of seven fasting plasma glucose [FPG] within 5-7.2mmol/L + mean for three consecutive FPG within 5-7.2mmol/L + no severe hypoglycemia) was 15% in LTHome versus 41% in EUT (noninferiority not met, P-value=0.92). Other outcomes were similar between the LTHome and EUT arms: alternate composite outcome achievement (last five FPG mean within the range of 5-7.2mmol/L + no hypoglycemia, 47% and 51%, P=0.73); A1c reduction (-1.0% and -1.1%, P=0.66); proportion achieving A1c 7% (14% and 20%, P=0.36); and hypoglycemia incidence (31% and 37%, P=0.4), respectively. Patient satisfaction score improvements were greater in LTHome versus EUT (change in fear of hypoglycemia score P=0.04 and change in diabetes distress score P=0.04). The mean number of additional healthcare provider visits was 0.13 for LTHome and 1.22 for EUT (P<0.01). Conclusion: INNOVATE trial suggests clinical utility of LTHome compared to EUT in real-life settings. Further research is needed to evaluate the efficacy and safety of automated insulin titration algorithms.
C1 [Bajaj, Harpreet S.; Venn, Karri; Aronson, Ronnie] LMC Diabet & Endocrinol, Toronto, ON, Canada.
   [Bajaj, Harpreet S.] Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Toronto, ON, Canada.
   [Ye, Chenglin] Hlth Qual Ontario, Toronto, ON, Canada.
RP Bajaj, HS (reprint author), 2130 North Pk Dr,Suite 238, Brampton, ON L6S 0C9, Canada.
EM harpreet.bajaj@lmc.ca
OI Bajaj, Harpreet/0000-0002-1461-1465
FU AstraZeneca; Eli Lilly; Janssen; Merck; Novo Nordisk; Pfizer; Regeneron;
   Sanofi; Takeda; Abbott; Bayer; Boehringer Ingelheim; BD;
   GlaxoSmithKline; Medtronic; Amgen
FX H.B.: Advisory Panel or Consultant: AstraZeneca, Boehringer Ingelheim,
   Eli Lilly, Janssen, Merck, Sanofi. Research Support; AstraZeneca, Eli
   Lilly, Janssen, Merck, Novo Nordisk, Pfizer, Regeneron, Sanofi, Takeda.
   Speaker's Bureau or fees; Abbott, AstraZeneca, Bayer, Boehringer
   Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Sanofi. No competing
   financial interests exist for authors K.V. and C.Y; R.A.: Funding
   (Grants/Honoraria): Sanofi, Takeda, BD, GlaxoSmithKline.
   Research/Clinical Trials: BD, Takeda, Sanofi, Merck, Janssen, Medtronic,
   Boehringer Ingelheim, Regeneron, Andromeda, Tolerx, Bristol-Myers
   Squibb, AstraZeneca, Novo Nordisk, Novartis, Eli Lilly, ConjuChem,
   Abbott, Piramal, Diartis, Roche, Abbott, Quintiles, ICON, Medpace, Essem
   Research. Speaker/Consulting Fees: Novo Nordisk, Janssen, Sanofi,
   Medtronic, Bristol-Myers Squibb, AstraZeneca, Takeda, Amgen.
CR American Diabetes Association, 2015, DIABETES CARE S1, V38, pS1, DOI DOI 10.2337/DC15-S001
   Anderson RM, 2005, DIABETES EDUCATOR, V31, P513, DOI 10.1177/0145721705278947
   [Anonymous], 2008, THESIS
   Boussageon R, 2011, BMJ-BRIT MED J, V343
   Bradley C, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-57
   Briscoe VJ, 2006, CLIN DIABETES, V24, P115, DOI DOI 10.2337/DIACLIN.24.3.115
   Canadian Diabetes Association, 2013, CANADIAN J DIABETES, V37, pA3
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9
   DCCT Res Grp, 1991, AM J MED, V90, P450
   Finkelstein J., 2012, EVIDENCE REPORTS TEC, V206
   Gerstein HC, 2006, DIABETIC MED, V23, P736, DOI 10.1111/j.1464-5491.2006.01881.x
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Harris S, 2008, CAN FAM PHYSICIAN, V54, P550
   Hollander P, 2008, CLIN THER, V30, P1976, DOI 10.1016/j.clinthera.2008.11.001
   Kostev K, 2015, DIABETES METAB SYNDR, V14, P45
   Lyles CR, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0534-9
   Morrison F, 2011, ARCH INTERN MED, V171, P1542, DOI 10.1001/archinternmed.2011.400
   Nicola N, 2005, DIABETES CARE, V28, P2948
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Roek MGA, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-40
   Rosenstock J, 2008, DIABETOLOGIA, V51, P408, DOI 10.1007/s00125-007-0911-x
   Seaquist ER, 2012, DIABETES CARE, V35, P409, DOI 10.2337/dc11-0996
   Simon ACR, 2014, J MED INTERNET RES, V16, P63, DOI 10.2196/jmir.3198
   Simon ACR, 2013, ARTIF INTELL MED, V59, P23, DOI 10.1016/j.artmed.2013.04.009
   Strange Poul, 2007, J Diabetes Sci Technol, V1, P540
   Swinnen SG, 2010, DIABETES CARE, V33, P1176, DOI 10.2337/dc09-2294
NR 27
TC 7
Z9 7
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD OCT
PY 2016
VL 18
IS 10
BP 610
EP 615
DI 10.1089/dia.2016.0182
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EA3BM
UT WOS:000386473000003
PM 27652718
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Hessler, D
   Layne, JE
   Zisser, H
AF Polonsky, William H.
   Hessler, Danielle
   Layne, Jennifer E.
   Zisser, Howard
TI Impact of the Omnipod((R)) Insulin Management System on Quality of Life:
   A Survey of Current Users
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
DE Continuous subcutaneous insulin infusion; Quality of life; Type 1
   diabetes; Glycemic control
ID RANDOMIZED-TRIAL; ADULTS; INFUSION; INJECTION; DISTRESS; THERAPY; TIME
AB Background: Few recent studies have examined the impact of continuous subcutaneous insulin infusion systems on patient-reported quality of life (QOL). We explored QOL changes resulting from treatment with the Omnipod((R)) Insulin Management System (Insulet Corp., Billerica, MA). Methods: One thousand two hundred forty-five adults (>18 years) with type 1 diabetes and current Omnipod users completed an online questionnaire examining perceived changes in QOL and glycemic control since Omnipod initiation. The QOL dimensions included overall well-being (World Health Organization-5, modified to examine changes retrospectively), diabetes distress (Type 1 Diabetes Distress Scale, current distress and a modified retrospective version), and psychosocial impact (two subscales from the Diabetes Technology Impact Measure, perceived control over diabetes, and hypoglycemic safety). Regression analyses examined associations between demographics, key psychological factors, and perceived change in glycemic control with the QOL dimensions. Results: Broad QOL and clinical benefits associated with Omnipod use were common. The majority reported positive changes in the following: overall well-being (53.5%), perceived control over diabetes (72.5%), hypoglycemic safety (50.6%), and diabetes distress (69.6%). Worsening in any of these areas was uncommon. In addition, 64.2% of patients reported glycemic improvement post-Omnipod initiation, while 35.2% reported a decrease in severe hypoglycemic episodes. Trust in one's Omnipod, perceived improvement in glycemic control, and reductions in severe hypoglycemia independently predicted benefits in all QOL measures (all P<0.001). Conclusions: These findings suggest that Omnipod users perceived substantial QOL benefits from the device; benefits are more apparent in those who trust the device and have noted positive changes in glycemic control.
C1 [Polonsky, William H.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Polonsky, William H.] Behav Diabet Inst, POB 2148, San Diego, CA 92014 USA.
   [Hessler, Danielle] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Layne, Jennifer E.] Insulet Corp, Billerica, MA USA.
   [Zisser, Howard] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.
RP Polonsky, WH (reprint author), Behav Diabet Inst, POB 2148, San Diego, CA 92014 USA.
EM whp@behavioraldiabetes.org
FU Insulet Corporation
FX This investigator-initiated study was supported by Insulet Corporation.
CR DeVries JH, 2002, DIABETES CARE, V25, P2074, DOI 10.2337/diacare.25.11.2074
   Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hoogma R. P., 2005, DIABETIC MED, V23, P141
   John O. P., 1999, HDB PERSONALITY THEO, V2, P102, DOI DOI 10.1525/FQ.1998.51.4.04A00260
   Lau C Y, 2004, J Postgrad Med, V50, P189
   Lebenthal Y, 2012, DIABETES TECHNOL THE, V14, P411, DOI 10.1089/dia.2011.0228
   Nicolucci A, 2008, DIABETIC MED, V25, P213, DOI 10.1111/j.1464-5491.2007.02346.x
   Peyrot M, 2011, DIABETES TECHNOL THE, V13, P471, DOI 10.1089/dia.2010.0167
   Polonsky WH, 2013, DIABETES TECHNOL THE, V15, P295, DOI 10.1089/dia.2012.0298
   Tsui E, 2001, DIABETES CARE, V24, P1722, DOI 10.2337/diacare.24.10.1722
NR 12
TC 1
Z9 1
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD OCT
PY 2016
VL 18
IS 10
BP 664
EP 670
DI 10.1089/dia.2016.0239
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EA3BM
UT WOS:000386473000010
PM 27673352
DA 2019-01-08
ER

PT J
AU Wang, SB
   Li, B
   Ungvari, GS
   Ng, CH
   Chiu, HFK
   Kou, CG
   Liu, YW
   Tao, YC
   Wu, YH
   Fu, YL
   Qi, Y
   Yu, YQ
   Xiang, YT
AF Wang, Shibin
   Li, Bo
   Ungvari, Gabor S.
   Ng, Chee H.
   Chiu, Helen F. K.
   Kou, Changgui
   Liu, Yawen
   Tao, Yuchun
   Wu, Yanhua
   Fu, Yingli
   Qi, Yue
   Yu, Yaqin
   Xiang, Yu-Tao
TI Poor mental health status and its associations with demographic
   characteristics and chronic diseases in Chinese elderly
SO SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
LA English
DT Article
DE Mental health; Chronic disease; Chinese elderly
ID LIFE-STYLE; HONG-KONG; PSYCHOLOGICAL DISTRESS; PREVALENCE; POPULATION;
   DISORDERS; MULTIMORBIDITY; DEPRESSION; CARE; CHALLENGES
AB Although poor mental health is associated with significant personal and societal burden, it is rarely reported in older Chinese populations. This study examined the mental health status of a large representative sample of Chinese elderly in relation to socio-demographic characteristics, lifestyle, and chronic diseases.
   Multistage stratified cluster sampling was used in this cross-sectional study. A total of 4115 people aged between 60 and 79 years were selected and interviewed with standardized assessment tools. The 12-item General Health Questionnaire (GHQ-12) was used to measure general mental health with the total score of aeyen4 as the threshold for poor mental health status.
   The adjusted percentage of poor mental health status in the whole sample was 23.8 %; 18.5 % in men and 28.9 % in women. Multivariate logistic regression analysis revealed that female gender, widowed/separated marital status, rural abode, low income, poor diet, lack of physical exercise, and multi-morbidity were independently associated with poor mental health. The percentage of poor mental health status was significantly higher in patients with anemia, diabetes, hyperlipidemia, cataract/glaucoma, ischemic heart disease, cerebrovascular diseases, nasopharyngitis, chronic gastroenteritis/peptic ulcer, liver diseases, cholecystitis/gallstone, arthritis, or chronic low back pain.
   Given the high rate of poor mental health status among older Chinese population, policy makers and health professionals in China should address the mental health burden of its aging population.
C1 [Wang, Shibin; Li, Bo; Kou, Changgui; Liu, Yawen; Tao, Yuchun; Wu, Yanhua; Fu, Yingli; Qi, Yue; Yu, Yaqin] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Peoples R China.
   [Wang, Shibin; Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Ave Univ,3-F,Bldg E12, Taipa, Macau, Peoples R China.
   [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia.
   [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia.
   [Ng, Chee H.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia.
   [Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.
RP Li, B (reprint author), Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Peoples R China.; Xiang, YT (reprint author), Univ Macau, Fac Hlth Sci, Unit Psychiat, Ave Univ,3-F,Bldg E12, Taipa, Macau, Peoples R China.
EM li_bo@jlu.edu.cn; xyutly@gmail.com
RI liu, yawen/J-2471-2014
FU Scientific Research Foundation of the Health Bureau of Jilin Province,
   China [2011Z116]
FX This study was funded by the Scientific Research Foundation of the
   Health Bureau of Jilin Province, China (Grant Number: 2011Z116).
CR Agborsangaya CB, 2013, QUAL LIFE RES, V22, P791, DOI 10.1007/s11136-012-0214-7
   Boey KW, 2005, AGING MENT HEALTH, V9, P555, DOI 10.1080/13607860500193351
   Bowling A, 2007, AGING MENT HEALTH, V11, P301, DOI 10.1080/13607860600963752
   Chiu HFK, 2004, ACTA PSYCHIAT SCAND, V109, P299, DOI 10.1046/j.1600-0447.2003.00263.x
   Cornah D. D., 2006, CHEERS UNDERSTANDING
   Edmans J, 2013, AGE AGEING, V42, P747, DOI 10.1093/ageing/aft054
   Feng ZL, 2012, HEALTH AFFAIR, V31, P2764, DOI 10.1377/hlthaff.2012.0535
   do Nascimento KKF, 2015, INT J GERIATR PSYCH, V30, P1171, DOI 10.1002/gps.4271
   Fone DL, 2006, HEALTH PLACE, V12, P332, DOI 10.1016/j.healthplace.2005.02.002
   Forsman AK, 2011, SCAND J PUBLIC HEALT, V39, P757, DOI 10.1177/1403494811418281
   Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337
   Fu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148990
   Gale CR, 2016, J EPIDEMIOL COMMUN H, V70, P813, DOI 10.1136/jech-2015-206479
   Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421
   Gorstein J, 2007, INDICATORS METHODS C
   Hassanzadeh J, 2018, AM J MENS HEALTH, V12, P96, DOI 10.1177/1557988316630720
   Jokela M, 2013, PSYCHOL MED, V43, P2037, DOI 10.1017/S0033291712003042
   KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007
   Li KQ, 2008, ASIAN J PSYCHIATR, V1, P51, DOI 10.1016/j.ajp.2008.09.010
   Lopresti AL, 2013, J AFFECT DISORDERS, V148, P12, DOI 10.1016/j.jad.2013.01.014
   Ma X, 2008, PSYCHOL MED, V38, P1723, DOI 10.1017/S0033291708003164
   Mui A. C., 2010, CHINA J SOCIAL WORK, V3, P111, DOI [10.1080/17525098.2010.492634, DOI 10.1080/17525098.2010.492634]
   Naimi TS, 2016, SELECTION BIASES OBS, DOI [10.1111/add.13451, DOI 10.1111/ADD.13451]
   National Bureau of Statistics of China, 2013, CHIN STAT ABSTR
   Paul Constanca, 2006, Psychol Health Med, V11, P221
   Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7
   Qu B, 2012, POPUL HEALTH MANAG, V15, P181, DOI 10.1089/pop.2011.0033
   Resnick Barbara, 2003, J Community Health Nurs, V20, P135, DOI 10.1207/S15327655JCHN2003_01
   Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141
   Schoenborn Charlotte A, 2010, Vital Health Stat 10, P1
   Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X
   Su D, 2012, ARCH GERONTOL GERIAT, V55, P564, DOI 10.1016/j.archger.2012.06.006
   Tian T, 2015, IRAN J PUBLIC HEALTH, V44, P1084
   Walsh R, 2011, AM PSYCHOL, V66, P579, DOI 10.1037/a0021769
   Wang SB, 2015, PUBLIC HEALTH, V129, P1539, DOI 10.1016/j.puhe.2015.06.013
   Wang SB, 2015, ASIA-PAC J PUBLIC HE, V27, P394, DOI 10.1177/1010539514551200
   WHO, 2004, LANCET, V363, P902
   Wong TS, 2014, AGING MENT HEALTH, V18, P588, DOI 10.1080/13607863.2013.856862
   Xiang YT, 2012, LANCET, V380, P1715, DOI 10.1016/S0140-6736(11)60893-3
   Xiang YT, 2009, ALCOHOL CLIN EXP RES, V33, P1111, DOI 10.1111/j.1530-0277.2009.00933.x
   Yamamoto N, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-32
   Yang Ting-zhong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P769
   Zhu H, 2010, J POPUL AGEING, V3, P161, DOI 10.1007/s12062-011-9034-8
NR 43
TC 5
Z9 5
U1 4
U2 24
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0933-7954
EI 1433-9285
J9 SOC PSYCH PSYCH EPID
JI Soc. Psychiatry Psychiatr. Epidemiol.
PD OCT
PY 2016
VL 51
IS 10
BP 1449
EP 1455
DI 10.1007/s00127-016-1271-y
PG 7
WC Psychiatry
SC Psychiatry
GA DY5SZ
UT WOS:000385164700010
PM 27539269
DA 2019-01-08
ER

PT J
AU Deschenes, SS
   Burns, RJ
   Graham, E
   Schmitz, N
AF Deschenes, Sonya S.
   Burns, Rachel J.
   Graham, Eva
   Schmitz, Norbert
TI Prediabetes, depressive and anxiety symptoms, and risk of type 2
   diabetes: A community-based cohort study
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Anxiety; Cohort study; Depression; Prediabetes; Type 2 diabetes
ID IMPAIRED GLUCOSE-TOLERANCE; WHITEHALL II; LIFE-STYLE; PSYCHOLOGICAL
   DISTRESS; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; PHYSICAL-ACTIVITY;
   FASTING GLUCOSE; MELLITUS; HEALTH
AB Objective: To examine the potential synergistic associations between prediabetes, depressive and anxiety symptoms, and the risk of incident type 2 diabetes.
   Methods: Data were from the Emotional Well-Being, Metabolic Factors and Health Status (EMHS) study and included 2486 adults between 40 and 69 years without diabetes at baseline. Hemoglobin Alc levels and measures of depressive and anxiety symptoms were collected at baseline and mutually exclusive groups were formed based on the presence/absence of prediabetes and high/low depressive and anxiety symptoms. A follow-up telephone interview conducted approximately 4.6 years later inquired about new diabetes diagnoses.
   Results: 86 participants developed diabetes during the follow-up period. After accounting for sociodemographic, lifestyle, and metabolic characteristics, participants with prediabetes and elevated depressive symptoms had an increased risk of developing diabetes compared to those without prediabetes and with low depressive symptoms (OR = 10.65, 95% CI = 4.60, 24.66). The joint effect of prediabetes and depressive symptoms on diabetes risk was synergistic (Synergy Index = 2.57, 95% CI = 1.02, 6.49). Similar results were found for participants with prediabetes and high symptoms of anxiety (OR = 8.95, 95% CI = 3.54, 22.63), however the joint effect of prediabetes and anxiety symptoms did not significantly exceed additive risk after adjusting for covariates (Synergy Index = 239, 95% CI = 0.83, 6.87).
   Conclusion: The combination of prediabetes and depressive or anxiety symptoms was associated with an increased risk of developing diabetes. This study underscores the importance of mental health in the progression from prediabetes to type 2 diabetes. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Deschenes, Sonya S.; Burns, Rachel J.; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada.
   [Deschenes, Sonya S.; Burns, Rachel J.; Graham, Eva; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, 6875 Boul Lasalle,Frank B Common Pavil,F2117-2, Montreal, PQ H4H 1R3, Canada.
   [Graham, Eva; Schmitz, Norbert] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
RP Deschenes, SS (reprint author), Douglas Mental Hlth Univ Inst, 6875 Boul Lasalle,Frank B Common Pavil,F2117-2, Montreal, PQ H4H 1R3, Canada.
EM sonya.deschenes@mail.mcgill.ca
RI Schmitz, Norbert/A-5177-2010; Deschenes, Sonya/G-6341-2017
OI Schmitz, Norbert/0000-0001-7777-6323; Burns, Rachel/0000-0002-5337-7878
FU Operating Grant from the Canadian Institutes of Health Research
   [MOP-130552]; Fonds de recherche du Quebec - Sante, Canada; fellowship
   from the Canadian Institutes of Health Research [201411MFE-338860
   FRN-142923]
FX This work was supported by an Operating Grant from the Canadian
   Institutes of Health Research (MOP-130552). Sonya Deschenes is supported
   by a fellowship from the Fonds de recherche du Quebec - Sante, Canada
   and Rachel Burns is supported by a fellowship from the Canadian
   Institutes of Health Research (201411MFE-338860 FRN-142923). The funding
   agencies had no role in the design and conduct of the study, the
   collection, analysis and interpretation of the data, in the writing of
   the report, or in the decision to submit the article for publication.
CR Association. A. D., 2010, DIABETES CARE S1, V33, pS62
   Au B, 2014, J PSYCHOSOM RES, V77, P180, DOI 10.1016/j.jpsychores.2014.07.012
   Awadalla P, 2013, INT J EPIDEMIOL, V42, P1285, DOI 10.1093/ije/dys160
   Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005
   Bonora E, 2011, DIABETES CARE, V34, P1038, DOI 10.2337/dc10-1180
   Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4
   Committee IR, 2005, GUIDELINES DATA PROC
   Da Silva MA, 2012, EUR J EPIDEMIOL, V27, P537, DOI 10.1007/s10654-012-9692-8
   Deschenes SS, 2015, J PSYCHOSOM RES, V78, P137, DOI 10.1016/j.jpsychores.2014.11.023
   Deuschle M, 2013, CURR OPIN PSYCHIATR, V26, P60, DOI 10.1097/YCO.0b013e32835a4206
   Eaton WW, 2007, INT REV PSYCHIATR, V19, P497, DOI 10.1080/09540260701564906
   Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95
   Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007
   HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lamers F, 2008, J CLIN EPIDEMIOL, V61, P679, DOI 10.1016/j.jclinepi.2007.07.018
   Mainous AG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005002
   Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829
   Meurs M, 2016, PSYCHOSOM MED, V78, P233, DOI 10.1097/PSY.0000000000000255
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2010, DISCOV MED, V9, P112
   Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x
   Schmitz N, 2016, MOL PSYCHIAT
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008
   Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x
   Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Virtanen M, 2014, DIABETES CARE, V37, P2091, DOI 10.2337/dc13-2725
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939
NR 41
TC 9
Z9 9
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD OCT
PY 2016
VL 89
BP 85
EP 90
DI 10.1016/j.jpsychores.2016.08.011
PG 6
WC Psychiatry
SC Psychiatry
GA DX8HU
UT WOS:000384629500014
PM 27663115
DA 2019-01-08
ER

PT J
AU Coccaro, EF
   Drossos, T
   Phillipson, L
AF Coccaro, Emil F.
   Drossos, Tina
   Phillipson, Louis
TI HbA(1c) levels as a function of emotional regulation and emotional
   intelligence in patients with type 2 diabetes
SO PRIMARY CARE DIABETES
LA English
DT Article
DE T2D; HbA(1c); Emotional regulation; Emotional intelligence
ID GLYCEMIC CONTROL; INSULIN-RESISTANCE; GLUCOSE-LEVELS; DEPRESSION;
   ADULTS; HYPERGLYCEMIA; METAANALYSIS; ADHERENCE; DISTRESS; MELLITUS
AB Aims: Understanding the role of emotion in glycemic control may be critical for the long-term treatment of patients with type 2 diabetes (T2D). In this study we investigated the relationship between measures of emotional regulation and emotional intelligence and HbA(1c) levels in adult patients with T2 diabetes.
   Methods: 100 adult patients with T2 diabetes completed assessments of emotional regulation (i.e., affect intensity/lability) and emotional intelligence and were then correlated with HbA(1c) levels with several relevant covariates.
   Results: HbA(1c) levels were significantly associated with affect intensity (AI: r = .24, p = .018) and with emotional intelligence (EI: r = -.29, p = .004), but not affect lability. These results were the same even after adding income, state depression scores, insulin-dependent status, serum cholesterol, diabetes literacy and self-care as covariates (AI: beta = .33, p = .001; EI: beta = -.31, p = .002). Diabetes self-care, but not diabetes literacy, was also associated with HbA(1c) levels (beta = -.29, p = .003).
   Conclusions: These data suggest that aspects of emotional regulation and emotional intelligence play a role in glycemic control in adult patients with T2 diabetes and do so even in the context of several variables relevant to diabetes. If so, interventions that can reduce affect intensity and/or increase emotional intelligence may represent a new strategy in the glycemic control of adult patients with T2 diabetes. (C) 2016 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Coccaro, Emil F.; Drossos, Tina] Univ Chicago, Pritzker Sch Med, Dept Psychiat & Behav Neurosci, Clin Neurosci Res Unit, Chicago, IL 60637 USA.
   [Phillipson, Louis] Univ Chicago, Pritzker Sch Med, Endocrinol Sect, Kovler Diabet Ctr,Dept Med, Chicago, IL 60637 USA.
RP Coccaro, EF (reprint author), Univ Chicago, Dept Psychiat & Behav Neurosci, Clin Neurosci Res Unit, 5841 South Maryland Ave, Chicago, IL 60637 USA.
EM ecoccaro@bsd.uchicago.edu
FU University of Chicago's Institute for Translational Medicine (ITM);
   Kovler Diabetes Center at the University of Chicago
FX This work was supported in part by a pilot grant from the University of
   Chicago's Institute for Translational Medicine (ITM; Drs. Drossos and
   Coccaro) and from the Kovler Diabetes Center at the University of
   Chicago (Dr. Phillipson).
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Arigo D, 2015, CHRONIC ILLN, V11, P33, DOI 10.1177/1742395314531990
   Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x
   Beck A, 1993, BECK ANXIETY INVENTO
   Beck AT, 1996, BECK DEPRESSION INVE
   Coccaro EF, 2011, BIOL PSYCHIAT, V69, P1153, DOI 10.1016/j.biopsych.2011.02.032
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Erus G, 2015, DIABETES CARE, V38, P97, DOI 10.2337/dc14-1196
   GONDERFREDERICK LA, 1989, HEALTH PSYCHOL, V8, P45, DOI 10.1037//0278-6133.8.1.45
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Gross J. J., 1998, REV GEN PSYCHOL, V2, P271, DOI DOI 10.1037/1089-2680.2.3.271
   HARVEY PD, 1989, J CLIN PSYCHOL, V45, P786, DOI 10.1002/1097-4679(198909)45:5<786::AID-JCLP2270450515>3.0.CO;2-P
   Hughes AE, 2012, J PEDIATR PSYCHOL, V37, P925, DOI 10.1093/jpepsy/jss062
   Karachan T.F., 2009, TURK KLIN J MED SCI, V1, P16
   Kruyt ND, 2012, DIABETES TECHNOL THE, V14, P311, DOI 10.1089/dia.2011.0171
   Kumar R, 2008, AM J GERIAT PSYCHIAT, V16, P989, DOI 10.1097/JGP.0b013e31818b40fc
   LARSEN RJ, 1987, J RES PERS, V21, P1, DOI 10.1016/0092-6566(87)90023-7
   Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Morris JK, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.018
   Nath CR, 2001, DIABETES EDUCATOR, V27, P857, DOI 10.1177/014572170102700611
   Nef G., 2012, J PSYCHIATR RES, V46, P549
   Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901
   ORZI F, 1988, J CEREBR BLOOD F MET, V8, P346, DOI 10.1038/jcbfm.1988.70
   Padala PR, 2008, DIABETES RES CLIN PR, V79, P37, DOI 10.1016/j.diabres.2007.06.012
   Penckofer S, 2012, DIABETES TECHNOL THE, V14, P303, DOI 10.1089/dia.2011.0191
   Ravona-Springer R, 2012, J ALZHEIMERS DIS, V30, P299, DOI 10.3233/JAD-2012-120106
   SALOVEY P, 1995, EMOTION DISCLOSURE H, P125, DOI DOI 10.1037/10182-006
   Sanz CM, 2013, DIABETES CARE, V36, P1512, DOI 10.2337/dc12-1017
   Schopf V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00212
   Shen BJ, 2008, DIABETES CARE, V31, P1293, DOI 10.2337/dc07-1945
   Siddiqui S, 2014, DIABETES METAB SYND, V8, P62, DOI 10.1016/j.dsx.2013.06.010
   Stankovic Z, 2011, PSYCHIAT DANUB, V23, P34
   van Harten B, 2007, AGE AGEING, V36, P164, DOI 10.1093/ageing/afl180
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   WHO, 2012, GLOBAL STATUS REPORT
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 40
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD OCT
PY 2016
VL 10
IS 5
BP 334
EP 341
DI 10.1016/j.pcd.2016.05.006
PG 8
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA DW8ZQ
UT WOS:000383944400004
PM 27344533
DA 2019-01-08
ER

PT J
AU Barnacle, M
   Strand, MA
   Werremeyer, A
   Maack, B
   Petry, N
AF Barnacle, Mykell
   Strand, Mark A.
   Werremeyer, Amy
   Maack, Brody
   Petry, Natasha
TI Depression Screening in Diabetes Care to Improve Outcomes: Are We
   Meeting the Challenge?
SO DIABETES EDUCATOR
LA English
DT Article
ID BIDIRECTIONAL RELATIONSHIP; SOCIOECONOMIC-STATUS; GLYCEMIC CONTROL;
   POPULATION; DISTRESS; COHORT; PHQ-9; RISK
AB Purpose Evidence-based guidelines recommend regular depression screening among individuals with type 2 diabetes mellitus (T2DM). The purpose of this study is to examine depression screening patterns among a primary care population with T2DM, through use of the Patient Health Questionnaire-9 (PHQ-9).
   Methods In total, 1817 patients with T2DM were analyzed through a retrospective observational study at 2 sites, a regional health center and a federally qualified health center (FQHC). The T2DM sample was divided into those with and without a major depressive disorder (MDD) diagnosis. Depression screening rates and depression severity were assessed through the PHQ-9.
   Results Both sites had higher rates of PHQ-9 screening among individuals with a history of MDD (64.82%) vs those without MDD (11.39%). Individuals from the FQHC without a history of depression had a higher mean PHQ-9 score (10.11) than those with a previous MDD diagnosis at both RHS and FQHC (7.16 and 9.85, respectively).
   Conclusions Depression screening rates among individuals with diabetes and no history of MDD were remarkably low. Patients with diabetes but no MDD diagnosis who sought health care at a FQHC clinic had more depressive symptoms than those with a history of MDD at both sites. Individuals with diabetes and who have a MDD diagnosis are much more likely to receive regular depression screening than those without MDD, which leaves a substantial proportion of patients with undetected depression. Depression screening must be enhanced for all individuals with diabetes, particularly for low-income individuals and those without a previous diagnosis of MDD.
C1 [Barnacle, Mykell] North Dakota State Univ, Sch Nursing, POB 6050, Fargo, ND 58108 USA.
   [Strand, Mark A.; Werremeyer, Amy; Maack, Brody; Petry, Natasha] North Dakota State Univ, Dept Pharm Practice, Fargo, ND 58108 USA.
   [Strand, Mark A.] North Dakota State Univ, Masters Publ Hlth Program, Fargo, ND 58108 USA.
RP Barnacle, M (reprint author), North Dakota State Univ, Sch Nursing, POB 6050, Fargo, ND 58108 USA.
EM Mykell.barnacle@ndsu.edu
FU Dean of the College of Health Professions, North Dakota State University
FX Partial funding for this research was provided by the Dean of the
   College of Health Professions, North Dakota State University.
CR American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011
   Ascher-Svanum H, 2015, DIABETES THER, V6, P303, DOI 10.1007/s13300-015-0118-y
   Bhautesh DJ, 2013, PLOS ONE, V8
   Bowser DM, 2009, DIABETES EDUCATOR, V35, P966, DOI 10.1177/0145721709345164
   Brieler JA, 2016, FAM PRACT, V33, P30, DOI 10.1093/fampra/cmv100
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Chen PC, 2013, DIABETES CARE, V36, P376, DOI 10.2337/dc12-0473
   Ducat L, 2014, JAMA-J AM MED ASSOC, V312, P691, DOI 10.1001/jama.2014.8040
   Egede LE, 2007, J GEN INTERN MED, V22, P701, DOI 10.1007/s11606-007-0170-z
   Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3
   Kosidou K, 2011, J AFFECT DISORDERS, V134, P160, DOI 10.1016/j.jad.2011.05.024
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   National Center for Health Statistics, 2011, HLTH US 2011 SPEC FE
   Renn BN, 2011, CLIN PSYCHOL REV, V31, P1239, DOI 10.1016/j.cpr.2011.08.001
   Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922
   Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392
   Strand M. A., 2014, International Journal of Social Ecology and Sustainable Development (IJSESD), V5, P31, DOI 10.4018/ijsesd.2014010104
   Tanenbaum ML, 2013, J AFFECT DISORDERS, V150, P533, DOI 10.1016/j.jad.2013.01.029
   Trangle M, ICSI I CLIN SYST IMP
   Urbine TF, 2012, JNP-J NURSE PRACT, V8, P231, DOI 10.1016/j.nurpra.2011.09.003
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
   Werremeyer A, 2016, J PRIM CARE COMMUNIT, V7, P130, DOI 10.1177/2150131915627423
NR 22
TC 3
Z9 3
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD OCT
PY 2016
VL 42
IS 5
BP 646
EP 651
DI 10.1177/0145721716662917
PG 6
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA DW1KW
UT WOS:000383403100011
PM 27558266
DA 2019-01-08
ER

PT J
AU Wahl, AK
   Osborne, RH
   Langeland, E
   Wentzel-Larsen, T
   Mengshoel, AM
   Ribu, L
   Peersen, K
   Elsworth, GR
   Nolte, S
AF Wahl, Astrid K.
   Osborne, Richard H.
   Langeland, Eva
   Wentzel-Larsen, Tore
   Mengshoel, Anne Marit
   Ribu, Lis
   Peersen, Kari
   Elsworth, Gerald R.
   Nolte, Sandra
TI Making robust decisions about the impact of health education programs:
   Psychometric evaluation of the Health Education Impact Questionnaire
   (heiQ) in diverse patient groups in Norway
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Health Education Impact Questionnaire (heiQ); Self-management; Norway;
   Chronic disease; Confirmatory factor analysis (CFA)
ID SELF-MANAGEMENT INTERVENTIONS; CHRONIC DISEASE; MEASUREMENT INVARIANCE;
   OUTCOMES; EMPOWERMENT; ADAPTATION; PSORIASIS; SEVERITY; VALIDITY; PEOPLE
AB Objective: To undertake a rigorous psychometric evaluation of the widely used eight-scale heiQ version 2.0 (evaluating immediate effects of self-management interventions) in diverse patient groups in Norway.
   Methods: Cross-sectional survey data were collected from 1019 Norwegians. Data were extracted from studies among people with musculoskeletal disorders (n = 516), psoriasis (n = 254), heart disease (n = 97), and Type 2 diabetes (n = 152). To investigate the factorial validity of the Norwegian heiQ, confirmatory factor analyses (CFA) were carried out using Mplus.
   Results: One-factor model fit, without modifications, was acceptable for the Emotional distress scale. Only one correlated residual was required to be fitted in each of the other scales to achieve satisfactory model fit. The postulated highly restricted full eight-factor model (no cross-loadings, no correlated residuals) showed good fit to the data. Internal consistency was acceptable for most scales (0.72-0.90) but low for Self-monitoring and insight.
   Conclusion: This study of the Norwegian heiQ replicates the factor structure of the original Australian heiQ, using robust and highly restricted CFA procedures, demonstrating a clean independent clusters model structure. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Wahl, Astrid K.; Mengshoel, Anne Marit] Univ Oslo, Inst Hlth & Soc, Dept Hlth Sci, POB 1089, N-0317 Oslo, Norway.
   [Osborne, Richard H.; Elsworth, Gerald R.; Nolte, Sandra] Deakin Univ, Sch Hlth & Social Dev, Hlth Syst Improvement Unit, Geelong, Vic, Australia.
   [Langeland, Eva] Bergen Univ Coll, Fac Hlth & Social Sci, Bergen, Norway.
   [Wentzel-Larsen, Tore] Ctr Child & Adolescent Mental Hlth Eastern & Sout, Oslo, Norway.
   [Wentzel-Larsen, Tore] Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway.
   [Ribu, Lis] Oslo & Akershus Univ Coll Appl Sci, Fac Hlth Sci, Dept Nursing, Oslo, Norway.
   [Peersen, Kari] Vestfold Hosp Trust, Tonsberg, Norway.
   [Nolte, Sandra] Charite, Ctr Internal Med & Dermatol, Dept Psychosomat Med, Berlin, Germany.
RP Wahl, AK (reprint author), Univ Oslo, Inst Hlth & Soc, Dept Hlth Sci, POB 1089, N-0317 Oslo, Norway.
EM a.k.wahl@medisin.uio.no; richard.osborne@deakin.edu.au;
   langeland@hib.no; tore.wentzel-larsen@r-bup.no;
   a.m.mengshoel@medisin.uio.no; lis.ribu@hioa.no; kari.peersen@siv.no;
   gerald.elsworth@deakin.edu.au; sandra.nolte@charite.de
RI Nolte, Sandra/B-7498-2008
OI Nolte, Sandra/0000-0001-6185-9423; Osborne, Richard/0000-0002-9081-2699;
   Langeland, Eva/0000-0003-3594-2877
CR Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1
   [Anonymous], 2014, WHITE PAPER MELD ST
   Browne M. W., 1993, TESTING STRUCTURAL E
   Brunet J, 2015, QUAL LIFE RES, V24, P2375, DOI 10.1007/s11136-015-0972-0
   Buchbinder R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3468
   Elsworth G. R., 2015, SAGE OPEN MED
   Epstein J, 2015, J CLIN EPIDEMIOL, V68, P360, DOI 10.1016/j.jclinepi.2013.07.013
   Holmen H, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3882
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Jordan JE, 2007, MED J AUSTRALIA, V186, P84
   Larsen MH, 2014, BRIT J DERMATOL, V171, P1458, DOI 10.1111/bjd.13363
   Maunsell E, 2014, CANCER-AM CANCER SOC, V120, P3228, DOI 10.1002/cncr.28847
   McDonald R. P., 1999, TEST THEORY UNIFIED
   Morita R, 2013, JPN J NURS SCI, V10, P255, DOI 10.1111/j.1742-7924.2012.00224.x
   Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2
   Nolte E., 2014, CONCEPTS APPROACHES
   Nolte S, 2007, PATIENT EDUC COUNS, V65, P351, DOI 10.1016/j.pec.2006.08.016
   Nolte S, 2013, QUAL LIFE RES, V22, P1805, DOI 10.1007/s11136-012-0302-8
   Nolte S, 2013, QUAL LIFE RES, V22, P1655, DOI 10.1007/s11136-012-0317-1
   Nolte S, 2009, J CLIN EPIDEMIOL, V62, P1173, DOI 10.1016/j.jclinepi.2009.01.021
   Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002
   Osborne RH, 2011, NURS CLIN N AM, V46, P255, DOI 10.1016/j.cnur.2011.05.010
   Richardson G, 2008, J EPIDEMIOL COMMUN H, V62, P361, DOI 10.1136/jech.2006.057430
   Schuler M, 2014, QUAL LIFE RES, V23, P2531, DOI 10.1007/s11136-014-0693-9
   Schuler M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-56
   Schuler M, 2013, QUAL LIFE RES, V22, P1391, DOI 10.1007/s11136-012-0268-6
   Torbjornsen A, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3535
   Wahl AK, 2015, ACTA DERM-VENEREOL, V95, P317, DOI 10.2340/00015555-1939
   Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641
NR 29
TC 6
Z9 6
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD OCT
PY 2016
VL 99
IS 10
BP 1733
EP 1738
DI 10.1016/j.pec.2016.05.001
PG 6
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA DW0VQ
UT WOS:000383361500026
PM 27211224
DA 2019-01-08
ER

PT J
AU Kuniss, N
   Kramer, G
   Muller, N
   Kloos, C
   Wolf, G
   Muller, UA
AF Kuniss, Nadine
   Kramer, Guido
   Mueller, Nicolle
   Kloos, Christof
   Wolf, Gunter
   Mueller, Ulrich Alfons
TI History of mild hypoglycaemia does not affect the prevalence of
   diabetes-related distress in people with diabetes
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Diabetes-related distress; Mild hypoglycaemia; PAID questionnaire
ID QUALITY-OF-LIFE; INSULIN THERAPY; TYPE-1; IMPACT; ADULTS; EVENTS; FEAR;
   ASSOCIATION; MANAGEMENT; AWARENESS
AB The occurrence of hypoglycaemia is assumed to be associated with increased diabetes-related distress. We investigated the association of mild hypoglycaemia (MH) with diabetes-related distress in a large outpatient cohort with diabetes type 1 (DM1) and type 2 (DM2).
   In a cross-sectional study, we recorded MH and simultaneously assessed diabetes-related distress with the PAID questionnaire in 783 people with diabetes [female 43.8 %, age 63.7 years, duration of diabetes 17.3 years, HbA1c 7.0 % (53 mmol/mol)] in an university outpatient department for metabolic diseases over a period of three months. Participants with and without MH were compared.
   People with DM1 (n = 191) had 1.09 MH per week. Diabetes-related distress was not different comparing people with DM1 with (n = 125) and without (n = 66) MH (PAID score 18.4 +/- 16.2 vs. 16.6 +/- 15.0, p = 0.449). The frequency of MH per week in people with DM2 on oral antidiabetic therapy (n = 182) and with insulin therapy (n = 410) is low (0.03 vs. 0.1 episodes). People with DM2 on insulin therapy with (n = 72) and without (n = 338) MH have a comparable PAID score (17.9 +/- 13.3 vs. 16.8 +/- 14.9, p = 0.552). 14.4 % of those with DM1 as well as 12.5 % of those with DM2 on insulin feel hypoglycaemic events to be a "somewhat serious problem" or "serious problem".
   In an outpatient setting, MH is not associated with increased diabetes-related distress or burden in people with DM1 or DM2.
C1 [Kuniss, Nadine; Kramer, Guido; Mueller, Nicolle; Kloos, Christof; Wolf, Gunter; Mueller, Ulrich Alfons] Jena Univ Hosp, Div Endocrinol & Metab Dis, Dept Internal Med 3, Bachstr 18, D-07743 Jena, Germany.
RP Kuniss, N (reprint author), Jena Univ Hosp, Div Endocrinol & Metab Dis, Dept Internal Med 3, Bachstr 18, D-07743 Jena, Germany.
EM nadine.kuniss@med.uni-jena.de
CR Bohme P, 2013, DIABETES METAB, V39, P63, DOI 10.1016/j.diabet.2012.10.006
   Brod M, 2013, DIABETES OBES METAB, V15, P546, DOI 10.1111/dom.12070
   Davis RE, 2005, CURR MED RES OPIN, V21, P1477, DOI 10.1185/030079905X61929
   Evans M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-90
   Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852
   Fulcher Gregory, 2014, J Med Econ, V17, P751, DOI 10.3111/13696998.2014.946992
   German Diabetes Association (DDG), 2015, GUID REC TREATM I CE
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   Green AJ, 2012, DIABETES RES CLIN PR, V96, P313, DOI 10.1016/j.diabres.2012.01.002
   Harris S, 2014, CAN J DIABETES, V38, P45, DOI 10.1016/j.jcjd.2013.09.001
   Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Hermanns N, 2007, DIABETES-METAB RES, V23, P528, DOI 10.1002/dmrr.710
   Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392
   Kovacs BK, 2013, DIABETIC MED, V30, P778, DOI DOI 10.1111/DME.12239
   Lopez JMS, 2014, PATIENT PREFER ADHER, V8, P683, DOI 10.2147/PPA.S58813
   Martyn-Nemeth P, 2014, ACTA DIABETOL, V51, P683, DOI 10.1007/s00592-014-0575-1
   Muller N, 2013, PATIENT EDUC COUNS, V93, P108, DOI 10.1016/j.pec.2013.05.008
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nicolucci A, 2015, ACTA DIABETOL, V52, P677, DOI 10.1007/s00592-015-0717-0
   Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987
   Pettersson B, 2011, DIABETES RES CLIN PR, V92, P19, DOI 10.1016/j.diabres.2010.12.005
   Rondags SMPA, 2016, DIABETIC MED, V33, P184, DOI 10.1111/dme.12876
   Samann A, 2005, DIABETOLOGIA, V48, P1965, DOI 10.1007/s00125-005-1905-1
   Schachinger H, 2005, J BEHAV MED, V28, P587, DOI 10.1007/s10865-005-9026-3
   Schumann M., 2013, ELECT MED INFORM SYS
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Sejling AS, 2016, DIABETIC MED, V33, P77, DOI 10.1111/dme.12810
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]
   Trento M, 2014, ACTA DIABETOL, V51, P509, DOI 10.1007/s00592-013-0530-6
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Yeoh E, 2015, DIABETES CARE, V38, P1592, DOI 10.2337/dc15-0102
NR 34
TC 2
Z9 2
U1 0
U2 5
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD OCT
PY 2016
VL 53
IS 5
BP 833
EP 838
DI 10.1007/s00592-016-0881-x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DV5CD
UT WOS:000382942400018
PM 27421991
DA 2019-01-08
ER

PT J
AU Perkins, JM
   Lee, HY
   James, KS
   Oh, J
   Krishna, A
   Heo, J
   Lee, JK
   Subramanian, SV
AF Perkins, Jessica M.
   Lee, Hwa-Young
   James, K. S.
   Oh, Juhwan
   Krishna, Aditi
   Heo, Jongho
   Lee, Jong-koo
   Subramanian, S. V.
TI Marital status, widowhood duration, gender and health outcomes: a
   cross-sectional study among older adults in India
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Widowhood; Aging; India; Gender; Self-rated health; Chronic disease;
   Cognition; Psychological distress
ID CARDIOVASCULAR RISK-FACTORS; LATER LIFE; LONGITUDINAL ANALYSIS;
   SOCIOECONOMIC-STATUS; DEPRESSIVE SYMPTOMS; MORTALITY; MARRIAGE;
   SELECTION; CHINESE; WOMEN
AB Background: Previous research has demonstrated health benefits of marriage and the potential for worse outcomes during widowhood in some populations. However, few studies have assessed the relevance of widowhood and widowhood duration to a variety of health-related outcomes and chronic diseases among older adults in India, and even fewer have examined these relationships stratified by gender.
   Methods: Using a cross-sectional representative sample of 9,615 adults aged 60 years or older from 7 states in diverse regions of India, we examine the relationship between widowhood and self-rated health, psychological distress, cognitive ability, and four chronic diseases before and after adjusting for demographic characteristics, socioeconomic status, living with children, and rural-urban location for men and women, separately. We then assess these associations when widowhood accounts for duration.
   Results: Being widowed as opposed to married was associated with worse health outcomes for women after adjusting for other explanatory factors. Widowhood in general was not associated with any outcomes for men except for cognitive ability, though men who were widowed within 0-4 years were at greater risk for diabetes compared to married men. Moreover, recently widowed women and women who were widowed long-term were more likely to experience psychological distress, worse self-rated health, and hypertension, even after adjusting for other explanatory variables, whereas women widowed 5-9 years were not, compared to married women.
   Conclusions: Gender, the duration of widowhood, and type of outcome are each relevant pieces of information when assessing the potential for widowhood to negatively impact health. Future research should explore how the mechanisms linking widowhood to health vary over the course of widowhood. Incorporating information about marital relationships into the design of intervention programs may help better target potential beneficiaries among older adults in India.
C1 [Perkins, Jessica M.; Subramanian, S. V.] Harvard TH Chan Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Boston, MA USA.
   [Perkins, Jessica M.] Massachusetts Gen Hosp, Massachusetts Ctr Global Hlth, Boston, MA 02114 USA.
   [Lee, Hwa-Young; Oh, Juhwan; Heo, Jongho; Lee, Jong-koo] Seoul Natl Univ, Coll Med, JW LEE Ctr Global Med, 71 Ihwajang Gil, Seoul 110810, South Korea.
   [James, K. S.] Jawaharlal Nehru Univ, New Delhi, India.
   [Krishna, Aditi; Subramanian, S. V.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA.
   [Heo, Jongho] San Diego State Univ, Publ Hlth Joint Doctoral Program, San Diego, CA 92182 USA.
   [Heo, Jongho] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Lee, Jong-koo] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea.
RP Lee, JK (reprint author), Seoul Natl Univ, Coll Med, JW LEE Ctr Global Med, 71 Ihwajang Gil, Seoul 110810, South Korea.; Lee, JK (reprint author), Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea.
EM docmohw@snu.ac.kr
OI Heo, Jongho/0000-0002-6405-3860
CR Agree E., 2003, ASIA PACIFIC POPULAT, V18, P53
   Ahmad N, 2009, WEB J CURR LEGAL ISS, V29, P1
   Alka R., 2001, EC POL WKLY, V36, P4088
   Basu S, 2013, AM J EPIDEMIOL, V178, P1620, DOI 10.1093/aje/kwt191
   Bennett KM, 2005, INT J GERIATR PSYCH, V20, P280, DOI 10.1002/gps.1280
   Bos AM, 2007, AGEING SOC, V27, P385, DOI 10.1017/S0144686X06005472
   Carr D., 2009, INT HDB POPULATION A, V1, P705, DOI DOI 10.1007/978-1-4020-8356-3_32
   Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x
   CHEN M, 1992, ECON POLIT WEEKLY, V27, pWS81
   CHEN M, 1995, ECON POLIT WEEKLY, V30, P2435
   Chen M., 1998, WIDOWS INDIA SOCIAL
   Chou KL, 2002, INT J AGING HUM DEV, V54, P1, DOI 10.2190/9K7T-6KXM-C0C6-3D64
   Dandavate P., 1989, WIDOWS ABANDONED DES, V4
   Denselow A, 2013, BBC NEWS
   Dey S, 2012, AGING ASIA FINDINGS, P371
   Dreze J, 1997, J DEV ECON, V54, P217, DOI 10.1016/S0304-3878(97)00041-2
   Dreze J., 1990, 26 DEP LOND SCH EC
   Dreze Jean, 1995, INDIA EC DEV SOCIAL
   FERRARO KF, 1984, J HEALTH SOC BEHAV, V25, P246, DOI 10.2307/2136423
   Ferraro KF, 1999, J GERONTOL B-PSYCHOL, V54, pS3, DOI 10.1093/geronb/54B.1.S3
   Fu HS, 1996, J MARRIAGE FAM, V58, P740, DOI 10.2307/353733
   Gallo LC, 2003, HEALTH PSYCHOL, V22, P453, DOI 10.1037/0278-6133.22.5.453
   GOLDBERG DP, 1970, BMJ-BRIT MED J, V2, P439, DOI 10.1136/bmj.2.5707.439
   Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   GOLDMAN N, 1995, SOC SCI MED, V40, P1717, DOI 10.1016/0277-9536(94)00281-W
   Gwatkin D. R., 2000, SOCIOECONOMIC DIFFER
   Hu B, 2012, J EPIDEMIOL, V22, P123, DOI 10.2188/jea.JE20100175
   HU YR, 1990, DEMOGRAPHY, V27, P233, DOI 10.2307/2061451
   Hughes ME, 2009, J HEALTH SOC BEHAV, V50, P344, DOI 10.1177/002214650905000307
   Jacob K S, 1997, Indian J Psychiatry, V39, P196
   Jang SN, 2009, SOC SCI MED, V69, P1608, DOI 10.1016/j.socscimed.2009.09.007
   Jensen R, 2005, ANALYSES IN THE ECONOMICS OF AGING, P357
   Johnson PS, 2001, VIOLENCE AGAINST WOM, V7, P1051, DOI 10.1177/10778010122182893
   Joung IMA, 1998, SOC SCI MED, V46, P425, DOI 10.1016/S0277-9536(97)00186-X
   Kadoya Y, 2015, J WOMEN AGING, V27, P59, DOI 10.1080/08952841.2014.928486
   Kim HK, 2002, J FAM ISSUES, V23, P885, DOI 10.1177/019251302237296
   Koball HL, 2010, J FAM ISSUES, V31, P1019, DOI 10.1177/0192513X10365834
   Krochalk PC, 2008, AUSTRALAS J AGEING, V27, P26, DOI 10.1111/j.1741-6612.2007.00269.x
   Lamb S, 1999, CONTRIB INDIAN SOC, V33, P541, DOI 10.1177/006996679903300303
   LaPierre TA, 2009, FAM RELAT, V58, P404, DOI 10.1111/j.1741-3729.2009.00562.x
   Lee G, 2000, GENDER DIFFERENCES C
   Lee GR, 2007, RES AGING, V29, P56, DOI 10.1177/0164027506294098
   Lee GR, 2001, J GERONTOL B-PSYCHOL, V56, pS56, DOI 10.1093/geronb/56.1.S56
   Li LD, 2005, SOC SCI MED, V60, P637, DOI 10.1016/j.socscimed.2004.06.014
   Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013
   Liu H, 2008, J HEALTH SOC BEHAV, V49, P239, DOI 10.1177/002214650804900301
   LOPATA H, 1987, WIDOWS MIDDLE E ASIA, V1
   Lorenz FO, 2006, J HEALTH SOC BEHAV, V47, P111, DOI 10.1177/002214650604700202
   Ma C, 2000, PERPETUAL MOURNING W
   Manor O, 2003, SOC SCI MED, V56, P405, DOI 10.1016/S0277-9536(02)00046-1
   Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031
   Maselko J, 2009, J AM GERIATR SOC, V57, P2293, DOI 10.1111/j.1532-5415.2009.02555.x
   Meyler D, 2007, SOC SCI MED, V64, P2297, DOI 10.1016/j.socscimed.2007.02.007
   Mohindra KS, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-28
   Moon JR, 2014, J PUBLIC HEALTH-UK, V36, P382, DOI 10.1093/pubmed/fdt101
   Murray JE, 2000, DEMOGRAPHY, V37, P511, DOI 10.1353/dem.2000.0010
   Niswade J, 2015, RES POLITICAL SOCIOL, V23, P113
   PALMORE E, 1987, Journal of Cross-Cultural Gerontology, V2, P93, DOI 10.1007/BF00117178
   Pande R, 2015, PAK J GEND STUD, V10, P209
   Pandey MK, 2011, INT REV APPL EC, V26, P111
   Reddy P. A, 2004, PROBLEMS WIDOWS INDI
   Roy K, 2008, SOC SCI MED, V66, P1951, DOI 10.1016/j.socscimed.2008.01.015
   Samanta T, 2015, J GERONTOL B-PSYCHOL, V70, P937, DOI 10.1093/geronb/gbu164
   Sasson I, 2014, J GERONTOL B-PSYCHOL, V69, P135, DOI 10.1093/geronb/gbt058
   Schaan B, 2013, J GERONTOL B-PSYCHOL, V68, P431, DOI 10.1093/geronb/gbt015
   Sengupta Manisha, 2002, J Cross Cult Gerontol, V17, P313, DOI 10.1023/A:1023079219538
   Seow LSE, 2015, J CLIN GERONTOL GERI, V6, P125, DOI 10.1016/j.jcgg.2015.05.002
   Shidhaye R, 2010, INT J EPIDEMIOL, V39, P1510, DOI 10.1093/ije/dyq179
   Skirbekk V, 2012, P NATL ACAD SCI USA, V109, P770, DOI 10.1073/pnas.1112173109
   Speakman JR, 2007, AM J CLIN NUTR, V86, P316
   Sreerupa Rajan SI, 2010, J ETHNIC CULT DIVERS, V19, P287
   Stroebe M., 2001, REV GEN PSYCHOL, V5, P62, DOI [10.1037//1089-2680.5.1.62, DOI 10.1037/1089-2680.5.1.62]
   Sudha S, 2006, J CROSS-CULT GERONTO, V21, P103, DOI 10.1007/s10823-006-9027-x
   UMBERSON D, 1992, J HEALTH SOC BEHAV, V33, P10, DOI 10.2307/2136854
   UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S
   UNFPA, 2012, BUILD KNOWL BAS AG I
   United Nations, 2015, WORLD POP PROSP 2015
   Vable AM, 2015, AM J GERIAT PSYCHIAT, V23, P283, DOI 10.1016/j.jagp.2014.05.004
   van Gelder BM, 2006, J GERONTOL B-PSYCHOL, V61, pP213, DOI 10.1093/geronb/61.4.P213
   van Grootheest DS, 1999, SOC PSYCH PSYCH EPID, V34, P391, DOI 10.1007/s001270050160
   Williams BR, 2008, J PALLIAT MED, V11, P848, DOI 10.1089/jpm.2007.0190
   Williams K, 2004, J HEALTH SOC BEHAV, V45, P81, DOI 10.1177/002214650404500106
   Williams K, 2004, J GERONTOL B-PSYCHOL, V59, pS343, DOI 10.1093/geronb/59.6.S343
   Williams P, 1988, USERS GUIDE GEN HLTH
   Wu ZH, 2000, GERONTOLOGIST, V40, P228, DOI 10.1093/geront/40.2.228
   Zheng YF, 2014, J PUBLIC HEALTH-UK, V36, P104, DOI 10.1093/pubmed/fdt044
NR 87
TC 7
Z9 7
U1 4
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD SEP 30
PY 2016
VL 16
AR 1032
DI 10.1186/s12889-016-3682-9
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DX4UD
UT WOS:000384375700001
PM 27716203
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Blackmon, S
   Laham, K
   Taylor, J
   Kemppainen, J
AF Blackmon, Stephen
   Laham, Kelly
   Taylor, Julie
   Kemppainen, Jeanne
TI Dimensions of medication adherence in African Americans with type 2
   diabetes in rural North Carolina
SO JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
LA English
DT Article
DE Adherence; African American; beliefs; diabetes type 2
ID PATIENT ADHERENCE; BELIEFS; DISEASE
AB Purpose: Personal perceptions and beliefs are one of the least studied patient factors influencing medication adherence. This study explored adherence experiences of rural African Americans with type 2 diabetes in rural southeastern North Carolina.
   Methods: Social-ecological theory guided a mixed methods approach. The Morisky Medication Adherence Scale (MMAS) assessed adherence. Clinical variables (HgA1c, fasting glucose levels, current medications) were obtained from medical records. Pearson correlation coefficients examined associations between demographics, clinical variables, and MMAS scores. Narrative data obtained from open-ended questions were analyzed through content analysis.
   Results: The study enrolled 45 rural residents with longstanding type 2 diabetes (11 years, 31% on insulin). The majority of MMAS scores (63%) reflected low adherence (< 6); 30% averaged moderate adherence (6 to < 8). Males had poor metabolic control (HgA1c 9.0); female glycemic control was moderately good (7.2). Adherence was associated with having health insurance (r =.594, p =.001) and working for pay (r =.440, p =.05). Participants frequently underused medications without consulting a provider; financial limitations served as a major barrier. Perceptions that diabetes only occurs when "sugar is high" are inconsistent with the course of this chronic disease.
   Conclusions: High levels of nonadherence remain a major challenge for nursing care providers in economically distressed rural counties.
C1 [Blackmon, Stephen] Southeastern Hlth, Lumberton, NC USA.
   [Laham, Kelly; Taylor, Julie; Kemppainen, Jeanne] Univ North Carolina Wilmington, Sch Nursing, 601 S Coll Rd, Wilmington, NC 28403 USA.
RP Kemppainen, J (reprint author), Univ North Carolina Wilmington, Sch Nursing, 601 S Coll Rd, Wilmington, NC 28403 USA.
EM kemppainenj@uncw.edu
FU Irwin Belk Distinguished Professor Fund at the University of North
   Carolina Wilmington
FX This study was funded in part through the Irwin Belk Distinguished
   Professor Fund at the University of North Carolina Wilmington.
CR Aikens JE, 2009, DIABETES CARE, V32, P19, DOI 10.2337/dc08-1533
   Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX
   Catlin B., 2014, 2014 N CAROLINA COUN
   Centers for Disease Control and Prevention, 2013, DIAB PUBL HLTH RES
   DiMatteo MR, 2007, MED CARE, V45, P521, DOI 10.1097/MLR.0b013e318032937e
   Hill-Briggs F, 2005, HEALTH PSYCHOL, V24, P349, DOI 10.1037/0278-6133.24.4.349
   Hseih H.F., 2005, QUALITATIVE HLTH RES, V15, P1277, DOI DOI 10.1177/1049732305276687
   Huang ES, 2009, DIABETES CARE, V32, P311, DOI 10.2337/dc08-1307
   Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413
   Kirk J., 2011, N CAROLINA MED J, V75, P345
   Konen J., 2011, N CAROLINA MED J, V75, P373
   Mann DM, 2009, J BEHAV MED, V32, P278, DOI 10.1007/s10865-009-9202-y
   Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   North Carolina State Center for Health Statistics, 2015, TRENDS KEY HLTH IND
   Piette JD, 2006, PATIENT EDUC COUNS, V60, P41, DOI 10.1016/j.pec.2004.12.001
   Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927
   Sakthong P., 2009, ANN PHARMACOTHER, V43, P950
   Smalls Brittany L, 2015, Glob J Health Sci, V7, P171, DOI 10.5539/gjhs.v7n5p171
   United States Census Bureau, 2010, URB RUR CLASS
   Whittemore Robin, 2004, J Community Health Nurs, V21, P87, DOI 10.1207/s15327655jchn2102_03
   Young Laura A, 2011, N C Med J, V72, P383
NR 22
TC 1
Z9 1
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2327-6886
EI 2327-6924
J9 J AM ASSOC NURSE PRA
JI J. Am. Assoc. Nurs. Pract.
PD SEP
PY 2016
VL 28
IS 9
BP 479
EP 486
DI 10.1002/2327-6924.12354
PG 8
WC Health Care Sciences & Services; Nursing
SC Health Care Sciences & Services; Nursing
GA DZ1PS
UT WOS:000385610900004
PM 26990616
DA 2019-01-08
ER

PT J
AU Quinn, SM
   Ambrosino, JM
   Doyle, EA
   Weyman, K
   Tamborlane, WV
   Jastreboff, AM
AF Quinn, Sheila M.
   Ambrosino, Jodie M.
   Doyle, Elizabeth A.
   Weyman, K.
   Tamborlane, William V.
   Jastreboff, Ania M.
TI UTILITY OF PSYCHOLOGICAL SCREENING OF YOUNG ADULTS WITH TYPE 1 DIABETES
   TRANSITIONING TO ADULT PROVIDERS
SO ENDOCRINE PRACTICE
LA English
DT Article
ID PSYCHOMETRIC PROPERTIES; METABOLIC-CONTROL; EATING-DISORDERS;
   ADOLESCENTS; DEPRESSION; CARE; PREVALENCE; DISTRESS; MELLITUS; VALIDITY
AB Objective: Screening for depression, diabetes distress, and disordered eating in youth with type 1 diabetes (T1D) is recommended, as these comorbidities contribute to poor glycemic control. No consensus exists on which measures are optimal, and most previous studies have used nondis-ease-specific measures. We examined the utility of screening for these disorders using two disease-specific and one general measure at the time of transition from pediatric to adult care.
   Methods: Forty-three young adults from a T1D transition clinic completed the Patient Health Questionnaire, the Diabetes Distress Scale, and the Diabetes Eating Problem Survey-Revised. Chart review determined if clinicians noted similar symptoms during the year prior to transition. Metabolic data were also recorded.
   Results: Chart review identified 5 patients with depressive symptoms and 8 patients with diabetes distress. Screening identified 2 additional patients with depressive symptoms and 1 additional patient with diabetes distress. Of those noted to have symptomatic depression or diabetes distress on chart review, several subsequently screened negative on transition. Disordered eating was not detected by chart review, but 23.5% screened positive on transition. While depression, diabetes distress, and disordered eating positively correlated with glycated hemoglobin (HbA1c) (r = 0.31, P =.05; r = 0.40, P = .009; r = 0.63, P<.001, respectively), disordered eating accounted for the majority of observed variance (df = 1; F = 18.6; P<.001). Even though HbA1c was higher in patients with versus without disordered eating (P<.001), body mass index did not differ between the 2 groups (P = .51).
   Conclusion: In young adults with T1D, formal screening provides an opportunity to detect psychological problems, which, when treated, may help optimize metabolic control during the transition process.
C1 [Quinn, Sheila M.] Yale Sch Med, Dept Internal Med Primary Care, New Haven, CT USA.
   [Ambrosino, Jodie M.; Weyman, K.; Tamborlane, William V.; Jastreboff, Ania M.] Yale Sch Med, Pediat Endocrinol, Dept Pediat, New Haven, CT USA.
   Fairfield Univ, Sch Nursing, Fairfield, CT 06430 USA.
   [Jastreboff, Ania M.] Yale Sch Med, Dept Internal Med Endocrinol & Metab, New Haven, CT USA.
RP Jastreboff, AM (reprint author), 2 Church St South, New Haven, CT 06519 USA.
EM ania.jastreboff@yale.edu
CR Affenito SG, 1997, DIABETES CARE, V20, P182, DOI 10.2337/diacare.20.2.182
   [Anonymous], 2014, DIABETES CARE, V37, pS14, DOI DOI 10.2337/DC14-S014
   Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950
   Clements MA, 2016, PEDIATR DIABETES, V17, P327, DOI 10.1111/pedi.12295
   Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163
   Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x
   Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Markowitz JT, 2010, DIABETES CARE, V33, P495, DOI 10.2337/dc09-1890
   Ortiz MS, 2014, REV MED CHILE, V142, P451, DOI 10.4067/S0034-98872014000400006
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pyatak EA, 2014, DIABETIC MED, V31, P1615, DOI 10.1111/dme.12485
   Pyatak EA, 2013, DIABETIC MED, V30, P1140, DOI 10.1111/dme.12248
   Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601
   Sassmann H, 2015, DIABETIC MED, V32, P1641, DOI 10.1111/dme.12788
   Silverstein J, 2015, DIABETES CARE, V38, P2341, DOI 10.2337/dc15-0982
   Tse J, 2012, J ACAD NUTR DIET, V112, P1810, DOI 10.1016/j.jand.2012.06.359
   Wisting L, 2013, DIABETES CARE, V36, P2198, DOI 10.2337/dc12-2282
   Young V, 2013, DIABETIC MED, V30, P189, DOI 10.1111/j.1464-5491.2012.03771.x
NR 23
TC 2
Z9 2
U1 3
U2 8
PU AMER ASSOC CLINICAL ENDOCRINOLOGISTS
PI JACKSONVILLE
PA 245 RIVERSIDE AVENUE, STE 200, JACKSONVILLE, FL 32202 USA
SN 1530-891X
EI 1934-2403
J9 ENDOCR PRACT
JI Endocr. Pract.
PD SEP
PY 2016
VL 22
IS 9
BP 1104
EP 1110
DI 10.4158/EP151190.OR
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DX3NN
UT WOS:000384279900010
PM 27295017
DA 2019-01-08
ER

PT J
AU Burns, KK
   Holt, RIG
   Nicolucci, A
   Lucisano, G
   Skovlund, SE
   Comaschi, M
   Vallis, M
   Peyrot, M
AF Burns, K. Kovacs
   Holt, R. I. G.
   Nicolucci, A.
   Lucisano, G.
   Skovlund, S. E.
   Comaschi, M.
   Vallis, M.
   Peyrot, M.
TI Correlates of psychological outcomes among family members of people with
   diabetes in the second Diabetes Attitudes, Wishes and Needs (DAWN2)
   study
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; HEALTH; PERSPECTIVE; RESOURCES; GENDER; CARE
AB AimsTo conduct a second Diabetes Attitudes, Wishes and Needs (DAWN2) study, examining the experiences of family members caring for adults with diabetes in order to identify correlates of family member psychological outcomes (generic psychological well-being, perceived quality of life, and diabetes-related burden, impact and distress).
   MethodsA total of 2057 family members living with a person with diabetes and involved in their care participated in an online, telephone or in-person survey. Samples of 120 respondents were recruited in each of 17 countries. Significant (P < 0.05) correlates of psychological outcomes were identified by multi-level multiple regression.
   ResultsOutcomes were worse for family members not working because of diabetes or those who had other competing obligations. Outcomes were worse if the person with diabetes was not a partner or parent, used injected diabetes medication, or had more frequent hypoglycaemia. Outcomes were worse for family members who believed that diabetes was more severe, were more involved in diabetes care, had more conflict over diabetes care or were frustrated about not knowing how to help the person with diabetes. Outcomes were better for those who had greater support from others and felt they found good ways to help the person with diabetes. There were significant differences in outcomes among countries before and after adjustment for individual characteristics, and correlates of outcomes varied by country.
   ConclusionsSeveral modifiable risk and protective factors for family member psychological outcomes were identified in this study. Diabetes education and social support were associated with improved outcomes, especially if they were helpful in supporting people with diabetes.
C1 [Burns, K. Kovacs] Univ Alberta, Edmonton Clin Hlth Acad, Edmonton, AB, Canada.
   [Holt, R. I. G.] Univ Southampton, Human Dev & Hlth, Fac Med, Southampton, Hants, England.
   [Nicolucci, A.; Lucisano, G.] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy.
   [Skovlund, S. E.] Novo Nordisk, Copenhagen, Denmark.
   [Comaschi, M.] Ist Clin Ligure Alta Specialita GVM Care & Res, Rapallo, Italy.
   [Vallis, M.] Dalhousie Univ, Halifax, NS, Canada.
   [Peyrot, M.] Loyola Univ Maryland, Baltimore, MD USA.
RP Burns, KK (reprint author), Univ Alberta, Edmonton Clin Hlth Acad, Edmonton, AB, Canada.
EM kathy.kovacsburns@ualberta.ca
OI Vallis, Michael/0000-0002-0165-5936; Holt, Richard/0000-0001-8911-6744
FU Novo Nordisk
FX The DAWN2 study was funded by Novo Nordisk. Novo Nordisk assisted with
   planning and designing the DAWN2 study, in collaboration with national,
   regional and global partners, including the International Diabetes
   Federation, International Alliance of Patient Organizations and the
   International Steno Diabetes Center, the DAWN2 survey working group, the
   DAWN2 International Publication Planning Committee and Harris
   Interactive. Data collection was funded by Novo Nordisk but performed
   independently by Harris Interactive. Data analysis and the preparation
   of this publication were performed by members of the DAWN2 International
   Publication Planning Committee and manuscript authors. Medical writing
   and editorial support was provided by Bioscript Medical Ltd, with
   financial support from Novo Nordisk.
CR Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Beverly EA, 2008, HEALTH EDUC BEHAV, V35, P707, DOI 10.1177/1090198107299787
   Chisholm Vivienne, 2011, Clin Child Psychol Psychiatry, V16, P443, DOI 10.1177/1359104510373312
   Harper A, 1998, PSYCHOL MED, V28, P551
   Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242
   Holt RIG, 2016, DIABET MED
   Kim Y, 2007, J PAIN SYMPTOM MANAG, V34, P294, DOI 10.1016/j.jpainsymman.2006.11.012
   Kovacs BK, 2013, DIABETIC MED, V30, P778, DOI DOI 10.1111/DME.12239
   Miller TA, 2013, DIABETES METAB SYNDR, V6, P421, DOI 10.2147/DMSO.S36368
   Nicolucci A, 2016, DIABETIC MED, V33, P1194, DOI 10.1111/dme.13178
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Paddison C, 2010, EUR DIABETES NURS, V7, P29, DOI DOI 10.1002/EDN.152
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Pinquart M, 2006, J GERONTOL B-PSYCHOL, V61, pP33, DOI 10.1093/geronb/61.1.P33
   Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899
   Rosland AM, 2012, J BEHAV MED, V35, P221, DOI 10.1007/s10865-011-9354-4
   Singer J. D., 2003, APPL LONGITUDINAL DA
   Snijders T, 1999, MULTILEVEL ANAL INTR
   Stodberg R, 2007, J CLIN NURS, V16, P215, DOI 10.1111/j.1365-2702.2006.01797.x
   Sullivan-Bolyai S, 2014, DIABETES EDUCATOR, V40, P178, DOI 10.1177/0145721713520568
   TODAY Study Group, 2010, INT J OBES LOND, V34, P217
   Tsiouli E, 2013, CAN FAM PHYSICIAN, V59, P143
   White P, 2009, DIABETES EDUCATOR, V35, P810, DOI 10.1177/0145721709340930
   Williang I, 2015, INT DIAB FED C VANC
NR 24
TC 6
Z9 6
U1 1
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2016
VL 33
IS 9
BP 1184
EP 1193
DI 10.1111/dme.13136
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DV9RW
UT WOS:000383280100005
PM 27086909
DA 2019-01-08
ER

PT J
AU Nicolucci, A
   Burns, KK
   Holt, RIG
   Lucisano, G
   Skovlund, SE
   Kokoszka, A
   Benedetti, MM
   Peyrot, M
AF Nicolucci, A.
   Burns, K. Kovacs
   Holt, R. I. G.
   Lucisano, G.
   Skovlund, S. E.
   Kokoszka, A.
   Benedetti, M. Massi
   Peyrot, M.
TI Correlates of psychological outcomes in people with diabetes: results
   from the second Diabetes Attitudes, Wishes and Needs (DAWN2) study
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; PSYCHOSOCIAL PROBLEMS; GLYCEMIC CONTROL; US ADULTS;
   CARE; DISTRESS; INCENTIVES; DEPRESSION; MANAGEMENT; ADHERENCE
AB AimsTo assess country- and individual-level correlates of psychological outcomes, and differences among countries in the associations of individual characteristics with psychological outcomes among adults with diabetes.
   MethodsThe second Diabetes Attitudes, Wishes and Needs (DAWN2) study assessed self-reported characteristics of people with diabetes in 17 countries, including 1368 adults with Type 1 diabetes and 7228 with Type 2 diabetes. In each country, a sample of 500 adults, stratified by diabetes type and treatment, completed a questionnaire incorporating the validated WHO-5 wellbeing index, the WHOQOL-BREF, and the five-item Problem Areas in Diabetes Scale, as well as the newly developed Diabetes Impact on Life Dimensions that assessed impact ranging from very positive to very negative, with no impact as the midpoint. Multilevel regression analyses identified significant (P < 0.05) independent correlates of psychological outcomes.
   ResultsThere were significant variations in all outcomes across countries before adjustment for individual-level factors; adjustment reduced between-country disparities. Worse psychological outcomes were associated with more complications, incidence of hypoglycaemia, hypoglycaemic medication, perceived burden of diabetes, family conflict and experience of discrimination. Better psychological outcomes were associated with higher self-rated health, greater access to diabetes education and healthcare, and more psychosocial support from others. The associations of many factors with the outcomes were mediated by modifiable factors. The association of all factors with the outcomes varied across (interacted with) countries, highlighting the need for country-specific analyses.
   ConclusionsImprovements in modifiable risk factors (reductions in burden and increases in support) may lead to better psychological outcomes in adults with diabetes.
C1 [Nicolucci, A.; Lucisano, G.] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy.
   [Burns, K. Kovacs] Univ Alberta, Edmonton Clin Hlth Acad, Edmonton, AB, Canada.
   [Holt, R. I. G.] Univ Southampton, Human Dev & Hlth, Fac Med, Southampton, Hants, England.
   [Skovlund, S. E.] Novo Nordisk, Copenhagen, Denmark.
   [Kokoszka, A.] Med Univ Warsaw, Warsaw, Poland.
   [Benedetti, M. Massi] Univ Perugia, Perugia, Italy.
   [Peyrot, M.] Loyola Univ Maryland, Baltimore, MD USA.
RP Nicolucci, A (reprint author), Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy.
EM nicolucci@coresearch.it
RI Kokoszka, Andrzej/O-7454-2018
OI Kokoszka, Andrzej/0000-0003-4518-5494
FU Novo Nordisk
FX The DAWN2 study was funded by Novo Nordisk. Novo Nordisk assisted with
   planning and designing the DAWN2 study, in collaboration with national,
   regional and global partners, including the International Diabetes
   Federation, International Alliance of Patient Organizations and the
   international Steno Diabetes Centre, the DAWN2 survey working group, the
   DAWN2 International Publication Planning Committee (IPPC) and Harris
   Interactive. Data collection was funded by Novo Nordisk but performed
   independently by Harris Interactive. Data analysis and the preparation
   of this publication were performed by members of the DAWN2 IPPC and the
   manuscript authors. Medical writing and editorial support was provided
   by Bioscript Medical Ltd., with financial support from Novo Nordisk.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Burns KK, 2016, DIABETIC MED, V33, P1184, DOI 10.1111/dme.13136
   Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Dodd AH, 2009, CURR MED RES OPIN, V25, P1605, DOI 10.1185/03007990902973300
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fonda Stephanie J, 2009, J Diabetes Sci Technol, V3, P117
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Gulliford MC, 2007, DIABETIC MED, V24, P505, DOI 10.1111/j.1464-5491.2007.02090.x
   Harper A, 1998, PSYCHOL MED, V28, P551
   Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1.572
   Holt RIG, 2016, DIABETIC MED, V33, P1174, DOI 10.1111/dme.13109
   Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242
   Kovacs BK, 2013, DIABETIC MED, V30, P778, DOI DOI 10.1111/DME.12239
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Miller ME, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5444
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004
   Pan A, 2014, AM J EPIDEMIOL, V180, P254, DOI 10.1093/aje/kwu136
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   RUBIN RR, 1992, DIABETES CARE, V15, P1640, DOI 10.2337/diacare.15.11.1640
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Singer J. D., 2003, APPL LONGITUDINAL DA
   Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0
   Thorpe CT, 2013, DIABETES EDUCATOR, V39, P33, DOI 10.1177/0145721712464400
   Vaghela P, 2009, DIABETES CARE, V32, P427, DOI 10.2337/dc08-1999
   World Health Organization, 2015, GEND WOM MENT HLTH
   World Health Organization (WHO), 2014, MENT HLTH STRENGTH O
NR 32
TC 8
Z9 8
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2016
VL 33
IS 9
BP 1194
EP 1203
DI 10.1111/dme.13178
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DV9RW
UT WOS:000383280100006
PM 27353119
DA 2019-01-08
ER

PT J
AU Asakura, R
   Miyatake, N
   Mochimasu, KD
   Kurato, R
   Kuwana, S
AF Asakura, Rie
   Miyatake, Nobuyuki
   Mochimasu, Kazumi Dokai
   Kurato, Risa
   Kuwana, Susumu
TI Comparison of health-related quality of life between type 2 diabetic
   patients with and without locomotive syndrome
SO ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE
LA English
DT Article
DE Locomotive syndrome; Loco-check; Type 2 diabetes mellitus;
   Health-related quality of life (HRQOL)
ID PSYCHOLOGICAL DISTRESS; GENERAL-POPULATION; SCREENING SCALES; EUROQOL;
   EQ-5D; JAPAN
AB Objective The aim of this study was to compare health-related quality of life (HRQOL) between type 2 diabetic patients with and without locomotive syndrome, which is a risk for becoming bedridden because of deteriorating locomotive organs.
   Subjects and methods A total of 135 patients with type 2 diabetes mellitus (69.2 +/- 10.2 years) were enrolled in this cross-sectional study. HRQOL was evaluated by the Euro-QOL-5 (EQ-5D), and locomotive syndrome was evaluated by "loco-check,'' established the Japanese Orthopedic Association. Clinical data, such as anthropometric parameters, blood and urine examination results, blood pressure (BP), drug usage, and psychological distress, were analyzed.
   Results Average HbA1c in all patients was 7.2 +/- 1.0 %, and 74 patients (54.8 %) were identified as having the locomotive syndrome. EQ-5D scores were significantly lower in type 2 diabetic patients with locomotive syndrome than in those without locomotive syndrome, even after adjusting for age, sex, body mass index (BMI), and HbA1c. By the multiple regression analysis, locomotive syndrome and age were identified as determinant factors of HRQOL in type 2 diabetic patients. C
   Conclusion In type 2 diabetic patients, lower HRQOL was a characteristic feature of subjects with locomotive syndrome, even after adjusting for confounding factors. Prevention or management of locomotive syndrome may be beneficial for improving HRQOL in type 2 diabetic patients.
C1 [Asakura, Rie] Takamatsu City Off, Takamatsu, Kagawa 7608571, Japan.
   [Asakura, Rie; Miyatake, Nobuyuki; Mochimasu, Kazumi Dokai; Kurato, Risa] Kagawa Univ, Dept Hyg, Fac Med, Miki, Kagawa 7610793, Japan.
   [Kuwana, Susumu] Attached Takamatsu Municipal Hosp, Kagawa Med Off, Takamatsu, Kagawa 7611703, Japan.
RP Asakura, R (reprint author), Takamatsu City Off, Takamatsu, Kagawa 7608571, Japan.; Asakura, R (reprint author), Kagawa Univ, Dept Hyg, Fac Med, Miki, Kagawa 7610793, Japan.
EM asakura1127@med.kagawa-u.ac.jp
CR Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Ebihara C, 2013, J PHYS THER SCI, V28, P569
   Eiichi A, 2014, TREATMENT GUIDE DIAB, P24
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Goto A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000785
   Hirano K, 2013, MOD RHEUMATOL, V23, P939, DOI 10.1007/s10165-012-0770-2
   Iizuka Y, 2014, J ORTHOP SCI, V19, P786, DOI 10.1007/s00776-014-0602-7
   Ikeda S, 1999, J HLTH CARE SOC, V9, P83
   Ikegami N, 2001, IGAKU SHOIN, P45
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Myers VH, 2013, DIABETES CARE, V36, P1884, DOI 10.2337/dc12-1153
   Nakagoshi R, 2015, RIGAKURYOHO KAGAKU, V30, P557
   Nakamura K, 2008, J ORTHOP SCI, V13, P1, DOI 10.1007/s00776-007-1202-6
   Nakamura K, 2011, J ORTHOP SCI, V16, P489, DOI 10.1007/s00776-011-0108-5
   Porojan M, 2012, Rom J Intern Med, V50, P27
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x
   Saleh Farzana, 2015, BMC Res Notes, V8, P497, DOI 10.1186/s13104-015-1453-9
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
NR 20
TC 1
Z9 1
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1342-078X
EI 1347-4715
J9 ENVIRON HEALTH PREV
JI Environ. Health Prev.
PD SEP
PY 2016
VL 21
IS 5
BP 356
EP 360
DI 10.1007/s12199-016-0537-z
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DT2DG
UT WOS:000381290400010
PM 27146070
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Mota, NP
   Tsai, J
   Kirwin, PD
   Sareen, J
   Southwick, SM
   Pietrzak, RH
AF Mota, Natalie P.
   Tsai, Jack
   Kirwin, Paul D.
   Sareen, Jitender
   Southwick, Steven M.
   Pietrzak, Robert H.
TI Purpose in Life is Associated with a Reduced Risk of Incident Physical
   Disability in Aging US Military Veterans
SO AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
LA English
DT Article
DE physical disability; veterans; medical burden; purpose in life
ID DWELLING OLDER PERSONS; POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL
   LIMITATIONS; COGNITIVE IMPAIRMENT; POSITIVE PSYCHIATRY; DEPRESSIVE
   SYMPTOMS; NATIONAL-HEALTH; ADULTS; ONSET; METAANALYSIS
AB Objectives: The current study evaluated the incidence and determinants of physical disability in a contemporary, nationally representative sample of U.S. military veterans. Design, Setting, Participants: Data were analyzed from the National Health and Resilience in Veterans Study, a nationally representative, prospective cohort study of 1,686 veterans aged 55 years and older. Waves 1 and 2 were conducted in 2011 and 2013, respectively. Measurements: Potential determinants of incident disability in activities of daily living (ADL; e.g., bathing, dressing) and instrumental activities of daily living (IADL; e.g., food preparation, medication adherence) were assessed atWave 1, and included sociodemographic characteristics, and risk (e.g., medical conditions, psychiatric distress), and protective psychosocial (e.g., psychological resilience, purpose in life) factors. Results: The two-year incidence of any physical disability (ADL or IADL) among veterans aged 55 years and older was 11.5%, and the incidence of ADL and IADL disability was 3.0% and 11.4%, respectively. Older age, being married/cohabiting, and number of medical conditions-specifically, diabetes, heart attack, and chronic pain-were associated with an increased risk of any incident physical disability and incident IADL disability (adjusted odds ratio [AOR] range: 1.10-3.10). Retirement was associated with an increased risk of incident ADL disability (AOR: 7.53, 95% CI: 1.37-41.51). Purpose in life was found to be protective for incident IADL disability (AOR: 0.93, 95% CI: 0.87-0.99). Conclusions: Although greater medical burden is associated with increased incidence of physical disability in U.S. veterans, results of this study suggest that initiatives designed to foster greater purpose in life may help protect against the development of physical disability in this rapidly growing segment of the population.
C1 [Mota, Natalie P.] Univ Manitoba, Dept Clin Hlth Psychol, Winnipeg, MB, Canada.
   [Sareen, Jitender] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada.
   [Sareen, Jitender] Univ Manitoba, Dept Psychol, Winnipeg, MB, Canada.
   [Sareen, Jitender] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   [Tsai, Jack] USDA, New England Mental Illness Res Educ & Clin Ctr, Clin Neurosci Div, West Haven, CT USA.
   [Mota, Natalie P.; Kirwin, Paul D.; Southwick, Steven M.; Pietrzak, Robert H.] USDA, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div, West Haven, CT USA.
   [Mota, Natalie P.; Tsai, Jack; Kirwin, Paul D.; Sareen, Jitender; Southwick, Steven M.; Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA.
RP Mota, NP (reprint author), 817 Bannatyne Ave, Winnipeg, MB R3E 0W2, Canada.
EM natalie.mota@umanitoba.ca
FU U.S. Department of Veterans Affairs National Center for Posttraumatic
   Stress Disorder
FX This study was supported by the U.S. Department of Veterans Affairs
   National Center for Posttraumatic Stress Disorder and a private
   donation. These funding sources had no role in the design and conduct of
   the study; collection, management, analysis, and interpretation of the
   data; preparation, review, or approval of the manuscript; or decision to
   submit the manuscript for publication. The views and opinions expressed
   in this manuscript are those of the authors and do not necessarily
   represent the views of sponsoring organizations, agencies, or the U.S.
   government. Dr. Pietrzak is a scientific consultant to Cogstate for work
   that bears no relationship to the present study. Drs. Mota, Tsai,
   Kirwin, Sareen, and Southwick do not have any conflicts of interest.
CR Diaz-Ramos JA, 2012, J AM GERIATR SOC, V60, P384, DOI 10.1111/j.1532-5415.2011.03805.x
   Avlund K, 2004, ARCH GERONTOL GERIAT, V38, P85, DOI 10.1016/j.archger.2003.08.003
   Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x
   Boyle PA, 2010, AM J GERIAT PSYCHIAT, V18, P1093, DOI 10.1097/JGP.0b013e3181d6c259
   Boyle PA, 2010, ARCH GEN PSYCHIAT, V67, P304, DOI 10.1001/archgenpsychiatry.2009.208
   Boyle PA, 2009, PSYCHOSOM MED, V71, P574, DOI 10.1097/PSY.0b013e3181a5a7c0
   Byers AL, 2014, JAMA PSYCHIAT, V71, P540, DOI 10.1001/jamapsychiatry.2014.5
   Chen LY, 2013, J AM MED DIR ASSOC, V14, p[309, e9]
   Chochinov HM, 2005, J CLIN ONCOL, V23, P5520, DOI 10.1200/JCO.2005.08.391
   Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004
   Congressional Budget Office, 2010, NONP AN US C POT COS
   Covinsky KE, 2010, J AM GERIATR SOC, V58, P551, DOI 10.1111/j.1532-5415.2010.02723.x
   d'Orsi E, 2014, J AM GERIATR SOC, V62, P1630, DOI 10.1111/jgs.12990
   Eggermont LHP, 2014, J AM GERIATR SOC, V62, P1007, DOI 10.1111/jgs.12848
   Fanning JR, 2013, J PSYCHIATR RES, V47, P1766, DOI 10.1016/j.jpsychires.2013.07.015
   Friedman EM, 2007, HEALTH PSYCHOL, V26, P305, DOI 10.1037/0278-6133.26.3.305
   Gill TM, 2009, J AM GERIATR SOC, V57, P1850, DOI 10.1111/j.1532-5415.2009.02443.x
   Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596
   Hayase D., 2004, AUSTR OCCUPATIONAL T, V51, P192, DOI [doi: 10.1111/0440-1630.2004.00425.x, DOI 10.1111/J.1440-1630.2004.00425.X]
   Hirsch CH, 2012, AGE AGEING, V41, P155, DOI 10.1093/ageing/afr151
   Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029
   Hooker SA, 2014, J HEALTH PSYCHOL, V19, P3
   Ishida R, 2006, STRESS HEALTH, V22, P275, DOI 10.1002/smi.1095
   James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231
   Jeste DV, 2015, J CLIN PSYCHIAT, V76, P675, DOI 10.4088/JCP.14nr09599
   Jeste DV, 2013, BRIT J PSYCHIAT, V202, P81, DOI 10.1192/bjp.bp.112.110643
   Koenig HG, 2014, J PSYCHOSOM RES, V77, P135, DOI 10.1016/j.jpsychores.2014.05.002
   Leskinen R, 2013, AGE AGEING, V42, P508, DOI 10.1093/ageing/aft051
   Liu H, 2013, POPUL RES POLICY REV, V32, P103, DOI 10.1007/s11113-012-9259-0
   Macklai NS, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-3
   Marshall M., 2012, LOGOTHERAPY REVISITE
   McGuire LC, 2006, AM J GERIAT PSYCHIAT, V14, P36, DOI 10.1097/01.JGP.0000192502.10692.d6
   Mehta KM, 2002, J AM GERIATR SOC, V50, P1045, DOI 10.1046/j.1532-5415.2002.50259.x
   Oman D, 1999, AM J EPIDEMIOL, V150, P834
   Ostchega Y, 2000, J AM GERIATR SOC, V48, P1132, DOI 10.1111/j.1532-5415.2000.tb04791.x
   Pietrzak RH, 2013, DEPRESS ANXIETY, V30, P432, DOI 10.1002/da.22083
   Pinquart M, 2012, AGING MENT HEALTH, V16, P541, DOI 10.1080/13607863.2011.651434
   Shah RC, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-63
   Spiers NA, 2005, J GERONTOL A-BIOL, V60, P248, DOI 10.1093/gerona/60.2.248
   Steptoe A, 2014, CAN MED ASSOC J, V186, pE150, DOI 10.1503/cmaj.131155
   United States Census Bureau, 2010, VET STAT 2010 AM COM
   United States Department of Veterans Affairs, 2013, PROF VET 2011 DAT AM
   United States Department of Veterans Affairs, 2014, TABL 1L VETPOP2014 L
   van Gool CH, 2011, INT J EPIDEMIOL, V40, P1056, DOI 10.1093/ije/dyr009
   van Reekum CM, 2007, J COGNITIVE NEUROSCI, V19, P237, DOI 10.1162/jocn.2007.19.2.237
   WIENER JM, 1990, J GERONTOL, V45, pS229, DOI 10.1093/geronj/45.6.S229
   Wong E, 2013, LANCET DIABETES ENDO, V1, P106, DOI 10.1016/S2213-8587(13)70046-9
   Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690
NR 48
TC 5
Z9 5
U1 5
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1064-7481
EI 1545-7214
J9 AM J GERIAT PSYCHIAT
JI Am. J. Geriatr. Psychiatr.
PD SEP
PY 2016
VL 24
IS 9
BP 706
EP 714
DI 10.1016/j.jagp.2016.03.004
PG 9
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA FE9QC
UT WOS:000408537200008
PM 27160984
DA 2019-01-08
ER

PT J
AU Hilliard, ME
   Yi-Frazier, JP
   Hessler, D
   Butler, AM
   Anderson, BJ
   Jaser, S
AF Hilliard, Marisa E.
   Yi-Frazier, Joyce P.
   Hessler, Danielle
   Butler, Ashley M.
   Anderson, Barbara J.
   Jaser, Sarah
TI Stress and A1c Among People with Diabetes Across the Lifespan
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Stress; Glycemic control; Type 1 diabetes; Type 2 diabetes
ID AFRICAN-AMERICAN WOMEN; QUALITY-OF-LIFE; GLYCEMIC CONTROL;
   METABOLIC-CONTROL; MEDICATION ADHERENCE; DEPRESSIVE SYMPTOMS; EMOTIONAL
   DISTRESS; GLUCOSE-METABOLISM; PERCEIVED CONTROL; RANDOMIZED-TRIAL
AB Stress is known to negatively affect health and is a potentially serious barrier to diabetes-related health outcomes. This paper synthesizes what is known about stress and glycemic control among people with type 1 and type 2 diabetes across the lifespan. Chronic stress-especially in relation to living with diabetes-was most strongly associated with A1c, particularly among subgroups that face disproportionate stress, such as minority groups or adolescents/young adults. Mechanisms of the stress-A1c association include physiological, psychological, behavioral, and environmental links. Understanding the dimensions of stress as they relate to health in diabetes can be of significant clinical importance, and interventions targeting mechanisms that either exacerbate or buffer stress have reported modest improvements in A1c.
C1 [Hilliard, Marisa E.; Butler, Ashley M.; Anderson, Barbara J.] Baylor Coll Med, Dept Pediat, 1102 Bates Ave,Suite 940, Houston, TX 77004 USA.
   [Hilliard, Marisa E.; Butler, Ashley M.; Anderson, Barbara J.] Texas Childrens Hosp, 1102 Bates Ave,Suite 940, Houston, TX 77004 USA.
   [Yi-Frazier, Joyce P.] Seattle Childrens Res Inst, Seattle, WA 98101 USA.
   [Hessler, Danielle] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Jaser, Sarah] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA.
RP Hilliard, ME (reprint author), Baylor Coll Med, Dept Pediat, 1102 Bates Ave,Suite 940, Houston, TX 77004 USA.; Hilliard, ME (reprint author), Texas Childrens Hosp, 1102 Bates Ave,Suite 940, Houston, TX 77004 USA.
EM Marisa.hilliard@bcm.edu
OI Hilliard, Marisa/0000-0002-8813-629X
FU National Institutes of Health [1K12 DK097696]
FX Marisa E. Hilliard, Ashley M. Butler, and Barbara J. Anderson report
   grants from the National Institutes of Health (1K12 DK097696).
CR Abelson JL, 2008, BIOL PSYCHIAT, V64, P701, DOI 10.1016/j.biopsych.2008.05.007
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   [Anonymous], 2016, DIABETES CARE S1, pS1, DOI DOI 10.2337/DC16-S001
   Barone MTU, 2011, DIABETES RES CLIN PR, V91, P129, DOI 10.1016/j.diabres.2010.07.011
   Baucom KJW, 2015, HEALTH PSYCHOL, V34, P522, DOI 10.1037/hea0000219
   Berlin KS, 2012, J PEDIATR PSYCHOL, V37, P990, DOI 10.1093/jpepsy/jss080
   Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216
   CESANA G, 1985, J OCCUP ENVIRON MED, V27, P357, DOI 10.1097/00043764-198505000-00015
   Cryer PE, 2010, ENDOCRIN METAB CLIN, V39, P641, DOI 10.1016/j.ecl.2010.05.003
   Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532
   Cutrona CE, 2015, BRIT J HEALTH PSYCH, V20, P662, DOI 10.1111/bjhp.12120
   Davidson M, 2004, APPL NURS RES, V17, P72, DOI 10.1016/j.apnr.2004.02.006
   DeSalvo D, 2013, CURR DIABETES REP, V13, P657, DOI 10.1007/s11892-013-0398-4
   Diabetes Control Complications Trial Research Group, 1999, DIABETES, V44, P968
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2014, DIABETIC MED, V31, P739, DOI 10.1111/dme.12403
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2015, DIABETIC MED
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494
   Glei DA, 2007, PSYCHOSOM MED, V69, P769, DOI 10.1097/PSY.0b013e318157cba6
   GOLDSTON DB, 1995, HEALTH PSYCHOL, V14, P409, DOI 10.1037/0278-6133.14.5.409
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   GRIFFITH LS, 1990, INT J PSYCHIAT MED, V20, P365, DOI 10.2190/APH4-YMBG-NVRL-VLWD
   Hagger V, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0694-2
   Helgeson VS, 2010, HEALTH PSYCHOL, V29, P153, DOI 10.1037/a0018163
   Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Hilliard ME, 2013, HEALTH PSYCHOL, V32, P388, DOI 10.1037/a0027811
   Hilliard ME, 2012, CURR DIABETES REP, V12, P739, DOI 10.1007/s11892-012-0314-3
   Hood KK, 2009, PEDIATRICS, V124, pE1171, DOI 10.1542/peds.2009-0207
   Jaser SS, 2010, J PEDIATR PSYCHOL, V35, P738, DOI 10.1093/jpepsy/jsp098
   Johnson SR, 2013, DIABETOLOGIA, V56, P2392, DOI 10.1007/s00125-013-3007-9
   Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002
   Katz ML, 2014, PEDIATR DIABETES, V15, P142, DOI 10.1111/pedi.12065
   Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69
   Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962
   Koloverou E, 2014, HORM-INT J ENDOCRINO, V13, P509, DOI 10.14310/horm.2002.1492
   Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138
   Laraia BA, 2012, SOC SCI MED, V74, P1082, DOI 10.1016/j.socscimed.2011.11.036
   Lawes T, 2014, PEDIATR DIABETES, V15, P372, DOI 10.1111/pedi.12100
   Lloyd CE, 1999, DIABETES CARE, V22, P1278, DOI 10.2337/diacare.22.8.1278
   Mayberry LS, 2012, DIABETES CARE, V35, P1239, DOI 10.2337/dc11-2103
   McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Mochari-Greenberger H, 2016, TELEMED E-HEALTH, V22, P624, DOI 10.1089/tmj.2015.0231
   Naranjo D, 2015, CURR DIABETES REV, V11, P251, DOI 10.2174/1573399811666150421115846
   Perfect MM, 2010, STRESS HEALTH, V26, P61, DOI 10.1002/smi.1262
   Phan-Hug F, 2011, PEDIATR DIABETES, V12, P713, DOI 10.1111/j.1399-5448.2011.00770.x
   Piette JD, 2006, PATIENT EDUC COUNS, V60, P41, DOI 10.1016/j.pec.2004.12.001
   Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606
   Pouwer F, 2010, DISCOV MED, V9, P112
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899
   Rosenberg AR, 2015, J PEDIATR PSYCHOL, V40, P992, DOI 10.1093/jpepsy/jsv004
   Sherr J, 2012, DIABETES CARE, V35, P817, DOI 10.2337/dc11-2190
   Shichiri M, 2000, DIABETES CARE, V23, pB21
   Stark CS, 2013, DIABETES CARE, V36, P2271, DOI DOI 10.2337/DC12-2258
   Stenstrom U, 1995, GEN HOSP PSYCHIAT, V17, P433, DOI 10.1016/0163-8343(95)00059-3
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Sturt J, 2015, INT DIABETES NURS, V2, P40
   Sturt J, 2015, CURR DIABETES REP, V15, P1, DOI DOI 10.1007/S11892-015-0660-Z
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977
   Tran V, 2011, HEALTH PSYCHOL, V30, P212, DOI 10.1037/a0022378
   Truninger R, 2013, EXP CLIN ENDOCR DIAB, V121, P420, DOI 10.1055/s-0033-1347246
   Tsiouli E, 2013, CAN FAM PHYSICIAN, V59, P143
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   van Houtum L, 2015, ANN BEHAV MED, V49, P221, DOI 10.1007/s12160-014-9649-0
   Viner R, 1996, ARCH DIS CHILD, V74, P418, DOI 10.1136/adc.74.5.418
   Wagner JA, 2015, ETHNIC DIS, V23, P421
   Wagner JA, 2013, STRESS HEALTH, V29, P214, DOI 10.1002/smi.2449
   Walders-Abramson N, 2014, J PEDIATR-US, V165, P504, DOI 10.1016/j.jpeds.2014.05.020
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Whittemore R, 2012, NURS RES, V61, P395, DOI 10.1097/NNR.0b013e3182690a29
   Wiesli P, 2005, DIABETES CARE, V28, P1910, DOI 10.2337/diacare.28.8.1910
   Wiesli P, 2007, DIABETES CARE, V30, P1599, DOI 10.2337/dc06-2102
   Willi SM, 2015, PEDIATRICS, V135, P424, DOI 10.1542/peds.2014-1774
   Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613
   Xu WX, 2011, J OCCUP HEALTH, V53, P334, DOI 10.1539/joh.11-0023-OA
   Yi JP, 2008, BRIT J HEALTH PSYCH, V13, P311, DOI 10.1348/135910707X186994
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 88
TC 14
Z9 14
U1 5
U2 23
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD AUG
PY 2016
VL 16
IS 8
AR 67
DI 10.1007/s11892-016-0761-3
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DU1UR
UT WOS:000381995900001
PM 27287017
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Linden, K
   Sparud-Lundin, C
   Adolfsson, A
   Berg, M
AF Linden, Karolina
   Sparud-Lundin, Carina
   Adolfsson, Annsofie
   Berg, Marie
TI Well-Being and Diabetes Management in Early Pregnant Women with Type 1
   Diabetes Mellitus
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE type 1 diabetes mellitus; pregnancy; well-being; diabetes management
ID POPULATION-BASED COHORT; PSYCHOMETRIC PROPERTIES; COHERENCE SCALE;
   SWEDISH VERSION; PROBLEM-AREAS; HYPOGLYCEMIA; MOTHERHOOD; SENSE; CARE;
   QUESTIONNAIRE
AB This paper explores well-being and diabetes management in women with type 1 diabetes mellitus (DM) in early pregnancy and investigates associations among perceived well-being, diabetes management, and maternal characteristics. Questionnaires were answered by 168 Swedish women. Correlation analyses were conducted with Spearman's correlation coefficient (r(s)). The women reported relatively high scores of self-efficacy in diabetes management (SWE-DES-10: 3.91 (0.51)) and self-perceived health (excellent (6.5%), very good (42.3%), good (38.7%), fair (11.3%) and poor (1.2%)). Moderate scores were reported for general well-being (WBQ-12: 22.6 (5.7)) and sense of coherence (SOC-13: 68.9 (9.7), moderate/low scores for hypoglycemia fear (SWE-HFS 26.6 (11.8)) and low scores of diabetes-distress (SWE-PAID-20 27.1 (15.9)). A higher capability of self-efficacy in diabetes management showed positive correlations with self-perceived health (r(s) = 0.41, p < 0.0001) and well-being (r(s) = 0.34, p < 0.0001) as well as negative correlations with diabetes distress (r(s) = 0.51, p < 0.0001) and hypoglycemia worries (r(s) = 0.27, p = 0.0009). Women with HbA1c levels of <= 48 mmL/mol scored higher in the subscales "goal achievement" in SWE-DES (p = 0.0028) and "comprehensibility" in SOC (p = 0.016). Well-being and diabetes management could be supported by strengthening the women's capability to achieve glycemic goals and their comprehensibility in relation to the treatment. Further studies are needed to test this.
C1 [Linden, Karolina; Sparud-Lundin, Carina; Berg, Marie] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, S-40530 Gothenburg, Sweden.
   [Linden, Karolina; Sparud-Lundin, Carina; Berg, Marie] Univ Gothenburg, Ctr Person Centred Care GPCC, S-40530 Gothenburg, Sweden.
   [Adolfsson, Annsofie] Univ Orebro, Sch Hlth Sci, S-70182 Orebro, Sweden.
   [Adolfsson, Annsofie] Vestfold Univ Coll Southeast Norway, Dept Nursing Sci, Fac Hlth Sci, N-3603 Kongsberg, Norway.
RP Linden, K (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, S-40530 Gothenburg, Sweden.; Linden, K (reprint author), Univ Gothenburg, Ctr Person Centred Care GPCC, S-40530 Gothenburg, Sweden.
EM karolina.linden@gu.se; carina.s-lundin@fhs.gu.se;
   annsofie.adolfsson@oru.se; marie.berg@fhs.gu.se
FU Swedish Diabetes Association; University of Gothenburg Centre for
   Person-centred Care, Sweden; Health & Medical Care Committee of the
   Regional Executive Board, Region Vastra Gotaland, Sweden; University of
   Gothenburg Institute of Health and Care Sciences; Sahlgrenska Academy,
   Sweden
FX We gratefully acknowledge the contribution of the women who participated
   in this study. We thank all health care professionals who took part in
   the data collection making the study possible. The study has received
   funding from the Swedish Diabetes Association; University of Gothenburg
   Centre for Person-centred Care, Sweden; Health & Medical Care Committee
   of the Regional Executive Board, Region Vastra Gotaland, Sweden;
   University of Gothenburg Institute of Health and Care Sciences together
   with the Sahlgrenska Academy, Sweden.
CR Adolfsson A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-513
   Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Anderbro T, 2010, DIABETIC MED, V27, P1151, DOI 10.1111/j.1464-5491.2010.03078.x
   Anderbro T, 2008, PATIENT EDUC COUNS, V73, P127, DOI 10.1016/j.pec.2008.03.022
   ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z
   Azar M, 2013, MINERVA ENDOCRINOL, V38, P339
   Berg M, 2000, J PSYCHOSOM OBST GYN, V21, P39, DOI 10.3109/01674820009075607
   Berg M., 2012, WOMENS HLTH CARE, V1
   Berg M, 2005, J PERINAT EDUC, V14, P23, DOI 10.1624/105812405X57552
   Berg M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-27
   Bradley C., 2003, HLTH PSYCHOL RES
   Cohen J., 1988, STAT POWER ANAL BEHA, V2
   Debono Miguel, 2007, Psychol Health Med, V12, P545, DOI 10.1080/13548500701235740
   DiPietro JA, 2004, J PSYCHOSOM OBST GYN, V25, P189, DOI 10.1080/01674820400017830
   Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008
   Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085
   Glinianaia SV, 2012, DIABETOLOGIA, V55, P3193, DOI 10.1007/s00125-012-2721-z
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   King R, 2009, MIDWIFERY, V25, P126, DOI 10.1016/j.midw.2007.01.016
   Kinsley B, 2007, CLIN THER, V29, pS153, DOI 10.1016/j.clinthera.2007.12.015
   Klemetti MM, 2016, DIABETOLOGIA, V59, P92, DOI 10.1007/s00125-015-3787-1
   Langius A, 1996, Vard Nord Utveckl Forsk, V16, P28
   Leksell J, 2007, SCAND J CARING SCI, V21, P247, DOI 10.1111/j.1471-6712.2007.00463.x
   Lenhard MJ, 2014, J MATERN-FETAL NEO M, V27, P1270, DOI 10.3109/14767058.2013.864631
   Morrell CJ, 2013, J REPROD INFANT PSYC, V31, P512, DOI 10.1080/02646838.2013.835795
   Nelson AM, 2003, JOGNN, V32, P465, DOI 10.1177/0884217503255199
   Ozcan S, 2014, DIABETES RES CLIN PR, V106, P35, DOI 10.1016/j.diabres.2014.07.023
   Polit D. F., 2012, NURSING RES GENERATI, V9
   Pouwer F, 1999, DIABETES CARE, V22, P2004, DOI 10.2337/diacare.22.12.2004
   Rasmussen B, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-218
   Ringholm L, 2012, DIABETIC MED, V29, P558, DOI 10.1111/j.1464-5491.2012.03604.x
   Ringholm L, 2012, NAT REV ENDOCRINOL, V8, P659, DOI 10.1038/nrendo.2012.154
   Sigurthardottir AK, 2005, J CLIN NURS, V14, P301, DOI 10.1111/j.1365-2702.2004.01043.x
   Simkin P, 1996, J Obstet Gynecol Neonatal Nurs, V25, P247, DOI 10.1111/j.1552-6909.1996.tb02432.x
   Singh H, 2013, CURR DIABETES REP, V13, P869, DOI 10.1007/s11892-013-0417-5
   Sjostrom H, 2004, ACTA OBSTET GYN SCAN, V83, P1112, DOI 10.1111/j.0001-6349.2004.00153.x
   Smith T, IMPACT ALTERNATIVE R
   Stenhouse E, 2013, MIDWIFERY, V29, P148, DOI 10.1016/j.midw.2011.12.007
   Stenhouse E, 2011, MIDWIFERY, V27, P120, DOI 10.1016/j.midw.2009.06.004
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Tabaei BP, 2004, QUAL LIFE RES, V13, P1153, DOI 10.1023/B:QURE.0000031336.81580.52
   The National Board of Health and Welfare Pregnancies Deliveries and Newborn Infants, 2014, SWED MED BIRTH REG 1
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Wikblad K., 2005, SWEDISH VERSION DIAB
NR 44
TC 3
Z9 3
U1 0
U2 5
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG
PY 2016
VL 13
IS 8
AR 836
DI 10.3390/ijerph13080836
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA DU8KV
UT WOS:000382462900091
PM 27556476
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Tanenbaum, ML
   Kane, NS
   Kenowitz, J
   Gonzalez, JS
AF Tanenbaum, M. L.
   Kane, N. S.
   Kenowitz, J.
   Gonzalez, J. S.
TI Diabetes distress from the patient's perspective: Qualitative themes and
   treatment regimen differences among adults with type 2 diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes mellitus; Qualitative methods; Diabetes distress;
   Insulin-treated; Focus groups
ID FACTOR SURVEILLANCE SYSTEM; EDUCATION-PROGRAM; INSULIN THERAPY; US
   ADULTS; DEPRESSION; MANAGEMENT; ASSOCIATION; INITIATION; ADHERENCE;
   SCALE
AB Aims: To explore diabetes distress in a sample of adults with type 2 diabetes, treated and not treated with insulin.
   Methods: Six focus groups were conducted with 32 adults with type 2 diabetes, divided by treatment regimen (insulin-treated N = 15; 67% female; 60% black; 46% Hispanic; M age 54; M HbA1c 73 mmol/mol (8.8%); non-insulin-treated N = 17; 53% female; 65% black; 13% Hispanic; M age 58; M HbA1c 55 mmol/mol (72%)). A coding team transcribed and analyzed interviews to describe themes. Themes were then compared between groups and with existing diabetes distress measures.
   Results: Participants in both groups described a range of sources of diabetes distress, including lack of support/understanding from others, difficulties communicating with providers, and distress from the burden of lifestyle changes. Insulin-treated participants described significant emotional distress related to the burden of their insulin regimen. They were more likely to report physical burden related to diabetes; to describe feeling depressed as a result of diabetes; and to express distress related to challenges with glycemic control. Non-insulin-treated participants were more likely to discuss the burden of comorbid medical illnesses.
   Conclusions: Our data generate hypotheses for further study into the emotional burdens of diabetes for insulin-treated adults with type 2 diabetes and are in line with quantitative research documenting increased diabetes-related distress among insulin-treated individuals. Data describe needs, currently unmet by most models of care, for comprehensive assessment and tailored management of diabetes-related distress. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Tanenbaum, M. L.] Stanford Univ, Sch Med, Dept Pediat, 780 Welch Rd, Palo Alto, CA 94304 USA.
   [Kane, N. S.; Kenowitz, J.; Gonzalez, J. S.] Yeshiva Univ, Ferkauf Grad Sch Psychol, 1300 Morris Pk Ave,Rousso Bldg, Bronx, NY 10461 USA.
   [Gonzalez, J. S.] Albert Einstein Coll Med, Diabet Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
RP Gonzalez, JS (reprint author), Yeshiva Univ, Ferkauf Grad Sch Psychol, 1300 Morris Pk Ave,Rousso Bldg, Bronx, NY 10461 USA.
EM mollyt@stanford.edu; naomiskane@gmail.com; joslyn.kenowitz@gmail.com;
   jeffrey.gonzalez@einstein.yu.edu
FU Einstein Diabetes Research Center [P60 DK020541]; National Institutes of
   Health [R01 DK104845, R18 DK098742]
FX This study was partially supported by a pilot and feasibility grant from
   the Einstein Diabetes Research Center (P60 DK020541). Dr. Gonzalez is
   supported by grants R01 DK104845 and R18 DK098742 from the National
   Institutes of Health.
CR Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Caballero E, 2004, DIABETES, V53, pA514
   Cabassa LJ, 2008, SOC SCI MED, V66, P2413, DOI 10.1016/j.socscimed.2008.01.054
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218
   Davies MJ, 2013, DIABETIC MED, V30, P512, DOI 10.1111/dme.12128
   Garcia JGD, 2007, SOC SCI MED, V64, P2223, DOI 10.1016/j.socscimed.2007.02.001
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hermanns N, 2012, PATIENT EDUC COUNS, V86, P226, DOI 10.1016/j.pec.2011.05.017
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392
   Holmes-Truscott E, 2015, DIABETIC MED, V32, P1297, DOI 10.1111/dme.12729
   Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154
   Li CY, 2012, J DIABETES COMPLICAT, V26, P17, DOI 10.1016/j.jdiacomp.2011.11.005
   Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912
   Patton MQ, 1999, HEALTH SERV RES, V34, P1189
   Peyrot Mark, 2010, Prim Care Diabetes, V4 Suppl 1, pS11, DOI 10.1016/S1751-9918(10)60004-6
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   QSR International, 2010, NVIVO QUAL DAT AN SO
   Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399
   Russell Cynthia K, 2003, Evid Based Nurs, V6, P36
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
NR 36
TC 6
Z9 6
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD AUG
PY 2016
VL 30
IS 6
BP 1060
EP 1068
DI 10.1016/j.jdiacomp.2016.04.023
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DS2FY
UT WOS:000380579000014
PM 27217023
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Fisher, L
   Hessler, D
   Polonsky, W
   Strycker, L
   Masharani, U
   Peters, A
AF Fisher, Lawrence
   Hessler, Danielle
   Polonsky, William
   Strycker, Lisa
   Masharani, Umesh
   Peters, Anne
TI Diabetes distress in adults with type 1 diabetes: Prevalence, incidence
   and change over time
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes distress; Prevalence; Incidence; Change over time; Predictors
   of change
ID CLINICALLY IMPORTANT DIFFERENCE; EMOTIONAL DISTRESS; DEPRESSION; CARE
AB Aims: To document the prevalence and 9-month incidence of elevated diabetes distress (DD) and the stability of DD over time using both single threshold and minimal clinically important differences (MCID) approaches.
   Methods: Adults with type 1 diabetes (T1D) (N = 224) completed the 28-item T1-Diabetes Distress Scale (T1-DDS) at baseline and 9 months. A T1-DDS threshold was identified with spline analysis and MCID was calculated from the standard error of measurement.
   Results: Analyses supported a cut-point of >= 2.0 for elevated DD. The prevalence and 9-month incidence of elevated DD was 42.1% and 54.4%, respectively. MCID was +/- 0.19 but varied by subscale (.26 to .50). Elevated DD was stable: only 20% crossed 2.0 over 9 months. MCID analyses showed that change also occurred among those who remained either below or above 2.0 over time. Change varied by source of distress, with Powerlessness the most prevalent and stable. Using MOD, only participant age, gender and number of complications predicted change.
   Conclusions: The prevalence, 9-month incidence and stability of elevated DD are high among adults with T1D, with change based on source of DD. We propose a combined cut-point/MCID framework for measuring change in DD, since each approach reflects unique characteristics of change over time. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Fisher, Lawrence; Hessler, Danielle] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Polonsky, William] Univ Calif San Diego, Dept Psychiat, San Diego, CA USA.
   [Polonsky, William] Behav Diabet Inst, San Diego, CA USA.
   [Strycker, Lisa] Oregon Res Inst, Eugene, OR USA.
   [Masharani, Umesh] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Peters, Anne] Univ So Calif, Los Angeles, CA USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
EM larry.fisher@ucsf.edu
OI Peters, Anne/0000-0003-0520-0776
FU National Institute of Diabetes, Digestive and Kidney Disease [DK094863]
FX DK094863 from the National Institute of Diabetes, Digestive and Kidney
   Disease.
CR ADA, 2015, DIABETES CARE S1, V38S, pS33
   Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2015, DIABETIC MED
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hilliard ME, 2013, DIABETES CARE, V36, P1891, DOI 10.2337/dc12-1708
   IBM Corp, 2010, SPSS STATISTICS FOR
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Marsh LC, 2002, SPLINE REGRESSION MO
   MOTULSKY HJ, 1987, FASEB J, V1, P365
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   Rai SK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0658-6
   Trief PM, 2014, DIABETES CARE, V37, P1563, DOI 10.2337/dc13-1867
NR 19
TC 17
Z9 17
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD AUG
PY 2016
VL 30
IS 6
BP 1123
EP 1128
DI 10.1016/j.jdiacomp.2016.03.032
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DS2FY
UT WOS:000380579000024
PM 27118163
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Zhu, YY
   Fish, AF
   Li, F
   Liu, L
   Lou, QQ
AF Zhu, Yuanyuan
   Fish, Anne F.
   Li, Fan
   Liu, Lin
   Lou, Qingqing
TI Psychosocial factors not metabolic control impact the quality of life
   among patients with type 2 diabetes in China
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Type 2 diabetes; Quality of life; Self-efficacy; Diabetes distress;
   Empowerment; China
ID SELF-EFFICACY; EMPOWERMENT SCALE; DISTRESS; PREVALENCE; MELLITUS; CARE;
   PERCEPTIONS; DEPRESSION; OUTCOMES; PEOPLE
AB Quality of life is a major focus of health care today. In published studies on patients with type 2 diabetes, findings on quality of life are mixed. Those with diabetes have chronic illness and must adhere to a complicated care regimen daily, which for many patients is challenging. This study analyzed psychosocial factors and metabolic control as potential predictors of quality of life among these patients.
   A cross-sectional study of 397 patients with type 2 diabetes was conducted in a hospital in Nanjing, China. Demographic information and clinical characteristics were collected from the medical record. The World Health Organization Quality of Life-BREF, General Self-Efficacy Scale, Diabetes Distress Scale, and Diabetes Empowerment Scale-Short Form were administered.
   The mean score of quality of life was 67.80 +/- 13.44 on a 100-point scale. General self-efficacy (beta = 0.340, P < 0.001), diabetes distress (beta = -0.266, P < 0.001), and diabetes empowerment ability (beta = 0.207, P < 0.001) were predictors of quality of life. In contrast, other factors including HbA1c, diabetes complications, and the duration of diabetes were not associated with quality of life (P > 0.05).
   Our study indicated that psychosocial factors such as self-efficacy, diabetes distress, and diabetes empowerment ability are related to quality of life. Assessment and interventions aimed at reducing psychosocial problems should be applied in diabetes care.
C1 [Zhu, Yuanyuan; Li, Fan; Liu, Lin; Lou, Qingqing] Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Jiangsu, Peoples R China.
   [Zhu, Yuanyuan; Li, Fan; Liu, Lin; Lou, Qingqing] Jiangsu Prov Acad Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.
   [Zhu, Yuanyuan] Nanjing Univ Chinese Med, Coll Nursing, Nanjing, Jiangsu, Peoples R China.
   [Fish, Anne F.] Univ Missouri, Coll Nursing, ISP Fellowship Support Program, St Louis, MO 63121 USA.
RP Lou, QQ (reprint author), Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Jiangsu, Peoples R China.; Lou, QQ (reprint author), Jiangsu Prov Acad Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.
EM lqq188@yahoo.com
CR Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   Anderson Robert M, 2009, Ther Patient Educ, V1, P3
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Carper MM, 2014, J BEHAV MED, V37, P501, DOI 10.1007/s10865-013-9505-x
   Celano CM, 2013, CURR DIABETES REP, V13, P917, DOI 10.1007/s11892-013-0430-8
   Chen MF, 2013, J COMMUN HEALTH NURS, V30, P201, DOI 10.1080/07370016.2013.838488
   Chew BH, 2014, WORLD J DIABETES, V5, P796, DOI 10.4239/wjd.v5.i6.796
   Critchley CR, 2012, DIABETES CARE, V35, P699, DOI 10.2337/dc11-1183
   Fal AM, 2011, ACTA DIABETOL, V48, P237, DOI 10.1007/s00592-010-0244-y
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Guo AM, 2002, CHIN J PUBLIC HLTH, V18, P849
   Hart HE, 2005, J CLIN EPIDEMIOL, V58, P1158, DOI 10.1016/j.jclinepi.2005.02.021
   [胡贝贝 Hu Beibei], 2011, [中华护理杂志, Chinese Journal of Nursing], V46, P225
   Jiang JW, 2011, SHANGHAI NURS, V11, P12
   Kolawole BA, 2009, AFR HEALTH SCI, V9, P161
   KUYKEN W, 1995, SOC SCI MED, V41, P1403
   Lu QC, 2014, J NURS TRAIN, V29, P783
   Ma GS, 2005, CHIN J PREV CONTROL, V13, P195
   Mashitani T, 2015, ACTA DIABETOL, V52, P639, DOI 10.1007/s00592-015-0725-0
   Matziou V, 2011, J DIABETES, V3, P82, DOI 10.1111/j.1753-0407.2010.00106.x
   Mngomezulu N, 2015, INT HEALTH, V7, P464, DOI 10.1093/inthealth/ihv019
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186
   Papelbaum M, 2010, DIABETES RES CLIN PR, V89, P227, DOI 10.1016/j.diabres.2010.05.024
   Penckofer S, 2012, DIABETES TECHNOL THE, V14, P303, DOI 10.1089/dia.2011.0191
   Raballo M, 2012, DIABETES CARE, V35, P242, DOI 10.2337/dc11-1495
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Schwarzer R, 1997, WORLD PSYCHOL, V3, P177
   Scollan-Koliopoulos M, 2013, DIABETES EDUCATOR, V39, P83, DOI 10.1177/0145721712467697
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Shrivastava U, 2016, J DIABETES, V8, P12, DOI 10.1111/1753-0407.12316
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029
   Tol Azar, 2015, J Educ Health Promot, V4, P13, DOI 10.4103/2277-9531.154022
   Tol Azar, 2015, J Educ Health Promot, V4, P9, DOI 10.4103/2277-9531.151903
   Trento M, 2015, ACTA DIABETOL, V52, P1157, DOI 10.1007/s00592-015-0806-0
   Wikblad K, 1996, QUAL LIFE RES, V5, P123, DOI 10.1007/BF00435977
   World Health Organization, 1999, DEF DIAGN CLASS DI 1
   Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118
   Yang Q., 2010, J NURSING CHINA, V17, P8
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   yuan-tao FJ-q Hao, 2000, MODERN REHABILITATIO, V4, P1127, DOI DOI 10.3321/J.ISSN:1673-8225.2000.08.002
   ZHANG JX, 1995, PSYCHOLOGIA, V38, P174
   [张文汉 ZHANG Wen-han], 2009, [中国全科医学, Chinese General Practice], V12, P166
   [张湘 Zhang Xiang], 2010, [中华高血压杂志, Chinese Journal of Hypertension], V18, P880
NR 51
TC 4
Z9 4
U1 0
U2 11
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD AUG
PY 2016
VL 53
IS 4
BP 535
EP 541
DI 10.1007/s00592-015-0832-y
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DR8FP
UT WOS:000380134100003
PM 26754324
DA 2019-01-08
ER

PT J
AU Hayashino, Y
   Okamura, S
   Tsujii, S
   Ishii, H
AF Hayashino, Yasuaki
   Okamura, Shintaro
   Tsujii, Satoru
   Ishii, Hitoshi
TI Association of serum uric acid levels with the risk of development or
   progression of albuminuria among Japanese patients with type 2 diabetes:
   a prospective cohort study [Diabetes Distress and Care Registry at Tenri
   (DDCRT 10)]
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Diabetes; Uric acid; Diabetic nephropathy; Kidney; Renal disease; Cohort
   study; Epidemiology; Adults
ID GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; GLYCEMIC CONTROL;
   CARDIOVASCULAR-DISEASE; EXCRETION RATE; HYPERURICEMIA; NEPHROPATHY;
   HYPERTENSION; MELLITUS; REGRESSION
AB To assess the prospective association between baseline serum uric acid level and subsequent risk of development or progression in albuminuria.
   Longitudinal data were obtained from 2518 patients with type 2 diabetes in the development cohort and registered in a Japanese diabetes registry. To assess the independent correlations between baseline serum uric acid quartiles and either the development or progression of diabetic nephropathy for 2 years, the Cox proportional hazards model was used and adjusted for potential confounders.
   The mean patient age, body mass index, and glycated hemoglobin (HbA1c) level were 66.1 years, 24.6 kg/m(2), and 7.5 % (57.6 mmol/mol), respectively. The baseline serum uric acid levels, with mean values of 3.6, 4.9, 5.8, and 7.3 mg/dL from the first to fourth quartiles, were significantly associated with the urinary albumin/creatinine ratio at baseline (p < 0.001). Baseline uric acid levels were not significantly associated with the development of nephropathy, but they were with the progression of nephropathy. The multivariable-adjusted hazards ratios for the progression from microalbuminuria to macroalbuminuria were 2.17 [95 % confidence interval (CI) 1.15-4.08; p = 0.016], 3.04 (95 % CI 1.67-5.53; p < 0.001), and 3.56 (95 % CI 1.83-6.93; p < 0.0011) for the first, third, and fourth quartiles of serum uric acid levels, respectively, as compared to that for the second quartile. We did not observe significant association between uric acid levels and change in estimated glomerular filtration rate.
   Low and high serum uric levels, independent of possible confounders, were associated with a subsequent risk of progression, not development, in albuminuria in type 2 diabetes patients. Therefore, serum uric acid levels may be useful for predicting the future risk of progression of microalbuminuria.
C1 [Hayashino, Yasuaki; Okamura, Shintaro; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
   [Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 6348521, Japan.
RP Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
EM hayasino-y@umin.net
OI Tsujii, Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and JSPS KAKENHI (Grant No. 25460641); however, they played
   no role in the study design or conduct, data collection, analysis, or
   interpretation, and the preparation, review, or approval of the
   manuscript. We would like to especially thank Yukari Moritsuji, Yuki
   Fujita, Noriko Nakamura, and Yoko Sakamoto (Department of Endocrinology,
   Tenri Hospital) for their clerical support. The authors would like to
   thank Enago (www.enago.jp) for the English language review.
CR AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858
   Bo S, 2001, EUR J CLIN INVEST, V31, P318, DOI 10.1046/j.1365-2362.2001.00812.x
   Brown ER, 2005, BIOMETRICS, V61, P64, DOI 10.1111/j.0006-341X.2005.030929.x
   Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399
   Domrongkitchaiporn S, 2005, J AM SOC NEPHROL, V16, P791, DOI 10.1681/ASN.2004030208
   DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716
   Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885
   Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227
   Fukui M, 2008, METABOLISM, V57, P625, DOI 10.1016/j.metabol.2007.12.005
   Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421
   Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257
   Hayashino Y, 2013, EXP CLIN ENDOCR DIAB, V121, P628, DOI 10.1055/s-0033-1355424
   Hayashino Y, 2014, DIABETES CARE, V37, P2947, DOI 10.2337/dc14-1357
   Hayashino Y, 2014, DIABETES CARE, V37, P2459, DOI 10.2337/dc13-2312
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6
   HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510
   Hovind P, 2009, DIABETES, V58, P1668, DOI 10.2337/db09-0014
   Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1053/j.ajkd.2004.06.006
   Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012
   Jalal DI, 2010, NEPHROL DIAL TRANSPL, V25, P1865, DOI 10.1093/ndt/gfp740
   Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5
   Johnson RJ, 1999, AM J KIDNEY DIS, V33, P225, DOI 10.1016/S0272-6386(99)70295-7
   Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x
   Lee SMK, 2009, AM J NEPHROL, V29, P79, DOI 10.1159/000151292
   Mashitani T, 2014, DIABETES CARE, V37, P252, DOI 10.2337/dc13-0407
   Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001
   Mene P, 2008, J HYPERTENS, V26, P2085, DOI 10.1097/HJH.0b013e32830e4945
   Molitch Mark E, 2004, Diabetes Care, V27 Suppl 1, pS79
   Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080
   Pan HZ, 2010, ACTA DIABETOL, V47, pS71, DOI 10.1007/s00592-009-0128-1
   Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506
   Rosolowsky ET, 2008, CLIN J AM SOC NEPHRO, V3, P706, DOI 10.2215/CJN.04271007
   Rossing P, 2006, DIABETOLOGIA, V49, P11, DOI 10.1007/s00125-005-0077-3
   Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y
   Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x
   Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x
   Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006
   Tanaka K, 2015, J DIABETES INVEST, V6, P98, DOI 10.1111/jdi.12243
   Tseng CH, 2005, KIDNEY INT, V68, P796, DOI 10.1111/j.1523-1755.2005.00459.x
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Wada T, 2014, CLIN EXP NEPHROL, V18, P613, DOI 10.1007/s10157-013-0879-4
   Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906
NR 45
TC 13
Z9 15
U1 1
U2 10
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD AUG
PY 2016
VL 53
IS 4
BP 599
EP 607
DI 10.1007/s00592-015-0825-x
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DR8FP
UT WOS:000380134100011
PM 26935413
DA 2019-01-08
ER

PT J
AU Linetzky, B
   Curtis, B
   Frechtel, G
   Montenegro, R
   Pulido, ME
   Stempa, O
   de Lana, JM
   Gagliardino, JJ
AF Linetzky, Bruno
   Curtis, Brad
   Frechtel, Gustavo
   Montenegro, Renan, Jr.
   Escalante Pulido, Miguel
   Stempa, Oded
   de Lana, Janaina Martins
   Jose Gagliardino, Juan
TI Challenges associated with insulin therapy progression among patients
   with type 2 diabetes: Latin American MOSAIc study baseline data
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Type 2 diabetes; Latin America; Observational study; Quality of care;
   Psychological impact; Diabetes knowledge; Diabetes self-care management;
   Insulin treatment; Diabetes education
ID GLYCEMIC CONTROL; RANDOMIZED-TRIAL; PRIMARY-CARE; MANAGEMENT; PEOPLE;
   QUALITY; GLUCOSE; INTERVENTION; MULTICENTER; COUNTRIES
AB Background: Poor glycemic control in patients with type 2 diabetes is commonly recorded worldwide; Latin America (LA) is not an exception. Barriers to intensifying insulin therapy and which barriers are most likely to negatively impact outcomes are not completely known. The objective was to identify barriers to insulin progression in individuals with type 2 diabetes mellitus (T2DM) in LA countries (Mexico, Brazil, and Argentina).
   Methods: MOSAIc is a multinational, non-interventional, prospective, observational study aiming to identify the patient-, physician-, and healthcare-based factors affecting insulin intensification. Eligible patients were >= 18 years, had T2DM, and were treated with insulin for >= 3 months with/without oral antidiabetic drugs (OADs). Demographic, clinical, and psychosocial data were collected at baseline and regular intervals during the 24-month follow-up period. This paper however, focuses on baseline data analysis. The association between glycated hemoglobin (HbA1c) and selected covariates was assessed.
   Results: A trend toward a higher level of HbA1c was observed in the LA versus non-LA population (8.40 +/- 2.79 versus 8.18 +/- 2.28; p <= 0.069). Significant differences were observed in clinical parameters, treatment patterns, and patient- reported outcomes in LA compared with the rest of the cohorts and between Mexico, Brazil, and Argentina. Higher number of insulin injections and lower number of OADs were used, whereas a lower level of knowledge and a higher level of diabetes-related distress were reported in LA. Covariates associated with HbA1c levels included age (-0.0129; p < 0.0001), number of OADs (0.0835; p = 0.0264), higher education level (-0.2261; p = 0.0101), healthy diet (-0.0555; p = 0.0083), self-monitoring blood glucose (-0.0512; p = 0.0033), hurried communication style in the process of care (0.1295; p = 0.0208), number of insulin injections (0.1616; p = 0.0088), adherence (-0.1939; p <= 0.0104), and not filling insulin prescription due to associated cost (0.2651; p = 0.0198).
   Conclusion: MOSAIc baseline data showed that insulin intensification in LA is not optimal and identified several conditions that significantly affect attaining appropriate HbA1c values. Tailored public health strategies, including education, should be developed to overcome such barriers.
C1 [Linetzky, Bruno] Eli Lilly & Co, Tronador 4890,Piso 12,C1430DNN Buenos Aires, Caba, Argentina.
   [Curtis, Brad] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.
   [Frechtel, Gustavo] Hosp Sirio Libanes, Serv Nutr & Diabet, Campana 4658,C1419HN Buenos Aires, Buenos Aires, DF, Argentina.
   [Montenegro, Renan, Jr.] Univ Fed Ceara, Sch Med, Rua Capitao Francisco Pedro 1290, BR-60430370 Fortaleza, Ceara, Brazil.
   [Escalante Pulido, Miguel] Ctr Med Occidente IMSS, Hosp Especialidades, Belisario Dominguez 1000,Piso 2, Guadalajara, Jalisco, Mexico.
   [Stempa, Oded] Eli Lilly & Co, Barranca Muerto 329-1, Mexico City 03900, DF, Mexico.
   [de Lana, Janaina Martins] Eli Lilly & Co, Av Morumbi 8-264, Sao Paulo, Brazil.
   [Jose Gagliardino, Juan] UNLP CONICET La Plata, CENEXA, Ctr Endocrinol Expt & Aplicada, Calle 60 & 120, La Plata, Buenos Aires, Argentina.
RP Linetzky, B (reprint author), Eli Lilly & Co, Tronador 4890,Piso 12,C1430DNN Buenos Aires, Caba, Argentina.
EM linetzky_bruno@lilly.com
FU Eli Lilly and Company
FX This study was sponsored by Eli Lilly and Company.
CR Ali MK, 2013, NEW ENGL J MED, V369, P287, DOI 10.1056/NEJMc1306652
   Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329
   Brown JB, 2003, AM J MANAG CARE, V9, P213
   Brownson CA, 2009, DIABETES EDUCATOR, V35, P761, DOI 10.1177/0145721709340931
   Buse JB, 2011, ANN INTERN MED, V154, P103, DOI 10.7326/0003-4819-154-2-201101180-00300
   Calvert MJ, 2007, BRIT J GEN PRACT, V57, P455
   Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435
   Commendatore V, 2013, INT J CLIN PRACT, V67, P1261, DOI 10.1111/ijcp.12208
   Davies MJ, 2013, DIABETIC MED, V30, P512, DOI 10.1111/dme.12128
   Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431
   Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8
   Escalante M, 2014, DIABETES RES CLIN PR, V104, P343, DOI 10.1016/j.diabres.2014.01.004
   Escobedo J, 2009, DIABETIC MED, V26, P864, DOI 10.1111/j.1464-5491.2009.02795.x
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Gagliardino JJ, 2013, DIABETIC MED, V30, P1102, DOI 10.1111/dme.12230
   Gagliardino JJ, 2001, DIABETES CARE, V24, P1001, DOI 10.2337/diacare.24.6.1001
   Gagliardino JJ, 2010, DIABETES RES CLIN PR, V88, P7, DOI 10.1016/j.diabres.2009.12.024
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   Gough S, 2006, DIABETES, V55, pA114
   Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337
   Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479
   Liu L, 2015, DIABETES-METAB RES, V31, P811, DOI 10.1002/dmrr.2757
   Lo-Ciganic WH, 2015, MED CARE, V53, P720, DOI 10.1097/MLR.0000000000000394
   McEwen LN, 2009, DIABETES CARE, V32, P971, DOI 10.2337/dc08-1911
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Philis-Tsimikas A, 2013, AM J MED, V126, pS21, DOI 10.1016/j.amjmed.2013.06.010
   Polinski JM, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-20
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260
   Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454
   Guzman JR, 2010, REV PANAM SALUD PUBL, V28, P463, DOI 10.1590/S1020-49892010001200008
   Shah S, 2013, DIABETES TECHNOL THE, V15, P954, DOI 10.1089/dia.2013.0074
   Stewart AL, 2007, HEALTH SERV RES, V42, P1235, DOI 10.1111/j.1475-6773.2006.00637.x
   Stewart GL, 2007, REV PANAM SALUD PUBL, V22, P12
   Teoh H, 2010, DIABETES CARE, V33, P2558, DOI 10.2337/dc10.0440
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trento M, 2010, DIABETES CARE, V33, P745, DOI 10.2337/dc09-2024
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695
   Wallace TM, 2000, QJM-MON J ASSOC PHYS, V93, P369, DOI 10.1093/qjmed/93.6.369
   Williams J, 2013, MED CARE, V51, P193, DOI 10.1097/MLR.0b013e318270dc52
   Yki-Jarvinen H, 2013, DIABETES CARE, V36, P3875, DOI 10.2337/dc12-2718
   Zoungas S, 2009, DIABETES CARE, V32, P2068, DOI 10.2337/dc09-0959
NR 44
TC 4
Z9 4
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD JUL 22
PY 2016
VL 8
AR 41
DI 10.1186/s13098-016-0157-1
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DR8LF
UT WOS:000380148700001
PM 27453733
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Jalowiec, A
   Grady, KL
   White-Williams, C
AF Jalowiec, Anne
   Grady, Kathleen L.
   White-Williams, Connie
TI Clinical outcomes in overweight heart transplant recipients
SO HEART & LUNG
LA English
DT Article
DE Overweight heart transplant patients; Obese heart transplant patients;
   Heart transplant outcomes; Heart transplant survival; Heart transplant
   hospitalization
ID QUALITY-OF-LIFE; CARDIAC ALLOGRAFT VASCULOPATHY; RISK-FACTORS;
   INTERNATIONAL SOCIETY; DIABETES-MELLITUS; PREOPERATIVE OBESITY; SYMPTOM
   DISTRESS; GRAFT FAILURE; PREDICTORS; SURVIVAL
AB Background: Few studies have examined the impact of patient weight on heart transplant (HT) outcomes.
   Objectives: Nine outcomes were compared in 2 groups of HT recipients (N = 347) based on their mean body mass index (BMI) during the first 3 years post-HT.
   Methods: Group 1 consisted of 108 non-overweight patients (BMI <25; mean age 52; 29.6% females; 16.7% minorities). Group 2 consisted of 239 overweight patients (BMI >= 25; mean age 52; 15.9% females; 13.8% minorities). Outcomes were: survival, re-hospitalization, rejections, infections, cardiac allograft vasculopathy (CAV), stroke, renal dysfunction, diabetes, and lymphoma.
   Results: Non-overweight patients had shorter survival, were re-hospitalized more days after the HT discharge, and had more lymphoma and severe renal dysfunction. Overweight patients had more CAV, steroid-induced diabetes, and acute rejections.
   Conclusions: Overweight HT patients had better survival, but more rejections, CAV, and diabetes. Non-overweight HT patients had worse survival, plus more re-hospitalization time, lymphoma, and renal dysfunction. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Jalowiec, Anne] Loyola Univ, Sch Nursing, Chicago, IL 60611 USA.
   [Grady, Kathleen L.] Northwestern Mem Hosp, Div Cardiac Surg, Bluhm Cardiovasc Inst, Ctr Heart Failure, Chicago, IL 60611 USA.
   [Grady, Kathleen L.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   [White-Williams, Connie] Univ Alabama Birmingham, Birmingham Hosp, Ctr Nursing Excellence, Birmingham, AL USA.
   [White-Williams, Connie] Univ Alabama Birmingham, Birmingham Sch Nursing, Birmingham, AL USA.
RP Jalowiec, A (reprint author), 346 North Deer Mt Rd, Florissant, CO 80816 USA.
EM ajalowiec@yahoo.com
OI White-Williams, Connie/0000-0002-1565-6200
FU National Institutes of Health (NINR) [NR01693, NR01693/S, 5R01-NR01693];
   National Institutes of Health (NHLBI) [HL49336]; Sandoz Pharmaceuticals
   Corporation; Earl Bane Estate; American Association of Critical Care
   Nurses; Sigma Theta Tau; Loyola University Research Committee; Loyola
   University School of Nursing; Loyola University Medical Center
FX National Institutes of Health (NINR: #NR01693, #NR01693/S,
   #5R01-NR01693; NHLBI: #HL49336), Sandoz Pharmaceuticals Corporation,
   Earl Bane Estate, American Association of Critical Care Nurses, Sigma
   Theta Tau, Loyola University Research Committee, Loyola University
   School of Nursing, Loyola University Medical Center.
CR Almenar L, 2005, TRANSPLANT P, V37, P4011, DOI 10.1016/j.transproceed.2005.09.160
   Augustine S M, 1998, J Transpl Coord, V8, P164
   Bedanova H, 2009, BIOMED PAP, V153, P283, DOI 10.5507/bp.2009.047
   Clark AL, 2007, EUR J HEART FAIL, V9, P839, DOI 10.1016/j.ejheart.2007.03.010
   Delgado JF, 2010, CLIN TRANSPLANT, V24, pE194, DOI 10.1111/j.1399-0012.2010.01249.x
   ESMORE D, 1991, J HEART LUNG TRANSPL, V10, P335
   FABBRI A, 1992, J HEART LUNG TRANSPL, V11, P701
   Grady K L, 1998, Am J Crit Care, V7, P106
   Grady K L, 1999, J Cardiovasc Nurs, V14, P12
   Grady K L, 1993, Cardiovasc Nurs, V29, P33
   Grady KL, 1996, J HEART LUNG TRANSPL, V15, P749
   Grady KL, 1999, J HEART LUNG TRANSPL, V18, P750, DOI 10.1016/S1053-2498(99)00035-2
   Grady KL, 1996, J HEART LUNG TRANSPL, V15, P863
   Grady KL, 2005, J HEART LUNG TRANSPL, V24, P1424, DOI 10.1016/j.healun.2004.08.010
   GRADY KL, 1995, J HEART LUNG TRANSPL, V14, P2
   Grady KL, 1999, J HEART LUNG TRANSPL, V18, P202, DOI 10.1016/S1053-2498(98)00048-5
   GRADY KL, 1992, HEART LUNG, V21, P434
   Grady KL, 1998, J HEART LUNG TRANSPL, V17, P383
   Rasco AG, 2010, TRANSPL P, V42, P3178, DOI 10.1016/j.transproceed.2010.05.139
   Hamour IM, 2009, NEPHROL DIAL TRANSPL, V24, P1655, DOI 10.1093/ndt/gfn759
   International Society for Heart and Lung Transplantation, 2015, REG DAT
   International Society for Heart and Lung Transplantation, 2010, REG DAT
   Jalowiec A, 1997, J HEART LUNG TRANSPL, V16, P604
   JALOWIEC A, 1994, BEHAV MED, V19, P145, DOI 10.1080/08964289.1994.9935185
   Jalowiec A, 2008, HEART LUNG, V37, P344, DOI 10.1016/j.hrtlng.2007.10.007
   Jalowiec A, 2007, NURS RES, V56, P260, DOI 10.1097/01.NNR.0000280612.83071.61
   Jalowiec A, 2007, J CARDIOPULM REHABIL, V27, P24
   Jalowiec A, 2012, J CARDIOVASC NURS, V27, P519, DOI 10.1097/JCN.0b013e31822ce6c9
   Jalowiec A, 2011, HEART LUNG, V40, P21, DOI 10.1016/j.hrtlng.2010.02.004
   Jalowiec Anne, 2006, Prog Cardiovasc Nurs, V21, P134, DOI 10.1111/j.0889-7204.2006.05565.x
   Kahn J, 2006, CLIN TRANSPLANT, V20, P62, DOI 10.1111/j.1399-0012.2005.00441.x
   Kilic A, 2012, ANN THORAC SURG, V93, P718, DOI 10.1016/j.athoracsur.2011.11.054
   Kobashigawa JA, 2006, J HEART LUNG TRANSPL, V25, P1063, DOI 10.1016/j.healun.2006.05.001
   Lietz K, 2001, TRANSPLANTATION, V72, P277, DOI 10.1097/00007890-200107270-00020
   Lietz K, 2001, CIRCULATION, V104, pI177
   Lund LH, 2015, J HEART LUNG TRANSPL, V34, P1244, DOI 10.1016/j.healun.2015.08.003
   Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006
   Martinez-Dolz L, 2005, TRANSPL P, V37, P4064, DOI 10.1016/j.transproceed.2005.09.161
   Mastrobuoni S, 2012, J CARDIOVASC SURG, V53, P677
   Milaniak I, 2014, TRANSPL P, V46, P2844, DOI 10.1016/j.transproceed.2014.09.025
   Jimenez MVM, 2008, TRANSPL P, V40, P3053, DOI 10.1016/j.transproceed.2008.09.045
   National Institutes of Health (NIH), 1998, CLIN GUID ID EV TREA
   Nieuwenhuis MG, 2001, J HEART LUNG TRANSPL, V20, P703, DOI 10.1016/S1053-2498(01)00257-1
   OPELZ G, 1993, LANCET, V342, P1514, DOI 10.1016/S0140-6736(05)80084-4
   Ramzy D, 2005, CAN J SURG, V48, P319
   Russo MJ, 2010, ANN SURG, V251, P144, DOI 10.1097/SLA.0b013e3181b5db3c
   Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002
   Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003
   Stehlik J, 2010, J HEART LUNG TRANSPL, V29, P1089, DOI 10.1016/j.healun.2010.08.007
   Thomas HL, 2012, TRANSPLANTATION, V93, P1151, DOI 10.1097/TP.0b013e31824e7620
   Valantine H, 2004, J HEART LUNG TRANSPL, V23, pS187, DOI 10.1016/j.healun.2004.03.009
   Weber DJ, 2014, CLIN TRANSPLANT, V28, P1279, DOI 10.1111/ctr.12460
   WECHSLER ME, 1995, CIRCULATION, V91, P1029, DOI 10.1161/01.CIR.91.4.1029
   White-Williams C, 2005, J HEART LUNG TRANSPL, V24, P2255, DOI 10.1016/j.healun.2005.08.006
   WINTERS GL, 1990, J HEART TRANSPLANT, V9, P364
   Ye XY, 2010, TRANSPLANTATION, V89, P1526, DOI 10.1097/TP.0b013e3181dd6bd9
NR 56
TC 2
Z9 2
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0147-9563
EI 1527-3288
J9 HEART LUNG
JI Heart Lung
PD JUL-AUG
PY 2016
VL 45
IS 4
BP 298
EP 304
DI 10.1016/j.hrtlng.2016.03.005
PG 7
WC Cardiac & Cardiovascular Systems; Nursing; Respiratory System
SC Cardiovascular System & Cardiology; Nursing; Respiratory System
GA DR4QN
UT WOS:000379887400002
PM 27086571
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Homko, C
   Siraj, ES
   Parkman, HP
AF Homko, Carol
   Siraj, Elias S.
   Parkman, Henry P.
TI The impact of gastroparesis on diabetes control: Patient perceptions
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Gastroparesis; Nausea; Vomiting; Diabetes; Diabetic gastroparesis
ID GASTROINTESTINAL SYMPTOMS; GLYCEMIC CONTROL; SELF-MANAGEMENT; MELLITUS;
   MOTILITY; DEPRESSION; SEVERITY; DISTRESS; ANXIETY; HBA(1C)
AB The impact of gastroparesis on diabetes management and control from the patient perspective has not been well characterized. The aim of this study was to identify patient perceptions regarding the impact of gastroparesis on managing their diabetes.
   Methods: Patients with diabetes being referred for gastroparesis were enrolled in this prospective study. Gastroparetic symptom severity was assessed with the Patient Assessment of Upper GI Symptoms (PAGI-SYM). A questionnaire examined the impact of gastroparesis on diabetes related symptoms and control.
   Results: 54 diabetic gastroparesis patients (36 T1DM, 18 T2DM) participated. Duration of diabetes averaged 17.4 +/- 1.4 years and gastroparetic symptoms 5.1 +/- 1.1 years. Patients rated their most severe symptoms as postprandial fullness, early satiety, and nausea. Two thirds of diabetic subjects identified that since their diagnosis of gastroparesis, their diabetes was more difficult to control (44 of 54 patients) and that extra time and effort were required for care of their diabetes (45 of 54). Patients with T1DM, compared to those with T2DM, more often expressed that since developing gastroparesis, their blood sugars have been higher, they have had more frequent episodes of hypoglycemia, and they found that their gastroparetic symptoms worsened if blood sugars were too high.
   Conclusions: Gastroparesis has a significant impact on patients' perceived ability to self-manage and control their diabetes. T1DM patients, in particular, associate their gastroparesis with episodes of hyper- and hypo-glycemia, and find their gastroparetic symptoms worsen with poor control. Future research should focus on strategies to support self-management of patients with diabetic gastroparesis. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Homko, Carol; Parkman, Henry P.] Temple Univ, Sch Med, Dept Med, Gastroenterol Sect, Philadelphia, PA 19122 USA.
   [Homko, Carol; Siraj, Elias S.] Temple Univ, Sch Med, Dept Med, Endocrinol Diabet & Metab, Philadelphia, PA 19122 USA.
RP Parkman, HP (reprint author), Temple Univ, Sch Med, Gastroenterol Sect, Parkinson Pavil,8th Floor,3401 North Broad St, Philadelphia, PA 19140 USA.
EM henry.parkman@temple.edu
CR Abell TL, 2008, AM J GASTROENTEROL, V103, P753, DOI 10.1111/j.1572-0241.2007.01636.x
   ANDREWS H, 1987, GUT, V28, P1600, DOI 10.1136/gut.28.12.1600
   Bharucha AE, 2015, CLIN GASTROENTEROL H, V13, P466, DOI 10.1016/j.cgh.2014.06.034
   Chang J, 2010, ENDOCRIN METAB CLIN, V39, P745, DOI 10.1016/j.ecl.2010.08.007
   Cherian D, 2012, NEUROGASTROENT MOTIL, V24, P217, DOI 10.1111/j.1365-2982.2011.01828.x
   de Kort S, 2012, DIABETES RES CLIN PR, V96, P248, DOI 10.1016/j.diabres.2012.01.021
   FRASER RJ, 1990, DIABETOLOGIA, V33, P675, DOI 10.1007/BF00400569
   Guirguis LM, 2007, J AM PHARM ASSOC, V47, P29, DOI 10.1331/1544-3191.47.1.29.Guirguis
   Hatwell T. S., 2002, DIABETES ED, V28, P99
   Heisler M, 2005, DIABETES CARE, V28, P816, DOI 10.2337/diacare.28.4.816
   Horowitz M, 2002, DIABETIC MED, V19, P177, DOI 10.1046/j.1464-5491.2002.00658.x
   HOROWITZ M, 1994, DIABETOLOGIA, V37, P543, DOI 10.1007/s001250050145
   Intagliata Nicolas, 2007, Curr Gastroenterol Rep, V9, P270, DOI 10.1007/s11894-007-0030-3
   Portney G., 2010, WATKINS FDN CLIN RES, P491
   Rayner CK, 2006, J CLIN INVEST, V116, P299, DOI 10.1172/JCI27758
   Rentz AM, 2004, QUAL LIFE RES, V13, P1737, DOI 10.1007/s11136-004-9567-x
   Revicki DA, 2004, QUAL LIFE RES, V13, P833, DOI 10.1023/B:QURE.0000021689.86296.e4
   Samsom M, 2003, DIABETES CARE, V26, P3116, DOI 10.2337/diacare.26.11.3116
   Schvarcz E, 1997, GASTROENTEROLOGY, V113, P60, DOI 10.1016/S0016-5085(97)70080-5
   Sogabe M, 2005, J GASTROENTEROL, V40, P583, DOI 10.1007/s00535-005-1592-1
   Talley NJ, 2001, AM J GASTROENTEROL, V96, P71
   Talley NJ, 2001, AM J GASTROENTEROL, V96, P1033
   Willaing I, 2013, DIABETIC MED, V30, pe139, DOI 10.1111/dme.12121
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 24
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL
PY 2016
VL 30
IS 5
BP 826
EP 829
DI 10.1016/j.jdiacomp.2016.03.025
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DP8PI
UT WOS:000378759700012
PM 27166926
DA 2019-01-08
ER

PT J
AU Bennetter, KE
   Clench-Aas, J
   Raanaas, RK
AF Bennetter, Karin Elisabeth
   Clench-Aas, Jocelyne
   Raanaas, Ruth Kjaersti
TI Sense of mastery as mediator buffering psychological distress among
   people with diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Mental health problems; Psychosocial resources; Chronic diseases; Social
   support; Depression anxiety
ID SELF-MANAGEMENT; SOCIAL SUPPORT; DEPRESSION; COMORBIDITY; ANXIETY;
   METAANALYSIS; DISORDERS; MELLITUS; DISEASES; HEALTH
AB Aims: The purpose of this study was to examine the association between diabetes with or without other comorbid somatic diseases and depression and anxiety, and to explore the mediating role of sense of mastery and social support.
   Methods: Data were obtained from a cross-sectional health survey conducted in Norway (n = 6827). People with diabetes alone or with simultaneous comorbid somatic diseases were compared to a group with no known somatic diseases.
   Results: Among people with diabetes alone, 163% reported having depression and anxiety. Having diabetes was associated with 3 times greater odds for anxiety compared to the control group, and 2 times greater odds for depression. Among individuals with diabetes and comorbid somatic diseases, 17.4% reported depression and 11.6% reported symptoms of anxiety. The odds for both were approximately 2 times greater than in the control group. Sense of mastery, but not social support, protected against depression in both groups and against anxiety in the diabetes with comorbidity group.
   Conclusions: Comorbidity between diabetes and other somatic diseases seems to be related to depression to a larger degree, whereas having diabetes alone relates more to anxiety. This can possibly be explained by the overall burden in the comorbidity group and the related absence of sense of mastery. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Bennetter, Karin Elisabeth; Raanaas, Ruth Kjaersti] Norwegian Univ Life Sci, Dept Landscape Architecture & Spatial Planning, As, Norway.
   [Clench-Aas, Jocelyne] Norwegian Inst Publ Hlth, Div Mental Hlth, Oslo, Norway.
RP Raanaas, RK (reprint author), Norwegian Univ Life Sci, Dept Landscape Architecture & Spatial Planning, Sect Publ Hlth Sci, POB 5003, N-1432 As, Norway.
EM ruth.raanaas@nmbu.no
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andreoulakis E, 2012, HIPPOKRATIA, V16, P205
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Bener A, 2011, ONCOL REV, V5, P5, DOI 10.1007/s12156-010-0061-0
   Clarke DM, 2009, MED J AUSTRALIA, V190, pS54
   Dalgard S., 2006, SOCIAL PSYCHIAT PSYC, V41, P444
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Fillenbaum G. G., 2000, J GERONTOL A-BIOL, V55, P84
   Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030
   Gili M, 2010, GEN HOSP PSYCHIAT, V32, P240, DOI 10.1016/j.genhosppsych.2010.01.013
   Gordon A, 2007, CAN J EXP PSYCHOL, V61, P366
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Hougen H, 2004, SAMORDNET LEVEKARSUN
   Jang Y, 2009, AGING MENT HEALTH, V13, P99, DOI 10.1080/13607860802154531
   Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008
   Kim J S, 2001, Issues Ment Health Nurs, V22, P63, DOI 10.1080/016128401750158768
   Labad J, 2010, DIABETOLOGIA, V53, P467, DOI 10.1007/s00125-009-1628-9
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   McDade-Montez EA, 2011, ANN BEHAV MED, V42, P341, DOI 10.1007/s12160-011-9298-5
   Osborne J. W., 2011, PRACTICAL ASSESSMENT, V16, P1
   PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676
   Qiu SH, 2012, DIABETES METAB J, V36, P1, DOI 10.4093/dmj.2012.36.1.1
   Raaijmakers LGM, 2014, PATIENT EDUC COUNS, V97, P75, DOI 10.1016/j.pec.2014.06.016
   Renn BN, 2011, CLIN PSYCHOL REV, V31, P1239, DOI 10.1016/j.cpr.2011.08.001
   Skaff MM, 1996, PSYCHOL AGING, V11, P247, DOI 10.1037/0882-7974.11.2.247
   Skaff MM, 2003, PSYCHOL HEALTH, V18, P295, DOI 10.1080/0887044031000084049
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932
   Strom H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-520
   Thorpe CT, 2013, DIABETES EDUCATOR, V39, P33, DOI 10.1177/0145721712464400
   Topic R, 2013, CROAT MED J, V54, P453, DOI 10.3325/cmj.2013.54.453
   van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001
   WHO, 2000, WHO TECHN REP SER, V894
NR 33
TC 1
Z9 1
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL
PY 2016
VL 30
IS 5
BP 839
EP 844
DI 10.1016/j.jdiacomp.2016.03.022
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DP8PI
UT WOS:000378759700015
PM 27085604
DA 2019-01-08
ER

PT J
AU Johnson, ST
   Al Sayah, F
   Mathe, N
   Johnson, JA
AF Johnson, Steven T.
   Al Sayah, Fatima
   Mathe, Nonsikelelo
   Johnson, Jeffrey A.
TI The relationship of diabetes-related distress and depressive symptoms
   with physical activity and dietary behaviors in adults with type 2
   diabetes: A cross-sectional study
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes distress; Depressive symptoms; Physical activity; Diet
   recommendations
ID SELF-CARE
AB Aims: Diabetes-related distress (DD) and depressive symptoms (DS) may influence self-management behaviors in people living with type 2 diabetes (T2D). We examined the association of DD and DS with physical activity (PA) and adherence to recommended dietary behaviors in adults with T2D.
   Methods: Using baseline data from 2040 adults with T2D in the Alberta's Caring for Diabetes (ABCD) cohort study, DD, DS, PA and adherence to dietary behaviors were assessed. A composite variable for presence of DD and DS was computed for analyses. ANOVA and logistic regression tested independent associations of DS and DD with PA and adherence to diet.
   Results: Participants were 64 +/- 10.6 years, 45% female, 76% with annual household income <= $80,000, and 86% with high school education or more. Those with DD alone were 1.8 times (95% CI 1.1, 2.9) and those with DD and DS combined were 2.0 times (95% CI 1.1, 3.7) more likely not to meet PA guidelines compared to those without DD or DS. The presence of DS alone was not significantly associated with meeting PA guidelines (OR 1.4; 95% CI 0.7, 3.0). Compared to those without DD or DS, patients with DD alone (OR 1.5; 95% CI 1.4, 3.4), DS alone (OR 5.2; 95% CI 2.7, 9.7), or DD and DS combined (OR 2.5; 95% CI 1.6, 3.8) were more likely to have poor adherence to recommended dietary behaviors.
   Conclusions: Greater distress or depressive symptoms were associated with worse self-management behaviors in adults with T2D. Attention to mental health status may improve participation in PA and adherence to diet recommendations in these patients. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Johnson, Steven T.; Mathe, Nonsikelelo] Athabasca Univ, Fac Hlth Disciplines, Ctr Nursing & Hlth Studies, 1 Univ Dr, Athabasca, AB T9S 3A3, Canada.
   [Johnson, Steven T.; Al Sayah, Fatima; Mathe, Nonsikelelo; Johnson, Jeffrey A.] Univ Alberta, Alliance Canadian Hlth Outcomes Res Diabet, Sch Publ Hlth, Li Ka Shing Ctr Hlth Res Innovat 2 040, Edmonton, AB T6G 2E1, Canada.
RP Johnson, ST (reprint author), Athabasca Univ, Fac Hlth Disciplines, Ctr Nursing & Hlth Studies, 1 Univ Dr, Athabasca, AB T9S 3A3, Canada.
EM sjohnson@athabascau.ca
OI Johnson, Jeffrey/0000-0001-8290-2857
FU CIHR Team Grant [OTG- 88588]; Alberta Health for the ABCD Project
FX Funding for this study was granted CIHR Team Grant (reference #: OTG-
   88588), to the Alliance for Canadian Health Outcomes Research in
   Diabetes (ACHORD) and a grant from Alberta Health for the ABCD Project
CR Al Sayah Fatima, 2015, Can J Diabetes, V39 Suppl 3, pS113, DOI 10.1016/j.jcjd.2015.05.005
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lockwood D, 1986, Diabetes Educ, V12, P30, DOI 10.1177/014572178601200107
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128
   Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   Sigal R., 2013, CANADIAN J DIABET S1, V37, pS1
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
NR 12
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL
PY 2016
VL 30
IS 5
BP 967
EP 970
DI 10.1016/j.jdiacomp.2016.02.019
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DP8PI
UT WOS:000378759700035
PM 27083444
DA 2019-01-08
ER

PT J
AU van de Vondervoort, I
   Poelmans, G
   Aschrafi, A
   Pauls, DL
   Buitelaar, JK
   Glennon, JC
   Franke, B
AF van de Vondervoort, Ilse
   Poelmans, Geert
   Aschrafi, Armaz
   Pauls, David L.
   Buitelaar, Jan K.
   Glennon, Jeffrey C.
   Franke, Barbara
TI An integrated molecular landscape implicates the regulation of dendritic
   spine formation through insulin-related signalling in
   obsessive-compulsive disorder
SO JOURNAL OF PSYCHIATRY & NEUROSCIENCE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; DIABETES-MELLITUS; GENE; BEHAVIOR;
   EPIDEMIOLOGY; PROTEIN; MICE; PATHOPHYSIOLOGY; SYMPTOMATOLOGY;
   COMORBIDITY
AB Background: Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder with onset in childhood and is characterized by obsessions (recurrent, intrusive, persistent thoughts, impulses and/or ideas that often cause anxiety or distress) and compulsions (ritualized and stereotypic behaviours or mental acts that are often performed to relieve anxiety or distress associated with obsessions). Although OCD is a heritable disorder, its complex molecular etiology is poorly understood. Methods: We combined enrichment analyses and an elaborate literature review of the top-ranked genes emerging from the 2 published genome-wide association studies of OCD and candidate genes implicated through other evidence in order to identify biological processes that, when dysregulated, increase the risk for OCD. Results: The resulting molecular protein landscape was enriched for proteins involved in regulating postsynaptic dendritic spine formation - and hence synaptic plasticity -through insulin-dependent molecular signalling cascades. Limitations: This study is a first attempt to integrate molecuar information from different sources in order to identify biological mechanisms underlying OCD etiology. Our findings are constrained by the limited information from hypothesis-free studies and the incompleteness and existing limitations of the OCD literature and the gene function annotations of gene enrichment tools. As this study was solely based on in silico analyses, experimental validation of the provided hypotheses is warranted. Conclusion: Our work suggests a key role for insulin and insulin-related signalling in OCD etiology and - if confirmed by independent studies - could eventually pave the way for the development of novel OCD treatments.
C1 [van de Vondervoort, Ilse; Poelmans, Geert; Buitelaar, Jan K.; Glennon, Jeffrey C.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands.
   [Poelmans, Geert; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101 HP 855, NL-6500 HB Nijmegen, Netherlands.
   [Poelmans, Geert] Radboud Univ Nijmegen, RIMLS, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, Nijmegen, Netherlands.
   [Aschrafi, Armaz] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neuroinformat, Nijmegen, Netherlands.
   [Pauls, David L.] Harvard Med Sch, Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA USA.
   [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, Nijmegen, Netherlands.
   [Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands.
RP Franke, B (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101 HP 855, NL-6500 HB Nijmegen, Netherlands.
EM Barbara.Franke@radboudumc.nl
RI Glennon, Jeffrey/D-2379-2013; Franke, Barbara/D-4836-2009
OI Glennon, Jeffrey/0000-0002-2371-0422; Franke,
   Barbara/0000-0003-4375-6572; Aschrafi, Armaz/0000-0003-4089-0960
FU European Community [278948]
FX The authors thank the families who made all the genetic studies of OCD
   possible and the many investigators whose work drives the OCD genetics
   field forward. The authors also thank the anonymous reviewers for their
   useful comments and suggestions regarding text revision. The research
   leading to these results has received funding from the European
   Community's Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no278948 (TACTICS). This funding organization has had no
   involvement with the conception, design, data analysis and
   interpretation, review and/or any other aspects relating to this paper.
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140
   Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769
   Arnold PD, 2004, PSYCHOPHARMACOLOGY, V174, P530, DOI 10.1007/s00213-004-1847-1
   Banks WA, 2004, EUR J PHARMACOL, V490, P5, DOI 10.1016/j.ejphar.2004.02.040
   Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088
   Bloch MH, 2008, AM J MED GENET B, V147B, P850, DOI 10.1002/ajmg.b.30699
   Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9
   Chen HJ, 2013, PEDIATR RES, V73, P492, DOI 10.1038/pr.2013.5
   Christoforou A, 2014, GENES BRAIN BEHAV, V13, P663, DOI 10.1111/gbb.12152
   Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864
   Gherman Adrian, 2009, Human Genomics, V3, P143
   Goodman WK, 2006, J CHILD NEUROL, V21, P704, DOI 10.2310/7010.2006.00169
   Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5
   Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003
   Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037
   Karayiorgou M, 1999, BIOL PSYCHIAT, V45, P1178, DOI 10.1016/S0006-3223(98)00319-9
   KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094
   Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669
   Kontoangelos K, 2013, INT J PSYCHIAT CLIN, V17, P48, DOI 10.3109/13651501.2012.697563
   Koo MS, 2010, EXPERT REV NEUROTHER, V10, P275, DOI 10.1586/ERN.09.148
   Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003
   Leggio L, 2008, ALCOHOL CLIN EXP RES, V32, P450, DOI 10.1111/j.1530-0277.2007.00589.x
   Lensi P, 1996, BRIT J PSYCHIAT, V169, P101, DOI 10.1192/bjp.169.1.101
   Maia TV, 2008, DEV PSYCHOPATHOL, V20, P1251, DOI 10.1017/S0954579408000606
   Matsui A, 2013, SCIENCE, V342, P1114, DOI 10.1126/science.1244505
   Mattheisen M, 2015, MOL PSYCHIATR, V20, P337, DOI 10.1038/mp.2014.43
   McDougle CJ, 1998, MOL PSYCHIATR, V3, P270, DOI 10.1038/sj.mp.4000391
   Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005
   Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888
   Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872
   Pittenger C, 2011, PHARMACOL THERAPEUT, V132, P314, DOI 10.1016/j.pharmthera.2011.09.006
   Poelmans G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.48
   Poelmans G, 2011, AM J PSYCHIAT, V168, P365, DOI 10.1176/appi.ajp.2010.10070948
   RASMUSSEN SA, 1992, PSYCHIAT CLIN N AM, V15, P743
   Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277
   Schoffelmeer ANM, 2011, J NEUROSCI, V31, P1284, DOI 10.1523/JNEUROSCI.3779-10.2011
   Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125
   Stern Michael, 2011, Front Endocrinol (Lausanne), V2, P54, DOI 10.3389/fendo.2011.00054
   Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85
   SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P335
   Taylor S, 2011, CLIN PSYCHOL REV, V31, P1361, DOI 10.1016/j.cpr.2011.09.008
   Torresan RC, 2013, PSYCHIAT RES, V209, P186, DOI 10.1016/j.psychres.2012.12.006
   Vaingankar JA, 2013, SOC PSYCH PSYCH EPID, V48, P835, DOI 10.1007/s00127-012-0601-y
   van Grootheest DS, 2009, TWIN RES HUM GENET, V12, P411, DOI 10.1375/twin.12.5.411
   Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214
   Wan YH, 2011, J NEUROSCI, V31, P16685, DOI 10.1523/JNEUROSCI.2533-11.2011
   WEISSMAN MM, 1994, J CLIN PSYCHIAT, V55, P5
   Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104
   WINOCOUR PH, 1990, DIABETES RES CLIN EX, V14, P171
NR 50
TC 5
Z9 5
U1 0
U2 8
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 1180-4882
EI 1488-2434
J9 J PSYCHIATR NEUROSCI
JI J. Psychiatry Neurosci.
PD JUL
PY 2016
VL 41
IS 4
BP 280
EP 285
DI 10.1503/jpn.140327
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DR2RK
UT WOS:000379751400010
PM 26854754
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Nelson, LA
   Coston, TD
   Cherrington, AL
   Osborn, CY
AF Nelson, Lyndsay A.
   Coston, Taylor D.
   Cherrington, Andrea L.
   Osborn, Chandra Y.
TI Patterns of User Engagement with Mobile- and Web-Delivered Self-Care
   Interventions for Adults with T2DM: A Review of the Literature
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Technology; Internet; Mobile; Intervention; Engagement; Diabetes; Review
ID BEHAVIOR-CHANGE INTERVENTIONS; MANAGEMENT SUPPORT PROGRAM; DIABETES
   MANAGEMENT; GLYCEMIC CONTROL; CELL PHONE; METAANALYSIS; PROMOTION;
   ADHERENCE; DISTRESS; EFFICACY
AB Technology-delivered interventions can improve the health behaviors and clinical outcomes of persons with diabetes, but only if end users engage with these interventions. To summarize the current knowledge on engagement with technology-based interventions, we conducted a review of recent mobile-and web-delivered intervention studies for adults with type 2 diabetes published from 2011 to 2015. Among 163 identified studies, 24 studies satisfied our inclusion criteria. There was substantial variation in how intervention engagement was reported across studies. Engagement rates were lower among interventions with a longer duration, and engagement decreased over time. In several studies, older age and lower health literacy were associated with less engagement, and more engagement was associated with intervention improvement in at least one outcome, including glycemic control. Future technology-based intervention studies should report on engagement, examine and report on associations between user characteristics and engagement, and aim to standardize how this is reported, particularly in longer trials.
C1 [Nelson, Lyndsay A.; Osborn, Chandra Y.] Vanderbilt Univ, Dept Med, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Nelson, Lyndsay A.; Osborn, Chandra Y.] Vanderbilt Univ, Med Ctr, Ctr Hlth Behav & Hlth Educ, Nashville, TN USA.
   [Coston, Taylor D.] Vanderbilt Univ, Med Ctr, Sch Med, Nashville, TN 37232 USA.
   [Cherrington, Andrea L.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
   [Cherrington, Andrea L.] Univ Alabama Birmingham, Div Preventat Med, Birmingham, AL USA.
   [Osborn, Chandra Y.] Vanderbilt Univ, Med Ctr, Ctr Diabet Translat Res, Nashville, TN USA.
   [Osborn, Chandra Y.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA.
RP Osborn, CY (reprint author), Vanderbilt Univ, Dept Med, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.; Osborn, CY (reprint author), Vanderbilt Univ, Med Ctr, Ctr Hlth Behav & Hlth Educ, Nashville, TN USA.; Osborn, CY (reprint author), Vanderbilt Univ, Med Ctr, Ctr Diabet Translat Res, Nashville, TN USA.; Osborn, CY (reprint author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA.
EM chandra.osborn@vanderbilt.edu
RI Emchi, Karma/Q-1952-2016
OI Osborn, Chandra/0000-0002-7668-028X
FU NIH/NIDDK [R01-DK100694, P30DK07962];  [K01-DK087894]
FX Drs. Nelson and Osborn are supported by NIH/NIDDK R01-DK100694, and Dr.
   Osborn is also supported by K01-DK087894. Dr. Cherrington is supported
   by NIH/NIDDK P30DK07962.
CR Aikens JE, 2015, PRIM CARE DIABETES, V9, P127, DOI 10.1016/j.pcd.2014.06.003
   Arora S, 2012, DIABETES TECHNOL THE, V14, P492, DOI 10.1089/dia.2011.0252
   Bell Amanda M, 2012, J Diabetes Sci Technol, V6, P310
   Brouwer W, 2011, J MED INTERNET RES, V13, P23, DOI 10.2196/jmir.1639
   Capozza Korey, 2015, Diabetes Spectr, V28, P83, DOI 10.2337/diaspect.28.2.83
   Centers for Disease Control and Prevention, 2014, REP C DIAB REP CARD
   Connelly J, 2013, DIABETIC MED, V30, P1420, DOI 10.1111/dme.12289
   Cotter AP, 2014, J DIABETES COMPLICAT, V28, P243, DOI 10.1016/j.jdiacomp.2013.07.003
   Dick Jonathan J, 2011, J Diabetes Sci Technol, V5, P1246
   Dobson R, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3988
   Fischer HH, 2012, AM J MANAG CARE, V18, pe42
   Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040
   Gao J., 2013, BMC FAMILY PRACTICE, V14, P1
   Garcia-Perez LE, 2013, DIABETES THER, V4, P175, DOI 10.1007/s13300-013-0034-y
   Glasgow RE, 2014, MED DECIS MAKING, V34, P180, DOI 10.1177/0272989X13498156
   Glasgow RE, 2012, PATIENT EDUC COUNS, V87, P81, DOI 10.1016/j.pec.2011.07.024
   Glasgow RE, 2011, J MED INTERNET RES, V13, P70, DOI 10.2196/jmir.1391
   Hanauer DA, 2009, DIABETES TECHNOL THE, V11, P99, DOI 10.1089/dia.2008.0022
   Head KJ, 2013, SOC SCI MED, V97, P41, DOI 10.1016/j.socscimed.2013.08.003
   Heinrich E, 2012, PATIENT EDUC COUNS, V86, P172, DOI 10.1016/j.pec.2011.04.032
   Holtz B, 2012, TELEMED E-HEALTH, V18, P175, DOI 10.1089/tmj.2011.0119
   Jennings CA, 2014, PREV MED, V60, P33, DOI 10.1016/j.ypmed.2013.12.011
   Jernigan VBB, 2011, HEALTH PROMOT PRACT, V12, P261, DOI 10.1177/1524839909335178
   Jethwani Kamal, 2012, J Diabetes Sci Technol, V6, P1328
   Katz R, 2012, J HEALTH COMMUN, V17, P67, DOI 10.1080/10810730.2012.650613
   Kirkman MS, 2015, DIABETES CARE, V38, P604, DOI 10.2337/dc14-2098
   Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017
   Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x
   Lustria MLA, 2013, J HEALTH COMMUN, V18, P1039, DOI 10.1080/10810730.2013.768727
   Mulvaney SA, 2011, CURR DIABETES REP, V11, P486, DOI 10.1007/s11892-011-0230-y
   Nelson LA, 2015, J AM MED INFORM ASS
   Nelson LA, 2016, JMIR HUMAN FACTORS
   Nundy S, 2014, HEALTH AFFAIR, V33, P265, DOI 10.1377/hlthaff.2013.0589
   Osborn C, 2016, J CLIN PHARM THER
   Osborn Chandra Y, 2013, J Diabetes Sci Technol, V7, P612
   Pal K, 2014, DIABETES CARE, V37, P1759, DOI 10.2337/dc13-1386
   Piette John D, 2014, Front Public Health, V2, P95, DOI 10.3389/fpubh.2014.00095
   Popay J., 2006, ESRC METHODS PROGRAM, V15, P47
   Ryan JG, 2013, DIABETES EDUCATOR, V39, P365, DOI 10.1177/0145721713484594
   Schubart JR, 2011, CIN-COMPUT INFORM NU, V29, pTC9, DOI 10.1097/NCN.0b013e3182155274
   Tatara N, 2013, STUD HEALTH TECHNOL, V192, P127, DOI 10.3233/978-1-61499-289-9-127
   Torbjornsen A, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3535
   Wood FG, 2015, NURS CLIN N AM, V50, P565, DOI 10.1016/j.cnur.2015.05.009
   Yu CH, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/s12911-014-0117-3
NR 44
TC 7
Z9 7
U1 1
U2 16
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD JUL
PY 2016
VL 16
IS 7
AR 66
DI 10.1007/s11892-016-0755-1
PG 20
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DO7CB
UT WOS:000377938700011
PM 27255269
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Conti, C
   Carrozzino, D
   Patierno, C
   Vitacolonna, E
   Fulcheri, M
AF Conti, Chiara
   Carrozzino, Danilo
   Patierno, Chiara
   Vitacolonna, Ester
   Fulcheri, Mario
TI The Clinical Link between Type D Personality and Diabetes
SO FRONTIERS IN PSYCHIATRY
LA English
DT Review
DE diabetes; Type D personality; distressed personality; adherence;
   clinimetrics
ID D DISTRESSED PERSONALITY; PRIMARY-CARE PATIENTS; COMPLICATIONS;
   NETHERLANDS; PREVENTION; OUTCOMES; DISEASE; ADULTS; MILES; LIFE
AB Introduction: Type D personality consists of a mixture of high levels of negative affectivity and social inhibition, resulting in a stable tendency to experience negative emotions, by inhibiting the expression of these emotions. We have reanalyzed the clinically relevant studies examining the role of this personality profile in diabetes, by providing a qualitative synthesis of the data. In this regard, the aim of this study is to provide a systematic review by evaluating the clinical link between Type D personality and diabetes.
   Method: When focusing on PRISMA guidelines, we have performed a comprehensive research of the literature on PubMed, Scopus, ScienceDirect, ISI Web of Science, PsycINFO, and Google Scholar by using search terms as "distressed personality" OR (i.e., Boolean operator) "Type D personality" combined with the Boolean "AND" operator with "diabetes."
   Results: A total of seven research studies were identified and included in the review. Type D was found to be more prevalent in diabetes patients than controls. As regards the specific association with diabetes variables, Type D personality is a significant predictor of both poor medication adherence and unhealthy behaviors, by predicting negative mental health consequences also (i.e., depressed mood, anhedonia, and anxiety).
   Conclusion: Our review emphasized for the first time that Type D personality affects clinical factors in patients with diabetes by provoking adverse outcomes. The core implication of the study comprises the clinical relevance to detect, from a clinimetric point of view, Type D personality in diabetes in order to prevent potentially negative clinical outcomes.
C1 [Conti, Chiara; Carrozzino, Danilo; Patierno, Chiara; Fulcheri, Mario] Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy.
   [Carrozzino, Danilo] Univ Copenhagen, Psychiat Res Unit, Mental Hlth Ctr North Zealand, Hillerod, Denmark.
   [Vitacolonna, Ester] Univ G dAnnunzio, Dept Med & Aging, Chieti, Italy.
RP Conti, C (reprint author), Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy.
EM cconti@unich.it
OI Carrozzino, Danilo/0000-0002-8164-8671; Fulcheri,
   Mario/0000-0002-2389-9800; VITACOLONNA, Ester/0000-0003-1756-661X
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005
   Bech P, 2016, J AFFECT DISORDERS, V193, P99, DOI 10.1016/j.jad.2015.12.039
   Bech P., 2012, CLIN PSYCHOMETRICS
   Bertini M., 2014, PSICOLOGIA SALUTE, V2, P26, DOI [10.3280/PDS2014-002003, DOI 10.3280/PDS2014-002003]
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0
   Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406
   Graham I, 2007, EUR J CARDIOV PREV R, V14, pE1, DOI 10.1097/01.hjr.0000277984.31558.c4
   Li XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146892
   Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006
   Marshall SM, 2006, BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80
   Milicevic R, 2015, PSYCHIAT DANUB, V27, P42
   Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714
   Nefs G, 2015, DIABETIC MED, V32, P1289, DOI 10.1111/dme.12739
   Nefs G, 2015, DIABETES RES CLIN PR, V108, P94, DOI 10.1016/j.diabres.2015.01.015
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Nefs G, 2012, J PSYCHOSOM RES, V72, P251, DOI 10.1016/j.jpsychores.2012.01.006
   Nefs G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-388
   Pedersen SS, 2003, EUR J CARDIOV PREV R, V10, P241, DOI 10.1097/01.hjr.0000085246.65733.06
   Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086
   van Dooren FEP, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0722-z
   Wiltink J, 2011, J AFFECT DISORDERS, V130, P429, DOI 10.1016/j.jad.2010.10.041
   Zimmet P, 2009, DIABETES RES CLIN PR, V84, P107, DOI 10.1016/j.diabres.2009.01.016
NR 24
TC 5
Z9 5
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-0640
J9 FRONT PSYCHIATRY
JI Front. Psychiatry
PD JUN 21
PY 2016
VL 7
AR 113
DI 10.3389/fpsyt.2016.00113
PG 6
WC Psychiatry
SC Psychiatry
GA DP3LB
UT WOS:000378393800001
PM 27445869
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Rosness, TA
   Strand, BH
   Bergem, ALM
   Nafstad, P
   Langballe, EM
   Engedal, K
   Tambs, K
   Bjertness, E
AF Rosness, Tor Atle
   Strand, Bjorn Heine
   Bergem, Astrid Liv Mina
   Nafstad, Per
   Langballe, Ellen Melbye
   Engedal, Knut
   Tambs, Kristian
   Bjertness, Espen
TI Association of psychological distress late in life and dementia-related
   mortality
SO AGING & MENTAL HEALTH
LA English
DT Article
DE longitudinal studies; geriatric medicine; mental health; dementia;
   distress
ID DEPRESSIVE SYMPTOMS; ALZHEIMER-DISEASE; VASCULAR-DEMENTIA; RISK;
   ANXIETY; DEATH; ANTIDEPRESSANTS; METAANALYSIS; RESIDENTS; HISTORY
AB Objective: It is not fully understood how subjective feelings of psychological distress prognosticate dementia. Our aim was to investigate the association between self-reported psychological distress and risk of dementia-related mortality.
   Method: We included 31,043 eligible individuals between the ages of 60 and 80 years, at time of examination, from the CONOR (Cohort of Norway) database. They were followed for a period of 17.4 years (mean 11.5 years). The CONOR Mental Health Index, a seven-item self-report scale was used. A cut-off score equal to or above 2.15 on the scale denoted psychological distress. Cox regression was used to assess the association between psychological distress and risk of dementia-related mortality.
   Results: Total number of registered deaths was 11,762 and 1118 (9.5%) were classified as cases of dementia-related mortality. We found that 2501 individuals (8.1%) had psychological distress, of these, 119 (10.6%) had concomitant dementia-related mortality. Individuals with psychological distress had an increased risk of dementia-related mortality HR = 1.52 (95% confidence interval (CI) 1.25-1.85) after adjusting for age, gender and education. The association remained significant although attenuated when implemented in a full adjusted model, including general health status, smoking, obesity, hypertension, diabetes and history of cardiovascular disease; hazard ratio, HR = 1.30 (95% CI 1.06-1.59).
   Conclusion: Our results indicate that psychological distress in elderly individuals is associated with increased risk of dementia-related mortality. Individuals at increased risk of dementia may benefit from treatments or interventions that lessen psychological distress, but this needs to be confirmed in future clinical studies.
C1 [Rosness, Tor Atle; Strand, Bjorn Heine; Nafstad, Per; Bjertness, Espen] Univ Oslo, Inst Hlth & Soc, Oslo, Norway.
   [Strand, Bjorn Heine; Tambs, Kristian] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Strand, Bjorn Heine; Langballe, Ellen Melbye; Engedal, Knut] Vestfold Hlth Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway.
   [Bergem, Astrid Liv Mina] Akershus Univ Hosp, Dept Geriatr Psychiat, Oslo, Norway.
RP Rosness, TA (reprint author), Univ Oslo, Inst Hlth & Soc, Oslo, Norway.
EM t.a.rosness@medisin.uio.no
OI Strand, Bjorn/0000-0003-4385-8886
CR Bains J, 2002, COCHRANE DB SYST REV, V4
   Barnes DE, 2012, ARCH GEN PSYCHIAT, V69, P493, DOI 10.1001/archgenpsychiatry.2011.1481
   Beuke CJ, 2003, CLIN PSYCHOL REV, V23, P831, DOI 10.1016/S0272-7358(03)00074-6
   Bjertness E, 1998, EPIDEMIOLOGY, V9, P584, DOI 10.1097/00001648-199809000-00027
   Chemerinski E, 2001, AM J PSYCHIAT, V158, P68, DOI 10.1176/appi.ajp.158.1.68
   Gatz JL, 2005, J GERONTOL A-BIOL, V60, P744, DOI 10.1093/gerona/60.6.744
   Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1
   HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6
   Kessing LV, 2007, INT PSYCHOGERIATR, V19, P902, DOI 10.1017/S1041610206004376
   Kessing LV, 2012, CURR OPIN PSYCHIATR, V25, P457, DOI 10.1097/YCO.0b013e328356c368
   Kessing LV, 2011, INT CLIN PSYCHOPHARM, V26, P316, DOI 10.1097/YIC.0b013e32834ace0f
   Kilkkinen A, 2007, AUST J RURAL HEALTH, V15, P114, DOI 10.1111/j.1440-1584.2007.00863.x
   Lenoir H, 2011, J ALZHEIMERS DIS, V26, P27, DOI 10.3233/JAD-2011-101614
   Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033
   Lyketsos CG, 2003, ARCH GEN PSYCHIAT, V60, P737, DOI 10.1001/archpsyc.60.7.737
   Mossaheb N, 2012, J CLIN PSYCHIAT, V73, P1009, DOI 10.4088/JCP.11m06962
   Naess O, 2008, INT J EPIDEMIOL, V37, P481, DOI 10.1093/ije/dym217
   National Heart Lung and Blood Institute NIH, 2014, WHAT IS HIGH BLOOD P
   Olazaran J, 2013, INT J ALZHEIMERS DIS, V2013
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Papassotiropoulos A, 1999, INT J GERIATR PSYCH, V14, P643, DOI 10.1002/(SICI)1099-1166(199908)14:8<643::AID-GPS997>3.3.CO;2-J
   Richard E., 2013, JAMA NEUROL, V70, P374, DOI DOI 10.1001/JAMANEUR0L.2013.603
   Russ TC, 2014, BRIT J PSYCHIAT, V205, P348, DOI 10.1192/bjp.bp.113.142984
   Russ TC, 2011, ARCH INTERN MED, V171, P1858, DOI 10.1001/archinternmed.2011.521
   Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138
   Schweitzer I, 2002, INT J GERIATR PSYCH, V17, P997, DOI 10.1002/gps.525
   SOGAARD AJ, 2003, NOR EPIDEMIOL, V13, P279
   Strand B. H., 2014, J NEUROL SCI, V15, P75
   Strand BH, 2013, J NEUROL SCI, V324, P124, DOI 10.1016/j.jns.2012.10.018
   Tambs K, 2004, PSYCHOSOM MED, V66, P776, DOI 10.1097/01.psy.000013328.03596.fb
   Thomas BM, 1997, AGE AGEING, V26, P401, DOI 10.1093/ageing/26.5.401
   van Asch IFM, 2013, INT J GERIATR PSYCH, V28, P312, DOI 10.1002/gps.3830
   Vilalta-Franch J, 2013, INT J GERIATR PSYCH, V28, P341, DOI 10.1002/gps.3826
   Wilson RS, 2010, NEUROLOGY, V75, P21, DOI 10.1212/WNL.0b013e3181e620c5
   Wilson RS, 2008, ARCH GEN PSYCHIAT, V65, P439, DOI 10.1001/archpsyc.65.4.439
   Wilson RS, 2002, NEUROLOGY, V59, P364, DOI 10.1212/WNL.59.3.364
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 37
TC 5
Z9 5
U1 0
U2 42
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1360-7863
EI 1364-6915
J9 AGING MENT HEALTH
JI Aging Ment. Health
PD JUN 2
PY 2016
VL 20
IS 6
BP 603
EP 610
DI 10.1080/13607863.2015.1031639
PG 8
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA DG5LH
UT WOS:000372119100006
PM 25871314
DA 2019-01-08
ER

PT J
AU Vallis, M
   Burns, KK
   Hollahan, D
   Ross, S
   Hahn, J
AF Vallis, Michael
   Burns, K. Kovacs
   Hollahan, Debbie
   Ross, Stuart
   Hahn, Jina
TI Diabetes Attitudes, Wishes and Needs Second Study (DAWN2): Understanding
   Diabetes-Related Psychosocial Outcomes for Canadians with Diabetes
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE DAWN; depression; diabetes; psychosocial; quality of life; support
ID WELL-BEING INDEX; PATIENT ASSESSMENT; GLYCEMIC CONTROL; PSYCHOMETRIC
   PROPERTIES; CLINICAL DEPRESSION; EMPOWERMENT SCALE; SELF-MANAGEMENT;
   PROBLEM AREAS; SHORT-FORM; CARE
AB Objectives: DAWN2 assessed the psychosocial impact of diabetes on persons with diabetes (PWDs), family members and healthcare professionals (HCPs) across 17 countries. This article reports on the Canadian cohort of PWDs.
   Methods: PWDs completed online, validated self-report scales assessing quality of life (QOL), self-management, beliefs, social support and priorities for improving diabetes care. Analyses used unweighted data.
   Results: Of 500 participants (80 type 1, 420 type 2) positive self-reported QOL was common (64.6%) and likely depression less common (12.8%). Diabetes distress, however, was identified by almost half of PWDs with type 1 diabetes, and one-quarter of PWDs with type 2 (47.5% vs. 25.7% type 2; p<0.001). Numerous life areas were negatively impacted, particularly finances, work and emotional well-being for those with type 1 diabetes (p<0.001 vs. type 2). Most PWDs reported support from family, friends and HCPs, but few reported being asked by HCPs how diabetes affected their lives. Most PWDs participated in (type 1, 90.0%; type 2, 85.7%) and valued (type 1, 84.7%; type 2, 78.1%) diabetes education. Few PWDs relied on community supports (type 1, 17.5%; type 2, 26.9%), and discrimination was not uncommon for those with type 1 (33.8% vs. 12.4% for type 2; p<0.001).
   Conclusions: PWDs experience psychological challenges that should be addressed within diabetes management services. (C) 2015 Canadian Diabetes Association.
C1 [Vallis, Michael] Capital Hlth, Halifax, NS, Canada.
   [Vallis, Michael] Dalhousie Univ, Halifax, NS, Canada.
   [Burns, K. Kovacs] Univ Alberta, Edmonton, AB, Canada.
   [Hollahan, Debbie] Langs Community Hlth Ctr, Cambridge, ON, Canada.
   [Ross, Stuart] Univ Calgary, Calgary, AB, Canada.
   [Hahn, Jina] Novo Nordisk, Mississauga, ON, Canada.
RP Vallis, M (reprint author), Mumford Profess Ctr, Diabet Management Ctr, Primary Care, Suite 265,6960 Mumford Rd, Halifax, NS B3L 4P1, Canada.
EM tvallis@dal.ca
OI Vallis, Michael/0000-0002-0165-5936
FU Novo Nordisk
FX The DAWN2 study is a global partnership of established organizations,
   including the International Diabetes Federation, the International
   Alliance of Patients' Organizations, the Steno Diabetes Center and Novo
   Nordisk. Novo Nordisk funded the DAWN2 study, which was overseen by the
   DAWN2 Study Group (www.dawnstudy.com). DAWN and DAWN2 are registered
   trademarks of Novo Nordisk. For more information, contact
   dawninfo@novonordisk.com. Editing support, funded by Novo Nordisk, was
   provided by Bioscript Medical, Macclesfield, Cheshire, United Kingdom.
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Alberti G, 2002, PRACT DIABETES INT, V19, P22, DOI DOI 10.1002/PDI.305/PDF
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   Association CD, 2014, DIAB CHART CAN
   Association CD, 2014, SECONDARY
   Barnard KD, 2012, DIABETIC MED, V29, P1358, DOI 10.1111/j.1464-5491.2012.03727.x
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Brod M, 2012, CURR MED RES OPIN, V28, P1933, DOI 10.1185/03007995.2012.743458
   Brod M, 2012, CURR MED RES OPIN, V28, P1947, DOI 10.1185/03007995.2012.743457
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Fisher L, 2009, DIABETES CARE
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c
   Goetz Katja, 2012, Am J Manag Care, V18, pe55
   Gonder-Frederick LA, 2013, DIABETIC MED, V30, P603, DOI 10.1111/dme.12129
   Group DS, 2004, PRACT DIABETES INT, V21, P201
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Harper A, 1998, PSYCHOL MED, V28, P551
   Hollahan D, 2015, DIABETES RES TREAT, V2, P126
   Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242
   Houlden R, 2003, CAN J DIABETES S2, V27, pS50
   IAPO, 2007, WHAT IS PAT CTR HEAL
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4
   Kovacs Burns K, 2015, DIABETES RES TREAT, V2, P125
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Lee EH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0142-z
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Naranjo D, 2012, CURR DIABETES REP, V12, P729, DOI 10.1007/s11892-012-0319-y
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Parkin T, 2003, DIABETIC MED, V20, P909, DOI 10.1046/j.1464-5491.2003.01056.x
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Plack K, 2010, CURR OPIN PSYCHIATR, V23, P131, DOI 10.1097/YCO.0b013e3283366555
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rick J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-293
   Robinson DJ, 2013, CAN J DIABETES, V37, pS87, DOI 10.1016/j.jcjd.2013.01.026
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   RUBIN RR, 1992, DIABETES CARE, V15, P1640, DOI 10.2337/diacare.15.11.1640
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Szende A, 2007, EQ D VALUE SETS INVE
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Torenholt R, 2014, DIABETIC MED, V31, P15, DOI 10.1111/dme.12290
   Vallis M, 2011, DIABETES CARE NOVA S, V21, P8
   Vallis M, 2012, CAN J DIABETES, V36, P210, DOI 10.1016/j.jcjd.2012.06.006
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WHO, 2007, PEOPL CTR HLTH CAR P
NR 56
TC 4
Z9 4
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD JUN
PY 2016
VL 40
IS 3
BP 234
EP 241
DI 10.1016/j.jcjd.2015.11.002
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DR5IK
UT WOS:000379936500008
PM 26948024
DA 2019-01-08
ER

PT J
AU Schmitt, A
   Reimer, A
   Kulzer, B
   Haak, T
   Ehrmann, D
   Hermanns, N
AF Schmitt, A.
   Reimer, A.
   Kulzer, B.
   Haak, T.
   Ehrmann, D.
   Hermanns, N.
TI How to assess diabetes distress: comparison of the Problem Areas in
   Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS)
SO DIABETIC MEDICINE
LA English
DT Article
ID EMOTIONAL DISTRESS; SELF-CARE; DEPRESSIVE SYMPTOMS; GLYCEMIC CONTROL;
   TYPE-2; MANAGEMENT; ANXIETY; TRIAL; FIT
AB Aims To compare the properties of the two most commonly used assessment tools for diabetes distress, the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS), in order to discriminate their psychometric capabilities and functions.
   Methods Six hundred and twenty-eight people with diabetes (67% Type 1, 33% Type 2) were cross-sectionally assessed with the PAID, the DDS and further self-report scales regarding coping, quality of life, depressive symptoms and self-care, and medical data were gained. We analysed the PAID and DDS for areas of contentual/psychometric divergence in assessing diabetes distress and compared their associations with criteria of interest.
   Results Content analysis: The PAID covers a greater variety of emotional concerns and shows a stronger focus on food-related problems and complications. The DDS is more reflective of physician-related distress and problems concerning diabetes self-management. Psychometric analysis: Exploratory factor analyses revealed four-factor structures of both scales, explaining 60% (PAID) and 67% (DDS) of variance. Confirmatory factor analyses confirmed that single-factor and four-factor models fit the data. Total scales proved high and subscales mostly satisfactory reliability. Associations with criteria of interest: The PAID was significantly more strongly associated with dysfunctional coping styles, quality of life and depressive symptoms. The DDS showed significantly stronger associations with diabetes self-care and metabolic outcomes.
   Conclusion Our results support both PAID and DDS as good self-report measures of diabetes distress. The observed contentual/psychometric differences suggest that a justified choice with regard to the intended clinical or scientific purpose can improve the acquisition of the required data.
C1 [Schmitt, A.; Reimer, A.; Kulzer, B.; Haak, T.; Ehrmann, D.; Hermanns, N.] Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.
RP Schmitt, A (reprint author), Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.
EM schmitt@diabetes-zentrum.de
OI Ehrmann, Dominic/0000-0002-5794-5596
FU 'Kompetenznetz Diabetes mellitus (Competence Network for Diabetes
   mellitus)' - Federal Ministry of Education and Research [01GI1107]
FX This work was supported by grants of the 'Kompetenznetz Diabetes
   mellitus (Competence Network for Diabetes mellitus)' funded by the
   Federal Ministry of Education and Research (grant number 01GI1107).
CR Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572
   Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861
   Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2014, DIABETIC MED, V31, P739, DOI 10.1111/dme.12403
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Greiner W., 2008, DIAGNOSTIC METHODS R, P74
   Hardt J, 2003, Z KL PSYCH PSYCHOTH, V32, P41, DOI 10.1026//1616-3443.32.1.41
   Hautzinger M, 2012, ADS GEN DEPRESSION I
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037//1082-989X.3.4.424
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Kamradt M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0185-1
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   Pibernik-Okanovic M, 2008, DIABETIC MED, V25, P1252, DOI 10.1111/j.1464-5491.2008.02553.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 30
TC 15
Z9 16
U1 1
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2016
VL 33
IS 6
BP 835
EP 843
DI 10.1111/dme.12887
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DR5FZ
UT WOS:000379930200017
PM 26287511
DA 2019-01-08
ER

PT J
AU Castaneda, SF
   Buelna, C
   Giacinto, RE
   Gallo, LC
   Sotres-Alvarez, D
   Gonzalez, P
   Fortmann, AL
   Wassertheil-Smoller, S
   Gellman, MD
   Giachello, AL
   Talavera, GA
AF Castaneda, Sheila F.
   Buelna, Christina
   Giacinto, Rebeca Espinoza
   Gallo, Linda C.
   Sotres-Alvarez, Daniela
   Gonzalez, Patricia
   Fortmann, Addie L.
   Wassertheil-Smoller, Sylvia
   Gellman, Marc D.
   Giachello, Aida L.
   Talavera, Gregory A.
TI Cardiovascular disease risk factors and psychological distress among
   Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos
   (HCHS/SOL)
SO PREVENTIVE MEDICINE
LA English
DT Article
DE Psychological distress; CVD risk factors; Hispanic/Latino
ID COMORBIDITY SURVEY REPLICATION; FACTOR SURVEILLANCE SYSTEM; MAJOR
   DEPRESSIVE DISORDER; CORONARY-ARTERY-DISEASE; UNITED-STATES;
   COLLABORATIVE CARE; HEART-DISEASE; OLDER-ADULTS; METABOLIC SYNDROME;
   ANXIETY DISORDERS
AB Studies show that cardiovascular disease (CVD) risk factors are correlated with psychological distress, yet research examining these relationships among Hispanic/Latinos is lacking. The population-basedHispanic Community Health Study/Study of Latinos enrolled a cohort of Hispanic/Latino adults (N= 16,415) 18-74 years of age at the time of recruitment, from four US metropolitan areas, between March 2008 and June 2011. Psychological distress (i.e., 10-item Center for Epidemiological Studies Depression Scale, 10 item Spielberger Trait Anxiety Scale, and a combined depression/anxiety score), socio-demographics (i.e., age, education, income, insurance, sex, and Hispanic/Latino background), acculturation (i.e., country of birth and language preference), and traditional CVD risk factors (i.e., dyslipidemia, obesity, current cigarette smoking, diabetes, and hypertension) were assessed at baseline. Associations between CVD risk factors and psychological distress measures by sex were examined using multiple linear regression models, accounting for complex survey design and sampling weights and controlling for socio-demographic and acculturation covariates. In adjusted analyses, all three psychological distress measures were significantly related to smoking. For females, greater psychological distress was significantly related to obesity and current smoking. Formales, diabetes and current smoking were associated with psychological distress. For males and females, dyslipidemia and hypertension were not associated with psychological distress after adjusting for other factors. Elevated depression and anxiety symptoms were associated with CVD risk factors for Hispanic/Latinomen and women. However, these results were not consistent across Hispanic/Latino groups. As promoted by the integrative caremodel, psychosocial concerns should be considered in research on CVD risk and chronic disease prevention. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Castaneda, Sheila F.; Buelna, Christina; Giacinto, Rebeca Espinoza; Gonzalez, Patricia; Talavera, Gregory A.] San Diego State Univ, Grad Sch Publ Hlth, 5500 Campanile Dr, San Diego, CA 92182 USA.
   [Gallo, Linda C.] San Diego State Univ, Dept Psychol, 5500 Campanile Dr, San Diego, CA 92182 USA.
   [Sotres-Alvarez, Daniela] Univ N Carolina, Dept Biostat, Collaborat Studies Coordinating Ctr, 137 E Franklin St,Suite 203,CB 8030, Chapel Hill, NC 27514 USA.
   [Fortmann, Addie L.] Scripps Whittier Diabet Inst, 10140 Campus Point Dr, San Diego, CA 92121 USA.
   [Wassertheil-Smoller, Sylvia] Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave,Belfer Bldg,Room 1312, Bronx, NY 10461 USA.
   [Gellman, Marc D.] Univ Miami, Behav Med Res Ctr, 1251 Stanford Dr, Coral Gables, FL 33146 USA.
   [Giachello, Aida L.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1400, Chicago, IL 60611 USA.
RP Castaneda, SF (reprint author), SDSU, Grad Sch Publ Hlth, 450 4th Ave,Ste 400, Chula Vista, CA 91910 USA.
EM scastaneda@mail.sdsu.edu
RI DeMarcus, Forrest/O-9190-2016; Sotres-Alvarez, Daniela/O-9085-2016
OI Sotres-Alvarez, Daniela/0000-0002-3226-6140; Gallo, Linda
   C./0000-0002-3678-5888; Castaneda, Sheila/0000-0002-1975-0544
FU National Heart, Lung, and Blood Institute [N01-HC65233]; University of
   Miami [N01-HC65234]; Albert Einstein College of Medicine [N01-HC65235];
   Northwestern University [N01-HC65236]; San Diego State University
   [N01-HC65237]
FX The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) was
   supported by contracts from the National Heart, Lung, and Blood
   Institute to the University of North Carolina (N01-HC65233), University
   of Miami (N01-HC65234), Albert Einstein College of Medicine
   (N01-HC65235), Northwestern University (N01-HC65236), and San Diego
   State University (N01-HC65237). The following Institutes/Centers/Offices
   contribute to the study: National Institute on Minority Health and
   Health Disparities, the National Institute of Deafness and Other
   Communications Disorders, the National Institute of Dental and
   Craniofacial Research, the National Institute of Diabetes and Digestive
   and Kidney Diseases, the National Institute of Neurological Disorders
   and Stroke, and the Office of Dietary Supplements. Its contents are
   solely the responsibility of the authors and do not represent the
   official views of the National Institutes of Health.
CR Alegria M, 2008, AM J PSYCHIAT, V165, P359, DOI 10.1176/appi.ajp.2007.07040704
   Alegria M, 2007, AM J PUBLIC HEALTH, V97, P68, DOI 10.2105/AJPH.2006.087205
   Alexander Jeanne Leventhal, 2007, Expert Rev Neurother, V7, pS45
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI [10.2337/dc14-S081, 10.2337/dc10-s062, 10.2337/dc11-S062, 10.2337/dc10-S062]
   ANDRESEN EM, 1994, AM J PREV MED, V10, P77
   Atlantis E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004706
   Beckles Gloria L., 2011, Morbidity and Mortality Weekly Report, V60, P13
   Bojadzievski T, 2011, DIABETES CARE, V34, P1047, DOI 10.2337/dc10-1671
   Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140
   Carek PJ, 2011, INT J PSYCHIAT MED, V41, P15, DOI 10.2190/PM.41.1.c
   Cersosimo E, 2011, AM J MED, V124, pS16, DOI 10.1016/j.amjmed.2011.07.019
   Covey LS, 1998, J ADDICT DIS, V17, P35, DOI 10.1300/J069v17n01_04
   Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517
   de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015
   Dube SR, 2009, INT J PUBLIC HEALTH, V54, P68, DOI 10.1007/s00038-009-0009-y
   Ell K, 2009, INT J PSYCHIAT MED, V39, P113, DOI 10.2190/PM.39.2.a
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252
   Glassy CM, 2010, PSYCHOL HEALTH MED, V15, P117, DOI 10.1080/13548501003615274
   Glymour MM, 2012, J BEHAV MED, V35, P211, DOI 10.1007/s10865-011-9356-2
   Goldstein JM, 2014, FRONT NEUROENDOCRIN, V35, P140, DOI 10.1016/j.yfrne.2013.12.001
   Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6
   GUZMAN B., 2001, HISPANIC POPULATION
   Harpole LH, 2005, GEN HOSP PSYCHIAT, V27, P4, DOI 10.1016/j.genhosppsych.2004.09.004
   Hawkley LC, 2003, BRAIN BEHAV IMMUN, V17, pS98
   Hawkley LC, 2006, PSYCHOL AGING, V21, P152, DOI 10.1037/0882-7974.21.1.152
   Hawkley LC, 2003, J PERS SOC PSYCHOL, V85, P105, DOI 10.1037/0022-3514.85.1.105
   Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8
   Hawkley LC, 2010, PSYCHOL AGING, V25, P132, DOI 10.1037/a0017805
   Huang YF, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-260
   Jiang W, 2005, AM HEART J, V150, P54, DOI 10.1016/j.ahj.2005.04.012
   Jonas BS, 1997, ARCH FAM MED, V6, P43, DOI 10.1001/archfami.6.1.43
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lorenzo-Blanco EI, 2013, AM J COMMUN PSYCHOL, V51, P332, DOI 10.1007/s10464-012-9553-3
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   Mather M., 2014, HISPANIC GAINS MINIM
   McGregor M, 2011, J AMBUL CARE MANAG, V34, P152, DOI 10.1097/JAC.0b013e31820ef6a4
   Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Moonesinghe Ramal, 2011, Morbidity and Mortality Weekly Report, V60, P35
   Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580
   Naqvi TZ, 2005, PSYCHOSOM MED, V67, pS15, DOI 10.1097/01.psy.0000164013.55453.05
   Okosun IS, 2001, PREV MED, V32, P429, DOI 10.1006/pmed.2001.0840
   Osborn CY, 2011, ANN BEHAV MED, V41, P300, DOI 10.1007/s12160-010-9241-1
   Papakostas GI, 2004, EUR NEUROPSYCHOPHARM, V14, P135, DOI 10.1016/S0924-977X(03)00099-3
   Park S, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-45
   Patel K, 2011, AM J HEALTH BEHAV, V35, P627
   Pew Hispanic Center, 2011, CENS 2010 50 MILL LA
   PewResearch, 2014, HISP TRENDS PROJ HIS
   PewResearch, 2014, HISP TRENDS PROJ US
   Polk Donna M, 2005, Curr Cardiol Rep, V7, P166, DOI 10.1007/s11886-005-0072-9
   Pratt Laura A, 2008, NCHS Data Brief, P1
   Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020
   Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0
   Shabbir F, 2013, NEUROCHEM INT, V62, P324, DOI 10.1016/j.neuint.2012.12.014
   Shanmugasegaram S, 2012, MATURITAS, V73, P305, DOI 10.1016/j.maturitas.2012.09.005
   Shimbo D, 2005, AM J CARDIOL, V96, P1016, DOI 10.1016/j.amjcard.2005.05.064
   Shin JY, 2008, ANN BEHAV MED, V36, P33, DOI 10.1007/s12160-008-9045-8
   Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015
   Spielberger C., 1983, ADV PERSONALITY ASSE, V2, P159
   Spielberger C. D., 1983, MANUAL STATE TRAIT A
   Trosclair A, 2010, ADDICT BEHAV, V35, P438, DOI 10.1016/j.addbeh.2009.12.011
   U. S. Census Bureau, 2013, 2010 CENS URB RUR CL
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   Wang MY, 2008, J CLIN NURS, V17, P2524, DOI 10.1111/j.1365-2702.2008.02301.x
   Wassertheil-Smoller S, 2004, ARCH INTERN MED, V164, P289, DOI 10.1001/archinte.164.3.289
   Wassertheil-Smoller S, 2014, ANN EPIDEMIOL, V24, P822, DOI 10.1016/j.annepidem.2014.09.003
   Watson LC, 2013, J PRIM CARE COMMUNIT, V4, P294, DOI 10.1177/2150131913484040
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
NR 80
TC 6
Z9 6
U1 2
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-7435
EI 1096-0260
J9 PREV MED
JI Prev. Med.
PD JUN
PY 2016
VL 87
BP 144
EP 150
DI 10.1016/j.ypmed.2016.02.032
PG 7
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA DQ2HX
UT WOS:000379024500022
PM 26921653
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Kalra, B
   Gupta, Y
   Kalra, S
AF Kalra, Bharti
   Gupta, Yashdeep
   Kalra, Sanjay
TI Timing of Delivery in Gestational Diabetes Mellitus: Need for
   Person-Centered, Shared Decision-Making
SO DIABETES THERAPY
LA English
DT Article
DE Antenatal corticosteroid therapy; Cephalopelvic disproportion; Diabetes;
   Fetomaternal distress; Labor; Macrosomia
ID PREVALENCE; PREGNANCY; HEALTH; TRENDS
AB Gestational diabetes mellitus (GDM) is a medical as well as obstetric challenge, which needs person-centered management. The timing of delivery of women with GDM is discussed by various obstetric professional bodies. We highlight pertinent medical, obstetric, and psychosocial factors which may influence the timing of delivery in women with GDM. This commentary proposes a person-centered approach to decide the delivery timing in GDM and supports shared decision-making based upon the individual's biopsychosocial characteristics and environmental factors.
C1 [Kalra, Bharti] Bharti Hosp, Dept Obstet, Karnal, India.
   [Gupta, Yashdeep] AIIMS, Dept Endocrinol, New Delhi, India.
   [Kalra, Sanjay] Bharti Hosp, Dept Endocrinol, Karnal, India.
RP Kalra, S (reprint author), Bharti Hosp, Dept Endocrinol, Karnal, India.
EM brideknl@gmail.com
OI Gupta, Yashdeep/0000-0002-4345-717X
CR American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P908, DOI 10.1097/01.AOG.0000428648.75548.00
   [Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a
   Aviram A, 2016, DIABETES RES CLIN PR, V113, P198, DOI 10.1016/j.diabres.2015.12.018
   Bajaj Sarita, 2013, Indian J Endocrinol Metab, V17, P548, DOI 10.4103/2230-8210.113720
   Ballas J, 2012, CURR DIABETES REP, V12, P33, DOI 10.1007/s11892-011-0249-0
   Barbour LA, 2014, CURR OPIN ENDOCRINOL, V21, P264, DOI 10.1097/MED.0000000000000080
   Bardenheier BH, 2015, AM J PREV MED, V49, P12, DOI 10.1016/j.amepre.2015.01.026
   Baruah Manash P, 2012, Indian J Endocrinol Metab, V16, P679, DOI 10.4103/2230-8210.100629
   Blumer I, 2013, J CLIN ENDOCR METAB, V98, P4227, DOI 10.1210/jc.2013-2465
   ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460
   Frise CJ, 2016, OBSTET MED, V9, P60, DOI 10.1177/1753495X15612330
   Gawlik S, 2015, J OBSTET GYNAECOL, V35, P455, DOI 10.3109/01443615.2014.969204
   Greuter MJE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-58
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P176, DOI 10.1016/j.diabres.2013.11.003
   Hod M, 1998, DIABETES CARE, V21, pB113
   Ignell C, 2014, ACTA OBSTET GYN SCAN, V93, P420, DOI 10.1111/aogs.12340
   Kalra Bharti, 2013, Indian J Endocrinol Metab, V17, pS593, DOI 10.4103/2230-8210.123539
   Kalra Bharti, 2013, Indian J Endocrinol Metab, V17, P815, DOI 10.4103/2230-8210.117216
   Kalra Sanjay, 2013, Indian J Endocrinol Metab, V17, P376, DOI 10.4103/2230-8210.111608
   Lee VR, 2015, OBSTET GYNECOL, V1, p103S
   Peleg D, 2015, AM J PERINAT, V32, P71, DOI 10.1055/s-0034-1376182
   Sutton AL, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.005
   Walmer R, 2015, DEPRESS ANXIETY, V32, P774, DOI 10.1002/da.22388
NR 23
TC 3
Z9 3
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1869-6953
EI 1869-6961
J9 DIABETES THER
JI Diabetes Ther.
PD JUN
PY 2016
VL 7
IS 2
BP 169
EP 174
DI 10.1007/s13300-016-0162-2
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DO7CR
UT WOS:000377940300001
PM 26961272
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Matsuba, I
   Sawa, T
   Kawata, T
   Kanamori, A
   Jiang, DF
   Machimura, H
   Takeda, H
   Han, JH
   Wang, K
   Tanaka, K
   Shen, L
   Ajima, M
   Kaneshiro, M
   Kim, SW
   Umezawa, S
   Asakura, T
   Suzuki, S
   Kim, SC
AF Matsuba, Ikuro
   Sawa, Tasuku
   Kawata, Takehiro
   Kanamori, Akira
   Jiang, Dingfeng
   Machimura, Hideo
   Takeda, Hiroshi
   Han, Jeong Hee
   Wang, Ke
   Tanaka, Keiji
   Shen, Li
   Ajima, Miho
   Kaneshiro, Mizuki
   Kim, Sang-Wook
   Umezawa, Shinichi
   Asakura, Taro
   Suzuki, Shuichi
   Kim, Seoyoung C.
TI Cross-National Variation in Glycemic Control and Diabetes-Related
   Distress Among East Asian Patients Using Insulin: Results from the
   MOSAIc Study
SO DIABETES THERAPY
LA English
DT Article
DE Asia; Diabetes Mellitus; Hypoglycemia; Insulin; Patient-reported
   outcomes; Type 2
ID QUALITY-OF-LIFE; BASAL INSULIN; TYPE-2; MELLITUS; MANAGEMENT; THERAPY;
   INTENSIFICATION; INITIATION; PATTERNS; TRENDS
AB Introduction: Guidelines recommend insulin progression for patients with type 2 diabetes (T2D) with inadequate glycemic control. The Multinational Observational Study Assessing Insulin use (MOSAIc [ClinicalTrials.gov identifier, NCT01400971]) study is a 2-year observational study, investigating factors that influence insulin progression in T2D patients. In this first of two reports, we describe baseline clinical and psychosocial characteristics of Chinese, Japanese, and South Korean patients who participated in MOSAIc. Insulin treatment, factors affecting progression, and outcomes will be reported separately.
   Methods: Patients with T2D using insulin for >= 3 months were eligible. Baseline demographic, clinical, and psychosocial data were collected from patients. Quality of life instruments, including the Diabetes Distress Scale (DDS), were used to assess patient's concerns about disease management, support, and emotional burden. The association between the DDS and the selected covariates was also assessed.
   Results: A total of 373 patients in China, 157 in Japan, and 141 in South Korea were enrolled from July 2011 to July 2013. Mean +/- standard deviation duration (years) of T2D differed across countries (China 11.4 +/- 7.5; Japan 13.8 +/- 8.7; South Korea 15.7 +/- 8.8; P < 0.0001). Japanese patients used more noninsulin anti-hyperglycemic agents than did Chinese or South Korean patients (P < 0.0001). Exclusive use of basal insulin was most common in Japan and South Korea compared with China, whereas approximately 66.8% of Chinese patients used mixed insulin. Covariates associated with the DDS were younger age [P = 0.044 (Japan)], higher incidence of monthly hypoglycemia [P = 0.036 [China]; P = 0.021 (South Korea)], and male gender [P = 0.037 (South Korea)].
   Conclusions: There were significant differences amongst East Asian patients with T2D treated with insulin, including in quality of life scores. Results from the MOSAIc longitudinal analyses will further investigate trends of insulin intensification and barriers to insulin progression.
C1 [Matsuba, Ikuro; Kawata, Takehiro; Kanamori, Akira; Machimura, Hideo; Takeda, Hiroshi; Tanaka, Keiji; Kaneshiro, Mizuki; Umezawa, Shinichi; Asakura, Taro] Kanagawa Phys Assoc, Study Grp, Diabet Comm, Kawasaki, Kanagawa, Japan.
   [Sawa, Tasuku] Kawasaki Saiwai Hosp, Dept Internal Med, Kawasaki, Kanagawa, Japan.
   [Jiang, Dingfeng] Eli Lilly & Co, Indianapolis, IN 46285 USA.
   [Han, Jeong Hee] Lilly Korea Ltd, Seoul, South Korea.
   [Wang, Ke; Shen, Li] Eli Lilly Suzhou Pharmaceut Co, Shanghai, Peoples R China.
   [Ajima, Miho] Kawasaki Saiwai Clin, Dept Diabetol, Kawasaki, Kanagawa, Japan.
   [Kim, Sang-Wook] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea.
   [Suzuki, Shuichi] Eli Lilly Japan KK, Kobe, Hyogo, Japan.
   [Kim, Seoyoung C.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.
   [Kim, Seoyoung C.] Harvard Univ, Sch Med, Boston, MA USA.
RP Matsuba, I (reprint author), Kanagawa Phys Assoc, Study Grp, Diabet Comm, Kawasaki, Kanagawa, Japan.
EM ikuro@matsuba-web.com
OI Kim, Seoyoung/0000-0002-2517-3579
FU Eli Lilly and Company
FX Eli Lilly and Company.
CR Blak BT, 2012, DIABETIC MED, V29, pE13, DOI 10.1111/j.1464-5491.2012.03586.x
   Charvat H, 2015, J DIABETES INVEST, V6, P533, DOI 10.1111/jdi.12333
   Chinese Diabetes Society, 2013, DIABETES, V2014, P447
   Cuddihy RM, 2011, DIABETES EDUCATOR, V37, P111, DOI 10.1177/0145721710388426
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479
   International Diabetes Federation, IDF DIABETES ATLAS
   Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413
   Ishii H, 2013, J DIABETES INVEST, V4, P560, DOI 10.1111/jdi.12086
   Ji L, 2016, DIABETES RES CLIN PR, V112, P82, DOI 10.1016/j.diabres.2015.08.005
   Ji LN, 2015, DIABETES TECHNOL THE, V17, P735, DOI 10.1089/dia.2015.0054
   Kanatsuka A, 2012, DIABETOL INT, V3, P164, DOI 10.1007/s13340-012-0073-z
   Kim SS, 2014, ACTA DIABETOL, V51, P655, DOI 10.1007/s00592-014-0572-4
   Kohro T, 2013, INT HEART J, V54, P93, DOI 10.1536/ihj.54.93
   Korean Diabetes Association, 2015, KOR DIAB FACT SHEET
   Korean Diabetes Association, 2013, KOR DIAB RES FDN INT
   Korean Diabetes Association, 2013, KOR DIAB ASS GUID 20
   Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025
   National Health and Family Planning Commission of the People's Republic of China, 2012, NAT ESS DRUG LIST
   Patrick AR, 2014, J GEN INTERN MED, V29, P320, DOI 10.1007/s11606-013-2643-6
   Polinski JM, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0044-z
   Polinski JM, 2014, PRIM CARE DIABETES, V8, P101, DOI 10.1016/j.pcd.2013.10.008
   Polinski JM, 2013, DIABETES EDUCATOR, V39, P53, DOI 10.1177/0145721712467696
   Polinski JM, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-20
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Shim YT, 2012, DIABETIC MED, V29, pE241, DOI 10.1111/j.1464-5491.2012.03689.x
   Tan AM, 2011, SINGAP MED J, V52, P801
   The Japan Diabetes Society, TREATM GUID DIAB 201
   Tsai ST, 2011, J DIABETES, V3, P208, DOI 10.1111/j.1753-0407.2011.00137.x
   Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R
   Wang WB, 2009, AM J MANAG CARE, V15, P593
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   Wong S, 2011, DIABETIC MED, V28, P206, DOI 10.1111/j.1464-5491.2010.03195.x
   Yang J, 2013, CHIN J ENDOCRINOL ME, V29, p5b
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 36
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1869-6953
EI 1869-6961
J9 DIABETES THER
JI Diabetes Ther.
PD JUN
PY 2016
VL 7
IS 2
BP 349
EP 360
DI 10.1007/s13300-016-0178-7
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DO7CR
UT WOS:000377940300014
PM 27255328
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Haenen, S
   Nyklicek, I
   van Son, J
   Pop, V
   Pouwer, F
AF Haenen, Sharon
   Nyklicek, Ivan
   van Son, Jenny
   Pop, Victor
   Pouwer, Francois
TI Mindfulness facets as differential mediators of short and long-term
   effects of Mindfulness-Based Cognitive Therapy in diabetes outpatients:
   Findings from the DiaMind randomized trial
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Diabetes; Mediators; Mindfulness; Psychological distress; Randomized
   trial
ID STRESS-REDUCTION INTERVENTION; QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS;
   EMOTIONAL DISTRESS; CANCER-PATIENTS; CLINICAL-TRIAL; METAANALYSIS;
   MEDITATION; BENEFITS; MELLITUS
AB Background: There is increasing evidence that mindfulness-based interventions reduce psychological distress in various medical populations. However, it has hardly been studied if these effects are mediated by an increase in mindfulness. The aim of this study was to examine mediating effects of various mindfulness facets on effects of a Mindfulness Based Cognitive Therapy (MBCT) on perceived stress and mood.
   Methods: Outpatients with diabetes types 1 and 2 and low levels of emotional wellbeing were randomized into a group receiving MBCT (n = 70) or a waiting-list control group (n = 69). Primary outcomes were mood and perceived stress. Before, after and at follow-up (6 months post intervention) relevant questionnaires were completed.
   Results: Mediation analysis using bootstrap resampling indicated that increases in total mindfulness and the facets observing and nonreactivity mediated the effects of the intervention on depressed and angry mood, anxiety (only observing), and perceived stress (only nonreactivity) from pre- to post-intervention. In contrast, from post-intervention to follow-up, besides total mindfulness the facets of acting with awareness and nonjudging mediated the effects on depressed, anxious, and angry mood, while only nonjudging mediated the effects on perceived stress.
   Discussion: The findings indicate that increases in levels of mindfulness mediate the effects of the Mindfulness Based Cognitive Therapy in patients with diabetes. It is notable that different facets may be important for immediate change versus long-term outcome. These findings might be relevant for post-intervention care. (c) 2016 Elsevier Inc. All rights reserved.
C1 [Haenen, Sharon; Nyklicek, Ivan; van Son, Jenny; Pop, Victor; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
RP Nyklicek, I (reprint author), POB 90153, NL-5000 LE Tilburg, Netherlands.
EM I.Nyldicek@tilburguniversity.edu
FU Dutch Diabetes Research Foundation or 'Diabetesfonds' [2008.13.005];
   Tilburg University, Center of Research on Psychology in Somatic diseases
   (CoRPS)
FX The study is supported by grants from 1) the Dutch Diabetes Research
   Foundation or 'Diabetesfonds' (project number 2008.13.005, awarded to
   Dr. I. Nyklicek) and 2) Tilburg University, Center of Research on
   Psychology in Somatic diseases (CoRPS).
CR Baer R. A., 2006, MINDFULNESS BASED TR
   Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015
   Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003
   Baer RA, 2012, J CLIN PSYCHOL, V68, P755, DOI 10.1002/jclp.21865
   Batink T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072778
   Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077
   Branstrom R, 2010, ANN BEHAV MED, V39, P151, DOI 10.1007/s12160-010-9168-6
   Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822
   Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Didonna Fabrizio, 2009, CLIN HDB MINDFULNESS
   Fjorback LO, 2011, ACTA PSYCHIAT SCAND, V124, P102, DOI 10.1111/j.1600-0447.2011.01704.x
   Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7
   Grossman P, 2008, J PSYCHOSOM RES, V64, P405, DOI 10.1016/j.jpsychores.2008.02.001
   Gu J, 2015, CLIN PSYCHOL REV, V37, P1, DOI 10.1016/j.cpr.2015.01.006
   Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343
   Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555
   Josefsson T., 2011, MINDFULNESS, V2, P49, DOI DOI 10.1007/S12671-011-0042-9
   Kabat-Zinn J., 1990, FULL CATASTROPHE LIV
   Keng SL, 2012, J COGN PSYCHOTHER, V26, P270, DOI 10.1891/0889-8391.26.3.270
   Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005
   Kuyken W, 2010, BEHAV RES THER, V48, P1105, DOI 10.1016/j.brat.2010.08.003
   Labelle LE, 2015, J CLIN PSYCHOL, V71, P21, DOI 10.1002/jclp.22117
   MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4
   Maxwell S. E., 1990, DESIGNING EXPT ANAL
   McManus F, 2012, J CONSULT CLIN PSYCH, V80, P817, DOI 10.1037/a0028782
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   Nyklicek I, 2008, ANN BEHAV MED, V35, P331, DOI 10.1007/s12160-008-9030-2
   Nyklicek I, 2014, J BEHAV MED, V37, P135, DOI 10.1007/s10865-012-9475-4
   Nyklicek I, 2013, J BEHAV MED, V36, P361, DOI 10.1007/s10865-012-9431-3
   Nyklicek I, 2011, EMOTION REGULATION AND WELL-BEING, P101, DOI 10.1007/978-1-4419-6953-8_7
   Ott MJ, 2006, INTEGR CANCER THER, V5, P98, DOI 10.1177/1534735406288083
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Raes F, 2009, BEHAV RES THER, V47, P623, DOI 10.1016/j.brat.2009.03.007
   Rogosa D., 1988, METHODOLOGICAL ISSUE, P171
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   Segal Z., 2002, MINDFULNESS BASED CO
   Sephton SE, 2007, ARTHRIT RHEUM-ARTHR, V57, P77, DOI 10.1002/art.22478
   Shapiro SL, 2008, J CLIN PSYCHOL, V64, P840, DOI 10.1002/jclp.20491
   Snippe E, 2015, J COUNS PSYCHOL, V62, P106, DOI 10.1037/cou0000057
   Tovote K.A., 2015, PSYCHOTHER PSYCHOSOM, V84
   Tovote KA, 2014, DIABETES CARE, V37, P2427, DOI 10.2337/dc13-2918
   van Aalderen JR, 2012, PSYCHOL MED, V42, P989, DOI 10.1017/S0033291711002054
   van Son J, 2014, J PSYCHOSOM RES, V77, P81, DOI 10.1016/j.jpsychores.2014.03.013
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   van Son J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-131
   Wald F., 1990, NED T PSYCHOL, V45, P86
   Witek-Janusek L, 2008, BRAIN BEHAV IMMUN, V22, P969, DOI 10.1016/j.bbi.2008.01.012
NR 49
TC 7
Z9 7
U1 3
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD JUN
PY 2016
VL 85
BP 44
EP 50
DI 10.1016/j.jpsychores.2016.04.006
PG 7
WC Psychiatry
SC Psychiatry
GA DO2RI
UT WOS:000377627200008
PM 27212669
DA 2019-01-08
ER

PT J
AU Twig, G
   Gerstein, HC
   Fruchter, E
   Shina, A
   Afek, A
   Derazne, E
   Tzur, D
   Cukierman-Yaffe, T
   Amital, D
   Amital, H
   Tirosh, A
AF Twig, Gilad
   Gerstein, Hertzel C.
   Fruchter, Eyal
   Shina, Avi
   Afek, Arnon
   Derazne, Estela
   Tzur, Dorit
   Cukierman-Yaffe, Tali
   Amital, Daniela
   Amital, Howard
   Tirosh, Amir
TI Self-Perceived Emotional Distress and Diabetes Risk Among Young Men
SO AMERICAN JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Article
ID AGED SWEDISH MEN; PSYCHOLOGICAL DISTRESS; WHITEHALL II; PSYCHOSOCIAL
   STRESS; INSULIN-RESISTANCE; WORK STRESS; TYPE-2; ADULTS; WOMEN; DISEASE
AB Introduction: There are mixed data regarding the effect of emotional distress on diabetes risk, especially among young adults. This study assessed the effect of self-perceived emotional distress on diabetes incidence among young men.
   Methods: Incident diabetes during a mean follow-up of 6.3 (4.3) years was assessed among 32,586 men (mean age, 31.0 [5.6] years) of the Metabolic, Lifestyle, and Nutrition Assessment in Young Adults cohort with no history of diabetes between 1995 and 2011. Emotional distress was assessed by asking participants as part of a computerized questionnaire: Are you preoccupied by worries or concerns that affect your overall wellbeing? Time-dependent Cox models were applied. Data analysis took place between 2014 and 2015.
   Results: There were 723 cases of diabetes during 206,382 person-years. The presence of distress was associated with a 53% higher incidence of diabetes (95% CI = 1.08, 2.18, p=0.017) after adjustment for age, BMI, fasting plasma glucose, family history of diabetes, triglyceride and high-density lipoprotein cholesterol levels, education, cognitive performance, white blood cell count, physical activity, and sleep quality. These results persisted when distress, BMI, physical activity, and smoking status were treated as time-dependent variables (hazard ratio=1.66, 95% CI=1.21, 2.17, p=0.002). An adjusted hazard ratio of 2.14 (95% CI=1.04, 4.47, p=0.041) for incident diabetes was observed among participants persistently reporting emotional distress compared with those persistently denying it.
   Conclusions: Sustained emotional distress contributes to the development of diabetes among young and apparently healthy men in a time-dependent manner. These findings warrant awareness by primary caregivers when stratifying diabetes risk. (C) 2016 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
C1 [Twig, Gilad; Amital, Howard] Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel.
   [Twig, Gilad; Shina, Avi; Tirosh, Amir] Chaim Sheba Med Ctr, Dr Pinchas Bornstein Talpiot Med Leadership Progr, IL-52621 Tel Hashomer, Israel.
   [Twig, Gilad; Fruchter, Eyal; Shina, Avi; Derazne, Estela; Tzur, Dorit] Israel Def Forces Med Corps, Haifa, Israel.
   [Twig, Gilad; Afek, Arnon; Derazne, Estela; Cukierman-Yaffe, Tali; Amital, Daniela; Amital, Howard] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.
   [Gerstein, Hertzel C.] McMaster Univ, Div Endocrinol & Metab, Hamilton, ON, Canada.
   [Gerstein, Hertzel C.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.
   [Gerstein, Hertzel C.] Hamilton Hlth Sci, Hamilton, ON, Canada.
   [Shina, Avi] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IL-52621 Tel Hashomer, Israel.
   [Afek, Arnon] Israel Minist Hlth, Jerusalem, Israel.
   [Cukierman-Yaffe, Tali; Tirosh, Amir] Chaim Sheba Med Ctr, Dept Endocrinol, IL-52621 Tel Hashomer, Israel.
   [Amital, Daniela] Ness Ziona Mental Hlth Ctr, Dept Psychiat B, Ness Ziona, Israel.
   [Tirosh, Amir] Harvard Univ, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Sch Med, Boston, MA 02115 USA.
RP Twig, G (reprint author), Chaim Sheba Med Ctr, Dept Med B, IL-52621 Ramat Gan, Israel.
EM gilad.twig@gmail.com
OI Gerstein, Hertzel/0000-0001-8072-2836
FU Israel Defense Forces Medical Corp; Israeli ministry of defense; Pinchas
   Borenstein Talpiot Medical Leadership Program; Sheba Medical Center, Tel
   Hashomer, Israel
FX This study was supported by a research grant of the Israel Defense
   Forces Medical Corp and the Israeli ministry of defense. GT and AT were
   partially supported by a grant from the Pinchas Borenstein Talpiot
   Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. Author
   contributions included the following: study concept and design (GT);
   data acquisition (DT); statistical analyses (GT, ED); interpretation of
   data (GT, HCG, AS, ED, HA, EF, TCY, AT); writing the first draft of the
   manuscript (GT); and critical revision of the manuscript (AA, AS, AT,
   ED, DA, TCY, HCG, EF). The content of this manuscript was presented in
   the 75th American Diabetes Association meeting (Boston, MA). GT had full
   access to all the data in the study and takes full responsibility for
   the integrity of the data and the accuracy of the data analysis.
CR Bergmann N, 2014, ENDOCR CONNECT, V3, pR55, DOI 10.1530/EC-14-0031
   Bhathena SJ, 2006, NUTR NEUROSCI, V9, P1, DOI 10.1080/10284150600627128
   Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3
   Chandola T, 2006, BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80
   Cukierman-Yaffe T, 2015, J CLIN ENDOCR METAB, V100, P4409, DOI 10.1210/jc.2015-2012
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Eriksson AK, 2013, DIABETES CARE, V36, P2683, DOI 10.2337/dc12-1738
   Falavigna A, 2011, SLEEP BREATH, V15, P519, DOI 10.1007/s11325-010-0396-6
   Furer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136464
   Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95
   Hermelink K, 2014, BREAST CARE, V9, P129, DOI 10.1159/000360788
   Keir ST, 2008, PSYCHO-ONCOL, V17, P621, DOI 10.1002/pon.1271
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   Littman AJ, 2006, EPIDEMIOLOGY, V17, P398, DOI 10.1097/01.ede.0000219721.89552.51
   Lundberg U, 2005, PSYCHONEUROENDOCRINO, V30, P1017, DOI 10.1016/j.psyneuen.2005.03.014
   Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009
   McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307
   Melamed S, 2002, SLEEP, V25, P315, DOI 10.1093/sleep/25.3.315
   Menke A, 2014, ANN INTERN MED, V161, P328, DOI 10.7326/M14-0286
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109
   Mooy JM, 2000, DIABETES CARE, V23, P197, DOI 10.2337/diacare.23.2.197
   Nielsen NR, 2008, AM J EPIDEMIOL, V168, P481, DOI 10.1093/aje/kwn157
   Nielsen NR, 2006, EPIDEMIOLOGY, V17, P391, DOI 10.1097/01.ede.0000220556.86419.76
   Nielsen NR, 2008, AM J EPIDEMIOL, V168, P492
   Non AL, 2014, LANDES BIOSCI, V9, P4, DOI DOI 10.1371/J0URNAL.P0NE.0094474
   Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037
   Nyberg ST, 2014, DIABETES CARE, V37, P2268, DOI 10.2337/dc13-2936
   Nguyen QM, 2011, DIABETES CARE, V34, P2603, DOI 10.2337/dc11-0919
   Reichenberg A, 2002, AM J PSYCHIAT, V159, P2027, DOI 10.1176/appi.ajp.159.12.2027
   Rod NH, 2009, J INTERN MED, V266, P467, DOI 10.1111/j.1365-2796.2009.02124.x
   Schubart JR, 2015, J PSYCHOSOC ONCOL, V33, P1, DOI 10.1080/07347332.2014.977415
   Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080
   Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992
   Twig G, 2015, ACTA DIABETOL
   Twig G, 2015, EUR J ENDOCRINOL, V173, P305, DOI 10.1530/EJE-15-0284
   Twig G, 2014, DIABETES CARE, V37, P2982, DOI 10.2337/dc14-0715
   Twig G, 2014, DIABETES CARE, V37, P2989, DOI 10.2337/dc14-0869
   Twig G, 2014, J CLIN ENDOCR METAB, V99, pE2123, DOI 10.1210/jc.2014-2096
   Twig G, 2014, J CLIN ENDOCR METAB, V99, P2095, DOI 10.1210/jc.2014-1213
   Vassy JL, 2014, DIABETES, V63, P2172, DOI 10.2337/db13-1663
   Virtanen M, 2014, DIABETES CARE, V37, P2091, DOI 10.2337/dc13-2725
   Williams ED, 2013, ANN BEHAV MED, V46, P62, DOI 10.1007/s12160-013-9473-y
   Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895
NR 45
TC 2
Z9 2
U1 2
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0749-3797
EI 1873-2607
J9 AM J PREV MED
JI Am. J. Prev. Med.
PD JUN
PY 2016
VL 50
IS 6
BP 737
EP 745
DI 10.1016/j.amepre.2015.12.006
PG 9
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA DM7CD
UT WOS:000376509900012
PM 26810356
DA 2019-01-08
ER

PT J
AU Beverly, EA
   Ritholz, MD
   Shepherd, C
   Weinger, K
AF Beverly, Elizabeth A.
   Ritholz, Marilyn D.
   Shepherd, Chelsea
   Weinger, Katie
TI The Psychosocial Challenges and Care of Older Adults with Diabetes:
   "Can't Do What I Used To Do; Can't Be Who I Once Was"
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Diabetes; Psychosocial challenges; Depression; Diabetes distress; Aging
ID QUALITY-OF-LIFE; GENERALIZED ANXIETY DISORDER; SEROTONIN REUPTAKE
   INHIBITORS; COGNITIVE-BEHAVIORAL THERAPY; MAJOR DEPRESSIVE DISORDER;
   GLYCEMIC CONTROL; GERIATRIC DEPRESSION; MEXICAN-AMERICANS; SOCIAL
   SUPPORT; NEEDS DAWN
AB The prevalence of diabetes is increasing in older populations worldwide. Older adults with diabetes have unique psychosocial and medical challenges that impact self-care and glycemic control. These challenges may include psychological factors such as depression or anxiety, social factors such loss of independence and removal from home environment/placement in a facility, and medical factors such as multiple comorbidities and polypharmacy. Importantly, these challenges interact and complicate the everyday life of the older adult with diabetes. Thus, timely identification and interventions for psychosocial and medical challenges are a necessary component of diabetes care. This review summarizes the current literature, research findings, and clinical recommendations for psychosocial care in older adults with diabetes.
C1 [Beverly, Elizabeth A.; Shepherd, Chelsea] Ohio Univ, Heritage Coll Osteopath Med, Dept Family Med, Athens, OH 45701 USA.
   [Ritholz, Marilyn D.; Weinger, Katie] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Ritholz, Marilyn D.; Weinger, Katie] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Ritholz, Marilyn D.] Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.
RP Beverly, EA (reprint author), Ohio Univ, Heritage Coll Osteopath Med, Dept Family Med, Athens, OH 45701 USA.
EM beverle1@ohio.edu; marilyn.ritholz@joslin.harvard.edu;
   cs034312@ohio.edu; katie.weinger@joslin.harvard.edu
FU NIDDK NIH HHS [P30 DK036836]
CR Albright TL, 2001, FAM MED, V33, P354
   American Geriatrics Society 2012 Beers Criteria Update Expert Panel, 2012, J AM GERIATR SOC, V60, P616, DOI DOI 10.1111/J.1532-5415.2012.03923.X
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 2004, PARTNERSHIP SOLUTION
   [Anonymous], 2016, DIABETES CARE S1, V39, pS4
   Apesoa-Varano EC, 2010, AM J GERIAT PSYCHIAT, V18, P586, DOI 10.1097/JGP.0b013e3181d145ea
   Arean PA, 2002, BIOL PSYCHIAT, V52, P293, DOI 10.1016/S0006-3223(02)01371-9
   Barrowclough C, 2001, J CONSULT CLIN PSYCH, V69, P756, DOI 10.1037//0022-006X.69.5.756
   Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4
   Bech P., 2001, DEPRESSION SOCIAL EC, P63
   Bech P., 1998, QUALITY LIFE PSYCHIA
   BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D
   Bell RA, 2005, DIABETES CARE, V28, P823, DOI 10.2337/diacare.28.4.823
   Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4
   Berry LL, 2008, ANN FAM MED, V6, P6, DOI 10.1370/afm.757
   Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471
   BESDINE R, 2005, J AM GERIATR SOC, V53, P245, DOI DOI 10.1111/J.1532-5415.2005.53350
   Beverly EA, 2011, DIABETIC MED, V28, P781, DOI 10.1111/j.1464-5491.2011.03282.x
   Beverly Elizabeth A, 2014, Diabetes Spectr, V27, P44, DOI 10.2337/diaspect.27.1.44
   Beverly Elizabeth A, 2014, Clin Diabetes, V32, P12, DOI 10.2337/diaclin.32.1.12
   Beverly EA, 2013, DIABETES CARE, V36, P1501, DOI 10.2337/dc12-2110
   Beverly EA, 2011, DIABETES CARE, V34, P1086, DOI 10.2337/dc10-2298
   Bottino CMC, 2012, CURR PSYCHIAT REP, V14, P289, DOI 10.1007/s11920-012-0281-z
   BourdelMarchasson I, 1997, J AM GERIATR SOC, V45, P295, DOI 10.1111/j.1532-5415.1997.tb00943.x
   Bower ES, 2015, HARVARD REV PSYCHIAT, V23, P329, DOI 10.1097/HRP.0000000000000064
   BRADLEY C, 1994, HDB PSYCHOL DIABETES, P89
   Brenes GA, 2012, PSYCHOL SERV, V9, P219, DOI 10.1037/a0025950
   Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x
   Bruce DG, 2003, DIABETES RES CLIN PR, V61, P59, DOI 10.1016/S0168-8227(03)00084-6
   Burke V, 2003, J CLIN EPIDEMIOL, V56, P421, DOI 10.1016/S0895-4356(02)00610-8
   Callaghan BC, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD007543.PUB2
   Centers for Disease Control and Prevention, 2010, CURR DEPR AD US 2006
   Chernof BA, 1999, MED CARE, V37, P738, DOI 10.1097/00005650-199908000-00004
   Chou KL, 2005, INT J GERIATR PSYCH, V20, P570, DOI 10.1002/gps.1328
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Clifford KM, 2015, J GERONTOL NURS, V41, P10, DOI 10.3928/00989134-20150313-03
   Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0
   CONNELL CM, 1994, HEALTH PSYCHOL, V13, P263, DOI 10.1037//0278-6133.13.3.263
   COONROD BA, 1994, DIABETES CARE, V17, P852, DOI 10.2337/diacare.17.8.852
   Corrigan PW, 2003, J NERV MENT DIS, V191, P619, DOI 10.1097/01.nmd.0000087190.09305.b6
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   de Frias CM, 2015, AGING MENT HEALTH, V19, P201, DOI 10.1080/13607863.2014.924090
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Deschenes SS, 2015, J PSYCHOSOM RES, V78, P137, DOI 10.1016/j.jpsychores.2014.11.023
   Deshauer D, 2008, CAN MED ASSOC J, V178, P1293, DOI 10.1503/cmaj.071068
   Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195
   Epple C, 2003, DIABETES CARE, V26, P2829, DOI 10.2337/diacare.26.10.2829
   Fisher E. B., 2007, DIABETES ED, V33, P1104
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Flint AJ, 2002, CAN J PSYCHIAT, V47, P734
   Gallo JJ, 1999, AM FAM PHYSICIAN, V60, P820
   GARAYSEVILA ME, 1995, J DIABETES COMPLICAT, V9, P81, DOI 10.1016/1056-8727(94)00021-F
   Gaudreau C, 2015, CLIN GERONTOLOGIST, V38, P68, DOI 10.1080/07317115.2014.970319
   Glasser M, 1997, ARCH FAM MED, V6, P433, DOI 10.1001/archfami.6.5.433
   Goldman LS, 1999, J GEN INTERN MED, V14, P569, DOI 10.1046/j.1525-1497.1999.03478.x
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Graham JE, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-39
   Haltiwanger EP, 2012, OCCUP THER INT, V19, P67, DOI 10.1002/oti.320
   Hassing LB, 2004, J INT NEUROPSYCH SOC, V10, P599, DOI 10.1017/S1355617704104165
   Health NIoM, 2010, SUIC US STAT PREV
   Heinzel S, 2015, GEROPSYCH, V28, P149, DOI 10.1024/1662-9647/a000133
   Hines LE, 2011, AM J GERIATR PHARMAC, V9, P364, DOI 10.1016/j.amjopharm.2011.10.004
   Huang ES, 2005, J AM GERIATR SOC, V53, P306, DOI 10.1111/j.1532-5415.2005.53119.x
   Ingersoll G M, 1991, Diabetes Educ, V17, P114, DOI 10.1177/014572179101700219
   International Diabetes Federation, 2013, ATL IDFD
   Jacobson AM, 1998, ANN INTERN MED, V129, P656, DOI 10.7326/0003-4819-129-8-199810150-00016
   Jacobson AM, 1996, NEW ENGL J MED, V334, P1249, DOI 10.1056/NEJM199605093341907
   JAEN CR, 1994, J FAM PRACTICE, V38, P166
   Joiner TE, 2005, PSYCHOL ASSESSMENT, V17, P267, DOI 10.1037/1040-3590.17.3.267
   Kalyani RR, 2010, DIABETES CARE, V33, P1055, DOI 10.2337/dc09-1597
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kirkman MS, 2012, J AM GERIATR SOC, V60, P2342, DOI 10.1111/jgs.12035
   Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801
   KOVACS M, 1995, DIABETES CARE, V18, P1592, DOI 10.2337/diacare.18.12.1592
   Kovacs M, 1997, DIABETES CARE, V20, P45, DOI 10.2337/diacare.20.1.45
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Laiteerapong N, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110287
   Laiteerapong N, 2011, ANN NY ACAD SCI, V1243, P69, DOI 10.1111/j.1749-6632.2011.06316.x
   Lenze EJ, 2014, INT J GERIATR PSYCH, V29, P991, DOI 10.1002/gps.4086
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin KN, 2003, EUR NEUROL, V49, P53, DOI 10.1159/000067026
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   LUSTMAN PJ, 1992, DIABETES CARE, V15, P1631, DOI 10.2337/diacare.15.11.1631
   Lustman PJ, 1996, PRACTICAL PSYCHOL DI, P143
   Mark TL, 2011, AM J GERIAT PSYCHIAT, V19, P211, DOI 10.1097/JGP.0b013e3181f1803d
   Meneilly GS, 2016, CAN J DIABETES, V40, P73, DOI 10.1016/j.jcjd.2015.09.006
   Mitchell AJ, 2005, AM J PSYCHIAT, V162, P1588, DOI 10.1176/appi.ajp.162.9.1588
   Mohr DC, 2005, ARCH GEN PSYCHIAT, V62, P1007, DOI 10.1001/archpsyc.62.9.1007
   Mohr DC, 2000, J CONSULT CLIN PSYCH, V68, P356, DOI 10.1037//0022-006X.68.2.356
   Moulton CD, 2015, BRAIN IMAGING BEHAV, V9, P651, DOI 10.1007/s11682-014-9348-2
   Munshi M, 2006, DIABETES CARE, V29, P1794, DOI 10.2337/dc06-0506
   Nicklett EJ, 2010, J GERONTOL B-PSYCHOL, V65, P390, DOI 10.1093/geronb/gbp050
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nobili A, 2011, EUR J INTERN MED, V22, P597, DOI 10.1016/j.ejim.2011.08.029
   Palmer Carol, 2005, J Am Acad Nurse Pract, V17, P60, DOI 10.1111/j.1041-2972.2005.00012.x
   Park M, 2015, CLIN GERIATR MED, V31, P117, DOI 10.1016/j.cger.2014.08.022
   Park M, 2011, PSYCHIAT CLIN N AM, V34, P469, DOI 10.1016/j.psc.2011.02.009
   PEREZSTABLE EJ, 1990, ARCH INTERN MED, V150, P1083, DOI 10.1001/archinte.150.5.1083
   Peters S, 2009, J GEN INTERN MED, V24, P443, DOI 10.1007/s11606-008-0872-x
   Petrella RJ, 2005, DIABETES CARE, V28, P694, DOI 10.2337/diacare.28.3.694
   Peyrot M, 2006, DIABETES CARE, V29, P1256, DOI 10.2337/dc05-2444
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Pieper BA, 1990, DIABETES ED, V16, P108
   Pinquart M, 2006, AM J PSYCHIAT, V163, P1493, DOI 10.1176/appi.ajp.163.9.1493
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Prinz N, 2016, DIABETES RES CLIN PR, V112, P73, DOI 10.1016/j.diabres.2015.10.026
   Quandt SA, 2007, ETHNIC DIS, V17, P471
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rakovac I, 2004, DIABETOLOGIA, V47, P1469, DOI 10.1007/s00125-004-1467-7
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Richardson BS, 2015, J COMMUN HEALTH, V40, P905, DOI 10.1007/s10900-015-0011-7
   Rosenthal MJ, 1998, DIABETES CARE, V21, P231, DOI 10.2337/diacare.21.2.231
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   RUGGIERO L, 1990, DIABETES CARE, V13, P441, DOI 10.2337/diacare.13.4.441
   Savoca M, 2001, J NUTR EDUC, V33, P224, DOI 10.1016/S1499-4046(06)60035-3
   Sclar DA, 1999, DIABETES EDUCATOR, V25, P331, DOI 10.1177/014572179902500305
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Semenkovich K, 2015, DRUGS, V75, P577, DOI 10.1007/s40265-015-0347-4
   Simon GE, 2001, WESTERN J MED, V175, P292, DOI 10.1136/ewjm.175.5.292
   Sircar M, 2016, CAN J DIABETES, V40, P66, DOI 10.1016/j.jcjd.2015.10.004
   Sirey JA, 2001, AM J PSYCHIAT, V158, P479, DOI 10.1176/appi.ajp.158.3.479
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Smolina K, 2015, DIABETOLOGIA, V58, P942, DOI 10.1007/s00125-015-3515-x
   Solai LKK, 2001, DRUG AGING, V18, P355, DOI 10.2165/00002512-200118050-00006
   Stahl ST, 2016, INT J GERIATR PSYCH, V31, P963, DOI 10.1002/gps.4434
   Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228
   Tang WL, 2006, PHARMACOEPIDEM DR S, V15, P123, DOI 10.1002/pds.1166
   Tennvall GR, 2000, J DIABETES COMPLICAT, V14, P235
   Tew JD, 1999, AM J PSYCHIAT, V156, P1865
   Thorlund K, 2015, J AM GERIATR SOC, V63, P1002, DOI 10.1111/jgs.13395
   Thorpe L., 2009, CANADIAN REV ALZHEIM, P17
   Trief PM, 2004, ANN BEHAV MED, V27, P148, DOI 10.1207/s15324796abm2703_2
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   US Preventive Services Task Force, 2014, SCREEN COGN IMP OLD
   Van Orden KA, 2015, GERONTOLOGIST, V55, P972, DOI 10.1093/geront/gnu026
   van Schaik AM, 2012, AM J GERIAT PSYCHIAT, V20, P5, DOI 10.1097/JGP.0b013e31820dcbf9
   Van't Veer-Tazelaar P. J., 2009, ARCH GEN PSYCHIAT, V66, P297, DOI DOI 10.1001/ARCHGENPSYCHIATRY.2008.555
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Weinger K, 2006, DIABETIC FOOT MED SU
   Weinstock RS, 2015, DIABETES CARE
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Wen LK, 2004, DIABETES EDUCATOR, V30, P980, DOI 10.1177/014572170403000619
   Werfalli M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007635
   Wetherell JL, 2003, J CONSULT CLIN PSYCH, V71, P31, DOI 10.1037/0022-006X.71.1.31
   Wetherell JL, 2013, AM J PSYCHIAT, V170, P782, DOI 10.1176/appi.ajp.2013.12081104
   Wetherell JL, 2010, AGING MENT HEALTH, V14, P764, DOI 10.1080/13607861003713240
   WHO/ FAO, 2014, PREV SUIC GLOB IMP, P1
   YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
NR 165
TC 3
Z9 3
U1 1
U2 16
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD JUN
PY 2016
VL 16
IS 6
AR 48
DI 10.1007/s11892-016-0741-7
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DM3YT
UT WOS:000376283400003
PM 27085863
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Grillo, MDF
   Neumann, CR
   Scain, SF
   Rozeno, RF
   Beloli, L
   Perinetto, T
   Gross, JL
   Leitao, CB
AF Ferreira Grillo, Maria de Fatima
   Neumann, Cristina Rolim
   Scain, Suzana Fiore
   Rozeno, Raquel Farias
   Beloli, Luis
   Perinetto, Tiago
   Gross, Jorge Luiz
   Leitao, Cristiane Bauermann
TI Diabetes education in primary care: a randomized clinical trial
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Diabetes Mellitus; Health Education; Primary Health Care
ID SELF-MANAGEMENT EDUCATION; MICROVASCULAR COMPLICATIONS; GLYCEMIC
   CONTROL; TYPE-2; PROGRAM; TERM; ASSOCIATION
AB The aim of the study was to evaluate the effect of a structured group education program administered by a primary care nurse in patients with type 2 diabetes mellitus. The sample included 137 patients with type 2 diabetes mellitus, randomized into two groups: intervention (5-week educational course and reinforcements every 4 months for one year) and control (with no structured diabetes mellitus education) with an evaluation of metabolic control, weight, blood pressure, distress scores, and knowledge on diabetes. There were no differences between the two groups in HbA1c at 4, 8, or 12 months when compared to baseline values. An increase in HbA1c was observed in the control group after adjusting for baseline HbA1c and insulin dose (p = 0.044 between groups). Knowledge scores and diabetes-related distress improved after the intervention. A structured educational program administered to type 2 diabetes mellitus patients seen at a primary care unit improved the knowledge and distress associated with the disease. The results also suggest the prevention of an increase in HbA1c.
C1 [Ferreira Grillo, Maria de Fatima; Neumann, Cristina Rolim; Scain, Suzana Fiore; Rozeno, Raquel Farias; Beloli, Luis; Perinetto, Tiago; Gross, Jorge Luiz; Leitao, Cristiane Bauermann] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Rua Ramiro Barcelos 2350,Predio 12,4 Andar, BR-90035003 Porto Alegre, RS, Brazil.
RP Grillo, MDF (reprint author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Rua Ramiro Barcelos 2350,Predio 12,4 Andar, BR-90035003 Porto Alegre, RS, Brazil.
EM mf.grillo@hotmail.com
FU Fundo de Incentivo a Pesquisa (FIPE) do HCPA
FX The authors wish to thank the health care professionals and patients of
   the Santa Cecilia Primary Care Unit/Hospital de Clinicas de Porto Alegre
   (HCPA) in Porto Alegre, Brazil, for their support during this research.
   This study was supported by Fundo de Incentivo a Pesquisa (FIPE) do
   HCPA.
CR [Anonymous], 2015, DIABETES CARE S, V38, pS1
   Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Duke SA, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gagliardino JJ, 2001, DIABETES CARE, V24, P1001, DOI 10.2337/diacare.24.6.1001
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5
   Matsudo SMM, 2001, REV BRAS ATIV FIS SA, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Powers MA, 2015, DIABETES CARE, V38, P1372, DOI 10.2337/dc15-0730
   REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502
   Renders CM, 2001, DIABETES CARE, V24, P1365, DOI 10.2337/diacare.24.8.1365
   Scain SF, 2009, DIABETES EDUCATOR, V35, P603, DOI 10.1177/0145721709336299
   Scheffel Rafael Selbach, 2004, Rev. Assoc. Med. Bras., V50, P263, DOI 10.1590/S0104-42302004000300031
   Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727
   Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427
   Sociedade Brasileira de Diabetes, 2009, DIR SOC BRAS DIAB
   Sperl-Hillen J, 2011, ARCH INTERN MED, V171, P2001, DOI 10.1001/archinternmed.2011.507
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158
NR 21
TC 1
Z9 1
U1 0
U2 8
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR e00097115
DI 10.1590/0102-311X00097115
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900006
PM 27253458
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Kuniss, N
   Kramer, G
   Muller, N
   Kloos, C
   Lehmann, T
   Lorkowski, S
   Wolf, G
   Muller, UA
AF Kuniss, N.
   Kramer, G.
   Mueller, N.
   Kloos, C.
   Lehmann, T.
   Lorkowski, S.
   Wolf, G.
   Mueller, U. A.
TI Diabetes-Related Burden and Distress is Low in People with Diabetes at
   Outpatient Tertiary Care Level
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Article
DE diabetes-related distress; PAID questionnaire; WHO-5 questionnaire
ID GLYCEMIC CONTROL; PROBLEM AREAS; EMOTIONAL-PROBLEMS; SELF-MANAGEMENT;
   DEPRESSION; ASSOCIATION; SCALE; ADHERENCE; EDUCATION; SYMPTOMS
AB Objective: The importance of diabetes-related distress (DRD) for the treatment of diabetes is emphasized in national and international guidelines recommending routinely screening for psychosocial problems. To detect DRD, the PAID (Problem Area In Diabetes) questionnaire provides a valid and reliable instrument.
   Research Design and Methods: 783 patients with diabetes mellitus type 1 (DM1, n = 191, age 54.5 y, diabetes duration 22.5 y, HbA1c 7.2 % (55 mmol/mol)) and type 2 (DM2, n = 592, age 66.6 y, diabetes duration 15.6 y, HbA1c 7.0 % (60.1 mmol/mol)) were interviewed with the PAID and WHO-5 questionnaire in a University outpatient department for endocrinology and metabolic diseases in 2012. A PAID score >= 40 (range 0-100) was considered as high DRD.
   Results: The mean PAID score was 17.1 +/- 15.1 in all participants. Only 8.9 % of all responders showed high DRD (score = 40). The PAID score neither differed in people with DM1 and DM2, nor between participants with DM2 with or without insulin therapy. Females achieved significantly higher scores than men (19.0 +/- 16.6 vs. 15.6 +/- 13.7, p = 0.003). A strong negative correlation existed between the PAID score and the WHO-5 Well-being Index (r = -0.482, p < 0.001). A 10 points higher WHO-5 Well-being Index was associated with 15.9 points lower PAID score in people with DM1 (p < 0.001), and 9.2 points lower PAID score in DM2 (p < 0.001), respectively. One percent higher HbA1c was associated with an increase of diabetes-related distress by 2.5 points in people with DM1 and by 2.0 points in people with DM2.
   Conclusions: Less than 10 % of our outpatients with diabetes showed high diabetes-related distress.
C1 [Kuniss, N.; Kramer, G.; Mueller, N.; Kloos, C.; Wolf, G.; Mueller, U. A.] Jena Univ Hosp, Dept Internal Med 3, D-07743 Jena, Germany.
   [Lehmann, T.] Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, D-07743 Jena, Germany.
   [Lorkowski, S.] Univ Jena, Inst Nutr, D-07745 Jena, Germany.
   [Lorkowski, S.] Competence Cluster Nutr & Cardiovasc Hlth nutriCA, Halle, Germany.
RP Kuniss, N (reprint author), Jena Univ Hosp, Endocrinol & Metab Disorders, Dept Med 3, Bachstr 18, D-07743 Jena, Germany.
EM nadine.kuniss@med.uni-jena.de
RI Lorkowski, Stefan/B-9689-2008
OI Lorkowski, Stefan/0000-0002-9649-840X
CR American Diabetes Association, 2015, DIABETES CARE, V38
   [Anonymous], 2014, DIABETES RES CLIN PR, V104, P1
   Baz L, 2012, DIABETIC MED, V29, P640, DOI 10.1111/j.1464-5491.2011.03455.x
   Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P733, DOI 10.1007/s00103-013-1688-3
   Busse R, 2004, HEALTH AFFAIR, V23, P56, DOI 10.1377/hlthaff.23.3.56
   Dulon M, 2003, GESUNDHEITSWESEN, V65, P629
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   German Diabetes Association (DDG), 2015, GUID REC TREATM I CE
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Hagen B, 2012, QUALITY ASSURANCE RE
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009
   Joensen LE, 2013, DIABETES RES CLIN PR, V101, P278, DOI 10.1016/j.diabres.2013.07.001
   Kulzer BAC, 2013, S2 GUIDELINE PSYCHOS
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Petrak F, 2011, DIABETES STOFFWECH H, V20, P7
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 2001, DIABETIC MED, V18, P595, DOI 10.1046/j.1464-5491.2001.00499.x
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Schumann M., 2013, ELECT MED INFORM SYS
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   World Health Organization, 1998, MAST DEPR PRIM CAR
NR 30
TC 3
Z9 3
U1 1
U2 8
PU JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH
PI STUTTGART
PA RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0947-7349
EI 1439-3646
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PD MAY
PY 2016
VL 124
IS 5
BP 307
EP 312
DI 10.1055/s-0042-103685
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DM8KG
UT WOS:000376610900007
PM 27219688
DA 2019-01-08
ER

PT J
AU Upenieks, L
   Schafer, MH
   Iveniuk, J
AF Upenieks, Laura
   Schafer, Markus H.
   Iveniuk, James
TI Does disorder get "into the head" and "under the skin"? Layered contexts
   and bi-directional associations
SO HEALTH & PLACE
LA English
DT Article
DE Household disorder; Neighborhood disorder; C-reactive protein; Stress;
   Distress; Gender
ID C-REACTIVE PROTEIN; DRIED BLOOD SPOTS; SELF-RATED HEALTH; OLDER-ADULTS;
   CARDIOVASCULAR-DISEASE; NEIGHBORHOOD DISORDER; SOCIOECONOMIC-STATUS;
   GENDER-DIFFERENCES; DIABETES-MELLITUS; NATIONAL SAMPLE
AB This paper utilizes a layered context approach to examine how neighborhood and household conditions are associated with the objective and subjective well-being of older adults. Using two waves of data from the National Social Life, Health, and Aging Project (n=2261), we assess subjective mental health through self-reported measures of perceived stress and distress and objective physical health through C-reactive protein (CRP). Environmental disorder was measured by independent, trained interviewers. Cross-sectional results indicate that household disorder is positively associated with perceived stress and distress, overwhelming the association between neighborhood disorder and mental health outcomes. Yet longitudinal findings point to a reverse process, whereby highly stressed women experience deterioration in their home environment across the two waves. Few significant findings surfaced for CRP. Taken together, our findings illustrate the complex interplay between health and proximal environments and underscore how feedback cycles operate between "health" and "place" across multiple outcomes. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Upenieks, Laura; Schafer, Markus H.] Univ Toronto, Dept Sociol, 725 Spadina Ave, Toronto, ON M5S 2J4, Canada.
   [Iveniuk, James] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 2J4, Canada.
RP Upenieks, L (reprint author), Univ Toronto, Dept Sociol, 725 Spadina Ave, Toronto, ON M5S 2J4, Canada.
EM laura.upenieks@mail.utoronto.ca
FU Canadian Social Sciences and Humanities Research Council [231615]
FX We acknowledge support from the Canadian Social Sciences and Humanities
   Research Council (Insight Development Grant #231615). Data were made
   available by the Interuniversity Consortium for Political and Social
   Research, Ann Arbor, MI. Neither the collector of the original data nor
   the Consortium bears any responsibility for the analyses or
   interpretations presented here.
CR Alfonzo M, 2008, J URBAN DES, V13, P29, DOI 10.1080/13574800701803456
   Beard JR, 2009, AM J PUBLIC HEALTH, V99, P1308, DOI 10.2105/AJPH.2007.125104
   Bernard P, 2007, SOC SCI MED, V65, P1839, DOI 10.1016/j.socscimed.2007.05.037
   Bird CE, 2010, J EPIDEMIOL COMMUN H, V64, P860, DOI 10.1136/jech.2008.084814
   Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV
   Brown SC, 2009, J GERONTOL B-PSYCHOL, V64, P234, DOI 10.1093/geronb/gbn011
   Cagney K. A., 2010, ANNU REV GERONTOL, V30, P323, DOI DOI 10.1891/0198-8794.30.323
   Chandola T, 2004, SOC SCI MED, V58, P1501, DOI 10.1016/S0277-9536(03)00352-6
   Choi M, 2012, J AGING HEALTH, V24, P1364, DOI 10.1177/0898264312460574
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Cornwell EY, 2014, J GERONTOL B-PSYCHOL, V69, pS51, DOI 10.1093/geronb/gbu052
   Cornwell EY, 2014, RES AGING, V36, P399, DOI 10.1177/0164027513497369
   Cutrona CE, 2000, J PERS SOC PSYCHOL, V79, P1088, DOI 10.1037//0022-3514.79.6.1088
   Danesh J, 2000, BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199
   Downey L, 2005, J HEALTH SOC BEHAV, V46, P289, DOI 10.1177/002214650504600306
   Echeverria MSE, 2004, J URBAN HEALTH, V81, P682, DOI DOI 10.1093/JURBAN/JTH151
   ELLAWAY A, 2001, GEOGRAPHIES WOMENS H
   Essex EL, 2005, FAM RELAT, V54, P448
   Evans GW, 2003, J SOC ISSUES, V59, P475, DOI 10.1111/1540-4560.00074
   Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349
   Finch BK, 2010, HEALTH PLACE, V16, P1058, DOI 10.1016/j.healthplace.2010.05.009
   Floro MS, 2003, CAMBRIDGE J ECON, V27, P881, DOI 10.1093/cje/27.6.881
   Fullilove MT, 2000, AM J PUBLIC HEALTH, V90, P183, DOI 10.2105/AJPH.90.2.183
   Gaskins AJ, 2012, AM J EPIDEMIOL, V175, P423, DOI 10.1093/aje/kwr343
   Glass T. A., 2003, NEIGHBORHOODS HLTH, P303, DOI [10.1093/acprof:oso/9780195138382.003.0014, DOI 10.1093/ACPROF:OSO/9780195138382.003.0014]
   Haas SA, 2006, J HEALTH SOC BEHAV, V47, P339, DOI 10.1177/002214650604700403
   Haas SA, 2010, J HEALTH SOC BEHAV, V51, P424, DOI 10.1177/0022146510386791
   Hill TD, 2005, J HEALTH SOC BEHAV, V46, P170, DOI 10.1177/002214650504600204
   Holmes LM, 2012, HEALTH PLACE, V18, P683, DOI 10.1016/j.healthplace.2011.11.006
   Joint Center for Housing Studies of Harvard University, 2014, HOUS AM OLD AD M NEE
   Kavanagh AM, 2006, J EPIDEMIOL COMMUN H, V60, P490, DOI 10.1136/jech.2005.043562
   Kawachi Ichiro, 2000, SOCIAL EPIDEMIOLOGY, P174
   Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051
   Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100
   King DE, 2003, DIABETES CARE, V26, P1535, DOI 10.2337/diacare.26.5.1535
   Krantz-Kent R, 2007, MON LABOR REV, V130, P8
   Kuo HK, 2006, J GERONTOL A-BIOL, V61, P380, DOI 10.1093/gerona/61.4.380
   Lakoski SG, 2006, AM HEART J, V152, P593, DOI 10.1016/j.ahj.2006.02.015
   Latkin CA, 2003, J HEALTH SOC BEHAV, V44, P34, DOI 10.2307/1519814
   Lawton M. P., 1973, PSYCHOL ADULT DEV AG, P619, DOI DOI 10.1037/10044-020
   LAWTON MP, 1983, GERONTOLOGIST, V23, P349, DOI 10.1093/geront/23.4.349
   Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247
   Martin-Storey A, 2012, ANN BEHAV MED, V43, P162, DOI 10.1007/s12160-011-9310-0
   Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038
   McDade TW, 2011, J GERONTOL B-PSYCHOL, V66, P129, DOI 10.1093/geronb/gbq008
   McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64
   McDade TW, 2004, CLIN CHEM, V50, P652, DOI 10.1373/clinchem.2003.029488
   Merkin SS, 2009, ANN EPIDEMIOL, V19, P194, DOI 10.1016/j.annepidem.2008.12.006
   MOHAI P, 1997, RACE GENDER CLASS, V0005
   Molinari C, 1998, SOC SCI MED, V47, P1113, DOI 10.1016/S0277-9536(98)00114-2
   Nazmi A, 2010, HEALTH PLACE, V16, P1104, DOI 10.1016/j.healthplace.2010.07.001
   O'Doherty K, 2014, J GERONTOL B-PSYCHOL, V69, pS27, DOI 10.1093/geronb/gbu045
   Oswald F., 2003, J HOUS ELDERLY, V17, P135, DOI DOI 10.1300/J081V17N01_
   Pearlin L., 2013, HDB SOCIOLOGY MENTAL, P325, DOI DOI 10.1007/978-94-007-4276-5_16
   PEARLIN LI, 1989, J HEALTH SOC BEHAV, V30, P241, DOI 10.2307/2136956
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Perkins DD, 1996, AM J COMMUN PSYCHOL, V24, P63, DOI 10.1007/BF02511883
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Robert SA, 2001, RES AGING, V23, P233
   Ross CE, 1999, URBAN AFF REV, V34, P412, DOI 10.1177/10780879922184004
   Ross CE, 2001, AM SOCIOL REV, V66, P568, DOI 10.2307/3088923
   Ross CE, 2000, J HEALTH SOC BEHAV, V41, P177, DOI 10.2307/2676304
   Rowles G. D., 2003, ANN REV GERONTOLOGY, V23, P167
   Royston P., 2005, STATA J, V5, P517
   Sampson RJ, 1999, AM J SOCIOL, V105, P603, DOI 10.1086/210356
   Sbarra DA, 2009, PSYCHOSOM MED, V71, P828, DOI 10.1097/PSY.0b013e3181b4c4f2
   Schafer MH, 2015, SOC SCI MED, V124, P152, DOI 10.1016/j.socscimed.2014.11.037
   Schafer MH, 2013, RES AGING, V35, P348, DOI 10.1177/0164027512441612
   Schieman S, 2004, J GERONTOL B-PSYCHOL, V59, pS89, DOI 10.1093/geronb/59.2.S89
   Schootman M, 2007, AM J EPIDEMIOL, V166, P379, DOI 10.1093/aje/kwm190
   Shiue I, 2013, INT J CARDIOL, V168, P5069, DOI 10.1016/j.ijcard.2013.07.200
   SOUTH SJ, 1994, AM SOCIOL REV, V59, P327, DOI 10.2307/2095937
   Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socsimed.2004.08.028
   Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260
   von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x
   Wahl HW, 2009, GERONTOLOGIST, V49, P355, DOI 10.1093/geront/gnp056
   Wen M, 2006, SOC SCI MED, V63, P2575, DOI 10.1016/j.socscimed.2006.06.025
   Wheaton B., 2010, HDB STUDY MENTAL HLT, P171
   Yen IH, 1999, AM J EPIDEMIOL, V149, P898
NR 80
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1353-8292
EI 1873-2054
J9 HEALTH PLACE
JI Health Place
PD MAY
PY 2016
VL 39
BP 131
EP 141
DI 10.1016/j.hcalthplace.2016.03.009
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM7DQ
UT WOS:000376515600017
PM 27086267
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Fisher, L
   Hessler, D
   Johnson, N
AF Polonsky, William H.
   Fisher, Lawrence
   Hessler, Danielle
   Johnson, Nicole
TI Emotional Distress in the Partners of Type 1 Diabetes Adults: Worries
   About Hypoglycemia and Other Key Concerns
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID EUROPEAN-AMERICAN; DEPRESSION
AB Background: Although the widespread prevalence of diabetes-related distress (DD) in adults with type 1 diabetes (T1D) has been well established, there has been little inquiry into the experiences of their spouse/partners. Therefore the goal of this study was to investigate the prevalence and sources of DD in the spouses and partners of adults with T1D (T1D partner) and to examine the associations of DD in this population with key demographic and contextual factors. Materials and Methods: Qualitative interviews with 11 T1D partners led to the development of 44 DD survey items, which were examined by exploratory factor analysis (EFA). Regression models examined associations of the resulting DD scales with four groups of variables: partner demographics and contextual variables, as well as person with diabetes (PWD) demographics, diabetes status, and behavioral factors. Results: EFA with 317 T1D partners yielded a 22-item scale with four factors: Hypoglycemia Distress, Emotional Distress, Management Distress, and Role Distress. All scales were significantly correlated with the three criterion variables (depression, general life stress, and diabetes-related relationship satisfaction), suggesting satisfactory concurrent validity. High DD was most common for Hypoglycemic Distress (64.4% of the sample) and least common for Management Distress (28.4%). Greater DD was significantly and independently linked with being younger, female, greater involvement in the PWD's diabetes management, lower levels of relationship satisfaction, less trusting of the PWD's physician, poorer PWD glycemic control, and more frequent hypoglycemic episodes. T1D partners also reported low levels of diabetes-related support from all sources. Conclusions: Four sources of partner DD were identified. Results suggest that DD in T1D partners is common, especially distress associated with hypoglycemia. Predictors of T1D partner DD come from multiple sources: demographic, disease-related, and contextual arenas, all pointing to opportunities for acknowledging and addressing DD directly in this population.
C1 [Polonsky, William H.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Fisher, Lawrence; Hessler, Danielle] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Johnson, Nicole] Bringing Sci Home, Tampa, FL USA.
RP Polonsky, WH (reprint author), POB 2148, Del Mar, CA 92014 USA.
EM whp@behavioraldiabetes.org
FU Bringing Science Home; Locemia Solutions
FX This investigator-initiated study was supported by Bringing Science Home
   and Locemia Solutions.
CR Fisher L, 2002, DIABETES CARE, V25, P1564, DOI 10.2337/diacare.25.9.1564
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   GonderFrederick L, 1997, DIABETES CARE, V20, P1543, DOI 10.2337/diacare.20.10.1543
   Hessler DM, 2012, DIABETES, V61, pA203
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lawton J, 2014, DIABETES CARE, V37, P109, DOI 10.2337/dc13-1154
   Pearlin LI, 1981, J HEALTH SOC BEHAV, V22, P333
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Trief PM, 2013, DIABETES CARE, V36, P2483, DOI 10.2337/dc12-1718
   Trief PM, 2004, ANN BEHAV MED, V27, P148, DOI 10.1207/s15324796abm2703_2
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   Tschann JM, 1999, J MARRIAGE FAM, V61, P269, DOI 10.2307/353747
NR 13
TC 6
Z9 6
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD MAY
PY 2016
VL 18
IS 5
BP 292
EP 297
DI 10.1089/dia.2015.0451
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DM0DW
UT WOS:000376014000007
PM 26859072
DA 2019-01-08
ER

PT J
AU Berman, DM
   Molano, D
   Fotino, C
   Ulissi, U
   Gimeno, J
   Mendez, AJ
   Kenyon, NM
   Kenyon, NS
   Andrews, DM
   Ricordi, C
   Pileggi, A
AF Berman, Dora M.
   Molano, Damaris
   Fotino, Carmen
   Ulissi, Ulisse
   Gimeno, Jennifer
   Mendez, Armando J.
   Kenyon, Norman M.
   Kenyon, Norma S.
   Andrews, David M.
   Ricordi, Camillo
   Pileggi, Antonello
TI Bioengineering the Endocrine Pancreas: Intraomental Islet
   Transplantation Within a Biologic Resorbable Scaffold
SO DIABETES
LA English
DT Article
ID MEDIATED INFLAMMATORY REACTION; OMENTAL POUCH SITE; LONG-TERM; TISSUE
   FACTOR; DIABETES-MELLITUS; HEPATIC STEATOSIS; COLD PRESERVATION;
   GRAFT-SURVIVAL; BLOOD; CELLS
AB Transplantation of pancreatic islets is a therapeutic option to preserve or restore -cell function. Our study was aimed at developing a clinically applicable protocol for extrahepatic transplantation of pancreatic islets. The potency of islets implanted onto the omentum, using an in situ-generated adherent, resorbable plasma-thrombin biologic scaffold, was evaluated in diabetic rat and nonhuman primate (NHP) models. Intraomental islet engraftment in the biologic scaffold was confirmed by achievement of improved metabolic function and preservation of islet cytoarchitecture, with reconstitution of rich intrainsular vascular networks in both species. Long-term nonfasting normoglycemia and adequate glucose clearance (tolerance tests) were achieved in both intrahepatic and intraomental sites in rats. Intraomental graft recipients displayed lower levels of serum biomarkers of islet distress (e.g., acute serum insulin) and inflammation (e.g., leptin and 2-macroglobulin). Importantly, low-purity (30:70% endocrine:exocrine) syngeneic rat islet preparations displayed function equivalent to that of pure (>95% endocrine) preparations after intraomental biologic scaffold implantation. Moreover, the biologic scaffold sustained allogeneic islet engraftment in immunosuppressed recipients. Collectively, our feasibility/efficacy data, along with the simplicity of the procedure and the safety of the biologic scaffold components, represented sufficient preclinical testing to proceed to a pilot phase I/II clinical trial.
C1 [Berman, Dora M.; Molano, Damaris; Fotino, Carmen; Ulissi, Ulisse; Gimeno, Jennifer; Mendez, Armando J.; Kenyon, Norman M.; Kenyon, Norma S.; Ricordi, Camillo; Pileggi, Antonello] Univ Miami, Diabet Res Inst, Cell Transplant Ctr, Miami, FL USA.
   [Berman, Dora M.; Kenyon, Norman M.; Kenyon, Norma S.; Ricordi, Camillo; Pileggi, Antonello] Univ Miami, DeWitt Daughtry Family Dept Surg, Miami, FL USA.
   [Mendez, Armando J.; Ricordi, Camillo] Univ Miami, Dept Med, Miami, FL USA.
   [Kenyon, Norma S.; Ricordi, Camillo; Pileggi, Antonello] Univ Miami, Dept Microbiol & Immunol, Miami, FL USA.
   [Kenyon, Norma S.; Ricordi, Camillo; Pileggi, Antonello] Univ Miami, Dept Biomed Engn, Miami, FL USA.
   [Andrews, David M.] Univ Miami, Dept Pathol, Miami, FL USA.
RP Berman, DM; Ricordi, C; Pileggi, A (reprint author), Univ Miami, Diabet Res Inst, Cell Transplant Ctr, Miami, FL USA.; Berman, DM; Ricordi, C; Pileggi, A (reprint author), Univ Miami, DeWitt Daughtry Family Dept Surg, Miami, FL USA.; Ricordi, C (reprint author), Univ Miami, Dept Med, Miami, FL USA.; Ricordi, C; Pileggi, A (reprint author), Univ Miami, Dept Microbiol & Immunol, Miami, FL USA.; Ricordi, C; Pileggi, A (reprint author), Univ Miami, Dept Biomed Engn, Miami, FL USA.
EM dberman2@med.miami.edu; ricordi@miami.edu; antonello.pileggi@nih.gov
OI Ricordi, Camillo/0000-0001-8092-7153; Pileggi,
   Antonello/0000-0001-7819-2813
FU Diabetes Research Institute Foundation; Leona M. and Harry B. Helmsley
   Charitable Trust; JDRF International [17-2012-361]; UM Clinical and
   Translational Science Institute; National Center for Advancing
   Translational Sciences; National Institute on Minority Health and Health
   Disparities [1UL1TR000460]
FX This study was partially supported by the Diabetes Research Institute
   Foundation (www.diabetesresearch.org), by the Leona M. and Harry B.
   Helmsley Charitable Trust, and by JDRF International (17-2012-361). The
   project was part of A.P.'s Master of Science in Clinical and
   Translational Investigation training, a program supported by the UM
   Clinical and Translational Science Institute, from the National Center
   for Advancing Translational Sciences and the National Institute on
   Minority Health and Health Disparities (1UL1TR000460).
CR ACKERMANN PC, 1991, ACTA ANAT, V140, P146
   ALEJANDRO R, 1986, J CLIN INVEST, V78, P1339, DOI 10.1172/JCI112720
   [Anonymous], 2014, CELLR4, V2, pe891
   AO Z, 1992, TRANSPLANT P, V24, P2789
   AO ZL, 1993, TRANSPLANTATION, V56, P524, DOI 10.1097/00007890-199309000-00007
   Badell IR, 2012, AM J TRANSPLANT, V12, P1918, DOI 10.1111/j.1600-6143.2012.04029.x
   Bartholomeus K, 2013, TRANSPLANTATION, V96, P1026, DOI 10.1097/TP.0b013e3182a6ee41
   Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059
   Berman DM, 2009, AM J TRANSPLANT, V9, P91, DOI 10.1111/j.1600-6143.2008.02489.x
   Berman DM, 2007, TRANSPLANTATION, V84, P308, DOI 10.1097/01.tp.0000275401.80187.le
   Berney T, 2006, AM J TRANSPLANT, V6, P1704, DOI 10.1111/j.1600-6143.2006.01373.x
   Bhargava R, 2004, DIABETES, V53, P1311, DOI 10.2337/diabetes.53.5.1311
   Brady AC, 2010, AM J TRANSPLANT, V10, P76
   Chaffanjon PCJ, 2005, SURG RADIOL ANAT, V27, P287, DOI 10.1007/s00276-005-0329-4
   Chinnakotla S, 2014, ANN SURG, V260, P56, DOI 10.1097/SLA.0000000000000569
   Cray C, 2009, COMPARATIVE MED, V59, P517
   Dong X, 2014, XENOTRANSPLANTATION, V21, P140, DOI [10.1111/xen.12077, 10.1111/xen.12086]
   Eckhard M, 2004, TRANSPLANT P, V36, P1111, DOI 10.1016/j.transproceed.2004.04.047
   Faradji RN, 2005, TRANSPL P, V37, P3433, DOI 10.1016/j.transproceed.2005.09.090
   Fotino N, 2015, PHARMACOL RES, V98, P76, DOI 10.1016/j.phrs.2015.02.010
   Guan J, 1995, TRANSPLANT P, V27, P3236
   Guan JY, 1998, DIABETES, V47, P1020, DOI 10.2337/diabetes.47.7.1020
   Ham SW, 2010, J BLOOD MED, V1, P135, DOI 10.2147/JBM.S6622
   Hefty TR, 2010, J SURG RES, V161, P134, DOI 10.1016/j.jss.2008.11.842
   Hogan AR, 2012, CELL TRANSPLANT, V21, P1349, DOI 10.3727/096368911X623853
   Ichii H, 2005, AM J TRANSPLANT, V5, P21, DOI 10.1111/j.1600-6143.2005.00698.x
   Ichii H, 2008, LAB INVEST, V88, P1167, DOI 10.1038/labinvest.2008.87
   Jackson S, 2013, ISLETS, V5, P16, DOI 10.4161/isl.24058
   Jacobs-Tulleneers-Thevissen D, 2010, DIABETOLOGIA, V53, P1690, DOI 10.1007/s00125-010-1721-0
   Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755
   Kakabadze Z, 2013, AM J TRANSPLANT, V13, P2550, DOI 10.1111/ajt.12412
   Kim HI, 2010, J KOREAN MED SCI, V25, P203, DOI 10.3346/jkms.2010.25.2.203
   Leitao CB, 2014, CELL TRANSPLANT, V23, P1221, DOI 10.3727/096368913X668663
   Maffi P, 2005, CELL TRANSPLANT, V14, P727, DOI 10.3727/000000005783982567
   Markmann JF, 2003, DIABETES, V52, P1591, DOI 10.2337/diabetes.52.7.1591
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779
   Pedraza E, 2013, CELL TRANSPLANT, V22, P1123, DOI 10.3727/096368912X657440
   Perez VL, 2011, DIABETOLOGIA, V54, P1121, DOI 10.1007/s00125-011-2091-y
   Philosophe B, 2001, ANN SURG, V234, P689, DOI 10.1097/00000658-200111000-00016
   Piemonti L, 2013, CELLR4, V1, P8
   Pileggi Antonello, 2004, Clin Transpl, P177
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   Pileggi A, 2013, DIABETES, V62, P3333, DOI 10.2337/db13-1039
   Pileggi A, 2009, TRANSPLANTATION, V87, P1442, DOI 10.1097/TP.0b013e3181a36b1e
   Platell C, 2000, WORLD J GASTROENTERO, V6, P169
   Posselt AM, 2010, TRANSPLANTATION, V90, P1595, DOI 10.1097/TP.0b013e3181fe1377
   Procaccini C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00143
   RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413
   Ricordi C, 2003, DIABETES, V52, P1595, DOI 10.2337/diabetes.52.7.1595
   Ricordi C, 1995, TRANSPLANT P, V27, P3382
   SIMEONOVIC CJ, 1986, AUST J EXP BIOL MED, V64, P37, DOI 10.1038/icb.1986.4
   Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107
   Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264
   YASUNAMI Y, 1983, TRANSPLANTATION, V36, P181, DOI 10.1097/00007890-198308000-00014
NR 55
TC 27
Z9 29
U1 2
U2 9
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD MAY
PY 2016
VL 65
IS 5
BP 1350
EP 1361
DI 10.2337/db15-1525
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DK6JA
UT WOS:000375028000024
PM 26916086
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Powers, MA
   Richter, S
   Ackard, D
   Craft, C
AF Powers, Margaret A.
   Richter, Sara
   Ackard, Diann
   Craft, Cheryl
TI Development and validation of the Screen for Early Eating Disorder Signs
   (SEEDS) in persons with type 1 diabetes
SO EATING DISORDERS
LA English
DT Article
ID EXAMINATION QUESTIONNAIRE; BODY DISSATISFACTION; DISTRESS SCALE;
   ADOLESCENTS; INSULIN; SAMPLE; LIFE; PREVALENCE; MORTALITY; BEHAVIOR
AB This study's objective was to develop and validate an instrument to identify those at risk of developing an eating disorder (ED) in persons with type 1 diabetes. The Screen for Early Eating Disorder Signs (SEEDS) instrument was developed using a multi-phase process including focus groups, cognitive interviews, and mailed questionnaires. Factor analysis revealed 20 items across three factors (Body Image, Feelings, Quality of Life) demonstrating strong psychometric properties. Scoring guidelines and interpretation are provided. SEEDS is a brief (20-item; 2-5minutes to complete), self-administered, screen designed for use in clinical practice or research to identify or confirm suspicions of ED risk and does not include weight-control behavior items.
C1 [Powers, Margaret A.] Int Diabet Ctr Pk Nicollet, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.
   [Richter, Sara; Craft, Cheryl] Pk Nicollet Inst, Minneapolis, MN USA.
   [Ackard, Diann] Pk Nicollet Melrose Ctr, Minneapolis, MN USA.
RP Powers, MA (reprint author), Int Diabet Ctr Pk Nicollet, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.
EM margaret.powers@parknicollet.com
FU Park Nicollet Foundation
FX This work was supported by a grant from the Park Nicollet Foundation.
   The study is registered through ClinicalTrials.gov (NCT00948311).
CR Ackard DM, 2008, PEDIATR DIABETES, V9, P312, DOI 10.1111/j.1399-5448.2008.00392.x
   Ajetunmobi O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002768
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Berg KC, 2012, INT J EAT DISORDER, V45, P850, DOI 10.1002/eat.20948
   Carter JC, 2001, BEHAV RES THER, V39, P625, DOI 10.1016/S0005-7967(00)00033-4
   Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140
   Colton PA, 2013, PEDIATR DIABETES, V14, P372, DOI 10.1111/pedi.12016
   Crow SJ, 1998, PSYCHOSOMATICS, V39, P233, DOI 10.1016/S0033-3182(98)71340-4
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272
   Fairburn C. G., 2008, COGNITIVE BEHAV THER
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967
   Gagnon C, 2012, DIABETES EDUCATOR, V38, P537, DOI 10.1177/0145721712446203
   Goebel-Fabbri AE, 2008, DIABETES CARE, V31, P415, DOI 10.2337/dc07-2026
   Hanlan ME, 2013, CURR DIABETES REP, V13, P909, DOI 10.1007/s11892-013-0418-4
   HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037//0033-295X.94.3.319
   Hill LS, 2010, INT J EAT DISORDER, V43, P344, DOI 10.1002/eat.20679
   Kelly SD, 2005, DIABETES EDUCATOR, V31, P572, DOI 10.1177/0145721705279049
   Markowitz JT, 2010, DIABETES CARE, V33, P495, DOI 10.2337/dc09-1890
   Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Powers MA, 2016, J HEALTH PSYCHOL, V21, P2966, DOI 10.1177/1359105315589799
   Powers MA, 2013, DIABETES EDUCATOR, V39, P387, DOI 10.1177/0145721713482737
   Powers MA, 2012, INT J EAT DISORDER, V45, P252, DOI 10.1002/eat.20928
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   RODIN G, 1991, PSYCHOSOMATICS, V32, P171, DOI 10.1016/S0033-3182(91)72088-4
   Rosenberg M, 1965, SOC ADOLESCENT SELF
   Rydall A., 2002, DIABETES SPECTRUM, V15, P90
   Schwarzer R, 1995, MEASURES HLTH PSYCHO, V1, P35
   Schwarzer R, 2005, SELF EFFICACY BELIEF, P139
   Stice E, 2009, J ABNORM PSYCHOL, V118, P587, DOI 10.1037/a0016481
   STRAUMAN TJ, 1991, J PERS SOC PSYCHOL, V61, P946, DOI 10.1037/0022-3514.61.6.946
   Suokas JT, 2013, PSYCHIAT RES, V210, P1101, DOI 10.1016/j.psychres.2013.07.042
   Wade TD, 2012, HEALTH PSYCHOL, V31, P352, DOI 10.1037/a0025956
   Wisting L, 2013, DIABETES CARE, V36, P3382, DOI 10.2337/dc13-0431
   Young V, 2013, DIABETIC MED, V30, P189, DOI 10.1111/j.1464-5491.2012.03771.x
   Zuijdwijk CS, 2014, DIABETES CARE, V37, pE26, DOI 10.2337/dc13-1637
NR 38
TC 1
Z9 1
U1 2
U2 7
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1064-0266
EI 1532-530X
J9 EAT DISORD
JI Eat. Disord
PD MAY-JUN
PY 2016
VL 24
IS 3
BP 271
EP 288
DI 10.1080/10640266.2015.1090866
PG 18
WC Psychology, Clinical; Psychiatry; Psychology
SC Psychology; Psychiatry
GA DL3UE
UT WOS:000375558100005
PM 26467220
DA 2019-01-08
ER

PT J
AU Raymond, KL
   Lovell, GP
AF Raymond, Karren-Lee
   Lovell, Geoff P.
TI Food addiction associations with psychological distress among people
   with type 2 diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Type 2 diabetes; psychological distress; BMI; food addiction; depression
ID NATIONAL EPIDEMIOLOGIC SURVEY; SUBSTANCE USE DISORDERS; BODY-MASS INDEX;
   NONCLINICAL SAMPLE; CONSTRUCT-VALIDITY; DEPRESSION; MOOD; ANXIETY;
   OBESITY; STRESS
AB Aims: To assess the relationship between a food addiction (FA) model and psychological distress among a type 2 diabetes (t2d) sample.
   Methods: A cross-sectional study of 334 participants with t2d diagnoses were invited to complete a web-based questionnaire. We measured variables of psychological distress implementing the Depression Anxiety and Stress Scale (DASS-21), the Yale Food Addiction Scale (YFAS), and other factors associated with t2d.
   Results: In our study a novel finding highlighted people with t2d meeting the FA criterion had significantly higher depression, anxiety, and stress scores as compared to participants who did not meet the FA criterion. Moreover, FA symptomology explained 35% of the unique variance in depression scores, 34% of the unique variance in anxiety scores, and 34% of the unique variance in stress scores, while surprisingly, BMI explained less than 1% of the unique variance in scores.
   Conclusion: We identified that psychological distress among people with t2d was associated with the FA model, apparently more so than BMI, thereby indicating further research being necessary lending support for future research in this realm. Moreover the FA model may be beneficial when addressing treatment approaches for psychological distress among people with t2d. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Raymond, Karren-Lee; Lovell, Geoff P.] Univ Sunshine Coast, Fac Arts & Social Sci, Maroochydore, Australia.
RP Raymond, KL (reprint author), Univ Sunshine Coast, Sch Social Sci, Locked Bag 4, Maroochydore, Qld 4558, Australia.
EM karren-lee.raymond@research.usc.edu.au; glovell@usc.edu.au
CR Abiles V, 2010, OBES SURG, V20, P161, DOI 10.1007/s11695-008-9726-1
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Bener A, 2011, ONCOL REV, V5, P5, DOI 10.1007/s12156-010-0061-0
   Brunault P, 2014, CAN J PSYCHIAT, V59, P276
   Burmeister JM, 2013, APPETITE, V60, P103, DOI 10.1016/j.appet.2012.09.013
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Corsica JA, 2010, CURR OPIN GASTROEN, V26, P165, DOI 10.1097/MOG.0b013e328336528d
   Corwin RL, 2009, J NUTR, V139, P617, DOI 10.3945/jn.108.097691
   Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x
   Feinkohl I, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0130-5
   Furuya M, 2013, ACTA DIABETOL, V50, P117, DOI 10.1007/s00592-010-0219-z
   Gearhardt AN, 2013, COMPR PSYCHIAT, V54, P500, DOI 10.1016/j.comppsych.2012.12.009
   Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P140
   Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003
   Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x
   Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807
   Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657
   Ifland JR, 2009, MED HYPOTHESES, V72, P518, DOI 10.1016/j.mehy.2008.11.035
   Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69
   Klimkiewicz A, 2015, PSYCHIATR POL, V49, P265, DOI 10.12740/PP/25704
   Lefever R., 2000, KICK THE HABIT
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lovibond SH, 1995, MANUAL DEPRESSION AN
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Martins SS, 2011, DRUG ALCOHOL DEPEN, V119, P28, DOI 10.1016/j.drugalcdep.2011.05.010
   Mather AA, 2009, J PSYCHOSOM RES, V66, P277, DOI 10.1016/j.jpsychores.2008.09.008
   McKay JR, 2011, ALCOHOL RES HEALTH, V33, P356
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029
   Muele A., 2014, CURRENT ADDICTION RE, V1, P193
   Pan A, 2015, LANCET DIABETES ENDO, V3, P958, DOI 10.1016/S2213-8587(15)00316-2
   Pedram P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074832
   Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651
   Pettinati HM, 2013, AM J PSYCHIAT, V170, P23, DOI 10.1176/appi.ajp.2012.12010112
   Pietras T, 2011, MED SCI MONITOR, V17, pCR272, DOI 10.12659/MSM.881767
   Raymond KL, 2015, APPETITE, V95, P383, DOI 10.1016/j.appet.2015.07.030
   Rubin RR, 2002, DIABETES METAB RES, V18, P173, DOI 10.1002/dmrr.292
   Schulte EM, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0563-3
   Sheppard K., 2000, FROM THE 1 BITE
   Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824
   Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032
   Sutin AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070048
   Svenningsson I, 2012, SCAND J CARING SCI, V26, P349, DOI 10.1111/j.1471-6712.2011.00940.x
   Tolliver BK, 2015, DIALOGUES CLIN NEURO, V17, P181
   Valabhji J., 2003, BRIT J DIABETES VASC, V3, P3
   Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x
   Willi C., 2007, JAMA-J AM MED ASSOC, V298, P286
   Willis T, 1971, DIABETES MED ODYSSEY
   Wu LT, 2015, DRUG ALCOHOL DEPEN, V156, P162, DOI 10.1016/j.drugalcdep.2015.09.003
   Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212
NR 50
TC 8
Z9 8
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD MAY-JUN
PY 2016
VL 30
IS 4
BP 651
EP 656
DI 10.1016/j.jdiacomp.2016.01.020
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DK4UQ
UT WOS:000374916200015
PM 26952267
DA 2019-01-08
ER

PT J
AU Ardakani, A
   Seghatoleslam, T
   Habil, H
   Jameei, F
   Rashid, R
   Zahirodin, A
   Motlaq, F
   Masjidi Arani, A
AF Ardakani, Abolfazl
   Seghatoleslam, Tahereh
   Habil, Hussain
   Jameei, Fahimeh
   Rashid, Rusdi
   Zahirodin, Alireza
   Motlaq, Farid
   Masjidi Arani, Abbas
TI Construct Validity of Symptom Checklist-90-Revised (SCL-90-R) and
   General Health Questionnaire-28 (GHQ-28) in Patients with Drug Addiction
   and Diabetes, and Normal Population
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE SCL-90-R; GHQ-28; Construct validity; Mental health
ID DISCRIMINANT VALIDITY; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL DISTRESS;
   SAMPLE; ANXIETY; RELIABILITY; CONVERGENT; VALIDATION; DIMENSIONS;
   DEPRESSION
AB Background: Given that validity is the baseline of psychological assessments, there is a need to provide evidence-based data for construct validity of such scales to advance the clinicians for evaluating psychiatric morbidity in psychiatric and psychosomatic setting.
   Methods: This comparative cross-sectional study aimed to investigate the construct validity of the Malaysian version of the GHQ-28 and the SCL-90-R. The sample comprised 660 individuals including diabetics, drug dependents, and normal population. The research scales were administered to the participants. Convergent and discriminant validity of both scales were investigated by Confirmatory Factor Analysis (CFA) using AMOS. The Pearson correlation coefficient was utilized to obtain the relationship between the two scales.
   Results: The internal consistency of the GHQ-28 and SCL-90-R were highly acceptable, and confirmatory factor analysis confirmed the convergent validity of both scales. The results of this study revealed that the construct validity of GHQ-28 was acceptable, whereas discriminant validity of SCL-90-R was not adequate. According to Pearson correlation coefficient the relationships between three common subscales of the GHQ-28 and SCL-90-R were significantly positive; somatization (r=0.671, P<0.01), Anxiety (r=0.728, P<0.01), and Depression (r=0.660, P<0.01).
   Conclusions: This study replicated the construct of the Malaysian version of GHQ-28, yet failed to support the nine-factor structure of the SCL-90-R. Therefore, multidimensionality of the SCL-90-R as clinical purposes is questionable, and it may be a better unitary measure for assessing and screening mental disorders. Further research need to be carried out to prove this finding.
C1 [Ardakani, Abolfazl; Seghatoleslam, Tahereh; Habil, Hussain; Jameei, Fahimeh; Rashid, Rusdi; Motlaq, Farid] Univ Malaya, Fac Med, UMCAS, Dept Psychol Med, Kuala Lumpur, Malaysia.
   [Seghatoleslam, Tahereh; Masjidi Arani, Abbas] Shahid Beheshti Univ Med Sci, Dept Clin Psychol, Tehran, Iran.
   [Habil, Hussain] Mahsa Univ, Dept Psychiat, Kuala Lumpur, Malaysia.
   [Zahirodin, Alireza] Shahid Beheshti Univ Med Sci, Behav Res Ctr, Dept Psychiat, Tehran, Iran.
RP Seghatoleslam, T (reprint author), Univ Malaya, Fac Med, UMCAS, Dept Psychol Med, Kuala Lumpur, Malaysia.; Seghatoleslam, T (reprint author), Shahid Beheshti Univ Med Sci, Dept Clin Psychol, Tehran, Iran.
EM drtseghatoleslam@yahoo.com
RI rashid, rusdi/D-1841-2012
OI rashid, rusdi/0000-0002-1295-7382
CR Aderibigbe YA, 1996, INT J PSYCHIAT MED, V26, P263, DOI 10.2190/3XAV-M1BC-DA2B-DCMF
   Anderson JG, 2011, J NUTR METAB, V2011
   Ardakani A, 2013, INTER MED J, P1
   Arrindell WA, 2006, BRIT J CLIN PSYCHOL, V45, P377, DOI 10.1348/014466505X68924
   Ayduk O, 2000, J PERS SOC PSYCHOL, V79, P776, DOI 10.1037/0022-3514.79.5.776
   Baillargeon J, 2010, ADM POLICY MENT HLTH, V37, P367, DOI 10.1007/s10488-009-0252-9
   Barry DT, 2009, J CLIN PSYCHIAT, V70, P1213, DOI 10.4088/JCP.08m04367
   BROPHY CJ, 1988, J PERS ASSESS, V52, P334, DOI 10.1207/s15327752jpa5202_14
   CYR JJ, 1985, J PERS ASSESS, V49, P571, DOI 10.1207/s15327752jpa4906_2
   Daubenmier J, 2011, J OBES, DOI 10.1155/2011/651936
   DEROGATIS LR, 1977, J CLIN PSYCHOL, V33, P981, DOI 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0
   Galanter M., 2008, AM PSYCHIAT PUBLISHI
   GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644
   Hasimah MN, 2010, INT MED J MALAYS, V9, P15
   Holi M., 2003, ASSESSMENT PSYCHIAT
   Inoue K, 2013, INTER MED J, V20, P129
   Institute of Public Health Ministry of Health Malaysia, 2008, 3 NAT HLTH MORB SURV
   IWATA N, 1992, EUR ARCH PSY CLIN N, V242, P172, DOI 10.1007/BF02191565
   Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69
   Kelsey Whittemore, 1996, METHODS OBSERVATIONA
   Kilic C, 1997, SOC PSYCH PSYCH EPID, V32, P327
   Leverone Donna, 2010, J Pharm Pract, V23, P101, DOI 10.1177/0897190009360025
   Li CY, 2010, DIABETES CARE, V33, P1061, DOI 10.2337/dc09-1515
   Malakouti SK, 2007, INT PSYCHOGERIATR, V19, P623, DOI 10.1017/S1041610206004522
   Martinez-Azumendi O, 2001, ACTAS ESP PSIQUIATRI, V29, P95
   Morgan CD, 1998, ASSESSMENT, V5, P197, DOI 10.1177/107319119800500210
   Mundt AP, 2012, PSYCHOTHERAPEUT, V57, P29, DOI 10.1007/s00278-011-0880-x
   Noorbala AA, 2009, HAKIM RES J, V11, P47
   Paap MCS, 2011, INT J METH PSYCH RES, V20, pE39, DOI 10.1002/mpr.347
   Moreno PP, 2010, ADICCIONES, V22, P65
   Purdy Jana, 2013, Yale Journal of Biology and Medicine, V86, P15
   Rauter UK, 1996, J CLIN PSYCHOL, V52, P625
   Raykov T, 2011, BRIT J MATH STAT PSY, V64, P38, DOI 10.1348/000711009X478616
   RIEF W, 1992, PSYCHOPATHOLOGY, V25, P128, DOI 10.1159/000284763
   Ross A, 2010, J ALTERN COMPLEM MED, V16, P3, DOI 10.1089/acm.2009.0044
   Sadr S, 2013, INTER MED J, V20, P418
   Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181
   Seghatoleslam T, 2013, INTER MED J, V20, P310
   Simonds MC, 2008, ASSESSMENT, V15, P78, DOI 10.1177/1073191107307529
   Terre L, 2008, AM J LIFESTYLE MED, V2, P126, DOI 10.1177/1559827607311903
   Tomioka M, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-19
   Vallejo MA, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.1.e2
   Wan Shahrazad WS, 2011, PERTANIKA J SOC SCI, V19, P99
NR 43
TC 3
Z9 3
U1 0
U2 9
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PD APR
PY 2016
VL 45
IS 4
BP 451
EP 459
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM0OK
UT WOS:000376045100005
PM 27252914
DA 2019-01-08
ER

PT J
AU Holmes-Truscott, E
   Blackberry, I
   O'Neal, DN
   Furler, JS
   Speight, J
AF Holmes-Truscott, Elizabeth
   Blackberry, Irene
   O'Neal, David N.
   Furler, John S.
   Speight, Jane
TI Willingness to initiate insulin among adults with type 2 diabetes in
   Australian primary care: Results from the Stepping Up Study
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes; Primary care; Insulin therapy
ID TREATMENT APPRAISAL SCALE; HEALTH-CARE; CLINICAL INERTIA; 4-T TRIAL;
   RESISTANCE; THERAPY; PEOPLE; MILES; DEPRESSION; MANAGEMENT
AB Aims: To determine 'hypothetical willingness' to initiate insulin, and identify associated factors, among adults with type 2 diabetes (T2DM) in primary care for whom insulin is clinically indicated.
   Methods: Eligible participants were adults with T2DM with an HbA1c >= 7.5% (58 mmol/mol) and prescribed maximum oral hypoglycaemic agents. A total of 261 participants were recruited from 74 Victorian general practices: mean age 62 +/- 10 years; 39% (n = 103) women; diabetes duration 10 +/- 6 years; HbA1c 9.0 +/- 1.3% (75 +/- 14 mmol/mol). Data collected by the Stepping Up Study: demographic and clinical characteristics, 'willingness' to initiate insulin, insulin appraisals, depressive symptoms, and diabetes-related distress. A multinomial regression investigated predictors of 'willingness'.
   Results: Nineteen percent (n = 50) were 'very willing' to initiate insulin, if recommended. The final regression model (R-2 = .44, chi(2)(12) 145.91, p < .001) demonstrated higher socioeconomic status and less negative attitudes to insulin were associated with increased willingness to initiate insulin.
   Conclusions: Among adults with T2DM for whom insulin is clinically indicated, only one in five are 'very willing' to begin insulin therapy. Independent of demographics, clinical factors and emotional wellbeing, insulin appraisals were associated with ` willingness'. This study highlights the importance of addressing attitudinal barriers to insulin therapy among adults with T2DM in primary care to improve insulin receptiveness. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Holmes-Truscott, Elizabeth; Speight, Jane] Diabet Victoria, Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Holmes-Truscott, Elizabeth; Speight, Jane] Deakin Univ, Sch Psychol, 221 Burwood Highway, Burwood, Vic 3125, Australia.
   [Blackberry, Irene; Furler, John S.] Univ Melbourne, Dept Gen Practice, 200 Berkeley St, Carlton, Vic 3052, Australia.
   [Blackberry, Irene] La Trobe Univ, Australian Inst Primary Care & Ageing, John Richards Initiat, POB 821, Wodonga, Vic 3689, Australia.
   [O'Neal, David N.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.
   [Speight, Jane] AHP Res, 16 Walden Way, Hornchurch RM11 2LB, England.
RP Holmes-Truscott, E (reprint author), Diabet Victoria, Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
EM etruscott@acbrd.org.au; i.blackberry@latrobe.edu.au; dno@unimelb.edu.au;
   j.furler@unimelb.edu.au; jspeight@acbrd.org.au
OI Speight, Jane/0000-0002-1204-6896; Blackberry,
   Irene/0000-0003-4482-4936; Holmes-Truscott,
   Elizabeth/0000-0001-9139-4663
FU Australian National Health and Medical Research Council [APP1023738];
   Roche Diagnostics Australia Pty Ltd; RACGP Foundation RACGP/Independent
   Practitioner Network Pty Ltd (IPN) Grant; NHMRC/PHCRED Career
   Development Fellowship; Australian Postgraduate Award/Deakin University
   PhD scholarship
FX We would like to acknowledge funding from the Australian National Health
   and Medical Research Council (Project Grant: APP1023738). The study is
   also supported by an unrestricted educational/research grant by Roche
   Diagnostics Australia Pty Ltd, the RACGP Foundation RACGP/Independent
   Practitioner Network Pty Ltd (IPN) Grant and receives in-kind support
   from Sanofi. JF is supported by an NHMRC/PHCRED Career Development
   Fellowship. EHT is supported by an Australian Postgraduate Award/Deakin
   University PhD scholarship.
CR [Anonymous], 1995, Diabetes, V44, P1249
   Australian Bureau of Statistics, 2011, SOC IND AR 2011 2011
   Azmiah ZN, 2011, INT MED J MALAYS, V10, P7
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Clark M, 2007, J DIABETES NURS, V11, P53
   Conner M, 1996, PREDICTING HLTH BEHA
   Furler J, 2011, AUST FAM PHYSICIAN, V40, P617
   Furler JS, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-20
   Gherman A, 2011, PRACT DIABETES INT, V28, P125, DOI DOI 10.1002/PDI.1574
   Holman RR, 1998, DIABETES RES CLIN PR, V40, pS21
   Holmes-Truscott E, 2016, PRIM CARE DIABETES, V10, P75, DOI 10.1016/j.pcd.2015.06.006
   Holmes-Truscott E, 2015, DIABETIC MED, V32, P1297, DOI 10.1111/dme.12729
   Holmes-Truscott E, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-87
   Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4
   Jeavons D, 2006, POSTGRAD MED J, V82, P347, DOI 10.1136/pgmj.2005.039545
   Jenkins N, 2011, DIABETIC MED, V28, P543, DOI 10.1111/j.1464-5491.2010.03200.x
   Jenkins N, 2010, DIABETES CARE, V33, P2178, DOI 10.2337/dc10-0494
   Khan H, 2008, DIABETIC MED, V25, P1108, DOI 10.1111/j.1464-5491.2008.02538.x
   Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Lee PY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-313
   LESLIE CA, 1994, DIABETES SPECTRUM, V7, P52
   Leslie CA, 1995, TODAYS THERAPEUTIC T, V13, P21
   Machinani S, 2013, PRIM CARE DIABETES, V7, P51, DOI 10.1016/j.pcd.2012.11.003
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Meneghini Luigi, 2010, Prim Care Diabetes, V4 Suppl 1, pS43, DOI 10.1016/S1751-9918(10)60008-3
   Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y
   Nefs G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078865
   Patel N, 2012, DIABETIC MED, V29, P1311, DOI 10.1111/j.1464-5491.2012.03669.x
   Phillips Anne, 2007, Nurs Stand, V21, P35
   Polonsky W, 2003, DIABETES, V52, pA417
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2004, CLIN DIABETES, V22, P147
   Polonsky W, 2007, DIABETES EDUCATOR, V33, p241S, DOI 10.1177/0145721707305701
   Polonsky WH, 2011, CURR MED RES OPIN, V27, P1169, DOI 10.1185/03007995.2011.573623
   Reid TS., 2007, INSULIN, V2, P182
   Shah BR, 2005, DIABETES CARE, V28, P600, DOI 10.2337/diacare.28.3.600
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Speight J, 2012, DIABETES RES CLIN PR, V97, P425, DOI 10.1016/j.diabres.2012.03.015
   Speight J, 2011, DIABETES MILES AUSTR
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83
   Wang HF, 2012, J ADV NURS, V68, P743, DOI 10.1111/j.1365-2648.2011.05853.x
   Wong S, 2011, DIABETIC MED, V28, P206, DOI 10.1111/j.1464-5491.2010.03195.x
   Woudenberg YJC, 2012, DIABETIC MED, V29, P796, DOI 10.1111/j.1464-5491.2011.03552.x
   Zafar A, 2010, PRIM CARE DIABETES, V4, P203, DOI 10.1016/j.pcd.2010.07.003
NR 49
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD APR
PY 2016
VL 114
BP 126
EP 135
DI 10.1016/j.diabres.2015.12.011
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DK7TW
UT WOS:000375129600018
PM 26818893
DA 2019-01-08
ER

PT J
AU Lynch, CP
   Williams, JS
   Voronca, D
   Walker, RJ
   Egede, LE
AF Lynch, Cheryl P.
   Williams, Joni Strom
   Voronca, Delia
   Walker, Rebekah J.
   Egede, Leonard E.
TI Meaning of Illness and Cardiovascular Risk Factors in Patients With Type
   2 Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID SELF-MANAGEMENT; DEPRESSION; MELLITUS; ADULTS; HEALTH; QUESTIONNAIRE;
   RELIABILITY; ASSOCIATION; DISTRESS; VALIDITY
AB Purpose The purpose of this study was to examine the relationship between meaning of illness and cardiovascular disease risk factors in patients with type 2 diabetes.
   Methods The sample population was recruited from primary care clinics in the southeastern United States. The meaning of illness was assessed by a validated questionnaire with 5 subscales. The primary outcomes were cardiovascular disease (CVD) risk factors, assessed by A1C, systolic and diastolic blood pressure (SBP and DBP, respectively), and low-density lipoprotein cholesterol (LDL-C). Multivariate linear regression models investigated associations between the clinical outcomes and the 5 MIQ factors, controlling for possible confounders.
   Results The sample comprised 302 black and white participants of whom more than half were elderly (65+ years) and the vast majority were male (98%). Systolic blood pressure was positively associated with non-anticipated vulnerability. Diastolic blood pressure was negatively associated with degree of stress/change in commitments and positively associated with challenge/motivation/hope and non-anticipated vulnerability. Low-density lipoprotein cholesterol was significantly and negatively associated with degree of stress/change in commitments.
   Conclusions Meaning of illness had a significant effect on measured outcomes of CVD risk. The specific factor included in the overarching concept of meaning of illness differed in its influence, with more positive views of stress/commitments associated with lower blood pressure and LDL but more positive views of the challenge/hope/motivation and negative views of non-anticipated vulnerability associated with diabetes associated with higher systolic and diastolic blood pressure.
C1 [Lynch, Cheryl P.; Walker, Rebekah J.; Egede, Leonard E.] Ralph H Johnson Vet Affairs Med Ctr, HEROIC, Charleston, SC USA.
   [Lynch, Cheryl P.; Williams, Joni Strom; Voronca, Delia; Walker, Rebekah J.; Egede, Leonard E.] Med Univ S Carolina, Dept Med, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.
   [Lynch, Cheryl P.; Williams, Joni Strom; Voronca, Delia; Egede, Leonard E.] Med Univ S Carolina, Dept Med, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Med Univ S Carolina, Ctr Hlth Dispar Res, Hlth Equ & Rural Outreach Innovat Ctr, 135 Rutledge Ave,Room 280G,POB 250593, Charleston, SC 29425 USA.
EM egedel@musc.edu
FU VHA Health Services Research and Development (HSRD) program [TRP 04-038]
FX This study was supported by grant No. TRP 04-038 funded by the VHA
   Health Services Research and Development (HSR&D) program. The funding
   agency did not participate in the design and conduct of the study;
   collection, management, analysis, and interpretation of the data; or
   preparation, review, or approval of the manuscript. The manuscript
   represents the views of the authors and not those of the VA or HSR&D.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BROWNE GB, 1988, NURS RES, V37, P368
   Bryant L H, 1990, J S C Med Assoc, V86, P389
   Bussing Arndt, 2009, BMC Womens Health, V9, P2, DOI 10.1186/1472-6874-9-2
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   de Groot M, 1999, J PSYCHOSOM RES, V46, P425, DOI 10.1016/S0022-3999(99)00014-8
   Dismuke CE, 2011, GEN HOSP PSYCHIAT, V33, P311, DOI 10.1016/j.genhosppsych.2011.03.014
   Egede LE, 2003, DIABETES EDUCATOR, V29, P105, DOI 10.1177/014572170302900115
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571
   Glasgow RE, 1997, DIABETES CARE, V20, P556, DOI 10.2337/diacare.20.4.556
   Hornsten A, 2004, J ADV NURS, V47, P174, DOI 10.1111/j.1365-2648.2004.03076.x
   Kohen D, 1998, QUAL LIFE RES, V7, P197, DOI 10.1023/A:1008817812520
   Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002
   Lynch CP, 2012, DIABETES EDUCATOR, V38, P427, DOI 10.1177/0145721712440335
   Malik S, 2007, DIABETES RES CLIN PR, V77, P126, DOI 10.1016/j.diabres.2006.10.016
   Mathew R, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-122
   McFarland K F, 2001, Endocr Pract, V7, P250
   McVeigh K. H., 2004, Morbidity and Mortality Weekly Report, V53, P1089
   Olshansky E, 2008, DIABETES EDUCATOR, V34, P1004, DOI 10.1177/0145721708327304
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Rew L, 2003, ADV NURS SCI, V26, P90, DOI 10.1097/00012272-200304000-00002
   Roberts J, 1992, MEANING ILLNESS QU 2
   Stark CS, 2013, DIABETES CARE, V36, P2271, DOI DOI 10.2337/DC12-2258
   Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0
   Todaro JF, 2003, AM J CARDIOL, V92, P901, DOI 10.1016/S0002-9149(03)00967-6
   Walker RJ, 2014, ENDOCRINE, V47, P29, DOI 10.1007/s12020-014-0195-0
   WEIR R, 1994, PAIN, V58, P377, DOI 10.1016/0304-3959(94)90132-5
NR 29
TC 0
Z9 0
U1 1
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD APR
PY 2016
VL 42
IS 2
BP 220
EP 227
DI 10.1177/0145721716631430
PG 8
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA DH6DV
UT WOS:000372882100007
PM 26879460
DA 2019-01-08
ER

PT J
AU Malanda, UL
   Bot, SDM
   Kostense, PJ
   Snoek, FJ
   Dekker, JM
   Nijpels, G
AF Malanda, U. L.
   Bot, S. D. M.
   Kostense, P. J.
   Snoek, F. J.
   Dekker, J. M.
   Nijpels, G.
TI Effects of self-monitoring of glucose on distress and self-efficacy in
   people with non-insulin-treated Type2 diabetes: a randomized controlled
   trial
SO DIABETIC MEDICINE
LA English
DT Article
ID BLOOD-GLUCOSE; EMOTIONAL DISTRESS; PROBLEM AREAS; VALIDITY; DESIGN;
   IMPACT; SCALE; DUTCH
AB AimsTo investigate the effects of self-monitoring of glucose in blood or urine, on diabetes-specific distress and self-efficacy, compared with usual care in people with non-insulin-treated Type2 diabetes mellitus.
   MethodsOne hundred and eighty-one participants with non-insulin-treated Type2 diabetes mellitus [diabetes duration 1year, age 45-75years, HbA(1c)53.0mmol/mol (7.0%), self-monitoring frequency <3 times in the previous year] were randomly assigned to blood self-monitoring (n=60), urine self-monitoring (n=59) or usual care (n=62). Primary outcomes were between-group differences in diabetes-specific distress [Problem Areas in Diabetes scale (PAID)] and self-efficacy [Confidence in Diabetes Self-Care questionnaire (CIDS-2)] after 12months. Secondary outcomes included changes in HbA(1c), treatment satisfaction and depressive symptoms.
   ResultsThere were no statistically significant between-group differences in changes in PAID and CIDS-2 after 12months. Mean difference in PAID between blood monitoring and control was -2.2 [95% confidence interval (CI) -7.1 to 2.7], between urine monitoring and control was -0.9 (95% CI -4.4 to 2.5) and between blood monitoring and urine monitoring was -2.0 (95% CI -4.1 to 0.1). Mean difference in CIDS-2 between blood monitoring and control was 0.6 [95% CI (-2.0 to 2.1), between urine monitoring and control was 2.8 (95% CI -2.3 to 7.9)] and between blood monitoring and urine monitoring was -3.3 (95% CI -7.9 to 1.3). No statistically significant between-group differences in change in any of the secondary outcome measures were found.
   ConclusionsThis study did not find statistical or clinical evidence for a long-term effect of self-monitoring of glucose in blood or urine on diabetes-specific distress and self-efficacy in people with moderately controlled non-insulin-treated Type2 diabetes mellitus. (Current Controlled Trials ISRCTN84568563)
C1 [Malanda, U. L.; Bot, S. D. M.; Nijpels, G.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands.
   [Kostense, P. J.; Dekker, J. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands.
   [Snoek, F. J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Med Psychol, Amsterdam, Netherlands.
RP Nijpels, G (reprint author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands.
EM g.nijpels@vumc.nl
FU European Foundation for the Study of Diabetes (EFSD); LifeScan, Inc.
FX This study was conducted with support from the European Foundation for
   the Study of Diabetes (EFSD) and the Investigator-Initiated Study
   Program of LifeScan, Inc.
CR American Association of Diabetes Educators, 2008, DIABETES ED, V34, P445, DOI DOI 10.1177/0145721708316625
   American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Barnard Katharine D, 2010, BMC Res Notes, V3, P318, DOI 10.1186/1756-0500-3-318
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   Clar C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14120
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Farmer A, 2007, BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE
   Fisher L, 2011, CURR MED RES OPIN, V27, P39, DOI 10.1185/03007995.2011.619176
   Franciosi M, 2001, DIABETES CARE, V24, P1870, DOI 10.2337/diacare.24.11.1870
   French DP, 2008, DIABETIC MED, V10, P1218
   Hermanns N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-113
   Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670
   International Diabetes Federation, 2009, IDF GUID SELF MON BL
   Kleefstra N, 2010, NETH J MED, V68, P311
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lawton J, 2004, DIABETIC MED, V21, P1045, DOI 10.1111/j.1464-5491.2004.01286.x
   Leventhal H., 1997, PERCEPTIONS HLTH ILL, P19
   Malanda UL, 2012, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD005060
   Malanda UL, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-26
   O'Kane MJ, 2008, BRIT MED J, V336, P1174, DOI 10.1136/bmj.39534.571644.BE
   Peel E, 2004, BRIT J GEN PRACT, V54, P183
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2009, DIABETES S1, V58
   Polonsky W, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-37
   Rutten G, 2009, NHG STANDAARDEN HUIS, P160
   Schwedes U, 2002, DIABETES CARE, V25, P1928, DOI 10.2337/diacare.25.11.1928
   Simon J, 2008, BRIT MED J, V336, P1177, DOI 10.1136/bmj.39526.674873.BE
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
NR 31
TC 3
Z9 3
U1 3
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD APR
PY 2016
VL 33
IS 4
BP 537
EP 546
DI 10.1111/dme.12849
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DI0OJ
UT WOS:000373196100018
PM 26171942
DA 2019-01-08
ER

PT J
AU Jacob, L
   Kostev, K
AF Jacob, Louis
   Kostev, Karel
TI Prevalence of depression in type 2 diabetes patients in German primary
   care practices
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes; Psychosocial stressors; Primary care; Prevalence;
   Macrovascular disease; Microvascular disease
ID GLYCEMIC CONTROL; ADULTS; MELLITUS; METAANALYSIS; ASSOCIATION; SYMPTOMS;
   DISTRESS; HEALTH; RISKS
AB Aims: To analyse depression in German type 2 diabetes patients with or without diabetes complications.
   Methods: Longitudinal data from nationwide general practices in Germany (n = 1,202) were analysed. People initially diagnosed with type 2 diabetes (2004-2013) were identified and 90,412 patients were included (age: 65.5 years, SD: 11.7). The main outcome measure was the first diagnosis of depression (ICD 10: F32, F33) within ten years after index date in patients with and without diabetes complications. Cox proportional hazards models were used to adjust for confounders.
   Results: At baseline, most patients had diabetes complications and 6.4% of them had private insurance. Ten years after type 2 diabetes diagnosis, 30.3% of patients showed symptoms of depression. The prevalence of depression was higher in women than in men (33.7% versus 26.8%), in patients with high HbA1c levels (31.3% when Hb1Ac >= 9 versus 27.5% when HbA1c < 7) and in patients with diabetes complications (37.7% when there were more than two complications versus 29.1% when there were no complications). Women and patients without private health insurance were at a higher risk of developing depression. Retinopathy, neuropathy, nephropathy, coronary heart disease, stroke and HbA1c levels higher than 7 were also positively associated with depression.
   Conclusions: Diabetes complications and high HbA1c levels had a substantial impact on depression in primary care patients with type 2 diabetes. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Jacob, Louis] Ecole Normale Super Lyon, Dept Biol, F-69364 Lyon, France.
   [Kostev, Karel] IMS Hlth, Frankfurt, Germany.
RP Kostev, K (reprint author), IMS Hlth, Epidemiol, Darmstadter Landstr 108, D-60598 Frankfurt, Germany.
EM kkostev@de.imshealth.com
OI Jacob, Louis/0000-0003-1071-1239
CR Abbatecola AM, 2006, NEUROLOGY, V67, P235, DOI 10.1212/01.wnl.0000224760.22802.e8
   Akhtar-Danesh N., 2007, INT J MENT HEALTH SY, V1, P1, DOI [10.1186/1752-4458-1-4, DOI 10.1186/1752-4458-1-4]
   Alonso-Moran E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-769
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Badawi G, 2013, J AFFECT DISORDERS, V145, P100, DOI 10.1016/j.jad.2012.07.018
   Becher H, 2009, INT J CLIN PHARM TH, V47, P617
   Blazer DG, 2002, J PSYCHOSOM RES, V53, P913, DOI 10.1016/S0022-3999(02)00314-8
   Chen G, 2011, DIABETES CARE, V34, P2586, DOI 10.2337/dc11-0958
   Feinkohl I, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0130-5
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   Poongothai Subramani, 2011, J Assoc Physicians India, V59, P644
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2009, DIABETES-METAB RES, V25, pS4, DOI 10.1002/dmrr.981
   Rouchell A M, 2000, Ochsner J, V2, P79
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Ruta LM, 2013, DIABETIC MED, V30, P387, DOI 10.1111/dme.12119
   Sheehan D. V., 2004, MANAGED CARE S, P6
   Skinner TC, 2010, DIABETIC MED, V27, P965, DOI 10.1111/j.1464-5491.2010.03028.x
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Stordal E, 2003, ACTA PSYCHIAT SCAND, V107, P132, DOI 10.1034/j.1600-0447.2003.02056.x
   Sweileh WM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-163
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   Wang LC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1567-y
   WHO (a), 2015, DAT STAT DIAB
   Zhang YY, 2015, J DIABETES, V7, P800, DOI 10.1111/1753-0407.12238
NR 32
TC 8
Z9 8
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD APR
PY 2016
VL 30
IS 3
BP 432
EP 437
DI 10.1016/j.jdiacomp.2015.12.013
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DH6ZJ
UT WOS:000372940300008
PM 26790576
DA 2019-01-08
ER

PT J
AU Karppinen, A
   Ritvonen, E
   Roine, R
   Sintonen, H
   Vehkavaara, S
   Kivipelto, L
   Grossman, AB
   Niemela, M
   Schalin-Jantti, C
AF Karppinen, Atte
   Ritvonen, Elina
   Roine, Risto
   Sintonen, Harri
   Vehkavaara, Satu
   Kivipelto, Leena
   Grossman, Ashley B.
   Niemela, Mika
   Schalin-Jantti, Camilla
TI Health-related quality of life in patients treated for nonfunctioning
   pituitary adenomas during the years 2000-2010
SO CLINICAL ENDOCRINOLOGY
LA English
DT Article
ID LONG-TERM REMISSION; SURGERY; MACROADENOMA; UTILITY; TUMORS;
   RADIOTHERAPY; EXPERIENCE; DISEASE
AB ObjectiveThe published data on health-related quality of life (HRQoL) after treatment of nonfunctioning pituitary adenomas (NFPAs) are conflicting. We evaluated HRQoL in a recent series of patients who had surgery for an NFPA.
   DesignCross-sectional study including a large control population.
   Patients and MeasurementsA HRQoL questionnaire (15D) was sent to all patients (n=161) having undergone transsphenoidal surgery for NFPA in the years 2000-2010 at the Helsinki University Hospital. The 15D score and dimension scores of the study population (n=137) were compared with those of a large (n=4967) gender- and age-standardized control population. Possible independent predictors of HRQoL in the patients were estimated with multivariate regression analysis.
   ResultsPostoperatively, 57% of the patients had normal visual function. After a mean follow-up of 7432years (mean +/- SD), 62% suffered from hypopituitarism. Overall, HRQoL was near-normal in patients compared to controls (15D scores 0885 +/- 0114 vs 0903 +/- 0093, respectively, P=007). On single dimensions, patients had impaired vision and sexual activity (both P<00005), more depression and distress (both P<0005) and less discomfort and symptoms (P<005). Age, body mass index, diabetes, depression and reoperation were independent predictors of impaired HRQoL (all P<005). Thyroxine substitution was associated with impaired and hydrocortisone and testosterone substitution (males only) with better HRQoL (all P<005).
   ConclusionsThis recent series of NFPA patients demonstrates that overall HRQoL is near-normal after medium term follow-up; the most impaired dimensions were in vision and sexual activity. Comorbidities are strong predictors of impaired HRQoL.
C1 [Karppinen, Atte; Kivipelto, Leena; Niemela, Mika] Univ Helsinki, Dept Neurosurg, Helsinki, Finland.
   [Karppinen, Atte; Ritvonen, Elina; Roine, Risto; Vehkavaara, Satu; Kivipelto, Leena; Niemela, Mika; Schalin-Jantti, Camilla] Helsinki Univ Hosp, POB 266, FI-00029 Hus Helsinki, Finland.
   [Ritvonen, Elina; Vehkavaara, Satu; Schalin-Jantti, Camilla] Univ Helsinki, Abdominal Ctr, Endocrinol, Helsinki, Finland.
   [Roine, Risto] Univ Helsinki, Grp Adm, Helsinki, Finland.
   [Roine, Risto] Univ Eastern Finland, Dept Hlth & Social Management, Kuopio, Finland.
   [Sintonen, Harri] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.
   [Grossman, Ashley B.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Dept Endocrinol, Oxford OX1 2JD, England.
RP Karppinen, A (reprint author), Helsinki Univ Hosp, Dept Neurosurg, POB 266, FI-00029 Hus Helsinki, Finland.
EM atte.karppinen@hus.fi
FU Novartis Finland Oyj; Helsinki University Hospital
FX The authors declare no conflict of interests that could be perceived as
   prejudicing the impartiality of the research reported. This work was
   supported by Novartis Finland Oyj and the research Funds of the Helsinki
   University Hospital.
CR Aken M.O.V., 2005, J CLIN ENDOCRINOLOGY, V90, P3279
   Alanne S, 2015, QUAL LIFE RES, V24, P599, DOI 10.1007/s11136-014-0787-4
   Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38
   Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05
   Ammirati M, 2013, J NEUROL NEUROSUR PS, V84, P843, DOI 10.1136/jnnp-2012-303194
   Andela CD, 2015, PITUITARY, V18, P752, DOI 10.1007/s11102-015-0636-7
   Biermasz NR, 2011, J CLIN ENDOCR METAB, V96, P1524, DOI 10.1210/jc.2010-2742
   Biermasz NR, 2004, J CLIN ENDOCR METAB, V89, P5369, DOI 10.1210/jc.2004-0669
   Brummelman P, 2011, CLIN ENDOCRINOL, V74, P481, DOI 10.1111/j.1365-2265.2010.03947.x
   Capatina C, 2013, CLIN ENDOCRINOL, V78, P86, DOI 10.1111/j.1365-2265.2012.04449.x
   Dekkers OM, 2006, J CLIN ENDOCR METAB, V91, P3364, DOI 10.1210/jc.2006-0003
   Fatemi N, 2008, NEUROSURGERY, V63, P244, DOI 10.1227/01.NEU.0000327025.03975.BA
   Hawthorne G, 2001, ANN MED, V33, P358, DOI 10.3109/07853890109002090
   HUNT SM, 1984, J EPIDEMIOL COMMUN H, V38, P156, DOI 10.1136/jech.38.2.156
   Jane JA, 2001, J AM COLL SURGEONS, V193, P651
   Kars M, 2007, EUR J ENDOCRINOL, V157, P133, DOI 10.1530/EJE-07-0259
   Kauppinen-Makelin R, 2006, J CLIN ENDOCR METAB, V91, P3891, DOI 10.1210/jc.2006-0676
   Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x
   Koskinen S, 2012, 682012 THL
   Moock J, 2008, QUAL LIFE RES, V17, P485, DOI 10.1007/s11136-008-9317-6
   Nielsen EH, 2007, PITUITARY, V10, P67, DOI 10.1007/s11102-007-0018-x
   Okamoto Y, 2010, INVEST OPHTH VIS SCI, V51, P3405, DOI 10.1167/iovs.09-3763
   Page RCL, 1997, CLIN ENDOCRINOL, V46, P401, DOI 10.1046/j.1365-2265.1997.1400957.x
   Rasanen P, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-74
   Ritvonen E, 2015, CLIN ENDOCRINOL, V82, P412, DOI 10.1111/cen.12550
   Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326
   Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086
   Song X, 2012, EUR J CLIN NUTR, V66, P156, DOI 10.1038/ejcn.2011.145
   Stavem K, 1999, QUAL LIFE RES, V8, P45, DOI 10.1023/A:1026475531996
   Tanemura E, 2012, ACTA NEUROCHIR, V154, P1895, DOI 10.1007/s00701-012-1473-3
   Taylor VH, 2013, BEST PRACT RES CL EN, V27, P139, DOI 10.1016/j.beem.2013.04.004
   Tiemensma J, 2011, J CLIN ENDOCR METAB, V96, P3550, DOI 10.1210/jc.2011-1645
   Van Beek AP, 2007, INT J RADIAT ONCOL, V68, P986, DOI 10.1016/j.ijrobp.2007.01.017
   van der Klaauw AA, 2008, CLIN ENDOCRINOL, V69, P775, DOI 10.1111/j.1365-2265.2008.03288.x
   Wagenmakers MAEM, 2012, EUR J ENDOCRINOL, V167, P687, DOI 10.1530/EJE-12-0308
NR 35
TC 5
Z9 5
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-0664
EI 1365-2265
J9 CLIN ENDOCRINOL
JI Clin. Endocrinol.
PD APR
PY 2016
VL 84
IS 4
BP 532
EP 539
DI 10.1111/cen.12967
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DH0WR
UT WOS:000372505300009
PM 26493182
DA 2019-01-08
ER

PT J
AU van Vugt, M
   de Wita, M
   Bader, S
   Snoek, FJ
AF van Vugt, Michael
   de Wita, Maartje
   Bader, Suzanne
   Snoek, Frank J.
TI Does low well-being modify the effects of PRISMA (Dutch DESMOND), a
   structured self-management-education program for people with type 2
   diabetes?
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Well-being; Self-management; Education; Type 2 diabetes mellitus
ID RANDOMIZED CONTROLLED-TRIAL; DEPRESSION; EFFICACY; MELLITUS; DISTRESS;
   SCALE; CARE; METAANALYSIS; DISORDERS; SYMPTOMS
AB Aims: Diabetes self-management education improves behavioural and clinical outcomes in type 2 diabetes patients, however little is known about the modifying effects of wellbeing. This is relevant given high prevalence of depression and distress among diabetes patients. We aimed to test whether low well-being modifies the effects of the PRISMA self management education program (Dutch DESMOND).
   Methods: 297 primary care type 2 diabetes patients participated in the PRISMA observational study with a pre-post measurement design. Patients were grouped in low (n = 63) and normal well-being (n = 234). Low well-being was defined as either low mood (WHO-5 < 50) and/or high diabetes-distress (PAID-5 > 8). Outcome measures were: diabetes self-efficacy (CIDS), illness perception (IPQ) and diabetes self-care activities (SDSCA).
   Results: Improvements were found in illness perception (b = 1.586, p < 0.001), general diet (b = 1.508, p = 0.001), foot care (b = 0.678, p = 0.037), weekly average diet (b = 1.140, p = 0.001), creating action plan (b = 0.405, p = 0.007). Well-being interaction effects were found for general diet (p = 0.009), weekly average diet (p = 0.022), and creating an action plan (p = 0.002).
   Conclusions: PRISMA self-management education seems as effective for people with normal well-being as for people with low well-being. Further research should examine whether addressing mood and diabetes-distress as part of self-management education could reduce attrition and maintain or improve well-being among participants. (C) 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [van Vugt, Michael; de Wita, Maartje; Bader, Suzanne; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Van der Boechorststr 7,MF D-345, NL-1081 BT Amsterdam, Netherlands.
   [van Vugt, Michael; de Wita, Maartje; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Bader, Suzanne] Vrije Univ Amsterdam, Med Ctr, Dietet, Amsterdam, Netherlands.
RP van Vugt, M (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Van der Boechorststr 7,MF D-345, NL-1081 BT Amsterdam, Netherlands.
EM m.vanvugt@vumc.nl
RI Albertin, Paloma/X-1093-2018
FU Novo Nordisk
FX The data we used was collected for an implementation study of the
   PRISMA-course throughout the Netherlands which was funded by Novo
   Nordisk with an unrestricted educational grant. We thank Wilmy Cleijne
   and Suzanne Vonk from the VU University medical center for assisting in
   the data collection.
CR Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   Chartier IS, 2013, J AFFECT DISORDERS, V145, P292, DOI 10.1016/j.jad.2012.07.023
   CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Funnel MM, 2009, DIABETES CARE, V32, pS87, DOI 10.2337/dc09-S087
   Gillett M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4093
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Heinrich E, 2010, EUR DIAB NURSING, V7, P71, DOI DOI 10.1002/EDN.160
   Hu F.B., 2003, TXB DIABETES
   King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746
   Leibbrandt AJ, 2010, CLIN NUTR, V29, P199, DOI 10.1016/j.clnu.2009.08.009
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Petrak F, 2009, CURR OPIN PSYCHIATR, V22, P211, DOI 10.1097/YCO.0b013e3283207b45
   Pickles A., 2005, ENCY BIOSTATISTICS
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Singh NA, 2001, J GERONTOL A-BIOL, V56, pM497, DOI 10.1093/gerona/56.8.M497
   Skinner TC, 2008, DIABETIC MED, V25, P1117, DOI 10.1111/j.1464-5491.2008.02492.x
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Steed L, 2003, PATIENT EDUC COUNS, V51, P5, DOI 10.1016/S0738-3991(02)00213-6
   STEPTOE A, 2006, DEPRESSION PHYS ILLN
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   TOOBERT DJ, 1994, HDB PSYCHOL DIABETES, P351
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
NR 34
TC 0
Z9 0
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD APR
PY 2016
VL 10
IS 2
BP 103
EP 110
DI 10.1016/j.pcd.2015.06.008
PG 8
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA DH3KY
UT WOS:000372687100002
PM 26186886
DA 2019-01-08
ER

PT J
AU Hakkarainen, P
   Moilanen, L
   Hanninen, V
   Heikkinen, J
   Rasanen, K
AF Hakkarainen, Pirjo
   Moilanen, Leena
   Hanninen, Vilma
   Heikkinen, Jarmo
   Rasanen, Kimmo
TI Work-related diabetes distress among Finnish workers with type 1
   diabetes: a national cross-sectional survey
SO JOURNAL OF OCCUPATIONAL MEDICINE AND TOXICOLOGY
LA English
DT Article
DE Type 1 diabetes; Work; Stress; Exhaustion; Blood glucose
ID SELF-MANAGEMENT; DEPRESSIVE SYMPTOMS; FOLLOW-UP; HEALTH; ASSOCIATION;
   MELLITUS; STRESS; IMPACT; WOMEN; FIT
AB Background: Diabetes distress is common among people with type 1 diabetes, but knowledge is scarce regarding the perceived burden of reconciling work with this disease. This cross-sectional study investigated work-related diabetes distress among Finnish workers with type 1 diabetes.
   Methods: A questionnaire was mailed to 2500 randomly sampled 18- to 65-year-old Finns with type 1 diabetes; 49.3 % responded. Work-related diabetes distress was measured by combining worry and exhaustion in reconciling work with diabetes. Self-perceived work-related diabetes distress was evaluated in the context of physical and psychosocial work conditions, job demands, work ability, general stress, diabetes acceptance, glycosylated hemoglobin (HbA1c) level, high blood glucose maintenance at work, and depressive symptoms. The data were analyzed with the use of cross-tabulation, chi-square tests, ANOVA analysis, Spearman correlation coefficients, and structural equation modeling.
   Results: Of the respondents, 70 % experienced work-related diabetes distress. Problems with physical work conditions (beta = 0.27), work ability (beta = -0.21), difficulty in accepting diabetes (beta = 0.18), and job demands (beta = 0.14) were found to be associated with work-related diabetes distress. This distress was strongly associated with the maintenance of a high blood glucose level at work (beta = 0.34). In turn, a high blood glucose level at work was associated with a high HbA1c level (beta = 0.29). Work-related diabetes distress and depressive symptoms had a bi-directional association (beta = 0.06 and beta = 0.14). Difficulty accepting diabetes had three-dimensional associations: work-related diabetes distress (beta = 0.18), depressive symptoms (beta = 0.13), and high HbA1c level (beta = 0.12). There was no notable association between work-related diabetes distress and general stress.
   Conclusions: Work-related diabetes distress is common among workers with type 1 diabetes, and it may influence metabolic control. This stress could be prevented by adapting physical work conditions. People with type 1 diabetes should also be encouraged to pursue their full educational potential, and psychological support should be provided for those with difficulty accepting their diabetes.
C1 [Hakkarainen, Pirjo; Heikkinen, Jarmo; Rasanen, Kimmo] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Sch Med, Kuopio, Finland.
   [Moilanen, Leena] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland.
   [Hanninen, Vilma] Univ Eastern Finland, Dept Social Sci, Kuopio, Finland.
RP Hakkarainen, P (reprint author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Sch Med, Kuopio, Finland.
EM pirjoirene.hakkarainen@uef.fi
OI Rasanen, Kimmo/0000-0003-0798-4631
FU Finnish Work Environment Fund; Social Insurance Institution of Finland;
   Foundation of Kyllikki and Uolevi Lehikoinen; Finnish Diabetes
   Association; Foundation of Occupational Health in Finland
FX Our study has been funded by The Finnish Work Environment Fund, The
   Social Insurance Institution of Finland, the Foundation of Kyllikki and
   Uolevi Lehikoinen, The Finnish Diabetes Association, and the Foundation
   of Occupational Health in Finland.
CR Adriaenssens J, 2015, J NURS MANAGE, V23, P346, DOI 10.1111/jonm.12138
   Ahlstrom L, 2010, SCAND J WORK ENV HEA, V36, P404, DOI 10.5271/sjweh.2917
   Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105
   [Anonymous], 2011, DIAB FINL FINDM DAT
   Aromaa A, 2004, HLTH FUNCTIONAL CAPA
   Audulv A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-452
   Balfe M, 2014, HEALTH PLACE, V26, P180, DOI 10.1016/j.healthplace.2013.12.016
   Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001
   Canivet C, 2013, INT ARCH OCC ENV HEA, V86, P307, DOI 10.1007/s00420-012-0766-4
   Clays E, 2007, SCAND J WORK ENV HEA, V33, P252, DOI 10.5271/sjweh.1140
   DEHKO, 2001, DEV PROGR PREV CAR D
   Dray-Spira R, 2013, DIABETIC MED, V30, P549, DOI 10.1111/dme.12076
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861
   El Fassi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-305
   Elo AL, 2003, SCAND J WORK ENV HEA, V29, P444, DOI 10.5271/sjweh.752
   Elovainio M, 2015, EUR J PUBLIC HEALTH, V25, P103, DOI 10.1093/eurpub/cku115
   Finne LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102514
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   FOLKMAN S, 1987, PSYCHOL AGING, V2, P171, DOI 10.1037//0882-7974.2.2.171
   Franciosi M, 2013, NUTR METAB CARDIOVAS, V23, P606, DOI 10.1016/j.numecd.2012.03.002
   Garrido MV, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0065-6
   Glise K, 2010, INT ARCH OCC ENV HEA, V83, P511, DOI 10.1007/s00420-009-0490-x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Ilmarinen J, 2009, SCAND J WORK ENV HEA, V35, P1
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Kneck A, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.24375
   Lunau T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1086
   Mache S, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0068-3
   Melchior M, 2007, PSYCHOL MED, V37, P1119, DOI 10.1017/S0033291707000414
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022
   Rugulies R, 2013, EUR J PUBLIC HEALTH, V23, P415, DOI 10.1093/eurpub/cks071
   Schmitt A, 2014, DIABETIC MED, V31, P1446, DOI 10.1111/dme.12553
   Seidler A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-10
   Shiri R, 2013, J OCCUP ENVIRON MED, DOI [10.1097/JOM.0b013e3182a4ffc4, DOI 10.1097/JOM.OBO13E3182A4FFC4]
   Szeto ACH, 2013, J OCCUP HEALTH PSYCH, V18, P191, DOI 10.1037/a0031806
   Tuomi K, 1998, WORK ABILITY INDEX
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Varekamp I, 2010, OCCUP MED-OXFORD, DOI [10.1093/occmed/kqq076, DOI 10.1093/OCCMED/KQQ076]
   von Bonsdorff MB, 2012, BMJ OPEN, DOI [10.1136/bmjopen-2012-00086, DOI 10.1136/BMJOPEN-2012-00086]
   Weijman I, 2005, PATIENT EDUC COUNS, V59, P87, DOI 10.1016/j.pec.2004.10.004
   Weijman I, 2005, DIABETES RES CLIN PR, V68, P56, DOI 10.1016/j.diabres.2004.08.004
   Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x
   Young J, 2013, OCCUP MED-OXFORD, V63, P70, DOI 10.1093/occmed/kqs176
NR 49
TC 6
Z9 6
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1745-6673
J9 J OCCUP MED TOXICOL
JI J. Occup. Med. Toxicol.
PD MAR 21
PY 2016
VL 11
AR 11
DI 10.1186/s12995-016-0099-4
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH1MB
UT WOS:000372547200001
PM 27006684
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Cheng, HL
   Medlow, S
   Steinbeck, K
AF Cheng, Hoi Lun
   Medlow, Sharon
   Steinbeck, Katharine
TI The Health Consequences of Obesity in Young Adulthood
SO CURRENT OBESITY REPORTS
LA English
DT Article
DE Young adult; Obesity; Metabolic syndrome X; Mental health; Polycystic
   ovary syndrome
ID POLYCYSTIC-OVARY-SYNDROME; BODY-MASS INDEX; WEIGHT-LOSS INTERVENTIONS;
   YOUTH MENTAL-HEALTH; OF-THE-LITERATURE; URINARY-INCONTINENCE;
   MICRONUTRIENT DEFICIENCIES; CARDIOVASCULAR-DISEASE; EMERGING ADULTHOOD;
   METABOLIC SYNDROME
AB Young adults are gaining weight faster than any age group. This weight gain and the appearance of obesity-related comorbidities often commence in adolescence. Psychosocial distress and mental health issues are common and debilitating, and treatment approaches are likely to be similar to those for adolescents. At the same time, young adults may have physical morbidities which will continue and worsen throughout adulthood, such as hypertension, diabetes and polycystic ovarian syndrome. Health consequences of obesity are challenging to manage in young adults as their symptoms may be minimal, they are less likely to engage with healthcare due to other life priorities and their neurocognitive developmental stage makes therapy adherence difficult. Clinicians who manage young adults with obesity need to be aware of these age-specific challenges, as well as the sexual and reproductive health concerns that are present in this age group.
C1 [Cheng, Hoi Lun; Medlow, Sharon; Steinbeck, Katharine] Childrens Hosp Westmead, Acad Dept Adolescent Med, Cnr Hawkesbury Rd & Hainsworth St,Locked Bag 4001, Westmead, NSW 2145, Australia.
   [Cheng, Hoi Lun; Medlow, Sharon; Steinbeck, Katharine] Univ Sydney, Discipline Paediat & Child Hlth, Sydney Med Sch, Cnr Hawkesbury Rd & Hainsworth St,Locked Bag 4001, Westmead, NSW 2145, Australia.
RP Steinbeck, K (reprint author), Childrens Hosp Westmead, Acad Dept Adolescent Med, Cnr Hawkesbury Rd & Hainsworth St,Locked Bag 4001, Westmead, NSW 2145, Australia.; Steinbeck, K (reprint author), Univ Sydney, Discipline Paediat & Child Hlth, Sydney Med Sch, Cnr Hawkesbury Rd & Hainsworth St,Locked Bag 4001, Westmead, NSW 2145, Australia.
EM helen.cheng@health.nsw.gov.au; sharon.medlow@health.nsw.gov.au;
   kate.steinbeck@health.nsw.gov.au
FU Marie Bashir Fellowship for Clinical Research in Adolescent Health
FX HLC holds the Marie Bashir Fellowship for Clinical Research in
   Adolescent Health. KS holds the Medical Foundation Chair in Adolescent
   Medicine at the University of Sydney.
CR Aarts E, 2014, CLIN ENDOCRINOL, V81, P378, DOI 10.1111/cen.12366
   Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146
   Agrawal R, 2004, FERTIL STERIL, V82, P1352, DOI 10.1016/j.fertnstert.2004.04.041
   Alberga AS, 2012, PEDIATR OBES, V7, P261, DOI 10.1111/j.2047-6310.2011.00046.x
   Allman-Farinelli MA, 2015, HEALTHCARE-BASEL, V3, P809, DOI 10.3390/healthcare3030809
   Alosco ML, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0495-z
   Anderson AD, 2014, SEMIN REPROD MED, V32, P202, DOI 10.1055/s-0034-1371092
   Anderson JE, 2010, CAN FAM PHYSICIAN, V56, P778
   Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Arora T, 2013, PEDIATR OBES, V8, P358, DOI 10.1111/j.2047-6310.2012.00119.x
   Astrup A, 2010, INT J OBESITY, V34, P947, DOI 10.1038/ijo.2010.81
   Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269
   Ayer JG, 2009, ARTERIOSCL THROM VAS, V29, P943, DOI 10.1161/ATVBAHA.109.184184
   Ball K, 2002, INT J OBESITY, V26, P1570, DOI 10.1038/sj.ijo.0802150
   Ball K, 2004, PUBLIC HEALTH NUTR, V7, P433, DOI 10.1079/PHN2003541
   Ball K, 2009, OBESITY, V17, P66, DOI 10.1038/oby.2008.497
   Barbour LA, 2014, CURR OPIN ENDOCRINOL, V21, P257, DOI 10.1097/MED.0000000000000079
   Barthelmess Erin K, 2014, Front Biosci (Elite Ed), V6, P104
   Bartz SK, 2015, J CLIN ENDOCR METAB, V100, P3393, DOI 10.1210/JC.2015-2230
   Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4
   Bayon V, 2014, ANN MED, V46, P264, DOI 10.3109/07853890.2014.931103
   Becker ES, 2001, INT J OBESITY, V25, pS5, DOI 10.1038/sj.ijo.0801688
   Beebe DW, 2013, SLEEP, V36, P827, DOI 10.5665/sleep.2704
   Beydoun MA, 2010, J AFFECT DISORDERS, V123, P52, DOI 10.1016/j.jad.2009.09.021
   Biro FM, 2012, J PEDIATR ADOL GYNEC, V25, P289, DOI 10.1016/j.jpag.2012.05.009
   Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177
   Butow P, 2010, J CLIN ONCOL, V28, P4800, DOI 10.1200/JCO.2009.22.2802
   Cheng HL, 2012, OBES REV, V13, P150, DOI 10.1111/j.1467-789X.2011.00938.x
   Cheng HL, 2014, J SCI MED SPORT, V17, P546, DOI 10.1016/j.jsams.2013.07.020
   Cheng HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068675
   Copeland KC, 2013, PEDIATRICS, V131, P364, DOI 10.1542/peds.2012-3494
   Cowan DN, 2011, OCCUP MED-OXFORD, V61, P247, DOI 10.1093/occmed/kqr028
   Crawford B, 2014, HEALTH PROMOT J AUST, V25, P71, DOI 10.1071/HE13090
   Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201
   Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208
   de Cock M, 2014, ENVIRON INT, V70, P15, DOI 10.1016/j.envint.2014.04.022
   De Coster S, 2012, J ENVIRON PUBLIC HEA, DOI 10.1155/2012/713696
   Donkin I, 2016, CELL METAB, V23, P369, DOI 10.1016/j.cmet.2015.11.004
   Dowd JB, 2014, AM J PREV MED, V46, P578, DOI 10.1016/j.amepre.2014.01.016
   Finkelstein EA, 2007, AM J HEALTH PROMOT, V21, P460, DOI 10.4278/0890-1171-21.5.460
   Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7
   Friend A, 2013, METAB SYNDR RELAT D, V11, P71, DOI 10.1089/met.2012.0122
   Frisco ML, 2013, AM J EPIDEMIOL, V178, P22, DOI 10.1093/aje/kws462
   Garcia OP, 2009, NUTR REV, V67, P559, DOI 10.1111/j.1753-4887.2009.00228.x
   Geiger AM, 2011, J CLIN ONCOL, V29, pE492, DOI 10.1200/JCO.2011.35.5602
   Gomez JE, 1998, CLIN J SPORT MED, V8, P115, DOI 10.1097/00042752-199804000-00010
   Griffin HJ, 2013, DIABETES OBES METAB, V15, P572, DOI 10.1111/dom.12056
   Hanson MA, 2015, BEST PRACT RES CL OB, V29, P24, DOI 10.1016/j.bpobgyn.2014.06.007
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Hart R, 2015, J CLIN ENDOCR METAB, V100, P911, DOI 10.1210/jc.2014-3886
   Herva A, 2006, INT J OBESITY, V30, P520, DOI 10.1038/sj.ijo.0803174
   Hickie IB, 2011, EARLY INTERV PSYCHIA, V5, P63, DOI 10.1111/j.1751-7893.2010.00243.x
   Hutchesson MJ, 2015, OBES REV, V16, P376, DOI 10.1111/obr.12268
   Institute of Medicine, 2009, WEIGHT GAIN PREGNANC
   James S, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-39
   Kelly-Weeder S, 2011, J AM ACAD NURSE PRAC, V23, P33, DOI 10.1111/j.1745-7599.2010.00568.x
   Kolotkin RL, 2012, OBESITY, V20, P2325, DOI 10.1038/oby.2012.104
   Koskinen J, 2014, DIABETES CARE, V37, P1870, DOI 10.2337/dc14-0008
   LaBan MM, 2013, PM&R, V5, P596, DOI 10.1016/j.pmrj.2013.04.010
   Langley-Evans SC, 2015, J HUM NUTR DIET, V28, P1, DOI 10.1111/jhn.12212
   Larson N, 2012, J ACAD NUTR DIET, V112, P1216, DOI 10.1016/j.jand.2012.03.035
   Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142
   Liat S, 2015, BEST PRACT RES CL OB, V29, P79, DOI 10.1016/j.bpobgyn.2014.05.010
   Mario S, 2014, EAT WEIGHT DISORD-ST, V19, P515, DOI 10.1007/s40519-014-0128-1
   McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226
   McCrea R, 2012, INT J OBESITY, V36, P414, DOI 10.1038/ijo.2011.65
   McGavock J, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0568-z
   Melchior M, 2014, AM J HEALTH PROMOT, V28, P321, DOI 10.4278/ajhp.121023-ARB-515
   Mishra GD, 2008, INT J OBESITY, V32, P1415, DOI 10.1038/ijo.2008.107
   Misso ML, 2013, HUM REPROD UPDATE, V19, P2, DOI 10.1093/humupd/dms036
   Murphy SK, 2014, NAT REV ENDOCRINOL, V10, P389, DOI 10.1038/nrendo.2014.81
   Musil R, 2015, EXPERT OPIN DRUG SAF, V14, P73, DOI 10.1517/14740338.2015.974549
   Needham BL, 2010, AM J PUBLIC HEALTH, V100, P1040, DOI 10.2105/AJPH.2009.172809
   Nye NS, 2014, MED SCI SPORT EXER, V46, P1951, DOI 10.1249/MSS.0000000000000329
   Obradovic MM, 2015, CLIN CHEM LAB MED, V53, P29, DOI 10.1515/cclm-2014-0590
   Okwuosa TM, 2013, ATHEROSCLEROSIS, V226, P214, DOI 10.1016/j.atherosclerosis.2012.10.043
   Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010
   Pedersen SD, 2013, BEST PRACT RES CL EN, V27, P179, DOI 10.1016/j.beem.2013.02.004
   Pila E, 2015, J HEALTH PSYCHOL, V20, P659, DOI 10.1177/1359105315573449
   Poobalan AS, 2010, OBES REV, V11, P580, DOI 10.1111/j.1467-789X.2009.00673.x
   Popkin BM, 2010, AM J CLIN NUTR, V91, p284S, DOI 10.3945/ajcn.2009.28473C
   Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008
   Prentice P, 2013, INT J OBESITY, V37, P1036, DOI 10.1038/ijo.2012.177
   Reis JP, 2013, ANN NEUROL, V73, P170, DOI 10.1002/ana.23836
   Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8
   Sangsawang B, 2014, EUR J OBSTET GYN R B, V178, P27, DOI 10.1016/j.ejogrb.2014.04.010
   Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0
   Shams TA, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0473-9
   Smith AR, 2013, HORM BEHAV, V64, P323, DOI 10.1016/j.yhbeh.2013.03.006
   Smith MJ, 2014, APPL NURS RES, V27, P67, DOI 10.1016/j.apnr.2013.11.004
   Staiano AE, 2012, INT J OBESITY, V36, P1261, DOI 10.1038/ijo.2012.95
   Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288
   Stone AL, 2012, ADDICT BEHAV, V37, P747, DOI 10.1016/j.addbeh.2012.02.014
   Suren P, 2014, PEDIATRICS, V133, pE1128, DOI 10.1542/peds.2013-3664
   Therapeutic Goods Administration, 2015, PRESCR MED PREGN DAT
   Thorpe MG, 2014, PUBLIC HEALTH NUTR, V17, P1767, DOI 10.1017/S1368980013001924
   Tinggaard J, 2012, CURR OPIN ENDOCRINOL, V19, P197, DOI 10.1097/MED.0b013e3283535614
   Triunfo S, 2014, J ENDOCRINOL INVEST, V37, P323, DOI 10.1007/s40618-014-0058-9
   Tussing-Humphreys LM, 2010, OBESITY, V18, P1449, DOI 10.1038/oby.2009.319
   Twig G, 2014, DIABETES CARE, V37, P2989, DOI 10.2337/dc14-0869
   Vissers D, 2014, OBES REV, V15, P610, DOI 10.1111/obr.12170
   Vitek W, 2014, SEMIN REPROD MED, V32, P214, DOI 10.1055/s-0034-1371093
   Watsford C, 2013, EARLY INTERV PSYCHIA, V7, P131, DOI 10.1111/j.1751-7893.2012.00361.x
NR 106
TC 9
Z9 9
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2162-4968
J9 CURR OBES REP
JI Curr. Obes. Rep.
PD MAR
PY 2016
VL 5
IS 1
BP 30
EP 37
DI 10.1007/s13679-016-0190-2
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA EB0SH
UT WOS:000387055300005
PM 26830309
DA 2019-01-08
ER

PT J
AU Achuko, O
   Walker, RJ
   Campbell, JA
   Dawson, AZ
   Egede, LE
AF Achuko, Obinna
   Walker, Rebekah J.
   Campbell, Jennifer A.
   Dawson, Aprill Z.
   Egede, Leonard E.
TI Pathways Between Discrimination and Quality of Life in Patients with
   Type 2 Diabetes
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID REPORTED RACIAL-DISCRIMINATION; RANDOMIZED CONTROLLED-TRIAL; PERCEIVED
   DISCRIMINATION; SOCIAL DETERMINANTS; AFRICAN-AMERICAN; GLYCEMIC CONTROL;
   HEALTH-CARE; EVERYDAY DISCRIMINATION; PSYCHOLOGICAL DISTRESS; WEIGHT
   DISCRIMINATION
AB Background: Discrimination is a social determinant that has been linked to poor physical and mental health outcomes. This study aimed to examine the pathway whereby discrimination influences quality of life in patients with type 2 diabetes.
   Subjects and Methods: Six hundred fifteen patients were recruited from two adult primary care clinics in the southeastern United States. Measures included perceived discrimination, perceived stress, social support, and social cohesion and were based on a theoretical model for the pathways by which perceived discrimination influences mental and physical health. Quality of life was measured using the SF-12 questionnaire.
   Results: The final model [chi(2)(106) = 157.35, P = 0.009, R-2 = 0.99, root mean square error of approximation = 0.03, comparative fit index = 0.99] indicates direct effects of higher perceived stress (r = -1.02, P < 0.05) and lower social support (r = 0.36, P < 0.001) significantly related to decreased mental health component score (MCS) of quality of life. Discrimination and social cohesion were not significantly directly related to MCS. However, higher discrimination (r = 0.47, P < 0.001), higher social cohesion (r = 0.14, P < 0.05), and lower social support (r = -0.43, P < 0.001) were significantly directly related to increased stress. No significant paths were found for the physical component score of quality of life.
   Conclusions: Perceived discrimination was significantly associated with stress and served as a pathway to influence the mental health component of quality of life (MCS). Social support had a direct and an indirect effect on MCS through a negative association with stress. These results suggest that future interventions should be developed to decrease stress and increase social support surrounding discrimination to improve the MCS of quality of life in patients with diabetes.
C1 [Achuko, Obinna; Walker, Rebekah J.; Campbell, Jennifer A.; Dawson, Aprill Z.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280, Charleston, SC 29425 USA.
   [Walker, Rebekah J.; Egede, Leonard E.] Ralph H Johnson VA Med Ctr, Charleston VA Hlth Serv Res & Dev COIN, Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC USA.
   [Walker, Rebekah J.; Egede, Leonard E.] Med Univ S Carolina, Dept Med, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280, Charleston, SC 29425 USA.
EM egedel@musc.edu
FU National Institute of Diabetes and Digestive and Kidney Disease
   [K24DK093699-01]
FX This study was supported by grant K24DK093699-01 from the National
   Institute of Diabetes and Digestive and Kidney Disease (Principal
   Investigator: L.E.E.).
CR Ajrouch KJ, 2010, ETHNIC HEALTH, V15, P417, DOI 10.1080/13557858.2010.484050
   Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287
   Andrews JO, 2014, J URBAN HEALTH, V91, P1158, DOI 10.1007/s11524-014-9911-6
   Attari A, 2006, DIABETES RES CLIN PR, V73, P23, DOI 10.1016/j.diabres.2005.11.014
   Banks KH, 2006, COMMUNITY MENT HLT J, V42, P555, DOI 10.1007/s10597-006-9052-9
   Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29
   Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218
   Pavao ALB, 2012, ETHNIC DIS, V22, P353
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS POP A, P44
   Centers for Disease Control and Prevention (CDC), 2014, NAT DIAB STAT REP 20
   Chan S, 2004, J ADV NURS, V45, P72, DOI 10.1046/j.1365-2648.2003.02863.x
   Cohen S., 1988, SOCIAL PSYCHOL HLTH
   Costello A. B., 2005, PRACTICAL ASSESSMENT, V10, P173, DOI DOI 10.1234/12345678
   Cowdery JE, 2002, AIDS CARE, V14, P235, DOI 10.1080/09540120220104730
   Dawson AZ, 2015, ENDOCRINE, V49, P422, DOI 10.1007/s12020-014-0482-9
   Dyrbye LN, 2007, ARCH INTERN MED, V167, P2103, DOI 10.1001/archinte.167.19.2103
   Earnshaw V. A., 2015, J HLTH PSYCHOL
   Ezenwa MO, 2014, J HLTH DISPAR RES PR, V5, P12
   Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9
   Healthy People, SECR ADV COMM HLTH P
   Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.1016/J.INFBEH.2006.11.010
   Jackson SE, 2015, OBESITY, V23, P1105, DOI 10.1002/oby.21052
   Johansson P, 2013, J HEALTH CARE POOR U, V24, P1531, DOI 10.1353/hpu.2013.0183
   Kopf S, 2014, EXP CLIN ENDOCR DIAB, V122, P341, DOI 10.1055/s-0034-1372583
   Latner JD, 2014, EAT BEHAV, V15, P586, DOI 10.1016/j.eatbeh.2014.08.014
   Lyles CR, 2011, PATIENT EDUC COUNS, V85, pE216, DOI 10.1016/j.pec.2011.04.031
   Marks J S, 2003, CHRONIC DIS NOTES RE, V16, P2
   Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6
   Merluzzi TV, 2015, CULT DIVERS ETHN MIN, V21, P337, DOI 10.1037/a0037543
   Moffet HH, 2009, INT J EPIDEMIOL, V38, P38, DOI 10.1093/ije/dyn040
   National Center for Health Statistics, 2004, SURV QUEST NAT HLTH
   Otiniano AD, 2012, J IMMIGR MINOR HEALT, V14, P189, DOI 10.1007/s10903-011-9473-6
   Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059
   Patnaik L, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.156267
   Peek ME, 2011, MED CARE, V49, P618, DOI 10.1097/MLR.0b013e318215d925
   Preau M, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000255081.24105.d7
   Resnick B, 2001, Outcomes Manag Nurs Pract, V5, P161
   Reynolds DB, 2015, DIABETES TECHNOL THE, V17, P243, DOI 10.1089/dia.2014.0285
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Ryan AM, 2008, J HEALTH CARE POOR U, V19, P149, DOI 10.1353/hpu.2008.0005
   Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918
   Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003
   Schumacker RE, 2010, BEGINNERS GUIDE STRU
   Sevillano V, 2014, ETHNIC HEALTH, V19, P178, DOI 10.1080/13557858.2013.797569
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Slopen N, 2016, SLEEP MED, V18, P88, DOI 10.1016/j.sleep.2015.01.012
   STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907
   Szanton SL, 2012, INT J BEHAV MED, V19, P489, DOI 10.1007/s12529-011-9188-z
   Thommasen HV, 2006, BCMJ, V48, P272
   Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4
   Walker RJ, 2014, ENDOCRINE, V47, P29, DOI 10.1007/s12020-014-0195-0
   Walls ML, 2015, J AM BOARD FAM MED, V28, P231, DOI 10.3122/jabfm.2015.02.140194
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Williams DR, 2010, J HEALTH SOC BEHAV, V51, pS15, DOI 10.1177/0022146510383838
   Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0
   Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200
NR 58
TC 1
Z9 1
U1 1
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD MAR 1
PY 2016
VL 18
IS 3
BP 151
EP 158
DI 10.1089/dia.2015.0305
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DG6HE
UT WOS:000372183700008
PM 26866351
OA Green Published
DA 2019-01-08
ER

PT J
AU Li, CL
   Wu, YC
   Kornelius, E
   Chen, YJ
   Lin, YT
   Hsiao, HW
   Peng, CH
   Yang, YS
   Huang, CN
AF Li, Ching-Lu
   Wu, Yueh-Chu
   Kornelius, Edy
   Chen, Yu-Ju
   Lin, Yu-Tze
   Hsiao, Huei-Wen
   Peng, Chiung-Huei
   Yang, Yi-Sun
   Huang, Chien-Ning
TI Comparison of Different Models of Structured Self-Monitoring of Blood
   Glucose in Type 2 Diabetes
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID GLYCEMIC CONTROL; RANDOMIZED-TRIAL; PARALLEL-GROUP; INSULIN; MELLITUS;
   MANAGEMENT
AB Background: The aim of this study is to compare the effectiveness of different models of structured self-monitoring of blood glucose (SMBG) in non-insulin-treated type 2 diabetes.
   Subjects and Methods: This was a prospective, three-arm, randomized, 36-week trial. There were 138 participants with a mean age of 58.7 years and glycated hemoglobin A1c (HbA1c) level of 8.72% who were allocated to the following groups: six-pair glucose test of pre- and postprandial blood glucose (BG) per week (n = 43); three-pair glucose test of pre- and postprandial BG per week (n = 39); and seven-point BG testing before and after each meal and at bedtime over a course of 3 days in 1 month (n = 40).
   Results: The intention-to-treat analysis revealed that all three groups showed significant reductions in HbA1c levels. Comparisons among the groups revealed that only the seven-point group had a significant greater reduction of HbA1c level compared with the three-pair group (between-group mean difference of -0.86 and -0.80 from baseline to 24 and 36 weeks, respectively). No severe hypoglycemic events were reported. Diabetes distress was slightly higher in the six-pair group.
   Conclusions: Our results demonstrated that BG testing at six pairs/week, three pairs/week, and seven points for 3 days/month were all effective in improving glycemic outcome, with greater reduction of HbA1c level in the seven-point for 3 days/month group, without increasing burdensome distress in SMBG.
C1 [Li, Ching-Lu; Wu, Yueh-Chu; Chen, Yu-Ju; Lin, Yu-Tze; Hsiao, Huei-Wen] Chung Shang Med Univ Hosp, Dept Nursing, Taichung, Taiwan.
   [Kornelius, Edy; Yang, Yi-Sun; Huang, Chien-Ning] Chung Shang Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan.
   [Kornelius, Edy; Yang, Yi-Sun; Huang, Chien-Ning] Chung Shan Med Univ, Sch Med, Inst Med, 110,Sect 1,Chien Kuo North Rd, Taichung 402, Taiwan.
   [Peng, Chiung-Huei] Hungkuang Univ, Dept Nursing, Taichung, Taiwan.
RP Yang, YS; Huang, CN (reprint author), Chung Shan Med Univ, Sch Med, Inst Med, 110,Sect 1,Chien Kuo North Rd, Taichung 402, Taiwan.
EM monica119@gmail.com; cshy049@csh.org.tw
FU Chung Shan Medical University Hospital [CSH-2014-A-004]
FX We thank all the patients, physicians, and diabetes educators who
   collaborated in the study. This study was supported by the Chung Shan
   Medical University Hospital (grant CSH-2014-A-004).
CR Akbar DH, 2003, SAUDI MED J, V24, P1109
   Austin MM, 2006, DIABETES EDUCATOR, V32, P835, DOI 10.1177/0145721706295873
   Barnett AH, 2008, DIABETES OBES METAB, V10, P1239, DOI 10.1111/j.1463-1326.2008.00894.x
   Bosi E, 2013, DIABETES CARE, V36, P2887, DOI 10.2337/dc13-0092
   Dailey G, 2007, MAYO CLIN PROC, V82, P229
   Davidson MB, 2005, AM J MED, V118, P422, DOI 10.1016/j.amjmed.2004.12.006
   Farmer A, 2007, BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE
   Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761
   Guerci B, 2003, DIABETES METAB, V29, P587, DOI 10.1016/S1262-3636(07)70073-3
   Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2
   Nathan DM, 1996, AM J MED, V100, P157, DOI 10.1016/S0002-9343(97)89453-3
   Parkin CG, 2002, CLIN DIABETES, V20, P71, DOI DOI 10.2337/DIACLIN.20.2.71
   Polonsky WH, 2011, DIABETES CARE, V34, P262, DOI 10.2337/dc10-1732
   Rodbard Helena W, 2007, Endocr Pract, V13 Suppl 1, P1
   Schwedes U, 2002, DIABETES CARE, V25, P1928, DOI 10.2337/diacare.25.11.1928
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
NR 16
TC 0
Z9 0
U1 1
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD MAR 1
PY 2016
VL 18
IS 3
BP 171
EP 177
DI 10.1089/dia.2015.0082
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DG6HE
UT WOS:000372183700011
PM 26950418
DA 2019-01-08
ER

PT J
AU Ervasti, J
   Kivimaki, M
   Pentti, J
   Salo, P
   Oksanen, T
   Vahtera, J
   Virtanen, M
AF Ervasti, Jenni
   Kivimaki, Mika
   Pentti, Jaana
   Salo, Paula
   Oksanen, Tuula
   Vahtera, Jussi
   Virtanen, Marianna
TI Health- and work-related predictors of work disability among employees
   with a cardiometabolic disease - A cohort study
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Cerebrovascular disease; Diabetes; Heart disease; Stage 2 hypertension;
   Obesity; Psychological distress
ID CARDIOVASCULAR-DISEASE; RISK-FACTOR; CONSTRUCTION WORKERS; SICKNESS
   ABSENCE; BLOOD-PRESSURE; SWEDISH MEN; SHIFT WORK; JOB STRAIN; FOLLOW-UP;
   PENSION
AB Objective: The proportion of aging employees with cardiometabolic diseases, such as heart or cerebrovascular disease, diabetes and chronic hypertension is on the rise. We explored the extent to which health- and work-related factors were associated with the risk of disability pension among individuals with such cardiometabolic disease.
   Methods: A cohort of 4798 employees with and 9716 employees without a cardiometabolic disease were followed up for 7 years (2005-2011) for disability pension. For these participants, register and survey data (from 2004) were linked to records on disability pensions. Cox proportional hazards modeling was used for estimating the hazard ratios (HR) with 95% confidence intervals (CI).
   Results: Individuals with heart or cerebrovascular disease had 2.88-fold (95% CI = 2.50-331) higher risk of all cause disability pension compared to employees with no cardiometabolic disease. Diabetes was associated with a 1.84-fold (95% CI = 1.52-2.23) and hypertension a 1.50-fold (95% CI = 131-1.72) increased risk of disability pension. Obesity in cases of diabetes and hypertension (15%) and psychological distress in cases of heart or cerebrovascular disease (9%) were the strongest contributing factors. All 12 health- and work-related risk factors investigated accounted for 24% of the excess work disability in hypertension, 28% in diabetes, and 11% in heart or cerebrovascular disease. Cause-specific analyses (disability pension due to mental, musculoskeletal and circulatory system diseases) yielded similar results.
   Conclusions: In this study, modifiable risk factors, such as obesity and mental comorbidity, predicted permanent exit from the labor market due to disability in individuals with cardiometabolic disease. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Ervasti, Jenni; Kivimaki, Mika; Pentti, Jaana; Salo, Paula; Oksanen, Tuula; Vahtera, Jussi; Virtanen, Marianna] Finnish Inst Occupat Hlth, Topeliuksenkatu 41 A A, Helsinki 00250, Finland.
   [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.
   [Kivimaki, Mika] Univ Helsinki, Fac Med, Clin, FIN-00014 Helsinki, Finland.
   [Salo, Paula] Univ Turku, Dept Psychol, SF-20500 Turku, Finland.
   [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland.
   [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland.
RP Ervasti, J (reprint author), Finnish Inst Occupat Hlth, Topeliuksenkatu 41 A A, Helsinki 00250, Finland.
EM jenni.ervasti@ttl.fi
RI Salo, Paula/D-6649-2013
OI Salo, Paula/0000-0002-0812-277X; Ervasti, Jenni/0000-0001-9113-2428;
   Kivimaki, Mika/0000-0002-4699-5627; Vahtera, Jussi/0000-0002-6036-061X
FU Academy of Finland [292824, 258598]; NordForsk (the Nordic Programme on
   Health and Welfare); Era-Age2 grant (Academy of Finland) [264944];
   Economic and Social Research Council [ES/J023299/1]; Medical Research
   Council [MR/K013351/1]
FX J Ervasti and M Virtanen received funding from the Academy of Finland
   (#292824, #258598). Mika Kivimaki is supported by the NordForsk (the
   Nordic Programme on Health and Welfare), and J Vahtera received funding
   from the Era-Age2 grant (Academy of Finland #264944).
CR American Diabetes Association, 2015, DIABETES CARE S1, V38, pS1, DOI DOI 10.2337/DC15-S001
   Caspersen CJ, 2012, AM J PUBLIC HEALTH, V102, P1482, DOI 10.2105/AJPH.2011.300616
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Christensen KB, 2008, EUR J PUBLIC HEALTH, V18, P235, DOI 10.1093/eurpub/ckm130
   Claessen H, 2010, OCCUP ENVIRON MED, V67, P84, DOI 10.1136/oem.2009.046318
   Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0
   Ervasti J., 2015, DIAB MED
   Ervasti J, 2015, AM J PUBLIC HEALTH, V105, pE22, DOI 10.2105/AJPH.2015.302646
   Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   Halonen JI, 2014, OBESITY, V22, P1910, DOI 10.1002/oby.20772
   Head J, 2013, PSYCHOL MED, V43, P2649, DOI 10.1017/S0033291713000342
   Heikkila K., 2012, PLOS ONE, V7, pe3563
   Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101
   Husemoen LLN, 2004, EUR J PUBLIC HEALTH, V14, P86, DOI 10.1093/eurpub/14.1.86
   Jespersen L, 2013, EUR HEART J, V34, P3294, DOI 10.1093/eurheartj/eht395
   Karasek R, 1990, HLTH WORK STRESS PRO
   Kark M, 2009, EUR J CARDIOV PREV R, V16, P597, DOI 10.1097/HJR.0b013e32832d7ce0
   Karnehed N, 2007, SCAND J PUBLIC HEALT, V35, P48, DOI 10.1080/14034940600858524
   Kivimaki M, 2007, OCCUP ENVIRON MED, V64, P659, DOI 10.1136/oem.2006.031310
   Kivimaki M, 2010, DIABETES CARE, V33, P2611, DOI 10.2337/dc10.1187
   Koskenvuo K, 2011, EUR RESPIR J, V37, P26, DOI 10.1183/09031936.00008910
   Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251
   Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183
   Laine S, 2009, J EPIDEMIOL COMMUN H, V63, P24, DOI 10.1136/jech.2007.071407
   Li J, 2015, INT J CARDIOL, V186, P149, DOI 10.1016/j.ijcard.2015.03.222
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   Mansson NO, 1999, ANN EPIDEMIOL, V9, P341, DOI 10.1016/S1047-2797(99)00014-9
   Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6
   Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894
   Robroek SJW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134867
   Schmitz N, 2008, J PSYCHOSOM RES, V65, P165, DOI 10.1016/j.jpsychores.2008.03.004
   Seligman F, 2015, ANN NY ACAD SCI, V1345, P25, DOI 10.1111/nyas.12738
   Siegrist J, 2014, INT ARCH OCC ENV HEA, V87, P249, DOI 10.1007/s00420-013-0855-z
   Stattin M, 2005, SCAND J PUBLIC HEALT, V33, P84, DOI 10.1080/14034940410019208
   Upmark M, 1999, J EPIDEMIOL COMMUN H, V53, P223, DOI 10.1136/jech.53.4.223
   Virtanen M, 2006, OCCUP ENVIRON MED, V63, P212, DOI 10.1136/oem.2005.020297
   Virtanen M., 2015, DIABETES CARE
   Von Korff M, 2005, PSYCHOSOM MED, V67, P233, DOI 10.1097/01.psy.0000155662.82621.50
   World Health Organization, AN THER CHEM COD IND
   World Health Organization, 1992, INT CLASS DIS
   Yeap BB, 2015, J CLIN ENDOCR METAB, V100, P1038, DOI 10.1210/jc.2014-3339
   Yong M, 2015, SCAND J WORK ENV HEA, V41, P259, DOI 10.5271/sjweh.3487
NR 43
TC 6
Z9 6
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD MAR
PY 2016
VL 82
BP 41
EP 47
DI 10.1016/j.jpsychores.2016.01.010
PG 7
WC Psychiatry
SC Psychiatry
GA DG1SW
UT WOS:000371848800008
PM 26944398
DA 2019-01-08
ER

PT J
AU Lipscombe, C
   Smith, KJ
   Gariepy, G
   Schmitz, N
AF Lipscombe, Carla
   Smith, Kimberley J.
   Gariepy, Genevieve
   Schmitz, Norbert
TI Gender differences in the association between lifestyle behaviors and
   diabetes distress in a community sample of adults with type 2 diabetes
SO JOURNAL OF DIABETES
LA English
DT Article
DE alcohol drinking; exercise; mental health; smoking; type 2 diabetes
   mellitus
ID ALCOHOL-CONSUMPTION; EMOTIONAL DISTRESS; GLYCEMIC CONTROL; PSYCHOLOGICAL
   DISTRESS; CLINICAL DEPRESSION; PHYSICAL-ACTIVITY; SEX-DIFFERENCES; USE
   DISORDERS; AUDIT-C; CARE
AB BackgroundThe present study examined the association between moderate and severe diabetes distress (DD) and lifestyle behaviors (physical activity, smoking, alcohol consumption) in a community sample of adults with type 2 diabetes mellitus (T2DM).
   MethodsA total of 1971 adults with T2DM were recruited using mixed methods sampling. Participants were considered eligible if they had a doctor diagnosis of T2DM (10 years), were insulin naive, aged 40-75 years, and were from Quebec, Canada. Participants provided information on DD, lifestyle behaviors, sociodemographic, and diabetes-related factors. Multinomial logistic regressions examined the association between moderate and severe DD and each lifestyle behavior, according to gender. Effect estimates can be interpreted as probability ratios (PR).
   ResultsIn females, physical inactivity was associated with an increased likelihood of moderate distress (PR 2.2; 95% confidence interval [CI] 1.49-3.24) and severe distress (PR 1.80; 95% CI 1.00-3.24). In males, only severe distress was associated with physical inactivity (PR 1.92; 95% CI 1.00-3.66). Current smoking was associated with a greater probability of severe distress in males (PR 3.0; 95% CI 1.54-5.84) and females (PR 1.32; 95% CI 0.67-2.60); however this effect was stronger in males. No association was found between alcohol consumption and DD in females. In males, frequent alcohol consumption was associated with a reduced probability of moderate (PR 0.56; 95% CI 0.34-0.91) and severe distress (PR 0.47; 95% CI 0.21-1.06).
   ConclusionsThe findings of this study suggest important gender differences in the association between DD and lifestyle behaviors.
C1 [Lipscombe, Carla; Gariepy, Genevieve; Schmitz, Norbert] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.
   [Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada.
   [Lipscombe, Carla; Gariepy, Genevieve; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.
   [Schmitz, Norbert] Montreal Diabet Res Ctr, Montreal, PQ, Canada.
   [Smith, Kimberley J.] Brunel Univ, Dept Life Sci, Uxbridge UB8 3PH, Middx, England.
   [Smith, Kimberley J.] Brunel Univ, Inst Environm Hlth & Soc, Hlth Ageing, Uxbridge UB8 3PH, Middx, England.
RP Schmitz, N (reprint author), McGill Univ, Douglas Mental Hlth Univ Inst, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.
EM norbert.schmitz@douglas.mcgill.ca
RI Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323; Smith,
   Kimberley/0000-0002-1323-627X
FU Canadian Institutes of Health Research
FX Funding for this study was provided by an operating grant from the
   Canadian Institutes of Health Research.
CR Ahmed AT, 2008, J GEN INTERN MED, V23, P275, DOI 10.1007/s11606-007-0502-z
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Al-Delaimy WK, 2002, ARCH INTERN MED, V162, P273, DOI 10.1001/archinte.162.3.273
   Al-Delaimy WK, 2001, DIABETES CARE, V24, P2043, DOI 10.2337/diacare.24.12.2043
   Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789
   Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5
   Cheng AYY, 2013, CAN J DIABETES, V37, pS1, DOI 10.1016/j.jcjd.2013.01.009
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Engler PA, 2013, ACTA DIABETOL, V50, P93, DOI 10.1007/s00592-010-0200-x
   Fincke BG, 2005, J AMBUL CARE MANAG, V28, P262
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Health Canada, 2011, CAN ALC DRUG US MON
   Health Canada, 2012, CAN TOB US MON SURV
   Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011
   Hrywna M, 2014, AM J HEALTH BEHAV, V38, P570, DOI 10.5993/AJHB.38.4.10
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005
   Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lysy Z, 2008, DIABETIC MED, V25, P1133, DOI 10.1111/j.1464-5491.2008.02545.x
   NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037//0033-2909.101.2.259
   Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063
   Pelletier C, 2012, CHRON DIS INJ CAN, V33, P53
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Shai I, 2007, DIABETES CARE, V30, P3011, DOI 10.2337/dc07-1103
   Shin JK, 2012, DIABETES RES CLIN PR, V95, P406, DOI 10.1016/j.diabres.2011.10.043
   Sluik D, 2012, ARCH INTERN MED, V172, P1285, DOI 10.1001/archinternmed.2012.3130
   Smith KJ, 2013, PSYCHOSOMATICS, V54, P35, DOI 10.1016/j.psym.2012.08.002
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Solberg LI, 2004, ANN FAM MED, V2, P26, DOI 10.1370/afm.36
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Statistics Canada, 2003, CAN COMM HLTH SURV M
   Tonstad S, 2009, DIABETES RES CLIN PR, V85, P4, DOI 10.1016/j.diabres.2009.04.013
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
NR 43
TC 4
Z9 4
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1753-0393
EI 1753-0407
J9 J DIABETES
JI J. Diabetes
PD MAR
PY 2016
VL 8
IS 2
BP 269
EP 278
DI 10.1111/1753-0407.12298
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DF5XE
UT WOS:000371425300014
PM 25850582
DA 2019-01-08
ER

PT J
AU Winchester, RJ
   Williams, JS
   Wolfman, TE
   Egede, LE
AF Winchester, Rhonda J.
   Williams, Joni S.
   Wolfman, Tamara E.
   Egede, Leonard E.
TI Depressive symptoms, serious psychological distress, diabetes distress
   and cardiovascular risk factor control in patients with type 2 diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes; Diabetes distress; Depressive symptoms; Serious psychological
   distress; Cardiovascular disease risk factor
ID CLINICAL DEPRESSION; GENERAL-POPULATION; GLYCEMIC CONTROL; SCREENING
   SCALE; MENTAL-ILLNESS; MORTALITY; HEALTH; ADULTS; K6
AB Objective: This study examined the association between cardiovascular disease (CVD) risk factor control and elevated depressive symptoms (EDS), serious psychological distress (SPD), and diabetes distress (DD) in patients with type 2 diabetes (T2DM).
   Methods: This was a cross-sectional study of adults seen at an academic medical center and Veterans Affairs Medical Center in the southeastern US. Linear regression models were computed using CVD risk factors as clinically meaningful outcomes (glycosylated hemoglobin A1c (HbA1c); systolic (SBP) and diastolic (DBP) blood pressure; and low-density lipoprotein cholesterol (LDL-C)); EDS, SPD, and DD were primary independent variables. Covariates included sociodemographics and comorbidities.
   Results: The sample consisted of 361 adults. Correlation analyses showed significant relationships between DD and HbA1c, DBP, and LDL-C. Adjusted linear regression models showed DD to be significantly associated with HbA1c and LDL-C, and SPD to be significantly associated only with LDL-C. In the fully adjusted model, DD remained significantly associated with HbA1c ((beta = 4349; 95% CI (-0.649, 2.222)).
   Conclusions: In this sample of adults with T2DM, DD and SPD were significantly associated with CVD risk factors; however, after controlling for covariates, only DD was shown to be significantly associated with poor glycemic control.
   Practice implications: Strategies are warranted to examine the relationship between DD and CVD risk factor control in patients with T2DM. Published by Elsevier Inc.
C1 [Winchester, Rhonda J.; Williams, Joni S.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,POB 250593, Charleston, SC 29425 USA.
   [Williams, Joni S.; Wolfman, Tamara E.; Egede, Leonard E.] Med Univ S Carolina, Div Gen Internal Med & Geriatr, Dept Med, 96 Jonathan Lucas St,Suite 803,MSC 623, Charleston, SC 29425 USA.
   [Egede, Leonard E.] Ralph H Johnson VA Med Ctr, Hlth Equ & Rural Outreach Innovat Ctr, 109 Beet St, Charleston, SC 29401 USA.
RP Egede, LE (reprint author), Med Univ S Carolina, Ctr Hlth Dispar Res, Hlth Equ & Rural Outreach Innovat Ctr, 135 Rutledge Ave,Room 280G,POB 250593, Charleston, SC 29425 USA.
EM runwithjane@gmail.com; stromjl@musc.edu; wolfmant@musc.edu;
   egedel@musc.edu
FU National Institute of Diabetes and Digestive and Kidney Disease
   [K24DK093699]
FX Funding Source: This study was supported by Grant K24DK093699 from The
   National Institute of Diabetes and Digestive and Kidney Disease (PI:
   Leonard Egede). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   [Anonymous], 2011, STATA VERS 12 0 COMP
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Centers for Disease Control and Prevention, 2004, SER PSYCH DISTR
   Dalsgaard EM, 2014, DIABETOLOGIA, V57, P710, DOI 10.1007/s00125-014-3165-4
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hamer M, 2010, PSYCHOSOM MED, V72, P882, DOI 10.1097/PSY.0b013e3181f6696e
   Hudson DL, 2013, AM J MANAG CARE, V19, P344
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310
   Khuwaja A. K., 2010, DIABETOL METAB SYNDR, V2, P2, DOI DOI 10.1186/1758-5996-2-72
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Li CY, 2010, DIABETES CARE, V33, P1061, DOI 10.2337/dc09-1515
   Mitchell CM, 2011, PSYCHOL ASSESSMENT, V23, P752, DOI 10.1037/a0023288
   Murphy T., 2010, EFFECTS CHRONIC MED
   New Hampshire Department of Health and Human Services, 2009, SER PSYCH DISTR NH A
   Okumura Y, 2013, GEN HOSP PSYCHIAT, V35, P233, DOI 10.1016/j.genhosppsych.2012.12.013
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Tol A., 2012, J DIABETES METABOLIC, V11
   Walker RJ, 2014, GEN HOSP PSYCHIAT, V36, P662, DOI 10.1016/j.genhosppsych.2014.06.011
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 30
TC 7
Z9 7
U1 2
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD MAR
PY 2016
VL 30
IS 2
BP 312
EP 317
DI 10.1016/j.jdiacomp.2015.11.010
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DF2SW
UT WOS:000371195100022
PM 26657725
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Wang, HF
   Yu, NC
   Sheu, WHH
   Yeh, MC
AF Wang, Huey-Fen
   Yu, Neng-Chun
   Sheu, Wayne H-H
   Yeh, Mei Chang
TI The development of a questionnaire measure of diabetes-related distress
   in Chinese-speaking patients: the Diabetes-Related Distress
   Questionnaire (DRDQ)
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE Chinese; Diabetes; Diabetes-related distress
ID QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; EMOTIONAL DISTRESS; REPORTED
   OUTCOMES; GLYCEMIC CONTROL; NEEDS DAWN; TYPE-2; HEALTH; ADAPTATION;
   DEPRESSION
AB To develop and evaluate the reliability and validity of a Diabetes-Related Distress Questionnaire for Chinese-speaking patients with diabetes.
   The Diabetes-Related Distress Questionnaire (DRDQ) included 11 quality-of-life questions translated from a Diabetes, Attitudes, Wishes, and Needs study and four native items developed by researchers based on patients' experiences. A sample of 981 Chinese-speaking patients with diabetes in Taiwan was invited to complete the questionnaire.
   A minimum of 4.2 % of patients used each response option for each item. Exploratory factor analysis suggested a two-factor structure, representing treatment-related distress (factor 1) and progression-related distress (factor 2). The mean loading of items on their corresponding factor was high (0.60), while the mean loading on the other factor was low (0.10). A confirmatory factor analysis confirmed a single structure of the DRDQ (root-mean-square error of approximation = 0.063, comparative fit index = 0.93). The Cronbach's alpha was 0.89 for the DRDQ scale, 0.87 for the factor 1, and 0.68 for the factor 2. As expected, people with insulin-treated and HbA1c > 7 % reported significantly greater negative scores than their counterparts on the total score and all items of the DRDQ, with the exception of item 2. A moderate effect size was demonstrated between insulin known groups (ranging from 0.14 to 0.46) and between HbA1c known groups (ranging from 0.08 to 0.87).
   The DRDQ is a psychometrically sound instrument that can be used to assess diabetes-related distress in Chinese-speaking patients in Taiwan.
C1 [Wang, Huey-Fen] Yuanpei Univ Med Technol, Dept Nursing, Hsinchu, Taiwan.
   [Yu, Neng-Chun] Neng Chun Diabet Clin, Taichung, Ilan County, Taiwan.
   [Sheu, Wayne H-H] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taichung, Taiwan.
   [Sheu, Wayne H-H] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.
   [Sheu, Wayne H-H] Natl Def Med Ctr, Coll Med, Taipei, Taiwan.
   [Yeh, Mei Chang] Natl Taiwan Univ, Sch Nursing, Coll Med, 1,Sec 1,Jen Ai Rd, Taipei 10051, Taiwan.
RP Yeh, MC (reprint author), Natl Taiwan Univ, Sch Nursing, Coll Med, 1,Sec 1,Jen Ai Rd, Taipei 10051, Taiwan.
EM mchang@ntu.edu.tw
OI CHANG, MEI/0000-0002-4166-3498
FU Health Promotion Administration, Ministry of Health and Welfare
   [990313A, 990313A-100]
FX The authors would like to acknowledge the contribution of funding from
   the Health Promotion Administration, Ministry of Health and Welfare
   (990313A; 990313A-100). The authors would also like to thank Miss Chen
   I-Chun from the Taiwanese Association of Diabetes Educators (TADE),
   Taiwan, ROC, and various colleagues from the diabetes health promotion
   institutes, Taiwan, for their assistance.
CR Alberti G, 2002, PRACT DIABETES INT, V19, P22, DOI DOI 10.1002/PDI.305/PDF
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Cappelleri JC, 2014, CH CRC BIOSTAT SER, P1
   Chuang LM, 2002, DIABETIC MED, V19, P978, DOI 10.1046/j.1464-5491.2002.00833.x
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   De Berardis G, 2005, DIABETES CARE, V28, P2637, DOI 10.2337/diacare.28.11.2637
   De Berardis G, 2002, DIABETES CARE, V25, P284, DOI 10.2337/diacare.25.2.284
   Debono Miguel, 2007, Psychol Health Med, V12, P545, DOI 10.1080/13548500701235740
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Funnell MM, 2006, CLIN DIABETES, V24, P154
   Glasgow RE, 2001, DIABETES SPECTRUM, V14, P33, DOI DOI 10.2337/DIASPECT.14.1.33
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   Kong DL, 2011, DIABETES RES CLIN PR, V94, P45, DOI 10.1016/j.diabres.2011.05.026
   Lee S, 2006, DIABETES RES CLIN PR, V74, P282, DOI 10.1016/j.diabres.2006.03.026
   Lou VWQ, 2006, RES SOCIAL WORK PRAC, V16, P491, DOI 10.1177/1049731506287084
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Mohamed M, 2008, CURR MED RES OPIN, V24, P507, DOI 10.1185/030079908X261131 
   Nakahara R, 2006, PSYCHOSOMATICS, V47, P240, DOI 10.1176/appi.psy.47.3.240
   Pan C, 2012, DIABETIC MED, V29, P515, DOI 10.1111/j.1464-5491.2011.03436.x
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x
   Yu NC, 2013, DIABETES RES CLIN PR, V99, P112, DOI 10.1016/j.diabres.2012.11.018
NR 29
TC 0
Z9 0
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
EI 1573-2649
J9 QUAL LIFE RES
JI Qual. Life Res.
PD MAR
PY 2016
VL 25
IS 3
BP 721
EP 729
DI 10.1007/s11136-015-1106-4
PG 9
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA DE7EB
UT WOS:000370796700022
PM 26296258
DA 2019-01-08
ER

PT J
AU Chao, AM
   Minges, KE
   Park, C
   Dumser, S
   Murphy, KM
   Grey, M
   Whittemore, R
AF Chao, Ariana M.
   Minges, Karl E.
   Park, Chorong
   Dumser, Susan
   Murphy, Kathryn M.
   Grey, Margaret
   Whittemore, Robin
TI General Life and Diabetes-Related Stressors in Early Adolescents With
   Type 1 Diabetes
SO JOURNAL OF PEDIATRIC HEALTH CARE
LA English
DT Article
DE Stress; type 1 diabetes; adolescents
ID QUALITATIVE CONTENT-ANALYSIS; METABOLIC-CONTROL; SELF-MANAGEMENT;
   CHILDREN; YOUTH; DEPRESSION; ADHERENCE; DISTRESS; PATTERNS; PROGRAMS
AB Introduction: To examine general and diabetes-related stressors in early adolescents with type 1 diabetes (T1D).
   Method: Data were from 205 participants (58% female; 33% minority; 11-14 years) enrolled in a clinical trial. Teens identified their top 3 stressors and responded to open-ended questions. A content analysis method was used to identify themes across stressor categories.
   Results: Eight-two percent of teens reported that school was a top stressor, followed by social life (49%) and diabetes (48%). We identified 5 themes of general life stressors (fitting in, having friends, balancing competing demands, living with family, and feeling pressure to do well) and 3 themes of diabetes-specific stressors (just having diabetes, dealing with emotions, and managing diabetes).
   Discussion: Though teens with T1D experienced stressors specific to T1D, they perceived stress related to normal adolescent growth and development more frequently. Teens with T1D may need psychosocial support that holistically addresses both typical developmental and diabetes-related stressors.
C1 [Chao, Ariana M.] Univ Penn, Sch Nursing, 418 Curie Blvd, Philadelphia, PA 19104 USA.
   [Minges, Karl E.; Park, Chorong; Grey, Margaret; Whittemore, Robin] Yale Univ, Sch Nursing, Orange, CT USA.
   [Dumser, Susan] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.
   [Murphy, Kathryn M.] Childrens Hosp Philadelphia, Diabet Ctr Children, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.
RP Chao, AM (reprint author), Univ Penn, Sch Nursing, 418 Curie Blvd, Philadelphia, PA 19104 USA.
EM AriChao@nursing.upenn.edu
FU National Institutes of Nursing Research (NINR)/National Institutes of
   Health (NIH) [2R01NR004009]; Jonas Center for Nursing Excellence;
   NINR/NIH [T32NR00834610, F31NR014375]; National Institute of Diabetes
   and Digestive and Kidney Diseases/NIH [T32DK07718]
FX Supported by the National Institutes of Nursing Research (NINR)/National
   Institutes of Health (NIH) grant 2R01NR004009 to Margaret Grey and Robin
   Whittemore, principal investigators. Development of the Internet
   programs was supported by intramural funds provided to Margaret Grey.
   Ariana M. Chao was funded by predoctoral fellowships from the Jonas
   Center for Nursing Excellence and the NINR/NIH (T32NR00834610;
   F31NR014375). Karl E. Minges was funded by a predoctoral fellowship from
   the National Institute of Diabetes and Digestive and Kidney Diseases/NIH
   (T32DK07718).
CR Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660
   Berlin KS, 2012, J PEDIATR PSYCHOL, V37, P990, DOI 10.1093/jpepsy/jss080
   Campbell MS, 2014, PEDIATR DIABETES, V15, P110, DOI 10.1111/pedi.12067
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C
   Christian B J, 1997, J Pediatr Nurs, V12, P3, DOI 10.1016/S0882-5963(97)80016-4
   Compas BE, 2012, ANNU REV CLIN PSYCHO, V8, P455, DOI 10.1146/annurev-clinpsy-032511-143108
   Davidson M, 2004, APPL NURS RES, V17, P72, DOI 10.1016/j.apnr.2004.02.006
   Decker CL, 2007, PSYCHO-ONCOLOGY, V16, P1, DOI 10.1002/pon.1073
   Delamater AM, 2013, PEDIATR DIABETES, V14, P50, DOI 10.1111/j.1399-5448.2012.00894.x
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Farrell SP, 2004, J ADOLESCENT HEALTH, V34, P461, DOI 10.1016/S1054-139X(03)00215-5
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Grey M, 2013, DIABETES CARE, V36, P2475, DOI 10.2337/dc12-2199
   Grey M, 2012, CONTEMP CLIN TRIALS, V33, P769, DOI 10.1016/j.cct.2012.03.012
   Grey M, 2009, RES NURS HEALTH, V32, P405, DOI 10.1002/nur.20336
   Guo J, 2011, J ADV NURS, V67, P2294, DOI 10.1111/j.1365-2648.2011.05697.x
   Hains AA, 2006, DIABETES CARE, V29, P818, DOI 10.2337/diacare.29.04.06.dc05-1828
   Hema DA, 2009, CHILD CARE HLTH DEV, V35, P330, DOI 10.1111/j.1365-2214.2009.00937.x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Huus Karina, 2007, Paediatr Nurs, V19, P29
   Jaser SS, 2011, DIABETES EDUCATOR, V37, P756, DOI 10.1177/0145721711422610
   Karsdorp PA, 2007, J PEDIATR PSYCHOL, V32, P527, DOI 10.1093/jpepsy/jsl047
   Kovacs M, 1997, DIABETES CARE, V20, P45, DOI 10.2337/diacare.20.1.45
   Krippendorff K., 2012, CONTENT ANAL INTRO I
   Malik JA, 2009, DIABETES CARE, V32, P774, DOI 10.2337/dc08-1306
   Marshall C., 2010, DESIGNING QUALITATIV
   McElhaney KB, 2008, CHILD DEV, V79, P720, DOI 10.1111/j.1467-8624.2008.01153.x
   Morgan D L, 1993, Qual Health Res, V3, P112, DOI 10.1177/104973239300300107
   Palta M, 1996, AM J EPIDEMIOL, V144, P954
   Paris CA, 2009, J PEDIATR-US, V155, P183, DOI 10.1016/j.jpeds.2009.01.063
   Sawyer SM, 2007, LANCET, V369, P1481, DOI 10.1016/S0140-6736(07)60370-5
   Schilling LS, 2002, J ADV NURS, V37, P87, DOI 10.1046/j.1365-2648.2002.02061.x
   Serido J, 2004, J HEALTH SOC BEHAV, V45, P17, DOI 10.1177/002214650404500102
   Stang J., 2005, ADOLESCENT GROWTH DE
   Steinberg L, 2001, ANNU REV PSYCHOL, V52, P83, DOI 10.1146/annurev.psych.52.1.83
   Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369
   Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048
   Whittemore R, 2012, NURS RES, V61, P395, DOI 10.1097/NNR.0b013e3182690a29
NR 40
TC 9
Z9 9
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5245
EI 1532-656X
J9 J PEDIATR HEALTH CAR
JI J. Pediatr. Health Care
PD MAR-APR
PY 2016
VL 30
IS 2
BP 133
EP 142
DI 10.1016/j.pedhc.2015.06.005
PG 10
WC Health Policy & Services; Nursing; Pediatrics
SC Health Care Sciences & Services; Nursing; Pediatrics
GA DE1GH
UT WOS:000370374400006
PM 26234658
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Speight, J
   Barendse, SM
   Singh, H
   Little, SA
   Inkster, B
   Frier, BM
   Heller, SR
   Rutter, MK
   Shaw, JAM
AF Speight, J.
   Barendse, S. M.
   Singh, H.
   Little, S. A.
   Inkster, B.
   Frier, B. M.
   Heller, S. R.
   Rutter, M. K.
   Shaw, J. A. M.
TI Characterizing problematic hypoglycaemia: iterative design and
   preliminary psychometric validation of the Hypoglycaemia Awareness
   Questionnaire (HypoA-Q)
SO DIABETIC MEDICINE
LA English
DT Article
ID IMPAIRED AWARENESS; ENDOCRINE-SOCIETY; FREQUENCY; ADULTS; SYMPTOMS;
   TRIAL
AB AimsTo design and conduct preliminary validation of a measure of hypoglycaemia awareness and problematic hypoglycaemia, the Hypoglycaemia Awareness Questionnaire.
   MethodsExploratory and cognitive debriefing interviews were conducted with 17 adults (nine of whom were women) with Type 1 diabetes (meansd age 4810years). Questionnaire items were modified in consultation with diabetologists/psychologists. Psychometric validation was undertaken using data from 120 adults (53 women) with Type 1 diabetes (meansd age 4416years; 50% with clinically diagnosed impaired awareness of hypoglycaemia), who completed the following questionnaires: the Hypoglycaemia Awareness Questionnaire, the Gold score, the Clarke questionnaire and the Problem Areas in Diabetes questionnaire.
   ResultsIterative design resulted in 33 items eliciting responses about awareness of hypoglycaemia when awake/asleep and hypoglycaemia frequency, severity and impact (healthcare utilization). Psychometric analysis identified three subscales reflecting impaired awareness', symptom level' and symptom frequency'. Convergent validity was indicated by strong correlations between the impaired awareness' subscale and existing measures of awareness: (Gold: r(s)=0.75, P<0.01; Clarke: r(s)=0.76, P<0.01). Divergent validity was indicated by weaker correlations with diabetes-related distress (Problem Areas in Diabetes: r(s)=0.25, P<0.01) and HbA(1c) (r(s)=-0.05, non-significant). The impaired awareness' subscale and other items discriminated between those with impaired and intact awareness (Gold score). The impaired awareness' subscale and other items contributed significantly to models explaining the occurrence of severe hypoglycaemia and hypoglycaemia when asleep.
   ConclusionsThis preliminary validation shows the Hypoglycaemia Awareness Questionnaire has robust face and content validity; satisfactory structure; internal reliability; convergent, divergent and known groups validity. The impaired awareness subscale and other items contribute significantly to models explaining recall of severe and nocturnal hypoglycaemia. Prospective validation, including determination of a threshold to identify impaired awareness, is now warranted.
C1 [Speight, J.; Barendse, S. M.] AHP Res, Hornchurch, England.
   [Speight, J.] Diabet Victoria, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Speight, J.] Deakin Univ, Sch Psychol, Burwood, Australia.
   [Singh, H.] Univ Virginia, Sch Med, Div Behav Hlth & Technol, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA.
   [Little, S. A.; Shaw, J. A. M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Inkster, B.; Frier, B. M.] Royal Infirm, Dept Diabet, Edinburgh EH3 9YW, Midlothian, Scotland.
   [Heller, S. R.] Univ Sheffield, Acad Unit Diabet Endocrinol & Metab, Sheffield S10 2TN, S Yorkshire, England.
   [Rutter, M. K.] Univ Manchester, Fac Med & Human Sci, Endocrinol & Diabet Res Grp, Inst Human Dev, Manchester M13 9PL, Lancs, England.
   [Rutter, M. K.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Diabet Ctr, Manchester, Lancs, England.
RP Speight, J (reprint author), AHP Res, Hornchurch, England.; Speight, J (reprint author), Diabet Victoria, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.; Speight, J (reprint author), Deakin Univ, Sch Psychol, Burwood, Australia.
EM jane.speight@deakin.edu.au
OI Speight, Jane/0000-0002-1204-6896; Rutter, Martin/0000-0001-6380-539X;
   Heller, Simon/0000-0002-2425-9565
FU Diabetes UK [07/0003556]
FX We thank Diabetes UK for funding the design of the HypoA-Q (Study 1) as
   part of the HypoCOMPaSS trial (ref: 07/0003556). No funding was sought
   for the psychometric validation (Study 2).
CR Choudhary P, 2010, DIABETIC MED, V27, P666, DOI 10.1111/j.1464-5491.2010.03006.x
   CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Cryer PE, 2002, DIABETES NUTR METAB, V15, P330
   Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410
   DEARY IJ, 1993, DIABETOLOGIA, V36, P771, DOI 10.1007/BF00401150
   Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x
   Geddes J, 2007, DIABETES CARE, V30, P1868, DOI 10.2337/dc06-2556
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Inkster B, 2013, DIABETES OBES METAB, V15, P775, DOI 10.1111/dom.12071
   Kline P, 1997, HDB PSYCHOL TESTING
   Kline P., 1994, EASY GUIDE FACTOR AN
   Little S, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-33
   Little SA, 2014, DIABETES CARE, V37, P2114, DOI 10.2337/dc14-0030
   MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   PRAMMING S, 1991, DIABETIC MED, V8, P217, DOI 10.1111/j.1464-5491.1991.tb01575.x
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Willis G. B., 2005, COGNITIVE INTERVIEWI
NR 20
TC 7
Z9 7
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD MAR
PY 2016
VL 33
IS 3
BP 376
EP 385
DI 10.1111/dme.12824
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DD8FW
UT WOS:000370162000016
PM 26042777
DA 2019-01-08
ER

PT J
AU Speight, J
   Holmes-Truscott, E
   Harvey, DM
   Hendrieckx, C
   Hagger, VL
   Harris, SE
   Knight, BA
   McIntyre, HD
AF Speight, Jane
   Holmes-Truscott, Elizabeth
   Harvey, Dianne M.
   Hendrieckx, Christel
   Hagger, Virginia L.
   Harris, Susan E.
   Knight, Brigid A.
   McIntyre, Harold D.
TI Structured type 1 diabetes education delivered in routine care in
   Australia reduces diabetes-related emergencies and severe
   diabetes-related distress: The OzDAFNE program
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Structured diabetes education; Diabetes distress;
   Hypoglycaemia
ID NORMAL EATING DAFNE; INTENSIFIED INSULIN THERAPY; ENABLE DIETARY
   FREEDOM; DOSE ADJUSTMENT; SEVERE HYPOGLYCEMIA; GLYCEMIC CONTROL;
   SELF-MANAGEMENT; PEOPLE; ADULTS; EXPERIENCES
AB Aims: To evaluate structured type 1 diabetes education delivered in routine practice throughout Australia.
   Methods: Participants attended a five-day training program in insulin dose adjustment and carbohydrate counting between April 2007 and February 2012. Using an uncontrolled before-and-after study design, we investigated: HbA1c (% and mmol/mol); severe hypoglycaemia; diabetes ketoacidosis (DKA) requiring hospitalisation, and diabetes-related distress (Problem Areas in Diabetes scale; PAID), weight (kg); body mass index. Data were collected pre-training and 6-18 months post-training. Change in outcome scores were examined overall as well as between groups stratified by baseline HbA1c quartiles. Data are mean +/- SD or % (n).
   Results: 506 participants had data eligible for analysis. From baseline to follow-up, significant reductions were observed in the proportion of participants reporting at least one severe hypoglycaemic event (24.7% (n = 123) vs 12.1% (n = 59), p < 0.001); and severe diabetes-related distress (29.3% (n = 145) vs 12.6% (n = 60), p < 0.001). DKA requiring hospitalisation in the past year reduced from 4.1% (n = 20) to 1.2% (n = 6). For those with above target baseline HbA1c there was a small, statistically significant improvement (n = 418, 8.4 +/- 1.1% (69 +/- 12 mmol/mol) to 8.2 +/- 1.1% (66 +/- 12 mmol/mol). HbA1c improvement was clinically significant among those in the highest baseline quartile (n = 122, 9.7 perpendicular to 1.1% (82 perpendicular to 11 mmol/mol) to 9.0 +/- 1.2% (75 +/- 13 mmol/mol), p < 0.001).
   Conclusions: The proportion of participants reporting severe hypoglycaemia, DKA and severe diabetes-related distress was at least halved, and HbA1c reduced by 0.7% (7 mmol/mol) among those with highest baseline levels. Structured type 1 diabetes education delivered in routine practice offers clinically important benefits for those with greatest clinical need. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Speight, Jane; Holmes-Truscott, Elizabeth; Hendrieckx, Christel; Hagger, Virginia L.] Australian Ctr Behav Res Diabet, Diabet Victoria, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Speight, Jane; Holmes-Truscott, Elizabeth; Hendrieckx, Christel; Hagger, Virginia L.] Deakin Univ, Sch Psychol, 221 Burwood Highway, Burwood, Vic 3125, Australia.
   [Speight, Jane] AHP Res, 16 Walden Way, Hornchurch, England.
   [Harvey, Dianne M.; Hagger, Virginia L.; Harris, Susan E.] Diabet Victoria, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Knight, Brigid A.; McIntyre, Harold D.] Mater Hlth Serv, Raymond Terrace, South Brisbane, Qld 4101, Australia.
   [Knight, Brigid A.] Lady Cilento Childrens Hosp, Stanley St, South Brisbane, Qld 4101, Australia.
   [McIntyre, Harold D.] Univ Queensland, Mater Clin Sch, Raymond Terrace, South Brisbane, Qld 4101, Australia.
RP Speight, J (reprint author), Australian Ctr Behav Res Diabet, Diabet Victoria, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
EM jspeight@acbrd.org.au
OI Speight, Jane/0000-0002-1204-6896; Holmes-Truscott,
   Elizabeth/0000-0001-9139-4663; Knight, Brigid/0000-0002-8660-5590
FU National Diabetes Services Scheme, an initiative of the Australian
   Government; Statewide Diabetes Network innovation; Abbott Diabetes Care;
   Diabetes Victoria; Deakin University
FX The OzDAFNE program receives no formal funding. Its coordination and the
   delivery of some programs are supported in Victoria by the National
   Diabetes Services Scheme, an initiative of the Australian Government
   administered by Diabetes Australia, and in Queensland by Statewide
   Diabetes Network innovation funding. Local funding arrangements vary for
   delivery of programs. Diabetes Victoria acknowledges funding received
   from Abbott Diabetes Care (from 2011 to 2012) to support OzDAFNE
   professional development days and website revision.; JS and CH are
   supported by the core funding provided to the ACBRD by Diabetes Victoria
   and Deakin University. EHT's analysis of the OzDAFNE dataset was funded
   by Diabetes Victoria.
CR Amiel S, 2002, BRIT MED J, V325, P746
   Bott S, 1997, DIABETOLOGIA, V40, P926, DOI 10.1007/s001250050769
   Cheung NW, 2009, MED J AUSTRALIA, V191, P339
   Cooke D, 2013, DIABETES CARE, V36, P270, DOI 10.2337/dc12-0080
   Cox DJ, 2006, DIABETES SPECTRUM, V19, P43, DOI DOI 10.2337/DIASPECT.19.1.43
   Elliott J, 2015, DIABETIC MED, V32, P391, DOI 10.1111/dme.12621
   Elliott J, 2014, DIABETIC MED, V31, P847, DOI 10.1111/dme.12441
   Gunn D, 2012, DIABETIC MED, V29, P807, DOI 10.1111/j.1464-5491.2011.03525.x
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579
   Jones A, 2015, DIABETIC MED, V32, P155, DOI 10.1111/dme.12620
   Lawton J, 2011, DIABETES RES CLIN PR, V91, P87, DOI 10.1016/j.diabres.2010.11.007
   McIntyre HD, 2010, MED J AUSTRALIA, V192, P637
   MUHLHAUSER I, 1983, DIABETOLOGIA, V25, P470
   MUHLHAUSER I, 1987, DIABETOLOGIA, V30, P681, DOI 10.1007/BF00296989
   Plank J, 2004, DIABETOLOGIA, V47, P1370, DOI 10.1007/s00125-004-1456-x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rankin D, 2012, DIABETIC MED, V29, P1079, DOI 10.1111/j.1464-5491.2012.03670.x
   Rankin D, 2011, DIABETIC MED, V28, P532, DOI 10.1111/j.1464-5491.2011.03243.x
   Rankin D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-652
   Samann A, 2005, DIABETOLOGIA, V48, P1965, DOI 10.1007/s00125-005-1905-1
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Speight J, 2010, DIABETES RES CLIN PR, V89, P22, DOI 10.1016/j.diabres.2010.03.017
NR 23
TC 11
Z9 11
U1 1
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD FEB
PY 2016
VL 112
BP 65
EP 72
DI 10.1016/j.diabres.2015.11.002
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DD2DF
UT WOS:000369732000010
PM 26688058
DA 2019-01-08
ER

PT J
AU Rondags, SMPA
   de Wit, M
   Snoek, FJ
AF Rondags, S. M. P. A.
   de Wit, M.
   Snoek, F. J.
TI HypoAware: development and pilot study of a brief and partly web-based
   psychoeducational group intervention for adults with Type 1 and
   insulin-treated Type 2 diabetes and problematic hypoglycaemia
SO DIABETIC MEDICINE
LA English
DT Article
ID FOLLOW-UP; INTERNET
AB Aim Our aim was to study the feasibility and acceptability of our partly online psychoeducational group intervention HypoAware targeted at adults with insulin-treated diabetes and hypoglycaemia problems in an uncontrolled multicentre pilot study.
   Methods We developed a 4-week, party online, group intervention, based on key elements of the evidence-based Blood Glucose Awareness Training (BGAT) and with input from diabetes healthcare professionals and people with diabetes. We recruited adults with Type 1 and insulin-treated Type 2 diabetes with impaired hypoglycaemia awareness, frequent hypoglycaemic episodes and/or fear of hypoglycaemia. Feasibility was assessed by means of self-report questionnaires. Pre-post outcomes included self-reported frequency of mild hypoglycaemia, fear of hypoglycaemia, confidence in diabetes self-care, subjective health status, diabetes-specific and general psychological distress and emotional well-being.
   Results Organization, recruitment, delivery of HypoAware, retention and compliance yielded no major problems, and both trainers and participants were very satisfied with the programme. The intervention materials required only minor changes. We obtained pre-post intervention measurements in 37 participants from eight hospitals with three drop-outs. Worries about hypoglycaemia, diabetes distress and confidence in self-care improved significantly (P < 0.05), although frequency of hypoglycaemia and hypoglycaemia awareness did not.
   Conclusions HypoAware is a new, feasible and acceptable intervention including online modules aimed to help adults with Type 1 and insulin-treated Type 2 diabetes reduce hypoglycaemia and related problems. A cluster-randomized controlled trial is planned to test effectiveness, combined with an economic evaluation.
C1 [Rondags, S. M. P. A.; de Wit, M.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Rondags, S. M. P. A.; de Wit, M.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Snoek, F. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
RP Rondags, SMPA (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.; Rondags, SMPA (reprint author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
EM s.rondags@vumc.nl
FU VU University Medical Center from LifeScan Benelux, division of Johnson
   & Johnson Medical BV
FX VU University Medical Center funded this study with an unrestricted
   educational grant from LifeScan Benelux, division of Johnson & Johnson
   Medical BV.
CR Broers S, 2005, NETH J MED, V63, P164
   Cox D, 2008, DIABETES CARE, V31, P1527, DOI 10.2337/dc07-1956
   COX DJ, 1994, DIABETES CARE, V17, P1, DOI 10.2337/diacare.17.1.1
   Cox DJ, 2006, DIABETES SPECTRUM, V19, P43, DOI DOI 10.2337/DIASPECT.19.1.43
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084
   Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852
   Gonder-Frederick L, 2000, PSYCHOL DIABETES CAR, P169
   Gonder-Frederick L., 2013, DIABETIC HYPOGLYCEMI, V5, P3
   GonderFrederick L, 1997, DIABETES CARE, V20, P661, DOI 10.2337/diacare.20.4.661
   Ha WC, 2012, DIABETES METAB J, V36, P280, DOI 10.4093/dmj.2012.36.4.280
   Khunti K, 2008, BMJ-BRIT MED J, V336, P491
   Kok PE, 2011, J CLIN NURS, V20, P2997, DOI 10.1111/j.1365-2702.2011.03743.x
   Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6
   Oyer DS, 2013, CURR DIABETES REV, V9, P195, DOI 10.2174/15733998113099990059
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Snoek FJ, 2014, HYPOGLYCAEMIA CLIN D, P323
   Speight J, 2010, DIABETES RES CLIN PR, V89, P22, DOI 10.1016/j.diabres.2010.03.017
   Unger J, 2011, POSTGRAD MED, V123, P81, DOI 10.3810/pgm.2011.07.2307
   van de Poll-Franse LV, 2008, SUPPORT CARE CANCER, V16, P1189, DOI 10.1007/s00520-008-0419-z
NR 20
TC 4
Z9 4
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD FEB
PY 2016
VL 33
IS 2
BP 184
EP 191
DI 10.1111/dme.12876
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DD8FU
UT WOS:000370161800007
PM 26234919
DA 2019-01-08
ER

PT J
AU Ervasti, J
   Kivimaki, M
   Dray-Spira, R
   Head, J
   Goldberg, M
   Pentti, J
   Jokela, M
   Vahtera, J
   Zins, M
   Virtanen, M
AF Ervasti, J.
   Kivimaki, M.
   Dray-Spira, R.
   Head, J.
   Goldberg, M.
   Pentti, J.
   Jokela, M.
   Vahtera, J.
   Zins, M.
   Virtanen, M.
TI Psychosocial factors associated with work disability in men and women
   with diabetes: a pooled analysis of three occupational cohort studies
SO DIABETIC MEDICINE
LA English
DT Article
ID GENERAL-HEALTH-QUESTIONNAIRE; WHITEHALL II COHORT; RISK-FACTOR; SICKNESS
   ABSENCE; GAZEL COHORT; JOB STRAIN; METAANALYSIS; PROFILE; IMPACT;
   MEDICATION
AB Aims To examine the extent to which adverse psychosocial factors, such as living alone, psychological distress, job strain and low support from supervisor, increase the risk of work disability (sickness absence and disability pension) among employees with diabetes.
   Methods In this pooled analysis of individual-participant data from three occupational cohort studies (the Finnish Public Sector Study, the British Whitehall II study, and the French GAZEL study), 1088 women and 949 men with diabetes were followed up to determine the duration (number of days) and frequency (number of spells) of work disability. The mean follow-up periods were 3.2 years in the GAZEL study, 4.6 years in the Whitehall II study and 4.7 years in the Finnish Public Sector Study. Psychosocial factors and potential confounding factors were assessed at baseline using standard questionnaires. Study-specific estimates were pooled using fixed-effects meta-analysis.
   Results In analysis adjusted for sociodemographic factors, health behaviours and comorbidities, participants with psychological distress had longer (rate ratio 1.66; 95% CI 1.31-2.09) and more frequent absences (rate ratio 1.33; 95% CI 1.19-1.49) compared with those with no psychological distress. Job strain was associated with slightly increased absence frequency (rate ratio 1.19 95% CI 1.05-1.35), but not with absence duration. Living alone and low supervisor support were not associated with absence duration or frequency. We observed no sex differences in these associations.
   Conclusions Psychological distress was associated with increased duration and frequency of work disability among employees with diabetes. Job strain was associated with increased absence frequency but not with absence duration.
C1 [Ervasti, J.; Pentti, J.; Virtanen, M.] Finnish Inst Occupat Hlth, Helsinki, Finland.
   [Kivimaki, M.; Head, J.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.
   [Kivimaki, M.] Univ Helsinki, Fac Med, Clinicum, FIN-00014 Helsinki, Finland.
   [Dray-Spira, R.] Univ Paris 06, INSERM, UMR S 1136, Paris, France.
   [Dray-Spira, R.] Univ Paris 06, Sorbonne Univ, UMR S 1136, Paris, France.
   [Goldberg, M.; Zins, M.] INSERM, UMS 011, Populat Based Cohorts Unit, Villejuif, France.
   [Goldberg, M.; Zins, M.] Univ Versailles St Quentin Yvelines, Paris, France.
   [Jokela, M.] Univ Helsinki, Inst Behav Sci, Helsinki, Finland.
   [Vahtera, J.] Univ Turku, Turku, Finland.
   [Vahtera, J.] Turku Univ Hosp, FIN-20520 Turku, Finland.
RP Ervasti, J (reprint author), Finnish Inst Occupat Hlth, Helsinki, Finland.
EM jenni.ervasti@ttl.fi
RI Jokela, Markus/A-4669-2009
OI Jokela, Markus/0000-0003-0117-0012; Dray-Spira,
   Rosemary/0000-0001-7646-3667; Vahtera, Jussi/0000-0002-6036-061X
FU Academy of Finland [265174, 264944, 258598]; UK Economic and Social
   Research Council; Medical Research Council under the Lifelong Health and
   Wellbeing Cross-Council Programme initiative [ES/L002892/1]; Economic
   and Social Research Council [ES/L002892/1, ES/J023299/1]; Medical
   Research Council [MR/K013351/1]
FX J.E. received funding from the Academy of Finland (#265174). J.H.
   received funding from the UK Economic and Social Research Council and
   Medical Research Council under the Lifelong Health and Wellbeing
   Cross-Council Programme initiative [ES/L002892/1]. J.V. received funding
   from Era-Age2 grant (Academy of Finland, #264944). M.V. received funding
   from the Academy of Finland (#258598). The funders played no role in
   study design, data collection and analyses, decision to publish, or
   preparation of the manuscript.
CR American Diabetes Association, 2013, DIABETES CARE, V36, P1033, DOI DOI 10.2337/DC12-2625
   BUCQUET D, 1990, SOC SCI MED, V30, P829, DOI 10.1016/0277-9536(90)90207-9
   Dray-Spira R, 2013, DIABETIC MED, V30, P549, DOI 10.1111/dme.12076
   Eriksson AK, 2013, DIABETES CARE, V36, P2683, DOI 10.2337/dc12-1738
   Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247
   Head J, 2013, PSYCHOL MED, V43, P2649, DOI 10.1017/S0033291713000342
   Head J, 2006, J EPIDEMIOL COMMUN H, V60, P55, DOI 10.1136//jech.2005.038752
   Heraclides AM, 2011, OBESITY, V20, P428
   Herttua K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001094
   HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185
   Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C
   Karasek R, 1990, HLTH WORK STRESS PRO
   Kivimaki M, 2013, CAN MED ASSOC J, V185, pE784, DOI 10.1503/cmaj.122010
   Kivimaki M, 2010, DIABETES CARE, V33, P1471, DOI 10.2337/dc09-2359
   Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372
   MCKENNA SP, 1989, FAM PRACT, V6, P3, DOI 10.1093/fampra/6.1.3
   Meisinger C, 2009, PSYCHOSOM MED, V71, P784, DOI 10.1097/PSY.0b013e3181ae5770
   Melchior M, 2003, J EPIDEMIOL COMMUN H, V57, P285, DOI 10.1136/jech.57.4.285
   Nyberg ST, 2014, DIABETES CARE, V37, P2268, DOI 10.2337/dc13-2936
   Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017
   Parent-Thirion A., 2012, EUROPEAN J PUBLIC HL, V23, P622, DOI DOI 10.1093/EURPUB/CKS124
   Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4
   Pulkki-Raback L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-236
   Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022
   Schaufeli WB, 2009, J ORGAN BEHAV, V30, P893, DOI 10.1002/job.595
   Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452
   Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0
   Trief PM, 1999, DIABETES CARE, V22, P569, DOI 10.2337/diacare.22.4.569
   Virtanen M, 2014, DIABETES CARE, V37, P2091, DOI 10.2337/dc13-2725
NR 31
TC 6
Z9 6
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD FEB
PY 2016
VL 33
IS 2
BP 208
EP 217
DI 10.1111/dme.12821
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DD8FU
UT WOS:000370161800010
PM 26036141
DA 2019-01-08
ER

PT J
AU Ervasti, J
   Kivimaki, M
   Dray-Spira, R
   Head, J
   Goldberg, M
   Pentti, J
   Jokela, M
   Vahtera, J
   Zins, M
   Virtanen, M
AF Ervasti, Jenni
   Kivimaeki, Mika
   Dray-Spira, Rosemary
   Head, Jenny
   Goldberg, Marcel
   Pentti, Jaana
   Jokela, Markus
   Vahtera, Jussi
   Zins, Marie
   Virtanen, Marianna
TI Socioeconomic gradient in work disability in diabetes: evidence from
   three occupational cohorts
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
ID WHITEHALL II COHORT; SICKNESS ABSENCE; GAZEL COHORT; PSYCHOLOGICAL
   DISTRESS; SOCIAL INEQUALITIES; MUNICIPAL EMPLOYEES; HEALTH INEQUALITIES;
   DIAGNOSIS; METAANALYSIS; IMPACT
AB Background The role of socioeconomic status in work disability among employees with diabetes is not well known. We examined the association between socioeconomic status and work disability among employees with and without diabetes taking into account comorbid conditions.
   Methods We used individual participant data from three occupational cohorts from Finland, France and the UK (employees with diabetes, n=2170, age-matched and sex-matched controls without diabetes, n=4340). In all cohorts, survey data were linked with register data and the employees were followed up on average for 4.4 years. Socioeconomic status was based on occupational titles. Work disability (sickness absence and disability pension) was indexed as the numbers of disability days and episodes. The study-specific estimates were pooled using meta-analysis and effect modifications were studied with meta-regression.
   Results The average numbers of disability days and episodes per year were 1.5-3.5 times higher for persons with diabetes compared to those without. Among persons with diabetes, the risk of work disability was almost four times higher in the lowest compared to the highest occupational position (relative index of inequality (RII) for days 3.82; 95% CI 2.77 to 5.56; RII for episodes 3.80; 95% CI 3.13 to 4.61). This association was consistent in both sexes and regardless of comorbid conditions. In relative terms, the association of socioeconomic status and work disability was similar among those free of diabetes.
   Conclusions A strong socioeconomic gradient in work disability was observed among people with and without diabetes.
C1 [Ervasti, Jenni; Pentti, Jaana; Vahtera, Jussi; Virtanen, Marianna] Finnish Inst Occupat Hlth, Topeliuksenkatu 41 A A, Helsinki 00250, Finland.
   [Kivimaeki, Mika; Head, Jenny] UCL, Dept Epidemiol & Publ Hlth, London, England.
   [Kivimaeki, Mika] Univ Helsinki, Fac Med, Dept Publ Hlth, Helsinki, Finland.
   [Dray-Spira, Rosemary] INSERM, UMR S 1136, Paris, France.
   [Dray-Spira, Rosemary] Univ Paris 06, Sorbonne Univ, UMR S 1136, Paris, France.
   [Goldberg, Marcel; Zins, Marie] INSERM, Populat Based Cohorts Unit, UMS 011, Villejuif, France.
   [Goldberg, Marcel; Zins, Marie] Univ Versailles St Quentin Yvelines, Paris, France.
   [Jokela, Markus] Univ Helsinki, Inst Behav Sci, Helsinki, Finland.
   [Vahtera, Jussi] Univ Turku, Turku, Finland.
   [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland.
RP Ervasti, J (reprint author), Finnish Inst Occupat Hlth, Topeliuksenkatu 41 A A, Helsinki 00250, Finland.
EM jenni.ervasti@ttl.fi
RI Jokela, Markus/A-4669-2009
OI Jokela, Markus/0000-0003-0117-0012; Vahtera, Jussi/0000-0002-6036-061X;
   Dray-Spira, Rosemary/0000-0001-7646-3667; Ervasti,
   Jenni/0000-0001-9113-2428
FU Academy of Finland [265174, 258598]; UK Economic and Social Research
   Council; Medical Research Council under the Lifelong Health and
   Wellbeing Cross-Council Programme initiative [ES/L002892/1]; Era-Age2
   grant (Academy of Finland) [264944]; Economic and Social Research
   Council [ES/L002892/1, ES/J023299/1]; Medical Research Council
   [MR/K013351/1]
FX JE received funding from the Academy of Finland (#265174). MK is
   supported by a professorial fellowship from the UK Economic and Social
   Research Council. JH received funding from the UK Economic and Social
   Research Council and Medical Research Council under the Lifelong Health
   and Wellbeing Cross-Council Programme initiative (ES/L002892/1). JV
   received funding from Era-Age2 grant (Academy of Finland, #264944). MV
   received funding from the Academy of Finland (#258598).
CR Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Altman DG, 2001, SYSTEMATIC REV HLTH
   Breton MC, 2013, DIABETES CARE, V36, P740, DOI 10.2337/dc12-0354
   Christensen KB, 2008, J EPIDEMIOL COMMUN H, V62, P181, DOI 10.1136/jech.2006.056135
   Dray-Spira R, 2013, DIABETIC MED, V30, P549, DOI 10.1111/dme.12076
   Dray-Spira R, 2010, DIABETES CARE, V33, P1200, DOI 10.2337/dc09-2094
   Ervasti J, 2015, AM J PUBLIC HEALTH, V105, pE22, DOI 10.2105/AJPH.2015.302646
   Espelt A, 2011, CURR DIABETES REV, V7, P148, DOI 10.2174/157339911795843131
   Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336
   Fuhrer R, 2002, AM J PUBLIC HEALTH, V92, P1290, DOI 10.2105/AJPH.92.8.1290
   Goldberg M, 2015, INT J EPIDEMIOL, V44, P77, DOI 10.1093/ije/dyu224
   Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101
   Herquelot E, 2011, DIABETES CARE, V34, P1344, DOI 10.2337/dc10-2225
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hill Jacqueline, 2013, Perm J, V17, P67, DOI 10.7812/TPP/12-099
   Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050547
   Kivimaki M, 2010, DIABETES CARE, V33, P1471, DOI 10.2337/dc09-2359
   Laaksonen M, 2010, J EPIDEMIOL COMMUN H, V64, P802, DOI 10.1136/jech.2009.093385
   Leinonen T, 2011, SCAND J WORK ENV HEA, V37, P464, DOI 10.5271/sjweh.3182
   Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975
   Love J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-545
   Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1
   Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372
   MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K
   Melchior M, 2005, AM J PUBLIC HEALTH, V95, P1206, DOI 10.2105/AJPH.2004.048835
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P900, DOI 10.1136/jech.2004.023036
   Ricci-Cabello I, 2010, HEALTH SOC CARE COMM, V18, P572, DOI 10.1111/j.1365-2524.2010.00960.x
   Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221
   Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108
   Saydah SH, 2013, DIABETES CARE, V36, P49, DOI 10.2337/dc11-1864
   Stansfeld SA, 2011, OCCUP ENVIRON MED, V68, P408, DOI 10.1136/oem.2010.056994
   Stringhini S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001479
   Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452
   Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X
   Venermo M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002395
   Virtanen M, 2014, DIABETES CARE, V37, P2091, DOI 10.2337/dc13-2725
   Von Korff M, 2005, DIABETES CARE, V28, P1326, DOI 10.2337/diacare.28.6.1326
NR 39
TC 2
Z9 2
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
EI 1470-2738
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD FEB
PY 2016
VL 70
IS 2
BP 125
EP 131
DI 10.1136/jech-2015-205943
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DD5KH
UT WOS:000369962000004
PM 26294769
DA 2019-01-08
ER

PT J
AU Teleni, L
   Chan, RJ
   Chan, A
   Isenring, EA
   Vela, I
   Inder, WJ
   McCarthy, AL
AF Teleni, Laisa
   Chan, Raymond J.
   Chan, Alexandre
   Isenring, Elisabeth A.
   Vela, Ian
   Inder, Warrick J.
   McCarthy, Alexandra L.
TI Exercise improves quality of life in androgen deprivation
   therapy-treated prostate cancer: systematic review of randomised
   controlled trials
SO ENDOCRINE-RELATED CANCER
LA English
DT Article
DE prostate cancer; androgen deprivation therapy; quality of life; diet;
   aerobic exercise; resistance exercise
ID BREAST-CANCER; HOT FLASHES; SUPPRESSION THERAPY; SOY PHYTOESTROGENS;
   PHYSICAL-ACTIVITY; AEROBIC EXERCISE; BODY-COMPOSITION; BONE METASTASES;
   BLOOD-PRESSURE; MEN
AB Men receiving androgen deprivation therapy (ADT) for prostate cancer (PCa) are likely to develop metabolic conditions such as diabetes, cardiovascular disease, abdominal obesity and osteoporosis. Other treatment-related side effects adversely influence quality of life (QoL) including vasomotor distress, depression, anxiety, mood swings, poor sleep quality and compromised sexual function. The objective of this study was to systematically review the nature and effects of dietary and exercise interventions on QoL, androgen deprivation symptoms and metabolic risk factors in men with PCa undergoing ADT. An electronic search of CINAHL, CENTRAL, Medline, PsychINFO and reference lists was performed to identify peer-reviewed articles published between January 2004 and December 2014 in English. Eligible study designs included randomised controlled trials (RCTs) with pre- and post-intervention data. Data extraction and assessment of methodological quality with the Cochrane approach was conducted by two independent reviewers. Seven exercise studies were identified. Exercise significantly improved QoL, but showed no effect on metabolic risk factors (weight, waist circumference, lean or fat mass, blood pressure and lipid profile). Two dietary studies were identified, both of which tested soy supplements. Soy supplementation did not improve any outcomes. No dietary counselling studies were identified. No studies evaluated androgen-deficiency symptoms (libido, erectile function, sleep quality, mood swings, depression, anxiety and bone mineral density). Evidence from RCTs indicates that exercise enhances health- and disease-specific QoL in men with PCa undergoing ADT. Further studies are required to evaluate the effect of exercise and dietary interventions on QoL, androgen deprivation symptoms and metabolic risk factors in this cohort.
C1 [Teleni, Laisa; Chan, Raymond J.; McCarthy, Alexandra L.] Queensland Univ Technol, Sch Nursing, Brisbane, Qld 4001, Australia.
   [Teleni, Laisa; Isenring, Elisabeth A.] Bond Univ, Bond Inst Hlth & Sport, Fac Hlth Sci & Med, 2 Promethean Way, Gold Coast, Qld 4226, Australia.
   [Chan, Raymond J.] West Moreton Hosp & Hlth Serv, Brisbane, Qld, Australia.
   [Chan, Alexandre] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore.
   [Chan, Alexandre] Natl Canc Ctr Singapore, Oncol Pharm, Singapore, Singapore.
   [Isenring, Elisabeth A.] Princess Alexandra Hosp, Dept Nutr & Dietet, Brisbane, Qld 4102, Australia.
   [Vela, Ian] Princess Alexandra Hosp, Dept Urol, Brisbane, Qld 4102, Australia.
   [Vela, Ian] Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld, Australia.
   [Inder, Warrick J.] Princess Alexandra Hosp, Dept Diabet & Endocrinol, Brisbane, Qld 4102, Australia.
   [Inder, Warrick J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia.
   [McCarthy, Alexandra L.] Princess Alexandra Hosp, Div Canc Serv, Brisbane, Qld 4102, Australia.
   [McCarthy, Alexandra L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.
RP Teleni, L (reprint author), Queensland Univ Technol, Sch Nursing, Brisbane, Qld 4001, Australia.; Teleni, L (reprint author), Bond Univ, Bond Inst Hlth & Sport, Fac Hlth Sci & Med, 2 Promethean Way, Gold Coast, Qld 4226, Australia.
EM laisa.teleni@qut.edu.au
RI Inder, Warrick/C-7121-2014; Chan, Alexandre/D-5035-2016
OI Inder, Warrick/0000-0001-5078-4980; Teleni, Laisa/0000-0001-9321-9586;
   Isenring, Elizabeth/0000-0002-4478-9707; Chan,
   Alexandre/0000-0003-4391-4219; Chan, Raymond/0000-0003-0248-7046
FU Queensland University of Technology
FX This work was supported by the New Professor Grant, Queensland
   University of Technology.
CR Abdollah F, 2015, EJSO-EUR J SURG ONC, V41, P1529, DOI 10.1016/j.ejso.2015.06.011
   Alberga AS, 2012, SUPPORT CARE CANCER, V20, P971, DOI 10.1007/s00520-011-1169-x
   Bourke L, 2014, EUR UROL, V65, P865, DOI 10.1016/j.eururo.2013.09.040
   Bourke L, 2011, CANCER EPIDEM BIOMAR, V20, P647, DOI 10.1158/1055-9965.EPI-10-1143
   Chipperfield K, 2014, HEALTH PSYCHOL, V33, P1288, DOI 10.1037/hea0000006
   Cormie P, 2013, PROSTATE CANCER P D, V16, P170, DOI 10.1038/pcan.2012.52
   Culos-Reed SN, 2010, SUPPORT CARE CANCER, V18, P591, DOI 10.1007/s00520-009-0694-3
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Ferlay J, 2013, GLOBOCAN 2012 V1 0 C
   Galvao DA, 2014, EUR UROL, V65, P856, DOI 10.1016/j.eururo.2013.09.041
   Galvao DA, 2010, J CLIN ONCOL, V28, P340, DOI 10.1200/JCO.2009.23.2488
   Grossmann M, 2011, MED J AUSTRALIA, V194, P301
   Higano CS, 2008, NAT CLIN PRACT UROL, V5, P24, DOI 10.1038/ncpuro0995
   Higano CS, 2004, UROL CLIN N AM, V31, P331, DOI 10.1016/j.ucl.2004.01.001
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x
   Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792
   Lewington S, 2007, LANCET, V370, P1829
   MacGregor CA, 2005, EUR J CANCER, V41, P708, DOI 10.1016/j.ejca.2005.01.005
   Michaud LB, 2010, AM J HEALTH-SYST PH, V67, pS20, DOI 10.2146/ajhp100078
   Napora JK, 2011, J ANDROL, V32, P40, DOI 10.2164/jandrol.110.010983
   Nguyen PL, 2011, JAMA-J AM MED ASSOC, V306, P2359, DOI 10.1001/jama.2011.1745
   Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068
   Rock CL, 2012, CA-CANCER J CLIN, V62, P243, DOI 10.3322/caac.21142
   Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x
   Sammon JD, 2015, EUR UROL, V68, P32, DOI 10.1016/j.eururo.2014.10.018
   Saylor PJ, 2009, J UROLOGY, V181, P1998, DOI 10.1016/j.juro.2009.01.047
   Segal RJ, 2009, J CLIN ONCOL, V27, P344, DOI 10.1200/JCO.2007.15.4963
   Seible DM, 2014, UROLOGY, V83, P1316, DOI 10.1016/j.urology.2014.02.006
   Sharma P, 2009, J UROLOGY, V182, P2265, DOI 10.1016/j.juro.2009.07.030
   Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
   Svartberg J, 2004, EUR J ENDOCRINOL, V150, P65, DOI 10.1530/eje.0.1500065
   Traish AM, 2009, J ANDROL, V30, P477, DOI 10.2164/jandrol.108.007245
   Uth J, 2014, SCAND J MED SCI SPOR, V24, P105, DOI 10.1111/sms.12260
   Van Patten CL, 2002, J CLIN ONCOL, V20, P1449, DOI 10.1200/JCO.20.6.1449
   Vitolins MZ, 2013, J CLIN ONCOL, V31, P4092, DOI 10.1200/JCO.2012.48.1432
   Whitsel EA, 2001, AM J MED, V111, P261, DOI 10.1016/S0002-9343(01)00833-6
   Zhao JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107516
NR 39
TC 19
Z9 20
U1 2
U2 21
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 1351-0088
EI 1479-6821
J9 ENDOCR-RELAT CANCER
JI Endocr.-Relat. Cancer
PD FEB
PY 2016
VL 23
IS 2
BP 101
EP 112
DI 10.1530/ERC-15-0456
PG 12
WC Oncology; Endocrinology & Metabolism
SC Oncology; Endocrinology & Metabolism
GA DC4ZR
UT WOS:000369230000009
PM 26584972
OA Bronze
DA 2019-01-08
ER

PT J
AU Joensen, LE
   Almdal, TP
   Willaing, I
AF Joensen, Lene E.
   Almdal, Thomas P.
   Willaing, Ingrid
TI Associations between patient characteristics, social relations, diabetes
   management, quality of life, glycaemic control and emotional burden in
   type 1 diabetes
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Type-1 diabetes; Adults; Diabetes distress; Emotional burden; Social
   support; Generic quality of life; Diabetes empowerment; Self-management;
   HbA1c
ID SELF-MANAGEMENT; EMPOWERMENT SCALE; CHRONIC ILLNESS; DISTRESS SCALE;
   SUPPORT; HEALTH; DEPRESSION; ADULTS; VALIDATION; ATTITUDES
AB Aim: The objective was to investigate associations between emotional burden and a number of individual variables: patient characteristics, social relations, diabetes management in everyday life, generic quality of life and glycaemic control, including determining to what extend these variables explain the differences in emotional burden in a large Danish population of people with type 1 diabetes.
   Methods: We analysed a cross-sectional survey of 2419 Danish adults with type-1 diabetes mellitus and data from an electronic patient record. Data were analysed using hierarchical regression of factors of interest with emotional burden of diabetes as the dependent variable.
   Results: High emotional burden of diabetes was associated with being female, younger age, other chronic illness, low diabetes-specific support, low generic quality of life, low diabetes empowerment and high Hba1c. Low diabetes empowerment, low generic quality of life and low diabetes-specific support were associated with the largest difference in emotional burden level.
   Conclusions: A variety of psychosocial and behavioural factors such as low social support, low generic quality of life and difficulties in managing diabetes are associated with high emotional burden in type-1 diabetes. These findings may call for an expansion of the effort to decrease the emotional burden of diabetes for those who are heavily burdened. Future research should explore the causality of the explored associations as well as potential subgroup differences in order to guide the development of appropriate interventions. (C) 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Joensen, Lene E.; Willaing, Ingrid] Steno Diabet Ctr, Steno Hlth Promot Res, DK-2820 Gentofte, Denmark.
   [Almdal, Thomas P.] Gentofte Univ Hosp, Gentofte, Denmark.
RP Joensen, LE (reprint author), Niels Steensens Vej 6, DK-2820 Gentofte, Denmark.
EM ljoe@steno.dk
OI Willaing, Ingrid/0000-0002-3082-8816; Joensen, Lene
   Eide/0000-0002-4790-8759
FU Novo Foundation; Novo Nordisk A/S
FX L.J. and I.W. are employed by Steno Diabetes Center A/S, a research
   hospital working in the Danish National Health Service and owned by Novo
   Nordisk A/S. Steno Diabetes Center receives part of its core funding
   from unrestricted grants from the Novo Foundation and Novo Nordisk A/S.
CR Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Christensen A.I., 2012, SCAND J PUBLIC HEALT, V40, P391
   COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310
   Due P, 1999, SOC SCI MED, V48, P661, DOI 10.1016/S0277-9536(98)00381-5
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030
   Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   GOVE WR, 1983, J HEALTH SOC BEHAV, V24, P122, DOI 10.2307/2136639
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Joensen LE, 2013, DIABETES RES CLIN PR, V101, P278, DOI 10.1016/j.diabres.2013.07.001
   KAPLAN GA, 1988, AM J EPIDEMIOL, V128, P370, DOI 10.1093/oxfordjournals.aje.a114977
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Petrak F, 2005, CURR DIABETES REV, V1, P255, DOI 10.2174/157339905774574329
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rogvi S, 2012, DIABETIC MED, V29, pe382, DOI 10.1111/j.1464-5491.2012.03703.x
   Schiotz ML, 2012, DIABETIC MED, V29, P654, DOI 10.1111/j.1464-5491.2011.03485.x
   Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief PM, 2013, DIABETES CARE, V36, P2483, DOI 10.2337/dc12-1718
   Wang RH, 2011, J ADV NURS, V67, P2658, DOI 10.1111/j.1365-2648.2011.05701.x
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   WIKBY A, 1991, DIABETES RES CLIN PR, V13, P53, DOI 10.1016/0168-8227(91)90033-A
NR 38
TC 15
Z9 15
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD FEB
PY 2016
VL 10
IS 1
BP 41
EP 50
DI 10.1016/j.pcd.2015.06.007
PG 10
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA DC1DW
UT WOS:000368958000006
PM 26163949
DA 2019-01-08
ER

PT J
AU Holmes-Truscott, E
   Skinner, TC
   Pouwer, F
   Speight, J
AF Holmes-Truscott, E.
   Skinner, T. C.
   Pouwer, F.
   Speight, J.
TI Explaining psychological insulin resistance in adults with
   non-insulin-treated type 2 diabetes: The roles of diabetes distress and
   current medication concerns. Results from Diabetes MILES-Australia
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Type 2 diabetes; Psychological insulin resistance; Beliefs about
   medications; Diabetes distress
ID PRIMARY-CARE; DEPRESSION; MANAGEMENT; THERAPY; SCALE; ANXIETY; SCOPE
AB Aims: To investigate the contribution of general and diabetes-specific emotional wellbeing and beliefs about medicines in the prediction of insulin therapy appraisals in adults with non-insulin-treated type 2 diabetes.
   Methods: The sample included Diabetes MILES-Australia cross-sectional survey participants whose primary diabetes treatment was oral hypoglycaemic agents (N=313; 49% women; mean SD age: 57 +/- 9 years; diabetes duration: 7 +/- 6 years). They completed validated measures of beliefs about the 'harm' and 'overuse' of medications in general (BMQ General); 'concerns' about and 'necessity' of current diabetes medications (BMQ Specific); negative insulin therapy appraisals (ITAS); depression (PHQ-9); anxiety (GAD-7), and diabetes distress (DDS-17). Factors associated with ITAS Negative scores were examined using hierarchical multiple regressions.
   Results: Twenty-two percent of the variance in ITAS Negative scores (52 +/- 10), was explained by: number of complications (beta = -.15, p = .005), DDS-17 subscale 'emotional burden' (beta=.23, p<.001), and 'concerns' about current diabetes treatment (beta=.29, p<.001). General beliefs about medications and general emotional wellbeing did not contribute significantly to the model.
   Conclusions: Psychological insulin resistance may reflect broader distress about diabetes and concerns about its treatment but not general beliefs about medicines, depression or anxiety. Reducing diabetes distress and current treatment concerns may improve attitudes towards insulin as a potential therapeutic option. (C) 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Holmes-Truscott, E.; Speight, J.] Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Holmes-Truscott, E.; Speight, J.] Deakin Univ, Sch Psychol, 221 Burwood Highway, Burwood, Vic 3125, Australia.
   [Skinner, T. C.] Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT 0909, Australia.
   [Pouwer, F.] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med & Clin Psychol, Postbus 90153, NL-5000 LE Tilburg, Netherlands.
   [Speight, J.] AHP Res, 16 Walden Way, Hornchurch RM11 2LB, England.
RP Holmes-Truscott, E (reprint author), Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
EM etruscott@acbrd.org.au; timothy.skinner@cdu.edu.au; F.Pouwer@uvt.nl;
   jspeight@acbrd.org.au
OI Skinner, Timothy/0000-0002-0018-6963; Holmes-Truscott,
   Elizabeth/0000-0001-9139-4663; Speight, Jane/0000-0002-1204-6896
FU National Diabetes Services Scheme (NDSS) Strategic Development Grant;
   Sanofi Aventis
FX The Diabetes MILES-Australia 2011 survey was funded by a National
   Diabetes Services Scheme (NDSS) Strategic Development Grant. The NDSS is
   an initiative of the Australian Government administered by Diabetes
   Australia. The Diabetes MILES Study was also supported by an
   unrestricted educational grant from Sanofi Aventis. None of the funding
   bodies had any involvement in the collection, analysis or interpretation
   of data, in the writing of the manuscript or the decision to submit for
   publication.
CR [Anonymous], 1995, Diabetes, V44, P1249
   Australian Bureau of Statistics, 2011, SOC IND AR 2011 2011
   Calvert MJ, 2007, BRIT J GEN PRACT, V57, P455
   Chen CC, 2011, DIABETES METAB, V37, P389, DOI 10.1016/j.diabet.2010.12.008
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Harris SB, 2010, CAN FAM PHYSICIAN, V56, pE418
   Hermanns N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-113
   Holmes-Truscott E, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-87
   Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4
   Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311
   Horne R., 1997, PERCEPTIONS HLTH ILL, P155
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441
   Ishii H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036361
   Khan H, 2008, DIABETIC MED, V25, P1108, DOI 10.1111/j.1464-5491.2008.02538.x
   Khunti K., 2013, DIABETES CARE
   Kostev K., 2013, PRIM CARE DIABETES, V36, P3411
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Makine C., 2009, RESEARCH, P28
   Mollema ED, 2001, J PSYCHOSOM RES, V51, P665, DOI 10.1016/S0022-3999(01)00229-X
   National Association of Diabetes Centres, 2011, AUSTR NAT DIAB INF A
   Nefs G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078865
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2011, CURR MED RES OPIN, V27, P1169, DOI 10.1185/03007995.2011.573623
   Snoek F.J., 2007, HEALTH QUAL LIFE OUT, P5
   Speight J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-120
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Turner RC, 1998, LANCET, V352, P837
   United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83
   Woudenberg YJC, 2012, DIABETIC MED, V29, P796, DOI 10.1111/j.1464-5491.2011.03552.x
   Zambanini A, 1999, DIABETES RES CLIN PR, V46, P239, DOI 10.1016/S0168-8227(99)00099-6
NR 35
TC 8
Z9 8
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD FEB
PY 2016
VL 10
IS 1
BP 75
EP 82
DI 10.1016/j.pcd.2015.06.006
PG 8
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA DC1DW
UT WOS:000368958000010
PM 26150327
DA 2019-01-08
ER

PT J
AU Jones, A
   Olsen, MZ
   Perrild, HJD
   Willaing, I
AF Jones, Allan
   Olsen, Mette Zander
   Perrild, Hans J. D.
   Willaing, Ingrid
TI The psychological impact of living with diabetes: Descriptive findings
   from the DAWN2 study in Denmark
SO PRIMARY CARE DIABETES
LA English
DT Article
DE People with diabetes; Family members; Psychological wellbeing; Quality
   of life
ID DEPRESSION; METAANALYSIS; MANAGEMENT; ATTITUDES; MORTALITY; SUPPORT;
   ADULTS; WISHES
AB Objective: The descriptive findings from the Danish sample of the second Diabetes, Attitudes, Wishes, and Needs (DAWN2) study are presented, with specific focus on the psychological impact of living with diabetes and quality of life for people with diabetes and family members of people with diabetes.
   Method: 502 people with diabetes over the age of 18 and 122 family members completed questionnaires online, by telephone or in person, including validated measures of diabetes-related distress, emotional well-being and quality of life as well as other measures of psychological well-being.
   Results: People with diabetes reported that living with diabetes was a psychological burden, with individuals taking insulin medication or diagnosed with type 1 diabetes reporting the most distress. Half of all family members sampled reported that living with diabetes impacted them negatively.
   Conclusion: The higher levels of emotional distress found in people taking insulin medication are likely due to greater disease severity and associated self-care burdens. Care and support programmes may need to be revised in order to better address these issues. Moreover, psychological support programmes may need to be extended to include family members that experience distress as a result of living with diabetes. (C) 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Jones, Allan] Univ Southern Denmark, Inst Psychol, Campusvej 55, DK-5230 Odense M, Denmark.
   [Olsen, Mette Zander; Perrild, Hans J. D.] Bispebjerg Hosp, DK-2400 Copenhagen, Denmark.
   [Willaing, Ingrid] Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
RP Jones, A (reprint author), Univ Southern Denmark, Inst Psychol, Campusvej 55, DK-5230 Odense M, Denmark.
EM ajones@health.sdu.dk
OI Willaing, Ingrid/0000-0002-3082-8816
FU Novo Nordisk A/S
FX The authors acknowledge the contribution of Mette Bogelund and Jens
   Olsen from Incentive Partners, Holte, Denmark, for their assistance with
   data management and data analysis. The DAWN2 study is funded by Novo
   Nordisk A/S.
CR de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Delehanty LM, 2007, DIABETIC MED, V24, P48
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Funnell MM, 2006, CLIN DIABETES, V24, P154
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Ross S.A., 2011, CURR MED RES OPIN S3, P13
   Schiotz ML, 2012, DIABETIC MED, V29, P654, DOI 10.1111/j.1464-5491.2011.03485.x
   Schiotz M, 2012, CHRONIC ILLN, V8, P56, DOI 10.1177/1742395311413307
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
NR 15
TC 8
Z9 10
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD FEB
PY 2016
VL 10
IS 1
BP 83
EP 86
DI 10.1016/j.pcd.2015.03.008
PG 4
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA DC1DW
UT WOS:000368958000011
PM 25890864
DA 2019-01-08
ER

PT J
AU Kaltman, S
   Serrano, A
   Talisman, N
   Magee, MF
   Cabassa, LJ
   Pulgar-Vidal, O
   Peraza, D
AF Kaltman, Stacey
   Serrano, Adriana
   Talisman, Nicholas
   Magee, Michelle F.
   Cabassa, Leopoldo J.
   Pulgar-Vidal, Olga
   Peraza, Dorys
TI Type 2 Diabetes and Depression: A Pilot Trial of an Integrated
   Self-management Intervention for Latino Immigrants
SO DIABETES EDUCATOR
LA English
DT Article
ID PATIENT HEALTH QUESTIONNAIRE; CES-D; EMOTIONAL DISTRESS; COLLABORATIVE
   CARE; ACTIVATION MEASURE; RANDOMIZED-TRIAL; VALIDITY; ADULTS; SCALE;
   PHQ-9
AB Purpose The purpose of the current study was to determine the feasibility, acceptability, and preliminary effectiveness of an integrated self-management intervention that simultaneously targets diabetes and depression self-management in a primary care clinic that serves the Latino immigrant community.
   Methods The integrated intervention included behavioral activation and motivational interviewing techniques. It was developed with patient, family member, and provider stakeholders, and it comprised 6 individual sessions, followed by 2 monthly booster sessions. Eighteen Latino immigrants participated in an open trial of the intervention. A1C levels were examined at baseline and postintervention. Participants also completed measures of depression, diabetes self-management behaviors, patient activation, and diabetes-related self-efficacy and gave open-ended feedback about the intervention.
   Results Feasibility of delivering the intervention in the primary care setting and acceptability to the target population were demonstrated. Among participants completing the intervention, A1C levels decreased significantly from baseline. A significant reduction in depressive symptoms and an improvement in diabetes self-management behaviors, patient activation, and diabetes-related self-efficacy were observed. Qualitative responses from participants indicated unilateral positive responses to the intervention and endorsed its continuation in the clinic.
   Conclusions This pilot trial demonstrated the feasibility and acceptability of an integrated self-management intervention for diabetes and depression. In addition, preliminary data suggest that the intervention may have a positive impact on diabetes and depression-related outcomes. Further evaluation is warranted.
C1 [Kaltman, Stacey; Serrano, Adriana; Talisman, Nicholas] Georgetown Univ, Med Ctr, Dept Psychiat, Washington, DC 20007 USA.
   [Magee, Michelle F.] MedStar Diabet Inst, Washington, DC USA.
   [Magee, Michelle F.] MedStar Hlth Res Inst, Washington, DC USA.
   [Cabassa, Leopoldo J.] Columbia Univ, Sch Social Work, New York, NY USA.
   [Cabassa, Leopoldo J.] New York State Psychiat Inst & Hosp, Ctr Excellence Cultural Competence, New York, NY 10032 USA.
   [Pulgar-Vidal, Olga; Peraza, Dorys] Spanish Catholic Ctr, Washington, DC USA.
RP Kaltman, S (reprint author), Georgetown Univ, Med Ctr, Dept Psychiat, 2115 Wisconsin Ave NW, Washington, DC 20007 USA.
EM sk279@georgetown.edu
FU American Diabetes Association [1-13-IN-24]
FX Funding for this study was provided by the American Diabetes Association
   (1-13-IN-24).
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Alegria M, 2009, J GEN INTERN MED, V24, P534, DOI 10.1007/s11606-009-1074-x
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794
   Conerly RC, 2002, J HEALTH PSYCHOL, V7, P107, DOI 10.1177/1359105302007001658
   de Burgos-Lunar C, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-95
   Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021
   Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658
   Echeverry D, 2009, DIABETES CARE, V32, P2156, DOI 10.2337/dc09-0785
   Ell K, 2009, INT J PSYCHIAT MED, V39, P113, DOI 10.2190/PM.39.2.a
   Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x
   Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x
   Kaltman S, 2015, DIABETES ED
   Kaltman S, 2011, J TRAUMA STRESS, V24, P635, DOI 10.1002/jts.20698
   Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lorig K, SPANISH DIABETES SEL
   Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8
   Luckett T, 2010, SUPPORT CARE CANCER, V18, P1241, DOI 10.1007/s00520-010-0932-8
   Miller W. R., 2013, MOTIVATIONAL INTERVI
   Naik AD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-37
   Parada H, 2012, DIABETES EDUCATOR, V38, P552, DOI 10.1177/0145721712445215
   Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9
   Posner SF, 2001, ETHNIC HEALTH, V6, P137, DOI 10.1080/13557850120068469
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rosal MC, 2011, DIABETES CARE, V34, P838, DOI 10.2337/dc10-1981
   Schiller JS, 2010, VITAL HLTH STAT, V2012, P1
   Schneiderman N, 2014, DIABETES CARE, V37, P2233, DOI 10.2337/dc13-2939
   Soler J, 1997, ACTAS LUSO-ESP NEUR, V25, P243
   Sorkin DH, 2011, DIABETES CARE, V34, P598, DOI 10.2337/dc10-1825
   Toobert D. J., 1994, HDB PSYCHOL DIABETES
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   Vincent D, 2008, NURS RES, V57, P101, DOI 10.1097/01.NNR.0000313484.18670.ab
   Wang ML, 2014, ANN BEHAV MED, V48, P256, DOI 10.1007/s12160-014-9606-y
   Williams CD, 2007, PSYCHIAT RES, V150, P173, DOI 10.1016/j.psychres.2006.02.007
   Wu B, 2014, CONTEMP CLIN TRIALS, V37, P342
   WULSIN L, 2002, PRIM CARE COMPANION, V4, P191, DOI DOI 10.4088/PCC.V04N0504
NR 40
TC 3
Z9 4
U1 0
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD FEB
PY 2016
VL 42
IS 1
BP 87
EP 95
DI 10.1177/0145721715617536
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA DB0DP
UT WOS:000368179100004
PM 26590385
DA 2019-01-08
ER

PT J
AU van Dooren, FEP
   Denollet, J
   Verhey, FRJ
   Stehouwer, CDA
   Sep, SJS
   Henry, RMA
   Kremers, SPJ
   Dagnelie, PC
   Schaper, NC
   van der Kallen, CJH
   Koster, A
   Pouwer, F
   Schram, MT
AF van Dooren, Fleur E. P.
   Denollet, Johan
   Verhey, Frans R. J.
   Stehouwer, Coen D. A.
   Sep, Simone J. S.
   Henry, Ronald M. A.
   Kremers, Stef P. J.
   Dagnelie, Pieter C.
   Schaper, Nicolaas C.
   van der Kallen, Carla J. H.
   Koster, Annemarie
   Pouwer, Frans
   Schram, Miranda T.
TI Psychological and personality factors in type 2 diabetes mellitus,
   presenting the rationale and exploratory results from The Maastricht
   Study, a population-based cohort study
SO BMC PSYCHIATRY
LA English
DT Article
DE Type 2 diabetes; Cohort; Design; Exploratory results; Depression;
   Anxiety; Personality
ID INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; D DISTRESSED PERSONALITY;
   GLYCATION END-PRODUCTS; CORONARY-HEART-DISEASE; PRIMARY-CARE PATIENTS;
   CO-MORBID DEPRESSION; QUALITY-OF-LIFE; VASCULAR DEPRESSION; GLYCEMIC
   CONTROL; INFLAMMATORY MARKERS
AB Background: Strong longitudinal evidence exists that psychological distress is associated with a high morbidity and mortality risk in type 2 diabetes. Little is known about the biological and behavioral mechanisms that may explain this association. Moreover, the role of personality traits in these associations is still unclear. In this paper, we first describe the design of the psychological part of The Maastricht Study that aims to elucidate these mechanisms. Next, we present exploratory results on the prevalence of depression, anxiety and personality traits in type 2 diabetes. Finally, we briefly discuss the importance of these findings for clinical research and practice.
   Methods: We measured psychological distress and depression using the MINI diagnostic interview, the PHQ-9 and GAD-7 questionnaires in the first 864 participants of The Maastricht Study, a large, population-based cohort study. Personality traits were measured by the DS14 and Big Five personality questionnaires. Type 2 diabetes was assessed by an oral glucose tolerance test. Logistic regression analyses were used to estimate the associations of depression, anxiety and personality with type 2 diabetes, adjusted for age, sex and education level.
   Results: Individuals with type 2 diabetes had higher levels of depressive and anxiety symptoms, odds ratios (95 % CI) were 3.15 (1.49; 6.67), 1.73 (0.83-3.60), 1.50 (0.72-3.12), for PHQ-9 >= 10, current depressive disorder and GAD-7 >= 10, respectively. Type D personality, social inhibition and negative affectivity were more prevalent in type 2 diabetes, odds ratios were 1.95 (1.23-3.10), 1.35 (0.93-1.94) and 1.70 (1.14-2.51), respectively. Individuals with type 2 diabetes were less extraverted, less conscientious, less agreeable and less emotionally stable, and similar in openness to individuals without type 2 diabetes, although effect sizes were small.
   Conclusions: Individuals with type 2 diabetes experience more psychological distress and have different personality traits compared to individuals without type 2 diabetes. Future longitudinal analyses within The Maastricht Study will increase our understanding of biological and behavioral mechanisms that link psychological distress to morbidity and mortality in type 2 diabetes.
C1 [van Dooren, Fleur E. P.; Stehouwer, Coen D. A.; Sep, Simone J. S.; Henry, Ronald M. A.; Schaper, Nicolaas C.; van der Kallen, Carla J. H.; Schram, Miranda T.] Maastricht Univ, Med Ctr, Dept Internal Med, Randwycksingel 35, NL-6229 EG Maastricht, Netherlands.
   [Stehouwer, Coen D. A.; Sep, Simone J. S.; Henry, Ronald M. A.; Dagnelie, Pieter C.; Schaper, Nicolaas C.; van der Kallen, Carla J. H.; Schram, Miranda T.] Maastricht Univ, CARIM Cardiovasc Res Inst Maastricht, NL-6229 EG Maastricht, Netherlands.
   [van Dooren, Fleur E. P.; Denollet, Johan; Pouwer, Frans] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands.
   [van Dooren, Fleur E. P.; Verhey, Frans R. J.] Maastricht Univ, Sch Mental Hlth & Neurosci, MHeNS Alzheimer Ctr Limburg, NL-6229 EG Maastricht, Netherlands.
   [Koster, Annemarie] Maastricht Univ, Dept Social Med, NL-6229 EG Maastricht, Netherlands.
   [Dagnelie, Pieter C.; Schaper, Nicolaas C.; Koster, Annemarie] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, NL-6229 EG Maastricht, Netherlands.
   [Dagnelie, Pieter C.] Maastricht Univ, Dept Epidemiol, NL-6229 EG Maastricht, Netherlands.
   [Kremers, Stef P. J.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Hlth Promot, NL-6229 EG Maastricht, Netherlands.
RP Schram, MT (reprint author), Maastricht Univ, Med Ctr, Dept Internal Med, Randwycksingel 35, NL-6229 EG Maastricht, Netherlands.; Schram, MT (reprint author), Maastricht Univ, CARIM Cardiovasc Res Inst Maastricht, NL-6229 EG Maastricht, Netherlands.
EM m.schram@maastrichtuniversity.nl
RI Koster, Annemarie/E-7438-2010; Schaper, Nicolaas/E-7112-2014
OI Schram, Miranda/0000-0003-0515-4124
FU European Regional Development Fund via OP-Zuid; Province of Limburg;
   Dutch Ministry of Economic Affairs [31O.041]; Stichting De Weijerhorst
   (Maastricht, the Netherlands); Pearl String Initiative Diabetes
   (Amsterdam, the Netherlands); Cardiovascular Center (CVC, Maastricht,
   the Netherlands); School for Mental Health and Neuroscience (MHeNS),
   Maastricht, The Netherlands); Cardiovascular Research Institute
   Maastricht (CARIM, Maastricht, the Netherlands); School for Public
   Health and Primary Care (CAPHRI, Maastricht, the Netherlands); School
   for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the
   Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health
   Foundation Limburg (Maastricht, the Netherlands); Janssen-Cileg B.V.
   (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den
   Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the
   Netherlands)
FX This study was supported by the European Regional Development Fund via
   OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs
   (grant 31O.041), Stichting De Weijerhorst (Maastricht, the Netherlands),
   the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the
   Cardiovascular Center (CVC, Maastricht, the Netherlands), School for
   Mental Health and Neuroscience (MHeNS), Maastricht, The Netherlands),
   Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the
   Netherlands), School for Public Health and Primary Care (CAPHRI,
   Maastricht, the Netherlands), School for Nutrition, Toxicology and
   Metabolism (NUTRIM, Maastricht, the Netherlands), Stichting Annadal
   (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht,
   the Netherlands) and by unrestricted grants from Janssen-Cileg B.V.
   (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den
   Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the
   Netherlands).
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Association AD, 2011, DIABETES CARE S1, V34, pS11
   Association AP, 1994, DIAGN STAT MAN MENT
   Balhara YPS, 2011, INDIAN J ENDOCRINO S, V15, P50, DOI DOI 10.4103/2230-8210.83057
   Barbee J G, 1998, Ann Clin Psychiatry, V10, P15, DOI 10.3109/10401239809148814
   Bener A, 2012, WORLD J DIABETES, V3, P123, DOI 10.4239/wjd.v3.i6.123
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Chen G, 2012, DIABETES TECHNOL THE, V14, P936, DOI 10.1089/dia.2012.0072
   Chiodini I, 2007, DIABETES CARE, V30, P83, DOI 10.2337/dc06-1267
   Chyun DA, 2006, BIOL RES NURS, V7, P279, DOI 10.1177/1099800405285748
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Coyne JC, 2011, PSYCHOSOM MED, V73, P557, DOI 10.1097/PSY.0b013e318227ac75
   De Bie S.E., 1987, STANDAARDVRAGEN 1987
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0
   Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406
   Dixon JB, 2013, DIABETES RES CLIN PR, V101, P131, DOI 10.1016/j.diabres.2013.05.017
   Godin O, 2008, BIOL PSYCHIAT, V63, P663, DOI 10.1016/j.biopsych.2007.09.006
   GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216
   Grande G, 2011, PSYCHOSOM MED, V73, P548, DOI 10.1097/PSY.0b013e318227a9bc
   Grool AM, 2013, BIOL PSYCHIAT, V73, P169, DOI 10.1016/j.biopsych.2012.08.024
   Habra ME, 2003, J PSYCHOSOM RES, V55, P235, DOI 10.1016/S0022-3999(02)00553-6
   Harris KF, 2003, PSYCHOSOM MED, V65, P402, DOI 10.1097/01.PSY.0000035720.08842.9F
   Hemingway H, 2003, AM J CARDIOL, V92, P984, DOI 10.1016/S0002-9149(03)00985-8
   Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y
   Klein S, 2004, DIABETES CARE, V27, P2067, DOI 10.2337/diacare.27.8.2067
   Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kupper N, 2007, J PERS ASSESS, V89, P265, DOI 10.1080/00223890701629797
   Laake JPS, 2014, DIABETES CARE, V37, P2186, DOI 10.2337/dc13-2522
   Lesperance F, 2004, AM J PSYCHIAT, V161, P271, DOI 10.1176/appi.ajp.161.2.271
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   Martin LA, 2010, INT J PSYCHOPHYSIOL, V76, P118, DOI 10.1016/j.ijpsycho.2010.03.001
   Muris DMJ, 2012, ARTERIOSCL THROM VAS, V32, P3082, DOI 10.1161/ATVBAHA.112.300291
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Nefs G, 2012, J PSYCHOSOM RES, V72, P251, DOI 10.1016/j.jpsychores.2012.01.006
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   O'Dell KR, 2011, J PSYCHOSOM RES, V71, P199, DOI 10.1016/j.jpsychores.2011.01.009
   Perez HCS, 2013, PSYCHIAT RES-NEUROIM, V211, P180, DOI 10.1016/j.pscychresns.2012.06.005
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Regier DA, 1998, BRIT J PSYCHIAT, V173, P24, DOI 10.1192/S0007125000293483
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Schmitz N, 2014, DIABETES CARE, V37, P970, DOI 10.2337/dc13-1832
   Schram MT, 2014, EUR J EPIDEMIOL, V29, P439, DOI 10.1007/s10654-014-9889-0
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Seldenrijk A, 2011, BIOL PSYCHIAT, V69, P795, DOI 10.1016/j.biopsych.2010.12.034
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   Sherwood A, 2005, J AM COLL CARDIOL, V46, P656, DOI 10.1016/j.jacc.2005.05.041
   Sima AAF, 2004, EUR J PHARMACOL, V490, P187, DOI 10.1016/j.ejphar.2004.02.056
   Skinner TC, 2014, DIABETIC MED, V31, P487, DOI 10.1111/dme.12339
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Strine TW, 2008, PSYCHIAT SERV, V59, P1383, DOI 10.1176/appi.ps.59.12.1383
   Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Taylor WD, 2013, MOL PSYCHIATR, V18, P963, DOI 10.1038/mp.2013.20
   Tiemeier H, 2003, J AM GERIATR SOC, V51, P1105, DOI 10.1046/j.1532-5415.2003.51359.x
   Twito O, 2013, DIABETES CARE, V36, P3425, DOI 10.2337/dc12-2503
   Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   van't Riet E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-949
   Vermulst AA, 2006, QUICK BIG 5 PERSOONL
   Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Williams L, 2009, PSYCHOL HEALTH, V24, P489, DOI 10.1080/08870440701885616
   World Health Organization, 2006, DEF DIAGN DIAB MELL
   Yoon JM, 2013, KOREAN J FAM MED, V34, P228, DOI 10.4082/kjfm.2013.34.4.228
   Zhang YY, 2013, J AFFECT DISORDERS, V151, P660, DOI 10.1016/j.jad.2013.07.014
NR 76
TC 11
Z9 12
U1 2
U2 22
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD JAN 27
PY 2016
VL 16
AR 17
DI 10.1186/s12888-016-0722-z
PG 11
WC Psychiatry
SC Psychiatry
GA DC1LX
UT WOS:000368978900001
PM 26817600
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Browne, JL
   Speight, J
   Martin, C
   Gilfillan, C
AF Browne, Jessica L.
   Speight, Jane
   Martin, Carina
   Gilfillan, Christopher
TI Building the evidence for integrated care for type 2 diabetes: a pilot
   study
SO AUSTRALIAN JOURNAL OF PRIMARY HEALTH
LA English
DT Article
DE patient satisfaction; quality of care; questionnaire; randomised
   controlled trial
ID QUALITY; DISTRESS
AB Integrated care models have the potential to reduce fragmentation in the health system and improve outcomes for people with type 2 diabetes. A pilot evaluation of an integrated care model for people with type 2 diabetes in Melbourne, Australia, is reported on. Two studies were conducted: (1) a 6-month pilot randomised controlled trial (n=56) evaluating the impact of the integrated care model relative to hospital outpatient clinics; and (2) a cross-sectional study (n=92) of patients attending the two services. The primary outcome was diabetes-specific distress; secondary outcomes were perceived quality of diabetes care, diabetes-specific self-efficacy and glycated haemoglobin (HbA1c). There was no effect of service setting on diabetes-specific distress. Participants from the integrated care setting perceived the quality of diabetes care to be higher than did participants from the hospital clinics. Significant HbA1c improvements were observed over time, but with no effect of service setting. The model holds promise for people with type 2 diabetes who need more specialist/multidisciplinary care than can be provided in primary care. Patients' evaluations of the quality of diabetes care received at the integrated care service are very positive, which is likely to be one of the key strengths of the integrated model.
C1 [Browne, Jessica L.; Speight, Jane] Australian Ctr Behav Res Diabet, Diabet Australia Victoria, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Browne, Jessica L.; Speight, Jane] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Wellbeing Res, 221 Burwood Highway, Burwood, Vic 3125, Australia.
   [Speight, Jane] AHP Res, 16 Walden Way, Hornchurch RM11 2LB, England.
   [Martin, Carina] Carrington Hlth, 3-43 Carrington Rd, Box Hill, Vic 3128, Australia.
   [Gilfillan, Christopher] Monash Univ, Eastern Hlth Clin Sch, Level 2,5 Arnold St, Box Hill, Vic 3128, Australia.
RP Browne, JL (reprint author), Australian Ctr Behav Res Diabet, Diabet Australia Victoria, 570 Elizabeth St, Melbourne, Vic 3000, Australia.; Browne, JL (reprint author), Deakin Univ, Sch Psychol, Ctr Mental Hlth & Wellbeing Res, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM jbrowne@acbrd.org.au
OI Speight, Jane/0000-0002-1204-6896
FU Department of Health, Victoria, through their Building; Eastern Health
   Foundation
FX Funding for this study was provided by the State Department of Health,
   Victoria, through their Building the Evidence initiative and from the
   Eastern Health Foundation through a research grant to Professor
   Gilfillan. The authors thank the people with type 2 diabetes who
   participated in the studies reported here. We acknowledge the
   contribution of the IDEAS Evaluation Study Working Group (in
   alphabetical order: Janice Beale, Jessica Browne, Cathy Canny, Jenny
   Cross, Anne Elkins, Christopher Gilfillan, Janine Scott, Jane Speight,
   Fiona Wallace and Edmond Wong) to the governance and oversight of these
   studies. Wethank the clinical and administrative staff at all study
   sites for their involvement in the studies, in particular Jenny Cross
   and Janice Beale at Eastern Health, and also Rachel Isaacs, Anna
   Scovelle and Laura Smith who, in their role as research assistants,
   undertook data collection and data entry for these studies.
CR Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909
   Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864
   Chin MH, 2000, AM J PUBLIC HEALTH, V90, P431, DOI 10.2105/AJPH.90.3.431
   Colagiuri S, 2009, NATL EVIDENCE BASED
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fagot-Campagna A, 2005, DIABETES METAB, V31, pS35, DOI 10.1016/S1262-3636(05)73650-8
   Ferrer Lourdes, 2014, Int J Integr Care, V14, pe037
   Mur-Veeman I, 2003, HEALTH POLICY, V65, P227, DOI 10.1016/S0168-8510(02)00215-4
   Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2002, QUAL SAF HEALTH CARE, V11, P131, DOI 10.1136/qhc.11.2.131
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Tabrizi JS, 2007, AUST NZ J PUBL HEAL, V31, P511, DOI 10.1111/j.1753-6405.2007.00134.x
NR 14
TC 1
Z9 1
U1 0
U2 2
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1448-7527
EI 1836-7399
J9 AUST J PRIM HEALTH
JI Aust. J. Prim. Health.
PY 2016
VL 22
IS 5
BP 409
EP 415
DI 10.1071/PY15020
PG 7
WC Health Care Sciences & Services; Health Policy & Services; Primary
   Health Care; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; General & Internal Medicine; Public,
   Environmental & Occupational Health
GA EA4PL
UT WOS:000386595100007
PM 26330286
DA 2019-01-08
ER

PT J
AU Leigh, L
   Byles, JE
   Chojenta, C
   Pachana, NA
AF Leigh, Lucy
   Byles, Julie E.
   Chojenta, Catherine
   Pachana, Nancy A.
TI Late life changes in mental health: a longitudinal study of 9683 women
SO AGING & MENTAL HEALTH
LA English
DT Article
DE mental health; older women; chronic disease
ID QUALITY-OF-LIFE; BODY-MASS INDEX; PSYCHOLOGICAL DISTRESS; OLDER-ADULTS;
   GENDER-DIFFERENCES; DEPRESSION; ANXIETY; PEOPLE; PREVALENCE; DISABILITY
AB Objectives: To identify latent subgroups of women in late life who are alike in terms of their mental health trajectories.Method: Longitudinal data are for 9683 participants in the 1921-1926 cohort of the Australian Longitudinal Study on Women's Health, who completed at least two surveys between 1999 (aged 73-78 years) and 2008 (aged 82-87 years). Mental health was measured using the five-item mental health inventory (MHI-5). Latent profile analysis uncovered patterns of change in MHI-5 scores.Results: Three patterns of change were identified for women who were still alive in 2008 (n = 7061), and three similar patterns for deceased women (n = 2622): (1) poor mental health' representing women with low MHI-5 scores, (2) good mental health' and (3) excellent' mental health, where scores remained very high. Deceased women had lower mental health scores for each class. Remote areas of residence, higher education, single marital status, higher Body Mass Index (BMI) and falls were the covariates associated with mental health in the survivor group. For the deceased group, education, BMI and falls were significant. Arthritis, stroke, heart disease, bronchitis/emphysema, diabetes and osteoporosis were associated with worse mental health for both groups, while asthma increased these odds significantly for the survivor group only. Hypertension and cancer were not significant predictors of poor mental health.Conclusion: The results show associations between chronic disease and level of mental health in older age, but no evidence of a large decline in mental health in the period prior to death.
C1 [Leigh, Lucy; Byles, Julie E.; Chojenta, Catherine] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Newcastle, NSW, Australia.
   [Pachana, Nancy A.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.
RP Leigh, L (reprint author), Univ Newcastle, Res Ctr Gender Hlth & Ageing, Newcastle, NSW, Australia.
EM Lucy.Leigh@newcastle.edu.au
OI Pachana, Nancy/0000-0002-8927-4205
FU Australian Government Department of Health
FX The research on which this paper is based was conducted as part of the
   Australian Longitudinal Study on Women's Health by the University of
   Newcastle and the University of Queensland. We are grateful to the
   Australian Government Department of Health for funding and to the women
   who provided the survey data.
CR Aarts JWF, 2015, PSYCHO-ONCOLOGY, V24, P950, DOI 10.1002/pon.3748
   Airagnes G, 2015, AM J GERIAT PSYCHIAT, V23, P941, DOI 10.1016/j.jagp.2014.12.004
   Arterburn D, 2012, OBES RES CLIN PRACT, V6, pE197, DOI 10.1016/j.orcp.2012.02.007
   Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI
   Banks E, 2010, MED J AUSTRALIA, V193, pS62
   BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008
   Bohannon RW, 2010, J GERIATR PHYS THER, V33, P16, DOI 10.1097/JPT.0b013e3181d0735e
   Brilleman SL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-71
   Brodaty H, 2001, INT J GERIATR PSYCH, V16, P504, DOI 10.1002/gps.382
   Brown W., 1997, NAT PUBL HLTH FOR DE
   Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P535, DOI 10.1111/j.1753-6405.2008.00305.x
   Brown WJBL, 1996, J WOMENS HEALTH, V5, P467, DOI DOI 10.1089/JWH.1996.5.467
   Butterworth P, 2006, SOC SCI MED, V62, P1179, DOI 10.1016/j.socscimed.2005.07.013
   Byles JE, 2014, DEPRESS ANXIETY, V31, P524, DOI 10.1002/da.22162
   Cairney J, 2005, J AGING HEALTH, V17, P807, DOI 10.1177/0898264305280985
   Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098
   Chang CS, 2013, J CLIN DENSITOM, V16, P204, DOI 10.1016/j.jocd.2012.03.008
   Dahl AK, 2013, J AM GERIATR SOC, V61, P512, DOI 10.1111/jgs.12158
   Deimling GT, 2006, PSYCHO-ONCOL, V15, P306, DOI 10.1002/pon.955
   Department of Health and Aged Care (GISCA), 2001, MEAS REM ACC REM IND, V14
   Diehr P, 2008, J AM GERIATR SOC, V56, P76, DOI 10.1111/j.1532-5415.2007.01500.x
   Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x
   Eckert KA, 2004, MED J AUSTRALIA, V181, P540
   Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x
   Gerstorf D, 2010, PSYCHOL AGING, V25, P477, DOI 10.1037/a0017543
   Kalucy L., 2013, 12 NAT RUR HLTH C AD
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kvaal K, 2008, INT J GERIATR PSYCH, V23, P229, DOI 10.1002/gps.1867
   Layte R, 2013, J AM GERIATR SOC, V61, pS299, DOI 10.1111/jgs.12198
   Leach LS, 2008, SOC PSYCH PSYCH EPID, V43, P983, DOI 10.1007/s00127-008-0388-z
   Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098
   Lucke JC, 2010, BIOL RES NURS, V12, P162, DOI 10.1177/1099800410373804
   Manetti A, 2014, AM J GERIAT PSYCHIAT, V22, P1292, DOI 10.1016/j.jagp.2013.05.001
   MCCALLUM J, 1995, AUST J PUBLIC HEALTH, V19, P160
   McLaughlin D, 2010, J HEALTH PSYCHOL, V15, P671, DOI 10.1177/1359105310368177
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Murray G, 2004, AUST NZ J PSYCHIAT, V38, P629, DOI 10.1111/j.1440-1614.2004.01426.x
   Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x
   Muthen L. K., 1998, MPLUS USERS GUIDE
   Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396
   Pirkis J, 2009, J AFFECT DISORDERS, V115, P54, DOI 10.1016/j.jad.2008.08.014
   Porensky EK, 2009, AM J GERIAT PSYCHIAT, V17, P473, DOI 10.1097/JGP.0b013e31819b87b2
   Powers J, 2000, AUST NZ J PUBL HEAL, V24, P526, DOI 10.1111/j.1467-842X.2000.tb00504.x
   Schilling OK, 2013, GEROPSYCH, V26, P29, DOI 10.1024/1662-9647/a000079
   Silveira E, 2005, QUAL LIFE RES, V14, P1263, DOI 10.1007/s11136-004-7753-5
   Trollor JN, 2007, AM J GERIAT PSYCHIAT, V15, P455, DOI 10.1097/JGP.0b013e3180590ba9
   VANITALLIE TB, 1990, PROG CLIN BIOL RES, V326, P89
   Vink D, 2009, AM J GERIAT PSYCHIAT, V17, P642, DOI 10.1097/JGP.0b013e3181a65228
   Walters K, 2004, AM J PUBLIC HEALTH, V94, P1768, DOI 10.2105/AJPH.94.10.1768
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Ware JE, 1994, SF 36 PHYS MENTAL HL
   Wilcox S, 2003, HEALTH PSYCHOL, V22, P513, DOI 10.1037/0278-6133.22.5.513
   Williams BR, 2008, J PALLIAT MED, V11, P848, DOI 10.1089/jpm.2007.0190
   World Health Organization, 2011, OB OV
   Yan LJL, 2004, OBES RES, V12, P69, DOI 10.1038/oby.2004.10
NR 56
TC 1
Z9 1
U1 0
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1360-7863
EI 1364-6915
J9 AGING MENT HEALTH
JI Aging Ment. Health
PY 2016
VL 20
IS 10
BP 1044
EP 1054
DI 10.1080/13607863.2015.1060943
PG 11
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA DT3SI
UT WOS:000381400800005
PM 26166070
DA 2019-01-08
ER

PT J
AU Wilfley, DE
   Citrome, L
   Herman, BK
AF Wilfley, Denise E.
   Citrome, Leslie
   Herman, Barry K.
TI Characteristics of binge eating disorder in relation to diagnostic
   criteria
SO NEUROPSYCHIATRIC DISEASE AND TREATMENT
LA English
DT Review
DE binge eating disorder; diagnosis; obesity; psychotherapy;
   pharmacotherapy; psychopathology
ID RANDOMIZED CONTROLLED-TRIAL; ETHNICALLY DIVERSE SAMPLE; DSM-5 SEVERITY
   INDICATOR; PRIMARY-CARE SETTINGS; MENTAL-HEALTH SURVEYS;
   BULIMIA-NERVOSA; OBESE WOMEN; NEGATIVE AFFECT; COMMUNITY SAMPLE; FOOD
   SELECTION
AB The objective of this review was to examine the evidentiary basis for binge eating disorder (BED) with reference to the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) diagnostic criteria for BED. A PubMed search restricted to titles and abstracts of English-language reviews, meta-analyses, clinical trials, randomized controlled trials, journal articles, and letters using human participants was conducted on August 7, 2015, using keywords that included "binge eating disorder," DSM-5, DSM-IV, guilt, shame, embarrassment, quantity, psychological, behavior, and "shape and weight concerns." Of the 257 retrieved publications, 60 publications were considered relevant to discussions related to DSM-5 diagnostic criteria and were included in the current review, and 20 additional references were also included on the basis of the authors' knowledge and/or on a review of the reference lists from relevant articles obtained through the literature search. Evidence supports the duration/frequency criterion for BED and the primary importance of loss of control and marked distress in identifying individuals with BED. Although overvaluation of shape/weight is not a diagnostic criterion, its relationship to the severity of BED psychopathology may identify a unique subset of individuals with BED. Additionally, individuals with BED often exhibit a clinical profile consisting of psychiatric (eg, mood, obsessive-compulsive, and impulsive disorders) and medical (eg, gastrointestinal symptoms, metabolic syndrome, and type 2 diabetes) comorbidities and behavioral profiles (eg, overconsumption of calories outside of a binge eating episode and emotional eating). Future revisions of the BED diagnostic criteria should consider the inclusion of BED subtypes, perhaps based on the overvaluation of shape/weight, and an evidence-based reassessment of severity criteria.
C1 [Wilfley, Denise E.] Washington Univ, Sch Med, Dept Psychiat, 660 South Euclid,Campus Box 8134, St Louis, MO 63110 USA.
   [Citrome, Leslie] New York Med Coll, Dept Psychiat & Behav Sci, Valhalla, NY 10595 USA.
   [Herman, Barry K.] Shire, Global Med Affairs, Lexington, MA USA.
RP Wilfley, DE (reprint author), Washington Univ, Sch Med, Dept Psychiat, 660 South Euclid,Campus Box 8134, St Louis, MO 63110 USA.
EM wilfleyd@psychiatry.wustl.edu
FU Shire Development LLC (Lexington, MA)
FX The authors would like to thank Dr Carlos Grilo for his input on the
   initial drafts of this manuscript and Dr Dawn Eichen for her thoughtful
   critiques and edits of this manuscript. Under the direction of the
   authors, writing assistance was provided by Stefan Kolata, PhD (a former
   employee of Complete Healthcare Communications, LLC [CHC; Chadds Ford,
   PA]) and Craig Slawecki, PhD (a current employee of CHC). Editorial
   assistance in the form of proofreading, copyediting, and fact-checking
   was also provided by CHC. The content of this manuscript, the ultimate
   interpretation, and the decision to submit it for publication in
   Neuropsychiatric Disease and Treatment were made by the authors. Shire
   Development LLC (Lexington, MA) provided funding to CHC for support in
   writing and editing this manuscript.
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Antoniou M, 2003, Eat Weight Disord, V8, P145
   Barnes RD, 2014, OBESITY, V22, P2508, DOI 10.1002/oby.20889
   Barnes Rachel D, 2011, Prim Care Companion CNS Disord, V13, DOI 10.4088/PCC.10m01050
   Bartholome LT, 2013, EUR J NUTR, V52, P193, DOI 10.1007/s00394-012-0302-z
   Blomquist KK, 2012, COMPR PSYCHIAT, V53, P1088, DOI 10.1016/j.comppsych.2012.05.003
   Burton AL, 2016, INT J EAT DISORDER, V49, P125, DOI 10.1002/eat.22453
   Carrard I, 2012, EUR EAT DISORD REV, V20, P350, DOI 10.1002/erv.2174
   Carrard I, 2012, EAT BEHAV, V13, P13, DOI 10.1016/j.eatbeh.2011.10.004
   Coker EL, 2015, EAT BEHAV, V17, P130, DOI 10.1016/j.eatbeh.2015.01.014
   Colles SL, 2008, OBESITY, V16, P608, DOI 10.1038/oby.2007.99
   Cotton MA, 2003, J GEN INTERN MED, V18, P53, DOI 10.1046/j.1525-1497.2003.20374.x
   Cremonini F, 2009, INT J OBESITY, V33, P342, DOI 10.1038/ijo.2008.272
   Davis C, 2015, CNS SPECTRUMS, V20, P522, DOI 10.1017/S1092852915000462
   Dingemans AE, 2012, INT J EAT DISORDER, V45, P135, DOI 10.1002/eat.20905
   Eldredge KL, 1996, INT J EAT DISORDER, V19, P73
   Fandino J, 2010, COMPR PSYCHIAT, V51, P110, DOI 10.1016/j.comppsych.2009.03.011
   Franko DL, 2007, INT J EAT DISORDER, V40, P156, DOI 10.1002/eat.20341
   Friederich HC, 2007, OBESITY, V15, P283, DOI 10.1038/oby.2007.545
   Goldschmidt AB, 2011, OBESITY, V19, P1515, DOI 10.1038/oby.2011.24
   Goldschmidt AB, 2010, BEHAV RES THER, V48, P187, DOI 10.1016/j.brat.2009.10.008
   Grilo CM, 2013, PSYCHOL MED, V43, P1335, DOI 10.1017/S0033291712002097
   Grilo CM, 2008, J ABNORM PSYCHOL, V117, P414, DOI 10.1037/0021-843X.117.2.414
   Grilo CM, 2015, BEHAV RES THER, V71, P110, DOI 10.1016/j.brat.2015.05.003
   Grilo CM, 2015, BEHAV RES THER, V66, P72, DOI 10.1016/j.brat.2015.01.004
   Grilo CM, 2013, COMPR PSYCHIAT, V54, P209, DOI 10.1016/j.comppsych.2012.07.012
   Grilo CM, 2013, INT J EAT DISORDER, V46, P208, DOI 10.1002/eat.22082
   Grilo CM, 2012, J PSYCHIATR PRACT, V18, P408, DOI 10.1097/01.pra.0000422738.49377.5e
   Grilo CM, 2012, BEHAV RES THER, V50, P298, DOI 10.1016/j.brat.2012.02.008
   Grilo CM, 2011, J CONSULT CLIN PSYCH, V79, P509, DOI 10.1037/a0024259
   Grilo CM, 2010, OBESITY, V18, P499, DOI 10.1038/oby.2009.280
   Grilo CM, 2009, BEHAV RES THER, V47, P692, DOI 10.1016/j.brat.2009.05.001
   Grilo CM, 2009, INT J EAT DISORDER, V42, P228, DOI 10.1002/eat.20599
   Grucza RA, 2007, COMPR PSYCHIAT, V48, P124, DOI 10.1016/j.comppsych.2006.08.002
   Guss JL, 2002, OBES RES, V10, P1021, DOI 10.1038/oby.2002.139
   Heaner MK, 2013, APPETITE, V65, P185, DOI 10.1016/j.appet.2013.01.005
   Herman Barry K, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.15m01896
   Hrabosky JI, 2007, J CONSULT CLIN PSYCH, V75, P175, DOI 10.1037/0022-006X.75.1.175
   Hrabosky JI, 2007, INT J EAT DISORDER, V40, P72, DOI 10.1002/eat.20323
   Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040
   Hudson JI, 2012, INT J EAT DISORDER, V45, P139, DOI 10.1002/eat.20890
   Hudson JI, 2010, AM J CLIN NUTR, V91, P1568, DOI 10.3945/ajcn.2010.29203
   Hudson JI, 2006, ARCH GEN PSYCHIAT, V63, P313, DOI 10.1001/archpsyc.63.3.313
   Javaras KN, 2008, INT J EAT DISORDER, V41, P174, DOI 10.1002/eat.20484
   Johnson JG, 2001, PSYCHOL MED, V31, P1455
   Johnson William G, 2002, Eat Behav, V3, P179, DOI 10.1016/S1471-0153(01)00057-5
   Kessler RC, 2014, EPIDEMIOL PSYCH SCI, V23, P27, DOI 10.1017/S2045796013000516
   Kessler RC, 2013, BIOL PSYCHIAT, V73, P904, DOI 10.1016/j.biopsych.2012.11.020
   Kjelsas E, 2004, Eat Weight Disord, V9, P7
   Kolotkin RL, 2004, OBES RES, V12, P999, DOI 10.1038/oby.2004.122
   Kornstein Susan G, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.15r01905
   Latner JD, 2008, INT J EAT DISORDER, V41, P1, DOI 10.1002/eat.20465
   Masheb RM, 2008, BEHAV RES THER, V46, P428, DOI 10.1016/j.brat.2008.01.004
   Masheb R M, 2004, Eat Weight Disord, V9, P194
   Masheb RM, 2006, INT J EAT DISORDER, V39, P141, DOI 10.1002/eat.20221
   McElroy SL, 2007, BIOL PSYCHIAT, V61, P1039, DOI 10.1016/j.biopsych.2006.08.008
   Mitchell KS, 2010, PSYCHOL MED, V40, P1899, DOI 10.1017/S0033291710000139
   Mond JM, 2007, BEHAV RES THER, V45, P929, DOI 10.1016/j.brat.2006.08.011
   Morgan CM, 2002, INT J EAT DISORDER, V31, P430, DOI 10.1002/eat.10038
   NANGLE DW, 1994, INT J EAT DISORDER, V16, P147, DOI 10.1002/1098-108X(199409)16:2<147::AID-EAT2260160206>3.0.CO;2-P
   Niego SH, 1997, INT J EAT DISORDER, V22, P291, DOI 10.1002/(SICI)1098-108X(199711)22:3<291::AID-EAT8>3.0.CO;2-I
   Ojserkis R, 2012, INT J EAT DISORDER, V45, P603, DOI 10.1002/eat.20981
   Palavras MA, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-26
   Peterson RE, 2012, J OBES, V2012, DOI DOI 10.1155/2012/407103
   Pollert GA, 2013, INT J EAT DISORDER, V46, P233, DOI 10.1002/eat.22061
   Pratt EM, 1998, INT J EAT DISORDER, V24, P307, DOI 10.1002/(SICI)1098-108X(199811)24:3<307::AID-EAT8>3.0.CO;2-Q
   Raymond NC, 2007, INT J EAT DISORDER, V40, P67, DOI 10.1002/eat.20312
   Reas DL, 2006, INT J EAT DISORDER, V39, P326, DOI 10.1002/eat.20236
   Ricca V, 2009, APPETITE, V53, P418, DOI 10.1016/j.appet.2009.07.008
   Sandberg RM, 2013, J OBES, V2013
   Schulz S, 2010, EAT WEIGHT DISORD-ST, V15, pE287, DOI 10.1007/BF03325311
   Sheehan David V, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.14r01732
   Sheehan KH, 2008, INT CLIN PSYCHOPHARM, V23, P70, DOI 10.1097/YIC.0b013e3282f2b4d6
   SPITZER RL, 1991, INT J EAT DISORDER, V10, P627, DOI 10.1002/1098-108X(199111)10:6<627::AID-EAT2260100602>3.0.CO;2-4
   SPITZER RL, 1993, INT J EAT DISORDER, V13, P161, DOI 10.1002/1098-108X(199303)13:2<161::AID-EAT2260130204>3.0.CO;2-R
   Stice E, 2013, J ABNORM PSYCHOL, V122, P445, DOI 10.1037/a0030679
   Striegel-Moore RH, 2000, INT J EAT DISORDER, V27, P270, DOI 10.1002/(SICI)1098-108X(200004)27:3<270::AID-EAT3>3.0.CO;2-1
   STUNKARD AJ, 1959, PSYCHIAT QUART, V33, P284, DOI 10.1007/BF01575455
   Sysko R, 2015, INT J EAT DISORDER, V48, P452, DOI 10.1002/eat.22388
   Sysko R, 2010, J CONSULT CLIN PSYCH, V78, P681, DOI 10.1037/a0019735
   Telch CF, 1998, INT J EAT DISORDER, V24, P313, DOI 10.1002/(SICI)1098-108X(199811)24:3<313::AID-EAT9>3.0.CO;2-P
   Trace SE, 2012, INT J EAT DISORDER, V45, P531, DOI 10.1002/eat.20955
   Udo T, 2013, GEN HOSP PSYCHIAT, V35, P587, DOI 10.1016/j.genhosppsych.2013.07.010
   Walsh BT, 2011, PHYSIOL BEHAV, V104, P525, DOI 10.1016/j.physbeh.2011.05.007
   Webb JB, 2011, EAT BEHAV, V12, P175, DOI 10.1016/j.eatbeh.2011.04.007
   White MA, 2011, J CONSULT CLIN PSYCH, V79, P75, DOI 10.1037/a0022210
   Wilson GT, 2009, INT J EAT DISORDER, V42, P603, DOI 10.1002/eat.20726
   Yanovski S Z, 1993, Obes Res, V1, P306
   YANOVSKI SZ, 1992, AM J CLIN NUTR, V56, P975
   Yip SW, 2011, J GAMBL STUD, V27, P257, DOI 10.1007/s10899-010-9207-z
NR 92
TC 5
Z9 5
U1 1
U2 8
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2021
J9 NEUROPSYCH DIS TREAT
JI Neuropsychiatr. Dis. Treat.
PY 2016
VL 12
BP 2213
EP 2223
DI 10.2147/NDT.S107777
PG 11
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DU4YF
UT WOS:000382218200001
PM 27621631
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Asemota, O
   Eldemire-Shearer, D
   Waldron, NK
   Standard-Goldson, A
AF Asemota, Otaniyenuwa
   Eldemire-Shearer, Denise
   Waldron, Norman K.
   Standard-Goldson, Aileen
TI Prevalence of Self-reported Urinary Incontinence in Community-dwelling
   Older Adults of Westmoreland, Jamaica
SO MEDICC REVIEW
LA English
DT Article
DE Urinary incontinence; prevalence; risk factors; cross-sectional studies;
   aged; elderly; Jamaica
ID QUALITY-OF-LIFE; UNITED-STATES; WOMEN; PEOPLE; POPULATION; SEVERITY;
   SEEKING; BURDEN; HEALTH; CARE
AB INTRODUCTION Urinary incontinence is a disorder of considerable significance in older adults. It causes distress and morbidity, yet its true prevalence in the community is likely underestimated, because stigma and other factors may cause underreporting. WHO has developed a 10-minute screening tool to help primary healthcare providers recognize and manage the most common geriatric conditions: falls, memory loss, depression and urinary incontinence.
   OBJECTIVE Determine prevalence of urinary incontinence in adults aged >= 60 years in Westmoreland Parish, Jamaica; examine some of the associated risk factors; estimate how much urinary incontinence goes unreported and explore related barriers.
   METHODS A cross-sectional study in April 2014 of 454 older adults was conducted in 12 community clusters in Westmoreland. Data collection was done using an interviewer-administered questionnaire. Data were analyzed using SPSS version 17. Chi-square and Fisher exact tests were used to assess significance of associations between dependent and independent variables.
   RESULTS The majority (241/454, 53.1%) of respondents were men aged 60-95 years (median age 69 years; interquartile range: 64-77). Prevalence of urinary incontinence was 10.6% (48/453). Statistically significant associations were found between urinary incontinence and hypertension, diabetes mellitus, prostate problems and arthritis, but not with kidney problems, stroke or parity. Among respondents with urinary incontinence, 30.2% had not reported the condition to their doctor (13/43 who answered this question). Reasons cited for nonreporting included belief that urinary incontinence is normal with aging (9 respondents), not being bothered by urinary incontinence (7), inability to pay for treatment (6), feeling ashamed to report the condition (4), not knowing the appropriate doctor to see (2) and lack of awareness of available treatment options (1). Among respondents who had unreported urinary incontinence, 10 indicated a preference for physician-initiated (as opposed to self-initiated) discussion of urinary incontinence.
   CONCLUSION The substantial prevalence of urinary incontinence and high rate of nonreporting (almost one in three) underscore the need for systematic screening of older adults by doctors, especially at the primary care level, for early detection and appropriate urinary incontinence management.
C1 [Asemota, Otaniyenuwa] Univ West Indies FMUWI, Fac Med Sci, Dept Community Hlth & Psychiat, Mona, Jamaica.
   [Eldemire-Shearer, Denise; Waldron, Norman K.] FMUWI, Mona Ageing & Wellness Ctr, Publ Hlth, Mona, Jamaica.
   [Standard-Goldson, Aileen] FMUWI, Dept Community Hlth & Psychiat, Publ Hlth, Mona, Jamaica.
RP Asemota, O (reprint author), Univ West Indies FMUWI, Fac Med Sci, Dept Community Hlth & Psychiat, Mona, Jamaica.
EM asemota@hotmail.com
CR Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870
   Barentsen JA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-153
   Berger MB, 2011, NEUROUROL URODYNAM, V30, P1442, DOI 10.1002/nau.21145
   Berlezi EM, 2011, REV BRAS GERIATR GER, V14
   Cameron AP, 2013, THER ADV UROL, V5, P181, DOI 10.1177/1756287213489720
   Silva Lígia da, 2009, Rev. esc. enferm. USP, V43, P72, DOI 10.1590/S0080-62342009000100009
   Dowling-Castronovo A, 2013, HARTFORD I GERIATRIC, V11, P2
   Eldemire-Shearer D., 2011, AGE FRIENDLY PRIMARY
   Farage MA, 2008, ARCH GYNECOL OBSTET, V277, P285, DOI 10.1007/s00404-007-0505-3
   Frank C, 2010, CAN FAM PHYSICIAN, V56, P1115
   Gerst K, 2011, J IMMIGR MINOR HEALT, V13, P1110, DOI 10.1007/s10903-010-9383-z
   Goepel M, 2010, DTSCH ARZTEBL INT, V107, P531, DOI 10.3238/arztebl.2010.0531
   Goode PS, 2010, JAMA-J AM MED ASSOC, V303, P2172, DOI 10.1001/jama.2010.749
   Horrocks S, 2004, FAM PRACT, V21, P689, DOI 10.1093/fampra/cmh622
   Hu TW, 2004, UROLOGY, V63, P461, DOI 10.1016/j.urology.2003.10.037
   Knorst MR, 2011, REV BRAS FISIOTER, V15, P109, DOI 10.1590/S1413-35552011000200005
   Ko Y, 2005, AM J MANAG CARE, V11, pS103
   Markland AD, 2011, J UROLOGY, V186, P589, DOI 10.1016/j.juro.2011.03.114
   Milsom I, 2014, EUR UROL, V65, P79, DOI 10.1016/j.eururo.2013.08.031
   Tamanini JTN, 2009, CAD SAUDE PUBLICA, V25, P1756, DOI 10.1590/S0102-311X2009000800011
   Statistical Institute of Jamaica, 2016, DEM STAT POP PAR POP
   Sung W, 2012, INT NEUROUROL J, V16, P23, DOI 10.5213/inj.2012.16.1.23
   Teunissen D, 2005, BRIT J GEN PRACT, V55, P776
   UN International Fund for Agricultural Development, 2016, RES CALC SAMPL SIZ
   Visser E, 2012, SCAND J PRIM HEALTH, V30, P21, DOI 10.3109/02813432.2011.628244
   Wallner LP, 2009, AM J MED, V122, P1037, DOI 10.1016/j.amjmed.2009.05.016
   World Health Organization, 2008, AG FRIENDL PRIM HLTH
NR 27
TC 1
Z9 1
U1 1
U2 1
PU MEDICC-MED EDUC COOPERATION CUBA
PI DECATUR
PA 1902 CLAIRMONT RD, STE 250, DECATUR, GEORGIA 30033-3406 USA
SN 1555-7960
J9 MEDICC REV
JI MEDICC Rev.
PD JAN-APR
PY 2016
VL 18
IS 1-2
BP 41
EP 45
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DQ9AJ
UT WOS:000379502500009
DA 2019-01-08
ER

PT J
AU Townsend, CKM
   Dillard, A
   Hosoda, KK
   Maskarinec, GG
   Maunakea, AK
   Yoshimura, SR
   Hughes, C
   Palakiko, DM
   Kehauoha, BP
   Kaholokula, JK
AF Townsend, Claire K. M.
   Dillard, Adrienne
   Hosoda, Kelsea K.
   Maskarinec, Gregory G.
   Maunakea, Alika K.
   Yoshimura, Sheryl R.
   Hughes, Claire
   Palakiko, Donna-Marie
   Kehauoha, Bridget Puni
   Kaholokula, Joseph Keawe'aimoku
TI Community-Based Participatory Research Integrates Behavioral and
   Biological Research to Achieve Health Equity for Native Hawaiians
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE community-based participatory research; epigenomics; diabetes
   self-management; Native Hawaiians
AB Native Hawaiians bear a disproportionate burden of type-2 diabetes and related complications compared to all other groups in Hawai'i (e.g., Whites, Japanese, Korean). Distrust in these communities is a significant barrier to participation in epigenetic research studies seeking to better understand disease processes. The purpose of this paper is to describe the community-based participatory research (CBPR) approach and research process we employed to integrate behavior and biological sciences with community health priorities. A CBPR approach was used to test a 3-month evidence-based, diabetes self-management intervention (N = 65). To investigate the molecular mechanisms linking inflammation with glucose homeostasis, a subset of participants (n = 16) provided peripheral blood mononuclear cells. Community and academic researchers collaborated on research design, assessment protocols, and participant recruitment, prioritizing participants' convenience and education and strictly limiting the use of the data collected. Preliminary results indicate significant changes in DNA methylation at gene regions associated with inflammation and diabetes signaling pathways and significant improvements in hemoglobin A1c, self-care activities, and diabetes distress and understanding. This study integrates community, behavioral, and epigenomic expertise to better understand the outcomes of a diabetes self-management intervention. Key lessons learned suggest the studies requiring biospecimen collection in indigenous populations require community trust of the researchers, mutual benefits for the community and researchers, and for the researchers to prioritize the community's needs. CBPR may be an important tool in providing communities the voice and protections to participate in studies requiring biospecimens.
C1 [Townsend, Claire K. M.; Hosoda, Kelsea K.; Maskarinec, Gregory G.; Maunakea, Alika K.; Kaholokula, Joseph Keawe'aimoku] Univ Hawaii Manoa, John A Burns Sch Med, Dept Native Hawaiian Hlth, 651 Ilalo St,MEB 307L, Honolulu, HI 96813 USA.
   [Dillard, Adrienne; Kehauoha, Bridget Puni] Kula No Na Poe Hawaii, POB 2368, Honolulu, HI 96823 USA.
   [Yoshimura, Sheryl R.] Kokua Kalihi Valley Comprehens Family Serv, 2239 N Sch St, Honolulu, HI 96819 USA.
   [Hughes, Claire] Assoc Hawaiian Civ Clubs, Hawaii Maoli, POB 3866, Honolulu, HI 96812 USA.
   [Palakiko, Donna-Marie] Ke Ola Mamo, Dillingham Plaza,1505 Dillingham Blvd 205, Honolulu, HI 96817 USA.
RP Townsend, CKM (reprint author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Native Hawaiian Hlth, 651 Ilalo St,MEB 307L, Honolulu, HI 96813 USA.
EM clairemt@hawaii.edu; kula.papakolea@gmail.com; khosoda@hawaii.edu;
   gregorym@hawaii.edu; amaunake@hawaii.edu; sryoshimura@gmail.com;
   hughes1926@aol.com; dpalakiko@keolamamo.org; punikekauoha@gmail.com;
   kaholoku@hawaii.edu
FU National Institute on Minority Health and Health Disparities of National
   Institutes of Health [R24MD001660, U54MD007584]; Queen's Health Systems
   Native Hawaiian Health Initiative
FX We thank the PILI 'Ohana Project participants, community researchers,
   and staff of the participating communities and community organizations:
   Hawai'i Maoli - The Association of Hawaiian Civic Clubs, Ke Ola Mamo,
   Kula no na Po'e Hawai'i, and Kokua Kalihi Valley Comprehensive Family
   Services. We would also like to thank our academic collaborators: the
   Hawai'i Center for AIDS core and Participant Clinical Resource core at
   JABSOM. This work was supported, in part, by the National Institute on
   Minority Health and Health Disparities (R24MD001660; U54MD007584) of the
   National Institutes of Health and The Queen's Health Systems Native
   Hawaiian Health Initiative. It was also registered on ClinicalTrials.gov
   (NCT02144909). The content is solely the responsibility of the authors
   and does not necessarily represent the official views of National
   Institute on Minority Health and Health Disparities, the National
   Institutes of Health, or The Queen's Health Systems.
CR Braun KL, 2014, GERONTOLOGIST, V54, P117, DOI 10.1093/geront/gnt067
   Chang R M, 2001, Pac Health Dialog, V8, P364
   Cook B P, 2001, Pac Health Dialog, V8, P368
   Fong M, 2003, CALIFORNIAN J HLTH P, V1, P136
   Hiratsuka V.Y., 2012, INT J CIRCUMPOLAR HL
   Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173
   Kaholokula JK, 2014, TRANSL BEHAV MED, V4, P149, DOI 10.1007/s13142-013-0244-x
   Kaholokula JK, 2014, OBESITY INTERVENTIONS IN UNDERSERVED COMMUNITIES: EVIDENCE AND DIRECTIONS, P313
   Manson Spero M, 2007, J Interprof Care, V21 Suppl 2, P31, DOI 10.1080/13561820701605540
   Matsunaga Doris Segal, 1996, Cancer, V78, P1582, DOI 10.1002/(SICI)1097-0142(19961001)78:7+<1582::AID-CNCR11>3.0.CO;2-1
   Mau Marjorie K, 2010, Prog Community Health Partnersh, V4, P7, DOI 10.1353/cpr.0.0111
   Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463
   Mouritz A, 1916, PATH DESTROYER HIST
   Nacapoy Andrea H, 2008, Hawaii Med J, V67, P237
   Nguyen D-M, 2013, HAWAII BEHAV RISK FA
   Rakyan V.K., 2011, PLOS GENET
   Riek AE, 2012, J BIOL CHEM, V287, P38482, DOI 10.1074/jbc.M112.386912
   Santos L., 2001, PAC HLTH DIALOG, V8, P193
   Sharp RR, 2002, ENVIRON HEALTH PERSP, V110, P145, DOI 10.1289/ehp.02110s2145
   Sinclair KA, 2013, ANN BEHAV MED, V45, P24, DOI 10.1007/s12160-012-9422-1
   Vawer M., 2013, INT J CIRCUMPOLAR HL, V72
   Wallerstein NB, 2006, HEALTH PROMOT PRACT, V7, P312, DOI 10.1177/1524839906289376
NR 22
TC 2
Z9 2
U1 0
U2 3
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN
PY 2016
VL 13
IS 1
AR 4
DI 10.3390/ijerph13010004
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA DJ4OO
UT WOS:000374186100123
PM 26703660
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Burns, RJ
   Deschenes, SS
   Schmitz, N
AF Burns, Rachel J.
   Deschenes, Sonya S.
   Schmitz, Norbert
TI Associations Between Coping Strategies and Mental Health in Individuals
   With Type 2 Diabetes: Prospective Analyses
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE coping; diabetes; depression; anxiety; diabetes-related distress
ID RISK-FACTORS; DEPRESSIVE SYMPTOMS; ANXIETY DISORDERS; COMMUNITY SAMPLE;
   DISTRESS SCALE; METAANALYSIS; STRESS; ADULTS; COMPLICATIONS; DISABILITY
AB Objective: Individuals with type 2 diabetes are at greater risk of developing a number of mental health conditions, including depression, anxiety, and diabetes-related distress, than individuals without type 2 diabetes. Cross-sectional studies suggest that some coping strategies may increase the risk of mental health conditions in individuals with diabetes, whereas others may be protective. This study extends the cross-sectional evidence base with a prospective study. Methods: Data were collected annually for 2 years from a community sample of 1,742 adults with type 2 diabetes. Coping strategies were measured at baseline and mental health conditions were assessed at each time point with self-report symptom measures. For comparison, cross-sectional and prospective analyses were conducted. Results: Cross-sectional analyses demonstrated that task-oriented coping was negatively associated with the likelihood of each of the mental health conditions, emotion-oriented coping was positively associated with the likelihood of each condition, and avoidance-oriented coping showed no association. Prospective analyses revealed that among individuals who did not have elevated depressive symptoms at baseline, only emotion-oriented coping predicted the likelihood of developing major depression syndrome during follow-up. Similar patterns of results were observed for elevated anxiety symptoms and diabetes-related distress. Conclusions: Cross-sectional results differed from prospective results. Only emotion-oriented coping appears to play a role in the development of depressive symptoms, anxiety symptoms, and diabetes-related distress. Results underscore the importance of examining prospective associations and suggest that interventions targeting specific coping strategies might alleviate mental health problems in individuals with type 2 diabetes.
C1 [Burns, Rachel J.; Deschenes, Sonya S.; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada.
   [Burns, Rachel J.; Deschenes, Sonya S.; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, 6875 Boul Lasalle,Frank B Common Pavil, Montreal, PQ H4H 1R3, Canada.
   [Schmitz, Norbert] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.
RP Burns, RJ (reprint author), Douglas Mental Hlth Univ Inst, 6875 Boul Lasalle,Frank B Common Pavil, Montreal, PQ H4H 1R3, Canada.
EM Rachel.burns@mail.mcgill.ca
RI Deschenes, Sonya/G-6341-2017; Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323; Burns, Rachel/0000-0002-5337-7878
FU Canadian Institutes of Health Research [MOP-106514]
FX The EDIT study is funded by Canadian Institutes of Health Research Grant
   MOP-106514.
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6
   Eaton WW, 2007, INT REV PSYCHIATR, V19, P497, DOI 10.1080/09540260701564906
   Endler N. S., 1994, PSYCHOL ASSESSMENT, V6, P50, DOI [10.1037/1040-3590.6.1.50, DOI 10.1037/1040-3590.6.1.50]
   ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844
   Fincke BG, 2005, J AMBUL CARE MANAG, V28, P262
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456
   FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839
   FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617
   Gafvels C, 2006, DIABETES RES CLIN PR, V71, P280, DOI 10.1016/j.diabres.2005.07.001
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Grey Margaret, 2004, Curr Diab Rep, V4, P126, DOI 10.1007/s11892-004-0068-7
   Hendriks SM, 2014, J AFFECT DISORDERS, V166, P227, DOI 10.1016/j.jad.2014.05.006
   HORWATH E, 1992, ARCH GEN PSYCHIAT, V49, P817
   Karlsen B, 2004, PATIENT EDUC COUNS, V53, P299, DOI 10.1016/j.pec.2003.10.008
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kroese FM, 2014, PSYCHOL HEALTH, V29, P110, DOI 10.1080/08870446.2013.841911
   Lazarus R. S., 1987, EUROPEAN J PERSONALI, V1, P141, DOI DOI 10.1002/PER.2410010304
   LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002
   Lecrubier Y, 2001, J CLIN PSYCHIAT, V62, P4
   Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040
   Macrodimitris SD, 2001, HEALTH PSYCHOL, V20, P208, DOI 10.1037//0278-6133.20.3.208
   Magkos F, 2009, ANNU REV NUTR, V29, P223, DOI 10.1146/annurev-nutr-080508-141200
   Melkus GD, 2010, BIOL RES NURS, V12, P7, DOI 10.1177/1099800410369825
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Moos RH, 2003, J CLIN PSYCHOL, V59, P1387, DOI 10.1002/jclp.10229
   MOOS RH, 1988, COPING RESPONSES INV
   Piatt GA, 2010, DIABETES EDUCATOR, V36, P301, DOI 10.1177/0145721710361388
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Shah BM, 2012, STRESS HEALTH, V28, P111, DOI 10.1002/smi.1410
   Smari J, 1997, PERS INDIV DIFFER, V22, P151, DOI 10.1016/S0191-8869(96)00199-7
   Smith KJ, 2014, PSYCHOSOMATICS, V55, P659, DOI 10.1016/j.psym.2014.05.015
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Smith KJ, 2013, PSYCHOSOMATICS, V54, P35, DOI 10.1016/j.psym.2012.08.002
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   STANTON AL, 1994, J PERS SOC PSYCHOL, V66, P350, DOI 10.1037/0022-3514.66.2.350
   Stanton AL, 2007, ANNU REV PSYCHOL, V58, P565, DOI 10.1146/annurev.psych.58.110405.085615
   STONE AA, 1991, J PERS SOC PSYCHOL, V61, P648, DOI 10.1037//0022-3514.61.4.648
   Tuncay T, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-79
   WELLS KB, 1992, ARCH GEN PSYCHIAT, V49, P788
NR 47
TC 3
Z9 3
U1 0
U2 15
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD JAN
PY 2016
VL 35
IS 1
BP 78
EP 86
DI 10.1037/hea0000250
PG 9
WC Psychology, Clinical; Psychology
SC Psychology
GA DI4MT
UT WOS:000373474700009
PM 26192382
OA Green Published
DA 2019-01-08
ER

PT J
AU van Vugt, M
   de Wit, M
   Sieverink, F
   Roelofsen, Y
   Hendriks, SH
   Bilo, HJG
   Snoek, FJ
AF van Vugt, M.
   de Wit, M.
   Sieverink, F.
   Roelofsen, Y.
   Hendriks, S. H.
   Bilo, H. J. G.
   Snoek, F. J.
TI Uptake and Effects of the e-Vita Personal Health Record with
   Self-Management Support and Coaching, for Type 2 Diabetes Patients
   Treated in Primary Care
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID BEHAVIOR-CHANGE; EDUCATION; METAANALYSIS; MELLITUS; PEOPLE; SCALE
AB We studied the use, uptake, and effects of e-Vita, a personal health record, with self-management support and personalized asynchronized coaching, for type 2 diabetes patients treated in primary care. Patients were invited by their practice nurse to join the study aimed at testing use and effects of a personal health record. Patients were followed up for 6 months. Uptake and usage were monitored using log data. Outcomes were self-reported diabetes self-care, diabetes-related distress, and emotional wellbeing. Patients' health status was collected from their medical chart. 132 patients agreed to participate in the study of which less than half (46.1%) did not return to the personal health record after 1st login. Only 5 patients used the self-management support program within the personal health record, 3 of whom asked a coach for feedback. Low use of the personal health record was registered. No statistical significant differences on any of the outcome measures were found between baseline and 6 month follow-up. This study showed minimal impact of implementing a personal health record including self-management support in primary diabetes care. Successful adoption of web-based platforms, as ongoing patient centered care, is hard to achieve without additional strategies aimed at enhancing patient motivation and engaging professionals.
C1 [van Vugt, M.; de Wit, M.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, NL-1081 HZ Amsterdam, Netherlands.
   [van Vugt, M.; de Wit, M.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 HZ Amsterdam, Netherlands.
   [Sieverink, F.] Univ Twente, Ctr eHlth & Wellbeing Res, NL-7522 NB Enschede, Netherlands.
   [Roelofsen, Y.; Hendriks, S. H.; Bilo, H. J. G.] Isala, Ctr Diabet, NL-8025 AB Zwolle, Netherlands.
   [Bilo, H. J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 GZ Groningen, Netherlands.
   [Snoek, F. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
RP van Vugt, M (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, NL-1081 HZ Amsterdam, Netherlands.; van Vugt, M (reprint author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 HZ Amsterdam, Netherlands.
EM m.vanvugt@vumc.nl
CR Amante DJ, 2014, DIABETES TECHNOL THE, V16, P784, DOI 10.1089/dia.2014.0078
   Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   Brown Linda Lockett, 2007, J Diabetes Sci Technol, V1, P892
   CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   Cruickshank K., 2003, TXB DIABETES, V46, P1
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11
   Fuji KT, 2015, TELEMED E-HEALTH, V21, P296, DOI 10.1089/tmj.2014.0084
   Funnel MM, 2009, DIABETES CARE, V32, pS87, DOI 10.2337/dc09-S087
   Gerich JE, 2003, TXB DIABETES
   Glasgow RE, 2004, AM J PREV MED, V27, P80, DOI 10.1016/j.amepre.2004.04.026
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Heinrich E, 2010, EUR DIAB NURSING, V7, P71, DOI DOI 10.1002/EDN.160
   International Diabetes Federation, 2014, IDF DIABETES ATLAS
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Pal K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008776.pub2
   Pereira K, 2015, DIABETES TECHNOL THE, V17, P55, DOI 10.1089/dia.2014.0155
   Price M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0159-1
   Ramadas A, 2011, INT J MED INFORM, V80, P389, DOI 10.1016/j.ijmedinf.2011.02.002
   Roelofsen Y., 2013, USE EFFECTS INTERACT
   Roelofsen Yvonne, 2014, J Diabetes Sci Technol, V8, P230
   Roelofsen Y, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-22
   Ruwaard J, 2015, EUR HLTH PSYCHOL, V17, P45, DOI DOI 10.2196/JMIR.2925
   SCHWARZER R, 2008, APPL PSYCHOL-INT REV, V57, P1
   Schwarzer R, 2011, REHABIL PSYCHOL, V56, P161, DOI 10.1037/a0024509
   Sieverink F., 2014, INT J ADV LIFE SCI, V6, P177
   Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213
   Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   TOOBERT DJ, 1994, HDB PSYCHOL DIABETES, P351
   van Vugt M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-53
   Willemse B., 2015, E INCLUSION AGEING E
NR 37
TC 3
Z9 3
U1 1
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2016
AR 5027356
DI 10.1155/2016/5027356
PG 9
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA DI6BH
UT WOS:000373583700001
PM 26955640
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Jones, LC
   Clay, OJ
   Ovalle, F
   Cherrington, A
   Crowe, M
AF Jones, LaRita C.
   Clay, Olivio J.
   Ovalle, Fernando
   Cherrington, Andrea
   Crowe, Michael
TI Correlates of Depressive Symptoms in Older Adults with Diabetes
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID COGNITIVE DECLINE; RISK-FACTORS; STROKE; DISTRESS; CARE; DEMENTIA;
   DISEASE; SCALE
AB Investigators examined correlates of depressive symptoms within a sample of older adults with diabetes. Participants completed a structured telephone interview with measures including depressive symptoms, health conditions, cognitive function, and diabetes distress. Correlations and hierarchical linear regression models were utilized to examine bivariate and covariate-adjusted correlates of depressive symptoms. The sample included 246 community-dwelling adults with diabetes (>= 65 years old). In bivariate analyses, African Americans, individuals with specific health issues (neuropathy, stroke, respiratory issues, arthritis, and cardiac issues), and those with higher levels of diabetes distress reported more depressive symptoms. Older age, higher education, more income, and better cognitive function were inversely associated with depressive symptoms. In the (f)inal covariate-adjusted regression model, stroke (B = .22, p < .001), cognitive function (B = -.14, p < .01), and higher levels of diabetes-related distress (B = .49, p < .001) each were uniquely associated with more depressive symptoms. Diabetes distress partially mediated the associations between cardiac issues and depressive symptoms and between cognitive function and depressive symptoms. Findings suggest that interventions targeted at helping older adults manage their diabetes-related distress and reducing the likelihood of experiencing additional health complications may reduce depressive symptoms within this population.
C1 [Jones, LaRita C.; Clay, Olivio J.; Crowe, Michael] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA.
   [Ovalle, Fernando] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Diabet & Endocrine Clin Res Unit, Birmingham, AL 35294 USA.
   [Cherrington, Andrea] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35294 USA.
RP Clay, OJ (reprint author), Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA.
EM oclay@uab.edu
OI Ovalle, Fernando/0000-0002-6711-071X; Clay, Olivio/0000-0002-7529-6120
FU National Institute on Aging (NIA) [P30AG022838]; National Center for
   Advancing Translational Sciences (NCATS) Award [UL1TR00165]
FX This work was supported in part by the National Institute on Aging (NIA)
   Grant P30AG022838 (UAB Roybal Center) and National Center for Advancing
   Translational Sciences (NCATS) Award number UL1TR00165 (UAB Center for
   Clinical and Translational Science).
CR ASTROM M, 1993, STROKE, V24, P976, DOI 10.1161/01.STR.24.7.976
   Borell-Carrio F, 2004, ANN FAMILY MED, V2, P576, DOI [10.1370/afm.245, DOI 10.1370/AFM.245]
   Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Chen PJ, 1999, ARCH GEN PSYCHIAT, V56, P261, DOI 10.1001/archpsyc.56.3.261
   CREED F, 1992, International Review of Psychiatry, V4, P23, DOI 10.3109/09540269209066299
   Crowe M, 2010, J AGING HEALTH, V22, P292, DOI 10.1177/0898264309357445
   Cumming TB, 2010, ACTA PSYCHIAT SCAND, V121, P424, DOI 10.1111/j.1600-0447.2010.01558.x
   CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443
   de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830
   ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Halanych JH, 2006, MED CARE, V44, P439, DOI 10.1097/01.mlr.0000207433.70159.23
   Haring HP, 2002, CURR OPIN NEUROL, V15, P79, DOI 10.1097/00019052-200202000-00012
   Harris MI, 2001, DIABETES CARE, V24, P454, DOI 10.2337/diacare.24.3.454
   IBM Corp, 2013, REL 2013 IBM SPSS ST
   Kales HC, 2006, GERIATRICS, V61, P18
   Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0
   Lehrer P, 2002, J CONSULT CLIN PSYCH, V70, P691, DOI 10.1037//0022-006X.70.3.691
   Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037//0022-3514.77.5.1061
   Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005
   Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282
   Paterniti S, 2002, BRIT J PSYCHIAT, V181, P406, DOI 10.1192/bjp.181.5.406
   Pischke CR, 2010, PSYCHOL HEALTH, V25, P1077, DOI 10.1080/08870440903002986
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Sale JEM, 2008, J RHEUMATOL, V35, P335
   SAS Institute, 2006, SAS 9 1 3 PROC GUID
   Schoenberg NE, 2001, J AGING HEALTH, V13, P443, DOI 10.1177/089826430101300401
   SHEIKH J I, 1986, Clinical Gerontologist, V5, P165
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   Vink D, 2008, J AFFECT DISORDERS, V106, P29, DOI 10.1016/j.jad.2007.06.005
   Wrosch C, 2002, HEALTH PSYCHOL, V21, P340, DOI 10.1037//0278-6133.21.4.340
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
NR 35
TC 3
Z9 3
U1 0
U2 0
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2016
AR 8702730
DI 10.1155/2016/8702730
PG 8
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA DE5YU
UT WOS:000370710200001
PM 26682235
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Roelofsen, Y
   van Vugt, M
   Hendriks, SH
   van Hateren, KJJ
   Groenier, KH
   Snoek, FJ
   Kleefstra, N
   Huijsman, R
   Bilo, HJG
AF Roelofsen, Yvonne
   van Vugt, Michael
   Hendriks, Steven H.
   van Hateren, Kornelis J. J.
   Groenier, Klaas H.
   Snoek, Frank J.
   Kleefstra, Nanne
   Huijsman, Robbert
   Bilo, Henk J. G.
TI Demographical, Clinical, and Psychological Characteristics of Users and
   Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID QUALITY-OF-LIFE; COST-EFFECTIVENESS; EHEALTH RESEARCH; CHRONIC DISEASE;
   SELF-CARE; TELEMEDICINE; RECORDS; EUROQOL; SCALE
AB Background. Online platforms offer opportunities for support in changing lifestyle and taking responsibility for one's health, but engaging patients with type 2 diabetes is challenging. Previous studies have shown that patients interested in platforms were more often male, younger, and higher educated. This study aims to investigate differences in clinical and psychological characteristics between users and nonusers of a newly developed platform. Methods. A prospective study started in the Drenthe region of Netherlands. Participants in the study concerning quality of care and quality of life were additionally invited to use the platform. Results. 633 patients were registered after they opted for platform use. Of these patients, 361 (57.0%) never logged on, 184 (29.1%) were labeled "curious" users, and 88 (13.9%) were identified as "active" users. Users had lower HbA1c levels and more often hypertension compared to nonusers, and reported higher quality of life, better well-being, lower diabetes-related distress, and better medication adherence. Discussion. Platform use was associated with more favorable clinical and psychological characteristics relative to nonuse. Those with greater severity of disease, lower mood, and progression of disease used the platform the least. Other approaches need to be developed to reach these patients. Furthermore, improving the platform could also help to reach them.
C1 [Roelofsen, Yvonne; Hendriks, Steven H.; van Hateren, Kornelis J. J.; Groenier, Klaas H.; Kleefstra, Nanne; Bilo, Henk J. G.] Ctr Diabet, Isala, Zwolle, Netherlands.
   [van Vugt, Michael; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [van Vugt, Michael; Snoek, Frank J.] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.
   [Kleefstra, Nanne; Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands.
   [Kleefstra, Nanne] Langerhans Med Res Grp, Zwolle, Netherlands.
   [Huijsman, Robbert] Erasmus Univ, Inst Healthcare Management & Policy, Rotterdam, Netherlands.
RP Roelofsen, Y (reprint author), Ctr Diabet, Isala, Zwolle, Netherlands.
EM y.roelofsen@isala.nl
OI Huijsman, Robbert/0000-0002-9776-129X
FU foundation Care Within Reach (in Dutch: stichting Zorg Binnen Bereik)
FX The authors wish to thank all the participating patients and primary
   health care workers in the Drenthe region of the Netherlands. Thanks
   also are due to Jurriaan Kok for his support and for managing the DM
   part of the e-Vita research program and all coordinators and supporters
   within the foundation Care Within Reach (in Dutch: stichting Zorg Binnen
   Bereik). The authors disclosed receipt of the following financial
   support for the research, authorship, and/or publication of this paper:
   the study has been funded by foundation Care Within Reach (in Dutch:
   stichting Zorg Binnen Bereik).
CR Amante DJ, 2014, DIABETES TECHNOL THE, V16, P784, DOI 10.1089/dia.2014.0078
   [Anonymous], 1998, WELL BEING IND 1998
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   Bech P., 2004, QUALITY LIFE NEWSLET, V32, P15
   Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0
   Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387
   Boshuizen D., 2014, PATIENTENPORTAAL WER
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Curry SJ, 2007, AM J PREV MED, V32, pS127, DOI 10.1016/j.amepre.2007.01.026
   Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11
   Flynn D, 2009, INT J MED INFORM, V78, P588, DOI 10.1016/j.ijmedinf.2009.03.008
   Grol R, 2000, BRIT J GEN PRACT, V50, P882
   Gustafson DH, 2004, BRIT MED J, V328, P1150, DOI 10.1136/bmj.328.7449.1150
   Hesse BW, 2007, AM J PREV MED, V32, pS97, DOI 10.1016/j.amepre.2007.01.019
   Hjelm NM, 2005, J TELEMED TELECARE, V11, P60, DOI 10.1258/1357633053499886
   Ko H, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.037531
   Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nijland N, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1603
   Osborn CY, 2010, CURR DIABETES REP, V10, P422, DOI 10.1007/s11892-010-0151-1
   Poortvliet M., 2007, OMVANG RISICOFACTORE
   Roelofsen Yvonne, 2014, J Diabetes Sci Technol, V8, P230
   Roelofsen Y, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-22
   Ronda MCM, 2013, DIABETES TECHNOL THE, V15, P556, DOI 10.1089/dia.2013.0023
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Sarkar U, 2011, J AM MED INFORM ASSN, V18, P318, DOI [10.1136/jamia.2010.006015, 10.1136/amiajnl.2010.006015]
   Sarkar U, 2010, J HEALTH COMMUN, V15, P183, DOI 10.1080/10810730.2010.499988
   Sieverink Floor, 2014, J Diabetes Sci Technol, V8, P247
   Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025
   Tenforde M, 2012, J GEN INTERN MED, V27, P420, DOI 10.1007/s11606-011-1889-0
   Tenforde M, 2011, FAM MED, V43, P351
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van Vugt M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-53
   Verhoeven Fenne, 2010, J Diabetes Sci Technol, V4, P666
   Wangberg Silje C, 2008, Patient Prefer Adherence, V2, P57
   Whitten PS, 2002, BRIT MED J, V324, P1434, DOI 10.1136/bmj.324.7351.1434
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   Zhai YK, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000312
NR 38
TC 1
Z9 1
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2016
AR 6343927
DI 10.1155/2016/6343927
PG 16
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA DE5YM
UT WOS:000370709300001
PM 26682232
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hofmann, M
   Dack, C
   Barker, C
   Murray, E
AF Hofmann, Megan
   Dack, Charlotte
   Barker, Chris
   Murray, Elizabeth
TI The Impact of an Internet-Based Self-Management Intervention
   (HeLP-Diabetes) on the Psychological Well-Being of Adults with Type 2
   Diabetes: A Mixed-Method Cohort Study
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; POOR GLYCEMIC CONTROL; METABOLIC-CONTROL;
   PROGRAM; DEPRESSION; EDUCATION; ANXIETY; MELLITUS; OUTCOMES; PATIENT
AB This mixed-method study assessed the impact of an internet-based, self-management intervention ("HeLP-Diabetes") on the psychological well-being of adults with type 2 diabetes. Nineteen participants were recruited from 3 general practices. Data were collected at baseline and at 6 weeks follow-up. Access to HeLP-Diabetes was associated with a significant decrease in participants' diabetes-related distress (Z = 2.04, p = 0.04, and d = 0.28). No significant differences were found in emotional distress or self-efficacy. The qualitative data found that participants reported improvements including increased self-efficacy and support, better management of low mood, greater diabetes awareness, and taking the condition more seriously. Participants also reported making improvements to their eating habits, exercise routine, and medical management. Some negative experiences associated with using the intervention were mentioned including feelings of guilt for not using the intervention as suggested or not making any behavioral changes, as well as technical and navigational frustrations with the intervention. Internet-based self-management interventions may have the potential to decrease diabetes-related distress in people with type 2 diabetes. The qualitative data also suggests internet interventions can positively impact both psychological and behavioural outcomes of adults with type 2 diabetes.
C1 [Hofmann, Megan; Barker, Chris] UCL, Dept Clin Educ & Hlth Psychol, Gower St, London WC1E 6BT, England.
   [Dack, Charlotte] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.
   [Murray, Elizabeth] UCL, Res Dept Primary Care & Populat Hlth, Royal Free Hosp, Upper Floor 3,Rowland Hill St, London NW3 2PF, England.
RP Dack, C (reprint author), Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.
EM c.n.dack@bath.ac.uk
RI Barker, Chris/C-2193-2008
OI Barker, Chris/0000-0002-9268-9356
FU National Institute for Health Research (NIHR) under Programme Grants for
   Applied Research Programme [RP-PG-0609-10135]
FX This paper presents independent research funded by the National
   Institute for Health Research (NIHR) under its Programme Grants for
   Applied Research Programme (Grant Reference no. RP-PG-0609-10135). The
   views expressed are those of the author(s) and not necessarily those of
   the NHS, the NIHR, or the Department of Health.
CR Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barker C, 2005, AM J COMMUN PSYCHOL, V35, P201, DOI 10.1007/s10464-005-3398-y
   Beverly EA, 2012, J GEN INTERN MED, V27, P1180, DOI 10.1007/s11606-012-2070-0
   Dack C., J MED INTERNET UNPUB
   Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x
   Diabetes UK, 2012, DIAB UK 2012 KEY STA
   Diabetes UK, 2010, DIAB UK 2010 KEY STA
   Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x
   Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Fonda Stephanie J, 2009, J Diabetes Sci Technol, V3, P117
   Garay-Sevilla ME, 1999, DIABETIC MED, V16, P238, DOI 10.1046/j.1464-5491.1999.00033.x
   Glasgow RE, 2003, PREV MED, V36, P410, DOI 10.1016/S0091-7435(02)00056-7
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   ISRCTN Registry, 2013, WEB BAS SELF MAN PRO
   Kerr C, 2005, J TELEMED TELECARE, V11, P32, DOI 10.1258/1357633054461912
   Khunti K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2333
   Lorig K, 2010, DIABETES CARE, V33, P1275, DOI 10.2337/dc09-2153
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   Mathew R, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-122
   National Collaborating Centre for Chronic Conditions (UK), 2008, TYP 2 DIAB NAT CLIN
   National Diabetes Audit, 2012, NAT DIAB AUD 2010 20
   Nicolucci A, 1996, DIABETES CARE, V19, P927, DOI 10.2337/diacare.19.9.927
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Object Planet, 2014, OP
   Pal K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008776.pub2
   Peel E, 2004, PATIENT EDUC COUNS, V53, P269, DOI 10.1016/j.pec.2003.07.010
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46
   QSR International, 2012, AB QSR
   Quinn CC, 2008, DIABETES TECHNOL THE, V10, P160, DOI 10.1089/dia.2008.0283
   RUBIN RR, 1989, DIABETES CARE, V12, P673, DOI 10.2337/diacare.12.10.673
   Russell LB, 2005, J FAM PRACTICE, V54, P52
   Stun J, 2010, PRIM HEALTH CARE RES, V11, P374, DOI DOI 10.1017/S1463423610000101
   Tankova T, 2004, PATIENT EDUC COUNS, V53, P285, DOI 10.1016/j.pec.2003.09.013
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   van der Molen B, 1999, EUR J CANCER CARE, V8, P238
   Wangberg SC, 2008, HEALTH EDUC RES, V23, P170, DOI 10.1093/her/cym014
   Williams C., 2015, LIVING LIFE FULL
   Ziebland S, 2012, MILBANK Q, V90, P219, DOI 10.1111/j.1468-0009.2012.00662.x
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 49
TC 3
Z9 3
U1 2
U2 13
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2016
AR 1476384
DI 10.1155/2016/1476384
PG 13
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA DD9MP
UT WOS:000370250200001
PM 26682226
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hagger, V
   Hendrieckx, C
   Sturt, J
   Skinner, TC
   Speight, J
AF Hagger, Virginia
   Hendrieckx, Christel
   Sturt, Jackie
   Skinner, Timothy C.
   Speight, Jane
TI Diabetes Distress Among Adolescents with Type 1 Diabetes: a Systematic
   Review
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Adolescent; Type 1 diabetes; Emotions; Psychological stress; Distress;
   Review
ID QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; METABOLIC-CONTROL;
   GLYCEMIC CONTROL; STRUCTURED EDUCATION; DEPRESSIVE SYMPTOMS; EMOTIONAL
   DISTRESS; INTENSIVE THERAPY; PROBLEM AREAS; YOUNG-PEOPLE
AB Diabetes distress (DD) refers to the negative emotions arising from living with diabetes and the burden of self-management. Among adults, the prevalence and significance of DD are well established, but this is not the case among adolescents. This systematic review investigated among adolescents with type 1 diabetes: the prevalence of DD; demographic, clinical, behavioral and psychosocial correlates of DD and interventions that reduce DD. Consistent with adult studies, around one third of adolescents experience elevated DD and this is frequently associated with suboptimal glycemic control, low self-efficacy and reduced self-care. Three measures of DD have been developed specifically for adolescents, as those designed for adults may not be sufficiently sensitive to adolescent concerns. Interventions reducing DD in the short term include strategies such as cognitive restructuring, goal setting and problem solving. Further work is needed to investigate sustainability of effect. Rigorous research is needed to progress this field among adolescents.
C1 [Hagger, Virginia; Hendrieckx, Christel; Speight, Jane] Diabet Victoria, Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Hagger, Virginia; Hendrieckx, Christel; Speight, Jane] Deakin Univ, Sch Psychol, Ctr Social & Early Emot Dev, Burwood, Vic, Australia.
   [Sturt, Jackie] Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, 57 Waterloo Rd, London SE1 8WA, England.
   [Skinner, Timothy C.] Charles Darwin Univ, Sch Psychol & Clin Sci, Casuarina, NT 0811, Australia.
   [Speight, Jane] AHP Res, Hornchurch, Essex, England.
RP Hagger, V (reprint author), Diabet Victoria, Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.; Hagger, V (reprint author), Deakin Univ, Sch Psychol, Ctr Social & Early Emot Dev, Burwood, Vic, Australia.
EM vhagger@deakin.edu.au; chendrieckx@acbrd.org.au; jackie.sturt@kcl.ac.uk;
   Timothy.Skinner@cdu.edu.au; jspeight@acbrd.org.au
OI Speight, Jane/0000-0002-1204-6896; Skinner, Timothy/0000-0002-0018-6963
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596.807874, DOI 10.1176/APPI.BOOKS.9780890425596.807874]
   Berlin KS, 2012, J PEDIATR PSYCHOL, V37, P990, DOI 10.1093/jpepsy/jss080
   Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950
   BOARDWAY RH, 1993, J PEDIATR PSYCHOL, V18, P29, DOI 10.1093/jpepsy/18.1.29
   Boland EA, 1999, DIABETES EDUCATOR, V25, P31, DOI 10.1177/014572179902500105
   Boland EA, 1999, DIABETES CARE, V22, P1779, DOI 10.2337/diacare.22.11.1779
   BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313
   Brierley S, 2012, DIABETIC MED, V29, P59
   Byrne M, 2012, DIABETES RES CLIN PR, V98, P243, DOI 10.1016/j.diabres.2012.09.017
   Cohen J, 1988, STAT POWER ANAL BEHA
   Davidson M, 2004, APPL NURS RES, V17, P72, DOI 10.1016/j.apnr.2004.02.006
   DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3
   Delamater AM, 2013, PEDIATR DIABETES, V14, P50, DOI 10.1111/j.1399-5448.2012.00894.x
   Delamater AM, 1988, 9 ANN M BEH MED BOST
   Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377
   Ellis DA, 2005, PEDIATRICS, V116, pE826, DOI 10.1542/peds.2005-0638
   Ellis DA, 2007, J CONSULT CLIN PSYCH, V75, P168, DOI 10.1037/0022-006X.75.1.168
   Esbitt SA, 2013, SCREENING DEPRESSION, P27
   Farrell S., 2000, THESIS U WISCONSIN M
   Farrell SP, 2004, J ADOLESCENT HEALTH, V34, P461, DOI 10.1016/S1054-139X(03)00215-5
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Franklin MD, 2008, THESIS VANDERBILT U
   Gage H, 2004, PATIENT EDUC COUNS, V53, P333, DOI 10.1016/j.pec.2003.06.003
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Gregory JW, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15290
   Grey M, 1998, DIABETES CARE, V21, P902, DOI 10.2337/diacare.21.6.902
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Grey M, 1999, APPL NURS RES, V12, P3, DOI 10.1016/S0897-1897(99)80123-2
   Grey M, 1999, DIABETES EDUCATOR, V25, P934
   Grey M, 1998, DIABETES CARE, V21, P909, DOI 10.2337/diacare.21.6.909
   Hains AA, 2006, DIABETES CARE, V29, P818, DOI 10.2337/diacare.29.04.06.dc05-1828
   Hains AA, 2000, DIABETES EDUCATOR, V26, P417, DOI 10.1177/014572170002600309
   Hains AA, 2001, J PEDIATR PSYCHOL, V26, P61, DOI 10.1093/jpepsy/26.1.61
   Hains AA, 2007, J PEDIATR PSYCHOL, V32, P561, DOI 10.1093/jpepsy/jsl040
   Hains AA, 2009, J PEDIATR PSYCHOL, V34, P97, DOI 10.1093/jpepsy/jsn041
   Hampson SE, 2000, DIABETES CARE, V23, P1416, DOI 10.2337/diacare.23.9.1416
   Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Herzer M, 2010, J PEDIATR PSYCHOL, V35, P415, DOI 10.1093/jpepsy/jsp063
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Hood KK, 2007, DIABETES CARE, V30, P1764, DOI 10.2337/dc06-2358
   Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579
   Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x
   Kibbey KJ, 2013, DIABETIC MED, V30, P878, DOI 10.1111/dme.12227
   KOVACS M, 1986, DIABETES CARE, V9, P472, DOI 10.2337/diacare.9.5.472
   Law GU, 2013, J PSYCHOSOM RES, V74, P334, DOI 10.1016/j.jpsychores.2012.12.009
   Lerman-Garber I, 2003, SALUD PUBLICA MEXICO, V45, P13, DOI 10.1590/s0036-36342003000100002
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   McNamara R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-36
   Murphy HR, 2007, DIABETIC MED, V24, P1261, DOI 10.1111/j.1464-5491.2007.02229.x
   Murphy HR, 2006, DIABETIC MED, V23, P935, DOI 10.1111/j.1464-5491.2005.01816.x
   Nouwen A, 2009, PSYCHOL HEALTH, V24, P1071, DOI 10.1080/08870440802254597
   Pallayova Maria, 2014, Diabetes Spectr, V27, P143, DOI 10.2337/diaspect.27.2.143
   Peinemann F, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008216.pub4, 10.1371/journal.pmed.1000097, 10.1136/bmj.c869, 10.1136/bmj.b2535, 10.1016/j.jclinepi.2010.02.006, 10.1002/14651858.CD008242.pub3, 10.1016/j.jclinepi.2010.03.004]
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Reynolds KA, 2011, ANN BEHAV MED, V42, P29, DOI 10.1007/s12160-011-9262-4
   Robling M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2359
   Salamon KS, 2010, PRIM CARE DIABETES, V4, P47, DOI 10.1016/j.pcd.2009.10.003
   Serlachius A., 2011, THESIS U MELBOURNE
   Serlachius AS, 2016, J HEALTH PSYCHOL, V21, P1157, DOI 10.1177/1359105314547940
   Silverman AH, 2003, J CLIN PSYCHOL MED S, V10, P119, DOI 10.1023/A:1023346222153
   Singh Emma, 2013, Int J Adolesc Med Health, V25, P91, DOI 10.1515/ijamh-2013-0013
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Speight J, 2011, DIABETES MILES AUSTR
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sturt J, 2015, INT DIAB NURS, V12, P40, DOI DOI 10.1179/2057332415Y.0000000004
   Sturt J, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0660-z
   Twenge JM, 2002, J ABNORM PSYCHOL, V111, P578, DOI 10.1037//0021-843X.111.4.578
   Vacha-Haase T, 2004, J COUNS PSYCHOL, V51, P473, DOI 10.1037/0022-0167.51.4.473
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Wagner Julie A, 2005, Health Qual Life Outcomes, V3, P38, DOI 10.1186/1477-7525-3-38
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Williams LB, 2009, DIABETIC MED, V26, P908, DOI 10.1111/j.1464-5491.2009.02794.x
   Young V, 2013, PSYCHOL HLTH S1, V28, P1
NR 81
TC 28
Z9 28
U1 3
U2 26
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD JAN
PY 2016
VL 16
IS 1
AR 9
DI 10.1007/s11892-015-0694-2
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DC5JB
UT WOS:000369256200002
PM 26748793
DA 2019-01-08
ER

PT J
AU Kasteleyn, MJ
   Vos, RC
   Rijken, M
   Schellevis, FG
   Rutten, GEHM
AF Kasteleyn, M. J.
   Vos, R. C.
   Rijken, M.
   Schellevis, F. G.
   Rutten, G. E. H. M.
TI Effectiveness of tailored support for people with Type 2 diabetes after
   a first acute coronary event: a multicentre randomized controlled trial
   (the Diacourse-ACE study)
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; HEALTH-STATUS; MYOCARDIAL-INFARCTION; CARE; DISTRESS;
   QUESTIONNAIRE; INTERVENTION; SATISFACTION; VALIDATION; DISCHARGE
AB AimsTo evaluate the effectiveness of a tailored, supportive intervention strategy in influencing diabetes-related distress, health status, well-being and clinical outcomes in people with Type 2 diabetes shortly after a first acute coronary event.
   MethodsPeople with Type 2 diabetes and a recent first acute coronary event (n=201) were randomized to the intervention group (three home visits by a diabetes nurse) or the attention control group (one telephone consultation). Outcomes were measured after discharge (baseline) and at 5months (follow-up) using validated questionnaires for diabetes-related distress (Problem Areas in Diabetes), well-being (WHO Well-Being Index) and health status (Euroqol 5 Dimensions; Euroqol Visual Analogue Scale). ancova was used to analyse change-over-time differences between groups.
   ResultsFollow-up data were available for 81 participants in the intervention group (66.09.3years, 76% male) and 80 in the control group (65.69.4years, 75% male) participants. Mean diabetes-related distress was low after hospital discharge (intervention group: 8.210.1; control group: 9.212.4) and did not change after 5months (intervention group: 9.212.4; control group: 9.0 +/- 11.2). Baseline well-being was less favourable but improved significantly in the intervention group (baseline: 58.5 +/- 28.0; follow-up: 65.5 +/- 23.7; P=0.005), but not in the control group (baseline: 57.5 +/- 25.2; follow-up: 59.6 +/- 24.4; P=0.481). Health status also improved in the intervention group (baseline: 69.9 +/- 17.3; follow-up: 76.8 +/- 15.6; P<0.001) but not in the control group (baseline: 68.6 +/- 15.9; follow-up: 69.9 +/- 16.7; P=0.470). A significant group effect was found for health status (F=7.9; P=0.006).
   ConclusionsAlthough the intervention had no effect on diabetes-related distress, this might be at least partially attributable to very low levels of diabetes-related distress at baseline. Interestingly, health status scores and well-being, which were less favourable at baseline, both improved after the tailored support intervention.
C1 [Kasteleyn, M. J.; Vos, R. C.; Rutten, G. E. H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Rijken, M.; Schellevis, F. G.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands.
   [Schellevis, F. G.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands.
RP Kasteleyn, MJ (reprint author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
EM M.J.Kasteleyn@umcutrecht.nl
OI Kasteleyn, Marise/0000-0001-7751-7516
FU Dutch Diabetes Research Foundation (Diabetes Fonds) [2009.70]
FX This study was funded by the Dutch Diabetes Research Foundation
   (Diabetes Fonds) 2009.70. The foundation's international review
   committee critically reviewed the design of the Dutch Diacourse Study
   and discussed it with the authors before grant assignment. The authors
   are entirely responsible for the conduct of the study, all study
   analyses, and the drafting and editing of the manuscript.
CR Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Boersma E, 2002, CARDIOVASCULAR DIS E
   Boter H, 2003, BRIT MED J, V327, P284, DOI 10.1136/bmj.327.7409.284
   Buunk A. P., 1996, GEDRAG GEZONDHEID, V24, P304
   Cleveringa FGW, 2010, DIABETIC MED, V27, P442, DOI 10.1111/j.1464-5491.2010.02968.x
   Cossette S, 2002, INT J NURS STUD, V39, P479, DOI 10.1016/S0020-7489(01)00051-7
   Dalteg T, 2011, EUR J CARDIOVASC NUR, V10, P140, DOI 10.1016/j.ejcnurse.2011.01.006
   de Raaij EJ, 2012, MANUAL THER, V17, P330, DOI 10.1016/j.math.2012.03.001
   FrasureSmith N, 1997, LANCET, V350, P473, DOI 10.1016/S0140-6736(97)02142-9
   Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302
   Ho PM, 2014, JAMA INTERN MED, V174, P186, DOI 10.1001/jamainternmed.2013.12944
   HOLM S, 1979, SCAND J STAT, V6, P65
   Kasteleyn MJ, 2014, PRIM CARE DIABETES, V8, P195, DOI 10.1016/j.pcd.2013.12.001
   Kasteleyn MJ, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-5
   Leventhal H, 2008, HDB PSYCHOL HLTH, VVI, P219
   Lindquist R, 2007, J NURS SCHOLARSHIP, V39, P214, DOI 10.1111/j.1547-5069.2007.00171.x
   Nv Ven, 2003, DIABETES CARE, V26, P713
   Peterson Pamela N, 2006, BMC Cardiovasc Disord, V6, P41, DOI 10.1186/1471-2261-6-41
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   Rutten GEHM, 2014, LANCET DIABETES ENDO, V2, P191, DOI 10.1016/S2213-8587(13)70122-0
   Schuz B, 2012, PSYCHOL HEALTH, V27, P13, DOI 10.1080/08870446.2010.541908
   Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van den Donk M, 2013, DIABETOLOGIA, V56, P2367, DOI 10.1007/s00125-013-3011-0
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Wennberg P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000760
   Wermeling PR, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-107
   Wermeling PR, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-121
   Wu CJ, 2008, J CLIN NURS, V17, P16, DOI 10.1111/j.1365-2702.2006.01926.x
NR 32
TC 3
Z9 3
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JAN
PY 2016
VL 33
IS 1
BP 125
EP 133
DI 10.1111/dme.12816
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DC7RP
UT WOS:000369418300018
PM 26031804
DA 2019-01-08
ER

PT J
AU Lasaite, L
   Ostrauskas, R
   Zalinkevicius, R
   Jurgeviciene, N
   Radzeviciene, L
AF Lasaite, Lina
   Ostrauskas, Rytas
   Zalinkevicius, Rimantas
   Jurgeviciene, Nijole
   Radzeviciene, Lina
TI Diabetes distress in adult type 1 diabetes mellitus men and women with
   disease onset in childhood and in adulthood
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Childhood-onset type 1 diabetes mellitus; Adulthood-onset type 1
   diabetes mellitus; Diabetes distress; Gender-specific differences;
   Diabetes Distress Scale
ID SERIOUS PSYCHOLOGICAL DISTRESS; QUALITY-OF-LIFE; GLYCEMIC CONTROL;
   CLINICAL DEPRESSION; SEX-DIFFERENCES; EMOTIONAL DISTRESS; YOUNG-ADULTS;
   HEALTH; ASSOCIATION; ADOLESCENTS
AB The aim: To determine whether or not diabetes distress varies by age of type 1 diabetes mellitus (T1DM) onset and/or gender.
   Subjects and Methods: A total of 700 adult T1DM patients were randomly selected from the Lithuanian Diabetes Registry; 214 of them (30.6%) agreed to participate and were recruited for the study. Diabetes distress (emotional burden, physician-related distress, regimen-related distress, interpersonal distress) was compared in 105 (42 men and 63 women) patients with T1DM diagnosed during 0-18 years of life, and in 109 (61 men and 48 women) with T1DM diagnosed in adulthood, using Diabetes Distress Scale (DDS).
   Results: Adult childhood-onset T1DM women have higher regimen-related distress (363 +/- 21.3 vs 26.6 +/- 16.2, p = 0.016) than adulthood-onset women. Adult childhood-onset T1DM women experience higher diabetes distress (higher emotional burden (27.0 +/- 22.0 vs 15.6 +/- 16.4, p = 0.006), physician-related distress (34.4 +/- 33.9 vs 20.7 +/- 29.4, p = 0.024), total diabetes distress (41.2 +/- 13.6 vs 34.8 +/- 10.9, p = 0.011)) than childhood-onset men.
   Adulthood-onset T1DM women experience higher physician-related distress (39.2 +/- 37.6 vs 23.4 +/- 32.5, p = 0.013), but lower regimen-related distress (26.6 +/- 16.2 vs 35.8 +/- 21.6, p = 0.014) than adulthood-onset men.
   In conclusion our findings reinforce the interdependence of psychological and biomedical factors in influencing health outcomes and support the need to provide psychological assessment and support to patients with T1DM. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Lasaite, Lina; Ostrauskas, Rytas; Zalinkevicius, Rimantas; Jurgeviciene, Nijole; Radzeviciene, Lina] Lithuanian Univ Hlth Sci, Inst Endocrinol, Kaunas, Lithuania.
RP Lasaite, L (reprint author), LSMU, Inst Endocrinol, Eiveniu 2, LT-50009 Kaunas, Lithuania.
EM linlasla@yahoo.com
FU Research Council of Lithuania, National Research Program of
   Noncommunicable Diseases [LIG-10019/LIG-06/2010]
FX The study was financially supported by the Research Council of
   Lithuania, National Research Program of Noncommunicable Diseases,
   contract number: LIG-10019/LIG-06/2010.
CR Ascher-Svanum H, 2015, DIABETES THER, V6, P303, DOI 10.1007/s13300-015-0118-y
   Barry CM, 2009, J ADULT DEV, V16, P209, DOI 10.1007/s10804-009-9067-x
   BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215
   Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011
   Chan O, 2001, ENDOCRINOLOGY, V142, P4872, DOI 10.1210/en.142.11.4872
   de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Eriksson AK, 2008, DIABETIC MED, V25, P831
   Esbitt SA, 2013, SCREENING DEPRESSION, P27
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Funnell MM, 2006, CLIN DIABETES, V24, P154
   GAFVELS C, 1993, DIABETIC MED, V10, P768, DOI 10.1111/j.1464-5491.1993.tb00162.x
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   GORTMAKER SL, 1990, PEDIATRICS, V85, P267
   Helgeson VS, 2010, HEALTH PSYCHOL, V29, P153, DOI 10.1037/a0018163
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Holt RIG, 2014, DIABETES CARE, V37, P2067, DOI 10.2337/dc13-2134
   Kendler KS, 2005, AM J PSYCHIAT, V162, P250, DOI 10.1176/appi.ajp.162.2.250
   Li CY, 2010, DIABETES CARE, V33, P1061, DOI 10.2337/dc09-1515
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Luyckx K, 2009, DIABETES CARE, V32, P797, DOI 10.2337/dc08-1990
   Matthews S, 1999, SOC SCI MED, V48, P49, DOI 10.1016/S0277-9536(98)00288-3
   METSCH J, 1995, INT J BEHAV MED, V2, P104, DOI 10.1207/s15327558ijbm0202_2
   Nakaya N, 2014, EUR J PUBLIC HEALTH, V24, P45, DOI 10.1093/eurpub/ckt017
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037//0033-2909.101.2.259
   Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Sharma AN, 2014, PEDIATR DIABETES, V15, P444, DOI 10.1111/pedi.12108
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Trento M, 2014, ACTA DIABETOL, V51, P509, DOI 10.1007/s00592-013-0530-6
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   *WHO, 1989, REPR HLTH AD STRAT A, P1
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
NR 48
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JAN-FEB
PY 2016
VL 30
IS 1
BP 133
EP 137
DI 10.1016/j.jdiacomp.2015.09.012
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DB5QH
UT WOS:000368568200024
PM 26490756
DA 2019-01-08
ER

PT J
AU Martyn-Nemeth, P
   Farabi, SS
   Mihailescu, D
   Nemeth, J
   Quinn, L
AF Martyn-Nemeth, Pamela
   Farabi, Sarah Schwarz
   Mihailescu, Dan
   Nemeth, Jeffrey
   Quinn, Laurie
TI Fear of hypoglycemia in adults with type 1 diabetes: impact of
   therapeutic advances and strategies for prevention - a review
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Review
DE Type 1 diabetes; Adults; Fear; Hypoglycemia; Review
ID QUALITY-OF-LIFE; SUBCUTANEOUS INSULIN INFUSION; RANDOMIZED
   CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; MULTIPLE DAILY INJECTIONS;
   AUGMENTED PUMP THERAPY; TREATMENT SATISFACTION; METABOLIC-CONTROL;
   GLYCEMIC CONTROL; EMERGING ADULTS
AB Purpose: This review summarizes the current state of the science related to fear of hypoglycemia (FOH) in adults with type 1 diabetes. Fear of hypoglycemia is a critical deterrent to diabetes self-management, psychological well-being, and quality of life. We examine the influence of contemporary treatment regimens, technology, and interventions to identify gaps in knowledge and opportunities for research and practice.
   Basic Procedures: A literature search was conducted of MEDLINE, PsycINFO, and EMBASE. Fifty-three studies that examined fear of hypoglycemia were included.
   Main Findings: Fear of hypoglycemia influences diabetes management and quality of life. Gender and age differences exist in experiences and responses. Responses vary from increased vigilance to potentially immobilizing distress. Fear of hypoglycemia is greater at night and may contribute to poor sleep quality. Strategies to reduce fear of hypoglycemia have had varying success. Newer technologies hold promise but require further examination.
   Conclusions: Fear of hypoglycemia remains a problem, despite advances in technology, insulin analogs, and evidence-based diabetes management. Clinical care should consistently include assessment for its influence on diabetes self-management and psychological health. Further research is needed regarding the influence of newer technologies and individualized strategies to reduce fear of hypoglycemia while maintaining optimal glucose control. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Martyn-Nemeth, Pamela; Farabi, Sarah Schwarz; Quinn, Laurie] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, 845 S Damen Ave MC 802, Chicago, IL 60612 USA.
   [Mihailescu, Dan] Univ Illinois, Dept Med, Chicago, IL 60612 USA.
   [Nemeth, Jeffrey] Edward Hosp & Hlth Ctr, Linden Oaks, Naperville, IL 60540 USA.
RP Martyn-Nemeth, P (reprint author), Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, 845 S Damen Ave MC 802, Chicago, IL 60612 USA.
EM pmartyn@uic.edu; sschwa24@uic.edu; danmih@uic.edu;
   jeffreymnemeth@lewisu.edu; lquinn1@uic.edu
CR Adolphs R, 2013, CURR BIOL, V23, pR79, DOI 10.1016/j.cub.2012.11.055
   Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Ortiz MTA, 2011, PSYCHOL ASSESSMENT, V23, P398, DOI 10.1037/a0021927
   Anderbro T, 2010, DIABETIC MED, V27, P1151, DOI 10.1111/j.1464-5491.2010.03078.x
   Anderbro T, 2008, PATIENT EDUC COUNS, V73, P127, DOI 10.1016/j.pec.2008.03.022
   Anderbro T, 2015, ACTA DIABETOL, V52, P581, DOI 10.1007/s00592-014-0694-8
   Barnard Katharine, 2012, J Diabetes Sci Technol, V6, P144
   Barnard KD, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000025
   Barnard KD, 2008, PRACT DIABETES INT, V25, P194
   Bazzazian S, 2012, PSYCHOL HEALTH MED, V17, P47, DOI 10.1080/13548506.2011.575168
   Beck RW, 2010, DIABETES CARE, V33, P2175, DOI 10.2337/dc10-0331
   Belendez M, 2009, CHRONIC ILLN, V5, P250, DOI 10.1177/1742395309346464
   Bohme P, 2013, DIABETES METAB, V39, P63, DOI 10.1016/j.diabet.2012.10.006
   Bott U, 1998, DIABETOLOGIA, V41, pA74
   Bott U, 1998, DIABETES CARE, V21, P757, DOI 10.2337/diacare.21.5.757
   Boyle S, 2004, BEHAV RES THER, V42, P357, DOI 10.1016/j.brat.2003.11.006
   Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720
   Brod Meryl, 2012, J Med Econ, V15, P77, DOI 10.3111/13696998.2011.624144
   Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007
   Costea M, 1993, Rom J Intern Med, V31, P291
   Cox D, 2008, DIABETES CARE, V31, P1527, DOI 10.2337/dc07-1956
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Cox DJ, 2001, DIABETES CARE, V24, P637, DOI 10.2337/diacare.24.4.637
   COX DJ, 1990, DIABETES CARE, V13, P458, DOI 10.2337/diacare.13.4.458
   Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9
   Cryer PE, 2014, DIABETES, V63, P2188, DOI 10.2337/db14-0059
   Currie CJ, 2006, CURR MED RES OPIN, V22, P1523, DOI 10.1185/030079906X115757
   Davey RJ, 2012, PRIM CARE DIABETES, V6, P35, DOI 10.1016/j.pcd.2011.09.004
   Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109
   Desjardins K, 2014, DIABETES OBES METAB, V16, P577, DOI 10.1111/dom.12232
   Diedrich L, 2002, CLIN AUTON RES, V12, P358, DOI 10.1007/s10286-002-0035-9
   Fulcher Gregory, 2014, J Med Econ, V17, P751, DOI 10.3111/13696998.2014.946992
   George JT, 2008, DIABETIC MED, V25, P1447, DOI 10.1111/j.1464-5491.2008.02607.x
   Gjerlow E, 2014, NURS RES, V63, P143, DOI 10.1097/NNR.0000000000000020
   Goebel-Fabbri AE, 2008, DIABETES CARE, V31, P415, DOI 10.2337/dc07-2026
   Gold AE, 1997, DIABETIC MED, V14, P309
   Gonder-Frederick LA, 2013, DIABETIC MED, V30, P603, DOI 10.1111/dme.12129
   Gonder-Frederick L. C., 2011, HYPOGLYCEMIA FEAR SU
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Gonzalez-Molero I, 2012, J TELEMED TELECARE, V18, P328, DOI 10.1258/jtt.2012.120103
   Graue M., 2013, Norsk Epidemiologi, V23, P75
   Green L, 2000, DIABETES METAB RES, V16, P287, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR123>3.3.CO;2-K
   Halford J, 2010, DIABETES TECHNOL THE, V12, P201, DOI 10.1089/dia.2009.0121
   Hanna KM, 2014, DIABETES EDUCATOR, V40, P533, DOI 10.1177/0145721714528997
   Hanna KM, 2013, DIABETES EDUCATOR, V39, P92, DOI 10.1177/0145721712465341
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Hermanides J, 2011, DIABETIC MED, V28, P1158, DOI 10.1111/j.1464-5491.2011.03256.x
   Irvine A., 1994, FEAR HYPOGLYCEMIA SC
   IRVINE AA, 1992, HEALTH PSYCHOL, V11, P135, DOI 10.1037/0278-6133.11.2.135
   Ismail K, 2008, ANN INTERN MED, V149, P708, DOI 10.7326/0003-4819-149-10-200811180-00005
   Jacobson AM, 2007, NEW ENGL J MED, V356, P1842
   Karges B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001742
   Kilgus M., 2009, ESSENTIAL PSYCHOPATH
   Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033
   Lawton J, 2013, DIABETIC MED, V30, P209, DOI 10.1111/dme.12007
   Leelarathna L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006075
   Leiter LA, 2005, CAN J DIABETES, V29, P1
   Linkeschova R, 2002, DIABETIC MED, V19, P746, DOI 10.1046/j.1464-5491.2002.00713.x
   Little SA, 2014, DIABETES CARE, V37, P2114, DOI 10.2337/dc14-0030
   Martyn-Nemeth P, 2014, DIABETES, V63, pA208
   Martyn-Nemeth P, 2014, ACTA DIABETOL, V51, P683, DOI 10.1007/s00592-014-0575-1
   McCoy RG, 2013, ENDOCR PRACT, V19, P792, DOI 10.4158/EP12382.OR
   Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078
   Nicolucci A, 2008, DIABETIC MED, V25, P213, DOI 10.1111/j.1464-5491.2007.02346.x
   Nixon R, 2011, DIABETES TECHNOL THE, V13, P93, DOI 10.1089/dia.2010.0192
   O'Connell SM, 2011, DIABETES CARE, V34, P2379, DOI 10.2337/dc11-0748
   POLONSKY WH, 1992, HEALTH PSYCHOL, V11, P199, DOI 10.1037/0278-6133.11.3.199
   Riaz M, 2014, PAK J MED SCI, V30, P233
   Richmond J, 1996, Br J Nurs, V5, P1054
   Rossi MC, 2013, DIABETES TECHNOL THE, V15, P670, DOI 10.1089/dia.2013.0021
   Rubin RR, 2012, DIABETES TECHNOL THE, V14, P143, DOI 10.1089/dia.2011.0162
   Schachinger H, 2005, J BEHAV MED, V28, P587, DOI 10.1007/s10865-005-9026-3
   Schmidt S, 2012, DIABETES TECHNOL THE, V14, P1174, DOI 10.1089/dia.2012.0148
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Tanenbaum ML, 2012, DIABETES EDUCATOR, V38, P695, DOI 10.1177/0145721712452795
   ter Braak EWMT, 2000, DIABETES CARE, V23, P1467, DOI 10.2337/diacare.23.10.1467
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977
   Walker Tomas C, 2014, J Diabetes Sci Technol, V8, P488, DOI 10.1177/1932296814528434
   WEINER MF, 1979, INT J PSYCHIAT MED, V9, P281, DOI 10.2190/NBJ2-NT0R-D8GN-K2TE
   Zander H, 2014, PRACT DIABETES, V31, P161, DOI 10.1002/pdi.1854
   Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795
NR 82
TC 20
Z9 20
U1 2
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JAN-FEB
PY 2016
VL 30
IS 1
BP 167
EP 177
DI 10.1016/j.jdiacomp.2015.09.003
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DB5QH
UT WOS:000368568200030
PM 26439754
DA 2019-01-08
ER

PT J
AU Abubakari, AR
   Cousins, R
   Thomas, C
   Sharma, D
   Naderali, EK
AF Abubakari, Abdul-Razak
   Cousins, Rosanna
   Thomas, Cecil
   Sharma, Dushyant
   Naderali, Ebrahim K.
TI Sociodemographic and Clinical Predictors of Self-Management among People
   with Poorly Controlled Type 1 and Type 2 Diabetes: The Role of Illness
   Perceptions and Self-Efficacy
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID MYOCARDIAL-INFARCTION; MEDICATION ADHERENCE; CARE; HEALTH;
   INTERVENTIONS; QUESTIONNAIRE; DISTRESS; SCALE; REPRESENTATION;
   ADOLESCENTS
AB Self-management is critical if people with diabetes are to minimise their risk of macrovascular and microvascular complications, yet adherence to self-management recommendations is suboptimal. Understanding the predictors of optimal diabetes self-management in specific populations is needed to inform effective interventions. This study investigated the role of demographic and clinical characteristics, illness perceptions, and self-efficacy in explaining adherence to self-management recommendations among people with poorly controlled diabetes in North West of England. Illness perceptions and self-efficacy data were collected using validated questionnaires and clinical data were obtained from hospital records. Correlations were used to investigate bivariate relationships between independent variables and self-management, and multiple regression techniques were used to determine demographic and psychosocial predictors of self-management. Various demographic and clinical characteristics were associated with adherence to self-management recommendations. In particular, employment status explained 11% of the variation in adherence to foot care whilst diabetes treatment category explained 9% of exercise and 21% of the variations in SMBG recommendations. Also, 22% and 8% of the variations in overall self-management were explained by illness perceptions and self-efficacy beliefs, respectively. Illness perceptions and self-efficacy beliefs of people with poorly controlled diabetes are important predictors of their self-management behaviours and could potentially guide effective interventions.
C1 [Abubakari, Abdul-Razak] Glasgow Caledonian Univ London, Sch Hlth & Life Sci, London E1 6PX, England.
   [Cousins, Rosanna; Naderali, Ebrahim K.] Liverpool Hope Univ, Liverpool L16 9JD, Merseyside, England.
   [Thomas, Cecil] Aintree Univ Teaching Hosp, Dept Endocrinol & Diabet, Liverpool L9 7AL, Merseyside, England.
   [Sharma, Dushyant] Royal Liverpool Univ Hosp, Dept Endocrinol & Diabet, Liverpool L7 8XP, Merseyside, England.
RP Abubakari, AR (reprint author), Glasgow Caledonian Univ London, Sch Hlth & Life Sci, London E1 6PX, England.
EM aab1@gcu.ac.uk
OI Cousins, Rosanna/0000-0003-4829-5138
FU Liverpool Hope University
FX The authors are grateful to all patients who participated in the study
   and to Liverpool Hope University for initial funding and sponsoring the
   study. They are also thankful to Asha Adan for initial secretarial work
   and literature search and Laadi Abdulai for help with preparation of
   questionnaires and study packs.
CR Abubakari A. R., 2011, DIABETES STOFFWECH H, V20, P424
   Abubakari A-R, 2011, J NURS HEALTHC CHRON, V3, P245, DOI DOI 10.1111/J.1752-9824.2011.01098.X
   Abubakari AR, 2013, INT J GEN MED, V6, P617, DOI 10.2147/IJGM.S46649
   American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Bean D, 2007, PSYCHOL HEALTH, V22, P787, DOI 10.1080/14768320600976240
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001
   Clark M, 2004, BRIT J HEALTH PSYCH, V9, P365, DOI 10.1348/1359107041557066
   Diefenbach MA, 1996, J SOC DISTRESS HOMEL, V5, P11, DOI 10.1007/BF02090456
   Fisher L, 2014, DIABETIC MED, V31, P739, DOI 10.1111/dme.12403
   Fitzpatrick SL, 2013, DIABETES RES CLIN PR, V100, P145, DOI 10.1016/j.diabres.2012.12.016
   French DP, 2006, J PSYCHOSOM RES, V61, P757, DOI 10.1016/j.jpsychores.2006.07.029
   Haas L, 2013, DIABETES CARE, V36, pS100, DOI 10.2337/dc13-S100
   Hunt CW, 2013, NURSING-RES REV, V3, P99, DOI 10.2147/NRR.S49406
   Iannotti RJ, 2006, J DEV BEHAV PEDIATR, V27, P98, DOI 10.1097/00004703-200604000-00003
   Keogh KM, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-36
   Law GU, 2013, J PSYCHOSOM RES, V74, P334, DOI 10.1016/j.jpsychores.2012.12.009
   Law GU, 2014, HEALTH PSYCHOL REV, V8, P362, DOI 10.1080/17437199.2012.747123
   Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425
   Leventhal HLBI, 2003, SELF REGULATION HLTH, P42
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lorig K, 2013, HEALTH EDUC BEHAV, V40, P67, DOI 10.1177/1090198112436969
   Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01
   Morrison G, 2013, J DIABETES NURSING, V17, P32
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x
   Nouwen A, 2009, PSYCHOL HEALTH, V24, P1071, DOI 10.1080/08870440802254597
   Panagioti M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-356
   Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536
   Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007
   Radhakrishnan K, 2012, J ADV NURS, V68, P496, DOI 10.1111/j.1365-2648.2011.05860.x
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   SMITH MS, 1995, HEALTH EDUC RES, V10, P51, DOI 10.1093/her/10.1.51
   Steed L, 2014, PSYCHOL HEALTH MED, V19, P536, DOI 10.1080/13548506.2013.845301
   Tabachnick B. G., 1996, USING MULTIVARIATE S
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker RJ, 2014, ETHNIC DIS, V24, P349
   Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y
   Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270
NR 40
TC 8
Z9 8
U1 5
U2 17
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2016
AR 6708164
DI 10.1155/2016/6708164
PG 12
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA DB2VK
UT WOS:000368368100001
PM 26697501
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Dill, EJ
   Manson, SM
   Jiang, L
   Pratte, KA
   Gutilla, MJ
   Knepper, SL
   Beals, J
   Roubideaux, Y
AF Dill, Edward J.
   Manson, Spero M.
   Jiang, Luohua
   Pratte, Katherine A.
   Gutilla, Margaret J.
   Knepper, Stephanie L.
   Beals, Janette
   Roubideaux, Yvette
CA Special Diabet Program Indians
TI Psychosocial Predictors of Weight Loss among American Indian and Alaska
   Native Participants in a Diabetes Prevention Translational Project
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID LIFE-STYLE INTERVENTION; RESERVATION COMMUNITIES; PSYCHOMETRIC
   EVALUATION; PSYCHOLOGICAL DISTRESS; FAMILY SUPPORT; DEPRESSION;
   SPIRITUALITY; MELLITUS; ADULTS; ASSOCIATION
AB The association of psychosocial factors (psychological distress, coping skills, family support, trauma exposure, and spirituality) with initial weight and weight loss among American Indians and Alaska Natives (AI/ANs) in a diabetes prevention translational project was investigated. Participants (n = 3,135) were confirmed as prediabetic and subsequently enrolled in the Special Diabetes Program for Indians Diabetes Prevention (SDPI-DP) demonstration project implemented at 36 Indian health care programs. Measures were obtained at baseline and after completing a 16-session educational curriculum focusing on weight loss through behavioral changes. At baseline, psychological distress and negative family support were linked to greater weight, whereas cultural spirituality was correlated with lower weight. Furthermore, psychological distress and negative family support predicted less weight loss, and positive family support predicted greater weight loss, over the course of the intervention. These bivariate relationships between psychosocial factors and weight remained statistically significant within a multivariate model, after controlling for sociodemographic characteristics. Conversely, coping skills and trauma exposure were not significantly associated with baseline weight or change in weight. These findings demonstrate the influence of psychosocial factors on weight loss in AI/AN communities and have substantial implications for incorporating adjunctive intervention components.
C1 [Dill, Edward J.] Univ Colorado, Dept Psychol, Denver, CO 80217 USA.
   [Manson, Spero M.; Pratte, Katherine A.; Gutilla, Margaret J.; Knepper, Stephanie L.; Beals, Janette; Special Diabet Program Indians] Univ Colorado, Colorado Sch Publ Hlth, Ctr Amer Indian & Alaska Native Hlth, Aurora, CO 80045 USA.
   [Jiang, Luohua] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92697 USA.
   [Roubideaux, Yvette] Indian Hlth Serv, Off Director, Rockville, MD 20852 USA.
RP Dill, EJ (reprint author), Univ Colorado, Dept Psychol, Denver, CO 80217 USA.
EM edward.dill@ucdenver.edu
FU Indian Health Service [HHSI242200400049C]; National Institute of
   Diabetes and Digestive and Kidney Diseases [1P30DK092923]; American
   Diabetes Association (ADA) [7-12-CT-36]
FX Funding for this project was provided by the Indian Health Service
   (HHSI242200400049C to S. M. Manson). Study preparation was supported in
   part by the National Institute of Diabetes and Digestive and Kidney
   Diseases (1P30DK092923 to S. M. Manson) and American Diabetes
   Association (ADA no. 7-12-CT-36 to L. Jiang). The authors are grateful
   to the IHS as well as the tribal and urban Native American health
   programs and participants involved in the SDPI-DP. Grant programs
   participating in the Special Diabetes Program for Indians Diabetes
   Prevention Demonstration Project are as follows: Confederated Tribes of
   the Chehalis Reservation, the Cherokee Nation, Cheyenne River Sioux
   Tribe, the Chickasaw Nation, Coeur d'Alene Tribe, Colorado River Indian
   Tribes, Colville Confederated Tribes, Cow Creek Band of Umpqua Tribe,
   Fond du Lac Reservation, Gila River Health Care, Haskell Health Center,
   Ho-Chunk Nation, Hunter Health, Indian Health Board of Minneapolis,
   Indian Health Center of Santa Clara Valley, Kenaitze Indian Tribe IRA,
   Lawton IHS Service Unit, Menominee Indian Tribe of Wisconsin,
   Mississippi Band of Choctaw Indians, Native American Rehabilitation
   Association of the NW, Norton Sound Health Corporation, Pine Ridge IHS
   Service Unit, Pueblo of San Felipe, the Quinault Indian Nation, Rapid
   City IHS Diabetes Program, Red Lake Comprehensive Health Services, Rocky
   Boy Health Board, the Seneca Nation of Indians, Sonoma County Indian
   Health Project, South East Alaska Regional Health Consortium,
   Southcentral Foundation, Trenton Indian Service Area, Tuba City Regional
   Health Care Corporation, United American Indian Involvement, Inc.,
   United Indian Health Services, Inc., Warm Springs Health and Wellness
   Center, Winnebago Tribe of Nebraska, and Zuni Pueblo.
CR Brown T. A., 2006, CONFIRMATORY FACTOR
   Campayo A, 2011, CURR PSYCHIAT REP, V13, P26, DOI 10.1007/s11920-010-0165-z
   Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038
   Centers for Disease Control and Prevention, 2012, DIAB REP CARD 2012
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V52, P702
   Cohen J, 1988, STAT POWER ANAL BEHA
   Delahanty LM, 2013, DIABETES CARE, V36, P34, DOI 10.2337/dc12-0733
   Delgado C, 2007, J NURS SCHOLARSHIP, V39, P229, DOI 10.1111/j.1547-5069.2007.00173.x
   Demakakos P, 2010, DIABETES CARE, V33, P792, DOI 10.2337/dc09-1663
   Enders CK, 2010, APPL MISSING DATA AN
   Epple C, 2003, DIABETES CARE, V26, P2829, DOI 10.2337/diacare.26.10.2829
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Garroutte EM, 2003, SOC SCI MED, V56, P1571, DOI 10.1016/S0277-9536(02)00157-0
   Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530
   Holden L, 2010, AUST NZ J PUBL HEAL, V34, P304, DOI 10.1111/j.1753-6405.2010.00531.x
   Hosmer DWLS, 2013, APPL LOGISTIC REGRES
   Jacob MM, 2013, J DIABETES COMPLICAT, V27, P553, DOI 10.1016/j.jdiacomp.2013.07.008
   Jiang LH, 2008, DIABETES CARE, V31, P427, DOI 10.2337/dc07-2044
   Jiang L, 2007, DIABETES CARE, V30, P2228, DOI 10.2337/dc07-0097
   Jiang LH, 2015, PREV SCI, V16, P41, DOI 10.1007/s11121-013-0451-1
   Jiang LH, 2013, DIABETES CARE, V36, P2027, DOI 10.2337/dc12-1250
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Kyrios M, 2009, MED J AUSTRALIA, V190, pS81
   Lewin AB, 2005, J CLIN PSYCHOL MED S, V12, P315, DOI 10.1007/s10880-005-7817-x
   Lipton R, 2003, ARCH PEDIAT ADOL MED, V157, P919, DOI 10.1001/archpedi.157.9.919
   Little T., 2006, HDB PERSONALITY DEV
   Little T. D., 2013, LONGITUDINAL STRUCTU
   Lynch CP, 2012, DIABETES EDUCATOR, V38, P427, DOI 10.1177/0145721712440335
   McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mokdad AH, 2001, DIABETES CARE, V24, P1508, DOI 10.2337/diacare.24.8.1508-a
   Muthen L. K., 1998, MPLUS USERS GUIDE
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Pinelli NR, 2011, ETHNIC DIS, V21, P480
   Polzer R, 2005, J HOLIST NURS, V23, P230, DOI 10.1177/0898010105276179
   Pratt Laura A, 2007, Adv Data, P1
   Ritsher JB, 2002, PSYCHIAT RES, V111, P199, DOI 10.1016/S0165-1781(02)00135-X
   Roberts H, 2009, ETHNIC DIS, V19, P276
   Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144
   Spicer P, 2007, SOUTH MED J, V100, P430, DOI 10.1097/SMJ.0b013e318031715c
   *US CENS BUR, 2002, AM IND AL NAT POP 20
   Walker EA, 2007, DIABETES EDUCATOR, V33, P103, DOI 10.1177/0145721706298198
   Wen LK, 2004, FAM MED, V36, P423
NR 46
TC 3
Z9 3
U1 0
U2 12
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2016
AR 1546939
DI 10.1155/2016/1546939
PG 10
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA DA7FZ
UT WOS:000367971300001
PM 26649314
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Cummings, DM
   Kirian, K
   Howard, G
   Howard, V
   Yuan, Y
   Muntner, P
   Kissela, B
   Redmond, N
   Judd, SE
   Safford, MM
AF Cummings, Doyle M.
   Kirian, Kari
   Howard, George
   Howard, Virginia
   Yuan, Ya
   Muntner, Paul
   Kissela, Brett
   Redmond, Nicole
   Judd, Suzanne E.
   Safford, Monika M.
TI Consequences of Comorbidity of Elevated Stress and/or Depressive
   Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results From
   the REasons for Geographic And Racial Differences in Stroke (REGARDS)
   Study
SO DIABETES CARE
LA English
DT Article
ID CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; MEDICATION
   ADHERENCE; GLYCEMIC CONTROL; FOLLOW-UP; DISTRESS; RISK; WOMEN;
   METAANALYSIS; MELLITUS
AB OBJECTIVE
   To evaluate the impact of comorbid depressive symptoms and/or stress on adverse cardiovascular (CV) outcomes in individuals with diabetes compared with those without diabetes.
   RESEARCH DESIGN AND METHODS
   Investigators examined the relationship between baseline depressive symptoms and/or stress in adults with and without diabetes and physician-adjudicated incident CV outcomes including stroke, myocardial infarction/acute coronary heart disease, and CV death over a median follow-up of 5.95 years in the national REGARDS cohort study.
   RESULTS
   Subjects included 22,003 adults (4,090 with diabetes) (mean age 64 years, 58% female, 42% black, and 56% living in the southeastern "Stroke Belt"). Elevated stress and/or depressive symptoms were more common in subjects with diabetes (36.8% vs. 29.5%; P < 0.001). In fully adjusted models, reporting either elevated stress or depressive symptoms was associated with a significantly increased incidence of stroke (HR 1.57 [95% CI 1.05, 2.33] vs. 1.01 [0.79, 1.30]) and CV death (1.53 [1.08, 2.17] vs. 1.12 [0.90, 1.38]) in subjects with diabetes but not in those without diabetes. The combination of both elevated stress and depressive symptoms in subjects with diabetes was associated with a higher incidence of CV death (2.15 [1.33, 3.47]) than either behavioral comorbidity alone (1.53 [1.08, 2.17]) and higher than in those with both elevated stress and depressive symptoms but without diabetes (1.27 [0.86, 1.88]).
   CONCLUSIONS
   Comorbid stress and/or depressive symptoms are common in individuals with diabetes and together are associated with progressively increased risks for adverse CV outcomes.
C1 [Cummings, Doyle M.; Kirian, Kari] E Carolina Univ, Brody Sch Med, Dept Family Med, Greenville, NC 27858 USA.
   [Cummings, Doyle M.; Kirian, Kari] E Carolina Univ, Brody Sch Med, Diabet & Obes Inst, Greenville, NC USA.
   [Howard, George; Yuan, Ya; Judd, Suzanne E.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA.
   [Howard, Virginia; Muntner, Paul] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.
   [Kissela, Brett] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA.
   [Redmond, Nicole; Safford, Monika M.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA.
RP Cummings, DM (reprint author), E Carolina Univ, Brody Sch Med, Dept Family Med, Greenville, NC 27858 USA.
EM cummingsd@ecu.edu
OI CUMMINGS, DOYLE/0000-0002-8237-7885; Kissela, Brett/0000-0002-9773-4013;
   Howard, George/0000-0002-3068-5720; Redmond, Nicole/0000-0001-7298-5804
FU National Institute of Neurological Disorders and Stroke, National
   Institutes of Health (NIH); U.S. Department of Health and Human Services
   [U01-NS-041588]; NIH [P30-DK-093002, HL R01080477, K24 HL111154]
FX This research project is supported by a cooperative agreement from the
   National Institute of Neurological Disorders and Stroke, National
   Institutes of Health (NIH), and the U.S. Department of Health and Human
   Services (U01-NS-041588). D.M.C. is also supported by NIH grant
   P30-DK-093002. S.E.J. is also supported by the following NIH grants: HL
   R01080477 and K24 HL111154. N.R. is also supported by NIH grant HL
   R01080477.
CR American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344
   Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atgersclerosis.2004.08.035
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Coleman SM, 2013, PSYCHOSOMATICS, V54, P428, DOI 10.1016/j.psym.2013.02.015
   Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678
   Katon WJ, 2013, ANN FAM MED, V11, P245, DOI 10.1370/afm.1501
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Lin EHB, 2012, ANN FAM MED, V10, P6, DOI 10.1370/afm.1343
   Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024
   *NAT CHOL ED PROGR, 2002, NIH PUBL
   Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   Pizzi C, 2014, ATHEROSCLEROSIS, V233, P530, DOI 10.1016/j.atherosclerosis.2014.01.012
   Plante GE, 2005, METABOLISM, V54, P45, DOI 10.1016/j.metabol.2005.01.013
   Prineas R, 2010, MINNESOTA CODE MANUA
   Prineas R. J, 1982, MINNESOTA CODE MANUA
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Redmond N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000447
   SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1
   Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060
   WHO Task Force on Stroke and other Cerebrovascular Disorders: Stroke-1989, 1989, STROKE, V20, P1407
NR 38
TC 21
Z9 21
U1 0
U2 7
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JAN
PY 2016
VL 39
IS 1
BP 101
EP 109
DI 10.2337/dc15-1174
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CZ8EA
UT WOS:000367331800031
PM 26577418
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Doherty, AM
   Gayle, C
   Morgan-Jones, R
   Archer, N
   Laura-Lee
   Ismail, K
   Werner, A
AF Doherty, Anne M.
   Gayle, Carol
   Morgan-Jones, Ruth
   Archer, Nicola
   Laura-Lee
   Ismail, Khalida
   Werner, Anne
TI Improving quality of diabetes care by integrating psychological and
   social care for poorly controlled diabetes: 3 Dimensions of Care for
   Diabetes
SO INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
LA English
DT Article
DE Quality improvement; patient-centred care; diabetes; psychosomatic
   medicine; psychology
ID DEPRESSION; NONADHERENCE; METAANALYSIS; POPULATION; MORTALITY; DISTRESS;
   MELLITUS; GLUCOSE; ANXIETY; PEOPLE
AB Objective Many people with persistent suboptimal diabetes control also have psychiatric morbidity and social problems which interfere with their ability to self-manage their diabetes. Current models of care in the UK do not integrate these different dimensions of care or address inequalities between physical and mental health. 3DFD (3 Dimensions of Care For Diabetes) integrated medical, psychological, and social care in diabetes for patients with persistent suboptimal glycemic control (HbA1c>75mmol/mol) despite guideline-based routine diabetes care, to improve glycemic control, reduce psychological distress, and improve social functioning.
   Methods The service delivered interventions including brief psychological therapies, mental health assessments, psychotropic medications, and social support, enhanced by patient-led case conferences aiming to optimize diabetes care. 3DFD measured changes in HbA1c, psychological functioning, quality of life, rates of unscheduled care, and levels of engagement with routine diabetes care at baseline and at 12 months.
   Conclusion At 12-month follow-up, 3DFD patients achieved significant reductions in HbA1c of 15mmol/mol, International Federation of Clinical Chemistry (1.4% Diabetes Control and Complications Trial) and improvements in depression scores and patient satisfaction. This model of care demonstrates that integrated care can improve diabetes outcomes in people with psychological and social comorbidities.
C1 [Doherty, Anne M.; Gayle, Carol; Ismail, Khalida; Werner, Anne] Kings Coll Hosp London, London SE5 9RS, England.
   [Morgan-Jones, Ruth] HearSay Charitable Trust, London, England.
   [Archer, Nicola] East London NHS Fdn Trust, Community Neurol Serv, London, England.
   [Laura-Lee] ThamesReach, London, England.
RP Doherty, AM (reprint author), Kings Coll Hosp London, Dept Diabet, Denmark Hill, London SE5 9RS, England.
EM anne.doherty@kcl.ac.uk
OI Herrmann-Werner, Anne/0000-0003-2413-7047
FU NHS London Innovation Fund; King's College Hospital NHS Foundation Trust
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by funding from the NHS London Innovation Fund and King's
   College Hospital NHS Foundation Trust.
CR Albrecht JS, 2012, AM J MED QUAL, V27, P503, DOI 10.1177/1062860612436576
   Allen D, 2009, DIABETIC MED, V23, P162
   Darzi L, 2007, HEALTHCARE LONDON FR
   Department of Health, PAYM RES NHS TAR 201
   Diabetes UK, 2011, DIAB UK 2011 12 KEY
   Diabetes UK and NHS Diabetes, 2010, EM PSYCH SUPP CAR DI
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Kadirvelu A, 2012, DIABETES METAB SYNDR, V5, P407, DOI 10.2147/DMSO.S37183
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346
   Medical Research Council, 2008, DEV EVALUATING COMPL
   NHS, 2009, DIAB GUID LOND
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Osborn CY, 2012, GEN HOSP PSYCHIAT, V34, P249, DOI 10.1016/j.genhosppsych.2012.01.015
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rouch I, 2012, AGING CLIN EXP RES, V24, P377
   Saydah SH, 2013, DIABETES CARE, V36, P49, DOI 10.2337/dc11-1864
   Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Think public, 2011, THINK PUBLIC FINDING
   Trigwell P, 2008, PROVISION PSYCHOL SU
   Turner RC, 1998, LANCET, V352, P837
   Viana LV, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-47
   WING RR, 1991, J CONSULT CLIN PSYCH, V59, P156, DOI 10.1037/0022-006X.59.1.156
   Winkley K, 2013, DIABETOLOGIA, V56, P1272, DOI 10.1007/s00125-013-2873-5
   Young V., 2012, DIABETIC MED, V30, P189
NR 30
TC 2
Z9 2
U1 1
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0091-2174
EI 1541-3527
J9 INT J PSYCHIAT MED
JI Int. J. Psychiatr. Med.
PD JAN
PY 2016
VL 51
IS 1
BP 3
EP 15
DI 10.1177/0091217415621040
PG 13
WC Psychiatry
SC Psychiatry
GA CZ6WJ
UT WOS:000367241400001
PM 26681232
DA 2019-01-08
ER

PT J
AU Briana, DD
   Baka, S
   Boutsikou, M
   Boutsikou, T
   Xagorari, M
   Gourgiotis, D
   Malamitsi-Puchner, A
AF Briana, Despina D.
   Baka, Stavroula
   Boutsikou, Maria
   Boutsikou, Theodora
   Xagorari, Marieta
   Gourgiotis, Dimitrios
   Malamitsi-Puchner, Ariadne
TI Cord blood copeptin concentrations in fetal macrosomia
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE Copeptin; AVP; Insulin; Cord blood; Fetal macrosomia
ID METABOLIC SYNDROME; BIRTH-WEIGHT; DIABETES-MELLITUS; PLASMA COPEPTIN;
   INSULIN-RESISTANCE; GESTATIONAL-AGE; VASOPRESSIN RESPONSES; VAGINAL
   DELIVERY; BORN LARGE; OBESITY
AB Background/aim. Excessive fetal growth is associated with increased adiposity and reduced insulin sensitivity at birth. Copeptin, a surrogate marker of arginine vasopressin (AVP) secretion, is upregulated in states of hyperinsulinemia and is considered one of the mediators of insulin resistance. We aimed to investigate cord blood concentrations of copeptin (C-terminal fragment of AVP pro-hormone) in healthy large-for-gestational-age (LGA) infants at term.
   Methods. This prospective study was conducted on 30 LGA (n = 30) and 20 appropriatefor-gestational-age (AGA, n = 20) singleton full-term healthy infants. Cord blood copeptin and insulin concentrations were determined by ELISA and IRMA, respectively. Infants were classified as LGA or AGA, based on customized birth-weight standards adjusted for significant determinants of fetal growth.
   Results. Cord blood copeptin concentrations were similar in LGA cases, compared to AGA controls, after adjusting for delivery mode. However, in the LGA group, cord blood copeptin concentrations positively correlated with birth-weight (r = 0.422, p = 0.020). In the AGA group, cord blood copeptin concentrations were elevated in cases of vaginal delivery vs elective cesarean section (p = 0.003). Cord blood insulin concentrations were higher in LGA cases, compared to AGA controls (p = 0.036). No association was recorded between cord blood copeptin concentrations and maternal age, parity, gestational age or fetal gender in both groups.
   Conclusions. Cord blood copeptin concentrations may not be up-regulated in non-distressed LGA infants. However, the positive correlation between cord blood copeptin concentrations and birth-weight in the LGA group may point to the documented association between AVP release and increased fat deposition. Vaginal delivery vs elective cesarean section is accompanied by a marked stress-related increase of cord blood copeptin concentrations. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Briana, Despina D.; Baka, Stavroula; Boutsikou, Maria; Boutsikou, Theodora; Malamitsi-Puchner, Ariadne] Univ Athens, Sch Med, Dept Neonatol, GR-11527 Athens, Greece.
   [Xagorari, Marieta; Gourgiotis, Dimitrios] Univ Athens, Sch Med, Dept Pediat 2, Lab Clin Biochem Mol Diagnost, GR-11527 Athens, Greece.
RP Malamitsi-Puchner, A (reprint author), 19 Soultani St, Athens 10682, Greece.
EM amalpu@aretaieio.uoa.gr
CR Abu-Basha EA, 2002, METABOLISM, V51, P1184, DOI 10.1053/meta.2002.34052
   Asferg CL, 2014, DIABETIC MED, V31, P728, DOI 10.1111/dme.12411
   Benzing J, 2011, J CLIN ENDOCR METAB, V96, pE982, DOI 10.1210/jc.2010-2858
   Bhandari SS, 2009, CLIN SCI, V116, P257, DOI 10.1042/CS20080140
   Bjorntorp P, 1999, ANN NY ACAD SCI, V892, P297, DOI 10.1111/j.1749-6632.1999.tb07803.x
   Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808
   Borruto F, 2006, Clin Exp Obstet Gynecol, V33, P219
   BRAY GA, 1987, ANN NY ACAD SCI, V499, P14, DOI 10.1111/j.1749-6632.1987.tb36194.x
   Briana DD, 2010, ANN NY ACAD SCI, V1205, P82, DOI 10.1111/j.1749-6632.2010.05650.x
   Briana DD, 2009, EUR J ENDOCRINOL, V160, P337, DOI 10.1530/EJE-08-0621
   Burckhardt MA, 2014, J CLIN ENDOCR METAB, V99, pE1750, DOI 10.1210/jc.2014-2244
   CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0
   Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077
   Chiesa C, 2008, CLIN CHEM, V54, P550, DOI 10.1373/clinchem.2007.095299
   Choong K, 2008, PEDIATR CRIT CARE ME, V9, P372, DOI 10.1097/PCC.0b013e318172d7c8
   Dyer JS, 2007, J CLIN ENDOCR METAB, V92, P3836, DOI 10.1210/jc.2007-0079
   Eidelman AI, 2002, SEMIN PERINATOL, V26, P232, DOI 10.1053/sper.2002.34215
   Enhorning S, 2013, INT J OBESITY, V37, P598, DOI 10.1038/ijo.2012.88
   Enhorning S, 2011, J CLIN ENDOCR METAB, V96, pE1065, DOI 10.1210/jc.2010-2981
   Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663
   Espineira AR, 2011, CLIN ENDOCRINOL, V75, P335, DOI 10.1111/j.1365-2265.2011.04054.x
   Evagelidou EN, 2006, DIABETES CARE, V29, P1197, DOI 10.2337/dc05-2401
   Evagelidou EN, 2010, DIABETES CARE, V33, P2468, DOI 10.2337/dc10-1190
   Eyzaguirre F, 2012, J PEDIATR ENDOCR MET, V25, P51, DOI [10.1515/JPEM.2011.446, 10.1515/jpem.2011.446]
   Foda AA, 2012, EUR J OBSTET GYN R B, V165, P215, DOI 10.1016/j.ejogrb.2012.08.012
   FOWDEN AL, 1989, J DEV PHYSIOL, V12, P173
   GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x
   HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248
   Johnsson IW, 2015, PEDIATR OBES, V10, P77, DOI 10.1111/ijpo.230
   KEPPENS S, 1979, BIOCHIM BIOPHYS ACTA, V588, P63, DOI 10.1016/0304-4165(79)90371-4
   L'Abate P, 2013, RESP PHYSIOL NEUROBI, V185, P222, DOI 10.1016/j.resp.2012.10.011
   LEFFLER CW, 1987, AM J PHYSIOL, V252, pR122
   Lepercq J., 2000, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V29, P6
   Li HP, 2013, INT J CLIN EXP PATHO, V6, P650
   Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038
   Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002
   PHILIPPS AF, 1984, J CLIN INVEST, V74, P279, DOI 10.1172/JCI111412
   Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951
   RAFF H, 1991, AM J PHYSIOL, V260, pR1077
   ROFE AM, 1983, BIOCHEM J, V212, P899, DOI 10.1042/bj2120899
   Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007
   Saleem U, 2009, J CLIN ENDOCR METAB, V94, P2558, DOI 10.1210/jc.2008-2278
   Schlapbach LJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-38
   Simental-Mendia LE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-94
   SPRUCE BA, 1985, CLIN ENDOCRINOL, V22, P463, DOI 10.1111/j.1365-2265.1985.tb00145.x
   Tenderenda-Banasiuk E, 2014, PEDIATR NEPHROL, V29, P423, DOI 10.1007/s00467-013-2683-5
   Treschan TA, 2006, ANESTHESIOLOGY, V105, P599, DOI 10.1097/00000542-200609000-00026
   Wellmann S, 2010, J CLIN ENDOCR METAB, V95, P5091, DOI 10.1210/jc.2010-1331
   WHITTON PD, 1978, BIOCHEM J, V176, P893, DOI 10.1042/bj1760893
   WILCOX AJ, 1983, INT J EPIDEMIOL, V12, P319, DOI 10.1093/ije/12.3.319
   ZERBE RL, 1979, DIABETES, V28, P503, DOI 10.2337/diabetes.28.5.503
NR 51
TC 5
Z9 5
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD JAN
PY 2016
VL 65
IS 1
BP 89
EP 94
DI 10.1016/j.metabol.2015.09.018
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CZ2TN
UT WOS:000366957600010
PM 26477270
DA 2019-01-08
ER

PT J
AU Wagner, J
   Bermudez-Millan, A
   Damio, G
   Segura-Perez, S
   Chhabra, J
   Vergara, C
   Perez-Escamilla, R
AF Wagner, Julie
   Bermudez-Millan, Angela
   Damio, Grace
   Segura-Perez, Sofia
   Chhabra, Jyoti
   Vergara, Cunegundo
   Perez-Escamilla, Rafael
TI Community health workers assisting Latinos manage stress and diabetes
   (CALMS-D): rationale, intervention design, implementation, and process
   outcomes
SO TRANSLATIONAL BEHAVIORAL MEDICINE
LA English
DT Article
DE Diabetes; Stress management; Latinos; Community health workers
ID AFRICAN-AMERICAN; ADULTS; TRIAL; DISPARITIES; PROGRAM; QUESTIONNAIRE;
   PEOPLE; WOMEN
AB Latinos have high rates of diabetes and mental distress, but lack appropriate services. A study was designed to compare enhanced standard diabetes care with enhanced standard care plus community health worker (CHW) delivered stress management for Latinos with type 2 diabetes. This paper reports intervention design and process outcomes. A formative process was used to develop and implement an eight-session, group stress management intervention. One hundred twenty-one participants completed baseline assessments; n= 107 attended diabetes education and were then randomized. Recruits reported high credibility and treatment expectancies. Treatment fidelity was high. Participants reported high treatment satisfaction and therapeutic alliance and their diabetes knowledge and affect improved over the short term. Retention and attendance at group sessions was challenging but successful relative to similar trials. This comprehensive and culturally sensitive stress management intervention, delivered by a well-trained CHW, was successfully implemented.
C1 [Wagner, Julie; Bermudez-Millan, Angela] Univ Connecticut, Ctr Hlth, Farmington, CT USA.
   [Damio, Grace; Segura-Perez, Sofia] Hispan Hlth Council, Hartford, CT USA.
   [Chhabra, Jyoti; Vergara, Cunegundo] Hartford Hosp, Hartford, CT 06115 USA.
   [Perez-Escamilla, Rafael] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
RP Wagner, J (reprint author), Univ Connecticut, Ctr Hlth, Farmington, CT USA.
EM juwagner@uchc.edu
FU National Institute of Minority Health and Health Disparities
   [5R01MD005879-03]; Chicago Center for Diabetes Translation Research;
   American Diabetes Association [7-13-TS-31]; National Institutes of
   Minority Health and Health Disparities [5 R01 MD005879-03]
FX This was an investigator-initiated study funded by a grant from the
   National Institute of Minority Health and Health Disparities
   (5R01MD005879-03). The study was also partially supported by a small
   grant from the Chicago Center for Diabetes Translation Research. JW is
   supported by a grant from the American Diabetes Association
   (#7-13-TS-31). The funders played no role in the design, conduct, or
   analysis of the study, nor in the interpretation and reporting of the
   study findings. The researchers were independent from the funders. All
   authors had access to all of the data (including statistical reports and
   tables) in the study and can take responsibility for the integrity of
   the data and the accuracy of the data analysis.; This study was
   supported by a grant from the National Institutes of Minority Health and
   Health Disparities 5 R01 MD005879-03.
CR Aikens JE, 1997, DIABETES CARE, V20, P1111, DOI 10.2337/diacare.20.7.1111
   Beck J. S., 2011, COGNITIVE BEHAV THER
   Bermudez-Millan A, 2011, J HEALTH CARE POOR U, V22, P1315, DOI 10.1353/hpu.2011.0108
   BUDMAN SH, 1989, PSYCHIATRY, V52, P339, DOI 10.1080/00332747.1989.11024456
   Castillo A, 2010, DIABETES EDUCATOR, V36, P586, DOI 10.1177/0145721710371524
   Cherrington A, 2010, ETHNIC DIS, V20, P189
   Cooper LA, 2003, MED CARE, V41, P479, DOI 10.1097/00005650-200304000-00004
   de Vibe M, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-107
   Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4
   Esposito-Del Puente A, 1994, INT J OBESITY, V18, P766
   EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905
   Feathers JT, 2007, DIABETES EDUCATOR, V33, P509, DOI 10.1177/0145721707301371
   Hawkins J, 2013, DIABETES EDUCATOR, V39, P647, DOI 10.1177/0145721713492569
   Hayes SC, 2011, ANNU REV CLIN PSYCHO, V7, P141, DOI 10.1146/annurev-clinpsy-032210-104449
   Interian A, 2007, PSYCHIAT SERV, V58, P1591, DOI 10.1176/appi.ps.58.12.1591
   Jiang HJ, 2005, AM J PUBLIC HEALTH, V95, P1561, DOI 10.2105/AJPH.2004.044222
   Kirk JK, 2008, DIABETES CARE, V31, P240, DOI 10.2337/dc07-0382
   Kollannoor-Samuel G, 2011, J IMMIGR MINOR HEALT, V13, P982, DOI 10.1007/s10903-011-9499-9
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Martin MA, 2011, ETHNIC DIS, V21, P7
   McGinnis RA, 2005, DIABETES CARE, V28, P2145, DOI 10.2337/diacare.28.9.2145
   Melnik TA, 2004, AM J PUBLIC HEALTH, V94, P434, DOI 10.2105/AJPH.94.3.434
   Perez-Escamilla R, 2015, DIABETES CARE, V38, P197, DOI 10.2337/dc14-0327
   Peyrot M, 2014, CURR MED RES OPIN, V30, P2241, DOI 10.1185/03007995.2014.947023
   Reinschmidt Kerstin M, 2007, Prev Chronic Dis, V4, pA101
   Roman LA, 2009, ARCH WOMEN MENT HLTH, V12, P379, DOI 10.1007/s00737-009-0083-4
   RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Selye H., 1956, STRESS LIFE
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   van Son J, 2014, J PSYCHOSOM RES, V77, P81, DOI 10.1016/j.jpsychores.2014.03.013
   Vincent D, 2013, DIABETES EDUCATOR, V39, P222, DOI 10.1177/0145721713475842
NR 32
TC 7
Z9 7
U1 0
U2 4
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1869-6716
EI 1613-9860
J9 TRANSL BEHAV MED
JI Transl. Behav. Med.
PD DEC
PY 2015
VL 5
IS 4
BP 415
EP 424
DI 10.1007/s13142-015-0332-1
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DC0LV
UT WOS:000368909700006
PM 26622914
OA Green Published
DA 2019-01-08
ER

PT J
AU Kasteleyn, MJ
   de Vries, L
   van Puffelen, AL
   Schellevis, FG
   Rijken, M
   Vos, RC
   Rutten, GEHM
AF Kasteleyn, M. J.
   de Vries, L.
   van Puffelen, A. L.
   Schellevis, F. G.
   Rijken, M.
   Vos, R. C.
   Rutten, G. E. H. M.
CA Diacourse Study Grp
TI Diabetes-related distress over the course of illness: results from the
   Diacourse study
SO DIABETIC MEDICINE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; EMOTIONAL DISTRESS; PROBLEM AREAS; TYPE-2;
   SUPPORT; DEPRESSION; MELLITUS; CARE; OUTCOMES; ANXIETY
AB Aims To investigate the relationship between diabetes duration and diabetes-related distress and to examine the impact of micro-and macrovascular complications and blood glucose-lowering treatment on this relationship.
   Methods We conducted a cross-sectional study in people with Type 2 diabetes who participated in the Dutch Diacourse study (n = 590) and completed the Problem Areas in Diabetes questionnaire. Data on diabetes duration, micro-and macrovascular complications and blood glucose-lowering treatment were collected. Multiple linear regression analysis was used to investigate the association between diabetes duration and diabetes-related distress, and to examine whether complications and treatment could explain this association.
   Results A significant linear and quadratic association between diabetes duration and diabetes-related distress was found (duration: beta = 0.27, P = 0.005; duration(2) : beta = -0.21, P = 0.030). The association between duration and distress could be explained by microvascular complications and insulin treatment, which were both more often present in people with a longer diabetes duration, and were associated with higher levels of diabetes-related distress (beta = 0.20, P < 0.001 and beta = 0.16, P = 0.006 respectively). Duration, age, gender, complications and treatment together explained 13.1% of the variance in distress.
   Conclusions Diabetes duration was associated with diabetes-related distress. This association can be explained largely by the presence of diabetes-related microvascular complications and insulin treatment. Healthcare providers should focus on distress in people with Type 2 diabetes in different stages over the course of illness, especially when complications are present or when people are on insulin treatment. As well as diabetes duration, complications and blood glucose-lowering treatment, diabetes-related distress is likely to be influenced by many other factors.
C1 [Kasteleyn, M. J.; Vos, R. C.; Rutten, G. E. H. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [van Puffelen, A. L.; Schellevis, F. G.; Rijken, M.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands.
   [de Vries, L.; Schellevis, F. G.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands.
RP Kasteleyn, MJ (reprint author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
EM m.j.kasteleyn@umcutrecht.nl
OI Kasteleyn, Marise/0000-0001-7751-7516
FU Dutch Diabetes Research Foundation (Diabetes Fonds) [2009.70]
FX This study was funded by the Dutch Diabetes Research Foundation
   (Diabetes Fonds) 2009.70. Its International Review Committee critically
   reviewed the design of the Diacourse Study and discussed it with the
   authors before grant assignment. Only the authors are responsible for
   the conduct of the study, all study analyses, and the drafting and
   editing of the manuscript.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Carroll C, 2003, DIABETIC MED, V20, P355, DOI 10.1046/j.1464-5491.2003.00910.x
   de Vries L, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-21
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fonda Stephanie J, 2009, J Diabetes Sci Technol, V3, P117
   Grgurevic M, 2014, DIABETIC MED, V31, P247, DOI 10.1111/dme.12323
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB
   Karlsen B, 2014, INT J NURS STUD, V51, P438, DOI 10.1016/j.ijnurstu.2013.06.016
   Kasteleyn MJ, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-5
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   van Puffelen AL, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-144
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Wermeling PR, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-107
NR 26
TC 13
Z9 15
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD DEC
PY 2015
VL 32
IS 12
BP 1617
EP 1624
DI 10.1111/dme.12743
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DA3HJ
UT WOS:000367687500013
PM 25763843
DA 2019-01-08
ER

PT J
AU Friis, AM
   Johnson, MH
   Cutfield, RG
   Consedine, NS
AF Friis, A. M.
   Johnson, M. H.
   Cutfield, R. G.
   Consedine, N. S.
TI Does kindness matter? Self-compassion buffers the negative impact of
   diabetes-distress on HbA(1c)
SO DIABETIC MEDICINE
LA English
DT Article
ID GLYCEMIC CONTROL; SCREENING INSTRUMENT; DEPRESSION; HEALTH;
   INTERLEUKIN-6; VALIDITY; TYPE-1; PHQ-9
AB Background Higher self-compassion is associated with mental and physical health benefits in both healthy and chronically ill populations. The current study investigated the role of self-compassion in predicting depression, diabetes-specific distress and HbA(1c) in patients with diabetes.
   Aims To assess the specific operationalization of negative emotionality that best predicted HbA(1c) and to test whether self-compassion would buffer HbA(1c) in patients with diabetes against the negative effects of distress.
   Methods Patients with diabetes (n = 110) completed measures assessing trait self-compassion, depression and diabetes-distress. HbA(1c) results were obtained through medical records.
   Results As expected, diabetes-specific distress was a better predictor of HbA(1c) than depression; self-compassion moderated the relationship between distress and HbA(1c) such that higher distress predicted higher HbA(1c) at lower levels of self-compassion, but not at higher levels of self-compassion.
   Conclusions In addition to further demonstrating the link between distress and metabolic outcomes, these findings suggest that self-compassion might buffer patients from the negative metabolic consequences of diabetes-distress.
C1 [Friis, A. M.; Johnson, M. H.; Cutfield, R. G.; Consedine, N. S.] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand.
RP Consedine, NS (reprint author), Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand.
EM n.consedine@auckland.ac.nz
FU University of Auckland
FX The study was funded by the University of Auckland as part of PhD
   research by Anna Friis.
CR Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Breines JG, 2014, BRAIN BEHAV IMMUN, V37, P109, DOI 10.1016/j.bbi.2013.11.006
   Breines JG, 2012, PERS SOC PSYCHOL B, V38, P1133, DOI 10.1177/0146167212445599
   Cameron LDLH, 2003, SELF REGULATION HLTH
   Daubenmier J, 2014, PSYCHONEUROENDOCRINO, V48, P11, DOI 10.1016/j.psyneuen.2014.05.012
   Deniz ME, 2008, SOC BEHAV PERSONAL, V36, P1151, DOI 10.2224/sbp.2008.36.9.1151
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Golden SH, 2007, CURR DIABETES REV, V3, P252, DOI 10.2174/157339907782330021
   Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7
   Katon WJ, 2004, MED CARE, V42, P1222, DOI 10.1097/00005650-200412000-00009
   Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Neff K.D., 2003, SELF IDENTITY, V2, P223, DOI DOI 10.1080/15298860309027
   Neff KD, MINDFULNESS IN PRESS
   Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002
   Rocklin H, 2008, CLIN NEUROPSYCHIATR, V5, P132
   Rustad L, 2011, PSYCHONEUROIMMUNOLOG, V36, P1276
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   Snoek FJ, 2002, DIABETIC MED, V19, P265, DOI 10.1046/j.1464-5491.2002.00678.x
   Terry ML, 2013, PERS SOC PSYCHOL B, V39, P911, DOI 10.1177/0146167213488213
   Terry ML, 2011, SELF IDENTITY, V10, P352, DOI 10.1080/15298868.2011.558404
   Turner JE, 2002, EDUC PSYCHOL-US, V37, P79, DOI 10.1207/S15326985EP3702_3
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
NR 28
TC 8
Z9 8
U1 3
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD DEC
PY 2015
VL 32
IS 12
BP 1634
EP 1640
DI 10.1111/dme.12774
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DA3HJ
UT WOS:000367687500015
PM 25845983
DA 2019-01-08
ER

PT J
AU Richard, A
   Rohrmann, S
   Schmid, SM
   Tirri, BF
   Huang, DJ
   Guth, U
   Eichholzer, M
AF Richard, Aline
   Rohrmann, Sabine
   Schmid, Seraina M.
   Tirri, Brigitte Frey
   Huang, Dorothy J.
   Gueth, Uwe
   Eichholzer, Monika
TI Lifestyle and health-related predictors of cervical cancer screening
   attendance in a Swiss population-based study
SO CANCER EPIDEMIOLOGY
LA English
DT Article
DE Cervical cancer; Screening; Lifestyle; Health; Switzerland
ID BODY-MASS INDEX; COLORECTAL-CANCER; HUMAN-PAPILLOMAVIRUS; PREVENTIVE
   CARE; RISK-FACTORS; BREAST; WOMEN; OBESITY; SERVICES; MAMMOGRAPHY
AB Background: Since the implementation of cervical cancer (CC) screening, incidence and mortality rates have decreased worldwide. Little is known about lifestyle and health-related predictors of cervical cancer screening attendance in Switzerland. Our aim was to examine the relationship between lifestyle and health-related factors and the attendance to CC screening in Switzerland.
   Methods: We analyzed data of 20-69 years old women (n = 7319) of the Swiss Health Survey (SHS) 2012. Lifestyle factors included body mass index, smoking status, alcohol consumption, physical activity and attention to diet. Health-related factors of interest were diabetes, hypertension, high cholesterol levels, chronic diseases, self-perceived health, and psychological distress. We performed multivariable logistic regression analyses with the dichotomized CC screening status as outcome measure and adjusted for demographic factors.
   Results: Obesity, low physical activity, and not paying attention to diet were statistically significantly associated with lower CC screening participation. High cholesterol levels and history of chronic diseases were statistically significantly positively associated with screening participation.
   Conclusion: Being obese, physically inactive and non-attention to diet are risk factors for CC screening attendance. These findings are of importance for improving the CC screening practices of low-user groups. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Richard, Aline; Rohrmann, Sabine; Eichholzer, Monika] Univ Zurich, Epidemiol Biostat & Prevent Inst, Div Chron Dis Epidemiol, CH-8001 Zurich, Switzerland.
   [Schmid, Seraina M.] Spital Grabs, Dept Gynecol & Obstet, CH-9472 Grabs, Switzerland.
   [Schmid, Seraina M.] Breast Ctr St Gallen, CH-9006 St Gallen, Switzerland.
   [Tirri, Brigitte Frey] Cantonal Hosp Baselland, Dept Gynecol & Obstet, CH-4410 Liestal, Switzerland.
   [Huang, Dorothy J.] Univ Basel Hosp, Dept Gynecol & Obstet, CH-4031 Basel, Switzerland.
   [Gueth, Uwe] Cantonal Hosp Winterthur, Dept Gynecol & Obstet, CH-8401 Winterthur, Switzerland.
   [Gueth, Uwe] Breast Ctr Senosuisse, CH-8401 Winterthur, Switzerland.
RP Richard, A (reprint author), Univ Zurich, Epidemiol Biostat & Prevent Inst, Div Chron Dis Epidemiol, Hirschengraben 84, CH-8001 Zurich, Switzerland.
EM aline.richard@uzh.ch; Sabine.rohrmann@uzh.ch; Seraina.Schmid@srrws.ch;
   Brigitte.FreyTirri@ksbl.ch; Dorothy.Huang@usb.ch; uwe.Gueth@usb.ch
CR Abdullah ASM, 2001, PUBLIC HEALTH, V115, P212, DOI 10.1016/S0033-3506(01)00446-2
   Aggarwal A, 2013, AM J PREV MED, V44, P392, DOI 10.1016/j.amepre.2012.12.006
   Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001
   Arbeitsgruppe Guideline Zervixabstrich, 2005, Gynakol Geburtshilfliche Rundsch, V45, P44
   Arbyn M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092615
   Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016
   Bang JY, 2012, J PUBLIC HEALTH-UK, V34, P532, DOI 10.1093/pubmed/fds019
   BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008
   Borrayo EA, 2004, WOMEN HEALTH, V39, P13, DOI 10.1300/J013v39n02_02
   Brankovic I, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-14
   Breitenecker G, 2009, Pathologe, V30 Suppl 2, P128, DOI 10.1007/s00292-009-1189-1
   Bukowska-Durawa A, 2014, WSPOLCZESNA ONKOL, V18, P153, DOI 10.5114/wo.2014.43158
   Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003
   Bussiere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104901
   Byrne MM, 2010, CANCER EPIDEMIOL, V34, P611, DOI 10.1016/j.canep.2010.06.017
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Carruth AK, 2006, NURS RES, V55, P121, DOI 10.1097/00006199-200603000-00007
   Cohen SS, 2008, CANCER-AM CANCER SOC, V112, P1892, DOI [10.1002/cncr.23408, 10.1002/cncr23408]
   Coughlin SS, 1999, PREV MED, V29, P287, DOI 10.1006/pmed.1999.0537
   Coughlin SS, 2004, PREV CHRONIC DIS, V1, pA04
   de Quadros CAT, 2004, REV PANAM SALUD PUBL, V16, P223, DOI 10.1590/S1020-49892004001000001
   Eichholzer M., 2012, EUR J CANC PREV
   Faeh D, 2008, SWISS MED WKLY, V138, P204, DOI 2008/13/smw-12065
   Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027
   Ferrante JM, 2006, CANCER DETECT PREV, V30, P459, DOI 10.1016/j.cdp.2006.09.003
   Fontaine KR, 2001, J WOMEN HEALTH GEN-B, V10, P463, DOI 10.1089/152460901300233939
   Galan I, 2006, PREV MED, V42, P343, DOI 10.1016/j.ypmed.2006.01.018
   Garcia AZG, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/483417
   Hansen BT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-264
   Howard M, 2009, CANCER CAUSE CONTROL, V20, P1, DOI 10.1007/s10552-008-9228-4
   IARC, 2005, IARC HDB CANC PREV, V10
   Kiefe CI, 1998, J GEN INTERN MED, V13, P357, DOI 10.1046/j.1525-1497.1998.00115.x
   Kim BH, 2009, J KOREAN ACAD NURS, V39, P641, DOI 10.4040/jkan.2009.39.5.641
   Klug SJ, 2005, EUR J PUBLIC HEALTH, V15, P70, DOI 10.1093/eurpub/cki118
   Lacey JV, 2003, CANCER-AM CANCER SOC, V98, P814, DOI 10.1002/cncr.11567
   Lagerlund M, 2015, EUR J CANCER PREV, V24, P44, DOI 10.1097/CEJ.0000000000000025
   Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066555
   Martins LFL, 2009, REV SAUDE PUBL, V43, P318, DOI 10.1590/S0034-89102009000200013
   Limmer Karen, 2014, J Adv Pract Oncol, V5, P31
   Liu BY, 2014, J AM BOARD FAM MED, V27, P669, DOI 10.3122/jabfm.2014.05.140005
   Lo SH, 2013, J MED SCREEN, V20, P73, DOI 10.1177/0969141313492508
   Lopez-de-Andres A, 2010, J WOMENS HEALTH, V19, P1675, DOI 10.1089/jwh.2009.1828
   Ludman EJ, 2010, AM J PREV MED, V38, P303, DOI 10.1016/j.amepre.2009.10.039
   Maruthur NM, 2009, OBESITY, V17, P375, DOI 10.1038/oby.2008.480
   Meissner HI, 2009, AM J HEALTH PROMOT, V23, P168, DOI 10.4278/ajhp.07082085
   Muus KJ, 2012, J RURAL HEALTH, V28, P320, DOI 10.1111/j.1748-0361.2011.00394.x
   Nascimento C M, 1996, Bull Pan Am Health Organ, V30, P302
   National Institue for Cancer Epidemiology and Registration, 2011, CANC SWITZ SIT DEV 1
   Nelson W, 2009, J WOMENS HEALTH, V18, P1759, DOI 10.1089/jwh.2009.1430
   Oncosuisse, 2011, NAT KREBS SCHWIZX 20
   Ostbye T, 2005, AM J PUBLIC HEALTH, V95, P1623, DOI 10.2105/AJPH.2004.047803
   Reidpath DD, 2002, OBES RES, V10, P526, DOI 10.1038/oby.2002.71
   Schumacher MC, 2008, CANCER CAUSE CONTROL, V19, P725, DOI 10.1007/s10552-008-9135-8
   Sicsic J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-465
   Tabaei BP, 2005, DIABETES CARE, V28, P2644, DOI 10.2337/diacare.28.11.2644
   The WHO STEPwise approach Surveillance of risk factors for non- communicable diseases 2011. WHO Press Geneva.) National Heart Lung and Blood Institute, 1998, OBES RES, V6, p51S, DOI DOI 10.1002/J.1550-8528.1998.TB00690.X
   TORNBERG SA, 1994, BRIT J CANCER, V69, P358, DOI 10.1038/bjc.1994.65
   US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM
   Vander Weg MW, 2012, NICOTINE TOB RES, V14, P123, DOI 10.1093/ntr/ntr141
   Webb P.M., 2013, ASCO AM SOC CLIN ONC
   Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003
   Xiang XL, 2015, WOMEN HEALTH ISS, V25, P49, DOI 10.1016/j.whi.2014.09.001
NR 62
TC 13
Z9 13
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1877-7821
EI 1877-783X
J9 CANCER EPIDEMIOL
JI Cancer Epidemiol.
PD DEC
PY 2015
VL 39
IS 6
BP 870
EP 876
DI 10.1016/j.canep.2015.09.009
PG 7
WC Oncology; Public, Environmental & Occupational Health
SC Oncology; Public, Environmental & Occupational Health
GA CZ9VE
UT WOS:000367444300014
PM 26651449
DA 2019-01-08
ER

PT J
AU Mendenhall, E
   Omondi, GB
   Bosire, E
   Isaiah, G
   Musau, A
   Ndetei, D
   Mutiso, V
AF Mendenhall, Emily
   Omondi, Gregory Barnabas
   Bosire, Edna
   Isaiah, Gitonga
   Musau, Abednego
   Ndetei, David
   Mutiso, Victoria
TI Stress, diabetes, and infection: Syndemic suffering at an urban Kenyan
   hospital
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Diabetes; HIV; Gender; Health inequalities; Syndemic suffering; Kenya
ID MENTAL-DISORDERS; LAY DISCOURSES; PUBLIC-HEALTH; PREVALENCE; POPULATION;
   TRANSITION; DEPRESSION; OBESITY; EMBODIMENT; NUTRITION
AB The complexity of sickness among Kenya's urban poor cannot be dissociated from how social and health problems become syndemic. Increasingly diabetes and other non-communicable diseases (NCDs) are emerging among low-income populations that also are most afflicted by social stress and infection. This article examines how social stress, psychological distress, and physical illness among patients in a public hospital in Nairobi, Kenya, produce syndemic suffering, defined by lived experiences of syndemic clustering such as diabetes with depression and infection. We recruited 100 urban public hospital patients, of which half were women, and half had type 2 diabetes from June to August 2014. We administered written informed consent and collected anthropometrics and blood samples before we conducted lengthy mixed qualitative and survey interviews. We analyzed social stress in narrative interviews using content analysis and evaluated social and physical contributors to mental distress with frequency tables and logistic regression. We found that people experienced diabetes through a complex social and medical framework, where social problems were cause and consequence to psychological and physical suffering. Women's narratives revealed more social suffering as well as more mental distress and somatic symptoms, including multi-morbidities, than men's. People with diabetes reported not only concurrent anxiety and depression but also common infections, including malaria, tuberculosis, and HIV/AIDS. Narratives reveal how NCDs concurrent with infections, and HIV in particular, produce financial challenges for patients, especially when HIV treatment is free and patients must pay out-of-pocket for diabetes care. Future studies should investigate syndemic clustering of infections and NCDs among low-income populations at the population-level. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Mendenhall, Emily] Georgetown Univ, Sch Foreign Serv, Washington, DC 20057 USA.
   [Omondi, Gregory Barnabas; Bosire, Edna; Isaiah, Gitonga; Musau, Abednego; Ndetei, David; Mutiso, Victoria] Africa Mental Hlth Fdn, Nairobi, Kenya.
   [Ndetei, David] Univ Nairobi, Dept Psychiat, Nairobi, Kenya.
RP Mendenhall, E (reprint author), Georgetown Univ, Sch Foreign Serv, Washington, DC 20057 USA.
EM em1061@georgetown.edu
OI Mendenhall, Emily/0000-0002-5826-1321; Omondi, Gregory
   B./0000-0001-7299-1489
FU Edmund A. Walsh School of Foreign Service at Georgetown University
FX This research study would have been impossible without the people who
   graciously agreed to share their life stories with us-we are grateful
   for their time, sincerity, and enthusiasm for the project. The support
   of our colleagues at the Africa Mental Health Foundation who work
   tirelessly to understand psychological suffering and design effective
   models of mental health care delivery in East Africa also must be
   recognized in the publication of this work. Further, the administration
   and staff at Mbagathi Hospital were welcoming and supportive of our
   research team, making this study a true success. Also, thank you to John
   Kraemer for comments on an earlier version of this article and four
   anonymous reviewers for greatly strengthening this manuscript. This
   study was funded by a Start-Up Faculty Research Grant provided to the
   first author by the Edmund A. Walsh School of Foreign Service at
   Georgetown University.
CR Aillon JL, 2014, SOC PSYCH PSYCH EPID, V49, P1257, DOI 10.1007/s00127-013-0755-2
   Ali MK, 2014, JAIDS-J ACQ IMM DEF, V67, pS27, DOI 10.1097/QAI.0000000000000256
   Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371
   Basu S, 2012, PUBLIC HEALTH NUTR, V16, P1, DOI DOI 10.1017/S1368980012003758
   Beck A., 1996, MANUAL BDI 2
   Beck AT, 1990, MANUAL BECK ANXIETY
   Carolina MS, 2003, SOC SCI MED, V57, P539, DOI 10.1016/S0277-9536(02)00379-9
   Cohen J, 2006, SCIENCE, V311, P162, DOI 10.1126/science.311.5758.162
   Copeland TJ, 2011, ANN ANTHROPL PRACT, V35, P81, DOI 10.1111/j.2153-9588.2011.01068.x
   Daniels M. E., 2014, EMERGING GLOBAL HLTH
   Degeling C, 2012, AM J PUBLIC HEALTH, V102, P99, DOI 10.2105/AJPH.2011.300329
   Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3
   Ferreira M., 2006, INDIGENOUS PEOPLES D
   Ferzacca S, 2012, ANNU REV ANTHROPOL, V41, P411, DOI 10.1146/annurev-anthro-081309-145806
   Frenk J., 1991, B SANIT PANAM, V11, P485
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Holt RIG, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0491-3
   Hulzebosch A, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0112-1
   Kleinman A., 1985, CULTURE DEPRESSION S
   Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822
   Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39
   Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003
   Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569
   Mendenhall E, 2012, SYNDEMIC SUFFERING S
   Mendenhall E, 2014, ANN ANTHROPL PRACT, V38, P300, DOI 10.1111/napa.12058
   Mendenhall E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078803
   Mendenhall E, 2010, MED ANTHROPOL Q, V24, P220, DOI 10.1111/j.1548-1387.2010.01098.x
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Ndetei DM, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-7
   Needham B, 2010, SOC SCI MED, V71, P1472, DOI 10.1016/j.socscimed.2010.07.016
   Nganga P., 2011, PREVALENCE ANXIETY D
   Oni T, 2015, INT HEALTH, V7, P390, DOI 10.1093/inthealth/ihv040
   Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1
   Panter-Brick C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23411
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Preiss K, 2013, OBES REV, V14, P906, DOI 10.1111/obr.12052
   Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3
   Riza AL, 2014, LANCET DIABETES ENDO, V2, P740, DOI 10.1016/S2213-8587(14)70110-X
   Rock Melanie, 2003, Med Anthropol, V22, P131, DOI 10.1080/01459740306764
   Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427
   SCHEDER J C, 1988, Medical Anthropology Quarterly, V2, P251, DOI 10.1525/maq.1988.2.3.02a00050
   Schoenberg NE, 2005, MED ANTHROPOL Q, V19, P171, DOI 10.1525/maq.2005.19.2.171
   Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045
   Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423
   Singer MC, 2009, INTRO SYNDEMICS SYST
   Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012
   Smith-Morris C., 2008, DIABETES PIMA STORIE
   Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038
   Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219
   Weaver LJ, 2015, SOC SCI MED, V131, P122, DOI 10.1016/j.socscimed.2015.03.002
   Weaver LJ, 2014, MED ANTHROPOL, V33, P92, DOI 10.1080/01459740.2013.808637
   Wiedman D, 2012, MED ANTHROPOL Q, V26, P595, DOI 10.1111/maq.12009
NR 52
TC 9
Z9 9
U1 2
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD DEC
PY 2015
VL 146
SI SI
BP 11
EP 20
DI 10.1016/j.socscimed.2015.10.015
PG 10
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA CX0EQ
UT WOS:000365370100002
PM 26476849
DA 2019-01-08
ER

PT J
AU Lee, J
   Lee, EH
   Kim, CJ
   Moon, SH
AF Lee, Jiyeon
   Lee, Eun-Hyun
   Kim, Chun-Ja
   Moon, Seung Hei
TI Diabetes-related emotional distress instruments: A systematic review of
   measurement properties
SO INTERNATIONAL JOURNAL OF NURSING STUDIES
LA English
DT Review
DE Diabetes; Emotional distress; Psychometric properties; Systematic review
ID PROBLEM-AREAS; PSYCHOMETRIC PROPERTIES; OUTCOME MEASURES; PAID SCALE;
   VALIDITY; RESPONSIVENESS; RELIABILITY; QUALITY; VERSION; ADULTS
AB Objectives: The objectives of this study were to identify all available diabetes-related emotional distress instruments and evaluate the evidence regarding their measurement properties to help in the selection of the most appropriate instrument for use in practice and research.
   Design: A systematic literature search was performed.
   Data sources: PubMed, Embase, CINAHL, and PsycINFO were searched systematically for articles on diabetes-related emotional distress instruments.
   Review methods: The Consensus-based Standards for the Selection of Health Measurement Instruments checklist was used to evaluate the methodological quality of the identified studies. The quality of results with respect to the measurement properties of each study was evaluated using Terwee's quality criteria. An ancillary meta-analysis was performed.
   Results: Of the 2345 articles yielded by the search, 19 full-text articles evaluating 6 diabetes-related emotional distress instruments were included in this study. No instrument demonstrated evidence for all measurement properties. The Problem Areas in Diabetes scale (PAID) was the most frequently studied and the best validated of the instruments. Pooled summary estimates of the correlation coefficient between the PAID and serum glycated hemoglobin revealed a positive but weak correlation.
   Conclusions: No diabetes-related emotional distress instrument demonstrated evidence for all measurement properties. No instrument was better than another, although the PAID was the best validated and is thus recommended for use. Further psychometric studies of the diabetes-related emotional distress instruments with rigorous methodologies are required. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Lee, Jiyeon] Chungnam Natl Univ, Coll Nursing, Daejeon, South Korea.
   [Lee, Eun-Hyun] Ajou Univ, Grad Sch Publ Hlth, Suwon 443380, South Korea.
   [Kim, Chun-Ja] Ajou Univ, Coll Nursing, Suwon 443380, South Korea.
   [Moon, Seung Hei] Inha Univ, Grad Sch, Dept Nursing, Inchon, South Korea.
RP Lee, EH (reprint author), Ajou Univ, Grad Sch Publ Hlth, 164 World Cup Ro, Suwon 443380, South Korea.
EM jiyeon.lee@cnu.ac.kr; ehlee@ajou.ac.kr; ckimha@ajou.ac.kr;
   moonseungh@gmail.com
OI Lee, Eun-Hyun/0000-0001-7188-3857; Moon, Seung Hei/0000-0002-8215-7612;
   Lee, Jiyeon/0000-0001-6413-329X; KIM, Chun-Ja/0000-0002-7594-5418
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Science, and Technology
   [2012R1A1B5000978]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Science, and Technology (grant no.
   2012R1A1B5000978). The funder did not play any role in the conduct or
   publication of the study.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   [Anonymous], 2009, GUID IND PAT REP OUT
   Arzaghi S. M., 2011, IRAN J DIABETES LIPI, V10, P1
   Beverly EA, 2012, DIABETES CARE, V35, P1466, DOI [10.2337/dc11-2422, 10.2337/dc12-0661]
   BLAND JM, 1986, LANCET, V1, P307
   Boger EJ, 2013, DISABIL REHABIL, V35, P1415, DOI 10.3109/09638288.2012.737080
   De Vet HC, 2011, MEASUREMENT MED PRAC
   de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479
   DUNN SM, 1986, DIABETES CARE, V9, P480, DOI 10.2337/diacare.9.5.480
   Eom YS, 2011, DIABETES METAB J, V35, P182, DOI 10.4093/dmj.2011.35.2.182
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   GUYATT GH, 1989, J CLIN EPIDEMIOL, V42, P403, DOI 10.1016/0895-4356(89)90128-5
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hsu HC, 2013, J NURS RES, V21, P212, DOI 10.1097/01.jnr.0000432048.31921.e2
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
   International Diabetes Federation, 2014, DIABETES ATLAS
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Lee J, 2014, QUAL LIFE RES, V23, P2779, DOI 10.1007/s11136-014-0716-6
   Li J, 2013, METHOD INFORM MED, V52, P395, DOI 10.3414/ME12-01-0054
   Makine C., 2011, CARDIOVASC PSYCHIAT, V2011
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Miller ST, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-70
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   Papathanasiou A, 2014, J PSYCHIATR MENT HLT, V21, P345, DOI 10.1111/j.1365-2850.2012.01875.x
   Park T, 2013, QUAL LIFE RES, V22, P2639, DOI 10.1007/s11136-013-0395-8
   Peinemann F, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008216.pub4, 10.1371/journal.pmed.1000097, 10.1136/bmj.c869, 10.1136/bmj.b2535, 10.1016/j.jclinepi.2010.02.006, 10.1002/14651858.CD008242.pub3, 10.1016/j.jclinepi.2010.03.004]
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2013, DIABETIC MED, V30, pE25, DOI 10.1111/dme.12031
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Rabinovich S.G., 2005, MEASUREMENT ERRORS U
   Ridner SH, 2004, J ADV NURS, V45, P536, DOI 10.1046/j.1365-2648.2003.02938.x
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1
   Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch G, 2007, ETHNIC DIS, V17, P541
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 51
TC 4
Z9 5
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7489
EI 1873-491X
J9 INT J NURS STUD
JI Int. J. Nurs. Stud.
PD DEC
PY 2015
VL 52
IS 12
BP 1868
EP 1878
DI 10.1016/j.ijnurstu.2015.07.004
PG 11
WC Nursing
SC Nursing
GA CW5VE
UT WOS:000365063900010
PM 26271434
DA 2019-01-08
ER

PT J
AU Lipscombe, C
   Burns, RJ
   Schmitz, N
AF Lipscombe, Carla
   Burns, Rachel J.
   Schmitz, Norbert
TI Exploring trajectories of diabetes distress in adults with type 2
   diabetes; a latent class growth modeling approach
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Diabetes distress; Mental health; Type 2 diabetes; Psychological
   comorbidities
ID ANALYZING DEVELOPMENTAL TRAJECTORIES; SOCIAL SUPPORT; CLINICAL
   DEPRESSION; EMOTIONAL DISTRESS; GLYCEMIC CONTROL; PRIMARY-CARE;
   ASSOCIATION; INDIVIDUALS; DISORDERS; SCALE
AB Background: Moderate to severe diabetes distress (DD) is a Common comorbidity among adults with type 2 diabetes. Cross-sectional studies find DD is strongly correlated with poor diabetes management, however little is known about the pattern of change of DD symptoms over long periods of time We sought to identity and describe a set of distinct longitudinal trajectories of DD over 4 years of follow-up time.
   Methods: We used data derived from the Evaluation of Diabetes Treatment study (2011-2014), a longitudinal community-based survey of Canadian adults (40-75 years) with type 2 diabetes (n=1135). To determine the number and shape of trajectories, we used a latent class growth modeling approach.
   Results: Five distinct trajectories of DD were identified. Trajectories 1 and 2 comprised participants with persistently low (61%) or persistently low, but at risk (22%) levels of distress. Trajectory 3(75%) included participants with decreasing moderate levels of distress. Trajectory 4 (6.5%) consisted of participants with increasing moderate levels of distress. Trajectory 5 (2.4%) included participants with persistently severe levels of distress.
   Limitations: Different populations may produce different DD trajectories and thus the generalizability of the strata identified in this report remains to be investigated. Future research is needed to determine the extent to which time-varying covariates might alter the path of DD trajectories.
   Conclusions: For most individuals, DD is a fairly stable condition over 4 years of follow-up time. However, for a subset of individuals, DD symptoms worsened over time. Medical health professionals might consider repeated screenings for DD in adults with type 2 diabetes. (c) 2015 Elsevier B.V. All rights reserved.
C1 [Burns, Rachel J.; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ H3A 1A1, Canada.
   [Lipscombe, Carla; Burns, Rachel J.; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada.
   [Lipscombe, Carla; Schmitz, Norbert] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 1A2, Canada.
   [Schmitz, Norbert] Montreal Diabet Res Ctr, Montreal, PQ H2X 0A9, Canada.
RP Lipscombe, C (reprint author), McGill Univ, Douglas Mental Hlth Univ Inst, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.
EM carla.lipscombe@gmail.com; norbert.schmitz@douglas.mcgill.ca
RI Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323; Burns, Rachel/0000-0002-5337-7878
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011
   Baek RN, 2014, ANN BEHAV MED, V48, P145, DOI 10.1007/s12160-013-9585-4
   Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789
   [Canada H Canada M.o.P.W.a.G.S], 2003, CANADIAN GUIDELINES
   Canada H, 2011, CANADIAN ALCOHOL DRU
   Canada H, 2012, CANADIAN TOBACCO USE
   Canada S, 2003, CANADIAN COMMUNITY H
   Cheng AYY, 2013, CAN J DIABETES, V37, pS1, DOI 10.1016/j.jcjd.2013.01.009
   COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037//0278-6133.7.3.269
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Fincke BG, 2005, J AMBUL CARE MANAG, V28, P262
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gariepy G., 2015, NEIGHBOURHO IN PRESS
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y
   Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005
   Karlsen B, 2014, INT J NURS STUD, V51, P438, DOI 10.1016/j.ijnurstu.2013.06.016
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lipscombe C., 2015, J DIABETES
   Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037//1082-989X.4.2.139
   Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037//1082-989X.6.1.18
   Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Smith KJ, 2013, PSYCHOSOMATICS, V54, P35, DOI 10.1016/j.psym.2012.08.002
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Von Korff M, 2005, DIABETES CARE, V28, P1326, DOI 10.2337/diacare.28.6.1326
   Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 40
TC 7
Z9 7
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD DEC 1
PY 2015
VL 188
BP 160
EP 166
DI 10.1016/j.jad.2015.08.003
PG 7
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA CV3OI
UT WOS:000364168100022
PM 26363265
DA 2019-01-08
ER

PT J
AU Trento, M
   Charrier, L
   Salassa, M
   Merlo, S
   Passera, P
   Cavallo, F
   Porta, M
AF Trento, Marina
   Charrier, Lorena
   Salassa, Martina
   Merlo, Stefano
   Passera, Pietro
   Cavallo, Franco
   Porta, Massimo
TI Depression, anxiety and cognitive function in patients with type 2
   diabetes: an 8-year prospective observational study
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Depression; Anxiety; Cognitive function; Type 2 diabetes; Metabolic
   control
ID QUALITY-OF-LIFE; PREVALENCE; DISTRESS; ADULTS; DISORDERS; HEALTH;
   IMPACT; ASSOCIATION; MELLITUS; DISEASE
AB Since depression, anxiety and cognitive function may be impaired in type 2 diabetes, we investigated the relationships between clinical and socioeconomic variables and these psychological dimensions.
   For an 8-year prospective observational study of 498 patients, 249 were not insulin-treated (NIT) and 249 were insulin-treated (IT). Demographic, socioeconomic and clinical data were monitored along with depression and anxiety (assessed by Zung questionnaire) and cognitive function by Mini Mental State Examination (MMSE).
   After 8 years, 131 patients remained NIT (NIT-NIT), 179 remained IT (IT-IT), 47 switched to insulin (NIT-IT), 111 were lost to follow-up and 30 were died. In all groups, HbA1c remained stable, BMI, glucose and lipid profile improved, and foot ulcers and retinopathy worsened. Mild worsening in depression and anxiety scores was observed in the IT-IT patients only. On multivariate analysis, worsening of depression was associated with female gender, disease duration and being IT-IT, and worsening of anxiety with disease duration. Decreased MMSE was associated inversely with smoking and directly with being IT-IT.
   Patients with type 2 diabetes are at relatively low risk of psycho-cognitive decline. However, being female and on long-term insulin treatment may be risk factors for psychological distress, suggesting that special attention is required for these patients.
C1 [Trento, Marina; Salassa, Martina; Merlo, Stefano; Passera, Pietro; Porta, Massimo] Univ Turin, Dept Med Sci, Lab Clin Pedag, I-10126 Turin, Italy.
   [Charrier, Lorena; Cavallo, Franco] Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy.
RP Trento, M (reprint author), Univ Turin, Dept Med Sci, Lab Clin Pedag, Corso AM Dogliotti 14, I-10126 Turin, Italy.
EM marina.trento@unito.it
RI Porta, Massimo/G-6146-2011
OI Porta, Massimo/0000-0002-3407-6017; Charrier,
   Lorena/0000-0002-1300-4508; TRENTO, Marina/0000-0003-3764-3539
FU Ricerca Sanitaria Finalizzata Regione Piemonte
FX The work described in this paper was supported by funds from Ricerca
   Sanitaria Finalizzata Regione Piemonte.
CR Adler AI, 2000, BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412
   Bianco A, 2014, ACTA DIABETOL, V51, P79, DOI 10.1007/s00592-013-0502-x
   Brown D, 2013, NEUROSCI LETT, V535, P57, DOI 10.1016/j.neulet.2012.12.046
   Browne JL, 2015, DIABETIC MED, V32, P133, DOI 10.1111/dme.12566
   Bruce DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081254
   Co MA, 2015, J DIABETES COMPLICAT, V29, P378, DOI 10.1016/j.jdiacomp.2015.01.009
   Dalsgaard EM, 2015, PLOS ONE, V5
   Degmecic Dunja, 2014, Coll Antropol, V38, P711
   Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356
   Feinkohl I, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0130-5
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Holmes-Truscott E, 2015, DIABETIC MED, V32, P1297, DOI 10.1111/dme.12729
   Jiang XL, 2013, J DIABETES RES, DOI 10.1155/2013/485082
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   Krall J, 2015, DIABETES TECHNOL THE, V17, P268, DOI 10.1089/dia.2014.0268
   Leray E, 2011, EUR PSYCHIAT, V26, P339, DOI 10.1016/j.eurpsy.2009.12.001
   Mashitani T, 2015, ACTA DIABETOL, V52, P639, DOI 10.1007/s00592-015-0725-0
   Minelli Alessandra, 2009, Clin Pract Epidemiol Ment Health, V5, P26, DOI 10.2174/1745017900905010026
   Nicolau J, 2015, ACTA DIABETOL, V52, P1037, DOI 10.1007/s00592-015-0742-z
   Orsitto G, 2012, SCI WORLD J, DOI 10.1100/2012/726948
   Petrak F, 2015, LANCET DIABETES ENDO, V3, P472, DOI 10.1016/S2213-8587(15)00045-5
   Potter L, 2015, J BEHAV MED, V38, P863, DOI 10.1007/s10865-015-9655-0
   Reitz C, 2007, NEUROLOGY, V69, P998, DOI 10.1212/01.wnl.0000271395.29695.9a
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Semenkovich K, 2015, DRUGS, V75, P577, DOI 10.1007/s40265-015-0347-4
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Taylor AE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006141
   Trento M, 2014, J ENDOCRINOL INVEST, V37, P79, DOI 10.1007/s40618-013-0028-7
   Trento M, 2012, ACTA DIABETOL, V49, P199, DOI 10.1007/s00592-011-0275-z
   Wang CC, 2010, ARCH GERONTOL GERIAT, V51, P143, DOI 10.1016/j.archger.2009.09.041
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
NR 34
TC 14
Z9 14
U1 0
U2 26
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD DEC
PY 2015
VL 52
IS 6
BP 1157
EP 1166
DI 10.1007/s00592-015-0806-0
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CV0OP
UT WOS:000363950500017
PM 26374233
DA 2019-01-08
ER

PT J
AU Megnin-Viggars, O
   Symington, I
   Howard, LM
   Pilling, S
AF Megnin-Viggars, Odette
   Symington, Iona
   Howard, Louise M.
   Pilling, Stephen
TI Experience of care for mental health problems in the antenatal or
   postnatal period for women in the UK: a systematic review and
   meta-synthesis of qualitative research
SO ARCHIVES OF WOMENS MENTAL HEALTH
LA English
DT Review
DE Postnatal; Pregnancy; Mental health problems; Systematic review;
   Qualitative research; Meta-synthesis
ID LISTENING VISITS; DIABETES CARE; DEPRESSION; MOTHERS; CHILDBIRTH;
   PREGNANCY; BLACK; VIEWS; PSYCHOSIS; SUPPORT
AB Pregnancy and the first postnatal year can be a difficult and distressing period for women with mental health problems, particularly if they are not able to access appropriate and timely assessment and treatment. The aim of this systematic review was to synthesise qualitative evidence on experiences of care for women with (or at risk of developing) antenatal or postnatal mental health problems across a range of disorders (including non-psychotic mental disorders).
   Six electronic databases were searched for papers published from 2000 to April 2014. Thirty-nine studies were identified that met the inclusion criteria. Findings were synthesised using secondary framework and thematic analysis approaches.
   Seven key themes were identified across mental disorder groups: an unmet need for collaborative and integrated care; stigma and fears about loss of custody; healthcare professionals unable or unwilling to address psychological needs; focus on babies over mothers; importance of non-judgemental and compassionate support; an unmet need for information; importance of service user involvement in treatment decisions.
   Women's experience of accessing and engaging with care for mental health problems could be improved if given the opportunity to develop trusting relationships with healthcare professionals who acknowledge and reinforce the woman's role in caring for her baby in a non-judgemental and compassionate manner, and foster hope and optimism about treatment. Information for women, their families and healthcare professionals, and the provision of individualised care and treatment, are also crucial to enable full implementation of a person-centred programme of care.
C1 [Megnin-Viggars, Odette; Symington, Iona; Pilling, Stephen] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8BB, England.
   [Symington, Iona; Pilling, Stephen] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 7HB, England.
   [Howard, Louise M.] Kings Coll London, Hlth Serv & Populat Res Dept, Sect Womens Mental Hlth, London SE5 8AF, England.
RP Megnin-Viggars, O (reprint author), Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, 21 Prescot St, London E1 8BB, England.
EM OMegnin@rcpsych.ac.uk; i.symington@ucl.ac.uk; louise.howard@kcl.ac.uk;
   s.pilling@ucl.ac.uk
RI Howard, Louise/E-3495-2010
OI Howard, Louise/0000-0001-9942-744X
FU Department of Health [NIHR-RP-R3-12-011, PB-PG-0906-11026]; National
   Institute for Health Research [PB-PG-0906-11026, NIHR-RP-R3-12-011]
CR Antonysamy A, 2009, ARCH WOMEN MENT HLTH, V12, P359, DOI 10.1007/s00737-009-0085-2
   Ayers Susan, 2006, Psychol Health Med, V11, P389, DOI 10.1080/13548500600708409
   Baumgartner LM, 2007, QUAL HEALTH RES, V17, P919, DOI 10.1177/1049732307305881
   BMJ, 2011, CONS CRIT REP QUAL R
   Boath E, 2004, J PSYCHOSOM OBST GYN, V25, P221, DOI 10.1080/01674820400017889
   Breustedt S, 2013, BR J MIDWIFERY, V21, P187
   Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3
   Carroll C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-29
   CASP: Critical Appraisal Skills Programme, 2013, QUAL CHECKL
   Chew-Graham CA, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-7
   Cooke Sam, 2012, Community Pract, V85, P34
   de Jonge A, 2001, J ADV NURS, V36, P49, DOI 10.1046/j.1365-2648.2001.01942.x
   Dixon-Woods M, 2006, QUAL RES, V6, P27, DOI DOI 10.1177/1468794106058867
   Dixon-Woods Mary, 2007, J Health Serv Res Policy, V12, P42, DOI 10.1258/135581907779497486
   Dolman C, 2013, ARCH WOMEN MENT HLTH, V16, P173, DOI 10.1007/s00737-013-0336-0
   Edge D, 2005, SOC SCI MED, V61, P15, DOI 10.1016/j.socscimed.2004.11.047
   EDGE D, 2007, PRIMARY HLTH CARE, V17, P32
   Edge D, 2011, BRIT J GEN PRACT, V61, P256, DOI 10.3399/bjgp11X567063
   Edge D, 2008, MIDWIFERY, V24, P379, DOI 10.1016/j.midw.2007.01.007
   Edwards E., 2005, J MENTAL HLTH, V14, P471, DOI [DOI 10.1080/09638230500271097, 10.1080/09638230500271097]
   Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44
   Hall Pauline, 2006, Community Pract, V79, P256
   Hanley J, 2006, MIDWIFERY, V22, P147, DOI 10.1016/j.midw.2005.08.004
   Heron J, 2012, ARCH WOMEN MENT HLTH, V15, P155, DOI 10.1007/s00737-012-0267-1
   Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9
   Hunt K, 2009, INT J NURS STUD, V46, P1111, DOI 10.1016/j.ijnurstu.2008.12.004
   Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2
   Lawton J, 2009, HEALTH EXPECT, V12, P138, DOI 10.1111/j.1369-7625.2009.00537.x
   Mapp T, 2005, BRIT J MIDWIFERY, V13, P30
   Mapp T, 2005, BRIT J MIDWIFERY, V13, P36
   McCreight BS, 2008, OMEGA-J DEATH DYING, V57, P1, DOI 10.2190/OM.57.1.a
   McGrath L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-341
   National Clinical Guideline Center [NCGC], 2012, PAT EXP AD NHS SERV
   National Collaborating Centre for Mental Health (NCCMH), 2012, SERV US EXP AD MENT
   National Institute for Health and Clinical Excellence (NICE), 2014, ANT POSTN MENT HLTH
   NICE, 2011, SERV US EXP AD MENT
   NICE, 2012, PAT EXP AD NHS SERV, V138
   Nicholls K, 2007, BRIT J HEALTH PSYCH, V12, P491, DOI 10.1348/135910706X120627
   Parvin A, 2004, FAM PRACT, V21, P254, DOI 10.1093/fampra/cmh307
   Patel S, 2013, MIDWIFERY, V29, P682, DOI 10.1016/j.midw.2012.06.012
   Peel E, 2007, BRIT MED J, V335, P493, DOI 10.1136/bmj.39302.444572.DE
   Raymond JE, 2009, MIDWIFERY, V25, P39, DOI 10.1016/j.midw.2007.01.005
   Robertson E, 2003, PSYCHOL PSYCHOTHER-T, V76, P411, DOI 10.1348/147608303770584755
   Ryninks K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-203
   Shakespeare J, 2006, J REPROD INFANT PSYC, V24, P149, DOI 10.1080/02646830600643866
   Shakespeare J, 2003, BRIT J GEN PRACT, V53, P614
   Simmons RK, 2006, SOC SCI MED, V63, P1934, DOI 10.1016/j.socscimed.2006.04.024
   Slade P, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X532611
   Smith Linda, 2007, Community Pract, V80, P24
   Snowdon C, 2012, MIDWIFERY, V28, P791, DOI [10.1016/j.midw.2011.12.012, 10.1016/j.midw.2011.12.2012]
   Stanley N., 2006, PRIM HEALTH CARE RES, V7, P257, DOI DOI 10.1191/1463423606PC2950A
   Stapleton H, 2008, MATERN CHILD NUTR, V4, P106, DOI 10.1111/j.1740-8709.2007.00121.x
   Templeton L, 2003, ETHNIC HEALTH, V8, P207, DOI 10.1080/1355785032000136425
   Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45
   Thomson G, 2013, MIDWIFERY, V29, P765, DOI 10.1016/j.midw.2012.07.008
   Thomson G, 2008, J PSYCHOSOM OBST GYN, V29, P268, DOI 10.1080/01674820802545453
   Thurtle V, 2003, COMMUNITY PRACTITION, V76, P261
   Tsartsara E, 2002, CLIN EFFECTIVENESS N, V6, P55
   Turner KM, 2010, PATIENT EDUC COUNS, V78, P234, DOI 10.1016/j.pec.2009.05.022
   Turner KM, 2008, FAM PRACT, V25, P450, DOI 10.1093/fampra/cmn056
   Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805
   Whitehead L, 2006, INT J NURS STUD, V43, P1023, DOI 10.1016/j.ijnurstu.2006.01.003
   Wittkowski A, 2011, J REPROD INFANT PSYC, V29, P480, DOI 10.1080/02646838.2011.639014
NR 63
TC 20
Z9 20
U1 3
U2 52
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 1434-1816
EI 1435-1102
J9 ARCH WOMEN MENT HLTH
JI Arch. Womens Ment. Health
PD DEC
PY 2015
VL 18
IS 6
BP 745
EP 759
DI 10.1007/s00737-015-0548-6
PG 15
WC Psychiatry
SC Psychiatry
GA CV0PS
UT WOS:000363953500001
PM 26184835
DA 2019-01-08
ER

PT J
AU Brandao, I
   Ramalho, S
   Pinto-Bastos, A
   Arrojado, F
   Faria, G
   Calhau, C
   Coelho, R
   Conceicao, E
AF Brandao, Isabel
   Ramalho, Sofia
   Pinto-Bastos, Ana
   Arrojado, Filipa
   Faria, Gil
   Calhau, Conceicao
   Coelho, Rui
   Conceicao, Eva
TI Metabolic profile and psychological variables after bariatric surgery:
   association with weight outcomes
SO EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY
LA English
DT Article
DE Bariatric surgery; Eating behavior; Depression; Metabolic profile; Type
   2 diabetes mellitus
ID FOLLOW-UP; EATING BEHAVIOR; DEPRESSION; FREQUENCY; DISORDER; OBESITY;
   STRESS; HEALTH; IMPACT; BYPASS
AB Purpose This study aims to examine associations between metabolic profile and psychological variables in post-bariatric patients and to investigate if metabolic and psychological variables, namely high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), glycated hemoglobin (HbA 1c), impulsivity, psychological distress, depressive and eating disorder symptoms are independently associated with percentage of excess weight loss (%EWL) after bariatric surgery.
   Methods One hundred and fifty bariatric patients (BMI = 33.04 +/- 5.8 kg/m(2)) who underwent to bariatric surgery for more than 28.63 +/- 4.9 months were assessed through a clinical interview, a set of self-report measures and venous blood samples. Pearson's correlations were used to assess correlations between %EWL, metabolic and psychological variables. Multiple linear regression was conducted to investigate which metabolic and psychological variables were independently associated with %EWL, while controlling for type of surgery.
   Results Higher TG blood levels were associated with higher disordered eating, psychological distress and depression scores. HDL-C was associated with higher depression scores. Both metabolic and psychological variables were associated with %EWL. Regression analyses showed that, controlling for type of surgery, higher % EWL is significantly and independently associated with less disordered eating symptoms and lower TG and HbA_1c blood concentrations (R-2 aj = 0.383, F (4, 82) = 14.34, p < 0.000).
   Conclusion An association between metabolic and psychological variables, particularly concerning TG blood levels, disordered eating and psychological distress/depression was found. Only higher levels of disordered eating, TG and HbA_1c showed and independent correlation with less weight loss. Targeting maladaptive eating behaviors may be a reasonable strategy to avoid weight regain and optimize health status post-operatively.
C1 [Brandao, Isabel; Arrojado, Filipa; Coelho, Rui] Univ Porto, Fac Med, Hosp Sao Joao, P-4200319 Oporto, Portugal.
   [Ramalho, Sofia; Pinto-Bastos, Ana; Arrojado, Filipa; Conceicao, Eva] Univ Minho, Sch Psychol, P-4710057 Braga, Portugal.
   [Faria, Gil] CINTESIS Ctr Res Hlth Technol & Informat Syst, P-4200450 Oporto, Portugal.
   [Faria, Gil; Calhau, Conceicao] Oporto Hosp Ctr, Dept Gen Surg, Oporto, Portugal.
   [Calhau, Conceicao] Univ Porto, Fac Med, Dept Biochem, Ctr Invest Med, P-4200450 Oporto, Portugal.
RP Conceicao, E (reprint author), Univ Minho, Sch Psychol, Campus Gualtar, P-4710057 Braga, Portugal.
EM econceicao@psi.uminho.pt
RI FMUP, CINTESIS/C-6631-2014; Calhau, Conceicao/L-8041-2013
OI FMUP, CINTESIS/0000-0001-7248-2086; Conceicao, Eva/0000-0002-1982-5796;
   Coelho, Rui/0000-0001-5790-8616; Calhau, Conceicao/0000-0001-9567-3379;
   Ramalho, Sofia/0000-0003-1782-8122; Faria, Gil/0000-0003-0074-3536
FU Fundacao para a Ciencia e a Tecnologia/Foundation for Science and
   Technology through European Union COMPETE program Grant [IF/01219/2014,
   PTDC/MHC-PCL/4974/2012, SFRH/BD/104159/2014, SFRH/BD/104182/2014]
FX This research was partially supported by Fundacao para a Ciencia e a
   Tecnologia/Foundation for Science and Technology through European Union
   COMPETE program Grant to Eva Conceicao (IF/01219/2014) and
   (PTDC/MHC-PCL/4974/2012), doctoral scholarship (SFRH/BD/104159/2014) to
   Ana Pinto-Bastos and doctoral scholarship (SFRH/BD/104182/2014) to Sofia
   Ramalho.
CR Beck NN, 2012, EAT BEHAV, V13, P394, DOI 10.1016/j.eatbeh.2012.06.001
   Brethauer SA, 2013, ANN SURG, V258, P628, DOI 10.1097/SLA.0b013e3182a5034b
   Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724
   Buchwald H, 2009, OBES SURG, V19, P1605, DOI 10.1007/s11695-009-0014-5
   Clum GA, 2014, J BEHAV MED, V37, P577, DOI 10.1007/s10865-013-9526-5
   Conceicao E, 2014, EAT BEHAV, V15, P558, DOI 10.1016/j.eatbeh.2014.08.010
   Conceicao E, 2014, EAT WEIGHT DISORD-ST, V19, P103, DOI 10.1007/s40519-013-0069-0
   Conceicao EM, 2014, SURG OBES RELAT DIS, V10, P973, DOI 10.1016/j.soard.2014.05.002
   Corradini SG, 2005, OBES SURG, V15, P367, DOI 10.1381/0960892053576839
   Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928
   de Zwaan M, 2011, J AFFECT DISORDERS, V133, P61, DOI 10.1016/j.jad.2011.03.025
   Deitel M, 2007, OBES SURG, V17, P565, DOI 10.1007/s11695-007-9116-0
   Elfhag Kristina, 2008, Eat Behav, V9, P285, DOI 10.1016/j.eatbeh.2007.10.003
   Ikramuddin S, 2011, BRIT J SURG, V98, P1339, DOI 10.1002/bjs.7652
   JENKINS DJA, 1992, AM J CLIN NUTR, V55, P461
   Jimenez A, 2012, ANN SURG, V256, P1023, DOI 10.1097/SLA.0b013e318262ee6b
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Kaur J, 2014, CARDIOL RES PRACT, DOI 10.1155/2014/943162
   Kenardy J, 2002, DIABETIC MED, V19, P234, DOI 10.1046/j.1464-5491.2002.00679.x
   Kinder LS, 2004, PSYCHOSOM MED, V66, P316, DOI 10.1097/01.psy.0000124755.91880.f4
   Kral JG, 2001, INT J OBESITY, V25, P258, DOI 10.1038/sj.ijo.0801469
   Lambert MJ, 1996, CLIN PSYCHOL PSYCHOT, V3, P249, DOI 10.1002/(SICI)1099-0879(199612)3:4<249::AID-CPP106>3.0.CO;2-S
   Langer FB, 2013, OBES SURG, V23, P776, DOI 10.1007/s11695-013-0892-4
   Machado PPP, 2014, EUR EAT DISORD REV, V22, P448, DOI 10.1002/erv.2318
   Morgen CS, 2014, NAT REV ENDOCRINOL, V10, P513, DOI 10.1038/nrendo.2014.124
   Myers VH, 2012, OBES SURG, V22, P230, DOI 10.1007/s11695-010-0324-7
   Niego SH, 2007, INT J EAT DISORDER, V40, P349, DOI 10.1002/eat.20376
   Odom J, 2010, OBES SURG, V20, P349, DOI 10.1007/s11695-009-9895-6
   Ortega E, 2012, SURG ENDOSC, V26, P1744, DOI 10.1007/s00464-011-2104-4
   Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
   Psota TL, 2007, J NUTR EDUC BEHAV, V39, pS171, DOI 10.1016/j.jneb.2007.05.004
   Roehrig M, 2009, OBESITY, V17, P481, DOI 10.1038/oby.2008.560
   Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007
   Sarwer DB, 2011, SURG OBES RELAT DIS, V7, P644, DOI 10.1016/j.soard.2011.06.016
   Saunders R, 2004, OBES SURG, V14, P98, DOI 10.1381/096089204772787374
   Schag K, 2013, OBES REV, V14, P477, DOI 10.1111/obr.12017
   Stoney CM, 2002, PSYCHOPHYSIOLOGY, V39, P80, DOI 10.1017/S0048577201020133
   Strain GW, 2015, OBES SURG, DOI [10.1007/s11695-014-1351-6ORIGINAL, DOI 10.1007/S11695-014-1351-6ORIGINAL]
   Tanofsky-Kraff M, 2012, INT J OBESITY, V36, P956, DOI 10.1038/ijo.2011.259
   Taylor AE, 1999, J CLIN ENDOCR METAB, V84, P428, DOI 10.1210/jc.84.2.428
   Teufel M, 2012, OBES SURG, V22, P1232, DOI 10.1007/s11695-012-0690-4
   Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503
   van Hout G, 2005, ACTA CHIR BELG, V105, P40, DOI 10.1080/00015458.2005.11679664
   van Hout GCM, 2005, OBES SURG, V15, P552, DOI 10.1381/0960892053723484
   van Hout G, 2009, OBESITY FACTS, V2, P10, DOI 10.1159/000193564
   Vaz-Serra A., 1973, COIMBRA MED, V20, P623
   White MA, 2010, J CLIN PSYCHIAT, V71, P175, DOI 10.4088/JCP.08m04328blu
   Wilson PWF, 2003, CIRCULATION, V108, P1537, DOI 10.1161/01.CIR.0000089506.12223.F1
NR 48
TC 9
Z9 9
U1 1
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1124-4909
EI 1590-1262
J9 EAT WEIGHT DISORD-ST
JI Eat. Weight Disord.-Stud. Anorex.
PD DEC
PY 2015
VL 20
IS 4
BP 513
EP 518
DI 10.1007/s40519-015-0199-7
PG 6
WC Psychiatry
SC Psychiatry
GA CV6NE
UT WOS:000364386100013
PM 26122195
DA 2019-01-08
ER

PT J
AU Jung, HY
   Lee, H
   Park, J
AF Jung, Hee Young
   Lee, Haejung
   Park, Jina
TI Comparison of the effects of Korean mindfulness-based stress reduction,
   walking, and patient education in diabetes mellitus
SO NURSING & HEALTH SCIENCES
LA English
DT Article
DE diabetes mellitus; meditation; mindfulness; rural population; stress;
   walking
ID RANDOMIZED CONTROLLED-TRIAL; GLYCEMIC CONTROL; SELF-MANAGEMENT;
   OLDER-ADULTS; PROGRAM; DISTRESS; PEOPLE; INTERVENTION; METAANALYSIS;
   SYMPTOMS
AB The purpose of this study was to compare the effects of Korean mindfulness-based stress reduction (K-MBSR), walking, and patient education regarding diabetes mellitus (DM) on stress response, glycemic control, and vascular inflammation in patients with diabetes mellitus. A cluster randomized trial including 56 adults with diabetes mellitus (K-MBSR group=21, walking group=18, patient education group=17) was conducted between 13 July and 14 September 2012. The questionnaire included the Diabetes Distress Scale and Perceived Stress Response Inventory. Fasting blood samples were used to measure levels of cortisol, blood glucose, plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator (t-PA). There were no statistically significant differences between the effects of K-MBSR, walking, and patient education on stress, glycemic control, or vascular inflammation. However, in the K-MBSR and walking groups, significant reductions in the levels of serum cortisol and PAI-1 were observed. A significant reduction in psychological responses to stress was observed in the walking and patient education groups. Longitudinal studies could provide better insight into the impact of K-MBSR, walking, and patient education on health outcomes in adults with diabetes mellitus.
C1 [Jung, Hee Young] Busan Womens Coll, Dept Nursing, Busan, South Korea.
   [Lee, Haejung; Park, Jina] Pusan Natl Univ, Coll Nursing, Yangsan 626770, South Korea.
RP Lee, H (reprint author), Pusan Natl Univ, Coll Nursing, Yangsan Campus, Yangsan 626770, South Korea.
EM haejung@pusan.ac.kr
RI Albertin, Paloma/X-1093-2018
CR Abdullah WZ, 2009, SINGAP MED J, V50, P604
   American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011
   Bishop SR, 2002, PSYCHOSOM MED, V64, P71, DOI 10.1097/00006842-200201000-00010
   Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7
   Cavalot F, 2013, DIABETES OBES METAB, V15, P3, DOI 10.1111/dom.12140
   Chang HK, 2007, KOREAN J HLTH PSYCHO, V12, P833
   Choi EJ, 2007, THESIS YONSEI U SEOU
   Choi MG, 2012, J SPORT LEISURE STUD, V49, P841
   Co MA, 2015, J DIABETES COMPLICAT, V29, P378, DOI 10.1016/j.jdiacomp.2015.01.009
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7
   Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343
   Inzucchi SE, 2012, DIABETES CARE, V35, P1367
   Jae SY, 2008, AM J CARDIOL, V102, P700, DOI 10.1016/j.amjcard.2008.05.012
   Jang NY., 2009, THESIS YEONGNAM U GY
   Jin HK, 2009, DIABETES METAB J, V33, P439
   Kabat- Zinn J., 2013, FULL CATASTROPHE LIV
   Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743
   Kho K. B, 2000, J KOREAN NEUROPSYCHI, V39, P707
   Kim CJ, 2010, J KOREAN ACAD ADULT, V22, P51
   Kim J., 2008, THESIS CHUNGNAM NATL
   Kontoangelos K, 2015, J DIABETES RES, DOI 10.1155/2015/354923
   Kopp M, 2012, DIABETES RES CLIN PR, V95, P25, DOI 10.1016/j.diabres.2011.09.017
   Lee BK, 2007, COGN BEHAV THER KORE, V7, P63
   Lee H, 2011, JPN J NURS SCI, V8, P129, DOI 10.1111/j.1742-7924.2010.00163.x
   Lee JH, 2010, J KOREAN ACAD COMMUN, V21, P409
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Mayo Clinic, 2012, HLTH LIF PROP WALK T
   Meisenberg G, 2011, PRINCIPLES MED BIOCH, P232
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention. Korea Health Statistics, 2011, KOR HLTH STAT 2011 K
   NILSSON IM, 1985, BRIT MED J, V290, P1453, DOI 10.1136/bmj.290.6480.1453
   North SL, 2015, J NUTR EDUC BEHAV, V47, P28, DOI 10.1016/j.jneb.2014.07.006
   Park S, 2010, J KOREAN ACAD NURS, V40, P191, DOI 10.4040/jkan.2010.40.2.191
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Roberts HR, 2007, HAEMOPHILIA AND HAEMOSTASIS: A CASE-BASED APPROACH TO MANAGEMENT, P1, DOI 10.1002/9780470692554
   Rosenkranz MA, 2013, BRAIN BEHAV IMMUN, V27, P174, DOI 10.1016/j.bbi.2012.10.013
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   Smith TC, 2007, J CLIN EPIDEMIOL, V60, P309, DOI 10.1016/j.jclinepi.2006.06.013
   Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213
   Sung K, 2012, NURS HEALTH SCI, V14, P438, DOI 10.1111/j.1442-2018.2012.00690.x
   van Son J, 2014, J PSYCHOSOM RES, V77, P81, DOI 10.1016/j.jpsychores.2014.03.013
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 42
TC 5
Z9 8
U1 3
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1441-0745
EI 1442-2018
J9 NURS HEALTH SCI
JI Nurs. Health Sci.
PD DEC
PY 2015
VL 17
IS 4
BP 516
EP 525
DI 10.1111/nhs.12229
PG 10
WC Nursing
SC Nursing
GA CU2AL
UT WOS:000363323500015
PM 26275164
DA 2019-01-08
ER

PT J
AU Lohan, A
   Morawska, A
   Mitchell, A
AF Lohan, A.
   Morawska, A.
   Mitchell, A.
TI A systematic review of parenting interventions for parents of children
   with type 1 diabetes
SO CHILD CARE HEALTH AND DEVELOPMENT
LA English
DT Review
DE children; parenting interventions; systematic review; type 1 diabetes
ID HEALTH OUTCOMES; METABOLIC CONTROL; GLYCEMIC CONTROL; MELLITUS;
   ADOLESCENTS; BEHAVIOR; RESPONSIBILITY; MANAGEMENT; CHILDHOOD; ADHERENCE
AB Objective To summarize the parenting intervention literature for parents of children aged 2-10 years (mean age < 10 years) with type 1 diabetes and to evaluate intervention efficacy in improving a range of parent, family and child outcomes. The present review de-emphasizes the traditional medical approach to illness management summarized in previous reviews and focuses on parenting factors identified in the literature as important to diabetes management. This review article is important as it outlines the present state of parenting intervention literature for this population.
   Methods Electronic searches were conducted for seven databases (Cumulative index to nursing and allied health literature, MEDLINE, PsycINFO, PubMed, Scopus, The Cochrane library and Web of Science) from their start dates until April 2014. Reference lists of all included papers were also searched for potentially relevant articles.
   Results Seven papers, representing six studies, met the inclusion criteria. Three studies primarily focused on improving parenting practices. The intervention programmes described in the remaining studies comprised multiple components; thus, it is difficult to establish the contribution of the parenting components to improving outcomes.
   Conclusions Parenting interventions may help to improve responsibility sharing and cooperation in diabetes management, child behaviour difficulties, parental behaviour, parents' psychological distress and child health outcomes. This review suggests the need for further well-designed trials of parenting interventions to determine their specific contribution to improving outcomes for this population.
C1 [Lohan, A.; Morawska, A.; Mitchell, A.] Univ Queensland, Sch Psychol, Parenting & Family Support Ctr, Brisbane, Qld 4072, Australia.
RP Lohan, A (reprint author), Univ Queensland, Sch Psychol, Parenting & Family Support Ctr, Brisbane, Qld 4072, Australia.
EM aditi.lohan@uqconnect.edu.au
RI Mitchell, Amy/D-2478-2015; Mitchell, Alex/A-3090-2009
OI Mitchell, Amy/0000-0003-3352-3046; Mitchell, Alex/0000-0001-6014-598X
FU Australian Research Council [DP140100781]
FX This work was supported by Australian Research Council's Discovery
   Projects scheme (Project ID: DP140100781).
CR AIHW (Australian Institute of Health and Welfare), 2015, INC TYP 1 DIAB AUSTR
   ANDERSON BJ, 1981, DIABETES CARE, V4, P586, DOI 10.2337/diacare.4.6.586
   Anderson BJ, 2001, J PEDIATR ENDOCR MET, V14, P645
   Armour TA, 2005, DIABETIC MED, V22, P1295, DOI 10.1111/j.1464-5491.2005.01618.x
   Armstrong B, 2011, J PEDIATR PSYCHOL, V36, P1052, DOI 10.1093/jpepsy/jsr039
   Cameron Fergus J, 2003, Pediatr Diabetes, V4, P132, DOI 10.1034/j.1399-5448.2003.00019.x
   CANAM C, 1993, J ADV NURS, V18, P46, DOI 10.1046/j.1365-2648.1993.18010046.x
   Chisholm V, 2014, CHILD CARE HLTH DEV, V40, P85, DOI 10.1111/cch.12004
   Dabadghao P, 2001, DIABETIC MED, V18, P889, DOI 10.1046/j.1464-5491.2001.00593.x
   Davidson S., 2005, EUROPEAN DIABETES NU, V2, P31
   Davis CL, 2001, J PEDIATR PSYCHOL, V26, P123, DOI 10.1093/jpepsy/26.2.123
   DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9
   FISHER EB, 1982, J CONSULT CLIN PSYCH, V50, P993, DOI 10.1037/0022-006X.50.6.993
   Fogel NR, 2010, CURR DIABETES REP, V10, P436, DOI 10.1007/s11892-010-0145-z
   Grey M, 2000, Annu Rev Nurs Res, V18, P149
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hoff A. L., 2005, FAMILIES SYSTEMS HLT, V23, P329, DOI DOI 10.1037/1091-7527.23.3.329
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   International Diabetes Federation, 2003, DIABETES ATLAS
   Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138
   Liakopoulou M, 2001, PSYCHOTHER PSYCHOSOM, V70, P78, DOI 10.1159/000056230
   Lohan A., 2014, 16 ANN HELP FAM CHAN
   McBroom LA, 2009, DIABETES EDUCATOR, V35, P428, DOI 10.1177/0145721709332814
   McDonnell CM, 2007, DIABETES CARE, V30, P2211, DOI 10.2337/dc07-0328
   MCNABB WL, 1994, DIABETES EDUCATOR, V20, P121, DOI 10.1177/014572179402000206
   MILLERJOHNSON S, 1994, J CONSULT CLIN PSYCH, V62, P603, DOI 10.1037/0022-006X.62.3.603
   Morawska A, 2015, J CHILD HEALTH CARE, V19, P5, DOI 10.1177/1367493513496664
   Northam EA, 2006, DIABETIC MED, V23, P113, DOI 10.1111/j.1464-5491.2005.01678.x
   Nowak C, 2008, CLIN CHILD FAM PSYCH, V11, P114, DOI 10.1007/s10567-008-0033-0
   Oksol E. M., 2004, THESIS
   PADGETT D, 1988, J CLIN EPIDEMIOL, V41, P1007, DOI 10.1016/0895-4356(88)90040-6
   Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7
   PATTERSON JM, 1998, DIABETES ADOLESCENT, P3
   SARGENT J, 1983, PRIMARY CARE, V10, P583
   Sassmann H, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-152
   SATIN W, 1989, J PEDIATR PSYCHOL, V14, P259, DOI 10.1093/jpepsy/14.2.259
   Snorer M, 2011, DIABETES CARE, V34, P1735, DOI 10.2337/dc10-1602
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Szumowski E. K., 1991, THESIS
   Wysocki T, 2000, J PEDIATR PSYCHOL, V25, P23, DOI 10.1093/jpepsy/25.1.23
NR 40
TC 10
Z9 10
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1862
EI 1365-2214
J9 CHILD CARE HLTH DEV
JI Child Care Health Dev.
PD NOV
PY 2015
VL 41
IS 6
BP 803
EP 817
DI 10.1111/cch.12278
PG 15
WC Psychology, Developmental; Pediatrics
SC Psychology; Pediatrics
GA DA6PZ
UT WOS:000367928800004
PM 26268836
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Fisher, L
   Hessler, D
   Edelman, SV
AF Polonsky, W. H.
   Fisher, L.
   Hessler, D.
   Edelman, S. V.
TI Identifying the worries and concerns about hypoglycemia in adults with
   type 2 diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Hypoglycemia; Fear; Worry; Avoidance; Type 2 diabetes; Distress
ID FEAR; PHQ-9
AB Aims: To identify the hypoglycemic concerns of adults with type 2 diabetes (T2D) and examine how these concerns are associated with key patient characteristics.
   Methods: Qualitative interviews with 16 T2D adults and 11 diabetes care providers were conducted. Survey items were then developed and submitted to exploratory factor analyses (EFAs). Construct validity was assessed by correlations with diabetes distress, anxiety and depressive symptoms, well-being, hypoglycemic fear, hypoglycemia history and glycemic control (A1C).
   Results: An EFA with 226 insulin users and 198 non-insulin users yielded 3 factors (14 items): Hypoglycemia Anxiety, Avoidance and Confidence. For both T2D groups, higher Anxiety and Avoidance were significantly associated with more hypoglycemia, lower well-being, and greater diabetes distress, depressive symptoms and hypoglycemic fear. Similar associations, in the converse direction, were found for Confidence. Among insulin users only, Anxiety was independently associated with greater emotional distress and more hypoglycemia, while Confidence was independently linked to less emotional distress and lower A1C Avoidance was independently associated with greater emotional distress in both groups.
   Conclusions: Using the new 14-item Hypoglycemic Attitudes and Behavior Scale (HABS), we found that hypoglycemic concerns are significant in T2D adults, are linked to emotional distress and A1C, and merit attention in clinical practice. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Polonsky, W. H.] Univ CA, Dept Psychiat, San Diego, CA USA.
   [Polonsky, W. H.] Behav Diabet Inst, San Diego, CA USA.
   [Fisher, L.; Hessler, D.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Edelman, S. V.] Univ Calif San Diego, Div Endocrinol & Metab, San Diego, CA 92103 USA.
   [Edelman, S. V.] Vet Affairs Med Ctr, San Diego, CA 92161 USA.
RP Polonsky, WH (reprint author), POB 2148, Del Mar, CA USA.
EM whp@behavioraldiabetes.org
FU Sanofi
FX This investigator-initiated study was supported by Sanofi.
CR COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852
   Gilbert RE, 2008, CAN J DIABETES, V32, P101, DOI 10.1016/S1499-2671(08)90000-9
   Gonder-Frederick L., 2013, DIABETIC HYPOGLYCEMI, V5, P3
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Hajos T.R., 2013, DIABETIC MED, V30, P63
   Hajos TRS, 2014, DIABETES CARE, V37, P102, DOI 10.2337/dc13-0971
   Irvine A, 1994, HDB PSYCHOL DIABETES
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Marrett E, 2009, DIABETES OBES METAB, V11, P1138, DOI 10.1111/j.1463-1326.2009.01123.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Stargardt T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-91
   Vexiau P, 2008, DIABETES OBES METAB, V10, P16, DOI 10.1111/j.1463-1326.2008.00883.x
   Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
NR 16
TC 13
Z9 14
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD NOV-DEC
PY 2015
VL 29
IS 8
BP 1171
EP 1176
DI 10.1016/j.jdiacomp.2015.08.002
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CZ1SF
UT WOS:000366884900034
PM 26338296
DA 2019-01-08
ER

PT J
AU Walker, RJ
   Smalls, BL
   Egede, LE
AF Walker, Rebekah J.
   Smalls, Brittany L.
   Egede, Leonard E.
TI Social determinants of health in adults with type 2
   diabetes-Contribution of mutable and immutable factors
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Social determinants; Socioeconomic; Psychological; Built
   environment
ID OF-THE-LITERATURE; GLYCEMIC CONTROL; SELF-CARE; PSYCHOMETRIC PROPERTIES;
   PSYCHOLOGICAL DISTRESS; SOCIOECONOMIC POSITION; MEDICATION ADHERENCE;
   DEPRESSION; MANAGEMENT; METAANALYSIS
AB Aims: Socioeconomic, psychosocial, and neighborhood factors influence clinical outcomes and self-care behaviors in diabetes; however, few studies simultaneously assessed the impact of multiple social determinant of health factors on glycemic control. We used an explanatory model to examine the differential contribution of social determinants and clinical factors on glycemic control. Secondarily, we examined the contribution of mutable and immutable factors to identify meaningful future interventions.
   Methods: Six hundred and fifteen adults with type 2 diabetes in the southeastern United States were recruited. A hierarchical model was run with HbA1c as the dependent variable and independent variables entered in blocks: demographics (block 1), socioeconomic (block 2), psychosocial (block 3), built environment (block 4), clinical (block 5), and knowledge/selfcare (block 6).
   Results: Significant associations for HbA1c included self-efficacy (beta = -0.10, p < 0.001), social support (beta = 0.01, p < 0.05), comorbidity (beta = -0.09, p < 0.05), insulin use (beta = 0.95, p < 0.001), medication adherence (beta = -0.11, p < 0.05), and being a former smoker (beta = 0.34, p < 0.05); accounting for 24.4% of the variance.
   Conclusions: Important factors that drive glycemic control are mutable, and amenable to health interventions. Greater attention should be given to interventions that increase self-efficacy and social support, reduce the burden of comorbidities, and enhance medication adherence and smoking cessation. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Walker, Rebekah J.; Egede, Leonard E.] Ralph H Johnson VAMC, Charleston VA HSR&D COIN, Hlth Equ & Rural Outreach Innovat Ctr HEROIC, Charleston, SC USA.
   [Walker, Rebekah J.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.
   [Smalls, Brittany L.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA.
   [Egede, Leonard E.] Med Univ S Carolina, Dept Med, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280,POB 250593, Charleston, SC 29425 USA.
EM egedel@musc.edu
FU National Institute of Diabetes and Digestive and Kidney Disease
   [K24DK093699-01]
FX This study was supported by Grant K24DK093699-01 from The National
   Institute of Diabetes and Digestive and Kidney Disease (PI: Leonard
   Egede).
CR ADA, 2015, DIABETES CARE, V38, pS20
   Aday L A, 1974, Health Serv Res, V9, P208
   Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x
   Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   Alam R, 2009, PATIENT EDUC COUNS, V75, P25, DOI 10.1016/j.pec.2008.08.026
   American Diabetes Association [ADA], 2015, DIABETES CARE S1, V38, pS5
   Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287
   [Anonymous], HLTH PEOPL 2020 OPP
   Bollen SD, 2014, J GEN INTERN MED, V29, P1166
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Carter BL, 2015, CIRC CARDIOVASC QUAL
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Chan JL, 2003, MAYO CLIN PROC, V78, P459, DOI 10.4065/78.4.459
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Chung WW, 2014, PATIENT PREFER ADHER, V8, P1185, DOI 10.2147/PPA.S66619
   Cohen S., 1988, SOCIAL PSYCHOL HLTH
   Echeverria SE, 2004, J URBAN HEALTH, V81, P682, DOI 10.1093/jurban/jth151
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Egede LE, 2010, J GEN INTERN MED, V25, P61, DOI 10.1007/s11606-009-1168-5
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Gao JL, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-66
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Gary-Webb TL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-349
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   Hassali MA, 2015, ALTERN THER HEALTH M, V21, P28
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Jack L, 1999, DIABETES EDUCATOR, V25, P775, DOI 10.1177/014572179902500510
   Jerant A, 2008, MED CARE, V46, P523, DOI 10.1097/MLR.0b013e31815f53a4
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)71146-6
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   Mayberry LS, 2015, J BEHAV MED, V38, P363, DOI 10.1007/s10865-014-9611-4
   McClintock HFDV, 2015, FAM COMMUNITY HEALTH, V38, P169, DOI 10.1097/FCH.0000000000000069
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   National Center for Health Statistics, 2004, SURV QUEST NAT HLTH
   Saydah S, 2010, PUBLIC HEALTH REP, V125, P377, DOI 10.1177/003335491012500306
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Skinner TC, 2004, EUR J ENDOCRINOL, V151, pT13, DOI 10.1530/eje.0.151T013
   Smalls BL, 2012, GEN HOSP PSYCHIAT, V43, P385
   Smalls BL, 2015, J DIABETES COMPLICAT, V29, P186, DOI 10.1016/j.jdiacomp.2014.10.008
   Tan ECK, 2014, RES SOC ADMIN PHARM, V10, P608, DOI 10.1016/j.sapharm.2013.08.006
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker RJ, 2014, GEN HOSP PSYCHIAT, V36, P662, DOI 10.1016/j.genhosppsych.2014.06.011
   Walker RJ, 2014, ENDOCRINE, V47, P29, DOI 10.1007/s12020-014-0195-0
   Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y
   Williams ED, 2013, ANN BEHAV MED, V46, P62, DOI 10.1007/s12160-013-9473-y
NR 48
TC 6
Z9 6
U1 0
U2 25
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD NOV
PY 2015
VL 110
IS 2
BP 193
EP 201
DI 10.1016/j.diabres.2015.09.007
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CY3NS
UT WOS:000366317100011
PM 26411692
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Hammad, S
   Darawad, M
   Hourani, E
   Demeh, W
AF Hammad, Sawsan
   Darawad, Muhammad
   Hourani, Eman
   Demeh, Waddah
TI Predictors of Glycated Hemoglobin among Jordanian Diabetic Patients
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Glycated hemoglobin; Diabetes related distress; Self-management;
   Diabetes
ID SELF-MANAGEMENT PRACTICES; GLYCEMIC CONTROL; TYPE-2 DIABETICS; CARE
   PRACTICES; RISK-FACTORS; KNOWLEDGE; MELLITUS; DISTRESS; ADULTS;
   PREVALENCE
AB Background: We explored the level of Jordanian patients' knowledge, diabetes related distress, self-management activities and these effects on the A1C level.
   Methodology: This descriptive cross-sectional correlational design (conducted in 2013) was utilized to recruit 289 diabetic patients from outpatient diabetes clinics, using self-reported questionnaires (Diabetes Knowledge Test, Diabetes Distress Scale, and Diabetes Self-Management Questionnaire) in addition to chart review for selected variables.
   Results: Participants' had mean glycated hemoglobin of 7.88%. Good glycemic control was significantly associated with higher self-management activities (r=-.147), high income (r=-.171), older age (r=-.252), shorter duration of illness (r=.153), and low levels of distress. Despite these relationships only age, duration of illness and income significantly predicted A1C (F (5, 284) =11.57, P<.001, R-2=.17). Further, diabetes knowledge, diabetes-related distress, and self-management could not predict A1C level.
   Conclusion: Only diabetes-related distress and self-management correlated with patients' A1C, with no predictive power. Thus, further research is required to shed the light on the large unexplained components of the A1C variance.
C1 [Hammad, Sawsan; Hourani, Eman] Univ Jordan, Fac Nursing, Dept Community Hlth Nursing, Amman, Jordan.
   [Darawad, Muhammad] Univ Jordan, Fac Nursing, Dept Clin Nursing, Amman, Jordan.
   [Demeh, Waddah] Al Farabi Coll, Al Farabi Coll Dent & Nursing, Dept Nursing, Riyadh, Saudi Arabia.
RP Hammad, S (reprint author), Univ Jordan, Fac Nursing, Dept Community Hlth Nursing, Amman, Jordan.
EM s.hammad@ju.edu.jo
RI D'emeh, Waddah/H-2585-2015
OI D'emeh, Waddah/0000-0003-3869-1196
FU University of Jordan
FX The authors declare that there is no conflict of interests. This study
   was funded by the University of Jordan.
CR Abdallah S., 2007, Eastern Mediterranean Health Journal, V13, P803
   Adham M., 2010, Eastern Mediterranean Health Journal, V16, P732
   Ajlouni K, 2008, J DIABETES COMPLICAT, V22, P317, DOI 10.1016/j.jdiacomp.2007.01.004
   Al Omari Mousa, 2009, Prim Care Diabetes, V3, P173, DOI 10.1016/j.pcd.2009.08.004
   Al-Adsani AMS, 2009, DIABETES METAB, V35, P121, DOI 10.1016/j.diabet.2008.09.005
   Al-Amer RM, 2011, J DIABETES COMPLICAT, V25, P247, DOI 10.1016/j.jdiacomp.2011.03.001
   Al-Bdour MD, 2008, MIDDLE EAST AFR J OP, V15, P77, DOI 10.4103/0974-9233.51997
   Al-Khawaldeh OA, 2012, J DIABETES COMPLICAT, V26, P10, DOI 10.1016/j.jdiacomp.2011.11.002
   Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857
   Al-Qazaz HK, 2011, INT J CLIN PHARM-NET, V33, P1028, DOI 10.1007/s11096-011-9582-2
   Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011
   Arcury TA, 2012, J AGING HEALTH, V24, P899, DOI 10.1177/0898264312449186
   Ayele K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035515
   Bains SS, 2011, DIABETES TECHNOL THE, V13, P335, DOI 10.1089/dia.2010.0160
   Bebb C, 2005, DIABETIC MED, V22, P1364, DOI 10.1111/j.1464-5491.2005.01662.x
   Daly JM, 2009, J AM BOARD FAM MED, V22, P280, DOI 10.3122/jabfm.2009.03.080114
   Dixon JB, 2014, DIABETIC MED, V31, P232, DOI 10.1111/dme.12306
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Gatt S, 2008, INT J NURS STUD, V45, P1525, DOI 10.1016/j.ijnurstu.2008.02.006
   Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04
   Hawthorne K, 1999, DIABETIC MED, V16, P591, DOI 10.1046/j.1464-5491.1999.00102.x
   Huang Jin, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P176, DOI 10.3969/j.issn.1672-7347.2013.02.011
   Jbour AS, 2003, SAUDI MED J, V24, P761
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008
   Mansour-Ghanaei R, 2013, INT J CLIN EXP MED, V6, P470
   Mesmar M, 2011, WORLD FAM MED, V9, P3
   Mosha TCE, 2009, ECOL FOOD NUTR, V48, P89, DOI 10.1080/03670240802577457
   Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x
   Ng SH, 2012, INT J COLLAB RES INT, V4, P723
   Ozcelik F, 2010, POL ARCH MED WEWN, V120, P399
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rogvi S, 2012, DIABETIC MED, V29, pe382, DOI 10.1111/j.1464-5491.2012.03703.x
   Rubin RR, 2005, AM J MED, V118, P27, DOI 10.1016/j.amjmed.2005.04.012
   Saleh F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1112
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Shakibazadeh E, 2011, IRAN J PUBLIC HEALTH, V40, P146
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Wilkinson A, 2014, INT J NURS STUD, V51, P111, DOI 10.1016/j.ijnurstu.2013.01.006
   Yusuff KB, 2008, PHARM WORLD SCI, V30, P876, DOI 10.1007/s11096-008-9243-2
   Zulman DM, 2012, PATIENT EDUC COUNS, V87, P74, DOI 10.1016/j.pec.2011.07.013
NR 47
TC 6
Z9 6
U1 0
U2 3
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PD NOV
PY 2015
VL 44
IS 11
BP 1482
EP 1491
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CX2OT
UT WOS:000365537200006
PM 26744705
DA 2019-01-08
ER

PT J
AU Pintaudi, B
   Lucisano, G
   Gentile, S
   Bulotta, A
   Skovlund, SE
   Vespasiani, G
   Rossi, MC
   Nicolucci, A
AF Pintaudi, Basilio
   Lucisano, Giuseppe
   Gentile, Sandro
   Bulotta, Angela
   Skovlund, Soren E.
   Vespasiani, Giacomo
   Rossi, Maria C.
   Nicolucci, Antonio
CA BENCH-D Study Grp
TI Correlates of diabetes-related distress in type 2 diabetes: Findings
   from the benchmarking network for clinical and humanistic outcomes in
   diabetes (BENCH-D) study
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Type 2 diabetes; Diabetes related distress; Quality of care;
   Patient-centered outcomes
ID EMOTIONAL DISTRESS; PSYCHOSOCIAL OUTCOMES; COMORBID DEPRESSION;
   OUTPATIENT CLINICS; CARE; NEEDS; ATTITUDES; WISHES; ADULTS; PREVALENCE
AB Objective: To evaluate correlates of high diabetes-related distress (HD) among individuals with type 2 diabetes mellitus (T2DM).
   Methods: The study involved a sample of patients with T2DM who filled in the Problem Areas in Diabetes questionnaire (PAID-5); a score >= 40 indicates HD. Additional instruments included: SF12 health survey (SF12), Well-Being Index (WHO-5), Diabetes Empowerment Scale-Short Form (DES-SF), Patient Assessment of Chronic Illness Care-Short Form (PACIC-SF), Health Care Climate-Short Form (HCC-SF), Global Satisfaction with Diabetes Treatment (GSDT), Summary of Diabetes Self-Care Activities (SDSCA-6); Barriers to Medications (BM), Perceived Social Support (PSS). Clinical data were extracted from computerized medical records. Multivariable logistic regression analyses were performed to identify correlates of HD.
   Results: Of 2374 patients (mean age 65.0 +/- 10.2 years, diabetes duration 14.0 +/- 15.3 years, 59.9% males), 1429 (60.2%) had HD. Compared to patients with a PAID-5 score < 40 those with HD were more often female, living alone, had a lower level of education, higher HbA1c levels, a greater perceived impact of hyperglycemic and hypoglycemic symptoms, a greater number of diabetes-related complications, lower scores of WHO-5, DES-SF, PSS, GSDT, SF-12 PCS, SDSCA-healthy diet and physical activity subscales, higher scores of BM and SDSCA-SMBG component. Multivariable analyses confirmed the relationship between HD and symptoms of hyperglycemia, levels of empowerment, global satisfaction with treatment, perception of barriers to medication, and psychological well-being.
   Conclusion HD is extremely common among people with T2DM, affecting almost two-thirds of patients. High levels of distress are associated with worse clinical and psychosocial outcomes and should be considered as a key patient-centered indicator. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Pintaudi, Basilio] Osped Niguarda Ca Granda, SSD Diabetol, Milan, Italy.
   [Lucisano, Giuseppe; Rossi, Maria C.; Nicolucci, Antonio] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy.
   [Gentile, Sandro] Univ Naples 2, Dept Clin & Expt Med, Naples, Italy.
   [Bulotta, Angela] Novo Nordisk SpA, Rome, Italy.
   [Skovlund, Soren E.] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark.
   [Vespasiani, Giacomo] Madonna del Soccorso Hosp, Diabet Unit, San Benedetto Tronto, AP, Italy.
RP Pintaudi, B (reprint author), Osped Niguarda Ca Granda, SSD Diabetol, Milan, Italy.
EM basiliopinta@yahoo.it
FU Novo Nordisk; Novartis; Merk Sharp Dohme
FX All authors have completed the Unified Competing Interest form at
   http://www.icmje.org/coi_disclosure.pdf and declare that AN is a member
   of the advisory board of Novo Nordisk, Novartis, Merk Sharp & Dohme. He
   has received speaker fees from Novo Nordisk, Novartis, Merk Sharp &
   Dohme; AB is an employee of Novo Nordisk, Rome, Italy; SES is an
   employee of Novo Nordisk A/S, Copenhagen, Denmark. BP, GL, SG, FP, GV,
   MCR declare that they have no competing interests to report. Spouses,
   partners, or children of all authors do not have financial relationships
   that may be relevant to the submitted work; authors do not have
   non-financial interests that may be relevant to the submitted work.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405
   Anderson Robert M, 2009, Ther Patient Educ, V1, P3
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   Barnard KD, 2012, DIABETIC MED, V29, P1358, DOI 10.1111/j.1464-5491.2012.03727.x
   Browne JL, 2013, DIABETIC MED, V30, P620, DOI 10.1111/dme.12078
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Franciosi M, 2001, DIABETES CARE, V24, P1870, DOI 10.2337/diacare.24.11.1870
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Haas L, 2013, DIABETES CARE, V36, pS100, DOI 10.2337/dc13-S100
   Knottnerus JA, 2012, J CLIN EPIDEMIOL, V65, P581, DOI 10.1016/j.jclinepi.2012.03.007
   Lloyd C.E., 2010, EPIDEMIOLOGY DEPRESS
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nicolucci A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-83
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Rossi M.C., 2015, PATIENT ED COUN 0521
   Rossi MCE, 2008, DIABETES CARE, V31, P2166, DOI 10.2337/dc08-0469
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Trief PM, 2007, DIABETES CARE, V30, P1266, DOI 10.2337/dc06-2476
   Young-Hyman D, 2012, PSYCHOSOCIAL CARE PE
NR 33
TC 16
Z9 18
U1 1
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD NOV
PY 2015
VL 79
IS 5
BP 348
EP 354
DI 10.1016/j.jpsychores.2015.08.010
PG 7
WC Psychiatry
SC Psychiatry
GA CV6BJ
UT WOS:000364355400003
PM 26526307
DA 2019-01-08
ER

PT J
AU Vorderstrasse, AA
   Melkus, GD
   Pan, W
   Lewinski, AA
   Johnson, CM
AF Vorderstrasse, Allison A.
   Melkus, Gail D.
   Pan, Wei
   Lewinski, Allison A.
   Johnson, Constance M.
TI Diabetes Learning in Virtual Environments Testing the Efficacy of
   Self-Management Training and Support in Virtual Environments (Randomized
   Controlled Trial Protocol)
SO NURSING RESEARCH
LA English
DT Article
DE e-health; randomized controlled trial; self-management; type 2 diabetes
   mellitus; virtual reality
ID INFORMATION-TECHNOLOGY; PERCENTAGE ENERGY; PROBLEM AREAS; OUTCOMES;
   CARE; EDUCATION; INTERVENTIONS; QUESTIONNAIRE; PROGRAM; WOMEN
AB Background: Ongoing self-management improves outcomes for those with Type 2 diabetes (T2D); however, there are many barriers to patients receiving assistance in this from the healthcare system and peers. Findings from our pilot study showed that a virtual diabetes community on the Internet with real-time interaction among peers with T2Dand with healthcare professionalsis feasible and has the potential to influence clinical and psychosocial outcomes.
   Objective: The purpose of this article is to present the protocol for the Diabetes Learning in Virtual Environments (LIVE) trial.
   Protocol: Diabetes LIVE is a two-group, randomized controlled trial to compare effects of a virtual environment and traditional Web site on diet and physical activity. Our secondary aims will determine the effects on metabolic outcomes; effects of level of engagement and social network formation in LIVE on behavioral outcomes; potential mediating effects of changes in self-efficacy; and diabetes knowledge, diabetes-related distress, and social support on behavior change and metabolic outcomes. We will enroll 300 subjects at two sites (Duke University/Raleigh-Durham, NC and New York University/New York, NY) who have T2D and do not have serious complications or comorbidities. Those randomly assigned to the intervention group have access to the LIVE site where they can find information, synchronous classes with diabetes educators, and peer support to enhance self-management. Those in the control group have access to the same informational and educational content in a traditional asynchronous Web format. Measures of self-management, clinical outcomes, and psychosocial outcomes are assessed at baseline and 3, 6, 12, and 18 months.
   Discussion: Should LIVE prove effective in improved self-management of diabetes, similar interventions could be applied to other prevalent chronic diseases. Innovative programs such as LIVE have potential for improving healthcare access in an easily disseminated alternative model of care that potentially improves the reach of self-management training and support.
C1 [Vorderstrasse, Allison A.; Pan, Wei; Lewinski, Allison A.; Johnson, Constance M.] Duke Univ, Sch Nursing, Durham, NC 27710 USA.
   [Vorderstrasse, Allison A.; Pan, Wei; Lewinski, Allison A.; Johnson, Constance M.] Duke Univ, Sch Med, Durham, NC 27710 USA.
   [Melkus, Gail D.] NYU, Res, New York, NY 10003 USA.
   [Melkus, Gail D.] NYU, Nursing Res, New York, NY 10003 USA.
RP Vorderstrasse, AA (reprint author), Duke Univ, Sch Nursing, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA.
EM allison.vorderstrasse@duke.edu
RI Albertin, Paloma/X-1093-2018
OI Lewinski, Allison/0000-0002-1356-1857; Pan, Wei/0000-0003-2410-9935
FU National Institutes of Health, National Heart, Lung, Blood Institute
   [1R01-HL118189-01]
FX The authors acknowledge that this study is funded by a grant from the
   National Institutes of Health, National Heart, Lung, Blood Institute
   (1R01-HL118189-01). The Diabetes LIVE protocol is registered at
   clinicaltrials.gov. The registration number is: NCT02040038.
CR *AM DIAB ASS, 2009, DIABETES CARE S1, V32, pS13, DOI DOI 10.2337/DC09-S013
   American Association of Diabetes Educators, 2008, DIABETES ED, V34, P445, DOI DOI 10.1177/0145721708316625
   [Anonymous], 2008, DESIGNING SOCIAL WEB
   Bailenson JN, 2005, PRESENCE-TELEOP VIRT, V14, P379, DOI 10.1162/105474605774785235
   Barrera M, 2002, AM J COMMUN PSYCHOL, V30, P637, DOI 10.1023/A:1016369114780
   Blascovich J, 2011, INFINITE REALITY AVA
   Boren SA, 2006, AMIA ANN S P, V2006, P51
   Collins LM, 2006, ANNU REV PSYCHOL, V57, P505, DOI 10.1146/annurev.psych.57.102904.190146
   Dannecker K. L., 2011, ANN M 1 WORLD C EX M
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   DERAMOMELKUS GA, 1992, DIABETES CARE, V15, P864, DOI 10.2337/diacare.15.7.864
   Diggle P., 2013, ANAL LONGITUDINAL DA
   Funnell Martha M, 2003, Curr Diab Rep, V3, P127, DOI 10.1007/s11892-003-0036-7
   Glasgow RE, 2012, PATIENT EDUC COUNS, V87, P81, DOI 10.1016/j.pec.2011.07.024
   Glasgow RE, 2011, J MED INTERNET RES, V13, P70, DOI 10.2196/jmir.1391
   Jackson CL, 2006, J GEN INTERN MED, V21, P105, DOI 10.1111/j.1525-1497.2005.00310.x
   Johnson C, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3045
   Kaufman N, 2010, Int J Clin Pract Suppl, P41, DOI 10.1111/j.1742-1241.2009.02277.x
   Levy J. A., 2005, ANN M SOC CLIN TRIAL
   Li R, 2014, MMWR-MORBID MORTAL W, V63, P1045
   Lorig K, 2010, DIABETES CARE, V33, P1275, DOI 10.2337/dc09-2153
   MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037//1082-989X.7.1.83
   MCCAUL KD, 1987, MED CARE, V25, P868, DOI 10.1097/00005650-198709000-00005
   Murray E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004274.pub4
   Newlin K, 2003, ETHNIC DIS, V13, P61
   Nijland N, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1603
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Or CKL, 2014, INT J MED INFORM, V83, P320, DOI 10.1016/j.ijmedinf.2014.01.009
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Ramadas A, 2011, INT J MED INFORM, V80, P389, DOI 10.1016/j.ijmedinf.2011.02.002
   Resnick PJ, 2010, J MED INTERNET RES, V12, P154, DOI 10.2196/jmir.1339
   Ruggiero L, 2014, JMIR SERIOUS GAMES, V2, P31, DOI 10.2196/games.3260
   Schroeder R, 2008, J VIRTUAL WORLDS RES, V1, P1, DOI DOI 10.4101/JVWR.V1I1.294
   SKELLY AH, 1995, DIABETES EDUCATOR, V21, P38, DOI 10.1177/014572179502100107
   Song M, 2009, NURS HEALTH SCI, V11, P277, DOI 10.1111/j.1442-2018.2009.00458.x
   Taylor-Piliae RE, 2010, J PHYS ACT HEALTH, V7, P87, DOI 10.1123/jpah.7.1.87
   Thompson FE, 2004, PUBLIC HEALTH NUTR, V7, P1097, DOI 10.1079/PHN2004642
   Thompson FE, 2007, J AM DIET ASSOC, V107, P760, DOI 10.1016/j.jada.2007.02.006
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Vorderstrasse A, 2014, WESTERN J NURS RES, V36, P1222, DOI 10.1177/0193945913518993
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch Garry, 2006, Curr Diab Rep, V6, P130, DOI 10.1007/s11892-006-0024-9
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Williams GC, 2007, HEALTH PSYCHOL, V26, P728, DOI 10.1037/0278-6133.26.6.728
   Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686
NR 46
TC 6
Z9 6
U1 3
U2 31
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-6562
EI 1538-9847
J9 NURS RES
JI Nurs. Res.
PD NOV-DEC
PY 2015
VL 64
IS 6
BP 485
EP 493
DI 10.1097/NNR.0000000000000128
PG 9
WC Nursing
SC Nursing
GA CV6YR
UT WOS:000364418800009
PM 26505161
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Fisher, L
   Hessler, D
   Edelman, SV
AF Polonsky, William H.
   Fisher, Lawrence
   Hessler, Danielle
   Edelman, Steven V.
TI Development of a New Measure for Assessing Insulin Delivery Device
   Satisfaction in Patients with Type 1 and Type 2 Diabetes
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID QUALITY-OF-LIFE; QUESTIONNAIRE; INSTRUMENT; DISTRESS; ADULTS
AB Background: Although many different types of insulin delivery devices are currently available, there is no well-accepted, validated method to assess patient satisfaction with these devices and their impact on quality of life and other patient-reported outcomes. To address this problem, we developed the Insulin Device Satisfaction Survey (IDSS) and herein describe its construction and validation. We then examine how key patient factors are associated with device satisfaction.
   Materials and Methods: Items were developed from interviews with adults with type 1 diabetes (T1D) (n=10) and type 2 diabetes (T2D) using insulin (n=10), as well as eight healthcare professionals, leading to an initial pool of 32 items. Separate exploratory factor analyses (EFAs) were conducted with T1D subjects (n=279) and insulin-using T2D subjects (n=209). Construct validity was established with overall well-being (World Health Organization-5), diabetes distress (Diabetes Distress Scale), diabetes self-efficacy (Self-Efficacy for Diabetes Management Scale), and subscales from the Insulin Delivery System Rating Questionnaire. Regression analyses examined associations between total scale satisfaction and demographics, insulin adherence, clinical indicators, and device type (pump vs. nonpump users).
   Results: The two EFAs resulted in a 14-item scale for T1D subjects and a 12-item scale for T2D subjects, with eight items common across both samples. The EFAs yielded three coherent, meaningful factors in each sample, accounting for 55.6% (T1D sample) and 64.1% (T2D sample) of the variance. Validity was established by significant correlations with all criterion variables. For both samples, higher IDSS scores were significantly associated with better glycemic control and greater insulin adherence and pump use. For T2D subjects only, IDDS scores were significantly linked to fewer long-term complications, fewer low blood glucose readings, and older age.
   Conclusions: The IDSS is a reliable, valid measure of insulin device satisfaction in both its T1D form and T2 form. It provides a comprehensive profile of sources of device satisfaction for use in clinical care and research.
C1 [Edelman, Steven V.] Div Endocrinol & Metab, San Diego, CA USA.
   [Polonsky, William H.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Fisher, Lawrence; Hessler, Danielle] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Edelman, Steven V.] Vet Affairs Med Ctr, San Diego, CA 92161 USA.
RP Polonsky, WH (reprint author), POB 2148, Del Mar, CA 92014 USA.
EM whp@behavioraldiabetes.org
FU Sanofi
FX This investigator-initiated study was supported by Sanofi.
CR Anderson RT, 2004, CLIN THER, V26, P565, DOI 10.1016/S0149-2918(04)90059-8
   Barnett AH, 1996, PRACTICAL DIABETES I, V13, P179
   Brod M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-83
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Iannotti RJ, 2006, J DEV BEHAV PEDIATR, V27, P98, DOI 10.1097/00004703-200604000-00003
   Kim M T, 2000, Prog Cardiovasc Nurs, V15, P90, DOI 10.1111/j.1751-7117.2000.tb00211.x
   Molife C, 2009, DIABETES TECHNOL THE, V11, P529, DOI 10.1089/dia.2009.0007
   Nicolucci A, 2008, DIABETIC MED, V25, P213, DOI 10.1111/j.1464-5491.2007.02346.x
   Peyrot M, 2005, DIABETES CARE, V28, P53, DOI 10.2337/diacare.28.1.53
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rubin RR, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-32
NR 13
TC 3
Z9 3
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD NOV 1
PY 2015
VL 17
IS 11
BP 773
EP 779
DI 10.1089/dia.2015.0140
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CV4IB
UT WOS:000364229300005
PM 26167948
DA 2019-01-08
ER

PT J
AU Sturt, J
   Dennick, K
   Due-Christensen, M
   McCarthy, K
AF Sturt, Jackie
   Dennick, Kathryn
   Due-Christensen, Mette
   McCarthy, Kate
TI The Detection and Management of Diabetes Distress in People With Type 1
   Diabetes
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Diabetes distress; Type 1; Review; Interventions; Correlation
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; NORMAL EATING DAFNE;
   GLYCEMIC CONTROL; PROBLEM-AREAS; EMOTIONAL DISTRESS; DEPRESSIVE
   SYMPTOMS; EDUCATION-PROGRAM; STRUCTURED EDUCATION; CLINICAL DEPRESSION
AB Diabetes distress (DD) represents a significant clinical burden in which levels of DD are related to both glycated haemoglobin (HbA1c) and some self-management behaviours. DD is related to, but different from, depression. Differences in DD experienced in people with type 1 and type 2 diabetes have been observed. Commonly measured using the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS), rates of elevated DD in research study participants range from 20 to 30 %. Risk factors for elevated DD in type 1 diabetes are longer duration of diabetes, severe hypoglycaemia, younger age and being female. A systematic review of intervention studies assessing DD identified eight randomised controlled trials (RCTs) and nine pre-post design studies. Only three studies targeted DD with the intervention. Intervention types were diabetes self-management education (DSME), psychologically informed self-management and devices. DSME pre-post studies, namely the Dose Adjustment For Normal Eating (DAFNE) programme, produced more consistent improvements in DD and HbA1c at follow-up. Psychologically informed self-management was more heterogeneous, but several RCTs were effective in reducing DD. Group interventions offered the greatest benefits across intervention designs.
C1 [Sturt, Jackie; Dennick, Kathryn; Due-Christensen, Mette] Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, London SE1 8WA, England.
   [McCarthy, Kate] Univ Hosp Coventry, Coventry, W Midlands, England.
   [McCarthy, Kate] Univ Hosp Warwickshire, Coventry, W Midlands, England.
   [Due-Christensen, Mette] Steno Diabet Ctr, Hlth Promot Res, DK-2820 Gentofte, Denmark.
RP Sturt, J (reprint author), Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, James Clerk Maxwell Bldg,57 Waterloo Rd, London SE1 8WA, England.
EM jackie.sturt@kcl.ac.uk; kathryn.dennick@kcl.ac.uk;
   mette.due-christensen@kcl.ac.uk; kate.mccarthy@uhcw.nhs.uk
OI Due-Christensen, Mette/0000-0003-2604-3730
FU Foundation of European Nurses in Diabetes (FEND); Steno Diabetes Centre;
   Novo Nordisk Foundation; Novo Nordisk A/S
FX Mette Due-Christensen reports salary and research funding from
   Foundation of European Nurses in Diabetes (FEND) and salary from Steno
   Diabetes Centre. Dr. Due-Christensen is presently employed at Steno
   Diabetes Centre A/S. Steno Diabetes Centre is a research hospital and an
   integrated part of the public Danish National Health Service that is
   owned by Novo Nordisk A/S. Steno Diabetes Centre receives part of its
   core funding from unrestricted grants from the Novo Nordisk Foundation
   and Novo Nordisk A/S. Dr. Due-Christensen owns shares in Novo Nordisk.
   No potential conflicts of interest relevant to this article exist.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Ali Z, 2013, DIABETIC MED, V30, P104
   American Diabetes Association, 2015, DIABETES CARE S1, V38, pS1, DOI DOI 10.2337/DC15-S001
   Amiel S, 2002, BRIT MED J, V325, P746
   Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   [Anonymous], 2009, VERHALTENSTHERAPIE V, V30, P458
   Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25
   Brierley S, 2012, DIABETIC MED, V29, P159
   Byrne M, 2012, DIABETES RES CLIN PR, V98, P243, DOI 10.1016/j.diabres.2012.09.017
   Duda-Sobczak A, 2014, DIABETOLOGIA, V57, pS420
   Due-Christensen M, 2012, DIABETIC MED, V29, P251, DOI 10.1111/j.1464-5491.2011.03521.x
   Ehrmann D, 2013, DIABETOLOGIA, V56, pS463
   Ehrmann D, 2014, DIABETES, V63, pA201
   Engel L, 2011, DIABETES RES CLIN PR, V91, P271, DOI 10.1016/j.diabres.2010.11.023
   Esbitt S. A., 2013, SCREENING DEPRESSION
   Esbitt SA, 2014, COGNITIVE BEHAV PRAC
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2014, 74 SCI SESS AM DIAB
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fleer J, 2013, DIABETIC MED, V30, P88, DOI 10.1111/dme.12001
   Friis AM, 2015, DIABET MED J BR DIAB
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Goebel-Fabbri AE, 2011, DIABETES CARE, V34, P545, DOI 10.2337/dc10-1547
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hermanides J, 2011, DIABETIC MED, V28, P1158, DOI 10.1111/j.1464-5491.2011.03256.x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2009, DIABETES TECHNOL THE, V11, P275, DOI 10.1089/dia.2008.0078
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Joensen LE, 2013, DIABETES RES CLIN PR, V101, P278, DOI 10.1016/j.diabres.2013.07.001
   Jones A, 2015, PRIMARY CARE DIABETE
   Keen AJA, 2012, DIABETIC MED, V29, P670, DOI 10.1111/j.1464-5491.2011.03479.x
   Kibbey KJ, 2013, DIABETIC MED, V30, P878, DOI 10.1111/dme.12227
   Law GU, 2013, J PSYCHOSOM RES, V74, P334, DOI 10.1016/j.jpsychores.2012.12.009
   Lerman-Garber I, 2003, SALUD PUBLICA MEXICO, V45, P13, DOI 10.1590/s0036-36342003000100002
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Luyckx K, 2015, PSYCHOL HEALTH MED, V20, P77, DOI 10.1080/13548506.2014.902482
   Markowitz JT, 2012, DIABETIC MED, V29, P526, DOI 10.1111/j.1464-5491.2011.03434.x
   Martyn-Nemeth P, 2014, ACTA DIABETOL, V51, P683, DOI 10.1007/s00592-014-0575-1
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   McIntyre HD, 2010, MED J AUSTRALIA, V192, P637
   Minet LKR, 2011, DIABETOLOGIA, V54, P1620, DOI 10.1007/s00125-011-2120-x
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Pibernik-Okanovic M, 2008, DIABETIC MED, V25, P1252, DOI 10.1111/j.1464-5491.2008.02553.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   POLONSKY WH, 1994, DIABETES CARE, V17, P1178, DOI 10.2337/diacare.17.10.1178
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Sheils E, 2012, DIABETIC MED, V29, P157
   Snoek FJ, 2008, DIABETIC MED, V25, P1337, DOI 10.1111/j.1464-5491.2008.02595.x
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Solomon P, 2004, PSYCHIATR REHABIL J, V27, P392, DOI 10.2975/27.2004.392.401
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Strandberg RB, 2015, DIABET MED
   Sturt J, 2015, DIAB UK PROF C LOND
   Sturt J, 2015, INT DIABETES NURSING
   Tanenbaum ML, 2012, DIABETES EDUCATOR, V38, P695, DOI 10.1177/0145721712452795
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   West Christina, 2002, Br J Community Nurs, V7, P606
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
   Zoffmann V, 2015, DIABETIC MED
   Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017
NR 85
TC 11
Z9 11
U1 1
U2 18
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD NOV
PY 2015
VL 15
IS 11
AR 101
DI 10.1007/s11892-015-0660-z
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CT7WP
UT WOS:000363025700006
PM 26411924
DA 2019-01-08
ER

PT J
AU Mohn, J
   Graue, M
   Assmus, J
   Zoffmann, V
   Thordarson, HB
   Peyrot, M
   Rokne, B
AF Mohn, J.
   Graue, M.
   Assmus, J.
   Zoffmann, V.
   Thordarson, H. B.
   Peyrot, M.
   Rokne, B.
TI Self-reported diabetes self-management competence and support from
   healthcare providers in achieving autonomy are negatively associated
   with diabetes distress in adults with Type 1 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID GLYCEMIC CONTROL; EMOTIONAL DISTRESS; MODEL; MOTIVATION; ATTITUDES;
   OUTCOMES; PEOPLE; WISHES
AB AimTo investigate the associations of self-perceived competence in diabetes management and autonomy support from healthcare providers with diabetes distress in adults with Type 1 diabetes mellitus that is not optimally controlled [HbA(1c) 64mmol/mol (8.0%)].
   MethodsThis cross-sectional study comprised blood sampling and three self-report questionnaires, the Problem Areas in Diabetes scale, the Perceived Competence in Diabetes Scale and a measure of autonomy support by healthcare providers, the Health Care Climate Questionnaire. We fitted blockwise linear regression models to assess the associations between Problem Areas in Diabetes score and the variables of interest (autonomy support and perceived diabetes competence), controlling for clinical and sociodemographic variables.
   ResultsOf the study sample [n=178; mean age 36.7 (10.7) years], 31.5% had long-term complications and 43.2% reported elevated (40) Problem Areas in Diabetes scores. A significant negative association was found between autonomy support and Problem Areas in Diabetes score (B=-3.61, P=0.001), indicating that lower autonomy support was associated with greater diabetes distress. When perceived competence was controlled, it mediated the association of autonomy support with diabetes distress, reducing it to non-significance. There was a significant negative association between perceived competence and Problem Areas in Diabetes score (B=-8.89, P<0.001), indicating that lower perceived competence was associated with greater perceived distress.
   ConclusionsThere was an indirect (fully mediated) relationship between autonomy support and diabetes distress; autonomy support was associated with increased perceived competence, which, in turn, was associated with reduced distress. Healthcare providers' communication styles enhancing perceived competence through autonomy support may contribute to effective treatment for people with Type 1 diabetes and suboptimum glycaemic control.
C1 [Mohn, J.; Thordarson, H. B.] Haukeland Hosp, Endocrinol Sect, Dept Med, N-5021 Bergen, Norway.
   [Mohn, J.; Rokne, B.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
   [Assmus, J.] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway.
   [Zoffmann, V.] Univ Copenhagen, Rigshosp, Res Unit Womens & Childrens Hlth, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark.
   [Zoffmann, V.] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark.
   [Mohn, J.; Graue, M.] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway.
   [Graue, M.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway.
   [Peyrot, M.] Loyola Univ Maryland, Dept Sociol, Baltimore, MD USA.
   [Rokne, B.] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway.
RP Mohn, J (reprint author), Haukeland Hosp, Endocrinol Sect, Dept Med, N-5021 Bergen, Norway.
EM jmoh@helse-bergen.no
FU Western Norway Regional Health Authority; Norwegian Diabetes
   Association; Norwegian Nurses Organisation; Bergen University College
FX The study was supported by the Western Norway Regional Health Authority,
   the Norwegian Diabetes Association, the Norwegian Nurses Organisation
   and Bergen University College.
CR American Association of Diabetes Educators, 2002, DIABETES ED, V28, P749
   Barnard KD, 2014, DIABETIC MED, V31, P522, DOI 10.1111/dme.12400
   Beard E, 2010, PATIENT EDUC COUNS, V80, P227, DOI 10.1016/j.pec.2009.11.008
   Clark Marie, 2008, Prim Care Diabetes, V2, P113, DOI 10.1016/j.pcd.2008.04.004
   Deci E. L, 2002, HDB SELF DETERMINATI
   Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hasvold PE, 2011, J TELEMED TELECARE, V17, P358, DOI 10.1258/jtt.2011.110707
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802
   Julien E, 2009, J HEALTH PSYCHOL, V14, P457, DOI 10.1177/1359105309102202
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Lee YY, 2010, SOC SCI MED, V71, P1811, DOI 10.1016/j.socscimed.2010.08.008
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 1996, J PEDIATR PSYCHOL, V21, P3, DOI 10.1093/jpepsy/21.1.3
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Thorne SE, 2001, PATIENT EDUC COUNS, V42, P81, DOI 10.1016/S0738-3991(00)00095-1
   Thorpe CT, 2013, DIABETES EDUCATOR, V39, P33, DOI 10.1177/0145721712464400
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Wasserman LI, 2006, SPAN J PSYCHOL, V9, P75, DOI 10.1017/S1138741600005990
   Williams GC, 2005, PATIENT EDUC COUNS, V57, P39, DOI 10.1016/j.pec.2004.04.001
   Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58
   Williams GC, 2009, DIABETES EDUCATOR, V35, P484, DOI 10.1177/0145721709333856
   World Health Organization (n.d), PROC TRANSL AD INSTR
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
NR 30
TC 4
Z9 4
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2015
VL 32
IS 11
BP 1513
EP 1519
DI 10.1111/dme.12818
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CU1EW
UT WOS:000363263800016
PM 26032125
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Luyckx, JRK
   Berg, CA
   Bijttebier, P
   Moons, P
   Weets, I
AF Luyckx, Jessica Rassart Koen
   Berg, Cynthia A.
   Bijttebier, Patricia
   Moons, Philip
   Weets, Ilse
TI Psychosocial Functioning and Glycemic Control in Emerging Adults With
   Type 1 Diabetes: A 5-Year Follow-Up Study
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE depressive symptoms; distress; emerging adulthood; longitudinal; Type 1
   diabetes
ID RANDOMIZED CONTROLLED-TRIAL; YOUNG-ADULTS; ILLNESS REPRESENTATIONS;
   DEPRESSIVE SYMPTOMS; COMORBID DEPRESSION; EMOTIONAL DISTRESS;
   HEALTH-CARE; SELF-CARE; METAANALYSIS; INDIVIDUALS
AB Objective: The principal aim of this study was to examine the longitudinal interplay of depressive symptoms, diabetes-specific perceptions and distress, and glycemic control in emerging adults with Type 1 diabetes. Methods: Emerging adults with Type 1 diabetes (18-30 years old) participated in a 2-wave longitudinal study spanning 5 years (N = 164 at Time 1). Patients completed questionnaires on depressive symptoms, diabetes-specific distress (treatment-related, food-related, emotional, and social support problems), and illness perceptions (consequences and personal control) at baseline and follow-up. HbA(1c) values were obtained from treating clinicians. The authors investigated the directionality of effects using cross-lagged path analysis. Results: Stronger perceptions of control predicted a relative decrease in treatment-related problems 5 years later, whereas stronger perceptions of consequences predicted a relative increase in depressive symptoms, treatment-related, food-related, emotional, and social support problems over time. Furthermore, higher depressive symptoms predicted a relative increase in social support problems 5 years later. None of the study variables were related to changes in glycemic control over time. Conclusions: Our findings stress the importance of addressing patients' perceptions and beliefs about their diabetes. Clinicians should find a delicate balance between stressing the importance of diabetes care and preventing patients from feeling overwhelmed or engulfed by the burden of diabetes care. Furthermore, our findings advocate for depression screening and treatment as key elements in holistic diabetes care, given the relatively high prevalence of elevated depressive symptoms in this population.
C1 [Luyckx, Jessica Rassart Koen; Bijttebier, Patricia; Moons, Philip] Katholieke Univ Leuven, B-3000 Louvain, Belgium.
   [Berg, Cynthia A.] Univ Utah, Salt Lake City, UT 84112 USA.
   [Moons, Philip] Univ Gothenburg, Gothenburg, Sweden.
   [Weets, Ilse] Free Univ Brussels, B-1050 Brussels, Belgium.
RP Luyckx, JRK (reprint author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Tiensestr 102, B-3000 Louvain, Belgium.
EM jessica.rassart@ppw.kuleuven.be
OI Moons, Philip/0000-0002-8609-4516
FU Research Foundation Flanders; Research Fund of KU Leuven [OT/11/033]
FX Funding was provided by the Research Foundation Flanders and through
   Grant OT/11/033 from the Research Fund of KU Leuven.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Beverly EA, 2014, ANN BEHAV MED, V48, P137, DOI 10.1007/s12160-014-9602-2
   BOUMA J, 1995, METEN SYMPTOMEN DEPR
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   COYNE JC, 1976, PSYCHIATRY, V39, P28, DOI 10.1080/00332747.1976.11023874
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   Dovey-Pearce G, 2005, HEALTH SOC CARE COMM, V13, P409, DOI 10.1111/j.1365-2524.2005.00577.x
   Edgar KA, 2003, J PEDIATR PSYCHOL, V28, P485, DOI 10.1093/jpepsy/jsg039
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321
   Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007
   Judd LL, 2002, PSYCHIAT CLIN N AM, V25, P685, DOI 10.1016/S0193-953X(02)00026-6
   Kline Rex B, 2005, PRINCIPLES PRACTICES
   Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36
   Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Luyckx K, 2008, J ADOLESCENT HEALTH, V43, P451, DOI 10.1016/j.jadohealth.2008.04.005
   Luyckx K, 2011, PATIENT EDUC COUNS, V85, P245, DOI 10.1016/j.pec.2010.11.013
   Luyckx K, 2010, J BEHAV MED, V33, P228, DOI 10.1007/s10865-010-9249-9
   Mc Sharry J, 2011, DIABETIC MED, V28, P1300, DOI 10.1111/j.1464-5491.2011.03298.x
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Paterson B, 2000, Clin Nurs Res, V9, P402, DOI 10.1177/10547730022158663
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Petrie KJ, 2012, CURR DIR PSYCHOL SCI, V21, P60, DOI 10.1177/0963721411429456
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rassart J, 2014, J CLIN PSYCHOL MED S, V21, P41, DOI 10.1007/s10880-014-9387-2
   Rassart J, 2014, J PSYCHOSOM RES, V76, P139, DOI 10.1016/j.jpsychores.2013.11.015
   Rohan JM, 2014, HEALTH PSYCHOL, V33, P1143, DOI 10.1037/hea0000025
   Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0
   Schulenberg JE, 2004, DEV PSYCHOPATHOL, V16, P799, DOI 10.1017/S0954579404040015
   Snoek FJ, 2008, DIABETIC MED, V25, P1337, DOI 10.1111/j.1464-5491.2008.02595.x
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   Vanhalst J, 2012, J YOUTH ADOLESCENCE, V41, P776, DOI 10.1007/s10964-011-9726-7
   Weissberg-Benchell J, 2007, DIABETES CARE, V30, P2441, DOI 10.2337/dc07-1249
NR 44
TC 7
Z9 7
U1 0
U2 22
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD NOV
PY 2015
VL 34
IS 11
BP 1058
EP 1065
DI 10.1037/hea0000212
PG 8
WC Psychology, Clinical; Psychology
SC Psychology
GA CU2EE
UT WOS:000363335000002
PM 25775385
DA 2019-01-08
ER

PT J
AU Chew, BH
AF Chew, Boon-How
TI Medication adherence on quality of life among adults with type 2
   diabetes mellitus: an exploratory analysis on the EDDMQoL study
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE Medication adherence; Quality of life; Type 2 diabetes mellitus; Primary
   care
ID DISTRESS SCALE; HEALTH; ASSOCIATION; VALIDITY; OUTCOMES; THERAPY
AB Purpose This study examined the association between medication adherence (MA) and health-related quality of life (HRQoL) among the adult type 2 diabetes mellitus at the primary care level.
   Methods In this cross-sectional study, the 8-item Morisky Medication Adherence Scale (MMAS) was the main independent variable and the World Health Organization Quality of Life-Brief the dependent variable. Besides socio-demographic data, diabetes-related distress (DRD) and depression (DS) were included as covariates. Independent association between the MMAS score and HRQoL was done using multiple linear regression.
   Results The participants' response rate was 93.1 % (700/752). Majorities were female (52.8 %), Malay (52.9 %) and married (79.1 %). The mean (SD) for age and the MMAS score was 56.9 (10.18) and 5.6 (1.42), respectively. MMAS total score correlated significantly with all HRQoL domains: overall QoL (OQoL) (r = 0.17), physical QoL (r = 0.11), psychological QoL (r = 0.10), social relationship QoL (r = 0.15) and environmental QoL (EQoL) (r = 0.18). After adjustment for covariates (age, gender, ethnicity, religion, education, income, exercise, macrovascular complications, DRD and DS), MA had persistent effects on OQoL (B = 0.53, 95 % CI 0.012-1.048) and EQoL (B = 0.95, 95 % CI 0.235-1.667).
   Conclusion MA showed prevalent correlation and positive effects on the domains of HRQoL. Despite the small effects of MA on HRQoL, the sheer presence of the independent effects provides healthcare providers good reason for initiative and intervention to improve MA, which would improve quality of life.
C1 Univ Putra Malaysia, Dept Family Med, Fac Med & Hlth Sci, Serdang 43400, Selangor, Malaysia.
RP Chew, BH (reprint author), Univ Putra Malaysia, Dept Family Med, Fac Med & Hlth Sci, Serdang 43400, Selangor, Malaysia.
EM chewboonhow@gmail.com
RI Chew, Boon How/B-2385-2010
OI Chew, Boon How/0000-0002-8627-6248
FU Research University Grants Scheme 2 [RUGS/04-02-2105RU]
FX This study received its funding from the Research University Grants
   Scheme 2 (RUGS/04-02-2105RU). I would like to record my acknowledgment
   to WHO and Dr. Al-Qazaz H.K. et al. for the use of WHOQOL-BREF and the
   MMAS-8 Malay version, respectively. I also like to acknowledge the
   Sepang and Petaling District Health Offices and officers for their
   support in this study and Director General of Health for his permission
   to publish this report. I thank Dr. Firdaus Mukhtar, Professor Sherina
   Mohd Sidik, Dr. NorKasmawati Jamaludin and Dr. Fuziah Paimin for their
   input during the study planning and assistance in data collection.
   Lastly, I would like to thank all the clinic staffs for facilitating the
   data collection.
CR Ahmad NS, 2013, PATIENT PREFER ADHER, V7, P525, DOI 10.2147/PPA.S44698
   Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012
   American Diabetes Association, 2015, DIABETES CARE S1, V38, pS1, DOI DOI 10.2337/DC15-S001
   [Anonymous], 2009, MED ADHERENCE INVOLV
   Asche C, 2011, CLIN THER, V33, P74, DOI 10.1016/j.clinthera.2011.01.019
   Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x
   Chew B. H., 2015, MALAYS FAM PHY UNPUB
   El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Group T, 1998, PSYCHOL MED, V28, P551
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Manan M. M., 2014, J CLIN DIAGNOSTIC RE, V8
   Martinez Y. V., 2008, BMC HEALTH SERV RES, V30, P164
   Ministry of Health Malaysia, 2009, MAN TYP 2 DIAB MELL
   Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x
   Non-Communicable Disease Section, 2013, NAT DIAB REG REP, V1, P2009
   Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100
   Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Sherina M S, 2012, Med J Malaysia, V67, P309
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Vermeire E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.Cd003638.pub2
   WHO Consultation, 1999, 992 WHO
NR 25
TC 6
Z9 6
U1 0
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
EI 1573-2649
J9 QUAL LIFE RES
JI Qual. Life Res.
PD NOV
PY 2015
VL 24
IS 11
BP 2723
EP 2731
DI 10.1007/s11136-015-1006-7
PG 9
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA CS7TO
UT WOS:000362289300017
PM 26001640
DA 2019-01-08
ER

PT J
AU Ehrmann, D
   Kulzer, B
   Haak, T
   Hermanns, N
AF Ehrmann, D.
   Kulzer, B.
   Haak, T.
   Hermanns, N.
TI Research: Educational and Psychological Issues Longitudinal relationship
   of diabetes-related distress and depressive symptoms: analysing
   incidence and persistence
SO DIABETIC MEDICINE
LA English
DT Article
ID CO-MORBID DEPRESSION; RANDOMIZED-TRIAL; METAANALYSIS; PROGRAM;
   PREVALENCE; PEOPLE; TYPE-1; ADULTS; OUTCOMES; RISK
AB Aim To investigate the longitudinal bi-directionality of diabetes-related distress and depressive symptoms.
   Methods A total of 509 patients receiving intensified insulin therapy completed the Centre for Epidemiological Studies Depression scale questionnaire for the assessment of depressive symptoms as well as the Problem Areas in Diabetes questionnaire for the assessment of diabetes-related distress at baseline and at 6-month follow-up. Separate logistic and linear regression analyses for incidence and persistence were performed with demographic (age, gender, BMI) and medical (diabetes type, HbA(1c), diabetes duration, late complications) control variables.
   Results Diabetes-related distress at baseline increased the risk of the incidence of elevated depressive symptoms by 2.56-fold (odds ratio 2.56; 95% CI 1.15-5.72; P = 0.02) when controlling for demographic and medical variables. In addition, diabetes-related distress at baseline doubled the chance of the persistence of elevated depressive symptoms (odds ratio 2.04, 95% CI 1.04-3.99; P = 0.04) when controlling for demographic and medical variables. The chance of having persistent elevated diabetes-related distress was increased 5.94-fold (odds ratio 5.94, 95% CI 2.60-13.59; P < 0.0001) when elevated depressive symptoms were present at baseline. None of the medical variables had an influence on incidence or persistence.
   Conclusions Diabetes-related distress was identified as a risk factor for the incidence and persistence of depressive symptoms. Reducing diabetes-related distress could help to prevent the development of elevated depressive symptoms. Furthermore, depressive symptoms were identified as an amplifier for diabetes-related distress. Diabetes-related distress and depressive symptoms were independent risk factors for each other and should be monitored in routine care to disentangle their influence.
C1 [Ehrmann, D.; Kulzer, B.; Haak, T.; Hermanns, N.] Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.
   [Kulzer, B.; Haak, T.; Hermanns, N.] Diabet Ctr Mergentheim, Diabet Clin, Bad Mergentheim, Germany.
RP Ehrmann, D (reprint author), Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.
EM ehrmann@diabetes-zentrum.de
OI Ehrmann, Dominic/0000-0002-5794-5596
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Castro VM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f288
   Ciechanowski P, 2011, CLIN DIABETES, V29, P43, DOI DOI 10.2337/DIACLIN.29.2.43
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2015, DIABETES CARE, V38, P551, DOI 10.2337/dc14-1416
   Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009
   Hermanns N, 2012, PATIENT EDUC COUNS, V86, P226, DOI 10.1016/j.pec.2011.05.017
   Huang H, 2012, PSYCHOSOMATICS, V53, P21, DOI 10.1016/j.psym.2011.07.001
   Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Psychiatric Research Unit, 1998, WHO 5 WELL BEING IND
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Rubin RR, 2008, DIABETES CARE, V31, P420, DOI 10.2337/dc07-182T
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613
NR 30
TC 18
Z9 18
U1 1
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2015
VL 32
IS 10
BP 1264
EP 1271
DI 10.1111/dme.12861
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CT8DB
UT WOS:000363044100005
PM 26202341
DA 2019-01-08
ER

PT J
AU Burns, RJ
   Deschenes, SS
   Schmitz, N
AF Burns, R. J.
   Deschenes, S. S.
   Schmitz, N.
TI Cyclical relationship between depressive symptoms and diabetes distress
   in people with Type 2 diabetes mellitus: results from the Montreal
   Evaluation of Diabetes Treatment Cohort Study
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; MAJOR DEPRESSION; SELF-CARE; ADULTS; POPULATION; PHQ-9;
   ASSOCIATION; DISORDERS; ADHERENCE; VALIDITY
AB Aims To determine if longitudinal cyclical relationships exist between depressive symptoms and diabetes distress in people with Type 2 diabetes mellitus.
   Methods Data were obtained from the Montreal Evaluation of Diabetes Treatment study, a cohort study of 1691 people with Type 2 diabetes mellitus. Depressive symptoms and diabetes distress, measured with the Patient Health Questionnaire and Diabetes Distress Scale, respectively, were assessed at baseline, 1 year and 2 years. A cross-lagged path model analysis with all autoregressive associations was used. Paths and indirect associations were examined.
   Results All paths in the model were significant. Depressive symptoms were positively associated with diabetes distress across consecutive time points and diabetes distress was positively associated with depressive symptoms across consecutive time points. The association between depressive symptoms at baseline and depressive symptoms at 2 years was mediated by both depressive symptoms and diabetes distress at 1 year. The association between diabetes distress at baseline and diabetes distress at 2 years was also mediated by both depressive symptoms and diabetes distress.
   Conclusions Depressive symptoms and diabetes distress are cyclically related; results suggest that depressive symptoms influence diabetes distress, which, in turn, influences depressive symptoms. Although many studies focus on the differences between depressive symptoms and diabetes distress, the present study is the first to provide longitudinal evidence that these constructs are cyclically related.
C1 [Burns, R. J.; Deschenes, S. S.; Schmitz, N.] McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ H3A 2T5, Canada.
   [Burns, R. J.; Deschenes, S. S.; Schmitz, N.] McGill Univ, Fac Med, Douglas Mental Hlth Univ Inst, Montreal, PQ H3A 2T5, Canada.
   [Schmitz, N.] McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ H3A 2T5, Canada.
RP Burns, RJ (reprint author), McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ H3A 2T5, Canada.
EM rachel.burns@mail.mcgill.ca
RI Deschenes, Sonya/G-6341-2017; Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323; Burns, Rachel/0000-0002-5337-7878
FU Canadian Institutes of Health Research [MOP-106514]
FX This study was funded by Canadian Institutes of Health Research Grant
   MOP-106514.
CR Acock A.C., 2013, DISCOVERING STRUCTUR
   Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Alloy L. B., 1988, COGNITIVE PROCESS, P223
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139
   Carper MM, 2014, J BEHAV MED, V37, P501, DOI 10.1007/s10865-013-9505-x
   CASSEM EH, 1995, PSYCHOSOMATICS, V36, pS2, DOI 10.1016/S0033-3182(95)71698-X
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   Ducat L, 2014, JAMA-J AM MED ASSOC, V312, P691, DOI 10.1001/jama.2014.8040
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2015, HEALTH PSYCHOL, V34, P505, DOI 10.1037/hea0000131
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hessler D, 2015, DIABETES RES CLIN PR, V108, P360, DOI 10.1016/j.diabres.2014.12.017
   Ingram RE, 2011, VULNERABILITY DEPRES
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3
   Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003
   MCDANIEL JS, 1995, ARCH GEN PSYCHIAT, V52, P89
   Moore MT, 2012, CLIN PSYCHOL REV, V32, P496, DOI 10.1016/j.cpr.2012.05.004
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Smith KJ, 2013, PSYCHOSOMATICS, V54, P35, DOI 10.1016/j.psym.2012.08.002
NR 31
TC 13
Z9 13
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2015
VL 32
IS 10
BP 1272
EP 1278
DI 10.1111/dme.12860
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CT8DB
UT WOS:000363044100006
PM 26202184
DA 2019-01-08
ER

PT J
AU Nefs, G
   Bevelander, S
   Hendrieckx, C
   Bot, M
   Ruige, J
   Speight, J
   Pouwer, F
AF Nefs, G.
   Bevelander, S.
   Hendrieckx, C.
   Bot, M.
   Ruige, J.
   Speight, J.
   Pouwer, F.
TI Fear of hypoglycaemia in adults with Type 1 diabetes: results from
   Diabetes MILES - The Netherlands
SO DIABETIC MEDICINE
LA English
DT Article
ID D DISTRESSED PERSONALITY; IMPAIRED AWARENESS; PATIENT EDUCATION;
   MELLITUS; ASSOCIATION; MANAGEMENT; SYMPTOMS; PROGRAM; RISK; CARE
AB Aims To examine sociodemographic, clinical and psychological factors associated with fear of hypoglycaemia in adults with Type 1 diabetes.
   Methods Data were obtained from Diabetes MILES - The Netherlands, an online self-report national survey. This cross-sectional analysis focused on participants with Type 1 diabetes who completed the 18-item Hypoglycaemia Fear Survey - Second Version Worry subscale (HFS-II-W; possible total score range 0-72, higher scores indicating higher fear) (n = 288). To explore correlates of fear of hypoglycaemia, a hierarchical linear regression analysis was performed in participants with full data on sociodemographic, clinical and psychological factors (n = 232; younger and more highly educated than those excluded).
   Results HFS-II-W mean score was 11.1 +/- 11.1. Gender, age, education and having a partner (model 1) were not associated with fear of hypoglycaemia. In model 2, history of severe hypoglycaemia (irrespective of number of events) was associated with (greater) fear of hypoglycaemia, whereas diabetes duration, pump therapy and HbA(1c) were not. Type D personality was positively correlated (model 3), as were symptoms of depression, but not anxiety (model 4). Adding loneliness (model 5) did not improve the model. The fully adjusted analysis showed that fear of hypoglycaemia was associated with depressive symptoms (beta = 0.38, P < 0.001) and history of hypoglycaemia (1-2 events: beta = 0.30, P < 0.001; >= 3 events: beta = 0.19, P = 0.002). Total explained variance was 23%.
   Conclusions Depressive symptoms and history of hypoglycaemia are associated with fear of hypoglycaemia in adults with Type 1 diabetes. These factors may help to identify people with excessive fear, who may particularly benefit from interventions to reduce hypoglycaemia risk and worries.
C1 [Nefs, G.; Bevelander, S.; Pouwer, F.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Hendrieckx, C.; Speight, J.] Diabet Australia, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Hendrieckx, C.; Speight, J.] Deakin Univ, Ctr Mental Hlth & Wellbeing Res, Burwood, Australia.
   [Bot, M.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.
   [Bot, M.] GGZ InGeest, Amsterdam, Netherlands.
   [Ruige, J.] Univ Hosp Ghent, Dept Endocrinol, Ghent, Belgium.
   [Speight, J.] AHP Res, Hornchurch, England.
RP Pouwer, F (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@tilburguniversity.edu
RI Nefs, Giesje/C-9992-2018
OI Speight, Jane/0000-0002-1204-6896
FU Dutch Association for Diabetes Research (Nederlandse Vereniging voor
   Diabetes Onderzoek)/Lilly Diabetes
FX This study was supported by the Prof. Dr J. Terpstra Young Investigator
   Award 2010 from the Dutch Association for Diabetes Research (Nederlandse
   Vereniging voor Diabetes Onderzoek)/Lilly Diabetes to GN. The funding
   source had no role in the design, data collection, analysis or
   interpretation of the study, or in the decision to submit the manuscript
   for publication.
CR Anderbro T, 2010, DIABETIC MED, V27, P1151, DOI 10.1111/j.1464-5491.2010.03078.x
   Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001
   Childs BP, 2005, DIABETES CARE, V28, P1245
   Cox DJ, 2006, DIABETES SPECTRUM, V19, P43, DOI DOI 10.2337/DIASPECT.19.1.43
   DCCT Res Grp, 1991, AM J MED, V90, P450
   de Zoysa N, 2014, DIABETES CARE, V37, P863, DOI 10.2337/dc13-1245
   Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406
   Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x
   Gold AE, 1997, DIABETIC MED, V14, P309
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   HEPBURN DA, 1994, DIABETES CARE, V17, P1273, DOI 10.2337/diacare.17.11.1273
   Hermanns Norbert, 2010, Diabetes Care, V33, pe36, DOI 10.2337/dc09-1656
   Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579
   IRVINE AA, 1992, HEALTH PSYCHOL, V11, P135, DOI 10.1037/0278-6133.11.2.135
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Little SA, 2014, DIABETES-METAB RES, V30, P175, DOI 10.1002/dmrr.2492
   MUHLHAUSER I, 1983, DIABETOLOGIA, V25, P470
   Nefs G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-925
   Nefs G, 2012, J PSYCHOSOM RES, V72, P251, DOI 10.1016/j.jpsychores.2012.01.006
   Ostenson CG, 2014, DIABETIC MED, V31, P92, DOI 10.1111/dme.12261
   Pedersen-Bjergaard U, 2004, DIABETES-METAB RES, V20, P479, DOI 10.1002/dmrr.482
   Pedersen-Bjergaard U, 2003, DIABETES-METAB RES, V19, P232, DOI 10.1002/dmrr.377
   POLONSKY WH, 1992, HEALTH PSYCHOL, V11, P199, DOI 10.1037/0278-6133.11.3.199
   Shiu ATY, 2000, PATIENT EDUC COUNS, V41, P251, DOI 10.1016/S0738-3991(99)00084-1
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   ter Braak EWMT, 2000, DIABETES CARE, V23, P1467, DOI 10.2337/diacare.23.10.1467
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
NR 30
TC 12
Z9 13
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2015
VL 32
IS 10
BP 1289
EP 1296
DI 10.1111/dme.12739
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CT8DB
UT WOS:000363044100008
PM 25764474
DA 2019-01-08
ER

PT J
AU Holmes-Truscott, E
   Skinner, TC
   Pouwer, F
   Speight, J
AF Holmes-Truscott, E.
   Skinner, T. C.
   Pouwer, F.
   Speight, J.
TI Negative appraisals of insulin therapy are common among adults with Type
   2 diabetes using insulin: Results from Diabetes MILES - Australia
   cross-sectional survey
SO DIABETIC MEDICINE
LA English
DT Article
ID SAMPLE CHARACTERISTICS; NATIONAL-SURVEY; RESISTANCE; BARRIERS; SCALE;
   EMPOWERMENT; DEPRESSION; DISTRESS; MELLITUS; CARE
AB Aim To identify insulin therapy appraisals among adults with Type 2 diabetes using insulin and how negative appraisals relate to clinical, self-care and psychosocial outcomes.
   Methods Diabetes MILES -Australia 2011 was a national survey of adults with diabetes, focused on behavioural and psychosocial issues. Subgroup analyses were conducted on the responses of 273 adults with Type 2 diabetes using insulin (46% women; mean +/- SD age: 59 +/- 9 years; diabetes duration: 12 +/- 7 years; years using insulin: 4 +/- 4). They completed validated measures of insulin therapy appraisals (ITAS), depression (PHQ-9), anxiety (GAD-7), diabetes distress (PAID) and diabetes-specific self-efficacy (DES-SF).
   Results Insulin was perceived to be very important, and its benefits (e. g. improves health) were endorsed by most (82%). Fifty-one per cent believed that taking insulin means their diabetes has become worse; 51% that insulin causes weight gain; 39% that they have 'failed to manage' their diabetes. Those with the greatest and least 'ITAS negative' scores did not differ by diabetes duration or years using insulin, or by average number of insulin injections or blood glucose checks per day. Those with more negative insulin appraisals were significantly younger (Mean Diff. = 5 years, P < 0.001), less satisfied with recent blood glucose levels (P < 0.001, d = 0.63), had reduced diabetes-specific self-efficacy (P < 0.001, d = 0.7), and were more likely to report depressive symptoms, anxiety or diabetes distress (all P < 0.001, d = 0.65-1.1).
   Conclusions Negative insulin therapy appraisals are common among adults with Type 2 diabetes using insulin, and are associated with lower general and diabetes-specific emotional well-being, reduced diabetes-specific self-efficacy and satisfaction with blood glucose.
C1 [Holmes-Truscott, E.; Speight, J.] Diabet Australia, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Holmes-Truscott, E.; Speight, J.] Deakin Univ, Sch Psychol, Burwood, Australia.
   [Skinner, T. C.] Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT 0909, Australia.
   [Pouwer, F.] Tilburg Univ, CoRPS, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
   [Speight, J.] AHP Res, Hornchurch, England.
RP Holmes-Truscott, E (reprint author), Diabet Australia, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
EM etruscott@acbrd.org.au
OI Skinner, Timothy/0000-0002-0018-6963; Holmes-Truscott,
   Elizabeth/0000-0001-9139-4663; Speight, Jane/0000-0002-1204-6896
FU National Diabetes Services Scheme (NDSS) Strategic Development Grant;
   Sanofi Aventis
FX The Diabetes MILES - Australia 2011 survey was funded by a National
   Diabetes Services Scheme (NDSS) Strategic Development Grant. The NDSS is
   an initiative of the Australian Government administered by Diabetes
   Australia. The Diabetes MILES Study was also supported by an
   unrestricted educational grant from Sanofi Aventis. None of the funding
   bodies had any involvement in the collection, analysis or interpretation
   of data, in the writing of the manuscript or the decision to submit for
   publication.
CR Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Azmiah ZN, 2011, INT MED J MALAYS, V10, P7
   Chen CC, 2011, DIABETES METAB, V37, P389, DOI 10.1016/j.diabet.2010.12.008
   Hermanns N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-113
   Holmes-Truscott E, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-87
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   LESLIE CA, 1994, DIABETES SPECTRUM, V7, P52
   Leslie CA, 1995, TODAYS THERAPEUTIC T, V13, P21
   Liebl A, 2013, INT J CLIN PRACT, V67, P740, DOI 10.1111/ijcp.12133
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Nam S, 2010, DIABETES CARE, V33, P1747, DOI 10.2337/dc10-0099
   Nefs G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-925
   Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x
   Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348
   Polinski JM, 2012, DIABETES ED, V39, P53
   Polonsky W, 2003, DIABETES, V52, pA417
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2004, CLIN DIABETES, V22, P147
   Rubin RR, 2009, DIABETES EDUCATOR, V35, P1014, DOI 10.1177/0145721709345773
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Speight J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-120
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   TURNER RC, 1995, DIABETES, V44, P1249
   UKPDS, 1998, LANCET, V352, P837
   van der Ven NCW, 2005, PATIENT EDUC COUNS, V56, P313, DOI 10.1016/j.pec.2004.03.005
   Wong S, 2011, DIABETIC MED, V28, P206, DOI 10.1111/j.1464-5491.2010.03195.x
   Woudenberg YJC, 2012, DIABETIC MED, V29, P796, DOI 10.1111/j.1464-5491.2011.03552.x
NR 29
TC 16
Z9 16
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2015
VL 32
IS 10
BP 1297
EP 1303
DI 10.1111/dme.12729
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CT8DB
UT WOS:000363044100009
PM 25683652
DA 2019-01-08
ER

PT J
AU Strandberg, RB
   Graue, M
   Wentzel-Larsen, T
   Peyrot, M
   Thordarson, HB
   Rokne, B
AF Strandberg, R. B.
   Graue, M.
   Wentzel-Larsen, T.
   Peyrot, M.
   Thordarson, H. B.
   Rokne, B.
TI Longitudinal relationship between diabetes-specific emotional distress
   and follow-up HbA(1c) in adults with Type 1 diabetes mellitus
SO DIABETIC MEDICINE
LA English
DT Article
ID GLYCEMIC CONTROL; DEPRESSIVE SYMPTOMS; SCALE; ASSOCIATION; OUTCOMES
AB Aim To examine whether diabetes-specific emotional distress was related to follow-up glycaemic control in adults with Type 1 diabetes mellitus.
   Methods Adults with Type 1 diabetes mellitus completed the Diabetes Distress Scale and reported sociodemographic information when attending a clinical consultation at a university endocrinology unit. Blood samples to determine baseline HbA(1c) were taken during consultations. All respondents' HbA(1c) measurements registered from January 2009 to December 2011 were collected from medical records. The relationship between baseline diabetes-specific emotional distress and HbA(1c) was examined with linear mixed-effects models in 175 patients with complete data.
   Results After controlling for confounders, baseline diabetes-specific emotional distress and glycaemic control were significantly associated (fixed-effect coefficient 0.40, P < 0.001) and the regimen-related distress subscale had the strongest association with glycaemic control (fixed-effect coefficient 0.47, P < 0.001). The two-item measure of diabetes-specific distress had a weaker but still significant association with glycaemic control (fixed-effect coefficient 0.31, P < 0.001). None of these relationships was significant after adjusting for the baseline HbA(1c).
   Conclusions People with elevated baseline diabetes-specific emotional distress are at risk of prolonged suboptimum glycaemic control; therefore, elevated diabetes-specific emotional distress, especially regimen-related distress, might be an important marker for prolonged suboptimum glycaemic control, and might indicate a need for special attention regarding patient self-management.
C1 [Strandberg, R. B.; Graue, M.] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway.
   [Strandberg, R. B.; Rokne, B.] Univ Bergen, Fac Med & Dent, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
   [Graue, M.] Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway.
   [Wentzel-Larsen, T.] Eastern & Southern Norway, Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway.
   [Wentzel-Larsen, T.] Eastern & Southern Norway, Ctr Child & Adolescent Mental Hlth, Oslo, Norway.
   [Wentzel-Larsen, T.] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway.
   [Peyrot, M.] Loyola Univ, Dept Sociol, New Orleans, LA 70118 USA.
   [Thordarson, H. B.] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway.
   [Rokne, B.] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway.
RP Strandberg, RB (reprint author), Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway.
EM rob@hib.no
FU Bergen University College
FX Bergen University College funded the data collection for this study.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Carpenter JR, 2011, J STAT SOFTW, P45
   Carpenter JR, 2013, MULTIPLE IMPUTATION
   Cohen J., 1969, STAT POWER ANAL BEHA
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Guidance for Industry, 2008, GUID IND DIAB MELL D
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hudson JL, 2014, J PSYCHOSOM RES, V76, P265, DOI 10.1016/j.jpsychores.2014.02.004
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Johansen CB, 2014, DIABETIC MED, V31, P1708, DOI 10.1111/dme.12584
   Jorde R, 2000, DIABETIC MED, V17, P451, DOI 10.1046/j.1464-5491.2000.00295.x
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Peyrot M, 2008, DIABETES TECHNOL THE, V10, P461, DOI 10.1089/dia.2008.0031
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rogvi S, 2012, DIABETIC MED, V29, pe382, DOI 10.1111/j.1464-5491.2012.03703.x
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Thanakwang K, 2014, CLIN INTERV AGING, V9, P1353, DOI 10.2147/CIA.S67200
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
NR 26
TC 12
Z9 14
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2015
VL 32
IS 10
BP 1304
EP 1310
DI 10.1111/dme.12781
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CT8DB
UT WOS:000363044100010
PM 25865313
OA Green Published
DA 2019-01-08
ER

PT J
AU Iversen, MM
   Nefs, G
   Tell, GS
   Espehaug, B
   Midthjell, K
   Graue, M
   Pouwer, F
AF Iversen, M. M.
   Nefs, G.
   Tell, G. S.
   Espehaug, B.
   Midthjell, K.
   Graue, M.
   Pouwer, F.
TI Anxiety, depression and timing of insulin treatment among people with
   type 2 diabetes: Nine-year follow-up of the Nord-Trondelag Health Study,
   Norway
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Anxiety; Depression; Insulin therapy; Insulin-naive people; Type 2
   diabetes; Prospective study
ID POOR GLYCEMIC CONTROL; HOSPITAL ANXIETY; EMOTIONAL DISTRESS; RESISTANCE;
   METAANALYSIS; THERAPY; ADULTS; SCALE; ASSOCIATION; PERSONALITY
AB Background: Depression and anxiety have been found to be predictors of poor health outcomes in diabetes, but mechanisms are still unclear.
   Aims: To examine whether symptoms of anxiety and depression were associated with timing of initiating insulin therapy.
   Methods: A cohort study of insulin-naive particpants with type 2 dabetes completed the Hospital Anxiey and Depression Scale, HADS-A (n = 731) and/or the HADS-D (n = 768) in the communy-based Nord-Trendelag Health Study (1995-1997). Information on insulin initiation was retrieved from the Norwegian Prescription Database from January 1, 2004 to November 21, 2012. Cox regression analyses were used to estimate the association between symptoms of anxiety, depression and time to insulin initiation.
   Results: At baseline, 19% reported anxiety symptoms (score >= 8) and 18% depressive symptoms (score >= 8). After a mean follow-up of 4.4 (SD 3.6) years, 337 (40%) participants had started insulin therapy. After adjustment for sociodemographic and clinical variables, anxiety symptoms were associated with later initiation of insulin therapy (HR 0.70,95% CI 0.49-0.99), while depressive symptoms were not. Considering groups simultaneously, having both elevated depressive and elevated anxiety symptoms was associated with later time to insulin initiation (HR 0.62, 95% CI 0.39-0.99), while having only anxiety symptoms (without depressive) HR 0.81, 95% CI 0.50-132) or only depressive symptoms (without anxiety) (HR 1.08,95% CI 0.68-1.72) were not.
   Conclusions: Anxiety was associated with a later initiation of insulin, while depressive symptoms were not. Persons with both elevated levels of anxiety and depression were also less likely to start insulin therapy. These results need further testing in other prospective studies. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Iversen, M. M.; Espehaug, B.; Graue, M.] Bergen Univ Coll, Ctr Evidence Based Practice, N-5020 Bergen, Norway.
   [Iversen, M. M.] Stavanger Univ Hosp, Dept Endocrinol, Stavanger, Norway.
   [Nefs, G.; Pouwer, F.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Tell, G. S.] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway.
   [Midthjell, K.] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Community Med & Gen Practice, Trondheim, Norway.
RP Iversen, MM (reprint author), Bergen Univ Coll, Ctr Evidence Based Practice, POB 7030, N-5020 Bergen, Norway.
EM marjolein.iversen@hib.no
RI Nefs, Giesje/C-9992-2018
CR American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Grant RW, 2007, DIABETES CARE, V30, P1448, DOI 10.2337/dc06-2499
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hastie T, 1990, GEN ADDITIVE MODELS
   Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19
   Iversen MM, 2008, SCAND J PUBLIC HEALT, V36, P62, DOI 10.1177/1403494807085314
   Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801
   Kjaergaard M, 2013, SCAND J PSYCHOL
   Lane JD, 2000, DIABETES CARE, V23, P1321, DOI 10.2337/diacare.23.9.1321
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Maters GA, 2013, PLOS ONE, V9
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537
   Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540
   Nam S, 2010, DIABETES CARE, V33, P1747, DOI 10.2337/dc10-0099
   Nefs G, 2015, DIABETES RES CLIN PR, V108, P94, DOI 10.1016/j.diabres.2015.01.015
   Nefs G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078865
   Nichols GA, 2007, J GEN INTERN MED, V22, P453, DOI 10.1007/s11606-007-0139-y
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Ratanawongsa N, 2012, DIABETES EDUCATOR, V38, P94, DOI 10.1177/0145721711432649
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Snaith R Philip, 2003, Health Qual Life Outcomes, V1, P29, DOI 10.1186/1477-7525-1-29
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Woudenberg YJC, 2012, DIABETIC MED, V29, P796, DOI 10.1111/j.1464-5491.2011.03552.x
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 37
TC 3
Z9 3
U1 0
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD OCT
PY 2015
VL 79
IS 4
BP 309
EP 315
DI 10.1016/j.jpsychores.2015.07.004
PG 7
WC Psychiatry
SC Psychiatry
GA CS8BG
UT WOS:000362310100009
PM 26208403
DA 2019-01-08
ER

PT J
AU Romani-Perez, M
   Outeirino-Iglesias, V
   Moya, CM
   Santisteban, P
   Gonzalez-Matias, LC
   Vigo, E
   Mallo, F
AF Romani-Perez, Marina
   Outeirino-Iglesias, Veronica
   Moya, Christian M.
   Santisteban, Pilar
   Gonzalez-Matias, Lucas C.
   Vigo, Eva
   Mallo, Federico
TI Activation of the GLP-1 Receptor by Liraglutide Increases ACE2
   Expression, Reversing Right Ventricle Hypertrophy, and Improving the
   Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
SO ENDOCRINOLOGY
LA English
DT Article
ID GLUCAGON-LIKE PEPTIDE-1; HYDROPHOBIC SURFACTANT PROTEINS;
   ANGIOTENSIN-CONVERTING ENZYME; RESPIRATORY-DISTRESS-SYNDROME;
   TRANSCRIPTION FACTOR-I; PULMONARY-HYPERTENSION; GENE-EXPRESSION;
   MESSENGER-RNAS; SMOOTH-MUSCLE; PNEUMOCYTES
AB Diabetes alters microvascular function in the vascular beds of organs, including the lungs. Cardiovascular complications of pulmonary vascular affectation may be a consequence of the overactivation of the vasoconstrictive and proliferative components of the renin-angiotensin system. We previously reported that pulmonary physiology and surfactant production is improved by the glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide (LIR) in a rat model of lung hypoplasia. Because we hypothesized that streptozotocin-induced diabetes rats would show deficiencies in lung function, including surfactant proteins, and develop an imbalance of the renin-angiotensin system in the lungs. This effect would in turn be prevented by long-acting agonists of the GLP-1R, such as LIR. The induction of diabetes reduced the surfactant protein A and B in the lungs and caused the vasoconstrictor component of the renin-angiotensin system to predominate, which in turn increased angiotensin II levels, and ultimately being associated with right ventricle hypertrophy. LIR restored surfactant protein levels and reversed the imbalance in the renin-angiotensin system in this type 1 diabetes mellitus rat model. Moreover, LIR provoked a strong increase in angiotensin-converting enzyme 2 expression in the lungs of both diabetic and control rats, and in the circulating angiotensin(1-7) in diabetic animals. These effects prompted complete reversion of right ventricle hypertrophy. The consequences of LIR administration were independent of glycemic control and of glucocorticoids, and they involved NK2 homeobox 1 signaling. This study demonstrates by first time that GLP-1R agonists, such as LIR, might improve the cardiopulmonary complications associated with diabetes.
C1 [Romani-Perez, Marina; Outeirino-Iglesias, Veronica; Gonzalez-Matias, Lucas C.; Vigo, Eva; Mallo, Federico] Univ Vigo, Fac Biol, Ctr Biomed Res CINBIO, Lab Endocrinol, E-36310 Vigo, Spain.
   [Romani-Perez, Marina; Outeirino-Iglesias, Veronica; Gonzalez-Matias, Lucas C.; Vigo, Eva; Mallo, Federico] Univ Vigo Sergas, Inst Biomed Res Vigo IBIV, E-36310 Vigo, Spain.
   [Moya, Christian M.; Santisteban, Pilar] Univ Autonoma Madrid, Spanish Council Res, Inst Biomed Res Alberto Sols, E-28029 Madrid, Spain.
RP Mallo, F (reprint author), Univ Vigo Sergas, Fac Biol, Univ Vigo,Physiol, Inst Biomed Res Vigo IBIV Vigo,Ctr Biomed Res CIN, Campus Vigo, E-36310 Vigo, Spain.
EM fmallo@uvigo.es
RI Santisteban, Pilar/E-7829-2016; Romani Perez, Marina/K-4124-2017;
   Gonzalez Matias, Lucas Carmelo/Q-8102-2018
OI Santisteban, Pilar/0000-0002-2758-796X; Romani Perez,
   Marina/0000-0002-1009-0156; Gonzalez Matias, Lucas
   Carmelo/0000-0003-3762-9219; Mallo, Federico/0000-0002-7119-731X
FU Ministerio de Economia y Competitividad (Spain) [BFU 2011-27790, SAF
   2013-44709-R]; University Teacher Training Fellowship Program of the
   Ministerio de Educacion, Cultura y Deportes (Spain) [AP2008-03120];
   Biomedical Capacities Support Program (BIOCAPS) of the seventh European
   Community Framework Program [REGPOT 2012-2013-1]
FX This work was supported by grants BFU 2011-27790 (to F.M.) and SAF
   2013-44709-R (to P.S.) from Ministerio de Economia y Competitividad
   (Spain). M. R.-P. was supported by the University Teacher Training
   Fellowship Program AP2008-03120 of the Ministerio de Educacion, Cultura
   y Deportes (Spain). E.V. was supported by a contract from the Biomedical
   Capacities Support Program (BIOCAPS) of the seventh European Community
   Framework Program (REGPOT 2012-2013-1).
CR Aras Omer, 2008, Curr Cardiol Rep, V10, P128, DOI 10.1007/s11886-008-0022-4
   Benito E, 1998, ENDOCRINOLOGY, V139, P2363, DOI 10.1210/en.139.5.2363
   BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671
   Bolt RJ, 2001, PEDIATR PULM, V32, P76, DOI 10.1002/ppul.1092
   BROWN LAS, 1986, BIOCHIM BIOPHYS ACTA, V878, P258, DOI 10.1016/0005-2760(86)90154-2
   BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531
   Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968
   Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101
   Chan O, 2002, ENDOCRINOLOGY, V143, P1761, DOI 10.1210/en.143.5.1761
   Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006
   CONDURACHE AP, 2005, P 9 IAPR C MACH VIS, P269
   Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752
   de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1
   Ferreira AJ, 2009, AM J RESP CRIT CARE, V179, P1048, DOI 10.1164/rccm.200811-1678OC
   Fiordaliso F, 2000, LAB INVEST, V80, P513, DOI 10.1038/labinvest.3780057
   Foster DJ, 2010, AM J PHYSIOL-LUNG C, V298, pL392, DOI 10.1152/ajplung.00041.2009
   Gil-Lozano M, 2010, ENDOCRINOLOGY, V151, P2629, DOI 10.1210/en.2009-0915
   Givvimani S., 2011, Archives of Physiology and Biochemistry, V117, P1, DOI 10.3109/13813455.2010.512042
   Guazzi M, 2002, AM J RESP CRIT CARE, V166, P978, DOI 10.1164/rccm.200203-234OC
   Hattori Y, 2010, DIABETOLOGIA, V53, P2256, DOI 10.1007/s00125-010-1831-8
   Heller RS, 1997, DIABETES, V46, P785, DOI 10.2337/diabetes.46.5.785
   Kaparianos A, 2011, CURR MED CHEM, V18, P3506, DOI 10.2174/092986711796642562
   KATO H, 1991, J HYPERTENS, V9, P17
   KIDA K, 1983, AM REV RESPIR DIS, V128, P125, DOI 10.1164/arrd.1983.128.1.125
   LILEY HG, 1989, J CLIN INVEST, V83, P1191, DOI 10.1172/JCI114000
   Liu HB, 2009, J ENDOCRINOL, V201, P59, DOI 10.1677/JOE-08-0468
   Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48
   Fernandez-Real JM, 2008, DIABETES CARE, V31, P958, DOI 10.2337/dc07-2173
   Fernandez-Real JM, 2010, DIABETES CARE, V33, P847, DOI 10.2337/dc09-0542
   Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006
   MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855
   Morrell NW, 1999, AM J PHYSIOL-LUNG C, V277, pL440
   Movahed MR, 2005, CHEST, V128, P3568, DOI 10.1378/chest.128.5.3568
   Nogueiras R, 2004, DIABETES, V53, P2552, DOI 10.2337/diabetes.53.10.2552
   ODOM MJ, 1987, ENDOCRINOLOGY, V121, P1155, DOI 10.1210/endo-121-3-1155
   OFULUE AF, 1988, AM REV RESPIR DIS, V137, P162, DOI 10.1164/ajrccm/137.1.162
   Patel VB, 2012, CIRC RES, V110, P1322, DOI 10.1161/CIRCRESAHA.112.268029
   Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005
   Rayani HH, 1999, EXP LUNG RES, V25, P69, DOI 10.1080/019021499270439
   Roman-Perez M, 2013, ENDOCRINOLOGY, V154, P1144, DOI 10.1210/en.2012-1786
   SANTOS RAS, 1992, HYPERTENSION, V19, P56
   SEEGER W, 1993, CLIN INVESTIGATOR, V71, P177
   Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010
   Shenoy V, 2011, CURR OPIN PHARMACOL, V11, P150, DOI 10.1016/j.coph.2010.12.002
   Shrikrishna D, 2012, CLIN SCI, V123, P487, DOI 10.1042/CS20120081
   SUGAHARA K, 1992, AM J RESP CELL MOL, V6, P307, DOI 10.1165/ajrcmb/6.3.307
   SUGAHARA K, 1994, AM J RESP CELL MOL, V11, P397, DOI 10.1165/ajrcmb.11.4.7917308
   Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0
   UHAL BD, 1986, BIOCHIM BIOPHYS ACTA, V878, P266, DOI 10.1016/0005-2760(86)90155-4
   Vara E, 2001, AM J RESP CRIT CARE, V163, P840, DOI 10.1164/ajrccm.163.4.9912132
   Viby NE, 2013, ENDOCRINOLOGY, V154, P4503, DOI 10.1210/en.2013-1666
   Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428
   Wagenaar GTM, 2013, AM J PHYSIOL-LUNG C, V305, pL341, DOI 10.1152/ajplung.00360.2012
   Weynand B, 1999, RESPIRATION, V66, P14, DOI 10.1159/000029331
   Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327
   YAMAMOTO K, 1992, HYPERTENSION, V19, P692, DOI 10.1161/01.HYP.19.6.692
NR 56
TC 8
Z9 8
U1 0
U2 5
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD OCT
PY 2015
VL 156
IS 10
BP 3559
EP 3569
DI 10.1210/en.2014-1685
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CS7AG
UT WOS:000362235300024
PM 26196539
OA Bronze
DA 2019-01-08
ER

PT J
AU Heru, AM
AF Heru, Alison M.
TI Family-centered Care in the Outpatient General Psychiatry Clinic
SO JOURNAL OF PSYCHIATRIC PRACTICE
LA English
DT Article
DE family interventions; family inclusion; family psychoeducation; family
   systems therapy; evidence-based treatment
ID SOCIAL SUPPORT; THERAPY; PATIENT; ADHERENCE; DISTRESS; MODEL
AB Although family research supports family-centered care for all medical specialties, the benefit of family-centered care has not been fully realized in outpatient practice. Physicians, including psychiatrists, are not routinely taught how to work with families and may not be aware of the evidence-base for family interventions. However, some medical specialties, such as family medicine and palliative care, have a clinical practice that routinely includes the family. Clinicians working in medical clinics, such as diabetes clinics, know that successful management of chronic illness requires family involvement. Psychiatric clinics, such as The Family Center for Bipolar Disorder at Beth Israel Medical Center in New York City, also have a family-centered practice and show improved patient outcomes. This article provides guidelines, including clinical interview questions, to help psychiatrists practice family-centered care, either in a private office or in a general psychiatric outpatient clinic. The guidelines include questions that identify when to seek an in-depth family assessment or consultation. Family-centered care will become more useful when health care reimbursement focuses on patient outcome.
C1 [Heru, Alison M.] Univ Colorado Denver, Dept Psychiat, Aurora, CO 80045 USA.
RP Heru, AM (reprint author), Univ Colorado Denver, 13001 East 17th Pl, Aurora, CO 80045 USA.
EM alison.heru@ucdenver.edu
CR [Anonymous], FAM INCL TREATM
   Berkowitz CB, 2002, MULTIFAMILY GROUPS T, P268
   de Haan KLB, 2015, FAM PROCESS, V54, P116, DOI 10.1111/famp.12113
   Campbell TL, 2002, FAM MED, V34, P312
   Center for Mental Health Services Substance Abuse and Mental Health Services Administration (SAMHSA), 2005, FAM PSYCH INTR VID
   Chung BW, 2014, COMMUNITY MENT HLT J, V50, P787, DOI 10.1007/s10597-014-9733-8
   Crowe M, 2011, J PSYCHIATR MENT HLT, V18, P342, DOI 10.1111/j.1365-2850.2010.01673.x
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   Donovan KA, 2014, PSYCHO-ONCOLOGY, V23, P241, DOI 10.1002/pon.3430
   EPSTEIN NB, 1978, J MARRIAGE FAM COUNS, V4, P19, DOI 10.1111/j.1752-0606.1978.tb00537.x
   Family Psychoeducation Development Team led by McFarlane RW and Dixon L, 2003, FAMILY PSYCHOEDUCATI
   Heru AM, 2007, WORKING FAMILIES PSY
   Katz ML, 2013, PEDIAT DIABETES, V15, P142
   Keogh KM, 2010, AM J MANAG CARE, V17, P105
   Levy RL, 2010, AM J GASTROENTEROL, V105, P946, DOI 10.1038/ajg.2010.106
   Mahler HIM, 2002, HEALTH PSYCHOL, V21, P427, DOI 10.1037//0278-6133.21.5.427
   McDaniel SH, 2001, HDB FAMILY ORIENTED
   Miklowitz D. J., 2010, BIPOLAR DISORDER FAM
   Mitchell AJ, 2011, PSYCHO-ONCOLOGY, V20, P572, DOI 10.1002/pon.1943
   Mitnick S, 2010, J GEN INTERN MED, V25, P255, DOI 10.1007/s11606-009-1206-3
   Molinaro M, 2012, AM J PSYCHIATR REHAB, V15, P81, DOI 10.1080/15487768.2012.655644
   Omole FS, 2011, AM FAM PHYSICIAN, V84, P780
   Rea MM, 2003, J CONSULT CLIN PSYCH, V71, P482, DOI 10.1037/0022-006X.71.3.482
   Rolland J. S., 1994, FAMILIES ILLNESS DIS
   Scheurer D, 2012, AM J MANAG CARE, V18, pE461
   Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215
   Steinglass P, 2011, FAM PROCESS, V50, P393, DOI 10.1111/j.1545-5300.2011.01359.x
   von Sydow K, 2010, FAM PROCESS, V49, P457, DOI 10.1111/j.1545-5300.2010.01334.x
   Wamboldt FS, 2013, WORKING FAMILIES MED, P23
   Wolff JL, 2015, HEALTH EXPECT, V18, P188, DOI 10.1111/hex.12019
NR 30
TC 2
Z9 2
U1 1
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1527-4160
EI 1538-1145
J9 J PSYCHIATR PRACT
JI J. Psychiatr. Pract.
PD SEP
PY 2015
VL 21
IS 5
BP 381
EP 388
DI 10.1097/PRA.0000000000000097
PG 8
WC Psychiatry
SC Psychiatry
GA DD1VQ
UT WOS:000369711300008
PM 26352224
DA 2019-01-08
ER

PT J
AU Carpenter, R
AF Carpenter, Roger
TI Harm/Loss, Threat, and Challenge of Living With Diabetes for Persons
   From Rural Appalachia A Qualitative Study
SO HOLISTIC NURSING PRACTICE
LA English
DT Article
DE Appalachia; diabetes; stress
ID CLINICAL DEPRESSION; DISTRESS; ADULTS; CARE
AB Living with the stress of diabetes involves suffering with pain, being frightened of the unknown, worrying about threats to family, trying to manage restrictions, taking on activities of living the everyday, and moving forward with confidence. The appraisal of the stress of diabetes indicates a need for development of person-centered interventions.
C1 [Carpenter, Roger] W Virginia Univ, Sch Nursing, POB 9600, Morgantown, WV 26506 USA.
RP Carpenter, R (reprint author), W Virginia Univ, Sch Nursing, POB 9600, Morgantown, WV 26506 USA.
EM rcarpenter@hsc.wvu.edu
CR Carpenter R, 2012, J HEALTH CARE POOR U, V23, P726, DOI 10.1353/hpu.2012.0049
   Coyne Cathy A, 2006, Prev Chronic Dis, V3, pA124
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Halverson JA, 2004, ANAL DISPARITIES HLT
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Karlsen B, 2011, J ADV NURS, V68, P391, DOI DOI 10.1111/J.1365-2648.2011.05751.X
   Krishna S, 2010, J RURAL HEALTH, V26, P3, DOI 10.1111/j.1748-0361.2009.00259.x
   Lazarus R. S., 1987, EUROPEAN J PERSONALI, V1, P141, DOI DOI 10.1002/PER.2410010304
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Papelbaum M, 2010, DIABETES RES CLIN PR, V89, P227, DOI 10.1016/j.diabres.2010.05.024
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Serrano E, 2007, J COMMUN HEALTH, V32, P121, DOI 10.1007/s10900-006-9034-4
   Shenton A. K., 2004, ED INFORM, V22, P63, DOI DOI 10.3233/EFI-2004-22201
   Smith C. A., 2011, HDB STRESS SCI BIOL, P195
   Stephens CC, 2005, APPALACHIAN CULTURAL, P197
   Tessaro I, PREVENTING CHRONIC D
   Yang J, 2009, J CLIN NURS, V18, P1295, DOI 10.1111/j.1365-2702.2008.02703.x
NR 22
TC 1
Z9 2
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0887-9311
EI 1550-5138
J9 HOLIST NURS PRACT
JI Holist. Nurs. Pract.
PD SEP-OCT
PY 2015
VL 29
IS 5
BP 323
EP 329
DI 10.1097/HNP.0000000000000103
PG 7
WC Integrative & Complementary Medicine; Nursing
SC Integrative & Complementary Medicine; Nursing
GA DD1YG
UT WOS:000369718600008
PM 26263292
DA 2019-01-08
ER

PT J
AU Ascher-Svanum, H
   Zagar, A
   Jiang, DF
   Schuster, D
   Schmitt, H
   Dennehy, EB
   Kendall, DM
   Raskin, J
   Heine, RJ
AF Ascher-Svanum, Haya
   Zagar, Anthony
   Jiang, Dingfeng
   Schuster, Dara
   Schmitt, Henry
   Dennehy, Ellen B.
   Kendall, David M.
   Raskin, Joel
   Heine, Robert J.
TI Associations Between Glycemic Control, Depressed Mood, Clinical
   Depression, and Diabetes Distress Before and After Insulin Initiation:
   An Exploratory, Post Hoc Analysis
SO DIABETES THERAPY
LA English
DT Article
DE Depressed mood; Depression; Diabetes distress; Glycemic control; Insulin
   therapy
ID HBA1C TARGET; RISK-FACTOR; SELF-CARE; SYMPTOMS; PEOPLE; METAANALYSIS;
   PREVALENCE; RESISTANCE; MORTALITY; MELLITUS
AB Introduction: Although depression is often associated with poor glycemic control in patients with type 2 diabetes mellitus (T2DM), this observation has been inconsistent. This exploratory, post hoc analysis investigated associations between depression parameters and glycemic control using data from a 24-month, prospective, observational, non-interventional study evaluating glycemic response following insulin initiation for T2DM.
   Methods: We analyzed data from a 24-month, prospective, observational study that evaluated glycemic response in patients with T2DM who initiated insulin therapy (N = 985) in 5 European countries. Secondary measures included patient-reported diagnosis of depression at baseline, severity of depressed/anxious mood (EuroQol (EQ)-5D item) and diabetes-related distress (Psychological Distress domain of the Diabetes Health Profile, DHP-18). The latter two measures were assessed at baseline and 5 time points throughout the study. Glycemic control was measured by glycated hemoglobin (HbA1c) at these same time points. Analyses employed t tests to assess the unadjusted baseline difference in HbA1c between patients with and without the respective depression parameter. The potential effect of demographic and clinical confounding variables was controlled through a linear model structure. Patient HbA1c levels were analyzed by presence/absence of a history of diagnosed depression, depressed mood, and diabetes-related distress.
   Results: Patients with higher depression parameters or distress at baseline had significantly higher rates of microvascularcomplications at baseline. Patients with a history of diagnosed depression or high diabetes-related distress had higher HbA1c than patients without. HbA1c of patients with or without depressed mood was not significantly different at baseline. The proportion of patients with depressed mood declined after insulin initiation, whereas the proportion of patients with high diabetes-related distress did not significantly change. HbA1c improved following insulin initiation, regardless of presence/absence of studied depression/distress parameters at baseline.
   Conclusion: History of diagnosed depression, diabetes-related distress, and depressed mood were associated with a higher rate of microvascular complications. Diagnosed depression and diabetes-related distress also showed higher HbA1c at baseline when insulin was initiated. Insulin therapy improved glycemic control, while preexisting depressed mood declined and diabetes-related distress remained unchanged.
C1 [Ascher-Svanum, Haya; Zagar, Anthony; Jiang, Dingfeng; Schuster, Dara; Dennehy, Ellen B.; Kendall, David M.; Raskin, Joel] Eli Lilly & Co, Indianapolis, IN 46285 USA.
   [Schmitt, Henry] Eli Lilly Benelux, Brussels, Belgium.
   [Dennehy, Ellen B.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.
   [Heine, Robert J.] Eli Lilly Canada, Toronto, ON, Canada.
RP Ascher-Svanum, H (reprint author), Eli Lilly & Co, Indianapolis, IN 46285 USA.
EM haya@lilly.com
CR Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Andreoulakis E, 2012, HIPPOKRATIA, V16, P205
   Bloomgarden ZT, 2007, DIABETES CARE, V30, P174, DOI 10.2337/dc07-zb01
   Bot M, 2012, DIABETES CARE, V35, P503, DOI 10.2337/dc11-1749
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Dailey G, 2008, DIABETES OBES METAB, V10, P5, DOI 10.1111/j.1463-1326.2008.00840.x
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Dirmaier J, 2010, PSYCHOTHER PSYCHOSOM, V79, P172, DOI 10.1159/000296135
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2009, GEN HOSP PSYCHIAT, V31, P422, DOI 10.1016/j.genhosppsych.2009.06.007
   Esposito K, 2012, DIABETES OBES METAB, V14, P228, DOI 10.1111/j.1463-1326.2011.01512.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Heckbert SR, 2010, J GEN INTERN MED, V25, P524, DOI 10.1007/s11606-010-1272-6
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Holt RIG, 2014, DIABETES CARE, V37, P2067, DOI 10.2337/dc13-2134
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184
   Katon W, 2009, PSYCHOSOMATICS, V50, P570, DOI 10.1176/appi.psy.50.6.570
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Khan H, 2008, DIABETIC MED, V25, P1108, DOI 10.1111/j.1464-5491.2008.02538.x
   Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Lustman PJ, 2007, PSYCHOSOM MED, V69, P297, DOI 10.1097/PSY.0b013e318060cc2d
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McKellar JD, 2004, DIABETES EDUCATOR, V30, P485, DOI 10.1177/014572170403000320
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Oguz A, 2013, CURR MED RES OPIN, V29, P911, DOI 10.1185/03007995.2013.803053
   Papelbaum M, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-26
   Paschalides C, 2004, J PSYCHOSOM RES, V57, P557, DOI 10.1016/j.jpsychores.2004.03.006
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Richardson LK, 2008, GEN HOSP PSYCHIAT, V30, P509, DOI 10.1016/j.genhosppsych.2008.07.001
   Riddle MC, 2013, DIABETES OBES METAB, V15, P819, DOI 10.1111/dom.12096
   Schmitz N, 2014, DIABETES CARE, V37, P970, DOI 10.2337/dc13-1832
   Sharma SK, 2008, DIABETES RES CLIN PR, V81, pS16, DOI 10.1016/j.diabres.2008.06.009
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Surwit RS, 2005, DIABETES RES CLIN PR, V69, P78, DOI 10.1016/j.diabres.2004.11.002
   Trief PM, 2006, DIABETES CARE, V29, P830, DOI 10.2337/diacare.29.04.06.dc05-1769
   Van Tilburg MAL, 2001, PSYCHOSOM MED, V63, P551, DOI 10.1097/00006842-200107000-00005
   Wagner JA, 2009, J IMMIGR MINOR HEALT, V11, P66, DOI 10.1007/s10903-008-9147-1
NR 49
TC 10
Z9 10
U1 0
U2 10
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1869-6953
EI 1869-6961
J9 DIABETES THER
JI Diabetes Ther.
PD SEP
PY 2015
VL 6
IS 3
BP 303
EP 316
DI 10.1007/s13300-015-0118-y
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CU9NB
UT WOS:000363870100005
PM 26159935
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Wang, GL
   Wang, L
   Wang, YL
   Li, ML
AF Wang, Gong-Ling
   Wang, Lei
   Wang, Yi-Ling
   Li, Ming-Long
TI Risk factors for sexual dysfunction among Chinese women with type 2
   diabetes
SO INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES
LA English
DT Article
DE Type 2 diabetesmellitus; Sexual dysfunction; Women
ID BECK DEPRESSION INVENTORY; FUNCTION INDEX FSFI; PREVALENCE; MELLITUS;
   POSTMENOPAUSAL; POPULATION; DISTRESS; SCORES; IMPACT; DESIRE
AB This study aims to investigate the prevalence of sexual dysfunction among women with type 2 diabetes and to identify the related clinical risk factors. A total of 353 married women with type 2 diabetes who visited the outpatient diabetes clinic of Tai'an Central Hospital completed the self-reported questionnaires, which evaluated depression and sexual dysfunction. The study was conducted from April 2011 to October 2012. Mean age of the participants was 49.19 +/- 9.32 (mean +/- SD) years, duration of diabetes was 3.46 +/- 1.74 years, and mean hemoglobin A1c (HbA1c) level was 7.60 +/- 0.74 %. The overall prevalence of female sexual dysfunction (FSD) among the diabetic women was 70.4 %. The rate was significantly higher in menopausal women (82.3 %) than in nonmenopausal women (60.3 %). No significant relationship between FSD and various factors, such as HbA1c and duration of diabetes, was found. ANOVA revealed a positive association between FSD and age (P = 0.000). In a binary logistic analysis, age (P = 0.049), body mass index (BMI) (P = 0.030), and menopausal status (P = 0.027) were associated with FSD. However, only depression (P = 0.002) was found to be a significant predictor of FSD. Results showed that sexual function among diabetic female patients is mainly related to age, BMI, menopausal status, and depression. Menopausal and depressive symptoms are significant predictors of FSD.
C1 [Wang, Gong-Ling; Li, Ming-Long] Shandong Univ, Dept Endocrinol, Prov Hosp Affiliated, Jinan 250021, Peoples R China.
   [Wang, Gong-Ling; Wang, Lei] Taian City Cent Hosp, Dept Endocrinol, Tai An 271000, Shandong, Peoples R China.
   [Wang, Yi-Ling] Jinan Stomatol Hosp, Dept Orthodont, Jinan 250001, Peoples R China.
RP Li, ML (reprint author), Shandong Univ, Dept Endocrinol, Prov Hosp Affiliated, 324 Weiqi Rd Huaiyin Dist, Jinan 250021, Peoples R China.
EM gllwdoc@163.com
CR Abu Ali RM, 2008, DIABETES CARE, V31, P1580, DOI 10.2337/dc08-0081
   Alder E, 1998, MATURITAS, V29, P19, DOI 10.1016/S0378-5122(98)00024-3
   Ali Naseer, 2013, J Assoc Physicians India, V61, P619
   Basson R, 2010, J SEX MED, V7, P314, DOI 10.1111/j.1743-6109.2009.01617.x
   Brown JS, 2005, DIABETES CARE, V28, P177, DOI 10.2337/diacare.28.1.177
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   Doruk H, 2005, ARCH ANDROLOGY, V51, P1, DOI 10.1080/014850190512798
   Enzlin P, 2003, DIABETES CARE, V26, P409, DOI 10.2337/diacare.26.2.409
   Enzlin P, 2002, DIABETES CARE, V25, P672, DOI 10.2337/diacare.25.4.672
   Eplov L, 2007, J SEX MED, V4, P47, DOI 10.1111/j.1743-6109.2006.00396.x
   Fatemi SS, 2009, DIABETES VASC DIS RE, V6, P38, DOI 10.3132/dvdr.2009.07
   Fedele D, 2000, INT J EPIDEMIOL, V29, P524, DOI 10.1093/ije/29.3.524
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gerstenberger EP, 2010, J SEX MED, V7, P3096, DOI 10.1111/j.1743-6109.2010.01871.x
   Goldstein I, 2007, J SEX MED, V4, P235, DOI 10.1111/j.1743-6109.2007.00450.x
   Hayes RD, 2008, J SEX MED, V5, P777, DOI 10.1111/j.1743-6109.2007.00768.x
   KOLODNY RC, 1971, DIABETES, V20, P557, DOI 10.2337/diab.20.8.557
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P24, DOI 10.1097/00006842-199701000-00004
   Mezones-Holguin E, 2008, GYNECOL ENDOCRINOL, V24, P470, DOI 10.1080/09513590802273749
   Olarinoye J, 2008, J SEX MED, V5, P878, DOI 10.1111/j.1743-6109.2007.00649.x
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   SCHREINERENGEL P, 1985, J SEX MARITAL THER, V11, P165, DOI 10.1080/00926238508405442
   Shi YF, 2012, BIOMED ENVIRON SCI, V25, P557, DOI 10.3967/0895-3988.2012.05.009
   Song SH, 2008, J SEX MED, V5, P1694, DOI 10.1111/j.1743-6109.2008.00840.x
   Steer RA, 2001, PSYCHOL REP, V88, P1075, DOI 10.2466/PR0.88.3.1075-1076
   Tao MF, 2013, PATIENT PREFER ADHER, V7, P223, DOI 10.2147/PPA.S42852
   Veronelli A, 2009, J SEX MED, V6, P1561, DOI 10.1111/j.1743-6109.2009.01242.x
   Wallner LP, 2010, J SEX MED, V7, P881, DOI 10.1111/j.1743-6109.2009.01510.x
   Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206
   Yencilek F, 2010, FERTIL STERIL, V94, P1840, DOI 10.1016/j.fertnstert.2009.10.060
   Yeung A, 2002, J NERV MENT DIS, V190, P94, DOI 10.1097/00005053-200202000-00005
   Zhang Ai-Xia, 2011, Zhonghua Nan Ke Xue, V17, P488
   Ziaei-Rad M, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-50
NR 34
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0973-3930
EI 1998-3832
J9 INT J DIABETES DEV C
JI Int. Diabetes Dev. Ctries.
PD SEP
PY 2015
VL 35
IS 3
BP 219
EP 224
DI 10.1007/s13410-014-0241-8
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CT7WQ
UT WOS:000363025800015
DA 2019-01-08
ER

PT J
AU Shaji, S
   Elayaraja, B
   Kumpatla, S
   Viswanathan, V
AF Shaji, Sripriya
   Elayaraja, B.
   Kumpatla, Satyavani
   Viswanathan, Vijay
CA WHO Collaborating Ctr Res Educ Tra
TI Assessment of depression among type 2 diabetic patients with
   complications and without complications
SO INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES
LA English
DT Article
DE Depression; Distress; Type 2 diabetes; Chronic illness
ID METAANALYSIS
AB Evidence from the past decades strongly suggests that diabetes and depression are associated. Approximately 10-15 % of patients with diabetes meet criteria for comorbid depression. This study is designed to assess the level of depression among type 2 diabetic patients without any complications and type 2 diabetic patients who developed more than two complications due to diabetes. A total of 204 (M:F 138:66) subjects were included in this cross-sectional study. Levels of depressive symptoms were measured using the centre for Epidemiologic Studies Depression scale (CED-D). Considering degree of depression, 74.3 vs. 97.1 % of male had moderate depression (lambda (2) = 12.6, p < 0.0001). In female group, 84.4 vs. 97.1 % of them had moderate depression (lambda (2) = 1.96, p = 0.162). There was no statistical significant difference noted among gender (p = 0.371). People with diabetes have mild/moderate depressive symptoms which can be better said as "Diabetic distress rather depression" irrespective of the presence of diabetic complications. The role of a psychologist here is more on education, reorienting and reconciliation.
C1 [Shaji, Sripriya; Elayaraja, B.; Kumpatla, Satyavani; Viswanathan, Vijay] MV Hosp Diabetes, Madras 600013, Tamil Nadu, India.
   [Shaji, Sripriya; Elayaraja, B.; Kumpatla, Satyavani; Viswanathan, Vijay] Prof M Viswanathans Diabet Res Ctr, Madras 600013, Tamil Nadu, India.
RP Shaji, S (reprint author), MV Hosp Diabetes, 4 Main Rd, Madras 600013, Tamil Nadu, India.
EM srisha250205@gmail.com
CR Adriaanse MC, 2005, QUAL LIFE RES, V14, P1501, DOI 10.1007/s11136-004-0028-3
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   de Groot Mary, 2010, Diabetes Spectr, V23, P15, DOI 10.2337/diaspect.23.1.15
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Poongothai S, 2011, ASS DEPRESSION COMPL, V59
   Solowiejczyk J., 2010, DIABETES SPECTRUM, V23, P11
NR 6
TC 0
Z9 0
U1 1
U2 5
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0973-3930
EI 1998-3832
J9 INT J DIABETES DEV C
JI Int. Diabetes Dev. Ctries.
PD SEP
PY 2015
VL 35
IS 3
BP 310
EP 313
DI 10.1007/s13410-014-0265-0
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CT7WQ
UT WOS:000363025800027
DA 2019-01-08
ER

PT J
AU McCauley, HL
   Blosnich, JR
   Dichter, ME
AF McCauley, Heather L.
   Blosnich, John R.
   Dichter, Melissa E.
TI Adverse Childhood Experiences and Adult Health Outcomes Among Veteran
   and Non-Veteran Women
SO JOURNAL OF WOMENS HEALTH
LA English
DT Article
ID MILITARY SEXUAL TRAUMA; MENTAL-HEALTH; HOUSEHOLD DYSFUNCTION; US ADULTS;
   LIFE-SPAN; ABUSE; RISK; MORTALITY; VIOLENCE; SERVICE
AB Background: Women veterans represent a vulnerable population with unique health needs and disparities in access to care. One constellation of exposures related to subsequent poor health includes adverse childhood experiences (ACEs; e.g., physical and sexual child abuse), though research on impacts of ACEs among women veterans is limited. Methods: Data were drawn from the 2010 Behavioral Risk Factor Surveillance System for the 11 states that included the ACE module (n=36,485). Weighted chi-squared tests and multivariable logistic regression were used to assess the prevalence of ACEs among women veterans compared with women non-veterans and differences in the following outcomes, controlling for ACEs: social support, inadequate sleep, life satisfaction, mental distress, smoking, heavy alcohol use, obesity, diabetes, cardiovascular disease symptoms, asthma, and disability. Results: Women veterans (1.6% of the total sample) reported a higher prevalence of 7 out of 11 childhood adversities and higher mean ACE score than women non-veterans. Women veterans were more likely to be current smokers and report a disability, associations which were attenuated when controlling for ACE. Conclusions: Despite women veterans' higher prevalence of ACE, their health outcomes did not differ substantially from non-veterans. Further research is needed to understand the intersections of traumatic experiences and sources of resilience over the lifecourse among women veterans.
C1 [McCauley, Heather L.] Univ Pittsburgh, Div Adolescent & Young Adult Med, Childrens Hosp Pittsburgh UPMC, Dept Pediat,Sch Med, Pittsburgh, PA 15213 USA.
   [Blosnich, John R.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA.
   [Dichter, Melissa E.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA.
RP McCauley, HL (reprint author), Univ Pittsburgh, Sch Med, Dept Pediat, 3414 Fifth Ave,CHOB Room 109, Pittsburgh, PA 15213 USA.
EM heather.mccauley@chp.edu
FU National Institutes of Health/Office of Research on Women's Health
   Building Interdisciplinary Research Careers in Women's Health
   [K12HD043441]; Office of Academic Affiliations in the Department of
   Veterans Affairs; Department of Veterans Affairs, Veterans Health
   Administration, Health Service Research and Development Service (CDA)
   [10-202]
FX This work was supported by National Institutes of Health/Office of
   Research on Women's Health Building Interdisciplinary Research Careers
   in Women's Health K12HD043441 scholar funds to HLM; a postdoctoral
   fellowship to JRB from the Office of Academic Affiliations in the
   Department of Veterans Affairs; and a career development award from the
   Department of Veterans Affairs, Veterans Health Administration, Health
   Service Research and Development Service to MED (CDA No. 10-202).
CR Afifi TO, 2008, AM J PUBLIC HEALTH, V98, P946, DOI 10.2105/AJPH.2007.120253
   Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4
   Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652
   Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015
   Banyard VL, 2001, J TRAUMA STRESS, V14, P697, DOI 10.1023/A:1013085904337
   Bean-Mayberry B, 2011, WOMEN HEALTH ISS, V21, pS84, DOI 10.1016/j.whi.2011.04.022
   Behavioral Risk Factor Surveillance System, 2013, BRFSS 2010 SURV DAT
   Blosnich JR, 2014, JAMA PSYCHIAT, V71, P1041, DOI 10.1001/jamapsychiatry.2014.724
   Booth BM, 2011, J TRAUMA STRESS, V24, P287, DOI 10.1002/jts.20643
   Bossarte RM, 2011, SOC PSYCH PSYCH EPID, V46, P403, DOI 10.1007/s00127-010-0204-4
   Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/its.20234
   Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021
   Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1609
   Centers for Disease Control and Prevention (CDC), 2010, BEH RISK FACT SURV S
   Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013
   Chartier MJ, 2010, CHILD ABUSE NEGLECT, V34, P454, DOI 10.1016/j.chiabu.2009.09.020
   Cypel Y, 2008, ANN EPIDEMIOL, V18, P244, DOI 10.1016/j.annepidem.2007.11.009
   Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54
   Dichter ME, 2013, MILITARY BEHAV HLTH, V1, P107, DOI [10.1080/21635781.2013.830062, DOI 10.1080/21635781.2013.830062]
   Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564
   Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8
   Finkelhor D, 2007, DEV PSYCHOPATHOL, V19, P149, DOI 10.1017/S0954579407070083
   Ford DC, 2014, PSYCHOL VIOLENCE, V4, P432, DOI 10.1037/a0037723
   Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x
   Kelly UA, 2011, RES NURS HEALTH, V34, P457, DOI 10.1002/nur.20453
   Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999
   Licht AS, 2012, AM J PUBLIC HEALTH, V102, P1868, DOI [10.2105/AJPH.2012.300717, 10.2105/AJPH.2012.301002]
   Liu X, 2005, POPUL RES POLICY REV, V24, P573, DOI 10.1007/s11113-005-5056-3
   Mattocks KM, 2012, SOC SCI MED, V74, P537, DOI 10.1016/j.socscimed.2011.10.039
   McLaughlin KA, 2014, LIFECOURSE APPROACH
   Montgomery AE, 2013, AM J PUBLIC HEALTH, V103, pS262, DOI 10.2105/AJPH.2013.301474
   Rose SMSF, 2014, PM&R, V6, P670, DOI 10.1016/j.pmrj.2014.01.013
   Sadler AG, 2000, OBSTET GYNECOL, V96, P473, DOI 10.1016/S0029-7844(00)00919-4
   Sadler AG, 2004, J WOMENS HEALTH, V13, P799, DOI 10.1089/jwh.2004.13.799
   Schneider KL, 2012, J EPIDEMIOL COMMUN H, V66, P290, DOI 10.1136/jech.2009.103861
   Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754
   Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003
   Timko C, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-15
   Ullman SE, 2013, ADDICT BEHAV, V38, P2219, DOI 10.1016/j.addbeh.2013.01.027
   Walsh K, 2014, J ADOLESCENT HEALTH, V54, P442, DOI 10.1016/j.jadohealth.2013.09.020
   Wheaton AG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-295
   Zinzow HM, 2007, TRAUMA VIOLENCE ABUS, V8, P384, DOI 10.1177/1524838007307295
NR 43
TC 10
Z9 10
U1 1
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-9996
EI 1931-843X
J9 J WOMENS HEALTH
JI J. Womens Health
PD SEP 1
PY 2015
VL 24
IS 9
BP 723
EP 729
DI 10.1089/jwh.2014.4997
PG 7
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal; Obstetrics & Gynecology; Women's Studies
SC Public, Environmental & Occupational Health; General & Internal
   Medicine; Obstetrics & Gynecology; Women's Studies
GA CR6RT
UT WOS:000361475700005
PM 26390379
OA Green Published
DA 2019-01-08
ER

PT J
AU Nefs, G
   Donga, E
   van Someren, E
   Bot, M
   Speight, J
   Pouwer, F
AF Nefs, Giesje
   Donga, Esther
   van Someren, Eus
   Bot, Mariska
   Speight, Jane
   Pouwer, Francois
TI Subjective sleep impairment in adults with type 1 or type 2 diabetes:
   Results from Diabetes MILES-The Netherlands
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Sleep quality; Glycaemic control; Self-care; Emotional
   distress; Fatigue
ID NOCTURNAL HYPOGLYCEMIC EVENTS; EXCESSIVE DAYTIME SLEEPINESS; ASSESSMENT
   SCALE FAS; GLYCEMIC CONTROL; SAMPLE CHARACTERISTICS; NATIONAL-SURVEY;
   QUALITY INDEX; DURATION; IMPACT; POPULATION
AB Aims: Despite growing recognition of the impact of sleep on diabetes, a clear profile of people with diabetes regarding subjective sleep impairment has yet to be established. This study examines: (1) subjective sleep characteristics in adults with type 1 and type 2 diabetes; (2) the relationship of poor subjective sleep quality with glycaemic control, self-care and daytime functioning; (3) possible risk markers for poor sleep quality.
   Methods: In a cross-sectional study, Dutch adults with type 1 (n = 267) or type 2 diabetes (n = 361) completed an online survey, including the Pittsburgh Sleep Quality Index (PSQI), socio-demographic, clinical, self-care and psychological measures.
   Results: Poor sleep quality (PSQI-score > 5) was reported by 31% of adults with type 1 and 42% of adults with type 2 diabetes. Participants with good and poor sleep quality did not differ in self-reported HbA1c or the frequency of meeting lifestyle recommendations. Poor sleep quality was related to a higher self-care burden and higher levels of daytime sleepiness, fatigue, depressive and anxiety symptoms, and diabetes-specific distress. In multivariable logistic regression analyses examining risk markers, poor sleep quality was associated with depressive symptoms in adults with type 1 (OR = 1.39, 95% CI 1.25-1.54) and type 2 diabetes (OR = 1.31, 1.16-1.47), and with being female in those with type 2 diabetes (OR = 2.72, 1.42-5.20).
   Conclusions: Poor subjective sleep quality is prevalent both in adults with type 1 and type 2 diabetes, and is related to poor daytime functioning and higher self-care burden. The temporal relation with depression and merits of therapy should be explored. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Nefs, Giesje; Bot, Mariska; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Donga, Esther] St Elizabeth Hosp, Dept Internal Med, NL-5000 LC Tilburg, Netherlands.
   [van Someren, Eus] Netherlands Inst Neurosci, Dept Sleep & Cognit, NL-1105 BA Amsterdam, Netherlands.
   [van Someren, Eus] VU Univ & Med Ctr, Neurosci Campus Amsterdam, Dept Integrat Neurophysiol & Med Psychol, Ctr Neurogen & Cognit Res CNCR, NL-1081 HV Amsterdam, Netherlands.
   [Bot, Mariska] VU Univ & Med Ctr, Dept Psychiat, NL-1081 HV Amsterdam, Netherlands.
   [Bot, Mariska] EMGO Inst Hlth & Care Res, NL-1081 HV Amsterdam, Netherlands.
   [Speight, Jane] Diabet Australia, Australian Ctr Behav Res Diabet, Melbourne, Vic 3000, Australia.
   [Speight, Jane] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Wellbeing Res, Burwood, Vic 3125, Australia.
   [Speight, Jane] HAHP Res, Hornchurch, England.
RP Nefs, G (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM g.m.nefs@tilburguniversity.edu
RI Nefs, Giesje/C-9992-2018
OI Speight, Jane/0000-0002-1204-6896
FU Dutch Association for Diabetes Research (Nederlandse Vereniging voor
   Diabetes Onderzoek)/Lilly Diabetes
FX This study was supported by the Prof. Dr. J. Terpstra Young Investigator
   Award 2010 from the Dutch Association for Diabetes Research (Nederlandse
   Vereniging voor Diabetes Onderzoek)/Lilly Diabetes to GN. The funding
   source had no role in the design, data collection, analysis or
   interpretation of the study or in the decision to submit the manuscript
   for publication.
CR American Psychiatric Association APA, 2000, DIAGN STAT MAN MENT
   Babson KA, 2010, PSYCHIAT CLIN N AM, V33, P629, DOI 10.1016/j.psc.2010.04.011
   Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9
   Becker PM, 2005, NEUROL CLIN, V23, P1149, DOI 10.1016/j.ncl.2005.05.002
   Borel AL, 2010, DIABETIC MED, V27, P1329, DOI 10.1111/j.1464-5491.2010.03096.x
   Borel AL, 2013, DIABETES CARE, V36, P2902, DOI 10.2337/dc12-2038
   Brod M, 2013, QUAL LIFE RES, V22, P997, DOI 10.1007/s11136-012-0234-3
   Brod Meryl, 2012, J Med Econ, V15, P77, DOI 10.3111/13696998.2011.624144
   BUYSSE DJ, 1991, SLEEP, V14, P331
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124
   Chasens ER, 2013, DIABETES EDUCATOR, V39, P74, DOI 10.1177/0145721712467683
   Chennaoui M, 2015, SLEEP MED REV, V20, P59, DOI 10.1016/j.smrv.2014.06.008
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Cuellar NG, 2008, J CLIN SLEEP MED, V4, P50
   De Vries J, 2004, BRIT J HEALTH PSYCH, V9, P279
   Doi Y, 2001, PSYCHIAT CLIN NEUROS, V55, P213, DOI 10.1046/j.1440-1819.2001.00830.x
   Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430
   Ebrahim IO, 2013, ALCOHOL CLIN EXP RES, V37, DOI 10.1111/acer.12006
   Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776
   Jauch-Chara K, 2010, BEST PRACT RES CL EN, V24, P801, DOI 10.1016/j.beem.2010.07.006
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Luyster FS, 2011, DIABETES EDUCATOR, V37, P347, DOI 10.1177/0145721711400663
   Medeiros C, 2013, ARQ BRAS ENDOCRINOL, V57, P425, DOI 10.1590/S0004-27302013000600003
   Michielsen HJ, 2004, EUR J PSYCHOL ASSESS, V20, P39, DOI 10.1027//1015-5759.20.1.39
   Nefs G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-925
   Nefs G, 2012, J PSYCHOSOM RES, V72, P251, DOI 10.1016/j.jpsychores.2012.01.006
   Ohkuma T, 2013, DIABETES CARE, V36, P611, DOI 10.2337/dc12-0904
   Okubo N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-562
   Porkka-Heiskanen T, 2013, ACTA PHYSIOL, V208, P311, DOI 10.1111/apha.12134
   Rajendran A, 2012, DIABETES METAB J, V36, P70, DOI 10.4093/dmj.2012.36.1.70
   Reutrakul S, 2014, ANN NY ACAD SCI, V1311, P151, DOI 10.1111/nyas.12355
   Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1
   Song YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054951
   Speight J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-120
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   St-Onge MP, 2013, J CLIN SLEEP MED, V9, P73, DOI 10.5664/jcsm.2348
   Trento M, 2008, ACTA DIABETOL, V45, P225, DOI 10.1007/s00592-008-0047-6
   Tsai YW, 2012, FAM PRACT, V29, P30, DOI 10.1093/fampra/cmr041
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Dijk M, 2011, DIABETOLOGIA, V54, P1967, DOI 10.1007/s00125-011-2184-7
   van Kralingen K, DIABETES CARE
   van Son J, 2015, J BEHAV MED, V38, P251, DOI 10.1007/s10865-014-9592-3
   Wan Mahmood WA, 2013, INT J ENDOCRINOL, V2013, DOI DOI 10.1155/2013/341506
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 48
TC 13
Z9 13
U1 1
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2015
VL 109
IS 3
BP 466
EP 475
DI 10.1016/j.diabres.2015.07.008
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CQ9BP
UT WOS:000360906200011
PM 26264411
DA 2019-01-08
ER

PT J
AU Soubani, AO
   Chen, W
   Jang, H
AF Soubani, Ayman O.
   Chen, Wei
   Jang, Hyejeong
TI The outcome of acute respiratory distress syndrome in relation to body
   mass index and diabetes mellitus
SO HEART & LUNG
LA English
DT Article
DE ARDS; BMI; Obesity; Diabetes mellitus; Outcome
ID ACUTE LUNG INJURY; INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED
   PATIENTS; HOSPITAL MORTALITY; PREDICTION SCORE; CLINICAL-TRIAL; SEPTIC
   SHOCK; RISK; OBESITY; SEPSIS
AB Objective: To determine the 28 day mortality of patients with ARDS in relation to body mass index (BMI) and presence diabetes mellitus (DM).
   Design: Retrospective cohort study of patients enrolled in the ARDS Network randomized controlled trials.
   Results: 2914 patients were enrolled in these trials. 112 patients were underweight (BMI < 18.5), 948 patients were normal range (18.5 <= BMI < 25.0), 801 patients were overweight (25.0 <= BMI <30.0), 687 patients were obese (30.0 <= BMI < 40.0), and 175 patients were severely obese (BMI >= 40.0). 469 patients had DM. There was no significant difference in the 28 day mortality in relation to BMI or presence of DM (underweight adjusted OR, 1.217; 95% CI, 0.749-1.979; overweight adjusted OR, 0.887; 95% Cl, 0.696-1.131; obese adjusted OR, 0.812; 95% Cl, 0.624-1.056; severely obese adjusted OR, 1.102; 95% CI, 0.716-1.695; and DM adjusted OR, 0.938; 95% Cl, 0.728-1.208).
   Conclusions: The short term mortality in patients with ARDS is not affected by BMI or the presence of DM. (c) 2015 Elsevier Inc. All rights reserved.
C1 [Soubani, Ayman O.] Wayne State Univ, Sch Med, Sect Pulm & Crit Care Med, Detroit, MI 48201 USA.
   [Chen, Wei; Jang, Hyejeong] Wayne State Univ, Sch Med, Karmanos Canc Ctr, Dept Oncol, Detroit, MI 48201 USA.
RP Soubani, AO (reprint author), Wayne State Univ, Sch Med, Div Pulm Crit Care & Sleep Med, 3990 John R-3 Hudson, Detroit, MI 48201 USA.
EM asoubani@med.wayne.edu
CR [Anonymous], 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801
   Asperen RMWV, 2008, EUR RESPIR J, V31, P363, DOI 10.1183/09031936.00060207
   Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F
   Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC
   Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471
   Brower RG, 2004, NEW ENGL J MED, V351, P327
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V
   Donald B, 1987, MULTIPLE IMPUTATION
   Esper AM, 2011, CRIT CARE MED, V39, P2728, DOI 10.1097/CCM.0b013e318236f27e
   Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7717
   Filgueiras LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044987
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Frank JA, 2000, CRIT CARE MED, V28, P2645, DOI 10.1097/00003246-200007000-00079
   Gajic O, 2005, INTENS CARE MED, V31, P922, DOI 10.1007/s00134-005-2625-1
   Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC
   Galanos AN, 1997, CRIT CARE MED, V25, P1962, DOI 10.1097/00003246-199712000-00010
   Gong MN, 2010, THORAX, V65, P44, DOI 10.1136/thx.2009.117572
   Goulenok C, 2004, CHEST, V125, P1441, DOI 10.1378/chest.125.4.1441
   Iscimen R, 2008, CRIT CARE MED, V36, P1518, DOI 10.1097/CCM.0b013e31816fc2c0
   Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004
   Jeschke MG, 2004, ENDOCRINOLOGY, V145, P4084, DOI 10.1210/en.2004-0592
   Krein PM, 2003, AM J RESP CRIT CARE, V167, P83, DOI 10.1164/rccm.2201012
   Leonidou L, 2007, J INFECTION, V55, P340, DOI 10.1016/j.jinf.2007.05.177
   Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC
   Morris AE, 2007, CHEST, V131, P342, DOI 10.1378/chest.06-1709
   Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001
   O'Brien JM, 2009, CRIT CARE, V13, DOI 10.1186/cc7926
   O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC
   O'Brien JM, 2004, ANN INTERN MED, V140, P338, DOI 10.7326/0003-4819-140-5-200403020-00009
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Ray DE, 2005, CHEST, V127, P2125, DOI 10.1378/chest.127.6.2125
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   RUBIN DB, 1977, J AM STAT ASSOC, V72, P538, DOI 10.2307/2286214
   Singla A, 2014, J CRIT CARE, V29, P66, DOI 10.1016/j.jcrc.2013.10.003
   Soubani AO, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.10.011
   Steinberg KP, 2006, NEW ENGL J MED, V354, P1671
   Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202
   Trillo-Alvarez C, 2011, EUR RESPIR J, V37, P604, DOI 10.1183/09031936.00036810
   van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463
   van Buuren S, 2011, J STAT SOFTW, V45, P1
   Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8866
   Wasmuth HE, 2004, CRIT CARE MED, V32, P1109, DOI 10.1097/01.CCM.0000124873.05080.78
   Wheeler AP, 2006, NEW ENGL J MED, V354, P2213
   Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564
   Yu S, 2013, CRIT CARE MED, V41, P2720, DOI 10.1097/CCM.0b013e318298a2eb
   Zaccardelli DS, 1996, CRIT CARE MED, V24, P247, DOI 10.1097/00003246-199602000-00011
NR 50
TC 7
Z9 8
U1 0
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0147-9563
EI 1527-3288
J9 HEART LUNG
JI Heart Lung
PD SEP-OCT
PY 2015
VL 44
IS 5
BP 441
EP 447
DI 10.1016/j.hrtlng.2015.06.007
PG 7
WC Cardiac & Cardiovascular Systems; Nursing; Respiratory System
SC Cardiovascular System & Cardiology; Nursing; Respiratory System
GA CR0OD
UT WOS:000361017100012
PM 26212460
DA 2019-01-08
ER

PT J
AU Rossi, MC
   Lucisano, G
   Funnell, M
   Piritaudi, B
   Bulotta, A
   Gentile, S
   Scardapane, M
   Skovlund, SE
   Vespasiani, G
   Nicolucci, A
AF Rossi, Maria Chiara
   Lucisano, Giuseppe
   Funnell, Martha
   Piritaudi, Basilio
   Bulotta, Angela
   Gentile, Sandro
   Scardapane, Marco
   Skovlund, Soren Eik
   Vespasiani, Giacomo
   Nicolucci, Antonio
CA BENCH-D Study Grp
TI Interplay among patient empowerment and clinical and person-centered
   outcomes in type 2 diabetes. The BENCH-D study
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Type 2 diabetes; Empowerment; Quality of care; Person-centered outcomes
ID CHRONIC CARE MODEL; SELF-MANAGEMENT EDUCATION; PERFORMANCE-MEASURES;
   COST-EFFECTIVENESS; PEOPLE; SCALE; PROGRAM; SUPPORT; BENCHMARKING;
   ATTITUDES
AB Objective: We evaluated empowerment in T2DM and identified its correlates.
   Methods: A sample of individuals self-administered the Diabetes Empowerment Scale-Short Form (DES-SF) and other 9 validated instruments (person-centered outcomes). Correlates of DES-SF were identified through univariate and multivariate analyses. For person-centered outcomes, ORs express the likelihood of being in upper quartile of DES-SF (Q4) by 5 units of the scale.
   Results: Overall, 2390 individuals were involved. Individuals in Q4 were younger, more often males, had higher levels of school education, lower HbA1c levels and prevalence of complications as compared to individuals in the other quartiles. The likelihood of being in Q4 was directly associated with higher selfreported self-monitoring of blood glucose (SDSCA6-SMBG) (OR=1.09; 95% Cl: 1.03-1.15), higher satisfaction with diabetes treatment (GSDT) (OR=1.15; 95% CI: 1.07-1.25), perceived quality of chronic illness care and patient support (PACIC-SF) (OR = 1.23; 95% CI: 1.16-1.31), and better person-centered communication (HCC-SF) (OR=1.10; 95% CI: 1.01-1.19) and inversely associated with diabetes-related distress (PAID-5) (OR=0.95; 95% CI: 0.92-0.98). Adjusted DES-SF mean scores ranged between centers from 69.8 to 93.6 (intra-class correlation = 0.10; p<0.0001).
   Conclusions: Empowerment was associated with better glycemic control, psychosocial functioning and perceived access to person-centered chronic illness care. Practice of diabetes center plays a specific role.
   Practice implications: DES-SF represents a process and outcome indicator in the practice of diabetes centers. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Rossi, Maria Chiara; Lucisano, Giuseppe; Scardapane, Marco; Nicolucci, Antonio] CORE Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy.
   [Rossi, Maria Chiara; Lucisano, Giuseppe; Piritaudi, Basilio; Scardapane, Marco; Nicolucci, Antonio] Fdn Mario Negri Sud, Lab Clin Epidemiol Diabet & Chron Dis, Santa Maria Imbaro, CH, Italy.
   [Funnell, Martha] Univ Michigan, Sch Med, Dept Med Educ, Ann Arbor, MI USA.
   [Piritaudi, Basilio] Osped Niguarda Ca Granda, SSD Diabetol, Milan, Italy.
   [Bulotta, Angela] NovoNordisk SpA, Rome, Italy.
   [Gentile, Sandro] Univ Naples 2, Dept Clin & Expt Med, Naples, Italy.
   [Skovlund, Soren Eik] NovoNordisk AS, Bagsvaerd, Denmark.
   [Vespasiani, Giacomo] Madonna del Soccorso Hosp, Diabet Unit, San Benedetto Tronto, Italy.
RP Rossi, MC (reprint author), CORE Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy.
OI richiardi, lorenzo/0000-0003-0316-9402
FU Novo Nordisk SpA, Rome
FX The study was supported by an unconditional grant from Novo Nordisk SpA,
   Rome.
CR American Diabetes Association, 2015, DIABETES CARE, P38
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   Anderson Robert M, 2009, Ther Patient Educ, V1, P3
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   Barnard KD, 2012, DIABETIC MED, V29, P1358, DOI 10.1111/j.1464-5491.2012.03727.x
   Beckerle C. M., 2013, Diabetes Spectrum, V26, P172, DOI 10.2337/diaspect.26.3.172
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909
   Bowman S, 2012, B WORLD HEALTH ORGAN, V90, P847, DOI 10.2471/BLT.12.104968
   Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75
   Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x
   Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x
   Fitzpatrick SL, 2013, DIABETES RES CLIN PR, V100, P145, DOI 10.1016/j.diabres.2012.12.016
   Forlani G, 2006, J ENDOCRINOL INVEST, V29, P405, DOI 10.1007/BF03344123
   Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108
   Funnell MM, 2011, TREAT STRATEG DIABET, V3, P98
   Giorda CB, 2014, DIABETIC MED, V31, P615, DOI 10.1111/dme.12366
   Glasgow RE, 2008, DIABETES CARE, V31, P1046, DOI 10.2337/dc07-1845
   Haas L, 2013, DIABETES CARE, V36, pS100, DOI 10.2337/dc13-S100
   Hernandez-Tejada MA, 2012, DIABETES TECHNOL THE, V14, P630, DOI 10.1089/dia.2011.0287
   Kaplan SH, 2009, MED CARE, V47, P378, DOI 10.1097/MLR.0b013e31818dce07
   Leksell J, 2007, SCAND J CARING SCI, V21, P247, DOI 10.1111/j.1471-6712.2007.00463.x
   Maher D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-355
   Musacchio N, 2011, DIABETIC MED, V28, P724, DOI 10.1111/j.1464-5491.2011.03253.x
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nicolucci A, 2010, DIABETIC MED, V27, P1041, DOI 10.1111/j.1464-5491.2010.03055.x
   Nicolucci A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-83
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735
   Schouten LMT, 2010, MED CARE, V48, P884, DOI 10.1097/MLR.0b013e3181eb318f
   Shiu ATY, 2003, DIABETES CARE, V26, P2817, DOI 10.2337/diacare.26.10.2817
   Sousa Valmi D, 2005, Res Theory Nurs Pract, V19, P217, DOI 10.1891/rtnp.2005.19.3.217
   Stuckey HL, 2014, DIABETES CARE, V37, P2466, DOI 10.2337/dc13-2536
   Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029
   Thorpe CT, 2013, DIABETES EDUCATOR, V39, P33, DOI 10.1177/0145721712464400
   Tol A, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-6
NR 37
TC 16
Z9 17
U1 0
U2 16
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD SEP
PY 2015
VL 98
IS 9
BP 1142
EP 1149
DI 10.1016/j.pec.2015.05.012
PG 8
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA CQ8PH
UT WOS:000360870200016
PM 26049679
DA 2019-01-08
ER

PT J
AU Davydow, DS
   Katon, JG
   Rollman, BL
   Unutzer, J
AF Davydow, Dimitry S.
   Katon, Jodie G.
   Rollman, Bruce L.
   Unuetzer, Juergen
TI Improving mental and physical health outcomes in general healthcare
   settings: a Gedenkschrift in honor of Wayne Katon, MD (1950-2015)
SO GENERAL HOSPITAL PSYCHIATRY
LA English
DT Article
DE Mental and physical health outcomes; General healthcare settings; Wayne
   Katon; Depression; Primary care
ID RANDOMIZED-CONTROLLED-TRIAL; LATE-LIFE DEPRESSION; INTEGRATED
   COLLABORATIVE CARE; DISTRESSED HIGH UTILIZERS; CORONARY-ARTERY-DISEASE;
   COST-EFFECTIVENESS; MAJOR DEPRESSION; DIABETES-MELLITUS; PANIC DISORDER;
   CHRONIC-FATIGUE
AB This special article pays tribute to Wayne Katon, MD (1950-2015) with a Gedenkschrift, or review, of his prolific academic career. Abstracts of all of Dr. Katon's Medline citations were reviewed to develop a narrative of his seminal epidemiological and interventional research findings. Specifically, we describe: (a) how Dr. Katon's clinical work and observational epidemiology and health services research informed and guided interventional studies; (b) the evolution of multidisciplinary interventional trials from primary care-based psychiatric consultation to primary care-based collaborative care for depression to multicondition collaborative care; and (c) how Dr. Katon's research has informed the work of other leading researchers in the field of psychosomatic medicine and helped develop a new generation of researchers at the interface of psychiatry and primary care. For more than three decades, Dr. Katon led a multidisciplinary research team that conducted seminal epidemiological studies and randomized trials and that influenced the thinking and research in the field of psychiatry in a number of areas: (a) the importance and impact of mental disorders presenting in primary care settings and (b) the organization of effective multidisciplinary care for primary care patients with common mental disorders and comor-bid medical conditions. Dr. Katon'swork revolutionized the care of psychiatric illnesses in primary care and other medical care settings to the benefit of countless patients worldwide. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Davydow, Dimitry S.; Unuetzer, Juergen] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
   [Katon, Jodie G.] US Dept Vet Affairs VA Puget Sound Hlth Care Syst, Seattle, WA USA.
   [Katon, Jodie G.] VA Off Patient Care, Womens Hlth Serv, Washington, DC USA.
   [Katon, Jodie G.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.
   [Rollman, Bruce L.] Univ Pittsburgh, Ctr Res Hlth Care, Div Gen Internal Med, Pittsburgh, PA USA.
RP Davydow, DS (reprint author), Univ Washington, Dept Psychiat & Behav Sci, Sch Med, Box 356560,1959 NE Pacific St, Seattle, WA 98195 USA.
EM ddavydo1@u.washington.edu
RI Unutzer, Jurgen/N-4048-2018
CR American Diabetes Association, 2008, DIABETES CARE S1, V31, pS12, DOI DOI 10.2337/DC08-S012
   ARCHER J, 2012, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD006525
   BEITMAN BD, 1987, ARCH INTERN MED, V147, P1548, DOI 10.1001/archinte.147.9.1548
   Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   CLARK MR, 1995, AM J MED, V98, P187, DOI 10.1016/S0002-9343(99)80403-3
   Coleman SM, 2013, PSYCHOSOMATICS, V54, P428, DOI 10.1016/j.psym.2013.02.015
   Davydow DS, 2015, GEN HOSP PSYCHIAT, V37, P195, DOI 10.1016/j.genhosppsych.2015.03.013
   Ell K, 2010, DIABETES CARE, V33, P706, DOI 10.2337/dc09-1711
   Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314
   Grote NK, 2014, CONTEMP CLIN TRIALS, V39, P34, DOI 10.1016/j.cct.2014.07.001
   Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111
   Hollifield M, 1997, AM J PSYCHIAT, V154, P766
   Huffman JC, 2014, JAMA INTERN MED, V174, P927, DOI 10.1001/jamainternmed.2014.739
   KATON W, 1982, AM J MED, V72, P241, DOI 10.1016/0002-9343(82)90816-6
   KATON W, 1982, AM J MED, V72, P127, DOI 10.1016/0002-9343(82)90599-X
   KATON W, 1988, AM J MED, V84, P1, DOI 10.1016/0002-9343(88)90001-0
   KATON W, 1985, AM J PSYCHIAT, V142, P1156
   KATON W, 1992, GEN HOSP PSYCHIAT, V14, P86, DOI 10.1016/0163-8343(92)90033-7
   KATON W, 1990, GEN HOSP PSYCHIAT, V12, P355, DOI 10.1016/0163-8343(90)90002-T
   KATON W, 1992, ARCH INTERN MED, V152, P1604, DOI 10.1001/archinte.152.8.1604
   Katon W, 2001, ARCH GEN PSYCHIAT, V58, P241, DOI 10.1001/archpsyc.58.3.241
   Katon W, 2003, GEN HOSP PSYCHIAT, V25, P158, DOI 10.1016/S0163-8343(03)00013-6
   Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109
   Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924
   KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026
   KATON W, 1991, AM J PSYCHIAT, V148, P34
   KATON W, 1984, COMPR PSYCHIAT, V25, P305, DOI 10.1016/0010-440X(84)90063-4
   Katon W J, 1991, Psychiatr Med, V9, P577
   Katon W, 2015, JAMA PSYCHIAT, V72, P612, DOI 10.1001/jamapsychiatry.2015.0082
   Katon W, 2015, AM J PSYCHIAT, V172, P32, DOI 10.1176/appi.ajp.2014.14020258
   Katon W, 2012, ARCH GEN PSYCHIAT, V69, P506, DOI 10.1001/archgenpsychiatry.2011.1548
   Katon W, 2012, ARCH GEN PSYCHIAT, V69, P410, DOI 10.1001/archgenpsychiatry.2011.154
   Katon W, 2010, GEN HOSP PSYCHIAT, V32, P233, DOI 10.1016/j.genhosppsych.2010.01.008
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Katon WJ, 2010, J GEN INTERN MED, V25, P423, DOI 10.1007/s11606-009-1248-6
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2005, ARCH GEN PSYCHIAT, V62, P1313, DOI 10.1001/archpsyc.62.12.1313
   Katon WJ, 2004, J GEN INTERN MED, V19, P1192, DOI 10.1111/j.1525-1497.2004.30405.x
   Katon WJ, 2002, ARCH GEN PSYCHIAT, V59, P1098, DOI 10.1001/archpsyc.59.12.1098
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   KATON WJ, 1991, J GEN INTERN MED, V6, P277, DOI 10.1007/BF02597420
   Kroenke K, 2014, JAMA-J AM MED ASSOC, V312, P240, DOI 10.1001/jama.2014.7689
   Kroenke K, 2010, JAMA-J AM MED ASSOC, V304, P163, DOI 10.1001/jama.2010.944
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428
   Lin EHB, 2012, ANN FAM MED, V10, P6, DOI 10.1370/afm.1343
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Ludman EJ, 2004, GEN HOSP PSYCHIAT, V26, P430, DOI 10.1016/j.genhosppsych.2004.08.010
   Melville JL, 2014, OBSTET GYNECOL, V123, P1237, DOI 10.1097/AOG.0000000000000231
   Melville JL, 2010, OBSTET GYNECOL, V116, P1064, DOI 10.1097/AOG.0b013e3181f60b0a
   Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013
   Pyne JM, 2011, ARCH INTERN MED, V171, P23, DOI 10.1001/archinternmed.2010.395
   Richardson LP, 2008, GEN HOSP PSYCHIAT, V30, P398, DOI 10.1016/j.genhosppsych.2008.06.004
   Richardson LP, 2014, JAMA-J AM MED ASSOC, V312, P809, DOI 10.1001/jama.2014.9259
   Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712
   Richardson LP, 2004, ARCH GEN PSYCHIAT, V61, P475, DOI 10.1001/archpsyc.61.5.475
   Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670
   Roy-Byrne PP, 2001, ARCH GEN PSYCHIAT, V58, P869, DOI 10.1001/archpsyc.58.9.869
   SHAPIRO S, 1984, ARCH GEN PSYCHIAT, V41, P971
   SHAPIRO S, 1985, MED CARE, V23, P1033, DOI 10.1097/00005650-198509000-00002
   Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9
   Simon GE, 2005, PSYCHOL MED, V35, P13, DOI 10.1017/S0033291704002624
   SIMON GE, 1990, AM J PSYCHIAT, V147, P901
   Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550
   Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935
   Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65
   Stanley BA, 1911, HEART THROBS, VTwo, p[1, ii]
   Stewart JC, 2014, PSYCHOSOM MED, V76, P29, DOI 10.1097/PSY.0000000000000022
   Strong V, 2008, LANCET, V372, P40, DOI 10.1016/S0140-6736(08)60991-5
   SULLIVAN M, 1993, ARCH INTERN MED, V153, P1479, DOI 10.1001/archinte.153.12.1479
   Sullivan MD, 2013, JAMA PSYCHIAT, V70, P1041, DOI 10.1001/jamapsychiatry.2013.1965
   Sullivan MD, 1997, AM J MED, V103, P348, DOI 10.1016/S0002-9343(97)00167-8
   Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618
   Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836
   Unutzer J, 2008, AM J MANAG CARE, V14, P95
   Von Korff M, 1998, PSYCHOSOM MED, V60, P143, DOI 10.1097/00006842-199803000-00005
   Von Korff M, 2011, BMJ-BRIT MED J, V10, P343
   VONKORFF M, 1992, ARCH GEN PSYCHIAT, V49, P91
   VONKORFF M, 1987, GEN HOSP PSYCHIAT, V9, P102
   Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391
   Walker EA, 1999, ARCH GEN PSYCHIAT, V56, P609, DOI 10.1001/archpsyc.56.7.609
   Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369
   Walker J, 2014, LANCET ONCOL, V15, P1168, DOI 10.1016/S1470-2045(14)70343-2
   Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212
   Williams JW, 2004, ANN INTERN MED, V140, P1015, DOI 10.7326/0003-4819-140-12-200406150-00012
   Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498
NR 87
TC 3
Z9 3
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0163-8343
EI 1873-7714
J9 GEN HOSP PSYCHIAT
JI Gen. Hosp. Psych.
PD SEP-OCT
PY 2015
VL 37
IS 5
BP 375
EP 386
DI 10.1016/j.genhosppsych.2015.07.005
PG 12
WC Psychiatry
SC Psychiatry
GA CQ4HD
UT WOS:000360564500002
PM 26260404
OA Other Gold
DA 2019-01-08
ER

PT J
AU Ell, K
   Katon, W
   Lee, PJ
   Guterman, J
   Wu, SY
AF Ell, Kathleen
   Katon, Wayne
   Lee, Pey-Jiuan
   Guterman, Jeffrey
   Wu, Shinyi
TI Demographic, clinical and psychosocial factors identify a high-risk
   group for depression screening among predominantly Hispanic patients
   with Type 2 diabetes in safety net care
SO GENERAL HOSPITAL PSYCHIATRY
LA English
DT Article
DE Depression; Type 2 diabetes; Risk factors; Safety net
ID RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; GLYCEMIC CONTROL;
   MENTAL-HEALTH; LOW-INCOME; BIDIRECTIONAL ASSOCIATION; BIOPSYCHOSOCIAL
   MODEL; UNITED-STATES; PREVALENCE; LATINOS
AB Objective: Identify biopsychosocial factors associated with depression for patients with Type 2 diabetes.
   Method: A quasi-experimental clinical trial of 1293 patients was predominantly Hispanic (91%) female (62%), mean age 53 and average diabetes duration 10 years; 373 (29%) patients were depressed and assessed by Patient Health Questionnaire-9. Demographic, baseline clinical and psychosocial variables were compared between depressed and nondepressed patients.
   Results: Bivariate analyses found depression significantly associated (p<0.05) with female gender, diabetes emotional burden and regimen distress, BMI >= 30, lack of an A1C test, diabetes duration, poor self-care, number of diabetes symptoms and complications, functional and physical characteristics (pain, self-rated health condition, Short-Form Health Survey SF-physical, disability score and comorbid illnesses), as well as higher number of ICD-9 diagnoses and emergency room use. A multivariable regression model with stepwise selection identified six key risk factors: greater disability, diabetes symptoms and regimen distress, female gender, less diabetes self-care and lack of A1C. In addition, after controlling for identified six factors, the number of psychosocial stressors significantly associated with increased risk of depression (adjusted odds ratio-1.37, 95% confidence intervals: 1.18-1.58, p<.0001).
   Conclusion: Knowing biopsychosocial factors could help primary care physicians and endocrinologists identify a high-risk group of patients needing depression screening. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ell, Kathleen; Lee, Pey-Jiuan; Wu, Shinyi] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA.
   [Katon, Wayne] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
   [Guterman, Jeffrey] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Guterman, Jeffrey] Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA.
   [Wu, Shinyi] Univ So Calif, Edward R Roybal Inst Aging, Los Angeles, CA 90089 USA.
   [Wu, Shinyi] Univ So Calif, Daniel J Epstein Dept Ind & Syst Engn, Los Angeles, CA 90089 USA.
RP Ell, K (reprint author), Univ So Calif, Sch Social Work, MRF 214,MC 0411, Los Angeles, CA 90089 USA.
EM ell@usc.edu; wkaton@u.washington.edu; peylee@usc.edu;
   JGuterman@dhs.lacounty.gov; shinyiwu@usc.edu
FU Assistant Secretary for Planning and Evaluation [1R18AE000054-01,
   NCT01781013]
FX The study is supported by Assistant Secretary for Planning and
   Evaluation (for the US Department of Health and Human Services)
   1R18AE000054-01. Trial Registration: NCT01781013,
   clinicaltrials.gov/ct/gui.
CR American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   Baig AA, 2014, ETHNIC DIS, V24, P28
   Bauer AM, 2014, PREV MED, V66, P167, DOI 10.1016/j.ypmed.2014.06.017
   Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245
   Bruce DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081254
   Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481
   Cabassa LJ, 2008, SOC SCI MED, V66, P2413, DOI 10.1016/j.socscimed.2008.01.054
   Clarke G, 2013, GEN HOSP PSYCHIAT, V35, P339, DOI 10.1016/j.genhosppsych.2013.03.013
   Druss BG, 2013, GEN HOSP PSYCHIAT, V35, P345, DOI 10.1016/j.genhosppsych.2013.03.012
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Ell K, 2008, CANCER, V112, P616, DOI 10.1002/cncr23203
   Ell K, 2014, PSYCHOSOMATICS, V55, P555, DOI 10.1016/j.psym.2014.03.007
   Ell K, 2012, PSYCHOSOMATICS, V53, P347, DOI 10.1016/j.psym.2011.12.009
   Ell K, 2010, DIABETES CARE, V33, P706, DOI 10.2337/dc09-1711
   Ell K, 2009, INT J PSYCHIAT MED, V39, P113, DOI 10.2190/PM.39.2.a
   ENGEL GL, 1980, AM J PSYCHIAT, V137, P535
   Fiscella K, 2008, ARCH INTERN MED, V168, P1843, DOI 10.1001/archinte.168.17.1843
   Fisher EB, 2012, J AFFECT DISORDERS, V142, pS56, DOI 10.1016/S0165-0327(12)70009-5
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fortmann AL, 2011, HEALTH PSYCHOL, V30, P251, DOI 10.1037/a0022850
   Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gross R, 2005, J GEN INTERN MED, V20, P460, DOI 10.1111/j.1525-1497.2005.30003.x
   Haberer JE, 2013, GEN HOSP PSYCHIAT, V35, P349, DOI 10.1016/j.genhosppsych.2013.03.009
   Hanas R, 2010, DIABETES CARE, V33, P1903, DOI 10.2337/dc10-0953
   Hofmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079809
   Hudson DL, 2013, AM J MANAG CARE, V19, P344
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Katon W, 2010, GEN HOSP PSYCHIAT, V32, P456, DOI 10.1016/j.genhosppsych.2010.04.001
   Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7
   Kendzor DE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-176
   Kimbro LB, 2014, J AM GERIATR SOC, V62, P1017, DOI 10.1111/jgs.12833
   Kollannoor-Samuel G, 2011, J IMMIGR MINOR HEALT, V13, P809, DOI 10.1007/s10903-010-9428-3
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829
   Mendenhall E, 2012, CULT MED PSYCHIAT, V36, P136, DOI 10.1007/s11013-011-9240-0
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mohr DC, 2013, GEN HOSP PSYCHIAT, V35, P332, DOI 10.1016/j.genhosppsych.2013.03.008
   O'Brien MJ, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140142
   PADILLA AM, 1988, J COMMUNITY PSYCHOL, V16, P418, DOI 10.1002/1520-6629(198810)16:4<418::AID-JCOP2290160407>3.0.CO;2-R
   Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x
   Pouwer F, 2011, DIABETOLOGIA, V54, P741, DOI 10.1007/s00125-010-2033-0
   Saitz R, 1999, ARCH INTERN MED, V159, P718, DOI 10.1001/archinte.159.7.718
   Schneiderman N, 2014, DIABETES CARE, V37, P2233, DOI 10.2337/dc13-2939
   Scollan-Koliopoulos Melissa, 2012, J Family Med Prim Care, V1, P97, DOI 10.4103/2249-4863.104955
   Smith RC, 2002, J GEN INTERN MED, V17, P309, DOI 10.1046/j.1525-1497.2002.20210.x
   SULLIVAN M, 1993, ARCH INTERN MED, V153, P2251, DOI 10.1001/archinte.153.19.2251
   TOOLBERT DJ, 2000, DIABETES CARE, V23, P943
   Unger JB, 2013, J IMMIGR MINOR HEALT, V15, P398, DOI 10.1007/s10903-012-9623-5
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Whitty P, 1997, QUAL LIFE RES, V6, P407, DOI 10.1023/A:1018443628933
   Wu S, 2014, ADM POLICY MENT HLTH
   Wu SY, 2014, CONTEMP CLIN TRIALS, V37, P342, DOI 10.1016/j.cct.2013.11.002
   Wu SY, 2014, J AMBUL CARE MANAG, V37, P138, DOI 10.1097/JAC.0000000000000027
NR 60
TC 5
Z9 5
U1 2
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0163-8343
EI 1873-7714
J9 GEN HOSP PSYCHIAT
JI Gen. Hosp. Psych.
PD SEP-OCT
PY 2015
VL 37
IS 5
BP 414
EP 419
DI 10.1016/j.genhosppsych.2015.05.010
PG 6
WC Psychiatry
SC Psychiatry
GA CQ4HD
UT WOS:000360564500006
PM 26059979
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Fisher, L
   Hessler, D
   Edelman, SV
AF Polonsky, William H.
   Fisher, Lawrence
   Hessler, Danielle
   Edelman, Steven V.
TI Development of a New Measure for Assessing Glucose Monitoring
   Device-Related Treatment Satisfaction and Quality of Life
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID BLOOD-GLUCOSE; DISTRESS; TYPE-1; SCALE; USERS
AB Background: Many different devices are available to patients to measure glucose levels, but there is no validated method to assess treatment satisfaction with glucose monitoring devices and its impact on quality of life and other patient-reported outcomes. To address this problem, we developed the Glucose Monitoring System Satisfaction Survey (GMSS). We describe the construction and validation of the GMSS and examine how key patient factors are associated with glucose device satisfaction.
   Materials and Methods: Items were developed from interviews with 15 adults with either type 1 diabetes (T1D) or type 2 diabetes (T2D) and 10 diabetes healthcare professionals, resulting in an initial pool of 42 items. Separate exploratory factor analyses (EFAs) were conducted with adults with T1D (n=254) and with insulin-using T2D (n=206). Construct validity was established with overall well-being (World Health Organization-5), diabetes distress (Diabetes Distress Scale), attitudes toward glucose monitoring (Self-Monitoring of Blood Glucose Obstacles scale), and the previously validated Blood Glucose Monitoring System Rating Questionnaire. Regression analyses examined associations between total scale satisfaction and demographics, diabetes status, and glucose monitor use.
   Results: The two EFAs resulted in two 15-item scales, one for T1D and one for T2D, and yielded four coherent and meaningful factors in each sample: three factors with the same items in common for both samples (Emotional Burden, Behavioral Burden, and Openness) and a fourth factor unique to each sample (Trust for T1D, Worthwhileness for T2D). The final EFA accounted for 66.5% of the variance in the T1D sample and 67.0% in the T2D sample. Validity was established by significant correlations with criterion variables.
   Conclusions: The GMSS is a reliable, valid measure of glucose device satisfaction in its T1D form and in its insulin-using T2D form. It provides a comprehensive profile of sources of device satisfaction for use in clinical care and research.
C1 [Edelman, Steven V.] Univ Calif San Diego, Div Endocrinol & Metab, San Diego, CA 92103 USA.
   [Polonsky, William H.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Fisher, Lawrence; Hessler, Danielle] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Edelman, Steven V.] Vet Affairs Med Ctr, San Diego, CA 92161 USA.
RP Polonsky, WH (reprint author), POB 2148, Del Mar, CA 92014 USA.
EM whp@behavioraldiabetes.org
FU Sanofi Diabetes Care
FX This investigator-initiated study was supported by Sanofi Diabetes Care.
CR Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449
   Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hirsch IB, 2010, DIABETES TECHNOL THE, V12, P679, DOI 10.1089/dia.2010.0015
   Parkin CG, 2009, DIABETES EDUCATOR, V35, P915, DOI 10.1177/0145721709347601
   Peyrot M, 2009, DIABETES TECHNOL THE, V11, P57, DOI 10.1089/dia.2008.0002
   Polonsky WH, 2014, DIABETIC MED, V31, P40, DOI 10.1111/dme.12275
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2013, DIABETES TECHNOL THE, V15, P295, DOI 10.1089/dia.2012.0298
   Polonsky WH, 2013, DIABETES CARE, V36, P179, DOI 10.2337/dc12-0731
   Polonsky WH, 2011, CURR MED RES OPIN, V27, P31, DOI 10.1185/03007995.2011.599838
NR 11
TC 5
Z9 5
U1 1
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD SEP 1
PY 2015
VL 17
IS 9
BP 657
EP 663
DI 10.1089/dia.2014.0417
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CP9LD
UT WOS:000360214700010
PM 25923812
DA 2019-01-08
ER

PT J
AU Katz, ML
   Volkening, LK
   Dougher, CE
   Laffel, LMB
AF Katz, M. L.
   Volkening, L. K.
   Dougher, C. E.
   Laffel, L. M. B.
TI Validation of the Diabetes Family Impact Scale: a new measure of
   diabetes-specific family impact
SO DIABETIC MEDICINE
LA English
DT Article
ID EMOTIONAL DISTRESS; TYPE-1; CHILDREN; PARENTS; MOTHERS; BURDEN;
   PERSPECTIVES; FATHERS
AB AimsTo develop and validate the Diabetes Family Impact Scale, a scale to measure the impact of diabetes on families.
   MethodsThe Diabetes Family Impact Scale was developed by an iterative process, with input from multidisciplinary diabetes providers and parents of children with Type 1 diabetes. The psychometric properties of the Diabetes Family Impact Scale were assessed in parents of children with Type 1 diabetes. This assessment included internal consistency, convergent validity and exploratory factor analysis.
   ResultsParents (n=148) of children (meansd age 12.93.3years) with Type 1 diabetes (meansd duration 6.23.6years) completed the 15-item Diabetes Family Impact Scale. After eliminating one item, the 14-item measure demonstrated good internal consistency (Cronbach's = 0.84). Correlations between the Diabetes Family Impact Scale and measures of parent diabetes burden (r=0.48, P<0.0001), stressful life events (r=0.28, P=0.0007), and child's quality of life (r=-0.52 and -0.54, P<0.0001 for generic and diabetes-specific quality of life, respectively) supported the convergent validity of the instrument. Factor analysis identified four factors corresponding to the four survey domains (school, work, finances and family well-being).
   ConclusionsThe Diabetes Family Impact Scale measures diabetes-specific family impacts with good internal consistency and convergent validity and may be a useful tool in clinical and research settings.
C1 [Katz, M. L.; Volkening, L. K.; Dougher, C. E.; Laffel, L. M. B.] Joslin Diabet Ctr, Genet & Epidemiol Sect, Boston, MA 02215 USA.
   [Katz, M. L.; Laffel, L. M. B.] Joslin Diabet Ctr, Adolescent & Young Adult Sect, Pediat, Boston, MA 02215 USA.
RP Katz, ML (reprint author), Joslin Diabet Ctr, Genet & Epidemiol Sect, Boston, MA 02215 USA.
EM michelle.katz@joslin.harvard.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases of the
   National Institutes of Health [K12DK094721, P30DK036836, T32DK007260];
   American Diabetes Association through the FSU Research Foundation;
   Katherine Adler Astrove Youth Education Fund; Maria Griffin Drury
   Pediatric Fund; Eleanor Chesterman Beatson Fund
FX This work was supported by grants from the National Institute of
   Diabetes and Digestive and Kidney Diseases of the National Institutes of
   Health under award numbers K12DK094721, P30DK036836, and T32DK007260; an
   American Diabetes Association subaward through the FSU Research
   Foundation; the Katherine Adler Astrove Youth Education Fund; the Maria
   Griffin Drury Pediatric Fund; and the Eleanor Chesterman Beatson Fund.
CR Blumberg Stephen J, 2008, Vital Health Stat 1, P1
   Buckloh LM, 2008, DIABETES CARE, V31, P1516, DOI 10.2337/dc07-2349
   Delarosa E, 2012, AUGMENT ALTERN COMM, V28, P171, DOI 10.3109/07434618.2012.704525
   Di Iorio CK, 2005, MEASUREMENT HLTH BEH
   Haugstvedt A, 2010, DIABETIC MED, V27, P72, DOI 10.1111/j.1464-5491.2009.02867.x
   Haugstvedt A, 2011, PEDIATR DIABETES, V12, P107, DOI 10.1111/j.1399-5448.2010.00661.x
   Hilliard ME, 2011, CHILD CARE HLTH DEV, V37, P224, DOI 10.1111/j.1365-2214.2010.01162.x
   Hoey H, 2006, QUAL LIFE RES, V15, P1033, DOI 10.1007/s11136-006-0042-8
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Johnson J, 1980, STRESS ANXIETY, P111
   KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575
   Katz ML, 2012, J PEDIATR-US, V160, P861, DOI 10.1016/j.jpeds.2011.10.010
   Kovacs BK, 2013, DIABETIC MED, V30, P778, DOI DOI 10.1111/DME.12239
   Markowitz JT, 2012, DIABETIC MED, V29, P526, DOI 10.1111/j.1464-5491.2011.03434.x
   Messer SC, 1996, INT J METH PSYCH RES, V6, P261, DOI 10.1002/(SICI)1234-988X(199612)6:4<261::AID-MPR169>3.3.CO;2-3
   Parent KB, 2009, PEDIATR DIABETES, V10, P554, DOI 10.1111/j.1399-5448.2009.00532.x
   Stein REK, 2003, J DEV BEHAV PEDIATR, V24, P9, DOI 10.1097/00004703-200302000-00004
   Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55
   Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006
   Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631
   West C, 2014, NURSE RES, V20, P6
NR 21
TC 1
Z9 1
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2015
VL 32
IS 9
BP 1227
EP 1231
DI 10.1111/dme.12689
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CP4LK
UT WOS:000359853000016
PM 25655562
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Zoffmann, V
   Vistisen, D
   Due-Christensen, M
AF Zoffmann, V.
   Vistisen, D.
   Due-Christensen, M.
TI Flexible guided self-determination intervention for younger adults with
   poorly controlled Type1 diabetes, decreased HbA(1c) and psychosocial
   distress in women but not in men: a real-life RCT
SO DIABETIC MEDICINE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; GLYCEMIC
   CONTROL; CARE; ADOLESCENTS; SUPPORT; SKILLS
AB AimTo report results from an 18-month randomized controlled trial (RCT) testing the effectiveness of a flexible guided self-determination (GSD) intervention on glycaemic control and psychosocial distress in younger adults with poorly controlled Type1 diabetes.
   MethodsBetween January 2010 and February 2012, we randomly allocated two hundred 18-35-year-olds [mean age 25.7 (5.1)years, 50% men] with Type1 diabetes for1year [mean duration 13.7(6.8)years] and HbA(1c)64mmol/mol (8.0%) to either an immediate GSD (intervention; n=134) or 18-months delayed GSD group (control; n=66). Group-based or individual GSD sessions were offered, drawing on reflection sheets and advanced professional communication. The primary outcome was HbA(1c) (measured at baseline and every three months thereafter) and among secondary outcomes was psychosocial distress (self-reported at baseline and after nine and 18months). Intention-to-treat analyses included linear regression and repeated measurement analyses.
   ResultsA borderline significant decrease in HbA(1c) in the intervention group compared with the control group (-4 vs-1mmol/mol or-0.4% vs-0.1%; P=0.073) was driven by a significantly greater reduction in the GSD women (-5 vs+1mmol/mol or-0.5% vs+0.1%; P=0.017); parallel decreases were observed in the GSD and control men (-3mmol/mol or -0.3%; P=0.955). Significantly greater reduction in the GSD group's psychosocial distress was again driven by differences between the GSD and the control women. The men's improvements were not connected with the intervention.
   ConclusionsThe flexible GSD intervention benefitted younger adult women by significantly improving glycaemic control and decreasing diabetes related distress. No effect was seen among men.
C1 [Zoffmann, V.; Vistisen, D.; Due-Christensen, M.] Steno Diabet Ctr AS, Gentofte, Denmark.
   [Zoffmann, V.] Copenhagen Univ Hosp, Juliane Marie Ctr, Res Unit Womens & Childrens Hlth, Copenhagen, Denmark.
   [Due-Christensen, M.] Kings Coll London, Fac Nursing & Midwifery, London WC2R 2LS, England.
RP Zoffmann, V (reprint author), Steno Diabet Ctr AS, Gentofte, Denmark.
EM vibeke.zoffmann@regionh.dk
OI Due-Christensen, Mette/0000-0003-2604-3730; Vistisen,
   Dorte/0000-0001-5045-5351
FU Danish Health and Medicine's Authority [7-203-02-434/5]; Novo Nordisk:
   Public Health Evidence Insights; Beckett Foundation; Steno Diabetes
   Center A/S, a research hospital working in the Danish National Health
   Service; Novo Nordisk Foundation; Novo Nordisk A/S
FX This study was supported by the Danish Health and Medicine's Authority
   7-203-02-434/5, Novo Nordisk: Public Health Evidence & Insights, the
   Beckett Foundation, Black-smith Niels Hansen and his wife Johanne (born
   Frederiksens) and the Steno Diabetes Center A/S, a research hospital
   working in the Danish National Health Service and owned by Novo Nordisk
   A/S. The Steno Diabetes Center receives part of its core funding from
   unrestricted grants from the Novo Nordisk Foundation and from Novo
   Nordisk A/S. VZ, MDC and DV are employed by Steno Diabetes Center A/S,
   and DV and MDC own shares in Novo Nordisk A/S.
CR Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Anderson BJ, 2004, PATIENT EDUC COUNS, V53, P347, DOI 10.1016/j.pec.2003.03.001
   Arborelius E., 1992, HVORFORGOR IKKESOM V
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bos AH, 2001, URTEILSBILDUNG GRUPP
   Brierley S, 2012, DIABETIC MED, V29, P677, DOI 10.1111/j.1464-5491.2012.03601.x
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Clabby J, 2004, FAM MED, V36, P541
   Eiser C, 2013, DIABETIC MED, V30, pE223, DOI 10.1111/dme.12185
   Farmer AJ, 2005, DIABETES CARE, V28, P2697, DOI 10.2337/diacare.28.11.2697
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Gordon T, 1999, FORAELDREUDDANNELSE
   Hampson SE, 2000, DIABETES CARE, V23, P1416, DOI 10.2337/diacare.23.9.1416
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Holmes-Walker DJ, 2007, DIABETIC MED, V24, P764, DOI 10.1111/j.1464-5491.2007.02152.x
   Husted GR, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-321
   Ismail K, 2008, ANN INTERN MED, V149, P708, DOI 10.7326/0003-4819-149-10-200811180-00005
   Jorgensen R, 2014, BMC PSYCHIATRY, V14
   Kirkevold M, 2012, INT J NURS STUD, V49, P386, DOI 10.1016/j.ijnurstu.2011.10.006
   Markowitz JT, 2012, DIABETIC MED, V29, P522, DOI 10.1111/j.1464-5491.2011.03537.x
   Mullen D., 1985, CONCEPTUAL FRAMEWORK
   Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309
   Peveler RC, 2005, DIABETES CARE, V28, P84, DOI 10.2337/diacare.28.1.84
   Plum I, REKALIBRERING HAMOGL
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Steinberg JM, 1986, AKTIVTVERDIVALG MENI
   Williams GC, 2000, SELF DETERMINATION H
   Zoffmann V, 2005, QUAL HEALTH RES, V15, P750, DOI 10.1177/1049732304273888
   Zoffmann V, 2014, DIABETIC MED, V31, P493, DOI 10.1111/dme.12363
   Zoffmann V, 2008, QUAL HEALTH RES, V18, P670, DOI 10.1177/1049732307311008
   Zoffmann V, 2007, QUAL HEALTH RES, V17, P625, DOI 10.1177/1049732307301230
   Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017
   Zoffmann V, 2012, QUAL HEALTH RES, V22, P103, DOI 10.1177/1049732311420735
NR 34
TC 9
Z9 9
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2015
VL 32
IS 9
BP 1239
EP 1246
DI 10.1111/dme.12698
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CP4LK
UT WOS:000359853000018
PM 25601214
DA 2019-01-08
ER

PT J
AU Rondags, SMPA
   de Wit, M
   van Tulder, MW
   Diamant, M
   Snoek, FJ
AF Rondags, Stefanie M. P. A.
   de Wit, Maartje
   van Tulder, Maurits W.
   Diamant, Michaela
   Snoek, Frank J.
TI HypoAware-a brief and partly web-based psycho-educational group
   intervention for adults with type 1 and insulin-treated type 2 diabetes
   and problematic hypoglycaemia: design of a cost-effectiveness randomised
   controlled trial
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
ID IMPAIRED AWARENESS; FREQUENCY; SCALE
AB Background: Problematic hypoglycaemia is a significant problem among people with insulin-treated type 1 and 2 diabetes mellitus, which adversely affects quality of life and leads to high societal costs. Blood glucose awareness training (BGAT) is a psycho-educational group intervention that has shown to be effective but difficult to implement in clinical practice, due to its demanding nature. The aim of this study is to evaluate the cost-effectiveness of the HypoAware intervention that has its roots in BGAT and helps patients to effectively recognize, treat and prevent hypoglycaemia, while also focussing on the psychosocial consequences of living with the constant risk of hypoglycaemia, both for patients and their significant others.
   Methods/design: An economic evaluation will be conducted alongside a cluster-randomised controlled trial in eight hospitals in the Netherlands. We aim to include 154 participants who will either receive HypoAware or care as usual. HypoAware consists of three group sessions and is combined with two online modules. The primary clinical outcome is severe hypoglycaemia. Secondary outcomes include mild hypoglycaemia, hypoglycaemia awareness, fear of hypoglycaemia, diabetes distress, anxiety and depression, health-related quality of life, diabetes-specific self-efficacy and HbA1c. Utilities will be measured using the EQ-5D-5 L questionnaire. Costs will be measured from a societal perspective and include health care utilization, medication and lost productivity costs. Measurements will be performed at baseline, 2, 4, and 6 months to compare both groups, and an additional 12 months for the intervention group only. Process outcomes will be gathered after every group meeting via telephone/email contact with health care professionals and via the online environment.
   Discussion: HypoAware is expected to significantly reduce episodes of severe hypoglycaemia, with subsequent beneficial effects on psychosocial outcomes and health care costs. When proven cost-effective, HypoAware will be incorporated in the clinical guidelines of Dutch diabetes care.
C1 [Rondags, Stefanie M. P. A.; de Wit, Maartje; Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, NL-1081 BT Amsterdam, Netherlands.
   [Rondags, Stefanie M. P. A.; de Wit, Maartje; van Tulder, Maurits W.; Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands.
   [van Tulder, Maurits W.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands.
   [Diamant, Michaela] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, NL-1081 BT Amsterdam, Netherlands.
   [Diamant, Michaela] Vrije Univ Amsterdam Med Ctr, Ctr Diabet, NL-1081 BT Amsterdam, Netherlands.
   [Snoek, Frank J.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands.
RP Rondags, SMPA (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Van der Boechorststr 7 D-342, NL-1081 BT Amsterdam, Netherlands.
EM s.rondags@vumc.nl
OI van Tulder, Maurits/0000-0002-7589-8471
FU ZonMw; Dutch Organisation for Health Research and Development; Novo
   Nordisk; Agis Achmea; VU University Medical Centre
FX The study and manuscript preparation is funded by ZonMw, the Dutch
   Organisation for Health Research and Development, and co-funded by Novo
   Nordisk, Agis Achmea and VU University Medical Centre. We thank Nienke
   Veldhuijzen, Department of Epidemiology & Biostatistics, VU University
   Medical Centre, the Netherlands, for her advice on the statistical
   analyses.
CR CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517
   Cox DJ, 2006, DIABETES SPECTRUM, V19, P43, DOI DOI 10.2337/DIASPECT.19.1.43
   Geddes J, 2007, DIABETES CARE, V30, P1868, DOI 10.2337/dc06-2556
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   GonderFrederick L, 1997, DIABETES CARE, V20, P661, DOI 10.2337/diacare.20.4.661
   Ha WC, 2012, DIABETES METAB J, V36, P280, DOI 10.4093/dmj.2012.36.4.280
   Hakkaart-Van Roijen L., 2002, TRIMBOS IMTA QUESTIO
   Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nederlandse Diabetes Federatie, 2009, NDF ZORGST ADD DIAB
   Oyer S, 2013, CURR DIABETES REV, V9, P195
   Pedersen-Bjergaard U, 2003, DIABETES-METAB RES, V19, P232, DOI 10.1002/dmrr.377
   Schachinger H, 2005, J BEHAV MED, V28, P587, DOI 10.1007/s10865-005-9026-3
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Twisk J. W. R, 2006, APPL MULTILEVEL ANAL
   Unger J, 2011, POSTGRAD MED, V123, P81, DOI 10.3810/pgm.2011.07.2307
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 19
TC 5
Z9 5
U1 0
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD AUG 21
PY 2015
VL 15
AR 43
DI 10.1186/s12902-015-0035-0
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CP7DU
UT WOS:000360048200001
PM 26292674
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Mashitani, T
   Hayashino, Y
   Okamura, S
   Kitatani, M
   Furuya, M
   Iburi, T
   Kuwata, H
   Tsujii, S
   Ishii, H
AF Mashitani, Tsuyoshi
   Hayashino, Yasuaki
   Okamura, Shintaro
   Kitatani, Masako
   Furuya, Miyuki
   Iburi, Tadao
   Kuwata, Hirohito
   Tsujii, Satoru
   Ishii, Hitoshi
TI Diabetes treatment-related quality of life is associated with levels of
   self-care activities in insulin injection among Japanese patients with
   type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8)
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Insulin; Self-care activities; Omission; Quality of life
ID GLYCEMIC CONTROL; TREATMENT SATISFACTION; TREATMENT PREFERENCES;
   QUESTIONNAIRE; THERAPY; VALIDATION; ADHERENCE; MELLITUS; IMPACT; ADULTS
AB We investigated the association between diabetes treatment-related quality of life (QOL) and levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes.
   Data from 1394 patients with type 2 diabetes on insulin therapy were obtained from a diabetes registry in Japan. We used the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire and relative risk regression analysis to assess the independent association of high levels of self-care activities in insulin injection and DTR-QOL scores while adjusting for possible confounders.
   The mean age, BMI and HbA1c level were 65.8 years, 24.8 kg/m(2) and 62 mmol/mol (7.8 %), respectively. The frequency of insulin injection omission was associated with DTR-QOL scores. In the multivariable-adjusted model, the relative risks for high levels of self-care activities in insulin injection was 1.15 (95 % confidence interval, 1.05-1.26) in the highest quintile compared with those in the lowest quintile of DTR-QOL scores. Subgroup analysis confirmed this association in patients < 65 years.
   DTR-QOL was associated with self-reported levels of self-care activities in insulin injection, particularly among Japanese patients < 65 years with type 2 diabetes. DTR-QOL might be a useful tool to identify patients who consequently omit insulin. For patients with low DTR-QOL score, healthcare providers should discuss their treatment-related problems to prevent insulin injection omission.
C1 [Mashitani, Tsuyoshi; Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 6348552, Japan.
   [Hayashino, Yasuaki; Okamura, Shintaro; Kitatani, Masako; Furuya, Miyuki; Iburi, Tadao; Kuwata, Hirohito; Tsujii, Satoru] Tenri Hosp, Dept Endocrinol, Tenri, Nara 6328552, Japan.
RP Mashitani, T (reprint author), Nara Med Univ, Dept Diabetol, 840 Shijo Cho, Kashihara, Nara 6348552, Japan.
EM mashiyan@gmail.com
OI Tsujii, Satoru/0000-0002-1834-6515; Hayashino,
   Yasuaki/0000-0002-2932-8478
FU Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and JSPS KAKENHI (Grant Number 25460641); however, they
   played no role in the study design or conduct, data collection, analysis
   or interpretation, and the preparation, review or approval of the
   manuscript. We would like to especially thank Yukari Moritsuji, Yuki
   Fujita, Noriko Nakamura and Yoko Sakamoto (Department of Endocrinology,
   Tenri Hospital) for their clerical support. The authors would like to
   thank Enago (www.enago.jp) for the English language review.
CR Anderson RT, 2004, CLIN THER, V26, P565, DOI 10.1016/S0149-2918(04)90059-8
   [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011]
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435
   Cherubini V, 2014, ACTA DIABETOL, V51, P43, DOI 10.1007/s00592-013-0466-x
   Chung JO, 2014, ACTA DIABETOL, V51, P1065, DOI 10.1007/s00592-014-0677-9
   Chung JO, 2013, INTERNAL MED, V52, P179, DOI 10.2169/internalmedicine.52.7513
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Cramer JA, 2005, DIABETES CARE, V28, P78, DOI 10.2337/diacare.28.1.78
   Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218
   Davies MJ, 2013, DIABETIC MED, V30, P512, DOI 10.1111/dme.12128
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Dhatt GS, 2005, CLIN CHIM ACTA, V358, P81, DOI 10.1016/j.cccn.2005.02.009
   Garg SK, 2015, ENDOCR PRACT, V21, P143, DOI 10.4158/EP14079.OR
   Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562
   Hayashino Y, 2013, EXP CLIN ENDOCR DIAB, V121, P628, DOI 10.1055/s-0033-1355424
   Hommel E, 2014, ACTA DIABETOL, V51, P845, DOI 10.1007/s00592-014-0598-7
   Ishii H, 2008, DIABETES RES CLIN PR, V81, P169, DOI 10.1016/j.diabres.2008.03.020
   Ishii Hitoshi, 2012, J Med Econ, V15, P556, DOI 10.3111/13696998.2012.665111
   Kobayashi M, 2006, DIABETES RES CLIN PR, V73, P198, DOI 10.1016/j.diabres.2006.01.013
   LEWIS KS, 1988, DIABETIC MED, V5, P235, DOI 10.1111/j.1464-5491.1988.tb00976.x
   Martinez L, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-53
   Mashitani T, 2014, DIABETES CARE, V37, P252, DOI 10.2337/dc13-0407
   Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006
   Mollema ED, 2000, DIABETES CARE, V23, P765, DOI 10.2337/diacare.23.6.765
   Mollema ED, 2001, J PSYCHOSOM RES, V51, P665, DOI 10.1016/S0022-3999(01)00229-X
   NICE, 2004, TYP 1 DIAB DIAGN MAN
   NICE, 2008, TYP 2 DIAB NAT CLIN
   Peyrot M, 2005, DIABETES CARE, V28, P53, DOI 10.2337/diacare.28.1.53
   Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348
   Sato F, 2014, DIABETOL INT, V5, P21, DOI 10.1007/s13340-013-0125-z
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624
   Trento M, 2014, ACTA DIABETOL, V51, P509, DOI 10.1007/s00592-013-0530-6
   TURNER RC, 1995, DIABETES, V44, P1249
   Uchmanowicz I, 2013, ACTA DIABETOL, V50, P217, DOI 10.1007/s00592-011-0280-2
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   WEINBERGER M, 1994, MED CARE, V32, P1173, DOI 10.1097/00005650-199412000-00002
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
NR 40
TC 14
Z9 14
U1 0
U2 4
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD AUG
PY 2015
VL 52
IS 4
BP 639
EP 647
DI 10.1007/s00592-015-0725-0
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CN0EE
UT WOS:000358085800002
PM 25854196
DA 2019-01-08
ER

PT J
AU Nicolucci, A
   Pintaudi, B
   Rossi, MC
   Messina, R
   Dotta, F
   Frontoni, S
   Caputo, S
   Lauro, R
AF Nicolucci, Antonio
   Pintaudi, Basilio
   Rossi, Maria Chiara
   Messina, Roberto
   Dotta, Francesco
   Frontoni, Simona
   Caputo, Salvatore
   Lauro, Renato
TI The social burden of hypoglycemia in the elderly
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Hypoglycemia; Elderly; Quality of life; Distress; Fear of hypoglycemia
ID QUALITY-OF-LIFE; CROSS-NATIONAL BENCHMARKING; TYPE-2 DIABETES-MELLITUS;
   WELL-BEING INDEX; NEEDS 2ND; MANAGEMENT; RISK; ATTITUDES; EVENTS; WISHES
AB The study aimed to evaluate the frequency of episodes of symptomatic hypoglycemia (SH) in elderly patients with type 2 diabetes and their impact on quality of life.
   The study was conducted in 12 Italian regions. Participants filled in a questionnaire collecting data on socio-demographic and clinical characteristics and episodes of SH occurred in the last 4 weeks. The questionnaire included validated scales measuring fear of hypoglycemia (FHQ), psychological well-being (WHO-5), and diabetes-related distress (PAID-5).
   Overall, 1,323 participants were involved (mean age 70.0 +/- A 8.7, 47.6 % male, disease duration 15.6 +/- A 11.7, 63.2 % treated with oral agents, 16.9 % with insulin alone, 14.4 % with insulin plus oral agents), of whom 44.6 % reported 1-3 episodes of SH and 23.8 % reported more than 3 episodes. Patients who reported SH had significantly higher levels of fear of hypoglycemia, lower psychological well-being, and higher diabetes-related distress (p < 0.0001 for all the scales). At multivariate analysis, the experience of more than 3 episodes of hypoglycemia was associated with a 13-fold higher risk of high fear of hypoglycemia (aOR = 13.3; CI 95 % 8.4-21.0), an almost 60-fold higher risk of high diabetes-related distress (PAID-5 score a parts per thousand yen40) (aOR = 59.1; CI 95 % 29.2-119.8), and a higher risk of low psychological well-being (WHO-5 < 50) (aOR = 1.5; CI 95 % 0.9-2.4).
   The occurrence of symptoms of hypoglycemia is very common among older adults with diabetes and their presence is associated with an extremely negative impact on quality of life. Minimizing the risk of hypoglycemia represents a high priority in the diabetes treatment of elderly people.
C1 [Nicolucci, Antonio; Dotta, Francesco; Frontoni, Simona; Caputo, Salvatore; Lauro, Renato] Univ Roma Tor Vergata, Italian Barometer Diabet Observ, Rome, Italy.
   [Nicolucci, Antonio; Pintaudi, Basilio; Rossi, Maria Chiara] Fdn Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, CH, Italy.
   [Messina, Roberto] FederAnziani, Rome, Italy.
   [Dotta, Francesco] Univ Siena, Dept Med Surg & Neurosci, Diabet Unit, I-53100 Siena, Italy.
   [Dotta, Francesco] Fdn Umberto Di Mario ONLUS, Toscana Life Sci, Siena, Italy.
   [Frontoni, Simona] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy.
   [Caputo, Salvatore] Univ Cattolica Sacro Cuore, Servizio Diabetol, Policlin Gemelli, I-00168 Rome, Italy.
RP Nicolucci, A (reprint author), Fdn Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, CH, Italy.
EM nicolucci@negrisud.it
OI Dotta, Francesco/0000-0003-4947-7478
CR Akram K, 2006, J DIABETES COMPLICAT, V20, P402, DOI 10.1016/j.jdiacomp.2005.08.005
   Alvarez-Guisasola F, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-86
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   [Anonymous], 2004, PRACT DIABETES INT, V21, P201
   Barendse S, 2012, DIABETIC MED, V29, P293, DOI 10.1111/j.1464-5491.2011.03416.x
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Bonds DE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b4909
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   Brod Meryl, 2012, J Med Econ, V15, P869, DOI 10.3111/13696998.2012.686465
   Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9
   DePablos-Velasco P, 2014, ENDOCRINOL NUTR, V61, P18, DOI [10.1016/j.endonu.2013.05.005, 10.1016/j.endoen.2014.01.011]
   Frier BM, 2007, DIABET MED, V2nd edn
   Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gulli G, 2014, ACTA DIABETOL, V51, P765, DOI 10.1007/s00592-014-0585-z
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Henkel V, 2003, BRIT MED J, V326, P200, DOI 10.1136/bmj.326.7382.200
   International Diabetes Federation, 2004, DIABETES VOICE, V49, P1
   Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6
   Kong APS, 2014, DIABETES CARE, V37, P1024, DOI 10.2337/dc13-2507
   Kulzer B, 2014, EXP CLIN ENDOCR DIAB, V122, P167, DOI 10.1055/s-0033-1363688
   Lundkvist Jonas, 2005, Eur J Health Econ, V6, P197, DOI 10.1007/s10198-005-0276-3
   Malabu UH, 2014, CLIN EPIDEMIOL, V14, P287, DOI [10.2147/CLEP.S66821, DOI 10.2147/CLEP.S66821]
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Nordin C, 2014, ACTA DIABETOL, V51, P5, DOI 10.1007/s00592-013-0528-0
   Ostenson CG, 2014, DIABETIC MED, V31, P92, DOI 10.1111/dme.12261
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Pilotto A, 2014, BIOMED RES INT, DOI 10.1155/2014/906103
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   Stahn A, 2014, DIABETES CARE, V37, P516, DOI 10.2337/dc13-0600
   Tsujimoto T, 2014, ACTA DIABETOL
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460
NR 38
TC 16
Z9 17
U1 0
U2 8
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD AUG
PY 2015
VL 52
IS 4
BP 677
EP 685
DI 10.1007/s00592-015-0717-0
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CN0EE
UT WOS:000358085800005
PM 25663036
DA 2019-01-08
ER

PT J
AU Nakaya, N
   Nakamura, T
   Tsuchiya, N
   Tsuji, I
   Hozawa, A
   Tomita, H
AF Nakaya, Naoki
   Nakamura, Tomohiro
   Tsuchiya, Naho
   Tsuji, Ichiro
   Hozawa, Atsushi
   Tomita, Hiroaki
TI The Association Between Medical Treatment of Physical Diseases and
   Psychological Distress After the Great East Japan Earthquake: The
   Shichigahama Health Promotion Project
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE psychological warfare; preventive health services; mental disorders;
   public health; earthquakes
ID OHSAKI COHORT 2006; SCREENING SCALES; MENTAL-HEALTH; POPULATION;
   DEPRESSION; METAANALYSIS; ADULTS; RISK; DISABILITY; DISASTER
AB Objective: Physical disease patients are known to experience high levels of psychological distress. This study examined the association between the medical treatment of physical diseases and psychological distress in the coastal area affected by the Great East Japan Earthquake.
   Methods: Using cross-sectional data, we studied 3032 individuals aged >= 40 years who lived in Shichigahama, Miyagi, Japan. We examined the associations between 8 medical treatments for physical diseases and psychological distress, defined as Kessler Psychological Distress scale score >= 13 of 24 points. To investigate the associations, we performed multiple logistic regression analyses.
   Results: There were statistically significant associations between psychological distress and medical treatments for myocardial infarction/angina pectoris (odds ratio [OR] = 1.8, 95% confidence interval [CI] = 1.0-3.0) and liver disease (OR = 3.1, 95% CI = 1.0-7.7). The other 4 medical treatments for physical diseases had ORs of 1.3 or higher and were positively associated with psychological distress: cancer, hyperlipidemia, kidney disease, and diabetes mellitus. The degree of damage to homes did not affect the association between most of the medical treatments for physical diseases and psychological distress.
   Conclusions: In the disaster area, most of the medical treatments for physical diseases had positive associations with psychological distress, irrespective of the degree of damage to homes.
C1 [Nakaya, Naoki; Nakamura, Tomohiro; Tsuchiya, Naho; Tsuji, Ichiro; Hozawa, Atsushi; Tomita, Hiroaki] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 9808573, Japan.
   [Tomita, Hiroaki] Tohoku Univ, Dept Disaster Psychiat, Int Res Inst Disaster Sci, Sendai, Miyagi 9808573, Japan.
   [Tsuji, Ichiro] Tohoku Univ Grad Sch Med, Div Epidemiol, Dept Publ Hlth & Forens Med, Sendai, Miyagi, Japan.
RP Nakaya, N (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, 2-1 Seiryo, Sendai, Miyagi 9808573, Japan.
EM nakaya-thk@umin.ac.jp
OI Tomita, Hiroaki/0000-0003-2628-880X; xing zhi, shi
   zhi/0000-0003-3289-5681
FU Japanese Society for the Promotion of Science (JSPS) [26350863];
   Kurokawa Cancer Research Foundation; MEXT Tohoku Medical Megabank
   Project
FX This study was supported by grants from the Japanese Society for the
   Promotion of Science (JSPS) for the Grant-in-Aid for Scientific Research
   (C) (No. 26350863) and the Grant-in-Aid from the Kurokawa Cancer
   Research Foundation. This work was supported by the MEXT Tohoku Medical
   Megabank Project. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7
   ANDA RF, 1992, ARCH INTERN MED, V152, P829, DOI 10.1001/archinte.152.4.829
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   AROMAA A, 1994, ACTA PSYCHIAT SCAND, V89, P77, DOI 10.1111/j.1600-0447.1994.tb05807.x
   Berkman L.F., 2000, SOCIAL EPIDEMIOLOGY
   Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725
   Dalton SO, 2009, J CLIN ONCOL, V27, P1440, DOI 10.1200/JCO.2008.20.5526
   Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008
   Fujihara K, 2012, EXP CLIN ENDOCR DIAB, V120, P560, DOI 10.1055/s-0032-1314873
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Hjollund NH, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-12
   Hozawa A, 2009, AM J CLIN NUTR, V90, P1390, DOI 10.3945/ajcn.2009.28214
   Jordan HT, 2011, PREV MED, V53, P370, DOI 10.1016/j.ypmed.2011.10.014
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kuriyama S, 2009, J EPIDEMIOL, V19, P294, DOI 10.2188/jea.JE20080076
   Lenze EJ, 2001, AM J GERIAT PSYCHIAT, V9, P113, DOI 10.1176/appi.ajgp.9.2.113
   Ministry of Health Labour and Welfare, 2013, PATIENTS SURVEY 2005
   Ministry of Health Labour and Welfare, 2007, PATIENTS SURVEY 2005
   Ministry of Health Labour and Welfare, 2010, PATIENTS SURVEY 2005
   Nakaya N, 2014, EUR J PUBLIC HEALTH, V24, P45, DOI 10.1093/eurpub/ckt017
   Oldehinkel AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1757, DOI 10.1016/j.neubiorev.2010.10.013
   Picavet HSJ, 1997, AM J PUBLIC HEALTH, V87, P1680, DOI 10.2105/AJPH.87.10.1680
   STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907
   Tayama J, 2012, PSYCHOSOMATICS, V53, P196, DOI 10.1016/j.psym.2011.11.005
   World Health Organization, 2004, GLOB BURD DIS 2004 U
   Yamanaka K, 2013, WORLD J GASTROENTERO, V19, P7426, DOI 10.3748/wjg.v19.i42.7426
NR 27
TC 9
Z9 9
U1 0
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD AUG
PY 2015
VL 9
IS 4
BP 374
EP 381
DI 10.1017/dmp.2015.52
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CN2YY
UT WOS:000358290600008
PM 25912962
DA 2019-01-08
ER

PT J
AU Egan, EA
   Corrigan, J
   Shurpin, K
AF Egan, Eileen A.
   Corrigan, Jean
   Shurpin, Kathleen
TI Building the Bridge From Pediatric to Adult Diabetes Care: Making the
   Connection
SO DIABETES EDUCATOR
LA English
DT Article
ID YOUNG-ADULTS; TRANSITIONAL CARE; CHRONIC ILLNESS; RECOMMENDATIONS;
   ADOLESCENTS; SERVICES; PEOPLE; CHILD; EXPERIENCES; GUIDELINES
AB Purpose The purpose of this study was to evaluate the effectiveness of a structured transition program by measuring clinical and psychometric properties related to transition and adherence to follow-up. Transition of emerging adults with type 1 diabetes can be problematic. This natural progression to adult health care is often delayed, leading to transition at less than optimal times. Implementation of a transition program will improve the transition process for emerging adults with type 1 diabetes.
   Methods Mixed-method, prospective longitudinal study involving collaboration between pediatric and adult providers. Subjects age 18 to 28 years were identified for transition. Transition was facilitated via joint appointment with pediatric and adult health care providers. Participants completed pre- and posttransition surveys measuring diabetes-related distress (Diabetes Distress Scale [DDS]), quality of life (Diabetes Quality of Life Youth-Short Form [DQOLY-SF]), and perceived health care provider autonomy support (Health Care Climate Questionnaire [HCCQ]). Primary outcome was adherence to follow-up. Secondary outcomes evaluated correlations in DDS, DQOLY-SF, HCCQ, and A1C. Chart review assessed acute complications, A1C, and adherence to follow-up.
   Results Adherence to follow-up was 100%. This study found that correlations between DQOLY-SF and DDS and correlations between DDS and A1C were highly significant during the pretransition phase. This study also indicated that the same correlations were highly significant following transition. Paired t test indicated a statistically significant reduction in diabetes distress from pre- to posttransition evaluations and an increase in HCCQ. Content comparative analysis of open-ended questions further illustrated issues related to transition.
   Conclusion Use of a structured transition process with joint appointments and transition coordinator improves adherence to follow-up and reduces diabetes-related distress.
C1 [Egan, Eileen A.] Winthrop Univ Hosp, Winthrop Comprehens Diabet Care Ctr, Garden City, NY 11503 USA.
   [Corrigan, Jean] Winthrop Univ Hosp, Pediat Diabet Program, Mineola, NY 11501 USA.
   [Shurpin, Kathleen] SUNY Stony Brook, Sch Nursing, Stony Brook, NY 11794 USA.
RP Egan, EA (reprint author), Winthrop Univ Hosp, Winthrop Comprehens Diabet Care Ctr, 1300 Franklin Ave,Suite ML-6, Garden City, NY 11503 USA.
EM eegan@winthrop.org
CR Allen D, 2011, DIABETIC MED, V28, P994, DOI 10.1111/j.1464-5491.2011.03310.x
   Betz C., 2014, COMP PEDIAT NURS, V27, P179, DOI [10.1080/01460860490497903, DOI 10.1080/01460860490497903]
   BLUM RW, 1993, J ADOLESCENT HEALTH, V14, P570, DOI 10.1016/1054-139X(93)90143-D
   Cefalu W, 2014, DIABETES CARE, V37, pS53
   Centers for Disease Control and Prevention, NAT DIAB STAT REP 20
   Crowley R, 2011, ARCH DIS CHILD, V96, P548, DOI 10.1136/adc.2010.202473
   Daneman D., 2011, DIABETES SPECTRUM, V24, P14, DOI DOI 10.2337/DIASPECT.24.1.14
   Dashiff C, 2011, NURS PEDIAT, V37, P304
   Garvey KC, 2014, ADOLESC HEALTH MED T, V5, P191, DOI 10.2147/AHMT.S67943
   Garvey KC, 2013, ENDOCR PRACT, V19, P946, DOI 10.4158/EP13109.OR
   Gosden C, 2010, ARCH DIS CHILD, V95, P837, DOI 10.1136/adc.2009.176925
   Grant C, 2011, CHILD CARE HLTH DEV, V37, P815, DOI 10.1111/j.1365-2214.2011.01322.x
   Hessler D, 2012, AM ASS DIAB ED NAT C
   Hilliard ME, 2014, DIABETES CARE, V37, P346, DOI 10.2337/dc13-1346
   Hynes L, 2016, PEDIATR DIABETES, V17, P509, DOI 10.1111/pedi.12198
   Jones Susan E, 2008, Br J Nurs, V17, P842
   McDonagh JE, 2011, EUROPEAN DIABETES NU, V8, P24, DOI DOI 10.1002/EDN.170
   Meleis AI, 2000, ADV NURS SCI, V23, P12, DOI 10.1097/00012272-200009000-00006
   Ogrinc G, 2008, QUAL SAF HEALTH CARE, V17, P13, DOI 10.1136/qshc.2008.029058
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Plichta S. B., 2013, MUNROS STAT METHODS
   Polit D. F., 2012, NURSING RES GENERATI
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rapley P, 2010, J CLIN NURS, V19, P313, DOI 10.1111/j.1365-2702.2009.03027.x
   Ritholz MD, 2014, DIABETES EDUCATOR, V40, P40, DOI 10.1177/0145721713513177
   Sheehan AM, 2015, DIABETIC MED, V32, P440, DOI 10.1111/dme.12639
   Skinner TC, 2006, DIABETOLOGIA, V49, P621, DOI 10.1007/s00125-005-0124-0
   Spaic T, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-163
   Steinbeck K, PEDIAT DIABETES, DOI [10.1111/pedi.122229, DOI 10.1111/PEDI.122229]
   van Staa AL, 2011, CHILD CARE HLTH DEV, V37, P821, DOI 10.1111/j.1365-2214.2011.01261.x
   Van Walleghem N, 2011, DIABETES SPECT, V24, P9, DOI DOI 10.2337/DIASPECT.24.1.9
   Visentin K, 2006, J CLIN NURS, V15, P761, DOI 10.1111/j.11365-2702.2006.01347.x
   Watson R, 2011, CHILD CARE HLTH DEV, V37, P780, DOI 10.1111/j.1365-2214.2011.01293.x
   Williams GC, 1996, J PERS SOC PSYCHOL, V70, P115, DOI 10.1037/0022-3514.70.1.115
   Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644
NR 35
TC 5
Z9 5
U1 1
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD AUG
PY 2015
VL 41
IS 4
BP 432
EP 443
DI 10.1177/0145721715581666
PG 12
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA CM9IV
UT WOS:000358023000003
PM 25916493
DA 2019-01-08
ER

PT J
AU Tang, TS
   Sohal, PS
   Garg, AK
AF Tang, T. S.
   Sohal, P. S.
   Garg, A. K.
TI Rethinking peer support for diabetes in Vancouver's South-Asian
   community: a feasibility study
SO DIABETIC MEDICINE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; SELF-MANAGEMENT;
   PHYSICAL-ACTIVITY; TRAINING-PROGRAM; GLYCEMIC CONTROL; INTERVENTION;
   CARE; EXPERIENCES; EDUCATION
AB AimTo examine the feasibility and potential health impact of a diabetes self-management education and support intervention involving peer support on glycaemic control and diabetes distress.
   MethodsA total of 41 South-Asian adults with Type 2 diabetes were recruited for a 24-week diabetes self-management education and support pilot intervention involving peer support. The intervention consisted of six weekly education sessions co-facilitated by a certified diabetes educator and two peer leaders, followed by 18 weekly support sessions facilitated by two peer leaders. Education sessions were guided entirely by participants' self-management questions and also emphasized goal setting and action planning. Support sessions were based on empowerment principles and participants discussed self-management challenges, shared emotions, asked self-management questions, problem-solved in a group, set goals, and developed and evaluated action plans. Feasibility outcomes included recruitment and retention. Primary health-related outcomes included HbA(1c) levels and diabetes distress (measured at baseline, 6 and 24weeks). Programme satisfaction was also assessed.
   ResultsPre-established criteria for recruitment and retention were met. Paired t-tests showed no changes in HbA(1c) and diabetes distress at 6weeks. At 24weeks, HbA(1c) levels deteriorated [54mmol/mol (7.1%) vs 61mmol/mol (7.7%)] while diabetes distress scores improved (2.0 vs 1.7).
   ConclusionsAlthough feasible, findings suggest this peer-support model may have a positive impact on diabetes distress, but not on HbA(1c) levels. Culturally responsive modifications (e.g. intervention location) to the pilot model are needed and could lead to more favourable health outcomes for this community. Such a re-designed peer-support model will require further investigation.
   What's new
   <list list-type="bulleted" id="dme12655-list-1001"> Few studies have incorporated peer support into diabetes self-management education and support interventions targeting South Asian Canadians. This study examined the feasibility and potential health impact of a diabetes self-management education and support intervention that involved peer support in Vancouver's South-Asian community. Cultural adaptations to peer-support models of diabetes are needed to accommodate practices and norms that may interfere with self-management efforts and to meet the unique needs of South-Asian people living in the district of Metro Vancouver.
C1 [Tang, T. S.] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada.
   [Sohal, P. S.] Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada.
   [Garg, A. K.] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada.
RP Tang, TS (reprint author), Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada.
EM tricia.tang@vch.ca
FU Vancouver General Hospital-University of British Columbia Foundation;
   Azad and Yasmin Shamji Family
FX This study was supported by a Vancouver General Hospital-University of
   British Columbia Foundation Grant and financially sponsored by the Azad
   and Yasmin Shamji Family.
CR Adepu R., 2007, Indian Journal of Pharmaceutical Sciences, V69, P519
   Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   Anderson-Loftin W, 2005, DIABETES EDUCATOR, V31, P555, DOI 10.1177/0145721705278948
   Baksi AK, 2008, DIABETIC MED, V25, P1076, DOI 10.1111/j.1464-5491.2008.02542.x
   Cade JE, 2009, DIABETIC MED, V26, P1048, DOI 10.1111/j.1464-5491.2009.02808.x
   Chiu M, 2010, CAN MED ASSOC J, V182, pE301, DOI 10.1503/cmaj.091676
   Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x
   Dale J, 2009, PATIENT EDUC COUNS, V75, P91, DOI 10.1016/j.pec.2008.09.014
   DeSouza M, 2003, CLIN EFFECTIVENESS N, V7, P63
   Due-Christensen M, 2012, DIABETIC MED, V29, P251, DOI 10.1111/j.1464-5491.2011.03521.x
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Galdas PM, 2010, J CLIN NURS, V19, P3134, DOI 10.1111/j.1365-2702.2010.03430.x
   Ghosh S., 2010, INT J PHARM BIO SCI, V1, P1
   Hawthorne K, 2001, HEALTH EDUC RES, V16, P373, DOI 10.1093/her/16.3.373
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   Horne M, 2012, PUBLIC HEALTH, V126, P417, DOI 10.1016/j.puhe.2012.02.002
   Kerssen Anneloes, 2009, Prim Care Diabetes, V3, P79, DOI 10.1016/j.pcd.2009.04.002
   Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576
   Khunti K, 2008, DIABETIC MED, V25, P985, DOI 10.1111/j.1464-5491.2008.02512.x
   Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313
   Lorig K, 2010, DIABETES CARE, V33, P1275, DOI 10.2337/dc09-2153
   Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316
   Naik AD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-37
   Narmadha MP, 2011, PHARMACISTS, V3, P65, DOI DOI 10.4103/0975-1483.76422]
   Pibernik-Okanovic M, 2004, PATIENT EDUC COUNS, V52, P193, DOI 10.1016/S0738-3991(03)00038-7
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Shah BR, 2008, J PUBLIC HEALTH-UK, V30, P327, DOI 10.1093/pubmed/fdn042
   Smith SM, 2011, BMJ-BRIT MED J, V342, P715
   Statistics Canada, 2010, STUD PROJ DIV CAN PO
   Stone M, 2005, FAM PRACT, V22, P647, DOI 10.1093/fampra/cmi069
   Tang TS, 2013, DIABETIC MED, V30, P746, DOI 10.1111/dme.12179
   Tang TS, 2014, DIABETES CARE, V37, P1525, DOI 10.2337/dc13-2161
   Tang TS, 2014, DIABETES EDUCATOR, V40, P223, DOI 10.1177/0145721713520569
   Utz SW, 2008, DIABETES EDUCATOR, V34, P854, DOI 10.1177/0145721708323642
NR 35
TC 4
Z9 5
U1 1
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD AUG
PY 2015
VL 32
IS 8
BP 1077
EP 1084
DI 10.1111/dme.12655
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CN0EC
UT WOS:000358085600014
PM 25472598
DA 2019-01-08
ER

PT J
AU Liu, Y
   Han, Y
   Shi, JL
   Li, RX
   Li, SF
   Jin, NN
   Gu, Y
   Guo, HL
AF Liu, Yan
   Han, Ying
   Shi, Jieli
   Li, Ruixia
   Li, Sufen
   Jin, Nana
   Gu, Yong
   Guo, Honglei
TI Effect of peer education on self-management and psychological status in
   type 2 diabetes patients with emotional disorders
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Emotional disorders; Peer education; Self-management
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; GLYCEMIC CONTROL;
   DEPRESSION; SUPPORT; PEOPLE; HEALTH; CARE; MELLITUS; INTERVENTION
AB Aims/IntroductionThe purpose of the present study was to assess the effect of peer education in type 2 diabetes patients with emotional disorders on the metabolic index and psychological status.
   Materials and MethodsEducators use psychological scales to screen type 2 diabetes patients with emotional disorders. Participants were divided into usual and peer education groups. Both groups received usual diabetes education. Peer leaders were recruited to provide support with the peer education group for 6months. The metabolic index, diabetes knowledge, self-management, diabetes-related distress, emotional status and quality of life were compared at the end of the study.
   ResultsA total of 127 patients participated in the study. There were 20 peer leaders engaged in the study as volunteers for peer education. All participants completed the study and fulfilled the scales. Improvements in the peer education group were significant compared with the usual education group with respect to anxiety (49.09.65 vs 54.0 +/- 8.48), depression (51.3 +/- 7.97 vs 55.8 +/- 7.52), diabetes knowledge (18.8 +/- 2.46 vs 16.3 +/- 2.08), distress (2.67 +/- 0.55 vs 3.02 +/- 0.56), self-management (66.5 +/- 4.26 vs 62.4 +/- 5.88) and quality of life (-1.98 +/- 0.82 vs -2.50 +/- 0.71), whereas no significant difference existed with respect to the metabolic index.
   ConclusionsPeer education, providing more attention to diabetes patients with emotional disorders, is a preferred model for delivering care.
C1 [Liu, Yan; Han, Ying; Shi, Jieli; Li, Ruixia; Li, Sufen; Jin, Nana] Tianjin Med Univ, General Hosp Dagang Oilfield, Tianjin, Peoples R China.
   [Guo, Honglei] Tianjin Med Univ, Key Lab Hormones, Tianjin, Peoples R China.
   [Gu, Yong; Guo, Honglei] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 200433, Peoples R China.
RP Guo, HL (reprint author), Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 200433, Peoples R China.
EM suxughl@gmail.com
CR Ashwell SG, 2008, DIABETES CARE, V31, P1112, DOI 10.2337/dc07-1183
   Baksi AK, 2008, DIABETIC MED, V25, P1076, DOI 10.1111/j.1464-5491.2008.02542.x
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Cade JE, 2009, DIABETIC MED, V26, P1048, DOI 10.1111/j.1464-5491.2009.02808.x
   [陈霭玲 CHEN Ailing], 2006, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V15, P434
   Chinese Medical Association, 2010, CHIN TYP 2 DIAB PREV
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5
   Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8
   Fisher EB, 2012, HLTH AFF, V31, P1, DOI [10.1377/hlthaff.20211.0914, DOI 10.1377/HLTHAFF.20211.0914]
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   Ghorob A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-208
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Guo HL, 2014, J DIABETES INVEST, V5, P410, DOI 10.1111/jdi.12152
   Heisler M, 2005, DIABETES EDUCATOR, V31, P869, DOI 10.1177/0145721705283247
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   Hu J, 2012, J CLIN NURS, V22, P51
   Ismail K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14220
   Jiang YD, 2011, J DIABETES INVEST, V2, P79, DOI 10.1111/j.2040-1124.2011.00110.x
   Kong LP, 2013, J CLIN NURS, V22, P1163, DOI 10.1111/jocn.12090
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Moskowitz D, 2013, J GEN INTERN MED, V28, P938, DOI 10.1007/s11606-013-2367-7
   Paul G, 2013, FAM PRACT, V30, P593, DOI 10.1093/fampra/cmt027
   Philis-Tsimikas A, 2014, TRANSL BEHAV MED, V4, P18, DOI 10.1007/s13142-014-0253-4
   Philis-Tsimikas A, 2011, DIABETES CARE, V34, P1926, DOI 10.2337/dc10-2081
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Riddell MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-843
   Rogers EA, 2014, DIABETES EDUCATOR, V40, P107, DOI 10.1177/0145721713513178
   Simon GE, 2005, GEN HOSP PSYCHIAT, V27, P344, DOI 10.1016/j.genhosppsych.2005.04.008
   Smith SM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d715
   Soon SS, 2010, APPL HEALTH ECON HEA, V8, P239, DOI 10.2165/11313920-000000000-00000
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   van der Wulp I, 2012, DIABETIC MED, V29, pe390, DOI 10.1111/j.1464-5491.2012.03629.x
   Wang JX, 1998, J NURSING, V45, P60
   Weinger K, 2006, NURS CLIN N AM, V41, P667, DOI 10.1016/j.cnur.2006.07.002
   Yang J, 2009, J CLIN NURS, V18, P1295, DOI 10.1111/j.1365-2702.2008.02703.x
   Yang WY, 2013, J DIABETES INVEST, V4, P223, DOI 10.1111/jdi.12057
   Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
NR 41
TC 7
Z9 9
U1 2
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1116
EI 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD JUL
PY 2015
VL 6
IS 4
BP 479
EP 486
DI 10.1111/jdi.12311
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CM2MU
UT WOS:000357515500016
PM 26221528
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Park, H
   Park, C
   Quinn, L
   Fritschi, C
AF Park, Hanjong
   Park, Chang
   Quinn, Laurie
   Fritschi, Cynthia
TI Glucose control and fatigue in type 2 diabetes: the mediating roles of
   diabetes symptoms and distress
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE depression; diabetes; fatigue; nursing; observational research; symptom
   management
ID GLYCOHEMOGLOBIN STANDARDIZATION PROGRAM; GLYCEMIC CONTROL; DEPRESSIVE
   SYMPTOMS; GLYCATED HEMOGLOBIN; FOLLOW-UP; COMPLICATIONS; HYPERGLYCEMIA;
   ASSOCIATION; METABOLISM; CHECKLIST
AB AimThe purpose of this study was to examine the mediating influence of diabetes health characteristics (diabetes distress, depression symptoms and diabetes symptoms) on the relationship between glucose control and fatigue in adults with type 2 diabetes.
   BackgroundIn patients with type 2 diabetes, fatigue is common and can affect diabetes self-management behaviours. Although long thought to result from hyperglycaemia, little evidence supports a relationship between fatigue and glucose control.
   DesignA cross-sectional, descriptive study design was used.
   MethodData were combined from two studies conducted at a large urban university in the Midwestern United States, resulting in a total sample of 155 urban-dwelling adults with type 2 diabetes. Data were collected over the course of 6days from 2013-March 2014. Fatigue and related biological and psychological phenomena were measured to perform path analyses using structural equation modelling methods. The STATA software was used to analyse the data.
   FindingsIn patients with A1C less than or equal to 7%, fatigue was related to diabetes distress and diabetes symptoms, but not to A1C directly or indirectly. In the group with A1C greater than 7%, fatigue was indirectly related to A1C; this relationship was mediated through diabetes symptoms, depression and diabetes distress.
   ConclusionOur findings suggest that fatigue is indirectly related to glucose control, but only in patients who have elevated A1C levels. In those with adequate glucose control, fatigue is mainly influenced by the presence of diabetes symptoms and distress. In both groups, the number and severity of diabetes symptoms were the strongest predictors of fatigue, regardless of blood glucose control.
C1 [Park, Hanjong] Kyung Hee Univ, Coll Nursing Sci, Seoul, South Korea.
   [Park, Chang] Univ Illinois, Coll Nursing Chicago, Dept Hlth Syst Sci, Chicago, IL USA.
   [Quinn, Laurie; Fritschi, Cynthia] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA.
RP Fritschi, C (reprint author), Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA.
EM fritschi@uic.edu
OI Park, HanJong/0000-0003-0896-654X; Fritschi, Cynthia/0000-0001-5447-8315
FU National Institutes of Health/National Institute for Nursing Research
   [K99 R00 NR012219, F31 NR009751]
FX This work was supported in part by the National Institutes of
   Health/National Institute for Nursing Research K99 R00 NR012219 and F31
   NR009751 (CF).
CR Acock A.C., 2013, DISCOVERING STRUCTUR
   Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Bode Bruce W, 2007, J Diabetes Sci Technol, V1, P405
   Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971
   Brod M, 2006, QUAL LIFE RES, V15, P481, DOI 10.1007/s11136-005-1624-6
   Byrne BM, 2009, STRUCTURAL EQUATION
   Chasens ER, 2014, WESTERN J NURS RES, V36, P294, DOI 10.1177/0193945913500567
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Franks MM, 2010, FAM RELAT, V59, P599, DOI 10.1111/j.1741-3729.2010.00626.x
   Fritschi C., 2014, AM DIAB ASS 74 SCI S
   Fritschi C, 2014, DIABETES, V63, pA195
   Fritschi C, 2012, DIABETES EDUCATOR, V38, P662, DOI 10.1177/0145721712450925
   Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021
   Goedendorp MM, 2014, DIABETES CARE, V37, P73, DOI 10.2337/dc13-0515
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hlatky MA, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.004
   Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470
   Huibers MJH, 2007, J PSYCHOSOM RES, V63, P137, DOI 10.1016/j.jpsychores.2007.02.014
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Lasselin J, 2012, BRAIN BEHAV IMMUN, V26, P1211, DOI 10.1016/j.bbi.2012.03.003
   Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183
   Little RR, 2001, CLIN CHEM, V47, P1985
   LUSTMAN PJ, 1988, INT J PSYCHIAT MED, V18, P295
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112
   Payne Judith K, 2004, Biol Res Nurs, V6, P141, DOI 10.1177/1099800404268280
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Preacher K. J., 2002, CALCULATION TEST DIF, V2014
   Sivo SA, 2006, J EXP EDUC, V74, P267, DOI 10.3200/JEXE.74.3.267-288
   St John A, 2006, CLIN CHIM ACTA, V365, P257, DOI 10.1016/j.cca.2005.09.003
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Sudore RL, 2012, J GEN INTERN MED, V27, P1674, DOI 10.1007/s11606-012-2132-3
   Tamborlane WV, 2005, PEDIATR DIABETES, V6, P13
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   Warren RE, 2003, DIABETES-METAB RES, V19, P408, DOI 10.1002/dmrr.396
   Wenzel J, 2005, DIABETES EDUCATOR, V31, P98, DOI 10.1177/0145721704273242
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 43
TC 6
Z9 6
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-2402
EI 1365-2648
J9 J ADV NURS
JI J. Adv. Nurs.
PD JUL
PY 2015
VL 71
IS 7
BP 1650
EP 1660
DI 10.1111/jan.12632
PG 11
WC Nursing
SC Nursing
GA CL0IH
UT WOS:000356624700017
PM 25690988
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Oliveira, RA
   Tostes, M
   Queiroz, VA
   Rodacki, M
   Zajdenverg, L
AF Oliveira, R. A.
   Tostes, M.
   Queiroz, V. A.
   Rodacki, M.
   Zajdenverg, L.
TI Insulin mediated improvement in glycemic control in elderly with type 2
   diabetes mellitus can improve depressive symptoms and does not seem to
   impair health-related quality of life
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Health- related quality of life; Depression; Diabetes mellitus; Elderly;
   Insulin
ID SHORT-ACTING INSULIN; EMOTIONAL DISTRESS; PROBLEM AREAS; INDIVIDUALS;
   VALIDATION; ANXIETY; VERSION; SCALE; RISK
AB Background and objectives: Type 2 diabetes (T2D) is very prevalent among the elderly. Insulin therapy is often required for glycemic control. The association of starting this therapy with depressive symptoms as well the health-related quality of life (HRQoL) is unknown among the elderly patients.
   Aims: Evaluate the association of starting insulin therapy depressive symptoms as well with HRQoL of elderly people with T2D.
   Methods: 36 T2D participants (67.9 % females, age 66.5 years +/- 5.1) were recruited, 26 of whom completed the follow-up. Generic (Short-Form 36 Health Survey - SF-36) and specific (Problem Areas in Diabetes - PAID) HRQoL questionnaires, Beck Depression Inventory (BDI), clinical, laboratorial and socio-demographic data were recorded on baseline and 6 months after the beginning of insulin treatment.
   Results: There was a reduction in the BDI score after the use of insulin, which means an improvement in depressive symptoms (Before/After: median - 10.5 / 7; p = 0008). There were no statistically significant differences in HRQoL scores between the two time periods There was also a reduction in HbA1c (Before/After: median - 8.7/7.9). Otherwise, there were no statistically significant differences in: BMI (28.1/28.3); Abdominal circumference:(100.5/99.5) and chronic complications status.
   Conclusion: Insulin therapy in elderly people with type 2 diabetes can lead to an improvement of depressive symptoms and does not seem to affect negatively HRQoL of the participants.
C1 [Oliveira, R. A.; Tostes, M.; Queiroz, V. A.; Rodacki, M.; Zajdenverg, L.] Univ Fed Rio de Janeiro, Nutrol & Diabet Sect, Rio De Janeiro, Brazil.
RP Oliveira, RA (reprint author), Univ Fed Rio de Janeiro, Nutrol & Diabet Sect, Rio De Janeiro, Brazil.
EM rico_de_oliveira@yahoo.com.br
CR Akinci F, 2008, DIABETES RES CLIN PR, V79, P117, DOI 10.1016/j.diabres.2007.07.003
   Ashwell SG, 2008, DIABETES CARE, V31, P1112, DOI 10.2337/dc07-1183
   Chmiel-Perzynska I, 2010, DIABETOL DOSWIADCZAL, V10, P41
   Daniele TMD, 2013, ARQ BRAS ENDOCRINOL, V57, P44, DOI 10.1590/S0004-27302013000100006
   Eljedi A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-268
   Fal AM, 2011, ACTA DIABETOL, V48, P237, DOI 10.1007/s00592-010-0244-y
   Funnell MM, 2008, INSULIN, p31 , DOI DOI 10.1016/S1557-0843(08)80009-7
   Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   Horvath K, 2007, COCHRANE DB SYST REV
   Hosoya T, 2012, INTERNAL MED, V51, P263, DOI 10.2169/internalmedicine.51.5768
   Kamoi K, 2004, DIABETES RES CLIN PR, V64, P19, DOI 10.1016/j.diabres.2003.10.005
   Kelley K, 2007, AM J NEPHROL, V27, P488, DOI 10.1159/000106672
   Kirkman S, 2012, J AM GERIATR SOC, V60, P2342, DOI DOI 10.1111/JGS.12035
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   Nicolau J, 2013, DIABETES RES CLIN PR, V101, P148, DOI 10.1016/j.diabres.2013.05.009
   Plank J, 2005, ARCH INTERN MED, V165, P1337, DOI 10.1001/archinte.165.12.1337
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pontiroli AE, 2011, DIABETES OBES METAB, V13, P1008, DOI 10.1111/j.1463-1326.2011.01433.x
   Shah S, 2011, DIABETES RES CLIN PR, V94, P364, DOI 10.1016/j.diabres.2011.10.020
   Tabak AG, 2013, LANCET DIABETES ENDO, V2, P236
   Aguiar CCT, 2008, ARQ BRAS ENDOCRINOL, V52, P931, DOI 10.1590/S0004-27302008000600004
   Wandell PE, 2005, SCAND J PRIM HEALTH, V23, P68, DOI 10.1080/02813430510015296
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Zhang Q, 2011, CHINESE MED J-PEKING, V124, P1616, DOI 10.3760/cma.j.issn.0366-6999.2011.11.003
NR 25
TC 4
Z9 4
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD JUN 24
PY 2015
VL 7
AR 55
DI 10.1186/s13098-015-0052-1
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CL0RF
UT WOS:000356650100001
PM 26110026
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Flores, KF
   Robledo, CA
   Hwang, BS
   Leishear, K
   Grantz, KL
   Mendola, P
AF Flores, Katrina F.
   Robledo, Candace A.
   Hwang, Beom Seuk
   Leishear, Kira
   Grantz, Katherine Laughon
   Mendola, Pauline
TI Does maternal asthma contribute to racial/ethnic disparities in
   obstetrical and neonatal complications?
SO ANNALS OF EPIDEMIOLOGY
LA English
DT Article
DE Asthma; Pregnancy; Infant; Ethnic groups; Health disparities
ID BLACK WOMENS HEALTH; PERINATAL OUTCOMES; PRETERM BIRTH;
   RACIAL-DISCRIMINATION; DEPRESSIVE SYMPTOMS; ETHNIC DISPARITIES;
   AFRICAN-AMERICAN; INFANT-MORTALITY; PREGNANT-WOMEN; UNITED-STATES
AB Purpose: To examine whether maternal asthma contributes to racial/ethnic differences in obstetrical and neonatal complications.
   Methods: Data on white (n = 110,603), black (n = 50,284), and Hispanic (n = 38,831) singleton deliveries came from the Consortium on Safe Labor. Multilevel logistic regression models, with an interaction term for asthma and race/ethnicity, estimated Within-group adjusted odds ratios (aORs) for gestational diabetes, gestational hypertension, pre-eclampsia, placental abruption, premature rupture of membranes, preterm delivery, maternal hemorrhage, neonatal intensive care unit admissions, small for gestational age, apnea, respiratory distress syndrome, transient tachypnea of the newborn, anemia, and hyperbilirubinemia after adjustment for clinical and demographic confounders. Nonasthmatics of the same racial/ethnic group were the reference group.
   Results: Compared with nonasthmatics, white asthmatics had increased odds of pre-eclampsia (aOR, 1.28; 95% confidence interval [CI], 1.15-1.43) and maternal hemorrhage (aOR, 1.14; 95% Cl, 1.04-1.23). White and Hispanic infants were more likely to have neonatal intensive care unit admissions (aOR, 1.19; 95% Cl, 1.11-1.28; aOR, 1.16; 95% Cl, 1.02-1.32, respectively) and be small for gestational age (aOR, 1.11; 95% Cl, 1.02-1.20; aOR, 1.26; 95% Cl, 1.10-1.44, respectively), and Hispanic infants were more likely to have apnea (aOR, 1.32; 95% Cl, 1.02-1.69).
   Conclusions: Maternal asthma did not affect most obstetrical and neonatal complication risks within racial/ethnic groups. Despite their increased risk for both asthma and many complications, our findings for black women were null. Asthma did not contribute to racial/ethnic disparities in complications. Published by Elsevier Inc.
C1 [Flores, Katrina F.; Robledo, Candace A.; Grantz, Katherine Laughon; Mendola, Pauline] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Intramural Populat Hlth Res, NIH, Rockville, MD 20852 USA.
   [Hwang, Beom Seuk] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biostat & Bioinformat Branch, Div Intramural Populat Hlth Res, NIH, Rockville, MD 20852 USA.
   [Leishear, Kira] US FDA, Div Epidemiol, Off Surveillance & Epidemiol, Off Pharmacovigilance & Epidemiol,Ctr Drug Evalua, Silver Spring, MD USA.
RP Mendola, P (reprint author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Intramural Populat Hlth Res, NIH, 6100 Execut Blvd,Room 7B03F, Rockville, MD 20852 USA.
EM pauline.mendola@nih.gov
OI Mendola, Pauline/0000-0001-5330-2844; Grantz,
   Katherine/0000-0003-0276-8534
FU Intramural Research Program of the National Institutes of Health (NIH);
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development (NICHD); Intramural Research Program of the NIH, NICHD
   [HHSN267200603425C]
FX This research was supported by the Intramural Research Program of the
   National Institutes of Health (NIH), Eunice Kennedy Shriver National
   Institute of Child Health and Human Development (NICHD). The data
   included in this article were obtained from the Consortium on Safe
   Labor, supported by the Intramural Research Program of the NIH, NICHD,
   through contract number HHSN267200603425C.
CR Alexander GR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.006
   Alexander S, 1998, OBSTET GYNECOL, V92, P435, DOI 10.1016/S0029-7844(98)00191-4
   Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864
   Bryant AS, 2009, PAEDIATR PERINAT EP, V23, P454, DOI 10.1111/j.1365-3016.2009.01059.x
   Cabacungan ET, 2012, MATERN CHILD HLTH J, V16, P1455, DOI 10.1007/s10995-011-0914-6
   Collins JW, 2004, AM J PUBLIC HEALTH, V94, P2132, DOI 10.2105/AJPH.94.12.2132
   Coogan PF, 2014, CHEST, V145, P480, DOI 10.1378/chest.13-0665
   Creanga AA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.039
   Dombrowski MP, 2006, IMMUNOL ALLERGY CLIN, V26, P81, DOI 10.1016/j.iac.2005.10.002
   Ehrenthal DB, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.015
   Enriquez R, 2007, J ALLERGY CLIN IMMUN, V120, P625, DOI 10.1016/j.jaci.2007.05.044
   Geronimus AT, 1996, SOC SCI MED, V42, P589, DOI 10.1016/0277-9536(95)00159-X
   Hayes Donald K, 2014, Hawaii J Med Public Health, V73, P49
   Hogue CJR, 2005, AM J OBSTET GYNECOL, V192, pS47, DOI 10.1016/j.ajog.2005.01.073
   Jesse DE, 2005, J MIDWIFERY WOM HEAL, V50, P405, DOI 10.1016/j.jmwh.2005.05.001
   Kwon HL, 2006, IMMUNOL ALLERGY CLIN, V26, P29, DOI 10.1016/j.iac.2005.11.002
   Kwon HL, 2003, ANN EPIDEMIOL, V13, P317, DOI 10.1016/S1047-2797(03)00008-5
   Lain SJ, 2012, MED CARE, V50, pE7, DOI 10.1097/MLR.0b013e31821d2b1d
   Liu SL, 2001, AM J OBSTET GYNECOL, V184, P90, DOI 10.1067/mob.2001.108073
   Lu MC, 2004, AM J OBSTET GYNECOL, V191, P691, DOI 10.1016/j.ajog.2004.04.018
   MacDorman Marian F, 2007, Natl Vital Stat Rep, V56, P1
   MacMullen NJ, 2006, MCN-AM J MATERN-CHIL, V31, P263
   Macmullen Nancy J, 2010, Appl Nurs Res, V23, pe9, DOI 10.1016/j.apnr.2009.03.004
   Mannisto T, 2013, AM J EPIDEMIOL, V178, P731, DOI 10.1093/aje/kwt031
   Matthews T J, 2013, Natl Vital Stat Rep, V62, P1
   Mendola P, 2014, J ALLERGY CLIN IMMUN, V133, P85, DOI 10.1016/j.jaci.2013.06.012
   Mendola P, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.007
   Murphy VE, 2011, BJOG-INT J OBSTET GY, V118, P1314, DOI 10.1111/j.1471-0528.2011.03055.x
   Namazy JA, 2005, CURR OPIN PULM MED, V11, P56, DOI 10.1097/01.mcp.0000148568.20273.f5
   Orr ST, 2006, ANN EPIDEMIOL, V16, P463, DOI 10.1016/j.annepidem.2005.08.004
   PERLOW JH, 1992, AM J OBSTET GYNECOL, V167, P963, DOI 10.1016/S0002-9378(12)80020-2
   Phillips GS, 2010, ANN EPIDEMIOL, V20, P8, DOI 10.1016/j.annepidem.2009.09.009
   POLEDNAK AP, 1991, AM J PUBLIC HEALTH, V81, P1480, DOI 10.2105/AJPH.81.11.1480
   Qin C, 2006, PAEDIATR PERINAT EP, V20, P279, DOI 10.1111/j.1365-3016.2006.00737.x
   Rosenberg L, 2002, EPIDEMIOLOGY, V13, P646, DOI 10.1097/01.EDE.0000030929.51122.20
   Rossen LM, 2014, AM J PUBLIC HEALTH, V104, P1549, DOI 10.2105/AJPH.2013.301272
   Schaaf JM, 2013, AM J PERINAT, V30, P433, DOI 10.1055/s-0032-1326988
   Schatz M, 2006, AM J OBSTET GYNECOL, V194, P120, DOI 10.1016/j.ajog.2005.06.028
   Wang G, 2014, J MATERN-FETAL NEO M, V27, P934, DOI 10.3109/14767058.2013.847080
   Wen SW, 2001, ANN EPIDEMIOL, V11, P7, DOI 10.1016/S1047-2797(00)00077-6
   Zhang J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.058
NR 41
TC 3
Z9 3
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1047-2797
EI 1873-2585
J9 ANN EPIDEMIOL
JI Ann. Epidemiol.
PD JUN
PY 2015
VL 25
IS 6
BP 392
EP 397
DI 10.1016/j.annepidem.2015.01.011
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CI8KM
UT WOS:000355021200002
PM 25724829
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Luca, A
   Luca, M
   Di Mauro, M
   Palermo, F
   Rampulla, F
   Calandra, C
AF Luca, A.
   Luca, M.
   Di Mauro, M.
   Palermo, F.
   Rampulla, F.
   Calandra, C.
TI Alexithymia, more than depression, influences glycaemic control of type
   2 diabetic patients
SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
LA English
DT Article
DE Alexithymia; Depression; Diabetes; Glycaemic control; HbA1c
ID QUALITY-OF-LIFE; RISK-FACTOR; FOLLOW-UP; MELLITUS; ASSOCIATION;
   SYMPTOMS; DISTRESS; METAANALYSIS; ADULTS; HEALTH
AB Purpose Psychiatric disorders could affect the patients' abilities to cope with diabetes. The objectives of this study were to assess the prevalence of depression and alexithymia among type 2 diabetic patients and investigate the possible correlations between these psychopathological phenomena and glycaemic control assessed through glycated hemoglobin (HbA1c).
   Methods All the patients were evaluated through 20-item Toronto Alexithymia Scale (TAS-20), Hamilton rating scale for depression and Quality of Life Index. HbA1c values, diabetes duration, therapy and socio-demographic characteristics were recorded.
   Results One hundred and twenty-eight patients (75 males and 53 female, mean age 64.7 +/- 11.2 years) were enrolled. Alexithymic patients, compared to non-alexithymic ones, presented a significantly higher HbA1c (7.7 +/- 1.5 vs. 7 +/- 1.5, p = 0.016). No statistically significant difference was found when comparing the HbA1c of depressed versus non-depressed patients. Considering the raw values of HbA1c, the higher percentage was recorded among patients suffering from depression plus alexithymia (comorbidity group) followed by patients presenting alexithymia only, patients with neither depression nor alexithymia (control group) and, finally, those presenting depression only. The comorbidity group presented a significantly higher value of HbA1c (7.7 +/- 1.2) than the control group (7 +/- 1.6, p < 0.04) and the depressed patients (6.9 +/- 1.3, p = 0.04). At the logistic regression, the HbA1c was found to be significantly associated only with alexithymia (TAS-20 total score) and insulin therapy.
   Conclusions Alexithymia more than depression influences glycaemic control. When evaluating a diabetic patient, a rapid screening for psychopathological alterations would guarantee a more accurate management. The treatment of any associated psychiatric disorders would improve the patients' quality of life.
C1 [Luca, A.] Univ Hosp Policlin Vittorio Emanuele Catania Sici, Sect Neurosci, Dept GF Ingrassia, I-95100 Catania, Italy.
   [Luca, M.; Rampulla, F.; Calandra, C.] Univ Hosp Policlin Vittorio Emanuele Catania Sici, Dept Med & Surg Specialties, Psychiat Unit, I-95100 Catania, Italy.
   [Di Mauro, M.] Univ Hosp Policlin Vittorio Emanuele Catania Sici, Androl & Endocrinol Unit, Dept Clin & Mol Biomed, I-95100 Catania, Italy.
   [Palermo, F.] Univ Catania, ARNAS Garibaldi Nesima, Dept Clin & Mol Biomed, Infect Dis Unit, I-95122 Catania, Italy.
RP Calandra, C (reprint author), Univ Hosp Policlin Vittorio Emanuele Catania Sici, Dept Med & Surg Specialties, Psychiat Unit, Via S Sofia 78, I-95100 Catania, Italy.
EM c.calandra@unict.it
OI DI MAURO, Maurizio/0000-0003-0443-6437
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Alonso-Moran E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-769
   *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS62, DOI DOI 10.2337/DC10-S062
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1
   Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008
   Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172
   Coleman SM, 2013, PSYCHOSOMATICS, V54, P428, DOI 10.1016/j.psym.2013.02.015
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   De Hert M, 2009, EUR PSYCHIAT, V24, P412, DOI 10.1016/j.eurpsy.2009.01.005
   Eren I, 2008, DEPRESS ANXIETY, V25, P98, DOI 10.1002/da.20288
   Farges F, 2004, ENCEPHALE, V30, P201
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Friedman S, 2003, J PSYCHOSOM RES, V55, P285, DOI 10.1016/S0022-3999(02)00636-0
   Gois C, 2011, J AFFECT DISORDERS, V134, P52, DOI 10.1016/j.jad.2011.05.021
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   Katon WJ, 2013, ANN FAM MED, V11, P245, DOI 10.1370/afm.1501
   Kazemi-Galougahi M H, 2012, Indian J Med Sci, V66, P230, DOI 10.4103/0019-5359.115216
   Lemche AV, 2014, PSYCHIAT RES, V215, P438, DOI 10.1016/j.psychres.2013.12.004
   Lemche AV, 2010, EUR PSYCHIAT, V25, P1019
   Luminet O, 2006, DIABETES METAB, V32, P417, DOI 10.1016/S1262-3636(07)70299-9
   Lumley MA, 1996, J PSYCHOSOM RES, V41, P505, DOI 10.1016/S0022-3999(96)00222-X
   Lumley MA, 2007, J PERS ASSESS, V89, P230, DOI 10.1080/00223890701629698
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Manoudi F, 2012, ENCEPHALE, V38, P404, DOI 10.1016/j.encep.2012.01.010
   De la Roca-Chiapas JM, 2013, REV INVEST CLIN, V65, P209
   Messier L, 2014, CAN J DIABETES, V38, P456, DOI 10.1016/j.jcjd.2014.01.005
   Picardi A, 2012, PSYCHOPATHOLOGY, V45, P159, DOI 10.1159/000330261
   Sacks DB, 2002, CLIN CHEM, V48, P436
   SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8
   Taylor GJ, 1997, DISORDERS AFFECT REG
   Topsever P, 2006, SCOT MED J, V51, P15
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Wiltink J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105499
NR 36
TC 3
Z9 5
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1720-8386
J9 J ENDOCRINOL INVEST
JI J. Endocrinol. Invest.
PD JUN
PY 2015
VL 38
IS 6
BP 653
EP 660
DI 10.1007/s40618-015-0238-2
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CI0CO
UT WOS:000354403600009
PM 25596663
DA 2019-01-08
ER

PT J
AU Snoek, FJ
   Bremmer, MA
   Hermanns, N
AF Snoek, Frank J.
   Bremmer, Marijke A.
   Hermanns, Norbert
TI Constructs of depression and distress in diabetes: time for an appraisal
SO LANCET DIABETES & ENDOCRINOLOGY
LA English
DT Article
ID NATIONAL-COMORBIDITY-SURVEY; QUALITY-OF-LIFE; POOR GLYCEMIC CONTROL;
   MAJOR DEPRESSION; PSYCHOLOGICAL DISTRESS; EMOTIONAL DISTRESS; METABOLIC
   SYNDROME; PROBLEM AREAS; RISK-FACTOR; FOLLOW-UP
AB Depression presents in roughly 20% of people with diabetes worldwide, and adversely affects quality of life and treatment outcomes. The causes of depression in diabetes are poorly understood, but research suggests a bi-directional association, at least for type 2 diabetes. Inconsistent findings regarding prevalence and depression treatment outcomes in patients with diabetes seem partly attributable to inconsistencies in the definition and measurement of depression and in distinguishing it from diabetes-distress, a psychological concept related to depression. We review evidence suggesting that diabetes-distress and depression are correlated and overlapping constructs, but are not interchangeable. Importantly, diabetes-distress seems to mediate the association between depression and glycaemic control. We propose a model to explain the direct and indirect effects of depression and diabetes-distress on glycaemic control. Additionally, using emerging insights from data-driven approaches, we suggest three distinct symptom profiles to define depression in patients with diabetes that could help explain differential associations between depression and metabolic abnormalities, and to tailor interventions for depression. Future research should focus on further refining depression profiles in patients with diabetes, taking into account the natural history of diabetes and depression, clinical characteristics, and diabetes-distress. The assessment of diabetes-distress and depression in research and clinical practice will be essential to identify high-risk patients with different mental health needs.
C1 [Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Snoek, Frank J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.
   [Bremmer, Marijke A.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, NL-1081 HZ Amsterdam, Netherlands.
   [Hermanns, Norbert] Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.
RP Snoek, FJ (reprint author), Vrije Univ Amsterdam, Med Ctr, Med Psychol, NL-1081 HZ Amsterdam, Netherlands.
EM fj.snoek@vumc.nl
CR Allen Frances, 2013, SAVING NORMAL INSIDE
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Angst J, 2007, ACTA PSYCHIAT SCAND, V115, P72, DOI 10.1111/j.1600-0447.2007.00965.x
   [Anonymous], 2014, DIABETES RES CLIN PR, V104, P1
   Badawi G, 2013, J AFFECT DISORDERS, V145, P100, DOI 10.1016/j.jad.2012.07.018
   Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027
   Baumeister H, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858
   Boschloo L, 2014, PSYCHOTHER PSYCHOSOM, V83, P279, DOI 10.1159/000362563
   Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90
   Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179
   Carper MM, 2014, J BEHAV MED, V37, P501, DOI 10.1007/s10865-013-9505-x
   de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8
   de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015
   Delamater AM, 2009, PEDIATR DIABETES, V10, P175, DOI 10.1111/j.1399-5448.2009.00580.x
   Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581
   Donga E, 2010, DIABETES CARE, V33, P1573, DOI 10.2337/dc09-2317
   DUNN SM, 1986, DIABETES CARE, V9, P480, DOI 10.2337/diacare.9.5.480
   Eaton WW, 2008, ARCH GEN PSYCHIAT, V65, P513, DOI 10.1001/archpsyc.65.5.513
   Egede LE, 2002, DIABETES EDUCATOR, V28, P258, DOI 10.1177/014572170202800211
   Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002
   Egede LE, 2013, EXPERT REV PHARM OUT, V13, P83, DOI [10.1586/ERP.12.86, 10.1586/erp.12.86]
   Fisher EB, 2012, J AFFECT DISORDERS, V142, pS56, DOI 10.1016/S0165-0327(12)70009-5
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Foley DL, 2010, TWIN RES HUM GENET, V13, P347, DOI 10.1375/twin.13.4.347
   Glahn DC, 2012, BIOL PSYCHIAT, V71, P6, DOI 10.1016/j.biopsych.2011.08.022
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   HAMBURG BA, 1983, DIABETES CARE, V6, P409, DOI 10.2337/diacare.6.4.409
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Hildrum B, 2009, ACTA PSYCHIAT SCAND, V120, P14, DOI 10.1111/j.1600-0447.2008.01315.x
   Holt RIG, 2014, DIABETES CARE, V37, P2067, DOI 10.2337/dc13-2134
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Kelly SJ, ANN REV PUB IN PRESS
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
   Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962
   Lamers F, 2012, PSYCHOL MED, V42, P2083, DOI 10.1017/S0033291712000141
   Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu
   Lloyd CE, 2012, SCREENING DEPRESSION
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   LUSTMAN PJ, 1992, PSYCHOSOM MED, V54, P602, DOI 10.1097/00006842-199209000-00007
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762
   Mendenhall E, 2014, DIABETES RES CLIN PR, V103, P276, DOI 10.1016/j.diabres.2014.01.001
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Nakaya N, 2014, EUR J PUBLIC HEALTH, V24, P45, DOI 10.1093/eurpub/ckt017
   Nefs G, 2012, J PSYCHIATR RES, V46, P549, DOI 10.1016/j.jpsychires.2012.01.013
   Parker G, 2005, PSYCHOL MED, V35, P467, DOI 10.1017/S0033291704004210
   Petrak F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-206
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2001, DIABETIC MED, V18, P595, DOI 10.1046/j.1464-5491.2001.00499.x
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Ridner SH, 2004, J ADV NURS, V45, P536, DOI 10.1046/j.1365-2648.2003.02938.x
   RODGERS B, 1991, J AFFECT DISORDERS, V21, P1, DOI 10.1016/0165-0327(91)90012-H
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Roy-Byrne PP, 2000, BRIT J PSYCHIAT, V176, P229, DOI 10.1192/bjp.176.3.229
   Schmitt A, 2014, DIABETIC MED, V31, P1446, DOI 10.1111/dme.12553
   Schmitt A, 2015, J BEHAV MED, V38, P556, DOI 10.1007/s10865-014-9604-3
   Schmitz N, 2014, DIABETES CARE, V37, P970, DOI 10.2337/dc13-1832
   Selye H., 1974, STRESS DISTRESS
   Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012
   Skinner TC, 2010, DIABETIC MED, V27, P965, DOI 10.1111/j.1464-5491.2010.03028.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208
   Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472
   Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015
   Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008
   Stroud CB, 2011, J ABNORM PSYCHOL, V120, P142, DOI 10.1037/a0021659
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   Tabak AG, 2014, LANCET DIABETES ENDO, V2, P236, DOI 10.1016/S2213-8587(13)70139-6
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Loo HM, 2014, DEPRESS ANXIETY, V31, P765, DOI 10.1002/da.22233
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
   VEIT CT, 1983, J CONSULT CLIN PSYCH, V51, P730, DOI 10.1037/0022-006X.51.5.730
   VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   World Health Organization, INT STAT CLASS DIS R
   Xu QY, 2011, OBES RES CLIN PRACT, V5, pE267, DOI 10.1016/j.orcp.2011.04.007
   Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879
NR 99
TC 68
Z9 68
U1 3
U2 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2213-8587
J9 LANCET DIABETES ENDO
JI Lancet Diabetes Endocrinol.
PD JUN
PY 2015
VL 3
IS 6
BP 450
EP 460
DI 10.1016/S2213-8587(15)00135-7
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CI6OR
UT WOS:000354880300022
PM 25995123
DA 2019-01-08
ER

PT J
AU Demmer, RT
   Gelb, S
   Suglia, SF
   Keyes, KM
   Aiello, AE
   Colombo, PC
   Galea, S
   Uddin, M
   Koenen, KC
   Kubzansky, LD
AF Demmer, Ryan T.
   Gelb, Sara
   Suglia, Shakira F.
   Keyes, Katherine M.
   Aiello, Allison E.
   Colombo, Paolo C.
   Galea, Sandro
   Uddin, Monica
   Koenen, Karestan C.
   Kubzansky, Laura D.
TI Sex Differences in the Association Between Depression, Anxiety, and Type
   2 Diabetes Mellitus
SO PSYCHOSOMATIC MEDICINE
LA English
DT Article
DE depression; anxiety; diabetes; mental health; epidemiology; sex
ID NUTRITION EXAMINATION SURVEY; C-REACTIVE PROTEIN; 12-YEAR FOLLOW-UP;
   RISK-FACTOR; INSULIN-RESISTANCE; NATIONAL-HEALTH; HEART-DISEASE;
   SYMPTOMS; POPULATION; METAANALYSIS
AB Background: Depression and anxiety have been inconsistently associated with diabetes. Sex differences in the biological and behavioral correlates of these forms of distress could partially explain these inconsistencies. We investigated sex-specific associations between depression/anxiety symptoms and diabetes in two separate samples.
   Methods: The First National Health and Nutrition Examination Survey enrolled 3233 participants aged 25 to 74 years from 1971 to 1974. Depression and anxiety symptoms were measured via General Well Being schedule subscales. Incident diabetes for 17 years was defined by the following: a) death certificate, b) participant self-report, or c) health care facility discharge. The Detroit Neighborhood Health Study enrolled 1054 participants 18 years or older from 2008 to 2010. The Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7 assessed depression and anxiety. Participants' self-reported physician-diagnosed prevalent diabetes.
   Results: In the First National Health and Nutrition Examination Survey, the risk ratio (RR; 95% confidence interval) for incident diabetes among men with high versus low anxiety symptoms was 0.85 (0.56-1.29) and that among women was 2.19 (1.17-4.09; p for interaction = .005). RRs comparing high versus low depressive symptoms for men and women were 0.69 (0.43-1.100) and 2.11 (1.06-4.19); p for interaction = .007. In the Detroit Neighborhood Health Study, the RRs for prevalent diabetes comparing those with high versus low anxiety symptoms were 0.24 (0.02-2.42) for men and 1.62 (0.61-4.32) for women (p for interaction = < .001), whereas RRs for depression were 1.30 (0.46-3.68) for men and 2.32 (1.10-4.89) for women (p for interaction = .16).
   Conclusions: In two separate samples, depressive symptoms were related to increased diabetes risk among women but not men. Although less robust, findings for anxiety were differentially associated with diabetes by sex.
C1 [Demmer, Ryan T.; Gelb, Sara; Suglia, Shakira F.; Keyes, Katherine M.; Galea, Sandro; Koenen, Karestan C.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10032 USA.
   [Keyes, Katherine M.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
   [Aiello, Allison E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   [Colombo, Paolo C.] Columbia Univ, Coll Physicians & Surg, Dept Med, New York, NY 10032 USA.
   [Uddin, Monica] Univ Illinois, Dept Psychol, Champaign, IL USA.
   [Uddin, Monica] Univ Illinois, Inst Genom Biol, Champaign, IL USA.
   [Kubzansky, Laura D.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.
RP Demmer, RT (reprint author), Columbia Univ, Dept Epidemiol, 722 W 168th St, New York, NY 10032 USA.
EM rtd2106@columbia.edu
OI Galea, Sandro/0000-0002-7534-0945; Demmer, Ryan/0000-0003-3429-0379
FU National Institutes of Health [DE018739, DA022720, DA022720-S1,
   MH088283, MH078152, MH082729, MH070627, MH078928, MH092526, HL103199]
FX This research has been supported by National Institutes of Health Grants
   DE018739 (to R.T.D.); DA022720 and DA022720-S1 (to A.E.A.); MH088283,
   MH078152, and MH082729 (to S.G.); MH070627 and MH078928 (to K.K.);
   MH092526 (to K.M.K.); and HL103199 (to S.F.S.). The authors declare no
   conflicts of interest.
CR Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129
   Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440
   Carnethon MR, 2007, ARCH INTERN MED, V167, P802, DOI 10.1001/archinte.167.8.802
   Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172
   Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a
   Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296
   Darnall BD, 2009, BRAIN BEHAV IMMUN, V23, P595, DOI 10.1016/j.bbi.2009.02.019
   Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026
   Demmer RT, 2012, DIABETES CARE, V35, P2235, DOI 10.2337/dc12-0072
   Demmer RT, 2010, DIABETES CARE, V33, P1037, DOI 10.2337/dc09-1778
   Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288
   Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097
   Edwards LE, 2012, J PSYCHOSOM RES, V73, P418, DOI 10.1016/j.jpsychores.2012.09.018
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856
   FAZIO AF, 1977, VITAL HLTH STAT, V2, P1
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429
   Golden SH, 2007, CURR DIABETES REV, V3, P252, DOI 10.2174/157339907782330021
   Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806
   Hanninen V, 1996, SOC SCI MED, V43, P1453, DOI 10.1016/0277-9536(96)00045-7
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043
   Jonas BS, 2000, PSYCHOSOM MED, V62, P463, DOI 10.1097/00006842-200007000-00001
   Kawakami N, 1999, DIABETES CARE, V22, P1071, DOI 10.2337/diacare.22.7.1071
   Keyes KM, 2013, DEPRESS ANXIETY, V30, P451, DOI 10.1002/da.22090
   KLEINKE CL, 1982, SEX ROLES, V8, P877, DOI 10.1007/BF00287857
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   Low CA, 2010, PSYCHOSOM MED, V72, P842, DOI 10.1097/PSY.0b013e3181f6934f
   Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762
   Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mikolajczyk RT, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-31
   Miller HW, 1971, PLAN OPERATION HLTH
   Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369
   Njolstad I, 1998, AM J EPIDEMIOL, V147, P49
   Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037//0022-3514.77.5.1061
   NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037//0033-2909.101.2.259
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Palinkas LA, 2004, DIABETIC MED, V21, P1185, DOI 10.1111/j.1464-5491.2004.01315.x
   Park K, 2009, DIABETOLOGIA, V52, P2337, DOI 10.1007/s00125-009-1486-5
   Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Pradhan AD, 2003, ARTERIOSCL THROM VAS, V23, P650, DOI 10.1161/01.ATV.0000065636.15310.9C
   Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016
   Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490
   Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693
   Thurston RC, 2006, PSYCHOSOM MED, V68, P25, DOI 10.1097/01.psy.0000195883.68888.68
   Thurston RC, 2009, PSYCHOSOM MED, V71, P836, DOI 10.1097/PSY.0b013e3181b40efc
   van den Akker M, 2004, ACTA PSYCHIAT SCAND, V110, P178
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607
   ZONDERMAN AB, 1989, JAMA-J AM MED ASSOC, V262, P1191, DOI 10.1001/jama.262.9.1191
NR 56
TC 22
Z9 22
U1 0
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0033-3174
EI 1534-7796
J9 PSYCHOSOM MED
JI Psychosom. Med.
PD MAY
PY 2015
VL 77
IS 4
BP 467
EP 477
DI 10.1097/PSY.0000000000000169
PG 11
WC Psychiatry; Psychology; Psychology, Multidisciplinary
SC Psychiatry; Psychology
GA CI2CR
UT WOS:000354553000013
PM 25867970
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Fisher, L
   Polonsky, WH
   Hessler, DM
   Masharani, U
   Blumer, I
   Peters, AL
   Strycker, LA
   Bowyer, V
AF Fisher, Lawrence
   Polonsky, William H.
   Hessler, Danielle M.
   Masharani, Umesh
   Blumer, Ian
   Peters, Anne L.
   Strycker, Lisa A.
   Bowyer, Vicky
TI Understanding the sources of diabetes distress in adults with type 1
   diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes distress; Type 1 diabetes; Distress profile; Assessing
   distress; Types of distress
ID EMOTIONAL DISTRESS; GLYCEMIC CONTROL; DEPRESSION; MANAGEMENT; VALIDITY;
   SCALE; CARE
AB Aims: To identify the unique sources of diabetes distress (DD) for adults with type 1 diabetes (T1D).
   Methods: Sources of DD were developed from qualitative interviews with 25 T1D adults and 10 diabetes health care providers. Survey items were then developed and analyzed using both exploratory (EFA) and confirmatory CFA) analyses on two patient samples. Construct validity was assessed by correlations with depressive symptoms (PHQ8), complications, HbA1C, BMI, and hypoglycemia worry scale (HWS). Scale cut-points were created using multiple regression.
   Results: An EFA with 305 U.S. participants yielded 7 coherent, reliable sources of distress that were replicated by a CFA with 109 Canadian participants: Powerlessness, Negative Social Perceptions, Physician Distress, Friend/Family Distress, Hypoglycemia Distress, Management Distress, Eating Distress. Prevalence of DD was high with 41.6% reporting at least moderate DD. Higher DD was reported for women, those with complications, poor glycemic control, younger age, without a partner, and non-White patients.
   Conclusions: We identified a profile of seven major sources of DD among T1D using a newly developed assessment instrument. The prevalence of DD is high and is related to glycemic control and several patient demographic and disease-related patient characteristics, arguing for a need to address DD in clinical care. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Fisher, Lawrence; Hessler, Danielle M.; Bowyer, Vicky] UCSF, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Masharani, Umesh] UCSF, Dept Med, San Francisco, CA 94143 USA.
   [Blumer, Ian] Charles H Best Diabet Ctr, Whitby, ON, Canada.
   [Peters, Anne L.] Univ So Calif, Los Angeles, CA USA.
   [Strycker, Lisa A.] Oregon Res Inst, Eugene, OR 97403 USA.
RP Fisher, L (reprint author), UCSF, Dept Family & Community Med, Box 0900, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
OI Peters, Anne/0000-0003-0520-0776
FU NIH [DK094863]
FX This research was funded by NIH Grant DK094863. Portions of this study
   were presented as an abstract at the American Diabetes Association
   meetings, San Francisco, California, June 2014. Appreciation is
   expressed to the following for their assistance with patient
   recruitment: Anna Chang, M.D., Paul FitzGerald, M.D., Martha Nolte
   Kennedy, M.D., Grace S. Kim, M.D., Sara Kim, M.D., Pooja Sherchan, M.D.,
   Peter M Sklarin, M.D., Amber Wheeler, M.D., Douglas W. Zlock, M.D.
CR Balfe M., 2013, BMC ENDOCR DISORD, V13, P13
   CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297, DOI DOI 10.1007/BF02310555
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DUNN SM, 1986, DIABETES CARE, V9, P480, DOI 10.2337/diacare.9.5.480
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2011, PATIENT EDUC COUNS, V86, P372
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Hajos T.R., 2013, DIABETIC MED, V30, P63
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Hessler D. M., 2010, DIABETES S1, V59, P1435
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Muthen L. K., 2012, MPLUS USERS GUIDE
   Nunnaly J. C., 1978, PSYCHOMETRIC THEORY
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   Polonsky W. H., 1999, DIABETES BURNOUT WHA
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Simmons JH, 2013, DIABETES CARE, V36, P3573, DOI 10.2337/dc12-2643
NR 24
TC 55
Z9 56
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD MAY-JUN
PY 2015
VL 29
IS 4
BP 572
EP 577
DI 10.1016/j.jdiacomp.2015.01.012
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CH6PE
UT WOS:000354157700020
PM 25765489
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Nobis, S
   Lehr, D
   Ebert, DD
   Baumeister, H
   Snoek, F
   Riper, H
   Berking, M
AF Nobis, Stephanie
   Lehr, Dirk
   Ebert, David Daniel
   Baumeister, Harald
   Snoek, Frank
   Riper, Heleen
   Berking, Matthias
TI Efficacy of a Web-Based Intervention With Mobile Phone Support in
   Treating Depressive Symptoms in Adults With Type 1 and Type 2 Diabetes:
   A Randomized Controlled Trial
SO DIABETES CARE
LA English
DT Article
ID GLYCEMIC CONTROL; MENTAL-DISORDERS; HOSPITAL ANXIETY; SELF-MANAGEMENT;
   METAANALYSIS; DISTRESS; CARE; QUESTIONNAIRE; THERAPIES; VALIDITY
AB OBJECTIVEDepression is common in diabetes and linked to adverse health outcomes. This study evaluated the efficacy of a guided web-based intervention in reducing depression in adults with type 1 and type 2 diabetes.RESEARCH DESIGN AND METHODSA total of 260 participants with diabetes and elevated depressive symptoms (Center for Epidemiologic Studies Depression Scale [CES-D 23]) were randomly assigned to the GET.ON Mood Enhancer Diabetes (a guided self-help intervention, n = 130) or a brief online unguided psychoeducation program for depression (n = 130). The primary outcome was depressive symptoms severity (CES-D). The secondary outcomes included diabetes-specific emotional distress (Problem Areas in Diabetes [PAID] scale) and participant satisfaction (adaption CSQ-8). Data were collected at baseline and 2 months after randomization. To identify differences in outcome between the groups, we used analyses of covariance with the baseline CES-D score as covariate on both intent-to-treat (ITT) and per-protocol (PP) basis.RESULTSCompared with the control group, the intervention group showed significantly less depressive symptom severity at posttreatment based on ITT (d = 0.89) and PP analyses (d = 1.00). The intervention participants displayed a significantly larger reduction in diabetes-specific emotional distress (d = 0.58, ITT). The intervention appeared to be acceptable to the participants; 95% (n = 121) would recommend the training to a friend with diabetes in need of psychological help.CONCLUSIONSA guided, web-based intervention to reduce depression in adults with type 1 and type 2 diabetes is effective in reducing both depressive symptoms and diabetes-specific emotional distress.
C1 [Nobis, Stephanie; Lehr, Dirk; Ebert, David Daniel; Riper, Heleen; Berking, Matthias] Univ Luneburg, Div Online Hlth Training, Innovat Incubator, D-21335 Luneburg, Germany.
   [Ebert, David Daniel] Harvard Univ, Dept Hlth Care Policy, Boston, MA 02115 USA.
   [Ebert, David Daniel; Berking, Matthias] Univ Erlangen Nurnberg, Dept Clin Psychol & Psychotherapy, D-91054 Erlangen, Germany.
   [Baumeister, Harald] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, D-79106 Freiburg, Germany.
   [Snoek, Frank; Riper, Heleen] Vrije Univ Amsterdam Med Ctr, Inst Hlth & Care Res EMGO, Amsterdam, Netherlands.
   [Snoek, Frank] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Snoek, Frank] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.
   [Riper, Heleen] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Riper, Heleen] Univ Southern Denmark, Inst Telepsychiat, Odense, Denmark.
RP Nobis, S (reprint author), Univ Luneburg, Div Online Hlth Training, Innovat Incubator, D-21335 Luneburg, Germany.
EM nobis@inkubator.leuphana.de
RI Emchi, Karma/Q-1952-2016
OI Ebert, David Daniel/0000-0001-6820-0146
FU European Union [EU EFRE: ZW6-80119999, CCI 2007DE161PR001]
FX The European Union funded this study (EU EFRE: ZW6-80119999, CCI
   2007DE161PR001).
CR Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083
   Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196
   Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X
   Baumeister H, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Bundesarztekammer KB, 2011, PATIENT GUIDELINES N
   Cohen J, 1988, STAT POWER ANAL BEHA
   COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452
   Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001
   Cuijpers P, 2007, EUR PSYCHIAT, V22, P9, DOI 10.1016/j.eurpsy.2006.11.001
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Donker T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-79
   Donkin L, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1772
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   First M., 1996, USER GUIDE STRUCTURE
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Gahr A, 2011, DIABETOLOGY METABOLI, P6
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hofmeister D, 2012, CTR EPIDEMIOLOGICAL
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037//0022-006X.59.1.12
   Katon WJ, 2004, MED CARE, V42, P1222, DOI 10.1097/00005650-200412000-00009
   Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423
   Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Melville KM, 2010, BRIT J CLIN PSYCHOL, V49, P455, DOI 10.1348/014466509X472138
   Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3
   Nobis S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-306
   Pal K, 2014, DIABETES CARE, V37, P1759, DOI 10.2337/dc13-1386
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   SCHMIDT J, 1989, PSYCHOTHER PSYCH MED, V39, P248
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van Bastelaar KMP, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1657
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   van Beugen S, 2014, J MED INTERNET RES, V16, P251, DOI 10.2196/jmir.2777
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 40
TC 32
Z9 32
U1 2
U2 28
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD MAY
PY 2015
VL 38
IS 5
BP 776
EP 783
DI 10.2337/dc14-1728
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CG7SP
UT WOS:000353505600016
PM 25710923
OA Bronze
DA 2019-01-08
ER

PT J
AU Ding, D
   Chong, S
   Jalaludin, B
   Comino, E
   Bauman, AE
AF Ding, Ding
   Chong, Shanley
   Jalaludin, Bin
   Comino, Elizabeth
   Bauman, Adrian E.
TI Risk factors of incident type 2-diabetes mellitus over a 3-year
   follow-up: Results from a large Australian sample
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Incidence; Risk prediction; Risk factor; Lifestyle; Behavior
ID DIABETES INCIDENCE; LIFE-STYLE; SOCIOECONOMIC-STATUS;
   INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; SLEEP DURATION; WHITEHALL II;
   METAANALYSIS; POPULATION; COHORT
AB Aims: To describe the incidence of type 2 diabetes mellitus (T2DM) among middle-aged and older Australian adults and to examine a broad range of risk factors of T2DM.
   Methods: A large cohort of Australian adults aged 45 and up was sampled from the general population and was followed up for approximately 3 years (n = 60,404). Physician-diagnosed T2DM was self-reported at baseline (2006-2008) and follow-up (2010). Incident T2DM was determined as not reporting T2DM at baseline, but reporting T2DM at follow-up. A broad range of risk factors, including socio-demographic characteristics, health status, family history, and lifestyle behaviors were examined at baseline. Multiple logistic regression was used for selecting potential predictors of incident T2DM, and age and reported family history of T2DM were tested as potential effect modifiers.
   Results: Of the 54,997 without T2DM at baseline, 888 reported T2DM at follow-up (cumulative incidence 1.6% over 3.4 years, annual incidence rate 0.44%). Adjusted for other risk factors, being male, older age, higher relative socio-economic disadvantage, being born in Asia, lower educational attainment, medical history of hypertension and dyslipidemia, family history of T2DM, overweight/obese, smoking, long sleeping hours, and psychological distress were significantly associated with higher odds of developing T2DM. Particularly, hypertension, dyslipidemia, and overweight/obesity were stronger predictors of T2DM among middle-aged than older adults (>= 60 years).
   Conclusions: Understanding risk factors for incident T2DM could help identify at-risk populations and develop upstream preventive strategies to combat the epidemic of diabetes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Ding, Ding; Bauman, Adrian E.] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia.
   [Chong, Shanley; Jalaludin, Bin] Liverpool Hosp, South Western Sydney Local Hlth Dist, Hlth People & Places Unit, Liverpool, NSW 2170, Australia.
   [Jalaludin, Bin] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.
   [Comino, Elizabeth] Univ New S Wales, Ctr Primary Hlth Care & Equ, Sydney, NSW 2052, Australia.
   [Comino, Elizabeth] Liverpool Hosp, South Western Sydney & Sydney Local Hlth Dist, Unit Populat Hlth, NSW Hlth, Liverpool, NSW 2170, Australia.
RP Ding, D (reprint author), Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia.
EM melody.ding@sydney.edu.au; Shanley.Chong@sswahs.nsw.gov.au;
   Bin.Jalaludin@sswahs.nsw.-gov.au; E.Comino@unsw.edu.au;
   adrian.bauman@sydney.edu.au
OI Ding, Ding/0000-0001-9850-9224
FU National Health and Medical Research Council
FX This study is funded by an Early Career Fellowship from the National
   Health and Medical Research Council (Ding).
CR Abiemo EE, 2013, BRIT J NUTR, V109, P1490, DOI 10.1017/S0007114512003339
   Australian Bureau of Statistics, 2006, CENS POP HOUS SOC IN
   Australian Government Department of Health and Ageing, 2013, EAT HLTH AUSTR DIET
   Australian Institute of Health and Welfare (AIHW), 2013, PREV DIAB
   Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID
   Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1
   Beulens JWJ, 2012, J INTERN MED, V272, P358, DOI 10.1111/j.1365-2796.2012.02532.x
   Boyle P, 2004, SOC SCI MED, V58, P2459, DOI 10.1016/j.socscimed.2003.09.011
   Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1
   Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585
   Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124
   Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000
   Chida Y, 2008, DIABETOLOGIA, V51, P2168, DOI 10.1007/s00125-008-1154-1
   Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103
   Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481
   Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85
   Cox M, 2007, SOC SCI MED, V65, P1953, DOI 10.1016/j.socscimed.2007.05.043
   Cugati S, 2007, MED J AUSTRALIA, V186, P131
   Cullmann M, 2012, DIABETIC MED, V29, P441, DOI 10.1111/j.1464-5491.2011.03450.x
   Department of Health of Australian Goverment, 2014, AUSTR PHYS ACT SED B
   DHAWAN J, 1994, BRIT HEART J, V72, P413
   Dinca-Panaitescu M, 2012, MATURITAS, V72, P229, DOI 10.1016/j.maturitas.2012.03.017
   Ding D, 2014, PREV MED, V60, P102, DOI 10.1016/j.ypmed.2013.12.021
   Hatami M, 2012, J HUM HYPERTENS, V26, P84, DOI 10.1038/jhh.2011.4
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842
   Lee CMY, 2013, DIABETES RES CLIN PR, V99, P385, DOI 10.1016/j.diabres.2012.12.002
   Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Lundberg U, 2005, PSYCHONEUROENDOCRINO, V30, P1017, DOI 10.1016/j.psyneuen.2005.03.014
   Lysy Z, 2013, DIABETES RES CLIN PR, V99, P372, DOI 10.1016/j.diabres.2012.12.005
   Magliano DJ, 2008, DIABETOLOGIA, V51, P2179, DOI 10.1007/s00125-008-1150-5
   Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167
   Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26
   Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x
   Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x
   Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60
   Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037
   Reis JP, 2011, ANN INTERN MED, V155, P292, DOI 10.7326/0003-4819-155-5-201109060-00006
   Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007
   Slade T, 2007, AUST NZ J PSYCHIAT, V41, P403, DOI 10.3109/00048674.2010.543653
   Smith PM, 2013, ANN EPIDEMIOL, V23, P143, DOI 10.1016/j.annepidem.2012.12.012
   Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337
   Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452
   Tanaka T, 2012, EUR J PUBLIC HEALTH, V22, P310, DOI 10.1093/eurpub/ckr050
   Tanamas S, 2012, AUSDIAB 2012 AUSTR D
   Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
   Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4
   Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z
   World Health Organization, 2003, SCREEN TYP 2 DIAB RE
   Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1
NR 51
TC 18
Z9 20
U1 1
U2 24
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAY
PY 2015
VL 108
IS 2
BP 306
EP 315
DI 10.1016/j.diabres.2015.02.002
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CG3YJ
UT WOS:000353215500018
PM 25737033
DA 2019-01-08
ER

PT J
AU Hessler, D
   Fisher, L
   Strycker, LA
   Arean, PA
   Bowyer, V
AF Hessler, Danielle
   Fisher, Lawrence
   Strycker, Lisa A.
   Arean, Patricia A.
   Bowyer, Vicky
TI Causal and bidirectional linkages over time between depression and
   diabetes regimen distress in adults with type 2 diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Regimen distress; Diabetes; Depression behavioral intervention
ID GLYCEMIC CONTROL; CLINICAL DEPRESSION; SELF-CARE; METAANALYSIS;
   PREVALENCE; SYMPTOMS; VALIDITY; OUTCOMES; THERAPY; PROGRAM
AB Aims: Diabetes regimen distress (RD) and depression are related constructs, however the nature of their relationship has not been explored over time, leading to difficulties differentiating between RD and depression and for selection of programs of care. We examined longitudinal associations between RD and depression to explicate the direction and mechanism of operation between these two constructs.
   Methods: 392 adults with type 2 diabetes participated in a randomized control trial (RCT) to reduce diabetes distress. Participants were assessed for RD and depression symptoms, using the PHQ-8, at baseline, and at 4 and 12 months. Latent growth curve models tested both predictive unidirectional and bidirectional longitudinal associations between changes in RD and depression.
   Results: Changes in RD did not significantly predict changes in PHQ-8, nor did changes in PHQ-8 predict changes in RD. A significant bidirectional association was found (Coefficient Estimate = .081, p = .001), where decreases in RD were associated with decreases in PHQ-8. The association was strongest among those with high baseline RD or PHQ-8 scores.
   Conclusions: In the context of an RCT to reduce distress, support was found for a covarying association, in which changes in RD and depression symptoms occurred in tandem over time. No support was found for a causative association. Findings point to RD and depression containing properties that may be related to a shared underlying dimension of emotional distress. Results suggest consideration of both RD and depression in clinical decision making, with interventions selected based on source of distress. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Hessler, Danielle; Fisher, Lawrence; Arean, Patricia A.; Bowyer, Vicky] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Strycker, Lisa A.] Oregon Res Inst, Eugene, OR 97403 USA.
RP Hessler, D (reprint author), Univ Calif San Francisco, Dept Family & Community Med, Box 0900, San Francisco, CA 94143 USA.
EM hesslerd@fcm.ucsf.edu
FU NIDDK [DK061937]
FX The opinions expressed are those of the authors and do not necessarily
   represent those of NIH or NIDDK. This research was funded by NIDDK grant
   number DK061937.
CR Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arean P, 2008, GERONTOLOGIST, V48, P311, DOI 10.1093/geront/48.3.311
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bowyer V, 2014, DIABETES S1, V63
   Duncan T., 2006, INTRO LATENT VARIABL
   Esbitt S. A., 2013, SCREENING DEPRESSION
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glasgow RE, 2010, J GEN INTERN MED, V25, P1315, DOI 10.1007/s11606-010-1480-0
   Glasgow RE, 2010, ANN BEHAV MED, V40, P40, DOI 10.1007/s12160-010-9189-1
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez Jeffrey S, 2010, Epidemiol Psichiatr Soc, V19, P110
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Nezu AM, 2004, BEHAV THER, V35, P1, DOI 10.1016/S0005-7894(04)80002-9
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Shafer JL, 1999, NORM USERS GUIDE MUL
   Tanenbaum ML, 2013, J AFFECT DISORDERS, V150, P533, DOI 10.1016/j.jad.2013.01.029
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Wakefield JC, 2013, WORLD PSYCHIATRY, V12, P44, DOI 10.1002/wps.20015
   Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052
   Zwarenstein M, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2390
NR 30
TC 7
Z9 7
U1 1
U2 14
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAY
PY 2015
VL 108
IS 2
BP 360
EP 366
DI 10.1016/j.diabres.2014.12.017
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CG3YJ
UT WOS:000353215500025
PM 25819480
DA 2019-01-08
ER

PT J
AU Gonzalez, JS
   Shreck, E
   Psaros, C
   Safren, SA
AF Gonzalez, Jeffrey S.
   Shreck, Erica
   Psaros, Christina
   Safren, Steven A.
TI Distress and Type 2 Diabetes-Treatment Adherence: A Mediating Role for
   Perceived Control
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE diabetes; depression; diabetes-related distress; perceived control;
   self-efficacy
ID SELF-EFFICACY; GLYCEMIC CONTROL; MEDICATION ADHERENCE; PERFORMANCE
   STANDARDS; DEPRESSIVE SYMPTOMS; PERSONAL MODELS; CARE; MANAGEMENT; MOOD;
   RISK
AB Objective: To better understand independent pathways linking emotional distress, medication adherence, and glycemic control in adults with Type 2 diabetes, as well as the potential mediating effects of perceived control over illness and self-efficacy. Method: Adults with Type 2 diabetes (N = 142) were recruited for an intervention study evaluating cognitive-behavioral therapy for adherence and depression. Depressive symptom severity was assessed via semistructured interview. Validated self-reports assessed diabetes-related distress, perceived control over diabetes (perceived control), self-efficacy for diabetes self-management, and medication adherence. Glycemic control was evaluated by hemoglobin A1C. Only baseline data were included in correlational and linear regression analyses. Results: Perceived control was an important mediator of emotional distress for both medication adherence and A1C outcomes. Specifically, regression analyses demonstrated that diabetes distress, but not depression severity, was significantly related to medication adherence and A1C. Self-efficacy and perceived control were also independently associated with medication adherence and A1C. Mediation analyses demonstrated a significant indirect effect for diabetes distress and medication adherence through perceived control and self-efficacy. The relationship between distress and A1C was accounted for by an indirect effect through perceived control. Conclusion: Results demonstrated that diabetes-related emotional distress is associated with poorer treatment adherence and glycemic control among adults with Type 2 diabetes; these relationships were partially mediated through perceived control over diabetes. Perceptions of one's personal ability to influence the course of diabetes may be important in understanding the pathway between emotional distress and poor diabetes-treatment outcomes.
C1 [Gonzalez, Jeffrey S.] Yeshiva Univ, Albert Einstein Coll Med, Ferkauf Grad Sch Psychol, Bronx, NY 10461 USA.
   [Gonzalez, Jeffrey S.] Yeshiva Univ, Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA.
   [Gonzalez, Jeffrey S.; Shreck, Erica] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY 10461 USA.
   [Psaros, Christina; Safren, Steven A.] Massachusetts Gen Hosp, Dept Psychiat, Behav Med Serv, Boston, MA 02114 USA.
   [Psaros, Christina; Safren, Steven A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA.
RP Gonzalez, JS (reprint author), Yeshiva Univ, Ferkauf Grad Sch Psychol, 1300 Morris Pk Ave,Rousso Bldg, Bronx, NY 10461 USA.
EM jeffrey.gonzalez@einstein.yu.edu
FU United States Department of Health and Human Services, National
   Institutes of Health (NIH) [R01MH078571]; NIH [P60DK020541, R18DK098742]
FX This project was supported by United States Department of Health and
   Human Services, National Institutes of Health (NIH), Grant R01MH078571
   (Principal investigator: Steven A. Safren). Dr. Gonzalez is partially
   supported by NIH Grants P60DK020541 and R18DK098742.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037//0003-066X.37.2.122
   BANDURA A, 1989, J PERS SOC PSYCHOL, V56, P805, DOI 10.1037/0022-3514.56.5.805
   Beck A. T., 1976, COGNITIVE THERAPY EM
   Beck A. T., 1967, DEPRESSION CLIN EXPT
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Casagrande SS, 2012, DIABETES CARE, V35, P1556, DOI 10.2337/dc11-1943
   CERVONE D, 1994, J PERS SOC PSYCHOL, V67, P499, DOI 10.1037/0022-3514.67.3.499
   Chao Jingdong, 2005, Res Social Adm Pharm, V1, P508, DOI 10.1016/j.sapharm.2005.09.002
   Cherrington A, 2010, J BEHAV MED, V33, P81, DOI 10.1007/s10865-009-9233-4
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9
   Egede LE, 2008, DIABETES TECHNOL THE, V10, P213, DOI 10.1089/dia.2007.0278
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2010, J COGN PSYCHOTHER, V24, P329, DOI 10.1891/0889-8391.24.4.329
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2013, DIABETES CARE, V36, P831, DOI 10.2337/dc12-0410
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Grant R, 2007, DIABETES CARE, V30, P807, DOI 10.2337/dc06-2170
   HAMPSON SE, 1990, HEALTH PSYCHOL, V9, P632, DOI 10.1037/0278-6133.9.5.632
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836
   JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037//0022-3514.45.1.20
   KAVANAGH DJ, 1985, COGNITIVE THER RES, V9, P507, DOI 10.1007/BF01173005
   Leventhal H., 1997, PERCEPTIONS HLTH ILL, P19
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   LITT MD, 1988, COGNITIVE THER RES, V12, P241, DOI 10.1007/BF01176188
   Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Macrodimitris SD, 2001, HEALTH PSYCHOL, V20, P208, DOI 10.1037//0278-6133.20.3.208
   Mc Sharry J, 2011, DIABETIC MED, V28, P1300, DOI 10.1111/j.1464-5491.2011.03298.x
   MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
   NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602
   Nathan DM, 2005, NEW ENGL J MED, V353, P2643
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   Rubin RR, 2005, AM J MED, V118, P27, DOI 10.1016/j.amjmed.2005.04.012
   Sacco WP, 2007, HEALTH PSYCHOL, V26, P693, DOI 10.1037/0278-6133.26.6.693
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   SALOVEY P, 1989, J PERS SOC PSYCHOL, V57, P539, DOI 10.1037/0022-3514.57.3.539
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   Skinner EA, 1996, J PERS SOC PSYCHOL, V71, P549, DOI 10.1037/0022-3514.71.3.549
   Skinner TC, 2001, DIABETES CARE, V24, P828, DOI 10.2337/diacare.24.5.828
   Turner RC, 1998, LANCET, V352, P837
   Wagner JA, 2010, DIABETIC MED, V27, P713, DOI 10.1111/j.1464-5491.2010.02996.x
NR 61
TC 38
Z9 38
U1 2
U2 45
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD MAY
PY 2015
VL 34
IS 5
BP 505
EP 513
DI 10.1037/hea0000131
PG 9
WC Psychology, Clinical; Psychology
SC Psychology
GA CG3EQ
UT WOS:000353161300006
PM 25110840
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Herbert, LJ
   Clary, L
   Owen, V
   Monaghan, M
   Alvarez, V
   Streisand, R
AF Herbert, Linda J.
   Clary, Lauren
   Owen, Victoria
   Monaghan, Maureen
   Alvarez, Vanessa
   Streisand, Randi
TI Relations among school/daycare functioning, fear of hypoglycaemia and
   quality of life in parents of young children with type 1 diabetes
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE diabetes management; hypoglycaemia; quality of life; type 1 diabetes;
   young children
ID SPECIAL NEEDS; SCHOOL; PERCEPTIONS; MANAGEMENT; PERSPECTIVES; TEACHERS;
   MELLITUS; CARE
AB Aims and objectivesTo investigate the type 1 diabetes-related school/daycare experiences of parents of young children and to examine the relationship among child school/daycare functioning, parent fear of hypoglycaemia and parent type 1 diabetes-related quality of life.
   BackgroundParents of young children who attend school/daycare must rely on others for daily type 1 diabetes management. Worry about school/daycare type 1 diabetes management may cause parental distress and contribute to diminished parent quality of life. Parental concerns about type 1 diabetes management in young children in the school/daycare setting have not been well described in the literature.
   DesignDescriptive correlational and cross-sectional parent report of questionnaires design.
   MethodsAs part of a randomised controlled trial for parents of young children with type 1 diabetes, 134 parents completed self-report measures at baseline. Data included demographic, school/daycare, and medical information, parent reports of child school/daycare functioning, parent fear of hypoglycaemia and parent type 1 diabetes-related quality of life.
   ResultsParents of younger children, children on a more intensive medical regimen and children who had experienced type 1 diabetes-related unconsciousness or seizures had more school/daycare concerns. Parents who perceived their children had higher school/daycare functioning had less fear about hypoglycaemia and reported better type 1 diabetes-related quality of life. School/daycare functioning and fear of hypoglycaemia were significantly associated with parent type 1 diabetes-related quality of life.
   ConclusionsParents' concerns about school/daycare functioning and fear of hypoglycaemia play an important role in parents' type 1 diabetes-related quality of life.
   Relevance to clinical practiceMembers of the healthcare team should be aware of concerns related to children attending school/daycare and provide additional support as warranted.
C1 [Herbert, Linda J.; Owen, Victoria; Monaghan, Maureen; Alvarez, Vanessa; Streisand, Randi] Childrens Natl Hlth Syst, Ctr Translat Sci, Washington, DC 20010 USA.
   [Clary, Lauren] Childrens Natl Hlth Syst, Div Endocrinol & Diabet, Washington, DC 20010 USA.
RP Herbert, LJ (reprint author), Childrens Natl Hlth Syst, Ctr Translat Sci, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM lherbert@childrensnational.org
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [R01DK080102]
FX This work was supported by The National Institute of Diabetes and
   Digestive and Kidney Diseases, Grant Number R01DK080102, awarded to
   Randi Streisand, PhD.
CR American Diabetes Association, 2012, DIABETES CARE S1, V35, pS76, DOI DOI 10.2337/DC12-S076
   American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011
   Amillategui B, 2007, DIABETIC MED, V24, P1073, DOI 10.1111/j.1464-5491.2007.02250.x
   Amillategui B, 2009, PEDIATR DIABETES, V10, P67, DOI 10.1111/j.1399-5448.2008.00457.x
   Bade-White PA, 2009, J DEV PHYS DISABIL, V21, P425, DOI 10.1007/s10882-009-9151-y
   Barnard K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-50
   Brener ND, 2001, J SCHOOL HEALTH, V71, P294, DOI 10.1111/j.1746-1561.2001.tb03506.x
   Goldbeck L, 2006, QUAL LIFE RES, V15, P1121, DOI 10.1007/s11136-006-0068-y
   GOLDEN MP, 1985, AM J DIS CHILD, V139, P448, DOI 10.1001/archpedi.1985.02140070022019
   Grey M., 2009, J ASS CARE CHILD HLT, V38, P91
   HATTON DL, 1995, J ADV NURS, V22, P569, DOI 10.1046/j.1365-2648.1995.22030569.x
   Jacquez F, 2008, DIABETES EDUCATOR, V34, P996, DOI 10.1177/0145721708325155
   Kushion W, 1991, Diabetes Educ, V17, P107, DOI 10.1177/014572179101700217
   Liese AD, 2006, PEDIATRICS, V118, P1510, DOI DOI 10.1542/PEDS.2006-0690
   MacLeish SA, 2013, DIABETES CARE, V36, pE52, DOI 10.2337/dc12-2083
   Nabors L, 2003, J SCHOOL HEALTH, V73, P216, DOI 10.1111/j.1746-1561.2003.tb06563.x
   Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7
   Patton SR, 2007, PEDIATR DIABETES, V8, P362, DOI 10.1111/j.1399-5448.2007.00242.x
   Pinelli L, 2011, PEDIATR DIABETES, V12, P485, DOI 10.1111/j.1399-5448.2010.00722.x
   SEARCH for Diabete in Youth Study Group, 2007, JAMA-J AM MED ASSOC, V24, P2716
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Sullivan-Bolyai Susan, 2002, J Spec Pediatr Nurs, V7, P93, DOI 10.1111/j.1744-6155.2002.tb00158.x
   Turque B, 2012, FEDS PROBE TREATMENT
   Vandagriff J L, 1992, Diabetes Educ, V18, P299, DOI 10.1177/014572179201800407
   Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006
   Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003
   Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631
   Vehik K, 2007, DIABETES CARE, V30, P503, DOI 10.2337/dc06-1837
NR 28
TC 2
Z9 2
U1 3
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD MAY
PY 2015
VL 24
IS 9-10
BP 1199
EP 1209
DI 10.1111/jocn.12658
PG 11
WC Nursing
SC Nursing
GA CG6GO
UT WOS:000353396200006
PM 25047499
DA 2019-01-08
ER

PT J
AU Hyphantis, T
   Kotsis, K
   Kroenke, K
   Paika, V
   Constantopoulos, S
   Drosos, AA
   Carvalho, AF
   Guthrie, E
AF Hyphantis, Thomas
   Kotsis, Konstantinos
   Kroenke, Kurt
   Paika, Vassiliki
   Constantopoulos, Stavros
   Drosos, Alexandros A.
   Carvalho, Andre F.
   Guthrie, Elspeth
CA ARISTEIA-ABREVIATE Study Grp
TI Lower PHQ-9 cutpoint accurately diagnosed depression in people with
   long-term conditions attending the Accident and Emergency Department
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Depression; Emergency Department; Diabetes; COPD; Screening
ID PATIENT HEALTH QUESTIONNAIRE; QUALITY-OF-LIFE; NEUROPSYCHIATRIC
   INTERVIEW MINI; OBSTRUCTIVE PULMONARY-DISEASE; PRIMARY-CARE;
   PSYCHIATRIC-DISORDERS; RHEUMATOID-ARTHRITIS; MAJOR DEPRESSION;
   MENTAL-DISORDERS; PRIME-MD
AB Background: Major Depressive Disorder (MOD) is frequent in the Accident and Emergency Department (AED) but is often unrecognized. We aimed to assess the prevalence of MDD and determine the psychometric properties of the PHQ-9 in diagnosing MDD in patients with long-term medical conditions attending an AED.
   Methods: The PHQ-9 was administered to 349 patients with diabetes, COED and chronic inflammatory rheumatic diseases, mainly rheumatoid arthritis and spondyloarthropathies, visiting an AED. The MINI interview was used as the criterion standard for MDD. Receiver operator characteristic (ROC) curve analysis was performed to determine the optimal PHQ-9 cutpoint for MDD. Construct validators included psychological distress (SCL-90-R), illness perceptions (B-IPQ) and Health Related Quality of Life (WHOQOL-BREF).
   Results: The prevalence of MDD was 27.2%. At an optimal cutpoint of 8, PHQ-9 had a sensitivity of 90.5% and specificity of 89.4%. The area under the curve (0.96) was excellent. Convergent validity was established by the strong associations between PHQ-9 scores and functional status, SCL-90-R depression, illness perceptions and AED visits during the previous year.
   Limitations: The sample consisted of multiple rather a single disease group, preventing us from accounting for illness severity using specific disease severity indices.
   Conclusion: MDD is frequent in patients with long-term medical conditions attending the AED and the PHQ-9, at a cutpoint of 8, is an accurate, reliable and valid measure for MDD screening in this patient population. (C) 2015 Elsevier B.V. All rights reserved
C1 [Hyphantis, Thomas; Kotsis, Konstantinos; Paika, Vassiliki] Univ Ioannina, Sch Hlth Sci, Div Med, Dept Psychiat, GR-45110 Ioannina, Greece.
   [Kroenke, Kurt] Indiana Univ, Regenstrief Inst Hlth Care, Bloomington, IN 47405 USA.
   [Kroenke, Kurt] Indiana Univ, Dept Med, Bloomington, IN 47405 USA.
   [Constantopoulos, Stavros] Univ Ioannina, Sch Med, Dept Pulm Med, GR-45110 Ioannina, Greece.
   [Drosos, Alexandros A.] Univ Ioannina, Sch Med, Dept Internal Med, Rheumatol Clin, GR-45110 Ioannina, Greece.
   [Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, CE, Brazil.
   [Guthrie, Elspeth] Univ Manchester, Sch Med, Psychiat Res Grp, Manchester, Lancs, England.
RP Hyphantis, T (reprint author), Univ Ioannina, Sch Hlth Sci, Div Med, Dept Psychiat, GR-45110 Ioannina, Greece.
EM tyfantis@cc.uoi.gr
OI Guthrie, Elspeth/0000-0002-5834-6616
FU European Union (European Social Fund - ESF); Greek national funds
   through the Operational Program "Education and Lifelong Learning" of the
   National Strategic Reference Framework (NSRF) - Research Funding Program
   ARISTEIA: Investing in knowledge society through the European Social
   Fund [1259-9380/7-9-2011]
FX This research has been co-financed by the European Union (European
   Social Fund - ESF) and Greek national funds through the Operational
   Program "Education and Lifelong Learning" of the National Strategic
   Reference Framework (NSRF) - Research Funding Program ARISTEIA:
   Investing in knowledge society through the European Social Fund (Grant
   number: 1259-9380/7-9-2011). The funding source had no involvement in
   study design; in the collection, analysis and interpretation of data; in
   the writing of the report; and in the decision to submit the article for
   publication.
CR Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Billings J, 2000, EMERGENCY DEP USE NE
   Blakemore A, 2014, INT J CHRONIC OBSTR, V9, P501, DOI 10.2147/COPD.S58136
   Boudreaux ED, 2008, GEN HOSP PSYCHIAT, V30, P4, DOI 10.1016/j.genhosppsych.2007.09.006
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Castilla-Puentes Ruby C, 2008, Depress Anxiety, V25, pE199, DOI 10.1002/da.20380
   Dickens C, 2012, J PSYCHOSOM RES, V73, P334, DOI 10.1016/j.jpsychores.2012.08.018
   Donias S., 1991, PSYCHIATRIKI, V2, P42
   Economou M, 2013, J AFFECT DISORDERS, V145, P308, DOI 10.1016/j.jad.2012.08.008
   Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003
   Field A., 2005, DISCOVERING STAT USI
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   Gilbody S, 2007, BRIT J GEN PRACT, V57, P650
   Ginieri-Coccossis M, 2012, Psychiatriki, V23, P130
   Graham N, 2003, INT J GERIATR PSYCH, V18, P670, DOI 10.1002/gps.876
   Hoyer D, 2012, J EMERG MED, V43, P786, DOI 10.1016/j.jemermed.2008.05.004
   Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x
   Hudson JL, 2014, J PSYCHOSOM RES, V76, P265, DOI 10.1016/j.jpsychores.2014.02.004
   Hyphantis T, 2013, CLIN RHEUMATOL, V32, P635, DOI 10.1007/s10067-012-2162-6
   Hyphantis T, 2011, ARTHRIT CARE RES, V63, P1313, DOI 10.1002/acr.20505
   KATON W, 1992, GEN HOSP PSYCHIAT, V14, P237, DOI 10.1016/0163-8343(92)90094-Q
   Katon W, 2002, J PSYCHOSOM RES, V53, P859, DOI 10.1016/S0022-3999(02)00313-6
   KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
   Kowalenko T, 2004, ACAD EMERG MED, V11, P177, DOI 10.1197/j.aem.2003.10.015
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Kroenke K, 2012, CAN MED ASSOC J, V184, P281, DOI 10.1503/cmaj.112004
   Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006
   Kumar A, 2004, ACAD EMERG MED, V11, P1284, DOI 10.1197/j.aem.2004.08.053
   Lamers F, 2008, J CLIN EPIDEMIOL, V61, P679, DOI 10.1016/j.jclinepi.2007.07.018
   Magid DJ, 2004, ANN EMERG MED, V43, P551, DOI 10.1016/j.annemergmed.2003.11.021
   Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829
   McCusker J, 2003, ACAD EMERG MED, V10, P1362, DOI 10.1197/S1069-6563(03)00539-6
   Mimiaga M. J., 2010, J CLIN PSYCHIAT, V12, P2
   Murray CJ, 1996, GLOBAL BURDEN DIS CO
   MYERS JK, 1984, ARCH GEN PSYCHIAT, V41, P959
   Papadimitriou GN, 2004, GREEK TRANSLATION MI
   Pincus T, 2009, RHEUM DIS CLIN N AM, V35, P861, DOI 10.1016/j.rdc.2009.10.015
   Rhodes KV, 2008, GEN HOSP PSYCHIAT, V30, P1, DOI 10.1016/j.genhosppsych.2007.10.009
   Rhodes KV, 2000, ACAD EMERG MED, V7, P1036, DOI 10.1111/j.1553-2712.2000.tb02097.x
   Saliou V, 2005, GEN HOSP PSYCHIAT, V27, P263, DOI 10.1016/j.genhosppsych.2005.03.009
   Schriger DL, 2001, ANN EMERG MED, V37, P132, DOI 10.1067/mem.2001.112255
   Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   Simon GE, 2006, PSYCHOL MED, V36, P27, DOI 10.1017/S0033291705006136
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Tsai CL, 2007, J GEN INTERN MED, V22, P799, DOI 10.1007/s11606-007-0191-7
   Twist K, 2013, PSYCHOSOM MED, V75, P791, DOI 10.1097/PSY.0b013e3182a2b108
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
   WHO, 2008, GLOBAL BURDEN DIS
   Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   Zhang MWB, 2011, GEN HOSP PSYCHIAT, V33, P217, DOI 10.1016/j.genhosppsych.2011.03.009
NR 56
TC 8
Z9 8
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD MAY 1
PY 2015
VL 176
BP 155
EP 163
DI 10.1016/j.jad.2015.01.062
PG 9
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA CD3JV
UT WOS:000350975500021
PM 25721612
DA 2019-01-08
ER

PT J
AU Aikens, JE
   Rosland, AM
   Piette, JD
AF Aikens, James E.
   Rosland, Ann-Marie
   Piette, John D.
TI Improvements in illness self-management and psychological distress
   associated with telemonitoring support for adults with diabetes
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Diabetes; mHealth; Primary care; Care management
ID MEDICATION ADHERENCE; PREDICTIVE-VALIDITY; HEALTH; DEPRESSION; MELLITUS;
   PEOPLE; FAMILY; SCALE
AB Objective: The objective of this observational open label trial was to characterize changes in diabetes self-management and psychological distress associated with a mobile health (mHealth) interactive voice response (IVR) self-management support program.
   Methods: For 3-6 months, 301 patients with diabetes received weekly IVR calls assessing health status and self-care and providing tailored pre-recorded self-management support messages. Patients could participate together with an informal caregiver who received suggestions on self-management support, and patients' clinicians were notified automatically when patients reported significant problems.
   Results: Patients completed 84% of weekly calls, providing 5682 patient-weeks of data. Thirty-nine percent participated with an informal caregiver. Outcome analyses adjusted for study design factors and sociodemographics indicated significant pre-post improvement in medication adherence, physical functioning, depressive symptoms, and diabetes-related distress (all p values <0.001). Analyses of self-management problems indicated that as the intervention proceeded, there were significant improvements in patients' IVR-reported frequency of weekly medication adherence, SMBG performance, checking feet, and frequency of abnormal self-monitored blood glucose readings (all p values <0.001).
   Conclusions: We conclude that the combined program of automated telemonitoring, clinician notification, and informal caregiver involvement was associated with consistent improvements in medication adherence, diabetes self-management behaviors, physical functioning, and psychological distress. A randomized controlled trial is needed to verify these encouraging findings. (C) 2014 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Aikens, James E.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48104 USA.
   [Rosland, Ann-Marie] Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48104 USA.
   [Rosland, Ann-Marie; Piette, John D.] VA Ann Arbor Ctr Clin Management Res, Ann Arbor, MI USA.
   [Piette, John D.] Univ Michigan, Dept Hlth Behav & Hlth Educ, Sch Publ Hlth, Ann Arbor, MI 48104 USA.
RP Aikens, JE (reprint author), Univ Michigan, Dept Family Med, 1018 Fuller St, Ann Arbor, MI 48104 USA.
EM aikensj@umich.edu
RI Rosland, Annmarie/B-7750-2016
FU Michigan Diabetes Translational Research Center [P30DK092926]; National
   Institute of Diabetes and Digestive and Kidney Diseases [R18DK088294]
FX JDP is a VA Senior Research Career Scientist and AMR is a VA HSR&D
   Career Development Awardee. Other financial support came from the
   Michigan Diabetes Translational Research Center (grant P30DK092926) and
   grant R18DK088294 from the National Institute of Diabetes and Digestive
   and Kidney Diseases. We appreciate the helpful statistical guidance that
   was generously provided by Ananda Sen, Ph.D. at the University of
   Michigan. Ms. Katie Grode at the University of Michigan provided
   editorial assistance. The views expressed in this manuscript are those
   of the authors and do not necessarily represent the opinions of the
   Department of Veterans Affairs.
CR Aikens JE, 2014, J DIABETES COMPLICAT, V28, P171, DOI 10.1016/j.jdiacomp.2013.11.008
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065
   Anderson Robert M, 2009, Ther Patient Educ, V1, P3
   Armour TA, 2005, DIABETIC MED, V22, P1295, DOI 10.1111/j.1464-5491.2005.01618.x
   Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X
   Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701
   Kohout F., 1993, J AGING HEALTH, P179
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x
   Piette JD, 1997, DIABETES EDUCATOR, V23, P672, DOI 10.1177/014572179702300607
   Piette JD, 2007, DIABETES CARE, V30, P2425, DOI 10.2337/dc07-1046
   Piette JD, 2014, MED CARE, V52, P511, DOI 10.1097/MLR.0000000000000131
   Piette JD, 2013, MED CARE, V51, P216, DOI 10.1097/MLR.0b013e318277ebf8
   Piette JD, 2010, CHRONIC ILLN, V6, P34, DOI 10.1177/1742395309347804
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rosland AM, 2013, FAM SYST HEALTH, V31, P119, DOI 10.1037/a0031535
   Schwartz S, 1998, Health Manag Technol, V19, P41
   StataCorp, 2014, STAT STAT SOFTW REL
   Stirratt M., 2014, SELF REPORT IN PRESS
   Talley RC, 2007, AM J PUBLIC HEALTH, V97, P224, DOI 10.2105/AJPH.2004.059337
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
NR 22
TC 16
Z9 16
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD APR
PY 2015
VL 9
IS 2
BP 127
EP 134
DI 10.1016/j.pcd.2014.06.003
PG 8
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA CG2IJ
UT WOS:000353097800006
PM 25065270
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Buttery, AK
   Mensink, GBM
   Busch, MA
AF Buttery, Amanda K.
   Mensink, Gert B. M.
   Busch, Markus A.
TI Healthy behaviours and mental health: findings from the German Health
   Update (GEDA)
SO EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID DISORDERS IDENTIFICATION TEST; LIFE-STYLE BEHAVIORS; ALL-CAUSE
   MORTALITY; SYSTEMATIC ANALYSIS; DIABETES-MELLITUS; GLOBAL BURDEN;
   OLDER-ADULTS; DEPRESSION; RISK; WOMEN
AB Background: Health risk behaviours such as smoking, physical inactivity and poor diet are independently associated with depression. However, there is a paucity of data examining associations between combined healthy behaviours and mental distress and depression. Methods: Using cross-sectional data from a nationwide population-based sample of adults in Germany [German Health Update (GEDA) 2009 and 2010 telephone surveys; n = 21 940 women, n = 17 061 men], we examined associations between five healthy behaviours and frequent mental distress (FMD) and self-reported diagnosed depression in the past 12 months. Healthy behaviours included non-smoking, low-risk alcohol drinking, regular sport, maintaining normal weight and healthy fruit and vegetable consumption. Multiple logistic regression analyses adjusted for potential confounders examined associations between the combined number of healthy behaviours and FMD and self-reported diagnosed depression. Results: FMD was reported by 13.6 and 8.0% and diagnosed depression in the last 12 months by 8.3 and 4.7% of women and men, respectively. At least four of five assessed healthy behaviours were reported by 29.1% of women and 17.8% of men. Compared with those with less than two healthy behaviours, women and men with at least four behaviours were about half as likely to report FMD [odds ratio (OR) 0.53, 95% confidence interval (CI) 0.44-0.64, and OR 0.52, 95% CI 0.41-0.66, respectively) and women with at least four behaviours were less likely to report diagnosed depression (OR 0.76, 95% CI 0.61-0.95). Conclusion: A higher number of healthy behaviours are associated with a lower prevalence of FMD for both women and men and of self-reported diagnosed depression in women.
C1 [Buttery, Amanda K.; Mensink, Gert B. M.; Busch, Markus A.] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, D-12101 Berlin, Germany.
RP Busch, MA (reprint author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Gen Pape Str 62-64, D-12101 Berlin, Germany.
EM buschm@rki.de
OI Mensink, Gert/0000-0001-6268-5998; Busch, Markus/0000-0003-4936-983X;
   Buttery, Amanda/0000-0001-5364-0739
FU German Federal Ministry of Health; Robert Koch Institute
FX The GEDA study was funded by the German Federal Ministry of Health and
   the Robert Koch Institute.
CR Akbaraly TN, 2013, AM J CLIN NUTR, V97, P419, DOI 10.3945/ajcn.112.041582
   Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339
   Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789
   Cox B, 2009, INT J PUBLIC HEALTH, V54, P55, DOI 10.1007/s00038-009-7104-y
   Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5
   Du Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-166
   Dybek I, 2006, J STUD ALCOHOL, V67, P473, DOI 10.15288/jsa.2006.67.473
   Ford ES, 2012, PREV MED, V55, P23, DOI 10.1016/j.ypmed.2012.04.016
   Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728
   Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237
   Gabler S, 2002, INT J PUBLIC OPIN R, V14, P339, DOI 10.1093/ijpor/14.3.339
   Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x
   Harrington J, 2010, EUR J PUBLIC HEALTH, V20, P91, DOI 10.1093/eurpub/ckp102
   Hausdorf K, 2008, CANCER CAUSE CONTROL, V19, P1339, DOI 10.1007/s10552-008-9205-y
   He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212
   Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a
   Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012
   Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433
   Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76
   Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P131, DOI 10.1007/s00103-012-1583-3
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   McAloney K, 2013, PREV MED, V56, P365, DOI 10.1016/j.ypmed.2013.03.002
   McGuire LC, 2007, AM J GERIAT PSYCHIAT, V15, P754, DOI 10.1097/JGP.0b013e3180986125
   Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37
   Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0
   Rabenberg M, 2011, R KOCH I BERLIN GBE, P2
   Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x
   Robert Koch-Institut, 2012, DAT FAKT ERG STUD GE
   Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730
   Steppuhn H, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-46
   Tamakoshi A, 2009, PREV MED, V48, P486, DOI 10.1016/j.ypmed.2009.02.017
   Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009
   UNESCO, 1997, INT STAND CLASS ED
   Verger P, 2009, EUR J PUBLIC HEALTH, V19, P618, DOI 10.1093/eurpub/ckp057
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Wahlbeck K, 2011, EUR J PUBLIC HEALTH, V21, P551, DOI 10.1093/eurpub/ckr122
   WHO, 2000, WHO TECHN REP SER, V894
NR 42
TC 3
Z9 3
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1101-1262
EI 1464-360X
J9 EUR J PUBLIC HEALTH
JI Eur. J. Public Health
PD APR
PY 2015
VL 25
IS 2
BP 219
EP 225
DI 10.1093/eurpub/cku094
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CE9ZE
UT WOS:000352201500011
PM 25061231
OA Bronze
DA 2019-01-08
ER

PT J
AU Weaver, LJ
   Worthman, CM
   DeCaro, JA
   Madhu, SV
AF Weaver, Lesley Jo
   Worthman, Carol M.
   DeCaro, Jason A.
   Madhu, S. V.
TI The signs of stress: Embodiments of biosocial stress among type 2
   diabetic women in New Delhi, India
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE India; Type 2 diabetes; Mental health; Biocultural anthropology; Mixed
   methods
ID C-REACTIVE PROTEIN; EPSTEIN-BARR-VIRUS; URBAN-RURAL EPIDEMIOLOGY;
   INSULIN-RESISTANCE; METABOLIC SYNDROME; IMMUNE FUNCTION; LIFE-STYLE;
   DEPRESSION; HEALTH; ASSOCIATION
AB Biocultural models of health and illness are increasingly used to trace how social pathways shape biological outcomes. Yet, data on the interactions between social and biological aspects of health are lacking in low- and middle-income regions, where two-thirds of all type 2 diabetes cases occur. This study explored health, social roles, and biological correlates among a group of 280 type 2 diabetic and nondiabetic women (n = 184 diabetic) in New Delhi, India, between 2009 and 2011. Using a biocultural framework, we developed and tested a series of hypotheses about the relationships that might exist between diabetes, psychological distress, social role fulfillment, and biological markers measuring blood sugar control, generalized inflammation, and immune stress. Although blood glucose and glycated hemoglobin levels indicated that women's diabetes was generally poorly controlled, they lacked the elevated inflammation, immune stress, and mental ill health that often accompany uncontrolled blood sugar. Qualitative work on explanatory models of diabetes and gendered models of appropriate behavior demonstrated that despite living with poorly controlled diabetes, women maintain participation in culturally valued roles involving the care of others. We suggest that behavioral congruence with these gendered roles may buffer diabetic women's mental health and perhaps even their long-term physical health, while simultaneously posing challenges for their diabetes self-care. To our knowledge, this is the first study to explore the experience of type 2 diabetes in India from an integrated biocultural perspective. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Weaver, Lesley Jo; DeCaro, Jason A.] Univ Alabama, Tuscaloosa, AL 35487 USA.
   [Worthman, Carol M.] Emory Univ, Atlanta, GA 30322 USA.
   [Madhu, S. V.] Univ Coll Med Sci, New Delhi, India.
RP Weaver, LJ (reprint author), Univ Alabama, Tuscaloosa, AL 35487 USA.
EM ljweaver@ua.edu
OI DeCaro, Jason/0000-0002-3333-212X; Worthman, Carol M/0000-0002-5397-2298
FU National Science Foundation [P022A0100030]; Fulbright Hays Foundation;
   Lemelson/SPA fund; Emory University Department of Anthropology
FX This research was supported by grants from the National Science
   Foundation (P022A0100030), the Fulbright Hays Foundation, the
   Lemelson/SPA fund, and Emory University Department of Anthropology. The
   authors wish to thank member physicians of the Research Society for the
   Study of Diabetes in India, and all participants in the study.
CR American Diabetes Association, 2011, DIABETES CARE, V34, pS16
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bolton P, 2002, SOC PSYCH PSYCH EPID, V37, P537, DOI 10.1007/s00127-002-0580-5
   Borgatti S, 1999, ENHANCED ETHNOGRAPHI, P115
   Brown Peter J, 2001, OBESITY PHYS GROWTH, P111
   Cacioppo JT, 2002, HORM BEHAV, V42, P32, DOI 10.1006/hbeh.2002.1801
   Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145
   Cohen Lawrence, 2000, NO AGING IN INDIA AL
   Copeland WE, 2012, PSYCHOL MED, V42, P2641, DOI 10.1017/S0033291712000554
   Corbin Juliet, 2007, BASICS OF QUALITATIV
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Derne S., 1995, CULTURE IN ACTION FA
   Donner Henrike, 2008, DOMESTIC GODDESSES M
   Dressler WW, 2000, AM ANTHROPOL, V102, P244, DOI 10.1525/aa.2000.102.2.244
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799
   ESTERLING BA, 1993, HEALTH PSYCHOL, V12, P132, DOI 10.1037/0278-6133.12.2.132
   Forouhi NG, 2001, INT J OBESITY, V25, P1327, DOI 10.1038/sj.ijo.0801723
   Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571
   Golden SH, 2007, CURR DIABETES REV, V3, P252, DOI 10.2174/157339907782330021
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Goodman A.H., 1998, BUILDING A NEW BIOCU
   Halliburton Murphy, 2005, Med Anthropol, V24, P111, DOI 10.1080/01459740590933849
   Hruschka DJ, 2005, ETHOS, V33, P1, DOI 10.1525/eth.2005.33.1.001
   International Diabetes Federation, 2014, DF DIABETES ATLAS 20
   JONES JF, 1987, ANNU REV MED, V38, P195, DOI 10.1146/annurev.me.38.020187.001211
   Joshi Shashank R, 2008, J Assoc Physicians India, V56, P443
   Katon W, 2002, J PSYCHOSOM RES, V53, P859, DOI 10.1016/S0022-3999(02)00313-6
   Kiecolt-Glaser JK, 1999, BRAIN BEHAV IMMUN, V13, P61, DOI 10.1006/brbi.1999.0552
   King DE, 2003, DIABETES CARE, V26, P1535, DOI 10.2337/diacare.26.5.1535
   Kleinman Arthur, 1988, THE ILLNESS NARRATIV
   Liburd L., 2004, DIABETES SPECTRUM, V17, P219, DOI DOI 10.2337/DIASPECT.17.4.219
   Mahajan A, 2009, J CLIN ENDOCR METAB, V94, P2123, DOI 10.1210/jc.2008-2754
   McDade TW, 2000, PSYCHOSOM MED, V62, P560, DOI 10.1097/00006842-200007000-00015
   McDade TW, 2005, ANNU REV ANTHROPOL, V34, P495, DOI 10.1146/annurev.anthro.34.081804.120348
   McLaughlin T, 2002, CIRCULATION, V106, P2908, DOI 10.1161/01.CIR.0000041046.32962.86
   Mendenhall E., 2013, SYNDEMIC SUFFERING S
   Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2
   Mollica RF, 2004, MEASURING TRAUMA MEA
   Nielsen, 2011, WOMEN OF TOMORROW A
   Pereira B, 2007, J AFFECT DISORDERS, V102, P209, DOI 10.1016/j.jad.2006.09.025
   Poongothai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007185
   Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161
   Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05
   Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601
   Singer M., 2009, INTRODUCTION TO SYND
   Singh G, 1984, Indian J Psychiatry, V26, P107
   Standing H., 1991, DEPENDENCE AND AUTON
   Weaver L.J., AM J PUBLIC HEALTH U
   Weaver L.J., 2014, FIELD METHODS
   Weaver LJ, 2011, ETHOS, V39, P211, DOI 10.1111/j.1548-1352.2011.01185.x
   Weaver Lesley Jo, 2014, THESIS
   Wiedman D., 2010, CHRONIC CONDITIONS F, P18
   Worthman CM, 2008, DEV PSYCHOPATHOL, V20, P233, DOI 10.1017/S0954579408000114
   Worthman CM, 2009, ANN HUM BIOL, V36, P281, DOI 10.1080/03014460902832934
   Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1
   Worthman CM, 2005, SOC SCI MED, V61, P861, DOI 10.1016/j.socscimed.2004.08.052
   Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616
   Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972
NR 59
TC 9
Z9 9
U1 0
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD APR
PY 2015
VL 131
BP 122
EP 130
DI 10.1016/j.socscimed.2015.03.002
PG 9
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA CF1SE
UT WOS:000352327400015
PM 25771481
DA 2019-01-08
ER

PT J
AU Xiang, XL
   Hernandez, R
   Larrison, CR
AF Xiang, Xiaoling
   Hernandez, Rosalba
   Larrison, Christopher R.
TI Provider Advice on Exercise and Diet Among Adults With Comorbid Serious
   Psychological Distress and Diabetes or Diabetes Risk Factors
SO DIABETES EDUCATOR
LA English
DT Article
ID MENTAL-ILLNESS; PHYSICAL-ACTIVITY; HEALTH-CARE; SCHIZOPHRENIA;
   BEHAVIORS; ANTIPSYCHOTICS; POPULATION; SUPPORT; PEOPLE; SAMPLE
AB Purpose To examine the lifetime prevalence and correlates of provider advice to increase exercise and reduce dietary fat intake among adults with comorbid serious psychological distress (SPD) and diabetes or diabetes risk factors.
   Methods Study sample (n = 5942) was selected from the Medical Expenditure Panel Survey Household Component (MEPS-HC) series of 2007-2011. SPD was defined as a score of 13 on the Kessler Psychological Distress Scale (K6). Multivariate logistic regression was used to examine correlates of lifetime provider advice.
   Results Less than half of adults with SPD had been advised to increase exercise (49.4%) or reduce dietary fat intake (45.6%). The prevalence of receiving provider advice increased in a linear fashion as the number of diabetes risk factors increased and was the highest among those with diabetes. Provision of provider advice was strongly associated with clinical factors rather than individuals' sociodemographic characteristics and current health behaviors.
   Conclusions Health care providers are missing opportunities to provide exercise and low-fat dietary advice to patients with SPD before they manifest clinical risk factors associated with diabetes. It is important that providers counsel them as early as possible about exercise and nutritional changes that reduce the risks associated with diabetes.
C1 [Xiang, Xiaoling; Hernandez, Rosalba; Larrison, Christopher R.] Univ Illinois, Urbana, IL 61801 USA.
RP Xiang, XL (reprint author), Univ Illinois, Sch Social Work, 1010 W Nevada, Urbana, IL 61801 USA.
EM xxiang3@illinois.edu
CR Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Babor TF, 2004, AM J PREV MED, V27, P42, DOI 10.1016/j.amepre.2004.04.018
   Bellivier F, 2005, EUR PSYCHIAT, V20, pS335, DOI 10.1016/S0924-9338(05)80187-7
   Bijl RV, 2003, HEALTH AFFAIR, V22, P122, DOI 10.1377/hlthaff.22.3.122
   Bull FC, 1998, AM J PREV MED, V15, P85, DOI 10.1016/S0749-3797(98)00040-3
   Cohen JW, 2009, MED CARE, V47, pS44, DOI 10.1097/MLR.0b013e3181a23e3a
   Daumit GL, 2005, J NERV MENT DIS, V193, P641, DOI 10.1097/01.nmd.0000180737.85895.60
   Dismuke CE, 2011, GEN HOSP PSYCHIAT, V33, P311, DOI 10.1016/j.genhosppsych.2011.03.014
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x
   Frayne SM, 2005, ARCH INTERN MED, V165, P2631, DOI 10.1001/archinte.165.22.2631
   Glasgow RE, 2001, AM J PREV MED, V21, P189, DOI 10.1016/S0749-3797(01)00350-6
   Greenlund KJ, 2002, STROKE, V33, P565, DOI 10.1161/hs0202.102882
   Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2001, HEALTH SERV RES, V36, P987
   Kilbourne AM, 2007, BIPOLAR DISORD, V9, P443, DOI 10.1111/j.1399-5618.2007.00386.x
   Kreuter MW, 1997, PREV MED, V26, P825, DOI 10.1006/pmed.1997.0216
   Lobo IE, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120086
   Morrato EH, 2006, DIABETES CARE, V29, P543, DOI 10.2337/diacare.29.03.06.dc05-2165
   Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805
   Nguyen HT, 2011, AM J HEALTH PROMOT, V25, P402, DOI 10.4278/ajhp.090918-QUAN-305
   Pariante CM, 2005, NEUROPSYCHOPHARMACOL, V30, P1923, DOI 10.1038/sj.npp.1300766
   Shin JK, 2012, DIABETES RES CLIN PR, V95, P406, DOI 10.1016/j.diabres.2011.10.043
   Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x
   StataCorp, 2009, STAT STAT SOFTW REL
   Sumlin LL, 2014, DIABETES EDUCATOR, V40, P731, DOI 10.1177/0145721714538925
   Thornicroft G, 2007, INT REV PSYCHIATR, V19, P113, DOI 10.1080/09540260701278937
   Thorpe JM, 2006, MED CARE, V44, P187, DOI 10.1097/01.mlr.0000196965.54871.d5
   Zhang ZJ, 2004, BRIT J PSYCHIAT, V184, P58, DOI 10.1192/bjp.184.1.58
NR 32
TC 5
Z9 5
U1 1
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD APR
PY 2015
VL 41
IS 2
BP 185
EP 193
DI 10.1177/0145721714567234
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA CE8EZ
UT WOS:000352075700002
PM 25588911
DA 2019-01-08
ER

PT J
AU Nefs, G
   Speight, J
   Pouwer, F
   Pop, V
   Bot, M
   Denollet, J
AF Nefs, G.
   Speight, J.
   Pouwer, F.
   Pop, V.
   Bot, M.
   Denollet, J.
TI Type D personality, suboptimal health behaviors and emotional distress
   in adults with diabetes: Results from Diabetes MILES-The Netherlands
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type D personality; Negative affectivity; Social inhibition; Diabetes;
   Health behaviors; Emotional distress
ID CORONARY-HEART-DISEASE; UNHEALTHY LIFE-STYLE; NEGATIVE AFFECTIVITY;
   SOCIAL INHIBITION; PROGNOSTIC ASSOCIATION; PSYCHOLOGICAL DISTRESS;
   SAMPLE CHARACTERISTICS; MYOCARDIAL-INFARCTION; GENERAL-POPULATION;
   PHYSICAL-ACTIVITY
AB Aims: Type D personality - defined as high negative affectivity (NA) and high social inhibition (SI) - has been associated with adverse cardiovascular prognosis. We explored the differential associations of Type D personality and its constituent components with health behaviors, emotional distress and standard biomedical risk factors as potential risk mechanisms in adults with diabetes.
   Methods: 3314 Dutch adults with self-reported type 1 or 2 diabetes completed an online survey, including the DS14 Type D Scale. AN(C)OVAs and X-2 tests were used to compare participants scoring (i) low on NA and SI; (ii) high on SI only; (iii) high on NA only; (iv) high on NA and SI (Type D).
   Results: Participants with Type D personality (29%) were less likely to follow a healthy diet or to consult healthcare professionals in case of problems with diabetes management than those scoring high on neither or only one component. They also reported more barriers surrounding medication use, diabetes-specific social anxiety, loneliness and symptoms of depression and anxiety. There were no differences in standard biomedical risk factors (body mass index, blood pressure, cholesterol, HbA(1c)). After adjustment for demographics, clinical characteristics, NA, and SI in multivariable logistic regression analyses, Type D personality was independently associated with 2 to 3-fold increased odds of suboptimal health behaviors and over 15-fold increased odds of general emotional distress.
   Conclusions: Type D personality was not related to standard biomedical risk factors, but was associated with unhealthy behaviors and negative emotions that are likely to have adverse impact on adults with diabetes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Nefs, G.; Pouwer, F.; Pop, V.; Bot, M.; Denollet, J.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Speight, J.] Diabet Australia Vic, Australian Ctr Behav Res Diabet, Melbourne, Vic 3000, Australia.
   [Speight, J.] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Wellbeing Res, Burwood, Vic 3125, Australia.
   [Speight, J.] AHP Res, Hornchurch, England.
   [Bot, M.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands.
   [Bot, M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 HL Amsterdam, Netherlands.
   [Bot, M.] GGZ inGeest, NL-1081 HL Amsterdam, Netherlands.
RP Nefs, G (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM g.m.nefs@tilburguniversity.edu
RI Nefs, Giesje/C-9992-2018
OI Speight, Jane/0000-0002-1204-6896
FU Dutch Association for Diabetes Research (Nederlandse Vereniging voor
   Diabetes Onderzoek)/Lilly Diabetes
FX This study was supported by the Prof. dr. J. Terpstra Young Investigator
   Award 2010 from the Dutch Association for Diabetes Research (Nederlandse
   Vereniging voor Diabetes Onderzoek)/Lilly Diabetes to GN. The funding
   source had no role in the design, data collection, analysis or
   interpretation of the study, or in the decision to submit the manuscript
   for publication.
CR Borkoles E, 2010, BODY IMAGE, V7, P39, DOI 10.1016/j.bodyim.2009.10.005
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Brostrom A, 2007, J SLEEP RES, V16, P439, DOI 10.1111/j.1365-2869.2007.00620.x
   Bunevicius A, 2014, INT J BEHAV MED, V21, P240, DOI 10.1007/s12529-013-9299-9
   Courneya KS, 1998, PERS INDIV DIFFER, V24, P625, DOI 10.1016/S0191-8869(97)00231-6
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Denollet J, 2006, EUR HEART J, V27, P171, DOI 10.1093/eurheartj/ehi616
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406
   Einvik G, 2011, EUR J CARDIOV PREV R, V18, P504, DOI 10.1177/1741826710389383
   Gilmour J, 2012, J HEALTH PSYCHOL, V17, P471, DOI 10.1177/1359105311423117
   Grande G, 2012, ANN BEHAV MED, V43, P299, DOI 10.1007/s12160-011-9339-0
   Grande G, 2011, PSYCHOSOM MED, V73, P548, DOI 10.1097/PSY.0b013e318227a9bc
   Hausteiner C, 2010, PSYCHOSOM MED, V72, P163, DOI 10.1097/PSY.0b013e3181cb8bae
   Kinder LS, 2002, HEALTH PSYCHOL, V21, P542, DOI 10.1037//0278-6133.21.6.542
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kubzansky LD, 2006, ANN BEHAV MED, V31, P21, DOI 10.1207/s15324796abm3101_5
   Kupper N, 2013, INT J CARDIOL, V166, P327, DOI 10.1016/j.ijcard.2011.10.084
   MacNicol SAM, 2003, PERS INDIV DIFFER, V35, P1753, DOI 10.1016/S0191-8869(02)00404-X
   Marshall SM, 2006, BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80
   Martens EJ, 2007, J PSYCHOSOM RES, V63, P545, DOI 10.1016/j.jpsychores.2007.06.005
   Matza LS, 2009, ANN PHARMACOTHER, V43, P1621, DOI 10.1345/aph.1M174
   Michal M, 2011, J AFFECT DISORDERS, V134, P396, DOI 10.1016/j.jad.2011.05.033
   Molloy GJ, 2012, PSYCHOSOM MED, V74, P100, DOI 10.1097/PSY.0b013e31823a5b2f
   Mols F, 2012, J PSYCHOSOM RES, V73, P232, DOI 10.1016/j.jpsychores.2012.07.004
   Mols F, 2010, GEN HOSP PSYCHIAT, V32, P66, DOI 10.1016/j.genhosppsych.2009.09.010
   Mols F, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-9
   Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714
   Nefs G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-925
   Nefs G, 2012, J PSYCHOSOM RES, V72, P251, DOI 10.1016/j.jpsychores.2012.01.006
   Pedersen SS, 2007, EUR J CARDIOV PREV R, V14, P135, DOI 10.1097/HJR.0b013e328045c282
   Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086
   Pelle AJ, 2010, CIRC-HEART FAIL, V3, P261, DOI 10.1161/CIRCHEARTFAILURE.109.871483
   Polman R, 2010, BRIT J HEALTH PSYCH, V15, P681, DOI 10.1348/135910709X479069
   Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002
   Rhodes RE, 2006, BRIT J SPORT MED, V40, P958, DOI 10.1136/bjsm.2006.028860
   Roest AM, 2010, PSYCHOSOM MED, V72, P563, DOI 10.1097/PSY.0b013e3181dbff97
   Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034
   Schiffer AA, 2007, HEART, V93, P814, DOI 10.1136/hrt.2006.102822
   Simson U, 2008, PSYCHOTHER PSYCH MED, V58, P44, DOI 10.1055/s-2007-971001
   Speight J, 2011, DIABETES MILES AUSTR
   Speight J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-120
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Svansdottir E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-42
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c
   WARDLE J, 1987, J PSYCHOSOM RES, V31, P161, DOI 10.1016/0022-3999(87)90072-9
   WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008
   Williams L, 2011, PSYCHOL HEALTH, V26, P703, DOI 10.1080/08870446.2010.488265
   Williams L, 2011, J PSYCHOSOM RES, V70, P141, DOI 10.1016/j.jpsychores.2010.07.015
NR 52
TC 17
Z9 18
U1 0
U2 17
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD APR
PY 2015
VL 108
IS 1
BP 94
EP 105
DI 10.1016/j.diabres.2015.01.015
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CF1AC
UT WOS:000352274900021
PM 25686507
DA 2019-01-08
ER

PT J
AU Shallcross, AJ
   Ojie, MJ
   Chaplin, W
   Levy, N
   Odedosu, T
   Ogedegbe, G
   Spruill, TM
AF Shallcross, Amanda J.
   Ojie, Mary-Jane
   Chaplin, William
   Levy, Natalie
   Odedosu, Taiye
   Ogedegbe, Gbenga
   Spruill, Tanya M.
TI Race/ethnicity moderates the relationship between chronic life stress
   and quality of life in type 2 diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Race/ethnicity; Social support; Stress
ID EMOTIONAL DISTRESS; PERCEIVED STRESS; SOCIAL SUPPORT; AFRICAN-AMERICAN;
   FOLLOW-UP; HEALTH; WOMEN; INTERVENTION; EXPERIENCES; PARADOX
AB Aims: To determine whether chronic life stress is differentially associated with quality of life (QoL) for Blacks vs. Hispanics with type 2 diabetes.
   Methods: We assessed self-reported chronic stress and QoL in 125 patients with type 2 diabetes who self-identified as either non-Hispanic Black or Hispanic. Separate cross-sectional two-way interaction models (stress x race/ethnicity) with physical and mental health as outcomes were examined.
   Results: The two-way interaction predicted mental (b = 3.12, P = .04) but not physical health. Simple slopes analyses indicated that under conditions of high stress, Blacks (b = -4.4, P < .001), but not Hispanics, experienced significantly lower levels of mental health. In exploratory analyses, we examined a three-way interaction (stress x race/ethnicity x social support) with physical and mental health as outcomes. Results indicated the three-way interaction predicted mental (b = .62, P = .01) but not physical health. Simple slopes analyses indicated that under conditions of high stress, high levels of social support improved mental health for Hispanics (b = 1.2, P < .001), but not for Blacks.
   Conclusions: Black patients with type 2 diabetes may be particularly vulnerable to the deleterious effects of high chronic stress. Social support buffers effects of stress on mental health in Hispanics but not Blacks, which suggests differences in the use and/or quality of social support between Hispanics and Blacks. Longitudinal investigations that examine race/ethnicity, stress, social support, and QoL should help clarify the processes that underlie these observed relations. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Shallcross, Amanda J.; Ojie, Mary-Jane; Chaplin, William; Levy, Natalie; Odedosu, Taiye; Ogedegbe, Gbenga; Spruill, Tanya M.] NYU, Sch Med, Dept Populat Hlth, Ctr Healthful Behav Change, New York, NY 10016 USA.
RP Spruill, TM (reprint author), NYU, Sch Med, Dept Populat Hlth, Ctr Healthful Behav Change, 227 E 30th St,Floor 6, New York, NY 10016 USA.
EM Tanya.Spruill@nyumc.org
OI Spruill, Tanya/0000-0003-2998-3007; shallcross,
   amanda/0000-0003-3166-8786
FU  [K24HL111315]
FX Funding from this study was provided by K24HL111315, awarded to G.O.
CR Aiken L. S, 1991, MULTIPLE REGRESSION
   Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376
   Bulatao RA, 2004, UNDERSTANDING RACIAL
   Campos B, 2008, CULT DIVERS ETHN MIN, V14, P155, DOI 10.1037/1099-9809.14.2.155
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Cohen S, 1985, SOCIAL SUPPORT THEOR, P73, DOI DOI 10.1007/978-94-009-5115-0_5
   Conroy K, 2010, J DEV BEHAV PEDIATR, V31, P154, DOI 10.1097/DBP.0b013e3181c21a1b
   Faulenbach M, 2012, DIABETIC MED, V29, P128, DOI 10.1111/j.1464-5491.2011.03431.x
   HassonF R.E., 2013, J OBES, V512914, P1
   Haxton CL, 2009, J FAM ISSUES, V30, P1019, DOI 10.1177/0192513X09333946
   Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132
   Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576
   KOHN PM, 1992, J BEHAV MED, V15, P221, DOI 10.1007/BF00848327
   LeBron AW, 2013, J IMMIGR MINOR HEALT, P1
   Mallinckrodt B, 2012, J COUNS PSYCHOL, V59, P150, DOI 10.1037/a0026549
   Marshall RP, 1998, PSYCHIATR SERV, V49, P1609, DOI 10.1176/ps.49.12.1609
   McCollister KE, 2012, DIABETES CARE, V35, P1692, DOI 10.2337/dc11-2433
   Mendelson T, 2008, J CONSULT CLIN PSYCH, V76, P355, DOI 10.1037/0022-006X.76.3.355
   Myers HF, 2009, J BEHAV MED, V32, P9, DOI 10.1007/s10865-008-9181-4
   National Diabetes Information Clearinghouse, 2011, NAT DIAB STAT
   Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037
   Nuru-Jeter A, 2008, STRESS HEALTH, V24, P337, DOI 10.1002/smi.1215
   Payne Thomas J, 2005, Ethn Dis, V15, pS6
   Raikkonen K, 2007, DIABETES CARE, V30, P872, DOI 10.2337/dc06-1857
   Rod NH, 2009, J INTERN MED, V266, P467, DOI 10.1111/j.1365-2796.2009.02124.x
   Ruiz JM, 2013, AM J PUBLIC HEALTH, V103, pE52, DOI 10.2105/AJPH.2012.301103
   SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932
   Serovich JM, 2001, AIDS CARE, V13, P335, DOI 10.1080/09540120120043982
   Shallcross AJ, 2010, BEHAV RES THER, V48, P921, DOI 10.1016/j.brat.2010.05.025
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Thompson J, 2012, INCOME INEQUALITY GR
   Thomson EF, 2013, INT J ENV RES PUB HE, V10, P1786, DOI 10.3390/ijerph10051786
   Trento M, 2001, DIABETES CARE, V24, P995, DOI 10.2337/diacare.24.6.995
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
NR 38
TC 4
Z9 4
U1 1
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD APR
PY 2015
VL 108
IS 1
BP 150
EP 156
DI 10.1016/j.diabres.2015.01.025
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CF1AC
UT WOS:000352274900028
PM 25704600
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Co, MA
   Tan, LSM
   Tai, ES
   Griva, K
   Amir, M
   Chong, KJ
   Lee, YS
   Lee, J
   Khoo, EYH
   Wee, HL
AF Co, Michelle Ang
   Tan, Luor Shyuan Maudrene
   Tai, E. Shyong
   Griva, Konstadina
   Amir, Mohamed
   Chong, Kok Joon
   Lee, Yung Seng
   Lee, Jeannette
   Khoo, Eric Yin-Hao
   Wee, Hwee-Lin
TI Factors associated with psychological distress, behavioral impact and
   health-related quality of life among patients with type 2 diabetes
   mellitus
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Type 2 diabetes mellitus; Health-related quality of life; Psychological
   distress; Disinhibited eating; Barriers to activity; Behavioral
   impairment
ID CARE UTILIZATION; GLYCEMIC CONTROL; PROBLEM AREAS; MORTALITY;
   QUESTIONNAIRE; POPULATION; DEPRESSION; SCALE; ADHERENCE; ATTITUDES
AB Background: Data on psychological distress (DIS), behavioral impact (BI) and health-related quality of life (HRQoL) are important yet lacking among Asian patients with Type 2 diabetes mellitus (T2DM). We aim to identify factors associated with DIS, BI and HRQoL among T2DM to better understand patient needs.
   Methods: DIS was measured with Diabetes Health Profile (DHP-18) Psychological Distress (DHP-PD) subscale, Problem Areas in Diabetes (PAID) and Kessler-10 (1(10), BI with DHP-18 Barriers to Activity and Disinhibited Eating subscales and HRQoL with Audit of Diabetes-Dependent Quality of Life. Multiple linear regression analyses were performed to evaluate the associations between these outcomes and patient demographic, socioeconomic status, glycated hemoglobin (HbA1C) and comorbidities.
   Results: 213 T2DM patients (mean (SD) age: 45.0 (12.1) years, mean (SD) HbA1C: 8.3% (1.9%) and 70.0% reported at least one comorbidity) were evaluated. Poorer glycemic control was significantly associated with higher DHP-PD, PAID and worse HRQoL. Taking oral hypoglycemic agents plus insulin was independently associated with Barrier to Activity and Disinhibited Eating.
   Conclusion: Poorer glycemic control was only associated with diabetes-related distress (measured by DHP-PD and PAID) but not major depressive disorder (measured by K10). It may be more appropriate to screen for diabetes-related distress rather than major depressive disorder for patients with T2DM. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Co, Michelle Ang; Tai, E. Shyong; Chong, Kok Joon; Lee, Jeannette; Khoo, Eric Yin-Hao] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore.
   [Tan, Luor Shyuan Maudrene; Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Sch Publ Hlth, Singapore 117595, Singapore.
   [Griva, Konstadina; Amir, Mohamed] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.
   [Lee, Yung Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore.
   [Wee, Hwee-Lin] Natl Univ Singapore, Dept Pharm, Singapore 119260, Singapore.
RP Wee, HL (reprint author), Natl Univ Singapore, Dept Pharm, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM phawhl@nus.edu.sg
RI Griva, Konstadina/A-6549-2018; Wee, Hwee-Lin/D-4126-2012; Lee, Yung
   Seng/F-2169-2014
OI Wee, Hwee-Lin/0000-0002-7150-1801; Lee, Yung Seng/0000-0002-1253-0557;
   Tai, E Shyong/0000-0003-2929-8966
FU Department of Pharmacy, Faculty of Science, National University of
   Singapore; Ministry of Education Singapore Academic Research Fund Tier 1
   [FY2011-FRC3-007]
FX This work was partly supported by a Final Year Project grant from the
   Department of Pharmacy, Faculty of Science, National University of
   Singapore and largely supported by the Ministry of Education Singapore
   Academic Research Fund Tier 1 (Grant No.: FY2011-FRC3-007).
CR Albright TL, 2001, FAM MED, V33, P354
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   [Anonymous], 2005, AUSTR MENTAL HLTH OU
   Atlantis E, 2012, AUST NZ J PSYCHIAT, V46, P445, DOI 10.1177/0004867411433218
   BJORNTORP P, 1991, J INTERN MED, V230, P195
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Carney RA, 2002, STROKE, V33, P5, DOI 10.1161/str.33.1.5
   Dominick KL, 2002, AGING CLIN EXP RES, V14, P499, DOI 10.1007/BF03327351
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Hermanns Norbert, 2007, Diabetes Care, V30, pe101, DOI 10.2337/dc07-1019
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Meadows K, 1996, QUAL LIFE RES, V5, P242, DOI 10.1007/BF00434746
   Meadows K., 2010, SCORING THE DHP 18
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2012, DIABETES OBES METAB, V14, P1081, DOI 10.1111/j.1463-1326.2012.01636.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Shim YT, 2012, DIABETIC MED, V29, pE241, DOI 10.1111/j.1464-5491.2012.03689.x
   Sicree R., 2009, IDF DIABETES ATLAS, P21
   Singh JA, 2005, SEMIN ARTHRITIS RHEU, V34, P755, DOI 10.1016/j.semarthrit.2004.08.001
   Soon SS, 2010, APPL HEALTH ECON HEA, V8, P239, DOI 10.2165/11313920-000000000-00000
   Sprenkle MD, 2004, CHEST, V126, P81, DOI 10.1378/chest.126.1.81
   Tan LSM, 2015, QUAL LIFE RES, V24, P153, DOI 10.1007/s11136-014-0747-z
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Venkataraman K, 2013, CLIN ENDOCRINOL, V78, P865, DOI 10.1111/j.1365-2265.2012.04480.x
   Verma SK, 2010, ANN ACAD MED SINGAP, V39, P913
   Wee HL, 2006, PHARMACOECONOMICS, V24, P673, DOI 10.2165/00019053-200624070-00006
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wielink G, 1997, EUR UROL, V31, P441
   Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026
NR 34
TC 10
Z9 10
U1 0
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD APR
PY 2015
VL 29
IS 3
BP 378
EP 383
DI 10.1016/j.jdiacomp.2015.01.009
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CE8TN
UT WOS:000352117100011
PM 25666950
DA 2019-01-08
ER

PT J
AU Chen, LM
   Zhang, Q
   Si, GX
   Chen, QS
   Ye, EL
   Yu, LC
   Peng, MM
   Yang, H
   Du, WJ
   Zhang, C
   Lu, XM
AF Chen, Liang-Miao
   Zhang, Qian
   Si, Guang-Xin
   Chen, Qing-Shou
   Ye, En-ling
   Yu, Le-Chu
   Peng, Meng-Meng
   Yang, Hong
   Du, Wen-Jun
   Zhang, Chi
   Lu, Xue-Mian
TI Associations between thyroid autoantibody status and abnormal pregnancy
   outcomes in euthyroid women
SO ENDOCRINE
LA English
DT Article
DE Thyroid peroxidase antibody (TPOAb); Thyroglobulin antibody (TgAb);
   Abnormal pregnancy outcome; Relationship
ID PEROXIDASE; DYSFUNCTION; ANTIBODIES; MANAGEMENT; HYPERTHYROIDISM;
   HYPOTHYROIDISM; THYROGLOBULIN; MISCARRIAGE; PREVALENCE; POSTPARTUM
AB We investigated whether thyroid autoantibody status influences pregnancy outcomes in euthyroid women, by comparing abnormal pregnancy outcome rates between those who tested positive for thyroid autoantibodies (Ab(+)) and those who tested autoantibody-negative (Ab(-)). Euthyroid pregnant women (n = 7,641) underwent tests for serum thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb). The subjects were divided into 4 groups according to thyroid antibody status: TPOAb(-)/TgAb(-) (92.9 %); TPOAb(+)/TgAb(-) (3.2 %); TPOAb(-)/TgAb(+) (2.0 %); and TPOAb(+)/TgAb(+) (1.9 %). The incidence rates of the following abnormal pregnancy outcomes were compared among the 4 groups and analyzed by Fisher's exact test: gestational diabetes, gestational hypertension, placenta previa, placental abruption, premature rupture of fetal membrane (PROM), intrauterine growth restriction, fetal distress, fetal anomalies, stillbirth, preterm birth, and low birth weight. Among the 4 groups, there were no significant differences in age, gestational age, or in the incidence rates of abnormal pregnancy outcomes, except for PROM and low birth weight. The highest incidence rates for PROM and low birth weight were in the TPOAb(-)/TgAb(+) and TPOAb(+)/TgAb(+) subjects, respectively. TgAb positivity and TPOAb positivity were associated with PROM and low birth weight, respectively. Underlying factors that govern the association between thyroid autoantibodies and PROM and low birth weight require further investigation.
C1 [Chen, Liang-Miao; Chen, Qing-Shou; Ye, En-ling; Yu, Le-Chu; Peng, Meng-Meng; Yang, Hong; Du, Wen-Jun; Lu, Xue-Mian] Wenzhou Med Univ, Affiliated Hosp 3, Dept Endocrinol, Ruian 325200, Zhejiang, Peoples R China.
   [Chen, Liang-Miao; Ye, En-ling; Yu, Le-Chu; Peng, Meng-Meng; Yang, Hong; Zhang, Chi; Lu, Xue-Mian] Wenzhou Med Univ, Affiliated Hosp 3, Ruian Ctr, Chinese Amer Res Inst Diabet Complicat, Wenzhou 325200, Peoples R China.
   [Zhang, Qian] Taizhou First Peoples Hosp, ICU, Taizhou 318020, Zhejiang, Peoples R China.
   [Si, Guang-Xin] Jining First Peoples Hosp, Dept Endocrinol, Jining 272011, Shandong, Peoples R China.
   [Zhang, Chi; Lu, Xue-Mian] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou 325035, Peoples R China.
RP Lu, XM (reprint author), Wenzhou Med Univ, Affiliated Hosp 3, Dept Endocrinol, 108 Wansong Rd, Ruian 325200, Zhejiang, Peoples R China.
EM zhangchi515@126.com; lu891118@medmail.com.cn
FU Medical Science Research Foundation of Zhejiang Province [2009A198];
   Third Batch of Science and Technology Project of Rui'an city [20093092]
FX This study was supported by Medical Science Research Foundation of
   Zhejiang Province (No. 2009A198), and the Third Batch of Science and
   Technology Project of Rui'an city (No. 20093092).
CR Abbassi-Ghanavati M, 2010, OBSTET GYNECOL, V116, P381, DOI 10.1097/AOG.0b013e3181e904e5
   Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127
   *AM DIAB ASS, 2006, DIABETES CARE S1, V29, pS43
   Balucan F.S., 2013, J THYROID RES, DOI [10.1155/2013/182472, DOI 10.1155/2013/182472]
   Carayanniotis G, 2003, AUTOIMMUNITY, V36, P423, DOI 10.1080/08916930310001602975
   De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803
   Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205
   GLINOER D, 1991, J CLIN ENDOCR METAB, V73, P421, DOI 10.1210/jcem-73-2-421
   Haddow JE, 2010, OBSTET GYNECOL, V116, P58, DOI 10.1097/AOG.0b013e3181e10b30
   Karakosta P, 2012, J CLIN ENDOCR METAB, V97, P4464, DOI 10.1210/jc.2012-2540
   KLEIN RZ, 1991, CLIN ENDOCRINOL, V35, P41, DOI 10.1111/j.1365-2265.1991.tb03494.x
   Korevaar TIM, 2013, J CLIN ENDOCR METAB, V98, P4382, DOI 10.1210/jc.2013-2855
   Lazarus JH, 2014, ENDOCRINE, V45, P190, DOI 10.1007/s12020-013-0086-9
   Lu XM, 2012, J MED RES, V41, P70
   Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520
   Prummel MF, 2005, BEST PRACT RES CL EN, V19, P1, DOI 10.1016/j.beem.2004.11.003
   Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023
   Stagnaro-Green A, 2012, NAT REV ENDOCRINOL, V8, P650, DOI 10.1038/nrendo.2012.171
   Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087
   Stagnaro-Green A, 2011, CLIN OBSTET GYNECOL, V54, P478, DOI 10.1097/GRF.0b013e3182272f32
   Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2
   Thangaratinam S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2616
   [徐艳红 Xu Yanhong], 2012, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V28, P377
   Yan JH, 2012, FERTIL STERIL, V98, P378, DOI 10.1016/j.fertnstert.2012.04.025
   Yu XH, 2013, ENDOCRINE, V44, P710, DOI 10.1007/s12020-013-9913-2
NR 25
TC 11
Z9 16
U1 0
U2 6
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD APR
PY 2015
VL 48
IS 3
BP 924
EP 928
DI 10.1007/s12020-014-0420-x
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CE2QT
UT WOS:000351661100025
PM 25209893
DA 2019-01-08
ER

PT J
AU Carolan, M
   Holman, J
   Ferrari, M
AF Carolan, Mary
   Holman, Jessica
   Ferrari, Michelle
TI Experiences of diabetes self-management: a focus group study among
   Australians with type 2 diabetes
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE diabetes; emotional distress; everyday life; focus groups
ID EPIDEMIOLOGIC EVIDENCE; HEALTH-CARE; DISEASE; WOMEN; MELLITUS;
   MORTALITY; OUTCOMES; UNCERTAINTY; INFORMATION; THERAPIES
AB Aims and objectivesThe aim of this study was to explore the experiences and concerns of individuals with type 2 diabetes mellitus, in a predominantly low socio-economic setting.
   BackgroundCurrently, approximately 1million Australians have diabetes and rates have more than doubled since 1989. Type 2 diabetes mellitus accounts for approximately 85% of diabetes cases. Risk factors include obesity, older age, low socio-economic status, sedentary lifestyle and ethnicity. Older individuals from low socio-economic backgrounds are particularly at risk of both developing and of mismanaging their condition.
   DesignExploratory qualitative design.
   MethodsFocus groups were used to collect data from 22 individuals, aged 40 to more than 70years, with type 2 diabetes mellitus, who were attending local health services for their diabetes care. Focus groups ranged in size from four to eight individuals and all were recorded, transcribed and analysed. Data were analysed using a thematic analysis approach.
   ResultsParticipants described their experiences of managing their diabetes as emotionally, physically and socially challenging. Data analysis revealed four main themes including: (1) diabetes the silent disease; (2) a personal journey (3) the work of managing diabetes; and (4) access to resources and services. Throughout, participants highlighted the impact of diabetes on the family, and the importance of family members in providing support and encouragement to assist their self-management efforts.
   ConclusionsParticipants in this study were generally satisfied with their diabetes care but identified a need for clear simple instruction immediately post-diagnosis, followed by a need for additional informal information when they had gained some understanding of their condition.
   Relevance to clinical practiceFindings reveal a number of unmet information and support needs for individuals with type 2 diabetes mellitus. In particular, it is important for healthcare professionals and family members to recognise the significant emotional burden that diabetes imposes, and the type and quantity of information individuals with diabetes prefer. It is also important to consider levels of health literacy in the community when developing diabetes-related information or programmes.
C1 [Carolan, Mary] Victoria Univ, Coll Hlth & Biomed, Nursing & Midwifery, Midwifery, Melbourne, Vic 8001, Australia.
   [Holman, Jessica] INWMML, Melbourne, Vic, Australia.
   [Ferrari, Michelle] INWMML, Hlth Integrat, Melbourne, Vic, Australia.
RP Carolan, M (reprint author), Victoria Univ, Coll Hlth & Biomed, Nursing & Midwifery, Midwifery, St Albans Campus,POB 14228, Melbourne, Vic 8001, Australia.
EM mary.carolan@vu.edu.au
FU INWMML
FX Many thanks to Mr Sean Lynch for his comments on the paper. The Inner
   North West Melbourne Medicare Local (INWMML) thanks the participants of
   the focus groups and clinical and research partners - The Health Issues
   Centre, Victoria University, Merri Community Health Service, Doutta
   Galla Community Health and Melbourne Health. This study was made
   possible through funding from the INWMML.
CR Abouzeid M, 2013, BIOMED CENTRAL PUBLI, V13, DOI [10.1186/1471-2458/13/252, DOI 10.1186/1471-2458/13/252]
   ABS: Australian Bureau of Statistics, 2011, 0 55 001 CENS POP HO
   ABS: Australian Bureau of Statistics, 2006, 4233 O HLTH LIT
   Ahlin K, 2012, SCAND J PRIM HEALTH, V30, P41, DOI [10.3109/02813432.2012.654193, 10.3109/02813432.2011.654193]
   AIHW: Australian Institute of Health and Welfare, 2008, DIAB AUSTR FACTS DIA, V8, P33
   Alam R, 2012, HEALTH SOC CARE COMM, V20, P155, DOI 10.1111/j.1365-2524.2011.01027.x
   [Anonymous], 2012, DIAB SIL PAND ITS IM
   Asimakopoulou KG, 2008, PATIENT EDUC COUNS, V71, P95, DOI 10.1016/j.pec.2007.12.007
   Atlantis E, 2009, OBES REV, V10, P543, DOI 10.1111/j.1467-789X.2009.00590.x
   Australian Institute of Health and Welfare (AIHW, 2011, DIAB PREV AUSTR DET
   Bays HE, 2012, AM J CARDIOL, V110, p4B, DOI 10.1016/j.amjcard.2012.08.029
   Bhattacharya G, 2012, J HEALTH CARE POOR U, V23, P161, DOI 10.1353/hpu.2012.0035
   Brinkley A, 2013, COURAGEOUS EXECTIONS
   Burnard P, 1991, Nurse Educ Today, V11, P461, DOI 10.1016/0260-6917(91)90009-Y
   Carolan M, 2010, MIDWIFERY, V26, P579, DOI 10.1016/j.midw.2009.01.006
   Carolan-Olah MC, 2013, BIOMED CENTRAL HLTH, V13
   Cooke M, 2012, J CLIN NURS, V21, P1524, DOI 10.1111/j.1365-2702.2012.04094.x
   Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042
   Department of Human Services, 2002, W METR REG HLTH SOC
   Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3
   Gross LS, 2004, AM J CLIN NUTR, V79, P774
   Holmstrom IM, 2005, J ADV NURS, V49, P146, DOI 10.1111/j.1365-2648.2004.03274.x
   Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1
   Kamberelis G, 2011, SAGE HDB QUALITATIVE, V4, P545
   Khalil CA, 2012, EUR J PREV CARDIOL, V19, P374, DOI 10.1177/1741826711409324
   Kim C, 2007, DIABETES CARE, V30, P1459, DOI 10.2337/dc06-2523
   KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299
   Kneck A, 2012, J ADV NURS, V68, P2486, DOI 10.1111/j.1365-2648.2012.05947.x
   Kokanovic R, 2006, CHRONIC ILLN, V2, P291, DOI 10.1179/174592006X157526
   Komatsu H, 2014, EUR J ONCOL NURS, V18, P419, DOI 10.1016/j.ejon.2014.03.006
   Li J, 2013, INT J NURS PRACT, V20, P126
   Liamputtong P, 2011, FOCUS GROPU METHODOL
   Liljeroos M, 2014, J CLIN NURS, V23, P2928, DOI 10.1111/jocn.12588
   Lippa Katherine D, 2008, Can J Nurs Res, V40, P80
   Macdonald L, 2013, BMC NURS, V12, DOI 10.1186/1472-6955-12-20
   Manderson L, 2009, CHRONIC ILLN, V5, P21, DOI 10.1177/1742395309102243
   Mathew R, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-122
   Middleton AV, 2012, HEALTH COMMUN, V27, P591, DOI 10.1080/10410236.2011.618435
   Murrock CJ, 2013, WOMEN HEALTH, V53, P173, DOI 10.1080/03630242.2012.753979
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   Noto H, 2012, J DIABETES INVEST, V3, P24, DOI 10.1111/j.2040-1124.2011.00183.x
   Onwudiwe NC, 2011, ETHNIC DIS, V21, P27
   Pagano E, 2013, DIABETOLOGIA, V56, P1726, DOI 10.1007/s00125-013-2933-x
   Park H, 2013, J ADV NURS, V69, P1400, DOI 10.1111/jan.12001
   Parry O, 2006, HEALTH EDUC RES, V21, P97, DOI 10.1093/her/cyh044
   Purcell N, 2013, AM J HEALTH EDUC, V44, P203, DOI 10.1080/19325037.2013.798212
   Reeves MM, 2013, PREV MED, V57, P471, DOI 10.1016/j.ypmed.2013.06.023
   Savoca MR, 2004, SOC SCI MED, V58, P2655, DOI 10.1016/j.socscimed.2003.09.031
   Shen HX, 2013, INT J NURS PRACT, V19, P627, DOI 10.1111/ijn.12114
   Siminerio L, 2013, DIABETES EDUCATOR, V39, P705, DOI 10.1177/0145721713492570
   Speight J, 2013, DIABETES ED, P12
   St. Jean B., 2012, P AM SOC INFORM SCI, V49, P1, DOI [10.1002/meet.14504901030, DOI 10.1002/MEET.14504901030]
   Tammaru M, 2010, J CLIN NURS, V19, P1343, DOI 10.1111/j.1365-2702.2009.02957.x
   Whitford DL, 2013, PRIM CARE DIABETES, V7, P103, DOI 10.1016/j.pcd.2013.01.006
   Wilkinson S, 1998, HEALTH PSYCHOL, V3, P329, DOI DOI 10.1177/135910539800300304
   Woodcock Hannah, 2013, Qual Prim Care, V21, P157
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 57
TC 16
Z9 17
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD APR
PY 2015
VL 24
IS 7-8
BP 1011
EP 1023
DI 10.1111/jocn.12724
PG 13
WC Nursing
SC Nursing
GA CE2GU
UT WOS:000351633800013
PM 25363710
DA 2019-01-08
ER

PT J
AU Hermanns, N
   Schmitt, A
   Gahr, A
   Herder, C
   Nowotny, B
   Roden, M
   Ohmann, C
   Kruse, J
   Haak, T
   Kulzer, B
AF Hermanns, Norbert
   Schmitt, Andreas
   Gahr, Annika
   Herder, Christian
   Nowotny, Bettina
   Roden, Michael
   Ohmann, Christian
   Kruse, Johannes
   Haak, Thomas
   Kulzer, Bernhard
TI The Effect of a Diabetes-Specific Cognitive Behavioral Treatment Program
   (DIAMOS) for Patients With Diabetes and Subclinical Depression: Results
   of a Randomized Controlled Trial
SO DIABETES CARE
LA English
DT Article
ID DISTRESS SCALE; SELF-CARE; ADULTS; METAANALYSIS; PEOPLE; INFLAMMATION;
   ASSOCIATION; PREVALENCE; ACCEPTANCE; SYMPTOMS
AB OBJECTIVESubclinical depression is one of the most frequent mental comorbidities in patients with diabetes and is associated with a poorer long-term prognosis. Since there is a lack of specific intervention concepts for this patient group, a self-management-oriented group program (DIAMOS [Diabetes Motivation Strengthening]) was newly developed and evaluated in a randomized trial.RESEARCH DESIGN AND METHODSDIAMOS is composed of cognitive behavioral interventions aiming at the reduction of diabetes distress. The active control group (CG) received diabetes education. The primary outcome was depressive symptoms. Secondary outcomes were diabetes distress, well-being, self-care behavior, diabetes acceptance, diabetes treatment satisfaction, HbA(1c), and subclinical inflammation.RESULTSTwo hundred fourteen participants (mean age 43.3 13.3 years, female sex 56.5%, type 2 diabetes 34.1%, mean diabetes duration 14.2 +/- 10.5 years, HbA(1c) 8.9 +/- 1.8%, BMI 28.7 +/- 71 kg/m(2)) were randomized. The 12-month follow-up revealed a significantly stronger reduction of depressive symptoms (Center for Epidemiologic Studies Depression Scale score) in the DIAMOS group compared with the CG (3.9 [95% CI 0.6-7.3], P = 0.021). Of the secondary variables, the Patient Health Questionnaire-9 (1.7 [95% CI 0.2-3.2], P = 0.023), Problem Areas in Diabetes scale (8.2 [95% CI 3.1-13.3], P = 0.002), and Diabetes Distress Scale scores (0.3 [95% CI 0.1-0.5], P = 0.012) displayed significant treatment effects. Moreover, the risk of incident major depression in the DIAMOS group was significantly reduced (odds ratio 0.63 [95% CI 0.42-0.96], P = 0.028). Inflammatory variables were not substantially affected.CONCLUSIONSDIAMOS is more effective in lowering depressive symptoms and diabetes-related distress in diabetic patients with subclinical depression. DIAMOS also has a preventive effect with respect to the incidence of major depression.
C1 [Hermanns, Norbert; Schmitt, Andreas; Gahr, Annika; Haak, Thomas; Kulzer, Bernhard] Res Inst Diabet Acad Mergentheim, Bad Mergentheim, Germany.
   [Hermanns, Norbert; Haak, Thomas; Kulzer, Bernhard] Diabet Ctr Mergentheim, Bad Mergentheim, Germany.
   [Hermanns, Norbert; Kulzer, Bernhard] Univ Bamberg, Inst Clin Psychol & Psychotherapy, Bamberg, Germany.
   [Herder, Christian; Nowotny, Bettina; Roden, Michael] Univ Dusseldorf, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.
   [Herder, Christian; Roden, Michael] Partner Dusseldorf, German Ctr Diabet Res, Dusseldorf, Germany.
   [Nowotny, Bettina; Roden, Michael] Univ Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany.
   [Ohmann, Christian] Univ Dusseldorf, Coordinat Ctr Clin Trials, Dusseldorf, Germany.
   [Kruse, Johannes] Univ Giessen, Univ Klinikum Giessen & Marburg, Klin Psychosomat & Psychotherapie, D-35390 Giessen, Germany.
   [Kruse, Johannes] Univ Marburg, Giessen, Germany.
RP Hermanns, N (reprint author), Res Inst Diabet Acad Mergentheim, Bad Mergentheim, Germany.
EM hermanns@diabetes-zentrum.de
OI Schmitt, Andreas/0000-0002-5913-1457
FU Competence Network Diabetes Mellitus - Federal Ministry of Education and
   Research (BMBF) [FKZ 01GI0809]; Ministry of Innovation, Science and
   Research of the State of North Rhine-Westphalia; German Federal Ministry
   of Health; BMBF
FX This research was supported by the Competence Network Diabetes Mellitus,
   which was funded by the Federal Ministry of Education and Research
   (BMBF) (grant FKZ 01GI0809); the Ministry of Innovation, Science and
   Research of the State of North Rhine-Westphalia; and the German Federal
   Ministry of Health. This work was supported in part by a grant from the
   BMBF to the German Center for Diabetes Research (DZD e.V.).
CR American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bassett J, 2012, J DIABETES METAB, V3
   Baumeister H, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Greiner W, 2007, GESUNDHEITSOKONOMISC, P403
   Hautzinger M, 1993, ALLGEMEINE DEPRESSIO
   Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155
   Herder C, 2013, DIABETES CARE, V36, P3663, DOI 10.2337/dc13-0382
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009
   Hermanns N, 2012, PATIENT EDUC COUNS, V86, P226, DOI 10.1016/j.pec.2011.05.017
   Hood KK, 2012, DIABETES CARE, V35, P2443, DOI 10.2337/dc11-2329
   Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b
   Judd LL, 2002, PSYCHIAT CLIN N AM, V25, P685, DOI 10.1016/S0193-953X(02)00026-6
   Kacerovsky-Bielesz G, 2009, DIABETOLOGIA, V52, P781, DOI 10.1007/s00125-009-1318-7
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Laake JPS, 2014, DIABETES CARE, V37, P2186, DOI 10.2337/dc13-2522
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   National Institute for Health and Care Excellence, 2009, DEPR AD CHRON PHYS H, V91
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Saatci E, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-67
   Schmitt A, 2014, DIABETIC MED, V31, P1446, DOI 10.1111/dme.12553
   Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Unutzer J, 2009, J AM GERIATR SOC, V57, P506, DOI 10.1111/j.1532-5415.2008.02134.x
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 40
TC 45
Z9 46
U1 1
U2 25
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD APR
PY 2015
VL 38
IS 4
BP 551
EP 560
DI 10.2337/dc14-1416
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CE2FX
UT WOS:000351630900015
PM 25605812
OA Bronze
DA 2019-01-08
ER

PT J
AU Welch, G
   Zagarins, SE
   Santiago-Kelly, P
   Rodriguez, Z
   Bursell, SE
   Rosal, MC
   Gabbay, RA
AF Welch, Garry
   Zagarins, Sofija E.
   Santiago-Kelly, Paula
   Rodriguez, Zoraida
   Bursell, Sven-Erik
   Rosal, Milagros C.
   Gabbay, Robert A.
TI An Internet-Based Diabetes Management Platform Improves Team Care and
   Outcomes in an Urban Latino Population
SO DIABETES CARE
LA English
DT Article
ID COMMUNITY-HEALTH WORKERS; DECISION-SUPPORT; PROGRAM; PEOPLE
AB OBJECTIVETo compare usual diabetes care (UDC) to a comprehensive diabetes care intervention condition (IC) involving an Internet-based diabetes dashboard management tool used by clinicians.RESEARCH DESIGN AND METHODSWe used a parallel-group randomized design. Diabetes nurses, diabetes dietitians, and providers used the diabetes dashboard as a clinical decision support system to deliver a five-visit, 6-month intervention to 199 poorly controlled (HbA(1c) >7.5% [58 mmol/mol]) Latino type 2 diabetic (T2D) patients (mean age 55 years, 60% female) at urban community health centers. We compared this intervention to an established, in-house UDC program (n = 200) for its impact on blood glucose control and psychosocial outcomes.RESULTSRecruitment and retention rates were 79.0 and 88.5%, respectively. Compared with UDC, more IC patients reached HbA(1c) targets of <7% (53 mmol/mol; 15.8 vs. 7.0%, respectively, P < 0.01) and <8% (64 mmol/mol; 45.2 vs. 25.3%, respectively, P < 0.001). In multiple linear regression adjusting for baseline HbA(1c), adjusted mean SE HbA(1c) at follow-up was significantly lower in the IC compared with the UDC group (P < 0.001; IC 8.4 +/- 0.10%; UDC 9.2 +/- 0.10%). The results showed lower diabetes distress at follow-up for IC patients (40.4 +/- 2.1) as compared with UDC patients (48.3 +/- 2.0) (P < 0.01), and also lower social distress (32.2 +/- 1.3 vs. 27.2 +/- 1.4, P < 0.01). There was a similar, statistically significant (P < 0.01) improvement for both groups in the proportion of patients moving from depressed status at baseline to nondepressed at follow-up (41.8 vs. 40%; no significance between groups).CONCLUSIONSThe diabetes dashboard intervention significantly improved diabetes-related outcomes among Latinos with poorly controlled T2D compared with a similar diabetes team condition without access to the diabetes dashboard.
C1 [Welch, Garry; Zagarins, Sofija E.; Santiago-Kelly, Paula; Rodriguez, Zoraida] Baystate Med Ctr, Behav Med Res, Springfield, MA 01199 USA.
   [Bursell, Sven-Erik] Univ Hawaii Manoa, Honolulu, HI 96822 USA.
   [Rosal, Milagros C.] Univ Massachusetts, Sch Med, Div Prevent & Behav Med, Worcester, MA USA.
   [Gabbay, Robert A.] Joslin Diabet Ctr, Boston, MA 02215 USA.
RP Welch, G (reprint author), Baystate Med Ctr, Behav Med Res, Springfield, MA 01199 USA.
EM garry@silverfernhealthcare.com
FU National Institute of Diabetes and Digestive and Kidney Diseases,
   National Institutes of Health [5R01-DK-084325-04]
FX This project was supported by the National Institute of Diabetes and
   Digestive and Kidney Diseases, National Institutes of Health, through
   grant 5R01-DK-084325-04.
CR *AM DIAB ASS, 1998, DIABETES CARE, V21, P2180
   American Association of Diabetes Educators, 2008, DIABETES ED, V34, P445, DOI DOI 10.1177/0145721708316625
   American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   Berner ES, 2010, METHOD INFORM MED, V49, P412, DOI 10.3414/ME9309
   Bodenheimer TS, 2013, HEALTH AFFAIR, V32, P1881, DOI 10.1377/hlthaff.2013.0234
   Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fonda SJ, 2008, DIABETES TECHNOL THE, V10, P16, DOI 10.1089/dia.2007.0252
   Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459
   Institute of Medicine, 2014, CAPT SOC BEH DOM EL
   Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331
   Koopman RJ, 2011, ANN FAM MED, V9, P398, DOI 10.1370/afm.1286
   KROENKE K, 2002, PSYCHIAT ANN, V32, P1, DOI DOI 10.3928/0048-5713-20020901-06
   Liebman J, 2008, CLIN DIABETES, V26, P75
   Liebman J, 2007, DIABETES EDUCATOR, V33, p132S, DOI 10.1177/0145721707304075
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   O'Connor PJ, 2011, ANN FAM MED, V9, P12, DOI 10.1370/afm.1196
   O'Connor PJ, 2005, ADV PATIENT SAFETY R, V2
   Ogunyemi O, 2010, STUD HEALTH TECHNOL, V160, P208, DOI 10.3233/978-1-60750-588-4-208
   Osborn CY, 2014, WESTERN J NURS RES, V36, P1091, DOI 10.1177/0193945914524639
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Rosal MC, 2011, DIABETES CARE, V34, P838, DOI 10.2337/dc10-1981
   Rosenthal EL, 2010, HEALTH AFFAIR, V29, P1338, DOI 10.1377/hlthaff.2010.0081
   Shah M, 2013, CURR DIABETES REP, V13, P163, DOI 10.1007/s11892-012-0359-3
   StataCorp, 2011, STAT STAT SOFTW REL
   Stuckey HL, 2009, CONTEMP CLIN TRIALS, V30, P366, DOI 10.1016/j.cct.2009.03.002
   United States Census Bureau, 2014, STAT COUNT QUICKFACT
   US Department of Health and human services, 2004, NIH PUBL, V04-5230
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch G, 2012, PSYCHOSOCIAL CARE PE, P101
   Welch G, 2007, 67 SCI SESS AM DIAB
   Welch G, 2007, ETHNIC DIS, V17, P541
   Welch G, 2011, DIABETES EDUCATOR, V37, P680, DOI 10.1177/0145721711416257
   Welch GW, 2011, DIABETES, V60, pA573
NR 35
TC 11
Z9 11
U1 0
U2 9
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD APR
PY 2015
VL 38
IS 4
BP 561
EP 567
DI 10.2337/dc14-1412
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CE2FX
UT WOS:000351630900016
PM 25633661
OA Bronze, Green Published
DA 2019-01-08
ER

PT J
AU Huyser, KR
   Manson, SM
   Nelson, LA
   Noonan, C
   Roubideaux, Y
AF Huyser, Kimberly R.
   Manson, Spero M.
   Nelson, Lonnie A.
   Noonan, Carolyn
   Roubideaux, Yvette
CA Special Diabet Program Indians Hlt
TI SERIOUS PSYCHOLOGICAL DISTRESS AND DIABETES MANAGEMENT AMONG AMERICAN
   INDIANS AND ALASKA NATIVES
SO ETHNICITY & DISEASE
LA English
DT Article
DE American Indian; Alaska Native; Diabetes; Serious Psychological Distress
ID GENERAL-POPULATION; AFRICAN-AMERICANS; MORTALITY; ADULTS; COMORBIDITY;
   COMMUNITIES; DEPRESSION; SYMPTOMS; COSTS; K6
AB Objective: Our study examined associations between serious psychological distress and blood glucose level (HbA1c) and body mass index (BMI) among American Indian and Alaska Native (AI/AN) participants in a cardiovascular disease prevention program.
   Design: Using linear regression, we assessed the relationships between serious psychological distress and HbA1c and BMI at baseline and one year later. Setting,
   Participants, and Intervention: AI/AN participants were aged >= 18 years, diagnosed with type 2 diabetes, and enrolled in the Special Diabetes Project for Indians Healthy Heart Project.
   Main Outcome Measures: Outcomes were percentage of HbA1c and BMI, measured at enrollment and first annual exam. Both outcomes were continuous measures in all analyses.
   Results: Serious psychological distress was associated at baseline with increased HbA1c in the unadjusted and adjusted models (adjusted b=.17%, P<0.01). Serious psychological distress also was associated at baseline with increased BMI (.635 kg/m(2), P=.01) and at one year with increased BMI (0.174 kg/m(2), P=.01) in the unadjusted model. After adjustment for demographic and health characteristics, these relationships were no longer significant.
   Conclusions: Cross-sectional baseline findings are consistent with existing literature. One-year findings suggest need for further inquiry into mediators of psychological distress and examination of additional diabetes-specific health outcomes. Additional years of observation may be needed to disentangle relationships between serious psychological. distress and BMI.
C1 [Huyser, Kimberly R.] Univ New Mexico, Dept Sociol, Albuquerque, NM 87131 USA.
   [Manson, Spero M.] Univ Colorado Denver, Colorado Sch Publ Hlth, Ctr Amer Indian & Alaska Nat Hlth, Aurora, CO USA.
   [Nelson, Lonnie A.] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA.
   [Noonan, Carolyn] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.
   [Roubideaux, Yvette] Indian Hlth Serv, Off Director, Rockville, MD USA.
RP Huyser, KR (reprint author), Univ New Mexico, Dept Sociol, 1915 Roma Ave NE,MSCO5 3080,1 Univ New Mexico, Albuquerque, NM 87131 USA.
EM khuyser@unm.edu
FU Indian Health Service [HHSI242200400049C]; National Institute of
   Diabetes, Digestive, and Kidney Diseases [P30DK092923]; National
   Institute on Aging [P30 AG15297]; Robert Wood Johnson Center for Health
   Policy at the University of New Mexico
FX Funding for the Special Diabetes Program for Indians Healthy Heart
   Project was provided by Indian Health Service (HHSI242200400049C, S.M.
   Manson). Preparation of this manuscript was supported by National
   Institute of Diabetes, Digestive, and Kidney Diseases (P30DK092923, S.M.
   Manson) and National Institute on Aging (P30 AG15297, S.M. Manson). We
   would like to express gratitude to the programs and participants
   involved in the Special Diabetes Program for Indians Healthy Heart
   Project. Finally, we thank the Robert Wood Johnson Center for Health
   Policy at the University of New Mexico for research support.
CR Alipour N, 2012, CURR DIABETES REP, V12, P286, DOI 10.1007/s11892-012-0273-8
   [Anonymous], 2002, SURV METH PROGR
   [Anonymous], SDPI OV
   Babor T., 2001, AUDIT
   Calhoun D, 2009, J DIABETES COMPLICAT, V24, P217
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Centres for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P1089
   Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020
   Dunbar JA, 2008, DIABETES CARE, V31, P2368, DOI 10.2337/dc08-0175
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Gary TL, 2000, DIABETES CARE, V23, P23, DOI 10.2337/diacare.23.1.23
   Geoffroy M, 2001, J EPIDEMIOL COMMU S1, V65, pA17
   Hamer M, 2010, PSYCHOSOM MED, V72, P882, DOI 10.1097/PSY.0b013e3181f6696e
   Jiang L, 2007, DIABETES CARE, V30, P2228, DOI 10.2337/dc07-0097
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kogan SA, 2009, J PSYCHOSOM RES, V67, P289, DOI 10.1016/j.jpsychores.2009.01.016
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Luppino FS, 2001, ARCH GEN PSYCHIAT, V67, P220
   Manson SM, 2011, GERONTOLOGIST, V51, pS21, DOI 10.1093/geront/gnq083
   Mitchell CM, 2011, PSYCHOL ASSESSMENT, V23, P752, DOI 10.1037/a0023288
   Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77
   Needham BL, 2010, AM J PUBLIC HEALTH, V100, P1040, DOI 10.2105/AJPH.2009.172809
   O'Connell JM, 2012, AM J PUBLIC HEALTH, V102, P301, DOI 10.2105/AJPH.2011.300332
   Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pratt LA, 2007, ADV DATA, V30, P1
   Pratt LA, 2009, ANN EPIDEMIOL, V19, P202, DOI 10.1016/j.annepidem.2008.12.005
   Roberts RE, 2003, INT J OBESITY, V27
   Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993
   Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   StataCorp, 2011, STAT STAT SOFTW V 12
   Williams SL, 2010, INT J PSYCHIAT MED, V40, P233, DOI 10.2190/PM.40.3.a
   Young BA, 2003, DIABETES CARE, V26, P2392, DOI 10.2337/diacare.26.8.2392
   Zhao G, 2009, INT J PUBLIC HEALTH, V51, pS30
   Zulman DM, 2012, PATIENT EDUC COUNS, V87, P74, DOI 10.1016/j.pec.2011.07.013
NR 37
TC 3
Z9 3
U1 1
U2 14
PU INT SOC HYPERTENSION BLACKS-ISHIB
PI ATLANTA
PA 100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA
SN 1049-510X
EI 1945-0826
J9 ETHNIC DIS
JI Ethn. Dis.
PD SPR
PY 2015
VL 25
IS 2
BP 145
EP 151
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CJ1JX
UT WOS:000355241000005
PM 26118140
DA 2019-01-08
ER

PT J
AU Littlewood, K
   Cummings, DM
   Lutes, L
   Solar, C
AF Littlewood, Kerry
   Cummings, Doyle M.
   Lutes, Lesley
   Solar, Chelsey
TI PSYCHOMETRIC PROPERTIES OF THE FAMILY SUPPORT SCALE ADAPTED FOR AFRICAN
   AMERICAN WOMEN WITH TYPE 2 DIABETES MELLITUS
SO ETHNICITY & DISEASE
LA English
DT Article
DE Social Support; Diabetes; African American; Women
ID RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; SOCIAL SUPPORT; WEIGHT-LOSS;
   ADULTS; INTERVENTION; PREDICTORS; BEHAVIOR
AB Objective: The purpose of our study was twofold: 1) adapt and test a social support measure specific to the experiences of African American women with type 2 diabetes mellitus (T2DM); 2) examine its relationship to psychosocial measures.
   Research Design and Methods: 200 rural African American women with uncontrolled T2DM participating in a randomized controlled trial completed surveys at baseline on their social support, empowerment, self-care, self-efficacy, depression and diabetes distress. Exploratory factor analysis and correlation analysis were conducted to test the psychometric properties of the Dunst Family Support Scale adapted for AA women with T2DM (FSS-AA T2DM) and its relationship with other psychosocial measures.
   Results: The 16 items of the FSS-AA T2DM loaded onto three distinct factors: parent and spouse/partner support, community and medical support, and extended family and friends support. Reliability for the entire scale was good (Cronbach's alpha=.90) and was acceptable to high across these three factors (Cronbach's a of alpha 86,.83, and .83 respectively). All three factors were significantly correlated with self-reported empowerment, self-care, self-efficacy, depression and diabetes distress, although the pattern was different for each factor. FSS-AA-T2DM showed good concurrent validity when compared with similar items on the Diabetes Distress Scale.
   Conclusion: The FSS-AA T2DM, a 16-item scale measuring social support among rural African American women with T2DM, is internally consistent and reliable. Findings support the utility of this screening tool in this population, although additional testing is needed with other groups in additional settings.
C1 [Littlewood, Kerry] E Carolina Univ, Sch Social Work, Coll Human Ecol, Greenville, NC 27858 USA.
   [Cummings, Doyle M.] E Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA.
   [Cummings, Doyle M.] E Carolina Univ, Ctr Hlth Dispar, Greenville, NC 27858 USA.
   [Lutes, Lesley; Solar, Chelsey] E Carolina Univ, Dept Psychol, Hlth Psychol Program, Greenville, NC 27858 USA.
RP Littlewood, K (reprint author), E Carolina Univ, Sch Social Work, Coll Human Ecol, Social Work, Greenville, NC 27858 USA.
EM littlewoodk@ecu.edu
OI CUMMINGS, DOYLE/0000-0002-8237-7885
FU Bristol-Myers Squibb Foundation's Together on Diabetes Initiative
FX The authors acknowledge the generous financial support of Bristol-Myers
   Squibb Foundation's Together on Diabetes Initiative that funded this
   study. The authors also acknowledge the substantial contributions of our
   Program Coordinator Dr. Bertha Hambidge, our community health
   workers-Ms. J. Royal-Burgess, Ms. J. Jordan, Ms. P. Gatlin, Ms. F.
   Parker, Ms. E. Roberson-Morning, and Ms. S. Taylor, staff member Ms. T.
   Kono, research assistants Ms. J. King, Mr. K. Quinn, Mr. E. Soto, Ms. L.
   Vines, and Ms. S. Williamson, our clinical laboratory scientists Mr. B.
   Gilpin, Ms. T. Davis, Ms. B. Whitehurst, Ms. N. Johnson and Ms. J.
   Sanderson, our Research Division supporters Ms. C. Kennedy and Ms. W.
   Wynne, and our community participants.
CR Albright TL, 2001, FAM MED, V33, P354
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Bennett GG, 2010, OBESITY, V18, P308, DOI 10.1038/oby.2009.242
   Bertera EM, 2003, HEALTH SOC WORK, V28, P33, DOI 10.1093/hsw/28.1.33
   Cummings DM, 2013, CONTEMP CLIN TRIALS, V36, P147, DOI 10.1016/j.cct.2013.06.006
   de Villis RF, 2003, SCALE DEV THEORY APP
   Deales A, 2014, NUTR METAB CARDIOVAS, V24, P563, DOI 10.1016/j.numecd.2013.11.008
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Dunn KI, 2011, APPETITE, V57, P349, DOI 10.1016/j.appet.2011.06.004
   Dunst C. J., 1984, J INDIVIDUAL FAMILY, V1, P45
   Early T. J., 2001, FAMILIES SOC, V82, P225
   Ford ME, 1998, J NATL MED ASSOC, V90, P425
   Griffith LS, 1990, INT J PSYCHIAT MED, V20, P364
   Hanley B., 1998, J CHILD FAM STUD, V7, P69, DOI DOI 10.1023/A:1022912130180
   Long K, 1996, OUTCOME MEASURES HLT
   Maillet NA, 1996, DIABETES EDUCATOR, V22, P39, DOI 10.1177/014572179602200106
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Tabachnick G. G., 2007, EXPT DESIGNS USING A
   van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001
   Wallston KA, 2005, J HEALTH PSYCHOL, V10, P623, DOI 10.1177/1359105305055304
   WILSON W, 1986, DIABETES CARE, V9, P614, DOI 10.2337/diacare.9.6.614
   Yank V, 2013, CONTEMP CLIN TRIALS, V34, P126, DOI 10.1016/j.cct.2012.10.007
NR 25
TC 4
Z9 4
U1 0
U2 10
PU INT SOC HYPERTENSION BLACKS-ISHIB
PI ATLANTA
PA 100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA
SN 1049-510X
EI 1945-0826
J9 ETHNIC DIS
JI Ethn. Dis.
PD SPR
PY 2015
VL 25
IS 2
BP 193
EP 199
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CJ1JX
UT WOS:000355241000013
PM 26118148
DA 2019-01-08
ER

PT J
AU Oni, O
   Harville, E
   Xiong, X
   Buekens, P
AF Oni, Olurinde
   Harville, Emily
   Xiong, Xu
   Buekens, Pierre
TI Relationships Among Stress Coping Styles and Pregnancy Complications
   Among Women Exposed to Hurricane Katrina
SO JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING
LA English
DT Article
DE stress; coping styles; pregnancy-induced hypertension; gestational
   diabetes; induction of labor; cesarean; Hurricane Katrina
ID GESTATIONAL DIABETES-MELLITUS; PERCEIVED STRESS; INDUCED HYPERTENSION;
   BIRTH OUTCOMES; SOCIAL SUPPORT; RISK-FACTORS; PREECLAMPSIA; HEALTH;
   DEPRESSION; DISTRESS
AB Objective: To examine the relationship between maternal stress exposure, stress coping styles, and pregnancy complications.
   Design: Quantitative, cross-sectional, and prospective study.
   Setting: Tulane-Lakeside Hospital, New Orleans, LA and Women's Hospital, Baton Rouge, LA.
   Participants: The study included 146 women (122 from New Orleans and 24 from Baton Rouge), who were pregnant during or immediately after Hurricane Katrina.
   Methods: Participants were interviewed regarding their hurricane experiences and perceived stress, and coping styles were assessed using the Brief COPE. Medical charts were also reviewed to obtain information about pregnancy outcomes. Logistic regression was performed to determine possible associations.
   Results: Hurricane exposure was significantly associated with induction of labor (adjusted odds ratio [aOR] = 1.39; 95% confidence interval [CI] [1.03, 1.86], P =.03) and current perceived stress (aOR = 1.50, CI [1.34, 1.99], P <.01). Stress perception significantly predisposed to pregnancy-induced hypertension (aOR = 1.16, CI [1.05, 1.30], P <.01) and gestational diabetes (aOR = 1.13, CI [1.02, 1.25], P =.03). Use of planning, acceptance, humor, instrumental support, and venting coping styles were associated with a significantly reduced occurrence of pregnancy complications (P <.05). Higher rates for gestational diabetes was found among women using the denial coping style (aOR = 2.25, CI [1.14, 4.45], P =.02).
   Conclusion: Exposure to disaster-related stress may complicate pregnancy, whereas some coping styles may mitigate its effects. Further research should explore how coping styles may mitigate or exacerbate the effect of major stressors and how positive coping styles can be encouraged or augmented.
C1 [Oni, Olurinde] Kansas City VA Med Ctr, Kansas City, MO 64128 USA.
   [Harville, Emily; Xiong, Xu] Tulane Univ, Sch Publ Hlth, Dept Epidemiol, New Orleans, LA 70118 USA.
   [Buekens, Pierre] Tulane Univ, Sch Publ Hlth, New Orleans, LA 70118 USA.
RP Oni, O (reprint author), Kansas City VA Med Ctr, 4801 E Linwood Blvd 151, Kansas City, MO 64128 USA.
EM ooni@tulane.edu
FU NIH HHS/United States [3U01 HD040477-05S2/HD/NICHD]
FX Supported by contract extension to 3U01 HD040477-05S2/HD/NICHD NIH
   HHS/United States.
CR Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI [10.2337/dc14-S081, 10.2337/dc10-s062, 10.2337/dc11-S062, 10.2337/dc10-S062]
   Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287
   Anorlu RI, 2005, AUST NZ J OBSTET GYN, V45, P278, DOI 10.1111/j.1479-828X.2005.00411.x
   Aspinwall LG, 1997, PSYCHOL BULL, V121, P417, DOI 10.1037//0033-2909.121.3.417
   Boyle A, 2012, SEMIN PERINATOL, V36, P308, DOI 10.1053/j.semperi.2012.04.012
   BROWN MA, 1986, NURS RES, V35, P72
   Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6
   CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267
   Centers for Disease Control and Prevention, 2014, REPR HLTH PREGN COMP
   Chaaya M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-111
   Chou FH, 2008, INT J NURS STUD, V45, P1185, DOI 10.1016/j.ijnurstu.2007.08.004
   Clark SL, 2008, AM J OBSTET GYNECOL, V199, P91, DOI [10.1016/j.ajog.2008.05.009, 10.1016/j.ajog.2008.03.007]
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Currie J, 2013, J HEALTH ECON, V32, P487, DOI 10.1016/j.jhealeco.2013.01.004
   Declercq ER, 2013, LISTENING TO MOTHERS
   DeCoster VA, 2004, SOC WORK HEALTH CARE, V40, P37, DOI 10.1300/J010v40n02_03
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Ehrlich M, 2010, J WOMENS HEALTH, V19, P877, DOI 10.1089/jwh.2009.1693
   FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571
   FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617
   Garay-Sevilla ME, 1999, DIABETIC MED, V16, P238, DOI 10.1046/j.1464-5491.1999.00033.x
   Garland E, 2009, EXPLORE-NY, V5, P37, DOI 10.1016/j.explore.2008.10.001
   Gonzalez-Freire B, 2010, J CLIN PSYCHOL MED S, V17, P220, DOI 10.1007/s10880-010-9198-z
   Goossens PJJ, 2008, ARCH PSYCHIAT NURS, V22, P245, DOI 10.1016/j.apnu.2007.07.001
   Grey M, 1997, NURS RES, V46, P312, DOI 10.1097/00006199-199711000-00003
   Harville E, 2010, OBSTET GYNECOL SURV, V65, P713, DOI 10.1097/OGX.0b013e31820eddbe
   Harville EW, 2011, J INTERPERS VIOLENCE, V26, P833, DOI 10.1177/0886260510365861
   Harville EW, 2010, DISASTER MED PUBLIC, V4, pS39, DOI 10.1001/dmp.2010.15
   Harville EW, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-21
   Harville EW, 2009, J WOMENS HEALTH, V18, P1425, DOI 10.1089/jwh.2008.1102
   Honey KL, 2003, J AFFECT DISORDERS, V76, P201, DOI 10.1016/S0165-0327(02)00085-X
   Hosler AS, 2011, PAEDIATR PERINAT EP, V25, P566, DOI 10.1111/j.1365-3016.2011.01221.x
   Huizink AC, 2003, J CHILD PSYCHOL PSYC, V44, P810, DOI 10.1111/1469-7610.00166
   Huizink AC, 2002, ANN BEHAV MED, V24, P132, DOI 10.1207/S15324796ABM2402_10
   Kardum I, 2001, PERS INDIV DIFFER, V30, P503, DOI 10.1016/S0191-8869(00)00041-6
   Kirchner T, 2010, PSICOTHEMA, V22, P382
   KlonoffCohen HS, 1996, EPIDEMIOLOGY, V7, P245, DOI 10.1097/00001648-199605000-00005
   Landsbergis PA, 1996, EPIDEMIOLOGY, V7, P346, DOI 10.1097/00001648-199607000-00002
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002
   Leeners B, 2007, HYPERTENS PREGNANCY, V26, P211, DOI 10.1080/10641950701274870
   Makhseed M, 1999, Med Confl Surviv, V15, P161, DOI 10.1080/13623699908409451
   Marcoux S, 1999, EPIDEMIOLOGY, V10, P376, DOI 10.1097/00001648-199907000-00007
   Martini J, 2010, EARLY HUM DEV, V86, P305, DOI 10.1016/j.earlhumdev.2010.04.004
   Messer LC, 2005, MATERN CHILD HLTH J, V9, P403, DOI 10.1007/s10995-005-0021-7
   Norris FH, 1999, ANXIETY STRESS COPIN, V12, P363, DOI 10.1080/10615809908249317
   North CS, 2005, BRIT J PSYCHIAT, V186, P487, DOI 10.1192/bjp.186.6.487
   Nugteren JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039263
   Oni Olurinde, 2012, Am J Disaster Med, V7, P199
   Parikh SV, 2007, BIPOLAR DISORD, V9, P589, DOI 10.1111/j.1399-5618.2007.00448.x
   PARKES KR, 1986, J PERS SOC PSYCHOL, V51, P1277, DOI 10.1037/0022-3514.51.6.1277
   Poel YHM, 2009, J PSYCHOSOM OBST GYN, V30, P65, DOI 10.1080/01674820802545990
   Rebelo F, 2010, ACTA OBSTET GYN SCAN, V89, P903, DOI 10.3109/00016349.2010.484044
   Reed S, 2004, J ATHL TRAINING, V39, P193
   Roy-Matton N, 2011, J OBSTET GYNAECOL CA, V33, P344, DOI 10.1016/S1701-2163(16)34852-6
   Rychik J, 2013, J PEDIATR-US, V162, P302, DOI 10.1016/j.jpeds.2012.07.023
   Saunders TA, 2006, J PSYCHOSOM OBST GYN, V27, P141, DOI 10.1080/01674820500420637
   Seyedfatemi N, 2007, BMC NURS, V6, DOI 10.1186/1472-6955-6-11
   Thompson ML, 2014, PAEDIATR PERINAT EP, V28, P287, DOI 10.1111/ppe.12128
   Vollebregt KC, 2008, BJOG-INT J OBSTET GY, V115, P607, DOI 10.1111/j.1471-0528.2008.01665.x
   Walsh JM, 2014, OBESITY, V22, P1594, DOI 10.1002/oby.20753
   Wangel AM, 2011, ACTA OBSTET GYN SCAN, V90, P238, DOI 10.1111/j.1600-0412.2010.01056.x
   Watson D, 1996, J PERS, V64, P737, DOI 10.1111/j.1467-6494.1996.tb00943.x
   Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23
   Xiong Xu, 2010, Am J Disaster Med, V5, P181
   Young BC, 2013, CURR DIABETES REP, V13, P12, DOI 10.1007/s11892-012-0338-8
   Zahran S, 2010, RISK ANAL, V30, P1590, DOI 10.1111/j.1539-6924.2010.01453.x
NR 67
TC 8
Z9 8
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0884-2175
EI 1552-6909
J9 JOGNN-J OBST GYN NEO
JI JOGNN
PD MAR-APR
PY 2015
VL 44
IS 2
BP 256
EP 267
DI 10.1111/1552-6909.12560
PG 12
WC Nursing; Obstetrics & Gynecology
SC Nursing; Obstetrics & Gynecology
GA CE9AN
UT WOS:000352135700014
PM 25712783
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Adal, E
   Onal, Z
   Ersen, A
   Yalcin, K
   Onal, H
   Aydin, A
AF Adal, Erdal
   Onal, Zerrin
   Ersen, Atilla
   Yalcin, Koray
   Onal, Hasan
   Aydin, Ahmet
TI Recognizing the Psychosocial Aspects of Type 1 Diabetes in Adolescents
SO JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY
LA English
DT Article
DE Type 1 diabetes; adolescent; depression; anxiety; social support
ID PERCEIVED SOCIAL SUPPORT; GLYCEMIC CONTROL; METABOLIC-CONTROL;
   DEPRESSIVE SYMPTOMS; FAMILY ENVIRONMENT; MENTAL-HEALTH; CHILDREN;
   YOUTHS; ADAPTATION; MELLITUS
AB Objective: Considering the ever increasing population of diabetic adolescents and the association of the disease with psychosocial problems throughout its course, depression and/or anxiety and social support from parents are issues of special concern in these patients. The study aimed to identify the depression and anxiety state of diabetic adolescents and its impact on the management of diabetes mellitus (DM).
   Methods: 295 adolescents with type 1 DM and their parents attended our study. Psychological distress was assessed using the Children's Depression Inventory and the State-Trait Anxiety Inventory (STAI I-II) for Children, Perceived Social Support from Family (PSS-Fa) scale, Beck Depression Inventory for adults, STAI I-II for adults and the Multidimensional Scale of Perceived Social Support (MSPSS). Records of glycemic measurements, insulin dosage and hemoglobin A1c levels were used as glycemic control parameters.
   Results: Depression rate was 12.9%. State (p<0.001) and trait anxiety (p<0.001) levels were high; PSS-Fa (p<0.001) and MSPSS (p<0.006) scores were low in the depressive patients. Positive correlations were noted between depression, PSS-Fa, STAI-I and STAI-II.
   Conclusion: Therapeutic strategies of DM should include co-existing psychiatric conditions throughout the course of the disease. In diabetic adolescents, PSS-Fa, STAI-I and STAI-II appear to be effective tools in the evaluation of depression.
C1 [Adal, Erdal] Medipol Univ Fac Med, Dept Pediat Endocrinol & Metab, Istanbul, Turkey.
   [Onal, Zerrin] Kanuni Sultan Suleyman Training & Res Hosp, Pediat Clin, Istanbul, Turkey.
   [Ersen, Atilla] Kasimpasa Mil Hosp, Pediat Clin, Istanbul, Turkey.
   [Yalcin, Koray] Okmeydani Educ & Res Hosp, Pediat Clin, Istanbul, Turkey.
   [Onal, Hasan] Kanuni Sultan Suleyman Training & Res Hosp, Clin Pediat Endocrionol & Metab, Istanbul, Turkey.
   [Aydin, Ahmet] Istanbul Univ Cerrahpasa Fac Med, Dept Pediat Metab Dis, Istanbul, Turkey.
RP Adal, E (reprint author), Medipol Univ Fac Med, Dept Pediat Endocrinol & Metab, Istanbul, Turkey.
EM erdaladal@yahoo.com
RI Ersen, Atilla/Q-2635-2015
OI Ersen, Atilla/0000-0002-2404-170X; onal, zerrin/0000-0002-7627-7423
CR Akre C, 2014, HEALTH EDUC RES, V29, P764, DOI 10.1093/her/cyu040
   ANDERSON BJ, 1981, DIABETES CARE, V4, P586, DOI 10.2337/diacare.4.6.586
   Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713
   BENNETT DS, 1994, J PEDIATR PSYCHOL, V19, P149, DOI 10.1093/jpepsy/19.2.149
   EKER D, 1995, TURK PSIKOL DERG, V10, P45
   ESKIN M, 1993, J CLIN PSYCHOL, V49, P515, DOI 10.1002/1097-4679(199307)49:4<515::AID-JCLP2270490408>3.0.CO;2-K
   Goldston DB, 1997, J AM ACAD CHILD PSY, V36, P1528, DOI 10.1016/S0890-8567(09)66561-8
   Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4
   HANSON CL, 1992, J PEDIATR PSYCHOL, V17, P555, DOI 10.1093/jpepsy/17.5.555
   Herzer M, 2010, J PEDIATR PSYCHOL, V35, P415, DOI 10.1093/jpepsy/jsp063
   Hilliard ME, 2011, DIABETES RES CLIN PR, V94, P39, DOI 10.1016/j.diabres.2011.05.027
   JACOBSON AM, 1994, PSYCHOSOM MED, V56, P401, DOI 10.1097/00006842-199409000-00004
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   KOKKONEN J, 1995, NORD J PSYCHIAT, V49, P175, DOI 10.3109/08039489509011903
   KOVACS M, 1995, AM J PSYCHIAT, V152, P523
   Kovacs M, 1997, DIABETES CARE, V20, P45, DOI 10.2337/diacare.20.1.45
   Kovacs M, 1996, DIABETES CARE, V19, P318, DOI 10.2337/diacare.19.4.318
   Kovacs M., 1992, CHILDRENS DEPRESSION
   McGrady ME, 2009, DIABETES CARE, V32, P804, DOI 10.2337/dc08-2111
   MILLERJOHNSON S, 1994, J CONSULT CLIN PSYCH, V62, P603, DOI 10.1037/0022-006X.62.3.603
   Mommersteeg PM, 2013, DIABETIC MED, V30, P208
   Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232
   Oner N, 1985, DURUMLUK SUREKLI KAY
   Oy B., 1991, TURK PSIKIYATR DERG, V2, P137
   Ozusta S, 1993, THESIS HACETTEPE U S
   Procidano M, 1983, AM J COMMUN PSYCHOL, V1, P23
   Sawyer MG, 2001, AUST NZ J PSYCHIAT, V35, P806, DOI 10.1046/j.1440-1614.2001.00964.x
   Spielberger CD, 1976, MONOGRAPH, P713
   Trief PM, 1998, DIABETES CARE, V21, P241, DOI 10.2337/diacare.21.2.241
   Whittemore Robin, 2002, Pediatr Diabetes, V3, P135, DOI 10.1034/j.1399-5448.2002.30303.x
   WYSOCKI T, 1993, J PEDIATR PSYCHOL, V18, P441, DOI 10.1093/jpepsy/18.4.441
   Yildirim I, 1997, EGITIM FAKULTESI DER, V13, P81
   Zimmet GD, 1998, J PERS ASSESS, V52, P30
NR 33
TC 7
Z9 7
U1 0
U2 14
PU GALENOS YAYINCILIK
PI FINDIKZADE
PA ERKAN MOR, MOLLA GURANI CAD 21-1, FINDIKZADE, ISTANBUL 34093, TURKEY
SN 1308-5727
EI 1308-5735
J9 J CLIN RES PEDIATR E
JI J. Clin Res. Pediatr. Endocrinol.
PD MAR
PY 2015
VL 7
IS 1
BP 57
EP 62
DI 10.4274/jcrpe.1745
PG 6
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA CD7WZ
UT WOS:000351307200009
PM 25800477
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Hansen, UM
   Jones, A
   Zander, M
   Willaing, I
AF Hansen, Ulla Moller
   Jones, Allan
   Zander, Mette
   Willaing, Ingrid
TI Denmark's comparative position regarding health status, healthcare
   provision, self-management and social support: Diabetes Attitudes,
   Wishes and Needs second study (DAWN2)
SO SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Diabetes; education; psychosocial health; social support; benchmark;
   health care
ID CROSS-NATIONAL BENCHMARKING; BARRIERS; PEOPLE
AB Aims: The aim of this study was to benchmark the Danish sample of the second Diabetes, Attitudes, Wishes and Needs (DAWN2) study with the global average in order to determine Denmark's comparative position for health status, healthcare provision, self-management and social support from the perspective of people with diabetes, family members of people with diabetes and healthcare professionals. Methods: A total of 502 Danish people with diabetes (PWD), 122 adult family members of people with diabetes (FM) and 283 healthcare professionals (HCPs) participated in the study. Data on healthcare provision and physical and psychosocial wellbeing were collected from the 17 participating countries. Results: Psychological wellbeing was higher among Danish PWD; conversely, self-management behaviour of PWD ranked below the global average. A substantial gap was found in the perceptions of PWD and HCPs regarding the extent to which healthcare provision was deemed person-centred. The gap was found to be larger, however, when looking at the global data. Danish FM reported higher education participation and satisfaction rates as well as lower distress than the global average, but there appears to be an untapped potential when it comes to converting education participation of FM into social support for PWD. Conclusions: Our findings suggest that PWD in Denmark rank above the global average on measures of psychological wellbeing, despite psychological wellbeing being under-prioritised by HCP. However, there is room for improvement when it comes to self-management behaviours. Special attention is needed to address this issue without compromising the psychological wellbeing of the PWD.
C1 [Hansen, Ulla Moller; Willaing, Ingrid] Steno Diabet Ctr, Hlth Promot Res, Gentofte, Denmark.
   [Jones, Allan] Univ Southern Denmark, Inst Psychol, Odense, Denmark.
   [Zander, Mette] Bispebjerg Hosp, DK-2400 Copenhagen, Denmark.
RP Hansen, UM (reprint author), Steno Diabet Ctr AS, Hlth Promot Res, Niels Steensens Vej 8, DK-2820 Gentofte, Denmark.
EM uamh@steno.dk
OI Willaing, Ingrid/0000-0002-3082-8816; Hansen, Ulla
   Moller/0000-0001-8416-9783
FU Novo Nordisk A/S; Novo Foundation
FX The DAWN2 study is funded by Novo Nordisk A/S. Steno Diabetes Centre
   receives part of its core funding from unrestricted grants from the Novo
   Foundation and Novo Nordisk A/S.
CR American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011
   Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239
   Funnell MM, 2006, CLIN DIABETES, V24, P154
   Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242
   Holt RI, 2013, INDIAN J ENDOCRIN S1, V17, pS95
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
NR 9
TC 1
Z9 1
U1 0
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1403-4948
EI 1651-1905
J9 SCAND J PUBLIC HEALT
JI Scand. J. Public Health
PD MAR
PY 2015
VL 43
IS 2
BP 111
EP 116
DI 10.1177/1403494814563372
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CD9SR
UT WOS:000351439100001
PM 25512098
DA 2019-01-08
ER

PT J
AU Gilbert, LK
   Breiding, MJ
   Merrick, MT
   Thompson, WW
   Ford, DC
   Dhingra, SS
   Parks, SE
AF Gilbert, Leah K.
   Breiding, Matthew J.
   Merrick, Melissa T.
   Thompson, William W.
   Ford, Derek C.
   Dhingra, Satvinder S.
   Parks, Sharyn E.
TI Childhood Adversity and Adult Chronic Disease An Update from Ten States
   and the District of Columbia, 2010
SO AMERICAN JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Article
ID EXPERIENCES; MORTALITY; HEALTH
AB Background: Adverse childhood experiences (ACEs), including child abuse and family dysfunction, are linked to leading causes of adult morbidity and mortality. Most prior ACE studies were based on a nonrepresentative patient sample from one Southern California HMO.
   Purpose: To determine if ACE exposure increases the risk of chronic disease and disability using a larger, more representative sample of adults than prior studies.
   Methods: Ten states and the District of Columbia included an optional ACE module in the 2010 Behavioral Risk Factor Surveillance Survey, a national cross-sectional, random-digit-dial telephone survey of adults. Analysis was conducted in November 2012. Respondents were asked about nine ACEs, including physical, sexual, and emotional abuse and household member mental illness, alcoholism, drug abuse, imprisonment, divorce, and intimate partner violence. An ACE score was calculated for each subject by summing the endorsed ACE items. After controlling for sociodemographic variables, weighted AORs were calculated for self-reported health conditions given exposure to zero, one to three, four to six, or seven to nine ACEs.
   Results: Compared to those who reported no ACE exposure, the adjusted odds of reporting myocardial infarction, asthma, fair/poor health, frequent mental distress, and disability were higher for those reporting one to three, four to six, or seven to nine ACEs. Odds of reporting coronary heart disease and stroke were higher for those who reported four to six and seven to nine ACEs; odds of diabetes were higher for those reporting one to three and four to six ACEs.
   Conclusions: These findings underscore the importance of child maltreatment prevention as a means to mitigate adult morbidity and mortality. Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine
C1 [Gilbert, Leah K.; Merrick, Melissa T.; Ford, Derek C.] CDC, Natl Ctr Injury Prevent & Control, Div Violence Prevent, Atlanta, GA 30341 USA.
   [Breiding, Matthew J.] CDC, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30341 USA.
   [Thompson, William W.] CDC, Natl Ctr Birth Defects & Dev Disabil, Div Birth Defects & Dev Disabil, Atlanta, GA 30341 USA.
   [Dhingra, Satvinder S.] CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Populat Hlth, Atlanta, GA 30341 USA.
   [Parks, Sharyn E.] CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA 30341 USA.
RP Gilbert, LK (reprint author), CDC, Natl Ctr Injury Prevent & Control, Div Violence Prevent, 4770 Buford Highway,NE,MS F-64, Atlanta, GA 30341 USA.
EM LGilbert@cdc.gov
CR Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021
   Center on the Developing Child at Harvard University, 2012, WORKING PAPER
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8
   Finkelhor D, 2013, JAMA PEDIATR, V167, P70, DOI 10.1001/jamapediatrics.2013.420
   Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9
   McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109
   Rogosch FA, 2011, DEV PSYCHOPATHOL, V23, P1107, DOI 10.1017/S0954579411000587
   Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754
   Sterling PaE J, 1988, HDB LIFE STRESS COGN
NR 9
TC 82
Z9 84
U1 5
U2 42
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0749-3797
EI 1873-2607
J9 AM J PREV MED
JI Am. J. Prev. Med.
PD MAR
PY 2015
VL 48
IS 3
BP 345
EP 349
DI 10.1016/j.amepre.2014.09.006
PG 5
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA CB6LZ
UT WOS:000349739800013
PM 25300735
HC Y
HP N
DA 2019-01-08
ER

PT J
AU Steel, A
   Lucke, J
   Adams, J
AF Steel, Amie
   Lucke, Jayne
   Adams, Jon
TI The prevalence and nature of the use of preconception services by women
   with chronic health conditions: an integrative review
SO BMC WOMENS HEALTH
LA English
DT Article
DE Preconception care; Chronic disease; Women's health services
ID NEURAL-TUBE DEFECTS; FOLIC-ACID; ALTERNATIVE MEDICINE; PREGNANCY
   OUTCOMES; DIABETES-MELLITUS; BIRTH-DEFECTS; PRETERM BIRTH; PRIMARY-CARE;
   RISK; IMPACT
AB Background: There is growing evidence that preconception care may have an important role in preventing short and long term adverse health consequences for women and their offspring. This is particularly the case for women with chronic health conditions due to the rising prevalence of chronic disease in global populations. With this in mind, this paper presents an integrative systematic review of contemporary research outlining the use of preconception services and practices by women with chronic health conditions.
   Methods: A search was conducted through PubMed, CINAHL, AMED, and Maternity and Infant Care databases which identified 672 papers examining preconception care and preconception services for women with chronic health conditions. Fourteen papers which were written in English, presented original research, and reported on the prevalence or nature of use of preconception care by women with chronic health conditions were included in the review. Critical appraisal of study quality and thematic categorical grouping of identified papers was undertaken.
   Results: Current research evidence, as identified through this review, examines three major topic areas: the prevalence of preconception care practices, use of services and characteristics of users; knowledge of the value and impact of preconception care and availability of preconception services for women with chronic health conditions; and women's attitudes, approaches and experiences of preconception care and preconception services. Prevalence estimates of engagement with preconception care range between 18.1% and 45%, with most studies focusing on women with type 1 or 2 diabetes. Significant gaps in women's knowledge of preconception care for women with chronic health conditions were also identified. Women with chronic health conditions reported experiencing emotional distress as a result of their engagement with preconception care services. They also commonly described feeling a need to employ discipline to comply with preconception care programs, and experiencing a fear of pregnancy complications.
   Conclusion: Future research requires a broad and sophisticated approach to research design and analysis, improved consideration of temporal changes to women's health behaviour, representative samples to more effectively inform health policy, and a deeper understanding of women's motivations, attitudes and perceptions of preconception care to assist in the development of tailored preconception health services.
C1 [Steel, Amie] Endeavour Coll Nat Hlth, Off Res, Brisbane, Qld, Australia.
   [Steel, Amie; Adams, Jon] Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Ultimo, NSW, Australia.
   [Lucke, Jayne] La Trobe Univ, Fac Hlth Sci, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia.
   [Lucke, Jayne] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.
RP Steel, A (reprint author), Endeavour Coll Nat Hlth, Off Res, Brisbane, Qld, Australia.
EM amie.steel@uts.edu.au
RI Lucke, Jayne/A-5538-2008
OI Lucke, Jayne/0000-0002-2885-5292; Adams, Jon/0000-0002-9901-5717
CR Adams J, 2013, HEADACHE, V53, P459, DOI 10.1111/j.1526-4610.2012.02271.x
   Ahluwalia Indu B., 2001, Morbidity and Mortality Weekly Report, V50, P3
   Anderson JE, 2006, MATERN CHILD HLTH J, V10, pS101, DOI 10.1007/s10995-006-0093-z
   [Anonymous], 2005, ACOG COMM OP
   Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001
   Bombard JM, 2012, MATERN CHILD HLTH J, V16, P60, DOI 10.1007/s10995-010-0717-1
   Boyles AL, 2011, HUM REPROD, V26, P2232, DOI 10.1093/humrep/der144
   Brunet C, 2005, DIABETES METAB, V31, P443
   Canti V, 2012, AUTOIMMUNITY, V45, P169, DOI 10.3109/08916934.2011.593600
   Case AP, 2007, JOGNN-J OBST GYN NEO, V36, P335, DOI 10.1111/J.1552-6909.2007.00163.x
   Chow S.-C., 2008, SAMPLE SIZE CALCULAT, V20
   Christiansen C, 2012, M DEV GLOB CONS PREC
   Chuang CH, 2010, MATERN CHILD HLTH J, V14, P713, DOI 10.1007/s10995-009-0518-6
   Creswell J. W., 2011, DESIGNING CONDUCTING
   Davern M., 2013, ENCY SURVEY RES METH, P721, DOI [10.4135/9781412963947.n469, DOI 10.4135/9781412963947.N469]
   Dean SV, 2013, SYSTEMATIC REV PRECO
   Diggle P., 2013, ANAL LONGITUDINAL DA
   Dunlop AL, 2013, AM J HEALTH PROMOT, V27, pS50, DOI 10.4278/ajhp.120116-QUAN-39
   Dunlop AL, 2013, AM J HEALTH PROMOT, V27, pS58, DOI 10.4278/ajhp.120109-QUAL-7
   Ehrenthal DB, 2013, OBSTET GYNECOL, V121, P115, DOI [10.1097/AOG.0b013e318278f56a, http://10.1097/AOG.0b013e318278f56a]
   Farrell-Carnahan L, 2013, TELEMED E-HEALTH, V19, P597, DOI 10.1089/tmj.2012.0247
   Fischl AFR, 2010, DIABETES CARE, V33, P701, DOI 10.2337/dc09-1821
   Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0
   Goldenberg RL, 2003, AM J OBSTET GYNECOL, V189, P861, DOI 10.1067/S0002-9378(03)00470-8
   Griffiths F, 2008, BRIT J GEN PRACT, V58, P184, DOI 10.3399/bjgp08X277294
   Harville EW, 2011, EPIDEMIOLOGY, V22, P724, DOI 10.1097/EDE.0b013e318225c960
   Heavey E, 2010, MCN-AM J MATERN-CHIL, V35, P213, DOI 10.1097/NMC.0b013e3181dd9d5a
   Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250
   JANZ NK, 1995, DIABETES CARE, V18, P157, DOI 10.2337/diacare.18.2.157
   Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Kain Juliana, 2003, Cad. Saúde Pública, V19, pS77, DOI 10.1590/S0102-311X2003000700009
   Kallas-Koeman M, 2012, CAN J DIABETES, V36, P170, DOI 10.1016/j.jcjd.2012.07.003
   Khan I, 2013, ENDOCR PRACT, V19, P656, DOI 10.4158/EP12421.OR
   Khodr ZG, 2014, BIRTH DEFECTS RES A, V100, P472, DOI 10.1002/bdra.23238
   Kim C, 2005, AM J OBSTET GYNECOL, V192, P227, DOI 10.1016/j.ajog.2004.06.105
   Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621
   Kind KL, 2006, REPROD BIOMED ONLINE, V12, P532, DOI 10.1016/S1472-6483(10)61178-9
   King R, 2009, MIDWIFERY, V25, P126, DOI 10.1016/j.midw.2007.01.016
   Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S5
   Lateef A, 2012, NAT REV RHEUMATOL, V8, P710, DOI 10.1038/nrrheum.2012.133
   Lavender T, 2010, MIDWIFERY, V26, P589, DOI 10.1016/j.midw.2009.01.003
   Le Clair C, 2009, CAN J PHYSIOL PHARM, V87, P161, DOI [10.1139/Y09-006, 10.1139/y09-006]
   Lowe SA, 2009, AUST NZ J OBSTET GYN, V49, P242, DOI 10.1111/j.1479-828X.2009.01003.x
   Lui CW, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/659419
   Mahmud M, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-5
   Marshall C., 2011, DESIGNING QUALITATIV
   McCorry NK, 2012, J MIDWIFERY WOM HEAL, V57, P396, DOI 10.1111/j.1542-2011.2011.00143.x
   McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428
   McQuillan J, 2011, MATERN CHILD HLTH J, V15, P178, DOI 10.1007/s10995-010-0604-9
   Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022
   Metcalfe A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-58
   Miligi L, 2013, OCCUP ENVIRON MED, V70, P648, DOI 10.1136/oemed-2012-100951
   Mittal Pooja, 2014, Perm J, V18, P28, DOI 10.7812/TPP/13-146
   Mortagy I, 2010, BRIT J GEN PRACT, V60, P815, DOI 10.3399/bjgp10X532594
   Murphy HR, 2010, DIABETIC MED, V27, P92, DOI 10.1111/j.1464-5491.2009.02890.x
   Nielsen A, 2006, ACTA OBSTET GYN SCAN, V85, P1057, DOI 10.1080/00016340600589560
   Oostdam N, 2011, J WOMENS HEALTH, V20, P1551, DOI 10.1089/jwh.2010.2703
   Phillips GS, 2010, ANN EPIDEMIOL, V20, P8, DOI 10.1016/j.annepidem.2009.09.009
   Posner SF, 2006, MATERN CHILD HLTH J, V10, pS197, DOI 10.1007/s10995-006-0107-x
   Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272
   Rahman A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001442
   Rayner JA, 2011, J ALTERN COMPLEM MED, V17, P685, DOI 10.1089/acm.2010.0435
   Sapiano K, 2012, GYNECOL ENDOCRINOL, V28, P1006, DOI 10.3109/09513590.2012.705370
   Shannon GD, 2013, BJOG-INT J OBSTET GY, V120, P555, DOI 10.1111/1471-0528.12116
   Signore LB, 2010, LANCET, V376, P624, DOI 10.1016/S0140-6736(10)60752-0
   Steel A, 2014, HLTH SOCIAL CARE COM, DOI 10.1111/hsc.12112
   Strutz KL, 2012, J ADOLESCENT HEALTH, V51, P629, DOI 10.1016/j.jadohealth.2012.03.013
   Temel S, 2014, EPIDEMIOL REV, V36, P19, DOI 10.1093/epirev/mxt003
   Tieu J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007776.pub2
   Tripathi A, 2010, DIABETES CARE, V33, P586, DOI 10.2337/dc09-1585
   van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024
   Wahabi HA, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-63
   Wang GY, 2013, J ADOLESCENT HEALTH, V52, pS14, DOI 10.1016/j.jadohealth.2012.04.019
   Wilson R Douglas, 2003, J Obstet Gynaecol Can, V25, P959
   Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616
   Yi YN, 2011, EUR J PEDIATR, V170, P1391, DOI 10.1007/s00431-011-1492-8
   Zhu HD, 2012, AUST NZ J OBSTET GYN, V52, P593, DOI 10.1111/ajo.12010
NR 77
TC 16
Z9 16
U1 0
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6874
J9 BMC WOMENS HEALTH
JI BMC Womens Health
PD FEB 18
PY 2015
VL 15
AR 14
DI 10.1186/s12905-015-0165-6
PG 12
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology
GA CD0WY
UT WOS:000350796000004
PM 25783639
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU LaVance, MS
   Fairchild, R
   Rosado, RJ
AF LaVance, Melisa S.
   Fairchild, Roseanne
   Rosado, Ricardo J.
TI Turning the Table: Depression Screening as the 6th Vital Sign
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Article
DE behavior modification; depression; diabetes; exercise; nutrition;
   obesity; survey
ID WEIGHT-LOSS; SELF-MANAGEMENT; ADULTS; INTERVENTIONS; OVERWEIGHT;
   DISTRESS; SUPPORT; OBESITY; DIET
AB Overweight and obesity, which lead to the development of type 2 diabetes, are serious health problems that nurse practitioners encounter in their practices. This pilot study uses a lifestyle survey instrument that determines patients' knowledge and perceptions of diet and exercise as healthy lifestyle behaviors in relation to their body mass index scores and diabetes status and addresses coping and support issues leading to a recommendation for depression screening as the 6th vital sign. These results lead to individualized diabetes education for prediabetic and type 2 diabetic patients.
C1 [Fairchild, Roseanne] Indiana State Univ, Terre Haute, IN 47809 USA.
EM mlavance@sycamores.indstate.edu
CR Adler RN, 2013, J FAM PRACTICE, V62, P542
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Barte JCM, 2010, OBES REV, V11, P899, DOI 10.1111/j.1467-789X.2010.00740.x
   Burns N, 2009, PRACTICE NURSING RES
   Centers for Disease Control and Prevention, VIT LINK CHRON DIS D
   Centers for Disease Control and Prevention, GROUPS ESP AFF
   Daly EJ, 2007, INT J PSYCHIAT CLIN, V11, P268, DOI 10.1080/13651500701245981
   Delahanty LM, 2010, J HUM NUTR DIET, V23, P360, DOI 10.1111/j.1365-277X.2010.01065.x
   Karlsen B, 2014, INT J NURS STUD, V51, P438, DOI 10.1016/j.ijnurstu.2013.06.016
   King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746
   Klausch T, 2013, SOCIOL METHOD RES, V42, P227, DOI 10.1177/0049124113500480
   Korkiakangas EE, 2010, SCAND J CARING SCI, V25, P62
   LaVance MS, 2013, EVIDENCE BASED PRACT
   LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006
   Lynch EB, 2012, HEALTH EDUC RES, V27, P814, DOI 10.1093/her/cys058
   National Institute of Diabetes and Digestive and Kidney Diseases, INS RES PRED
   Robert Wood Johnson Foundation, LIFEST SURV
   Soderlund A, 2009, PERSPECT PUBLIC HEAL, V129, P132, DOI 10.1177/1757913908094805
   Stun J, 2010, PRIM HEALTH CARE RES, V11, P374, DOI DOI 10.1017/S1463423610000101
   Unick JL, 2010, MED SCI SPORT EXER, V42, P745, DOI 10.1249/MSS.0b013e3181bd1a57
   United States Preventive Services Task Force, SCREEN MAN OB ADULTS
   Williamson DA, 2010, J BEHAV MED, V33, P305, DOI 10.1007/s10865-010-9253-0
   Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x
NR 23
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD FEB
PY 2015
VL 11
IS 2
BP 199
EP 206
DI 10.1016/j.nurpra.2014.10.026
PG 8
WC Nursing
SC Nursing
GA CC7IA
UT WOS:000350539700015
DA 2019-01-08
ER

PT J
AU Kiecolt-Glaser, JK
   Jaremka, L
   Andridge, R
   Peng, J
   Habash, D
   Fagundes, CP
   Glaser, R
   Matarkey, WB
   Belury, MA
AF Kiecolt-Glaser, Janice K.
   Jaremka, Lisa
   Andridge, Rebecca
   Peng, Juan
   Habash, Diane
   Fagundes, Christopher P.
   Glaser, Ronald
   Matarkey, William B.
   Belury, Martha A.
TI Marital discord, past depression, and metabolic responses to high-fat
   meals: Interpersonal pathways to obesity
SO PSYCHONEUROENDOCRINOLOGY
LA English
DT Article
DE Marriage; Depression; Resting energy expenditure; Triglycerides;
   Insulin; Inflammation
ID BODY-WEIGHT REGULATION; NECROSIS-FACTOR-ALPHA; MIDDLE-AGED WOMEN;
   NONFASTING TRIGLYCERIDES; CHRONIC STRESS; POSTPRANDIAL LIPEMIA; INDIRECT
   CALORIMETRY; CARDIOVASCULAR RISK; ENERGY-EXPENDITURE; HEART-DISEASE
AB Background: Longitudinal studies have implicated both marital distress and depression in the development of the metabolic syndrome, a risk factor for diabetes and cardiovascular disease. This study addressed the impact of hostile marital interactions and a mood disorder history on obesity-related metabolic responses to high-fat meals.
   Methods: This double-blind, randomized crossover study included serial assessments of resting energy expenditure (REE), fat and carbohydrate oxidation, triglycerides, insulin, glucose, interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF-alpha) before and after two high-fat meals. During two separate 9.5 h visits, 43 healthy married couples, ages 24-61 (mean = 38.22), received either a high saturated fat meal or a high oleic sunflower oil meal, both 930 kcal and 60 g fat. The Structured Diagnostic Interview for DSM-IV assessed mood disorder history. Couples discussed a marital disagreement during both visits; behavioral coding of these interactions provided data on hostile marital behaviors.
   Results: Men and women who displayed more hostile behaviors and who also had a mood disorder history had significantly lower post-meal REE, higher insulin, and higher peak triglyceride responses than other participants, with nonsignificant effects for fat and carbohydrate oxidation. Participants with a mood disorder history had a steeper rise in postprandial IL-6 and glucose than those without a past history. Higher levels of hostile behaviors were associated with higher post-meal TNF-alpha. The two meals did not differ on any outcome assessed.
   Conclusions: People spend about 18 of every 24 h in a postprandial state, and dining with one's partner is a common daily event. Among subjects with a mood disorder history, the cumulative 6.75-h difference between high and low hostile behaviors translates into 128 kcal, a difference that could add 7.6 pounds/year. Our findings illustrate novel pathways through which chronic marital stress and a mood disorder history synergistically heighten the risk for obesity, metabolic syndrome, and cardiovascular disease. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Kiecolt-Glaser, Janice K.; Glaser, Ronald; Matarkey, William B.] Ohio State Univ, Coll Med, Inst Behav Med Res, Columbus, OH 43210 USA.
   [Kiecolt-Glaser, Janice K.; Matarkey, William B.] Ohio State Univ, Med Ctr, Dept Psychiat, Columbus, OH 43210 USA.
   [Jaremka, Lisa] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.
   [Andridge, Rebecca; Peng, Juan] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA.
   [Habash, Diane] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA.
   [Fagundes, Christopher P.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA.
   [Matarkey, William B.] Ohio State Univ, Med Ctr, Dept Med, Columbus, OH 43210 USA.
   [Belury, Martha A.] Ohio State Univ, Coll Educ & Human Ecol, Dept Human Sci, Columbus, OH 43210 USA.
RP Kiecolt-Glaser, JK (reprint author), Ohio State Univ, Coll Med, Inst Behav Med Res, 460 Med Ctr Dr, Columbus, OH 43210 USA.
EM Janice.Kiecolt-Glaser@osumc.edu
FU National Institute of Health (NIH) [CA158868, CA172296, UL1RR025755,
   CA016058]; American Cancer Society [121911-PF-12-040-01-CPPB]
FX The study was supported in part by National Institute of Health (NIH)
   Grants CA158868, CA172296, UL1RR025755, and CA016058, as well as
   American Cancer Society Post-doctoral Fellowship Grant
   121911-PF-12-040-01-CPPB. The sponsors had no role in the design and
   conduct of the study; collection, management, analysis, and
   interpretation of the data; and preparation, review, or approval of the
   manuscript.
CR Ajuwon KM, 2005, J NUTR, V135, P1841
   Allman-Farinelli MA, 2005, J AM DIET ASSOC, V105, P1071, DOI 10.1016/j.jada.2005.04.008
   Aschbacher K, 2014, PSYCHONEUROENDOCRINO, V46, P14, DOI 10.1016/j.psyneuen.2014.04.003
   Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309
   Beach S. R. H., 2014, INTERPERSONAL RELATI, P133, DOI 10.1093/acprof:oso/9780199936632.003.0007
   Bergouignan A, 2009, PROG LIPID RES, V48, P128, DOI 10.1016/j.plipres.2009.02.004
   Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598
   Boquist S, 1999, CIRCULATION, V100, P723, DOI 10.1161/01.CIR.100.7.723
   Dai J, 2008, CIRCULATION, V117, P169, DOI 10.1161/CIRCULATIONAHA.107.710699
   Dallman M. F, 2010, TRENDS ENDOCRIN MET, V21, P159
   First M. B., 1996, USERS GUIDE STRUCTUR
   Flatt JP, 2012, CRIT REV CL LAB SCI, V49, P150, DOI 10.3109/10408363.2012.712904
   Freiberg J, 2009, JAMA-J AM MED ASSOC, V301, P1339
   Funk JL, 2007, J FAM PSYCHOL, V21, P572, DOI 10.1037/0893-3200.21.4.572
   Gallo LC, 2003, PSYCHOSOM MED, V65, P952, DOI 10.1097/01.PSY.0000097350.95305.FE
   Gudmundsson A, 1997, CLIN CHEM, V43, P2199
   Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350
   HAMMEN C, 1991, J ABNORM PSYCHOL, V100, P555, DOI 10.1037/0021-843X.100.4.555
   Herieka M, 2014, MOL NUTR FOOD RES, V58, P136, DOI 10.1002/mnfr.201300104
   Herr NR, 2007, J FAM PSYCHOL, V21, P694, DOI 10.1037/0893-3200.21.4.694
   Heyman R. E, 2004, COUPLE OBSERVATIONAL, P67
   HOLLEY JW, 1964, EDUC PSYCHOL MEAS, V24, P749, DOI 10.1177/001316446402400402
   Husky MM, 2009, COGNITIVE THER RES, V33, P264, DOI 10.1007/s10608-008-9212-z
   Jackson KG, 2012, ATHEROSCLEROSIS, V220, P22, DOI 10.1016/j.atherosclerosis.2011.08.012
   Jones DJ, 2003, ARCH GEN PSYCHIAT, V60, P153, DOI 10.1001/archpsyc.60.2.153
   Joseph NT, 2014, PSYCHOSOM MED, V76, P347, DOI 10.1097/PSY.0000000000000071
   Kennedy AP, 2009, OBESITY, V17, P2094, DOI 10.1038/oby.2009.101
   Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558
   Kiecolt-Glaser J. K., 2014, BIOL PSYCHIAT
   Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011
   Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377
   Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472
   Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100
   Knox D, 1971, MARRIAGE HAPPINESS
   Lairon D, 2007, EUR J CLIN NUTR, V61, P1145, DOI 10.1038/sj.ejcn.1602749
   Lara J., 2010, Clinical obesity in adults and children, P151
   Laugero KD, 2008, ENDOCRINOLOGY, V149, P2712, DOI 10.1210/en.2008-0328
   Lindman AS, 2010, EUR J EPIDEMIOL, V25, P789, DOI 10.1007/s10654-010-9501-1
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   Madec S, 2011, BRIT J NUTR, V106, P364, DOI 10.1017/S0007114511000286
   Manning P.J., 2008, OBESITY, V16, P2046
   Margolin G, 1996, J FAM PSYCHOL, V10, P304, DOI 10.1037/0893-3200.10.3.304
   Milaneschi Y, 2011, MOL PSYCHIATR, V16, P589, DOI 10.1038/mp.2010.113
   Moles A, 2006, PSYCHONEUROENDOCRINO, V31, P623, DOI 10.1016/j.psyneuen.2006.01.004
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2
   NELSON KM, 1992, AM J CLIN NUTR, V56, P848
   Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299
   Orth-Gomer K, 2000, JAMA-J AM MED ASSOC, V284, P3008, DOI 10.1001/jama.284.23.3008
   Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055
   Panel on Macronutrients Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2002, DIET REF INT EN CARB
   Pastromas S, 2008, INT J CARDIOL, V126, P3, DOI 10.1016/j.ijcard.2007.04.172
   Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524
   Poppitt SD, 2008, NUTRITION, V24, P322, DOI 10.1016/j.nut.2007.12.012
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Raikkonen K, 2007, DIABETES CARE, V30, P872, DOI 10.2337/dc06-1857
   Reeves MM, 2004, J APPL PHYSIOL, V97, P130, DOI 10.1152/japplphysiol.01212.2003
   Rehman US, 2008, CLIN PSYCHOL REV, V28, P179, DOI 10.1016/j.cpr.2007.04.007
   Ridker PM, 2008, CLIN CHEM, V54, P11, DOI 10.1373/clinchem.2007.097907
   Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859
   Shively CA, 2009, OBESITY, V17, P1513, DOI 10.1038/oby.2009.74
   SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399
   Stoney CM, 2002, PSYCHOPHYSIOLOGY, V39, P80, DOI 10.1017/S0048577201020133
   Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13
   Teno S, 2000, DIABETES CARE, V23, P1401, DOI 10.2337/diacare.23.9.1401
   Tomiyama AJ, 2011, PSYCHONEUROENDOCRINO, V36, P1513, DOI 10.1016/j.psyneuen.2011.04.005
   Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022
   Uchino BN, 2013, HEALTH PSYCHOL, V32, P1067, DOI 10.1037/a0033515
   Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562
   Vogelzangs N, 2008, ARCH GEN PSYCHIAT, V65, P1386, DOI 10.1001/archpsyc.65.12.1386
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1
   WEISSMAN MM, 1987, AM J PUBLIC HEALTH, V77, P445, DOI 10.2105/AJPH.77.4.445
   Whisman MA, 2014, HEALTH PSYCHOL, V33, P832, DOI 10.1037/hea0000064
   Whisman MA, 2012, HEALTH PSYCHOL, V31, P80, DOI 10.1037/a0025671
   Whisman MA, 2010, J FAM PSYCHOL, V24, P367, DOI 10.1037/a0019547
   Xu S., 2014, J CONSULT CLIN PSYCH
NR 77
TC 18
Z9 18
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4530
J9 PSYCHONEUROENDOCRINO
JI Psychoneuroendocrinology
PD FEB
PY 2015
VL 52
BP 239
EP 250
DI 10.1016/j.psyneuen.2014.11.018
PG 12
WC Endocrinology & Metabolism; Neurosciences; Psychiatry
SC Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry
GA CA9UT
UT WOS:000349271000022
PM 25506778
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Ducat, L
   Rubenstein, A
   Philipson, LH
   Anderson, BJ
AF Ducat, Lee
   Rubenstein, Arthur
   Philipson, Louis H.
   Anderson, Barbara J.
TI A Review of the Mental Health Issues of Diabetes Conference
SO DIABETES CARE
LA English
DT Review
ID POOR GLYCEMIC CONTROL; EMOTIONAL DISTRESS; YOUNG-ADULTS; DEPRESSION;
   CARE; CHILDREN; HYPOGLYCEMIA; ADOLESCENTS; PREVALENCE; TRIAL
AB Individuals with type 1 diabetes are at increased risk for depression, anxiety disorder, and eating disorder diagnoses. People with type 1 diabetes are also at risk for subclinical levels of diabetes distress and anxiety. These mental/behavioral health comorbidities of diabetes are associated with poor adherence to treatment and poor glycemic control, thus increasing the risk for serious short- and long-term physical complications, which can result in blindness, amputations, stroke, cognitive decline, decreased quality of life, as well as premature death. When mental health comorbidities of diabetes are not diagnosed and treated, the financial cost to society and health care systems is catastrophic, and the human suffering that results is profound. This review summarizes state-of-the-art presentations and working group scholarly reports from the Mental Health Issues of Diabetes Conference (7-8 October 2013, Philadelphia, PA), which included stakeholders from the National Institutes of Health, people living with type 1 diabetes and their families, diabetes consumer advocacy groups, the insurance industry, as well as psychologists, psychiatrists, endocrinologists, and nurse practitioners who are all nationally and internationally recognized experts in type 1 diabetes research and care. At this landmark conference current evidence for the incidence and the consequences of mental health problems in type 1 diabetes was presented, supporting the integration of mental health screening and mental health care into routine diabetes medical care. Future research directions were recommended to establish the efficacy and cost-effectiveness of paradigms of diabetes care in which physical and mental health care are both priorities.
C1 [Ducat, Lee] Mental Hlth Issues Diabet Fdn, Philadelphia, PA USA.
   [Rubenstein, Arthur] Univ Penn, Div Endocrinol Diabet & Metab, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Philipson, Louis H.] Univ Chicago, Kovler Diabet Ctr, Chicago, IL 60637 USA.
   [Anderson, Barbara J.] Baylor Coll Med, Dept Pediat, Psychol Sect, Houston, TX 77030 USA.
RP Anderson, BJ (reprint author), Baylor Coll Med, Dept Pediat, Psychol Sect, Houston, TX 77030 USA.
EM bja@bcm.edu
FU Universal Health Services, Inc.; JDRF; University of Chicago Diabetes
   Research and Training Center [P30-DK-020595, 1U01-DK-103153-01];
   National Institute of Diabetes and Digestive and Kidney Diseases
   [R01-DK-095373]
FX The Mental Health Issues of Diabetes: A National Conference (7-8 October
   2013, Philadelphia, PA) was supported primarily by Universal Health
   Services, Inc., and cosponsored by the JDRF. L.H.P. was partly funded by
   the University of Chicago Diabetes Research and Training Center
   (P30-DK-020595 and 1U01-DK-103153-01). B.J.A. was funded in part by a
   grant (R01-DK-095373) from the National Institute of Diabetes and
   Digestive and Kidney Diseases.
CR American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   Anderson BJ, 2014, THERAPY DIABETES MEL, P134
   Anderson BJ, 2013, TYPE 1 DIABETES SOUR, P153
   Anderson BJ, 2007, JOSLINS DIABETES DES, P641
   Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Cameron FJ, 2007, DIABETES CARE, V30, P2716, DOI 10.2337/dc07-0603
   de Groot M, 2014, PSYCHOSOCIAL CARE PE, P1
   de Groot M, 2011, CURR DIABETES REP, V11, P503, DOI 10.1007/s11892-011-0231-x
   Delamater AM, 2009, PEDIATR DIABETES, V10, P175, DOI 10.1111/j.1399-5448.2009.00580.x
   Dittmann M, 2005, MONITOR, V36, P35
   Ducat L, 2014, JAMA-J AM MED ASSOC, V312, P691, DOI 10.1001/jama.2014.8040
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P2746, DOI 10.2337/dc07-1166
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Garfield SA, 2003, DIABETES CARE, V26, P2670, DOI 10.2337/diacare.26.9.2670
   Goebel-Fabbri A.E., 2013, TYPE 1 DIABETES SOUR, P180
   Goebel-Fabbri AE, 2008, DIABETES CARE, V31, P415, DOI 10.2337/dc07-2026
   Gonder-Frederick L, 2012, PSYCHOSOCIAL CARE PE, P33
   Gonder-Frederick Linda, 2011, Diabetes Manag (Lond), V1, P627
   Gonder-Frederick LA, 2009, DIABETES CARE, V32, P1001, DOI 10.2337/dc08-1722
   Gonzales J. S., 2013, TYPE 1 DIABETES SOUR, P169
   Haugstvedt A, 2010, DIABETIC MED, V27, P72, DOI 10.1111/j.1464-5491.2009.02867.x
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Holmes CS, 2012, PSYCHOSOCIAL CARE PE, P57
   Jacobson AM, 2011, DIABETOLOGIA, V54, P245, DOI 10.1007/s00125-010-1883-9
   Keynote Rodgers G., 2013, MENT HLTH ISS DIAB N
   Lawrence JM, 2006, PEDIATRICS, V117, P1348, DOI 10.1542/peds.2005-1398
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   MATARAZZO JD, 1980, AM PSYCHOL, V35, P807, DOI 10.1037/0003-066X.35.9.807
   Munshi MN, 2011, ARCH INTERN MED, V171, P362, DOI 10.1001/archinternmed.2010.539
   Munshi MN, 2013, TYPE 1 DIABETES SOUR, P585
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Schwartz DD, 2011, DIABETES CARE, V34, P326, DOI 10.2337/dc10-1553
   Seaquist ER, 2013, TYPE 1 DIABETES SOUR, P341
   Trief PM, 2014, DIABETES CARE, V37, P1563, DOI 10.2337/dc13-1867
   Trief PM, 2013, DIABETES CARE, V36, P2483, DOI 10.2337/dc12-1718
   Trief PM, 2003, AGE AGEING, V32, P613, DOI 10.1093/ageing/afg105
   Trief PM, 2014, PSYCHOSOCIAL CARE PE, P251
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Wysocki T, 2012, PSYCHOSOCIOAL CARE P, P229
NR 46
TC 27
Z9 27
U1 4
U2 26
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD FEB
PY 2015
VL 38
IS 2
BP 333
EP 338
DI 10.2337/dc14-1383
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AZ8JK
UT WOS:000348461400036
PM 25614689
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Walker, RJ
   Gebregziabher, M
   Martin-Harris, B
   Egede, LE
AF Walker, Rebekah J.
   Gebregziabher, Mulugeta
   Martin-Harris, Bonnie
   Egede, Leonard E.
TI Quantifying Direct Effects of Social Determinants of Health on Glycemic
   Control in Adults with Type 2 Diabetes
SO Diabetes Technology & Therapeutics
LA English
DT Article
ID OF-THE-LITERATURE; SELF-CARE; PSYCHOLOGICAL DISTRESS; SOCIOECONOMIC
   POSITION; SUPPORT; METAANALYSIS; DEPRESSION; MELLITUS; VALIDITY;
   OUTCOMES
AB Background: The aim of this study was to investigate if self-care is the pathway through which social determinants of health impact diabetes outcomes by analyzing the direct and indirect effects of socioeconomic and psychosocial factors on self-care and glycemic control.
   Subjects and Methods: Six hundred fifteen adults were recruited from two primary care clinics in the southeastern United States. A series of confirmatory factor analyses identified the latent factors underlying social status, psychosocial determinants (psychological distress, self-efficacy, and social support), and self-care (diet, exercise, foot care, glucose testing, and medication adherence). Structured equation modeling investigated the relationship among social determinants, self-care and glycemic control.
   Results: Latent variables were created for diabetes self-care, psychological distress, self-efficacy, social support, and social status. The final model [chi(2)(275)=450.07, P<0.001, R-2=99, root mean square error of approximation=0.03, comparative fit index=0.98] showed lower psychological distress (r=-0.13, P=0.012), higher social support (r=0.14, P=0.01), and higher self-efficacy (r=0.47, P<0.001) were significantly related to diabetes self-care. Lower psychological distress (r=0.10, P=0.03), lower social support (r=0.10, P=0.02), and higher self-efficacy (r=-0.37, P<0.001) were significantly related to lower glycemic control. When social determinants of health variables were included in the model, self-care was no longer significantly associated with glycemic control (r=0.01, P=0.83).
   Conclusions: This study suggests a direct relationship between psychosocial determinants of health and glycemic control. Although associated with self-care, the relationship between social determinants of health and glycemic control is not mediated by self-care. Development of interventions should take psychosocial factors into account as independent influences on diabetes outcomes, rather than as indirect influences via self-care behavior.
C1 [Walker, Rebekah J.; Gebregziabher, Mulugeta; Egede, Leonard E.] Ralph H Johnson Vet Adm Med Ctr, Hlth Equ & Rural Outreach Innovat Ctr, Charleston Vet Affairs Hlth Serv, Res & Dev Serv,Ctr Innovat, Charleston, SC USA.
   [Walker, Rebekah J.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.
   [Walker, Rebekah J.; Martin-Harris, Bonnie] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA.
   [Gebregziabher, Mulugeta] Med Univ S Carolina, Dept Med, Div Publ Hlth Sci, Charleston, SC 29425 USA.
   [Egede, Leonard E.] Med Univ S Carolina, Dept Med, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA.
   [Martin-Harris, Bonnie] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280,POB 250593, Charleston, SC 29425 USA.
EM egedel@musc.edu
OI Gebregziabher, Mulugeta/0000-0002-4826-481X
FU National Institute of Diabetes and Digestive and Kidney Disease
   [K24DK093699-01]
FX This study was supported by grant K24DK093699-01 from the National
   Institute of Diabetes and Digestive and Kidney Disease (Principal
   Investigator: Leonard E. Egede).
CR Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Byrne BM, 2005, J PERS ASSESS, V85, P17, DOI 10.1207/s15327752jpa8501_02
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310
   Cohen S, 2007, JAMA-J AM MED ASSOC, V32, P1
   Cosansu G, 2014, J TRANSCULT NURS, V25, P51, DOI 10.1177/1043659613504112
   Costello A, 2005, PRACT ASSESS RES EVA, V10, P7
   Cundiff JM, 2013, INT J BEHAV MED, V20, P148, DOI 10.1007/s12529-011-9206-1
   Delamater AM, 2001, DIABETES CARE, V24, P1286, DOI 10.2337/diacare.24.7.1286
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Egede LE, 2010, DIABETES EDUCATOR, V36, P276, DOI 10.1177/0145721710361389
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Gao JL, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-66
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.1016/J.INFBEH.2006.11.010
   Hoyle R. H., 2000, HDB APPL MULTIVARIAT
   International Diabetes Federation, 2013, IDF DIABETES ATLAS
   Irwin A., 2010, 2 WHO
   Jaremka LM, 2013, DEPRESS ANXIETY, V30, P288, DOI 10.1002/da.22078
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   National Center for Health Statistics, 2004, SURV QUEST NAT HLTH
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Osborn CY, 2010, PATIENT EDUC COUNS, V79, P49, DOI 10.1016/j.pec.2009.07.016
   Sanchez BN, 2005, J AM STAT ASSOC, V100, P1443, DOI 10.1198/016214505000001005
   Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003
   Schumacker RE, 2010, BEGINNERS GUIDE STRU
   Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0
   Tahmasebi R, 2013, ASIA-PAC J PUBLIC HE, DOI [10.1177/1010539513475652, DOI 10.1177/1010539513475652]
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker RJ, 2014, ENDOCRINE, V47, P29, DOI 10.1007/s12020-014-0195-0
   Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y
NR 39
TC 14
Z9 14
U1 1
U2 20
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD FEB 1
PY 2015
VL 17
IS 2
BP 80
EP 87
DI 10.1089/dia.2014.0166
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CA6GU
UT WOS:000349009600003
PM 25361382
OA Green Published
DA 2019-01-08
ER

PT J
AU Haugstvedt, A
   Wentzel-Larsen, T
   Aarflot, M
   Rokne, B
   Graue, M
AF Haugstvedt, Anne
   Wentzel-Larsen, Tore
   Aarflot, Morten
   Rokne, Berit
   Graue, Marit
TI Assessing fear of hypoglycemia in a population-based study among parents
   of children with type 1 diabetes - psychometric properties of the
   hypoglycemia fear survey - parent version
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Hypoglycemia; Fear; Parents; HFS; HFS-P; Reliability; Validity
ID EMOTIONAL DISTRESS; ADOLESCENTS; MANAGEMENT; FATHERS; MOTHERS
AB Background: In the treatment of childhood type 1 diabetes, being aware of the parents' fear of hypoglycemia is important, since the parents' fear may influence the management of treatment and the children's blood glucose regulation. The availability of proper instruments to assess the parents' fear of hypoglycemia is essential. Thus, the aim of this study was to examine the psychometric properties of the Hypoglycemia Fear Survey - Parent version (HFS-P).
   Methods: In a Norwegian population-based sample, 176 parents representing 102 children with type 1 diabetes (6-15 years old) completed the HFS-P, comprising a 15-item worry subscale and a 10-item behavior subscale. We performed exploratory and confirmatory factor analysis and further analysis of the scales' construct validity, content validity and reliability.
   Results: The Norwegian version of the HFS-P had an acceptable factor structure and internal consistency for the worry subscale, whereas the structure and internal consistency of the behavior subscale was more questionable. The HFS-P subscales were significantly correlated (from moderately to weakly) with symptoms of emotional distress, as measured by the Hopkins Symptom Checklist - 25 items. The mothers scored higher than fathers on both HFS-P subscales, but the difference was not statistically significant for the worry subscale.
   Conclusions: The HFS-P worry subscale seems to be a valid scale for measuring anxiety-provoking aspects of hypoglycemia, and the validity of the HFS-P behavior subscale needs to be investigated further.
C1 [Haugstvedt, Anne; Graue, Marit] Bergen Univ Coll, Fac Hlth & Social Sci, Dept Nursing, N-5020 Bergen, Norway.
   [Haugstvedt, Anne; Aarflot, Morten; Graue, Marit] Bergen Univ Coll, Ctr Evidence Based Practice, N-5020 Bergen, Norway.
   [Wentzel-Larsen, Tore] Ctr Child & Adolescent Mental Hlth Eastern & Sout, Oslo, Norway.
   [Wentzel-Larsen, Tore] Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway.
   [Wentzel-Larsen, Tore] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway.
   [Rokne, Berit] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway.
   [Graue, Marit] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway.
   [Rokne, Berit] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
RP Haugstvedt, A (reprint author), Bergen Univ Coll, Fac Hlth & Social Sci, Dept Nursing, Post Box 7030, N-5020 Bergen, Norway.
EM ahau@hib.no
FU Diabetes Research Foundation of Western Norway; Norwegian Diabetes
   Association; Norwegian Nurses' Association; Western Norway Regional
   Health Authority; University of Bergen; Bergen University College
FX We thank all the parents and children who participated in this study.
   The Diabetes Research Foundation of Western Norway, the Norwegian
   Diabetes Association, the Norwegian Nurses' Association, the Western
   Norway Regional Health Authority, the University of Bergen and Bergen
   University College supported the study.
CR Anderbro T, 2008, PATIENT EDUC COUNS, V73, P127, DOI 10.1016/j.pec.2008.03.022
   Clarke WL, 1998, J PEDIATR ENDOCR MET, V11, P189
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Fayers P., 2007, QUALITY LIFE ASSESSM
   Gonder-Frederick LA, 2013, DIABETIC MED, V30, P603, DOI 10.1111/dme.12129
   Gonder-Frederick Linda, 2011, Diabetes Manag (Lond), V1, P627
   Gonder-Frederick LA, 2006, PEDIATR DIABETES, V7, P215, DOI 10.1111/j.1399-5448.2006.00182.x
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Gorsuch R. L., 2013, FACTOR ANAL
   Graue M., 2013, Norsk Epidemiologi, V23, P75
   Haugstvedt A, 2010, DIABETIC MED, V27, P72, DOI 10.1111/j.1464-5491.2009.02867.x
   Haugstvedt A, 2011, PEDIATR DIABETES, V12, P107, DOI 10.1111/j.1399-5448.2010.00661.x
   Irvin A, 1994, HDB PSYCHOL DIABETES, P133
   Ly TT, 2014, PEDIATR DIABETES, V15, P180, DOI 10.1111/pedi.12174
   Naerde A, 2002, ACTA PSYCHIAT SCAND, V105, P301, DOI 10.1034/j.1600-0447.2002.1010.x
   Patton SR, 2007, PEDIATR DIABETES, V8, P362, DOI 10.1111/j.1399-5448.2007.00242.x
   Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064
   Shepard JA, 2014, J PEDIATR PSYCHOL, V39, P1115, DOI 10.1093/jpepsy/jsu068
   Tamborlane WV, 2006, REV ENDOCR METAB DIS, V7, P205, DOI 10.1007/s11154-006-9018-9
   The DCCT Research Group, 1997, DIABETES, V46, P271, DOI 10.2337/diabetes. 46.2.271
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395
NR 22
TC 6
Z9 7
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD JAN 19
PY 2015
VL 15
AR 2
DI 10.1186/1472-6823-15-2
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CC0WN
UT WOS:000350059800001
PM 25599725
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Milicevic, R
   Jaksic, N
   Margetic, BA
   Jakovljevic, M
AF Milicevic, Ruza
   Jaksic, Nenad
   Margetic, Branka Aukst
   Jakovljevic, Miro
TI PERSONALITY TRAITS AND TREATMENT COMPLIANCE IN PATIENTS WITH TYPE 2
   DIABETES MELLITUS
SO PSYCHIATRIA DANUBINA
LA English
DT Article
DE personality; type D personality; diabetes; T2DM; treatment compliance
ID DISTRESSED PERSONALITY; BEHAVIORS; DISEASE; DS14
AB Background: Personality traits, especially types A/B and D, have been linked to negative outcomes in various somatic illnesses. In this study, we aimed to assess the prevalence of personality types and their association with certain aspects of treatment compliance in patients with type 2 diabetes mellitus (T2DM).
   Subjects and methods: Participants in this study were 91 in-and outpatients suffering from T2DM and 73 healthy control subjects. All the participants filled out standardized self-report measures of personality types A/B (Bortner Rating Scale) and D (Type D Scale; DS-14). In addition, two aspects of treatment compliance were assessed: blood glucose assessment and visits to the primary care physician.
   Results: We found a higher incidence of personality type B (chi(2)=4.086, p=0.049) and personality type D (chi(2)=4.215, p=0.048) in the group of T2DM patients compared to healthy controls. Patients with type D personality were less compliant in terms of the visits to the primary care physician (chi(2)=4.229, p=0.040), although they were more prevalent among those who were compliant regarding the frequency of blood glucose assessment (chi(2)=4.022, p=0.045).
   Conclusion: The current study shows that type B and type D personality are frequent among T2DM patients. Moreover, type D personality could lead to certain aspects of suboptimal health behaviors and, therefore, interfere with disease management in diabetic populations.
C1 [Milicevic, Ruza] Univ Hosp Ctr Mostar, Dept Psychiat, Mostar, Bosnia & Herceg.
   [Milicevic, Ruza; Margetic, Branka Aukst; Jakovljevic, Miro] Sch Med Mostar, Mostar, Bosnia & Herceg.
   [Jaksic, Nenad; Margetic, Branka Aukst; Jakovljevic, Miro] Univ Hosp Ctr Zagreb, Dept Psychiat, Zagreb, Croatia.
RP Milicevic, R (reprint author), Univ Hosp Ctr Mostar, Dept Psychiat, Mostar, Bosnia & Herceg.
EM ruza.milicevic@tel.net.ba
CR Aquarius AE, 2005, AM J CARDIOL, V96, P996, DOI 10.1016/j.amjcard.2005.05.059
   BORTNER RW, 1969, J CHRON DIS, V22, P87, DOI 10.1016/0021-9681(69)90061-7
   Chapman BP, 2007, EUR J PERSONALITY, V21, P911, DOI 10.1002/per.645
   Cosci F, 2012, ADV PSYCHOSOM MED, V32, P133, DOI 10.1159/000330014
   Cukic I, 2014, J PSYCHOSOM RES, V77, P163, DOI 10.1016/j.jpsychores.2014.07.004
   Day Arla L, 2002, J Occup Health Psychol, V7, P109, DOI 10.1037//1076-8998.7.2.109
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Denollet J, 2009, AM J CARDIOL, V103, P399, DOI 10.1016/j.amjcard.2008.09.096
   Mols F, 2010, GEN HOSP PSYCHIAT, V32, P66, DOI 10.1016/j.genhosppsych.2009.09.010
   Nefs G, 2015, DIABETES RES CLIN PR, V108, P94, DOI 10.1016/j.diabres.2015.01.015
   Nefs G, 2012, J PSYCHOSOM RES, V72, P251, DOI 10.1016/j.jpsychores.2012.01.006
   Pedersen SS, 2004, J PSYCHOSOM RES, V57, P265, DOI 10.1016/S0022-3999(03)00614-7
   Pedersen SS, 2003, EUR J CARDIOV PREV R, V10, P241, DOI 10.1097/01.hjr.0000085246.65733.06
   Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086
   Skinner TC, 2014, DIABETIC MED, V31, P487, DOI 10.1111/dme.12339
   Vukovic O, 2014, PSYCHIAT DANUB, V26, P46
   Whitehead DL, 2007, J PSYCHOSOM RES, V62, P419, DOI 10.1016/j.jpsychores.2006.11.005
   Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008
   Zheng YY, 2015, PSYCHIAT DANUB, V27, P174
NR 19
TC 3
Z9 3
U1 0
U2 3
PU MEDICINSKA NAKLADA
PI ZAGREB
PA VLASKA 69, HR-10000 ZAGREB, CROATIA
SN 0353-5053
J9 PSYCHIAT DANUB
JI Psychiatr. Danub.
PY 2015
VL 27
SU 2
BP 42
EP 45
PG 4
WC Psychiatry
SC Psychiatry
GA DP2UB
UT WOS:000378347400005
PM 26657986
DA 2019-01-08
ER

PT J
AU Siddiqui, A
   Madhu, SV
   Sharma, SB
   Desai, NG
AF Siddiqui, Azaz
   Madhu, S. V.
   Sharma, S. B.
   Desai, N. G.
TI Endocrine stress responses and risk of type 2 diabetes mellitus
SO STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
LA English
DT Article
DE Activation; alpha amylase; cortisol; diabetes; salivary; stress-pathways
ID SALIVARY ALPHA-AMYLASE; PITUITARY-ADRENAL AXIS;
   SYMPATHETIC-NERVOUS-SYSTEM; AGED SWEDISH MEN; INSULIN-RESISTANCE;
   METABOLIC SYNDROME; PSYCHOLOGICAL DISTRESS; PERCEIVED STRESS; WHITEHALL
   II; WORK STRESS
AB This study was carried to ascertain whether stress responses are associated with abnormalities in glucose tolerance, insulin sensitivity and pancreatic beta cell function and risk of type 2 Diabetes Mellitus. Salivary cortisol, a marker of hypothalamic-pituitary-adrenal (HPA) axis and salivary a-amylase, a marker of sympathetic nervous system (SNS) were compared in 125 subjects of newly detected diabetes mellitus (NDDM) and normal glucose tolerance (NGT) subjects who were diagnosed on the basis of oral glucose tolerance test (OGTT). Assessment of stress in them was done through stress scales - presumptive stressful life events scale (PSLES), perceived stress scale (PSS) and sense of coherence (SOC) and correlated with these and other stress response markers. Significantly higher 10 pm salivary cortisol and post dexamethasone salivary cortisol were found in NDDM subjects as compared to NGT. 10 pm salivary cortisol correlated significantly with fasting plasma glucose (FPG), 2 h plasma glucose (2h PG) and glycated hemoglobin (HbA1c) while post dex salivary cortisol correlated with 2h PG, HbA1c and salivary a-amylase with 2h PG. Stepwise logistic regression analysis showed that body mass index (OR: 1.840), SOC (OR: 0.688) and 10 pm salivary cortisol (OR: 1.427) were the strongest predictors of NDDM. The results of the present study indicate that NDDM subjects display significantly higher chronic stress and stress responses when compared to subjects with NGT. Chronic stress and endocrine stress responses are significantly associated with glucose intolerance, insulin resistance and diabetes mellitus.
C1 [Siddiqui, Azaz] Cent Res Inst, Kasauli, Himachal Prades, India.
   [Siddiqui, Azaz; Madhu, S. V.] Univ Delhi, Univ Coll Med Sci, Dept Med, Ctr Diabet Endocrinol & Metab, Delhi 110007, India.
   [Sharma, S. B.] Univ Delhi, Univ Coll Med Sci, Dept Med Biochem, Delhi 110007, India.
   [Desai, N. G.] Inst Human Behav & Allied Sci, Dept Psychiat, Delhi, India.
RP Madhu, SV (reprint author), Univ Coll Med Sci, Dept Med, Delhi 110095, India.
EM drsvmadhu@gmail.com
FU Indian Council of Medical Research, New Delhi, India
FX All authors declare no conflict of interest. This work was supported by
   a grant from Indian Council of Medical Research, New Delhi, India.
CR Agardh EE, 2003, DIABETES CARE, V26, P719, DOI 10.2337/diacare.26.3.719
   Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370
   ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z
   Bjorntorp P, 1999, DIABETIC MED, V16, P373, DOI 10.1046/j.1464-5491.1999.00067.x
   Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6
   Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743
   Eriksson AK, 2013, DIABETES CARE, V36, P2683, DOI 10.2337/dc12-1738
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Fukunishi I, 1998, J PSYCHOSOM RES, V45, P361, DOI 10.1016/S0022-3999(98)00029-4
   Genuth S, 2003, DIABETES CARE, V26, P3160
   Grissom R.J, 2012, EFFECT SIZES RES UNI
   GUECHOT J, 1987, NEUROPSYCHOBIOLOGY, V18, P1, DOI 10.1159/000118384
   Hackett RA, 2014, J CLIN ENDOCR METAB, V99, P4625, DOI 10.1210/jc.2014-2459
   Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132
   King SL, 2002, BIOL RES NURS, V4, P93
   KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2
   Kouvonen AM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-46
   Ljung T, 2000, OBES RES, V8, P487, DOI 10.1038/oby.2000.61
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   MCMAHON M, 1988, DIABETES METAB REV, V4, P17, DOI 10.1002/dmr.5610040105
   Misra M, 2008, AM J PHYSIOL-ENDOC M, V295, pE385, DOI 10.1152/ajpendo.00052.2008
   Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109
   Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014
   Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037
   Pasquali R, 2006, ANN NY ACAD SCI, V1083, P111, DOI 10.1196/annals.1367.009
   Plat L, 1996, AM J PHYSIOL-ENDOC M, V270, pE36
   Raff H, 1998, J CLIN ENDOCR METAB, V83, P2681, DOI 10.1210/jc.83.8.2681
   Raff H, 2009, J CLIN ENDOCR METAB, V94, P3647, DOI 10.1210/jc.2009-1166
   Ramachandran A, 1999, DIABETES RES CLIN PR, V44, P207, DOI 10.1016/S0168-8227(99)00024-8
   Reinehr T, 2004, HORM RES, V62, P107, DOI 10.1159/000079841
   Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033
   Rosmond R, 2000, OBES RES, V8, P445, DOI 10.1038/oby.2000.55
   Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853
   Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x
   Rosmond R, 2003, MED SCI MONITOR, V9, P35
   Sherwin R S, 1977, Prim Care, V4, P255
   Singh G, 1984, Indian J Psychiatry, V26, P107
   Singh H, 2002, Indian J Med Sci, V56, P172
   SURWIT RS, 1992, DIABETES CARE, V15, P1413, DOI 10.2337/diacare.15.10.1413
   van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008
   VINING RF, 1983, ANN CLIN BIOCHEM, V20, P329, DOI 10.1177/000456328302000601
   Virtanen M, 2014, DIABETES CARE, V37, P2091, DOI 10.2337/dc13-2725
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 45
TC 14
Z9 16
U1 1
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1025-3890
EI 1607-8888
J9 STRESS
JI Stress
PY 2015
VL 18
IS 5
BP 498
EP 506
DI 10.3109/10253890.2015.1067677
PG 9
WC Behavioral Sciences; Endocrinology & Metabolism; Neurosciences
SC Behavioral Sciences; Endocrinology & Metabolism; Neurosciences &
   Neurology
GA DD4JP
UT WOS:000369888600002
PM 26303379
DA 2019-01-08
ER

PT J
AU Seixas, AA
   Nunes, JV
   Airhihenbuwa, CO
   Williams, NJ
   Pandi-Perumal, SR
   James, CC
   Jean-Louis, G
AF Seixas, Azizi A.
   Nunes, Joao V.
   Airhihenbuwa, Collins O.
   Williams, Natasha J.
   Pandi-Perumal, Seithikurippu Ratnas
   James, Caryl C.
   Jean-Louis, Girardin
TI Linking emotional distress to unhealthy sleep duration: analysis of the
   2009 National Health Interview Survey
SO NEUROPSYCHIATRIC DISEASE AND TREATMENT
LA English
DT Article
DE emotional distress; unhealthy sleep; sleep duration; sleep; mental
   health; depression; anxiety
ID UNITED-STATES; ASSOCIATION; ADOLESCENTS; DEPRESSION; QUALITY; STRESS;
   SYSTEM; WOMEN
AB Objective: The objective of the study was to examine the independent association of emotional distress with unhealthy sleep duration (defined as <7 or >8 hours).
   Methods: Data from the 2009 National Health Interview Survey (NHIS), a cross-sectional household survey, were analyzed to investigate the associations of emotional distress with unhealthy sleep durations, adjusting for sociodemographic factors, health risks, and chronic diseases through hierarchical multiple logistic regression analysis.
   Participants: A total of 27,731 participants (age range 18-85 years) from the NHIS 2009 dataset were interviewed.
   Measures: Unhealthy sleep duration is defined as sleep duration <7 or >8 hours, whereas healthy sleep is defined as sleep duration lasting for 7-8 hours. Emotional distress is based on the Kessler 6 Non-Specific Distress Battery, which assesses the frequency of feeling sad, nervous, restless, hopeless, worthless, and burdened, over a 30-day period.
   Results: Of the sample, 51.7% were female; 83.1% were white and 16.9% were black. Eleven percent experienced emotional distress and 37.6% reported unhealthy sleep. Adjusted logistic regression analysis revealed that individuals with emotional distress had 55% greater odds of reporting unhealthy sleep (odds ratio [OR] = 1.55, 95% confidence interval [CI] = 1.42, 1.68, P<0.001).
   Conclusion: Emotional distress, an important proxy for poor psychological health, was a significant predictor of unhealthy sleep, independent of the influences of several factors including demographic (age, education, sex, race/ethnicity, and family income), health risks (alcohol consumption and smoking status), and chronic diseases/conditions (diabetes, obesity, hypertension, heart disease, cancer, and arthritis).
C1 [Seixas, Azizi A.; Williams, Natasha J.; Pandi-Perumal, Seithikurippu Ratnas; Jean-Louis, Girardin] NYU, Sch Med, Ctr Healthful Behav Change, Dept Populat Hlth,Div Populat Hlth, New York, NY 10016 USA.
   [Nunes, Joao V.] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY USA.
   Penn State Univ, Dept Biobehav Hlth, State Coll, PA 16802 USA.
   [James, Caryl C.] Univ W Indies, Dept Sociol Psychol & Social Work, Mona, Jamaica.
RP Seixas, AA (reprint author), NYU, Sch Med, Ctr Healthful Behav Change, Dept Populat Hlth,Div Populat Hlth, 227 East 30th St,6th Floor, New York, NY 10016 USA.
EM azizi.seixas@nyumc.org
RI Seithikurippu R, Pandi-Perumal/Q-8281-2016
OI Seithikurippu R, Pandi-Perumal/0000-0002-8686-7259; Jean-Louis,
   Girardin/0000-0001-6777-2724
FU NIH [R01MD007716, U54NS081765, K24HL111315]
FX This work was supported by funding from the NIH (R01MD007716,
   U54NS081765, and K24HL111315).
CR Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005
   Basta M, 2007, SLEEP MED CLIN, V2, P279, DOI 10.1016/j.jsmc.2007.04.002
   Blasco-Fontecilla H, 2011, J AFFECT DISORDERS, V133, P239, DOI 10.1016/j.jad.2011.04.003
   Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI [10.1016/isocscimed.2010.05.041, 10.1016/j.socscimed.2010.05.041]
   Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007
   Feketich AK, 2005, EUR HEART J, V26, P1923
   Fernandez-Mendoza J, 2014, J SLEEP RES, V23, P489, DOI 10.1111/jsr.12168
   Foster JH, 2002, ADDICT BIOL, V7, P55, DOI 10.1080/135562101200100616
   GONCHARENKO A M, 1979, Human Physiology (English Translation of Fiziologiya Cheloveka), V5, P468
   Grandner MA, 2012, SLEEP, V35, P395, DOI 10.5665/sleep.1704
   Harvey AG, 2000, BRIT J CLIN PSYCHOL, V39, P275, DOI 10.1348/014466500163284
   Kalmbach DA, 2014, J SLEEP RES, V23, P636, DOI 10.1111/jsr.12190
   Kaneita Y, 2007, J CLIN PSYCHIAT, V68, P1426, DOI 10.4088/JCP.v68n0916
   Kang HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114463
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256
   Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023
   Liu Y, 2013, SLEEP, V36, P1421, DOI 10.5665/sleep.3028
   Papp Klara K, 2002, Sleep Breath, V6, P103, DOI 10.1007/s11325-002-0103-3
   Prather AA, 2013, PSYCHOSOM MED, V75, P350, DOI 10.1097/PSY.0b013e31828ef15b
   Reimann D., 2010, SLEEP MED REV, V14, P19
   Riemann D, 2001, BIOL PSYCHOL, V57, P67, DOI 10.1016/S0301-0511(01)00090-4
   Roberts RE, 2014, SLEEP, V37, P239, DOI 10.5665/sleep.3388
   Sarchiapone M, 2014, SLEEP MED, V15, P248, DOI 10.1016/j.sleep.2013.11.780
   SCHOENBORN CA, 2008, NCHS HLTH E STATS
   Stamatakis KA, 2007, ANN EPIDEMIOL, V17, P948, DOI 10.1016/j.annepidem.2007.07-096
   te Velde SJ, 2013, TWIN RES HUM GENET, V16, P1015, DOI 10.1017/thg.2013.74
   Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x
   Weinstock TG, 2014, SLEEP, V37, P261, DOI 10.5665/sleep.3394
   Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005
   Zhang L, 2006, AM J EPIDEMIOL, V164, P529, DOI 10.1093/aje/kwj231
NR 31
TC 9
Z9 9
U1 0
U2 7
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2021
J9 NEUROPSYCH DIS TREAT
JI Neuropsychiatr. Dis. Treat.
PY 2015
VL 11
BP 2425
EP 2430
DI 10.2147/NDT.S77909
PG 6
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA CS8FY
UT WOS:000362323000001
PM 26442563
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Jarmuzek, P
   Wielgos, M
   Bomba-Opon, DA
AF Jarmuzek, Patrycja
   Wielgos, Miroslaw
   Bomba-Opon, Dorota A.
TI Placental pathologic changes in gestational diabetes mellitus
SO NEUROENDOCRINOLOGY LETTERS
LA English
DT Review
DE great obstetrical syndromes; gestational diabetes mellitus; placenta;
   hypoxia; oxidative stress; VEGF
ID GLUCOSE-INTOLERANCE; FETAL; PREGNANCIES; INSULIN; GROWTH; ABNORMALITIES;
   ANGIOGENESIS; WOMEN
AB Nowadays, the continuous rise of maternal obesity is followed by increased gestational diabetes mellitus incidence. GDM is associated with adverse fetal and neonatal outcome that often presents with macrosomia, birth trauma, neonatal hypoglycemia, and respiratory distress syndrome. Inclusion of GDM into 'the great obstetrical syndromes' emphasizes the role of the placenta in interactions of the maternal and fetal unit.
   The placenta acts as a natural selective barrier between maternal and fetal blood circulations. Placenta is sensitive to the hyperglycemic milieu and responses with adaptive changes of the structure and function. Alteration of the placental development and subsequent vascular dysfunction are presented in 6 out of 7 women with all ranges of diabetic severity.
   Most placentas from GDM pregnancies present typical histological findings such as villous immaturity, villous fibrinoid necrosis, chorangiosis, and increased angiogenesis. The type of dysfunction depends on how early in pregnancy glycaemia disorders occurred. Generally, if impaired glucose metabolism is diagnosed in the early pregnancy, mainly structural dysfunctions are observed. GDM that is detected in late gestation affects placental function to a greater extent. Moreover many studies suggest that diabetic placental changes are associated with inflammation and oxidative stress that can lead to the chronic fetal hypoxia.
   This article aims to review particular changes of the development, anatomy and function of the placenta in the environment of abnormal glucose metabolism which can establish the maternal-placental-fetal interface dysfunction as a potential source of adverse pregnancy outcomes. A detailed sequence of events that leads from hyperglycemia to placental dysfunction and subsequent pregnancy complications may become an important issue for further studies.
C1 [Jarmuzek, Patrycja; Wielgos, Miroslaw; Bomba-Opon, Dorota A.] Med Univ Warsaw, Dept Obstet & Gynecol 1, PL-02015 Warsaw, Poland.
RP Bomba-Opon, DA (reprint author), Med Univ Warsaw, Dept Obstet & Gynecol 1, Plac Starynkiewicza 1-3, PL-02015 Warsaw, Poland.
EM dorota.bomba-opon@wum.edu.pl
CR ALOKAIL MS, 1994, ENDOCR J, V41, P355, DOI 10.1507/endocrj.41.355
   Bartha JL, 2000, AM J OBSTET GYNECOL, V182, P346, DOI 10.1016/S0002-9378(00)70222-5
   Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009
   Catalano PM, 2014, DIABETIC MED, V31, P273, DOI 10.1111/dme.12381
   Cetin I, 2005, AM J OBSTET GYNECOL, V192, P610, DOI 10.1016/j.ajog.2004.08.011
   Coughlan MT, 2004, PLACENTA, V25, P78, DOI 10.1016/S0143-4004(03)00183-8
   Daskalakis G, 2008, ACTA OBSTET GYN SCAN, V87, P403, DOI 10.1080/00016340801908783
   DESOYE G, 1994, HISTOCHEMISTRY, V101, P277, DOI 10.1007/BF00315915
   Dorner G, 2000, NEUROENDOCRINOL LETT, V21, P355
   Ferber A, 2005, AM J OBSTET GYNECOL, V192, P1427, DOI 10.1016/j.ajog.2004.12.076
   Gabbay-Benziv R, 2014, BEST PRACT RES CLIN, pS1521
   Gauster M, 2012, CURR DIABETES REP, V12, P16, DOI 10.1007/s11892-011-0244-5
   Hiden U, 2009, J ANAT, V215, P60, DOI 10.1111/j.1469-7580.2008.01035.x
   Hytinantti TK, 2000, DIABETOLOGIA, V43, P709, DOI 10.1007/s001250051367
   Jahan S, 2011, DIABETES METAB SYND, V5, P33, DOI 10.1016/j.dsx.2010.10.001
   Jirkovska M, 2002, J VASC RES, V39, P268, DOI 10.1159/000063692
   JONES CJP, 1976, OBSTET GYNECOL, V48, P274
   Kessous R, 2013, HEART, V99, P1118, DOI 10.1136/heartjnl-2013-303945
   Khaliq A, 1996, GROWTH FACTORS, V13, P243, DOI 10.3109/08977199609003225
   Kwak SH, 2013, J CLIN ENDOCR METAB, V98, pE744, DOI 10.1210/jc.2012-3324
   Lao TT, 1997, PLACENTA, V18, P227, DOI 10.1016/S0143-4004(97)90097-7
   LAURINI RN, 1987, PLACENTA, V8, P153, DOI 10.1016/0143-4004(87)90018-X
   Leach L, 2009, J ANAT, V215, P69, DOI 10.1111/j.1469-7580.2009.01098.x
   Lucas J, 2008, MICROCIRCULATION, V15, P672
   Madazli R, 2008, GYNECOL OBSTET INVES, V65, P227, DOI 10.1159/000113045
   Manderson JG, 2002, DIABETOLOGIA, V45, P991, DOI 10.1007/s00125-002-0865-y
   Mayhew TM, 2002, DIABETOLOGIA, V45, P1434, DOI 10.1007/s00125-002-0927-1
   Meyer WJ, 1996, J REPROD MED, V41, P675
   Nelson SM, 2009, DIABETES, V58, P2634, DOI 10.2337/db09-0739
   Nordin NM, 2006, J OBSTET GYNAECOL RE, V32, P107, DOI 10.1111/j.1447-0756.2006.00360.x
   Radaelli T, 2009, AM J OBSTET GYNECOL, V201
   Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033
   Romero R, 2009, J MATERN-FETAL NEO M, V22, P639
   Schneider S, 2012, J PERINAT MED, V40, P511, DOI 10.1515/jpm-2012-0015
   Taricco E, 2003, PLACENTA, V24, P343, DOI 10.1053/plac.2002.0913
   Taricco E, 2009, BJOG-INT J OBSTET GY, V116, P1729, DOI 10.1111/j.1471-0528.2009.02341.x
   Wender-Ozegowska E, 2014, GINEKOL POL, V85, P476
   World Health Organization, 2013, DIAGN CRIT CLASS HYP
NR 38
TC 27
Z9 27
U1 2
U2 24
PU MAGHIRA & MAAS PUBLICATIONS
PI STOCKHOLM
PA PO BOX 26132, S-100 41 STOCKHOLM, SWEDEN
SN 0172-780X
J9 NEUROENDOCRINOL LETT
JI Neuroendocrinol. Lett.
PY 2015
VL 36
IS 2
BP 101
EP 105
PG 5
WC Endocrinology & Metabolism; Neurosciences
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA CL4ZV
UT WOS:000356968700001
PM 26071574
DA 2019-01-08
ER

PT J
AU Peacock, AS
   Bogossian, FE
   Wilkinson, SA
   Gibbons, KS
   Kim, C
   McIntyre, HD
AF Peacock, A. S.
   Bogossian, F. E.
   Wilkinson, S. A.
   Gibbons, K. S.
   Kim, C.
   McIntyre, H. D.
TI A Randomised Controlled Trial to Delay or Prevent Type 2 Diabetes after
   Gestational Diabetes: Walking for Exercise and Nutrition to Prevent
   Diabetes for You
SO INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID LIFE-STYLE INTERVENTIONS; PSYCHOLOGICAL DISTRESS; COST-EFFECTIVENESS;
   PHYSICAL-ACTIVITY; RECENT HISTORY; RISK-FACTORS; FOLLOW-UP; MELLITUS;
   WOMEN; PROGRAM
AB Aims. To develop a program to support behaviour changes for women with a history of Gestational Diabetes Mellitus (GDM) and a Body Mass Index (BMI) > 25 kg/m(2) to delay or prevent Type 2 Diabetes Mellitus. Methods. Women diagnosed with GDM in the previous 6 to 24 months and BMI > 25 kg/m(2) were randomized to an intervention (I) (n = 16) or a control (C) (n = 15) group. The intervention was a pedometer program combined with nutrition coaching, with the primary outcome increased weight loss in the intervention group. Secondary outcomes included decreased waist and hip measurements, improved insulin sensitivity and body composition, increased physical activity, and improved self-efficacy in eating behaviours. Results. Median (IQR) results were as follows: weight: I -2.5 (2.3) kg versus C +0.2 (1.6) kg (P = 0.009), waist: I -3.6 (4.5) cm versus C -0.1 (3.6) cm (P = 0.07), and hip: I -5.0 (3.3) cm versus C -0.2 (2.6) cm (P = 0.002). There was clinical improvement in physical activity and eating behaviours and no significant changes in glucose metabolism or body composition. Conclusion. A pedometer program and nutrition coaching proved effective in supporting weight loss, waist circumference, physical activity, and eating behaviours in women with previous GDM.
C1 [Peacock, A. S.; Bogossian, F. E.] Univ Queensland, Sch Nursing & Midwifery, Brisbane, Qld 4067, Australia.
   [Peacock, A. S.; Wilkinson, S. A.; Gibbons, K. S.] Univ Queensland, Mater Res Inst, Brisbane, Qld 4101, Australia.
   [Wilkinson, S. A.; McIntyre, H. D.] Mater Hlth Serv, Brisbane, Qld 4101, Australia.
   [Kim, C.] Univ Michigan, Ann Arbor, MI 48109 USA.
   [McIntyre, H. D.] Univ Queensland, Sch Med, Brisbane, Qld 4067, Australia.
RP Peacock, AS (reprint author), Univ Queensland, Sch Nursing & Midwifery, Brisbane, Qld 4067, Australia.
EM a.peacock2@uq.edu.au
RI Bogossian, Fiona/F-2273-2010; Peacock, Ann/H-6617-2015
OI Bogossian, Fiona/0000-0001-9909-5852; Peacock, Ann/0000-0002-5282-8155;
   Wilkinson, Shelley/0000-0003-3365-3473
FU Mater Hospital Golden Casket Nursing and Midwifery Scholarship; Mater
   Foundation Research Grants (Mater Health Services, Brisbane); Mater
   Hospital Golden Casket Nursing and Midwifery Research Scholarship; Mater
   Foundation Research Grants; Mater Health Services; Australian
   Postgraduate Award
FX The researchers would like to thank the team at The University of
   Michigan (Drs. Cathy Kim, Caroline Richardson, and Elizabeth Wilson) for
   their invaluable help with supply of pedometers and collaboration to
   develop the website and Elin Donaldson for her help with the Nutrition
   Workshop. The researchers would also like to acknowledge the Mater
   Hospital Golden Casket Nursing and Midwifery Scholarship for financial
   assistance and Mater Research Institute-The University of Queensland for
   statistical and administration support. They also acknowledge Mater
   Foundation Research Grants (Mater Health Services, Brisbane) for
   financial assistance for study materials, pathology costs, and
   consumables. They received funds from Mater Hospital Golden Casket
   Nursing and Midwifery Research Scholarship, Mater Foundation Research
   Grants, Mater Health Services, and Australian Postgraduate Award.
CR Amorim AR, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005627.pub3, DOI 10.1002/14651858.CD005627.PUB3]
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   [Anonymous], 2014, GESTATIONAL DIABETES
   Baptiste-Roberts K, 2009, AM J MED, V122, P207, DOI 10.1016/j.amjmed.2008.09.034
   Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5
   Bertram MY, 2010, DIABETOLOGIA, V53, P875, DOI 10.1007/s00125-010-1661-8
   Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4
   Cheung NW, 2007, DIABETES RES CLIN PR, V77, P333, DOI 10.1016/j.diabres.2006.10.025
   Clark A., 2014, GREAT IDEAS NUTR POR
   CLARK MM, 1991, J CONSULT CLIN PSYCH, V59, P739, DOI 10.1037//0022-006X.59.5.739
   Clarke KK, 2007, J AM DIET ASSOC, V107, P962, DOI 10.1016/j.jada.2007.03.010
   Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579
   Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155
   Feig DS, 2008, CAN MED ASSOC J, V179, P344, DOI 10.1503/cmaj.081087
   Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012
   Ferrara A, 2011, DIABETES CARE, V34, P1519, DOI 10.2337/dc10-2221
   Fjeldsoe BS, 2009, MED SCI SPORT EXER, V41, P1020, DOI 10.1249/MSS.0b013e31819461c2
   Frierson GM, 2012, J NATL MED ASSOC, V104, P544, DOI 10.1016/S0027-9684(15)30221-2
   IBM, 2012, IBM SPSS STAT WIND V
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kim C, 2012, DIABETIC MED, V29, P278, DOI 10.1111/j.1464-5491.2011.03415.x
   Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862
   Kim C, 2007, DIABETES CARE, V30, P2281, DOI 10.2337/dc07-0618
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816
   Lee H, 2008, DIABETES RES CLIN PR, V81, P124, DOI 10.1016/j.diabres.2008.02.017
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Linne Y, 2002, BJOG-INT J OBSTET GY, V109, P1227
   Lohse N, 2011, INT J GYNECOL OBSTET, V115, pS20, DOI 10.1016/S0020-7292(11)60007-6
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Maturi MS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-103
   McIntyre HD, 2012, INT J ENDOCRINOL, DOI 10.1155/2012/892019
   Morrison MK, 2010, DIABETIC MED, V27, P882, DOI 10.1111/j.1464-5491.2010.03032.x
   Moses RG, 2011, MED J AUSTRALIA, V194, P338
   Nascimento S. L., 2013, INT J OBESITY
   National Health and Medical Research Council (NHMRC), 2013, AUSTR DIET GUID
   Nicklas JM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-23
   Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772
   Razee H, 2010, HEALTH PROMOT J AUST, V21, P130
   Reeves M, 2010, NUTR DIET S1, V67, P57
   Sterne V. L., 2011, Practical Diabetes International, V28, P64, DOI 10.1002/pdi.1559
   Tuomilehto J, 2011, DIABETES CARE, V34, pS210, DOI 10.2337/dc11-s222
   van der Pligt P, 2013, OBES REV, V14, P792, DOI 10.1111/obr.12053
   Wilkinson SA, 2015, J HUM NUTR DIET, V28, P15, DOI 10.1111/jhn.12193
   Williams T., 2011, THIS THAT A LIFE SIZ
NR 45
TC 9
Z9 9
U1 0
U2 18
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-8337
EI 1687-8345
J9 INT J ENDOCRINOL
JI Int. J. Endocrinol.
PY 2015
AR 423717
DI 10.1155/2015/423717
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CJ4MV
UT WOS:000355460400001
PM 26089886
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Okasha, T
   Radwan, AS
AF Okasha, Tarek
   Radwan, Ash-Shayma
TI The Bidirectional Relation Between Psychiatric Disorders With Selected
   Cardiovascular and Endocrinal Diseases: An Egyptian Perspective
SO CURRENT PSYCHIATRY REPORTS
LA English
DT Article
DE Psychiatric morbidity; Cardiovascular diseases; Endocrinal diseases;
   Diabetes mellitus; Thyroid disease; Ischemic heart disease; Heart
   failure; Depression; Anxiety; Egyptian sample
ID CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; MAJOR DEPRESSIVE DISORDER;
   ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; ARTERY-DISEASE;
   DIABETES-MELLITUS; INFLAMMATORY MECHANISMS; GLUCOSE-METABOLISM;
   RATE-VARIABILITY
AB Cardiovascular and endocrine diseases may act as burdens for individuals suffering from one of these medical illnesses, and whether through the ensuing psychological distress, or some biological mechanisms, these medical diseases can eventually lead to the development of psychiatric morbidities. Moreover, psychiatric morbidities negatively affect the prognosis of both cardiovascular and endocrine diseases. Despite transcultural differences, Egyptian patients with ischemic heart diseases (ISHD), heart failure (HF), diabetes mellitus (DM), or thyroid diseases (TD) endure the same psychological distress as their Western counterparts. Psychiatric assessment and evaluation should be regularly repeated among patients with cardiovascular and endocrinal diseases, and patients who are at risk should be closely followed up.
C1 [Okasha, Tarek; Radwan, Ash-Shayma] Ain Shams Univ, Inst Psychiat, Cairo, Egypt.
RP Okasha, T (reprint author), Ain Shams Univ, Inst Psychiat, Cairo, Egypt.
EM tokasha@internetegypt.com; shayma.radwan@gmail.com
CR Abd El-Hay MA, 2005, EGYPT J PSYCHIAT, V24, P103
   Adewuya AO, 2006, PSYCHOSOMATICS, V47, P479, DOI 10.1176/appi.psy.47.6.479
   Almahmeed W, 2012, THER CLIN RISK MANAG, V8, P65, DOI 10.2147/TCRM.S26414
   Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   [Anonymous], 2005, CAN J DIABETES, V29, P113
   Arne M, 2009, SCAND J PRIM HEALTH, V27, P141, DOI 10.1080/02813430902808643
   Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012
   Bankier B, 2008, EUR HEART J, V29, P2212, DOI 10.1093/eurheartj/ehn326
   Bankier B, 2009, J PSYCHOSOM RES, V66, P189, DOI 10.1016/j.jpsychores.2008.09.010
   Bener A, 2011, ONCOL REV, V5, P5, DOI 10.1007/s12156-010-0061-0
   Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971
   Bunevicius A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-37
   Celano Christopher M, 2011, Dialogues Clin Neurosci, V13, P109
   Chakrabarti S, 2011, J THROID RES, DOI 10.4061/2011/306367
   Chiodini I, 2007, DIABETES CARE, V30, P83, DOI 10.2337/dc06-1267
   Chung ML, 2011, HEART LUNG, V40, P492, DOI [10.1016/j.hrtlng.2010.08.001, 10.1016/j.hrtlng.2010.11.005]
   Chung ML, 2009, J PSYCHOSOM RES, V67, P29, DOI 10.1016/j.jpsychores.2009.01.009
   Church CO, 2009, ANN PHARMACOTHER, V43, P2113, DOI 10.1345/aph.1M369
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Cully JA, 2009, PSYCHOSOMATICS, V50, P592, DOI 10.1176/appi.psy.50.6.592
   De Hert M, 2009, WORLD PSYCHIATRY, V8, P15
   De Jong MJ, 2011, HEART LUNG, V40, P393, DOI 10.1016/j.hrtlng.2011.02.002
   Delisle VC, 2012, J PSYCHOSOM RES, V73, P356, DOI 10.1016/j.jpsychores.2012.08.021
   Demet MM, 2002, ARCH MED RES, V33, P552, DOI 10.1016/S0188-4409(02)00410-1
   Dickens CM, 2006, BRIT J PSYCHIAT, V189, P367, DOI 10.1192/bip.bp.105.018234
   Diez-Quevedo C, 2013, INT J CARDIOL, V167, P1217, DOI 10.1016/j.ijcard.2012.03.143
   Dimos AK, 2009, HELL J CARDIOL, V50, P410
   Drago S, 2007, INT J CARDIOL, V115, P46, DOI 10.1016/j.ijcard.2006.04.029
   Eker SS, 2008, PROG NEURO-PSYCHOPH, V32, P955, DOI 10.1016/j.pnpbp.2007.12.029
   El-Islam AF, 2008, TRANSCULT PSYCHIATRY, V45, P671, DOI 10.1177/1363461508100788
   El-Mougi F A, 2004, East Mediterr Health J, V10, P863
   Ellabany E, 2006, 200506 WHO STEPS
   Engum A, 2005, J PSYCHOSOM RES, V59, P263, DOI 10.1016/j.jpychores.2005.04.002
   Engum A, 2002, ACTA PSYCHIAT SCAND, V106, P27, DOI 10.1034/j.1600-0447.2002.01250.x
   Eren I, 2008, DEPRESS ANXIETY, V25, P98, DOI 10.1002/da.20288
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Feret BM, 2000, ANN PHARMACOTHER, V34, P483
   Filik R, 2006, ACTA PSYCHIAT SCAND, V113, P298, DOI 10.1111/j.1600-0447.2006.00768.x
   Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4
   Geiser F, 2008, PSYCHOTHER PSYCHOSOM, V77, P377, DOI 10.1159/000151518
   Gitlin M, 2004, J PSYCHIATR NEUROSCI, V29, P383
   Goff DC, 2005, SCHIZOPHR RES, V80, P45, DOI 10.1016/j.schres.2005.08.010
   Goodwin RD, 2003, PSYCHOSOM MED, V65, P501, DOI 10.1097/01.PSY.0000041544.14277.EC
   Guallar-Castillon P, 2006, REV ESP CARDIOL, V59, P770
   Holzapfel N, 2007, PSYCHOSOMATICS, V48, P112, DOI 10.1176/appi.psy.48.2.112
   Huffman JC, 2008, J PSYCHOSOM RES, V65, P557, DOI 10.1016/j.jpsychores.2008.08.001
   Ioannis Paraskevaidis, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P109
   Israel AK, 2011, SCHIZOPHR RES, V128, P44, DOI 10.1016/j.schres.2011.02.007
   Jiang W, 2005, AM HEART J, V150, P54, DOI 10.1016/j.ahj.2005.04.012
   Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7
   Joynt KE, 2004, J CARD FAIL, V10, P258, DOI 10.1016/j.cardfail.2003.09.008
   Khalil RB, 2011, CLIN NEUROPHARMACOL, V34, P248, DOI 10.1097/WNF.0b013e31823429a7
   Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Koike MK., 2013, PROG HLTH SCI, V3, P123
   Krishna VN, 2013, ASIAN J PSYCHIATR, V6, P42, DOI 10.1016/j.ajp.2012.08.003
   Kruse J, 2003, DIABETES CARE, V26, P1841, DOI 10.2337/diacare.26.6.1841
   Kupka RW, 2002, BIOL PSYCHIAT, V51, P305, DOI 10.1016/S0006-3223(01)01217-3
   Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688
   Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998
   Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B
   Martens EJ, 2008, PSYCHOL MED, V38, P375, DOI 10.1017/S0033291707002097
   Masopust J, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-2
   Mazereeuw G, 2013, NEUROSCI BIOBEHAV R, V37, P1611, DOI 10.1016/j.neubiorev.2013.06.010
   McDermott S, 2005, COMMUNITY MENT HLT J, V41, P747, DOI 10.1007/s10597-005-6431-6
   Merswolken M, 2013, INT J BEHAV MED, V20, P461, DOI 10.1007/s12529-012-9233-6
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Miu AC, 2009, AUTON NEUROSCI-BASIC, V145, P99, DOI 10.1016/j.autneu.2008.11.010
   Moser DK, 2010, HEART LUNG, V39, P378, DOI 10.1016/j.hrtlng.2009.10.017
   Nair N, 2012, AM J CARDIOL, V109, P768, DOI 10.1016/j.amjcard.2011.10.039
   Naqvi TZ, 2007, GENDER MED, V4, P339, DOI 10.1016/S1550-8579(07)80063-5
   Nemeroff CB, 2000, AM HEART J, V140, P557, DOI 10.1067/emory.edu
   O'Donovan A, 2013, NEUROSCI BIOBEHAV R, V37, P96, DOI 10.1016/j.neubiorev.2012.10.013
   Ogawa M, 2011, ARCH PSYCHIAT NURS, V25, P63, DOI 10.1016/j.apnu.2010.06.002
   Okasha A, 2004, BRIT J PSYCHIAT, V185, P266, DOI 10.1192/bjp.185.3.266
   Otte C, 2004, BIOL PSYCHIAT, V56, P241, DOI 10.1016/j.biophysch.2004.06.003
   Parker G, 2011, PSYCHIAT RES, V185, P347, DOI 10.1016/j.psychres.2010.07.015
   Patten SB, 2006, GEN HOSP PSYCHIAT, V28, P503, DOI 10.1016/j.genhosppsych.2006.09.001
   Petrak F, 2003, DIABETES-METAB RES, V19, P216, DOI 10.1002/dmrr.374
   Pizzi C, 2011, AM J CARDIOL, V107, P972, DOI 10.1016/j.amjcard.2010.11.017
   Radwan A, 2013, THESIS AIN SHAMS U C
   Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034
   Rogers Donald, 2008, Psychiatry (Edgmont), V5, P28
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005
   Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055
   Sarkar S, 2012, GEN HOSP PSYCHIAT, V34, P160, DOI 10.1016/j.genhosppsych.2011.09.016
   Sharaf Y, 2003, MED J CAIRO U, V71, P747
   Sherwood A, 2005, J AM COLL CARDIOL, V46, P656, DOI 10.1016/j.jacc.2005.05.041
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3
   Steiner J, 2014, PROG NEURO-PSYCHOPH, V48, P287, DOI 10.1016/j.pnpbp.2012.09.016
   Strine TW, 2008, PSYCHIAT SERV, V59, P1383, DOI 10.1176/appi.ps.59.12.1383
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001
   Sundquist K, 2006, ACTA PSYCHIAT SCAND, V113, P283, DOI 10.1111/j.1600-0447.2006.00774.x
   Suvisaari J, 2010, PSYCHIAT RES, V175, P126, DOI 10.1016/j.psychres.2008.07.021
   Tovilla-Zarate C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036887
   Turner J, 2000, WESTERN J MED, V172, P124, DOI 10.1136/ewjm.172.2.124
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   van Melick EJM, 2010, AM J GERIAT PSYCHIAT, V18, P395, DOI 10.1097/JGP.0b013e3181c6584e
   van Melle JP, 2006, INT J CARDIOL, V109, P88, DOI 10.1016/j.ijcard.2005.05.053
   van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c
   Verma SK, 2009, J CLIN PSYCHIAT, V70, P997, DOI 10.4088/JCP.08m04508
   Walker E, 2008, ANNU REV CLIN PSYCHO, V4, P189, DOI 10.1146/annurev.clinpsy.4.022007.141248
   Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002
   Wirtz PH, 2010, BRAIN BEHAV IMMUN, V24, P366, DOI 10.1016/j.bbi.2009.02.004
   Wu EL, 2013, J PSYCHOSOM RES, V74, P233, DOI 10.1016/j.jpsychores.2012.12.016
   Yu DSF, 2009, INT J CARDIOL, V131, P384, DOI 10.1016/j.ijcard.2007.10.043
   Zainal N, 2010, EUR PSYCHIAT S, V25, P527
NR 111
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3812
EI 1535-1645
J9 CURR PSYCHIAT REP
JI Curr. Psychiatry Rep.
PD JAN
PY 2015
VL 17
IS 1
AR 528
DI 10.1007/s11920-014-0528-y
PG 8
WC Psychiatry
SC Psychiatry
GA CC8XM
UT WOS:000350651900001
PM 25413635
DA 2019-01-08
ER

PT J
AU Dzhambov, A
   Dimitrova, D
AF Dzhambov, Angel
   Dimitrova, Donka
TI Chronic noise exposure and testosterone deficiency - meta-analysis and
   meta-regression of experimental studies in rodents
SO ENDOKRYNOLOGIA POLSKA
LA English
DT Article
DE hypogonadism; testosterone deficiency; male fertility; noise exposure;
   noise pollution; rats; quality effects model; meta-analysis
ID ROAD TRAFFIC NOISE; QUALITY-EFFECTS MODEL; VITAMINS C; STRESS;
   INFERTILITY; POLLUTION; MEN
AB Introduction: Chronic psychological distress can cause suppression of the hypothalamic-pituitary-testicular axis and thus lead to male hypogonadism, which is associated with psycho-social dysfunction, chronic diseases, and as a result, considerable economic costs. Conversely, noise is a prototypal environmental stressor of growing importance, already linked to birth outcomes and diabetes. However, its effects on male testosterone levels have been paid little attention.
   Material and methods: This paper reports a systematic review and meta-analysis of experimental studies in rodents, which have examined the effect of chronic noise stress on serum testosterone levels. A systematic search in MEDLINE, EMBASE and the Internet yielded seven studies. A quality effects meta-analytical model was applied to compute pooled Hedges's g. Quality effects meta-regression was carried out as well.
   Results: We found pooled Hedges's g of -2.41 (95% CI: -3.28, -1.54), indicating a very large effect of noise exposure on testosterone. Metaregression confirmed that the overall duration of exposure explained a significant proportion of the variance across individual effect sizes (Q ((1)) = 3.95, p = 0.047). However, there was considerable inter-study heterogeneity (I-2 = 82%) and publication bias (p = 0.016). After inputting two studies previously thought to be missing, the pooled effect dropped to g = -1.53 (95% CI: -3.01, -0.05).
   Conclusions: Chronic noise exposure of approximate to 100 dB leads to a significant reduction of serum testosterone in male rodents. Research on humans is highly warranted, especially given the steady trend in Western societies for increasing the burden of both male hypogonadism and noise pollution.
C1 [Dzhambov, Angel] Med Univ Plovdiv, Fac Med, Plovdiv, Bulgaria.
   [Dimitrova, Donka] Med Univ Plovdiv, Fac Publ Hlth, Dept Hlth Management Hlth Econ & Primary Care, Plovdiv, Bulgaria.
RP Dzhambov, A (reprint author), Med Univ Plovdiv, Fac Med, Plovdiv, Bulgaria.
EM angelleloti@gmail.com
RI Dimitrova, Donka/B-9781-2014
OI Dimitrova, Donka/0000-0002-0713-7566; Dzhambov,
   Angel/0000-0003-2540-5111
CR ARMARIO A, 1984, J ENDOCRINOL INVEST, V7, P659, DOI 10.1007/BF03349502
   Babisch W, 2014, NOISE HEALTH, V16, P1, DOI 10.4103/1463-1741.127847
   Barendregt J.J., METAXL USER GUIDE VE
   Chandralekha G., 2002, THESIS MGR MED U RES
   Croteau A., 2009, EFFETS BRUIT MILIEU
   Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160
   Diab AA, 2012, J AM SCI, V8, P198
   Dohle GR, 2012, GUIDELINES MALE HYPO
   Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7
   Doi SAR, 2009, EPIDEMIOLOGY, V20, P314, DOI 10.1097/EDE.0b013e318196a8d0
   Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004
   Dzhambov A, 2014, NOISE HEALTH, V16, P95, DOI 10.4103/1463-1741.132090
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   European Community, 1996, COMM GREEN PAP FUT N
   Fathollahi A, 2013, ARAB J UROL, V11, P101, DOI 10.1016/j.aju.2012.12.002
   Fu R, 2010, METHODS GUIDE COMP E
   Goines L, 2007, SOUTH MED J, V100, P287, DOI 10.1097/SMJ.0b013e3180318be5
   Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118
   Higgins J, 2008, COCHRANE HDB SYSTEMA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jozkow P, 2012, ENDOKRYNOL POL, V63, P44
   Kaltenboeck A, 2012, J SEX MED, V9, P2438, DOI 10.1111/j.1743-6109.2012.02810.x
   Kaminetsky J, 2013, J SEX MED, V10, P1628, DOI 10.1111/jsm.12116
   Kopke RD, 2000, HEARING RES, V149, P138, DOI 10.1016/S0378-5955(00)00176-3
   McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3
   MOSHER WD, 1991, FERTIL STERIL, V56, P192
   Nieschlag E, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P1, DOI 10.1007/978-3-540-78355-8
   Rajabzadeh A, 2013, J QOM U MED SCI, V7
   Romeo Rosa, 2004, Italian Journal of Anatomy and Embryology, V109, P45
   Ruffoli R, 2006, ANDROLOGIA, V38, P159, DOI 10.1111/j.1439-0272.2006.00732.x
   Saki G, 2013, NOISE HEALTH, V15, P194, DOI 10.4103/1463-1741.112374
   Seftel AD, 2006, INT J IMPOT RES, V18, P115, DOI 10.1038/sj.ijir.3901397
   Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503
   Stansfeld S.A, 1992, PSYCHOL MED S, V22S, P1, DOI DOI 10.1017/S0264180100001119
   Swami CG, 2007, MALAYS J MED SCI, V14, P28
   THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433
   van Kempen E, 2012, J HYPERTENS, V30, P1075, DOI 10.1097/HJH.0b013e328352ac54
   Vosoughi S, 2012, HEALTH SCOPE, V1, P110, DOI 10.17795/jhealthscope-7973
   WESTMAN JC, 1981, ENVIRON HEALTH PERSP, V41, P291, DOI 10.2307/3429324
   WHO, 1997, 5 WHO
NR 41
TC 3
Z9 3
U1 2
U2 7
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 0423-104X
J9 ENDOKRYNOL POL
JI Endokrynol. Pol.
PY 2015
VL 66
IS 1
BP 39
EP 46
DI 10.5603/EP.2015.0007
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CC6OC
UT WOS:000350483800006
PM 25754280
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Lou, PA
   Qin, Y
   Zhang, P
   Chen, PP
   Zhang, L
   Chang, GQ
   Li, T
   Qiao, C
   Zhang, N
AF Lou, Peian
   Qin, Yu
   Zhang, Pan
   Chen, Peipei
   Zhang, Lei
   Chang, Guiqiu
   Li, Ting
   Qiao, Cheng
   Zhang, Ning
TI Association of sleep quality and quality of life in type 2 diabetes
   mellitus: A cross-sectional study in China
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes mellitus; Pittsburgh sleep quality index; Diabetes
   specificity quality of life scale
ID GLYCEMIC CONTROL; HEALTH; DEPRESSION; PREVALENCE; ADULTS; POPULATION;
   DISTRESS; HYPOGLYCEMIA; ANXIETY; IMPACT
AB Objective: The aim of this study is to investigate sleep quality and quality of life, and to assess the relationship between sleep quality and quality of life in Chinese patients with type 2 diabetes mellitus (T2DM).
   Research design and methods: 944 patients with T2DM were enrolled in our study. General characteristics and laboratory testing such as glycosylated hemoglobin A1c (HbA1c) were measured. Each patient completed a Chinese version of the Pittsburgh sleep quality index (PSQI) and the diabetes specificity quality of life scale (DSQL) questionnaires. A PSQI global score > 7 was defined as poor sleep quality. A global DSQL score < 40 was defined as a good quality of life. Multiple logistic regression analysis was used to examine the relationships between PSQI and DSQL.
   Results: Poor quality of life in participants was associated with a longer duration of diabetes, a greater number of diabetes complications, no alcohol drinking, poor glycemic control and having depression and anxiety (all P < 0.001). Of the participants, 33.6% of them were poor sleepers according to their PSQI. Poor sleepers had significantly lower DSQL (P < 001). After adjustment for confounders, poor sleep quality was positively associated with a lower health-related quality of life (OR: 3.67, 95% CI: 1.30-10.33, P < 0.001).
   Conclusions: Our results suggest that poor sleep is prevalent in T2DM and inversely associated with quality of life. It is necessary for primary health-care workers to include sleep related knowledge in diabetes self-management programs to improve sleep quality in diabetes patients. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Lou, Peian; Zhang, Pan; Chen, Peipei; Zhang, Lei; Chang, Guiqiu; Li, Ting; Qiao, Cheng; Zhang, Ning] Xuzhou Ctr Dis Control & Prevent, Dept Control & Prevent Chron Noncommunicable Dis, Xuzhou, Peoples R China.
   [Qin, Yu] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.
RP Qin, Y (reprint author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.
EM lpa82835415@126.com; qinyu@jscdc.cn; xzzhangpan@126.com;
   71772690@qq.com; 18905218811@189.cn; 1548857561@qq.com;
   nfykliting@126.com; qc101273528@126.com; 494174@qq.com
FU Preventive Medicine research projects of Jiangsu Province Health
   Department [Y2012025]; Science and Technology projects of Xuzhou City
   [XF11C090]; Double-Hundred Talents Project of Xuzhou city [BRA201224];
   Jiangsu Provincial Center for Disease Control and Prevention
   [JKRC2011006]
FX This research was funded by the Preventive Medicine research projects of
   Jiangsu Province Health Department in 2012 (Y2012025), the Science and
   Technology projects of Xuzhou City in 2011 (XF11C090) and the
   Double-Hundred Talents Project of Xuzhou city in 2012 (BRA201224). Yu
   Qin was financed by Jiangsu Provincial Center for Disease Control and
   Prevention (JKRC2011006).
CR *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS62, DOI DOI 10.2337/DC10-S062
   Andyani TM, 2010, INT J PHARM PHARM SC, V2, P139
   Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Chan AM, 2009, MATURITAS, V62, P294, DOI 10.1016/j.maturitas.2009.01.005
   [陈霭玲 CHEN Ailing], 2006, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V15, P434
   Chinese Medical Association Diabetes Branch, 2012, CHIN J DIABETES, V201, ps1
   Cooperative Meta- Analysis Group of China Obesity Task Force, 2002, ZHONGHUA LIU XING BI, V23, P5
   Cunha MCB, 2008, REV LAT-AM ENFERM, V16, P850
   Donald M, 2013, HEALTH QUAL LIFE OUT, V16, P170
   Ghanbari A, 2005, PUBLIC HEALTH NURS, V22, P311, DOI 10.1111/j.0737-1209.2005.220406.x
   Hanninen JA, 1999, DIABETES CARE, V22, P997, DOI 10.2337/diacare.22.6.997
   Hiltunen L, 1996, SCAND J PRIM HEALTH, V14, P229, DOI 10.3109/02813439608997090
   Hu L, 1996, CHINESE J PSYCHIAT, V29, P103, DOI DOI 10.1007/BF02951625
   Imayama I, 2011, QUAL LIFE RES, V20, P551, DOI 10.1007/s11136-010-9772-8
   Ji LN, 2012, CHIN J DIABETES MELL, V4, P397
   Jin Qi-Hui, 2012, Zhonghua Nei Ke Za Zhi, V51, P357
   KeinanenKiukaanniemi S, 1996, DIABETIC MED, V13, P382, DOI 10.1002/(SICI)1096-9136(199604)13:4<382::AID-DIA14>3.0.CO;2-Y
   Kendzor DE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-176
   Kiadaliri AA, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-54
   Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768
   Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17
   Laiteerapong N, 2011, DIABETES CARE, V34, P1749, DOI 10.2337/dc10-2424
   Landman GWD, 2010, DIABETES CARE, V33, P2378, DOI 10.2337/dc10-0979
   Luyster FS, 2011, DIABETES EDUCATOR, V37, P347, DOI 10.1177/0145721711400663
   [马立萍 MA Li-ping], 2009, [中国糖尿病杂志, Chinese Journal of Diabetes], V17, P693
   McEwen Laura N, 2009, Prim Care Diabetes, V3, P37, DOI 10.1016/j.pcd.2009.01.001
   Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007
   Paschalides C, 2004, J PSYCHOSOM RES, V57, P557, DOI 10.1016/j.jpsychores.2004.03.006
   Redekop WK, 2004, J POSTGRAD MED, V5, P194
   Rombopoulos G, 2013, HORM-INT J ENDOCRINO, V12, P550, DOI 10.14310/horm.2002.1443
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Saito I, 2005, J OCCUP HEALTH, V47, P496, DOI 10.1539/joh.47.496
   Seligowski AV, 2013, J CLIN PSYCHOL, V69, P1121, DOI 10.1002/jclp.21866
   Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1
   Solli O, 2010, HEALTH QUAL LIFE OUT, V8, P8
   Song YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054951
   Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011
   Sundaram M, 2007, QUAL LIFE RES, V16, P165, DOI 10.1007/s11136-006-9105-0
   Sundaram M, 2009, PATIENT, V2, P121, DOI 10.2165/01312067-200902020-00008
   Tabaei BP, 2004, QUAL LIFE RES, V13, P1153, DOI 10.1023/B:QURE.0000031336.81580.52
   Tsai YW, 2012, FAM PRACT, V29, P30, DOI 10.1093/fampra/cmr041
   Wandell PE, 2005, SCAND J PRIM HEALTH, V23, P68, DOI 10.1080/02813430510015296
   Wandell PE, 2000, DIABETES METAB, V26, P465
   Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9
   Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   Zammitt NN, 2005, DIABETES CARE, V28, P2948, DOI 10.2337/diacare.28.12.2948
   Zhang J, 2013, NEUROPSYCH DIS TREAT, V9, P1289, DOI 10.2147/NDT.S49798
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
NR 50
TC 19
Z9 22
U1 1
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JAN
PY 2015
VL 107
IS 1
BP 69
EP 76
DI 10.1016/j.diabres.2014.09.060
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AZ2DW
UT WOS:000348045800011
PM 25458325
DA 2019-01-08
ER

PT J
AU Tan, LSM
   Khoo, EYH
   Tan, CS
   Griva, K
   Mohamed, A
   New, M
   Lee, YS
   Lee, J
   Tai, ES
   Wee, HL
AF Tan, L. S. M.
   Khoo, E. Y. H.
   Tan, C. S.
   Griva, K.
   Mohamed, Amir
   New, Michelle
   Lee, Y. S.
   Lee, Jeannette
   Tai, E. S.
   Wee, Hwee-Lin
TI Sensitivity of three widely used questionnaires for measuring
   psychological distress among patients with type 2 diabetes mellitus
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE Sensitivity; DHP; PAID; K10; Psychological distress; Diabetes
ID QUALITY-OF-LIFE; PROBLEM AREAS; PSYCHOMETRIC EVALUATION; SCREENING
   SCALES; HEALTH; DEPRESSION; POPULATION; RESPONSIVENESS; METAANALYSIS;
   PREVALENCE
AB Although a range of generic and diabetes-specific instruments are available to assess emotional distress, no studies have evaluated sensitivity in relation to sample size requirement. The present study sets out to compare the sensitivity among the Diabetes Health Profile Psychological Distress scale (DHP-PD), Problem Areas in Diabetes (PAID) and Kessler-10 Psychological Distress scale (K10). We hypothesized that the diabetes-specific measures (DHP-PD and PAID) would require smaller sample sizes than the generic measure (K10), yet remain specific.
   A total of 208 patients with type 2 diabetes mellitus (mean age 45.2 (12.4) years; 63.1 % males, 45.8 % Chinese, 11.3 % Malay and 26.6 % Indian), recruited from a Singapore tertiary hospital diabetes clinic, completed the English DHP-PD, PAID and K10. Clinical information derived from medical records and HbA1c was recorded. Effect sizes (ES), ratio of ES and sample size requirement relative to the most sensitive questionnaire were computed.
   A comparison of patients with good versus poor glycaemic control (HbA1c a parts per thousand yen7.0) revealed that using K10 will require 4 times the sample size of a study using the PAID in order to detect the same level of psychological distress. The DHP-PD and PAID had similar sensitivity when comparing between patients with good versus poor glycaemic control.
   As hypothesized, sample size requirement is largest for K10 and remarkably similar for PAID and DHP-PD. This information is useful for designing clinical trials and studies.
C1 [Tan, L. S. M.; Tan, C. S.; Lee, Jeannette; Tai, E. S.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 119260, Singapore.
   [Khoo, E. Y. H.; New, Michelle; Tai, E. S.] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore.
   [Griva, K.; Mohamed, Amir] Natl Univ Singapore, Dept Psychol, Singapore 119260, Singapore.
   [Lee, Y. S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore.
   [Wee, Hwee-Lin] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore.
   [Wee, Hwee-Lin] Natl Univ Singapore, Dept Pharm, Singapore 119260, Singapore.
RP Wee, HL (reprint author), Natl Univ Singapore, Dept Pharm, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM phawhl@nus.edu.sg
RI Wee, Hwee-Lin/D-4126-2012; Griva, Konstadina/A-6549-2018; Lee, Yung
   Seng/F-2169-2014
OI Wee, Hwee-Lin/0000-0002-7150-1801; Lee, Yung Seng/0000-0002-1253-0557;
   Tai, E Shyong/0000-0003-2929-8966; Tan, Chuen Seng/0000-0002-6513-2309
FU Ministry of Education Singapore Academic Research Fund [FY2011-FRC3-007]
FX This work was supported by the grant from Ministry of Education
   Singapore Academic Research Fund Tier 1 (Grant No.: FY2011-FRC3-007).
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   [Anonymous], 2013, R LANG ENV STAT COMP
   [Anonymous], 2005, AUSTR MENT HLTH OUTC
   Beurskens AJHM, 1996, PAIN, V65, P71, DOI 10.1016/0304-3959(95)00149-2
   Board HP, 2011, NAT REG DIS OFF
   Cairney J, 2007, CAN J PSYCHIAT, V52, P111, DOI 10.1177/070674370705200209
   Chong SA, 2009, ASIAN J PSYCHIATR, V2, P66, DOI 10.1016/j.ajp.2009.04.012
   Cohen J, 1988, STAT POWER ANAL BEHA
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Ismail-Beigi F, 2012, NEW ENGL J MED, V366, P1319, DOI 10.1056/NEJMcp1013127
   Jena AB, 2013, JAMA INTERN MED, V173, P166, DOI 10.1001/jamainternmed.2013.1418
   Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008
   KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 1999, ACTA PSYCHIAT SCAND, V99, P2, DOI 10.1111/j.1600-0447.1999.tb05378.x
   Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537
   Machin D, 1997, SAMPLE SIZE TABLES C
   Meadows K, 1996, QUAL LIFE RES, V5, P242, DOI 10.1007/BF00434746
   Meadows K., 2010, SCORING THE DHP 18
   Meadows KA, 2000, DIABETIC MED, V17, P572, DOI 10.1046/j.1464-5491.2000.00322.x
   Pawaskar MD, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-50
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rajaram R., 2012, VALIDATION PROBLEM A
   Sherbourne C., 1992, MEASURING FUNCTIONIN, P183
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Support ST, 2011, STAT STAT SOFTW REL
   Tan L., 2014, RELIABILITY VALIDITY
   Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164
   Verma SK, 2010, ANN ACAD MED SINGAP, V39, P913
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006
NR 34
TC 4
Z9 4
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
EI 1573-2649
J9 QUAL LIFE RES
JI Qual. Life Res.
PD JAN
PY 2015
VL 24
IS 1
BP 153
EP 162
DI 10.1007/s11136-014-0747-z
PG 10
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA AY0OO
UT WOS:000347296200015
PM 24972975
DA 2019-01-08
ER

PT J
AU Walker, RJ
   Gebregziabher, M
   Martin-Harris, B
   Egede, LE
AF Walker, Rebekah J.
   Gebregziabher, Mulugeta
   Martin-Harris, Bonnie
   Egede, Leonard E.
TI Understanding the influence of psychological and socioeconomic factors
   on diabetes self-care using structured equation modeling
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Diabetes; Self-care; Psychosocial factors; Social determinants;
   Socioeconomic
ID OF-THE-LITERATURE; PSYCHOMETRIC PROPERTIES; DEPRESSION; DISTRESS;
   VALIDITY; HEALTH; SCALE; METAANALYSIS; PERSPECTIVES; INSTRUMENT
AB Objective: To develop and test latent variables of the social determinants of health that influence diabetes self-care.
   Methods: 615 adults with type 2 diabetes were recruited from two adult primary care clinics in the southeastern United States. Confirmatory factor analyses (CFA) identified the latent factors underlying socioeconomic determinants, psychosocial determinants, and self-care (diet, exercise, foot care, glucose testing, and medication adherence). Structured equation modeling (SEM) investigated the relationship between determinants and self-care.
   Results: Latent variables were created for diabetes self-care, psychological distress, self-efficacy, social support and social status. The initial model (chi2(254) = 388.04, p < 0.001, RMSEA = 0.03, CFI = 0.98) showed that lower psychological distress (r = -0.13, p = 0.019), higher social support (r = 0.15, p = 0.008), and higher self-efficacy (r = 0.47, p < 0.001) were significantly related to diabetes self-care. Social status was not significantly related to self-care (r = 0.003, p = 0.952). In the trimmed model (chi2(189) = 211.40, p = 0.126, RMSEA = 0.01, CFI = 0.99) lower psychological distress (r = -0.13, p = 0.016), higher social support (r = 0.15, p = 0.007), and higher self-efficacy (r = 0.47, p <0.001) remained significantly related to diabetes self-care.
   Conclusion: Based on theoretical relationships, three latent factors that measure social determinants of health (psychological distress, social support and self-efficacy) are strongly associated with diabetes self-care.
   Practice implications: This suggests that social determinants should be taken into account when developing patient self-care goals. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Walker, Rebekah J.; Gebregziabher, Mulugeta; Egede, Leonard E.] HEROIC, Charleston VA HSR&D COIN, Ralph H Johnson VAMC, Charleston, SC USA.
   [Walker, Rebekah J.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.
   [Walker, Rebekah J.; Martin-Harris, Bonnie] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA.
   [Gebregziabher, Mulugeta] Med Univ S Carolina, Dept Med, Div Publ Hlth Sci, Charleston, SC 29425 USA.
   [Martin-Harris, Bonnie] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA.
   [Egede, Leonard E.] Med Univ S Carolina, Dept Med, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280,POB 250593, Charleston, SC 29425 USA.
EM egedel@musc.edu
OI Gebregziabher, Mulugeta/0000-0002-4826-481X
FU National Institute of Diabetes and Digestive and Kidney Disease
   [K24DK093699-01]
FX This study was supported by Grant K24DK093699-01 from The National
   Institute of Diabetes and Digestive and Kidney Disease (PI: Leonard
   Egede).
CR Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   Alam R, 2009, PATIENT EDUC COUNS, V75, P25, DOI 10.1016/j.pec.2008.08.026
   American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287
   [Anonymous], HLTH PEOPL 2020 OPP
   Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605
   Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Byrne BM, 2005, J PERS ASSESS, V85, P17, DOI 10.1207/s15327752jpa8501_02
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Cohen S., 1988, SOCIAL PSYCHOL HLTH
   COSTELLO AB, 2005, PRACT ASSESS RES EVA, V10
   Cundiff JM, 2013, INT J BEHAV MED, V20, P148, DOI 10.1007/s12529-011-9206-1
   Delamater AM, 2001, DIABETES CARE, V24, P1286, DOI 10.2337/diacare.24.7.1286
   Dray-Spira R, 2010, DIABETES CARE, V33, P1200, DOI 10.2337/dc09-2094
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Egede LE, 2010, DIABETES EDUCATOR, V36, P276, DOI 10.1177/0145721710361389
   Egede LE, 2010, J GEN INTERN MED, V25, P61, DOI 10.1007/s11606-009-1168-5
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2010, DIABETES CARE, V33, P10346
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Funnell MM, 2012, DIABETES CARE, V35, pS101, DOI [10.2337/dc12-s101, 10.2337/dc12-S089]
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   International Diabetes Federation, 2013, IDF DIABETES ATLAS
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Marmot M, 2010, FAIR SOC HLTH LIVES
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   National Center for Health Statistics, 2004, SURV QUEST NAT HLTH
   Osborn CY, 2010, PATIENT EDUC COUNS, V79, P49, DOI 10.1016/j.pec.2009.07.016
   Sanchez BN, 2005, J AM STAT ASSOC, V100, P1443, DOI 10.1198/016214505000001005
   Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003
   Schumacker RE, 2010, BEGINNERS GUIDE STRU
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Sigurthardottir AK, 2005, J CLIN NURS, V14, P301, DOI 10.1111/j.1365-2702.2004.01043.x
   Tahmasebi R, 2014, ASIA PACIFIC J PUBLI
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker RJ, 2014, ENDOCRINE       0215
   Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y
   Whiting D, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P77
   Zheng P, 2013, BMC FAM PRACT, V14, P66
NR 47
TC 12
Z9 13
U1 1
U2 19
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD JAN
PY 2015
VL 98
IS 1
BP 34
EP 40
DI 10.1016/j.pec.2014.10.002
PG 7
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA AX5FO
UT WOS:000346952400004
PM 25455793
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Sukkarieh-Haraty, O
   Howard, E
AF Sukkarieh-Haraty, Ola
   Howard, Elizabeth
TI Is Social Support Universally Adaptive in Diabetes? A Correlational
   Study in an Arabic-Speaking Population With Type 2 Diabetes
SO HOLISTIC NURSING PRACTICE
LA English
DT Article
DE diabetes self-care; diabetes-specific emotional distress; glycemic
   control; Lebanese; social support; type 2 diabetes
ID GLYCEMIC CONTROL; PROBLEM AREAS; SELF-CARE; EDUCATION; SCALE; COMMUNITY;
   DISTRESS
AB The purpose of this study was to assess the relationship between diabetes self-care, diabetes-specific emotional distress, and social support and glycemic control (hemoglobin A(1C) levels: HbA(1c)) among a sample of Lebanese adults with type 2 diabetes. A descriptive correlational design was adapted with descriptive statistics and multiple logistic regressions for analyses. A convenience sample of 140 adults diagnosed with type 2 diabetes was recruited from 2 diabetes clinics in Greater Beirut. Participants were asked to complete 4 questionnaires in Arabic. Significant associations (P<.05) were found between following a general diet for more than 3.5 days per week and higher social support and HbA(1c) levels of 7% or more. Social support was positively associated with HbA(1c) levels such that participants with uncontrolled glycemic levels, as evidenced by higher values for HbA(1c), received more support from their social network.
C1 [Sukkarieh-Haraty, Ola] Lebanese Amer Univ, Sch Nursing, Byblos 11022801, Lebanon.
   [Howard, Elizabeth] Northeastern Univ, Bouve Coll Hlth Sci, Sch Nursing, Boston, MA 02115 USA.
RP Sukkarieh-Haraty, O (reprint author), Lebanese Amer Univ, Sch Nursing, Byblos 11022801, Lebanon.
EM ola.sukkarieh@lau.edu.lb
FU Lebanese American University
FX This work was supported by funding from the Lebanese American
   University.
CR Al-Akour N, 2003, RELATIONSHIPS KNOWLE
   Alragum SN, 2008, HLTH RELATED QUALITY
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Baffera M, 2008, HEALTH PSYCHOL, V27, pS118, DOI 10.1037/0278-6133.27.2(Suppl.).S118
   Batal M, 2007, FOOD NUTR BULL, V28, pS303, DOI 10.1177/15648265070282S209
   Doumit MAA, 2007, EUR J ONCOL NURS, V11, P309, DOI 10.1016/j.ejon.2007.02.008
   Dumit N, 2008, PERCEPTIONS CARDIAC
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Funnell MM, 2007, DIABETES SPECTR, V20, P221, DOI DOI 10.2337/DIASPECT.20.4.221
   Gherman A, 2011, PRACT DIABETES INT, V28, P125, DOI DOI 10.1002/PDI.1574
   Glasgow RE, 1999, DIABETES EDUCATOR, V25, P74, DOI 10.1177/014572179902500625
   Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04
   Goudswaard AN, 2004, EUR J EPIDEMIOL, V19, P541
   Haas L, 2013, DIABETES CARE, V36, pS100, DOI 10.2337/dc13-S100
   Huang MF, 2010, INT J NURS STUD, V47, P542, DOI 10.1016/j.ijnurstu.2009.10.012
   International Diabetes Federation, 2013, IDF DIABETES ATLAS
   International Diabetes Federation, 2011, IDF DIABETES ATLAS
   Johnson JA, 1996, DIABETES EDUCATOR, V22, P237, DOI 10.1177/014572179602200307
   Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008
   Naja F, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-111
   Newlin K, 2008, NURS RES, V57, P331, DOI 10.1097/01.NNR.0000313497.10154.66
   Papathanasiou Athanasia, 2008, Ment Health Fam Med, V5, P85
   Pollard SL, 2014, DIABETES ED, V31, P31
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Sabourin BC, 2013, CAN J DIABETES, V37, P36, DOI 10.1016/j.jcjd.2013.01.002
   Sibai A, 2010, WHO STEPS CHRONIC DI, P1
   Snoek FJ, 2002, INT J CLIN PRACT, P80
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Song M, 2010, J CARDIOVASC NURS, V25, P93, DOI 10.1097/JCN.0b013e3181c5a364
   Sulaiman N, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-80
   Tang WL, 2006, PHARMACOEPIDEM DR S, V15, P123, DOI 10.1002/pds.1166
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Turner RC, 1998, LANCET, V352, P837
   van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001
   Weigner K, 2009, ED YOUR PATIENTS DIA
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wysocki Tim, 2006, Curr Diab Rep, V6, P117, DOI 10.1007/s11892-006-0022-y
   Yoon PW, 2009, PREV CHRONIC DIS, V6
NR 38
TC 6
Z9 6
U1 2
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0887-9311
EI 1550-5138
J9 HOLIST NURS PRACT
JI Holist. Nurs. Pract.
PD JAN-FEB
PY 2015
VL 29
IS 1
BP 37
EP 47
DI 10.1097/HNP.0000000000000060
PG 11
WC Integrative & Complementary Medicine; Nursing
SC Integrative & Complementary Medicine; Nursing
GA AW1YH
UT WOS:000346084200007
PM 25470479
DA 2019-01-08
ER

PT J
AU Helgeson, VS
   Reynolds, KA
   Siminerio, LM
   Becker, DJ
   Escobar, O
AF Helgeson, Vicki S.
   Reynolds, Kerry A.
   Siminerio, Linda M.
   Becker, Dorothy J.
   Escobar, Oscar
TI Cognitive adaptation theory as a predictor of adjustment to emerging
   adulthood for youth with and without type 1 diabetes
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Cognitive adaptation theory; Diabetes; Emerging adult; Resilience
ID PSYCHOLOGICAL ADJUSTMENT; GLYCEMIC CONTROL; SELF-CARE; OUTCOMES;
   INTERVENTION; ADOLESCENTS; TRANSITION; STRESS; HEALTH; ANGIOPLASTY
AB Objective: The purpose of the study was to determine whether resilience, defined by cognitive adaptation theory, predicted emerging adulthood outcomes among youth with and without type 1 diabetes.
   Methods: Youth with (n = 118) and without type 1 diabetes (n = 122), who were part of a previous longituciinal study during adolescence, completed on-line questionnaires during their senior year of high school and one and two years later. They were average age 18, 53% female, and 93% white. Questionnaires assessed cognitive adaptation theory (CAT) indicators (self-esteem, mastery, optimism) and psychological, relationship, behavioral, vocational, and, for those with diabetes, diabetes outcomes.
   Results: The CAT index at baseline predicted reduced psychological distress, enhanced psychological well-being, increased friend support, reduced friend conflict, the presence of romantic relationships, reduced likelihood of romantic breakups, higher CPA, higher work satisfaction, and lower work stress during the transition to emerging adulthood. Among those with diabetes, the CAT index predicted better self-care behavior and revealed a marginal relation to better glycemic control. Analyses controlled for baseline levels when appropriate. Findings were stronger one year than two years post high school graduation, and findings were stronger for those with than without diabetes. Youth with diabetes also scored lower on the CAT index than youth without diabetes.
   Conclusions: These findings suggest that the implications of CAT include not only psychological health but also relationship, vocational, and diabetes outcomes. Those who score lower on CAT indicators should be identified as children so that interventions designed to enhance resilience can be implemented. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Helgeson, Vicki S.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.
   [Reynolds, Kerry A.] RAND Corp, Santa Monica, CA 90406 USA.
   [Siminerio, Linda M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.
   [Becker, Dorothy J.; Escobar, Oscar] Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA.
RP Helgeson, VS (reprint author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.
EM vh2e@andrew.cmu.edu
FU National Institutes of Health [R01 DK060586]
FX We appreciate the support of the study project manager, Pamela Snyder,
   and the research assistants, in particular Abigail Kunz-Vaughn, who
   worked on this project. This work was supported by the National
   Institutes of Health (R01 DK060586).
CR Aiken LS, 1996, MULTIPLE REGRESSION
   Allen D, 2009, DIABETIC MED, V26, P162, DOI 10.1111/j.1464-5491.2008.02647.x
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   [Anonymous], 1988, 9 ANN SESS SOC BEH M
   Arnett J. J., 2007, HDB SOCIALIZATION TH, P208, DOI DOI 10.1093/ACPROF:OSO/9780199757176.001.0001
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   BERNDT TJ, 1995, CHILD DEV, V66, P1312, DOI 10.1111/j.1467-8624.1995.tb00937.x
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   COYNE JC, 1976, J ABNORM PSYCHOL, V85, P186, DOI 10.1037/0021-843X.85.2.186
   DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542
   Eisenberg N, 2011, EFFORTFUL CONTROL RE, P259
   GARMEZY N, 1991, AM BEHAV SCI, V34, P416, DOI 10.1177/0002764291034004003
   Garner DM, 1990, EARING DISORDER INVE
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   Helgeson VS, 2013, DIABETIC MED, V30, P610, DOI 10.1111/dme.12067
   Helgeson V. S., 2012, HDB HLTH PSYCHOL, P518
   Helgeson VS, 2008, J PEDIATR PSYCHOL, V33, P497, DOI 10.1093/jpepsy/jsm081
   Helgeson VS, 2007, J PEDIATR PSYCHOL, V32, P794, DOI 10.1093/jpepsy/jsm020
   Helgeson VS, 2003, HEALTH PSYCHOL, V22, P30, DOI 10.1037/0278-6133.22.1.30
   HELGESON VS, 1992, J PERS SOC PSYCHOL, V63, P656, DOI 10.1037/0022-3514.63.4.656
   Helgeson VS, 1999, HEALTH PSYCHOL, V18, P561, DOI 10.1037/0278-6133.18.6.561
   HIBBARD JH, 1993, SOC SCI MED, V36, P217, DOI 10.1016/0277-9536(93)90005-O
   Hollingshead AB, 1975, 4 FACTOR INDEX SOCIA
   Johnston LD, 2005, MONITORING FUTURE NA, VII
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Kessler RC, 2004, MAC FDN MEN, P227
   King PS, 2011, J ADOLESCENT HEALTH, V50, P491
   Knaevelsrud C, 2010, J HEALTH PSYCHOL, V15, P1030, DOI 10.1177/1359105309360073
   Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138
   Lee V, 2006, SOC SCI MED, V62, P3133, DOI 10.1016/j.socscimed.2005.11.041
   Lewin AB, 2009, J PEDIATR PSYCHOL, V34, P999, DOI 10.1093/jpepsy/jsp032
   Luecken J. L., 2010, HDB ADULT RESILIENCE, P238
   Luyckx K, 2009, DIABETES CARE, V32, P797, DOI 10.2337/dc08-1990
   Lyons SK, 2014, PEDIAT DIAB IN PRESS
   Marigold DC, 2010, J EXP SOC PSYCHOL, V46, P624, DOI 10.1016/j.jesp.2010.02.011
   NORRIS FH, 1993, J APPL SOC PSYCHOL, V23, P1263, DOI 10.1111/j.1559-1816.1993.tb01032.x
   Palladino DK, 2013, J PEDIATR PSYCHOL, V38, P506, DOI 10.1093/jpepsy/jst002
   PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Reynolds KA, 2011, ANN BEHAV MED, V42, P29, DOI 10.1007/s12160-011-9262-4
   Rosenberg M, 1965, SOC ADOLESCENT SELF
   Ruehlman L. S., 1991, PSYCHOL ASSESSMENT, V3, P97, DOI DOI 10.1037/1040-3590.3.1.97
   Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2
   Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601
   RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719, DOI 10.1037//0022-3514.69.4.719
   SCHEIER MF, 1985, J APPL SOC PSYCHOL, V15, P687, DOI 10.1111/j.1559-1816.1985.tb02268.x
   Staudinger U. M., 1995, DEV PSYCHOPATHOL, V2, P801
   STEEL JM, 1989, BRIT J PSYCHIAT, V155, P515, DOI 10.1192/bjp.155.4.515
   Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107
   Substance Abuse and Mental Health Services Administration, 2011, RES 2010 NAT SURV DR
   Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x
   TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193
   Tomich PL, 2006, J CONSULT CLIN PSYCH, V74, P980, DOI 10.1037/0022-006X.74.5.980
   WALLANDER JL, 1988, J PEDIATR PSYCHOL, V13, P197, DOI 10.1093/jpepsy/13.2.197
   Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613
   Yi JP, 2008, BRIT J HEALTH PSYCH, V13, P311, DOI 10.1348/135910707X186994
   Yi-Frazier JP, 2010, STRESS HEALTH, V26, P51, DOI 10.1002/smi.1258
   Yi-Frazier JP, 2013, J HEALTH PSYCHOL, P1
   Zautra AJ, 2010, OXFORD HDB STRESS HL, P173, DOI DOI 10.1093/OXFORDHB/9780195375343.013.0009
NR 60
TC 3
Z9 3
U1 0
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD DEC
PY 2014
VL 77
IS 6
BP 484
EP 491
DI 10.1016/j.jpsychores.2014.09.013
PG 8
WC Psychiatry
SC Psychiatry
GA AY7LM
UT WOS:000347741700008
PM 25294781
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Zhao, GX
   Okoro, CA
   Li, J
   White, A
   Dhingra, S
   Li, CY
AF Zhao, Guixiang
   Okoro, Catherine A.
   Li, Jun
   White, Arica
   Dhingra, Satvinder
   Li, Chaoyang
TI Current depression among adult cancer survivors: Findings from the 2010
   Behavioral Risk Factor Surveillance System
SO CANCER EPIDEMIOLOGY
LA English
DT Article
DE Cancer survivor; Current depression; Depressive symptoms; Patient Health
   Questionnaire-8 (PHQ-8); BRFSS
ID QUALITY-OF-LIFE; HEALTH INTERVIEW SURVEY; LONG-TERM SURVIVORS;
   PSYCHOLOGICAL DISTRESS; BREAST-CANCER; UNITED-STATES; ANXIETY;
   POPULATION; PREVALENCE; DIAGNOSIS
AB Background: A cancer diagnosis and subsequent treatments constitute a significantly increased psychological burden among cancer patients. This study examined the prevalence of current depression and the risk factors associated with a high burden of depression among cancer survivors in the US.
   Methods: We analyzed data from 3550 cancer survivors (aged >= 18 years) and 26,917 adults without cancer who participated in the 2010 Behavioral Risk Factor Surveillance System. Depressive symptoms were assessed by the Patient Health Questionnaire-8 diagnostic algorithm. Participants with a total depression severity score of >= 10 were defined as having current depression. Prevalence and prevalence ratios were estimated by conducting log-linear regression analysis while controlling for potential confounders.
   Results: Overall, 13.7% of cancer survivors (vs. 8.9% of adults without cancer, P < 0.001) reported having current depression; the prevalence varied significantly by cancer category. Among cancer survivors, after multivariate adjustment for covariates, cancer diagnosis within a year, being in 'other' racial/ethnic group, divorced, separated, widowed, or never married, current or former smoker, or having histories of diabetes, disability, or depression were associated with significantly higher prevalence ratios for current depression; whereas being at an advanced age (>= 60 years old), attaining educational levels of >high school graduate, or engaging in leisure-time physical activity were associated with significantly lower prevalence ratios for current depression.
   Conclusion: Our results indicate that cancer survivors are at increased risk of current depression. Targeting cancer survivors at high risk of depressive issues may be especially important for clinical support and interventions aimed at improving mental well-being. Published by Elsevier Ltd.
C1 [Zhao, Guixiang; Okoro, Catherine A.; Li, Chaoyang] Ctr Dis Control & Prevent, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30345 USA.
   [Li, Jun; White, Arica] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30345 USA.
   [Dhingra, Satvinder] Northrop Grumman Corp, Atlanta, GA 30345 USA.
   [Li, Chaoyang] Ctr Dis Control & Prevent, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30345 USA.
RP Zhao, GX (reprint author), Ctr Dis Control & Prevent, 2500 Century Pkwy,Mailstop E-83, Atlanta, GA 30345 USA.
EM GZhao@cdc.gov
CR Banks E, 2010, MED J AUSTRALIA, V193, pS62
   Boyes AW, 2011, J AFFECT DISORDERS, V135, P184, DOI 10.1016/j.jad.2011.07.016
   Boyes AW, 2009, MED J AUSTRALIA, V190, pS94
   Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3
   Carlson Linda E, 2003, Health Qual Life Outcomes, V1, P8, DOI 10.1186/1477-7525-1-8
   Centers for Disease Control and Prevention, 2014, BEH RISK FACT SURV S
   DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235
   Di FF, 2008, TUMORI, V94, P30
   Diedrich K, 2011, REPROD BIOMED ONLINE, V22, P232, DOI 10.1016/j.rbmo.2010.11.001
   Gordon LG, 2011, ASIA-PAC J CLIN ONCO, V7, P96, DOI 10.1111/j.1743-7563.2011.01395.x
   Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82
   Hoffman KE, 2009, ARCH INTERN MED, V169, P1274, DOI 10.1001/archinternmed.2009.179
   Kash KM, 2005, SEMIN ONCOL, V32, P211, DOI 10.1053/j.seminoncol.2004.11.011
   Kasparian NA, 2009, ARCH DERMATOL, V145, P1415, DOI 10.1001/archdermatol.2009.308
   Krebber AMH, 2014, PSYCHO-ONCOLOGY, V23, P121, DOI 10.1002/pon.3409
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   KROENKE K, 2002, PSYCHIAT ANN, V32, P1, DOI DOI 10.3928/0048-5713-20020901-06
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Krouse RS, 2009, J CLIN ONCOL, V27, P4664, DOI 10.1200/JCO.2008.20.9502
   Ku PW, 2012, AM J PREV MED, V42, P355, DOI 10.1016/j.amepre.2011.11.010
   Li C, 2014, J CANC SURVIV
   Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025
   Loeb S, 2013, J UROLOGY, V190, P1742, DOI 10.1016/j.juro.2013.05.054
   Management of localised prostate cancer, 2012, PRESCRIRE INT, V21, P242
   Massie Mary Jane, 2004, J Natl Cancer Inst Monogr, P57
   Mehnert A, 2008, J PSYCHOSOM RES, V64, P383, DOI 10.1016/j.jpsychores.2007.12.005
   Mitchell AJ, 2013, LANCET ONCOL, V14, P721, DOI 10.1016/S1470-2045(13)70244-4
   Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X
   Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1
   Murphy SL, 2014, NATL VITAL STAT REPO
   Neilson KA, 2010, MED J AUSTRALIA, V193, pS48
   Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335
   Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3
   O'Connor M, 2010, MED J AUSTRALIA, V193, pS44
   Parry C, 2011, CANCER EPIDEM BIOMAR, V20, P1996, DOI 10.1158/1055-9965.EPI-11-0729
   Richardson LC, 2008, CANCER, V112, P1380, DOI 10.1002/cncr.23291
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Stagl JM, 2014, HLTH PSYCHOL
   Strine TW, 2008, PSYCHIAT SERV, V59, P1383, DOI 10.1176/appi.ps.59.12.1383
   Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9
   Wallace WHB, 2003, HUM REPROD, V18, P117, DOI 10.1093/humrep/deg016
   Weaver KE, 2012, CANCER EPIDEM BIOMAR, V21, P2108, DOI 10.1158/1055-9965.EPI-12-0740
   Yabroff KR, 2004, J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255
   Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268
   Zhao GX, 2013, J CANCER SURVIV, V7, P131, DOI 10.1007/s11764-012-0254-6
NR 45
TC 9
Z9 10
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1877-7821
EI 1877-783X
J9 CANCER EPIDEMIOL
JI Cancer Epidemiol.
PD DEC
PY 2014
VL 38
IS 6
BP 757
EP 764
DI 10.1016/j.canep.2014.10.002
PG 8
WC Oncology; Public, Environmental & Occupational Health
SC Oncology; Public, Environmental & Occupational Health
GA AW8IC
UT WOS:000346503900016
PM 25455653
DA 2019-01-08
ER

PT J
AU Dempsey, PC
   Howard, BJ
   Lynch, BM
   Owen, N
   Dunstan, DW
AF Dempsey, Paddy C.
   Howard, Bethany J.
   Lynch, Brigid M.
   Owen, Neville
   Dunstan, David W.
TI Associations of television viewing time with adults' well-being and
   vitality
SO PREVENTIVE MEDICINE
LA English
DT Article
DE Television viewing; Sedentary behaviour; Quality of life; Well-being;
   Vitality; Mental health; Gender; Physical activity
ID QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; AUSTRALIAN
   ADULTS; SITTING TIME; OLDER-ADULTS; MENTAL-HEALTH; LEISURE-TIME;
   SCREEN-TIME; PSYCHOLOGICAL DISTRESS
AB Objective. Television (TV) viewing, a common leisure-time sedentary behaviour, is associated adversely with cardio-metabolic health, fatigue, depression and mental health. However, associations of TV viewing time with health-related quality of life attributes are less well understood. We examined associations of TV viewing time with physical well-being, mental well-being and vitality in a large population-based sample of Australian adults.
   Method. The study sample comprised 4,483 men and 5,424 women (mean age 51 +/- 14 years) from the Australian Diabetes, Obesity and Lifestyle study (1999-2000). Multiple linear regressions examined associations of TV viewing time (h/day) with the SF-36v1 physical and mental health component summary scores and the vitality sub-score, adjusting for leisure-time physical activity and waist circumference.
   Results. Each 1-h/day increment in TV viewing time was associated with lower physical (-0.56 [95% Cl: -0.77, -034]) and mental (-0.41 [-0.70, -0.12]) component summary scores and vitality (-0.51 [-0.81, -0.21]). Associations remained significant after adjustment for leisure-time physical activity and waist circumference. There was a gender interaction for the association of TV viewing time with vitality (significant in men only).
   Conclusions. TV viewing time is associated adversely with physical well-being, mental well-being and vitality. Further studies are required to better understand potential causal relationships and variations by gender and leisure-time physical activity. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Dempsey, Paddy C.; Howard, Bethany J.; Lynch, Brigid M.; Owen, Neville; Dunstan, David W.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia.
   [Dempsey, Paddy C.; Howard, Bethany J.; Owen, Neville; Dunstan, David W.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia.
   [Lynch, Brigid M.; Owen, Neville] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia.
   [Owen, Neville; Dunstan, David W.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.
   [Dunstan, David W.] Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia.
   [Dunstan, David W.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.
   [Dunstan, David W.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia.
RP Dempsey, PC (reprint author), Baker IDI Heart & Diabet Inst, Phys Act & Behav Epidemiol Lab, 99 Commercial Rd, Melbourne, Vic 3004, Australia.
EM Paddy.Dempsey@bakeridi.edu.au
RI Dunstan, David/E-8473-2010; Owen, Neville/K-5986-2012
OI Dunstan, David/0000-0003-2629-9568; Owen, Neville/0000-0003-2784-4820
FU National Health and Medical Research Council [566940, 586727]; Victorian
   Government's OIS Program; Commonwealth Department of Health and Aged
   Care; Abbott Australasia Pty Ltd.; Alphapharm Pty Ltd.; Aventis
   Pharmaceutical; AstraZeneca; Bristol-Myers Squibb Pharmaceuticals; Eli
   Lilly (Aust) Pty Ltd.; GlaxoSmithKline; Janssen-Cilag (Aust) Pty Ltd.;
   Merck Lipha s.a; Merck Sharp 82 Dohme (Aust); Novartis Pharmaceutical
   (Aust) Pty Ltd.; Novo Nordisk Pharmaceutical Pty Ltd.; Pharmacia and
   Upjohn Pty Ltd.; Pfizer Pty Ltd.; Sanofi Synthelabo (Aust) Pty Ltd.;
   Servier Laboratories (Aust) Pty Ltd.; BioRad Laboratories Pty Ltd.;
   HITECH Pathology Pty Ltd.; Australian Kidney Foundation; Diabetes
   Australia; Diabetes Australia (Northern Territory); Queensland Health;
   South Australian Department of Human Services; Tasmanian Department of
   Health and Human Services; Territory Health Services; Victorian
   Department of Human Services; National Health and Medical Research
   Council/National Heart Foundation Postgraduate Scholarship [1056320];
   Australian Research Council Research Fellowship [FT100100918]; Senior
   Principal Research Fellowship [1003960]; Roche Diagnostics; Health
   Department of Western Australia
FX This work was supported by the following: National Health and Medical
   Research Council Program Grant [grant number 566940 to NO], National
   Health and Medical Research Council/National Heart Foundation
   Postgraduate Scholarship [grant number 1056320 to BJH], National Health
   and Medical Research Council Early Career Fellowship [grant number
   586727 to BML], Australian Research Council Research Fellowship to DWD
   [FT100100918] and Senior Principal Research Fellowship [grant number
   1003960 to NO]. This study was also supported in part by the Victorian
   Government's OIS Program. The funders of this study had no role in the
   data analysis or interpretation of the results. We are most grateful to
   the following for their support of the study: Commonwealth Department of
   Health and Aged Care, Abbott Australasia Pty Ltd., Alphapharm Pty Ltd.,
   Aventis Pharmaceutical, AstraZeneca, Bristol-Myers Squibb
   Pharmaceuticals, Eli Lilly (Aust) Pty Ltd., GlaxoSmithKline,
   Janssen-Cilag (Aust) Pty Ltd., Merck Lipha s.a., Merck Sharp 82 Dohme
   (Aust), Novartis Pharmaceutical (Aust) Pty Ltd., Novo Nordisk
   Pharmaceutical Pty Ltd., Pharmacia and Upjohn Pty Ltd., Pfizer Pty Ltd.,
   Roche Diagnostics, Sanofi Synthelabo (Aust) Pty Ltd., Servier
   Laboratories (Aust) Pty Ltd., BioRad Laboratories Pty Ltd., HITECH
   Pathology Pty Ltd., the Australian Kidney Foundation, Diabetes
   Australia, Diabetes Australia (Northern Territory), Queensland Health,
   South Australian Department of Human Services, Tasmanian Department of
   Health and Human Services, Territory Health Services, Victorian
   Department of Human Services and Health Department of Western Australia.
   Also, we are enormously grateful to the following for their invaluable
   contribution to the field activities of AusDiab: Annie Allman, Marita
   Dalton, Adam Meehan, Claire Reid, Alison Stewart, Robyn Tapp and Fay
   Wilson. The AusDiab Steering Committee consists of Dr. B. Atkins, Dr. S.
   Bennett, Dr. S. Chadban, Prof. S. Colagiuri, Dr. M. de Courten, Dr. M.
   D'Embden, Dr. D. Dunstan, Prof. T. Dwyer, Dr. D. Jolley, Dr. P. Magnus,
   Prof. J. Mathews, Dr. D. McCarty, Prof. K. O'Dea, Dr. P. Phillips, Dr.
   P. Popplewell, Mr. I. Kemp, Prof. H. Taylor, Prof. T. Welborn and Prof.
   P. Zimmet. We are most grateful to Parneet Sethi for statistical
   support; and especially the participants for volunteering their time to
   be in the study.
CR Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624
   Atkin AJ, 2012, ANN BEHAV MED, V43, P181, DOI 10.1007/s12160-011-9320-y
   [Australian Bureau of Statistics Statistics ABo], 1997, NAT HLTH SURV SF36 P, P13
   Australian Institute of Health and Welfare, 2003, ACT AUSTR SURV GUID
   Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47
   Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]
   Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185
   Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017
   Brown WJ, 2012, DEV EVIDENCE BASED P
   Brunet J, 2014, PREV MED, V60, P16, DOI 10.1016/j.ypmed.2013.12.003
   Cameron AJ, 2003, MED J AUSTRALIA, V178, P427
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Clark BK, 2009, OBES REV, V10, P7, DOI 10.1111/j.1467-789X.2008.00508.x
   Davies CA, 2012, PREV MED, V55, P46, DOI 10.1016/j.ypmed.2012.05.003
   Duncan MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1060
   Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824
   Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4
   Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6
   Ellingson LD, 2014, MED SCI SPORT EXER, V46, P192, DOI 10.1249/MSS.0b013e3182a036ab
   Faulkner G, 2013, MENT HEALTH PHYS ACT, V6, P1, DOI 10.1016/j.mhpa.2013.02.003
   Gilson ND, 2011, HEALTH PROMOT J AUST, V22, P38
   Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812
   GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009
   Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1
   Hamer M, 2013, BRAIN BEHAV IMMUN, V33, P29, DOI 10.1016/j.bbi.2013.05.001
   Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030
   Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4
   Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305
   Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046
   Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421
   Howard B.J., 2014, BR J SPORTS MED
   Kikuchi H, 2014, PREV MED, V67, P335, DOI 10.1016/j.ypmed.2014.08.011
   Kilpatrick M, 2013, MENT HEALTH PHYS ACT, V6, P103, DOI 10.1016/j.mhpa.2013.06.004
   Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017
   Lynch BM, 2010, CANCER CAUSE CONTROL, V21, P283, DOI 10.1007/s10552-009-9460-6
   Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620
   Nang EEK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-70
   Newby PK, 2003, AM J CLIN NUTR, V78, P941
   Owen N, 2012, PREV MED, V55, P535, DOI 10.1016/j.ypmed.2012.08.024
   Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444
   Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2
   Primack BA, 2009, ARCH GEN PSYCHIAT, V66, P181, DOI 10.1001/archgenpsychiatry.2008.532
   Rosenkranz RR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1071
   Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203
   Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178
   Sloan RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-885
   Sugiyama T, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-35
   Teychenne M, 2011, INT J BEHAV MED, V17, P246, DOI 10.1007/s12529-010-9075-z
   Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493
   Valiance JK, 2013, MENT HEALTH PHYS ACT, V6, P49, DOI 10.1016/j.mhpa.2013.02.002
   Vallance JK, 2011, PREV MED, V53, P284, DOI 10.1016/j.ypmed.2011.07.013
   Veerman JL, 2011, BR J SPORTS MED
   Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728
   Ware JE, 2001, SF 36 PHYS MENTAL HL
   Wijndaele K, 2009, EUR J CLIN NUTR, V63, P421, DOI 10.1038/sj.ejcn.1602944
   Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105
   Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac
   World Health Organization, 2006, CONST WHO
   Yorston LC, 2012, J AM GERIATR SOC, V60, P719, DOI 10.1111/j.1532-5415.2012.03906.x
NR 62
TC 13
Z9 13
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-7435
EI 1096-0260
J9 PREV MED
JI Prev. Med.
PD DEC
PY 2014
VL 69
BP 69
EP 74
DI 10.1016/j.ypmed.2014.09.007
PG 6
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA AW3ZN
UT WOS:000346221600013
PM 25230366
DA 2019-01-08
ER

PT J
AU Belendez, M
   Hernandez-Mijares, A
   Marco, J
   Dominguez, JR
   Pomares, FJ
AF Belendez, Marina
   Hernandez-Mijares, Antonio
   Marco, Jose
   Dominguez, Jose R.
   Pomares, Francisco J.
TI Validation of the Spanish version of the Problem Areas in Diabetes
   (PAID-SP) Scale
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Paid; Stress
ID EMOTIONAL DISTRESS; DEPRESSION; VALIDITY
AB This study aimed to assess the psychometric properties of the Spanish version of the Problem Areas in Diabetes (PAID-SP) Scale. Data were collected from patients with type 1 and type 2 diabetes. The findings suggested that the PAID-SP is a reliable and valid measure of diabetes-specific emotional problems. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Belendez, Marina] Univ Alicante, Dept Comunicac & Psicol Social, E-03080 Alicante, Spain.
   [Hernandez-Mijares, Antonio; Marco, Jose] Univ Hosp Doctor Peset, Serv Endocrinol, Valencia, Spain.
   [Hernandez-Mijares, Antonio] Univ Valencia, Dept Med, Valencia, Spain.
   [Dominguez, Jose R.; Pomares, Francisco J.] Univ Hosp San Juan, Dept Endocrinol, Alicante, Spain.
RP Belendez, M (reprint author), Univ Alicante, Dept Comunicac & Psicol Social, Campus San Vicente Raspeig,Ap 99, E-03080 Alicante, Spain.
EM marina.belendez@ua.es
RI Hernandez Mijares, Antonio/D-3411-2011; POMARES, FRANCISCO/F-8068-2016
OI Hernandez Mijares, Antonio/0000-0003-2197-0607; POMARES,
   FRANCISCO/0000-0002-0202-1265; Hernandez Mijares,
   Antonio/0000-0003-4099-1905; Belendez, Marina/0000-0002-5567-1069
CR Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Belendez M, 2009, CHRONIC ILLN, V5, P250, DOI 10.1177/1742395309346464
   BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004
   Burnham K. P., 2002, MODEL SELECTION INFE
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2013, PRIM CARE DIABETES, V7, P1, DOI 10.1016/j.pcd.2012.11.002
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   Huis In T, 2011, CARDIOVASC PSYCHIAT
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spielberger CD, 1982, CUESTIONARIO ANSIEDA
   Vieta A, 2011, CLIN THER, V33, P1225, DOI 10.1016/j.clinthera.2011.07.013
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch G, 2007, ETHNIC DIS, V17, P541
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 18
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD DEC
PY 2014
VL 106
IS 3
BP E93
EP E95
DI 10.1016/j.diabres.2014.09.012
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AW1PF
UT WOS:000346060800012
PM 25451898
DA 2019-01-08
ER

PT J
AU D'Addio, F
   Trevisani, A
   Ben Nasr, M
   Bassi, R
   El Essawy, B
   Abdi, R
   Secchi, A
   Fiorina, P
AF D'Addio, Francesca
   Trevisani, Alessio
   Ben Nasr, Moufida
   Bassi, Roberto
   El Essawy, Basset
   Abdi, Reza
   Secchi, Antonio
   Fiorina, Paolo
TI Harnessing the immunological properties of stem cells as a therapeutic
   option for diabetic nephropathy
SO ACTA DIABETOLOGICA
LA English
DT Review
DE Diabetic nephropathy; Stem cells; Type 2 diabetes; Type 1 diabetes
ID ACUTE KIDNEY INJURY; RENAL PROGENITORS; OXIDATIVE STRESS; DISEASE;
   TRANSPLANTATION; INFLAMMATION; MICE; RATS; PATHOGENESIS; PROGRESSION
AB Diabetic nephropathy is the leading and possibly the most devastating complication of diabetes, with a prevalence ranging from 25 to 40 % in diabetic individuals, and as such represents an important challenge for public health worldwide. As a major cause of end-stage renal disease, diabetic nephropathy also accounts for a large proportion of deaths in diabetic individuals. To date, therapeutic options for overt diabetic nephropathy include medical interventions to reduce blood glucose levels and to control blood pressure and proteinuria. Recent evidence suggests a strong role for inflammation in the development and progression of diabetic nephropathy. Various immune cells, cytokines and chemokines have been implicated in the onset of diabetic nephropathy, while immune-related transcription factors and adhesion molecules have been correlated with the establishment of a renal proinflammatory microenvironment. Both inflammation and immune activation may promote severe distress in the kidney, with subsequent increased local fibrosis, ultimately leading to the development of end-stage renal disease. Stem cells are undifferentiated cells capable of regenerating virtually any organ or tissue and bearing important immunoregulatory and anti-inflammatory properties. Due to the aforementioned considerations, significant interest has been ignited with regard to the use of stem cells as novel therapeutics for diabetic nephropathy. Here, we will be examining in detail how anti-inflammatory properties of different populations of stem cells may offer novel therapy for the treatment of diabetic nephropathy.
C1 [D'Addio, Francesca; Bassi, Roberto; Secchi, Antonio; Fiorina, Paolo] IRCCS Osped San Raffaele, Milan, Italy.
   [D'Addio, Francesca; Ben Nasr, Moufida; Bassi, Roberto; Fiorina, Paolo] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA.
   [Trevisani, Alessio] Univ Roma Tor Vergata, Rome, Italy.
   [El Essawy, Basset] Al Azhar Univ, Dept Med, Cairo, Egypt.
   [Abdi, Reza] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Nephrol, Boston, MA 02115 USA.
   [Secchi, Antonio] Univ Vita Salute San Raffaele, Milan, Italy.
RP Fiorina, P (reprint author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Nephrol, 300 Longwood Ave,Enders Bldg 5th Floor Room En511, Boston, MA 02115 USA.
EM paolo.fiorina@childrens.harvard.edu
RI D'Addio, Francesca/F-3417-2017
OI D'Addio, Francesca/0000-0002-0345-0694
FU JDRF Career Development Award; ASN Career Development Award; ADA
   Mentor-based Fellowship grant; Translational Research Program (TRP)
   grant from Boston Children's Hospital; Harvard Stem Cell Institute
   [DP-0123-12-00]; Italian Ministry of Health [RF-2010-2303119,
   RF-2010-2314794, RF-FSR-2008-1213704]; Italian Scientists and Scholars
   of North America Foundation (ISSNAF)-Fondazione Marche Fellowship
FX Paolo Fiorina is the recipient of a JDRF Career Development Award, an
   ASN Career Development Award and an ADA Mentor-based Fellowship grant.
   P. F. is also supported by a Translational Research Program (TRP) grant
   from Boston Children's Hospital, a Harvard Stem Cell Institute grant
   ("Diabetes Program" DP-0123-12-00) and an Italian Ministry of Health
   grant (RF-2010-2303119, RF-2010-2314794 and RF-FSR-2008-1213704).
   Francesca D'Addio is the recipient of an Italian Scientists and Scholars
   of North America Foundation (ISSNAF)-Fondazione Marche Fellowship.
CR Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377
   Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180
   Adhikary L, 2004, DIABETOLOGIA, V47, P1210, DOI 10.1007/s00125-004-1437-0
   Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Astorri E, 1997, CARDIOLOGY, V88, P152, DOI 10.1159/000177322
   Atkins RC, 2010, J NEPHROL, V23, P1
   Bennett WM, 1996, AM J KIDNEY DIS, V28, pS56, DOI 10.1016/S0272-6386(96)90570-3
   Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067
   Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022
   Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6
   Caramori ML, 2002, DIABETES, V51, P506, DOI 10.2337/diabetes.51.2.506
   Chang JW, 2011, CELL TRANSPLANT, V20, P245, DOI 10.3727/096368910X520056
   Chhabra P, 2009, CURR OPIN ORGAN TRAN, V14, P72, DOI 10.1097/MOT.0b013e328320d2f5
   Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938
   D'Addio F, 2014, DIABETES IN PRESS
   D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031
   Doria A, 2012, SEMIN NEPHROL, V32, P437, DOI 10.1016/j.semnephrol.2012.07.006
   Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299
   Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188
   Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006
   Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171
   Fang Y, 2012, INT J MOL MED, V30, P85, DOI 10.3892/ijmm.2012.977
   Fiorina P, 2014, J AM SOC NEPHROL
   Fiorina P, 2012, ACTA DIABETOL, V49, pS133, DOI 10.1007/s00592-012-0369-2
   Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008
   Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010
   Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859
   Gammaitoni L, 2004, BLOOD, V103, P4440, DOI 10.1182/blood-2003-09-3079
   Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164
   Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013
   Himmelfarb J, 2013, NEW ENGL J MED, V369, P2549, DOI 10.1056/NEJMe1313104
   Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148
   Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104
   Lee PY, 2012, CELL TRANSPLANT, V21, P2569, DOI 10.3727/096368912X636902
   Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463
   Lim AKH, 2009, DIABETOLOGIA, V52, P1669, DOI 10.1007/s00125-009-1399-3
   Lim AK, 2012, MEDIAT INFLAMM, V2012, P146
   Lin FM, 2008, PEDIATR NEPHROL, V23, P851, DOI 10.1007/s00467-007-0634-8
   Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210
   Little MH, 2006, J AM SOC NEPHROL, V17, P2390, DOI 10.1681/ASN.2006030218
   Luz-Crawford P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045272
   MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048
   Maffi P, 2007, DIABETES CARE, V30, P1150, DOI 10.2337/dc06-1794
   Fernandez-Real JM, 2012, ACTA DIABETOL, V49, P301, DOI 10.1007/s00592-011-0349-y
   Masoad RE, 2012, PHARMACOL REP, V64, P1223, DOI 10.1016/S1734-1140(12)70918-0
   Mima A, 2012, SEMIN NEPHROL, V32, P471, DOI 10.1016/j.semnephrol.2012.07.010
   Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293
   Nathan DM, 2005, NEW ENGL J MED, V353, P2643
   National Kidney F, 2012, AM J KIDNEY DIS, V60, P850, DOI DOI 10.1053/J.AJKD.2012.07.005
   Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51
   Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627
   Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586
   Paroni R, 2005, AMINO ACIDS, V28, P389, DOI 10.1007/s00726-005-0191-z
   Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a
   RamachandraRao SP, 2009, J AM SOC NEPHROL, V20, P1765, DOI 10.1681/ASN.2008090931
   Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699
   Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59
   Rojas-Rios P, 2014, STEM CELLS, V32, P852, DOI 10.1002/stem.1621
   Romagnani P, 2013, NAT REV NEPHROL, V9, P137, DOI 10.1038/nrneph.2012.290
   Romagnani P, 2013, TRENDS ENDOCRIN MET, V24, P13, DOI 10.1016/j.tem.2012.09.002
   Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057
   Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522
   Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997
   Suarez-Alvarez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010192
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Taylor CJ, 2011, PHILOS T R SOC B, V366, P2312, DOI 10.1098/rstb.2011.0030
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   US Renal Data System, 2010, USRDS 2010 ANN DAT R
   Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198
   Wang S, 2013, BIOL BLOOD MARROW TR, V19, P538, DOI 10.1016/j.bbmt.2013.01.001
   Williams WW, 2012, DIABETES, V61, P2187, DOI 10.2337/db11-0751
   Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572
   Zhou H, 2009, CHINESE MED J-PEKING, V122, P2573, DOI 10.3760/cma.j.issn.0366-6999.2009.21.009
NR 74
TC 14
Z9 14
U1 0
U2 15
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD DEC
PY 2014
VL 51
IS 6
BP 897
EP 904
DI 10.1007/s00592-014-0603-1
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AU1PJ
UT WOS:000345392300001
PM 24894496
DA 2019-01-08
ER

PT J
AU Amer, NRY
   Hamdan-Mansour, AM
AF Amer, Nuha Remon Yacoub
   Hamdan-Mansour, Ayman M.
TI Psychosocial Predictors of Suicidal Ideation in Patients Diagnosed with
   Chronic Illnesses in Jordan
SO Issues in Mental Health Nursing
LA English
DT Article
ID MAJOR DEPRESSION; PSYCHOLOGICAL DISTRESS; MEDICAL INPATIENTS;
   CANCER-PATIENTS; UNITED-STATES; RISK-FACTOR; DISEASE; PREVALENCE;
   THOUGHTS; OPTIMISM
AB Suicide ideation (SI) is considered a major psychiatric emergency in patients diagnosed with chronic illnesses. Suicide ideation is a multifaceted issue that involves bio-psychosocial and cultural factors that interfere with patients' abilities. The purpose of this study is to investigate the psychosocial predictors of SI among Jordanian patients with chronic illnesses. A cross-sectional design using self-administered questionnaires was used to collect data from 480 patients diagnosed with diabetes mellitus, cardiovascular diseases, and cancer. The mean score of suicide ideation was 4.07 (SD = 1.7) and almost 20% (n = 85) of the participants found to be suicidal, the majority were suffering from moderate to severe depressive symptoms and low levels of life satisfaction. Also, the analysis showed that the patients had a high level of optimism and moderate perception of social support from family, friends, and significant other. Type of illness has a significant relation to the 'seriousness' component of SI (p = 0.023). Depression (beta = 0.345, p<0.001) was a significant risk factor for 'thought' component of SI, and optimism (beta = -0.008, p < 0.05) a significant protective factor against the thought component of SI. Patients with chronic illnesses suffer serious psychological disturbances and are in need of psychological care, and periodic psychological screening to maintain their psychological wellbeing.
C1 [Amer, Nuha Remon Yacoub] Royal Med Serv Coll Allied Profess, Amman, Jordan.
   [Hamdan-Mansour, Ayman M.] Univ Jordan, Fac Nursing, Amman, Jordan.
   [Hamdan-Mansour, Ayman M.] Al Farabi Coll, Dept Nursing, Riyadh, Saudi Arabia.
RP Amer, NRY (reprint author), Royal Med Serv Coll Allied Profess, Acad Wing, Amman, Jordan.
EM nuhamaster@gmail.com
CR Alberdi-Sudupe J, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-51
   Alderson SL, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-41
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Anguiano L, 2012, CANCER NURS, V35, pE14, DOI 10.1097/NCC.0b013e31822fc76c
   Arabiat DH, 2012, J PEDIATR ONCOL NURS, V29, P283, DOI 10.1177/1043454212451524
   Bakst S, 2010, SCHIZOPHRENIA BULL, V36, P880, DOI 10.1093/schbul/sbp001
   Beck AT, 1996, BECK DEPRESSION INVE
   Botega NJ, 2010, GEN HOSP PSYCHIAT, V32, P396, DOI 10.1016/j.genhosppsych.2010.02.004
   BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301
   Chapman D. W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI DOI 10.3102/01623737001003071
   Crosby Alex E., 2011, Morbidity and Mortality Weekly Report, V60, P1
   de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8
   Denney JT, 2009, SOC SCI QUART, V90, P1167, DOI 10.1111/j.1540-6237.2009.00652.x
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Forster N., 2012, J BURN CARE RES, V33
   Furlanetto LM, 2011, GEN HOSP PSYCHIAT, V33, P572, DOI 10.1016/j.genhosppsych.2011.08.002
   Grote NK, 2007, SOC WORK RES, V31, P19, DOI 10.1093/swr/31.1.19
   Hamdan- Mansour A., 2008, INT J MENT HEALTH AD, V6, P442, DOI DOI 10.1007/S11469-007-9112-6
   Hamdan- Mansour A., 2014, WULFENIA, V21, P98
   Hamdan-Mansour Ayman M, 2007, J Psychosoc Nurs Ment Health Serv, V45, P31
   HAMDANMANSOUR AM, 2013, LIFE SCI J, V10, P3044
   Han MA, 2009, PREV MED, V49, P248, DOI 10.1016/j.ypmed.2009.06.014
   Hirsch JK, 2009, INT J GERIATR PSYCH, V24, P671, DOI 10.1002/gps.2174
   Kalivas PW, 2003, AM J PSYCHIAT, V160, P1, DOI 10.1176/appi.ajp.160.1.1
   Kendler KS, 2009, ARCH GEN PSYCHIAT, V66, P857, DOI 10.1001/archgenpsychiatry.2009.94
   Kivimaki M, 2009, DIABETES CARE, V32, P1867, DOI 10.2337/dc09-0716
   Koenig HG, 2007, J NERV MENT DIS, V195, P389
   LaFromboise T. D, 2007, RES HUMAN DEV, V41, P119, DOI DOI 10.1080/15427600701481020
   Lett HS, 2009, INT J BEHAV MED, V16, P248, DOI 10.1007/s12529-009-9040-x
   Leurent B, 2013, PSYCHOL MED, V43, P2109, DOI 10.1017/S0033291712003066
   Lotaief F., 2012, CURRENT PSYCHIAT, V19, P190
   Louis-Jacques J, 2011, CURR OPIN PEDIATR, V23, P367, DOI 10.1097/MOP.0b013e3283481101
   McLachlan E. M., 2011, INNOVAIT, V4, P272
   Nichols GA, 2011, DIABETOLOGIA, V54, P523, DOI 10.1007/s00125-010-1965-8
   Okifuji A, 2011, J APPL BIOBEHAV RES, V16, P57, DOI 10.1111/j.1751-9861.2011.00065.x
   Patten SB, 2009, PSYCHOSOM MED, V71, P273, DOI 10.1097/PSY.0b013e3181988e5f
   Purcell B., 2012, AM J GERIATRIC PSYCH, V20
   Rezaeian M, 2010, CRISIS, V31, P36, DOI 10.1027/0227-5910/a000005
   SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063
   Schneider KL, 2008, J PSYCHOSOC ONCOL, V26, P49, DOI 10.1300/J077v26n02_04
   Schoen O., 2009, HLTH AFFAIRS MILLWOO, V28, pw1, DOI DOI 10.1377/HLTHAFF.28.1.W1
   Spearing R, 2012, INT J THER REHABIL, V19, P394, DOI 10.12968/ijtr.2012.19.7.394
   Tol A, 2011, J DIABETES METABOLIC, V10, P1
   Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271
   Utsey SO, 2008, J COUNS PSYCHOL, V55, P49, DOI 10.1037/0022-0167.55.1.49
   WHO, 2011, STAT SUIC PREV PREV
   Willmott S, 2008, J MENT HEALTH, V17, P435, DOI 10.1080/09638230701528485
   World Health Organization, 2010, INT STAT CLASS DIS R
   Yehia DBM, 2013, J PERINAT NEONAT NUR, V27, P25, DOI 10.1097/JPN.0b013e31827ed6db
   ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2
NR 50
TC 3
Z9 3
U1 0
U2 11
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0161-2840
EI 1096-4673
J9 ISSUES MENT HEALTH N
JI Issues Ment. Health Nurs.
PD NOV
PY 2014
VL 35
IS 11
BP 864
EP 871
DI 10.3109/01612840.2014.917752
PG 8
WC Nursing; Psychiatry
SC Nursing; Psychiatry
GA CG4HR
UT WOS:000353246700008
PM 25353299
DA 2019-01-08
ER

PT J
AU Siminerio, L
   Ruppert, K
   Huber, K
   Toledo, FGS
AF Siminerio, Linda
   Ruppert, Kristine
   Huber, Kimberly
   Toledo, Fredrico G. S.
TI Telemedicine for Reach, Education, Access, and Treatment (TREAT) Linking
   Telemedicine With Diabetes Self-management Education to Improve Care in
   Rural Communities
SO DIABETES EDUCATOR
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE; PATIENT SATISFACTION; NEEDS
   DAWN; OUTCOMES; PERCEPTIONS; EMPOWERMENT; ATTITUDES; WISHES; SCALE
AB Purpose
   The purpose of this study was to examine diabetes-related behavioral and psychosocial outcomes as well as patient satisfaction with the Telemedicine for Reach, Education, Access, and Treatment (TREAT) model.
   Methods
   TREAT employs telemedicine services provided by an endocrinologist at an urban area in partnership with a diabetes educator in a rural area, working together with patients and primary care providers (PCPs). Thirty-five patients with type 2 diabetes were referred by PCPs and received glycemic management and education in the TREAT model. A diabetes educator operated the video-conferencing equipment, remained with the patient to receive and review plan communicated by the endocrinologist during the visit, coordinated services, administered surveys, and provided self-management education and support. Empowerment, self-care, diabetes distress, adherence to monitoring, and patient satisfaction were assessed by survey at baseline and follow-up.
   Results
   There was significant improvement in empowerment, self-care (adherence to diet and monitoring), and reduction in diabetes distress. Patients reported high levels of satisfaction.
   Conclusions
   In rural areas, the TREAT model delivers improvements in behavioral and psychosocial outcomes and high patient satisfaction. The TREAT model may be a viable option for rural communities that suffer from a shortage of team-based diabetes specialist and self-management support services.
C1 [Siminerio, Linda; Toledo, Fredrico G. S.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15203 USA.
   [Ruppert, Kristine] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15203 USA.
   [Huber, Kimberly] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15203 USA.
RP Siminerio, L (reprint author), Univ Pittsburgh, Dept Med, 2 Hot Met St,2nd Floor,Rm 275, Pittsburgh, PA 15203 USA.
EM simineriol@upmc.edu
RI Toledo, Frederico/G-9071-2013
OI Ruppert, Kristine/0000-0002-3008-6584
FU Air Force Medical Support Agency, Modernization Directorate AFMSA/SG9
   [FA7014-10-2-0005]
FX This material is based on research sponsored by the Air Force Medical
   Support Agency, Modernization Directorate AFMSA/SG9 under agreement
   number FA7014-10-2-0005.
CR ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   [Anonymous], SAS 9 1 3
   Aoki N, 2003, TELEMED J E-HEALTH, V9, P393, DOI 10.1089/153056203772744734
   Bakken S, 2006, J AM MED INFORM ASSN, V13, P660, DOI 10.1197/jamia.M2146
   De Berardis G, 2004, DIABETES CARE, V27, P398, DOI 10.2337/diacare.27.2.398
   Glasgow RE, 2008, DIABETES CARE, V31, P1046, DOI 10.2337/dc07-1845
   Haas L, DIABETES CARE S1, V36, pS100
   KENNY DT, 1995, PSYCHOL HEALTH, V10, P427, DOI 10.1080/08870449508401961
   Larson SL, 2003, MED CARE, V41, P65, DOI 10.1097/01.MLR.0000076053.28108.F2
   Lutfiyya MN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-940
   Peyrot M, 2006, DIABETOLOGIA, V49, P279, DOI 10.1007/s00125-005-0048-8
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   Seshamani M, HARD TIMES HEARTLAND
   Siminerio L, 2013, DIABETES EDUCATOR, V39, P705, DOI 10.1177/0145721713492570
   Siminerio LM, 2007, DIABETES EDUCATOR, V33, P152, DOI 10.1177/0145721706298194
   Toledo FG, 2012, JMIR RES PROTOC, V1, DOI 10.2196/resprot.2235
   Toledo FGS, 2014, DIABETES CARE, V37, pE179, DOI 10.2337/dc13-1909
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van Dis J, 2002, JAMA-J AM MED ASSOC, V287, P108
   Wagner E H, 1996, Manag Care Q, V4, P12
   Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569
   Williams TL, 2001, BRIT J DERMATOL, V145, P911, DOI 10.1046/j.1365-2133.2001.04472.x
   Zgibor JC, 2000, DIABETES CARE, V23, P472, DOI 10.2337/diacare.23.4.472
NR 25
TC 31
Z9 35
U1 1
U2 25
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD NOV-DEC
PY 2014
VL 40
IS 6
BP 797
EP 805
DI 10.1177/0145721714551993
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA AX7QZ
UT WOS:000347111300007
PM 25253624
DA 2019-01-08
ER

PT J
AU Walker, RJ
   Gebregziabher, M
   Martin-Harris, B
   Egede, LE
AF Walker, Rebekah J.
   Gebregziabher, Mulugeta
   Martin-Harris, Bonnie
   Egede, Leonard E.
TI Independent effects of socioeconomic and psychological social
   determinants of health on self-care and outcomes in Type 2 diabetes
SO GENERAL HOSPITAL PSYCHIATRY
LA English
DT Article
DE Diabetes; Social determinants; Socioeconomic; Psychological; Self-care
ID OF-THE-LITERATURE; PSYCHOMETRIC PROPERTIES; GLYCEMIC CONTROL; VALIDITY;
   SCALE; DEPRESSION; DISTRESS; ADULTS; QUESTIONNAIRE; METAANALYSIS
AB Objective: The purpose of this study was to investigate the independent effects of socioeconomic and psychological social determinants of health on diabetes knowledge, self-care, diabetes outcomes and quality of life.
   Research design and methods: Cross-sectional sample of 615 adults from two adult primary care clinics in the southeastern United States. Primary outcome variables were diabetes knowledge, self-care behaviors (diet, exercise, medication adherence, blood sugar testing, foot care) and diabetes outcomes (HbA1c, low-density lipoprotein, blood pressure, physical component summary score of SF12 quality of life, mental component summary score of SF12 quality of life). Covariates included age, sex, race/ethnicity, marital status, health literacy and comorbidity. Linear regression models were used to assess independent associations controlling for covariates.
   Results: In final adjusted models, significant associations for HbA1c included education [beta=-0.72, 95% confidence interval (CI): -1.36 to -0.08], income (beta=-0.66, CI: -1.30 to -0.16), self-efficacy (beta=-0.12, CI: -0.15 to -0.08) and diabetes distress (beta=0.43, CI: 0.14 to 0.72). Significant associations for self-care included medication adherence with diabetes distress (beta=-0.58, CI: -0.91 to -0.25) and perceived stress (beta=-0.12, CI: -0.18 to -0.05) and exercise with depression (beta=-0.06, CI: -0.10 to-0.01) and self-efficacy (beta=0.06, CI: 0.01 to 0.10). Significant associations for quality of life included depression (beta=-0.08, CI: -0.12 to -0.03), serious psychological distress (beta=-0.09, CI: -0.12 to -0.05), social support (beta=0.01, CI: 0.001 to 0.02) and perceived stress (beta=-0.12, CI: -0.19 to -0.06).
   Conclusions: Social determinants of health were significantly associated with diabetes self-care and outcomes with socioeconomic factors being most often associated with diabetes outcomes and psychological factors, specifically self-efficacy and perceived stress being most often associated with self-care and quality of life. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Walker, Rebekah J.; Gebregziabher, Mulugeta; Egede, Leonard E.] Ralph H Johnson VAMC, Charleston VA HSR & D COIN, Hlth Equity & Rural Outreach Innovat Ctr, Charleston, SC USA.
   [Walker, Rebekah J.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.
   [Walker, Rebekah J.; Martin-Harris, Bonnie] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA.
   [Gebregziabher, Mulugeta] Med Univ S Carolina, Dept Med, Div Publ Hlth Sci, Charleston, SC 29425 USA.
   [Martin-Harris, Bonnie] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA.
   [Egede, Leonard E.] Med Univ S Carolina, Dept Med, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280,POB 250593, Charleston, SC 29425 USA.
EM egedel@musc.edu
OI Gebregziabher, Mulugeta/0000-0002-4826-481X
FU The National Institute of Diabetes and Digestive and Kidney Disease
   [K24DK093699-01]
FX This study was supported by Grant K24DK093699-01 from The National
   Institute of Diabetes and Digestive and Kidney Disease (PI: Leonard
   Egede).
CR Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x
   Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   Al-Khawaldeh OA, 2012, J DIABETES COMPLICAT, V26, P10, DOI 10.1016/j.jdiacomp.2011.11.002
   Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287
   Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5
   Bierman AS, 2006, J GEN INTERN MED, V21, P99, DOI 10.1111/j.1525-1497.2005.00317.x
   Bonnefoy J. A., 2007, CONSTRUCTING EVIDENC
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Cohen S., 1988, SOCIAL PSYCHOL HLTH
   Cundiff JM, 2013, INT J BEHAV MED, V20, P148, DOI 10.1007/s12529-011-9206-1
   Dray-Spira R, 2010, DIABETES CARE, V33, P1200, DOI 10.2337/dc09-2094
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Egede LE, 2010, J GEN INTERN MED, V25, P61, DOI 10.1007/s11606-009-1168-5
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Friel S, 2011, ANNU REV PUBL HEALTH, V32, P225, DOI 10.1146/annurev-publhealth-031210-101220
   Gao JL, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-66
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   Healthy People 2020, 2010, HLTH PEOPL 2020 OPP
   International Diabetes Federation, 2013, IDF DIABETES ATLAS
   Irwin A., 2010, 2 WHO
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)71146-6
   Marmot M, 2010, FAIR SOC HLTH LIVES
   Marmot M, 2003, SOCIAL DETERMINANTS
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   National Center for Health Statistics, 2004, SURV QUEST NAT HLTH
   Resnick B, 2001, Outcomes Manag Nurs Pract, V5, P161
   Saydah S, 2010, PUBLIC HEALTH REP, V125, P377, DOI 10.1177/003335491012500306
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker RJ, 2014, ENDOCRINE, P1
   Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Whiting D, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P77
   Williams ED, 2013, ANN BEHAV MED, V46, P62, DOI 10.1007/s12160-013-9473-y
NR 40
TC 28
Z9 28
U1 2
U2 42
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0163-8343
EI 1873-7714
J9 GEN HOSP PSYCHIAT
JI Gen. Hosp. Psych.
PD NOV-DEC
PY 2014
VL 36
IS 6
BP 662
EP 668
DI 10.1016/j.genhosppsych.2014.06.011
PG 7
WC Psychiatry
SC Psychiatry
GA AU2GK
UT WOS:000345434400020
PM 25103544
OA Green Accepted
DA 2019-01-08
ER

PT J
AU McDonald, S
   Sharpe, L
   Blaszczynski, A
AF McDonald, S.
   Sharpe, L.
   Blaszczynski, A.
TI The psychosocial impact associated with diabetes-related amputation
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; LOWER-LIMB AMPUTATION; DEPRESSION; COMPLICATIONS;
   METAANALYSIS; ADJUSTMENT; PREVALENCE; PEOPLE; ADULTS
AB AimsResearch has suggested that the additional impact of a diabetes-related amputation is associated with poorer physical functioning, poorer psychosocial outcome and greater body image disturbance. However, no study to date has compared patients with diabetes with and without amputation and adequately controlled for additional medical morbidity often found among individuals with an amputation. The aim of this study was to statistically control for any group differences on medical and demographic variables to examine the isolated psychosocial impact of diabetes-related amputation.
   MethodsIndividuals with diabetes with an amputation (n=50) were compared to a control sample (individuals with diabetes without an amputation; n=240). All participants completed a demographic and medical questionnaire, as well as measures of psychological distress, quality of life and body image.
   ResultsThe results indicated that, in univariate analyses, depression, physical quality of life and body image disturbance were all poorer in the amputee group. These differences remained for body image disturbance (P=0.005), but were no longer significant for depression or physical quality of life in multivariate analyses controlling for important demographic and medical variables.
   ConclusionsThe present study found that the impact of diabetes-related amputation was significant for body image disturbance. However, it appears that other psychosocial outcomes are better accounted for by medical co-morbidities common in this group rather than the amputation itself. This research certainly highlights that clinicians must assess for and address all potential medical contributors to psychosocial outcomes, rather than assuming that people will experience poorer outcomes following amputation.
C1 [McDonald, S.; Sharpe, L.] Univ Sydney, Sch Psychol, Clin Psychol Unit, Sydney, NSW 2006, Australia.
   [Blaszczynski, A.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.
RP Sharpe, L (reprint author), Univ Sydney, Sch Psychol, Clin Psychol Unit, Sydney, NSW 2006, Australia.
EM louise.sharpe@sydney.edu.au
OI Sharpe, Louise/0000-0002-8790-6272
FU New South Wales Institute of Psychiatry; National Health and Medical
   Research Council
FX SM was supported by a Trainee Research Fellowship from the New South
   Wales Institute of Psychiatry to conduct this research. LS is supported
   by a Senior Research Fellowship from the National Health and Medical
   Research Council.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson LA, 1997, DIABETES EDUCATOR, V23, P301, DOI 10.1177/014572179702300309
   Boutoille D, 2008, FOOT ANKLE INT, V29, P1074, DOI 10.3113/FAI.2008.1074
   Carrington AL, 1996, DIABETES RES CLIN PR, V32, P19, DOI 10.1016/0168-8227(96)01198-9
   Carroll P, 1999, J BEHAV MED, V22, P59, DOI 10.1023/A:1018799618864
   Cash TF, 2004, BODY IMAGE, V1, P363, DOI DOI 10.1016/J.B0DYIM.2004.10.001
   Coffey L, 2009, DIABETIC MED, V26, P1063, DOI 10.1111/j.1464-5491.2009.02802.x
   desGroot M, 2001, PSYCHOSOM MED, V63, P619
   Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6
   Fritz C. O., 2011, J EXPT PSYCHOL GEN, V141, P2, DOI [10.1037/aoo24338, DOI 10.1037/A0024338]
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Harwell TS, 2002, DIABETES EDUCATOR, V28, P99, DOI 10.1177/014572170202800111
   Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869
   Kyrius M, 2006, E J APPL PSYCHOL CLI, V2, P3
   Laiteerapong N, 2011, DIABETES CARE, V34, P1749, DOI 10.2337/dc10-2424
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McDonald S., 2013, THESIS U SYDNEY SYDN
   Murphy B, 2000, AUSTR WHOQOL INSTRUM
   Pan HH, 2012, J PSYCHOSOM RES, V73, P180, DOI 10.1016/j.jpsychores.2012.06.003
   Peters EJG, 2001, DIABETES CARE, V24, P1799, DOI 10.2337/diacare.24.10.1799
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Shehatah A, 2010, J AFFECT DISORDERS, V123, P197, DOI 10.1016/j.jad.2009.09.002
   Sundaram M, 2007, QUAL LIFE RES, V16, P165, DOI 10.1007/s11136-006-9105-0
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Willrich A, 2005, FOOT ANKLE INT, V26, P128, DOI 10.1177/107110070502600203
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 26
TC 4
Z9 4
U1 0
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2014
VL 31
IS 11
BP 1424
EP 1430
DI 10.1111/dme.12474
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AS1BB
UT WOS:000344010200021
PM 24766143
DA 2019-01-08
ER

PT J
AU Schmitt, A
   Reimer, A
   Kulzer, B
   Haak, T
   Gahr, A
   Hermanns, N
AF Schmitt, A.
   Reimer, A.
   Kulzer, B.
   Haak, T.
   Gahr, A.
   Hermanns, N.
TI Assessment of diabetes acceptance can help identify patients with
   ineffective diabetes self-care and poor diabetes control
SO DIABETIC MEDICINE
LA English
DT Article
ID PROBLEM AREAS; DISTRESS; SCALE; MANAGEMENT; MELLITUS; COMPLICATIONS;
   DEPRESSION; BEHAVIORS; TRIAL
AB AimsTo estimate the associations between insufficient diabetes acceptance and relevant diabetes outcomes.
   MethodsA total of 320 patients completed questionnaires on diabetes non-acceptance (the Acceptance and Action Diabetes Questionnaire), diabetes distress (the Problem Areas in Diabetes Scale), depressive mood (the Center for Epidemiologic Studies Depression Scale), coping with illness (the Freiburg Questionnaire of Coping with Illness), self-care activities (the Summary of Diabetes Self-Care Activities Measure) and quality of life (the Short Form-36 Health Questionnaire). A six-item version of the Acceptance and Action Diabetes Questionnaire showing good reliability and validity was established, and the associations between insufficient acceptance and clinical outcomes were estimated.
   ResultsHigher diabetes non-acceptance correlated significantly with less active coping (-0.37), reduced self-care (-0.43) and higher HbA(1c) levels (0.31), higher diabetes distress (0.53) and more depressive symptoms (0.36). Correlations of diabetes non-acceptance with diabetes self-care/glycaemic control were significantly higher than were those of depressive mood or diabetes distress with these criteria.
   ConclusionsLow diabetes acceptance is associated with impaired self-care and glycaemic control. Assessment of diabetes acceptance may facilitate the detection of patients at high risk and may present an essential target for treatments to improve diabetes control that is more relevant than elevated depressive mood or diabetes distress.
C1 [Schmitt, A.; Reimer, A.; Kulzer, B.; Haak, T.; Gahr, A.; Hermanns, N.] Diabet Acad Mergentheim, Res Inst, Bad Mergentheim, Germany.
   [Schmitt, A.; Reimer, A.; Kulzer, B.; Haak, T.; Gahr, A.; Hermanns, N.] German Diabet Ctr Mergentheim, Bad Mergentheim, Germany.
RP Schmitt, A (reprint author), Diabet Acad Mergentheim, Res Inst, Bad Mergentheim, Germany.
EM schmitt@diabetes-zentrum.de
OI Schmitt, Andreas/0000-0002-5913-1457
FU 'Kompetenznetz Diabetes mellitus' (Competence Network for Diabetes
   mellitus) - Federal Ministry of Education and Research [01GI1107]
FX This work was supported by grants from the 'Kompetenznetz Diabetes
   mellitus' (Competence Network for Diabetes mellitus) funded by the
   Federal Ministry of Education and Research (grant number 01GI1107).
CR Brooks SK, 2011, J PSYCHOSOM RES, V71, P411, DOI 10.1016/j.jpsychores.2011.08.001
   Bullinger M, 1995, J PUBLIC HLTH, V3, P21, DOI DOI 10.1007/BF02959944
   Dlugosch GE, 2002, PSYCHODIABETOLOGIE, P150
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Garay-Sevilla ME, 1999, DIABETIC MED, V16, P238, DOI 10.1046/j.1464-5491.1999.00033.x
   Gfeller R., 1987, VERHALTENSMEDIZIN DI, P63
   Gregg J., 2007, DIABETES LIFESTYLE B
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Harb BM, 2008, DIAGNOSTISCHE VERFAH, P266
   Hardt J, 2003, Z KL PSYCH PSYCHOTH, V32, P41, DOI 10.1026//1616-3443.32.1.41
   Hautzinger M, 2012, ADS GEN DEPRESSION S
   Home P, 2006, DIABETIC MED, V23, P579
   HOOGWERF BJ, 1994, CLEV CLIN J MED, V61, P34, DOI 10.3949/ccjm.61.1.34
   King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746
   Kubiak T, 2008, DIAGNOSTISCHE VERFAH
   Petrak F, 2005, CURR DIABETES REV, V1, P255, DOI 10.2174/157339905774574329
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Richardson A, 2001, J ADV NURS, V33, P758, DOI 10.1046/j.1365-2648.2001.01717.x
   Sanden-Eriksson B, 2000, J ADV NURS, V31, P1393, DOI 10.1046/j.1365-2648.2000.01410.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Turner RC, 1998, LANCET, V352, P837
   Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002
   Walker RJ, 2012, GEN HOSP PSYCHIAT, V34, P598, DOI 10.1016/j.genhosppsych.2012.07.005
NR 28
TC 16
Z9 16
U1 1
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2014
VL 31
IS 11
BP 1446
EP 1451
DI 10.1111/dme.12553
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AS1BB
UT WOS:000344010200024
PM 25047992
DA 2019-01-08
ER

PT J
AU Shiu, ATY
   Choi, KC
   Lee, DTF
   Yu, DSF
   Ng, WM
AF Shiu, Ann Tak Ying
   Choi, Kai Chow
   Lee, Diana Tze Fan
   Yu, Doris Sau Fung
   Ng, Wai Man
TI Application of a health-related quality of life conceptual model in
   community-dwelling older Chinese people with diabetes to understand the
   relationships among clinical and psychological outcomes
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Diabetes; Quality of life; Structural equation modeling
ID MENTAL-HEALTH; PRIMARY-CARE; HONG-KONG; ADULTS; POPULATION; PATIENT;
   INTERVENTIONS; SATISFACTION; VALIDATION; DEPRESSION
AB Aims/IntroductionThe present study applied the Wilson-Cleary model of health-related quality of life (HRQOL) by using the structural equation modeling (SEM) approach to understand the interrelationships among clinical, sociodemographic and psychological characteristics in older people with diabetes.
   Materials and MethodsThis was a cross-sectional study with 452 Chinese older people with diabetes recruited from three primary care clinics. A series of assessments were made, including four instruments: the Chinese version of the Short Form 36 Health Survey, Older American Resources and Services Multidimensional Functional Assessment Questionnaire, Rand Mental Health Inventory and Medical Outcomes Study Social Support Survey; and clinical outcomes (diabetes-related characteristics and physiological data).
   ResultsIn the present study, we identified six patient individual and environmental characteristics, namely, age, sex, physical activity, psychological distress, social support and adequacy of income, that significantly influence HRQOL directly or by way of physical functional status and general health perception.
   ConclusionsImproving social and financial support as well as providing interventions to promote physical activity and to cope with psychological distress in this patient population might be effective to eventually enhance their HRQOL. The present findings add to the literature the underlying complex biological and psychological processes of HRQOL, and take the body of knowledge in HRQOL of older people with diabetes to a theoretical level, and provide insights for development of appropriate strategies to optimize their HRQOL.
C1 [Shiu, Ann Tak Ying; Choi, Kai Chow; Lee, Diana Tze Fan; Yu, Doris Sau Fung; Ng, Wai Man] Chinese Univ Hong Kong, Nethersole Sch Nursing, Shatin, Hong Kong, Peoples R China.
RP Choi, KC (reprint author), Chinese Univ Hong Kong, Nethersole Sch Nursing, Shatin, Hong Kong, Peoples R China.
EM kchoi@cuhk.edu.hk
RI Lee, Diana/O-7364-2015; Yu, Doris/B-5853-2015; Choi, Kai
   Chow/F-1398-2018
OI Lee, Diana/0000-0001-7227-5204; Choi, Kai Chow/0000-0001-7157-8668
CR Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065
   *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS4, DOI DOI 10.2337/DC10-S004
   ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037//0033-2909.103.3.411
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   Araki A, 2009, GERIATR GERONTOL INT, V9, P105, DOI 10.1111/j.1447-0594.2008.00495.x
   Baernholdt M, 2012, QUAL LIFE RES, V21, P527, DOI 10.1007/s11136-011-9954-z
   Best JH, 2011, DIABETES CARE, V34, P314, DOI 10.2337/dc10-1119
   Brett CE, 2012, QUAL LIFE RES, V21, P505, DOI 10.1007/s11136-011-9951-2
   Chia L, 2007, THESIS U PITTSBURGH
   Chiu H.C., 1997, CHINESE J PUBLIC HLT, V16, P119
   Collins MM, 2009, DIABETES CARE, V32, P603, DOI 10.2337/dc08-1169
   Glasgow RE, 2008, DIABETES CARE, V31, P1046, DOI 10.2337/dc07-1845
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Hu BF, 2011, DIABETES CARE, V34, P1249, DOI DOI 10.2337/DC11-0442.PMID:21617109
   Huang Chiung-Yu, 2008, J Nurs Res, V16, P264
   Huang IC, 2008, VALUE HEALTH, V11, P450, DOI 10.1111/j.1524-4733.2007.00261.x
   Janus ED, 1997, CLIN EXP PHARMACOL P, V24, P987, DOI 10.1111/j.1440-1681.1997.tb02736.x
   Laiteerapong N, 2011, DIABETES CARE, V34, P1749, DOI 10.2337/dc10-2424
   Lam CLK, 2005, J CLIN EPIDEMIOL, V58, P815, DOI 10.1016/j.jclinepi.2004.12.008
   Landman GWD, 2010, DIABETES CARE, V33, P2378, DOI 10.2337/dc10-0979
   Li TC, 2006, QUAL LIFE RES, V15, P1613, DOI 10.1007/s11136-006-0024-x
   LIANG J, 1992, MED CARE, V30, P659, DOI 10.1097/00005650-199208000-00001
   Logtenberg SJ, 2010, DIABETES CARE, V33, P1169, DOI 10.2337/dc09-1758
   Mishra GD, 2011, QUAL LIFE RES, V20, P1005, DOI 10.1007/s11136-010-9838-7
   Nokes KM, 2000, RES AGING, V22, P290, DOI 10.1177/0164027500223004
   Ose D, 2009, DIABETES CARE, V32, P1594, DOI 10.2337/dc08-2223
   Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940
   Schuz B, 2011, QUAL LIFE RES, V20, P1573, DOI 10.1007/s11136-011-9909-4
   Shiu ATY, 2008, J CLIN NURS, V17, P125, DOI 10.1111/j.1365-2702.2007.02036.x
   Sousa KH, 2006, QUAL LIFE RES, V15, P725, DOI 10.1007/s11136-005-3975-4
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   Strickland PAO, 2010, J AM BOARD FAM MED, V23, P295, DOI 10.3122/jabfm.2010.03.090141
   Tang WL, 2006, PHARMACOEPIDEM DR S, V15, P123, DOI 10.1002/pds.1166
   Wang RH, 2011, J ADV NURS, V67, P2658, DOI 10.1111/j.1365-2648.2011.05701.x
   WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59
   Wyrwich KW, 2011, QUAL LIFE RES, V20, P255, DOI 10.1007/s11136-010-9734-1
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   Yu DSF, 2004, RES NURS HEALTH, V27, P135, DOI 10.1002/nur.20008
   Yu DSF, 2004, RES NURS HEALTH, V27, P332, DOI 10.1002/nur.20030
   Zhang XP, 2007, MED CARE, V45, P820, DOI 10.1097/MLR.0b013e3180618b55
NR 41
TC 4
Z9 5
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1116
EI 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD NOV
PY 2014
VL 5
IS 6
BP 677
EP 686
DI 10.1111/jdi.12198
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AS6EZ
UT WOS:000344358600010
PM 25422768
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hayashino, Y
   Mashitani, T
   Tsujii, S
   Ishii, H
AF Hayashino, Yasuaki
   Mashitani, Tsuyoshi
   Tsujii, Satoru
   Ishii, Hitoshi
CA Tenri Study Grp
TI Serum High-Sensitivity C-Reactive Protein Levels Are Associated With
   High Risk of Development, Not Progression, of Diabetic Nephropathy Among
   Japanese Type 2 Diabetic Patients: A Prospective Cohort Study (Diabetes
   Distress and Care Registry at Tenri [DDCRT7])
SO DIABETES CARE
LA English
DT Article
ID LOW-GRADE INFLAMMATION; GLYCEMIC CONTROL; ENDOTHELIAL DYSFUNCTION;
   ALBUMIN EXCRETION; URINARY ALBUMIN; MELLITUS; DISEASE; INTERLEUKIN-6;
   PREVENTION; MARKERS
AB OBJECTIVE
   To assess the prospective association between baseline serum hs-CRP concentration and the subsequent risk of development or progression of diabetic nephropathy.
   RESEARCH DESIGN AND METHODS
   Longitudinal data were obtained from 2,518 patients with type 2 diabetes registered in a Japanese diabetes registry. To assess the independent correlations between serum baseline hs-CRP and either the development or progression of diabetic nephropathy 1 year later, the Cox proportional hazards model was used and adjusted for potential confounders.
   RESULTS
   The mean patient age, BMI, and HbA(1c) level were 66.1 years, 24.6 kg/m(2), and 7.5% (57.6 mmol/mol), respectively. Baseline serum hs-CRP levels were significantly associated with the urinary albumin-to-creatinine ratio at baseline (P < 0.001). Multivariable adjusted hazard ratio for the development from normoalbuminuria to microalbuminuria was 1.31 (95% CI 0.80-2.17; P = 0.286), 1.55 (1.16-2.08; P = 0.003), and 1.57 (1.22-2.03; P = 0.001), respectively, for the second, third, and fourth quartiles of serum hs-CRP levels, showing a statistically significant linear trend across categories (P < 0.001). We did not observe a significant association between hs-CRP levels and the subsequent risk of diabetic nephropathy progression (P for trend = 0.575).
   CONCLUSIONS
   Serum hs-CRP levels, independent of possible confounders, were associated with a subsequent risk of developing, not progressing, diabetic nephropathy in type 2 diabetic patients. Serum hs-CRP may be useful for predicting the future risk of developing diabetic nephropathy.
C1 [Hayashino, Yasuaki; Tsujii, Satoru; Ishii, Hitoshi] Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.
   [Mashitani, Tsuyoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 634, Japan.
RP Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.
EM hayasino-y@umin.net
OI Hayashino, Yasuaki/0000-0002-2932-8478; Tsujii,
   Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and JSPS KAKENHI (grant 25460641).
CR Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679
   Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009
   Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716
   Elmarakby AA, 2010, EPMA J, V1, P117, DOI 10.1007/s13167-010-0004-7
   Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510
   Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   Molitch Mark E, 2004, Diabetes Care, V27 Suppl 1, pS79
   Navarro JF, 2003, AM J KIDNEY DIS, V42, P53, DOI 10.1016/S0272-6386(03)00408-6
   Navarro JF, 2006, NEPHROL DIAL TRANSPL, V21, P3428, DOI 10.1093/ndt/gfl469
   Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51
   Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506
   Rossing P, 2006, DIABETOLOGIA, V49, P11, DOI 10.1007/s00125-005-0077-3
   Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y
   Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5
   Schalkwijk CG, 1999, DIABETOLOGIA, V42, P351, DOI 10.1007/s001250051162
   Scott DP, 2010, INTERN MED J, V40, P275, DOI 10.1111/j.1445-5994.2009.01941.x
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812
   Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Wada T, 2013, CLIN EXP NEPHROL
   Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906
NR 29
TC 7
Z9 8
U1 0
U2 7
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD NOV
PY 2014
VL 37
IS 11
BP 2947
EP 2952
DI 10.2337/dc14-1357
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AR4XD
UT WOS:000343588500020
PM 25168126
OA Other Gold
DA 2019-01-08
ER

PT J
AU Walker, RJ
   Gebregziabher, M
   Martin-Harris, B
   Egede, LE
AF Walker, Rebekah J.
   Gebregziabher, Mulugeta
   Martin-Harris, Bonnie
   Egede, Leonard E.
TI Relationship between social determinants of health and processes and
   outcomes in adults with type 2 diabetes: validation of a conceptual
   framework
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Diabetes; Social determinants; Socioeconomic; Psychological; Glycemic
   control; Conceptual framework
ID GLYCEMIC CONTROL; SELF-CARE; PSYCHOMETRIC PROPERTIES; SOCIOECONOMIC
   POSITION; SCALE; METAANALYSIS; VALIDITY; SUPPORT; QUESTIONNAIRE;
   DEPRESSION
AB Background: The aim of this study was to empirically validate a conceptual framework and elucidate the pathways linking social determinants of health to outcomes in individuals with type 2 diabetes.
   Methods: 615 adults were recruited from adult primary care clinics in the southeastern United States. The model was estimated using path analysis to determine if socioeconomic (education, employment, income) and psychosocial (fatalism, self-efficacy, depression, diabetes distress, serious psychological distress, social support, and perceived stress) factors would independently predict glycemic control or be associated with mediator/moderators of self-care, access to care, and processes of care. Covariates were gender, age, race and health literacy.
   Results: The final model (chi2 (15) = 17.68, p = 0.28; RMSEA = 0.02, CFI = 0.99) showed lower glycemic control was directly associated with less hours worked (r = 0.13, p = 0.002), more fatalistic attitudes (r = -0.09, p = 0.03), more self-efficacy (r = -0.30, p < 0.001), and less diabetes distress (r = 0.12, p = 0.03), with the majority of total effects being direct. Significant paths associated self-care with diabetes distress (r = -0.14, p = 0.01) and perceived stress (r = -0.15, p = .001); access to care with income (r = 0.08, p = 0.03), diabetes distress (r = -0.21, p < 0.001) and social support (r = 0.08, p = 0.03); and processes of care with income (r = -0.11, p = 0.03), social support (r = 0.10, p = 0.04), and perceived stress (r = 0.10, p = 0.04). The paths explained 76% of the variance in the model.
   Conclusions: Consistent with the conceptual framework, social determinants were associated with glycemic control through a direct association and mediators/moderators of self-care, access to care and processes of care. This study provides the first validation of a conceptual framework for the relationship between socioeconomic and psychological components of social determinants of health and diabetes outcomes.
C1 [Walker, Rebekah J.; Gebregziabher, Mulugeta; Egede, Leonard E.] Ralph H Johnson VAMC, Charleston VA HSR&D COIN, Hlth Equ & Rural Outreach Innovat Ctr HEROIC, Charleston, SC 29401 USA.
   [Walker, Rebekah J.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.
   [Walker, Rebekah J.; Martin-Harris, Bonnie] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA.
   [Gebregziabher, Mulugeta] Med Univ S Carolina, Dept Med, Div Publ Hlth Sci, Charleston, SC 29425 USA.
   [Martin-Harris, Bonnie] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA.
   [Egede, Leonard E.] Med Univ S Carolina, Dept Med, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Ralph H Johnson VAMC, Charleston VA HSR&D COIN, Hlth Equ & Rural Outreach Innovat Ctr HEROIC, Charleston, SC 29401 USA.
EM egedel@musc.edu
OI Gebregziabher, Mulugeta/0000-0002-4826-481X
FU National Institute of Diabetes and Digestive and Kidney Disease
   [K24DK093699-01]
FX This study was supported by Grant K24DK093699-01 from The National
   Institute of Diabetes and Digestive and Kidney Disease (PI: Leonard
   Egede).
CR Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   Alam R, 2009, PATIENT EDUC COUNS, V75, P25, DOI 10.1016/j.pec.2008.08.026
   American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287
   [Anonymous], 2010, SURV QUEST BEH RISK
   Bierman AS, 2006, J GEN INTERN MED, V21, P99, DOI 10.1111/j.1525-1497.2005.00317.x
   Bonnefoy J. A., 2007, CONSTRUCTING EVIDENC
   Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Byrne BM, 2005, J PERS ASSESS, V85, P17, DOI 10.1207/s15327752jpa8501_02
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Cohen S., 1988, SOCIAL PSYCHOL HLTH
   Cosansu G, 2014, J TRANSCULT NURS, V25, P51, DOI 10.1177/1043659613504112
   Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI DOI 10.1316/S0782-051X03024046-9
   Egede LE, 2010, J GEN INTERN MED, V25, P61, DOI 10.1007/s11606-009-1168-5
   Fisher L, 2014, DIABET MED
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Gao JL, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-66
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.1016/J.INFBEH.2006.11.010
   International Diabetes Federation, 2013, IDF DIABETES ATLAS
   Irwin A., 2010, 2 WHO
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Liburd LC, 2005, AM J PREV MED, V29, P18, DOI 10.1016/j.amepre.2005.07.013
   Maddigan SL, 2006, AM J PUBLIC HEALTH, V96, P1649, DOI 10.2105/AJPH.2005.067728
   Marmot M, 2010, FAIR SOC HLTH LIVES
   Marmot M, 2003, SOCIAL DETERMINANTS
   Medical Expenditure Panel Survey, 2010, QUEST MED EXP PAN SU
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   National Center for Health Statistics, 2004, SURV QUEST NAT HLTH
   Sanchez BN, 2005, J AM STAT ASSOC, V100, P1443, DOI 10.1198/016214505000001005
   Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003
   Schumacker RE, 2010, BEGINNERS GUIDE STRU
   Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0
   Tahmasebi R, 2014, ASIAN PACIFIC J PUBL
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker RJ, 2014, ENDOCRINE
   Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y
   Whiting D, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P77
NR 45
TC 22
Z9 22
U1 2
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD OCT 9
PY 2014
VL 14
AR 82
DI 10.1186/1472-6823-14-82
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AT1PD
UT WOS:000344705000001
PM 25298071
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU McGovern-Phalen, AM
AF McGovern-Phalen, Amy M.
TI Impact of the Breast Cancer Care Measures Pilot Study on
   Quality-Improvement Initiatives
SO CLINICAL JOURNAL OF ONCOLOGY NURSING
LA English
DT Article
DE depression; cancer; Patient Health Questionnaire; evidence-based
   practice; quality improvement
ID DEPRESSION
AB As a participant in the ONS Foundation-supported Breast Cancer Care Quality Measures Set in 2010, the Edward Cancer Center (ECC) identified gaps in patient assessment. Sleep-wake disturbance and distress were two common areas that were lacking consistent assessment when nurses saw patients during their visits. Another issue is the lack of standard methods of practice or a standardized tool. The ECC, in collaboration with Edward Diabetes Center, Linden Oaks Hospital, and other outpatient offices, adopted the use of the Patient Health Questionnaire-9 depression screening tool. The ECC also modified the intervention recommendations to meet the needs of the oncology population. As a result of the findings in the pilot, the ECC was able to implement an evidence-based practice change to improve the overall quality of patient care and provide earlier intervention in an effort to further improve patient outcomes.
C1 Edward Canc Ctr, Naperville, IL 60540 USA.
RP McGovern-Phalen, AM (reprint author), Edward Canc Ctr, Naperville, IL 60540 USA.
EM aphalen@edward.org
FU Breast Cancer Fund of the National Philanthropic Trust
FX The author received editorial support from Kristen Fessele, PhD, RN,
   AOCN (R), in preparation of this article, funded by a grant to the ONS
   Foundation from the Breast Cancer Fund of the National Philanthropic
   Trust.
CR Common terminology criteria for adverse events (ctcae), 2009, COMM TERM CRIT ADV E
   Fessele K, 2014, CLIN J ONCOL NURS, V18, P7, DOI 10.1188/14.CJON.S2.7-11
   Fulcher CD, 2008, CLIN J ONCOL NURS, V12, P131, DOI 10.1188/08.CJON.131-140
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   KROENKE K, 2002, PSYCHIAT ANN, V32, P1, DOI DOI 10.3928/0048-5713-20020901-06
   Pfizer Inc., 2002, INSTR PAT HLTH QUEST
   US Department of Health and Human Services, 2006, COMM TERM CRIT ADV E
NR 7
TC 1
Z9 1
U1 0
U2 3
PU ONCOLOGY NURSING SOC
PI PITTSBURGH
PA 125 ENTERPRISE DR, PITTSBURGH, PA 15275 USA
SN 1092-1095
EI 1538-067X
J9 CLIN J ONCOL NURS
JI Clin. J. Oncol. Nurs.
PD OCT
PY 2014
VL 18
SU S
BP 17
EP 20
DI 10.1188/14.CJON.S2.17-20
PG 4
WC Oncology; Nursing
SC Oncology; Nursing
GA AX9OL
UT WOS:000347231700004
PM 25252986
DA 2019-01-08
ER

PT J
AU Dart, AB
   Wicklow, BA
   Sellers, EA
   Dean, HJ
   Malik, S
   Walker, J
   Chateau, D
   Blydt-Hansen, TD
   McGavock, JM
AF Dart, Allison B.
   Wicklow, Brandy A.
   Sellers, Elizabeth A.
   Dean, Heather J.
   Malik, Sayma
   Walker, John
   Chateau, Dan
   Blydt-Hansen, Tom D.
   McGavock, Jonathan M.
CA iCARE Investigators
TI The Improving Renal Complications in Adolescents With Type 2 Diabetes
   Through the REsearch (iCARE) Cohort Study: Rationale and Protocol
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Review
DE albuminuria; cohort; inflammation; psychological factors; type 2
   diabetes
ID CHRONIC KIDNEY-DISEASE; MENTAL-HEALTH; PERCEIVED STRESS; YOUTH;
   NEPHROPATHY; ONSET; PREVALENCE; CHILDREN; MELLITUS; INJURY
AB Background: Youth-onset type 2 diabetes is associated with a high burden of renal complications, culminating with end stage kidney disease in early adulthood. The establishment of relevant bioclinical determinants of albuminuria and ultimately progression of chronic kidney disease in youth is critically important to facilitate patient risk stratification and aid in the development of treatment targets and tailored prevention strategies. In response to the important gaps in knowledge, we created a prospective cohort study of youth with type 2 diabetes titled the Improving Renal Complications in Adolescents with Type 2 Diabetes through the REsearch (iCARE) Study.
   Methods: iCARE is a prospective observational cohort study of individuals with type 2 diabetes diagnosed prior to 18 years of age; the recruitment target was 400 patients. Phase 1 entailed a detailed phenotypic assessment of youth, including anthropometrics, biochemistry, 24-hour ambulatory blood pressure monitoring, overnight urine collections for albumin excretion, renal ultrasound and iohexol-derived glomerular filtration rate. Phase 2 of the study is an evaluation of psychological factors, including hair-derived cortisol; validated questionnaires for perceived stress, distress and resiliency; and a detailed evaluation of systemic and urine inflammatory biomarkers. Annual follow up is planned to assess temporal associations between clinical risk factors and renal outcomes, including progression of albuminuria.
   Conclusion: This study will provide novel insight into the risk factors for albuminuria and progression of chronic kidney disease in youth with type 2 diabetes. New knowledge generated by this study will inform clinical care, and the infrastructure developed will provide a framework for future intervention studies. (C) 2014 Canadian Diabetes Association
C1 [Dart, Allison B.; Blydt-Hansen, Tom D.] Univ Manitoba, Nephrol Sect, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1S1, Canada.
   [Wicklow, Brandy A.; Sellers, Elizabeth A.; Dean, Heather J.] Univ Manitoba, Sect Endocrinol & Metab, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1S1, Canada.
   [Malik, Sayma; Walker, John] Univ Manitoba, Dept Clin Hlth Psychol, Winnipeg, MB R3A 1S1, Canada.
   [Chateau, Dan] Univ Manitoba, Manitoba Ctr Hlth Policy, Dept Community Hlth Sci, Winnipeg, MB R3A 1S1, Canada.
   [McGavock, Jonathan M.] Manitoba Inst Child Hlth, Winnipeg, MB, Canada.
RP Dart, AB (reprint author), Univ Manitoba, Nephrol Sect, Dept Pediat & Child Hlth, FE009,840 Sherbrook St, Winnipeg, MB R3A 1S1, Canada.
EM adart@hsc.mb.ca
OI Walker, John/0000-0002-5349-1689; Blydt-Hansen, Tom/0000-0002-8864-0197;
   HayGlass, Kent/0000-0002-4621-7737; chateau, Dan/0000-0002-2215-820X
FU Canadian Diabetes Association [OG-3-11-3354-AD]; Manitoba Health
   Research Council [1475]; Winnipeg Children's Hospital Foundation
FX We thank all of the patients and their physicians who are participating
   in this study. We gratefully acknowledge the financial support of our
   funders. Direct costs: Phase 1 of the study, designed to address
   research question #1 was funded by the Canadian Diabetes Association
   (2011-2014; grant OG-3-11-3354-AD). Phase 2 of the study, which was
   designed to address Research Question #2 and recruit matched adolescents
   without diabetes, was funded by the Manitoba Health Research Council
   (2012-2014; grant 1475). Additional support is provided by a renewable
   team grant from the Winnipeg Children's Hospital Foundation, which funds
   a theme in translational research focused on type 2 diabetes in children
   (Diabetes Research Envisioned and Accomplished in Manitoba [DREAM]). An
   application for additional funding for the expanded study is currently
   under review.
CR Acosta-Perez E, 2012, PSYCHOSOMATICS, V53, P162, DOI 10.1016/j.psym.2011.07.011
   Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Allan CL, 2008, MATERN CHILD HLTH J, V12, pS103, DOI 10.1007/s10995-008-0365-x
   Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Awad AS, 2011, AM J PHYSIOL-RENAL, V301, pF1358, DOI 10.1152/ajprenal.00332.2011
   Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950
   Booth ML, 2002, MED SCI SPORT EXER, V34, P1986, DOI 10.1249/01.MSS.0000038981.35052.D3
   Brandt JR, 2010, PEDIATR NEPHROL, V25, P1131, DOI 10.1007/s00467-010-1451-z
   Buysse DJ, 1989, RES PSYCHIAT, V193, P213, DOI DOI 10.1016/0165-1781(89)90047-4
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109
   Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x
   Copeland KC, 2011, J CLIN ENDOCR METAB, V96, P159, DOI 10.1210/jc.2010-1642
   Dart AB, 2012, DIABETES CARE, V35, P1265, DOI 10.2337/dc11-2312
   Dean H, 1988, Arctic Med Res, V47 Suppl 1, P532
   DeFilippis AP, 2010, JACC-CARDIOVASC IMAG, V3, P595, DOI 10.1016/j.jcmg.2010.01.008
   Donker T, 2010, PSYCHIAT RES, V176, P45, DOI 10.1016/j.psychres.2009.01.012
   Dunson DB, 2007, STAT METHODS MED RES, V16, P399, DOI 10.1177/0962280206075309
   Eppens MC, 2006, DIABETES CARE, V29, P1300, DOI 10.2337/dc05-2470
   Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040
   Haase-Fielitz A, 2014, ANN CLIN BIOCHEM, V51, P335, DOI 10.1177/0004563214521795
   Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012
   Jerums G, 2010, DIABETOLOGIA, V53, P2093, DOI 10.1007/s00125-010-1794-9
   KDOQI, 2007, Am J Kidney Dis, V49, pS12
   Keyes CLM, 2008, CLIN PSYCHOL PSYCHOT, V15, P181, DOI 10.1002/cpp.572
   Keyes CLM, 2007, AM PSYCHOL, V62, P95, DOI 10.1037/0003-066X.62.2.95
   Kim NH, 2010, PEDIATRICS, V125, pE844, DOI 10.1542/peds.2009-1230
   Krolewski AS, 2012, SEMIN NEPHROL, V32, P407, DOI 10.1016/j.semnephrol.2012.07.002
   Kyiak Iu H, 2012, Fiziol Zh, V58, P65
   Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690
   Lu XT, 2013, J CARDIOVASC PHARM, V62, P6, DOI 10.1097/FJC.0b013e3182858fac
   Lynch J, 2013, DIABETES CARE, V36, P1735, DOI 10.2337/dc12-2420
   Maahs DM, 2007, DIABETES CARE, V30, P2593, DOI 10.2337/dc07-0450
   McFarlane P, 2013, CAN J DIABETES, V37, pS129, DOI 10.1016/j.jcjd.2013.01.037
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   Panagiotopoulos C, 2013, CAN J DIABETES, V37, pS163, DOI 10.1016/j.jcjd.2013.01.043
   PARVING HH, 1983, LANCET, V1, P1175
   Patten SB, 2005, CAN J PSYCHIAT, V50, P195, DOI 10.1177/070674370505000402
   Pavkov ME, 2006, JAMA-J AM MED ASSOC, V296, P421, DOI 10.1001/jama.296.4.421
   Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835
   Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042
   Pinhas-Hamiel O, 2007, LANCET, V369, P1823, DOI 10.1016/S0140-6736(07)60821-6
   Prince-Embury S, 2011, PSYCHOL SCHOOLS, V48, P672, DOI 10.1002/pits.20581
   Nguyen QM, 2012, DIABETES CARE, V35, P1341, DOI 10.2337/dc11-1818
   Robitaille Annie, 2011, Health Rep, V22, P33
   Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385
   Schwartz GJ, 2009, CLIN J AM SOC NEPHRO, V4, P1832, DOI 10.2215/CJN.01640309
   Sellers EAC, 2002, DIABETES CARE, V25, P2202, DOI 10.2337/diacare.25.12.2202
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Tabacchi G, 2013, PUBLIC HEALTH NUTR, V18, P1
   Tashiro K, 2002, J CLIN LAB ANAL, V16, P1, DOI 10.1002/jcla.2057
   Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008
   Titan SM, 2012, J DIABETES COMPLICAT, V26, P546, DOI 10.1016/j.jdiacomp.2012.06.006
   Triggs-Raine BL, 2002, P NATL ACAD SCI USA, V99, P4614, DOI 10.1073/pnas.062059799
   Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x
   Yokoyama H, 1998, DIABETES CARE, V21, P1080, DOI 10.2337/diacare.21.7.1080
   Yokoyama H, 2000, KIDNEY INT, V58, P302, DOI 10.1046/j.1523-1755.2000.00166.x
   Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333
NR 60
TC 2
Z9 2
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD OCT
PY 2014
VL 38
IS 5
BP 349
EP 355
DI 10.1016/j.jcjd.2014.07.224
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AU1KX
UT WOS:000345380700015
PM 25284698
DA 2019-01-08
ER

PT J
AU Stoop, CH
   Nefs, G
   Pop, VJ
   Wijnands-van Gent, CJM
   Tack, CJ
   Geelhoed-Duijvestijn, PHLM
   Diamant, M
   Snoek, FJ
   Pouwer, F
AF Stoop, C. H.
   Nefs, G.
   Pop, V. J.
   Wijnands-van Gent, C. J. M.
   Tack, C. J.
   Geelhoed-Duijvestijn, P. H. L. M.
   Diamant, M.
   Snoek, F. J.
   Pouwer, F.
TI Diabetes-specific emotional distress in people with Type 2 diabetes: a
   comparison between primary and secondary care
SO DIABETIC MEDICINE
LA English
DT Article
ID DEPRESSIVE SYMPTOMS; GLYCEMIC CONTROL; PROBLEM AREAS; NETHERLANDS;
   OUTCOMES; ADULTS; ASSOCIATION; MANAGEMENT; VALIDITY; BEHAVIOR
AB Aims To compare levels of diabetes distress in people with Type 2 diabetes treated in primary and secondary care and to examine demographic and clinical correlates that may explain potential differences in levels of distress between care settings.
   Methods People with Type 2 diabetes from 24 primary care practices (n = 774) and three secondary care clinics (n = 526) completed the Problem Areas In Diabetes questionnaire. Data on HbA(1c) levels and diabetes complications were derived from medical charts. Hierarchical ordinal regression analysis was used to investigate which correlates could explain the potential differences in level of diabetes distress between care settings.
   Results Diabetes distress levels and the prevalence of elevated diabetes distress were considerably lower in the participants treated in primary care (mean (SD) total diabetes distress score 8 (11); 4% of participants with a Problem Areas In Diabetes score = 40) than in secondary care (mean (SD) total diabetes distress score 23 (21); 19% of participants with a Problem Areas In Diabetes score >= 40, P < 0.001). In addition to care setting, the following variables were also independently related to diabetes distress: younger age, ethnic minority status, using insulin, having a higher HbA(1c) level, having a higher BMI and the presence of neuropathy. Other diabetes complications were not independently associated with diabetes distress.
   Conclusions In primary care, lower levels of diabetes distress were reported than in secondary care. The difference in diabetes distress between care settings can be largely, but not fully, explained by specific demographic and clinical characteristics. These results need to be interpreted with caution as they are based on two separate studies, but do call into question the need to screen for diabetes distress in people with Type 2 diabetes in primary care.
C1 [Stoop, C. H.; Nefs, G.; Pop, V. J.; Pouwer, F.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Wijnands-van Gent, C. J. M.] PoZoB, Veldhoven, Netherlands.
   [Tack, C. J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.
   [Geelhoed-Duijvestijn, P. H. L. M.] Haaglanden Med Ctr, Dept Internal Med, The Hague, Netherlands.
   [Diamant, M.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands.
   [Snoek, F. J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
RP Pouwer, F (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@tilburguniversity.edu
RI Nefs, Giesje/C-9992-2018; Tack, Cees/A-2368-2014
FU Dutch Diabetes Research Foundation (Diabetes Fonds) [2000.00.018]; ZonMw
   the Netherlands Organisation for Health Research and Development, the
   Hague, the Netherlands [300020015]; CoRPS, Tilburg University
FX This study was funded by the Dutch Diabetes Research Foundation
   (Diabetes Fonds) 2000.00.018; ZonMw the Netherlands Organisation for
   Health Research and Development, the Hague, the Netherlands: grant
   number 300020015 and CoRPS, Tilburg University.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Browne JL, 2013, DIABETIC MED, V30, P620, DOI 10.1111/dme.12078
   Centraal Bureau voor de Statistiek, 2013, BEV LEEFT HERK ROEP
   de Graaf R, 2013, J AFFECT DISORDERS, V149, P100, DOI 10.1016/j.jad.2013.01.009
   Dekkers J, 2008, BMC MED RES METHODOL, V8, P1
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   ESRC National Centre for Research Methods, 2011, US STAT REGR METH ED
   Faber-Wildeboer AT, 2013, J NURS ED PRACT, V3, P61
   Field A., 2005, DISCOVERING STAT USI
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fleer J, 2013, DIABETIC MED, V30, P88, DOI 10.1111/dme.12001
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hamberg-van Reenen HH, 2011, DIABETES MELLITUS HO
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Jansen YFM, 2011, NED TIJDSCHR GENEES, V155, pA3117
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kohinor MJE, 2011, ETHNIC HEALTH, V16, P245, DOI 10.1080/13557858.2011.563557
   Lanting LC, 2008, PATIENT EDUC COUNS, V72, P146, DOI 10.1016/j.pec.2008.03.008
   NICE, 2010, DEPR AD CHRON PHYS H
   Peen J, 2002, TIJDSCHR PSYCHIAT, V44, P225
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2011, DIABETOLOGIA, V54, P741, DOI 10.1007/s00125-010-2033-0
   Prospective UK., 1999, DIABETES CARE, V22, P1125, DOI 10.2337/diacare.22.7.1125
   Sluiter AC, 2012, HUISARTS WET, V55, P1
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421
   Stoop CH, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-139
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Uiters E, 2006, EUR J PUBLIC HEALTH, V16, P388, DOI 10.1093/eurpub/ckl040
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
NR 34
TC 16
Z9 17
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2014
VL 31
IS 10
BP 1252
EP 1259
DI 10.1111/dme.12472
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AS1AY
UT WOS:000344009900016
PM 24766062
DA 2019-01-08
ER

PT J
AU Skinner, TC
   Khunti, K
   Carey, ME
   Dallosso, H
   Heller, S
   Davies, MJ
AF Skinner, T. C.
   Khunti, K.
   Carey, M. E.
   Dallosso, H.
   Heller, S.
   Davies, M. J.
TI Stability and predictive utility, over 3 years, of the illness beliefs
   of individuals recently diagnosed with Type 2 diabetes mellitus
SO DIABETIC MEDICINE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; GLYCEMIC CONTROL; SELF-MANAGEMENT;
   PERCEPTIONS; QUESTIONNAIRE; ADOLESCENTS; DEPRESSION; EDUCATION; DESMOND;
   PROGRAM
AB Aim To determine the stability of beliefs of patients with Type 2 diabetes about their diabetes over 3 years, following diagnosis.
   Methods Data were collected as part of a multicentre cluster randomized controlled trial of a 6-h self-management programme, across 207 general practices in the UK. Participants in the original trial were eligible for follow-up with biomedical data (HbA(1c) levels, blood pressure, weight, blood lipid levels) collected at the practice, and questionnaire data collected by postal distribution and return. Psychological outcome measures were depression (Hospital Anxiety and Depression Scale) and diabetes distress (Problem Areas in Diabetes scale). Illness beliefs were assessed using the Illness Perceptions Questionnaire-Revised and the Diabetes Illness Representations Questionnaire scales.
   Results At 3-year follow-up, all post-intervention differences in illness beliefs between the intervention and the control group remained significant, with perceptions of the duration of diabetes, seriousness of diabetes and perceived impact of diabetes unchanged over the course of the 3-year follow-up. The control group reported a greater understanding of diabetes during the follow-up, and the intervention group reported decreased responsibility for diabetes outcomes during the follow-up. After controlling for 4-month levels of distress and depression, the perceived impact of diabetes at 4 months remained a significant predictor of distress and depression at 3-year follow-up.
   Conclusions Peoples' beliefs about diabetes are formed quickly after diagnosis, and thereafter seem to be relatively stable over extended follow-up. These early illness beliefs are predictive of later psychological distress, and emphasize the importance of initial context and provision of diabetes care in shaping participants' future well-being.
C1 [Skinner, T. C.] Charles Darwin Univ, Darwin, NT 0909, Australia.
   [Khunti, K.; Davies, M. J.] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England.
   [Carey, M. E.; Dallosso, H.] Univ Hosp Leicester, Leicester Diabet Ctr, Leicester, Leics, England.
   [Heller, S.] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England.
RP Skinner, TC (reprint author), Charles Darwin Univ, Darwin, NT 0909, Australia.
EM timothy.skinner@cdu.edu.au
OI Skinner, Timothy/0000-0002-0018-6963; Heller, Simon/0000-0002-2425-9565;
   Davies, Michael/0000-0002-5196-6919
FU Diabetes UK
FX This study was funded by a grant from Diabetes UK secured by a joint
   team from Leicester University and the University Hospitals of Leicester
   NHS Trust. The writing of the report and the decision to submit the
   article for publication was entirely independent of the funder. The
   study funder had no input into the study design or analysis, nor the
   interpretation of data.
CR *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   International Diabetes Federation Clinical Guidelines Task Force, 2012, GLOB GUID TYP 2 DIAB
   Khunti K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2333
   Lawson VL, 2008, DIABETIC MED, V25, P482, DOI 10.1111/j.1464-5491.2008.02394.x
   Lawton J, 2005, SOC SCI MED, V60, P1423, DOI 10.1016/j.socscimed.2004.08.013
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Mc Sharry J, 2011, DIABETIC MED, V28, P1300, DOI 10.1111/j.1464-5491.2011.03298.x
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Skinner TC, 2003, DIABETIC MED, V20, P283, DOI 10.1046/j.1464-5491.2003.00923.x
   Skinner TC, 2002, HEALTH PSYCHOL, V21, P61, DOI 10.1037//0278-6133.21.1.61
   Tasmoc A, 2013, ARCH MED SCI, V9, P831, DOI 10.5114/aoms.2013.38678
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 15
TC 7
Z9 7
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2014
VL 31
IS 10
BP 1260
EP 1263
DI 10.1111/dme.12484
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AS1AY
UT WOS:000344009900017
PM 24798395
DA 2019-01-08
ER

EF